why_stopped	subclasses	superclasses
Health restrictions due to the COVID-19 pandemic	['Covid19']	['Neutral']
Study withdrawn due to logistical and safety concerns relating to Covid-19.	['Covid19']	['Neutral']
SARS-CoV-2 Pandemic	['Covid19']	['Neutral']
Unable to secure clinic support for conducting research	['Business_Administrative']	['Possibly_Negative']
Principal Investigator left study site	['Study_Staff_Moved']	['Neutral']
Lack of Funding	['Business_Administrative']	['Possibly_Negative']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
low recruitment	['Insufficient_Enrollment']	['Neutral']
Study terminated because PI left the institution.	['Study_Staff_Moved']	['Neutral']
Sponsor terminated due to clinical staffing changes and enrolment	['Logistics_Resources']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Staff for the study is no longer available.	['Logistics_Resources']	['Neutral']
First cohort completed. Per sponsor decision.	['Business_Administrative']	['Possibly_Negative']
Difficulty in enrolling subjects	['Insufficient_Enrollment']	['Neutral']
manufacturing problem with study drug	['Logistics_Resources']	['Neutral']
The protocol will be discussed and consulted. Potentially will resume.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Recruitment challenges and lack of intervention engagement by participants.	['Insufficient_Enrollment']	['Neutral']
Lack of additional funding; patients (3) no longer receiving intervention.	['Business_Administrative']	['Possibly_Negative']
Lack of funding; logistics of conducting study were very complex.	['Business_Administrative']	['Possibly_Negative']
Recommendation after interim analysis	['Interim_Analysis', 'Negative']	['Neutral', 'Negative']
Optimal dose obtained for engraftment and minimizing toxicity	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
The study plan was cancelled because patient registration was delayed for the trials.	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Sponsor's discretion to terminate study prematurely for further evaluation.	['Business_Administrative']	['Possibly_Negative']
The study was stopped due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
Study did not enroll enough subjects to make a statistically sound conclusion.	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
Did not receive IRB approval from our institution therefore the study was closed.	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
lack of efficacy	['Negative']	['Negative']
The deparment failed to detect patients that were willing to participate in this study	['Insufficient_Enrollment']	['Neutral']
Halted due to slow recruitment	['Insufficient_Enrollment']	['Neutral']
Was not able to recruit patients for randomization.	['Insufficient_Enrollment']	['Neutral']
"The study was terminated after 118 weeks from the study start, during the maintenance phase,
    due to regulatory approval in Japan."	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Difficulty in obtaining the solution from the compounding pharmacies caused a two year delay in
    start-up; the funding ended prior to study completion."	['Business_Administrative']	['Possibly_Negative']
Loss of Funding	['Business_Administrative']	['Possibly_Negative']
Closed due to lack of recruitment	['Insufficient_Enrollment']	['Neutral']
It was not possible to enroll patients into the study in a realistic timeframe.	['Insufficient_Enrollment']	['Neutral']
"Closed due to patient recruitment challenges. No interim analyses were completed; study closure
    was not related to any concerns about safety or futility."	['Insufficient_Enrollment', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
The PI is relocating to another State/ another hospital	['Study_Staff_Moved']	['Neutral']
Shortage of personnel / main study initiator no longer available	['Logistics_Resources']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Lack of support to continue	['Business_Administrative']	['Possibly_Negative']
Grant support ended following which the key personnel (PI) left the institution.	['Business_Administrative']	['Possibly_Negative']
"Awaiting response from FDA as to status of parenteral ascorbic acid manufactured by Bioniche
    (Ireland)."	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
The foundations of our pilotstudy planning has changed.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
The manufacturer decided to stop drug production.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Poor recruitement	['Insufficient_Enrollment']	['Neutral']
Excess toxicity was identified intraoperatively	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Funding not available.	['Business_Administrative']	['Possibly_Negative']
Studies emerged that demonstrated the superiority of vitrification	['Negative', 'Another_Study']	['Negative', 'Neutral']
Patient recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Removal of Darvocet from US market	['Logistics_Resources', 'Endpoint_Met', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
difficulty to enroll more subjects	['Insufficient_Enrollment']	['Neutral']
Due to poor patient accrual	['Insufficient_Enrollment']	['Neutral']
No improvement obtained in 3 cases. Retinal detachment observed in 2 cases	['Negative']	['Negative']
Researchers terminated study due to limited enrollment.	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Moved to another country, not possible to recruit from abroad.	['Insufficient_Enrollment']	['Neutral']
accrual rate	['Insufficient_Enrollment']	['Neutral']
"The trial was terminated at week 195 due to an insufficient number of subjects remaining to
    obtain reasonable statistical power"	['Insufficient_Enrollment']	['Neutral']
Accrual is complete.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Not able to recruit any subjects.	['Insufficient_Enrollment']	['Neutral']
Slow patient recruitment and expiry of study medication(aug2009)	['Insufficient_Enrollment']	['Neutral']
Replaced by another study	['Negative', 'Another_Study']	['Negative', 'Neutral']
The pharmaceutical company discontinued further development of SU5416.	['Logistics_Resources']	['Neutral']
"Based on interim analysis at the end of Stage 1, and predefined stopping rules for futility,
    further enrollment was stopped due to lack of efficacy"	['Negative']	['Negative']
The enrollment was too low	['Insufficient_Enrollment']	['Neutral']
PI request - low enrollment	['Insufficient_Enrollment']	['Neutral']
Covid-19 Crisis	['Covid19']	['Neutral']
This study was suspended by QTultrasound as other studies were reprioritized.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Terminated Prematurely due to COVID-19	['Covid19']	['Neutral']
"Due to COVID-19 lockdown restrictions trainings and group sessions could not take place. As
    soon as trainings can take place recruiting will start."	['Covid19']	['Neutral']
Acquired asset	['Business_Administrative']	['Possibly_Negative']
Accrual and treatment with CG1940/CG8711 stopped due to IDMC recommendation.	['Negative']	['Negative']
"6 month vital status report not collected after 28 day follow up analysis indicated no
    difference between placebo & tezosentan"	['Negative']	['Negative']
Lack of efficacy with respect to skin-related lesions in the short-term phase	['Negative']	['Negative']
slow recruitment rate	['Insufficient_Enrollment']	['Neutral']
The planned recruitment number of 180 Patient could not been achieved.	['Insufficient_Enrollment']	['Neutral']
More than 2 of 6 patients treated experienced dose limiting toxicities.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"This study has been terminated; alternative study designs are being considered. Fusidic acid
    remains available under an Expanded Access Protocol."	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Ph I Exempt as it did not proceed to the Phase II terminated early by the supporter	['Regulatory', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Logistical problems.	['Logistics_Resources']	['Neutral']
Because of low recruitment rates	['Insufficient_Enrollment']	['Neutral']
No Go decision for ABBV-838	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Exploratory protocol, convincing results, robust analysis	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Based on FDA requirements	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
To difficult to recruit.	['Insufficient_Enrollment']	['Neutral']
Elective surgeries suspended due to COVID-19	['Covid19']	['Neutral']
Independent statistical review advice	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
"Study design modified to collect specimens from a bank requiring a separate IRB-approved
    protocol."	['Study_Design']	['Neutral']
Study was withdrawn due issuses related to the science	['Logistics_Resources']	['Neutral']
COVID-19	['Covid19']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Protocol modification	['Study_Design']	['Neutral']
Study terminated due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
Hepatic Safety Signal Identified.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Inadequate flow of patients	['Insufficient_Enrollment']	['Neutral']
no more recruitment in the centers	['Insufficient_Enrollment']	['Neutral']
Pilot study results not meaningful. Students researchers graduated.	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
no authorization obtained	['Regulatory', 'Invalid_Reason', 'Negative']	['Neutral', 'Invalid_Reason', 'Negative']
"The study was prematurely discontinued due to administrative reasons on August 18, 2003. There
    were no safety concerns that led to the decision to terminate."	['Business_Administrative']	['Possibly_Negative']
Problems with availability of cardiac output monitoring system	['Logistics_Resources']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Recruitment difficulty	['Insufficient_Enrollment']	['Neutral']
FDA Hold for Combination Studies using Imids and PD1/PDL1 Compounds	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor Decision based on strategic considerations	['Business_Administrative']	['Possibly_Negative']
"This study was terminated on January 6, 2010, due to toxicology findings in animals exposed to
    PF-04455242 for three months."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Funding issue	['Business_Administrative']	['Possibly_Negative']
lack of patient accrual	['Insufficient_Enrollment']	['Neutral']
We have not been able to enroll patients.	['Insufficient_Enrollment']	['Neutral']
"Study terminated early due to manufacturer not replenishing study site supply of inserts,
    despite repeated requests for more inserts."	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Due to administrative procedures	['Business_Administrative']	['Possibly_Negative']
"Development program ended due to inability to pair with other cytidine analogs and higher risk
    of hyperlipasemia when not used with 3TC/FTC."	['Safety_Sideeffects', 'Logistics_Resources', 'Endpoint_Met']	['Safety_Sideeffects', 'Neutral', 'Neutral']
poor accrual	['Insufficient_Enrollment']	['Neutral']
difficulties to recruit patients.	['Insufficient_Enrollment']	['Neutral']
insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Low enrollment and no plans for analysis	['Insufficient_Enrollment']	['Neutral']
low accrual,loss of funding and results from EU study showing drug ineffective.	['Insufficient_Enrollment', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Absence of patients for recruitment	['Insufficient_Enrollment']	['Neutral']
The study was terminated	['Invalid_Reason']	['Invalid_Reason']
"Study suspended in October 2017 and terminated April 17, 2018 after decision to discontinue the
    study drug development"	['Business_Administrative']	['Possibly_Negative']
Futility in recruitment	['Negative']	['Negative']
This project will resume upon the completion of other research committments.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
It was decided to not run the Japanese cohorts in the study.	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
insufficient recruitment on the part of clinic; study will not resume	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Study was terminated due to administrative reasons	['Business_Administrative']	['Possibly_Negative']
Study is no longer necessary (outmoded, outdated, science has changed)	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
No funding	['Business_Administrative']	['Possibly_Negative']
Investor Initiated Grant support stopped when drug was sold.	['Business_Administrative']	['Possibly_Negative']
Funding not received; study was never started	['Business_Administrative']	['Possibly_Negative']
Preclinical finding	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
Recruitment was suspended prematurely for safety concerns and closed after IDMC review	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
"Futility: Impossible to recruit enough hypertensive participants to match Chronic Kidney
    Disease (CKD) participants on needed parameters."	['Insufficient_Enrollment']	['Neutral']
changed drug approval	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Please see Detailed Description for termination reason.	['No_Context']	['Invalid_Reason']
Difficulty in recruting patients	['Insufficient_Enrollment']	['Neutral']
slow recruiting	['Insufficient_Enrollment']	['Neutral']
Study stopped due to low recruitment	['Insufficient_Enrollment']	['Neutral']
Study suspended due to Covid-19	['Covid19']	['Neutral']
PI left National Jewish Health	['Study_Staff_Moved']	['Neutral']
This study was terminated early due to insufficient recruitment.	['Insufficient_Enrollment']	['Neutral']
"the study was halted after the first interim analysis as there were significantly more patients
    who recovered at one month in the control arm"	['Negative']	['Negative']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Inadequate recruitment to meet completion date	['Insufficient_Enrollment']	['Neutral']
possible lack of efficacy	['Negative']	['Negative']
Difficulty in enrolling subjects and transporting scope for sterilization	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
suspension of clinical trials with hydroxychloroquine by health authorities	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
PI left the institution.	['Study_Staff_Moved']	['Neutral']
Study ended due to lack of funding.	['Business_Administrative']	['Possibly_Negative']
"Patient recruitment is very slow, economic grant has ended and the number of patients is enough
    according to sample size (22 children/ arm)."	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Delays in IRB approval and interval start of a competing study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Failure to Recruit in a Timely manner	['Insufficient_Enrollment']	['Neutral']
Primary Investigator resigned from Hospital	['Study_Staff_Moved']	['Neutral']
for administrative reasons (no safety concerns), no analysis completed	['Business_Administrative']	['Possibly_Negative']
Drug no longer available	['Logistics_Resources']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
"Inability to accrue subjects that met the exclusion criterion ""Any prior (within the past 30
    days) or current Sodium Thiosulfate treatment""."	['Insufficient_Enrollment']	['Neutral']
Funding unavailable to perform study.	['Business_Administrative']	['Possibly_Negative']
Sub-investigator left the university	['Study_Staff_Moved']	['Neutral']
Inadequate resources to support study start-up	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
FHI 360 participation in the study was terminated due to lack of funding	['Business_Administrative']	['Possibly_Negative']
"Study was originally halted due to the COVID-19 pandemic. The study was later terminated
    prematurely as the participants will have the option to enter into an open-label extension
    portion of a planned future study. It was not due to safety concerns."	['Covid19']	['Neutral']
The study was terminated because not enough subjects could be recruited.	['Insufficient_Enrollment']	['Neutral']
Low accrual rate	['Insufficient_Enrollment']	['Neutral']
Data needs met	['Invalid_Reason']	['Invalid_Reason']
failure of recruiting a sufficient number of patients	['Insufficient_Enrollment']	['Neutral']
Insufficient recruitment was obtained	['Insufficient_Enrollment']	['Neutral']
COVID-19	['Covid19']	['Neutral']
Registration poor	['Insufficient_Enrollment']	['Neutral']
Lack of funding prevented the recruitment of 1000 HIV Patients all over India	['Business_Administrative']	['Possibly_Negative']
no patient recruited	['Insufficient_Enrollment']	['Neutral']
Enrollment was difficult	['Insufficient_Enrollment']	['Neutral']
Poor Accrual	['Insufficient_Enrollment']	['Neutral']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Difficulty to enrollment patients	['Insufficient_Enrollment']	['Neutral']
"Results of the study would unfortunately no longer be of any scientific interest to the sponsor
    and would not be used to inform future studies."	['Negative', 'Business_Administrative']	['Negative', 'Possibly_Negative']
"Due to FDA comments, changes required unavailable resources. There are no results for this
    study."	['Logistics_Resources', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Due to change in development plan.	['Business_Administrative']	['Possibly_Negative']
Amgen decision following interim review of efficacy and safety data from the AMG 337 program.	['Negative', 'Business_Administrative']	['Negative', 'Possibly_Negative']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
stopped due to slow recruitment and no effect	['Negative']	['Negative']
"The Sponsor has made a decision, driven by business needs, to cease promotion, manufacturing,
    distribution and sales of Amevive"	['Business_Administrative']	['Possibly_Negative']
Slow patient accrual	['Insufficient_Enrollment']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
The registry was discontinued due to significant resources required.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Company dissolved	['Business_Administrative']	['Possibly_Negative']
Poor recruitment and lack of funding	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The study was terminated based on an included stopping rule in the study protocol	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
"Preliminary analysis determined there was sufficient data to support objectives and allow early
    completion. The last patient visit occurred on November 6, 2007."	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
not relevant to the sponsor	['Business_Administrative']	['Possibly_Negative']
"Study population not regularly admitted to hospital and approaches have shifted away from
    repurposing old drugs."	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Sponsor discontinued development of CO-1686 for NSCLC	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Protocol stopped for safety reason	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Study did not start up as planned.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Company Decision	['Business_Administrative']	['Possibly_Negative']
Company decision	['Business_Administrative']	['Possibly_Negative']
Enrollment	['Insufficient_Enrollment']	['Neutral']
"Due to availability of eligible subjects at center and enrollment competition with other
    studies."	['Insufficient_Enrollment']	['Neutral']
Difficulty enrolling patients	['Insufficient_Enrollment']	['Neutral']
expiration of IRB approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Poor Recruitment	['Insufficient_Enrollment']	['Neutral']
One of the examinations (double contrast baium enema) became outdated in Norway	['Study_Design']	['Neutral']
Logistics and feasibility	['Logistics_Resources']	['Neutral']
No three dimensional transthoracic echo available currently	['Interim_Analysis', 'Logistics_Resources', 'Negative']	['Neutral', 'Neutral', 'Negative']
Withdrawal requested by D3	['Regulatory', 'Invalid_Reason', 'Negative']	['Neutral', 'Invalid_Reason', 'Negative']
Trial was terminated due to an insufficient benefit/tolerability ratio	['Negative']	['Negative']
Re-evaluate indication with the referring physicians	['Study_Design']	['Neutral']
Study terminated due to low recruitment.	['Insufficient_Enrollment']	['Neutral']
FDA indicated study should have had prior IDE submission & approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Administrative closure prior to any enrollments	['Business_Administrative']	['Possibly_Negative']
Closure of Drexel University Hahnemann Hospital where Referring Physician Worked	['Study_Staff_Moved']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Low accrual	['Insufficient_Enrollment']	['Neutral']
"The primary objectives have not been met due to no patient enrollment therefore, the PI is
    requesting to close the study at this time."	['Insufficient_Enrollment']	['Neutral']
"1. Interim results suggested a reduction of sample size.

      2. Anticipated length of enrolment period with resulting funding issues to pose a threat to
         the study."	['Business_Administrative']	['Possibly_Negative']
Role of calcium in menopause is not clear. Product maybe reformulated and the study relaunched.	['Study_Design']	['Neutral']
No eligible patient was enrolled.	['Insufficient_Enrollment']	['Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
At the request of the ad interim Department Chairman due to PI is no longer at institution.	['Study_Staff_Moved']	['Neutral']
technical problems	['Logistics_Resources']	['Neutral']
This study was terminated due to a lack of efficacy.	['Negative']	['Negative']
COVID-19	['Covid19']	['Neutral']
At sponsor's discretion	['Business_Administrative']	['Possibly_Negative']
For business reasons	['Business_Administrative']	['Possibly_Negative']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
6 month follow up for the patients in progress	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
Terminated due to difficulty in accruing patients	['Insufficient_Enrollment']	['Neutral']
"Discontinuation of this study was based on Novartis decision to discontinue development of
    fingolimod for the treatment of ADON"	['Business_Administrative']	['Possibly_Negative']
Technical problems.	['Logistics_Resources']	['Neutral']
Unable to accrue subjects.	['Insufficient_Enrollment']	['Neutral']
Terminated due to low enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsor issue	['Business_Administrative']	['Possibly_Negative']
Changing standard of care therapy regimen	['Study_Design']	['Neutral']
No more eligible patients	['Insufficient_Enrollment']	['Neutral']
"Very small percentage of enrolled patients needing non-invasive support and small chance of us
    reaching target enrollment within funding period."	['Business_Administrative']	['Possibly_Negative']
Sponsor decision based on portfolio prioritization	['Business_Administrative']	['Possibly_Negative']
Canceled [By sponsor decision)	['Business_Administrative']	['Possibly_Negative']
drug combination not providing any efficacy. Will use this data in opening new trial	['Negative', 'Another_Study']	['Negative', 'Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
It was decided to use the QRH for a new study.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
P. I. left the Institution. Study never opened	['Study_Staff_Moved']	['Neutral']
"Principle Investigator moved to another institution. Research funds transferred. Study to be
    performed at new institution"	['Business_Administrative']	['Possibly_Negative']
Terminated per PI's request	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Poor enrollment; termination not due to safety reasons.	['Insufficient_Enrollment']	['Neutral']
The study was on hold and later withdrawn due to shortage of staff	['Logistics_Resources']	['Neutral']
Redesign of study protocol.	['Study_Design']	['Neutral']
Poor Enrollment	['Insufficient_Enrollment']	['Neutral']
recrutment difficulties	['Insufficient_Enrollment']	['Neutral']
Recruitment	['Insufficient_Enrollment']	['Neutral']
limited resources	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
No funding	['Business_Administrative']	['Possibly_Negative']
IND Withdrawn	['Regulatory', 'Invalid_Reason', 'Negative']	['Neutral', 'Invalid_Reason', 'Negative']
Principle Investigator relocated to a new institution	['Study_Staff_Moved']	['Neutral']
Due to a Medicines for Malaria Venture (MMV) strategic business decision	['Business_Administrative']	['Possibly_Negative']
No acute neurological patients presented with concomitant COVID-19	['Covid19']	['Neutral']
Loss of funding	['Business_Administrative']	['Possibly_Negative']
Low enrollment rate	['Insufficient_Enrollment']	['Neutral']
Did not receive full funding to proceed	['Business_Administrative']	['Possibly_Negative']
"Novartis discontinued the development of imatinib in PAH due to requirement of regulatory
    authorities for additional data to secure marketing approval in PAH."	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Lack of Accrual	['Insufficient_Enrollment']	['Neutral']
"Emerging evidence does not support the use of HCQ for treatment or prevention of SARS -CoV2
    infection. No pts have been enrolled."	['Negative']	['Negative']
"The product used in the comparator arm (BRS) has become unavailable in April 2017. The
    recruitment has been stopped."	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Safety lead-in data did not support continuation of study.	['Negative']	['Negative']
Enrollment was never begun.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Clinical trial was cancelled	['Invalid_Reason']	['Invalid_Reason']
It didn't get IRB approval.	['Regulatory', 'Ethical_Reason', 'Negative']	['Neutral', 'Neutral', 'Negative']
Study closed by sponser	['Business_Administrative']	['Possibly_Negative']
Terminated due to slow patient accrual.	['Insufficient_Enrollment']	['Neutral']
Not moving forward with program.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Loss of staff for completion	['Logistics_Resources']	['Neutral']
Slow enrollment and planned change of institution by PI	['Insufficient_Enrollment']	['Neutral']
not sufficiency inclusion	['Insufficient_Enrollment']	['Neutral']
3 patients enrolled, no meaningful repigmentation observed. Recruitment halted.	['Insufficient_Enrollment']	['Neutral']
Study not begun due to continued laboratory work on the feasibility of outcome measures.	['Logistics_Resources', 'Endpoint_Met', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
FDA has placed all trials involving Pacritinib on Full Clinical Hold	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Admisnitrative issues	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
This study has been cancelled prior to enrollment	['Invalid_Reason']	['Invalid_Reason']
difficulted recruiting	['Insufficient_Enrollment']	['Neutral']
Low recruitment rate, and study patients were removed prior to completion	['Insufficient_Enrollment']	['Neutral']
lack of accrual	['Insufficient_Enrollment']	['Neutral']
for technical and funding issues	['Business_Administrative']	['Possibly_Negative']
have to adjust recuriting paticipants projects and have to halted the research	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Due to COVID-19	['Covid19']	['Neutral']
logistic reasons (insufficient funding, technical problems with MEMS)	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Futility	['Negative']	['Negative']
Trial terminated early per business decision	['Business_Administrative']	['Possibly_Negative']
The VITAL study was terminated due to futility analysis	['Negative']	['Negative']
PI	['Study_Staff_Moved']	['Neutral']
PMA not approved. FDA granted permission to close the study.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Poor accrual and risk/benefit ratio.	['Insufficient_Enrollment']	['Neutral']
Dose limiting toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Sponsor and principal investigator decision	['Business_Administrative']	['Possibly_Negative']
Management Decision	['Business_Administrative']	['Possibly_Negative']
Sponsor requested termination	['Business_Administrative']	['Possibly_Negative']
PI left institution.	['Study_Staff_Moved']	['Neutral']
"difficulties by enrolling patients fundings consumed, no staff could be recruited and payed to
    continue enrolling patients,"	['Business_Administrative']	['Possibly_Negative']
This study terminated prematurely because of slow enrollment	['Insufficient_Enrollment']	['Neutral']
PhD Student stopped working on this project	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
Limited time for enrollment of required number of subjects	['Insufficient_Enrollment']	['Neutral']
Study closed early due to poor accrual.	['Insufficient_Enrollment']	['Neutral']
Patient accrual was slow due to exclusion of patients with prior cancers	['Insufficient_Enrollment']	['Neutral']
Study stopped because slow enrolment.	['Insufficient_Enrollment']	['Neutral']
Technical and financial feasibility of the study cannot be assured by the sponsor.	['Business_Administrative']	['Possibly_Negative']
No Her-2 changes was found in Her-2 negative human breast cancer after radiotherapy	['Negative', 'Another_Study']	['Negative', 'Neutral']
Due to futility of recruitment.	['Negative']	['Negative']
Breakdown of communication between departments involved	['Logistics_Resources']	['Neutral']
No more funding	['Business_Administrative']	['Possibly_Negative']
Early termination for discouraging results	['Negative']	['Negative']
Covid-19	['Covid19']	['Neutral']
Inadequate enrollment	['Insufficient_Enrollment']	['Neutral']
"Terminated by the DSMB based on low chance of finding differences in mGFR slopes, but higher
    risk of serious adverse events in the IV iron group (aIRR = 1.60)"	['Negative']	['Negative']
Study enrollment impacted by COVID-19 pandemic and Sponsor terminated for business reasons	['Covid19']	['Neutral']
limited recruitment	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
sample size recruited is not enough	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Insufficient funding	['Business_Administrative']	['Possibly_Negative']
Unable to find subjects with schizophrenia that were using only cannabis	['Insufficient_Enrollment']	['Neutral']
Primary efficacy was not demonstrated in Stage 1	['Negative']	['Negative']
The investigators decided not to proceed this study because of some internal matters.	['Logistics_Resources', 'Study_Staff_Moved', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
The study was terminated by the sponsor	['Business_Administrative']	['Possibly_Negative']
Unable to recruit subjects - unworkable	['Insufficient_Enrollment']	['Neutral']
"The study was terminated on 26 February 2013. Risk-benefit assessment is no longer positive and
    does not support further development"	['Negative']	['Negative']
On going discussions with FDA	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
study met study halting rules	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Sponsor's decision	['Business_Administrative']	['Possibly_Negative']
"Participants found the study procedures to be too cumbersome and no longer wanted to
    participate"	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Required resources not available at the moment.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
lack of funding	['Business_Administrative']	['Possibly_Negative']
administrative hurdles	['Business_Administrative']	['Possibly_Negative']
Insufficient recruitment rate	['Insufficient_Enrollment']	['Neutral']
"Study has been suspended due to the occurrence of SUSAR at University of Oxford sponsored
    Phase2/3 study. Study will continue to be on hold until Russian MOH approval is received."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
recruitment issues	['Insufficient_Enrollment']	['Neutral']
"Study was prematurely discontinued due to GSK's change in prioritization for the portfolio and
    is not due to any safety concerns or regulatory interaction."	['Business_Administrative']	['Possibly_Negative']
PI retired and moved- funding sponsor contacted and Oked	['Business_Administrative']	['Possibly_Negative']
Terminated (halted prematurely) due to tolerability issues.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
The required results were obtained through alternate methodology	['Negative', 'Another_Study']	['Negative', 'Neutral']
High cancellation rate in LH test group in interim analysis	['Negative']	['Negative']
Corporate reasons unrelated to safety and efficacy	['Business_Administrative']	['Possibly_Negative']
Due to decrease in Avaulta mesh kit usage & inability to recruit study subjects.	['Insufficient_Enrollment']	['Neutral']
"The PI has moved to another institution, which resulted in significant changes in the study
    design and study title."	['No_Context', 'Study_Staff_Moved', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
On September 24, 2020 due to unexpected sudden death on study.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Covid-19	['Covid19']	['Neutral']
inclusion difficulties	['Insufficient_Enrollment']	['Neutral']
Not initiated	['Invalid_Reason']	['Invalid_Reason']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsor suspended development of the drug on September 3, 2008.	['Business_Administrative']	['Possibly_Negative']
"One of the study drugs will no longer be supplied by manufacturer and the pembrolizumab +
    abemaciclib study arm is removed due to toxicity seen in other trials."	['Covid19', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
PI changed work place	['Study_Staff_Moved']	['Neutral']
Early termination of study due to changes in funding.	['Business_Administrative']	['Possibly_Negative']
Study was closed early due to toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Due to unmet accrual/randomization goals	['Insufficient_Enrollment']	['Neutral']
Study was terminated due to sponsor decision	['Business_Administrative']	['Possibly_Negative']
interim analysis : discontinuation for efficacy of the intervention	['Negative']	['Negative']
Slow Accrual and withdrawn/exclusion of 2 participants.	['Insufficient_Enrollment']	['Neutral']
Sponsor Request	['Business_Administrative']	['Possibly_Negative']
"UroGen's RTGelTM delivery system technology for use with neurotoxins licensed to Allergan plc
    before the activation of this trial."	['Logistics_Resources', 'Study_Design', 'Another_Study']	['Neutral', 'Neutral', 'Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
The preliminary result didn't show any benefit.	['Negative']	['Negative']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
Replacing this trial with a new trial.	['Negative', 'Another_Study']	['Negative', 'Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
not performing Trabectomes	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Sponsor withdrawal	['Business_Administrative']	['Possibly_Negative']
Insufficient patient enrollment	['Insufficient_Enrollment']	['Neutral']
Stopped due to low enrollment	['Insufficient_Enrollment']	['Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Scientific coordinator left the hospital	['Study_Staff_Moved']	['Neutral']
Primary investigator is no longer a part of the VA.	['Study_Staff_Moved']	['Neutral']
inclusion/exclusion criteria limited enrollment	['Insufficient_Enrollment']	['Neutral']
Low enrollment.	['Insufficient_Enrollment']	['Neutral']
PI has terminated the study at this time.	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
study device broke	['Logistics_Resources']	['Neutral']
"Study was found to be non-feasible. Not enough patients to perform an adequate study in the
    allocated time period."	['Insufficient_Enrollment']	['Neutral']
Not enough subject enrollment	['Insufficient_Enrollment']	['Neutral']
no patients recruited	['Insufficient_Enrollment']	['Neutral']
suspended due to administrative problems	['Business_Administrative']	['Possibly_Negative']
It was a pilot study and we enrolled sufficient numbers to evaluate the proposed outcomes.	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
lack of recruting	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
This study will be conducted in healthy volunteer subjects.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Lack of Enrollment	['Insufficient_Enrollment']	['Neutral']
Study terminated due to toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Trial re-design; no safety issues identified	['Study_Design']	['Neutral']
Did not want to enroll and proceed with this study concept.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Extreme toxicity, met toxicity stopping rules	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
No patients enrolled.	['Insufficient_Enrollment']	['Neutral']
the study was terminated because of slow enrollment	['Insufficient_Enrollment']	['Neutral']
"We have not succeeded in developing an approach that uses hdEEG to control a communication
    interface at an accuracy needed to complete the protocol."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
default recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of efficacy following an interim analysis	['Negative']	['Negative']
Due to the discontinuation of the development of the Notch inhibitor PF-03084014-04	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Insufficient accrual	['Insufficient_Enrollment']	['Neutral']
"Subject contact has been suspended until it is safe to screen hearing and participants feel
    safe seeing clinicians."	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Sponsor's decision.	['Business_Administrative']	['Possibly_Negative']
There was a lack of accrual	['Insufficient_Enrollment']	['Neutral']
immunohistochemistry markers are not recieved yet	['Logistics_Resources']	['Neutral']
for efficacy and safety reasons	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Funding not received.	['Business_Administrative']	['Possibly_Negative']
Business objectives have changed	['Business_Administrative']	['Possibly_Negative']
unable to meet recruitment goals	['Insufficient_Enrollment']	['Neutral']
Because of COVID-19, we cann't carry out recruiting according to the original plan	['Covid19']	['Neutral']
Sponsor stopped study to re-design trial	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Treatment became standard.	['Study_Design']	['Neutral']
Seeking further funding	['Business_Administrative']	['Possibly_Negative']
due to the pandemic	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
The study has not been funded so far, but we will study it in the future.	['Business_Administrative']	['Possibly_Negative']
"Previous other study including EPC capture stent raised the issue of safety (significant high
    incidence of instent restenosis)"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Due to lack of biological efficacy and CD19 CAR CTL persistence	['Negative']	['Negative']
The study has been halted prematurely due to a low recruitment.	['Insufficient_Enrollment']	['Neutral']
Investigator left institution.	['Study_Staff_Moved']	['Neutral']
Zevalin is not available due to supply chain issues	['Logistics_Resources']	['Neutral']
Nellix stent cannot be placed in patients yet.	['Logistics_Resources']	['Neutral']
Patient population not available	['Insufficient_Enrollment']	['Neutral']
The trial was terminated for strategic reasons.	['Business_Administrative']	['Possibly_Negative']
IRB Approval on study expired May 28, 2009	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Low enrollment; PI left institution	['Insufficient_Enrollment']	['Neutral']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
Due to termination of study D3801C00001, due to reports of turbid urine.	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Due to the COVID-19 pandemic, elective surgeries were temporarily delayed in our country. It's
    targeted to take cases again as of August 2020."	['Covid19']	['Neutral']
PI retired and co investigator left institution.	['Study_Staff_Moved']	['Neutral']
Study was defunded.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Study on-hold due to COVID-19 pandemic restrictions. Will resume when possible.	['Covid19']	['Neutral']
Due to COVID-19 we are not able to recruit in the foreseeable future	['Covid19']	['Neutral']
"No participant enrolled. The human resources to perform the study also due to the COBID
    emegency"	['Logistics_Resources']	['Neutral']
"27 couples were recruited. This unexpected poor recruitment was due to more clinical
    pregnancies (for a better patients' selection) and more freeze-all cycles."	['Insufficient_Enrollment']	['Neutral']
Slow/insufficient accrual	['Insufficient_Enrollment']	['Neutral']
Not reaching targeted enrollment	['Insufficient_Enrollment']	['Neutral']
2 NaNose devices provided inconsistent results in lab calibration testing	['Negative']	['Negative']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsor withdrawn their agreement	['Business_Administrative']	['Possibly_Negative']
Funding stopped and no one met IRB approved enrollment criteria	['Business_Administrative']	['Possibly_Negative']
COVID related limitations	['Covid19']	['Neutral']
Safety-related	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Device was unacceptable to patients and did not provide expected outputs	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
insufficiant recruitment	['Insufficient_Enrollment']	['Neutral']
"This study was withdrawn on November 2017 due to no subject accrual. No subjects were enrolled
    in this study."	['Insufficient_Enrollment']	['Neutral']
Due to COVID-19	['Covid19']	['Neutral']
Could not get any patients to sign up	['Insufficient_Enrollment']	['Neutral']
Equipment and personnel discontinuity	['Logistics_Resources']	['Neutral']
Unable to recruit resaerch staff for study	['Insufficient_Enrollment']	['Neutral']
End of EU funding for the work package under investigation	['Business_Administrative']	['Possibly_Negative']
Slow/Insufficient accrual	['Insufficient_Enrollment']	['Neutral']
"Early termination of study due to fewer subjects available than expected resulting in small
    sample size."	['Insufficient_Enrollment']	['Neutral']
Unobtainable sample size	['Insufficient_Enrollment']	['Neutral']
Slow enrollment due to subjects not meeting inclusion/exclusion criteria	['Insufficient_Enrollment']	['Neutral']
need new PI, i moved	['Study_Staff_Moved']	['Neutral']
The study was closed to recruitment due to feasibility problems.	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Difficulty recruiting patients	['Insufficient_Enrollment']	['Neutral']
Too slow accrual.	['Insufficient_Enrollment']	['Neutral']
Regarding the comments of the iDSMB, the sponsor decided to stop the inclusions	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Terminated by study sponsor.	['Business_Administrative']	['Possibly_Negative']
Company supplying drug declared bankruptcy, thus there was no drug supply.	['Logistics_Resources']	['Neutral']
Unable to adequately enroll over a reasonable enrollment period.	['Insufficient_Enrollment']	['Neutral']
inability to obtain CMS approval	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
The rythm of enrollment was not compatible with the objective of recruitement in the research.	['Insufficient_Enrollment']	['Neutral']
"New studies were reporting that sutures are beneficial, hindering the possibility of
    enrollment."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Recruitment problems	['Insufficient_Enrollment']	['Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of efficacy	['Negative']	['Negative']
Recruitment has been terminated prematurely because of poor enrollment.	['Insufficient_Enrollment']	['Neutral']
Due to slow enrollment and feasibility issues.	['Insufficient_Enrollment']	['Neutral']
No Participants completed study	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Low enrollment due to the stringent enrollment criteria. Unable to answer study questions	['Insufficient_Enrollment']	['Neutral']
"Conditional analysis showed observed differences were significantly less than power
    calculations"	['Negative']	['Negative']
Closed by PI final report submitted	['Invalid_Reason', 'Negative', 'Business_Administrative']	['Invalid_Reason', 'Negative', 'Possibly_Negative']
Avastin approved for first-in-line treatment.	['Study_Design']	['Neutral']
Withdrawal of Funding	['Business_Administrative']	['Possibly_Negative']
Patients' enrollment was not sufficient.	['Insufficient_Enrollment']	['Neutral']
No enough inclusion. The aim is no longer relevant. The sponsor decided to stop this study.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
"Lapatinib-topotecan arm enrollment closed early per protocol amendment 2. Then enrollment into
    remaining arm terminated due to operational issues."	['Study_Design']	['Neutral']
"Failure to recruit patients with membranous lupus nephritis not previously treated with
    azathioprine ."	['Insufficient_Enrollment']	['Neutral']
This study was stopped early due to slow enrollment.	['Insufficient_Enrollment']	['Neutral']
20 subjects completed for a pilot, further funding required to continue study	['Business_Administrative']	['Possibly_Negative']
insufficient enrollment rate	['Insufficient_Enrollment']	['Neutral']
Not completed	['Invalid_Reason']	['Invalid_Reason']
No objective response documented, protocol terminated after 12 patients.	['Negative']	['Negative']
Pandemic Related Challenges	['Covid19', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
"The study was terminated based on its primary and secondary outcome measures in three
    consecutive patients."	['Endpoint_Met', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"Sponsor voluntarily decided to terminate trial due to increased MS disease activity in
    atacicept arms as compared to placebo during a routine IDMC review."	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
data from a similar did not show efficacy.	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Interim analysis results showed that ixabepilone did not improve survival compared with control
    chemotherapies."	['Negative']	['Negative']
As recommended by the DSMB.	['Interim_Analysis', 'Regulatory', 'Negative']	['Neutral', 'Neutral', 'Negative']
only 1 inclusion in 1.5 years due to strict exclusion criteria	['Insufficient_Enrollment']	['Neutral']
Lack of pre-treatment tissue to make the study plan feasible.	['Logistics_Resources']	['Neutral']
Because there are enough data to present the conclusions	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Unbalance in the composite endpoint between arms.	['Interim_Analysis', 'Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Poor Accrual	['Insufficient_Enrollment']	['Neutral']
Because of COVID-19, we could complete the follow-ups	['Covid19']	['Neutral']
"low recruitment rate; difficulties to achieve planned number of participants within reasonable
    time frame"	['Insufficient_Enrollment']	['Neutral']
In response to COVID pandemic	['Covid19']	['Neutral']
Safety	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"Pre-planned IA (global study) showed lack of efficacy in this indication. No new safety signals
    observed, findings consistent with known profile."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Investigational medical device no longer available	['Logistics_Resources']	['Neutral']
Covid-19 resulted in school closures.	['Covid19']	['Neutral']
lack of equipment	['Logistics_Resources']	['Neutral']
Was unable to enroll any participants	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Adverse change in the risk/benefit	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
MHRA CTA rejected due to no UK MHRA MA certificate or equivalent product info	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
PI closed study early, all patients experienced severe toxicities and progressed	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Funding unavailable	['Business_Administrative']	['Possibly_Negative']
"Sponsor discontinued the study following the discovery of a number of incompletely sealed
    batches that were unusable."	['Study_Design']	['Neutral']
difficult to include patients	['Insufficient_Enrollment']	['Neutral']
The trial was terminated early due to slow recruitment.	['Insufficient_Enrollment']	['Neutral']
COVID-19	['Covid19']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Problems with product performance	['Interim_Analysis', 'Logistics_Resources', 'Endpoint_Met']	['Neutral', 'Neutral', 'Neutral']
technical difficulties coordinating study	['Logistics_Resources']	['Neutral']
Other - NRG reassessing accrual strategies	['Insufficient_Enrollment']	['Neutral']
Study stopped due to slow enrollment; sufficient data collected for analysis.	['Insufficient_Enrollment']	['Neutral']
The IRB required this protocol to be split into two different protocols	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Weight loss center programming suspended due to COVID-19 pandemic	['Covid19']	['Neutral']
recruiting too slowly	['Insufficient_Enrollment']	['Neutral']
"HGRAC approval letter had expired. The enrollment speed of FAST CTO is much slower than
    planning and the scientific value becomes limited due to the delayed data readout anticipation."	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Trial terminated no patients were screened or enrolled	['Invalid_Reason']	['Invalid_Reason']
"Decision to modify the product under study as a result of feedback regarding subjective feeling
    during installation procedure. For more info, see brief summary."	['Study_Design']	['Neutral']
PI Decision	['Invalid_Reason']	['Invalid_Reason']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
PRMS No Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Covid-19	['Covid19']	['Neutral']
Manufacturer unable to produce	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
"Published study provided evidence that intervention would provide little effect; study not
    approved by provider community."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Sponsor decided to pursue an alternative study prior to subject enrollment.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Funding organization requested to stop the study	['Business_Administrative']	['Possibly_Negative']
"Sponsor decision to discontinue the SHP647 (ontamalimab) clinical trial development program for
    inflammatory bowel diseases (IBD) early."	['Business_Administrative']	['Possibly_Negative']
Feasibility cohorts competed. Efficacy cohort not initiated for business reasons	['Business_Administrative']	['Possibly_Negative']
Study was terminated with the IRB ended early as logistical concerns of the SBRT	['Logistics_Resources']	['Neutral']
Main Study was completed. LT-OLE was discontinued as sufficient safety data has been generated.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Canceled	['Invalid_Reason']	['Invalid_Reason']
"The study was terminated because at least one year follow-up was achieved for each patient and
    the achievement of 965 exposure years to the drug."	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
lack of accrual and funding is about to expire.	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Due to the Pandemic of COVID-19	['Covid19']	['Neutral']
Similar to another study.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Recruitment of subjects has been difficult.	['Insufficient_Enrollment']	['Neutral']
"The study has stopped early due to enrollment challenges related largely to the current
    pandemic"	['Insufficient_Enrollment']	['Neutral']
Request of Health Canada after publication of https://doi.org/10.7326/M20-4207	['No_Context', 'Regulatory', 'Ethical_Reason']	['Invalid_Reason', 'Neutral', 'Neutral']
Sponsor decision. The study is not anticipated to start	['Business_Administrative']	['Possibly_Negative']
No funding issues, poor prevalence of low cervical motor control	['Business_Administrative']	['Possibly_Negative']
Terminated prematurely as data from cohort no longer needed due to indication change.	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
difficulty recruiting	['Insufficient_Enrollment']	['Neutral']
Sponsor halted study.	['Business_Administrative']	['Possibly_Negative']
Terminated	['Invalid_Reason']	['Invalid_Reason']
Patients did not want to be randomized in hybrid ablation.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Discontinued due to incomplete recruitment	['Insufficient_Enrollment']	['Neutral']
Slow accrual; PI left primary institution	['Insufficient_Enrollment']	['Neutral']
Discordance in contractual language and terms.	['Business_Administrative']	['Possibly_Negative']
Company decision	['Business_Administrative']	['Possibly_Negative']
Lack of efficacy	['Negative']	['Negative']
Product development discontinued unrelated to safety.	['Business_Administrative']	['Possibly_Negative']
research cancelled	['Invalid_Reason']	['Invalid_Reason']
COVID-19	['Covid19']	['Neutral']
insufficient data quality	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Recruitment to slow, most patients to well for treatment	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
The study has been terminated due to business reasons.	['Business_Administrative']	['Possibly_Negative']
"Because the Russian Authorities already approved the 2-dose Cervarix schedule, the study was
    no longer needed for registration and hence it was cancelled."	['Regulatory', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Research Cancelled	['Invalid_Reason']	['Invalid_Reason']
Sponsor has currently elected to withhold study initiation	['Business_Administrative']	['Possibly_Negative']
Administrative reasons	['Business_Administrative']	['Possibly_Negative']
End of funding and low enrollment	['Business_Administrative']	['Possibly_Negative']
Insufficient recruitment rate; technical issues with sample storage	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Study closed by the NCI.	['Interim_Analysis', 'Regulatory', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
formulation/dose changes; planned changes to safety monitoring/reporting	['Study_Design']	['Neutral']
Study design not adequate	['Study_Design']	['Neutral']
Study methodology redesigned	['Study_Design']	['Neutral']
Lack of accrual and software issues	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
No enough eligable participants enrolled	['Insufficient_Enrollment']	['Neutral']
Project never funded. No subjects were recruited.	['Business_Administrative']	['Possibly_Negative']
Primary endpoint was reached.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Substantial design modifications required.	['Study_Design']	['Neutral']
difficulties in recruiting participants	['Insufficient_Enrollment']	['Neutral']
Study drug supply issues	['Logistics_Resources']	['Neutral']
"(Investigation of ACE-083 for use in patients with CMT is being discontinued as it did not
    achieve functional secondary endpoints in the A083-03 trial."	['Negative', 'Another_Study']	['Negative', 'Neutral']
no patient accrual	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Closed due to slow accrual. Nine subjects enrolled over 7 years.	['Insufficient_Enrollment']	['Neutral']
"GSK decision to return rights to sirukumab to Janssen and discontinue sirukumab development in
    polymyalgia rheumatica."	['Business_Administrative']	['Possibly_Negative']
Break in funding	['Business_Administrative']	['Possibly_Negative']
stopped due to protocol mistakes	['Study_Design']	['Neutral']
Study feasibility issues	['Logistics_Resources']	['Neutral']
Insufficient accrual	['Insufficient_Enrollment']	['Neutral']
lake of efficacy	['Negative']	['Negative']
declined enrollment	['Insufficient_Enrollment']	['Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
The surgical approach has changed.	['Study_Design']	['Neutral']
"As the treatment model of extensive-stage small cell lung cancer changed rapidly and the
    enrollment speed significantly lower than expected, ZaiLab decided to terminate this study"	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Study has stopped due to a decision by Amgen to terminate the program	['Business_Administrative']	['Possibly_Negative']
PI left institution and site did not have resources to continue study	['Logistics_Resources', 'Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Solanezumab did not meet the primary endpoint in study H8A-MC-LZAX.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
Sponsor decision due to low subject recrcuitment	['Insufficient_Enrollment']	['Neutral']
Trial will not proceed due to changes in the treatment landscape.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Reformulation of study drug to help reduce the pill burden as higher doses are evaluated.	['Study_Design']	['Neutral']
Competing study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
"According to study protocol the trial was terminated because the recruitment of trial
    participants was insufficient."	['Insufficient_Enrollment']	['Neutral']
Low enrollment and funding loss.	['Business_Administrative']	['Possibly_Negative']
AOI Pharma terminated the license agreement. IND Transferred to NCI	['Business_Administrative']	['Possibly_Negative']
Study was terminated early due to results from another CMX study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Change in approach to study.	['Study_Design']	['Neutral']
Unable to execute a contract agreement with the drug manufacturer.	['Business_Administrative']	['Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
"The study was terminated due to a need for a reformulation of the study drug. Phase 1
    completed, no patients enrolled in Phase 2."	['Study_Design']	['Neutral']
Data Monitoring Committee discontinued the trial due to futility-based outcome	['Negative']	['Negative']
Study scope re-assessed.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Local IRB in process to close down study.	['Interim_Analysis', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Unable to obtain funding to complete study never started study	['Business_Administrative']	['Possibly_Negative']
Low enrollment of qualified subjects	['Insufficient_Enrollment']	['Neutral']
PI was unable to locate appropriate population	['Insufficient_Enrollment']	['Neutral']
"due to company changes and lack of funding-unlikely to have sufficient numbers to analyze
    meaningfully"	['Business_Administrative']	['Possibly_Negative']
Funding ended	['Business_Administrative']	['Possibly_Negative']
No funding for project.	['Business_Administrative']	['Possibly_Negative']
Slow enrollment and business decision. No safety concerns were identified for the study drugs.	['Business_Administrative']	['Possibly_Negative']
recruitment	['Insufficient_Enrollment']	['Neutral']
Insufficient funding to complete study	['Business_Administrative']	['Possibly_Negative']
Unable to recruit further patients.	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Not enough study subjects	['Insufficient_Enrollment']	['Neutral']
"the article is not a clinical trial but is a hospital based randomized comparative study. This
    was inadvertently uploaded."	['Success', 'No_Context', 'Insufficient_Data']	['Success', 'Invalid_Reason', 'Neutral']
Sponsor decision due to low enrollment and not safety concerns.	['Insufficient_Enrollment']	['Neutral']
Could not get funding for fMRI studies at this time.	['Business_Administrative']	['Possibly_Negative']
Difficulty with recruitment	['Insufficient_Enrollment']	['Neutral']
The received reliability with increase in quantity of participants of research did not vary	['Negative']	['Negative']
It was found that 20g of alcohol daily had no effect on ABCA1 expression or HDL levels.	['Negative']	['Negative']
Funding ended.	['Business_Administrative']	['Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Due to lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Research cancelled	['Invalid_Reason']	['Invalid_Reason']
Logistics regarding PET/CT portion of study	['Logistics_Resources']	['Neutral']
Withdrawn as company has shut down and filed for bankruptcy	['Business_Administrative']	['Possibly_Negative']
Competing other studies	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study will not be completed. No participants were enrolled.	['Invalid_Reason']	['Invalid_Reason']
"The study was terminated early due to insufficient subject enrolment in order to meet the
    primary and secondary endpoints"	['Insufficient_Enrollment']	['Neutral']
sponsor strategy decision	['Business_Administrative']	['Possibly_Negative']
Study withdrawn because of toxicity reported on the adult phase 1 trial.	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Neurogen acquired by Ligand Pharmaceuticals - no further support for the study. No safety
    concerns identified."	['Business_Administrative']	['Possibly_Negative']
study materials have expired, no patients were enrolled	['Logistics_Resources']	['Neutral']
Per Group Chair: This study will not move forward.	['Invalid_Reason']	['Invalid_Reason']
Terminated due to difficult recruitment	['Insufficient_Enrollment']	['Neutral']
PI left the institution	['Study_Staff_Moved']	['Neutral']
Very slow recruitment (only one patient was recruited)	['Insufficient_Enrollment']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
accrual goal met	['Invalid_Reason']	['Invalid_Reason']
Sponsor no longer pursuing regulatory approval of investigational device	['Regulatory', 'Ethical_Reason', 'Negative']	['Neutral', 'Neutral', 'Negative']
loss of funding	['Business_Administrative']	['Possibly_Negative']
Terminated due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Release of Post Marketing Requirement for this study. Terminated November 2013.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Loss of Funding	['Business_Administrative']	['Possibly_Negative']
Low patient accrual	['Insufficient_Enrollment']	['Neutral']
stopped prematurely due to the absence of safety signal	['Safety_Sideeffects', 'Logistics_Resources', 'Endpoint_Met']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Closed prematurely due to low accrual.	['Insufficient_Enrollment']	['Neutral']
Closed Prematurely.	['Invalid_Reason']	['Invalid_Reason']
The PI has elected to terminate study at this time	['Invalid_Reason']	['Invalid_Reason']
High early failure rates and adverse reactions in similar devices	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Change in study staff at the site, change in Sponsor direction	['Logistics_Resources', 'Study_Staff_Moved', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Not considered to be human subjects research	['Study_Staff_Moved', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Withdrawn-was not approved by IRB	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
PI decision	['Invalid_Reason']	['Invalid_Reason']
Lack of inclusion	['Insufficient_Enrollment']	['Neutral']
IRB closure	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Nepal Ministry of Health implemented public drug treatment prior to the proposed start date	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"In 2013 the FDA put a temporary hold on the trial and the Phase II portion of this study was
    cancelled."	['No_Context', 'Regulatory', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
IRB terminated the study	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Decision to discontinue product development at this time	['Business_Administrative']	['Possibly_Negative']
NO available budget and difficulty in recruiting	['Business_Administrative']	['Possibly_Negative']
Due to lack of time.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Withdrew the IND with the FDA.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Study recruitment is temporary on hold by the sponsor due to patient recruitment challenges and
    the ongoing review of the investigational adjuvant."	['Covid19', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Negative sorafenib results from ESCAPE trial and safety concerns of regimen	['Safety_Sideeffects', 'Endpoint_Met', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
"current grant expiration in May, insufficient funds remaining, travel restrictions, COVID-19
    restrictions in Tanzania, etc."	['Covid19', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Agreement between interested partied ended	['Business_Administrative']	['Possibly_Negative']
paperwork delay	['Business_Administrative']	['Possibly_Negative']
Impossible to involve a sufficient number of centers in the study.	['Insufficient_Enrollment']	['Neutral']
Logistics	['Logistics_Resources']	['Neutral']
Manufacturer is no longer making the drug.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"The trial was terminated prematurely on June 19, 2015 for business reasons. There were no
    safety concerns in the study which led to the decision."	['Business_Administrative']	['Possibly_Negative']
Slow accrual and loss of sponsor	['Insufficient_Enrollment']	['Neutral']
Study was cancelled before enrolment for reasons not related to vaccine safety or efficacy.	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Due to changes to the standard of care within the proposed market for CS-7017.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study halted prematurely due to low recruitment and will not resume.	['Insufficient_Enrollment']	['Neutral']
The recruitment rate was very low (one screening failure and one early withdrawal patient)	['Insufficient_Enrollment']	['Neutral']
Interim Analysis report indicates trial futility	['Negative']	['Negative']
Lead investigator moved to a new medical center; study was stopped when he left.	['Study_Staff_Moved']	['Neutral']
safety	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
This sub-study was not done because main study results reached significance.	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
FDA Clinical Hold	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study did not enroll, was closed	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
PI is no longer with the University	['Study_Staff_Moved']	['Neutral']
Enrollment and study activities are temporarily suspended due to COVID-19	['Covid19']	['Neutral']
Study sponsor discontinued	['Business_Administrative']	['Possibly_Negative']
NICHD cut funding	['Business_Administrative']	['Possibly_Negative']
Principal Investigator Decided to stop recruitment in the trial.	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Unable to recruit sufficient number of participants	['Insufficient_Enrollment']	['Neutral']
Administrative reasons	['Business_Administrative']	['Possibly_Negative']
Never got medical equipment that worked properly	['Logistics_Resources']	['Neutral']
Recruitment obstacles; data to be combined with other resources for analysis	['Interim_Analysis', 'Logistics_Resources']	['Neutral', 'Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of patients with the criteria established in the protocol.	['Insufficient_Enrollment']	['Neutral']
study was no longer feasible	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Study was never opened to accrual. There is no clinical benefit to patients.	['Negative']	['Negative']
administrative reasons	['Business_Administrative']	['Possibly_Negative']
Part 1 was completed. Part 2 was terminated for safety reasons.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Peramivir EUA terminated by FDA.	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
it was never started because it was never funded	['Business_Administrative']	['Possibly_Negative']
The sponsor terminated funding for the study.	['Business_Administrative']	['Possibly_Negative']
We decided to discontinue this particular clinical study through internal discussion.	['Invalid_Reason']	['Invalid_Reason']
Strategic Business Decision	['Business_Administrative']	['Possibly_Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
"FDA asked to administratively split from IND115621- to open a new IND you need to file a
    protocol we only drafted it to get the IND open - never initiated"	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
"The study was terminated due to low enrollment. This resulted in the study being underpowered
    and inconclusive."	['Insufficient_Enrollment']	['Neutral']
Slow enrollment.	['Insufficient_Enrollment']	['Neutral']
Linked data not available for research within requisite time period	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Sponsor Aveo has withdrawn support for this trial.	['Business_Administrative']	['Possibly_Negative']
Accrual Factor	['Insufficient_Enrollment']	['Neutral']
Contractual issues	['Business_Administrative']	['Possibly_Negative']
OBI business decision not to complete any additional research in HIV.	['Business_Administrative']	['Possibly_Negative']
Terminated at the request of the study sponsor	['Business_Administrative']	['Possibly_Negative']
Expected recruitment numbers have not been achieved.	['Insufficient_Enrollment']	['Neutral']
Replaced with another study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study not funded.	['Business_Administrative']	['Possibly_Negative']
"Trial was terminated due to the impact of the COVID-19 on trial activities. 68 patients with
    refractory chronic cough were enrolled with 52 completing treatment"	['Covid19']	['Neutral']
Inability to safely recruit subjects during Covid pandemic	['Covid19']	['Neutral']
Forum has decided not to proceed with this study at this time.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Study terminated due to enrollment challenges during COVID-19 pandemic.	['Covid19']	['Neutral']
Lack of Accrual	['Insufficient_Enrollment']	['Neutral']
Unanticipated Toxicities	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
COVID	['Covid19']	['Neutral']
poor recruitment, pilot outcome measures inappropriate	['Study_Design']	['Neutral']
Management decision	['Business_Administrative']	['Possibly_Negative']
Accrual was very low. No subject had been enrolled in a year.	['Insufficient_Enrollment']	['Neutral']
Inferior efficacy of study drug in renal indication.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Stopped for futility. Phase 3 studies not likely to meet primary endpoints.	['Negative']	['Negative']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
No funds available, hard to enroll patients-Terminated in 2008	['Business_Administrative']	['Possibly_Negative']
PI Discretion	['Study_Staff_Moved', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
One of the diuretic which is planned to be used in the study is no longer available.	['Logistics_Resources']	['Neutral']
Unable to recruit qualified participants	['Insufficient_Enrollment']	['Neutral']
The study was terminated due to too slow recruitment	['Insufficient_Enrollment']	['Neutral']
"Study was stopped due to slow recruitment. All subjects completed their participation including
    follow up period per protocol. No safety issues."	['Insufficient_Enrollment']	['Neutral']
The study was stopped due to difficulties in including patients	['Insufficient_Enrollment']	['Neutral']
Business decision to reevaluate clinical needs.	['Business_Administrative']	['Possibly_Negative']
"During treatment session 3, a subject had a pattern of AEs of severe intensity, suggestive of
    brainstem toxicity/encephalopathy during lidocaine/saline infusion"	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
interim analysis found the study drug to be ineffective	['Negative']	['Negative']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
investigators felt sufficient data has been collected	['Invalid_Reason']	['Invalid_Reason']
Hepatic safety signal identified.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
was replaced by another study. Problems with recruitment.	['No_Context', 'Insufficient_Enrollment', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
Insufficient funding	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Funding source discontinued	['Business_Administrative']	['Possibly_Negative']
end of recruitment	['Invalid_Reason']	['Invalid_Reason']
The company who was sponsoring devices and funding pulled out before we enrolled any subjects.	['Business_Administrative']	['Possibly_Negative']
Poor recruitment & not feasible to continue	['Insufficient_Enrollment']	['Neutral']
Drug is no longer being manufactured	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"We chose to use an exsisting NMR pulse sequence already established and available at the
    hospital."	['Covid19', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
No open study.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
one investigator left the study site	['Study_Staff_Moved']	['Neutral']
"Part A of study was completed per protocol. Conduct of Part B of the study (confirmatory phase)
    was not necessary."	['Invalid_Reason', 'Study_Design']	['Invalid_Reason', 'Neutral']
Due to poor patient accrual, the study was closed prior to reaching the desired study size	['Insufficient_Enrollment']	['Neutral']
Logistical Issues	['Logistics_Resources']	['Neutral']
"The biological effect seen with natalizumab was not sufficient to warrant further development
    in RA."	['Negative']	['Negative']
The study enrollment is not enough	['Insufficient_Enrollment']	['Neutral']
There was a change in the institutional flow reducing the cases of covid 19	['Covid19']	['Neutral']
Relinquished grant funding due to receipt of another incompatible grant	['Business_Administrative']	['Possibly_Negative']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
"completed accrual to phase I but drug did not show activity, so halted before initiation of
    phase II"	['Negative']	['Negative']
slow accural	['Insufficient_Enrollment']	['Neutral']
business strategy	['Business_Administrative']	['Possibly_Negative']
Limited numbers of patients	['Insufficient_Enrollment']	['Neutral']
Lack of reliable supply of of preservative free IV Hydromorphone for intrathecal use.	['Logistics_Resources']	['Neutral']
Difficulties in recruiting eligible participants	['Insufficient_Enrollment']	['Neutral']
This study was terminated due to inability to recruit sufficient patients.	['Insufficient_Enrollment']	['Neutral']
Difficulties in recruiting	['Insufficient_Enrollment']	['Neutral']
New Related Protocol to be submitted	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
poor recruitment	['Insufficient_Enrollment']	['Neutral']
The study was terminated for strategic reasons.	['Business_Administrative']	['Possibly_Negative']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
Slow accrual, availability of other clinical options	['Insufficient_Enrollment']	['Neutral']
"Further recruitment into the study was ceased on 10th December 2009, not attributed to safety.
    All patients recruited in the study completed all study visits."	['Invalid_Reason']	['Invalid_Reason']
"Improved algorithms have resulted in a proposed redesign of detection system. Once completed, a
    new trial will be planned."	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Suspended pending acquisition of additional study staff.	['Logistics_Resources', 'Study_Staff_Moved', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
"Prematurely stopped after Independent Data Monitoring Committee (IDMC) evaluation for lack of
    efficacy."	['Negative']	['Negative']
Insurance companies no longer cover this procedure	['Business_Administrative']	['Possibly_Negative']
Failure rate was 100% in one arm of the study (the intervention)	['Negative', 'Another_Study']	['Negative', 'Neutral']
Need improve the strategy	['Study_Design']	['Neutral']
Enrollment barriers made study completion impossible	['Insufficient_Enrollment']	['Neutral']
Target patient population - difficult to find patientes	['Insufficient_Enrollment']	['Neutral']
"The decision to halt the trial in October was made in June, as the anticipated no. of
    events(ankle sprains) required for the analyses was almost reached in June"	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Civil unrest in region/country of study	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
"Despite recruitment of healthy volunteers, participants from the population of interest were
    unable to be recruited."	['Insufficient_Enrollment']	['Neutral']
Study was stopped due to low enrollment and lack of clinical activity.	['Insufficient_Enrollment']	['Neutral']
Study was never approved by the IRB	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of funding to enroll additional participants	['Business_Administrative']	['Possibly_Negative']
Liquidation of Research Department	['Business_Administrative']	['Possibly_Negative']
No enrollment	['Insufficient_Enrollment']	['Neutral']
no more budget for personal to enrol participants	['Business_Administrative']	['Possibly_Negative']
Study never started	['Invalid_Reason']	['Invalid_Reason']
Difficult to recruit patients	['Insufficient_Enrollment']	['Neutral']
Slow accrual; Received grant funding for a similar but different study.	['Insufficient_Enrollment', 'Study_Design', 'Another_Study']	['Neutral', 'Neutral', 'Neutral']
Investigator decided not to proceed.	['Invalid_Reason']	['Invalid_Reason']
Because of the lack of personnel and the recruitment failure of participants.	['Insufficient_Enrollment']	['Neutral']
Problems for satellite centers in obtaining ethical clearance.	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Terminated by the funder due to low recruitment rates.	['Insufficient_Enrollment']	['Neutral']
PI left institution prior to enrollment of subjects	['Study_Staff_Moved']	['Neutral']
Not enough interest	['Business_Administrative']	['Possibly_Negative']
Decision of investigator	['Invalid_Reason']	['Invalid_Reason']
Study has been placed on hold due to unavailability of funding.	['Business_Administrative']	['Possibly_Negative']
The number of enrolled subjects did not meet the goal during the study	['Insufficient_Enrollment']	['Neutral']
"The study oversight committees unanimously decided to stop the study early on 26/07/2017 due to
    poor recruitment."	['Insufficient_Enrollment']	['Neutral']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
Awaiting funding to facilitate selected-ion flow-tube mass spectrometry (SIFT/MS)	['Business_Administrative']	['Possibly_Negative']
Lack of efficacy at time of interim analysis	['Negative']	['Negative']
One of the investigators left the institution.	['Study_Staff_Moved']	['Neutral']
Study was terminated due to lack of significant signal of efficacy	['Negative']	['Negative']
Loss of funding; could not complete building the testing device.	['Business_Administrative']	['Possibly_Negative']
The independent Data Monitoring Committee recommended an early termination.	['Negative']	['Negative']
Obtained results were not good. Protocol was proved ineffective.	['Negative']	['Negative']
Futility	['Negative']	['Negative']
"The number of successes is not reached at the end of first stage of the phase II. The study is
    stopped."	['Negative', 'Another_Study']	['Negative', 'Neutral']
company decision	['Business_Administrative']	['Possibly_Negative']
PI left the institution prior to any data being collected	['Study_Staff_Moved']	['Neutral']
"Unable to secure funding for second phase of study (i.e., niacin skin flush test in early
    psychosis patients)."	['Business_Administrative']	['Possibly_Negative']
We were unable to recruit enough sibling pairs in a timely manner.	['Insufficient_Enrollment']	['Neutral']
Due to lack of continue funding	['Business_Administrative']	['Possibly_Negative']
changes in practice	['Study_Design']	['Neutral']
The study was terminated because we were not able to obtain the study drug.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
the manufacturer never released the instruments	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Pilot enrollment criteria did not yield intended population.	['Insufficient_Enrollment']	['Neutral']
Terminated due to slow accrual,primary endpoint reached & investigator left NIH.	['Insufficient_Enrollment']	['Neutral']
Terminated due to slow recruitment.	['Insufficient_Enrollment']	['Neutral']
The PI has been unable to continue with the study.	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Because it seemed not of interest based on the current literature	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
All subjects transferred to long term study NCT00817726 RBD Longitudinal	['Negative', 'Another_Study']	['Negative', 'Neutral']
Due to the clear advantage of carotid endarterectomy	['Success', 'No_Context', 'Safety_Sideeffects']	['Success', 'Invalid_Reason', 'Safety_Sideeffects']
Terminated - Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
It was very difficult to enroll patients in this study.	['Insufficient_Enrollment']	['Neutral']
Due to insufficient funds	['Business_Administrative']	['Possibly_Negative']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
difficulty in achieving target enrollment numbers	['Insufficient_Enrollment']	['Neutral']
"It was stopped primarily because of safety concerns along with low conditional power to detect
    a treatment effect on the primary outcome."	['Negative']	['Negative']
Inadequate patient enrollment	['Insufficient_Enrollment']	['Neutral']
Termininated for business reasons	['Business_Administrative']	['Possibly_Negative']
Unforeseen difficulty identifying and enrolling eligible subjects	['Insufficient_Enrollment']	['Neutral']
Head of the study has left the institution. Study never started.	['Study_Staff_Moved']	['Neutral']
On of the liners has been taken from the market	['Logistics_Resources']	['Neutral']
Slow enrolement	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Temporarily paused due to COVID19, expected to resume. This is not a suspension of IRB approval	['Covid19']	['Neutral']
The study was terminated early due to slow enrollment and difficulties with long-term follow-up	['Insufficient_Enrollment']	['Neutral']
The study was prematurely interrupted for futility.	['Negative']	['Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Recruitment stopped due to slow recruitment	['Insufficient_Enrollment']	['Neutral']
Awaiting results from sub analysis to decide if study continues	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
"The primary objective for high grade gliomas has been met and the FDA has now approved the drug
    (Gleolan) for use in the United States."	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
"The IRB considered our trial risky. Although there were debates between investigators and IRB,
    we terminated our trial in accordance with the suggestion of IRB."	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Enrollment issues	['Insufficient_Enrollment']	['Neutral']
closed to recruitment early due to AstraZeneca not developing cediranib further	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Slow enrollment.	['Insufficient_Enrollment']	['Neutral']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
Business Decision, No Safety or Efficacy Concerns	['Business_Administrative']	['Possibly_Negative']
Strategic considerations	['Business_Administrative']	['Possibly_Negative']
"The focus of the project has shifted to publishing a protocol for future trials because we were
    unable to recruit. Three participants signed the consent forms but withdrew before the
    randomization."	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Lack of recruitment due to COVID-19 pandemic; chloroprocaine shortage	['Covid19']	['Neutral']
combine with NCT03356808	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study PI changed institutions	['Study_Staff_Moved']	['Neutral']
Slow recruitement	['Insufficient_Enrollment']	['Neutral']
no participants enrolled in a three year period	['Insufficient_Enrollment']	['Neutral']
PI leaving instutition	['Study_Staff_Moved']	['Neutral']
No cases enrollment	['Insufficient_Enrollment']	['Neutral']
Poor Accrual	['Insufficient_Enrollment']	['Neutral']
Clinic Closed	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Study was terminated for business purposes, not for safety or efficacy reasons.	['Business_Administrative']	['Possibly_Negative']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
recruitment suspended due to COVID-related social distancing requirements	['Covid19']	['Neutral']
This study never moved forward due to funding constraints.	['Business_Administrative']	['Possibly_Negative']
"In order to focus efforts on the combination ring formulation, IPM decided not to move forward
    with this trial."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Due to existing evidence eligible patients receive CRT treatment in first place	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of subject participation	['Insufficient_Enrollment']	['Neutral']
Due to slow enrollment.	['Insufficient_Enrollment']	['Neutral']
Study terminated because unable to obtain access to study drug for study population.	['Logistics_Resources']	['Neutral']
Interim analysis of efficacy trial showed no drug efficacy.	['Negative']	['Negative']
Review of safety and preliminary efficacy data showed marginal anti-tumor activity.	['Negative']	['Negative']
Study has been completed	['Invalid_Reason']	['Invalid_Reason']
lack of funding	['Business_Administrative']	['Possibly_Negative']
no approval	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
due to patient recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
"Due to slow enrollment, the extensive time projected to conclude the study hypothesis rendered
    the study no longer reasonably feasible to complete."	['Insufficient_Enrollment']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Low (no) enrollment.	['Insufficient_Enrollment']	['Neutral']
Drugs unavailable	['Logistics_Resources']	['Neutral']
Business Reasons	['Business_Administrative']	['Possibly_Negative']
"Enrollment has not begun; study suspended indefinitely due to change in management at company
    where we were going to conduct the study."	['Business_Administrative']	['Possibly_Negative']
PI left institution	['Study_Staff_Moved']	['Neutral']
Business Decisions; No Safety Concerns	['Business_Administrative']	['Possibly_Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
study abandoned prior to opening to accrual or study start	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Invalid data collection	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Voluntarily terminated based on preliminary non-clinical findings.	['Negative']	['Negative']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
No enrollment	['Insufficient_Enrollment']	['Neutral']
Commercial reasons	['Business_Administrative']	['Possibly_Negative']
internal decision	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Change in study design [Randomization not feasible]	['Study_Design']	['Neutral']
Investigator decided to stop the study because it was difficult to proceed with the study.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
Low accrual.	['Insufficient_Enrollment']	['Neutral']
No patients were enrolled.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Inability to meet protocol objectives	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
No Participants Enrolled	['Insufficient_Enrollment']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Study terminated for lack of accrual.	['Insufficient_Enrollment']	['Neutral']
the sponsor did not provide the treatment	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
50% of eligible patients refused to enter the study	['Insufficient_Enrollment']	['Neutral']
Technical problems	['Logistics_Resources']	['Neutral']
Slow Enrollment	['Insufficient_Enrollment']	['Neutral']
Logistical problems prevented enrollment	['Logistics_Resources']	['Neutral']
Competing study	['Negative', 'Another_Study']	['Negative', 'Neutral']
PI passed away	['Study_Staff_Moved']	['Neutral']
Study never moved forward due to no accrual	['Insufficient_Enrollment']	['Neutral']
Business decision	['Business_Administrative']	['Possibly_Negative']
poor recruitment	['Insufficient_Enrollment']	['Neutral']
Due to poor Accrual	['Insufficient_Enrollment']	['Neutral']
Trial was stopped due to difficult enrolment	['Insufficient_Enrollment']	['Neutral']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Development halted by management	['Business_Administrative']	['Possibly_Negative']
Closed incomplete due to Artes Medical Closing	['Business_Administrative']	['Possibly_Negative']
Sponsor did not want to move forward with protocol; study was never opened.	['Business_Administrative']	['Possibly_Negative']
Original Principal Investigator left institution. No data analyzed.	['Study_Staff_Moved']	['Neutral']
Sponsor terminated study due to financial constraints.	['Business_Administrative']	['Possibly_Negative']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Data did not evidence [123I]MNI-330 as a useful tool in the detection of AD.	['Negative']	['Negative']
sponsor decision	['Business_Administrative']	['Possibly_Negative']
PI left institution	['Study_Staff_Moved']	['Neutral']
Harvard University dining workers went on strike, we hope to relaunch in Fall 2017.	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
recruitment efforts did not result in a sufficient number of patients	['Insufficient_Enrollment']	['Neutral']
The study drug was not provided resulting in termination for unacceptable delays	['Logistics_Resources']	['Neutral']
full RCT funded. no need to continue pilot data collection.	['Business_Administrative']	['Possibly_Negative']
Lack of Efficacy.	['Negative']	['Negative']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Parent trials were either not initiated or terminated	['Invalid_Reason']	['Invalid_Reason']
"The Trial could not get permit from Department of Health, Taiwan; Furthermore, no research fund
    could support the expensive (photosensitizer) photosan"	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor elected not to continue with study.	['Business_Administrative']	['Possibly_Negative']
was not able to recruit enough patients	['Insufficient_Enrollment']	['Neutral']
"Enrollment and interactions/interventions paused due to COVID-19. Expected to resume in the
    future. This is not a suspension of IRB approval"	['Covid19']	['Neutral']
Enrollment of the subject could not reach statistically required number.	['Insufficient_Enrollment']	['Neutral']
Study not funded - never initiated	['Business_Administrative']	['Possibly_Negative']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
not enough patients	['Insufficient_Enrollment']	['Neutral']
Stage 1 Complete; Stage 2 and 3 not pursued	['Invalid_Reason', 'Study_Design']	['Invalid_Reason', 'Neutral']
approval of ethical committee was denied	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Withdraw the study because further analysis showed that it would be futile.	['Negative']	['Negative']
Currently on hold due to COVID-19 restrictions in community program sites	['Covid19']	['Neutral']
other studies with more patients already publicated	['Negative', 'Another_Study']	['Negative', 'Neutral']
Difficulty recruiting (early discharge scheme initiated)	['Insufficient_Enrollment']	['Neutral']
Initiated a new study with improved device	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Primary investigator left the Institution	['Study_Staff_Moved']	['Neutral']
Ended early due to inability to identify eligible subjects	['Insufficient_Enrollment']	['Neutral']
New evidence came to light to indicate that study was no longer relevant	['Negative', 'Another_Study']	['Negative', 'Neutral']
rare overload and low recruitment	['Insufficient_Enrollment']	['Neutral']
Due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
This study was terminated for administrative reasons.	['Business_Administrative']	['Possibly_Negative']
"This study was terminated May 7, 2007. The study stopped due to tablet formulation issues. No
    safety issues were involved in the termination decision."	['Study_Design']	['Neutral']
"The syndrome of hyperstimulation is so rare that after one year no patients were eligible.The
    study was withdrawn and never started."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"Company making the device no longer in existence. Did not finish supplying data to research
    team"	['Business_Administrative']	['Possibly_Negative']
No eligible patient was enrolled.	['Insufficient_Enrollment']	['Neutral']
Study terminated prematurely due to financial constraints.	['Business_Administrative']	['Possibly_Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Corporate decision to spend money on other development programs.	['Business_Administrative']	['Possibly_Negative']
Non-compliance	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study did not get ethical approval, therefore study was not initiated	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Due to the Pandemic, we decided to end this study.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Could not make FDA required changes	['No_Context', 'Regulatory', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
Not enough patients included	['Insufficient_Enrollment']	['Neutral']
"Due to failure to control sufficient patients in the active arm, this study has now been
    closed."	['Insufficient_Enrollment']	['Neutral']
Product withdrawn from the market due to a shift in sponsor business focus	['Business_Administrative']	['Possibly_Negative']
Decision made by the PI to withdraw study	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
this trial enroll extremely slow and No funding support	['Business_Administrative']	['Possibly_Negative']
"Dr. Hazen is no longer full-time faculty / was not able to find an appropriate PI to take over
    study."	['Study_Staff_Moved']	['Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Funding for this pilot transitioned into funding for a fully powered study.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
The trial was stopped earlier than planned because of the slow accrual rate.	['Insufficient_Enrollment']	['Neutral']
Funding is late, unforseeable.	['Business_Administrative']	['Possibly_Negative']
Logistical difficulties leading to an extremely slow recruitment rate	['Insufficient_Enrollment']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
low enrollment	['Insufficient_Enrollment']	['Neutral']
This study was terminated for reasons not related to efficacy or safety	['Negative']	['Negative']
"Due to our experience, the small number of new inclusions, and the uncertainty regarding the
    COVID-19 outbreak, we have decided to discontinue the study."	['Covid19']	['Neutral']
This study was terminated due to internal technical issues at study site	['Logistics_Resources']	['Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
Non applicable clinical trial	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Technical issues with RSA at main site and departure of Principal Investigator	['Study_Staff_Moved']	['Neutral']
Low patient enrollment and no clinical findings.	['Insufficient_Enrollment']	['Neutral']
Study halted prior to enrollment of first participant.	['Invalid_Reason']	['Invalid_Reason']
difficult to recruit participants	['Insufficient_Enrollment']	['Neutral']
Study Not Activated Due to Contract Issues	['Business_Administrative']	['Possibly_Negative']
Project termination	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Sponsor decision not related to patient safety	['Business_Administrative']	['Possibly_Negative']
"At the planned study start new treatment guidelines for this disease with new drugs were
    implemented in clinical practice."	['Study_Design']	['Neutral']
Sponsor lost funding	['Business_Administrative']	['Possibly_Negative']
To Low recruitment and competing studies	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Terminated due to non-safety reasons	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"Results of step1: none of the experimental arms fulfills expectations and the study will not
    continue as a phase III."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study was closed because we could not find these types of patients.	['Insufficient_Enrollment']	['Neutral']
Recruitment was very slow.	['Insufficient_Enrollment']	['Neutral']
"The study was withdrawn due to difficulties in recruiting appropriate patients in community
    clinic setting"	['Insufficient_Enrollment']	['Neutral']
No IRB approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
A Phase I/II study (NCT01758458) is now recruiting	['Negative', 'Another_Study']	['Negative', 'Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Funding expired prior to implementing subject recruitment.	['Business_Administrative']	['Possibly_Negative']
Finance stop	['Business_Administrative']	['Possibly_Negative']
Funding could not be secured	['Business_Administrative']	['Possibly_Negative']
The study did not start.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Closed by PI prior to approval	['Interim_Analysis', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
drug product became unavilable	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
"Mild/moderate hepatic impairment (HI) cohorts completed with no impact to erdafitinib exposure.
    Severe HI cohort enrollment stopped early."	['Negative']	['Negative']
Sponsor has designed another study to replace the current study	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
The backgroud of this study was not well discussed.	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
end of normal study	['Invalid_Reason']	['Invalid_Reason']
lack of funding	['Business_Administrative']	['Possibly_Negative']
low recruitment	['Insufficient_Enrollment']	['Neutral']
lack of inclusion and prophylaxy plateform being free to use for everyone in septembre 2016	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Did not receive funding.	['Business_Administrative']	['Possibly_Negative']
"Investigator changed institutions, study closed out by original IRB and still pending approval
    by the new IRB"	['Study_Staff_Moved', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
"Failure to accrue subjects. All activity has stopped & no analysis will be done on what has
    been collected."	['Insufficient_Enrollment']	['Neutral']
Change in methodology too important - end of randomization	['Study_Design']	['Neutral']
Recruitment terminated, all follow-up visits were canceled due to quarantine	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
New study initiated to replace this one	['Negative', 'Another_Study']	['Negative', 'Neutral']
PI no longer part of practice	['Study_Staff_Moved']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
The study was terminated due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
Study entered in error	['No_Context', 'Insufficient_Enrollment', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
Toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Change in protocol strategy	['Study_Design']	['Neutral']
trial logistics	['Logistics_Resources']	['Neutral']
Unable to recruit into the study	['Insufficient_Enrollment']	['Neutral']
Low enrollment -- We could not recruit patients willing to be enrolled	['Insufficient_Enrollment']	['Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
No longer able to recruit participants	['Insufficient_Enrollment']	['Neutral']
The portable PSG machine can not be available any more.	['Logistics_Resources']	['Neutral']
Reevaluating recruitment strategies	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Enrollment not initiated for study.	['Insufficient_Enrollment']	['Neutral']
"Lack of funds; FDA approved a topical form of diclofenac during study, no need to continue
    study of pharmacy-compounded drug."	['Business_Administrative']	['Possibly_Negative']
Stopped early due to inability to recruit full 100 subjects over 2 years	['Insufficient_Enrollment']	['Neutral']
Low enrollment, grant term expired	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of funds	['Business_Administrative']	['Possibly_Negative']
Transferred study to Antwerp, Belgium	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
No funding received	['Business_Administrative']	['Possibly_Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
no subjects agreed to participate	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Corporate decision	['Business_Administrative']	['Possibly_Negative']
"Several factors contributed to significant challenges in enrollment and led the Sponsor to
    discontinue the AMAG-FER-CKD-253 study as designed."	['Covid19', 'Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
recruitment was not started	['Insufficient_Enrollment']	['Neutral']
The study was terminated early as it failed to recruit.	['Insufficient_Enrollment']	['Neutral']
Study site will join the TARGIT-US trial in lieu of this trial	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
No linger a clinically relevant research question	['Success', 'No_Context', 'Logistics_Resources']	['Success', 'Invalid_Reason', 'Neutral']
"Portfolio prioritization due to slow enrollment and variable spectrum of potential complement
    abnormalities in DDD patients."	['Insufficient_Enrollment', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Quantitative assessment of fFN only able to be performed at one laboratory.	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Withdrawn as NCI rescinded approval for parent study NSABP-B-45	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
due to the Covid 19 pandemic	['Covid19']	['Neutral']
The study was stopped due to the feasibility of recruiting the study in a timely manner	['No_Context', 'Logistics_Resources', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
slow recruiting, difficulties in finding eligible patients	['Insufficient_Enrollment']	['Neutral']
Study was ended due to lack of available participants who met criteria.	['Insufficient_Enrollment']	['Neutral']
Study did not recieve funding, currenlty undergoing protocol revision.	['Business_Administrative']	['Possibly_Negative']
Low number of patients enrolled	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
The study was halted after a Phase 3 study of dimebon failed to show efficacy.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Withdrawn due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Business decision	['Business_Administrative']	['Possibly_Negative']
Data collection has halted due to no further assays provided by AmniSURE	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
study terminated due to low enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of recruting patients to the study	['Insufficient_Enrollment']	['Neutral']
january 2019	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Lack of eligible patient.	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Drug expired before was completed.	['Logistics_Resources']	['Neutral']
"Safety Issue: The trial was prematurely terminated on Dec 9, 2010, due to safety concerns,
    specifically new emerging evidence of hepatic injury."	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
"The study was terminated early, due to the lack of approval of data exportation from the Office
    of Human Genetic Resource Administration (OHGRA) China."	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
"Stopped early due to inadequate separation on primary efficacy endpoint in the lead-in HONOR
    study, TNX-CY-P301"	['Negative', 'Another_Study']	['Negative', 'Neutral']
A study was terminated due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
Very slow recruitment of patients and the current COVID-19 pandemic situation.	['Covid19']	['Neutral']
Due to no patient enrollment this study was withdrawn/closed	['Insufficient_Enrollment']	['Neutral']
withdrawn due to non-response. PI left university	['Study_Staff_Moved']	['Neutral']
Funding ended	['Business_Administrative']	['Possibly_Negative']
problems recruiting the sample; derived from pandemic situation COVID-19	['Covid19']	['Neutral']
Lack of eligible patients	['Insufficient_Enrollment']	['Neutral']
Halt in funding	['Business_Administrative']	['Possibly_Negative']
No patient accrual.	['Insufficient_Enrollment']	['Neutral']
The unit's standard nutrition practices change which impacted our methodology.	['Study_Design']	['Neutral']
Delayed recruitment, funding exhausted	['Business_Administrative']	['Possibly_Negative']
The PI is no longer with the University	['Study_Staff_Moved']	['Neutral']
no patients randomized	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
COVID 19 which is preventing outpatient and elective procedures	['Covid19']	['Neutral']
Sponsor withdrew study. Accrual not completed	['Insufficient_Enrollment']	['Neutral']
Prinicipal Investigator initiated study closure.	['No_Context', 'Study_Staff_Moved', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
Results inconclusive	['Negative']	['Negative']
This study has been withdrawn prior to enrollment.	['Invalid_Reason']	['Invalid_Reason']
This study is being replaced by another protocol.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
The study was prematurely terminated due to recruitment issues	['Insufficient_Enrollment']	['Neutral']
Insufficient recruiting	['Insufficient_Enrollment']	['Neutral']
IRB ended and NIH study ended	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Principal investigator leaving Washington University and halting studies	['Study_Staff_Moved']	['Neutral']
The number of enrolled cases is too small.	['Insufficient_Enrollment']	['Neutral']
Sponsor/Investigator has decided to close out the study	['Business_Administrative']	['Possibly_Negative']
Loss of patients	['Insufficient_Enrollment']	['Neutral']
PI left JHU	['Study_Staff_Moved']	['Neutral']
This trial will open as an NCTN trial.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Company business decision	['Business_Administrative']	['Possibly_Negative']
Lack of funds	['Business_Administrative']	['Possibly_Negative']
The number of patients were enough for statistic treatment	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
not funded	['Business_Administrative']	['Possibly_Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Changement of study design. Restart spring 2021.	['Study_Design']	['Neutral']
Internal funding not awarded.	['Business_Administrative']	['Possibly_Negative']
"Urgent shift among clinical sites toward efforts to combat COVID-19 pandemic;impacted
    feasibility of completing study within shelf-life of current IP supply"	['Covid19']	['Neutral']
The study was terminated due to extensive Covid-19 delay.	['Covid19']	['Neutral']
"Insufficient enrolment and ""business reasons"""	['Business_Administrative']	['Possibly_Negative']
Enrollment suspended pending protocol revision to change study to observational	['Study_Design']	['Neutral']
Problems recruiting; patient relapse following treatment	['Negative']	['Negative']
closed by sponser	['Business_Administrative']	['Possibly_Negative']
futility	['Negative']	['Negative']
Lack of primary outcome efficacy.	['Negative']	['Negative']
Unable to recruit sufficient number of patients	['Insufficient_Enrollment']	['Neutral']
Low enrollment.	['Insufficient_Enrollment']	['Neutral']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
IRB has requested additional information regarding IDE	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Enrollment Difficulties	['Insufficient_Enrollment']	['Neutral']
10 patients inclued instead of 50	['Insufficient_Enrollment']	['Neutral']
Changes in the profile of patients assisted by the hospital	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Person working on the trial left	['Study_Staff_Moved']	['Neutral']
Low Enrolment	['Insufficient_Enrollment']	['Neutral']
Halted due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
There are no fund to support	['Business_Administrative']	['Possibly_Negative']
not enough patients enrolled in study	['Insufficient_Enrollment']	['Neutral']
Inability to enroll sufficient patients	['Insufficient_Enrollment']	['Neutral']
study team decision because of IP supply issue and necessary amendment to protocol	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
No subjects were enrolled since the first subject completed the study 08Jun2007	['Insufficient_Enrollment']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
PI is no longer at this institution	['Study_Staff_Moved']	['Neutral']
"Most patients were unable to perform the test being used to measure lung function, thus it
    became clear the study would not yield clinically meaningful data"	['Logistics_Resources']	['Neutral']
PI moving to new institution prior to study activation	['Study_Staff_Moved']	['Neutral']
This study was cancelled. No subjects were enrolled and no data has been collected	['Invalid_Reason']	['Invalid_Reason']
No participants were enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"Due to COVID-19 this research needed to pause in March 2020. We plan to start the study again
    when we have approval to do so."	['Covid19']	['Neutral']
Study requires Medicines Control council approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"availability of new and more promising therapeutic agents than expected in the experimentation
    in question"	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
concerns related to study drug	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Study was discontinued due to non-safety related business prioritization decisions	['Business_Administrative']	['Possibly_Negative']
Futility and underpowering of endpoint data	['Negative']	['Negative']
at Sponsor's discretion	['Business_Administrative']	['Possibly_Negative']
PI left institution	['Study_Staff_Moved']	['Neutral']
Study not started	['Invalid_Reason']	['Invalid_Reason']
Trouble with recruting	['Insufficient_Enrollment']	['Neutral']
Patients were not appropriately enrolled	['Insufficient_Enrollment']	['Neutral']
Recent abstract publication questioning the need for our study	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Not funded	['Business_Administrative']	['Possibly_Negative']
The site closed down, therefore the study has been terminated.	['Invalid_Reason']	['Invalid_Reason']
COVID-19 general concerns.	['Covid19']	['Neutral']
Development of new chemotherapy standard of care for treatment rendered the trial obsolete.	['Study_Design']	['Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Protocol approval expired	['Business_Administrative']	['Possibly_Negative']
"prematurely terminated due to impossibility of recruiting the planned number of patients by the
    study centre."	['Insufficient_Enrollment']	['Neutral']
"moved forward with another protocol utilizing pan genotypic treatment once it became
    commercially available and FDA approved"	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Mifne began treating younger patients who could not be diagnosed with the ADOS used in the
    study"	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Change in company direction	['Business_Administrative']	['Possibly_Negative']
"COVID-19 pandemic, unable to recruit and conduct study procedures per state, local, and
    university policies."	['Covid19']	['Neutral']
Due to COVID-19	['Covid19']	['Neutral']
Limited patient enrollment	['Insufficient_Enrollment']	['Neutral']
PI job change	['Study_Staff_Moved']	['Neutral']
Terminated before the complete enrollment due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
Investigator is no longer at Northwestern University	['Study_Staff_Moved']	['Neutral']
Per Coordinator Study was closed and data was never analyzed	['Logistics_Resources', 'Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Recruitment has not started yet due to COVID pandemic.	['Covid19']	['Neutral']
Technical problems and employee shortage	['Logistics_Resources']	['Neutral']
Closed by sponsor	['Business_Administrative']	['Possibly_Negative']
PI changed Institution	['Study_Staff_Moved']	['Neutral']
"Application of monitoring tools seemed inappropriate in ICU patients who were ventilated during
    a prolonged period."	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
no participants have been able to qualify for study	['Insufficient_Enrollment']	['Neutral']
PI leaving	['Study_Staff_Moved']	['Neutral']
PI no longer employed at Institution	['Study_Staff_Moved']	['Neutral']
Lost research support for enrolling patients	['Logistics_Resources', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Inability to recruit	['Insufficient_Enrollment']	['Neutral']
Unable to quantify caffeine	['Negative']	['Negative']
"Lack of financial support to continue with the study recruitment. Independent study financially
    supported by a national grant with a 4.5 years duration."	['Business_Administrative']	['Possibly_Negative']
"The enrollment of this study was slow. With the approval of lenvatinib in HCC,many patients
    choose the new drug, so subsequent enrollment may be more difficult."	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
The company decided not to enroll subjects. The app was never developed.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Recruitment	['Insufficient_Enrollment']	['Neutral']
Study staff not available to complete the trial	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
cost of medicine too expensive to continue without funding	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study halted prematurely and will not resume	['Invalid_Reason']	['Invalid_Reason']
"Temporarily suspended to focus on other projects. At suspension, no participants were
    determined eligible and none started the protocol."	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
inclusion rate too low & investigators enable to recruit new patients rapidly	['Insufficient_Enrollment']	['Neutral']
Patient enrollment was slow and we were not able to accrue participants at a decent pace.	['Insufficient_Enrollment']	['Neutral']
Company at this time unable to secure sufficient financial resources to complete	['Business_Administrative']	['Possibly_Negative']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
Recommendation from Independent Medicines & Medical Devices Safety Review.	['Regulatory']	['Neutral']
Primary endpoint reached based on data projection from interim analysis.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
PI left University and no study was ever done	['Study_Staff_Moved']	['Neutral']
Preliminary analysis showed no difference between groups.	['Negative']	['Negative']
Funding cessation.	['Business_Administrative']	['Possibly_Negative']
suspended due to lack of data.	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Study was closed prematurely due to low enrollment numbers.	['Insufficient_Enrollment']	['Neutral']
Change in technology	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Funding	['Business_Administrative']	['Possibly_Negative']
data income too low	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Insufficient recruitment and unavailability of the treatment	['Insufficient_Enrollment']	['Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
PI decided not to proceed with this project. No participants were enrolled.	['Invalid_Reason']	['Invalid_Reason']
Closed due prolonged enrollment timelines	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
IRB modifications made study impractical.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Funding discontinued.	['Business_Administrative']	['Possibly_Negative']
Investigator left the institution	['Study_Staff_Moved']	['Neutral']
Amendment of Study Protocol	['Study_Design']	['Neutral']
"1 Indication for further investigations (brain ultrasound). 2 Change of study design to
    efficacy study with historical control group."	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Due to insufficient funds	['Business_Administrative']	['Possibly_Negative']
A replacement protocol was created to replace this current version of protocol.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Investigator decisions based on slow enrollment.	['Insufficient_Enrollment']	['Neutral']
Planned interim analysis: no significant outcome differences between groups	['Negative']	['Negative']
Principal investigator and sponsor did not reach an agreement.	['Business_Administrative']	['Possibly_Negative']
insufficient recruitment, the planed sample size appears not achievable	['Insufficient_Enrollment']	['Neutral']
"Change of practice to antibiotic impregnated catheters and large study published showing their
    efficacy. Made topical antibiotics obselete."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Parent study CIS001 was completed	['Negative', 'Another_Study']	['Negative', 'Neutral']
Slow recruitment,changes in protocols, larger than anticipated differences	['Negative']	['Negative']
Principal Investigator left the institution requested termination.	['Study_Staff_Moved']	['Neutral']
Study terminated due to withdrawal from market of Daclizumab	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
PI left the institution	['Study_Staff_Moved']	['Neutral']
"Slow enrollment and due to personnel change there was no viable way to quantify glycine levels
    through imaging"	['Logistics_Resources']	['Neutral']
Per request of Principal Investigator this study was closed.	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Due to insufficient patient inclusion the study has been stopped prematurely.	['Insufficient_Enrollment']	['Neutral']
The number of patients desired has been reached	['Invalid_Reason']	['Invalid_Reason']
DSMB determined toxicity of regimen more than originally thought. Slow accrual.	['Insufficient_Enrollment']	['Neutral']
Failure to recruit in expected time period.	['Insufficient_Enrollment']	['Neutral']
Difficulty recruiting eligible patients in timely fashion	['Insufficient_Enrollment']	['Neutral']
Administratively Terminated by PI	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Gathering information from the PI records to provide this response.	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Lack of technical support and supplies	['Logistics_Resources']	['Neutral']
No subject accrual	['Insufficient_Enrollment']	['Neutral']
The trial was discontinued early due to no confirmed partial responses.	['Insufficient_Enrollment', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
EORTC trail showed TMZ & RT conferred significant survivial in this population	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Recruitment was at a standstill. We are currently preparing our results for publication.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Regolatory National Agency (AIFA) not approved	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Awaiting New CoInvestigator with TTE Expertise	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Based on futility analysis showing <30% chance of meeting primary endpoint.	['Negative']	['Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Study stopped because of toxicity concerns.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"Futility on primary endpoint.Study confounded by statistically significant differences between
    the two arms re: atherectomy, duration of support."	['Success', 'Logistics_Resources', 'Endpoint_Met']	['Success', 'Neutral', 'Neutral']
"Instruments necessary to continue project have been removed via medical center staff.
    Therefore, the project cannot continue until they have been replaced."	['Logistics_Resources']	['Neutral']
Interim analysis showed that the odds for proving primary hypothesis are low.	['Negative']	['Negative']
"Results of a planned interim analysis did not show significant effects for any of the 3 AIN
    dose regimens versus placebo on any primary or secondary endpoint"	['Negative']	['Negative']
Efficacy	['Negative']	['Negative']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
"The study has been halted prematurely beacuse of the occurence of convulsions in one case after
    TAP block."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"Terminated [CYTHERISSA filed for banckcuptcy in June 2013.Subjects treated by CYT107 were
    followed up for at the least 3 months.]"	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
"AZ decision to discontinue fostamatinib development in RA; rights to fostamatinib returned to
    Rigel Pharmaceuticals."	['Business_Administrative']	['Possibly_Negative']
Lack of patient inclusion	['Insufficient_Enrollment']	['Neutral']
Study was terminated due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
Due to potential concerns about liver safety (See Detailed Description)	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Low events rate. Scarce economical resources	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Study was terminated due to safety measures.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Recruitment very time consuming, too few wanting participation	['Insufficient_Enrollment']	['Neutral']
"Recruitment halted following TSC meeting due to poor recruitment and study unlikely to
    complete. Funders withdrew continued support"	['Insufficient_Enrollment']	['Neutral']
Decided by the investigator due to the difficulties to recruit	['Insufficient_Enrollment']	['Neutral']
Terminated due to futility	['Negative']	['Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Trial was cancelled due to availability of clinical supplies.	['Logistics_Resources']	['Neutral']
Terminated due to lack of efficacy	['Negative']	['Negative']
Terminated due to COVID-19 pandemic.	['Covid19']	['Neutral']
Early termination of the study, since July 31, 2020 for insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Change to recommended season flu vaccine in UK	['Study_Design']	['Neutral']
Analyzing sensor data to eliminate noise/ movement or EM equipment artifacts	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Efficacy	['Negative']	['Negative']
Covid department protocol prevented patient recruitment and affected funding.	['Covid19']	['Neutral']
"Patients not meeting inclusion criteria, therefore recruitment rate low, terminated due to the
    lack of feasibility to complete the study in a timely manner."	['Insufficient_Enrollment']	['Neutral']
Decision made to develop different intervention	['Study_Design']	['Neutral']
"Staffing changes impacted by COVID-19 pandemic resulting in inadequate personnel to facilitate
    study."	['Covid19']	['Neutral']
Difficulty recruiting donors and recipients, looking for alternative sites	['Insufficient_Enrollment']	['Neutral']
Terminated due to delay in site enrollment timelines	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Loss of recrutement	['Insufficient_Enrollment']	['Neutral']
Insufficient personel	['Logistics_Resources']	['Neutral']
Administratively Complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Strategic considerations	['Business_Administrative']	['Possibly_Negative']
negatives results	['Negative']	['Negative']
Unable to recruit sufficient number of subjects	['Insufficient_Enrollment']	['Neutral']
Low likelihood of identifying a statistically significant treatment effect.	['Negative']	['Negative']
Strategic considerations	['Business_Administrative']	['Possibly_Negative']
PI no longer affiliated with institution; only 2 subjects enrolled	['Study_Staff_Moved']	['Neutral']
no eligible subjects were available for recruitment	['Insufficient_Enrollment']	['Neutral']
Study personnel left institution, anticipated funding did not occur	['Business_Administrative']	['Possibly_Negative']
The trial was terminated due to investigator's decision	['Invalid_Reason']	['Invalid_Reason']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Dose Limiting Toxicities	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Closure due to lack of funding.	['Business_Administrative']	['Possibly_Negative']
Difficulty recruiting	['Insufficient_Enrollment']	['Neutral']
Awaiting decision on financial support by Deutsche Forschungsgemeinschaft (DFG)	['Business_Administrative']	['Possibly_Negative']
The study was stopped because of futility due to unexpected low weight gain in both groups.	['Negative']	['Negative']
New sponsor, other treatments available	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Not enough study participants, difficulties in recruitment	['Insufficient_Enrollment']	['Neutral']
Low patient enrollment; toxicities	['Insufficient_Enrollment']	['Neutral']
no recruitment	['Insufficient_Enrollment']	['Neutral']
End of the study	['Invalid_Reason']	['Invalid_Reason']
Never funded	['Business_Administrative']	['Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Terminated: participants are no longer being enrolled	['Invalid_Reason']	['Invalid_Reason']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
slow enrolment	['Insufficient_Enrollment']	['Neutral']
Principal Investigator left the institution	['Study_Staff_Moved']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
low accrual	['Insufficient_Enrollment']	['Neutral']
no participants enrolled	['Insufficient_Enrollment']	['Neutral']
Company decision to withdraw before study started	['Business_Administrative']	['Possibly_Negative']
The development was stopped due to company's strategy consideration	['Business_Administrative']	['Possibly_Negative']
"Due to COVID-19 restrictions and the closure of the research clinic site, the study ended
    prematurely. Not all data was collected on all participants."	['Covid19']	['Neutral']
Sponsor business decision unrelated to product safety or efficacy.	['Business_Administrative']	['Possibly_Negative']
Withdrawn due to lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Repros stopped study due to safety and FDA placed study on hold	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Due to low enrollment, registration closed in agreement with the Regulatory Agency	['Insufficient_Enrollment']	['Neutral']
Criteria not met for second stage at time of interim analysis	['Negative']	['Negative']
Study stopped by sponsor due to difficulty enrolling at site	['Insufficient_Enrollment']	['Neutral']
Changes in the organisation	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Terminated due to lack of eligible patients	['Insufficient_Enrollment']	['Neutral']
Replaced with ongoing study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Sponsor withdrew funding for reasons unrelated to safety or efficacy	['Business_Administrative']	['Possibly_Negative']
"The study was terminated after the European Medicines Agency recommended to suspend the
    marketing authorisation of Raptiva in the European Union"	['Study_Design']	['Neutral']
Suspended pending amendment	['Study_Design']	['Neutral']
Study never recruited	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
trial stopped on Sept 24, 2007	['Invalid_Reason']	['Invalid_Reason']
"last patient recruited Feb 2015,completion of data review; study data do not meet statistical
    significance to answer proposed study question"	['Negative']	['Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Due to COVID-19 policies this usability pilot study was stopped after enrolling 4 participants.	['Covid19']	['Neutral']
Study was terminated due to insufficient funds	['Business_Administrative']	['Possibly_Negative']
Withdrawing study from PRS-this is not an actual clinical trial	['Study_Staff_Moved', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
The trial was funded in part by a grant; the trial closed when the grant ended.	['Business_Administrative']	['Possibly_Negative']
The funding for the study was relinquished and so study terminated early.	['Business_Administrative']	['Possibly_Negative']
Study drug currently unavailable	['Logistics_Resources']	['Neutral']
Poor patient accrual	['Insufficient_Enrollment']	['Neutral']
Project has ended	['Invalid_Reason']	['Invalid_Reason']
Low subject recruitment	['Insufficient_Enrollment']	['Neutral']
same information will be collected in upcoming IDE trial	['Negative', 'Another_Study']	['Negative', 'Neutral']
Stopped for internal decisions	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Study terminated due to withdrawl of participating co-investigators.	['Study_Staff_Moved']	['Neutral']
"Published RECOVERY trial provides evidence that further recruitment would not provide
    conclusive proof of worthwhile benefit of Colchicine on COVID patients."	['Covid19', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"The results obtained 1 year after surgery were clearly indicative of the outcome and the
    investigators decided to terminate follow-up at that point."	['Negative']	['Negative']
Study was cancelled by Sponsor.	['Business_Administrative']	['Possibly_Negative']
Principal Investigator separating employment from University.	['Study_Staff_Moved']	['Neutral']
The study was withdrawn due to an internal decision.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Sponsor's decision	['Business_Administrative']	['Possibly_Negative']
There were no eligible patients with CoVID-19 in the paticipated centers.	['Covid19']	['Neutral']
"After enrolling 25 patients an interim analysis was done.The study was discontinued in the
    absence of the minimum number of 6 patients free of events"	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
PI left UAB; protocol administratively terminated by UAB IRB.	['Study_Staff_Moved']	['Neutral']
We no longer had an appropriate patient population.Study closed	['Insufficient_Enrollment']	['Neutral']
unsuccessful recruitment	['Insufficient_Enrollment']	['Neutral']
Inability to recruit patients	['Insufficient_Enrollment']	['Neutral']
Primary objective not met after planned interim analysis	['Negative']	['Negative']
Unable to recruit enough participants.	['Insufficient_Enrollment']	['Neutral']
Limited recourse to intestinal resection due to new management of CD	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
no enrollment	['Insufficient_Enrollment']	['Neutral']
The device test article is no longer available	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Other - response analysis	['Negative']	['Negative']
Clearly identifiable benefits 50% of patients included	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
sponsor on campus training restrictions	['Business_Administrative']	['Possibly_Negative']
Terminated by IRB	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
technical problem	['Logistics_Resources']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Study recruitment temporarily halted due to COVID-19.	['Covid19']	['Neutral']
Company decision to discontinue trial	['Business_Administrative']	['Possibly_Negative']
Study withdrawn due to business decisions. No subjects were treated.	['Business_Administrative']	['Possibly_Negative']
Study was terminated due to enrollment futility.	['Negative']	['Negative']
study stopped due to Financial problems	['Business_Administrative']	['Possibly_Negative']
treatment deemed ineffective so accrual was closed	['Insufficient_Enrollment']	['Neutral']
Primary endpoint data review concluded no further patients required.	['Interim_Analysis', 'Endpoint_Met', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Study terminated due to no patient population available	['Insufficient_Enrollment']	['Neutral']
study close-out	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Only 2 patients screened but none of them were enrolled.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"Protocol was comparing to standard of practice, which has changed over the course of slow
    recruitment and no longer can be used as a comparator."	['Study_Design']	['Neutral']
Study terminated 7/23/2019 due to limited participation and testing challenges.	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Slow recruitment and limited funding. The treatment intervention is instituted in clinical
    practice as and end-stage treatment option at hospitals in Denmark"	['Business_Administrative']	['Possibly_Negative']
"Results from first few subjects was not significantly improved over standard, traditional
    procedures."	['Negative']	['Negative']
Decision of the funder: Almond Board of California	['Business_Administrative']	['Possibly_Negative']
Analysis of first 10 participants showed the technique was not efficacious	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Discontinued by Investigator	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
"Terminated early because a similar study with Ataluren exhibited lack of efficacy at the high
    dose (not due to safety concerns)."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Due to COVID-19 concerns and restrictions in our at-risk population, interactions were halted.	['Covid19']	['Neutral']
Strategic closure by sponsor to pursue other indications.	['Business_Administrative']	['Possibly_Negative']
"GanLee cancelled study -FDA Draft Guidance: ""Clinical Immunogenicity Considerations for
    Biosimilar & Interchangeable Insulin Products"" released 11/25/2019"	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Termination of study by investigator related to COVID pandemic.	['Covid19']	['Neutral']
Lack of efficacy of the study medication	['Negative']	['Negative']
The study was not deemed feasible to conduct.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
"Study was never initiated under new location/provider group. Contract to continue was never
    signed between TEVA and Kennedy Headache Center"	['Business_Administrative']	['Possibly_Negative']
Device modifications required prior to trial proceeding.	['Study_Design']	['Neutral']
"The study was terminated because the first Phase 3 did not demonstrate efficacy on the
    co-primary endpoints. The known safety profile remained unchanged."	['Negative']	['Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
withdrawn because of insufficient financial capacities	['Business_Administrative']	['Possibly_Negative']
lack of participant accrual	['Insufficient_Enrollment']	['Neutral']
"In the context of the ongoing evaluation of our data, we have determined that there is no need
    to generate additional safety data at this time in the 1L mRCC pa"	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Based on preliminary safety data.	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
low enrollment	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
"Institutional Ethics Board concern regarding sham procedure, requiring modifications that are
    not feasible within the man-power limitations of our institution."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"The PI left and then the PI who would be taking over has left. No other investigator wanted to
    take the study since not sponsored"	['Study_Staff_Moved']	['Neutral']
Sponsor is no longer pursuing the study.	['Business_Administrative']	['Possibly_Negative']
Manufacturer did not develop and deliver the necessary biopsy forceps needles in time	['Logistics_Resources']	['Neutral']
"After an interim analysis of the data, it became clear that the imaging results did not
    correlate to the primary outcome measures in this subset of patients."	['Negative']	['Negative']
"The treatment planned was determined to be of low feasibility as no subject was found eligible
    and able to enroll after screening over 30 subjects"	['Insufficient_Enrollment']	['Neutral']
Administrative withdrawal by IRB	['Business_Administrative']	['Possibly_Negative']
Released by he FDA from this Post-Marketing Commitment	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
In this feasibility study device did not perform as well as expected.	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Terminated due to recruitment problems	['Insufficient_Enrollment']	['Neutral']
The company decided to cancel this study in conformity with PH FDA Circular 2013-004	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
"Limited time frame and financial resources. The anticipated increase of eligable migrant women
    did not occur during the period because of changes in migration policies."	['Business_Administrative']	['Possibly_Negative']
Difficulties of recruitment, lack of elligible patients	['Insufficient_Enrollment']	['Neutral']
suspended for this protocol due to the pandemic,	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Financial difficulties	['Business_Administrative']	['Possibly_Negative']
Study closed due to low accrual.	['Insufficient_Enrollment']	['Neutral']
Forms are not ready	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
New protocol now being used for cardiopulmonary bypass	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Low recruitment after the expected time to finish the study	['Insufficient_Enrollment']	['Neutral']
The Primary Investigator is no longer with UPMC. No patients have been enrolled.	['Study_Staff_Moved']	['Neutral']
"The step-wedge implementation of the study has proved not to be feasible due to uncertainty
    about funding, hiring, and staffing the new hospitalist service."	['Business_Administrative']	['Possibly_Negative']
The recruitment rate was too slow according to study protocol and agreement.	['Insufficient_Enrollment']	['Neutral']
Protocol as presented by investigator was not approved by the NIDDK.	['Regulatory', 'Insufficient_Enrollment', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Withdrawn by PI	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Business decision to close study based on low enrollment	['Business_Administrative']	['Possibly_Negative']
Slow/insufficient accrual and investigators have left the study.	['Insufficient_Enrollment']	['Neutral']
Novartis paused all study start-up activities due to safety evaluation of IDH305 compound.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
The study was terminated due to hepatoxicity of compound	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Patient target could not be reached within the planned timeframe.	['Insufficient_Enrollment']	['Neutral']
Sponsor's Decision	['Business_Administrative']	['Possibly_Negative']
"This study was terminated by the sponsor since study timelines were extended significantly due
    to slow enrollment, partly influenced by the COVID-19 pandemic."	['Covid19']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
"Study temporarily paused due to COVID-19 and expected to resume. This is not a suspension of
    IRB approval."	['Covid19']	['Neutral']
"statistical significance of the results was reached for the 34 subjects who participated in teh
    study."	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Study halted prematurely, prior to enrolment of first patient.	['Invalid_Reason']	['Invalid_Reason']
"Sponsor decision to discontinue the SHP647 (ontamalimab) clinical trial development program for
    inflammatory bowel diseases (IBD) early."	['Business_Administrative']	['Possibly_Negative']
slow enrollment; resource re-allocation	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
closed by sponser	['Business_Administrative']	['Possibly_Negative']
COVID-related laboratory shutdown.	['Covid19']	['Neutral']
insufficient quality of data	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Low recruiment.	['Insufficient_Enrollment']	['Neutral']
"Covid paused recruitment after the first participant was recruited. Subsequently, key study
    staff moved institution meaning it was no longer possible to run the trial."	['Covid19', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Feasibility study, sufficient amount of data collected.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
"All clinical trials within the Department of Psychiatry at UMN were suspended and this study
    was withdrawn due to no enrollment."	['Insufficient_Enrollment']	['Neutral']
Terminated due to safety concerns.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
No patients enrolled for long period of time. No scientific interest any more	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Not sufficient staff to complete the trial.	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
poor accrual	['Insufficient_Enrollment']	['Neutral']
Low accrual rate.	['Insufficient_Enrollment']	['Neutral']
technical difficulties of probe measurement	['Logistics_Resources']	['Neutral']
was not funded	['Business_Administrative']	['Possibly_Negative']
The funding ended.	['Business_Administrative']	['Possibly_Negative']
PI is leaving institution	['Study_Staff_Moved']	['Neutral']
similar study in USA published with same protocol	['Negative', 'Another_Study']	['Negative', 'Neutral']
Will answer study question through other research means.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
- Interest in the use of HCQ is controversial.	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Data analysis completed	['Invalid_Reason']	['Invalid_Reason']
Sponsor Decision based on strategic considerations.	['Business_Administrative']	['Possibly_Negative']
Stopped due to a strategic decision.	['Business_Administrative']	['Possibly_Negative']
"""the study has been closed due to a low rate of patient enrollment (2 patients since the start
    of the trial)"""	['Insufficient_Enrollment']	['Neutral']
poor enrollment and lack of study staff	['Insufficient_Enrollment']	['Neutral']
Active Duty principle investigator currently deployed	['Study_Staff_Moved']	['Neutral']
IRB will be terminated	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
suspended due to COVID	['Covid19']	['Neutral']
Study was closed due to extremely low enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsor decision based on enrollment	['Business_Administrative']	['Possibly_Negative']
Terminated, new protocol to be developed	['Study_Design']	['Neutral']
fail to get funding	['Business_Administrative']	['Possibly_Negative']
"Due to a substantial response to placebo an interim analysis indicated the need for a larger
    than expected study population to achieve the level of significance"	['Negative']	['Negative']
Lack of Accrual	['Insufficient_Enrollment']	['Neutral']
COVID-19	['Covid19']	['Neutral']
Other - Protocol amendment required for expansion	['Study_Design']	['Neutral']
closed to accrual due to low accrual	['Insufficient_Enrollment']	['Neutral']
Closing due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
Study was terminated early due to results from previous CMX study	['Negative', 'Another_Study']	['Negative', 'Neutral']
PI closed the study before any enrollment	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
The enrollment is slower than expected	['Insufficient_Enrollment']	['Neutral']
PI elected to close study	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
recruitment problems	['Insufficient_Enrollment']	['Neutral']
Financial shortages due to lack of funderx	['Business_Administrative']	['Possibly_Negative']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of efficacy	['Negative']	['Negative']
Pilot early noninvasive ventilation on all children who met the criteria was effective.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Study was not initiated	['Invalid_Reason']	['Invalid_Reason']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Sample not reached in traumathology arm	['Insufficient_Enrollment']	['Neutral']
R&D portfolio review and in light of the global impact of the COVID-19 pandemic	['Covid19']	['Neutral']
Grant projects were revised in response to COVID-19.	['Covid19']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
analysing images ongoing	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Monotherapy arm completed. Combination arm did not proceed (sponsor decision).	['Business_Administrative']	['Possibly_Negative']
already several publications in the literature	['Success', 'No_Context', 'Logistics_Resources']	['Success', 'Invalid_Reason', 'Neutral']
"This study was not conducted due to concerns about collaboration with an outside vendor for the
    control condition."	['Business_Administrative']	['Possibly_Negative']
Recruiting problems	['Insufficient_Enrollment']	['Neutral']
Interim futility analysis	['Negative']	['Negative']
The Sponsor decided to terminate the study due to the low patient recruitment.	['Insufficient_Enrollment']	['Neutral']
experimental drug prohibited by the ANSM (French competent authority)	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The changing aetiology of squamous cell carcinoma of the head and neck (SCCHN).	['Covid19', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Funding unclear	['Business_Administrative']	['Possibly_Negative']
Study ended after diabetes development plan review. .	['Business_Administrative']	['Possibly_Negative']
lack of participants	['Insufficient_Enrollment']	['Neutral']
Closed due to low accrual	['Insufficient_Enrollment']	['Neutral']
Slow enrollment with limited population for study parameters.	['Insufficient_Enrollment']	['Neutral']
Lack of recruitable patients	['Insufficient_Enrollment']	['Neutral']
"Study design was altered such that a treatment component was removed through the VA IRB. We did
    not and will not begin this clinical trial."	['Study_Design']	['Neutral']
Low enrollment, short stay; lacked statistically powered evaluation for efficacy.	['Negative']	['Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Changes in country regulation	['No_Context', 'Regulatory', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
Study concept vacated due to sample collection issues	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Recruitment Challenges	['Insufficient_Enrollment']	['Neutral']
An enhanced device has been developed	['Logistics_Resources', 'Endpoint_Met', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
"Study was conducted to fulfill a post marketing commitment (PMC 6). FDA acknowledged
    fulfillment of PMC."	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
abandonment	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Because of COVID-19	['Covid19']	['Neutral']
Due to COVID-19 pandemic, it was no possible to recruit patients for this study.	['Covid19']	['Neutral']
Enrollment goal could not be met.	['Insufficient_Enrollment']	['Neutral']
For business reasons	['Business_Administrative']	['Possibly_Negative']
Funding withdrawn - slow enrollment	['Business_Administrative']	['Possibly_Negative']
not enough recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Study was not initiated it was decided to cancel this study	['Invalid_Reason']	['Invalid_Reason']
terminated by funding agency	['Business_Administrative']	['Possibly_Negative']
Changes in staff resulted in logistic difficulties to perform the study	['Logistics_Resources']	['Neutral']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
PI decision due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Withdrawn due to transfer of Investigator	['Study_Staff_Moved']	['Neutral']
because of unexpected administrative barrier, it was very difficult to enroll case.	['Business_Administrative']	['Possibly_Negative']
The entire drug development program for this molecule was sold to another company.	['Business_Administrative']	['Possibly_Negative']
Not NIH defined clinical trial study.	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
No participants.	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
COVID-19 Pandemic	['Covid19']	['Neutral']
study could not recruit any more patients	['Insufficient_Enrollment']	['Neutral']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Difficulty acquiring fresh tissue from mastectomy specimens.	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Lack of study enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsor withdrew support	['Business_Administrative']	['Possibly_Negative']
"The study includes adults vulnerable to COVID-19 and procedures cannot accommodate social
    distancing."	['Covid19']	['Neutral']
COVID-19 lockdown	['Covid19']	['Neutral']
Study was redesigned and taken over by a ph.D-student	['Study_Staff_Moved', 'Study_Design', 'Another_Study']	['Neutral', 'Neutral', 'Neutral']
Study was stopped due because recrutation.was much slower as anticipated.	['Insufficient_Enrollment']	['Neutral']
Myriad has discontinued the development of Flurizan.	['Business_Administrative']	['Possibly_Negative']
Study proposal was not accepted for funding and therefore not further explored at this stage.	['Business_Administrative']	['Possibly_Negative']
failure to recruit patients	['Insufficient_Enrollment']	['Neutral']
Toxicity issues	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
The study was closed to enrollment due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
"Change in Principal Investigator and protocol revisions delayed study start and ultimately the
    decision was made to cancel the study."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
too limited number of eligible patients	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
The study has been halted pending additional funding.	['Business_Administrative']	['Possibly_Negative']
Insufficient population of eligible patients.	['Insufficient_Enrollment']	['Neutral']
Funding unavailable	['Business_Administrative']	['Possibly_Negative']
Toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"Study was terminated prematurely due to 2 cases of agranulocytosis in a different clinical
    trial with this same drug."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Strategic decision	['Business_Administrative']	['Possibly_Negative']
This study has been cancelled prior to FSFV due to business reasons	['Business_Administrative']	['Possibly_Negative']
"Exposure of these high-risk patients to clinic or in-person visits during the pandemic
    presented an unacceptable risk to their health"	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Due to thrombosis	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"Observation of low incidence of asymptomatic, transiently elevated liver enzymes in a subset of
    study subjects"	['Safety_Sideeffects', 'Endpoint_Met', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
All required data are already collected.	['Invalid_Reason']	['Invalid_Reason']
Slow Accural	['Insufficient_Enrollment']	['Neutral']
Abandoned due to poor recruitment	['Insufficient_Enrollment']	['Neutral']
Research lab not accessible due to the pandemic.	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
'Recruitment not possible given changes to trial criteria	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Unable to recruit	['Insufficient_Enrollment']	['Neutral']
Due to technical details recruitment was unreasonably slow	['Insufficient_Enrollment']	['Neutral']
Funding not available. Could not start this study.	['Business_Administrative']	['Possibly_Negative']
Because of difficulties in recruiting	['Insufficient_Enrollment']	['Neutral']
Development of compound has been put on hold.	['Business_Administrative']	['Possibly_Negative']
study halted prematurely, prior to enrollment of first participant	['Invalid_Reason']	['Invalid_Reason']
Due to lack of participant recruitment	['Insufficient_Enrollment']	['Neutral']
study not started	['Invalid_Reason']	['Invalid_Reason']
Slow/low enrollment	['Insufficient_Enrollment']	['Neutral']
Company could not supply the accommodating intraocular lenses for the study	['Logistics_Resources']	['Neutral']
Investigator left institution	['Study_Staff_Moved']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Withdrawn	['Invalid_Reason']	['Invalid_Reason']
Study did not receive funding and was administratively withdrawn.	['Business_Administrative']	['Possibly_Negative']
Slow patient recruitment after arrival of macitentan on the market	['Insufficient_Enrollment']	['Neutral']
underenrollment	['Insufficient_Enrollment']	['Neutral']
Insufficient enrollment; non-interest by target sample	['Insufficient_Enrollment']	['Neutral']
Due to a low inclusion rate	['Insufficient_Enrollment']	['Neutral']
research group's decision	['Business_Administrative']	['Possibly_Negative']
Working on complying with the Research Ethics Board requirements.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Changed to quality improvement project	['Study_Design']	['Neutral']
waiting for additional funding to complete trial	['Business_Administrative']	['Possibly_Negative']
PI Left the Institution	['Study_Staff_Moved']	['Neutral']
Interim analysis showed primary outcome was not going to be achieved.	['Negative']	['Negative']
Suspended temporarily due to staff changes	['Logistics_Resources']	['Neutral']
New funding required	['Business_Administrative']	['Possibly_Negative']
departure of the investigator from the CHU Grenoble Alpes	['Study_Staff_Moved']	['Neutral']
"Study reached pre-determined futility criteria following interim analysis. No safety concerns
    were noted."	['Negative']	['Negative']
Research manpower shortage	['Logistics_Resources']	['Neutral']
Number of subjects could not be achieved due to slow recruitment	['Insufficient_Enrollment']	['Neutral']
Insufficient CO2 removal obtained with the PrismaLung membrane oxygenator	['Logistics_Resources']	['Neutral']
Difficult recruitment	['Insufficient_Enrollment']	['Neutral']
Insufficient personnel to complete the study.	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
At the moment no participants are enrolled untill a new agreement is made	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Attending physician left network	['Study_Staff_Moved']	['Neutral']
Variability of the pneumocephalus volume mean was higher than initially assumed	['Negative']	['Negative']
Study halted/terminated prematurely due to COVID.	['Covid19']	['Neutral']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Renewal of PET/CT scanners and slow recruitment	['Insufficient_Enrollment']	['Neutral']
Because lack of funding	['Business_Administrative']	['Possibly_Negative']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Difficulty including patients	['Insufficient_Enrollment']	['Neutral']
Recruitment of planned number of Subjects was not feasible.	['Insufficient_Enrollment']	['Neutral']
lack of support resources to complete study appropriately	['Business_Administrative']	['Possibly_Negative']
low accrual rate	['Insufficient_Enrollment']	['Neutral']
"1. New data from a published trial requires substantial change in study protocol

      2. no funding available to carry the study further"	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
recruitment issues	['Insufficient_Enrollment']	['Neutral']
PI no longer at institution	['Study_Staff_Moved']	['Neutral']
The trial was prematurely closed due to lack of accrual.	['Insufficient_Enrollment']	['Neutral']
H1N1 pandemic concluded	['Safety_Sideeffects', 'Endpoint_Met', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Interim analysis showed futility of primary endpoint	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
minimal accrual	['Insufficient_Enrollment']	['Neutral']
"Combination of insufficient research staff support, insufficient subjects meeting enrollment
    criteria, and investigators changing role responsibilities."	['Insufficient_Enrollment']	['Neutral']
Due to limited population of research participants.	['Insufficient_Enrollment']	['Neutral']
Difficulty in recruiting subjects for the trial.	['Insufficient_Enrollment']	['Neutral']
Unable to recruit participants	['Insufficient_Enrollment']	['Neutral']
No subjects enrolled.	['Insufficient_Enrollment']	['Neutral']
Non Hep C study arm has been completed, Hep C study arm has not been completed.	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
Sponsor withdrew funding of study.	['Business_Administrative']	['Possibly_Negative']
Toxicity was not felt to be acceptable for further development.	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
The study was never initiated	['Invalid_Reason']	['Invalid_Reason']
Study failed to recruit a sufficient number of subjects in the time anticipated.	['Insufficient_Enrollment']	['Neutral']
Local regulations	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Withdrawal of funding from sponsor	['Business_Administrative']	['Possibly_Negative']
"based on interim analysis statistical significance in primary endpoint cannot be achieved with
    planned sample size, no safety concerns"	['Negative']	['Negative']
Low enrollment exceeding trial deadlines	['Insufficient_Enrollment']	['Neutral']
difficulty in enrollment	['Insufficient_Enrollment']	['Neutral']
Because very low number of patients were enrolled	['Insufficient_Enrollment']	['Neutral']
"Results of an interim analysis showed that it was unlikely that creatine was effective in
    slowing loss of function in early symptomatic Huntington's Disease."	['Negative']	['Negative']
Lack of financial support	['Business_Administrative']	['Possibly_Negative']
Recruitment was proceeding too slowly	['Insufficient_Enrollment']	['Neutral']
Slow accrual and loss of funding	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
"Amgen discontinued the development of AMG706 because 20050201 did not meet its primary
    objective."	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
HandyLab device determined to not work for the science	['Logistics_Resources']	['Neutral']
Limitation of funding	['Business_Administrative']	['Possibly_Negative']
recruitment of patients did not reach sufficient numbers	['Insufficient_Enrollment']	['Neutral']
Unable to recruit enough subjects	['Insufficient_Enrollment']	['Neutral']
lost funding	['Business_Administrative']	['Possibly_Negative']
Low acrual	['Insufficient_Enrollment']	['Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
insufficient patients with CKD willing to be injected with heparin	['Insufficient_Enrollment']	['Neutral']
PI Left before primary outcome was established	['Study_Staff_Moved']	['Neutral']
No enrollments	['Insufficient_Enrollment']	['Neutral']
Enrollment of eligible subjects, delays due to the COVID-19 Virus, and lack of funding	['Covid19']	['Neutral']
terminated	['Invalid_Reason']	['Invalid_Reason']
enrolling participants stopped	['Invalid_Reason']	['Invalid_Reason']
"High drop-out rate leads to the conclusion: not enough data will be available to perform proper
    analyses of data collected after follow-up month 24 visit"	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
"Efficacy endpoint met, but overall experimental dosing regimen not considered optimal to
    support further clinical development in this population."	['Negative']	['Negative']
Due to limited rate of patient inclusion	['Insufficient_Enrollment']	['Neutral']
Study Closed after completion of Phase I	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
"Terminated: Study in Behcet's disease with mostly active uveitis did not meet its primary
    endpoint."	['Negative']	['Negative']
Slow patients enrollment	['Insufficient_Enrollment']	['Neutral']
PI left Geisinger-study terminated prematurely - 4 patients enrolled	['Study_Staff_Moved']	['Neutral']
Delayed recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of efficacy identified during a preliminary analysis	['Negative']	['Negative']
"All non-COVID research has been temporarily ""suspended"" until further notice."	['Covid19']	['Neutral']
PI leaving the institution	['Study_Staff_Moved']	['Neutral']
"The required number of patients was not reached. The sites were not able to include more
    patients.Despite several actions the stop of the study has been decided"	['Insufficient_Enrollment']	['Neutral']
Recruitment was halted due to the difficulties in recruiting.	['Insufficient_Enrollment']	['Neutral']
Due to low recruitment, it was decided to terminate the study.	['Insufficient_Enrollment']	['Neutral']
due to organisational changes	['Business_Administrative']	['Possibly_Negative']
Recruitment was too slow and we cannot anticipate to recruit the target sample size	['Insufficient_Enrollment']	['Neutral']
Sponsor decision to analyze available safety and efficacy data	['Interim_Analysis', 'Regulatory', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Remaining outdated treatments and additional costs too high for new manufacturing	['Logistics_Resources']	['Neutral']
By Data Safety and Monitoring Board after second interim analysis and follow-up safety check.	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
The study was terminated early due to business reasons	['Business_Administrative']	['Possibly_Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Study to resume after FDA and IRB review (IND application)	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Change in research plan	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
"United Neuroscience has decided to terminate V203-AD-EXT study based on a treatment assignment
    error"	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
failure to recruit	['Insufficient_Enrollment']	['Neutral']
Due to serious adverse events	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Because of difficulties in recruting	['Insufficient_Enrollment']	['Neutral']
unable to replace Fellow conducting the study who left institution in 2007	['Study_Staff_Moved']	['Neutral']
Sponsor decision unrelated to safety	['Business_Administrative']	['Possibly_Negative']
Could not recruit enough patients	['Insufficient_Enrollment']	['Neutral']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
28 of 168 patients only were enrolled, numbers too low to be conclusive	['Insufficient_Enrollment']	['Neutral']
impossible to retain participants in 3-year longitudinal study	['Insufficient_Enrollment']	['Neutral']
5-Y FUP will not result in new perception, no diff. between groups at 1+3y FUP	['Negative']	['Negative']
We were not able to recruit enough patients for this study within a given time frame.	['Insufficient_Enrollment']	['Neutral']
Consolidated study with another protocol	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"Based on available data, UCB has decided to stop development of padsevonil as adjunctive
    treatment of focal-onset seizures"	['Regulatory', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Withdrawal of Industry support for the study	['Business_Administrative']	['Possibly_Negative']
Business decision	['Business_Administrative']	['Possibly_Negative']
study did not meet pre-specified criteria for continuation following interim futility analysis	['Negative']	['Negative']
study stopped at this site, as investigator left the institution	['Study_Staff_Moved']	['Neutral']
"Terminated early when the results from Study NCT00300885 showed an overall lack of efficacy in
    NSCLC and increased mortality in subjects with squamous subtype."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study withdrawn - changing study design.	['Study_Design']	['Neutral']
Challenges with funding acquisition prevented study commencement.	['Business_Administrative']	['Possibly_Negative']
Sponsor terminated open-label extension	['Business_Administrative']	['Possibly_Negative']
Termination due to high current screen rate failure and unreliable PSA mRNA assay.	['Logistics_Resources', 'Endpoint_Met', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Contact issues	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
COVID 19 RELATED FACTORS	['Covid19']	['Neutral']
Older participants could not tolerate the acidity of the product and withdrew.	['Covid19', 'Interim_Analysis', 'Safety_Sideeffects']	['Neutral', 'Neutral', 'Safety_Sideeffects']
Physycians' refusal to continue the study	['Logistics_Resources', 'Insufficient_Enrollment', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
"The study is terminated prematurely as the sponsor decided to discontinue program with
    Tecemotide in NSCLC"	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
"As another Mps1 inhibitor was being developed in parallel, the strategic decision was to move
    forward with the development of the follow up compound only."	['Business_Administrative']	['Possibly_Negative']
"The REMAP-CAP and RECOVERY substudy results appear to support the survival benefit of
    tocilizumab in corticosteroid-treated or untreated patients with critically ill
    COVID-19-associated ARDS."	['Covid19']	['Neutral']
Not enough participants were included	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Study terminated at Sponsor's request.	['Business_Administrative']	['Possibly_Negative']
Withdrawn due to drug availability and funding	['Business_Administrative']	['Possibly_Negative']
Impractical to enroll the #s needed for statistical significance; project manager relocated	['Insufficient_Enrollment']	['Neutral']
Failed study, participants showed no improvements	['Negative']	['Negative']
decreasing rate of enrollment	['Insufficient_Enrollment']	['Neutral']
Business Reasons	['Business_Administrative']	['Possibly_Negative']
Following recommendation by SOLAR Study IDMC, Astellas closed enrollment in ASP8273 studies.	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Invalid_Reason']	['Safety_Sideeffects', 'Neutral', 'Invalid_Reason']
lack of accrual	['Insufficient_Enrollment']	['Neutral']
Retirement of the Principal Investigator	['Study_Staff_Moved']	['Neutral']
The patient passed before treatment could be started	['Invalid_Reason']	['Invalid_Reason']
New study with lenalidomide pending	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of efficacy of the drug; no safety concern	['Negative']	['Negative']
No safety issues. Need to rewrite protocol	['Study_Design']	['Neutral']
withdrawn prior to patient recruitment	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Difficulties with recruitment	['Insufficient_Enrollment']	['Neutral']
Failure to recruit sufficient participants	['Insufficient_Enrollment']	['Neutral']
Amgen has chosen at this time not to continue with AMG 745 study 20080733	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Did not get approval	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
No funding, lost support staff. No data collected/processed	['Business_Administrative']	['Possibly_Negative']
Due to clinical trial supplies shortage	['Logistics_Resources']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
"After review, recruitment was halted as the images obtained needed improvement. To be presented
    at the British Oculoplastic Surgery Society in Jun 17"	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Due to funding limitations	['Business_Administrative']	['Possibly_Negative']
Sponsors decision	['Business_Administrative']	['Possibly_Negative']
Inclusion curve too poor.	['Insufficient_Enrollment']	['Neutral']
study was never started due to lack of resources	['Logistics_Resources']	['Neutral']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
Difficulty enrolling patients	['Insufficient_Enrollment']	['Neutral']
study team plans to revise the treatment plan of the study.	['Study_Design']	['Neutral']
investigator left UCSF and study was closed prematurely in 2008. No results to report.	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
change of study population and chemotherapeutic regimen	['Study_Design']	['Neutral']
Other - Protocol moved to Disapproved	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Results from Phase II Study did not support ""dismantling"""	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
PI left institution. Efforts made to contact PI unsuccessful. No study data available.	['Study_Staff_Moved']	['Neutral']
Study not initiated	['Invalid_Reason']	['Invalid_Reason']
Clinical development strategy adjustment, non-safety reason	['Business_Administrative']	['Possibly_Negative']
"Believed that a better study was to compare the response to engerix B vs Sci-B-Vac vaccine in
    this patient group."	['Negative', 'Another_Study']	['Negative', 'Neutral']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
Terminated early due to redeployment of study site staff during Covid-19 pandemic	['Covid19']	['Neutral']
funding issues	['Business_Administrative']	['Possibly_Negative']
Lack of Funding	['Business_Administrative']	['Possibly_Negative']
not enough personnel to conduct study at site	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Trial not initiated	['Invalid_Reason']	['Invalid_Reason']
delayed recruitment	['Insufficient_Enrollment']	['Neutral']
change in imaging priorities	['Logistics_Resources', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
"MSD would not able to support the study's continuation after protocol modifications required by
    ANSM through dose de-escalation of pembrolizumab"	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
"Primary study outcome achieved; investigator decided to conduct the study without sponsor
    support after 2009."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
terminated	['Invalid_Reason']	['Invalid_Reason']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
Study was terminated due to low enrollment	['Insufficient_Enrollment']	['Neutral']
Suspended due to COVID-19; no suspension of IRB approval.	['Covid19']	['Neutral']
Terminated due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
The IDE wasn't approved	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Because the principal investigator has moved to another hospital	['Study_Staff_Moved']	['Neutral']
Lack of Accrual.	['Insufficient_Enrollment']	['Neutral']
Problems with data collection	['Logistics_Resources']	['Neutral']
On hold pending product development	['Business_Administrative']	['Possibly_Negative']
Patients enrollment problem	['Insufficient_Enrollment']	['Neutral']
"Rights for the further development of drisapersen have been transferred to Prosensa. Therefore
    this study has been cancelled before enrollment."	['Business_Administrative']	['Possibly_Negative']
Study was terminated early as sponsor wanted to develop an improved formulation.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Delay due to infrastructural reasons. Funding withdrawn	['Business_Administrative']	['Possibly_Negative']
insufficient data	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
a significant number of patients were not selected	['Insufficient_Enrollment']	['Neutral']
lack of resources to finance the project	['Business_Administrative']	['Possibly_Negative']
Sponsor has terminated study due to COVID-19 related concerns	['Covid19']	['Neutral']
The study got discontinued due to lack of efficacy	['Negative']	['Negative']
"The study was prematurely terminated on 06 October 2016 due to the potential risk of further
    dosing in healthy subjects"	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
The study was stopped for technical reasons	['Logistics_Resources']	['Neutral']
study cancelled. Device evolves.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Interim assessment: Lack of efficacy	['Negative']	['Negative']
lack of funding to cover staff salary (clinician and research coordinator)	['Business_Administrative']	['Possibly_Negative']
Policy approved describing all procedures as standard of care	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
No eligible patient was enrolled.	['Insufficient_Enrollment']	['Neutral']
Study stopped due to opening Expanded Access Protocol.	['Study_Design']	['Neutral']
default recruitment	['Insufficient_Enrollment']	['Neutral']
Terminated due to inadequate rate of accrual.	['Insufficient_Enrollment']	['Neutral']
unable to recruit	['Insufficient_Enrollment']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Unable to recruit during COVID-19 crisis	['Covid19']	['Neutral']
Please see detailed description for termination reason.	['No_Context']	['Invalid_Reason']
"The study was stopped due to low subject enrollment. No safety issue or other concern factored
    into this decision."	['Insufficient_Enrollment']	['Neutral']
"Very low recruitment rate. The Study Site classifies as tertiary referral hospital. Therefore,
    GERD Patients being referred to the site are mostly those with comorbidities included in the
    exclusion criteria."	['Insufficient_Enrollment']	['Neutral']
Technical problems, unreliability of the measured parameters	['Logistics_Resources']	['Neutral']
PI moved to a different institution.	['Study_Staff_Moved']	['Neutral']
Recruitment was unfeasible due to patients being unavailable to recruit.	['Insufficient_Enrollment']	['Neutral']
closed early due to poor accrual	['Insufficient_Enrollment']	['Neutral']
Funding issues	['Business_Administrative']	['Possibly_Negative']
No subject meeting criteria	['Insufficient_Enrollment']	['Neutral']
Study enrollment was stopped due to insufficient subject accrual.	['Insufficient_Enrollment']	['Neutral']
COVID-19	['Covid19']	['Neutral']
Terminated due to low accrual and toxicity concerns.	['Insufficient_Enrollment']	['Neutral']
Inadequate Accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor Terminated	['Business_Administrative']	['Possibly_Negative']
low enrollment	['Insufficient_Enrollment']	['Neutral']
Study was halted due to poor recruitment and date on the biscuits expiring	['Insufficient_Enrollment']	['Neutral']
re-evaluation of radiotracer	['Study_Design']	['Neutral']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Sponsor cannot conduct research due to insufficient funding supportment	['Business_Administrative']	['Possibly_Negative']
Recruitment temporarily suspended due to COVID-19 pandemic.	['Covid19']	['Neutral']
The main reason for the early termination is the low recruitment rate.	['Insufficient_Enrollment']	['Neutral']
"In consideration of the progress now and the expected enrollment in the next few years,the NDA
    will not be acquired before the patent went out."	['Business_Administrative']	['Possibly_Negative']
"Due to the uncertain regulatory landscape for erythropoiesis-stimulating agents in oncology
    indications."	['Regulatory']	['Neutral']
"Enrollment slow over 2 years a change in the population less on metoprolol than initially
    anticipated"	['Insufficient_Enrollment']	['Neutral']
low enrollling	['Insufficient_Enrollment']	['Neutral']
"The trial was closed due to the changing efficacy of treatments for metastatic urothelial
    cancer."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Insufficient data to answer the study question	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Withdrawn due to inability to reach an acceptable agreement with industry sponsor	['Business_Administrative']	['Possibly_Negative']
did not meet target accrual	['Insufficient_Enrollment']	['Neutral']
Logistical challenges; no safety concerns	['Logistics_Resources']	['Neutral']
The primary objective was considered sufficient for follow-up.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Logistical issues	['Logistics_Resources']	['Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
"Study product bottles were found on site that did not meet product specifications. This
    prompted a 6-week safety review of participants (no study-related findings) and resulted in the
    study's termination."	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Funding terminated	['Business_Administrative']	['Possibly_Negative']
funding stopped due to slow enrollment.	['Business_Administrative']	['Possibly_Negative']
Funding unavailable	['Business_Administrative']	['Possibly_Negative']
poor response to questionnaire	['Insufficient_Enrollment', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Interim analysis indicated adaptations to intervention may be required.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Principal Investigator made aware of similar studies that have already been published.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Changes in funding status	['Business_Administrative']	['Possibly_Negative']
On hold due to competing departmental studies	['Negative', 'Another_Study']	['Negative', 'Neutral']
unable to accrue	['Insufficient_Enrollment']	['Neutral']
Study objectives met	['Invalid_Reason']	['Invalid_Reason']
Difficult to enroll patients; limited resources available	['Insufficient_Enrollment']	['Neutral']
Halted before intervention due to approval of service.	['Regulatory', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
The study was prematurely stopped due to business reasons.	['Business_Administrative']	['Possibly_Negative']
Pending first five participants responses	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
Recruitment issues	['Insufficient_Enrollment']	['Neutral']
COVID-19 pandemic	['Covid19']	['Neutral']
"After reviewing the feasibility and projected completion date of the study, UCB has made the
    decision to stop the study"	['Business_Administrative']	['Possibly_Negative']
Study cancelled before enrollment	['Invalid_Reason']	['Invalid_Reason']
Drug development suspended by current holder of IND	['Business_Administrative']	['Possibly_Negative']
Pending resolution of study drug issues	['Interim_Analysis', 'Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
study to be redesigned based on initial results	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"Several factors contributed to significant challenges in enrollment and led the Sponsor to
    discontinue the AMAG-FER-CKD-251 study as designed."	['Covid19', 'Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
The study was terminated after a covid-related suspension and the unavailability of drug.	['Covid19']	['Neutral']
Sponsor election	['Business_Administrative']	['Possibly_Negative']
Accrual issues - Low Accrual	['Insufficient_Enrollment']	['Neutral']
"Study was discontinued based on futility analysis conducted on Phase 3 trials (NCT02477800 and
    NCT02484547) and not based on safety concerns."	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Non achievement of the estimated sample size of the group silicone arthroplasty in a reasonable
    recruitment time."	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
not enough recruitment	['Insufficient_Enrollment']	['Neutral']
Study has been prematurely halted because of failure of patient recruitment.	['Insufficient_Enrollment']	['Neutral']
difficult recruitment - redesign in discussion	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor stopped supplying study drug	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Major change to study design	['Study_Design']	['Neutral']
no funding- study never began	['Business_Administrative']	['Possibly_Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
Inability to perform the study at present time.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Funding withdrawn	['Business_Administrative']	['Possibly_Negative']
loss of funding	['Business_Administrative']	['Possibly_Negative']
Funding source withdrew financial support prior to start of Phase II portion of study	['Business_Administrative']	['Possibly_Negative']
study close-out	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
The sponsor decide to terminate	['Business_Administrative']	['Possibly_Negative']
Assessing Feasibility	['Logistics_Resources']	['Neutral']
The Study could not be started due to an insufficient number of new EVD cases.	['Insufficient_Enrollment']	['Neutral']
did not meet efficacy goals after interim analysis	['Negative']	['Negative']
unable to secure funding	['Business_Administrative']	['Possibly_Negative']
Investigators decision	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
It is difficult to recruit partcipants under COVID-19.	['Covid19']	['Neutral']
Funding support withdrawn.	['Business_Administrative']	['Possibly_Negative']
Early findings identified the need to update the design of the study device.	['Study_Design']	['Neutral']
Lack of MR scanning capacity	['Logistics_Resources']	['Neutral']
Business reasons	['Business_Administrative']	['Possibly_Negative']
Continuing the trial was considered to be superfluous.	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
funding expired	['Business_Administrative']	['Possibly_Negative']
Repros stopped the study for safety and FDA put the study on hold for safety.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Clinical partner left University,	['Study_Staff_Moved']	['Neutral']
Terminated due to lagging follow-up.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Change in isolation method	['Study_Design']	['Neutral']
Insufficient enrollment during 2009-2010 flu season, new study initiated.	['Insufficient_Enrollment']	['Neutral']
No outside recruitment of subjects from Main Atenolol VS Losartan NIH study	['Insufficient_Enrollment']	['Neutral']
Business Reasons	['Business_Administrative']	['Possibly_Negative']
Dr. Jorizzo has withdrawn from this study due to time it is taking to start	['Business_Administrative']	['Possibly_Negative']
Poor subject accrual	['Insufficient_Enrollment']	['Neutral']
"Due to the principal investigator leaving the institution and slow enrollment, we have decided
    to close the study prior to study completion"	['Insufficient_Enrollment']	['Neutral']
study staff change	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
The trial was terminated early because fair/poor cosmesis developed in 7 of 32 women.	['Safety_Sideeffects', 'Negative']	['Safety_Sideeffects', 'Negative']
Can not recruit the patients due to the pandemic of COVID-19	['Covid19']	['Neutral']
Suspended to by the institution due to sub-investigator protocol adherence concerns	['Study_Design']	['Neutral']
failure in regulatory statements	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
the efficency is not good enough to enroll more patients	['Insufficient_Enrollment']	['Neutral']
New data suggests that insufficient target engagement would be achieved for efficacy.	['Negative', 'Another_Study']	['Negative', 'Neutral']
low recruitement rate	['Insufficient_Enrollment']	['Neutral']
problems of insuffisant recruitment	['Insufficient_Enrollment']	['Neutral']
Collaboration could not be established	['Business_Administrative']	['Possibly_Negative']
"Recruitment challenges and difficulties performing upright hemodynamic measurements using
    current cath lab setup lead to termination."	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Significantly lower accrual rate than anticipated, time constraints.	['Insufficient_Enrollment']	['Neutral']
unable to procure supplement for clinical trial use	['Logistics_Resources']	['Neutral']
Lack of referrals.	['Insufficient_Enrollment']	['Neutral']
Study withdrawn. No participants enrolled.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
due to slow enrollment and approval of the Trikafta for CF patients	['Insufficient_Enrollment']	['Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Availability of relevant new efficacy data from another study	['Negative', 'Another_Study']	['Negative', 'Neutral']
PI left inistitution	['Study_Staff_Moved']	['Neutral']
The accrual rate was not high enough to reach the target sample size.	['Insufficient_Enrollment']	['Neutral']
"Despite considerable efforts to boost recruitment during the final year of the study, no new
    patients were enrolled."	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Results showing no effect	['Negative']	['Negative']
"All treatment arms met the futility criteria for efficacy during the pre-planned interim
    analysis, therefore the study was stopped."	['Negative']	['Negative']
Change in the benefit-risk balance	['Interim_Analysis', 'Regulatory', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Sponsor decided to stop the study due to expiration of blinded placebo .	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
lower recruitment rates as expected	['Insufficient_Enrollment']	['Neutral']
The study was terminated due to procurement of new funding sources.	['Business_Administrative']	['Possibly_Negative']
Insufficient recruitment of suitable patients.	['Insufficient_Enrollment']	['Neutral']
Clinical workflow was too high	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Researchers go abroad to study	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
Technical problems.	['Logistics_Resources']	['Neutral']
Difficulty with recruiting patients; poor quality of EMG	['Insufficient_Enrollment']	['Neutral']
Withdrawn due to lack of study centers interested in participating.	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
No accrual	['Insufficient_Enrollment']	['Neutral']
difficulty to include patients	['Insufficient_Enrollment']	['Neutral']
(Recruitment was early terminated due to slow recruitment. Not linked to any safety concern.)	['Insufficient_Enrollment']	['Neutral']
Could not receive FDA approval for IND	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The company has decided not to conduct the study	['Business_Administrative']	['Possibly_Negative']
End of inclusion period	['Invalid_Reason']	['Invalid_Reason']
not able to recruit	['Insufficient_Enrollment']	['Neutral']
The study was terminated in the interest of patient safety.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
declined enrollment	['Insufficient_Enrollment']	['Neutral']
No response to EC questions were given	['Regulatory', 'Insufficient_Enrollment', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
COVID-19 pandemic	['Covid19']	['Neutral']
insufficient patients to satisfy study protocol(s) inclusion criteria	['Insufficient_Enrollment']	['Neutral']
"Terminated based on lack of efficacy seen in participants taking danirixin in dose ranging
    study and Sponsor decision to stop development of danirixin for COPD"	['Negative']	['Negative']
"Study stopped as it would not address important survival concerns raised in other recently
    conducted clinical studies."	['Negative', 'Another_Study']	['Negative', 'Neutral']
No recommended Phase II dose was determined.	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Expiry of grant funding	['Business_Administrative']	['Possibly_Negative']
Based on results from Alexion PROTECT DGF study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Poor local tolerance to injection.	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Company strategy adjustment	['Business_Administrative']	['Possibly_Negative']
Groin surgery was changed to a laparoscopic technique; recruitable patients ceased.	['Study_Design']	['Neutral']
Study cancelled prior to FSI	['Invalid_Reason']	['Invalid_Reason']
"Due to a challenging protocol inclusion/ exclusion criteria, only one subject was enrolled
    since the trial was initiated in June 2011."	['Insufficient_Enrollment']	['Neutral']
"The TDE-DU-202 extension study was discontinued after the randomized, placebo-controlled
    TDE-DU-201 study did not meet its primary efficacy objective."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study withdrawn prior to IRB approval and enrollment	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Funding Issues	['Business_Administrative']	['Possibly_Negative']
Study stopped due to funding limitations	['Business_Administrative']	['Possibly_Negative']
PI no longer in practice.	['Study_Staff_Moved']	['Neutral']
"IRB recommended to stop the trial becasue none of the 4 procedures showed a predictive value
    for VAP, duration of MV or mortality."	['Negative']	['Negative']
funding	['Business_Administrative']	['Possibly_Negative']
Low enrollment.	['Insufficient_Enrollment']	['Neutral']
Study was resurrected as NCT00727558 (CR-0808)	['Negative', 'Another_Study']	['Negative', 'Neutral']
program has been put on hold by the sponsor	['Business_Administrative']	['Possibly_Negative']
could not and did not recruit any participants	['Insufficient_Enrollment']	['Neutral']
Study was not initiated due to lack of funding by the sponsor	['Business_Administrative']	['Possibly_Negative']
Animal Safety Data	['Negative', 'Another_Study']	['Negative', 'Neutral']
PI decision	['Invalid_Reason']	['Invalid_Reason']
"After pilot study no difference in the primary end point was found between the two primary.
    Non-inferiority trial not deemed feasible."	['Negative']	['Negative']
Study was cancelled by Sponsor.	['Business_Administrative']	['Possibly_Negative']
To pursue broader program objectives in oncology.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
sponsor withdrew the funds because the smell of sodium butyrate made blinding impossible	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Grant was not renewed	['Business_Administrative']	['Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
combine with another trial	['Negative', 'Another_Study']	['Negative', 'Neutral']
Expired with UF IRB.	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Administrative Closure	['Business_Administrative']	['Possibly_Negative']
unfunded	['Business_Administrative']	['Possibly_Negative']
refusal ethics comity	['Logistics_Resources', 'Regulatory', 'Study_Staff_Moved']	['Neutral', 'Neutral', 'Neutral']
Because only a few patients follow the inclusion and exclusion criteria.	['Insufficient_Enrollment']	['Neutral']
Study was terminated for futility following the planned interim analysis.	['Negative']	['Negative']
Discontinuation of development program	['Business_Administrative']	['Possibly_Negative']
Because of COVID epidemic	['Covid19']	['Neutral']
"The second study arm including radio-frequency microneedling was withdrawn due to availability
    of newer treatment options."	['Study_Design']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
"UCL CTC were informed by Merck Sharp & Dohme on 22.08.11 that support for the trial had been
    withdrawn in light of results from another trial with trial drug."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Focus resources on a planned phase 2/3 study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Closed: low enrollment, many treatment options available for Colorectal Cancer	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Not initiated	['Invalid_Reason']	['Invalid_Reason']
Investigator left institution prior to enrollment of study participants	['Study_Staff_Moved']	['Neutral']
Arm A - reached goal; Arm B - poor accrual	['Insufficient_Enrollment']	['Neutral']
No participants	['Insufficient_Enrollment']	['Neutral']
"Patients are receiving detailed packet from department and do not feel they need to go online
    for additional support."	['Business_Administrative']	['Possibly_Negative']
Principle investigator changed practice location and discontinued study	['Study_Staff_Moved']	['Neutral']
Significantly increased incidence of primary endpoint in the FiO2 60% group	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Did not pass set-up phase	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Project postponed	['Invalid_Reason']	['Invalid_Reason']
lack of patients	['Insufficient_Enrollment']	['Neutral']
low enrollment	['Insufficient_Enrollment']	['Neutral']
Similar projects have been registered, and it need to be withdrawn.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Study stopped prematurely due to enrolment challenges.	['Insufficient_Enrollment']	['Neutral']
unable to enroll subjects study stopped due to lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
unexpected toxicities	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
investigational radiotracer was not approved	['Interim_Analysis', 'Logistics_Resources', 'Endpoint_Met']	['Neutral', 'Neutral', 'Neutral']
Terminated due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Study timeline is not feasible	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
No participants enrolled.	['Insufficient_Enrollment']	['Neutral']
IND application did not get approved	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"We experienced challenges recruiting unmedicated women with high blood pressure for the
    intervention."	['Insufficient_Enrollment']	['Neutral']
Unable to find any suitable patients to enroll	['Insufficient_Enrollment']	['Neutral']
Unable to enroll any participants.	['Insufficient_Enrollment']	['Neutral']
Unable to recruit participants due to lack of patients eligible at the time	['Insufficient_Enrollment']	['Neutral']
IRB expired, PI no longer at institution.	['Study_Staff_Moved']	['Neutral']
Study deemed not feasible	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
On February 2019 Astra-Zeneca Greece decided to stop the financial support of the study.	['Business_Administrative']	['Possibly_Negative']
Not recruiting subjects currently	['Insufficient_Enrollment']	['Neutral']
Principal Investigator has moved to another institution	['Study_Staff_Moved']	['Neutral']
No enrollment in study.	['Insufficient_Enrollment']	['Neutral']
"Suspected side effects to the combination of clarithromycin and VCD (bortezomib,
    cyclophosphamide and dexamethasone)"	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Slow recruition	['Insufficient_Enrollment']	['Neutral']
Closed by IRB	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Trial was discontinued due to inadequate signal from study eeg leads.	['Logistics_Resources', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Original P.I. of this study transferred to a different institution.	['Study_Staff_Moved']	['Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Serious Adverse Event of Patient who completed study and follow-up.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Drug not available	['Logistics_Resources']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
Study was never started.	['Invalid_Reason']	['Invalid_Reason']
Results from other RCT made randomization unethical.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Futility of recruitment	['Negative']	['Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
loss of funding	['Business_Administrative']	['Possibly_Negative']
Study was terminated due to poor accrual.	['Insufficient_Enrollment']	['Neutral']
"Protocol not considered a clinical trial for registration purposes; no subjects enrolled to
    date pending further grant funding"	['Business_Administrative']	['Possibly_Negative']
The study was stopped due to lack of inclusion	['Insufficient_Enrollment']	['Neutral']
We were unable to recruit subjects for this study.	['Insufficient_Enrollment']	['Neutral']
A series of administrative delays on all sides involved, combined with funding problems.	['Business_Administrative']	['Possibly_Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
"Per design: Stop if fewer than 3 cohorts by molecular classification were with 10 participants
    or only 1 cohort enrolled at least 15 participants of 50."	['No_Context', 'Safety_Sideeffects', 'Logistics_Resources']	['Invalid_Reason', 'Safety_Sideeffects', 'Neutral']
the H1N1 pandemic is now over, and fewer cases than expected were observed	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
inability to recruit adequate numbers of subjects	['Insufficient_Enrollment']	['Neutral']
Futility	['Negative']	['Negative']
To allow assessment of isolated events of seizure during program	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
To allow assessment of isolated events of seizure during program	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
"NINDS DSMB recommended trial be terminated for futility after reviewing an interim analysis of
    84 subjects."	['Negative']	['Negative']
Unexpected and severe difficulties in recruitment.	['Insufficient_Enrollment']	['Neutral']
"Decision of independent monitoring committee: Risk of non-response to treatment significantly
    higher in midodrine group than in terlipressin group."	['Negative']	['Negative']
in order to prepare a new clinical trial to evaluate with pathological change	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Too difficult to satisfy all the inclusion criteria.	['Insufficient_Enrollment']	['Neutral']
Unable to recruit enough participants.	['Insufficient_Enrollment']	['Neutral']
Closed early for poor accrual.	['Insufficient_Enrollment']	['Neutral']
The project leader left our hospital and the project were shut down.	['Study_Staff_Moved']	['Neutral']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
With 2078 patients, a statistical stopping boundary has now been crossed	['Negative', 'Another_Study']	['Negative', 'Neutral']
Suspended until capitalization is completed	['Business_Administrative']	['Possibly_Negative']
Inadequate number of patients, lack of funding	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
slow accrual/lack of resources/low priority due to combining 2 consortia	['Insufficient_Enrollment']	['Neutral']
due to published data on Rosiglitazone	['Negative', 'Another_Study']	['Negative', 'Neutral']
"This trial was terminated following a futility analysis confirming futility of continuing the
    study"	['Negative', 'Another_Study']	['Negative', 'Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Approval lapse	['Regulatory', 'Invalid_Reason', 'Negative']	['Neutral', 'Invalid_Reason', 'Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Covid-19 pandemic	['Covid19']	['Neutral']
due to current political circumstances in study site area.	['Logistics_Resources', 'Study_Staff_Moved', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Change in the study plan	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
"Per the Division of Project Management, Office of Regulatory Operations, Office of Generic
    Drugs, FDA there is no regulatory requirement to continue this Registry."	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Halted by NICHD after recommendation by DSMC to stop for futility	['Negative']	['Negative']
"Primary efficacy analysis at Week 24 did not demonstrate non-inferiority of raltegravir versus
    lopinavir (+) ritonavir"	['Negative']	['Negative']
Competing studies	['Negative', 'Another_Study']	['Negative', 'Neutral']
significant reduction in length of hospital stay (primary endpoint)	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Enrollment has been terminated due to a slow rate of enrollment.	['Insufficient_Enrollment']	['Neutral']
"Data collection is completed. As no changes in the endpoints were expected in the future, no
    further data is needed."	['Interim_Analysis', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Malaria prev. fell in the study area, so we cannot evaluate the primary endpoint	['Logistics_Resources']	['Neutral']
"This trial was stopped prematurely due to the Sponsor's decision not to continue the
    development of esmertazapine for this indication."	['Business_Administrative']	['Possibly_Negative']
recruitment problem due to administrative process being too long	['Business_Administrative']	['Possibly_Negative']
"CYTHERISSA filed for banckcuptcy in June 2013.Subjects treated by CYT 107 were followed up for
    at the least 3 months."	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
"Novartis discontinued the development of imatinib in PAH due to requirement of regulatory
    authorities for additional data to secure marketing approval in PAH."	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Amicus Therapeutics discontinued Study AT1001-041 for logistical reasons.	['Logistics_Resources']	['Neutral']
End of inclusions without reaching the expected number of patients	['Insufficient_Enrollment']	['Neutral']
Business reasons	['Business_Administrative']	['Possibly_Negative']
The study is being terminated for lack of efficacy.	['Negative']	['Negative']
Recruitment failure	['Insufficient_Enrollment']	['Neutral']
"After a positive interim analysis, the decision was made to terminate the study early to allow
    for participants to enroll into an open label study"	['Negative']	['Negative']
Sponsor withdrawn due to low inclusion rate	['Insufficient_Enrollment']	['Neutral']
"GSK decision to return rights to sirukumab to Janssen and discontinue sirukumab development in
    giant cell arteritis."	['Business_Administrative']	['Possibly_Negative']
"2 Phase 3 trials didn't meet their primary endpoint, so further development and testing of
    TH-302 is uncertain"	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
Principal Investigator decision to stop trial	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Safety	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"The study was terminated early for business reasons, and not due to concerns regarding safety
    or lack of efficacy."	['Business_Administrative']	['Possibly_Negative']
Without CDE Approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
due to COVID19 pandemic	['Covid19']	['Neutral']
Study terminated prior to initiation	['Invalid_Reason']	['Invalid_Reason']
Difficulty enrolling subjects	['Insufficient_Enrollment']	['Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor withdrew funding for Nivolumab	['Business_Administrative']	['Possibly_Negative']
No funding	['Business_Administrative']	['Possibly_Negative']
Recruitment	['Insufficient_Enrollment']	['Neutral']
Study was terminated based on sponsor discretion.	['Business_Administrative']	['Possibly_Negative']
Assay not evaluated for purpose of clearance	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Initiating a new study with revised Statistics.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Unable to complete accrual	['Insufficient_Enrollment']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Stopped early by DSMB due to slow enrollment - obtained data to be analyzed	['Insufficient_Enrollment']	['Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
Difficulty in enrolling subjects.	['Insufficient_Enrollment']	['Neutral']
Very slow in enrolling participants	['Insufficient_Enrollment']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Funding withdrawn due to low enrollment	['Business_Administrative']	['Possibly_Negative']
This study was terminated early due to slow enrollment.	['Insufficient_Enrollment']	['Neutral']
Reduced access to AchEI medication-naive mild AD patients.	['Insufficient_Enrollment']	['Neutral']
"Study was stopped due to difficulties in recruitment and changes in standard care for invasive
    aspergillosis"	['Study_Design']	['Neutral']
Closed by CHUM REB for incomplete documentation of research activities.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
sufficient data collected for conclusion of retrospective study	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
sponsor decision	['Business_Administrative']	['Possibly_Negative']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Ran out of funding	['Business_Administrative']	['Possibly_Negative']
new product design	['Study_Design']	['Neutral']
Protocol change	['Study_Design']	['Neutral']
The trial was terminated due to change in new standard of therapy during the study period.	['Study_Design']	['Neutral']
unfavorable opinion of the ethics committee	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Difficulty including subjects corresponding to the criteria.	['Insufficient_Enrollment']	['Neutral']
Lack of funds and insufficient patient population for study enrollment.	['Business_Administrative']	['Possibly_Negative']
"Teminated by the DSMB because there are no differences between the control group and the
    Vapreotide group"	['Negative']	['Negative']
Due to unavailability of testing for gene mutation	['Logistics_Resources', 'Insufficient_Data', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Continuing review not submitted to IRB within 365 days.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Failure to recruit/enroll	['Insufficient_Enrollment']	['Neutral']
Due to the slow rate of recruitment the study was stopped.	['Insufficient_Enrollment']	['Neutral']
Request to close per funding sponsor. Site not moving forward with trial.	['Business_Administrative']	['Possibly_Negative']
Due to COVID-19 and research restrictions put in place by the university	['Covid19']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Very low recruitement rate.	['Insufficient_Enrollment']	['Neutral']
Due to Covid-19	['Covid19']	['Neutral']
The project has been transferred to Viatris	['Business_Administrative']	['Possibly_Negative']
Lack of Funding	['Business_Administrative']	['Possibly_Negative']
Sponsor making changes to manufacturing of vaginal ring.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Investigator left institution	['Study_Staff_Moved']	['Neutral']
Sluggish enrollment.	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
For safety concerns	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Trial was stopped because study not required for development.	['Business_Administrative']	['Possibly_Negative']
Change of sponsor	['Business_Administrative']	['Possibly_Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
Poor patient accrual	['Insufficient_Enrollment']	['Neutral']
Time constraints of primary investigator.	['Business_Administrative']	['Possibly_Negative']
The research questions was changed/de-prioritized. Only one subject completed.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
study team unable to start up study at this time	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Did not meet enrollment	['Insufficient_Enrollment']	['Neutral']
Study was withdrawn prior to any enrollment.	['Invalid_Reason']	['Invalid_Reason']
The supporting pharamceutical company elected not to pursue this study at this time.	['Business_Administrative']	['Possibly_Negative']
"Issues with participant recruitment & enrollment which made the trial impossible or highly
    impracticable. Trial termination was not due to safety reasons."	['Insufficient_Enrollment']	['Neutral']
Relocation of PI	['Study_Staff_Moved']	['Neutral']
Due to business strategic reasons, LEO Pharma has decided to close down the FCF-38 trial.	['Business_Administrative']	['Possibly_Negative']
Recruitment challenges	['Insufficient_Enrollment']	['Neutral']
Slow inclusion resulting in premature termination due to logistics	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Inability to successfully recruit study participants	['Insufficient_Enrollment']	['Neutral']
"No answer received from the Philippines Food and Drug Administration on protocol amendment
    issued due to IDMC recommendations. CYD vaccine 3rd dose not given."	['Regulatory', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Removal of Adrnaline lots for safety reasons.	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
No enrollment	['Insufficient_Enrollment']	['Neutral']
This study terminated early due to low accrual.	['Insufficient_Enrollment']	['Neutral']
Protocol redundancy	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
The study lost funding.	['Business_Administrative']	['Possibly_Negative']
inadequate enrollment	['Insufficient_Enrollment']	['Neutral']
Low enrollment. Not enough data for interim analysis.	['Insufficient_Enrollment']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
funding withdrawn	['Business_Administrative']	['Possibly_Negative']
Logistical issues prevent efficient enrollment	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
internal decision	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
PI left JHU	['Study_Staff_Moved']	['Neutral']
Suspended due to Covid	['Covid19']	['Neutral']
No recruitment	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
"Please see ""Purpose"" statement"	['No_Context']	['Invalid_Reason']
The study never opened due to funding issues	['Business_Administrative']	['Possibly_Negative']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Potential subjects did not meet eligibility criteria	['Insufficient_Enrollment']	['Neutral']
Closed after being on administrative hold	['Business_Administrative']	['Possibly_Negative']
Low Recruitment	['Insufficient_Enrollment']	['Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
"Following the internal pilot, the study did not meet prespecified stop/go criteria for
    continuation."	['Negative']	['Negative']
"Edwards acquired CardiAQ and opted to terminate this study. 2 patients were enrolled and
    follow-up is complete. No further enrollment or follow-up will occur."	['Business_Administrative']	['Possibly_Negative']
This study was terminated because the drug company stopped making the study drug	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
The study was completed as planned	['Invalid_Reason']	['Invalid_Reason']
Preliminary data was inconclusive to warrant keeping the study open.	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
difficulty with recruitment	['Insufficient_Enrollment']	['Neutral']
Pending final analysis for termination	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
"Recruitment prematurely stopped based on decision to stop HPC program (not due to safety or
    efficacy results) + On 31 Jan 2018 decision to stop the study"	['Negative']	['Negative']
unale to recruit , progress report not filed by PI	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Closed due to delay by GSK	['Business_Administrative']	['Possibly_Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Funding unavailable	['Business_Administrative']	['Possibly_Negative']
poor accrual	['Insufficient_Enrollment']	['Neutral']
administratively withdrawn	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
No results, funding terminated and PI no longer at institution	['Business_Administrative']	['Possibly_Negative']
Investigational Medical Device is no longer available	['Logistics_Resources']	['Neutral']
Enrollment	['Insufficient_Enrollment']	['Neutral']
lack of funding and patients	['Business_Administrative']	['Possibly_Negative']
"The reason for early termination is difficulties recruiting that caused a premature ending of
    financial resources ensuring protected time for research."	['Business_Administrative']	['Possibly_Negative']
Withdrawn. Not enough time to go through with the study.	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Study terminated by sponsor due to bad risk/benefit ratio.	['Negative']	['Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Enrollment on hold due to COVID-19 pandemic.	['Covid19']	['Neutral']
Sufficient evidence of efficacy not met.	['Negative']	['Negative']
COVID-19 Pandemic Measures	['Covid19']	['Neutral']
Sponsor to start with different protocol, postponed due to COVID	['Covid19']	['Neutral']
No subjects were enrolled into the study	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Unable to enroll	['Insufficient_Enrollment']	['Neutral']
"Enrolling 8 more patients would be statistically unlikely that the primary endpoint would be
    reached (reduce day 180 grade II-IV GVHD rates to 20% or less)"	['Negative']	['Negative']
Development of SHP630 was discontinued based on lack of preclinical efficacy.	['Negative']	['Negative']
not going to be conducted	['Invalid_Reason']	['Invalid_Reason']
The study was never performed and closed.	['Invalid_Reason']	['Invalid_Reason']
Do not have necessary resources to continue	['Business_Administrative']	['Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Slow recruitment rate	['Insufficient_Enrollment']	['Neutral']
Protocol to be re-designed (primary outome still GCSI)	['Study_Design']	['Neutral']
Replaced by new study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Difficulties with recruitment due to change in referral rates.	['Insufficient_Enrollment']	['Neutral']
Inadequate enrollement	['Insufficient_Enrollment']	['Neutral']
Lack of patients. Investigator changed job.	['Insufficient_Enrollment']	['Neutral']
"Not considered a clinical trial because both treatment protocols have been approved as usual
    care"	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
Due to COVID-19 policies.	['Covid19']	['Neutral']
Terminated - due to low accrual	['Insufficient_Enrollment']	['Neutral']
With 50 patients, the measure of assist vital capacity has been validated	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
never started	['Invalid_Reason']	['Invalid_Reason']
Insufficient funds	['Business_Administrative']	['Possibly_Negative']
Production plan adjustment	['Business_Administrative']	['Possibly_Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
due to slow recruitment	['Insufficient_Enrollment']	['Neutral']
The study was withdrawn from the IND.	['Regulatory', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
"The study was stopped secondary to the research curtailment and reallocation of testing
    resources secondary to the COVID-19 pandemic."	['Covid19']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Commercial decision to discontinue the study	['Business_Administrative']	['Possibly_Negative']
Principal Investigator Departed University	['Study_Staff_Moved']	['Neutral']
Lack of funding to continue study.	['Business_Administrative']	['Possibly_Negative']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Terminated to financial cut	['Business_Administrative']	['Possibly_Negative']
enrollment of participants has halted prematurely; difficulty with recruitment	['Insufficient_Enrollment']	['Neutral']
Grant not funded	['Business_Administrative']	['Possibly_Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
"Placebo - Active Drug Not Available. No patients received drug. There are no study results to
    disclose."	['Logistics_Resources', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
"Pairing D-Cycloserine with Clozapine was found to worsen negative side effects in patients with
    Schizophrenia, so the study was suspended."	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
Poor Accrual	['Insufficient_Enrollment']	['Neutral']
IRB study closure facilitated by Investigator	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Due to supply constraints & prioritization according to medical need (availability of
    alternative rabies vaccines), Rabipur will no longer be supplied to China."	['Logistics_Resources']	['Neutral']
"The primary endpoint of non-inferiority to daily therapy in the pediatric Phase 3 study was not
    achieved"	['Negative']	['Negative']
Withdrawn funding	['Business_Administrative']	['Possibly_Negative']
no patient available for 18 months	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Should not have been listed on ClinicalTrials	['Interim_Analysis', 'Regulatory', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Could not enroll enough participants, and lost funding.	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Up to sponsor decision	['Business_Administrative']	['Possibly_Negative']
Sponsor decision - pending further analysis of available data	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Key Personnel Left Institution Prior to Study Completion	['Study_Staff_Moved']	['Neutral']
Study medication could not be supplied. An alternative project will be conducted	['Logistics_Resources', 'Study_Design', 'Another_Study']	['Neutral', 'Neutral', 'Neutral']
enrolment behind expectation	['Insufficient_Enrollment']	['Neutral']
"This study was terminated due to the released lenses not representing what will be made
    commercially available and thus the objectives could not be met"	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Efforts at recruitment have halted as recruitment was poor.	['Insufficient_Enrollment']	['Neutral']
Budget issues	['Business_Administrative']	['Possibly_Negative']
Administrative barriers	['Business_Administrative']	['Possibly_Negative']
Enrollment was going slowly and needed to be closed.	['Insufficient_Enrollment']	['Neutral']
Change study drug dosage form	['Study_Design']	['Neutral']
The intermediate analyses did not allowed to continue the clinical study.	['Negative']	['Negative']
We are not going to complete this study with healthy volunteers at this time.	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Poor recruitment results.	['Insufficient_Enrollment']	['Neutral']
Sponser terminated early to start a larger feasability study	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Procedure needs to be changed	['Study_Design']	['Neutral']
Study was terminated early due to lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
Merck terminated the study for business reasons in November 2013.	['Business_Administrative']	['Possibly_Negative']
" Long delay due to challenges with sample analysis at local labs;  Low recruitment of case
    and control subjects;  Constant staff turn-over in the sites."	['Insufficient_Enrollment']	['Neutral']
Several studies going on at the same time.	['Negative', 'Another_Study']	['Negative', 'Neutral']
"delayed start of the trial, both treatment options already have market authorizations, study
    medication expired"	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Study was not renewed timely with IRB of record.	['Regulatory', 'Ethical_Reason', 'Negative']	['Neutral', 'Neutral', 'Negative']
funding and drug were withdrawn	['Business_Administrative']	['Possibly_Negative']
Program Development discontinued	['Business_Administrative']	['Possibly_Negative']
Could not obtain an IDE on the FGFR2 assay	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
No convincing results	['Negative']	['Negative']
possibility to discriminate the active drug from placebo	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Terminated due to recruitment not meeting expectations.	['Insufficient_Enrollment']	['Neutral']
Dendreon was sold and new company decided not to fund study.	['Business_Administrative']	['Possibly_Negative']
competing study at site	['Negative', 'Another_Study']	['Negative', 'Neutral']
Sponsor decision to discontinue study.	['Business_Administrative']	['Possibly_Negative']
"The scope of the program has been reduced to focus resources on studies which can potentially
    enable the registration of duvelisib."	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
Not approved for funding	['Business_Administrative']	['Possibly_Negative']
PI left institution	['Study_Staff_Moved']	['Neutral']
Moving of coordinator.	['Study_Staff_Moved']	['Neutral']
Recruitment problems (especially for chronic migraine patients)	['Insufficient_Enrollment']	['Neutral']
"Study was terminated due to toxicology findings after screening started but before first
    subject first dose."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
covid health crisis	['Covid19']	['Neutral']
Business decision to stop the program.	['Business_Administrative']	['Possibly_Negative']
Side effects valuation	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Investigator left the institution before enrolling any participants	['Study_Staff_Moved']	['Neutral']
The study was interrupted by recruitment failure.	['Insufficient_Enrollment']	['Neutral']
Unable to enroll adequate number of participants	['Insufficient_Enrollment']	['Neutral']
Study stopped because of disappointing inclusion rates	['Insufficient_Enrollment']	['Neutral']
Insufficient accrual over 12 mo period	['Insufficient_Enrollment']	['Neutral']
Study enrollment significantly below protocol expectations	['Insufficient_Enrollment']	['Neutral']
Interim analysis revealed a negative effect.	['Negative']	['Negative']
Challenges enrolling subjects in study	['Insufficient_Enrollment']	['Neutral']
departure of the principal recruiter in the study	['Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
low recruitment	['Insufficient_Enrollment']	['Neutral']
Closed early due to poor accrual.	['Insufficient_Enrollment']	['Neutral']
Difficulties of enrolment of Patient	['Insufficient_Enrollment']	['Neutral']
Stopped Enrollment	['Insufficient_Enrollment']	['Neutral']
"End of the COVID 19 epidemic in the region and decision to participate in a national study on
    the same subject (COVI-DOSE)."	['Covid19']	['Neutral']
"Based on the clinical activity, not safety data, of the AKT inhibitor, GSK has decided at this
    time to suspend further development of GSK2110183 as monotherapy."	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
Study stopped due to lost of interest.	['Business_Administrative']	['Possibly_Negative']
sponsor requested	['Business_Administrative']	['Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
Inadequate funding	['Business_Administrative']	['Possibly_Negative']
Due to new insights	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Insufficient patient recruitment (only 2 patients)	['Insufficient_Enrollment']	['Neutral']
Budgetary Issues	['Business_Administrative']	['Possibly_Negative']
major planned changes to study design	['Study_Design']	['Neutral']
End of finantial support	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Study terminated due to potential safety concerns in combination with platinum-based therapies	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
The study was withdrawn prior to IRB approval.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Terminated by IRB	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
See Detailed Description	['No_Context']	['Invalid_Reason']
the study was terminated for patient recruitment difficulty and interim power analysis	['Insufficient_Enrollment']	['Neutral']
Reallocation of funding.	['Business_Administrative']	['Possibly_Negative']
Funding	['Business_Administrative']	['Possibly_Negative']
Poor recruitment rate.	['Insufficient_Enrollment']	['Neutral']
Study Stopped	['Invalid_Reason']	['Invalid_Reason']
"Study was never initiated due to company decision. No study subjects were ever enrolled or
    dosed."	['Business_Administrative']	['Possibly_Negative']
Will be replaced by honest broker program	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
No patients were enrolled; Senior author (Dr. Melamed) departed institution	['Study_Staff_Moved']	['Neutral']
Principal investigator left institution	['Study_Staff_Moved']	['Neutral']
This study was terminated based on preliminary safety data.	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Prinicipal Investigator separating employment from University.	['Study_Staff_Moved']	['Neutral']
Study was never started. Full IDE-approval not obtained. new IDE will be submitted	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
study revised and reinitiated under another protocol	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Lack of resources	['Logistics_Resources']	['Neutral']
higher POCD in nimodipine Group	['Safety_Sideeffects', 'Negative']	['Safety_Sideeffects', 'Negative']
Logistical issues with study process and recruitment	['Logistics_Resources']	['Neutral']
Adverse Events	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
recruitment issues	['Insufficient_Enrollment']	['Neutral']
Lack of funding.	['Business_Administrative']	['Possibly_Negative']
Study terminated due to difficulty in enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of patients to enroll.	['Insufficient_Enrollment']	['Neutral']
enrollment difficulties	['Insufficient_Enrollment']	['Neutral']
recrutment difficulties	['Insufficient_Enrollment']	['Neutral']
On completion of part 1 it was felt that there would be no benefit in completing part 2	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Strategic considerations	['Business_Administrative']	['Possibly_Negative']
Study drug not available	['Logistics_Resources']	['Neutral']
More important number of SAE in one arms	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
no subjects consented due to competing studies	['Negative', 'Another_Study']	['Negative', 'Neutral']
Recruitment too slow, probably due to the procedure considered too complicated.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Loss of funding due to difficulty with recruitment and participant retention.	['Business_Administrative']	['Possibly_Negative']
The study failed to meet its accrual targets.	['Insufficient_Enrollment']	['Neutral']
Fellow unable to complete enrollment before completing training.	['Insufficient_Enrollment']	['Neutral']
See statement in Detailed Description.	['No_Context']	['Invalid_Reason']
Study withdrawn by sponsor	['Business_Administrative']	['Possibly_Negative']
Unable to address regulatory concerns.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Difficulty recruiting and following more patients during Covid-19 pandemic	['Covid19']	['Neutral']
Study was terminated because of slow recruitment	['Insufficient_Enrollment']	['Neutral']
To redefine study population	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
A better study with a better drug was started and thus this study was terminated	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Lack of research assistant to work on study	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
We could not secure adequate medication	['Logistics_Resources']	['Neutral']
Terminated by sponsor	['Business_Administrative']	['Possibly_Negative']
Drug sponsor decision to discontinue study.	['Business_Administrative']	['Possibly_Negative']
Inability to recruit study subjects	['Insufficient_Enrollment']	['Neutral']
IRB approval expired when PI left UNLV	['Logistics_Resources', 'Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
The study was never initiated	['Invalid_Reason']	['Invalid_Reason']
recruitment goals met	['Invalid_Reason']	['Invalid_Reason']
Novartis decision based on Cohort 1 results	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
Lower enrollment rate than expected	['Insufficient_Enrollment']	['Neutral']
Covid related	['Covid19']	['Neutral']
The grant for this study was not allowed.	['Business_Administrative']	['Possibly_Negative']
"The study used a two-stage design. After stage one, the study was terminated due to excess
    toxicity."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Administrative reason. Lack of funding.	['Business_Administrative']	['Possibly_Negative']
Poor enrollment; funding ending Dec 31, 2018.	['Business_Administrative']	['Possibly_Negative']
The study stopped due to lack of funding.	['Business_Administrative']	['Possibly_Negative']
Slow recuitment	['Insufficient_Enrollment']	['Neutral']
The study is no longer required for the PREA for this product.	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
poor accrual	['Insufficient_Enrollment']	['Neutral']
Administrative reasons	['Business_Administrative']	['Possibly_Negative']
Secondary to medicare coverage determination	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of efficacy	['Negative']	['Negative']
This study was terminated early in April 2005 due to low patient enrollment	['Insufficient_Enrollment']	['Neutral']
The research project has been cancelled before any participants were enrolled.	['Invalid_Reason']	['Invalid_Reason']
"The study was terminated after the episodic cluster study was terminated due to a pre specified
    futility analyses"	['Negative']	['Negative']
Product supplier change - bought out. Unable to enroll patients.	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Difficulty in implementing study protocol in the study population.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
study withdrawn due to funding	['Business_Administrative']	['Possibly_Negative']
NO need	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Difficulties with the Recruitement	['Insufficient_Enrollment']	['Neutral']
Due to covid-19 and social distancing, this study was terminated.	['Covid19']	['Neutral']
Due to the COVID-19 pandemic, we were unable to begin the study	['Covid19']	['Neutral']
COVID-19 pandemic	['Covid19']	['Neutral']
no sufficient enrolled pateints	['Insufficient_Enrollment']	['Neutral']
Intermediate analysis	['Negative']	['Negative']
"This study never enrolled any subjects. It was terminated due to staffing and technology
    changes."	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Collecting data as part of a Patient Registry; redundant study.	['Covid19', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
"[The risk of inhaled allergen challenge and anakinra treatment outweigh benefits to
    participants with allergic asthma due to the COVID-19 pandemic."	['Covid19']	['Neutral']
"Due to a reduction in surgical wait times, there was insufficient time to complete the
    intervention prior to surgery."	['Insufficient_Enrollment']	['Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
Not enough cervical interlaminar patients who meet criteria in order to meet recruitment goals.	['Insufficient_Enrollment']	['Neutral']
Insufficient accrual rate	['Insufficient_Enrollment']	['Neutral']
recruitment too low	['Insufficient_Enrollment']	['Neutral']
Sponsor withdrew funding	['Business_Administrative']	['Possibly_Negative']
No resources	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Delayed study materials, poor recruitment	['Insufficient_Enrollment']	['Neutral']
"This study was terminated early due to lack of efficacy based on the results of the Week 48
    analysis as prespecified in the clinical study protocol."	['Negative']	['Negative']
Not enough participants enrolled	['Insufficient_Enrollment']	['Neutral']
Safety concerns led to early termination.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Lack of Study Substance	['Logistics_Resources']	['Neutral']
Sponsor Decision to Stop Recruitment	['Business_Administrative']	['Possibly_Negative']
Study stopped due to COVID-19 pandemic and will not resume.	['Covid19']	['Neutral']
No patients enrolled in the study.	['Insufficient_Enrollment']	['Neutral']
Difficulty with recruitment	['Insufficient_Enrollment']	['Neutral']
"Most centres are now using oral steroids as 1st line treatment so question of efficacy is no
    longer of high interest."	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Low recruitment, completion of funding cycle	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Drug supplier suspended further clinical development of Ganetespib	['Logistics_Resources']	['Neutral']
Study was withdrawn due to lack of funding and staff availability.	['Business_Administrative']	['Possibly_Negative']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Unable to recruit subjects, patients want active treatment instead of placebo.	['Insufficient_Enrollment']	['Neutral']
intermittent evaluation of results: high incendence of complications	['Interim_Analysis', 'Safety_Sideeffects', 'Endpoint_Met']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Unable to enroll participants	['Insufficient_Enrollment']	['Neutral']
Inclusion criteria difficulties to receive the case, it is taken off the case to apply	['Insufficient_Enrollment']	['Neutral']
awaiting FDA approval for next dose group	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
A similar study was recently published with definitive results.	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Main objectives of the study were met; consensus among investigators that continuing the study
    would not add new information beyond that already learned."	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
"The study has been decided to be early terminated for the FAS 500 mg has launched in 2015. The
    use mothod of 250mg per month in clinical practice is off-label."	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Unable to meet enrollment expectations.	['Insufficient_Enrollment']	['Neutral']
"Isotope needed to conduct RBC/PV analysis (primary endpoint) no longer available from
    manufacturer. No alternatives available for use."	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Insufficient evidence of efficacy	['Negative']	['Negative']
Toxicities, lack of funding	['Business_Administrative']	['Possibly_Negative']
No recruitment	['Insufficient_Enrollment']	['Neutral']
Premature closure - investigator left the National Institutes of Health.	['Study_Staff_Moved']	['Neutral']
<11 subjects were enrolled to each Arm	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Targeted enrollment was not reached.	['Insufficient_Enrollment']	['Neutral']
Unable to adequately recruit subjects.	['Insufficient_Enrollment']	['Neutral']
Low recruitment.	['Insufficient_Enrollment']	['Neutral']
Study device required infeasible modifications. No patients received device.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Failure to recruit sufficient participants.	['Insufficient_Enrollment']	['Neutral']
Funding not enough to complete the study	['Business_Administrative']	['Possibly_Negative']
Pharmacy temporarily suspended by FDA	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The rate of cure in both arms was higher than expected	['Negative']	['Negative']
"Infusion reactions during re-induction cycles after a period of no treatment. Please see
    ""Purpose"" section."	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
"Due to unacceptable non-dose limiting toxicities, excessive treatment delays and limited
    clinical responses."	['Negative']	['Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Due to the recent meta-analysis about CV adverse effects.	['Negative', 'Another_Study']	['Negative', 'Neutral']
This study was withdrawn prior to enrollment.	['Invalid_Reason']	['Invalid_Reason']
Original Principal Investigator left the institution.	['Study_Staff_Moved']	['Neutral']
Suspended due to COVID19; Non-essential at this time per IRB. The study never started.	['Covid19']	['Neutral']
Interim analysis shown futility to continue due to lack of benefit.	['Negative']	['Negative']
In order to ensure patients and research staff safety due to COVID-19 pandemic	['Covid19']	['Neutral']
Poor enrollment, inability to achieve required number of subjects	['Insufficient_Enrollment']	['Neutral']
Principal Investigator decision to close the study.	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
"FDA placed AVXS-101 IT administration studies on clinical hold pending further discussions
    regarding pre-clinical findings."	['Regulatory', 'Negative']	['Neutral', 'Negative']
Accrual Goal Met	['Invalid_Reason']	['Invalid_Reason']
business reasons	['Business_Administrative']	['Possibly_Negative']
terminated for administrative reasons	['Business_Administrative']	['Possibly_Negative']
The study is prematurely terminated due to a safety issue	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Due to the low rate of primary endpoint events experienced in the study to date	['Negative']	['Negative']
Did not reach one of the primary endpoints of decreased total acute GVHD	['Negative']	['Negative']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Terminated not based on safety concerns, but due to insufficient efficacy.	['Negative']	['Negative']
Clinical development program terminated due to failure to achieve efficacy	['Negative']	['Negative']
IDMC recommendation for safety concerns	['Covid19', 'Safety_Sideeffects', 'Regulatory']	['Neutral', 'Safety_Sideeffects', 'Neutral']
"The pharmacokinetic properties of the molecule do not allow for further dose escalation or
    development."	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
"Dr. Kumar left Nationwide Children's Hospital. The study expired with the Nationwide Children's
    Hospital on 7/16/14."	['Study_Staff_Moved']	['Neutral']
On DSMB advice, trial recruitment has been halted for efficacy. F/U continues	['Negative']	['Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Enrollment target not reached	['Insufficient_Enrollment']	['Neutral']
Sponsor decision due to the low recruitment rate	['Insufficient_Enrollment']	['Neutral']
"This study was stopped because ustekinumab did not achieve key endpoints in a related study.
    The safety profile was consistent with past ustekinumab studies."	['Negative', 'Another_Study']	['Negative', 'Neutral']
There was a problem with the municipality and they have choose to suspend it.	['Business_Administrative']	['Possibly_Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
"The Investigator-Coordinator has moved to Rennes University Hospital. It will be done under the
    sponsor of Rennes University Hospital : NCT03686306"	['Logistics_Resources', 'Study_Staff_Moved', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Coronavirus	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
The recruitment of potential participants is suspended due to the covid-19 pandemic.	['Covid19']	['Neutral']
"Drop out from surgeons from 3 to 1. It will take too long to feasibly accrue with only one
    provider."	['Insufficient_Enrollment']	['Neutral']
Terminated due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Record owner left institution	['Logistics_Resources', 'Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Subjects from lead-in study VTI-206 - NCT00973817 lost to follow-up before enrollment in
    VTI-207 (NCT1452295)"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Initial clinical data require further evaluation	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Funding withdrawn. Design not feasible.	['Business_Administrative']	['Possibly_Negative']
Terminated early by Sponsor for business reasons unrelated to safety.	['Business_Administrative']	['Possibly_Negative']
"Recruiting took longer than expected due to a lack of eligible patients (very strong inclusion
    and exclusion criterias)"	['Insufficient_Enrollment']	['Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
COVID-19 safety precautions	['Covid19']	['Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
Low patient enrollment	['Insufficient_Enrollment']	['Neutral']
Enrolment halted prematurely and not resumed. 2 patients enrolled. No data was obtained.	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Principal Investigator left institution.	['Study_Staff_Moved']	['Neutral']
Enrollment difficulty	['Insufficient_Enrollment']	['Neutral']
withdrawal industrial	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Company resources only allows adequate oversight for one pivotal trial at a time	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Suspended due to COVID-19	['Covid19']	['Neutral']
"Due to delay in the study and the impact on the development timelines, not due to any
    identified safety concerns"	['Business_Administrative']	['Possibly_Negative']
did not meet planned recruitment expectations with a slow recruitment rate	['Insufficient_Enrollment']	['Neutral']
Other - pending protocol updates	['Study_Design']	['Neutral']
The study was stopped solely based on lower than expected enrollment rate.	['Insufficient_Enrollment']	['Neutral']
Application to CA withdrawn due to technical reasons of the manufacturer	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"The objectives of this trial are no longer deemed appropriate for the clinical development of
    L-BLP25 therefore this trial is withdrawn"	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Lack of available resources to complete study	['Business_Administrative']	['Possibly_Negative']
"Due to development challenges associated with the SARS-CoV-2 pandemic and emerging nonclinical
    data"	['Covid19', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
PI leaving UM at the end of the month	['Study_Staff_Moved']	['Neutral']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
Enrollment and study activities are temporarily suspended due to COVID-19.	['Covid19']	['Neutral']
Due to the achievement of minimum required sample size and new changes in local regulations.	['Regulatory', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Pre-defined criteria for continuation were not reached	['Interim_Analysis', 'Regulatory', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
unexpected histological findings in a phase 2 study in NASH patients CB8025-21730	['Negative', 'Another_Study']	['Negative', 'Neutral']
We were not able to secure IRB approval in the timeline necessary to do this study.	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Slow enrollment rate.	['Insufficient_Enrollment']	['Neutral']
Operational barriers prevent critical specimen analyses from being performed.	['Logistics_Resources']	['Neutral']
due to difficulties with recruiting	['Insufficient_Enrollment']	['Neutral']
Stopped early	['Invalid_Reason']	['Invalid_Reason']
Sponsor's decision	['Business_Administrative']	['Possibly_Negative']
decision of sponsor to withdraw before initiation; 0 patients enrolled	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
New study created.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Poor study design and too many study groups.	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Protocol has changed	['Study_Design']	['Neutral']
The study was stopped due to business/operational issues.	['Business_Administrative']	['Possibly_Negative']
Principal Investigator was deployed overseas	['Study_Staff_Moved']	['Neutral']
"Recruiting beyond September 10, 2018 would mean that the training occurred more than a year in
    the past. For this reason, we terminated recruitment."	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"Protocol Changes (Sponsor) - Significant protocol revisions pending; site temporarily suspended
    start-up activity"	['Study_Design']	['Neutral']
Inadequate patient enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Internal decision to progress alternate molecule with more preferable profile	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Cant obtain IMP	['Logistics_Resources']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Due to safety concern of active control drug	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"NeuroCatch Platform became commercially available (Health Canada License approved) and can now
    be incorporated into the ABI Wellness Program"	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
The industry sponsor has discontinued the product under evaluation in the study.	['Business_Administrative']	['Possibly_Negative']
Unforeseen complications due to COVID-19 and funding	['Covid19']	['Neutral']
Sponsor terminated study; no impact on overall benefit risk evaluation of AR101	['Negative']	['Negative']
insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
lack of accrual	['Insufficient_Enrollment']	['Neutral']
stop trial due to proposals for possible optimizations of the device by the investigators.	['Study_Design']	['Neutral']
House Research no longer conducting research.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
major recruitment failure	['Insufficient_Enrollment']	['Neutral']
Did not meet the criteria for continuation to second stage	['Negative']	['Negative']
Recruitment rate to low; changed environment made protocol in its current state obsolete	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Drug manufacturer, Astellas Pharma, informed us that safety and efficacy of Erlotinib and
    OSI-906 in other oncology studies was determined to be unfavorable."	['Negative']	['Negative']
withdrawn during planning stages	['Business_Administrative']	['Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
low recruitment	['Insufficient_Enrollment']	['Neutral']
"This non-therapeutic study was registered in error. The PRS team doesn't delete studies once
    registered, so they recommended changing the status to Withdrawn"	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Initial data review.	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
Due to Slow Accrual study was terminated.	['Insufficient_Enrollment']	['Neutral']
Study was not renewed with the IRB	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Unable to get funding	['Business_Administrative']	['Possibly_Negative']
Difficulty in financing the research	['Business_Administrative']	['Possibly_Negative']
"Sanofi ended collaboration with Lexicon for Sotagliflozin. In China no regulatory pathway to
    transfer sponsorship during the conduct of ongoing studies."	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
PI has left Trust currently.	['Study_Staff_Moved']	['Neutral']
This was an initial unfunded pilot project stopped after similar studies were funded.	['Negative', 'Another_Study']	['Negative', 'Neutral']
"FDA safety concerns with repeated use of gadolinium-based contrast; subjects received
    additional dose of contrast with no direct clinical benefit"	['Negative']	['Negative']
too few patients included	['Insufficient_Enrollment']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
the data was completed.	['Invalid_Reason']	['Invalid_Reason']
The previous data needs to be analyzed.	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
PK results demonstrated no systemic absorption	['Negative']	['Negative']
There was no funding for the device to be used in the study.	['Business_Administrative']	['Possibly_Negative']
Funding issues	['Business_Administrative']	['Possibly_Negative']
Study terminated early due to slow accrual	['Insufficient_Enrollment']	['Neutral']
futility	['Negative']	['Negative']
Poor patient accrual	['Insufficient_Enrollment']	['Neutral']
Ethical approval was denied	['Interim_Analysis', 'Success', 'Logistics_Resources']	['Neutral', 'Success', 'Neutral']
"Slow recruitment, investigators not wishing to continue with randomisation and a decision to
    rationalise this product from the Sponsors portfolio."	['Business_Administrative']	['Possibly_Negative']
It was decided to discontinue the study due to insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Study was terminated due to the untimely death of the investigator	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Decision of the investigator	['Invalid_Reason']	['Invalid_Reason']
Accrual factor	['Insufficient_Enrollment']	['Neutral']
Voluntarily closed and terminated by the PI due to lack of feasibility	['Logistics_Resources']	['Neutral']
PI left hospital	['Study_Staff_Moved']	['Neutral']
Security and effect data from another ongoing study.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of recruitment.	['Insufficient_Enrollment']	['Neutral']
no participants enrolled	['Insufficient_Enrollment']	['Neutral']
No patients recruited.	['Insufficient_Enrollment']	['Neutral']
Sufficient evidence of efficacy not met. Discontinuation not based on any safety concerns.	['Negative']	['Negative']
no patients to recruit	['Insufficient_Enrollment']	['Neutral']
Sponsor terminated study early due to limited enrollment and follow-up.	['Insufficient_Enrollment']	['Neutral']
Business Decision; No Safety or Efficacy Concerns	['Business_Administrative']	['Possibly_Negative']
Study was stopped due to low follow-up compliance at study sites.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Additional outcome measures have been developed and added to the protocol.	['Endpoint_Met', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Will study new T-cell construct for the same indication	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Limited recruitment	['Insufficient_Enrollment']	['Neutral']
Funding not secured. IRB approval has been withdrawn as of January 2017.	['Business_Administrative']	['Possibly_Negative']
Investigators decision	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
"The sponsor and the PIs both agreed that the CSPPT-CKD should be a sub-study of the CSPPT
    insted of an independent randomized trial."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Study early terminated due to lower drug exposure	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
funding and compounding issues	['Business_Administrative']	['Possibly_Negative']
Huntmans Cancer Institute terminated study	['Invalid_Reason']	['Invalid_Reason']
Adverse Events	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Preliminary results showed no ability to predict pain by measuring hippus with pupillometry	['Negative']	['Negative']
Enrollment rate slower than anticipated.	['Insufficient_Enrollment']	['Neutral']
Major protocol changes needeed	['Study_Design']	['Neutral']
protocol cancelled	['Invalid_Reason']	['Invalid_Reason']
Difficulty to recruit all the patients	['Insufficient_Enrollment']	['Neutral']
Study was never funded by NIH as anticipated.	['Business_Administrative']	['Possibly_Negative']
Funding	['Business_Administrative']	['Possibly_Negative']
Not started and now discontinued	['Invalid_Reason']	['Invalid_Reason']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Difficult for recruting	['Insufficient_Enrollment']	['Neutral']
failure to accure	['Insufficient_Enrollment']	['Neutral']
Study ended early due to toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Lack of suitable participants	['Insufficient_Enrollment']	['Neutral']
IDMC recommendation for safety concerns	['Covid19', 'Safety_Sideeffects', 'Regulatory']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Not feasible due to low accrual	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Abbott made a decision to not further develop the RDN program.	['Business_Administrative']	['Possibly_Negative']
poor recruitment	['Insufficient_Enrollment']	['Neutral']
The number of included patients is sufficient.	['Invalid_Reason']	['Invalid_Reason']
Study terminated early due to lack of funding and the COVID-19 pandemic.	['Covid19']	['Neutral']
"Study was completed as per amended protocol. Protocol was amended to close enrollment earlier
    than initially planned (study continued as per plan)."	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Business decision to stop the program.	['Business_Administrative']	['Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
"Preliminary data collected and diets developed. Funding has ended and data used to support a
    larger application to test the hypothesis."	['Business_Administrative']	['Possibly_Negative']
Failure to recruit participants due to change in local clinical practice.	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
COVID-19, loss of research facilitators	['Covid19']	['Neutral']
Funding was time sensitive and expired. No subjects enrolled.	['Business_Administrative']	['Possibly_Negative']
Lack of efficacy demonstrated in study ICA-17043-10	['Negative', 'Another_Study']	['Negative', 'Neutral']
Not enough patients included	['Insufficient_Enrollment']	['Neutral']
Company strategic decision	['Business_Administrative']	['Possibly_Negative']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
PI has left the institution	['Study_Staff_Moved']	['Neutral']
low enrollment	['Insufficient_Enrollment']	['Neutral']
Colloborator-Sponsor decision to terminate.	['Business_Administrative']	['Possibly_Negative']
Study closed due to poor accrual	['Insufficient_Enrollment']	['Neutral']
"The Sponsor has made a decision, driven by business needs, to cease promotion, manufacturing,
    distribution and sales of Amevive"	['Business_Administrative']	['Possibly_Negative']
A business decision was made to not initiate this study	['Business_Administrative']	['Possibly_Negative']
low enrollment	['Insufficient_Enrollment']	['Neutral']
Due to unsuccessful trial accrual	['Insufficient_Enrollment']	['Neutral']
Slow Accrual-2 patients were registered Phase I and none in Phase II	['Insufficient_Enrollment']	['Neutral']
Closed due to historically slow enrollment compounded by the COVID-19 pandemic.	['Covid19']	['Neutral']
"Testing required by FDA for IND approval was too expensive to move forward with conduct of the
    study."	['Regulatory', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Suspended collaboration with the company providing the study drug	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Business reasons	['Business_Administrative']	['Possibly_Negative']
The trial was terminated prematurely by the sponsor for administrative reasons.	['Business_Administrative']	['Possibly_Negative']
Intervention appeared to be associated with increased nausea in some patients.	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
feasibility challenges	['Logistics_Resources']	['Neutral']
Funding stopped	['Business_Administrative']	['Possibly_Negative']
Inability to adequately recruit participants during pre-post operative period.	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
insufficient number of replies by patients	['Insufficient_Enrollment']	['Neutral']
We now offer the repair as standard of care up to BMI of 40.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of inclusion	['Insufficient_Enrollment']	['Neutral']
Collaborators did not enter patients into the study	['Insufficient_Enrollment']	['Neutral']
Investigational device changes	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Investigator's decision	['Invalid_Reason']	['Invalid_Reason']
Study was withdrawn due to lack of eligible population for study	['Insufficient_Enrollment']	['Neutral']
"Lack of patient interest in participating (for adult patients), and lack of parental consent to
    participate (for pediatric patients)"	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
The study was stopped before start because the project was not fully-funded.	['Business_Administrative']	['Possibly_Negative']
Tocilizumab was licenced in Canada for children, so the study was not necessary	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Funding unavailable	['Business_Administrative']	['Possibly_Negative']
poor recruitment	['Insufficient_Enrollment']	['Neutral']
Limited resources available to met accrual goal.	['Insufficient_Enrollment']	['Neutral']
Recruitment Goal of 20 Not Met	['Insufficient_Enrollment']	['Neutral']
Closed for lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Resources	['Logistics_Resources']	['Neutral']
Covid-19 Pandemic halted my study due to exposure risks.	['Covid19']	['Neutral']
Priorities other studies	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Interim analyses showed insufficient result. Termination for reasons of futility	['Negative']	['Negative']
Study PI left the institution and study was stopped at that time.	['Study_Staff_Moved']	['Neutral']
"Study closed after the 5 year end-point was reached after a review of the status further to a
    request from the investigators to discontinue participation."	['Regulatory', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
patient sample not reached	['Insufficient_Enrollment']	['Neutral']
poor accrual and response less than expected on interim analysis	['Insufficient_Enrollment']	['Neutral']
Administrative closure based on sponsor recommendation, prior to subject enrollment	['Business_Administrative']	['Possibly_Negative']
Sponsor's decision of the Early Termination of the study.	['Business_Administrative']	['Possibly_Negative']
Study stopped due to lack of efficacy.	['Negative']	['Negative']
The Investigator left the institution and was withdrarwn	['Study_Staff_Moved']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
PI is closing the trial as he will be leaving the University of Pittsburgh Medical Center	['Study_Staff_Moved']	['Neutral']
COVID-19 Restrictions	['Covid19']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
The study was terminated early due to company decision (non-safety related).	['Business_Administrative']	['Possibly_Negative']
Primary PI left institution	['Study_Staff_Moved']	['Neutral']
No correlation between FIAU uptake and bone biopsy results.	['Negative']	['Negative']
Insufficient funding to complete pilot.	['Business_Administrative']	['Possibly_Negative']
"A recommended Phase 2 dose and schedule was not identified and the study was terminated before
    initiation of Stage 2B."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Not moving forward staff shortage	['Logistics_Resources']	['Neutral']
investigation of adverse events in a related clinical study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study abandoned due to drug billing issues	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Number of eligible patients too small.	['Insufficient_Enrollment']	['Neutral']
Suitable implanted technolgy was not available	['Logistics_Resources']	['Neutral']
Manufacturing Issues	['Logistics_Resources']	['Neutral']
Group B not started for business reasons.	['Business_Administrative']	['Possibly_Negative']
Understaffing	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Study met stopping criteria specified within protocol.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
stopped by sponsor	['Business_Administrative']	['Possibly_Negative']
The study will not be submitted to authority for IND application.	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Sponsors	['Business_Administrative']	['Possibly_Negative']
Too few inclusions	['Insufficient_Enrollment']	['Neutral']
"Participant enrollment has remained significantly behind plan despite increased site enrollment
    activity."	['Insufficient_Enrollment']	['Neutral']
Another study was opened.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Only 1 patient recruited, and he withdrew	['Insufficient_Enrollment']	['Neutral']
Loss of external funding	['Business_Administrative']	['Possibly_Negative']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Difficult patient recruitment. No patients enrolled.	['Insufficient_Enrollment']	['Neutral']
Due to the achievement of minimum required sample size and new changes in local regulations.	['Regulatory', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
See termination reason in detailed description	['No_Context']	['Invalid_Reason']
halted by the PI only 3 of 45 subjects were accrued.	['Insufficient_Enrollment']	['Neutral']
DSMB stopped study because placebo arm had more adverse events	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
No subjects were ever enrolled.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
not enough inclusions	['Insufficient_Enrollment']	['Neutral']
no logistical support to carry out the study fairly	['Logistics_Resources']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Protocol never received funding.	['Business_Administrative']	['Possibly_Negative']
Funding unavailable	['Business_Administrative']	['Possibly_Negative']
"The clinical development of intravenously administered ofatumumab in RA will no longer be
    pursued, so this study was prematurely terminated by the Sponsor."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
biostatistician determined 20 subjects would be adequate to perform statistics	['Interim_Analysis', 'Logistics_Resources', 'Endpoint_Met']	['Neutral', 'Neutral', 'Neutral']
Terminated (Business Reasons)	['Business_Administrative']	['Possibly_Negative']
"The investigational cases were no longer relevant considering the recent implementation of our
    current national healthcare system."	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Recruitment problems due to very restricted inclusion criteria	['Insufficient_Enrollment']	['Neutral']
Study suspended pending further funding	['Business_Administrative']	['Possibly_Negative']
Preliminary data from this study does not support expected inhibition of GH and IGF-1	['Negative']	['Negative']
Sponsor decided to discontinue the study due to poor enrollment.	['Insufficient_Enrollment']	['Neutral']
Protocol is completed	['Invalid_Reason']	['Invalid_Reason']
PI indicating she was withdrawing her study submission due to lack of funding as of 6/20/2016	['Business_Administrative']	['Possibly_Negative']
New treatment option introduced for patients with the study indication	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Was not approved by funding organization	['Business_Administrative']	['Possibly_Negative']
difficulty of selection of inclusion	['Insufficient_Enrollment']	['Neutral']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
Business decision based on the inability to enroll subjects into the trial	['Business_Administrative']	['Possibly_Negative']
low enrollment	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Suspended while we determine if usable data can be collected from this device.	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
Slow recruitment rate	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
closure of dialysis center where study was being conducted	['Logistics_Resources', 'Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Futility; unable to complete screening due to clinical practice change	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Too slow accrual	['Insufficient_Enrollment']	['Neutral']
Trial closed just prior to study receiving Investigational Review Board approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Our citicoline supply expired and the exact product has discontinued.	['Logistics_Resources']	['Neutral']
enrollment challenges, only one patient enrolled	['Insufficient_Enrollment']	['Neutral']
Recruitment was too slow, primary investigator has left the organisation	['Insufficient_Enrollment']	['Neutral']
Funding has ended and unable to recruit due to COVID 19	['Covid19']	['Neutral']
Due to the COVID-19 pandemic	['Covid19']	['Neutral']
Recruitment faillure. Similar study published by others. Not yet entered treatment phase.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Covid-19 pandemic	['Covid19']	['Neutral']
Too slow recruitment and study data to be recorded not available.	['Insufficient_Enrollment']	['Neutral']
Sponsor decision based on portfolio prioritization	['Business_Administrative']	['Possibly_Negative']
Due to recruitment difficulties the trial was stopped after an interim analysis at 30 patients.	['Insufficient_Enrollment']	['Neutral']
Principal Investigator not available (Sabbatical)	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Delay in the R & D stage	['Business_Administrative']	['Possibly_Negative']
Problems with contracts .	['Business_Administrative']	['Possibly_Negative']
Project terminated due to revision of local regulations	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
"The primary reason for the decision to discontinue the study is lack of enrolment; this
    decision is not related to any tolerability concerns with Givinostat"	['Insufficient_Enrollment']	['Neutral']
IRB suspension	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
No participants. IND denied by FDA.	['Regulatory', 'Insufficient_Enrollment', 'Negative']	['Neutral', 'Neutral', 'Negative']
Low enrollment numbers precluded completion of the study during a reasonable amount of time.	['Insufficient_Enrollment']	['Neutral']
Previous principal investigators left institution	['Study_Staff_Moved']	['Neutral']
"Substudy 1 was terminated for futility at interim analysis and Substudy 2 was terminated per
    sponsor decision."	['Negative']	['Negative']
Departmental research hold	['Business_Administrative']	['Possibly_Negative']
Recruitment lagged behind goal;exhaustion of funding.	['Business_Administrative']	['Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Study not progressing toward scientific goals	['Logistics_Resources', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
"Unable to accrue all planned subjects in a timely fashion, but data collected will still be
    analyzed."	['Insufficient_Enrollment']	['Neutral']
no additional parcipitants could be recruited at site.	['Insufficient_Enrollment']	['Neutral']
App to be used in study needs revision.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
not feasible	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Lack of study population	['Insufficient_Enrollment']	['Neutral']
"unexpected alcohol use increase identified in preliminary analysis after half of study
    enrollments"	['Safety_Sideeffects', 'Logistics_Resources', 'Endpoint_Met']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Change in business priority	['Business_Administrative']	['Possibly_Negative']
"were not able to find enough eligible patients. We recruited 6, with incomplete data on those
    participants."	['Insufficient_Enrollment']	['Neutral']
Medication expired	['Logistics_Resources']	['Neutral']
terminated due to corporate transaction.	['Business_Administrative']	['Possibly_Negative']
"The trial was discontinued due to sponsor's decision and not a consequence of any safety
    concern"	['Regulatory', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Inability to reach enrollment as planned	['Insufficient_Enrollment']	['Neutral']
Business objectives have changed	['Business_Administrative']	['Possibly_Negative']
A correction needs to be made to the device's algorithm.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
"The study was terminated as other related studies of ruxolitinib did not provide sufficient
    efficacy to warrant continuation."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Difficulty recruiting target sample	['Insufficient_Enrollment']	['Neutral']
Lack of staff	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Poor accrual and change in standards of care	['Insufficient_Enrollment']	['Neutral']
Terminated by sponsor	['Business_Administrative']	['Possibly_Negative']
Business objectives have changed.	['Business_Administrative']	['Possibly_Negative']
The trial is being stopped for futility. Season 2 cancelled.	['Negative']	['Negative']
early termination due to slow recruitment	['Insufficient_Enrollment']	['Neutral']
Inclusion of patients slow	['Insufficient_Enrollment']	['Neutral']
No participants enrolled in the trial	['Insufficient_Enrollment']	['Neutral']
"The retrospective data review did not provide adequate information to continue the
    investigation."	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Corporation Decision	['Business_Administrative']	['Possibly_Negative']
Early termination leading to small number of subjects analyzed	['Insufficient_Enrollment']	['Neutral']
Study was terminated by sponsor and decision was not due to any safety signals.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
No cases on NmA meningitis were recorded following vaccination with MenAfriVac	['Safety_Sideeffects', 'Endpoint_Met', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
the product was delisted.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Design change	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
could not enroll patients	['Insufficient_Enrollment']	['Neutral']
low inclusion	['Insufficient_Enrollment']	['Neutral']
"The aims represented in this study are also included in another, larger study of at-home COPD
    care. There was insufficient research team support to complete both protocols and the work
    would have been duplicative. Thus, we have terminated this study."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Due to safety concerns	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
Slow accrual within enrollment time period: projected accrual goal not achieved.	['Insufficient_Enrollment']	['Neutral']
Study closed with no enrollment due to unavailability of reagent.	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Slow accrual coupled with discontinuation of study drug.	['Insufficient_Enrollment']	['Neutral']
Take care recommendations for Her2 equivok patients has changed.	['Study_Design']	['Neutral']
Study was closed due to lack of participants	['Insufficient_Enrollment']	['Neutral']
"Study CCX115383 has been terminated prior to enrolment of any patients. A decision was made by
    GSK to delay pursuit of this indication as the biology evolves."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Management Decision	['Business_Administrative']	['Possibly_Negative']
Due to limited data available, efficacy, and PK analyses were not performed.	['Logistics_Resources', 'Insufficient_Data', 'Negative']	['Neutral', 'Neutral', 'Negative']
"The study was terminated due to poor feasibility and lack of interest at the participating
    sites."	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study topic is no longer being pursued by study team members	['Logistics_Resources', 'Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Device modification and simplification of procedural steps	['Study_Design']	['Neutral']
Terminated due to low accrual.	['Insufficient_Enrollment']	['Neutral']
Sponsor decision based on portfolio prioritization	['Business_Administrative']	['Possibly_Negative']
Unavailable drug in Egypt.	['Logistics_Resources']	['Neutral']
Lack of participant enrollment	['Insufficient_Enrollment']	['Neutral']
losing of funding for the study	['Business_Administrative']	['Possibly_Negative']
No eligible patients were identified so the study was terminated.	['Insufficient_Enrollment']	['Neutral']
Limited patient recruitment	['Insufficient_Enrollment']	['Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
Company strategic decision	['Business_Administrative']	['Possibly_Negative']
Recruitment stopped according to early stopping rule (by protocol)	['Negative']	['Negative']
Inability to produce placebo tablets similar to the drug tested	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Stopped prior to enrollment per PI and DSMB decision.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
lack of subjects and manpower issues	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Inadequate recruitment	['Insufficient_Enrollment']	['Neutral']
changes in the R&D strategy	['Business_Administrative']	['Possibly_Negative']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
PI re-located.	['Study_Staff_Moved']	['Neutral']
US FDA/EMA/SFDA decisions to rosiglitazone-containing medicines, ethic	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The funding period for the study has ended.	['Business_Administrative']	['Possibly_Negative']
Due to COVID-19 pandemic	['Covid19']	['Neutral']
"Study was stopped because the Promoter was changed and a new study on convalescent plasma
    promoted by AIFA was started in Italy."	['Negative', 'Another_Study']	['Negative', 'Neutral']
"It was confirmed that cuffed RAE tubes with small diameter could be used, so there was no
    reason to use RAE cuffless tubes."	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
The study was not feasible.	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Institutional Review Board did not approve	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"The PI is dealing with recurrent cancer and multiple side effects of treatment. N o one else to
    do the study."	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Lack of recruitment - no eligible participants.	['Insufficient_Enrollment']	['Neutral']
Change of study staff	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
Changed to a QI project	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"termination of the study due to the slowness of the recruitment activity, according to the
    contract signed with the Sponsor"	['Insufficient_Enrollment']	['Neutral']
The sponsor terminated industrial support	['Business_Administrative']	['Possibly_Negative']
"Due to difficulty with recruiting patients meeting the inclusion criteria the PI decided to
    retire this project."	['Insufficient_Enrollment']	['Neutral']
Resources to be able to screen and enroll patients are no longer available.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The developer of the BCI left the institution so the study could not continue	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
Protocol being reconsidered	['Study_Design']	['Neutral']
Primary Investigator no longer with institution	['Study_Staff_Moved']	['Neutral']
Lengthy delays and inadequate support to proceed.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Insufficient accrual to Horizon Bluecross Blueshield cohort	['Insufficient_Enrollment']	['Neutral']
PI change of institution	['Study_Staff_Moved']	['Neutral']
Due to unwillingness of surgeons to use monopolar energy & technical problems	['Logistics_Resources']	['Neutral']
protocol violation	['Study_Design']	['Neutral']
Unable to enroll	['Insufficient_Enrollment']	['Neutral']
Suboptimal subject recruitment	['Insufficient_Enrollment']	['Neutral']
Study was withdrawn	['Invalid_Reason']	['Invalid_Reason']
problem of recruitment (not enough patients)	['Insufficient_Enrollment']	['Neutral']
Enrollment was stopped early (see limitations and caveats section).	['Covid19', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
We elected to stop this study due to our inability to recruit suitable subjects.	['Insufficient_Enrollment']	['Neutral']
Not enough inclusion	['Insufficient_Enrollment']	['Neutral']
Disease prevalence lower than expected in population.	['Insufficient_Enrollment']	['Neutral']
Could not be implemented	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
PI left institution	['Study_Staff_Moved']	['Neutral']
Due in part, to reduced transplant volume and enrollment has been difficult.	['Insufficient_Enrollment']	['Neutral']
Sara Cheng, MD has left the Univ. of Colorado and the study has been closed.	['Study_Staff_Moved']	['Neutral']
ChloroPrep Wipes no longer available	['Logistics_Resources']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
occurrence of retinal hemorrhage , increase in macular edema of some patients in TPA group	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"Pre-determined stopping point met with signficant difference between intervention and control
    groups."	['Negative']	['Negative']
"A new study had shown that polar body biopsies might negatively effect the implantation
    potential of the embryo."	['Negative', 'Another_Study']	['Negative', 'Neutral']
IND not obtained	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Difficulty in recruiting subjects for study	['Insufficient_Enrollment']	['Neutral']
Funding was unavailable to complete the study as originally planned.	['Business_Administrative']	['Possibly_Negative']
lack of funding	['Business_Administrative']	['Possibly_Negative']
"Study terminated early prior to completing targeted enrollment of participants <6 months of age
    due to recruitment challenges."	['Insufficient_Enrollment']	['Neutral']
Business Reasons	['Business_Administrative']	['Possibly_Negative']
Just Terminated for the end of the pandemia	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
For Strategic Reasons	['Business_Administrative']	['Possibly_Negative']
No patient completed protocol	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
inadequate participant	['Insufficient_Enrollment']	['Neutral']
"IRB approval not renewed/approval lapsed. Prior status: insufficient enrollment; study
    suspended pending analysis"	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Because we did not find funds to do it	['Business_Administrative']	['Possibly_Negative']
"FDA and EMA agreed that the information that had been submitted to date was acceptable to meet
    the requirements of the post-marketing commitment."	['Interim_Analysis', 'Regulatory', 'Negative']	['Neutral', 'Neutral', 'Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Slow patient enrollment.	['Insufficient_Enrollment']	['Neutral']
Protocol was not feasible - only 1 of 18 enrollees completed procedures.	['Study_Design']	['Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
all patients recruited	['Invalid_Reason']	['Invalid_Reason']
Budget exceeded for project.	['Business_Administrative']	['Possibly_Negative']
IDMC recommendation	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
This study had to be suspended due to COVID-19 Pandemic.	['Covid19']	['Neutral']
Difficulty of recruiting	['Insufficient_Enrollment']	['Neutral']
The study was terminated on expiry of the frozen and stored plasma components.	['Interim_Analysis', 'Logistics_Resources']	['Neutral', 'Neutral']
because of COVID-19	['Covid19']	['Neutral']
"The study terminated early due to slow enrollment that significantly extended the expected
    study duration."	['Insufficient_Enrollment']	['Neutral']
inclusion was finished	['Invalid_Reason']	['Invalid_Reason']
Terminated early because the first phase didn't meet the endpoint.	['Negative']	['Negative']
PI assigned to a different hospital;difficulty recruiting patients	['Insufficient_Enrollment']	['Neutral']
"One of the instruments in the study was withdrawn from the market before the calculated number
    of persons were included."	['Logistics_Resources']	['Neutral']
The study was terminated due to unanticipated safety issues	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
PI terminated at the recommendation of DSMC & IRB	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
Project moved to new university	['Study_Staff_Moved']	['Neutral']
Recruitment goals could not be met before ending of funding for this project.	['Business_Administrative']	['Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Sponsor has taken the decision to terminate further development of the compound	['Business_Administrative']	['Possibly_Negative']
"The study was stopped due to the inability to determine an acceptable dose with the potential
    for further study"	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Unable to recruite enough subjects to reach statistical power	['Insufficient_Enrollment']	['Neutral']
"On February 28, 2019, Capricor ceased ongoing follow-up activities and terminated the ALLSTAR
    trial to focus resourcing on its active CAP-1002 program, HOPE-2."	['Business_Administrative']	['Possibly_Negative']
The primary objective of the study was met.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
The study was halted prematurely at the funding partner's request.	['Business_Administrative']	['Possibly_Negative']
company dissolved	['Business_Administrative']	['Possibly_Negative']
Suspended due to COVID-19	['Covid19']	['Neutral']
insufficient funding	['Business_Administrative']	['Possibly_Negative']
Study is completed; primary analysis completed.	['Invalid_Reason']	['Invalid_Reason']
"This study was prematurely discontinued because the program for progressive supranuclear palsy
    was discontinued due to lack of efficacy of study drug."	['Negative']	['Negative']
Mainly due to insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
interim analysis produced significant results, so we ended enrollment	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Recruitment is finished	['Invalid_Reason']	['Invalid_Reason']
Due to the COVID-19 pandemic, study enrollment has been prematurely terminated.	['Covid19']	['Neutral']
No statistical difference observed for outcomes.	['Negative']	['Negative']
Primary investigator left VA employment	['Study_Staff_Moved']	['Neutral']
"1. Few eligible patients at study start

      2. Patients received HFNC prior to intermediate care ward admission

      3. NIV was locally considered a step-up therapy to HFNC

      4. Full-face masks replaced the Helmet interface as local NIV standard"	['Study_Design']	['Neutral']
Unable to enroll	['Insufficient_Enrollment']	['Neutral']
Co-Investigator left institution. No data analysis occurred.	['Study_Staff_Moved']	['Neutral']
Never funded.	['Business_Administrative']	['Possibly_Negative']
Study Never Began	['Invalid_Reason']	['Invalid_Reason']
Study ended prior to completion of planning stage. No participants enrolled.	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
"University of Rostock terminated participation in the study conduct; Study Sponsorship is moved
    to Centogene AG"	['Business_Administrative']	['Possibly_Negative']
"Patient eligibility has limited accrual and patient sample has changed with the change in
    referral patients."	['Insufficient_Enrollment']	['Neutral']
ganaxolone did not significantly reduce spasms after an 8-day placebo control period	['Negative']	['Negative']
low enrollment	['Insufficient_Enrollment']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
closed for low accrual and no data is available.	['Insufficient_Enrollment']	['Neutral']
withdrawn	['Invalid_Reason']	['Invalid_Reason']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Study abandoned; Could not obtain final SRC approval due to IND disagreements	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
"Due to Negative feasibility assessment of recruiting the planned number of subjects within the
    study timelines"	['Insufficient_Enrollment']	['Neutral']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
unable to enroll subjects	['Insufficient_Enrollment']	['Neutral']
Business decision	['Business_Administrative']	['Possibly_Negative']
"The study was prematurely terminated, due to difficulties in the recruitment of T2DM patients
    who are not under statin therapy at inclusion."	['Insufficient_Enrollment']	['Neutral']
Study was halted prematurely due to lack of efficacy	['Negative']	['Negative']
Raptiva was withdrawn from the market	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
The company decided to cancel this study in conformity with PH FDA Circular 2013-004	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
low recruitment	['Insufficient_Enrollment']	['Neutral']
The study encountered significant difficulties in patient enrollment.	['Insufficient_Enrollment']	['Neutral']
Recruitment inadequate	['Insufficient_Enrollment']	['Neutral']
Project never got initiated	['Invalid_Reason']	['Invalid_Reason']
slow accrual and financial resource limitation	['Business_Administrative']	['Possibly_Negative']
"The study was withdrawn due to insufficient interest in study participation due to recent
    approval in this rare condition."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Infeasible	['Insufficient_Enrollment']	['Neutral']
P.I decided to prematurely end this study.	['Invalid_Reason']	['Invalid_Reason']
"This study was terminated before the planned sample size was enrolled due to very slow
    enrollment"	['Insufficient_Enrollment']	['Neutral']
Study was not opened.	['Invalid_Reason']	['Invalid_Reason']
Lack of Accrual	['Insufficient_Enrollment']	['Neutral']
Lack of inclusion and departure of the investigator	['Study_Staff_Moved']	['Neutral']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
"Terminated prematurely Sept 22, 2016 following an internal portfolio prioritization. It is not
    due to any safety concern or change in benefit:risk assessment."	['Business_Administrative']	['Possibly_Negative']
Sponsor terminated early as moving to a new larger study program	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Change in Formulation	['Study_Design']	['Neutral']
Inadequate study staff to appropriately manage trial.	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
lack of patients	['Insufficient_Enrollment']	['Neutral']
Trial not initiated	['Invalid_Reason']	['Invalid_Reason']
Administrative issues	['Business_Administrative']	['Possibly_Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Lack of inclusion	['Insufficient_Enrollment']	['Neutral']
Suspended as we are looking for more durable method/device	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Logistic reasons, lack of funding	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
no patients recruited, responsible physician left clinic	['Study_Staff_Moved']	['Neutral']
"Lack of clarity regarding the PMS study requirement from the RA and Ethics committee hence it
    was concluded GSK will submit local PSURs"	['Interim_Analysis', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
"PI has terminated study as the sequencing on patients and volunteers didn't yield the results
    expected. PI has no plans for scholarly/scientific presentations."	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Data collection was halted prematurely due to COVID-19.	['Covid19']	['Neutral']
Portfolio prioritization due to slow enrollment	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
The study was stopped because of loss of funding and no safety issues	['Business_Administrative']	['Possibly_Negative']
Terminated due to poor enrollment.	['Insufficient_Enrollment']	['Neutral']
Greater-than-anticipated rate of revisions	['Study_Design']	['Neutral']
Terminated before starting due to need for IND determined by FDA.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study was never initiated	['Invalid_Reason']	['Invalid_Reason']
Safety evaluation due to recent publications.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Due to accrual not met and PI no longer at the institution	['Insufficient_Enrollment']	['Neutral']
Patient recruitment and Funding inadequate to finish trial	['Business_Administrative']	['Possibly_Negative']
Population of interest was no longer available	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Difficulty of Recruitment	['Insufficient_Enrollment']	['Neutral']
bad recruitment of suitable participants, just 8 patients in one year	['Insufficient_Enrollment']	['Neutral']
DSMC Recommendation	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
PI left University	['Study_Staff_Moved']	['Neutral']
additional recruitment not needed	['Insufficient_Enrollment']	['Neutral']
Did not receive NIH Funding	['Business_Administrative']	['Possibly_Negative']
Change in current areas of research interest of the collaborator	['Logistics_Resources', 'Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Study halted prematurely, prior to enrollment of first patient, due to recruiting problems.	['Insufficient_Enrollment']	['Neutral']
"preceding efficacy study of avoralstat in its current formulation was not significant and does
    not support continued development"	['Negative', 'Another_Study']	['Negative', 'Neutral']
The investiagtor abandoned the project.	['Business_Administrative']	['Possibly_Negative']
The study was closed by the investigators due to lack of study population to enroll.	['Insufficient_Enrollment']	['Neutral']
This is a basic research study with no clinical data to report	['Success', 'No_Context', 'Logistics_Resources']	['Success', 'Invalid_Reason', 'Neutral']
Lack of Funding	['Business_Administrative']	['Possibly_Negative']
"The sample for statistical analysis of results could not be recruited within the specified
    timeframe upon retirement of the original principal investigator."	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
toxicities were worse than expected	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Change in clinical strategy	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Funding issue	['Business_Administrative']	['Possibly_Negative']
Sponsor discontinued clinical trial before enrollment of subjects.	['Business_Administrative']	['Possibly_Negative']
Per IRB COVID-19 guidance on conducting human subjects research	['Covid19']	['Neutral']
According to Sponsor decision.	['Business_Administrative']	['Possibly_Negative']
never activated	['Invalid_Reason']	['Invalid_Reason']
Sponsor is winding down business operations	['Business_Administrative']	['Possibly_Negative']
never started	['Invalid_Reason']	['Invalid_Reason']
Not Funded	['Business_Administrative']	['Possibly_Negative']
Financial Reasons	['Business_Administrative']	['Possibly_Negative']
no participants enrolled	['Insufficient_Enrollment']	['Neutral']
Terminated by sponsor owing to slow enrollment	['Insufficient_Enrollment']	['Neutral']
"Enrollment and other trial activities have temporarily paused due to COVID-19 and are expected
    to resume in the future; This is not a suspension of IRB approval"	['Covid19']	['Neutral']
Funding issue	['Business_Administrative']	['Possibly_Negative']
The principal investigator Dr.YinLi is working in other Hospital	['Study_Staff_Moved']	['Neutral']
Changing the study design	['Study_Design']	['Neutral']
Temporarily suspended due to pandemic	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
poor recruitment	['Insufficient_Enrollment']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Need to recruit research staff	['Insufficient_Enrollment']	['Neutral']
Study closed due to substantial decrease in the desired patient population.	['Insufficient_Enrollment']	['Neutral']
COVID-19 Pandemic	['Covid19']	['Neutral']
Inadequate enrollment	['Insufficient_Enrollment']	['Neutral']
study not started due to lack of funding	['Business_Administrative']	['Possibly_Negative']
Study closed in response to COVID-19 and overall program objectives.	['Covid19']	['Neutral']
Closed by the sponsor for not fully meeting subject recruitment targets.	['Insufficient_Enrollment']	['Neutral']
"during Period 1 due to numerous orthostatic AEs that occurred. Subsequently, RLD was reduced to
    5 mg due to safety concerns."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Enrollment	['Insufficient_Enrollment']	['Neutral']
Inadequate patient recruitment	['Insufficient_Enrollment']	['Neutral']
Failure to obtain HGR approval.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Slow accrual rates/ lack of funding	['Insufficient_Enrollment']	['Neutral']
Due to a low recruitment rate since start of recruitment period.	['Insufficient_Enrollment']	['Neutral']
"GSK has decided to terminate the Product Development of foretinib and conclude our Development
    Agreement with Exelixis"	['Business_Administrative']	['Possibly_Negative']
Absence of patient's recruitment in the study due to administrative reasons	['Business_Administrative']	['Possibly_Negative']
Principal Investigator moved institutions	['Study_Staff_Moved']	['Neutral']
No paticipants enrolled	['Insufficient_Enrollment']	['Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Insufficient efficacy observed in study BCDM (NCT01198002) and BCDV (NCT01202773).	['Negative', 'Another_Study']	['Negative', 'Neutral']
logistics	['Logistics_Resources']	['Neutral']
reformulation	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Principal Investigator is away on business	['Study_Staff_Moved']	['Neutral']
Difficulty of patients enrollments	['Insufficient_Enrollment']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
lack of funds	['Business_Administrative']	['Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
sponsor stopped study due to recruitment problems	['Insufficient_Enrollment']	['Neutral']
Lack of available clinical time to complete	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
not funded	['Business_Administrative']	['Possibly_Negative']
Production of the IMP (plasmid AMEP) has been terminated by the supplier (BioAlliance Pharma)	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"The Sponsor decided to discontinue the development of idasanutlin in the polycythemia vera
    indication."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Funding terminated	['Business_Administrative']	['Possibly_Negative']
"Due to patient enrollment challenges stemming from the COVID-19 pandemic, Aclaris has decided
    to focus its efforts and resources on other immuno-inflammatory diseases."	['Covid19']	['Neutral']
Slow recruitment of subjects	['Insufficient_Enrollment']	['Neutral']
Not approved by ethical committee	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Budgetary constraints	['Business_Administrative']	['Possibly_Negative']
Determination to stop enrollment made due to funding	['Business_Administrative']	['Possibly_Negative']
Cancelled before active due to the results of emerging scientific data	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
Stopped due to COVID-19 pandemic, low priority among initiatives and officially terminated.	['Covid19']	['Neutral']
Funding not received	['Business_Administrative']	['Possibly_Negative']
due to end of validity of peptide vaccine	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Sponsor decision to terminate the study	['Business_Administrative']	['Possibly_Negative']
"Two patients in the first dose level be counted as reaching DLT. DSMB recommend terminated
    early this trial."	['Negative', 'Another_Study']	['Negative', 'Neutral']
"This study was terminated January 11, 2011 due to low enrollment. This study is not being
    terminated because of safety or efficacy concerns."	['Insufficient_Enrollment']	['Neutral']
"The sponsor was not the good one. We will redo the clincal trial gov to be concordant with the
    actual sponsor"	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
See Detailed Description	['No_Context']	['Invalid_Reason']
Because economic problems	['Business_Administrative']	['Possibly_Negative']
Low accrual.	['Insufficient_Enrollment']	['Neutral']
Received funding for larger randomized study so terminated pilot study	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Temporarily suspension due to the COVID19 pandemic and will resume once it is deemed safe.	['Covid19']	['Neutral']
"Study has not been able to start due to difficulty in obtaining an intravenous formulation of
    cyclodextrin (intravenous 2HPBCD) suitable for man"	['Logistics_Resources']	['Neutral']
Lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
Lack of lab ressources	['Logistics_Resources']	['Neutral']
"According to the protocol, the sponsor terminated the study after it was determined that less
    than 2 of the first 22 patients showed a PSA50 response."	['Negative']	['Negative']
Prematurely terminated at institution request	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
These is understaffed to excute study now.	['Interim_Analysis', 'Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral', 'Neutral']
The study was terminated due to difficulty in recruiting subjects	['Insufficient_Enrollment']	['Neutral']
Project development priorities changed.	['Business_Administrative']	['Possibly_Negative']
"The funding agency, DoD, determined that the study could not meet its enrollment numbers by the
    end of the grant"	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
COVID-19 Pandemic	['Covid19']	['Neutral']
EF decided suspended the study because the investigational product was changed.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
patients not enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Institution shut down due to COVID-19	['Covid19']	['Neutral']
PI transferred to a new institution	['Study_Staff_Moved']	['Neutral']
Lower than expected accrual rate and desire to reassess overall study strategy.	['Insufficient_Enrollment']	['Neutral']
No patients available	['Insufficient_Enrollment']	['Neutral']
Novartis terminated funding	['Business_Administrative']	['Possibly_Negative']
Grant support was withdrawn from Amgen Pharmaceuticals	['Business_Administrative']	['Possibly_Negative']
Low tolerability of fibers included in the product	['Safety_Sideeffects', 'Logistics_Resources', 'Endpoint_Met']	['Safety_Sideeffects', 'Neutral', 'Neutral']
No participant enrolled	['Insufficient_Enrollment']	['Neutral']
COVID-19 pandemic and patient recruitment issues	['Covid19']	['Neutral']
Unable to identify and recruit eligible participants	['Insufficient_Enrollment']	['Neutral']
"Edwards acquired Valtech Cardio Ltd in 2017 and opted to replace this study with NCT03600688.11
    patients were enrolled in REPAIR and follow-up is complete."	['Business_Administrative']	['Possibly_Negative']
"After year 1, there was insufficient statistical power to detect a difference in the primary
    outcome measure during planned study period."	['Negative']	['Negative']
Due to Ebola virus disease outbreak	['Covid19', 'Safety_Sideeffects', 'Insufficient_Enrollment']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Investigator Voluntary Pause	['Invalid_Reason']	['Invalid_Reason']
Corona.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Strategic Reasons	['Business_Administrative']	['Possibly_Negative']
Data could not be interpreted. Re-design efforts failed.	['Study_Design']	['Neutral']
"Because the study sponsor chose to discontinue funding for this protocol following a change in
    leadership, the study was terminated early."	['Business_Administrative']	['Possibly_Negative']
Unable to obtain funding to continue recruitment; no accrual	['Business_Administrative']	['Possibly_Negative']
"AstraZeneca has discontinued the development of AZD0530. No new AstraZeneca-sponsored clinical
    studies will be initiated.."	['Business_Administrative']	['Possibly_Negative']
Terminated (failure to enroll)	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Limited clinical capacity	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
lack of subjects	['Insufficient_Enrollment']	['Neutral']
Sponsor decision to cancel TRIAL, not related to safety concern	['Safety_Sideeffects', 'Business_Administrative']	['Safety_Sideeffects', 'Possibly_Negative']
funding	['Business_Administrative']	['Possibly_Negative']
Stopped due to low percentage of patients with detectable CTCs at baseline.	['Negative']	['Negative']
Insufficient subject recruitment.	['Insufficient_Enrollment']	['Neutral']
The antibody used did not appear prognostic/predictive based on interim results.	['Negative']	['Negative']
Unable to recruit the anticipated number of subjects for this study	['Insufficient_Enrollment']	['Neutral']
The study protocol needed to be modified	['Study_Design']	['Neutral']
Strategy changes.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Terminated early due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
"We will not initiate recruitment for this protocol due to lack of funding to support this
    placebo-controlled trial."	['Business_Administrative']	['Possibly_Negative']
FDA approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study never opened (terminated as study drug no longer available)	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Study terminated by Sponsor as a result of a business decision to discontinue the development
    program for MK-8342B for reasons unrelated to safety or efficacy."	['Business_Administrative']	['Possibly_Negative']
Participants not interested in enrolling.	['Insufficient_Enrollment']	['Neutral']
Study start delayed due to pending collection and analysis of additional phase 1 data.	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Lack of financial support	['Business_Administrative']	['Possibly_Negative']
Study terminated due to low subject enrollment. Safety results consistent with product label.	['Negative', 'Another_Study']	['Negative', 'Neutral']
FAST-Mag study finished	['Invalid_Reason', 'Study_Design']	['Invalid_Reason', 'Neutral']
screening survey data was not correctly collected; Study halted prematurely	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
principal investigator left for another job, project leader retired	['Study_Staff_Moved']	['Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
we could not fined enough patients for the study	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Insuffisent recrutment	['Insufficient_Enrollment']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
no more funding available	['Business_Administrative']	['Possibly_Negative']
"Selective inclusion/exclusion criteria led to low enrollment which was not viable for the
    sponsor and site."	['Insufficient_Enrollment']	['Neutral']
Grant not funded so clinical trial not started.	['Business_Administrative']	['Possibly_Negative']
Other studies with the same protocol have already published.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Due to lack of accrual and trial has demonstrated too little clinical benefit	['Insufficient_Enrollment']	['Neutral']
Study stopped due to business decision to not continue to gather clinical evidence on product	['Business_Administrative']	['Possibly_Negative']
Enough data to conclude	['Success', 'Endpoint_Met', 'Invalid_Reason']	['Success', 'Neutral', 'Invalid_Reason']
Only 12 subjects enrolled. DSMB recommended closing due to lack of feasibility	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"The study was withdrawn due to difficult recruitment of patients for the study; No participants
    were enrolled in the study."	['Insufficient_Enrollment']	['Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
Sponsor terminated study	['Business_Administrative']	['Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
"Elevation of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in some
    participants."	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Study stopped due to lack of efficacy.	['Negative']	['Negative']
See Detailed Description	['No_Context']	['Invalid_Reason']
"Study enrollment was terminated due to company decision before the target enrollment of 220
    patients was reached."	['Business_Administrative']	['Possibly_Negative']
difficulty enrolling patients, no patient recruited	['Insufficient_Enrollment']	['Neutral']
low accrual due to competing study for same group of patients	['Insufficient_Enrollment']	['Neutral']
Change in business strategy	['Business_Administrative']	['Possibly_Negative']
Superseded by larger funded study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
poor recruitment	['Insufficient_Enrollment']	['Neutral']
Mode of application to be reconsidered by Sponsor	['Business_Administrative']	['Possibly_Negative']
"Study terminated on the recommendation of an independent Data Monitoring Committee (DMC)
    subsequent to an interim efficacy analysis for futility.]"	['Negative']	['Negative']
The study was withdrawn due to not being able to recruit subjects.	['Insufficient_Enrollment']	['Neutral']
We cannot enroll enough participants.	['Insufficient_Enrollment']	['Neutral']
"The study was terminated as other related studies of ruxolitinib did not provide sufficient
    efficacy to warrant continuation."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study accrual rate is very slow, it was mandated by NCI to be terminated.	['Insufficient_Enrollment']	['Neutral']
Study completed per investigator.	['Invalid_Reason']	['Invalid_Reason']
No eligible patients were enrolled	['Insufficient_Enrollment']	['Neutral']
Based in the negative of patients to shave de hair.	['Negative', 'Another_Study']	['Negative', 'Neutral']
This study is withdrawn due to feasibility issues.	['Logistics_Resources']	['Neutral']
PI unable to secure funding for the project so study was not pursued.	['Business_Administrative']	['Possibly_Negative']
No problems with planned study- insufficient funding for this study to proceed.	['Business_Administrative']	['Possibly_Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
The PI will be leaving the institution and not continuing the study	['Study_Staff_Moved']	['Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Study was inactivated by the IRB since PI left institution.	['Study_Staff_Moved']	['Neutral']
observed benefit of treatment larger than expected	['Negative']	['Negative']
"This application needs further attention in terms of FDA approval and will be reassigned under
    a different trial number later."	['Regulatory', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
"The experimental design was not sufficient to answer the proposed questions. A new study design
    is now being considered."	['Study_Design']	['Neutral']
Not meeting recruitment targets	['Insufficient_Enrollment']	['Neutral']
"The study was stopped due to lack of efficacy in a study conducted in a similar
    population,38518168ARA2002-NCT01679951."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Investigator has moved to another institution	['Study_Staff_Moved']	['Neutral']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Accrual	['Insufficient_Enrollment']	['Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Staffing issues	['Logistics_Resources']	['Neutral']
Accrual not met	['Insufficient_Enrollment']	['Neutral']
The results fell short of expectations.	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Staffing issues resulted in the closure of the study prior to any participants being enrolled.	['Logistics_Resources']	['Neutral']
Terminated due to poor accrual.	['Insufficient_Enrollment']	['Neutral']
due to difficulties to attract participants	['Insufficient_Enrollment']	['Neutral']
COVID pandemic precluded trial initiation. No longer clinical equipoise	['Covid19']	['Neutral']
Study is open, but enrollment is on hold pending interim data review.	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
difficulty recruiting patients	['Insufficient_Enrollment']	['Neutral']
"Open label study part reduced from n=10 to n=6 because of insufficient number of patients under
    antiaggregation."	['Insufficient_Enrollment']	['Neutral']
"The biscuits contain higher than the UK recommended daily dose of vitamins C and E, and
    selenium."	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Administrative change	['Business_Administrative']	['Possibly_Negative']
"The trial was planned to be conducted in 4 cohorts but was terminated after completion of
    Cohort 2 for strategic reasons due to limited PD effects."	['Business_Administrative']	['Possibly_Negative']
Change in study design based on phase 1 data collection; patient burden was not feasible	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Due to other projects priority	['Business_Administrative']	['Possibly_Negative']
Study halted due to drug sponsor decision to not continue.	['Business_Administrative']	['Possibly_Negative']
Business decision to stop the program.	['Business_Administrative']	['Possibly_Negative']
PI relocated	['Study_Staff_Moved']	['Neutral']
The study was terminated due to recruitment challenges	['Insufficient_Enrollment']	['Neutral']
"We terminated the study to run it as a sub-study of NCT02371889, which is a 13 week, placebo
    controlled, double-blind, trial of topiramate in heavy drinkers."	['Negative', 'Another_Study']	['Negative', 'Neutral']
No enrollment	['Insufficient_Enrollment']	['Neutral']
"Laproscopic procedure not offered at this time; will not be offered for the foreseeable, thus
    we are unable to randomize participants between the two arms."	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
See detailed description for termination reason	['No_Context']	['Invalid_Reason']
Terminated due to difficulty in recruiting participants.	['Insufficient_Enrollment']	['Neutral']
Principal Investigator departed from institution	['Study_Staff_Moved']	['Neutral']
Enrollment on Hold (COVID-19)	['Covid19']	['Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
the study was stopped due to failure to recruit sufficient participants	['Insufficient_Enrollment']	['Neutral']
Trial terminated early per business decision	['Business_Administrative']	['Possibly_Negative']
Research personnel changes prevented study initiation and enrollment	['Logistics_Resources']	['Neutral']
All enrollment, treatment, follow-up & data analysis completed	['Invalid_Reason']	['Invalid_Reason']
Study termination by the Sponsor	['Business_Administrative']	['Possibly_Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
The sample size was not completed	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
No enrolled subjects	['Insufficient_Enrollment']	['Neutral']
"Study was terminated due to unforeseen difficulties with subject recruitment. No safety issues
    were identified in the study with this new formulation."	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Study was not opened.	['Invalid_Reason']	['Invalid_Reason']
Subjects were not recruited as intended.	['Insufficient_Enrollment']	['Neutral']
Due to slow recruitment, the study was prematurely discontinued	['Insufficient_Enrollment']	['Neutral']
Due to small number of participants entering randomization. Not a safety issue.	['Insufficient_Enrollment']	['Neutral']
Covid19 locked down	['Covid19']	['Neutral']
no eligible subjects identified during recruitment	['Insufficient_Enrollment']	['Neutral']
Participant enrollment into stepped-care model was not feasible.	['Insufficient_Enrollment']	['Neutral']
achievement of MTD in the eligible study population	['Insufficient_Enrollment', 'Invalid_Reason', 'Negative']	['Neutral', 'Invalid_Reason', 'Negative']
The study design was not compatible with recruiting patients to the investigation	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
lack of funding	['Business_Administrative']	['Possibly_Negative']
No recruitment	['Insufficient_Enrollment']	['Neutral']
Study not approved	['Interim_Analysis', 'Regulatory', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Safety concerns	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"The study was terminated due to cessation of clinical development of S-888711 for chronic ITP
    based on a business decision by the Sponsor."	['Business_Administrative']	['Possibly_Negative']
Lack of human ressources	['Logistics_Resources']	['Neutral']
accrual goal met	['Invalid_Reason']	['Invalid_Reason']
This was never a clinical trial and should never have been approved.	['Regulatory', 'Insufficient_Enrollment', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
published data suggest potential harm in other investigations.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study was never funded.	['Business_Administrative']	['Possibly_Negative']
Interim analysis: no statistically significant difference in the 2 study arms.	['Negative']	['Negative']
"Sponsor decision based on portfolio prioritization and changing treatment landscape in
    frontline DLBCL"	['Business_Administrative']	['Possibly_Negative']
Unable to find enough patients who accept randomization of surgical procedures.	['Insufficient_Enrollment']	['Neutral']
PI relocated to another institution. No subjects went on treatment.	['Study_Staff_Moved']	['Neutral']
The stopping rule was met and hence the study was closed	['Endpoint_Met', 'Invalid_Reason', 'Negative']	['Neutral', 'Invalid_Reason', 'Negative']
Study terminated: Recruitment delay due to equipment malfunction	['Logistics_Resources']	['Neutral']
Sponsor is no longer pursuing this study	['Business_Administrative']	['Possibly_Negative']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Enrollment difficulties	['Insufficient_Enrollment']	['Neutral']
Not feasible, did not have the study population.	['Insufficient_Enrollment']	['Neutral']
Animal Toxicity Findings	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"After IELSG25A study amendment, patients subject of the present study were eligible for
    inclusion in the IELSG25A study"	['Negative', 'Another_Study']	['Negative', 'Neutral']
"The study recruitment was terminated in Dec-2015 for strategic reasons related to the
    development of the compound."	['Business_Administrative']	['Possibly_Negative']
We did not recruit the research assistant and terminated the study	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
failure to enroll participants	['Insufficient_Enrollment']	['Neutral']
The development program has been terminated	['Business_Administrative']	['Possibly_Negative']
Due to COVID-19 pandemic	['Covid19']	['Neutral']
Research at the University of Chicago was halted in March 2020.	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
"1. Limit number of patients during COVID-19 situation

      2. Too small number of wheat allergic patients who are using wheat containing soap"	['Covid19']	['Neutral']
Too few elible patients but only one gave informed consent	['Insufficient_Enrollment']	['Neutral']
funding not obtained	['Business_Administrative']	['Possibly_Negative']
Sponsor decision to end study.	['Business_Administrative']	['Possibly_Negative']
Infeasible to conduct at this time.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Study IRB approval expired	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Principal Investigator left the NIH.	['Study_Staff_Moved']	['Neutral']
Withdrawn due to loss of funding	['Business_Administrative']	['Possibly_Negative']
technical problems in equipment	['Logistics_Resources']	['Neutral']
change in study design before recruitment began	['Study_Design']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Data collection sites lost research personnel that were recruiting subjects.	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
Administrative changes precluded enrollment.	['Business_Administrative']	['Possibly_Negative']
Due to slow recruitment study is being terminated.	['Insufficient_Enrollment']	['Neutral']
Unable to enroll IRB approved sample of participants.	['Insufficient_Enrollment']	['Neutral']
Study design changed for recruitment purposes; no participants enrolled	['Study_Design']	['Neutral']
Major protocol revision needed, current project terminated after enrollment of 25 patients.	['Study_Design']	['Neutral']
The company responsible for funding has filed for bankruptcy	['Business_Administrative']	['Possibly_Negative']
Sponsor stopped producing device	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Looking for funding opportunities	['Business_Administrative']	['Possibly_Negative']
due to constraints with collaborator and subject matter expert, recruitment was unable to begin	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Study never got started; can't delete results	['No_Context', 'Logistics_Resources', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
The study was stopped due to recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Difficult in patient enrollment	['Insufficient_Enrollment']	['Neutral']
lack of efficacy.	['Negative']	['Negative']
"Disposables required for the measurements in short supply and not provided by the company /
    supplier"	['Logistics_Resources']	['Neutral']
Another study was commenced for this patient group	['Negative', 'Another_Study']	['Negative', 'Neutral']
"A general TL algorithm with higher predicting power became available in 2015 (Petersen et al.)
    and speed of recruitment was slower than expected."	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
PI no longer at institution	['Study_Staff_Moved']	['Neutral']
no participants agreed to enroll since study start	['Insufficient_Enrollment']	['Neutral']
Difficulty to recruit patient due to lack of eligible patient	['Insufficient_Enrollment']	['Neutral']
study conducted under Clinical Trials Agreement as NIAID registration NCT02234570	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
prolonged recruitment phase	['Insufficient_Enrollment']	['Neutral']
No patients were treated due to enrollment challenges.	['Insufficient_Enrollment']	['Neutral']
A single cohort, alternative trial was started.	['Negative', 'Another_Study']	['Negative', 'Neutral']
"The trial was terminated prematurely following a suspected data processing concern in the study
    device. The concern did not pose a patient safety issue."	['Covid19', 'Interim_Analysis', 'Safety_Sideeffects']	['Neutral', 'Neutral', 'Safety_Sideeffects']
Original investigator left this institution, replacement investigator retired.	['Study_Staff_Moved']	['Neutral']
No eligible patients were enrolled.	['Insufficient_Enrollment']	['Neutral']
Low recruitment in intervention study. Baseline data published.	['Insufficient_Enrollment']	['Neutral']
Terminated due to insufficient accrual.	['Insufficient_Enrollment']	['Neutral']
very poor patient recruitement	['Insufficient_Enrollment']	['Neutral']
Caps became unavailable by manufacturer	['Logistics_Resources']	['Neutral']
company withdrew interest	['Business_Administrative']	['Possibly_Negative']
Hypoxemia(SPaO2<80%) episodes occured significantly in the arm titration by 0.5ug/ml	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
reduced recruitment rate due to non infectious, but competitive trials at our institution	['Insufficient_Enrollment']	['Neutral']
Terminated prematurely due to low accrual.	['Insufficient_Enrollment']	['Neutral']
Difficulty in accrual of study subjects, small numbers of potential subjects	['Insufficient_Enrollment']	['Neutral']
Failed to reach expected enrollment by anticipated dates.	['Insufficient_Enrollment']	['Neutral']
"This study was terminated after the first patient treated on study died as a result of the
    treatment."	['No_Context', 'Safety_Sideeffects', 'Insufficient_Enrollment']	['Invalid_Reason', 'Safety_Sideeffects', 'Neutral']
study was stopped due to low accrual	['Insufficient_Enrollment']	['Neutral']
Termination due to interim analysis results, inclusion problems in small ICUs.	['Negative']	['Negative']
Study withdrawn due to lack of staffing resources and subject interest	['Logistics_Resources']	['Neutral']
study moved to alternate site	['Study_Staff_Moved']	['Neutral']
No enrollment	['Insufficient_Enrollment']	['Neutral']
Enrollment stopped prior to complete enrollment due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Recruiting problems	['Insufficient_Enrollment']	['Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
Terminated by PI r/t lack of funding and retirement of study personel.	['Business_Administrative']	['Possibly_Negative']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of accrual, study closed.	['Insufficient_Enrollment']	['Neutral']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Funding didn't support further recruitment	['Business_Administrative']	['Possibly_Negative']
Increased risk of PML associated with raptiva in other studies	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Based on the results of the interim analysis, it was determined that the study would not meet
    its primary efficacy endpoint and the study was terminated early."	['Negative']	['Negative']
manufacturer could not finance the study	['Business_Administrative']	['Possibly_Negative']
Insufficient potential subjects	['Insufficient_Enrollment']	['Neutral']
Administrative	['Business_Administrative']	['Possibly_Negative']
Administrative	['Business_Administrative']	['Possibly_Negative']
Aims of the study re-evaluated, did not justify allocation of resources.	['Business_Administrative']	['Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Study closed due to unanticipated toxicity/risks to subjects.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Due to the meta-analysis about CV adverse effects of rosiglitazone.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of efficacy at review by DSMB using pre-specified monitoring criteria	['Negative']	['Negative']
In-person recruitment suspended due to COVID	['Covid19']	['Neutral']
"The FDA advised of a possible health risk associated with lorcaserin and the drug is being
    withdrawn."	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Terminated for poor accrual.	['Insufficient_Enrollment']	['Neutral']
futility analysis showed low probability of detecting a significant difference	['Negative']	['Negative']
"We did not achieve a tolerogenic profile. Subjects withdrew from protocol and enrolled in other
    islet transplant trials."	['Negative']	['Negative']
Stopped at the request of the Data Safety Monitoring Board for safety reasons.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
"Protocol A0221057 was terminated on December 25, 2009 for futility. There were no safety
    concerns related to this decision."	['Negative']	['Negative']
"Early end of trial notification after termination of long term follow up due to lack of
    scientific justification to continue collect information."	['Interim_Analysis', 'Logistics_Resources', 'Insufficient_Data']	['Neutral', 'Neutral', 'Neutral']
Slower than anticipated enrollment for pilot study.	['Insufficient_Enrollment']	['Neutral']
The authors finished their jobs in the hospitals where the study was begun.	['Study_Staff_Moved']	['Neutral']
"The decision to stop the trial was based on efficacy results in the overall schizophrenia
    participant population."	['Success', 'Endpoint_Met', 'Negative']	['Success', 'Neutral', 'Negative']
"CIP was amended to include long-term FU but, not all sites accepted it so the nr. of pts
    participating in the extended FU will be small."	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Terminated not based on safety concerns, but due to insufficient efficacy.	['Negative']	['Negative']
"The non significative reduction of CRBSI adverse events,the need for a high frecuency of
    catheter manipulations"	['Covid19', 'Interim_Analysis', 'Safety_Sideeffects']	['Neutral', 'Neutral', 'Safety_Sideeffects']
This project was not funded.	['Business_Administrative']	['Possibly_Negative']
enrollment of patients insufficient	['Insufficient_Enrollment']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
when a blind review highlighted that at least 43% of patients had a virological response	['Negative', 'Another_Study']	['Negative', 'Neutral']
Slow and low enrollment	['Insufficient_Enrollment']	['Neutral']
"CI Decision:That once the last patient has reached 1 year follow-up, no further follow up needs
    to be completed on patients recruited in PIT"""	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Company is closed	['Business_Administrative']	['Possibly_Negative']
Insufficient efficacy in planned interim futility analysis	['Negative']	['Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Budget exceeded	['Business_Administrative']	['Possibly_Negative']
Safety reasons	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Increased local adverse effect (breast inflamation and infection)	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Low recruitment rate	['Insufficient_Enrollment']	['Neutral']
The trial ended early due to GI intolerability and treatment-emergent resistance.	['Negative']	['Negative']
Internal business decision	['Business_Administrative']	['Possibly_Negative']
"Neither dose achieved the study's primary or major secondary endpoints. The safety profile was
    consistent with previous ustekinumab studies."	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
slow enrolment	['Insufficient_Enrollment']	['Neutral']
Following recommendation by SOLAR Study IDMC, Astellas closed enrollment in ASP8273 studies	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Overall response rate was 3% (only 1 out of 33 participants had confirmed PR).	['Negative']	['Negative']
No funding	['Business_Administrative']	['Possibly_Negative']
Insufficient Funding.	['Business_Administrative']	['Possibly_Negative']
Business Decision	['Business_Administrative']	['Possibly_Negative']
Funding depleted	['Business_Administrative']	['Possibly_Negative']
Poor recruitment to the study	['Insufficient_Enrollment']	['Neutral']
Poor Accrual	['Insufficient_Enrollment']	['Neutral']
change regimen	['Study_Design']	['Neutral']
Difficulty enrolling, aim already examined in literature.	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Recruitment problem	['Insufficient_Enrollment']	['Neutral']
"Th trial got cancelled and no subjects signed informed consent form (ICF); study design not
    appropriate any longer."	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Did not achieve enrollment goal	['Insufficient_Enrollment']	['Neutral']
Inadequate number of potential participants	['Insufficient_Enrollment']	['Neutral']
"The sponsor decided to terminate the study early due to enrolment not proceeding in accordance
    with expectations, independently from the study outcome."	['Insufficient_Enrollment']	['Neutral']
unable to meet the target enrollment goal	['Insufficient_Enrollment']	['Neutral']
"Nathan Kline Institute (NKI) decided not to accept study grant from Stanley Medical Research
    Foundation. because of budget considerations."	['Business_Administrative']	['Possibly_Negative']
Sponsor decision-lack of mechanistic signal and competing industry studies	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
closed to enrollment due to slow patient accrual	['Insufficient_Enrollment']	['Neutral']
"The primary endpoint of non-inferiority to daily therapy in the pediatric Phase 3 study was not
    achieved"	['Negative']	['Negative']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
See Detailed Description	['No_Context']	['Invalid_Reason']
Continuation of the trial cannot serve a scientific purpose	['Logistics_Resources', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
"Seqirus discontinued V451_07 Phase 2 start-up activities prior to enrolling subjects. Data from
    Phase 1 did not support further development. Further details are here:
    www.seqirus.com/news/update-on-the-university-of-queensland-covid-19-vaccine"	['Covid19']	['Neutral']
Trial not initiated	['Invalid_Reason']	['Invalid_Reason']
"BIOTRONIK received FDA approval to transition the ongoing Sentus QP Study to a new EP PASSION
    real-world data methodology."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"Per Amgen's decision to discontinue co-development and co-commercialization of brodalumab,
    study is being cancelled/closed."	['Business_Administrative']	['Possibly_Negative']
Because of a strategic decision by Novartis	['Business_Administrative']	['Possibly_Negative']
Principal investigator left the university.	['Study_Staff_Moved']	['Neutral']
not yet funded	['Business_Administrative']	['Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
Principal investigator Peter Johnstone, MD relocated to another institution	['Study_Staff_Moved']	['Neutral']
The 2008-09 North American peak influenza season ended prior to study completion.	['Insufficient_Enrollment']	['Neutral']
Sponsor withdrew funding	['Business_Administrative']	['Possibly_Negative']
"The study was cancelled for scientifically legitimate reasons not related to safety or efficacy
    of the vaccine."	['Interim_Analysis', 'Logistics_Resources', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Was unable to obtain funding	['Business_Administrative']	['Possibly_Negative']
lack of resources	['Logistics_Resources']	['Neutral']
Issues & unreliability with [11C]Carfentanil production	['Logistics_Resources']	['Neutral']
Technology was approved by FDA before study enrolled subjects	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Decision by Sponsor.	['Business_Administrative']	['Possibly_Negative']
Investigator left institution	['Study_Staff_Moved']	['Neutral']
"Withdrawn because there were no dramatic changes in the main endpoint, as well as low
    enrollment numbers. The data are not interpretable in terms of efficacy."	['Insufficient_Enrollment']	['Neutral']
Not enough subject participation	['Insufficient_Enrollment']	['Neutral']
Administrative issues	['Business_Administrative']	['Possibly_Negative']
Sample size can not be obtained at this site.	['Insufficient_Enrollment']	['Neutral']
Study withdrawn for technical reasons	['Logistics_Resources']	['Neutral']
Commercial decision	['Business_Administrative']	['Possibly_Negative']
Please see Detailed Description for termination reason.	['No_Context']	['Invalid_Reason']
Investigator decided to close study without enrollment	['Insufficient_Enrollment']	['Neutral']
"cost of conducting the study and increased burden on the clinical trial professionals make it
    impossible for us to proceed with the development of the drug."	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"PI is moving to another university; resident researcher does not wish to continue study with
    another PI."	['Study_Staff_Moved']	['Neutral']
Further product development is needed prior to clinical study testing	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Slow accrual; toxicity; change in priorities	['Insufficient_Enrollment']	['Neutral']
Recruitment difficulties and bad data quality	['Insufficient_Enrollment']	['Neutral']
Study was terminated due to low recruitment.	['Insufficient_Enrollment']	['Neutral']
PI left	['Study_Staff_Moved']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
New information on IMP affected the cost/benefit ratio	['Success', 'Insufficient_Data', 'Study_Design']	['Success', 'Neutral', 'Neutral']
Funding issues caused the study to not be opened the at local IRB	['Business_Administrative']	['Possibly_Negative']
We were unable to find patients that fit the eligibility criteria.	['Insufficient_Enrollment']	['Neutral']
Updates to device	['Covid19', 'Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
This study was dependent on an IT interoperability component requiring additional development.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Study prematurely terminated due to randomization imbalance.	['Insufficient_Enrollment']	['Neutral']
Terminated- the study was not started (per Investigator's/sponsor decision)	['Business_Administrative']	['Possibly_Negative']
Enrolled subjects were unable to receive drug from dispensing pharmacy.	['Logistics_Resources']	['Neutral']
slow recruitment of patients	['Insufficient_Enrollment']	['Neutral']
PI deployed.	['Study_Staff_Moved']	['Neutral']
PI left the institution	['Study_Staff_Moved']	['Neutral']
"Study terminated by Sponsor following a recommendation from external DMC to terminate the
    ongoing Phase 3 CD studies; there were no new emergent safety findings"	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
recruitment was going too slowly	['Insufficient_Enrollment']	['Neutral']
Business reasons	['Business_Administrative']	['Possibly_Negative']
DIfficulties with recruitment	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Poor enrollment of patients	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Change in study design	['Study_Design']	['Neutral']
Due to technical problems	['Logistics_Resources']	['Neutral']
Due to poor patient enrollment	['Insufficient_Enrollment']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Developed a better regimen: DIAD. Cast. 2018 NCT03593902	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Difficulty to include more patients	['Insufficient_Enrollment']	['Neutral']
"Regulatory issues(trial temporarily suspended December 28, 2005. Permanently suspended January
    19, 2007. Institutional Reveiw Board informed April 18, 2007"	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
slow accrual rate	['Insufficient_Enrollment']	['Neutral']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
Attrition rate complicated by COVID-19 led to termination.	['Covid19']	['Neutral']
recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Terminated due to insufficient funding	['Business_Administrative']	['Possibly_Negative']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Investigational device no longer has Health Canada approval.	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Change in company priorities	['Business_Administrative']	['Possibly_Negative']
"The incidence of post-operative delirium observed from interim blinded data in DEX-06-09 was
    significantly lower than the current literature in this population."	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Difficulty accruing subjects the study accrual was closed	['Insufficient_Enrollment']	['Neutral']
Study terminated.	['Invalid_Reason']	['Invalid_Reason']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
discontinued due to low enrollment	['Insufficient_Enrollment']	['Neutral']
Internal decision of the sponsor	['Business_Administrative']	['Possibly_Negative']
Recruitment below expectation	['Insufficient_Enrollment']	['Neutral']
"Enrollment was slower than anticipated by the investigators and the funding research
    foundation."	['Insufficient_Enrollment']	['Neutral']
Slow inclusion rate (partly due to Covid-19)	['Covid19']	['Neutral']
Lack of enrollment and commercial availability of drug	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Lack of funding/resources	['Business_Administrative']	['Possibly_Negative']
"This study was terminated due to treatment stop resulting in an inability to draw conclusions
    from the data. Evaluation of nonclinical rat findings is ongoing."	['Logistics_Resources', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
primary goal not achievable	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Target patient population reevaluated prior to enrollment	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
No recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of efficacy	['Negative']	['Negative']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
Unanticipated side effects and futility	['Negative']	['Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
No patients included	['Insufficient_Enrollment']	['Neutral']
Inadequate recruitment	['Insufficient_Enrollment']	['Neutral']
Difficulty recruiting patients	['Insufficient_Enrollment']	['Neutral']
Due low efficacy of FMT in interim analysis.	['Negative']	['Negative']
Discontinued due to difficulty in recruitment	['Insufficient_Enrollment']	['Neutral']
"Antiviral activity was considered insufficient to warrant further clinical development of
    TMC649128."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Diffculty in participant enrollment	['Insufficient_Enrollment']	['Neutral']
End of H1N1 Swine Flu Pandemic	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Lack of efficacy in Cohort 2; slow enrollment in Cohort 1	['Negative', 'Another_Study']	['Negative', 'Neutral']
"The effect of CT053PTSA in preciously treated patients with advanced and metastatic RCC is not
    as good as pre-expected"	['Negative']	['Negative']
terminated due to an inability to recruit study subjects	['Insufficient_Enrollment']	['Neutral']
"The sponsor has decided to start with a separate protocol for phase 3 and therefore this study
    was terminated with only phase 2."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Change in resources to support study activities	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"We did not commence the trial because there were no patients who could fulfill the inclusion
    criteria."	['Insufficient_Enrollment']	['Neutral']
Based on scientific data collected during the trial and high screen fail rate.	['Negative', 'Another_Study']	['Negative', 'Neutral']
lack of efficacy	['Negative']	['Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Study stopped due to low recruitment	['Insufficient_Enrollment']	['Neutral']
Study cancelled before protocol was implemented.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Patient recruitment issues.	['Insufficient_Enrollment']	['Neutral']
Change company strategy	['Business_Administrative']	['Possibly_Negative']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Unable to enroll due to criteria for stable baseline pain	['Safety_Sideeffects', 'Negative']	['Safety_Sideeffects', 'Negative']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
low recruiting	['Insufficient_Enrollment']	['Neutral']
Study terminated due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
failure of recruit	['Insufficient_Enrollment']	['Neutral']
The medical device arrived at expirationand it was not possible to have new one	['Logistics_Resources']	['Neutral']
enrollment volume due to placebo arm of trial	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
COVID-19	['Covid19']	['Neutral']
Funding for study was withdrawn	['Business_Administrative']	['Possibly_Negative']
Sponsor Decision; strategic - based on changing treatment landscape	['Business_Administrative']	['Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
concern over safety of rosiglitazone in heart failure	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
the PI is no longer work at Hadassah	['Study_Staff_Moved']	['Neutral']
Major side-effects	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
recruiting problems	['Insufficient_Enrollment']	['Neutral']
Reevaluation of development strategy	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
no one ever enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Originally 500 patients were planned but only 59 have been enrolled	['Insufficient_Enrollment']	['Neutral']
Manufacturing change in one of the two lipid emulsion products being studied.	['Study_Design']	['Neutral']
Sponsor decided to withdraw from study.	['Business_Administrative']	['Possibly_Negative']
Lack of enrollment. Difficult to obtain Physician approval.	['Insufficient_Enrollment']	['Neutral']
Former PI left institution and had plans to continue at another institution.	['Study_Staff_Moved']	['Neutral']
Withdrawn due to low accrual	['Insufficient_Enrollment']	['Neutral']
"After enrollment of the first 3 subjects, an interim assessment was conducted. Comparing DBS
    sampling to plasma PK levels yielded unconvincing results."	['Negative']	['Negative']
Hepatic safety signal identified.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Change of CRO	['Logistics_Resources', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Departure of Chief Investigator/Principal Investigator	['Study_Staff_Moved']	['Neutral']
Enrollment not initiated	['Insufficient_Enrollment']	['Neutral']
efficacy lower than expected	['Negative']	['Negative']
Trial was terminated due to halt in funding.	['Business_Administrative']	['Possibly_Negative']
difficulties of recruitment, high number of patients lost to follow-up	['Insufficient_Enrollment']	['Neutral']
Inhability to recruit further participants due to SARS-CoV-2 pandemics.	['Covid19', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
Recuitment to slow	['Insufficient_Enrollment']	['Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Study not started	['Invalid_Reason']	['Invalid_Reason']
Changed focus of the program	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
The main limitations were the small sample size and low completion rate.	['Insufficient_Enrollment']	['Neutral']
"AZ decision to discontinue fostamatinib development in RA; rights to fostamatinib returned to
    Rigel Pharmaceuticals."	['Business_Administrative']	['Possibly_Negative']
the study has never started	['Invalid_Reason']	['Invalid_Reason']
recruitment	['Insufficient_Enrollment']	['Neutral']
Evidence of very low probability to success. No safety issues	['Negative']	['Negative']
lack of funding	['Business_Administrative']	['Possibly_Negative']
"Patients' numebr randomized not achieved. Investigators team with lack of interest and
    commitment. The sponsor closed prematurely patients' recruitment."	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Inadequate enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Cancellation by sponsor	['Business_Administrative']	['Possibly_Negative']
Lack of Enrollment	['Insufficient_Enrollment']	['Neutral']
sufficient data collected	['Invalid_Reason']	['Invalid_Reason']
COVID prevented us from continuing recruitment and interventions at community sites	['Covid19']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
"The study was cancelled by the sponsor prior to initiation of study enrollment. No subjects
    were accrued."	['Insufficient_Enrollment']	['Neutral']
No Participants	['Insufficient_Enrollment']	['Neutral']
Study was stopped due to termination of funding	['Business_Administrative']	['Possibly_Negative']
Did not meet enrolment target for phase 1	['Insufficient_Enrollment']	['Neutral']
Study terminated due to lack of efficacy	['Negative']	['Negative']
closed due to competing neoadjuvant studies for a small patient population	['Negative', 'Another_Study']	['Negative', 'Neutral']
Difficulties in recruiting patients	['Insufficient_Enrollment']	['Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
appropriate study medication supply could not be identified	['Logistics_Resources']	['Neutral']
Study terminated early due to funding reasons prior to completing Phase 1	['Business_Administrative']	['Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
"Terminated: recruiting or enrolling participants has halted prematurely and will not resume;
    participants are no longer being examined or treated"	['Invalid_Reason']	['Invalid_Reason']
Business reasons	['Business_Administrative']	['Possibly_Negative']
Poor recruitment to experimental arms and study remained unfunded	['Insufficient_Enrollment']	['Neutral']
"Interim analysis showed very low possibility for significant differences between the two
    instruments."	['Negative']	['Negative']
Loss of funding for the continuation of the Study	['Business_Administrative']	['Possibly_Negative']
inclusion rate insufficient	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
No patient accrual	['Insufficient_Enrollment']	['Neutral']
Study determined not to be feasible to continue.	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Terminated by sponsor - Single dose safety objective achieved.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
"Sponsor quit partnership in Oncotyrol-Center for Personalized Medicine, and consequential loss
    of public funding."	['Business_Administrative']	['Possibly_Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
"Changes in preclinical treatment of stroke patients, no more emergency physician will met this
    patients"	['Study_Design']	['Neutral']
Recruitment/study discontinued after withdrawal of marketing authorisation. No data entered.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Due to slow participant accrual	['Insufficient_Enrollment']	['Neutral']
"Based on the results of study PTC124-GD-021-CF (NCT02139306), clinical development of ataluren
    in cystic fibrosis was discontinued and this study was closed."	['Negative', 'Another_Study']	['Negative', 'Neutral']
PI turned down funding.	['Business_Administrative']	['Possibly_Negative']
"Enrollment challenges due to changes in standards of care resulted in premature termination. No
    safety or efficacy events factored into this action."	['Study_Design']	['Neutral']
difficulty in the enrolment	['Insufficient_Enrollment']	['Neutral']
Personnel Changes	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
On hold pending amendment approval	['Study_Design']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Investigators were not able to continue recruiting and enrolling.	['Insufficient_Enrollment']	['Neutral']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
altered situation in study population; not enough patients meeting enrollment criteria	['Insufficient_Enrollment']	['Neutral']
Closed due to insufficient recruitment.	['Insufficient_Enrollment']	['Neutral']
Poor Accural	['Insufficient_Enrollment']	['Neutral']
investigator has left the institution	['Study_Staff_Moved']	['Neutral']
no patients recruited	['Insufficient_Enrollment']	['Neutral']
No longer aligned with the revised clinical development plan and commercial strategy	['Business_Administrative']	['Possibly_Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Endpoints were investigated in parallel in NCT00877305	['Negative', 'Another_Study']	['Negative', 'Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Terminated early due to lack of change in primary and secondary outcome measures.	['Negative']	['Negative']
No patient recruitment possible during COVID-19, inavailability RDTs	['Covid19']	['Neutral']
Were not able to meet enrollment goal due to inclusion/exclusion criteria	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Funding, MedWatch change to study drug	['Business_Administrative']	['Possibly_Negative']
PureGen was taken off of the market	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Accrual was insufficient to meet study endpoints	['Insufficient_Enrollment']	['Neutral']
Insufficient enrollment and extended study duration	['Insufficient_Enrollment']	['Neutral']
Change of the study site due to the current political climate in Myanmar.	['Covid19', 'Interim_Analysis', 'Logistics_Resources']	['Neutral', 'Neutral', 'Neutral']
Business decision of the management	['Business_Administrative']	['Possibly_Negative']
Ineffectiveness	['Negative']	['Negative']
there was no participants who were enrolled in this study	['Insufficient_Enrollment']	['Neutral']
"The study was terminated because clinical development of depatuxizumab mafodotin in
    glioblastoma was stopped due to lack of survival benefit."	['Negative']	['Negative']
The sponsor decided to terminate the study.	['Business_Administrative']	['Possibly_Negative']
FDA Full Clinical Hold due to safety concerns, as of 12/21/07	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Company Decision	['Business_Administrative']	['Possibly_Negative']
There were few eligible subjects from other centers.	['Insufficient_Enrollment']	['Neutral']
Due to futility, identified after 5 subjects completed treatment in Part B	['Negative', 'Another_Study']	['Negative', 'Neutral']
Per PI Request. 2) No additional benefit was noted with the addition of Ruxolitinib.	['Negative']	['Negative']
Lack of patients	['Insufficient_Enrollment']	['Neutral']
Lack of resources	['Logistics_Resources']	['Neutral']
evolution of patient's care allows no more recruitment	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Covid19	['Covid19']	['Neutral']
Poor Enrollment	['Insufficient_Enrollment']	['Neutral']
unable to get study up and enrolling	['Insufficient_Enrollment']	['Neutral']
Insufficient Recruitment	['Insufficient_Enrollment']	['Neutral']
unable to recruit patients due to COVID19	['Covid19']	['Neutral']
insufficient time to accrue sufficient subjects before end of funding	['Insufficient_Enrollment']	['Neutral']
Poor accrual so the study was halted on May 16, 2017.	['Insufficient_Enrollment']	['Neutral']
Strategic reasons of the company	['Business_Administrative']	['Possibly_Negative']
"Inadequate enrollment due to investigational product becoming newly available on the Canadian
    market soon after study start"	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
investigator choice	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Study withdrawn. No participants enrolled.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Corneal Inlay supplier no longer in business	['Logistics_Resources']	['Neutral']
PI No Longer at University of Maryland. Now at Fox Chase	['Study_Staff_Moved']	['Neutral']
"Insufficient number of patients included compared to the expected duration of inclusion.

    sponsor's decision"	['Insufficient_Enrollment']	['Neutral']
Due to emerging safety data	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
Principal Investigator left the institution	['Study_Staff_Moved']	['Neutral']
lack of recruitment of participants	['Insufficient_Enrollment']	['Neutral']
study was never initiated due to logistic causes	['Logistics_Resources']	['Neutral']
Study activities were not initiated, and we do not plan to initiate them in the future.	['Invalid_Reason']	['Invalid_Reason']
Administrative	['Business_Administrative']	['Possibly_Negative']
Study stopped due to project prioritization	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
The trial was terminated in line with the endpoint committee charter.	['Business_Administrative']	['Possibly_Negative']
due to insufficient quality of biopsy samples	['Logistics_Resources']	['Neutral']
Study not started, no longer required	['Invalid_Reason']	['Invalid_Reason']
Unfeasible because of low accrual	['Insufficient_Enrollment']	['Neutral']
Funding issues	['Business_Administrative']	['Possibly_Negative']
"In the Netherlands we wanted to add pilimumab to nivolumab. This resulted in a very long METC
    procedure which resulted in a to slow inclusion rate."	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Study_Design']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Lack of efficacy	['Negative']	['Negative']
IND voluntarily withdrawn, without prejudice	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
unsufficient patient recruitment	['Insufficient_Enrollment']	['Neutral']
Duplication	['Covid19', 'Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
"enrollment has been lower than anticipated due to growth in the minimally invasive mitral valve
    repair practice."	['Study_Design']	['Neutral']
The sample size should be re-calculated based on the first 28 cases.	['Interim_Analysis', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
not enough patients enrolled	['Insufficient_Enrollment']	['Neutral']
Enrollment rate was too slow.	['Insufficient_Enrollment']	['Neutral']
Original PI left and company withdrew support.	['Study_Staff_Moved']	['Neutral']
Re-initiate a new trial per the discussion with FDA	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
This study is terminated due to an inability to recruit a sufficient number of participants.	['Insufficient_Enrollment']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Sites could not enroll patients.	['Insufficient_Enrollment']	['Neutral']
PI No longer with the University	['Study_Staff_Moved']	['Neutral']
The study has been stopped because of the lack of enrollment	['Insufficient_Enrollment']	['Neutral']
"Great difficulties were encountered during recruitment, for fear Denozumab. Only 2 patients
    have been included since the study start."	['Insufficient_Enrollment']	['Neutral']
Our enrollment numbers were low - very few eligible study subjects.	['Insufficient_Enrollment']	['Neutral']
Issue of priority of resources	['Logistics_Resources']	['Neutral']
Short of supply of fibrin glue	['Logistics_Resources']	['Neutral']
Low Accrual, Funding	['Insufficient_Enrollment']	['Neutral']
study never started	['Invalid_Reason']	['Invalid_Reason']
Slow Accrual.	['Insufficient_Enrollment']	['Neutral']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
Former PI Left the Institution	['Study_Staff_Moved']	['Neutral']
Inadequate patient population to complete enrollment	['Insufficient_Enrollment']	['Neutral']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Study will not proceed, no participants enrolled.	['Invalid_Reason']	['Invalid_Reason']
FDA concerns regarding Avandamet	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
It was decided to discontinuate the study due to a very low recruitment.	['Insufficient_Enrollment']	['Neutral']
very slow patient recruitment and concerns about the actuality of the study design	['Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral']
Investigators left Joslin	['Study_Staff_Moved']	['Neutral']
study was stopped due to funding issues	['Business_Administrative']	['Possibly_Negative']
"Termination date was 20-Oct-2008. Subjects were monitored during the post treatment 90 day
    follow-up period (per protocol) resulting in LPLV 19-Jan-2009."	['Invalid_Reason']	['Invalid_Reason']
Study closed	['Invalid_Reason']	['Invalid_Reason']
Investigator abruptly left Carilion.	['Study_Staff_Moved']	['Neutral']
Asset terminated by PIB	['Business_Administrative']	['Possibly_Negative']
insufficient funding	['Business_Administrative']	['Possibly_Negative']
"Due to changes in EMA guidelines on modified release dosage forms (Feb 2013;
    EMA/CHMP/EWP/280/96). The Part B formulation would not meet the new guidelines."	['No_Context', 'Regulatory', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
difficulty obtaining funding	['Business_Administrative']	['Possibly_Negative']
PI left institution	['Study_Staff_Moved']	['Neutral']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
Business decision.	['Business_Administrative']	['Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Record Owner no longer with the institution	['Business_Administrative']	['Possibly_Negative']
The study was terminated due to recruitment challenges	['Insufficient_Enrollment']	['Neutral']
PI left the institution	['Study_Staff_Moved']	['Neutral']
Difficult recruitment -	['Insufficient_Enrollment']	['Neutral']
Low accrual.	['Insufficient_Enrollment']	['Neutral']
unexpected adverse events	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
surgery considered elective and cant be performed within corona restrictions	['Endpoint_Met', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
"Study recruitment was suspended due to interruption of in-person testing after the start of the
    COVID19 pandemic in March 2020. The current study's protocol is being revised to be delivered
    fully remotely."	['Covid19']	['Neutral']
"We were not able to recruit participants to enrol the study. As it was not able, the
    investigation team decided not to proced."	['Insufficient_Enrollment']	['Neutral']
Investigator is leaving the University	['Study_Staff_Moved']	['Neutral']
Study considered futile	['Invalid_Reason']	['Invalid_Reason']
Protocol violation occurred frequently during the postoperative period.	['Study_Design']	['Neutral']
The results are negtive.	['Negative']	['Negative']
Commercial decision	['Business_Administrative']	['Possibly_Negative']
Work focused in other areas, other groups working on this.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Minor design modifications to device to be investigated in new trial	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Because of recruitment challenges	['Insufficient_Enrollment']	['Neutral']
IRB reviewing study conduct and adverse events	['Interim_Analysis', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
inadequate personel	['Logistics_Resources']	['Neutral']
Study did not receive funding and will not be implemented.	['Business_Administrative']	['Possibly_Negative']
Resource issue	['Logistics_Resources']	['Neutral']
Investigator left institution	['Study_Staff_Moved']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
machine malfunction and updated work rutines	['Logistics_Resources']	['Neutral']
Difficulty in recruiting participants	['Insufficient_Enrollment']	['Neutral']
The study experienced enrollment difficulties.	['Insufficient_Enrollment']	['Neutral']
Hard to enroll expected number of eligible patients.	['Insufficient_Enrollment']	['Neutral']
Standard of care was modified at the primary institution	['Study_Design']	['Neutral']
PI no longer at institution	['Study_Staff_Moved']	['Neutral']
A priori hypothesis confirmed with interim analysis.	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
Equipment was loaned Lifglobal, Guilford, CT, USA and had to be returned.	['Logistics_Resources']	['Neutral']
interim analysis showed incorrect use of simple rules	['No_Context', 'Logistics_Resources', 'Endpoint_Met']	['Invalid_Reason', 'Neutral', 'Neutral']
"Clinical benefit was noted before the scheduled completion of the trial and the extension study
    was terminated early."	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
"The recruitment rate was very slow, and it was concluded that it was not feasible to do this
    trial."	['Insufficient_Enrollment']	['Neutral']
recruitment failure within the interval of available CRY BC-PLTs for the study	['Insufficient_Enrollment']	['Neutral']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
The collected data was finished	['Invalid_Reason']	['Invalid_Reason']
Failure to recruit patients with hemochromatosis to the Deferasirox arm	['Insufficient_Enrollment']	['Neutral']
required documentation too onerous	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Institutional approval of study has expired.	['Regulatory', 'Invalid_Reason', 'Negative']	['Neutral', 'Invalid_Reason', 'Negative']
Lack of pediatric recruitment ability	['Insufficient_Enrollment']	['Neutral']
no clinical investigator present	['No_Context', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
Primary researcher not able to continue research at the moment.	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Slow accrual and high levels of toxicity lead to early termination.	['Insufficient_Enrollment']	['Neutral']
interim anlaysis failed: palifermin does not promote thymopoeisis after alemtuzumab	['Negative']	['Negative']
Missing evidence of the effectiveness of the study medication	['Negative']	['Negative']
Principal investigator decided to terminate the study.	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Premature closure. Protocol did not meet its primary objective.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Low enrollment rate	['Insufficient_Enrollment']	['Neutral']
A main person involved left the site	['Study_Staff_Moved']	['Neutral']
the number of patients will be included is reach	['Invalid_Reason']	['Invalid_Reason']
"Now we use better procedures for the patient instead of nasal catheter for epistaxis. So it
    would be unethical to use the nasal catheter to complete the trial."	['Study_Design']	['Neutral']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
Funding ceased	['Business_Administrative']	['Possibly_Negative']
Accrual closed by sponsor due to lack of accrual and study progress	['Insufficient_Enrollment']	['Neutral']
Unable to recruit suitable subjects within a reasonable time period.	['Insufficient_Enrollment']	['Neutral']
Strategic business decision not to pursue indication due to lack of demonstrable medical need	['Business_Administrative']	['Possibly_Negative']
"The study was terminated based on a recommendation of the DSMB following the identification of
    two patients with significant elevations in serum transaminases"	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Study concluded prematurely prior to meeting intended goal recruitment.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Failure to demonstrate a tolerable dose that had potential for efficacy.	['Negative']	['Negative']
poor accrual	['Insufficient_Enrollment']	['Neutral']
Cannot get enough plasma to manufacture IVIG for human trials	['Logistics_Resources']	['Neutral']
Futility	['Negative']	['Negative']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Unable to recruit subjects into the trial.	['Insufficient_Enrollment']	['Neutral']
"State of Mass. tightened regulations for making intravenous solutions for research subjects.
    Study was withdrawn and no participants were enrolled."	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Concerns related to availability of drug product	['Logistics_Resources']	['Neutral']
no accrual achieved	['Insufficient_Enrollment']	['Neutral']
IND was withdrawn by CTEP due to low accrual and cost of maintaining the IND.	['Insufficient_Enrollment']	['Neutral']
Nonapplicable clinical trial	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Technical issues	['Logistics_Resources']	['Neutral']
Investigator Decision	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Difficulty in recruiting patients	['Insufficient_Enrollment']	['Neutral']
Covid-19	['Covid19']	['Neutral']
Unlikely to provide evidence of significant effect	['Negative']	['Negative']
The study was halted in January 2007 due to safety concerns.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
No difference in protein excretion at 6&12 months. No safety issues.	['Negative']	['Negative']
Lack of Efficacy	['Negative']	['Negative']
Terminated due to suboptimal dosing schedule	['Study_Design']	['Neutral']
Futility	['Negative']	['Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
unable to recruit enough patients	['Insufficient_Enrollment']	['Neutral']
Experimental treatment not feasible due to high rate of drop out	['Insufficient_Enrollment']	['Neutral']
"The trial was terminated early based on an interim review by the Data and Safety Monitoring
    Committee for positive efficacy outcome and no safety concerns."	['Negative']	['Negative']
"Ceased production of the study drug, Lymphoglobulin. Recruitment of patients onto the trial was
    too slow."	['Insufficient_Enrollment']	['Neutral']
Company withdrew interest	['Business_Administrative']	['Possibly_Negative']
Due to potential concerns about liver safety (See Detailed Description)	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
"An interim analysis showed that there is no difference in the primary endpoint, given the small
    number of events in the groups examined."	['Negative']	['Negative']
Practice on postoperative pain management changed	['Study_Design']	['Neutral']
"The preliminary data does not suggest any safety signal, but an ad hoc interim analysis showed
    an imbalance of PFS between the two arms"	['Negative']	['Negative']
Company decision to discontinue trial	['Business_Administrative']	['Possibly_Negative']
DSMB's decision following the first step analysis	['Negative']	['Negative']
"availability of new and more promising therapeutic agents than expected in the experimentation
    in question"	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Financial reason	['Business_Administrative']	['Possibly_Negative']
Funding period ended and slow enrollment	['Business_Administrative']	['Possibly_Negative']
Study stopped due to COVID-19 Pandemic	['Covid19']	['Neutral']
Interim analysis indicated no statistical difference between treatment arms.	['Negative']	['Negative']
"Unable to complete the sample size needed for 80% power due to changes in surgical approach to
    adductor block usage."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Stop the study for futility based on recommendation from Independent Data Committee.	['Negative']	['Negative']
Unable to conduct the study due to Covid-19.	['Covid19']	['Neutral']
Loss of funding.	['Business_Administrative']	['Possibly_Negative']
not enough patient	['Insufficient_Enrollment']	['Neutral']
"The investigators decided to terminate the study early because there were no patient candidates
    available for registration in the center."	['Insufficient_Enrollment']	['Neutral']
Management Decision	['Business_Administrative']	['Possibly_Negative']
Due to difficult patient enrollment.	['Insufficient_Enrollment']	['Neutral']
Administratively terminated.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Inadequate recruitment	['Insufficient_Enrollment']	['Neutral']
device development placed on hold	['Business_Administrative']	['Possibly_Negative']
"Enrollment is temporarily paused due to COVID-19; interactions/interventions with current
    participants continue. This is not a suspension of IRB approval."	['Covid19']	['Neutral']
Protocol study design was re-done in collaboration with CMS	['Study_Design']	['Neutral']
FlowMedica was purchased by AngioDynamics. Study will be re-started by AngioDynamics.	['Business_Administrative']	['Possibly_Negative']
Due to CART processing facility construction	['Logistics_Resources']	['Neutral']
Insufficient funding	['Business_Administrative']	['Possibly_Negative']
PI moved institutions	['Study_Staff_Moved']	['Neutral']
Interim analysis revealed that only 1 patient had a partial response.	['Negative']	['Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
No patients enrolled due to change in standard practice	['Study_Design']	['Neutral']
recruitment of subjects was halted prematurely. recruiting subjects halted prematurely	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
funding was not secured	['Business_Administrative']	['Possibly_Negative']
Finding to be unable to reach the primary endpoint	['Negative']	['Negative']
"Biosense stopped Study enrollment following publications that reported PVAC ablation is linked
    with a higher incidence of asymptomatic cerebral embolic lesions"	['Negative', 'Another_Study']	['Negative', 'Neutral']
The investigator decided not to continue the study.	['Invalid_Reason']	['Invalid_Reason']
Manufacturer updated device technology.	['Study_Design']	['Neutral']
unable to accrue study participants	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Because of economic issue, we could just enrolled total 150 patients.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Interim analysis showed no statistical significance achieved.	['Negative']	['Negative']
Study closed to accrual due to low accrual numbers.	['Insufficient_Enrollment']	['Neutral']
Study abandoned	['Invalid_Reason']	['Invalid_Reason']
Decided not to enroll into this study due to costs and other factors	['Business_Administrative']	['Possibly_Negative']
Low observed spontaneous coronary event rate among enrolled subjects	['Negative', 'Another_Study']	['Negative', 'Neutral']
"The dose limiting toxicity of cardiac QTc prolongation was identifiedin the phase 1 study in
    patients with refractory prostate and lymphoma"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Abandoned - Lack of funding after only 2 patients enrolled	['Business_Administrative']	['Possibly_Negative']
The study is terminated due to lower enrollment	['Insufficient_Enrollment']	['Neutral']
"Due to non-recruitment, the study is being halted. There are no major safety or tolerability
    concerns in the study conducted so far."	['Insufficient_Enrollment']	['Neutral']
"The investigators chose to terminate the study due to participant attrition. Of the limited
    data evaluable, none of the patients experienced adverse events."	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment and loss of funding	['Business_Administrative']	['Possibly_Negative']
investigator decision	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Recruitment	['Insufficient_Enrollment']	['Neutral']
Funding ended	['Business_Administrative']	['Possibly_Negative']
The study was withrawn do to logistic difficulties	['Logistics_Resources']	['Neutral']
Surgeons chose not to provide patients for testing	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
post-surgical complications in the last 2 patients	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Marketing of CE marked device has been discontinued.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
following the non-renewal of the loan agreement for the medical device	['Business_Administrative']	['Possibly_Negative']
Company's strategic reasons	['Business_Administrative']	['Possibly_Negative']
insufficient efficacy	['Negative']	['Negative']
Could not get IRB approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Withdrawn for administrative reasons	['Business_Administrative']	['Possibly_Negative']
It was difficult to enrol patients.	['Insufficient_Enrollment']	['Neutral']
Study suspended because of Covid-19 - no vaccinations are occurring in schools	['Covid19']	['Neutral']
"Temporarily paused due to COVID-19 and will resume based on guidance of public health
    authorities. This is not a suspension of IRB approval."	['Covid19']	['Neutral']
lack of funding to hire a dedicated study interventionist	['Business_Administrative']	['Possibly_Negative']
health statement of pre-screenined patients were too bad for being enrolled in the study	['No_Context', 'Logistics_Resources', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
RSS recommendation	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
A phase III RCT was published showing this approach is effective	['Negative', 'Another_Study']	['Negative', 'Neutral']
Early termination for futility	['Negative']	['Negative']
Lack of drug supply for doxercalciferol for this study	['Logistics_Resources']	['Neutral']
Not finding patients for including	['Insufficient_Enrollment']	['Neutral']
Epidemic dynamics	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Could not recruit subjects as they routinely chose surgical option	['Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral']
PI withdrew protocol	['Study_Staff_Moved', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Study terminated at this time by investigator. Will create new protocol.	['Study_Design']	['Neutral']
Low enrollment and lack of clinical activity in other CRS-207 studies.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Unable to obtain funding	['Business_Administrative']	['Possibly_Negative']
"The sponsor decided to stop further dosing of healthy volunteers after reviewing the obtained
    efficacy data. The decision is not related to any safety concern."	['Negative']	['Negative']
Study terminated due to change in business of US site.	['Business_Administrative']	['Possibly_Negative']
Project funding ended before reaching Phase 4.	['Business_Administrative']	['Possibly_Negative']
new protocol started 31/18	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
"Following the emergence of an unexpected pharmacodynamic effect, the sponsor has decided to
    conclude the study early without fully achieving its objective"	['Safety_Sideeffects', 'Negative', 'Another_Study']	['Safety_Sideeffects', 'Negative', 'Neutral']
Lack of funding/resources	['Business_Administrative']	['Possibly_Negative']
No funding was obtained for this study. No subject were receruited.	['Business_Administrative']	['Possibly_Negative']
Recruitment rates too low to continue with the study	['Insufficient_Enrollment']	['Neutral']
Stopped due to a strategic decision.	['Business_Administrative']	['Possibly_Negative']
Initial analysis of results warranted a study re-design and work on the study was suspended.	['Study_Design']	['Neutral']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
See Detailed Description	['No_Context']	['Invalid_Reason']
ethics approval not renewed by Study Group	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
The Chief Investigator (John Keating)	['Study_Staff_Moved']	['Neutral']
Low accrual rate	['Insufficient_Enrollment']	['Neutral']
PI Sabbatical	['Study_Staff_Moved']	['Neutral']
Unable to recruit subjects in the Turkey site.	['Insufficient_Enrollment']	['Neutral']
PI left institution, study did not continue, funding stopped	['Business_Administrative']	['Possibly_Negative']
Difficulties to sign a contract with the hospital, due to logistic changes in the hospital.	['Logistics_Resources']	['Neutral']
Never approved by the IRB	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Poor Enrollment- schedule of assessments too complex and time-consuming.	['Insufficient_Enrollment']	['Neutral']
PI decided to focus on more current topics of interest.	['Study_Staff_Moved', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Unable to reach sample size to satisfy the primary objective	['Insufficient_Enrollment']	['Neutral']
Study is being abandoned.	['Invalid_Reason']	['Invalid_Reason']
the PI is no longer work at Hadassah	['Study_Staff_Moved']	['Neutral']
Number of candidates for this study is expected to be too small.	['Insufficient_Enrollment']	['Neutral']
Site Decision	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Changes in approach to PDA therapy	['Study_Design']	['Neutral']
No participants	['Insufficient_Enrollment']	['Neutral']
difficult of recruiting	['Insufficient_Enrollment']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Insufficient funds	['Business_Administrative']	['Possibly_Negative']
diffculty to include patients	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
PI left institution	['Study_Staff_Moved']	['Neutral']
Unable to enroll sufficient patients	['Insufficient_Enrollment']	['Neutral']
Difficulty in recruiting patients given a 1 year funding period	['Business_Administrative']	['Possibly_Negative']
Created Extension study - This study was no longer feasible	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Terminated for futility reasons.	['Negative']	['Negative']
Unable to continue enrollment for dissertation study due to COVID-19	['Covid19']	['Neutral']
Business decision to terminate trial	['Business_Administrative']	['Possibly_Negative']
The study was stopped due to safety concerns	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Business Decision	['Business_Administrative']	['Possibly_Negative']
"This study was terminated by the Sponsor due to a business decision to discontinue product
    development for reasons unrelated to safety or efficacy outcomes."	['Business_Administrative']	['Possibly_Negative']
slow patient recruitment	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Internal business decision	['Business_Administrative']	['Possibly_Negative']
very low enrollment due to low access to study population	['Insufficient_Enrollment']	['Neutral']
"It was considered by the sponsor that the study objective has been met by dosing 13 instead of
    15 patients"	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Insufficient funding	['Business_Administrative']	['Possibly_Negative']
Suspended with COVID-9 pandemic; will resume post-pandemic.	['Covid19']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
No patients enrolled and clinician no longer at institution.	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Insufficient target engagement of ABT-957 (preclinical data)	['Negative']	['Negative']
Not a clinical trial study.	['Invalid_Reason']	['Invalid_Reason']
"Negative data from a GSK PoC study in RA combined with evidence of greater sensitivity of
    toll-like receptor pathways to p38 inhibition."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Covid-19 restrictions with screening/surveillance colonoscopies	['Covid19']	['Neutral']
"Termination of the study was made after a full review of program data and assessment of the
    current risk-benefit profile."	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
The results obtained are sufficient	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
"This is a voluntary registry formerly managed by a unit within CTSI that was disbanded in 2013.
    The registry has been dormant since that time."	['Study_Staff_Moved', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Study was stopped due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
The Sponsor has no interest in continuing the study.	['Business_Administrative']	['Possibly_Negative']
The study team did not enroll any patients due to difficulty with recruitment.	['Insufficient_Enrollment']	['Neutral']
Similar study being conducted, Sponsor decided to not duplicate study	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Sample size was too small to evaluate the clinical implications.	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
No resources available	['Business_Administrative']	['Possibly_Negative']
Never proceeded with trial. Failure initiate protocol among other centers.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
there was almost no patient would enroll in this study.	['Insufficient_Enrollment']	['Neutral']
no subject enrolled in nearly 2 years	['Insufficient_Enrollment']	['Neutral']
based on interim anaylsis	['Negative']	['Negative']
Slow Enrollment	['Insufficient_Enrollment']	['Neutral']
Inadequate effect size.	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Invalid_Reason']	['Safety_Sideeffects', 'Neutral', 'Invalid_Reason']
low recruitment rate	['Insufficient_Enrollment']	['Neutral']
"protocol needs complete restructuring in order to make it feasible and to complete the
    enrollment of 23 patients"	['Study_Design']	['Neutral']
To allow evaluation of emerging non-clinical data (see detailed description below)	['Covid19', 'No_Context', 'Insufficient_Data']	['Neutral', 'Invalid_Reason', 'Neutral']
Sponsor discontinued the research	['Business_Administrative']	['Possibly_Negative']
Workforce issues precluding study completion.	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Inadequate recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of funding.	['Business_Administrative']	['Possibly_Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Pharmaceutical company decided to withdraw funding and not provide drug.	['Business_Administrative']	['Possibly_Negative']
principle investigator moved to an another hospital	['Study_Staff_Moved']	['Neutral']
Insufficient number of inclusion	['Insufficient_Enrollment']	['Neutral']
Device development still ongoing and not ready for a formal study yet.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Delayed subject enrollment	['Insufficient_Enrollment']	['Neutral']
The study was halted after enrollment of the first cohort because of lack of funding	['Business_Administrative']	['Possibly_Negative']
Study has been terminated early due to financial constraints.	['Business_Administrative']	['Possibly_Negative']
Not enough subjects	['Insufficient_Enrollment']	['Neutral']
Difficult recruitment.	['Insufficient_Enrollment']	['Neutral']
Population not available for enrollment	['Insufficient_Enrollment']	['Neutral']
New data: The study was terminated based on new efficacy data from another study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Revise risk profile category of CAR-T cells in the consent document.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
lack of complaince	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Closure due to low accrual	['Insufficient_Enrollment']	['Neutral']
Abandoned due to lack of recruitment Oct 2006	['Insufficient_Enrollment']	['Neutral']
Change of a principal investigator	['Study_Staff_Moved']	['Neutral']
terminated due to enrollment	['Insufficient_Enrollment']	['Neutral']
Halted prematurely - Covid-19 pandemic prevented recruitment/testing in ED	['Covid19']	['Neutral']
"The study needed to be terminated due to new knowledge about cancer vaccines. A new protocol
    with an expected more efficient vaccine is currently being written."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
P.I. decided to terminate study due to multiple unresolved issues	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
inadequate no of constip patients	['Insufficient_Enrollment']	['Neutral']
Drug shortage	['Logistics_Resources']	['Neutral']
The STC has had financial limitations to start implementing the intervention.	['Business_Administrative']	['Possibly_Negative']
Business Reasons	['Business_Administrative']	['Possibly_Negative']
The marketing authorization for Intrinsa was withdrawn.	['Business_Administrative']	['Possibly_Negative']
Issues with Hospice	['Logistics_Resources']	['Neutral']
recrutment difficulties	['Insufficient_Enrollment']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Due to lack of sufficient eligible subjects, no safety concerns	['Insufficient_Enrollment']	['Neutral']
"Decision to terminate the study as anticipated target profile (confirmation of the selected
    dose of SJX-653 as safe and efficacious for further development for the treatment of moderate
    to severe vasomotor symptoms in postmenopausal women) not met"	['Negative']	['Negative']
Study terminated due to safety concerns; participant follow up will continue until March 2018	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Study DAR-312 did not meet its primary co-endpoints.	['Negative']	['Negative']
Sponsor decision to cancel TRIAL, not related to safety concern	['Safety_Sideeffects', 'Business_Administrative']	['Safety_Sideeffects', 'Possibly_Negative']
Study terminated by sponsor	['Business_Administrative']	['Possibly_Negative']
Slow enrollment along with new competing studies, investigators decided to stop study	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
No sufficient increase in plasma osmolarity by galactose (one patient included)	['Negative']	['Negative']
funding withdrawn	['Business_Administrative']	['Possibly_Negative']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Unable to obtain mitochondrial samples	['Logistics_Resources']	['Neutral']
none enrolled per PI	['Insufficient_Enrollment']	['Neutral']
Difficulty recruiting patients	['Insufficient_Enrollment']	['Neutral']
Per PI at time of CR. mt	['Study_Staff_Moved']	['Neutral']
Participants were unable to use the device. No data was collected	['Logistics_Resources']	['Neutral']
Sponsor decision due to change the clinical indication to Chronic Insomnia	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Investigator left Rockefeller University	['Study_Staff_Moved']	['Neutral']
termination of the study due to difficulties to include patients	['Insufficient_Enrollment']	['Neutral']
No subjects enrolled	['Insufficient_Enrollment']	['Neutral']
Low enrollment.	['Insufficient_Enrollment']	['Neutral']
PI left for another institution	['Study_Staff_Moved']	['Neutral']
"Protocol closed based on new (and as yet unpublished) information from a phase II clinical
    trial."	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Trial discontinued on 04Apr2016 as a strategic business decision not to pursue the indication.
    Decision to terminate not due to safety or efficacy concerns."	['Business_Administrative']	['Possibly_Negative']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Too selective recrutment criteria, none eligible patients	['Insufficient_Enrollment']	['Neutral']
study never initiated	['Invalid_Reason']	['Invalid_Reason']
funding has been exhausted	['Business_Administrative']	['Possibly_Negative']
Study terminated by Principal Investigator; no patients completed study.	['Invalid_Reason']	['Invalid_Reason']
Product was divested to Chiesi USA, who decided to not move forward with study.	['Business_Administrative']	['Possibly_Negative']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Insufficient enrollment rate	['Insufficient_Enrollment']	['Neutral']
Study closed. PI left the institution.	['Study_Staff_Moved']	['Neutral']
No signal on pain-score	['Negative']	['Negative']
no more participants taking atripla	['Insufficient_Enrollment']	['Neutral']
Awaiting verification of assay	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
"Low compliance with CBT, and challenges with the CBT provider. Previous participants will be
    considered the pilot phase."	['Study_Design']	['Neutral']
Hard to recruit due to COVID-19 issue.	['Covid19']	['Neutral']
Terminated.	['Invalid_Reason']	['Invalid_Reason']
Clinical trial being transferred to Columbia University with the Investigator.	['Study_Staff_Moved']	['Neutral']
PI Left	['Study_Staff_Moved']	['Neutral']
To conserve remaining capital, Sponsor decided to terminate the study early.	['Business_Administrative']	['Possibly_Negative']
"No patients will be recruited at Massachsetts General hospital. IRB approval changed to core
    center."	['Regulatory', 'Insufficient_Enrollment', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
evidence showed chloroquine is not effective against COVID-19	['Covid19']	['Neutral']
Low patient accrual	['Insufficient_Enrollment']	['Neutral']
Study was terminated due to funding issues.	['Business_Administrative']	['Possibly_Negative']
insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Resources needed to complete the study were not able to be obtained.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Due to manufacturing problems the transdermal patch was not produced.	['Logistics_Resources']	['Neutral']
Principal Investigator is deceased	['Study_Staff_Moved']	['Neutral']
It was a project initiated by a trainee but did not progress to subject accrual.	['Insufficient_Enrollment']	['Neutral']
Contractual and financial issues.	['Business_Administrative']	['Possibly_Negative']
Business strategic decision not related to safety.	['Business_Administrative']	['Possibly_Negative']
sponsor decision	['Business_Administrative']	['Possibly_Negative']
Insufficient funding	['Business_Administrative']	['Possibly_Negative']
Loss of funding	['Business_Administrative']	['Possibly_Negative']
Study Drug Backorder	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
a cardinal member of The research team withdrawn from study, the study has beem terminated.	['Study_Staff_Moved']	['Neutral']
Repros stopped the study for safety and FDA put the study on hold for safety.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Due to Sorafenib became first line treatment for HCC, the designed treatment became less
    competitive. The company Sanofi decided not to continue to support"	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study was terminated early due to low accrual.	['Insufficient_Enrollment']	['Neutral']
At interim analysis the study did not meet the response criteria to continue	['Negative']	['Negative']
Lack of resources to run the trial	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Test products expired.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Drugs unavailable:unable to make radioactive topotecan	['Logistics_Resources']	['Neutral']
The PI left the institution.	['Study_Staff_Moved']	['Neutral']
Business objective has changed	['Business_Administrative']	['Possibly_Negative']
change development strategy	['Business_Administrative']	['Possibly_Negative']
Study has been stopped by sponsor decision	['Business_Administrative']	['Possibly_Negative']
failure to recruit	['Insufficient_Enrollment']	['Neutral']
"Due to an unfavorable risk-benefit ratio including no evidence of potential efficacy, and the
    adverse event profile of E2609 being worse than placebo."	['Negative']	['Negative']
"Study terminated early because of insufficient enrollment before expiration date of the
    investigational vaccine lot"	['Insufficient_Enrollment']	['Neutral']
PI no longer with the institution, funding issues, poor accrual	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Difficulty in recruitment, Funding has run out.	['Business_Administrative']	['Possibly_Negative']
Investigator decided not to pursue	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Safety concerns.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Study was stopped due to COVID-19 pandemic.	['Covid19']	['Neutral']
Intervention worsened performance for first 17 of 24 planned participants.	['Negative']	['Negative']
Stopped the study due to feasibility issues, no enrollment has taken place.	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Subsequent data generated by our collaborators have shown efficacy with curcumin and quercetin
    in 5 patients in a non placebo controlled trial."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Sponsor decision not related to patient safety	['Business_Administrative']	['Possibly_Negative']
Study halted prematurely during COVID-19 outbreak	['Covid19']	['Neutral']
Withdrawn due to concerns for patient safety during COVID-19 crisis	['Covid19']	['Neutral']
Service provider challenges precluded intervention delivery.	['Logistics_Resources']	['Neutral']
low enrollment	['Insufficient_Enrollment']	['Neutral']
"The study was terminated due to poor recruitment (after enrolling 62 of planned 300 patients in
    20 months"	['Insufficient_Enrollment']	['Neutral']
PI left Nationwide Children's Hosp.	['Study_Staff_Moved']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
lost sponsor support	['Business_Administrative']	['Possibly_Negative']
The study has been temporarily suspended due to funding issues	['Business_Administrative']	['Possibly_Negative']
Study will not be conducted as a RCT due to limited project timeline.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
In the context of COVID-19 pandemic.	['Covid19']	['Neutral']
Due to the Pandemic and the nature of this study we decided to terminate this study.	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Enrollment stopped for missing availability of the site	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
FDA drug recall on July 30, 2010	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
internal recruitment difficulties and reorganization of the Intensive Care Units	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Accrual was too slow. Trial terminated	['Insufficient_Enrollment']	['Neutral']
Lack of subject recruitment	['Insufficient_Enrollment']	['Neutral']
Newer technologies available; poor accrual to study.	['Insufficient_Enrollment']	['Neutral']
Regulatory	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Recruiting process could not be completed; lack of participants	['Insufficient_Enrollment']	['Neutral']
Stop of the study by competent authority (ANSM)	['Interim_Analysis', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
"Strategic decision given our current development of AMG 176 (a similar MCL-1 inhibitor) that is
    in clinic, and not because of safety concerns"	['Business_Administrative']	['Possibly_Negative']
Departure of principal investigator	['Study_Staff_Moved']	['Neutral']
Poor subject recruitment	['Insufficient_Enrollment']	['Neutral']
Suspended due to COVID-19 pandemic	['Covid19']	['Neutral']
"Because of many competing trials using the same mechanism of action, but being further advanced
    in development"	['Negative', 'Another_Study']	['Negative', 'Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
"due to very low recruitment. For this reason, there will be no further analysis and reporting
    of this study."	['Insufficient_Enrollment']	['Neutral']
We have submitted a multi center study, with the same nutritional therapy	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Due to the lack of approval from the Air Force IRB patient enrollment was never initiated.
    Thus, no clinical results could be examined or can be reported"	['Regulatory', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
This study was terminated due to low enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Recruitment issues	['Insufficient_Enrollment']	['Neutral']
Never received IRB approval; Withdrawn before enrollment ever started	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Study product manufacturing suspended due to manufacturing problems, before initiation of study
    intervention."	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
Subject recruitment and enrollment was low throughout the three years the study was active.	['Insufficient_Enrollment']	['Neutral']
Contract agreement not reached	['Business_Administrative']	['Possibly_Negative']
interim analysis findings	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
sponsor withdrew support	['Business_Administrative']	['Possibly_Negative']
Study was completed at other sites	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Difficulty enrolling eligible subjects	['Insufficient_Enrollment']	['Neutral']
The study was withdrawn following a strategic portfolio re-prioritization.	['Business_Administrative']	['Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
"CO Phase 2 data did not show sufficient improvement in cath opening at higher
    dose/concentration evaluated. Nuvelo ended further clinical dev of alfimeprase."	['Negative']	['Negative']
"Institution changed surgical method to small incision lenticule extraction. Study never
    started."	['Study_Design']	['Neutral']
Pending IRB continuing review approval.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Sponsor decided to discontinue study drug development	['Business_Administrative']	['Possibly_Negative']
PI has decided to put this study on hold at this time.	['Invalid_Reason']	['Invalid_Reason']
recruit too slowly	['Insufficient_Enrollment']	['Neutral']
The study was terminated due to slow accrual of subjects.	['Insufficient_Enrollment']	['Neutral']
New revised SAA BMT study opened to take over this study	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"The data from the first 48 patients recruited has now been analysed, and it has been determined
    that it is sufficient to meet the study objectives."	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Study never started.	['Invalid_Reason']	['Invalid_Reason']
Funding discontinued	['Business_Administrative']	['Possibly_Negative']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
Suspended due to Covid-19	['Covid19']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Termination of study was due to safety reasons	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Investigator decided not to go forward with the trial.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Patterns of practice changed and this technique is no longer used.	['Study_Design']	['Neutral']
No longer pursuing development of serlopitant	['Business_Administrative']	['Possibly_Negative']
"FDA approved higher dose of study drug. Dose used in protocol lower than SOC - enrollment
    stopped, those on treatment were given option to opt out."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
unsufficient recruitment	['Insufficient_Enrollment']	['Neutral']
due to lack of finace	['Covid19', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
To perform a interim analyzes	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
There is no longer need for this study.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Two participants enrolled, both inevaluable.	['Insufficient_Enrollment']	['Neutral']
Closure of IU Health Proton Facility	['Logistics_Resources', 'Study_Staff_Moved', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Unable to fulfill intention of study, lost investigators.	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
treatment effects not as desired	['Negative']	['Negative']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Insufficient number of participants	['Insufficient_Enrollment']	['Neutral']
Other - Pending amendment to change study design	['Study_Design']	['Neutral']
Plan to change the trial design	['Study_Design']	['Neutral']
Potential AE	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
PI has left our Inst.	['Study_Staff_Moved']	['Neutral']
Change in priorities, study closed prior to enrollment	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Study stopped and was not completed	['Invalid_Reason']	['Invalid_Reason']
Study was stopped because Principal Investigator did not obtain sponsorship to carry it out	['Business_Administrative']	['Possibly_Negative']
Risks to participation	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
IRB -- need to reframe study as a feasibility study before it being a RCT.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
It is hard to enroll patients due to Covid-19 pandemic.	['Covid19']	['Neutral']
No funding was raised	['Business_Administrative']	['Possibly_Negative']
unable to enroll any participants	['Insufficient_Enrollment']	['Neutral']
unable to agree on budget terms	['Business_Administrative']	['Possibly_Negative']
Enrollment goal was not met.	['Insufficient_Enrollment']	['Neutral']
No participants	['Insufficient_Enrollment']	['Neutral']
A recent publication answered the study question being asked	['Negative', 'Another_Study']	['Negative', 'Neutral']
"It was more difficult than planned to find patients filling inclusion criteria and those which
    corresponded didn't agree to participate"	['Insufficient_Enrollment']	['Neutral']
Inadequate patient recruitment and coordinator left organization	['Insufficient_Enrollment']	['Neutral']
Feasibility of the trial was proven to be absent.	['Logistics_Resources']	['Neutral']
Slow recruitment of subjects	['Insufficient_Enrollment']	['Neutral']
loss of funding. No data was collected.	['Business_Administrative']	['Possibly_Negative']
The study does not seem to provide benefits to patients.	['Negative']	['Negative']
Registration of the medicine is no longer being pursued in South Korea, Taiwan or Vietnam	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Recruitment goals not being met	['Insufficient_Enrollment']	['Neutral']
low rate in patient accrual	['Insufficient_Enrollment']	['Neutral']
Complication rate in operative group on interim analysis and safety monitoring.	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Slow/insufficient accrual	['Insufficient_Enrollment']	['Neutral']
Study was modified to in vitro design and no longer involves participants	['Study_Design']	['Neutral']
Centers could not meet enrollment goals	['Insufficient_Enrollment']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
PI changed job and project was not economically viable and therefor terminated	['Logistics_Resources', 'Study_Staff_Moved', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Principal Investigator left the University of Kentucky before enrollment could begin.	['Study_Staff_Moved']	['Neutral']
Unable to recruit patients and lack of efficacy in ETV arm	['Negative']	['Negative']
no patients to include	['Insufficient_Enrollment']	['Neutral']
withdrawn due to poor recruitment	['Insufficient_Enrollment']	['Neutral']
"In 2008, new data highlighted that Cetuximab had no efficacy in case of KRAS mutation. As such,
    eligibility criteria were revised and limited to KRAS wild-type. Inclusions were thus slown
    down considerably, and the trial was stopped."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Principal Investigator left institution.	['Study_Staff_Moved']	['Neutral']
Due to lack of funding	['Business_Administrative']	['Possibly_Negative']
Not funded	['Business_Administrative']	['Possibly_Negative']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
The study is suspended due to the pandemic	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
PI left and no data or information is available.	['Study_Staff_Moved']	['Neutral']
Study drug no longer available resulting in lack of study drug for participants.	['Logistics_Resources']	['Neutral']
Projected neutral significance for primary composite efficacy endpoint.	['Negative']	['Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Insufficient study materials	['Logistics_Resources']	['Neutral']
Slow study recruitment and lack of clinical equipoise over time	['Insufficient_Enrollment']	['Neutral']
safety concerns with pioglitazone	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Study terminated after 240 patients because of slow accrual and lack of additional funding	['Insufficient_Enrollment']	['Neutral']
No longer able to recruit subjects due to unavailability of orthopedic surgeon.	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Slower than anticipated participant accrual	['Insufficient_Enrollment']	['Neutral']
Due to COVID-19, we have suspended enrollment for this study.	['Covid19']	['Neutral']
Business Decision	['Business_Administrative']	['Possibly_Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
No funding	['Business_Administrative']	['Possibly_Negative']
Difficulty to continue follow-up during the coronavirus epidemic	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
study terminated prematurely for financial reasons and Covid-19 pandemic	['Covid19']	['Neutral']
"COVID-Epidemic with changes in patient mix, restructuring of wards/departments, new
    standard-precautions"	['Covid19']	['Neutral']
"Available clinical data has shown limited anti-tumor activity and reaching target study drug
    dose levels may not be feasible."	['Negative']	['Negative']
COVID-19 trials gained priority	['Covid19']	['Neutral']
Surgeon doing procedures amenable to this study left institution.	['Covid19', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
poor accrual	['Insufficient_Enrollment']	['Neutral']
Development plan of retigabine XR in Japan was readjusted.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
PI left study site	['Study_Staff_Moved']	['Neutral']
We could not enrole or recruite enough participants.	['Insufficient_Enrollment']	['Neutral']
LOE	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
Terminated this trial and added a Lenalidomide arm to KCP-330-017	['Negative', 'Another_Study']	['Negative', 'Neutral']
Change of circumstances for CI/PI.	['No_Context', 'Study_Staff_Moved', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
"The study was terminated early by the Sponsor due to the high rate of discontinuation of
    subjects unrelated to patient safety."	['Insufficient_Enrollment']	['Neutral']
Stopped in accordance with pre-specified stopping rules for poor recruitment.	['Insufficient_Enrollment']	['Neutral']
The study was terminated due to lack of patient accrual.	['Insufficient_Enrollment']	['Neutral']
"Study enrollment was suspended in response to an FDA alert regarding the study drug. The study
    was subsequently terminated"	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
PI, Dr. K. Polonsky has moved to the University of Chicago.	['Study_Staff_Moved']	['Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Decision to suspend inclusions during covid-19 epidemic.	['Covid19']	['Neutral']
Due to a change in Biogen Idec's medical research plans.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
another clinical study for regulatory approval is planned	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Funder decision - lack of accrual	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Principal Investigator has left the UMDNJ	['Study_Staff_Moved']	['Neutral']
Lead investigator moved to a new medical center; study was stopped when he left.	['Study_Staff_Moved']	['Neutral']
Site is no longer participating in study	['Business_Administrative']	['Possibly_Negative']
Drug withdrawal	['Logistics_Resources']	['Neutral']
insufficient patients enrolled	['Insufficient_Enrollment']	['Neutral']
Study was stopped for severe toxicity causing concern for patients	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Lack of compliance of the clinical site	['Study_Design']	['Neutral']
subject enrollment goals not met	['Insufficient_Enrollment']	['Neutral']
"Celgene terminated its collaboration agreement with MethylGene for the development of MGCD0103.
    All Celgene-sponsored trials with MGCD0103 will be closed."	['Business_Administrative']	['Possibly_Negative']
Withdrawn due to unavailability of rifampin for clinical trial use	['Logistics_Resources']	['Neutral']
"The study closed temporarily in February 2012 pending analysis of samples collected. In
    October, 2012, Celgene requested closure of the study."	['Business_Administrative']	['Possibly_Negative']
Portfolio prioritization	['Business_Administrative']	['Possibly_Negative']
Study closed with no enrollment.	['Insufficient_Enrollment']	['Neutral']
Administartive and technical problems	['Logistics_Resources']	['Neutral']
Long-term animal toxicology findings (see detailed description).	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Futility	['Negative']	['Negative']
due to COVID-19 Pandemic	['Covid19']	['Neutral']
Terminated by Sponsor	['Business_Administrative']	['Possibly_Negative']
Difficulty finding eligible patients	['Insufficient_Enrollment']	['Neutral']
At the request of the Ethical Committee	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
PI left, study to be re-open with new PI, no planned data analysis	['Study_Staff_Moved']	['Neutral']
Retrospective part completed, prospective part response too low	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
inconclusive results, market feasiblity	['Negative']	['Negative']
Business reasons	['Business_Administrative']	['Possibly_Negative']
Project was completed	['Invalid_Reason']	['Invalid_Reason']
terminated	['Invalid_Reason']	['Invalid_Reason']
lack of efficacy and tolerability	['Negative']	['Negative']
"Merck Sharp & Dohme Corp (MSD) received exemption from PFDA on conduct of post-marketing
    surveillance (PMS) study"	['Business_Administrative']	['Possibly_Negative']
End of recruitment period	['Invalid_Reason']	['Invalid_Reason']
Arthrex stopped manufacturing the device	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
enrollment did not meet projections and numerous lost to follow-up	['Insufficient_Enrollment']	['Neutral']
Withdrawn because of personal ressources before inclusion of the first patient	['Logistics_Resources']	['Neutral']
never started	['Invalid_Reason']	['Invalid_Reason']
Terminated early due to funding suspension by grant sponsor.	['Business_Administrative']	['Possibly_Negative']
all active subjects were rolled into study 209AS209/NCT01706523	['Negative', 'Another_Study']	['Negative', 'Neutral']
"During the study pause, current data was analyzed and primary endpoint was met; thus completing
    the study would provide limited additional information and unlik"	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Suspended due to COVID-19 pandemic	['Covid19']	['Neutral']
"The study only accrued 4 patients in 2 years, far below target (40). It was closed with no
    subject reached the primary endpoint, thus no results to publish."	['Insufficient_Enrollment']	['Neutral']
Withdrawn due to lack of accrual	['Insufficient_Enrollment']	['Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Low inclusion frequency and not enough human resources for completing study	['Insufficient_Enrollment']	['Neutral']
Improved, different standard of care caused business decision to terminate	['Business_Administrative']	['Possibly_Negative']
"This decision was made for business reasons only and is not related to any safety concerns
    regarding crisaborole."	['Business_Administrative']	['Possibly_Negative']
Study Terminated.priority changes in product development.	['Business_Administrative']	['Possibly_Negative']
Program terminated	['Invalid_Reason']	['Invalid_Reason']
Funding	['Business_Administrative']	['Possibly_Negative']
administrative decision- PI retired and treating physician left the institution	['Business_Administrative']	['Possibly_Negative']
Lack of patients	['Insufficient_Enrollment']	['Neutral']
The company decided to cancel the study in conformity with Philippine FDA Circular 2013-004	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Study PI passed away We had trouble recruiting for the drug arm	['Study_Staff_Moved']	['Neutral']
No recruitment	['Insufficient_Enrollment']	['Neutral']
"Only two subjects have been recruited from start of the study. We decided to start the study in
    this topic, after revising the study protocol."	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Investigator decision	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Inadequate enrollment (2 subjects in 4 years)	['Insufficient_Enrollment']	['Neutral']
"For increased induction mortality in older patients due to specific combinations of drugs,
    other clinical factors such as patient age and comorbidities."	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Temporarily closed to accrual pending availablity of drug.	['Logistics_Resources']	['Neutral']
due to COVID-19	['Covid19']	['Neutral']
Change to Primary Endpoint resulted in development of new protocol	['Study_Design']	['Neutral']
Study withdrawn due to lack of available patients meeting entry criteria	['Insufficient_Enrollment']	['Neutral']
insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Funding unavailable	['Business_Administrative']	['Possibly_Negative']
No access to study drug Trilostan. Company closed down	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Recruitment difficulties (study stopped before the expected 80 inclusions)	['Insufficient_Enrollment']	['Neutral']
The data safety monitoring inboard recommended stopping the study.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
The PI left institution	['Study_Staff_Moved']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Lack of initial funding after approval of study	['Business_Administrative']	['Possibly_Negative']
Declined to pursue Study due to anticipated low enrollment numbers	['Insufficient_Enrollment']	['Neutral']
Scientific/feasibility approval required prior to IRB review	['Interim_Analysis', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Business objectives have changed	['Business_Administrative']	['Possibly_Negative']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
End of study	['Invalid_Reason']	['Invalid_Reason']
1 patient enrolled (consented) but screen failed. Study stopped as unable to enroll.	['Insufficient_Enrollment']	['Neutral']
Study was withdrawn due to scientific and business considerations.	['Business_Administrative']	['Possibly_Negative']
Lack of accrual, lack of continued funding.	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Low patient recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of patients	['Insufficient_Enrollment']	['Neutral']
revised and combined with another protocol	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
slow recruitment and high drop-out rate	['Insufficient_Enrollment']	['Neutral']
"No patients can be recruited for this trial anymore due to other therapeutical approaches that
    became available."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Other - Amendment submitted to CTEP to add 3 additional arms	['Study_Design']	['Neutral']
Slow Accruals	['Insufficient_Enrollment']	['Neutral']
The hospital was converted to attend only covid19 patients	['Covid19']	['Neutral']
No participants were identified per inclusion/exclusion criteria	['Insufficient_Enrollment']	['Neutral']
Withdrawn due to inability to recruit eligible participants	['Insufficient_Enrollment']	['Neutral']
Terminated early for insufficient evidence of clinical efficacy	['Negative']	['Negative']
Funding	['Business_Administrative']	['Possibly_Negative']
Company has reprioritized clinical plans to focus on later-stage studies.	['Business_Administrative']	['Possibly_Negative']
never started	['Invalid_Reason']	['Invalid_Reason']
Withdrawn for administrative reasons.	['Business_Administrative']	['Possibly_Negative']
difficulties in including patients	['Insufficient_Enrollment']	['Neutral']
The study was terminiated due the lack of recruitment.	['Insufficient_Enrollment']	['Neutral']
The study has been terminated due to pending data analysis	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
systematic literature review has been completed	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
low enrollment, termination of funding	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The study was terminated due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
Closed due to low accrual	['Insufficient_Enrollment']	['Neutral']
Potential participants had concerns about taking the study drug (methotrexate).	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
The study was terminated due to slow accrual of subjects.	['Insufficient_Enrollment']	['Neutral']
"recruitment prematurely halted following company's decision to stop financial support to the
    study"	['Business_Administrative']	['Possibly_Negative']
Lack of efficacy	['Negative']	['Negative']
The development program has been terminated	['Business_Administrative']	['Possibly_Negative']
"Standard of care evolved during the timeframe of the study and had critical impact on
    recruitment.

    Early termination is not based on safety reasons but because of recruitment issues.

    Patients ongoing will be completed. Planned LPLV 25Jan2021"	['Study_Design']	['Neutral']
Due to participants withdrawal prior to anticipated end of study.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Main study concluded before enrollment	['Invalid_Reason']	['Invalid_Reason']
lack of recruitement	['Insufficient_Enrollment']	['Neutral']
Difficulty in recruiting patients and then the PI left the institution	['Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
imbalance of gastrointestinal and the lipase events	['Safety_Sideeffects', 'Logistics_Resources', 'Endpoint_Met']	['Safety_Sideeffects', 'Neutral', 'Neutral']
"Business reason, Pfizer's requested withdrawal of the Biologics License Application (BLA) .
    This study is not being discontinued for efficacy or safety reason"	['Business_Administrative']	['Possibly_Negative']
in error	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Safety Review	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"Due to poor accrual. This decision was taken without any safety reasons. Since beginning of the
    study (June 2011) only six patients were enrolled."	['Insufficient_Enrollment']	['Neutral']
At the request of the IRB	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
recruitment issues due to feasability issues in centers	['Insufficient_Enrollment']	['Neutral']
Operating Company decided to stop study due to strategic realignment and budgetary reasons	['Business_Administrative']	['Possibly_Negative']
Insufficient improvement in primary measures under either condition.	['Negative']	['Negative']
Stopped due to funding constraints and recruitment was slower than was expected	['Business_Administrative']	['Possibly_Negative']
COVID-19 pandemic imposed restrictions to normal study conduct	['Covid19']	['Neutral']
"The study did not continue to phase II due to the importance of HPV status as a prognostic
    factor to guide treatment decisions."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"Temporarily paused while we develop newer study techniques. We expect to resume; this is not a
    suspension of IRB approval."	['Study_Design']	['Neutral']
Unable to secure funding	['Business_Administrative']	['Possibly_Negative']
physician decision to stop study early due to low enrollment	['Insufficient_Enrollment']	['Neutral']
No patient has never been included in the trial	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
The study was stopped because of lack of funding.	['Business_Administrative']	['Possibly_Negative']
"Unable to continue due to medical equipment necessary for research study was removed from
    facility."	['Logistics_Resources']	['Neutral']
Halt in funding	['Business_Administrative']	['Possibly_Negative']
Terminated due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
Study stopped due to budget (personnel) limitations.	['Business_Administrative']	['Possibly_Negative']
recruitment problem	['Insufficient_Enrollment']	['Neutral']
funding issues	['Business_Administrative']	['Possibly_Negative']
Accrual below target levels	['Insufficient_Enrollment']	['Neutral']
Safety issue	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Difficulties in data collection	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
no participants enrolled	['Insufficient_Enrollment']	['Neutral']
poor accrual	['Insufficient_Enrollment']	['Neutral']
protocol changed and a new study using verapamil in epilepsy will be started in the near future	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study cancelled	['Invalid_Reason']	['Invalid_Reason']
Not approved by the coordinating Ethical Committee	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Feasibility objectives were obtained	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Subjects were enrolled in other studies about sepsis	['Negative', 'Another_Study']	['Negative', 'Neutral']
failure rate 91.1%	['Negative']	['Negative']
No eligible participants for the RCT were found	['Insufficient_Enrollment']	['Neutral']
"This study was terminated June 28 2016 for low enrollment and PI moving away. No results were
    obtained"	['Insufficient_Enrollment']	['Neutral']
Children could not be examined due to COVID-19 pandemic and schools closure.	['Covid19']	['Neutral']
Slow recruitment and lack of funding to expand to other sites.	['Business_Administrative']	['Possibly_Negative']
Stopped funding by Regional Healthcare System.	['Business_Administrative']	['Possibly_Negative']
A pilot study is recruiting	['Negative', 'Another_Study']	['Negative', 'Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Due to low recruitment rate	['Insufficient_Enrollment']	['Neutral']
Was never initiated.	['Invalid_Reason']	['Invalid_Reason']
Was unable to accrue any patients	['Insufficient_Enrollment']	['Neutral']
Study was never approved by IRB so was never initiated	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study was terminated prematurely as costs incurred were more than the available funds.	['Business_Administrative']	['Possibly_Negative']
Low enrollment rate	['Insufficient_Enrollment']	['Neutral']
The study didn't have sufficient flow of subjects (discontinued by the Sponsor)	['Insufficient_Enrollment']	['Neutral']
Unable to obtain funding	['Business_Administrative']	['Possibly_Negative']
This study was withdrawn prior to enrollment.	['Invalid_Reason']	['Invalid_Reason']
Lack of support staff	['Logistics_Resources']	['Neutral']
Difficulty enrolling last cohort of subjects	['Insufficient_Enrollment']	['Neutral']
- The research team is not able to obtain the necessary support to continue the study.	['Business_Administrative']	['Possibly_Negative']
Planned independent DMC Interim review: ended for futility w/no safety concerns	['Negative']	['Negative']
Resources not available to complete.	['Business_Administrative']	['Possibly_Negative']
"Serious adverse events with prednisolone, primarily temporary growth retardation, <5th
    percentile."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Problems with patient recruitment	['Insufficient_Enrollment']	['Neutral']
"TAC treatment was associated with better survial outcome compared with TC treatment, we
    terminated recruiting and waiting for longer follow up period."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study terminated due to resources and slow enrollment; not due to safety	['Insufficient_Enrollment']	['Neutral']
Study halted by sponsor due to slow enrollment.	['Insufficient_Enrollment']	['Neutral']
PI withdrew due to increased responsibilities in clinical department.	['Study_Staff_Moved']	['Neutral']
Insufficient funding	['Business_Administrative']	['Possibly_Negative']
The drug needed for the study is not available in Mexico anymore.	['Logistics_Resources']	['Neutral']
Based on preliminary parent study results	['Negative', 'Another_Study']	['Negative', 'Neutral']
"The compound has a benign safety profile with short-term use, clinically sig efficacy responses
    have not been demonstrated, or if so, have not been sustained."	['Negative']	['Negative']
no financial resources were available to complete the study	['Business_Administrative']	['Possibly_Negative']
Study was terminated by the sponsor due to low accrual.	['Insufficient_Enrollment']	['Neutral']
difficulty of recrutement	['Insufficient_Enrollment']	['Neutral']
Premature closure due to inability to accrue to ARM IVD, cohorts 1 and 2	['Insufficient_Enrollment']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
poor accrual	['Insufficient_Enrollment']	['Neutral']
Interim analysis showed the primary outcome was not reached	['Negative']	['Negative']
For business reasons	['Business_Administrative']	['Possibly_Negative']
Terminated due to discontinuation of Acular PF (investigational medication)	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Stopped for futility	['Negative']	['Negative']
Data were published that superseded this study.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Insufficient participants recruited for the trial	['Insufficient_Enrollment']	['Neutral']
drug company is no longer making the drug	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
no participants enrolled	['Insufficient_Enrollment']	['Neutral']
Slow enrollment and reached number needed for analysis.	['Insufficient_Enrollment']	['Neutral']
Slow recruitment in stratum 3: enrolled only 2 instead of 8 pts. within predicted time	['Insufficient_Enrollment']	['Neutral']
"Futility of vitamin D supplementation based on protocol threshold: <30% conditional power to
    detect pre-specified effect- 16% reduction in severe exacerbations."	['Negative']	['Negative']
The software modules were not completed.	['Logistics_Resources']	['Neutral']
Trial closed early due to poor recruitment	['Insufficient_Enrollment']	['Neutral']
study terminated due to low subject accrual	['Insufficient_Enrollment']	['Neutral']
Insufficient subject accrual	['Insufficient_Enrollment']	['Neutral']
See Detailed Description	['No_Context']	['Invalid_Reason']
Due to Covid-19 pandemia the study was never initiated	['Covid19']	['Neutral']
short of study staff	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
"Change of hospital when the study will be done. We will redo the clinical trial to have the
    good sponsor for the study."	['Logistics_Resources', 'Study_Staff_Moved', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
children were not able to be enrolled. Withdrawal was required by IRB	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Study closed due to lack of funding	['Business_Administrative']	['Possibly_Negative']
Sponsor requirements	['Business_Administrative']	['Possibly_Negative']
The study was closed due to poor accrual	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
"The study was stopped due to slower than expected recruitment and the additional limitations on
    clinical research imposed by the COVID-19 pandemic, both of which made study completion within
    a reasonable timeframe appear unlikely."	['Covid19']	['Neutral']
SARS-CoV-2 coronavirus outbreak and end of funding	['Covid19', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
"It's no longer feasible to continue to recruit patients into the study as severe recruitment
    difficulties have been experienced since the study start"	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
not funded	['Business_Administrative']	['Possibly_Negative']
Inadequate data analysis	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Completed	['Invalid_Reason']	['Invalid_Reason']
Loss of funding	['Business_Administrative']	['Possibly_Negative']
Market move to DES	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Due to COVID-19 Royal Brompton Hospital's internal imposed restrictions	['Covid19']	['Neutral']
Unacceptable morbidity & mortality	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Comparator sawblade no longer available	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
IND voluntarily withdrawn, without prejudice	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Due to an imbalance in graft infections between groups.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Decision made to close study early.	['Invalid_Reason']	['Invalid_Reason']
Termination of sponsorship	['Business_Administrative']	['Possibly_Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Study terminated due to halt in funding; may resume recruiting in future	['Business_Administrative']	['Possibly_Negative']
Study was completed, only life long extended follow-up phase was discontinued after 12 years	['Invalid_Reason']	['Invalid_Reason']
terminated due to lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Study was terminated due to lack of enrollment and business decisions.	['Business_Administrative']	['Possibly_Negative']
Due to lack of malaria patients in Zanzibar the study has been suspended.	['Insufficient_Enrollment']	['Neutral']
Stem cell transplant was determined SOC for this disease (study is not relevant)	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Lead Researcher left the Department	['Study_Staff_Moved']	['Neutral']
Strategic decision unrelated to safety or efficacy	['Business_Administrative']	['Possibly_Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Research Cancelled	['Invalid_Reason']	['Invalid_Reason']
Co-PI left institution, PI not pursuing	['Study_Staff_Moved']	['Neutral']
Critical study personnel left the institution	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
Business Decision	['Business_Administrative']	['Possibly_Negative']
"Preliminary monotherapy data in relapsed/refractory AML and high-risk MDS did not offer a
    sufficiently encouraging profile for further dose escalation/expansion"	['Negative']	['Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Investigator taking position at another university-0 enrolled under this protocol.	['Study_Staff_Moved']	['Neutral']
Sirolimus usage discontinued since black box warning	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
IRB temporarily halted enrollment	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Tinzaparin will no longer be available in the United States	['Logistics_Resources']	['Neutral']
Lack of an available patient population	['Insufficient_Enrollment']	['Neutral']
The study was closed early due to slow enrollment.	['Insufficient_Enrollment']	['Neutral']
funding was withdrawn from Drug company	['Business_Administrative']	['Possibly_Negative']
Terminated 25Sep17 due to insufficient efficacy. Not due to safety reasons.	['Negative']	['Negative']
Recruiting problems	['Insufficient_Enrollment']	['Neutral']
COVID19 pandemic	['Covid19']	['Neutral']
HCV treatment expansion occurred in Egypt	['Logistics_Resources', 'Study_Design', 'Another_Study']	['Neutral', 'Neutral', 'Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Company business decision	['Business_Administrative']	['Possibly_Negative']
"The results of the primary endpoints of this study are expected to be difficult to identify,
    thus canceling the study to readjust the study plan."	['Negative']	['Negative']
no patient enrolled	['Insufficient_Enrollment']	['Neutral']
This study was Cancelled Before Active	['Invalid_Reason']	['Invalid_Reason']
study terminated due to lower than expected enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of institutional support and IRB related issues.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Enrollment by invitation only	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Corporate business reasons	['Business_Administrative']	['Possibly_Negative']
Initial PI Dr. Marentis left the University of Michigan hospital	['Study_Staff_Moved']	['Neutral']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
Change of jobs	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
Number of known toxicities observed despite a treatment-nave population	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
The cytokines in the samples were undetectable.	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
"The co-investigator and recipient of funding for the project left the department and we were
    unable to complete the study without her as a co-investigator."	['Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Primary objective has been met in the absence of clinically meaningful remissions	['Negative']	['Negative']
Departure of PI from the study facility	['Study_Staff_Moved']	['Neutral']
extremely slow enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
Not approved by IRB	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Terminated due to low accrual.	['Insufficient_Enrollment']	['Neutral']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Changed plans	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
project withdrawn	['Invalid_Reason']	['Invalid_Reason']
Not enough patients available	['Insufficient_Enrollment']	['Neutral']
Ended prematurely - The trial never commenced.	['Invalid_Reason']	['Invalid_Reason']
"Because there are questions about adjuvant radiotherapy in this study, the clinical trial is
    under re-design."	['Study_Design']	['Neutral']
Due to funding that was never obtained, the MOMS Grow arm was not completed.	['Business_Administrative']	['Possibly_Negative']
Adequate data to satisfy PAS as agreed to with FDA 02OCT2019	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
Completed due to low number of eligible patients	['Insufficient_Enrollment']	['Neutral']
Not enough participants for study to be completed	['Insufficient_Enrollment']	['Neutral']
Inadequate enrollment	['Insufficient_Enrollment']	['Neutral']
No Participants Enrolled	['Insufficient_Enrollment']	['Neutral']
Decision of sponsor: impossibility of contract with Takeda	['Business_Administrative']	['Possibly_Negative']
Study was terminated by funding entity	['Business_Administrative']	['Possibly_Negative']
"No interested parties agreed to enroll. Poor enrolling rate. In March 2018, the study was
    terminated."	['Insufficient_Enrollment']	['Neutral']
Sponsor withdraw	['Business_Administrative']	['Possibly_Negative']
Application to a CPP	['Business_Administrative']	['Possibly_Negative']
"The study was prematurely terminated after core study CQGE031B2201 failed to meet the primary
    objective of demonstrating superiority for QGE031 versus placebo."	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Because of approval of Bevacizumab, it was difficult to perform clinical study in 1st line
    setting."	['Study_Design']	['Neutral']
Withdrawal of funding support	['Business_Administrative']	['Possibly_Negative']
PI has left institution	['Study_Staff_Moved']	['Neutral']
"Sponsor terminated study due to unforeseen recruitment circumstances amidst the COVID19
    pandemic."	['Covid19']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Due to funding and accrual issues	['Business_Administrative']	['Possibly_Negative']
inclusion problem	['Insufficient_Enrollment']	['Neutral']
Business decision	['Business_Administrative']	['Possibly_Negative']
The study activities are suspended due to COVID-19	['Covid19']	['Neutral']
Study had a minor contingency that could not be resolved with the IRB.	['Interim_Analysis', 'Logistics_Resources', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
The development program has been terminated	['Business_Administrative']	['Possibly_Negative']
PI recommended closure	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Terminated after interim analysis	['Interim_Analysis', 'Endpoint_Met', 'Negative']	['Neutral', 'Neutral', 'Negative']
Regulatory agency commitment fulfilled.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
PI Leaving Site	['Study_Staff_Moved']	['Neutral']
Unable to determine the optimum tolerated dose	['Negative']	['Negative']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
PI relocated to UNCP; Study is not being transferred	['Study_Staff_Moved']	['Neutral']
poor accrual	['Insufficient_Enrollment']	['Neutral']
Study was terminated due to cardiac toxicities	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
No longer required study by FDA for NDA approval.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
COVID-19 Pandemic sufficient data gathered to achieve the study objective	['Covid19']	['Neutral']
Study was terminated because of extrem low recruitment	['Insufficient_Enrollment']	['Neutral']
Different study was designed	['Study_Design']	['Neutral']
COVID-19 policy	['Covid19']	['Neutral']
Lack of financial support and low inclusion rate	['Business_Administrative']	['Possibly_Negative']
"Need of change to the protocol. As the Principal Investigator has left the University Hospital
    Ghent end 2010, the change of protocol was never submitted."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Reduction in available resources	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Covid 19 Pandemic - Unable to enroll patients	['Covid19']	['Neutral']
Investigator left the institution, another PI has not been named.	['Study_Staff_Moved']	['Neutral']
withdrawn	['Invalid_Reason']	['Invalid_Reason']
Unable to enroll patients	['Insufficient_Enrollment']	['Neutral']
Slow recruitment of participants	['Insufficient_Enrollment']	['Neutral']
Inadequate recruitment of study clinics	['Insufficient_Enrollment']	['Neutral']
The principal investigator of the study relocated to another institution.	['Study_Staff_Moved']	['Neutral']
Not enough participants recruited.	['Insufficient_Enrollment']	['Neutral']
Unable to obtain intervention materials	['Logistics_Resources']	['Neutral']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
PI left the institution	['Study_Staff_Moved']	['Neutral']
Principal Investigators no longer in business	['Business_Administrative']	['Possibly_Negative']
"Dr Zhu, collaborator and the inventor of the photoacoustic system, is leaving the institution
    and it is not feasible to conduct the study without the machine."	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
"Per protocol, 3 sequential dose cohorts were planned. Study discontinued by Sponsor based upon
    serious adverse events in first 2 of 3 participants in Cohort 1."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Preliminary terminated due to inefficacy	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
slow accrual, interim analysis showed no statistical significance	['Insufficient_Enrollment', 'Negative']	['Neutral', 'Negative']
Recruitment issues, interim analysis indicated a reduced sample size of 162 was acceptable.	['Insufficient_Enrollment']	['Neutral']
Unable to recruit patients	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
"Study was canceled due to instability of the PreF antigen during manufacturing. No safety
    concern has been identified in past or ongoing studies."	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Recruitment issues.	['Insufficient_Enrollment']	['Neutral']
Study stopping criteria met with regards to vital sign measurements post dose.	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Inability to recruit adequate Sample Size who met the entry criteria	['Insufficient_Enrollment']	['Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Protocol re-design required following inconclusive EU Phase III results	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Not NIH defined clinical trial	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
under review	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Unable to accrue subjects in a timely fashion.	['Insufficient_Enrollment']	['Neutral']
This study will never recruit. The protocol was renamed and will be resubmitted.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Cancellation was not safety related but a shift in study priorities for Shire.	['Business_Administrative']	['Possibly_Negative']
Lack of efficacy	['Negative']	['Negative']
Study population too narrow - unable to recruit any patients.	['Insufficient_Enrollment']	['Neutral']
slow enrollment; resource re-allocation	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Unable to recruit in time before end of PhD studentship	['Insufficient_Enrollment']	['Neutral']
COVID-19 pandemic & expiration of grant funds	['Covid19']	['Neutral']
Difficulty in recruitment due to approval of maintenance pemetrexed treatment	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Principal investigator leaving institution.	['Study_Staff_Moved']	['Neutral']
Study did not receive final approval however it was decided to not pursue.	['Business_Administrative']	['Possibly_Negative']
Sponsor termination, not related to efficacy, safety or feasibility.	['Business_Administrative']	['Possibly_Negative']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
COVID-19 restrictions	['Covid19']	['Neutral']
Study paused due to COVID-19	['Covid19']	['Neutral']
Investigator is leaving the institution.	['Study_Staff_Moved']	['Neutral']
Lack of Funding	['Business_Administrative']	['Possibly_Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
determined not to be feasible at our site	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Technical problems	['Logistics_Resources']	['Neutral']
Other - Drug Manufacturer decision to close study	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"In 2017, GSK2820151 was terminated due to development of another BET Inhibitor (GSK525762) with
    a better understanding of the risk benefit profile."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Not enough participation.	['Insufficient_Enrollment']	['Neutral']
Organisation issues	['Business_Administrative']	['Possibly_Negative']
Unable to recruit patients because the surgeon left the hospital	['Insufficient_Enrollment']	['Neutral']
no enough patients have been enrolled	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Overlap with other RCT	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Opened up a separate Clinicaltrials.gov trial form, study ID TACE	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
We were unable to enroll participants into the study.	['Insufficient_Enrollment']	['Neutral']
The study was terminated on the basis that protocol defined stopping criteria had been met.	['Interim_Analysis', 'Regulatory', 'Endpoint_Met']	['Neutral', 'Neutral', 'Neutral']
Many patients were lost to follow-up	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
study was closed by PI due to no accrual	['Insufficient_Enrollment']	['Neutral']
study closed prematurely because investigator left National Institutes of Health	['Study_Staff_Moved']	['Neutral']
"Unique provision in the American Recovery and Reinvestment Act prevented approval of second
    year no-cost-extension in which completion of analyses were planned."	['Regulatory', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Amgen Administrative Decision - termination of LTFU	['Business_Administrative']	['Possibly_Negative']
Business reason	['Business_Administrative']	['Possibly_Negative']
Business reason	['Business_Administrative']	['Possibly_Negative']
Patent being pursued prior to trial initiation	['Business_Administrative']	['Possibly_Negative']
lack of follow up	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Not enough data collected to work with	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
No more funding support for additional procedures	['Business_Administrative']	['Possibly_Negative']
terminated early due to meeting end point with fewer patients than anticipated	['Insufficient_Enrollment']	['Neutral']
"4 patients have been enrolled into the pilot study. No complications reported. Another clinical
    trial has been designed."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Low subject recruitment and enrollment.	['Insufficient_Enrollment']	['Neutral']
Failed to reach the expected enrollment rates by the end of 2010	['Insufficient_Enrollment']	['Neutral']
Study was unable to recruit subjects meeting the study requirements.	['Insufficient_Enrollment']	['Neutral']
No subjects were enrolled. Sciatic blocks infrequently used for pain control.	['Logistics_Resources', 'Negative']	['Neutral', 'Negative']
Unavailability of investigational product	['Logistics_Resources']	['Neutral']
"The investigator at Cedars stopped this study due to problems collecting payment from the
    sponsor."	['Business_Administrative']	['Possibly_Negative']
Study discontinued due to poor accrual.	['Insufficient_Enrollment']	['Neutral']
lower than anticipated events;slow recruitment;larger than predicted sample size	['Insufficient_Enrollment']	['Neutral']
lower than anticipated accrual	['Insufficient_Enrollment']	['Neutral']
slow accrual and lack of resources and priority due to combining 2 consortia	['Insufficient_Enrollment']	['Neutral']
Not opened at Fox Chase Cancer Center	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
IRB approval lapsed and PI has not responded to requests to submit CR.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Pending COVID-19 pandemic	['Covid19']	['Neutral']
Unable to recruit and enroll patients	['Insufficient_Enrollment']	['Neutral']
Study terminated based on DSMB recommendation in December 2006	['Negative']	['Negative']
Study terminated.24 subjects enrolled;provided adequate data for decision making.	['Interim_Analysis', 'Success', 'Endpoint_Met']	['Neutral', 'Success', 'Neutral']
the intervention could not be performed. All participants received Usual clinical practice	['Invalid_Reason', 'Study_Design']	['Invalid_Reason', 'Neutral']
Study period is over and recruitment was stopped due to time constraints.	['Business_Administrative']	['Possibly_Negative']
Terminated after Aspirin was recommended by the USPTF to Prevent Preeclampsia.	['Interim_Analysis', 'Safety_Sideeffects', 'Regulatory']	['Neutral', 'Safety_Sideeffects', 'Neutral']
"The overall benefit-risk profile did not support continued development of LY2409021 for type 2
    diabetes."	['Negative']	['Negative']
Study data do not support development in AML.	['Logistics_Resources', 'Invalid_Reason', 'Negative']	['Neutral', 'Invalid_Reason', 'Negative']
Business decision.	['Business_Administrative']	['Possibly_Negative']
Low accrual rate	['Insufficient_Enrollment']	['Neutral']
Study halted prematurely, prior to enrollment of first participant.	['Invalid_Reason']	['Invalid_Reason']
unable to recruit patients	['Insufficient_Enrollment']	['Neutral']
Business decision	['Business_Administrative']	['Possibly_Negative']
slow enrolment of patients and new insights	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Sponsor decision due to lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
insufficient for the fund	['Business_Administrative']	['Possibly_Negative']
Terminated due to departure of PI from institution.	['Study_Staff_Moved']	['Neutral']
Futility	['Negative']	['Negative']
Participant mortality rates were higher than expected.	['Insufficient_Enrollment']	['Neutral']
Not able to enroll any participants due to disinterest	['Insufficient_Enrollment']	['Neutral']
"Due to less than expected enrollment rates, Cook has reevaluated the need for this clinical
    study."	['Insufficient_Enrollment']	['Neutral']
"Based on available data, UCB has decided to stop development of padsevonil as adjunctive
    treatment of focal-onset seizures"	['Regulatory', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Due to funding limitations	['Business_Administrative']	['Possibly_Negative']
complete patients samples required	['Invalid_Reason']	['Invalid_Reason']
Laser company cannot provide laser unit for the study.	['Logistics_Resources']	['Neutral']
Trial terminated due to focus of primary therapeutic areas.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Lack of time currently.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
PI left institution	['Study_Staff_Moved']	['Neutral']
departure of a collaborator in charge of the data collection	['Study_Staff_Moved']	['Neutral']
We faced technical problem before conducting this study	['Logistics_Resources']	['Neutral']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
Lack of efficacy.	['Negative']	['Negative']
Local IRB closed the study due to poor accural.	['Insufficient_Enrollment']	['Neutral']
Insufficient patient enrollment.	['Insufficient_Enrollment']	['Neutral']
Parent Study stopped due to poor recruitment and enrollment	['Insufficient_Enrollment']	['Neutral']
Insufficient numbers of Sino-implant users available for study participation.	['Insufficient_Enrollment']	['Neutral']
Due to difficulties in patient recruitment	['Insufficient_Enrollment']	['Neutral']
Business decision	['Business_Administrative']	['Possibly_Negative']
PI resigned.	['Study_Staff_Moved']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
"Withdrawn before enrollment due to issues around the FDA hold on PD-1/PD-L1 drugs in
    combination with IMIDs."	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The trial was terminated as per Sponsor decision.	['Business_Administrative']	['Possibly_Negative']
The study was ended early due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
"Due to the crisis SARS-COV-2 pandemic: recruitment of patients for the trial is stopped,
    healthcare pressure generated, suspend the non-essential scheduled surgical activity and on
    June 30, 2020 medication expired, funding has been exhausted."	['Business_Administrative']	['Possibly_Negative']
SB-656933 is no longer being developed for ulcerative colitis.	['Logistics_Resources', 'Regulatory', 'Endpoint_Met']	['Neutral', 'Neutral', 'Neutral']
Low enrolment	['Insufficient_Enrollment']	['Neutral']
Due to Sponsor's financial reasons	['Business_Administrative']	['Possibly_Negative']
MRI scanner de-commissioned and there was no suitable alternative.	['Logistics_Resources']	['Neutral']
FDA IND Approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Inability to recruit the patients due to the short supply and changed local hospital protocol	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Not funded.	['Business_Administrative']	['Possibly_Negative']
Unable to accrue enough subjects to analyze data.	['Insufficient_Enrollment']	['Neutral']
Study discontinued due to data quality issues.	['Interim_Analysis', 'Logistics_Resources', 'Negative']	['Neutral', 'Neutral', 'Negative']
Lack of efficacy	['Negative']	['Negative']
Failure to recruit any participants in more than one year of recruiting.	['Insufficient_Enrollment']	['Neutral']
The applicant decided to close the study	['Invalid_Reason']	['Invalid_Reason']
Inaccurate patient accrual for trial	['Insufficient_Enrollment']	['Neutral']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
Participants are no longer being examined or receiving intervention.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
"Study put on hold due to CIV-19 pandemic and NHLBI directive for PETAL network to redirect
    efforts to COVI-19 specific treatment trials."	['Covid19', 'Study_Design', 'Another_Study']	['Neutral', 'Neutral', 'Neutral']
Enrollment held for toxicity evaluation; then closed due to competing trial	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
JNJ-54416076 program has been stopped for strategic business reasons.	['Business_Administrative']	['Possibly_Negative']
Abandoned research	['Invalid_Reason']	['Invalid_Reason']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Most potential subjects had already been prescribed Cymbalta.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Trial was terminated due to the need to re-formulate the study drug.	['Study_Design']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
"To ensure the safety of participants during the COVID-19 pandemic, this clinical trial is
    suspended until further notice. This study was terminated due to the lockdown requirements."	['Covid19']	['Neutral']
Competing Trials	['Negative', 'Another_Study']	['Negative', 'Neutral']
This study was stopped because of lack of posterior only major spine surgeries.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
"Decision to discontinue development of investigational Hep C treatment regimen JNJ-4178: 3
    direct acting antivirals - AL-335, ODV & SMV."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
The study was terminated due to lack of accrual.	['Insufficient_Enrollment']	['Neutral']
recruitment shortened	['Insufficient_Enrollment']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
No funding source.	['Business_Administrative']	['Possibly_Negative']
change in concept	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Funding not received	['Business_Administrative']	['Possibly_Negative']
Due to lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
Futility; study coordinator left and were unable to continue data collection; missing data	['Logistics_Resources', 'Study_Staff_Moved', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
PI relocated	['Study_Staff_Moved']	['Neutral']
Decided to stop development of this compound globally	['Business_Administrative']	['Possibly_Negative']
Enrollment difficulties	['Insufficient_Enrollment']	['Neutral']
new clinical strategies have rendered the question posed by this study less relevant	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Study halted prematurely due to COVID-19 but potentially will resume. Follow-up visits continue
    virtually."	['Covid19']	['Neutral']
FDA review time caused window for subject's enrollment to be missed	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
non-enrollment	['Insufficient_Enrollment']	['Neutral']
difficulty in patients's inclusion	['Insufficient_Enrollment']	['Neutral']
Slow recruitment and preliminary observations leading to early termination	['Insufficient_Enrollment']	['Neutral']
Investigator no longer at university	['Study_Staff_Moved']	['Neutral']
PI leaving the NIH	['Study_Staff_Moved']	['Neutral']
"We conclude that the doses we administered were safe, but too low. We plan to continue the
    study with higher doses (0.1 mg/kg iv and 0.2 mg/kg intranasal)."	['Negative']	['Negative']
the study was suspended due to shortage of the study drug (amicar).	['Logistics_Resources']	['Neutral']
Slow Accruals	['Insufficient_Enrollment']	['Neutral']
per PI request	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
No plan to continue enrollment	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Company decision to halt study	['Business_Administrative']	['Possibly_Negative']
Sponsor company decision to terminate study	['Business_Administrative']	['Possibly_Negative']
By the moment nvestigators are not recuiting because logistics issues	['Logistics_Resources']	['Neutral']
Primary investigator retired, rest of staff cannot continue	['Study_Staff_Moved']	['Neutral']
questions of the benefit efficacy/risks of ddI during the meal not resolved	['Negative']	['Negative']
Study discontinued due to business reasons.	['Business_Administrative']	['Possibly_Negative']
Recruitment issues due to the corona virus and lack of funding to continue	['Business_Administrative']	['Possibly_Negative']
Part 2 of study replaced by NTRP-101-202, assessing 3 doses of bryostatin.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Inadequate recruitment, investigator left institution	['Insufficient_Enrollment']	['Neutral']
Insufficient staff for measurement assessments	['Logistics_Resources']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Due to a lack of enrollment	['Insufficient_Enrollment']	['Neutral']
The overall benefit risk profile of ocrelizumab was not favorable in RA	['Negative']	['Negative']
A retrospective study has already been conducted on the same topic	['Negative', 'Another_Study']	['Negative', 'Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
New provision of supplementary feeds for moderately malnourished children	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
low enrollment low enrollment	['Insufficient_Enrollment']	['Neutral']
Study was terminated due to poor enrollment	['Insufficient_Enrollment']	['Neutral']
"Loss to follow-up rate too high for publication and data on completed patients does not allow
    for a powered analysis."	['Logistics_Resources', 'Negative']	['Neutral', 'Negative']
low enrolment rate	['Insufficient_Enrollment']	['Neutral']
No participants enrolled in study.	['Insufficient_Enrollment']	['Neutral']
The study was stopped early due to feasibility concerns.	['Logistics_Resources']	['Neutral']
Sponsor decision based on portfolio prioritization	['Business_Administrative']	['Possibly_Negative']
Protocol proved to be ineffective for adequate sedation for third molar surgery.	['Negative']	['Negative']
"Suspended due to data issues revealed at DSMB meeting. Planned amendment but was never
    submitted. Study was then closed."	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
"Bexion will not move forward with the Part 2 expansion portion of the trial in order to focus
    resources on the further development of BXQ-350 as an earlier treatment measure in the
    pediatric population."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
The Principal Investigator left the University	['Study_Staff_Moved']	['Neutral']
The study was terminated after 9 participants completed due to lack of enrollment for 6 months.	['Insufficient_Enrollment']	['Neutral']
"Per protocol, the results of a planned interim analysis demonstrated insufficient efficacy and
    led to early termination of the study."	['Negative']	['Negative']
Funding ran out and no subjects recruited.	['Business_Administrative']	['Possibly_Negative']
pending further evaluation	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
Unable to continue study due to time constraints	['Business_Administrative']	['Possibly_Negative']
Core Study in Behcet's disease with mostly active uveitis did not meet its primary endpoint	['Negative']	['Negative']
"In a Phase II study in HIV-infected patients there were a number of seizures, although exact
    causality could not be assessed phase 1 activity was terminated."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Stopped on November 16th 2016, because of recruitment failure.	['Insufficient_Enrollment']	['Neutral']
Study was terminated due to enrollment challenges.	['Insufficient_Enrollment']	['Neutral']
lack of recruitment of patients	['Insufficient_Enrollment']	['Neutral']
"After interim analysis, the pilot study was terminated and modified to a larger multicenter
    study (NCT01919346) to better assess efficacy."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Project funding ended before Phase 3b could be completed.	['Business_Administrative']	['Possibly_Negative']
inadequate recruitment	['Insufficient_Enrollment']	['Neutral']
Change of direction	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Safety	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
PI leaving institution	['Study_Staff_Moved']	['Neutral']
Participation of single subject enrolled was terminated.	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Company business decision, IDE closed, no commercialization planned	['Business_Administrative']	['Possibly_Negative']
"Issues with development and supply of infusion system for delivery of IMP. Lack of favorable
    benefit risk ratio in sNN0029-003 study (review of interim data)."	['Negative']	['Negative']
Unable to perform study due to unavailable drug, then unable to partner with cath lab	['Logistics_Resources']	['Neutral']
"After review of safety events and have decided that further dose escalation of MEDI-507 as a
    single agent is not feasible."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Couldn't enough accrue patients	['Insufficient_Enrollment']	['Neutral']
recruitment challenge	['Insufficient_Enrollment']	['Neutral']
COVID-19	['Covid19']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
"This study was terminated early by Genzyme because there were insufficient data to support
    clinical benefit to HCC patients on the study."	['Negative', 'Another_Study']	['Negative', 'Neutral']
The study was stopped for commercial reasons. No safety issues were reported.	['Business_Administrative']	['Possibly_Negative']
PI discretion	['Study_Staff_Moved', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
"It was determined that the study design may not be optimal given the changing AML treatment
    landscape."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study did not meet required enrollment numbers	['Insufficient_Enrollment']	['Neutral']
Insufficient Accrual	['Insufficient_Enrollment']	['Neutral']
Prematurely terminated due to financial considerations	['Business_Administrative']	['Possibly_Negative']
Funding	['Business_Administrative']	['Possibly_Negative']
Due low rate of participation and lack of funding	['Business_Administrative']	['Possibly_Negative']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Investigator left UTHSC-Houston	['Study_Staff_Moved']	['Neutral']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Terminated due to loss of funding and former PI left the institution	['Business_Administrative']	['Possibly_Negative']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
study stopped because of lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Based on a business decision unrelated to any safety concerns.	['Business_Administrative']	['Possibly_Negative']
Funding withdrawn from study sponsor.	['Business_Administrative']	['Possibly_Negative']
Poor recruitment rate	['Insufficient_Enrollment']	['Neutral']
Study never started due to COVID pandemic and lack of study funding.	['Covid19']	['Neutral']
"The study was terminated at the point the primary endpoint and early milestones were reached
    and because long term outcomes were available from other sources"	['Logistics_Resources', 'Endpoint_Met', 'Negative']	['Neutral', 'Neutral', 'Negative']
The trial was terminated because of deviations from the protocol.	['Study_Design']	['Neutral']
Pharmaceutical co. withdrew support. Study was never activated and did not accrue any patients.	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
we didn't have any patient	['Insufficient_Enrollment']	['Neutral']
Strategic	['Business_Administrative']	['Possibly_Negative']
An incident, burned tube, happened before intubation. The promoter decided to stop the study.	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
The study terminated early due to concerns about drug toxicity.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Lack of Vaccine Supplies	['Logistics_Resources']	['Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
Due to COVID-19, we have suspended enrollment.	['Covid19']	['Neutral']
defect inclusion	['Insufficient_Enrollment']	['Neutral']
sensor calibration and other R&D activities	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
The study was closed due to poor accrual and because of competing protocols.	['Insufficient_Enrollment']	['Neutral']
it's difficult to recruit enough participants eligible for this study	['Insufficient_Enrollment']	['Neutral']
Logistics	['Logistics_Resources']	['Neutral']
Poor recruitment, PI leaving university	['Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Difficulty in enrollment and COVID-19 pandemic.	['Covid19']	['Neutral']
Trial investigators were unable to recruit the estimated sample	['Insufficient_Enrollment']	['Neutral']
Recruitment difficulties / lack of participants	['Insufficient_Enrollment']	['Neutral']
Study replaced by an observational study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Pending investigation of an unexpected animal toxicology finding.	['Negative', 'Another_Study']	['Negative', 'Neutral']
COVID-19 pandemic and resource constraints	['Covid19']	['Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
Clinical studies stopped, pending funding.	['Business_Administrative']	['Possibly_Negative']
Current design not able to measure the outcomes anticipated.	['Study_Design', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
"Study did not meet the predefined primary surrogate efficacy endpoint, no safety issues
    identified"	['Negative']	['Negative']
Lack of inclusion	['Insufficient_Enrollment']	['Neutral']
"Low scientific relevance due to the marketing of new treatments, and expected inclusion
    difficulties"	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
The coronavirus broke out in China at the end of 2019	['Covid19', 'Safety_Sideeffects', 'Insufficient_Enrollment']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Discontinuation of study due to site staffing and resources available to conduct the study	['Logistics_Resources']	['Neutral']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Recruitment was not possible	['Insufficient_Enrollment']	['Neutral']
Study will not be implemented and did not enroll participants.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Interim Analysis showed no significance	['Negative']	['Negative']
"We were unable to recruit patients because the clinician doing the testing was no longer
    available between Sep 15 2017 and Mar 1 2018."	['Insufficient_Enrollment']	['Neutral']
Study was never initiated due to contracting issues	['Business_Administrative']	['Possibly_Negative']
No suitable candidates	['Insufficient_Enrollment']	['Neutral']
Not enough patients signed up	['Insufficient_Enrollment']	['Neutral']
It doesn't meet the requirements of randomized trials	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Due to insolvency of sponsor	['Business_Administrative']	['Possibly_Negative']
Study terminated due to poor patient recruitment	['Insufficient_Enrollment']	['Neutral']
due to a decision by the research team not to continuos the study	['Study_Staff_Moved', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Study closed due to poor accrual.	['Insufficient_Enrollment']	['Neutral']
Trial was never initiated due to PATH executive decision.	['Business_Administrative']	['Possibly_Negative']
recommandation of the Data Safety monitoring Board	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Industry decline to supply study drug	['Logistics_Resources']	['Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
Difficulties to recruit patients	['Insufficient_Enrollment']	['Neutral']
not enough data collected	['Success', 'No_Context', 'Logistics_Resources']	['Success', 'Invalid_Reason', 'Neutral']
Terminated: Amgen decision following Primary Analysis. Not due to safety reason	['Interim_Analysis', 'Regulatory', 'Negative']	['Neutral', 'Neutral', 'Negative']
Insufficient funding	['Business_Administrative']	['Possibly_Negative']
The blood pressure did not decrease following furosemide administration	['Safety_Sideeffects', 'Logistics_Resources', 'Endpoint_Met']	['Safety_Sideeffects', 'Neutral', 'Neutral']
"due to unavoidable circumstances relating to logistic issues and regulatory processes in
    various countries causing unacceptable delays."	['Logistics_Resources']	['Neutral']
Protocol not renewed	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
PI has left institution	['Study_Staff_Moved']	['Neutral']
Publication of MA17 results (similar trial in the extented adjuvant setting with letrozole)	['Negative', 'Another_Study']	['Negative', 'Neutral']
Terminated as the active treatment was associated with an increased hazard	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Unable to recruit adequate numbers of patients	['Insufficient_Enrollment']	['Neutral']
Nitric Oxide analyzer not functioning properly	['Logistics_Resources']	['Neutral']
Enrolment was halted prematurely because of the observed excess in recurrences	['Insufficient_Enrollment']	['Neutral']
difficulty with technical aspect of fMRI, resources to complete the study ran out	['Logistics_Resources']	['Neutral']
Determined not feasible	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
COVID-19 Research Restrictions	['Covid19']	['Neutral']
Due to allegations of non-compliance; pending review by Indian Health Service.	['Regulatory', 'Insufficient_Enrollment', 'Negative']	['Neutral', 'Neutral', 'Negative']
We were unable to recruit sufficient patients within the confines of our budget	['Insufficient_Enrollment']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
The study was terminated due to a change in sponsor prioritization.	['Business_Administrative']	['Possibly_Negative']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
Company strategy	['Business_Administrative']	['Possibly_Negative']
Preliminar results not favorable	['Negative']	['Negative']
Trial was terminated by sponsor due to lack of efficacy.	['Negative']	['Negative']
Significant results at 50% enrollment	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Difficulty in finding suitable patients.	['Insufficient_Enrollment']	['Neutral']
"this is an observational project and doesn't not meet any of the four criteria required for
    listing on clinical trials.gov"	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
Drexel Oncology was shut down a few days before first patient in.	['Logistics_Resources']	['Neutral']
"Based on two-stage design, the study ended at stage 1 with no evidence of promise based on
    pre-specified decision rule."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Due to mechanical issue with device	['Logistics_Resources']	['Neutral']
"It has been impossible to recruit any participants fulfilling both the inclusion criteria.
    Therefore, the current study protocol is no longer valid."	['Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
suspended due to inability to enroll subjects	['Insufficient_Enrollment']	['Neutral']
Principal Investigator is taking appointment with another institution.	['Study_Staff_Moved']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
insufficient patient recruitment	['Insufficient_Enrollment']	['Neutral']
IND for this study remained on clinical hold	['Interim_Analysis', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Futility	['Negative']	['Negative']
Study was never able to start in IRAN	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
unable to get MHRA approval for formulation in present form	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
"We observed a very high referral rate for patients with HF in the Duke Health System,
    eliminating the need for an automated referral process."	['No_Context', 'Safety_Sideeffects', 'Logistics_Resources']	['Invalid_Reason', 'Safety_Sideeffects', 'Neutral']
Recruitment	['Insufficient_Enrollment']	['Neutral']
PI has left the institution.	['Study_Staff_Moved']	['Neutral']
Unable to accrue subjects	['Insufficient_Enrollment']	['Neutral']
Business objectives have changed	['Business_Administrative']	['Possibly_Negative']
same study already published	['Negative', 'Another_Study']	['Negative', 'Neutral']
Financial constraints	['Business_Administrative']	['Possibly_Negative']
"Ethical approval not obtained yet as questioning the danger of providing 100% oxygen to
    parturients."	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
Funding unavailable	['Business_Administrative']	['Possibly_Negative']
Project cancelled prior to commencing recruitment	['Invalid_Reason']	['Invalid_Reason']
This study was stopped prematurely due to lack of enrollment within a 1-5-year period.	['Insufficient_Enrollment']	['Neutral']
This study was terminated early due to company decision.	['Business_Administrative']	['Possibly_Negative']
Ethics approval delay	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Recruitment trouble	['Insufficient_Enrollment']	['Neutral']
incomplete enrollment	['Insufficient_Enrollment']	['Neutral']
Early stopping rule	['Negative']	['Negative']
Unable to recruit participants	['Insufficient_Enrollment']	['Neutral']
Slow accrual of patients.	['Insufficient_Enrollment']	['Neutral']
Sponsor decision; lack of research sites	['Business_Administrative']	['Possibly_Negative']
Investigator left University No results are possible	['Logistics_Resources', 'Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Change in the clinical practices	['Study_Design']	['Neutral']
See Termination Reason in Detailed Description	['No_Context']	['Invalid_Reason']
Insufficient elligible patients available in a reasonable time frame.	['Insufficient_Enrollment']	['Neutral']
Not a clinical trial study	['Invalid_Reason']	['Invalid_Reason']
This was a pilot study, but the larger study was not funded.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
Due to low accrual	['Insufficient_Enrollment']	['Neutral']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
Study closed prematurely upon PI's departure	['Study_Staff_Moved']	['Neutral']
recent publication (Ghezel-Ahmadi. Thorac Cardiovasc Surg. 2014 Nov 21)	['Negative', 'Another_Study']	['Negative', 'Neutral']
A similar study was funded by PCORI so PI decided to not begin this study.	['Negative', 'Another_Study']	['Negative', 'Neutral']
recruitment problems	['Insufficient_Enrollment']	['Neutral']
there was an unacceptably high adverse event rate in the treatment group.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Sufficient data was collected through the app to achieve initial results	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Not being able to recuit sufficient patients due to a lack of complience	['Insufficient_Enrollment']	['Neutral']
Change in resources available for study procedures.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Neutron therapy has become unavailable	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
Principal Investigator has left Sponsoring Instiution	['Study_Staff_Moved', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Dr. Gyurak is no longer doing and ended her NARSAD early.	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Business objectives have changed	['Business_Administrative']	['Possibly_Negative']
This study did not receive funding	['Business_Administrative']	['Possibly_Negative']
Risks to subjects due to COVID-19	['Covid19']	['Neutral']
No patient corresponding to inclusion criteria couldn't be enrolled in the study	['Insufficient_Enrollment']	['Neutral']
no patients enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"PI decided to withdraw the study after it opened for enrollment but before any patients were
    enrolled"	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Termination after a few pilot participants due to further protocol development	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
The research fund, which is yet to be raised and expected to take for a while	['Business_Administrative']	['Possibly_Negative']
Study was not started at site.	['Invalid_Reason']	['Invalid_Reason']
No patients recruted since recruiting is open	['Insufficient_Enrollment']	['Neutral']
"Study was discontinued due to non-safety related business prioritization decisions. No subjects
    were randomized"	['Business_Administrative']	['Possibly_Negative']
Terminated due to lack of recruitment and difficulty in the selection of sites	['Insufficient_Enrollment']	['Neutral']
IDMC recommendation for safety concerns	['Covid19', 'Safety_Sideeffects', 'Regulatory']	['Neutral', 'Safety_Sideeffects', 'Neutral']
The sponsor determined at one study (PRO-010) was sufficient	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Not approved by CMS	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Terminated due to safety concerns.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
The study was terminated due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
"The study was terminated following an internal review of the company's current research and
    development portfolio."	['Business_Administrative']	['Possibly_Negative']
Low accrual due to COVID-19 pandemic.	['Covid19']	['Neutral']
"Study is replaced by some Risk Manag. Activities covering the whole Russian Federation. Primary
    objectives could not be met due to critical missing information."	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
inadequate enrollment	['Insufficient_Enrollment']	['Neutral']
poor tolerability and low enrollment rate	['Insufficient_Enrollment']	['Neutral']
no recruitment on time	['Insufficient_Enrollment']	['Neutral']
Protocol violations	['Study_Design']	['Neutral']
Local resource issue - never actually started post ethics approval.	['Logistics_Resources', 'Ethical_Reason', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Business objectives have changed	['Business_Administrative']	['Possibly_Negative']
Study terminated due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
change company strategy	['Business_Administrative']	['Possibly_Negative']
difficulties of inclusion of subjects	['Insufficient_Enrollment']	['Neutral']
Delay in opening the study due to COVID-19, and following the sponsor's decision	['Covid19']	['Neutral']
Lack of accrual/Slow accrual	['Insufficient_Enrollment']	['Neutral']
Study terminated because PI left institution. Planned Statistical analysis not available	['Logistics_Resources', 'Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Terminated prior to its planned completion as anticipated by the protocol).	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
inability to enroll in this subject population	['Insufficient_Enrollment']	['Neutral']
Due to continuing review	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
Study drug expiration and supply shortage	['Logistics_Resources']	['Neutral']
funding to complete was inadequate	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
No longer recruiting patients to this study	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Insufficient enrollment & high rate of failure to complete protocol	['Insufficient_Enrollment']	['Neutral']
PI moving to another institution.	['Study_Staff_Moved']	['Neutral']
Sponsor business reasons	['Business_Administrative']	['Possibly_Negative']
Sponsor decided not to go forward with study. No subjects were enrolled.	['Business_Administrative']	['Possibly_Negative']
"Due to COVID-19 recruitment was terminated prematurely following approval from the trial
    steering committee. Overall impact was minimal, study sample was reduced by four participants."	['Covid19']	['Neutral']
No patients were accrued to the trial	['Insufficient_Enrollment']	['Neutral']
Slower than expected recruitment rate	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
"Regeneron has discontinued further clinical development of REGN5069, an antibody to GFR3,
    which was previously being studied in osteoarthritis pain of the knee"	['Regulatory', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Unable to identify any qualifying subjects willing to enroll into this study.	['Insufficient_Enrollment']	['Neutral']
insufficient patient enrollment, insufficient funds for completion	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Never initiated.	['Invalid_Reason']	['Invalid_Reason']
"The Sponsor put on temporary halt the study. None of the participants have been randomized or
    dosed at the time of this halt"	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Sponsor decided not to pursue study	['Business_Administrative']	['Possibly_Negative']
Not accepted	['Invalid_Reason']	['Invalid_Reason']
Funding not obtained	['Business_Administrative']	['Possibly_Negative']
"Enrolling too slowly due to insurance plans no longer covering the cost of the Percutaneous
    Tibial Nerve Stimulation treatment."	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Covid-19 paused human subjects research at study site, funding expired.	['Covid19']	['Neutral']
"Due to enrollment challenges resulting from changing treatment patterns in the use of
    cetuximab, the study has been terminated. No patients remain on study."	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Inability to enroll subjects	['Insufficient_Enrollment']	['Neutral']
Administrative reasons	['Business_Administrative']	['Possibly_Negative']
"The study was terminated after the EMEA recommended to suspend the marketing authorisation of
    Raptiva in the EU"	['Study_Design']	['Neutral']
no acitve participants	['Insufficient_Enrollment']	['Neutral']
Preoperative period is very short time	['Insufficient_Enrollment']	['Neutral']
we are finished	['Invalid_Reason']	['Invalid_Reason']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
pause for further assessment and study adjustment	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Further understanding about the role of androgen signaling in TNBC was required	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Closed due to early stopping rule-Low accrual	['Insufficient_Enrollment']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Sponsor withdrew PMA	['Business_Administrative']	['Possibly_Negative']
Failure to recruit participants	['Insufficient_Enrollment']	['Neutral']
Inadequate funding	['Business_Administrative']	['Possibly_Negative']
The study was terminated on June 25th, 2009 due to strategic decision	['Business_Administrative']	['Possibly_Negative']
Study was neer started and PI left the institution.	['Study_Staff_Moved']	['Neutral']
"Deployment site not obtained in 5 patients with endoscopic screening and intent-to-treat. No
    devices implanted and no AEs through 30days."	['Interim_Analysis', 'Logistics_Resources', 'Endpoint_Met']	['Neutral', 'Neutral', 'Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
The study has finished.	['Invalid_Reason']	['Invalid_Reason']
Study terminated prior to recruitment - recruitment proved impossible	['Insufficient_Enrollment']	['Neutral']
"The project is terminated due to that fact that the PI has moved to another institution and
    there are no resources to keep the study open in either institution."	['Logistics_Resources', 'Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Funds for the study expired	['Business_Administrative']	['Possibly_Negative']
Not enough recruitment	['Insufficient_Enrollment']	['Neutral']
Interim analysis provided enough data	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Early termination due to low accrual	['Insufficient_Enrollment']	['Neutral']
PI left the institution	['Study_Staff_Moved']	['Neutral']
Study Terminated Prematurely	['Invalid_Reason']	['Invalid_Reason']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
Company shifted focus	['Business_Administrative']	['Possibly_Negative']
Staff changes and retirement of the primary investigator during the study	['Study_Staff_Moved']	['Neutral']
"This study was terminated in November 2008 due to ""a business decision (resources)""."	['Business_Administrative']	['Possibly_Negative']
insufficient recruitment/enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of support from pharmaceutical collaborator.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
does not meet criteria for clinical trial	['Negative']	['Negative']
PI left UCSF and the study was closed without any accruals.	['Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Preclinical finding	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
"The trial was ended after one year due to the suspension of in-person research as a result of
    the COVID-19 pandemic. We have returned to the program development stage as we explore
    telehealth alternative options."	['Covid19']	['Neutral']
The research who recruited the patients abandoned the project.	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Study not started	['Invalid_Reason']	['Invalid_Reason']
No enrollment	['Insufficient_Enrollment']	['Neutral']
Investigator is no longer at Northwestern University	['Study_Staff_Moved']	['Neutral']
no patients enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
research determined not to be human subject research	['Logistics_Resources', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
The primary investigator was transferred to another hospital	['Study_Staff_Moved']	['Neutral']
Patient enrollment was hard mainly due to we need at least three lesions suitable for SBRT	['Insufficient_Enrollment']	['Neutral']
Study was terminated due to slow, insufficient accrual.	['Insufficient_Enrollment']	['Neutral']
PI terminated study with no subjects enrolled.	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Lack of available study participants.	['Insufficient_Enrollment']	['Neutral']
High failure rate	['Insufficient_Enrollment']	['Neutral']
"Unable to continue enrollment due to lack of resources (research coordinator no longer
    available)."	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
PI left JHU and is not able to be reached for updates	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
Study does not meet the new legal requirements set forth in the Human Research Act	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Unable to gain approval from commanding Army and Navy officers to conduct study.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
We will focus on other Tamiflu research studies. No subjects were enrolled.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
loss of interest before enrolment started	['Business_Administrative']	['Possibly_Negative']
superceded by another similar study	['Negative', 'Another_Study']	['Negative', 'Neutral']
The overall profile does not support development for obesity	['Negative']	['Negative']
Interim analysis showed differential treatment effects.	['Interim_Analysis', 'Endpoint_Met', 'Negative']	['Neutral', 'Neutral', 'Negative']
Inability to recruit in time a sufficient number of patients	['Insufficient_Enrollment']	['Neutral']
This study was withdrawn prior to enrollment.	['Invalid_Reason']	['Invalid_Reason']
Insufficient financial support; lack of efficacy for primary endpoint	['Business_Administrative']	['Possibly_Negative']
The study was terminated due to logistics at a local hospital.	['Logistics_Resources']	['Neutral']
Pharmaceutical sponsor withdrew financial support.	['Business_Administrative']	['Possibly_Negative']
"Record is an ACRN grant summary & not reflective of an individual trial. All ACTs conducted by
    ACRN were individually registered on the PRS."	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Funding ended	['Business_Administrative']	['Possibly_Negative']
covid interrupted initial start, then trainees involved finished program and no one took it on	['Covid19']	['Neutral']
Withdrawn due to an excess of toxic deaths	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"This protocol terminated prematurely on July 8, 2013 due to slow enrollment, not because of any
    safety issues or concerns."	['Insufficient_Enrollment']	['Neutral']
"Study stopped not for safety reasons. Due to review of clinical development plans and
    priorities, Sponsor decided to stop development of the product."	['Business_Administrative']	['Possibly_Negative']
Study termination due to program termination.	['Business_Administrative']	['Possibly_Negative']
Company closed	['Business_Administrative']	['Possibly_Negative']
"Insufficient clinical benefit to participants at the selected recommended phase 2 (RP2D) dose
    in Part A."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Withdrawal of study support	['Business_Administrative']	['Possibly_Negative']
"Study must be registered under the sponsor instead of the site, so we have created a new
    posting in the sponsor's account."	['Covid19', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
inability to recruit sufficient number of patients	['Insufficient_Enrollment']	['Neutral']
"New Brazilian Guidelines for Viral Hepatitis C and Coinfetions. It does not include the
    treatment of chronic HCV Metavir < F3 and abandon the use of interferon."	['Study_Design']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Withdrawn	['Invalid_Reason']	['Invalid_Reason']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Investigator left institution. 7 patients accrued and there is insufficient data to analyze.	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Because of departure of study personnel and lack of funding	['Business_Administrative']	['Possibly_Negative']
"Recruitment was terminated after enrolment of 35 instead of 36 evaluable patients for
    administrative reasons."	['Business_Administrative']	['Possibly_Negative']
IRB approval lapsed.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
No participants enrolled.	['Insufficient_Enrollment']	['Neutral']
"Per PI, results from another similar study were published prior to study analysis. Negative
    study results were published therefore analysis was not completed"	['Negative', 'Another_Study']	['Negative', 'Neutral']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
Study cancelled	['Invalid_Reason']	['Invalid_Reason']
"Novartis is no longer pursuing this study because of planned investigation of novel CAR-T
    therapies in this patient population."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Low rate of enrollment	['Insufficient_Enrollment']	['Neutral']
Study funding was terminated.	['Business_Administrative']	['Possibly_Negative']
Major difficulties of patient inclusions	['Insufficient_Enrollment']	['Neutral']
redesigned trial using another placebo controlled drug	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
The study never opened and not sure if it ever will.	['Invalid_Reason']	['Invalid_Reason']
COVID19	['Covid19']	['Neutral']
Could not recruit enough subjects	['Insufficient_Enrollment']	['Neutral']
Insufficient closure	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Business decision based on lack of enrollment	['Business_Administrative']	['Possibly_Negative']
difficulty to include patients	['Insufficient_Enrollment']	['Neutral']
unreached recruitment objectives	['Insufficient_Enrollment']	['Neutral']
Sponsor decision to terminate.	['Business_Administrative']	['Possibly_Negative']
Study withdrawn; no participants enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Principal Investigator moved to Chile from Argentina	['Study_Staff_Moved']	['Neutral']
Pre-specified Interim Analysis Indicated Futility	['Negative']	['Negative']
Study was withdrawn for business reasons before study start.	['Business_Administrative']	['Possibly_Negative']
Prematurely closed due to ongoing challenging enrollment requirements.	['Insufficient_Enrollment']	['Neutral']
Lack of study enrollment.	['Insufficient_Enrollment']	['Neutral']
High postoperative morbidity rate	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
This study was closed due to lack of funding.	['Business_Administrative']	['Possibly_Negative']
Study drug is now commercially available in tablet format	['Covid19', 'Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Terminated due to poor accrual.	['Insufficient_Enrollment']	['Neutral']
No accrual	['Insufficient_Enrollment']	['Neutral']
"Recruitment goal cannot be achieved any more as only 8 patients have been recruited since start
    of the study in 2012."	['Insufficient_Enrollment']	['Neutral']
Houston site withdrew as a study site.	['Logistics_Resources', 'Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
as per sponsor	['Business_Administrative']	['Possibly_Negative']
The study has been terminated because too few patients have been recruited	['Insufficient_Enrollment']	['Neutral']
Research administration changes.	['Business_Administrative']	['Possibly_Negative']
Study was cancelled prior to enrolling any patients.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Not approved	['Interim_Analysis', 'Regulatory', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Due to lack of funding from the sponsor this study is being withdrawn.	['Business_Administrative']	['Possibly_Negative']
"GSK confirmed misrepresentation of preclinical data that supported the rationale for GSK2618960
    in MS. This decreased benefit assessment for MS"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
never received funding	['Business_Administrative']	['Possibly_Negative']
inefficiency	['Safety_Sideeffects', 'Logistics_Resources', 'Endpoint_Met']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Feasibility concerns regarding recruitment	['Logistics_Resources']	['Neutral']
"Delay in enrollment as compared to plan (impacted by COVID-19 pandemic) and availability of
    data from alternative data sources to support the products in scope."	['Covid19']	['Neutral']
Feasibility	['Logistics_Resources']	['Neutral']
Funding terminated; company closed	['Business_Administrative']	['Possibly_Negative']
"Interim analysis: results of the analysis showed no significant difference between the two
    study groups"	['Negative']	['Negative']
due to PI's change to private practice	['Study_Staff_Moved']	['Neutral']
Investigator left the institution prior to enrollment of first participant	['Study_Staff_Moved']	['Neutral']
"Potential participants to date all had etiological factors for their sexual dysfunction
    additional to the antidepressant. Thus they all had exclusion criterior"	['Safety_Sideeffects', 'Logistics_Resources', 'Endpoint_Met']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Limited funding, change in research priorities.	['Business_Administrative']	['Possibly_Negative']
Device withdrawn from the market	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
insufficient recuirment	['Insufficient_Enrollment']	['Neutral']
Difficulties in meeting recruitment target	['Insufficient_Enrollment']	['Neutral']
The study was not funded	['Business_Administrative']	['Possibly_Negative']
Portfolio re-prioritization	['Business_Administrative']	['Possibly_Negative']
Potential participants have not yet been identified.	['Insufficient_Enrollment']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
"An independent DMC determined continuation was unlikely to demonstrate a statistically
    significant advantage of ASP8825 over placebo on the primary endpoint"	['Negative']	['Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Protocol issues. Modifications potentially will be undertaken and resubmitted to IRB	['Study_Design']	['Neutral']
Lack of resources to manage trial; lack of efficacy.	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Study was terminated due to COVID-19.	['Covid19']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Resources not available to conduct the research.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
PI left the institution	['Study_Staff_Moved']	['Neutral']
Time constraints	['Business_Administrative']	['Possibly_Negative']
study stopped because of insuficient number of comparable patients available.	['Insufficient_Enrollment']	['Neutral']
Study was terminated due to unsuccessful accrual.	['Insufficient_Enrollment']	['Neutral']
Investigator's decision (departure from Institution)	['Study_Staff_Moved']	['Neutral']
Lack of sufficient clinical benefit	['Negative']	['Negative']
Lack of patient population	['Insufficient_Enrollment']	['Neutral']
"Recruitment was terminated early before meeting target enrolment due to a high screen failure
    rate and the feasibility of completing the study in a timely way"	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Unable to recruit adequate number of patients	['Insufficient_Enrollment']	['Neutral']
"ONTAK has been pulled off the market for further testing. Subsequently, EISAI will no longer be
    supporting clinical trials that utilize this drug."	['Business_Administrative']	['Possibly_Negative']
recruitement problem	['Insufficient_Enrollment']	['Neutral']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
More advanced treatments superceded study design	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
The study could not be conducted since funding was not obtained.	['Business_Administrative']	['Possibly_Negative']
SurgAssist device is no longer clinically available.	['Logistics_Resources']	['Neutral']
Insufficient/slow patient recruitment	['Insufficient_Enrollment']	['Neutral']
"Medical practices have evolved and are not conform with the study procedure. Actually, all
    patients receive an ambulatory ECG telemetry monitoring"	['Study_Design']	['Neutral']
Stopped for lack of funds	['Business_Administrative']	['Possibly_Negative']
Closed by Investigator	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Funding limitations and enrollment was too low.	['Business_Administrative']	['Possibly_Negative']
Inability meet enrollment in study population.	['Insufficient_Enrollment']	['Neutral']
Due to a single, unexpected serious event, the trial was stopped.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Insufficient funding	['Business_Administrative']	['Possibly_Negative']
PI left institution	['Study_Staff_Moved']	['Neutral']
safety issues	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
study closed prematurely upon PI's departure from VICC	['Study_Staff_Moved']	['Neutral']
Fitbit was not giving the necessary data.	['Logistics_Resources']	['Neutral']
Study never enrolled any subjects before auto-terminated by the internal IRB.	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
study terminated due to lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of patients meeting the criteria for admission	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Lack of efficacy for Brodalumab in Rheumatoid Arthritis (RA)	['Negative']	['Negative']
not recruitment	['Insufficient_Enrollment']	['Neutral']
Insufficient tumor-to-background ratios in the first three dose groups	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Investigator no longer works fulltime at investigational site	['Study_Staff_Moved']	['Neutral']
The PI left the Columbia University Medical Center. Study was not Completed.	['Study_Staff_Moved']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Due to results shown by the Cerecyte Clinical Trial, HCAT stopped enrolling.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Difficulty aquiring investigational drug	['Logistics_Resources']	['Neutral']
Company decision	['Business_Administrative']	['Possibly_Negative']
Only N=8 subjects randomized; funding ran out; too small N to yield useful data.	['Business_Administrative']	['Possibly_Negative']
Study terminated by PI due to inability to accrue.	['Insufficient_Enrollment']	['Neutral']
logistics	['Logistics_Resources']	['Neutral']
COVID 19 (waiting of Fall Semester to restart work)	['Covid19']	['Neutral']
No Subjects enrolled	['Insufficient_Enrollment']	['Neutral']
Unable to accrue to the study. Original PI no longer with the institute.	['Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
too slow patient recruitment	['Insufficient_Enrollment']	['Neutral']
Principal Investigator left her employment at the University.	['Study_Staff_Moved']	['Neutral']
"Subjects not entered into electronic database due to current construct of database and
    associated privacy legislations within Alberta."	['No_Context', 'Logistics_Resources', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
Terminated (due to no accrual)	['Insufficient_Enrollment']	['Neutral']
Osiris decision	['Invalid_Reason']	['Invalid_Reason']
"The results of the interim analysis indicate the futility criterion have been met, therefore
    enrollment was terminated."	['Negative']	['Negative']
Due to recruitment difficulties the study is terminated.	['Insufficient_Enrollment']	['Neutral']
limited recruitment	['Insufficient_Enrollment']	['Neutral']
Closed study. Study is retrospective in nature and never enrolled any subjects.	['Insufficient_Enrollment']	['Neutral']
Administrative reasons	['Business_Administrative']	['Possibly_Negative']
current BVS safety issue	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Unable to recruit enough participants	['Insufficient_Enrollment']	['Neutral']
terminated due to slow recruitment	['Insufficient_Enrollment']	['Neutral']
PI leaving institution	['Study_Staff_Moved']	['Neutral']
"Takeda has determined that the benefit/risk profile does not support continuation of the
    surgery Study for this specific Congenital Hemophilia A with Inhibitors patient population."	['Negative']	['Negative']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
reevaluation of compound development	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
terminated for lack of enrollment	['Insufficient_Enrollment']	['Neutral']
The study has been terminated due to low accrual.	['Insufficient_Enrollment']	['Neutral']
the study stopped becaust the sponsor did not wish to proceede with the study	['Business_Administrative']	['Possibly_Negative']
ANSM decision due to veino occlusive disease (security alert)	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
inadequate accrual	['Insufficient_Enrollment']	['Neutral']
"Primary, 8-week efficacy endpoint not achieved. No additional benefit for subjects receiving a
    corticosteroid together with an intravitreal anti-VEGF agent."	['Negative']	['Negative']
Due to funding issue, study has been terminated.	['Business_Administrative']	['Possibly_Negative']
lost nurse researcher support	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
"PI and sponsor will re-open study at new institution, will not transfer data due to COVID-19
    situation"	['Covid19']	['Neutral']
No patient enrollment occurred.	['Insufficient_Enrollment']	['Neutral']
There was no resources to complete the study at this time	['Business_Administrative']	['Possibly_Negative']
Business decision to stop the study.	['Business_Administrative']	['Possibly_Negative']
funding not available	['Business_Administrative']	['Possibly_Negative']
At half the sample size, the results were negative with no benefit demonstrated with adenosine.	['Negative']	['Negative']
Study device discontinued & insufficient sample size for statistical results.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Unable to put forth the human resources for patient enrollment	['Logistics_Resources']	['Neutral']
"Study enrolment was delayed in starting and too slow to support further development in this
    setting"	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Unable to obtain funding	['Business_Administrative']	['Possibly_Negative']
Study withdrawn for no sufficient fund support.	['Business_Administrative']	['Possibly_Negative']
no longer necessary	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
terminated due to lack of accrual.	['Insufficient_Enrollment']	['Neutral']
Principal Investigator left institution before study could complete.	['Study_Staff_Moved']	['Neutral']
Study Enrollment was stopped pending review of another study in the same therapeutic area.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study terminated early due to business reasons	['Business_Administrative']	['Possibly_Negative']
Study was prematurely stop based on DMC recommendation	['Regulatory', 'Negative']	['Neutral', 'Negative']
"The study was terminated on September 12, 2010 per protocol following a serious adverse event
    that occurred with the first subject dosed at 600 mg."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Study terminated early for business reasons	['Business_Administrative']	['Possibly_Negative']
Business Strategic Decision	['Business_Administrative']	['Possibly_Negative']
The study has been suspended until further notice due to COVID-19.	['Covid19']	['Neutral']
"The local Healthcare authorities extended the planned intervention to all nursing homes of the
    district after the emergence of multiple outbreaks of severe COVID-19 in several nursing homes."	['Covid19']	['Neutral']
The study will not be conducted by Dr Lubenow	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Patient recruitment is temporarily suspended due to COVID-19.	['Covid19']	['Neutral']
"The principal investigator left George Washington University and closed the study at their
    departure."	['Study_Staff_Moved']	['Neutral']
"The primary trial was halted due to covid-19 in the last 6 months of the trial; as a result,
    the intervention was not fully implemented and the final outcomes were not measured. Outcomes
    will be assessed with the data available (BL, Y1, Y2)."	['Covid19']	['Neutral']
"Enrollment and interactions/interventions paused due to COVID-19. Expected to resume in the
    future. This is not a suspension of IRB approval"	['Covid19']	['Neutral']
"No subjects who met the study criteria agreed to participate in two years prior to the COVID-19
    crisis."	['Covid19']	['Neutral']
No devices currently available for study.	['Logistics_Resources']	['Neutral']
no funding or finacial support	['Business_Administrative']	['Possibly_Negative']
Intellectual property issues with drug manufacture.	['Business_Administrative']	['Possibly_Negative']
Potential subjects were already on the combination therapy.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
No participants available	['Insufficient_Enrollment']	['Neutral']
The sponsor is pursuing a different product for this indication	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Business decision - strategy changes and budget limitations	['Business_Administrative']	['Possibly_Negative']
Insufficient infrastructure/funding for enrollment	['Business_Administrative']	['Possibly_Negative']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Minor device modifications required, move revised device to clinical site in USA.	['Study_Design']	['Neutral']
Insufficient accruals; PI leaving site	['Insufficient_Enrollment']	['Neutral']
Principal Investigator (Dr. Sporn) left the sponsoring institution.	['Study_Staff_Moved']	['Neutral']
Low recruitment numbers	['Insufficient_Enrollment']	['Neutral']
EndoHPB probe is FDA approved and considered standard of care	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
The study was terminated due to slower than anticipated subject accrual.	['Insufficient_Enrollment']	['Neutral']
The Investigator has changed institutions.	['Study_Staff_Moved']	['Neutral']
Experimental results were unsatisfatory compared with control.	['Negative']	['Negative']
"The interim analysis showed no tendency in favour of the verum group. Therefore it was decided
    to stop the study prematurely."	['Negative']	['Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
This study was terminated for administrative reasons.	['Business_Administrative']	['Possibly_Negative']
One of the principal investigators has moved to a different institution	['Study_Staff_Moved']	['Neutral']
Less patients than expected for inclusion, therefore patient recruitment is to low	['Insufficient_Enrollment']	['Neutral']
no actual patients recruited within year 1 after ethical committee approval	['Insufficient_Enrollment']	['Neutral']
Administrative - Suspended by IRB	['Business_Administrative']	['Possibly_Negative']
Retirement of former Qualified Investigator and lack of resources to complete study.	['Logistics_Resources', 'Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
funding	['Business_Administrative']	['Possibly_Negative']
"This study was initially planned to enroll patients in Mongolia. However, due to challenges in
    setting it up in Mongolia, this study was later determined not to be initiated."	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
"No chance to enroll sufficient cases. Several coinvestigator centers have never started
    recruiting."	['Insufficient_Enrollment']	['Neutral']
Insufficient accrual	['Insufficient_Enrollment']	['Neutral']
"STOP due to recent data in literature questioning the need to continue DAP beyond six months in
    patients with stable coronary artery stenting with DES."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Problem with recruitment of subjects	['Insufficient_Enrollment']	['Neutral']
Unavailable study resources	['Logistics_Resources']	['Neutral']
"Study ceased enrolling due to poor overall recruitment. Long-term follow up of enrolled
    participants ongoing."	['Insufficient_Enrollment']	['Neutral']
Enough participants enrolled to provide adequate statistical power	['No_Context', 'Insufficient_Enrollment', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
slow accrual led to early closure.	['Insufficient_Enrollment']	['Neutral']
Funder Decision	['Business_Administrative']	['Possibly_Negative']
competing trial on same population.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study has been terminated early due to financial constraints.	['Business_Administrative']	['Possibly_Negative']
difficulty in enrollment	['Insufficient_Enrollment']	['Neutral']
inability to recruit and retain	['Insufficient_Enrollment']	['Neutral']
Terminated due to poor subject enrolment	['Insufficient_Enrollment']	['Neutral']
Enrollenment has been suspended due to poor enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of Enrollment	['Insufficient_Enrollment']	['Neutral']
very slow accrual.	['Insufficient_Enrollment']	['Neutral']
Strategic Considerations	['Business_Administrative']	['Possibly_Negative']
"The decision to stop the trial was based on efficacy results in the overall schizophrenia
    patient population."	['Success', 'Logistics_Resources', 'Endpoint_Met']	['Success', 'Neutral', 'Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Unable to find eligible patients with untreated hepatitis C virus.	['Insufficient_Enrollment']	['Neutral']
MTD determined	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Patient population require high amount of opioids.	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
No Accrual	['Insufficient_Enrollment']	['Neutral']
Study recruiter withdrew from study. Suspended until replacement found.	['Study_Staff_Moved']	['Neutral']
"Administrative hold until a new trial begins that would allow co-enrollment of subjects into
    this study."	['Business_Administrative']	['Possibly_Negative']
Drug unavailable	['Logistics_Resources']	['Neutral']
Terminated due to lack of funding	['Business_Administrative']	['Possibly_Negative']
Training procedure was not effective.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Development not proceeding	['Business_Administrative']	['Possibly_Negative']
"Study has received ethics approval, however funding limitations have resulted in suspending
    date of commencement."	['Business_Administrative']	['Possibly_Negative']
Suspended pending internal review/direction of the company's focus.	['Business_Administrative']	['Possibly_Negative']
Original Principal Investigator (Andrew Trout M.D.) left the University.	['Study_Staff_Moved']	['Neutral']
difficulty in recruiting subjects	['Insufficient_Enrollment']	['Neutral']
Insufficient recruited participants due to a lack of collaborating study centers	['Insufficient_Enrollment']	['Neutral']
"Do to our inability to meet recruitment targets - Sponsor stopped funding. Looking for new
    sponsor and protocol modifications"	['Business_Administrative']	['Possibly_Negative']
Sponsor withdrew support	['Business_Administrative']	['Possibly_Negative']
Competing studies	['Negative', 'Another_Study']	['Negative', 'Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Low enrollment because of the specifics of the inclusion criteria	['Insufficient_Enrollment']	['Neutral']
Protocol study design was re-done in collaboration with CMS	['Study_Design']	['Neutral']
Safety Review	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Other studies on the same theme	['Negative', 'Another_Study']	['Negative', 'Neutral']
lack of patients	['Insufficient_Enrollment']	['Neutral']
"Issues with development and supply of infusion system for delivery of IMP. Lack of favorable
    benefit risk ratio in sNN0029-003 study (review of interim data)."	['Negative']	['Negative']
Unable to recruit target enrollment numbers	['Insufficient_Enrollment']	['Neutral']
Principal Investigator felt risk to patients was too high.	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Termination of Investigator Initiated Studies using Ibrutinib	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Funding not received	['Business_Administrative']	['Possibly_Negative']
Other - Pending amendment to change M3814 dosing schedule	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Change in Regulatory Status	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
See Detailed Description for Termination Reason	['No_Context']	['Invalid_Reason']
Difficulty with patient enrollment and carrying out the study logistics due to COVID-19	['Covid19']	['Neutral']
Administrative suspension. PI/grant holder transferred to new institution.	['Business_Administrative']	['Possibly_Negative']
Obsolete study	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Study is withdrawn due to company decision	['Business_Administrative']	['Possibly_Negative']
Sponsor did not move forward with study	['Business_Administrative']	['Possibly_Negative']
Study terminated by the Sponsor due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
No patients enrolled after three years	['Insufficient_Enrollment']	['Neutral']
INVO Bioscience is suspending trial per ASRM's recommendations during Covid-19 pandemic.	['Covid19']	['Neutral']
MA of product has been withdrawn from the European market due to stability data	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
Management decision	['Business_Administrative']	['Possibly_Negative']
Low accrual.	['Insufficient_Enrollment']	['Neutral']
no resources available	['Business_Administrative']	['Possibly_Negative']
Halted prematurely due to low enrollment	['Insufficient_Enrollment']	['Neutral']
Feasibility	['Logistics_Resources']	['Neutral']
there was not enough patients recruited in this study	['Insufficient_Enrollment']	['Neutral']
"Only 1 patient was enrolled. No funding, small number of eligible patients so would not achieve
    statistical power."	['Business_Administrative']	['Possibly_Negative']
change sponsor	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Site decided not to move forward with trial. Study never opened to enrollment.	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
"The early termination is not related to safety/toxicity but to initiate new Phase III with
    biomarker to enrich population & to further strengthen OS benefit"	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
COVID-19 hold	['Covid19']	['Neutral']
Funding Unavailable	['Business_Administrative']	['Possibly_Negative']
Loss of study staffing	['Logistics_Resources']	['Neutral']
Closed for futility	['Negative']	['Negative']
The study was terminated prematurely due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
Funding was terminated	['Business_Administrative']	['Possibly_Negative']
Study has been updated with new protocol number	['Study_Design']	['Neutral']
Portfolio proritisation	['Business_Administrative']	['Possibly_Negative']
"A high percentage of patients were dropping out of the study and were not able to complete the
    protocol."	['Insufficient_Enrollment']	['Neutral']
would not substantially add to existing contributions in the literature	['Business_Administrative']	['Possibly_Negative']
"The trial was early terminated after it was concluded that there was no added benefit from
    exposing further participants after an unblinded interim analysis."	['Negative']	['Negative']
Difficulty enrolling subjects	['Insufficient_Enrollment']	['Neutral']
The patients enrolled are limited.	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Research question deemed not of enough clinical importance to proceed.	['Logistics_Resources', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
COVID-19 pandemic	['Covid19']	['Neutral']
Scientific data called into question the viability of the substance class	['Success', 'No_Context', 'Logistics_Resources']	['Success', 'Invalid_Reason', 'Neutral']
Convenience of Government Funding Sponsor	['Business_Administrative']	['Possibly_Negative']
Subjects were no longer able to remain compliant with follow-up intervals	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Achievement of feasibility and safety without achievement of clinical response.	['Negative']	['Negative']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Company decision	['Business_Administrative']	['Possibly_Negative']
Sponsor does not wish to proceed	['Business_Administrative']	['Possibly_Negative']
difficulty to recruit	['Insufficient_Enrollment']	['Neutral']
Feasibility (barriers to implantation within the institution)	['Logistics_Resources']	['Neutral']
"Due to safety results from another trial of LY3023703. No participants in this study received
    study drug."	['Negative', 'Another_Study']	['Negative', 'Neutral']
We wish to wait until there is more data available using this substance.	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Unable to get materials from GE, study not proceeding and never opened to accrual	['Insufficient_Enrollment']	['Neutral']
1 day data collection	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Unable to obtain funding	['Business_Administrative']	['Possibly_Negative']
Sponsor is raising funds for the remainder of the study	['Business_Administrative']	['Possibly_Negative']
poor accrual	['Insufficient_Enrollment']	['Neutral']
Second cohort not opened because Simon-Two_Step model failed	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
terminated due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
withdrawn support for study	['Business_Administrative']	['Possibly_Negative']
Sponsor business decision	['Business_Administrative']	['Possibly_Negative']
Not enough participants	['Insufficient_Enrollment']	['Neutral']
Problems with recruiting	['Insufficient_Enrollment']	['Neutral']
Study funding was dropped.	['Business_Administrative']	['Possibly_Negative']
Terminated due to a patent legal settlement	['Business_Administrative']	['Possibly_Negative']
Decision from the Sponsor	['Business_Administrative']	['Possibly_Negative']
We did not enroll any patients for logistic reasons.	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Withdrawn	['Invalid_Reason']	['Invalid_Reason']
funding withdrawn	['Business_Administrative']	['Possibly_Negative']
Poor patient recruitment	['Insufficient_Enrollment']	['Neutral']
"The study was ""withdrawn"" due to certain adverse events [hypersensitivity]."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
PI left center	['Study_Staff_Moved']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Study stopped due to lack of efficacy.	['Negative']	['Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Strategic decision	['Business_Administrative']	['Possibly_Negative']
The maintenance doses were too low to maintain testosterone suppression	['Logistics_Resources']	['Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
Enrollment is temporarily suspended due to COVID-19.	['Covid19']	['Neutral']
Business Decision	['Business_Administrative']	['Possibly_Negative']
unfunded	['Business_Administrative']	['Possibly_Negative']
The decision is based on company re-evaluation of indications to be pursued within SCCHN	['Business_Administrative']	['Possibly_Negative']
expiration time limit of recruitment	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Unable to recruit	['Insufficient_Enrollment']	['Neutral']
Study not launched due to logistical issues that could not be resolved.	['Logistics_Resources']	['Neutral']
Low recruitment rate	['Insufficient_Enrollment']	['Neutral']
"PolyMedix decided to stop enrollment in both clinical trials due to observations of reductions
    in blood pressure."	['Safety_Sideeffects', 'Endpoint_Met', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
"Pfizer released from post-marketing commitment and study terminated because too few patients in
    the age group; not because of efficacy or safety issues."	['Business_Administrative']	['Possibly_Negative']
Not sufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Temporarily suspended due to COVID-19 policies.	['Covid19']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
"Study delayed for over a year by research shutdown at Seattle VA and other issues. Study
    designer moved to Ann Arbor in the interim, so the study was closed."	['Study_Staff_Moved']	['Neutral']
Poor enrollment.	['Insufficient_Enrollment']	['Neutral']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
The study was halted early due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
Management decision	['Business_Administrative']	['Possibly_Negative']
Myoscience recently acquired - decided to redesign study.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The study could not be performed as planned for organizational reasons.	['Business_Administrative']	['Possibly_Negative']
Funding withdrawal	['Business_Administrative']	['Possibly_Negative']
Principle Investigator has left the University.	['Study_Staff_Moved']	['Neutral']
The study stopped because patient enrollment requirements were not met.	['Insufficient_Enrollment']	['Neutral']
We opened a competing study with the TACL consortium	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Funding agent withdrew funding	['Business_Administrative']	['Possibly_Negative']
Study was previously paused and is now terminated	['Invalid_Reason']	['Invalid_Reason']
Slow Accrual.	['Insufficient_Enrollment']	['Neutral']
The 001 trial did not show benefit versus placebo	['Negative']	['Negative']
Study never started. Study was redesgined.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
PI started new position.	['Study_Staff_Moved']	['Neutral']
Dose Limiting Toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"On further investigation, it was found that the continuous glucose monitors required a
    calibration period that precluded reliable data collection."	['Logistics_Resources']	['Neutral']
The primary efficacy endpoint was not met	['Negative']	['Negative']
Didn't meet accrual goal, change in standard of care.	['Insufficient_Enrollment']	['Neutral']
Due to participants not completing the cognitive training requirement.	['Insufficient_Enrollment']	['Neutral']
COVID-19	['Covid19']	['Neutral']
"The scope of the program has been reduced to focus resources on studies which can potentially
    enable the registration of duvelisib."	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
recruitment problems	['Insufficient_Enrollment']	['Neutral']
Failed to recruit sufficient subjects	['Insufficient_Enrollment']	['Neutral']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Business decision	['Business_Administrative']	['Possibly_Negative']
Study was terminated because of very low enrollment rate.	['Insufficient_Enrollment']	['Neutral']
No participants enrolled into study and protocol has been superseded	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Feasibility issues for subject recruitment and PI left the institution	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
COVID	['Covid19']	['Neutral']
Program Terminated	['Invalid_Reason']	['Invalid_Reason']
Suspended due to COVID-19	['Covid19']	['Neutral']
"The study team was not able to start the study and they never completed the IRB submission, so
    the study was terminated."	['Business_Administrative']	['Possibly_Negative']
Pl left institution	['Study_Staff_Moved']	['Neutral']
Lack of supporting staff	['Logistics_Resources']	['Neutral']
Study has been suspended due to inability to obtain funding.	['Business_Administrative']	['Possibly_Negative']
lack of eligible study participants	['Insufficient_Enrollment']	['Neutral']
Investigator left the NIH.	['Study_Staff_Moved']	['Neutral']
Could not adequately recruit enough subjects to reach appropriate sample size	['Insufficient_Enrollment']	['Neutral']
"Study halted prematurely and will not resume; participants are no longer being examined or
    receiving intervention. Low enrollment and PI leaving institution"	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
PI is no longer with UF. No New PI assigned to date.	['Study_Staff_Moved']	['Neutral']
Safety	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
planned surgical procedures decreased	['Study_Design']	['Neutral']
Insufficient eligible participants to meet recruitment goal	['Insufficient_Enrollment']	['Neutral']
"The study was terminated prior to a planned interim analysis based on lack of required efficacy
    in the first 32 participants enrolled."	['Negative']	['Negative']
problem with balloon catheter	['Logistics_Resources']	['Neutral']
Low accrual and no further funding.	['Insufficient_Enrollment']	['Neutral']
Difficulty with recruitment/funding	['Business_Administrative']	['Possibly_Negative']
Additional pharmacovigilance activity was considered as fulfilled by the EMA.	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
"We had very low recruitment rates that would have resulted in several years being added to the
    study to achieve an appropriate sample size."	['Insufficient_Enrollment']	['Neutral']
"Time elapsed to require permissions and a recent paper showed a high efficacy of a 48-week
    regimen in this setting. It seems non-ethical to start this trial"	['Negative', 'Another_Study']	['Negative', 'Neutral']
The study was terminated early due to business reasons.	['Business_Administrative']	['Possibly_Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Issues with recruitment. PI decided to terminate study	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Study technique has been declared part of standard care	['Study_Design']	['Neutral']
"Closed accrual due to unpromising results and the opening of study 14C0053 targeting the same
    population."	['No_Context', 'Insufficient_Enrollment', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
Trial met futility stopping point	['Negative']	['Negative']
Sponsor restructuring.	['Business_Administrative']	['Possibly_Negative']
No funding source for device purchasing	['Business_Administrative']	['Possibly_Negative']
Manufacturer discontinued support of the study	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
projected enrollment rate not feasible	['Insufficient_Enrollment']	['Neutral']
Study closed by Institutional Review Board	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Difficulty enrolling subjects	['Insufficient_Enrollment']	['Neutral']
low recruitment	['Insufficient_Enrollment']	['Neutral']
It has proved extremely difficult	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Clinical volume of patients for recruitment stopped.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"Because of unsatisfactory results of previous trial which assessed the effect of different
    onset times of PDL on surgical scars."	['Negative', 'Another_Study']	['Negative', 'Neutral']
prior to participant recruitment, PI left Emory, study stopped	['Study_Staff_Moved']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
low enrollment	['Insufficient_Enrollment']	['Neutral']
Slow/Insufficient accrual	['Insufficient_Enrollment']	['Neutral']
Drugs unavailable	['Logistics_Resources']	['Neutral']
PI is transitioning to another institution	['Study_Staff_Moved']	['Neutral']
Total number of pts expected to be enrolled would not be met.	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Study stopped to open expanded phase II study	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Per memo from study team	['Covid19', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Study Terminated due to Insufficient Efficacy	['Negative']	['Negative']
Low recruitment rate (17 patients;43% enrollment for 2 years).	['Insufficient_Enrollment']	['Neutral']
Not enough recruitment	['Insufficient_Enrollment']	['Neutral']
Day 90 results indicate IMP did not reduce mortality or ventilator free days	['Negative']	['Negative']
Due to Covid-19 disruption	['Covid19']	['Neutral']
Withdrawn with IRB	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
Funding terminated	['Business_Administrative']	['Possibly_Negative']
Administrative Reasons	['Business_Administrative']	['Possibly_Negative']
recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Early Terminated	['Invalid_Reason']	['Invalid_Reason']
Recruiting failure	['Insufficient_Enrollment']	['Neutral']
Accrual too slow; Study P.I. passed away.	['Insufficient_Enrollment']	['Neutral']
inconclusive results, large inter-individual variation, insufficient statistical power	['Negative']	['Negative']
Study was terminated due to lack of accrual	['Insufficient_Enrollment']	['Neutral']
FDA allowed other data to be leveraged to meet the study requirements	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Due to the principal investigator having left the institution.	['Study_Staff_Moved']	['Neutral']
Due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Suspended due to lack of funding.	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Complications to procedure	['Covid19', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
"Principal investigator made the decision to close study and not submit a renewal. Lack of fixed
    research personnel to carry out the study effectively."	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
the end of inclusion period	['Invalid_Reason']	['Invalid_Reason']
transfer to another sponsor	['Business_Administrative']	['Possibly_Negative']
PI left VUMC	['Study_Staff_Moved']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Biomarker Samples Not Collected	['Interim_Analysis', 'Logistics_Resources']	['Neutral', 'Neutral']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
"Enrolling participants has halted prematurely and will not resume due to the Departure of the
    principal investigator"	['Study_Staff_Moved']	['Neutral']
PI left the VA.	['Study_Staff_Moved']	['Neutral']
Very low rate of recruitment anticipated futility of pursuing the study	['Negative']	['Negative']
The trial is terminated due to the extremely low recruitment rate.	['Insufficient_Enrollment']	['Neutral']
"Enrollment of patients has halted prematurely and will not resume. No future patients will be
    enrolled or treated."	['Invalid_Reason']	['Invalid_Reason']
Difficulties with enrollment	['Insufficient_Enrollment']	['Neutral']
Difficulty recruiting patients. PI left research facility.	['Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Accrual issues - Slow accrual	['Insufficient_Enrollment']	['Neutral']
Unable to recruit sufficient number of patients.	['Insufficient_Enrollment']	['Neutral']
Prior to recruitment, study terminated lack of recruitment interest.	['Insufficient_Enrollment']	['Neutral']
Insufficient enrollment of eligible patients	['Insufficient_Enrollment']	['Neutral']
Investigator relocated and study funding ended.	['Business_Administrative']	['Possibly_Negative']
Lack of staff and funding.	['Business_Administrative']	['Possibly_Negative']
Preliminary tests found that some newborns heel blood amount could not meet the test needs.	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
unexpected high grade of mucositis observed	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"Other authors showed the same metabolic effect may be obtained when BMMC are delivered
    peripherally, with lower risk and cost than through hepatic artery."	['Negative', 'Another_Study']	['Negative', 'Neutral']
The primary objectives were achieved.	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Investigator left institution.	['Study_Staff_Moved']	['Neutral']
"Recruitment strategy not working. This information was really useful to design a randomised
    controlled trial."	['No_Context', 'Invalid_Reason', 'Study_Design']	['Invalid_Reason', 'Invalid_Reason', 'Neutral']
"Study is now terminated due to technical difficulties with administration of study drug in this
    patient population with this schedule"	['Logistics_Resources']	['Neutral']
The Sponsor has no interest in continuing the study.	['Business_Administrative']	['Possibly_Negative']
NO AVAILABLE FUND	['Business_Administrative']	['Possibly_Negative']
Program discontinued	['Invalid_Reason']	['Invalid_Reason']
The study stopped due to a death in the arm control	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Lack of efficacy of test drug	['Negative']	['Negative']
Drug availability issues	['Logistics_Resources']	['Neutral']
"Study halted prematurely and will not resume; participants are no longer being examined or
    receiving intervention."	['Invalid_Reason']	['Invalid_Reason']
the trial was never opened and then withdrawn permanently	['Invalid_Reason']	['Invalid_Reason']
The study was terminated prematurely due to withdrawal of support by the sponsor.	['Business_Administrative']	['Possibly_Negative']
No patients were enrolled, study cancelled before start	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
PI left Institution	['Study_Staff_Moved']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Failed treatment response	['Negative']	['Negative']
Poor recruitement	['Insufficient_Enrollment']	['Neutral']
the enrollment was slow and never completed.	['Insufficient_Enrollment']	['Neutral']
PI job change	['Study_Staff_Moved']	['Neutral']
Poor patient recruitment.	['Insufficient_Enrollment']	['Neutral']
Due to recruitment problems	['Insufficient_Enrollment']	['Neutral']
Business Reasons	['Business_Administrative']	['Possibly_Negative']
The study was terminated per the PI decision.	['Invalid_Reason']	['Invalid_Reason']
Could not power primary endpoint due to lost to follow-up rate	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Study had funding issues and difficulties with recruitment.	['Business_Administrative']	['Possibly_Negative']
Principle investigator resigned in 2013	['Study_Staff_Moved']	['Neutral']
study never initiated	['Invalid_Reason']	['Invalid_Reason']
Strategy change	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Results Invalid, study closed, analysis cannot proceed.	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
Terminated following completion of 2 year time point: Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Need more time to optimize the sensor	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Discontinuing the study because of COVID-19	['Covid19']	['Neutral']
The study has been postponed due to mobility constrains during covid-19 crisis.	['Covid19']	['Neutral']
Trial was terminated prematurely because of recruitment difficulties.	['Insufficient_Enrollment']	['Neutral']
The study was ended early due to the lack of efficacy seen in the parent study GA30044.	['Negative', 'Another_Study']	['Negative', 'Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Results already published by another team	['Negative', 'Another_Study']	['Negative', 'Neutral']
Low recruitment and published data with no benefit	['Negative']	['Negative']
difficulty to recrut	['Insufficient_Enrollment']	['Neutral']
"Study terminated on 04Oct2013 for business reasons after being on hold for 10 months. Early
    termination was not due to safety concerns."	['Business_Administrative']	['Possibly_Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Business objectives have changed.	['Business_Administrative']	['Possibly_Negative']
Business decision	['Business_Administrative']	['Possibly_Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
patient safety	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
slow inclusion rate	['Insufficient_Enrollment']	['Neutral']
Termination following reassessment of the potential benefit-risk of AVE0657	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study only randomized 1 subject and was determined not feasible by DSMB	['Negative']	['Negative']
COVID-19	['Covid19']	['Neutral']
PI no longer at institution	['Study_Staff_Moved']	['Neutral']
Administrative problems with study director	['Business_Administrative']	['Possibly_Negative']
Principle Investigator is no longer at Loma Linda University Medical Center	['Study_Staff_Moved']	['Neutral']
Executive committee determined to close study after interim analysis.	['Negative']	['Negative']
PI has relocated	['Study_Staff_Moved']	['Neutral']
Only one center could be open and the center could not include all patients	['Insufficient_Enrollment']	['Neutral']
Futility reasons after Independent Data Monitoring Committee interim analysis	['Negative']	['Negative']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Due to coronavirus pandemic	['Covid19', 'Safety_Sideeffects', 'Insufficient_Enrollment']	['Neutral', 'Safety_Sideeffects', 'Neutral']
COVID-19	['Covid19']	['Neutral']
No longer pursuing FDA submission/approval.	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Difficult recruitment	['Insufficient_Enrollment']	['Neutral']
Interim analysis also showed a lack of benefit in the experimental arm.	['Negative']	['Negative']
"This is a retrospective study reviewing subject questionnaires. No treatments will be
    administered in this study."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Principal investigator is not longer at this institution	['Study_Staff_Moved']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
No signal of efficacy with Entospletinib	['Negative']	['Negative']
Funding was rescinded	['Business_Administrative']	['Possibly_Negative']
The study is stopped for Portfolio prioritization.	['Business_Administrative']	['Possibly_Negative']
anticipated results not seen and population not seen	['Negative']	['Negative']
PI decided to close study due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
"According to NIH definition of clinical trial studies, this study does not meet requirement for
    clinical trial study."	['Regulatory', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Underrecruitment	['Insufficient_Enrollment']	['Neutral']
Failed to meet success criteria	['Negative']	['Negative']
sponsor withdrew study	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Discontinued development of rociletinib in NSCLC. Stopped enrollment of new patients into all
    studies involving rociletinib."	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
"At this point, the current study in HL does not fit into clinical development and regulatory
    strategy."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Very slow enrollment of participants	['Insufficient_Enrollment']	['Neutral']
Performance of BCI switch insufficient in pilot testing.	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Changes in study design	['Study_Design']	['Neutral']
Insufficient enrollment; No safety concerns	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
"Unable to identify eligible subjects with traumatic brain injury who also have banked umbilical
    cord blood at CBR."	['Insufficient_Enrollment']	['Neutral']
pending intrim analysis	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
Did not meet accrual goals.	['Insufficient_Enrollment']	['Neutral']
Funding ended prior to resolution of all equipment (polarizer) issues.	['Business_Administrative']	['Possibly_Negative']
"The study was discontinued due to slow recruitment and subjects not completing follow up
    period."	['Insufficient_Enrollment']	['Neutral']
Loss of funding	['Business_Administrative']	['Possibly_Negative']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
The study has been terminated because of recruitment difficulties and lack of further funding	['Business_Administrative']	['Possibly_Negative']
"slow inclusion, due to difficulties in obtaining the patients consent for the 2 months invasive
    follow-up, as required by protocol design."	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Low enrollment led sponsor to terminate study early.	['Insufficient_Enrollment']	['Neutral']
Funding no longer available	['Business_Administrative']	['Possibly_Negative']
Inadequate number of subjects meet study criteria	['Insufficient_Enrollment']	['Neutral']
Due to slow recruitment and a significant delay in reaching the recruitment target.	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
"The primary objective (to evaluate the long-term safety of Praluent) was adequately evaluated
    in other studies."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Terminated, because it is not possible to recruit enough participants	['Insufficient_Enrollment']	['Neutral']
Difficulties in the patient's enrolment	['Insufficient_Enrollment']	['Neutral']
PI left the institution.	['Study_Staff_Moved']	['Neutral']
Investigator is leaving the institution and has terminated the study.	['Study_Staff_Moved']	['Neutral']
No clinical significant	['Negative']	['Negative']
recruitment failed	['Insufficient_Enrollment']	['Neutral']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Orphan Drug Designation for this indication not granted	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Extensive protocol revisions initiated.	['Study_Design']	['Neutral']
"PI moved away from Bern; lack of personnel in Bern to conduct the study within a reasonable
    time frame."	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
The manufacturer is not currently supporting research in this indication.	['Business_Administrative']	['Possibly_Negative']
Severe difficulties with recruiting participants	['Insufficient_Enrollment']	['Neutral']
Main clinician cancelled collaboration for personal reasons.	['Logistics_Resources', 'Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
To conduct interim analysis and assess whether assay changes are recommended.	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Project terminated due to revision of local regulations	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
"Due to change in Sanofi's development strategy for DNL747/SAR443060 - not due to any safety
    concerns"	['Business_Administrative']	['Possibly_Negative']
Lack of efficacy with renal denervation in multicenter trials	['Negative', 'Another_Study']	['Negative', 'Neutral']
Recruitment problems	['Insufficient_Enrollment']	['Neutral']
Futility	['Negative']	['Negative']
New medication coming on the market, made study obsolete.	['Study_Design']	['Neutral']
we decided to change the protocol completely to an RCT.	['Study_Design']	['Neutral']
Surgeon mistakenly removed liver and fat tissue from a non-LABS2a participant	['Logistics_Resources']	['Neutral']
Business Decision (no enrollment)	['Business_Administrative']	['Possibly_Negative']
Inadequate eligible subjects to expect sufficient numbers to analyse outcomes.	['Insufficient_Enrollment']	['Neutral']
not funded	['Business_Administrative']	['Possibly_Negative']
Inability to recruit eligible subjects	['Insufficient_Enrollment']	['Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Due to COVID-19 pandemic, patients recruitment is not possible at the moment.	['Covid19']	['Neutral']
Study staffing constraints	['Logistics_Resources']	['Neutral']
Because of the economic consequences of the COVID-19 pandemic 2020	['Covid19']	['Neutral']
Study on hold due to COVID-19 research restrictions for in-person research	['Covid19']	['Neutral']
The study is not proceeding at this time.	['Invalid_Reason']	['Invalid_Reason']
No eligible patients could be recruited.	['Insufficient_Enrollment']	['Neutral']
Pandemic (Covid-19)	['Covid19']	['Neutral']
Updated results by guidelines and bibliography	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
"The study was terminated since fosmetpantotenate did not show statistically significant effects
    or clinical benefits during the double-blind period."	['Negative']	['Negative']
We are working on the logistics of having this program occur in the same day procedure setting.	['Logistics_Resources', 'Endpoint_Met', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
"This study is being closed due to the inability to acquire the required technology to complete
    the study"	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Logistical reasons and slow recruitment	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
No funding was obtained for this study.	['Business_Administrative']	['Possibly_Negative']
Study was amalgamated with another study to include exercise as another intervention.	['Negative', 'Another_Study']	['Negative', 'Neutral']
No eligible patient was enrolled.	['Insufficient_Enrollment']	['Neutral']
No subject enrollment.	['Insufficient_Enrollment']	['Neutral']
New study protocol started including targeted biopsies	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
IAC is now recognized as part of standard of care treatment options in the US.	['Endpoint_Met', 'Study_Design', 'Another_Study']	['Neutral', 'Neutral', 'Neutral']
No grant was received then we stopped the recruitment	['Business_Administrative']	['Possibly_Negative']
Study technique has been declared part of standard care	['Study_Design']	['Neutral']
Changes in the clinical practice	['Study_Design']	['Neutral']
Other projects warranted more attention	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Unanticipated study design flaw; PCO evaluator interrater reliability was not performed.	['Covid19', 'Logistics_Resources', 'Endpoint_Met']	['Neutral', 'Neutral', 'Neutral']
To focus on a similar study NCT01175408 prior to recruiting participants.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Adequate no. of patients could not be recruited in the set time frame.	['Insufficient_Enrollment']	['Neutral']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
An independent Data Safety Monitoring Board recommended the study be stopped due to futility	['Negative']	['Negative']
pending design changes to the device	['Study_Design']	['Neutral']
Due to changes in portfolio review	['Business_Administrative']	['Possibly_Negative']
Recruitment problems	['Insufficient_Enrollment']	['Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
Study completed	['Invalid_Reason']	['Invalid_Reason']
enrollment problems	['Insufficient_Enrollment']	['Neutral']
No patients; only 6 enrolled after 2 years	['Insufficient_Enrollment']	['Neutral']
Because of the low probability of achieving the primary endpoint.	['Negative']	['Negative']
COV-19 pandemic	['Covid19']	['Neutral']
Concerns about safety of Hydroxychloroquine	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"Slow accrual and evidence from other studies showing benefit of early initiation of pemetrexed
    after first-line therapy"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of ongoing funding	['Business_Administrative']	['Possibly_Negative']
"Futility for immune responses to the vaccine. Also, a component of study drug was in short
    supply."	['Logistics_Resources', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
"During the study two patients have experienced serious liver events related to AKN-028. The
    risk-benefit balance was judged to be negative."	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Difficulties in recruiting the planned number of patients	['Insufficient_Enrollment']	['Neutral']
Due to lack of funding	['Business_Administrative']	['Possibly_Negative']
Five immune related serious adverse events	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
PI is leaving the institution	['Study_Staff_Moved']	['Neutral']
"Study recruitment was terminated on 24 June 2015, due to a Pfizer business decision. This study
    was not terminated for reasons of safety or efficacy"	['Business_Administrative']	['Possibly_Negative']
Enrollment and study activities are temporarily suspended due to COVID-19.	['Covid19']	['Neutral']
Changes in standard of care have altered the feasibility of the study.	['Study_Design']	['Neutral']
Clinical research currently on hold	['Invalid_Reason']	['Invalid_Reason']
Study was cancelled due to reclassification of study design. No subjects enrolled in the study.	['Study_Design']	['Neutral']
Difficulty of recruitment	['Insufficient_Enrollment']	['Neutral']
Difficulties with recruitment	['Insufficient_Enrollment']	['Neutral']
lack of efficacy	['Negative']	['Negative']
IND exemption pending	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Discontinued PB127 development program for business reasons	['Business_Administrative']	['Possibly_Negative']
low recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of Drug Supply	['Logistics_Resources']	['Neutral']
Funding support withdrawn	['Business_Administrative']	['Possibly_Negative']
No funding was received, no subjects were enrolled	['Business_Administrative']	['Possibly_Negative']
Long term safety follow-up no longer required	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
"At the request of the global principal investigator, no subjects were enrolled in this study at
    any site."	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
All study procedures have been suspended since March 20, 2020 due to Coronavirus Disease 2019.	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
No enrollment occured. Subjects will be enrolled under a new protocol.	['Study_Design']	['Neutral']
insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
"The B5201003 OLE study was terminated based on the failure of the 'parent"" B5201002 study to
    meet its efficacy endpoints. Termination was not due to safety."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study stopped due to lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Study withdrawn due to volunteer disinterest in participating.	['Insufficient_Enrollment']	['Neutral']
Design, sponsorship changed prior to initiation. No study procedures done.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Sponsor	['Business_Administrative']	['Possibly_Negative']
"In a limited number of patients, no additional activity was evident for the combination vs.
    Loncastuximab tesirine monotherapy."	['Negative']	['Negative']
Funding issues	['Business_Administrative']	['Possibly_Negative']
Difficulty in enrolling particpants	['Insufficient_Enrollment']	['Neutral']
Not feasible	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Delay in recruitment due to covid and a newer version of mobile app is available for testing.	['Covid19']	['Neutral']
Bb	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Study terminated prematurely due to financial contraints.	['Business_Administrative']	['Possibly_Negative']
Recruitment considerations only and not because of safety or outcomes issues	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Research cancelled.	['Invalid_Reason']	['Invalid_Reason']
The device was withdrawn from clinical use	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
difficulty in recruiting patients	['Insufficient_Enrollment']	['Neutral']
Technical problems with simulator	['Logistics_Resources']	['Neutral']
difficulties in enrolling patients	['Insufficient_Enrollment']	['Neutral']
High dropout, problems recruiting, and smaller than expected decline in FEV1.	['Negative']	['Negative']
PI moved	['Study_Staff_Moved']	['Neutral']
Principal Investigator moved to another institution.	['Study_Staff_Moved']	['Neutral']
After interim results data showed no evidence of a difference between both groups	['Negative']	['Negative']
Inability to accrue.	['Insufficient_Enrollment']	['Neutral']
Decision to obtain PK data at a later date	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
The study was cancelled.	['Invalid_Reason']	['Invalid_Reason']
"Based on R&D strategic reasons, our co-development Partner financing the study disengaged from
    the development of GNbAC1."	['Business_Administrative']	['Possibly_Negative']
unable to enroll	['Insufficient_Enrollment']	['Neutral']
"In light of the company's current financial position we have indefinately suspended the
    Rheo-AMD trial."	['Business_Administrative']	['Possibly_Negative']
This research described in this protocol was not funded.	['Business_Administrative']	['Possibly_Negative']
Slow recruitment rate	['Insufficient_Enrollment']	['Neutral']
Poor enrollment, patients were lost to follow up	['Insufficient_Enrollment']	['Neutral']
"This project has undergone a significant amount of updates and has been resubmitted under IRB#
    201708778"	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Lack of eligible patients due to introduction of new drugs for Hepatitis C	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Terminated at request of FDA	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Another institution conducted and published this study.No subjects enrolled.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Only 2 participants were enrolled	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Principal Investigator decided not to initiate the study.	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Study stopped after results of cabozantinib Phase 3 CRPC study XL184-307.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Funding not received	['Business_Administrative']	['Possibly_Negative']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
"Due to enrollment challenges & improved SOC during run-in phase; no patients received KPT-330.
    Withdrawal is not a consequence of any safety concern."	['Insufficient_Enrollment', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
company decision based on other studies	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Unable to enroll enough participants	['Insufficient_Enrollment']	['Neutral']
lack of funds	['Business_Administrative']	['Possibly_Negative']
Strategic decision of Sponsor	['Business_Administrative']	['Possibly_Negative']
Did not go through with the study for logistical reasons	['Logistics_Resources']	['Neutral']
"This study was terminated due to the lack of efficacy of GSK1605786A in Crohn's disease based
    on the results of Study CCX114151."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Terminated due to reasons unrelated to safety	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
No Participants Enrolled	['Insufficient_Enrollment']	['Neutral']
Study withdrawn prior to enrollment due to changing standard of care landscape.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Shutdown of The Department of Inflammatory Diseases at Novo Nordisk.	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
Study terminated for cGCP non-compliance. Analyses could not be performed.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Not due to safety reasons	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Study suspended to determine if enrollment is sufficient to meet endpoints.	['Interim_Analysis', 'Regulatory', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Sponsor withdrew funding - May 2016	['Business_Administrative']	['Possibly_Negative']
Close out study w/o Cohort D; Severe Impairment (eGFR=15 to <30mL/min/1.73m)	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
"Negative pharmacodynamics due to lack of Interleukin-13 signature in biomarker data from Part I
    of the study."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Problems with patient recruitement	['Insufficient_Enrollment']	['Neutral']
lack of enrolment	['Insufficient_Enrollment']	['Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
lack of patients	['Insufficient_Enrollment']	['Neutral']
Study was withdrawn due to scientific and business considerations.	['Business_Administrative']	['Possibly_Negative']
difficulty in recruiting	['Insufficient_Enrollment']	['Neutral']
study stopped due to lack of activity	['Negative']	['Negative']
Safety	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Key Personnel left institution	['Study_Staff_Moved']	['Neutral']
Osiris decision	['Invalid_Reason']	['Invalid_Reason']
Failed to recruit	['Insufficient_Enrollment']	['Neutral']
Investigator decided not to move forward with study prior to study start date	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Recruitment rate was not sufficient	['Insufficient_Enrollment']	['Neutral']
There were difficulties in implementation	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Slow enrollment. None of the subjects received EXPAREL.	['Insufficient_Enrollment']	['Neutral']
The design of this protocol was rewritten due to regulatory recommendations.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Reconsideration of Study Design; plan for alternative protocol	['Study_Design']	['Neutral']
NOT ENOUGH DATA AVAILABLE	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Study is temporarily suspended due to COVID-19.	['Covid19']	['Neutral']
The study was stopped due to lack of resources of the study coordinator's time	['Logistics_Resources']	['Neutral']
this was not a clinical trial	['Invalid_Reason']	['Invalid_Reason']
Stability of the DNA when admixed with the liposome failed	['Safety_Sideeffects', 'Logistics_Resources', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Poor accrual.	['Insufficient_Enrollment']	['Neutral']
Increased incidence of respiratory depression in the morphine group	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
The study was discontinued due to low recruitment.	['Insufficient_Enrollment']	['Neutral']
Closed early due to low accrual.	['Insufficient_Enrollment']	['Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
futility following planned interim analysis	['Negative']	['Negative']
unable to recruit patients	['Insufficient_Enrollment']	['Neutral']
"Serious difficulties for patient recruitment

    to recruit patients"	['Insufficient_Enrollment']	['Neutral']
Strategic decision to stop pimodivir phase 1 studies	['Business_Administrative']	['Possibly_Negative']
Low enrollment, too many subjects getting second injection	['Insufficient_Enrollment']	['Neutral']
Toxicity of combination from other trials	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Low rythm of inclusions	['Insufficient_Enrollment']	['Neutral']
No Funding Received from ADA	['Business_Administrative']	['Possibly_Negative']
Logistic issues could not be resolved - study closed without any patients recruited	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Dr. Grose has left this practice, this study is terminated	['Study_Staff_Moved']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
No patients recruited	['Insufficient_Enrollment']	['Neutral']
Protocol not approved	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Abandoned due to limited resources	['Logistics_Resources']	['Neutral']
Funding withdrawn	['Business_Administrative']	['Possibly_Negative']
PI Left University	['Study_Staff_Moved']	['Neutral']
Study terminated due to sponsor decision	['Business_Administrative']	['Possibly_Negative']
Study halted prematurely, prior to enrollment of first participant	['Invalid_Reason']	['Invalid_Reason']
Slow accrual and lack of funding	['Insufficient_Enrollment']	['Neutral']
the company's decision to de-prioritize 4718 development	['Business_Administrative']	['Possibly_Negative']
Issues w/recruitment	['Insufficient_Enrollment']	['Neutral']
investigator choice	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Enrollment challenges	['Insufficient_Enrollment']	['Neutral']
Suspected Serious Adverse Events related to treatment	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Integrated into another study	['Negative', 'Another_Study']	['Negative', 'Neutral']
company dissolved	['Business_Administrative']	['Possibly_Negative']
PI separated employment from the university.	['Study_Staff_Moved']	['Neutral']
Study TLK199.2107 was terminated for business reasons.	['Business_Administrative']	['Possibly_Negative']
COVID-19 Regulations	['Covid19']	['Neutral']
Study non feasible following changes in organisation of service	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Only part three, the individual interviews, has been carried out. We have not been able to get
    funding to complete the rest of the study."	['Business_Administrative']	['Possibly_Negative']
The study was terminated due to slow rate of accrual resulting in a sample size.	['Insufficient_Enrollment']	['Neutral']
This protocol was created to support work as part of an NIH-funded study.	['Negative', 'Another_Study']	['Negative', 'Neutral']
problem with recruiting participants	['Insufficient_Enrollment']	['Neutral']
"Part A reached a predefined stopping criteria. Relevant doses for part B could not be
    established based on A and subsequently study was stopped."	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Enrollment challenges	['Insufficient_Enrollment']	['Neutral']
No Patients were recruited during the study period	['Insufficient_Enrollment']	['Neutral']
"It was decided by Sponsor on 13 January 2014 to terminate study early at primary efficacy
    endpoint as part of a decision to modify drug development plan."	['Business_Administrative']	['Possibly_Negative']
Funding withdrawn	['Business_Administrative']	['Possibly_Negative']
Stop of drug development	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"We could not receive the support from the national medical insurance owing to the changed
    policy of the government for clincal trials."	['Business_Administrative']	['Possibly_Negative']
"Strategic decision due to emerging new data for patients with HR+, HER2- metastatic breast
    cancer."	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Steroids were given for 2 patients who had biopsy proven Drug induced Liver Injury and both
    have them developed sepsis."	['Safety_Sideeffects', 'Endpoint_Met', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Protocol Violations noted for 6 of 8 patients	['Study_Design']	['Neutral']
Study terminated due to low enrollment	['Insufficient_Enrollment']	['Neutral']
Significantly more resources would have been necessary to complete the study.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Recruitment difficulty	['Insufficient_Enrollment']	['Neutral']
Interim analysis indicated treatment was effective and statistically significant	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Supporting agency withdrew funding for study.	['Business_Administrative']	['Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Management Decision	['Business_Administrative']	['Possibly_Negative']
FDA Clinical Hold	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of recruitment and of study staff	['Insufficient_Enrollment']	['Neutral']
Study C11-01 started	['No_Context', 'Invalid_Reason', 'Study_Design']	['Invalid_Reason', 'Invalid_Reason', 'Neutral']
Study slow to accrue.	['Insufficient_Enrollment']	['Neutral']
To revise protocol for a more concise inclusion/exclusion criteria	['Study_Design']	['Neutral']
Drug no longer available	['Logistics_Resources']	['Neutral']
The Investigator left the organization.	['Study_Staff_Moved']	['Neutral']
Not enough patients with the specified criteria could not	['Insufficient_Enrollment']	['Neutral']
PI did not attempt to open the study.	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
regulatory strategy	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"due to evolving scientific knowledge in the field that would make the questions being addressed
    in the trial less relevant"	['Logistics_Resources', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Business Decision	['Business_Administrative']	['Possibly_Negative']
low recruitment	['Insufficient_Enrollment']	['Neutral']
Capacity shortage	['Logistics_Resources']	['Neutral']
Covid Restrictions have impacted longitudinal assessments for the effect of the intervention	['Covid19']	['Neutral']
The intervention becomes obsolete for participating centres pending regulatories.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Company decision	['Business_Administrative']	['Possibly_Negative']
Poor patient accrual	['Insufficient_Enrollment']	['Neutral']
Reached required analyzable sample size; COVID-19 recruitment challenges	['Covid19']	['Neutral']
Study was terminated due to lack of recruitment	['Insufficient_Enrollment']	['Neutral']
accrual to slow, target not achievable	['Insufficient_Enrollment']	['Neutral']
Problematic has become outdated in relation with current litterature advances.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Sponsor withdrew support of study due to reorganization and project prioritization	['Business_Administrative']	['Possibly_Negative']
Study was terminated due to cardiac toxicities in the subejcts	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Study was not and will not be initiated due to lack of funding.	['Business_Administrative']	['Possibly_Negative']
Funding unsuccessful	['Business_Administrative']	['Possibly_Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
COVID-19	['Covid19']	['Neutral']
COVID-19, study status being reviewed on an ongoing basis.	['Covid19']	['Neutral']
Study was stopped due to inavailability of subjects meeting eligibility criteria.	['Insufficient_Enrollment']	['Neutral']
Inadequate enrollment	['Insufficient_Enrollment']	['Neutral']
"Post-marketing reports of hepatotoxicity associated with obeticholic acid emerged in June 2017,
    investigators temporarily halted patient recruitment June 2017."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Enrollment too low.	['Insufficient_Enrollment']	['Neutral']
Study terminated. Eisai's Targretin acquired by another pharmaceutical company.	['Business_Administrative']	['Possibly_Negative']
Slow enrolment & potential regulatory changes for allograft in cartilage repair	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
COVID-19	['Covid19']	['Neutral']
Company is redesigning measuring tool.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Investigator left this hospital	['Study_Staff_Moved']	['Neutral']
"Study recruitment was stopped due to difficulty in enrolling the targeted number of patients on
    March 21, 2018. See details in Description section."	['Insufficient_Enrollment']	['Neutral']
Corporate decision to discontinue distribution of MJS Knee.	['Business_Administrative']	['Possibly_Negative']
the viability of the study is being analyzed	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
suspected unfavorable risk/benefit assessment	['Negative']	['Negative']
Due to COVID-19 lockdown	['Covid19']	['Neutral']
Change in the design of the study	['Study_Design']	['Neutral']
The PI has decided to close the study due to the outdated study design.	['Study_Design']	['Neutral']
Unable to use manometry lab.	['Logistics_Resources']	['Neutral']
Ethics Committe decision	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
no patients recruited	['Insufficient_Enrollment']	['Neutral']
Changing of specialty	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study was closed because investigator left the National Institutes of Health.	['Study_Staff_Moved']	['Neutral']
The device used was removed from the market	['Logistics_Resources']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
This trial never started due to lack of funding.	['Business_Administrative']	['Possibly_Negative']
because of difficulties of enrolling appropriate participants	['Insufficient_Enrollment']	['Neutral']
no participant enrolled	['Insufficient_Enrollment']	['Neutral']
Unable to obtain data needed to run the RCT; project never began recruitment	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Vapocoolant not effective controlling pain compared with Lidocaine.	['Negative']	['Negative']
Not a significant difference in outcomes between groups	['Negative']	['Negative']
Sub study was not pursued as overall trial was negative	['Negative']	['Negative']
not enough patients recruited on time	['Insufficient_Enrollment']	['Neutral']
Shortages of study drug, difficulty enrolling patients	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
The sample size of the planned interims analysis was achieved	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
No funding	['Business_Administrative']	['Possibly_Negative']
Inability to meet accrual goals within the funding period.	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
This study was closed to recruitment and follow-up early due to low recruitment.	['Insufficient_Enrollment']	['Neutral']
The result of a pre-planned interim futility analysis	['Negative']	['Negative']
"At the end of the planned recruitment period the expected number of subjects could not be
    included in the trial."	['Insufficient_Enrollment']	['Neutral']
"Principal Investigator (central contact) has left the organization and requests the study be
    terminated"	['Study_Staff_Moved']	['Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
Study was cancelled	['Invalid_Reason']	['Invalid_Reason']
Poor enrollment and infeasibility of ever reaching the necessary sample size	['Insufficient_Enrollment']	['Neutral']
Design Problem	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
classified by the IRB as non human subjects research	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
"Before starting the recruitment process, new data from literature were available. The
    investigators considered that this study was no longer needed."	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
"Futility & potential safety concern (increased early mortality in the HS/HSD arms for those
    with no PRBC in 1st 24 hr, post-randomization subgp)"	['Safety_Sideeffects', 'Negative']	['Safety_Sideeffects', 'Negative']
Insufficient number of interested potentital subjects	['Insufficient_Enrollment']	['Neutral']
difficulty to include patients	['Insufficient_Enrollment']	['Neutral']
We obtained the final results due to the interim analysis.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
This study was terminated due to low accrual.	['Insufficient_Enrollment']	['Neutral']
Concerns regarding neonatal data	['Negative']	['Negative']
Business decision	['Business_Administrative']	['Possibly_Negative']
Recruitment and intervention provision paused due to COVID-19 situation. Planned to resume.	['Covid19']	['Neutral']
Due to low accrual rate	['Insufficient_Enrollment']	['Neutral']
currently postponed	['Invalid_Reason']	['Invalid_Reason']
Withdrawn due to lack of recruitment	['Insufficient_Enrollment']	['Neutral']
"The study was terminated prematurely on May 18, 2012 due to slow enrollment. The study was not
    terminated due to any safety issues or concerns."	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Inadequate patient recruitment	['Insufficient_Enrollment']	['Neutral']
Substantial benefit was observed in the active treatment group	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Stage 1 accrual completed. Study did not proceed to Stage 2 accrual.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Futility	['Negative']	['Negative']
Correction of inspection findings	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Study enrollment was terminated due to inability to recruit participants	['Insufficient_Enrollment']	['Neutral']
Efficacy	['Negative']	['Negative']
Due to the COVID-19, the study has been suspended since November 2020	['Covid19']	['Neutral']
Slow enrollment as a result of the rapid flattening of the curve of COVID-19 cases in Greece	['Covid19']	['Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
recruitment problems	['Insufficient_Enrollment']	['Neutral']
never started	['Invalid_Reason']	['Invalid_Reason']
Other drugs others studies	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
PI initiated closure due to limited clinical resources and lack of participation.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Funding withdrawn; study closed due to lack of accrual.	['Business_Administrative']	['Possibly_Negative']
Funding	['Business_Administrative']	['Possibly_Negative']
could not come to budget agreement	['Business_Administrative']	['Possibly_Negative']
too slow enrollment	['Insufficient_Enrollment']	['Neutral']
Study not selected to receive funding	['Business_Administrative']	['Possibly_Negative']
Recruiting problems	['Insufficient_Enrollment']	['Neutral']
withdrawn by sponsor	['Business_Administrative']	['Possibly_Negative']
Sponsor decision to discontinue study.	['Business_Administrative']	['Possibly_Negative']
"UTSW Family Medicine refused to comply with agreement to implement study after department head
    left university. Attempts to implement elsewhere failed."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Grant funding ended for pilot work	['Business_Administrative']	['Possibly_Negative']
Difficulty getting labs in this setting. After pilot study, this study was not continued.	['Insufficient_Enrollment', 'Study_Design', 'Another_Study']	['Neutral', 'Neutral', 'Neutral']
Enrollment closed due to impending graduation from Fellowship	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Terminated: recruiting or enrolling participants has halted.	['Invalid_Reason']	['Invalid_Reason']
Sponsor decision based on portfolio prioritization	['Business_Administrative']	['Possibly_Negative']
Study was never initiated.	['Invalid_Reason']	['Invalid_Reason']
Per PI	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
Unanticipated delays.	['Logistics_Resources']	['Neutral']
Lack of consistent reference devices	['Logistics_Resources']	['Neutral']
not able to meet enrollment	['Insufficient_Enrollment']	['Neutral']
"The patient population (CLL & SLL) was included in another ongoing study involving NHL
    patients."	['Negative', 'Another_Study']	['Negative', 'Neutral']
insuffisient recruitment	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
No funding for study	['Business_Administrative']	['Possibly_Negative']
Sponsor decision to terminate	['Business_Administrative']	['Possibly_Negative']
Drug not available.	['Logistics_Resources']	['Neutral']
Study closed early with no enrollment.	['Insufficient_Enrollment']	['Neutral']
Company decision to discontinue trial	['Business_Administrative']	['Possibly_Negative']
Subject no longer able to participate in this single pt study.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Increasing off-label practice of IV ketamine administration for treatment-resistant depression.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Temporarily suspended due to Covid 19	['Covid19']	['Neutral']
"Due to changes in scanning procedure, and infeasible biopsy and baseline imaging, the trial
    closed for poor accrual and inability to follow patients."	['Insufficient_Enrollment']	['Neutral']
Researchers left the institute	['Study_Staff_Moved']	['Neutral']
The 20070201 study was terminated based on evaluation of Palifermin solid tumor data.	['Negative', 'Another_Study']	['Negative', 'Neutral']
"The trainee for whom I designed the study did not begin enrollment and has left our
    institution."	['Study_Staff_Moved']	['Neutral']
Slow accrual onto the study	['Insufficient_Enrollment']	['Neutral']
Inability to recruit required sample size.	['Insufficient_Enrollment']	['Neutral']
"The trial has been terminated due to an estimated low probability of clinical benefit based on
    limited anti-leukemic effects observed in safety run-in (Part 1)"	['Negative']	['Negative']
Sponsor decision was made not to initiate and to focus on other initiatives	['Business_Administrative']	['Possibly_Negative']
PI no longer with the University	['Study_Staff_Moved']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Per PI instruction.	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
Sponsor support and funding was terminated due to pandemic	['Business_Administrative']	['Possibly_Negative']
Lapse in study funding.	['Business_Administrative']	['Possibly_Negative']
Not enough enrollment to determine efficacy	['Insufficient_Enrollment', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
"Unable to recruit - multiple reasons.- inclusion/exclusion criteria too strict was th emain
    reason."	['Insufficient_Enrollment']	['Neutral']
Study never started at our site Funding issue	['Business_Administrative']	['Possibly_Negative']
New Safety Information	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Withdrawn by the study sponsor.	['Business_Administrative']	['Possibly_Negative']
No Participants Enrolled	['Insufficient_Enrollment']	['Neutral']
Low accrual combined with expiration of study drug	['Insufficient_Enrollment']	['Neutral']
early stopping rule	['Negative']	['Negative']
1st two cohorts provided the required data, therefore 3rd cohort was not deemed necessary	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
The production of the device used in this study has been suspended.	['Interim_Analysis', 'Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
To be confirmed	['Invalid_Reason']	['Invalid_Reason']
Diffiult patient recruitment	['Insufficient_Enrollment']	['Neutral']
The primary outcome has been reached.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
No recruitment (Feasibility study).	['Insufficient_Enrollment']	['Neutral']
This study was closed early due to poor accrual.	['Insufficient_Enrollment']	['Neutral']
Funding constraints	['Business_Administrative']	['Possibly_Negative']
low enrollment	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
No patients accrued.	['Insufficient_Enrollment']	['Neutral']
Study terminated due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
After IRB review, this study is no longer considered a clinical trial	['Regulatory', 'Invalid_Reason', 'Negative']	['Neutral', 'Invalid_Reason', 'Negative']
Study shut-down in 12/2010 when NeoPharm merged with Insys.	['Business_Administrative']	['Possibly_Negative']
it was not possible to recruit any patient in the study	['Insufficient_Enrollment']	['Neutral']
Low recruitment and competing studies have published.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Low enrollment, sponsor withdrew support for study	['Insufficient_Enrollment']	['Neutral']
Not possible due to COVID-19	['Covid19']	['Neutral']
Business decision to stop the program	['Business_Administrative']	['Possibly_Negative']
The trial was stopped for futility in view of the results of the interim analysis	['Negative']	['Negative']
"This trial was prematurely terminated on Dec 9 2010 due to safety concerns, specifically
    emerging evidence of hepatic injury."	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
not funded	['Business_Administrative']	['Possibly_Negative']
This study was COMPLETED, but no patients were enrolled.	['Invalid_Reason']	['Invalid_Reason']
No patients enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
End in funding	['Business_Administrative']	['Possibly_Negative']
IND application was not approved by the US FDA - Project was never started	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Could not find interested researchers/clinicians to complete study protocol.	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Accrual did not meet expectations. Over nearly 2 years just 4 subjects were treated on study.
    The goal of 30 subjects was not attainable."	['Insufficient_Enrollment']	['Neutral']
Commercial reasons	['Business_Administrative']	['Possibly_Negative']
The study was terminated before reaching its accrual goal due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
Investigator left the institute.	['Study_Staff_Moved']	['Neutral']
enrollment completed	['Invalid_Reason']	['Invalid_Reason']
The PI passed away.	['Study_Staff_Moved']	['Neutral']
Repros stopped the study for safety and FDA put the study on hold for safety.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
This study was terminated due to lack of efficacy	['Negative']	['Negative']
lack of materials, not moving forward	['Logistics_Resources']	['Neutral']
Revised Development Program	['Business_Administrative']	['Possibly_Negative']
Lack of funds	['Business_Administrative']	['Possibly_Negative']
Company decision; No safety or efficacy concerns (see detailed description)	['Business_Administrative']	['Possibly_Negative']
Not a Clinical Trial study	['Invalid_Reason']	['Invalid_Reason']
Study BAY1128688/17472 (AKRENDO 1) was terminated early on 20 July 2018 due to hepatotoxicity	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Study NCT01656603 supersedes this study; FDA IND 6637	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study AFF006A was early terminated by the sponsor based on the results of study AFF006.	['Negative', 'Another_Study']	['Negative', 'Neutral']
See Termination Reason in Detailed Description	['No_Context']	['Invalid_Reason']
Trial screening data did not support the medical hypothesis	['Negative']	['Negative']
"A new protocol was developed to replace this protocol in 2008, with removal of ATG and
    extension of MMF duration."	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
The investigator left the organization	['Study_Staff_Moved']	['Neutral']
Terminated due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
Study terminated due to poor patient recruitment.	['Insufficient_Enrollment']	['Neutral']
"The funding agency set a mandatory deadline for the study in order to be able to conclude the
    project."	['Business_Administrative']	['Possibly_Negative']
Business decision	['Business_Administrative']	['Possibly_Negative']
Study suspended due to priority of other projects. No participants have been recruited.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
"Due to lack of clinical efficacy and lack of drug supply, trial was closed early and
    correlative studies were not pursued further."	['Logistics_Resources']	['Neutral']
Funding expired	['Business_Administrative']	['Possibly_Negative']
Per IRB COVID-19 guidance on conducting human subjects research	['Covid19']	['Neutral']
Closed by PI.	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
COVID restrictions prohibit further study activies	['Covid19']	['Neutral']
IRB Recommendation	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study did not accrue any participants, the PI has left the institution.	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Study was withdrawn owing to Sponsor decision	['Business_Administrative']	['Possibly_Negative']
PI deceased	['Study_Staff_Moved']	['Neutral']
Alternate study projected to assess imaging endpoints versus clinical endpoints.	['Negative', 'Another_Study']	['Negative', 'Neutral']
The development program has been terminated	['Business_Administrative']	['Possibly_Negative']
No enrollment	['Insufficient_Enrollment']	['Neutral']
toxicity (protocol amendment under approval)	['Study_Design']	['Neutral']
Lack of Subject Recruitment	['Insufficient_Enrollment']	['Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
The original PI, Alexander Neumeister, left NYULMC. No data was analyzed.	['Study_Staff_Moved']	['Neutral']
Poor Enrollment	['Insufficient_Enrollment']	['Neutral']
"Investigational Medical Device is not available and the 15 patients enrolled completed their
    1-yr follow-up per protocol"	['Logistics_Resources']	['Neutral']
Change in formulation	['Study_Design']	['Neutral']
recruitment difficult	['Insufficient_Enrollment']	['Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
The study was stoppend before recruitment start for preclinical safety finding in rats.	['Safety_Sideeffects', 'Endpoint_Met', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Change in research objectives.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Withdrawn for poor accrual	['Insufficient_Enrollment']	['Neutral']
"Completion of study in orig timeframe not feasible considering evolving treatments for MM in
    US."	['Study_Design']	['Neutral']
Limited study funding	['Business_Administrative']	['Possibly_Negative']
Not enough recruitment	['Insufficient_Enrollment']	['Neutral']
Difficulty in downloading and saving data from the oximetry machine.	['Logistics_Resources']	['Neutral']
The FDA has approved Kuvan (BH4) as a therapeutic agent for phenylketonuria	['No_Context', 'Regulatory', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Study halted due to lack of funding	['Business_Administrative']	['Possibly_Negative']
Difficulties of recrutment	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Study was never submitted to the IRB & never opened. PI is leaving institution.	['Study_Staff_Moved']	['Neutral']
insufficient resource for recruitment	['Insufficient_Enrollment']	['Neutral']
unfortunately lacked manpower to carry out the study	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Approval denied by national ethical committee of Burkina Faso	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
"Virtual/telephone appointments for patients due to Covid restrictions have halted this
    research. We may resume when we have the resources, however the current plan is to publish the
    data we have so far."	['Covid19']	['Neutral']
Study was withdrawn due to administrative reasons	['Business_Administrative']	['Possibly_Negative']
ECOG will not proceed with activation	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Funding not currently active	['Business_Administrative']	['Possibly_Negative']
"We randomized 18 patients, but was impossible to measure adrenomedullin in Brazil. However, we
    analysed some interesting clinical and laboratorial results."	['Interim_Analysis', 'Logistics_Resources', 'Endpoint_Met']	['Neutral', 'Neutral', 'Neutral']
Inconsistent treatment benefit	['Negative']	['Negative']
No data have been obtained at all in this time.	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Interim analysis failed to show efficacy benefit	['Negative']	['Negative']
Intervention did not appear to be effective in most enrolled patients.	['Negative']	['Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
An six-month follow-up was completed after the treatment	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Due to operational changes at the participating agency.	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Business Decision	['Business_Administrative']	['Possibly_Negative']
The Sponsor elected to discontinue the study prematurely due to business reasons	['Business_Administrative']	['Possibly_Negative']
The study has been terminated due to lack of subject enrollment.	['Insufficient_Enrollment']	['Neutral']
Study is permanently closed to enrollment	['Insufficient_Enrollment']	['Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
"The study was terminated by Spiraur (original sponsor). Efforts were made to contact the
    PI/study team members, but were unsuccessful."	['Business_Administrative']	['Possibly_Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Drug manufacturer ceased operations	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Lack of participants	['Insufficient_Enrollment']	['Neutral']
due to lack of efficacy	['Negative']	['Negative']
closed due to lack of availability of vaccine	['Logistics_Resources']	['Neutral']
Interim analysis of data failed to meet primary endpoint.	['Negative']	['Negative']
The development program has been terminated	['Business_Administrative']	['Possibly_Negative']
"Study has now been terminated due to changes in project strategy. Current available data will
    be analysed and reported in a synoptic study report."	['Invalid_Reason']	['Invalid_Reason']
Study discontinued following 57 subjects enrolled over 2 years	['Insufficient_Enrollment']	['Neutral']
Recruitment for study has been suspended due to Covid-19.	['Covid19']	['Neutral']
funding withdrew	['Business_Administrative']	['Possibly_Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
marginal statistical significance	['Negative']	['Negative']
The research project has been cancelled before any participants were enrolled.	['Invalid_Reason']	['Invalid_Reason']
Failure to secure adequate funding	['Business_Administrative']	['Possibly_Negative']
early termination due to Sponsor decision (slow recruitment)	['Insufficient_Enrollment']	['Neutral']
An interim analysis showed that nitric oxide patches are not enough effective	['Negative']	['Negative']
unable to enroll participants	['Insufficient_Enrollment']	['Neutral']
Phase 2 portion not initiated, no longer pursuing ovarian cancer indication	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"A decision to stop the study was made by the site and GSK project team based on pre-defined
    stopping criteria in the protocol"	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Covid-19	['Covid19']	['Neutral']
Management decision	['Business_Administrative']	['Possibly_Negative']
No eligible subjects identified. Study closed with IRB.	['Insufficient_Enrollment']	['Neutral']
"Intervention includes tasks that encourage participants to interact with the social environment
    which is unethical due to the outbreak of COVID-19."	['Covid19']	['Neutral']
Funding no longer available	['Business_Administrative']	['Possibly_Negative']
Temporarily suspended due to Pandemic.	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
"Change in literature to suggest at least 6 weeks of initial elimination is necessary to see
    decrease in eosinophil count."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
logistics recruitment	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
study was stopped du to of patient lack	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Funding ended at the end of 2016	['Business_Administrative']	['Possibly_Negative']
low recruitment rate and high rate of loss-to-followup	['Insufficient_Enrollment']	['Neutral']
"Lack of resources to complete the study. Descriptive statistics for the outcome measures
    collected are provided."	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
There were difficulties meeting the enrollment goal within stipulated time frames.	['Insufficient_Enrollment']	['Neutral']
PI left institution--only 8 subjects were enrolled.	['Study_Staff_Moved']	['Neutral']
Poor enrollment due to the introduction of immunotherapy	['Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral']
Due to futility due to lower than expected recruitment	['Insufficient_Enrollment']	['Neutral']
Cost	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Failure to recruit.	['Insufficient_Enrollment']	['Neutral']
Terminated early dt to acquisition of Sponsor and change in corporate priorities	['Business_Administrative']	['Possibly_Negative']
Study was terminated base on Sponsor's decision.	['Business_Administrative']	['Possibly_Negative']
Insufficient funding to complete total projected enrollment	['Business_Administrative']	['Possibly_Negative']
Study team left institution; no one remaining to finish study	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Inadequate subject accrual	['Insufficient_Enrollment']	['Neutral']
The trial closed early due to poor accrual.	['Insufficient_Enrollment']	['Neutral']
Difficult for recruiting	['Insufficient_Enrollment']	['Neutral']
"It was determined that the study was not appropriate for demonstrating therapeutic benefit in
    the cardiopulmonary bypass patient population."	['Negative']	['Negative']
Protocol design was changed so it no longer fit the description of this study.	['Study_Design']	['Neutral']
Limited clinical staff	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Terminated because of lack of drug supply	['Logistics_Resources']	['Neutral']
Difficulty in recruiting participants	['Insufficient_Enrollment']	['Neutral']
Difficulty recruiting	['Insufficient_Enrollment']	['Neutral']
"The study was terminated based on the recommendation by the DSMB following a pre-planned
    protocol interim analysis because the endpoint was not achieved."	['Negative']	['Negative']
The overall program was terminated	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Insufficient recruitment, no additional funding available	['Business_Administrative']	['Possibly_Negative']
Study terminated prematurely due to futility	['Negative']	['Negative']
High exclusion rate	['Insufficient_Enrollment']	['Neutral']
"The scope of the program has been reduced to focus resources on studies which can potentially
    enable the registration of duvelisib."	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
poor accrual	['Insufficient_Enrollment']	['Neutral']
Low recruitment rate	['Insufficient_Enrollment']	['Neutral']
Company decision	['Business_Administrative']	['Possibly_Negative']
Problems in recruitment	['Insufficient_Enrollment']	['Neutral']
Study halted prematurely and will not resume. Subjects were seen until February 2017	['Invalid_Reason']	['Invalid_Reason']
"The patient population presenting in the department has evolved and no longer allows for the
    recruitment of the necessary number of patients."	['Insufficient_Enrollment']	['Neutral']
The research question was resolved in a metanalysis	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
"Attendance at study sites carries risk of COVID-19 infection. Non-attendance at planned study
    site visits has unacceptable study related patient safety risk."	['Covid19']	['Neutral']
funding/ enrollment	['Business_Administrative']	['Possibly_Negative']
Termination due to lack of adequate enrollment	['Insufficient_Enrollment']	['Neutral']
Adverse findings from nonclinical carcinogenicity studies.	['Covid19', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
terminated early for administrative reasons unrelated to safety or efficacy	['Business_Administrative']	['Possibly_Negative']
Corporate decision	['Business_Administrative']	['Possibly_Negative']
insufficient patient populations	['Insufficient_Enrollment']	['Neutral']
Due to poor accrual	['Insufficient_Enrollment']	['Neutral']
"The study was formally terminated given that GSK is not submitting an application for
    regulatory approval for drisapersen in Duchenne Muscular Dystrophy."	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study terminated when aripiprazole available commercially per protocol	['Logistics_Resources', 'Study_Design', 'Another_Study']	['Neutral', 'Neutral', 'Neutral']
poor recruitment	['Insufficient_Enrollment']	['Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
"Patient pathway has become infeasible due to pressure for shorter hospital stays. Not enough
    inclusions."	['Insufficient_Enrollment']	['Neutral']
Sponsor discontinued development of CO-1686 for NSCLC	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Accrual goal met for cohort 4	['Invalid_Reason']	['Invalid_Reason']
Drug not available	['Logistics_Resources']	['Neutral']
New research priorities	['Business_Administrative']	['Possibly_Negative']
Feasibility	['Logistics_Resources']	['Neutral']
Insufficient enrollment.	['Insufficient_Enrollment']	['Neutral']
Study was terminated due to lack of accrual.	['Insufficient_Enrollment']	['Neutral']
"While the clinical need for and the scientific merit remain valid, this regulated drug trial
    was not feasible logistically due to limited funds."	['Business_Administrative']	['Possibly_Negative']
Study was terminated early due to lack of efficacy.	['Negative']	['Negative']
Funding for study fell through	['Business_Administrative']	['Possibly_Negative']
Siemens Management decided not to release the product in the USA.	['Business_Administrative']	['Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
Study terminated due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Grant not funded, study will not launch	['Business_Administrative']	['Possibly_Negative']
Unable to begin study due to funding. PI has left organization	['Business_Administrative']	['Possibly_Negative']
Difficulty in patient recruiting	['Insufficient_Enrollment']	['Neutral']
lack of patients	['Insufficient_Enrollment']	['Neutral']
Loss of funding.	['Business_Administrative']	['Possibly_Negative']
Due to administrative reasons	['Business_Administrative']	['Possibly_Negative']
Loss of department staff and COVID	['Covid19']	['Neutral']
"The investigator's workplace and department were changed so that the study could no longer be
    carried out."	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Enrollment closed	['Insufficient_Enrollment']	['Neutral']
Project was cancelled before any participants were enrolled.	['Invalid_Reason']	['Invalid_Reason']
PI decision due to under accrual.	['Insufficient_Enrollment']	['Neutral']
Study terminated due to slower than anticipated enrollment.	['Insufficient_Enrollment']	['Neutral']
sponsor funding	['Business_Administrative']	['Possibly_Negative']
others	['Covid19', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Minimal efficacy of maraviroc alone was found in preliminary data analysis of another study.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Terminated due to COVID-19	['Covid19']	['Neutral']
Slow accrual and Bayer decision not to extend the contract.	['Insufficient_Enrollment']	['Neutral']
Inability to obtain grant funding	['Business_Administrative']	['Possibly_Negative']
Low feasibility	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
difficult recruitment	['Insufficient_Enrollment']	['Neutral']
Business Decision	['Business_Administrative']	['Possibly_Negative']
"The study was terminated because the first Phase 3 did not demonstrate efficacy on the
    co-primary endpoints. The known safety profile remained unchanged."	['Negative']	['Negative']
Site did not enroll any patients to the study.	['Insufficient_Enrollment']	['Neutral']
We were unable to continue field activities due to COVID-19	['Covid19']	['Neutral']
"This study is being discontinued based on data suggesting that none of the doses tested
    demonstrated both glycemic & body fluid benefits vs. the comparitor"	['Negative']	['Negative']
Investigator left Institution.	['Study_Staff_Moved']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Supporting company withdrew interest	['Business_Administrative']	['Possibly_Negative']
"Patient enrollment was stopped prior to completion of the study in order to re-evaluate the
    dosing regimen."	['Study_Design']	['Neutral']
Lack of efficacy in combination.	['Negative']	['Negative']
The PI was ended her work in the hospital and no replacement was found.	['Study_Staff_Moved']	['Neutral']
The PI is leaving MSK.	['Study_Staff_Moved']	['Neutral']
No patients enrolled; Executive Committee Decision;Feasibility of recruitment	['Insufficient_Enrollment']	['Neutral']
Unable to recruit participants	['Insufficient_Enrollment']	['Neutral']
New departmental administration, loss of key study faculty	['Logistics_Resources', 'Study_Staff_Moved', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
"Unworkable. This study had several PIs and attempted several avenues of recruitment. Still were
    only able to recruit 34 out of the 120 needed."	['Insufficient_Enrollment']	['Neutral']
No sites identified with IRB approval	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
PI is leaving the university.	['Study_Staff_Moved']	['Neutral']
low enrollment	['Insufficient_Enrollment']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
sufficient data collected for significant conclusion	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Difficulty in recruiting subjects for the trial.	['Insufficient_Enrollment']	['Neutral']
due to absence of evidence of clinical activity up to toxic doses	['Negative']	['Negative']
We originally had a collaboration with a PI but he has left the University.	['Study_Staff_Moved']	['Neutral']
"Due to the wide availability of the drug in clinical practice, it was impossible to recruit
    adequate numbers for scientific power."	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Due to projected low enrollment, it has decided not to move forward with the study.	['Insufficient_Enrollment']	['Neutral']
We could not obtain proper funding to complete this study.	['Business_Administrative']	['Possibly_Negative']
No subjects were enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Study cancelled	['Invalid_Reason']	['Invalid_Reason']
COVID-19 increased risk of participation	['Covid19']	['Neutral']
Funding not secured	['Business_Administrative']	['Possibly_Negative']
Unable to recruit sufficient local qualifying volunteers for study.	['Insufficient_Enrollment']	['Neutral']
PI left Washington University	['Study_Staff_Moved']	['Neutral']
See Detailed Description.	['No_Context']	['Invalid_Reason']
Practice change created contamination of usual care arm	['Study_Design']	['Neutral']
Funding Issues	['Business_Administrative']	['Possibly_Negative']
Management decision to suspend the study due to recruitment issues	['Business_Administrative']	['Possibly_Negative']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Staffing difficulties to run project.	['Logistics_Resources']	['Neutral']
Repair of minor software glitches	['Logistics_Resources']	['Neutral']
Funding unavailable	['Business_Administrative']	['Possibly_Negative']
unable to meet recruitment goals	['Insufficient_Enrollment']	['Neutral']
"From the interim analysis resulted that more than 1000 patients were required to demonstrate a
    significant difference between the 2 treatments."	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Due to slow accrual the supllier of BKM120 asked we cease further enrollment.	['Insufficient_Enrollment']	['Neutral']
Recruitment problems	['Insufficient_Enrollment']	['Neutral']
patient enrollment was failed.	['Insufficient_Enrollment']	['Neutral']
All the patients who had been targeted were registered.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Insufficient Accrual	['Insufficient_Enrollment']	['Neutral']
"The first cohort of 6 subjects that has been enrolled is being analyzed and evaluated on all
    safety parameters as described in the study protocol."	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
"The comparator product was withdrawn from the brazilian market not being possible to conduct
    the design regarding initially planned."	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
"Withdrawn due to difficulties in to recruiting due to competing studies, changing treatment
    practices, unavailability of eligible study population"	['Insufficient_Enrollment']	['Neutral']
New study design will be made	['Study_Design']	['Neutral']
sufficient data collected for analysis	['Invalid_Reason']	['Invalid_Reason']
Budgetary and operational issues	['Business_Administrative']	['Possibly_Negative']
No longer viable	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
"The study was terminated prematurely after an interim analysis for futility. The study did not
    provide any evidence for efficacy of BAF312 in dermatomyositis."	['Negative']	['Negative']
IRB application withdrawn	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
The study was not funded.	['Business_Administrative']	['Possibly_Negative']
objective of the study demonstrated by other research teams	['Negative', 'Another_Study']	['Negative', 'Neutral']
Recruitment issues	['Insufficient_Enrollment']	['Neutral']
Drug not available.	['Logistics_Resources']	['Neutral']
Terminated due to safety concerns	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Slow accrual, loss of sponsor support	['Insufficient_Enrollment']	['Neutral']
"In January 2021 Novartis acquired Cadent Therapeutics. As part of a pipeline reassessment, the
    Synchrony-1 trial will not proceed as initially scheduled."	['Business_Administrative']	['Possibly_Negative']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Early termination due to lesser accrual, and data analysis not done.	['Insufficient_Enrollment']	['Neutral']
The study has been withdrawn because of lack of funding	['Business_Administrative']	['Possibly_Negative']
Study was terminated due to low recruitment rates	['Insufficient_Enrollment']	['Neutral']
Lack of Efficacy	['Negative']	['Negative']
No longer clinically relevant	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Omegaven is now FDA approved.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
"Results of an interim analysis and a hardly ongoing enrolment in the last 10 months in all six
    participating centres"	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Difficulties with including patients	['Insufficient_Enrollment']	['Neutral']
Slow recruitment rate	['Insufficient_Enrollment']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
inadequate enrollement	['Insufficient_Enrollment']	['Neutral']
"Form 46 from DCGI for the manufacturing & commercial marketing of Stempeucel directs
    Stempeutics to conduct PMS study. Hence this study is being terminated."	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
No safety issues. Low enrollment secondary to negative stroke studies 2013	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Study_Design']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Lactobacillus reuteri (Gastrus) was not anymore available in the region	['Logistics_Resources']	['Neutral']
Dose escalation completed; Sponsor decision	['Business_Administrative']	['Possibly_Negative']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Combination of departure of Investigator from one site and slow recruitment rate	['Insufficient_Enrollment']	['Neutral']
Unable to enroll patients, no longer at institution.	['Insufficient_Enrollment']	['Neutral']
no enrollment	['Insufficient_Enrollment']	['Neutral']
Nonapplicable clinical trial	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"""We were unable to enroll any subjects in this study due to lack of interest."""	['Insufficient_Enrollment']	['Neutral']
no reponse of the of the treatment	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
this study was determined by IRB not to be humans subjects research	['Regulatory', 'Invalid_Reason', 'Negative']	['Neutral', 'Invalid_Reason', 'Negative']
Research question was answered by Acta Anaesthesiol Scand 2012; 56: 102-109.	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Investigator decision in accordance with the promotor	['Business_Administrative']	['Possibly_Negative']
Funding expired, low recruitment	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
no one enrolled	['Insufficient_Enrollment']	['Neutral']
Resident working on this study left our department	['Study_Staff_Moved']	['Neutral']
"The study was terminated after the European Medicines Evaluation Agency recommended to suspend
    the marketing authorisation of Raptiva in the European Union"	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Interim review indicated that the dose selected was too high for diabetics	['Study_Design', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Recruitment and enrollment currently suspended due to COVID-19.	['Covid19']	['Neutral']
"The study was terminated due to slow enrollment and failure to identify adequate patients that
    met entry criteria."	['Insufficient_Enrollment']	['Neutral']
"The study was prematurely discontinued due to a business-related decision on 09-FEB-2016. The
    decision to terminate the trial was based on the overall results."	['Business_Administrative']	['Possibly_Negative']
PI changed institutions	['Study_Staff_Moved']	['Neutral']
"ALS-2158 showed insufficient antiviral activity to warrant proceeding with further clinical
    development."	['Negative']	['Negative']
Problems with the software intervention, PI finished training and left UCSF.	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
"The research equipment was not available for more than a year after the study was submitted. A
    new trial was being done during delivery of patients that competed with the study."	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Study deemed non-essential under COVID pandemic,	['Covid19']	['Neutral']
poor intermediate-term results	['Negative']	['Negative']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Per sponsor and PI institution discussions	['Business_Administrative']	['Possibly_Negative']
"Enrollment would not have been met prior to the end of the pneumonia season. Termination is
    based on slow enrollment and not related to safety or efficacy."	['Insufficient_Enrollment']	['Neutral']
Reformulation of test compound	['Study_Design']	['Neutral']
Numbe of eligible patients has been decreased over time.	['Insufficient_Enrollment']	['Neutral']
Company have withdrawn the product	['Business_Administrative']	['Possibly_Negative']
"The study was terminated due to company restructuring and changes in drug development
    priorities."	['Business_Administrative']	['Possibly_Negative']
Successful completion of Part A. Company decision to end early.	['Business_Administrative']	['Possibly_Negative']
Restructuring Cell Lab	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"No statistical analysis was performed as only one subject was treated with MDGN201 TARGTEPO due
    to the Sponsor's decision to discontinue study."	['Negative']	['Negative']
Last subject enrolled experienced bradycardia; study was terminated by Sponsor.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Due to unfixable problem in the research machine we had to withdrawn from the study	['Logistics_Resources']	['Neutral']
Phase 3 trial RTB-101-204 study did not meet its primary endpoint	['Negative', 'Another_Study']	['Negative', 'Neutral']
Funder withdrawn funding.	['Business_Administrative']	['Possibly_Negative']
Equipment used for metabolic testing is no longer serviced and/or supported by the company.	['Logistics_Resources']	['Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Protocol Deviation	['Study_Design']	['Neutral']
"Principal investigator (M.K.) left for another workplace. Patient recruitment more difficult
    than expected."	['Insufficient_Enrollment']	['Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Due to COVID-19	['Covid19']	['Neutral']
Principal Investigator moved to another institution	['Study_Staff_Moved']	['Neutral']
Halted prematurely due to low recruitment rate.	['Insufficient_Enrollment']	['Neutral']
79% participant retention after 1 year	['Insufficient_Enrollment']	['Neutral']
Not able to recruit the number required and due to financial difficulty to pay for intralipids	['Business_Administrative']	['Possibly_Negative']
Not enough staff resource to complete study.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
PI left University and project not continued	['Study_Staff_Moved']	['Neutral']
Closed by IRB	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Recruiting problems	['Insufficient_Enrollment']	['Neutral']
Need to obtain IDE prior to commencement of study	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
This study was terminated due to lack of recruitment.	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Durability of study medications could not be guaranteed after the expire date.	['Logistics_Resources']	['Neutral']
Investigators could not identify subjects who met all inclusion criteria.	['Insufficient_Enrollment']	['Neutral']
Concern for volume depletion and electrolyte abnormalities in furosemide arm.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Device no longer available	['Covid19', 'Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Slow enrollment, feasibility issues	['Insufficient_Enrollment']	['Neutral']
PI has left institution	['Study_Staff_Moved']	['Neutral']
Interim analysis performed without efficient results	['Negative']	['Negative']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Poor Reducibility - primary endpoint measure not obtainable	['Negative']	['Negative']
Difficulty in recruitment.	['Insufficient_Enrollment']	['Neutral']
The perceived risk-benefit ratio for individuals with early active RA	['Negative']	['Negative']
"new insights have let us to expect marginal annexin targeting with a 10 minutes delay between
    reperfusion and administration of Annexin A5"	['Success', 'Endpoint_Met', 'Negative']	['Success', 'Neutral', 'Negative']
PI relocated	['Study_Staff_Moved']	['Neutral']
Technical problem	['Logistics_Resources']	['Neutral']
Sponsor decided to end long term extension phase for business reasons unrelated to safety.	['Business_Administrative']	['Possibly_Negative']
terminated	['Invalid_Reason']	['Invalid_Reason']
"State of Mass. tightened regulations for making intravenous solutions for research subjects.
    Study was withdrawn and no participants were enrolled."	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Pending end of COVID-19 pandemic	['Covid19']	['Neutral']
"The study was terminated early following assessment of the two co-primary endpoints showing the
    lack of efficacy of the study product."	['Negative']	['Negative']
Not enough resources to continue the study especially with Covid-19	['Covid19']	['Neutral']
DSMB review at 50% recruitment, further recruitment unlikely to change result	['Negative']	['Negative']
"Company decision has been taken in light of recent demands by certain national health
    authorities"	['Business_Administrative']	['Possibly_Negative']
The PI left the Institution.	['Study_Staff_Moved']	['Neutral']
Unjustified decision of company that funded the trial.	['Business_Administrative']	['Possibly_Negative']
recruitment prematurely stopped due to a lack of eligible patients.	['Insufficient_Enrollment']	['Neutral']
30th November 2012. Please see breif summary.	['Covid19', 'No_Context']	['Neutral', 'Invalid_Reason']
"Interim review showed a statistically significant treatment effect and the DMC recommended that
    the study be stopped with ongoing follow-up of enrolled subjects"	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Completed	['Invalid_Reason']	['Invalid_Reason']
The study was terminated because Cell Genesys stopped all activities for GVAX.	['Business_Administrative']	['Possibly_Negative']
Problems recruiting patients (not willing, travel time, no respons)	['Insufficient_Enrollment']	['Neutral']
One of the study drugs was no longer available on a worldwide level.	['Logistics_Resources']	['Neutral']
Recruitment problems	['Insufficient_Enrollment']	['Neutral']
Slower than expected enrollment	['Insufficient_Enrollment']	['Neutral']
"Multiple reminders were carried out but despite these measures, the GP has not enough
    participated ."	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Patient enrollment to low to support an analysis	['Insufficient_Enrollment']	['Neutral']
Study discontinued after Part A due to Sponsor's discretion.	['Business_Administrative']	['Possibly_Negative']
Outbreak of COVID-19.	['Covid19']	['Neutral']
No Patients enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Difficulty identifying eligible candidates	['Insufficient_Enrollment']	['Neutral']
Study originally suspended pending a protocol amendment but study now terminated.	['Study_Design']	['Neutral']
insufficient funds and participants, thus terminated	['Business_Administrative']	['Possibly_Negative']
Enrollment rate	['Insufficient_Enrollment']	['Neutral']
Just one subject enrolled in this trial during one and a half years.	['Insufficient_Enrollment']	['Neutral']
no difference found between two groups in a preliminary analysis	['Negative']	['Negative']
Due to slow enrollment and lack of funding the study was terminated prior to completion.	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Trial was never activated	['Invalid_Reason']	['Invalid_Reason']
slow patient enrollment	['Insufficient_Enrollment']	['Neutral']
Subject withdrew consent to participate	['Business_Administrative']	['Possibly_Negative']
Higher than expected rate of acute rejection	['Negative']	['Negative']
Lack of Accrual	['Insufficient_Enrollment']	['Neutral']
Loss of funding	['Business_Administrative']	['Possibly_Negative']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Lack of funding, never moved into the phase II portion that was originally planned.	['Business_Administrative']	['Possibly_Negative']
study terminated early due to change in Sponsorship	['Business_Administrative']	['Possibly_Negative']
Sponsor's decision to terminate	['Business_Administrative']	['Possibly_Negative']
Slower than anticipated accrual	['Insufficient_Enrollment']	['Neutral']
unable to enroll patients	['Insufficient_Enrollment']	['Neutral']
See Detailed Description.	['No_Context']	['Invalid_Reason']
Study suspended temporarily due to coronavirus pandemic.	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
"CALGB 81003 closed about a week after it was activated because of withdrawal of support. No
    patients were registered on this study."	['Business_Administrative']	['Possibly_Negative']
1st years Enrollment #s showed study was not going to meet criteria randomization.	['Insufficient_Enrollment']	['Neutral']
No subjects enrolled at site.	['Insufficient_Enrollment']	['Neutral']
Withdrawal of funding by CR UK due to poor recruitment	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Sponsor decision to stop enrollment.	['Business_Administrative']	['Possibly_Negative']
"Law agreement between Triggerfish signal and GAT IOP during both sessions. However, an increase
    in the Triggerfish signal was observed during jogging phase."	['Safety_Sideeffects', 'Regulatory', 'Endpoint_Met']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Due to Protocol AC-055B201 (MUSIC) not meeting it's primary end point	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Change in guidelines by the manufacturer.	['Regulatory', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
The Study had to stop due to organizational changes in Nordsjllands Hospital	['Business_Administrative']	['Possibly_Negative']
TRS probe performance does not meet primary outcome data requirements	['Negative']	['Negative']
"Interim Goals met. Decision made to terminate in favor of completing the study as a second
    protocol in the future."	['Invalid_Reason', 'Study_Design', 'Another_Study']	['Invalid_Reason', 'Neutral', 'Neutral']
Failure to accrue	['Insufficient_Enrollment']	['Neutral']
FDA Clinical Hold as of 12/21/07 due to safety concerns	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Study terminated due to low enrollment	['Insufficient_Enrollment']	['Neutral']
Main objective of study was met. Further recruitment was difficult.	['Insufficient_Enrollment']	['Neutral']
To focus on STRIDENT intervention studies as this study population is heterogenous	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"Due to low enrollment the decision was made to terminate study prior to final data collection
    for any individual."	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Strategic business decision was made to terminate the program. There were no safety concerns.	['Business_Administrative']	['Possibly_Negative']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Medtronic shift in strategic direction for study device	['Business_Administrative']	['Possibly_Negative']
"Insufficient scientific evidence that solanezumab would likely demonstrate a meaningful benefit
    to participants with prodromal AD as defined by study protocol."	['Negative']	['Negative']
Lack of qualified participants	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
"Study suspended due to COVID-19 restrictions. Study will be resumed once plans for appropriate
    social distancing are in place."	['Covid19']	['Neutral']
Recruitement too slow	['Insufficient_Enrollment']	['Neutral']
Unavailability of the clinical team	['Logistics_Resources']	['Neutral']
Due to recent findings relating MRI contrast to nephrogenic systemic fibrosis	['Negative', 'Another_Study']	['Negative', 'Neutral']
Part A completed successfully 22 July 2010, Part B will be separate PET study	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
not enough participants	['Insufficient_Enrollment']	['Neutral']
The researcher and principal investigator working on this study left the institution.	['Study_Staff_Moved']	['Neutral']
Slow recruitment; Study was terminated for futility reasons	['Negative']	['Negative']
"STEBA decided to develop WST11 that is soluble in aqueous solutions. The property of WST 11
    make it safer and better candidate for therapeutic applications."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
logistics	['Logistics_Resources']	['Neutral']
The MRI company forbidded additional scans with endorectal colil in this machine	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
not enough enrollment	['Insufficient_Enrollment']	['Neutral']
Study cancelled - no results	['Invalid_Reason', 'Negative', 'Another_Study']	['Invalid_Reason', 'Negative', 'Neutral']
Based on feedback from FDA	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
No surgeon available to perfrom gastroscopy	['Logistics_Resources']	['Neutral']
This study was terminated regarding to slow enrollment.	['Insufficient_Enrollment']	['Neutral']
The assistant who was going to do this study moved to a different med center	['Study_Staff_Moved']	['Neutral']
Lack of accrual and funding expires in June, 2014.	['Business_Administrative']	['Possibly_Negative']
Caelyx was not available anymore	['Logistics_Resources']	['Neutral']
The company will design a new study	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
failure to recruit	['Insufficient_Enrollment']	['Neutral']
Change in study design	['Study_Design']	['Neutral']
The study was stopped due to lack of recruitment.	['Insufficient_Enrollment']	['Neutral']
Funding/grant expired.	['Business_Administrative']	['Possibly_Negative']
Investigator left the Institution	['Study_Staff_Moved']	['Neutral']
Data was not sufficiently complete and reliable for analysis (retrospective chart research)	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Futility	['Negative']	['Negative']
Poor accrual; did not enter phase 2	['Insufficient_Enrollment']	['Neutral']
Delay in site selection and recruitment.	['Insufficient_Enrollment']	['Neutral']
Study discontinued by DSMB due to loss of equipoise.	['Logistics_Resources']	['Neutral']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
Investigator has left institution	['Study_Staff_Moved']	['Neutral']
Not enough patient	['Insufficient_Enrollment']	['Neutral']
Recruitment difficulty	['Insufficient_Enrollment']	['Neutral']
The sponsor withdrew support for the study before any patients were enrolled.	['Business_Administrative']	['Possibly_Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Terminate the study because it is difficult to recruit the subject.	['Insufficient_Enrollment']	['Neutral']
Limitaiotn of financial support	['Business_Administrative']	['Possibly_Negative']
Sponsor decision to temporarily suspend enrollment while the program is reassessed.	['Business_Administrative']	['Possibly_Negative']
"FDA approval of supplementation to IDE/protocol amendment to terminate subject long term follow
    up"	['Study_Design']	['Neutral']
The recruitment rate was very poor. The study was stopped by amendment on 2015-08-28.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
recruiting difficulties	['Insufficient_Enrollment']	['Neutral']
"Due to a change in the research priorities of the principal investigator in combination with
    low subject interest."	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Change in drug product development strategy	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Poor accrual and suspension of head and neck committee	['Insufficient_Enrollment']	['Neutral']
too complicated recruitment	['Insufficient_Enrollment']	['Neutral']
Problem with drug supply	['Logistics_Resources']	['Neutral']
Terminated by sponsor.	['Business_Administrative']	['Possibly_Negative']
Study not initiated, no participants enrolled.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Difficulty enrolling patients	['Insufficient_Enrollment']	['Neutral']
Lack of Funds	['Business_Administrative']	['Possibly_Negative']
Project end after 3 years; prolongation was rejected	['Invalid_Reason']	['Invalid_Reason']
In adequate enrollment	['Insufficient_Enrollment']	['Neutral']
problems recruiting patients	['Insufficient_Enrollment']	['Neutral']
Pediatric development program terminated by sponsor	['Business_Administrative']	['Possibly_Negative']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of cooperation among centers, Financial reasons	['Business_Administrative']	['Possibly_Negative']
Not enough participants	['Insufficient_Enrollment']	['Neutral']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
a result of slow accrual	['Insufficient_Enrollment']	['Neutral']
"The study was terminated with a total of 35 patients finally enrolled, due to the Sars-Cov-2
    (COVID-19) global pandemic breakout and the confinement measures considered."	['Covid19']	['Neutral']
no enrollment	['Insufficient_Enrollment']	['Neutral']
Ethical concerns with efficacy of technique.	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Study terminated due to recruitment challenges.	['Insufficient_Enrollment']	['Neutral']
Terminated early due to administrative reasons.	['Business_Administrative']	['Possibly_Negative']
recruitments issues	['Insufficient_Enrollment']	['Neutral']
PI departure, operational issues	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
No suitable case available and many techinical error	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
"Terminated is based on the availability of long-term safety and effectiveness data from the OSB
    Lead-HERo-002 study and published literature."	['Negative', 'Another_Study']	['Negative', 'Neutral']
"The drug manufacture were unable to produce liquid formulation of the IMP within a reasonable
    time frame so the funding was relinquished."	['Business_Administrative']	['Possibly_Negative']
"FDA placed a clinical hold on the Pediatric Program requiring retigabine discontinuation in
    subjects; early termination allows for timely reporting of results."	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
inability to recruit an adequate number of subjects.	['Insufficient_Enrollment']	['Neutral']
Patients would improve naturally due to weather conditions	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
The study never got funded so never started enrolling	['Business_Administrative']	['Possibly_Negative']
Low enrollment and lack of funding for study	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Closed for lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Teminated due to changes in treatment guidelines .	['Study_Design']	['Neutral']
Sufficient follow-up information obtained to support study goals	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
"We failed to recruit enough patients by regular recruitment methods (i.e., newspaper ads,
    hospital postings, radios and television ads)."	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Study is prematurely ended due to poor patient recruitment rate.	['Insufficient_Enrollment']	['Neutral']
Lack of support	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Independent biostatistician recommended early termination of the trial due to low probability
    of success."	['Negative']	['Negative']
Site unable to recruit the agreed upon number of participants	['Insufficient_Enrollment']	['Neutral']
lack of efficacy	['Negative']	['Negative']
New Principal Investigator	['Study_Staff_Moved']	['Neutral']
Business Decision; No Safety Or Efficacy Concerns. (See below)	['Business_Administrative']	['Possibly_Negative']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
"This study was withdrawn due to lack of necessary resources from the liver transplant surgical
    group."	['Logistics_Resources']	['Neutral']
funding ended	['Business_Administrative']	['Possibly_Negative']
No sufficient numbers of eligible participants	['Insufficient_Enrollment']	['Neutral']
Business objectives changed.	['Business_Administrative']	['Possibly_Negative']
Unlikely to Accrue	['Insufficient_Enrollment']	['Neutral']
COVID-19 protocol suspension per Duke	['Covid19']	['Neutral']
lack of participants	['Insufficient_Enrollment']	['Neutral']
Outcome measures are included in another, similar study.	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Sponsor's decision due to absence of demonstration of efficacy of volinanserin in primary
    insomnia with predominant sleep maintenance problems"	['Negative']	['Negative']
low recruitment	['Insufficient_Enrollment']	['Neutral']
Study never started.	['Invalid_Reason']	['Invalid_Reason']
Funding ended	['Business_Administrative']	['Possibly_Negative']
Study did not enroll any subjects	['Insufficient_Enrollment']	['Neutral']
Pharmaceutical company no longer manufactures drug	['Logistics_Resources']	['Neutral']
Protocol Modifications	['Study_Design']	['Neutral']
Business decision to close study due to slow enrollment.	['Business_Administrative']	['Possibly_Negative']
Study is on hold whilst a grant application for further funding is put together	['Business_Administrative']	['Possibly_Negative']
"The decision to withdraw the study was based on pandemic-related concerns of conducting a Phase
    IV study requiring multiple clinic visits when medication is commercially available. The study
    was withdrawn before any participants were recruited."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
This study was terminated due to the benefit-risk balance of MT-4666.	['Negative']	['Negative']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Decision to start a new study on DVT with another protocol	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Business Decision	['Business_Administrative']	['Possibly_Negative']
Early Closure due to rare patient population	['Insufficient_Enrollment']	['Neutral']
"Study terminated due to a safety event which rendered the risk-benefit profile in NASH to no
    longer be adequately favorable"	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
study was published during initial recruitment that showed no difference	['Negative']	['Negative']
lack of resources research fellow left	['Logistics_Resources']	['Neutral']
slow inclusion rate	['Insufficient_Enrollment']	['Neutral']
Recruitment suspended as of March 16, 2020 due to COVID-19 pandemic	['Covid19']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Not for safety reasons	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
Business decision	['Business_Administrative']	['Possibly_Negative']
No patient has been included in 9 months because of strict incl/excl criteria	['Regulatory', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Issues with CTM stability.	['Logistics_Resources']	['Neutral']
Difficulties with recruitment.	['Insufficient_Enrollment']	['Neutral']
d/t changes in routine modality of milk expression by electric pump.	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Drug Manufacturer withdrew support for studies not in metastatic breast cancer	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Enrollment and interactions/interventions paused due to COVID-19. Expected to resume in the
    future. This is not a suspension of IRB approval"	['Covid19']	['Neutral']
"At the planned IA for decision making, no evidence was demonstrated of MEDI8968 activity in
    reducing (HS) severity or pain over that seen with placebo."	['Negative']	['Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Resignation of Principal Investigator	['Study_Staff_Moved']	['Neutral']
Error made by local pharmacy caused mixed randomization of 20 participants	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Study not started, funding	['Business_Administrative']	['Possibly_Negative']
toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
The study team was unable to recruit and enroll subjects. The study is now closed.	['Insufficient_Enrollment']	['Neutral']
Unable to recruit	['Insufficient_Enrollment']	['Neutral']
Original drug sponsor withdrew from study, replacement sponsor not obtained.	['Business_Administrative']	['Possibly_Negative']
Delays in equipment procurement prevented the start of the study in time	['Logistics_Resources']	['Neutral']
Improper design of the trial and no participants enrolled.	['Study_Design']	['Neutral']
PI unexpectedly passed away, study future to be determined	['Study_Staff_Moved']	['Neutral']
No facility to measure volatile anaesthetic concentration in human blood sample	['Logistics_Resources']	['Neutral']
the treatment was found to be inefficient for all recruited patients	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Gabapentin increased hypopnea-apnea index in the first 8 recruited subjects.	['Safety_Sideeffects', 'Negative', 'Another_Study']	['Safety_Sideeffects', 'Negative', 'Neutral']
enrollment was terminated because of the poor recruitment rate	['Insufficient_Enrollment']	['Neutral']
Pending Pilot study results evaluation	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Will no longer be conducted. We have started a different project.	['Invalid_Reason', 'Study_Design', 'Another_Study']	['Invalid_Reason', 'Neutral', 'Neutral']
Technical problems with measure of CFU's. Outcomes published: PMID:16986483	['Logistics_Resources']	['Neutral']
Investigator no longer recruiting subjects.	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
recommendation by the study's DSMB due to insufficient data to determine efficacy.	['Negative']	['Negative']
Study was closed to enrollment before dose level one was completed.	['Insufficient_Enrollment']	['Neutral']
No objective responses were observed.	['Negative']	['Negative']
"Based on the planned interim analysis results at 50% recruitment, after IRB reviewed the
    results, further enrollment was stopped."	['Negative']	['Negative']
No subjects enrolled. Funding withdrawn by sponsor.	['Business_Administrative']	['Possibly_Negative']
My main collaborator got sick and cannot continue the project. The study ended.	['Study_Staff_Moved']	['Neutral']
The participants signed an old version of the informed consent.	['Invalid_Reason', 'Study_Design', 'Another_Study']	['Invalid_Reason', 'Neutral', 'Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Changes to study personnel.	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
No participants met inclusion criteria.	['Insufficient_Enrollment']	['Neutral']
Did not meet enrollment goals	['Insufficient_Enrollment']	['Neutral']
Failure to recruit necessary number of patients.	['Insufficient_Enrollment']	['Neutral']
Change in treatment plan for this population terminated the project	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Insufficient response rate	['Insufficient_Enrollment']	['Neutral']
Investigator closed study and left VAMC.	['Study_Staff_Moved']	['Neutral']
Withdrawn as company has shut down and filed for bankruptcy	['Business_Administrative']	['Possibly_Negative']
"The study had failed to meet the primary objective of tumor response rate at 12 weeks from
    first dose."	['Negative']	['Negative']
Poor tolerability of drug and side effects	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Only one patient was enrolled. Due to low accrual study was terminated	['Insufficient_Enrollment']	['Neutral']
"Study was stopped by the principal investigator due to nonsatisfactory clinical benefit even in
    patients treated at the highest dose (200 mg )."	['Negative']	['Negative']
Study was terminated due to the termination of tasisulam development.	['Business_Administrative']	['Possibly_Negative']
study expired	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Recruitment issues due to marketing authorization of study drug	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Newly identified safety concerns have changed the risk and benefit considerations	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
After results of other studies published : EASY study became lapsed	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Inability to recruit patients within the specified time period. No patients have been enrolled
    in the study."	['Insufficient_Enrollment']	['Neutral']
Supplier of product went into bankruptcy proceedings	['Business_Administrative']	['Possibly_Negative']
Low enrollment/PI relocated. New site couldn't reach agreement with manufacturer	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"In HPS2-THRIVE, MK-0524A did not meet the primary efficacy objective and there was a
    significant increase in incidence of some types of non-fatal SAEs."	['Negative']	['Negative']
50cc TAH-t received FDA approval March 5, 2020.	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Low Enrollment	['Insufficient_Enrollment']	['Neutral']
Insufficient enrollment potential	['Insufficient_Enrollment']	['Neutral']
Insufficient funds to complete study.	['Business_Administrative']	['Possibly_Negative']
Preliminary data did not show expected outcomes.	['Negative']	['Negative']
lack of inclusion in the study	['Insufficient_Enrollment']	['Neutral']
low numbers of participants	['Insufficient_Enrollment']	['Neutral']
Loss of funding	['Business_Administrative']	['Possibly_Negative']
"After 1 year only 2 subjects enrolled and treated thus no meaningful efficacy analyses could be
    performed."	['Negative']	['Negative']
Poor Accrual	['Insufficient_Enrollment']	['Neutral']
The study has not managed to recruit adequate number of participants.	['Insufficient_Enrollment']	['Neutral']
Never recruited any patients.	['Insufficient_Enrollment']	['Neutral']
Referral physician no longer available	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
"Cubist has reached an agreement with the FDA that enrollment in the DAP-RENSE-08-05 study can
    stop."	['No_Context', 'Regulatory', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
Lack of adequate accrual.	['Insufficient_Enrollment']	['Neutral']
Stopped due to poor recruitment	['Insufficient_Enrollment']	['Neutral']
recruitment issues	['Insufficient_Enrollment']	['Neutral']
study closed due to difficulty enrolling subjects - no results	['Insufficient_Enrollment']	['Neutral']
Low recruitement rate	['Insufficient_Enrollment']	['Neutral']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
Insufficient efficacy for this indication. The study stopped after Part B.	['Negative']	['Negative']
Low recruitment / DSMB approval to halt recruitment	['Insufficient_Enrollment']	['Neutral']
Feasibility issues	['Logistics_Resources']	['Neutral']
Difficulty in recruiting patients	['Insufficient_Enrollment']	['Neutral']
management decision; non patient safety related reason	['Business_Administrative']	['Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Terminated following the completion of ImpACT-24B study	['Negative', 'Another_Study']	['Negative', 'Neutral']
study product composition to move from liquid to solid	['Interim_Analysis', 'Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Drug unavailable	['Logistics_Resources']	['Neutral']
NO participants	['Insufficient_Enrollment']	['Neutral']
Sponsor has designed another study to replace the current study	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
The study fully enrolled and completed after last patient completed the study	['Invalid_Reason']	['Invalid_Reason']
rate of enrollment	['Insufficient_Enrollment']	['Neutral']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
loss of funding	['Business_Administrative']	['Possibly_Negative']
Company decided to stop study for reasons other than safety	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of funding and subject acuity	['Business_Administrative']	['Possibly_Negative']
Change Company strategy	['Business_Administrative']	['Possibly_Negative']
Unexpected low accrual	['Insufficient_Enrollment']	['Neutral']
Absence of inclusion criteria	['Insufficient_Enrollment']	['Neutral']
Additional research	['Negative', 'Another_Study']	['Negative', 'Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Withdrawn	['Invalid_Reason']	['Invalid_Reason']
Futility	['Negative']	['Negative']
difficulty with recruitment	['Insufficient_Enrollment']	['Neutral']
"Protocol is not adapted to cancer pancreas disease as progression is very fast and patients
    stopped the study before 1st study assessment"	['Study_Design']	['Neutral']
Sponsor request	['Business_Administrative']	['Possibly_Negative']
Similar study just got done	['Negative', 'Another_Study']	['Negative', 'Neutral']
insufficient subjects recruited in allotted time	['Insufficient_Enrollment']	['Neutral']
Funding ended	['Business_Administrative']	['Possibly_Negative']
Due to COVID-19	['Covid19']	['Neutral']
Limited resources.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Contract never executed; withdrawn by sponsor	['Business_Administrative']	['Possibly_Negative']
"Based on available data, UCB has decided to stop development of padsevonil as adjunctive
    treatment of focal-onset seizures"	['Regulatory', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Inability to obtain final specimen routinely	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Unable to enroll. Change in patient population.	['Insufficient_Enrollment']	['Neutral']
Interim analysis showed lack of efficacy	['Negative']	['Negative']
"The Co-Principal Investigator has moved and is no longer interested in continuing this study at
    this site."	['Study_Staff_Moved']	['Neutral']
"Enrollement was stopped due to a recommendation by the IDMC/FDA for a parallel clinical trial
    with TALA, where potentielly no efficancy could be determined."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study Lapsed	['Invalid_Reason']	['Invalid_Reason']
protocol not fully appropriate technical issues with EIT device	['Logistics_Resources']	['Neutral']
sponsor discontinued funding	['Business_Administrative']	['Possibly_Negative']
Lack of study staff	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
We could not get funding for study.	['Business_Administrative']	['Possibly_Negative']
Slow recruitment rate	['Insufficient_Enrollment']	['Neutral']
other project got priority	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study halted prior to enrollment of first participant	['Invalid_Reason']	['Invalid_Reason']
bad taste of Caphosol - early stop of intake by patients	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
The study was terminated due to a company decision.	['Business_Administrative']	['Possibly_Negative']
Withdrawn - no participants enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
PI left institution; project closed.	['Study_Staff_Moved']	['Neutral']
Ongoing juvenile rat toxicology studies.	['Negative', 'Another_Study']	['Negative', 'Neutral']
investigator closed study	['Invalid_Reason']	['Invalid_Reason']
The study was closed due to poor enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
No patients accrued.	['Insufficient_Enrollment']	['Neutral']
The study was finished since the University has been closed	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Participants recruitment failure	['Insufficient_Enrollment']	['Neutral']
Study was transferred to partner who will conduct under its own IND	['Business_Administrative']	['Possibly_Negative']
Terminated early due to sufficient data acquired to meet our study objectives	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
"The enrollment rate at most centers was unlikely to result in the recruitment of the planned
    sample size of 40 evaluable subjects."	['Insufficient_Enrollment']	['Neutral']
Safety Issues	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
CO2 temperature delivered revealed that warmed CO2 was not being delivered.	['Logistics_Resources']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
The study was halted prematurely as the PI was no longer an employee of UMass Medical School.	['Study_Staff_Moved']	['Neutral']
Business decision, no safety or efficacy concerns	['Business_Administrative']	['Possibly_Negative']
"Recent publications demonstrating the clinical interest in performing 68Ga-PSMA for recurrence
    detection of prostate cancer patients with biochemical relapse"	['Negative', 'Another_Study']	['Negative', 'Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
Much slower recruitment than anticipated	['Insufficient_Enrollment']	['Neutral']
"The study was closed to enrollment when it became clear that enrollment was too slow to
    complete the full enrollment target within the time frame allowed."	['Insufficient_Enrollment']	['Neutral']
There was lack of enrollment since January 2013	['Insufficient_Enrollment']	['Neutral']
Low patient recruitment	['Insufficient_Enrollment']	['Neutral']
Change in sponsor strategy	['Business_Administrative']	['Possibly_Negative']
No one consented for this study.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Slow enrollment.	['Insufficient_Enrollment']	['Neutral']
Change in drug product development strategy.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Poor efficacy (2 of 31 completing participants with H.pylori eradication)	['Negative', 'Another_Study']	['Negative', 'Neutral']
Administratively withdrawn	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Funding/material support withdrawn	['Business_Administrative']	['Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Study never officially began- currently closed with IRB.	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Devices proposed for use in the protocol no longer used by physician	['Logistics_Resources', 'Study_Staff_Moved', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Drug was no longer available	['Logistics_Resources']	['Neutral']
Withdrawn	['Invalid_Reason']	['Invalid_Reason']
"It was difficult to proceed with the study according to the protocol, the research was
    terminated early."	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
PI is leaving the Institution, IRB will close the protocol.	['Study_Staff_Moved']	['Neutral']
Investigational drugs no longer available	['Logistics_Resources']	['Neutral']
Administrative reasons.	['Business_Administrative']	['Possibly_Negative']
a feasibility study showed low recruitment and adherence	['Insufficient_Enrollment', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
The study was closed due to the slow enrollment rate.	['Insufficient_Enrollment']	['Neutral']
"The study was paused initially pending a review of the study design. The decision was then
    taken not to resume the study."	['Study_Design']	['Neutral']
"Due to the clinically and statistically significant inferior results for the D3 group following
    evaluation by the institutional review board."	['Success', 'Logistics_Resources', 'Endpoint_Met']	['Success', 'Neutral', 'Neutral']
There was to much artifact on the readings and could not be interpreted	['Logistics_Resources']	['Neutral']
The study difficulty is more serious than expected. The budget isn't enough.	['Business_Administrative']	['Possibly_Negative']
PI left the institution	['Study_Staff_Moved']	['Neutral']
Amgen determined no further need for this study.	['Business_Administrative']	['Possibly_Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Lack of efficacy of experimental treatment	['Negative']	['Negative']
"Acute COVID-19 treatments have improved significantly leading to decreased use of ventilatory
    support. This, coupled with approval of a vaccine, has changed the profile/prognosis of
    patients and led to a lack of patients with long-term hypoxia."	['Covid19']	['Neutral']
The study was terminated due to futility analysis.	['Negative']	['Negative']
"slow recruitment, evolution of investigational device, differences in healthcare models
    affecting trial"	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Preset pharmacokinetic stopping criteria met at lower doses than expected.	['Negative']	['Negative']
Recommendations of HAS have changed, the study is now useless	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Low inclusion rate	['Insufficient_Enrollment']	['Neutral']
Study withdrawn prior to patient enrollment	['Invalid_Reason']	['Invalid_Reason']
Low subject enrollment due to obseleted product.	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
"Study halted at interim analysis to allow the sponsor to focus on a new study with different
    design."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Business Decision (please see below)	['Business_Administrative']	['Possibly_Negative']
Low use of Otiprio among otolaryngologists.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Covid-19, Funding ended	['Covid19']	['Neutral']
Because no staff to consent or enroll subjects	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Investigator decision	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
"The study stopped based on Pfizer portfolio prioritization and not due to safety and/or
    efficacy concern or change in benefit:risk assessment of PF-04457845."	['Business_Administrative']	['Possibly_Negative']
IIS - PI left the institution. Subjects just followed to study completion	['Study_Staff_Moved']	['Neutral']
Due to unstalbe cell sheet quality. We didn't use this tech on patients.	['Logistics_Resources']	['Neutral']
Funding not acquired	['Business_Administrative']	['Possibly_Negative']
Study was stopped because of ineffectiveness of one investigated Drug	['Negative']	['Negative']
The sponsor declared the early termination of the study due to poor recruitment of patients.	['Insufficient_Enrollment']	['Neutral']
PRMC Administrative Disapproval - Slow accrual	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Unable to reconcile record due to age	['Logistics_Resources']	['Neutral']
an alternate plan of investigation was developed.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Study never developed due to a change in business priority.	['Business_Administrative']	['Possibly_Negative']
Terminated due to lack of efficacy	['Negative']	['Negative']
Stopped due to low enrollment. Patients will be followed up for 3 months.	['Insufficient_Enrollment']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Lack of patients with recruitment criteria	['Insufficient_Enrollment']	['Neutral']
The study was terminated because recruitment was too slow.	['Insufficient_Enrollment']	['Neutral']
"Principal Investigator resigned position with the University of Cincinnati, closing study at
    this site will reopen study in new position"	['Study_Staff_Moved']	['Neutral']
Manufacturer stopped drug development	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Due to personnel changes / departure of Dr. Chi.	['Logistics_Resources', 'Study_Staff_Moved', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Failure to recruit participants	['Insufficient_Enrollment']	['Neutral']
sponsor's decision	['Business_Administrative']	['Possibly_Negative']
Sponsor decision not to proceed with study	['Business_Administrative']	['Possibly_Negative']
Intervention was inferior in pilot trial.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Study has been terminated due to recruitment challenges in targeted area.	['Insufficient_Enrollment']	['Neutral']
Serious adverse events	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
until further notice due to COVID-19 pandemic.	['Covid19']	['Neutral']
Transferring study to another University	['Study_Staff_Moved']	['Neutral']
Withdrawn by Sponsor	['Business_Administrative']	['Possibly_Negative']
We were unable to enroll eligible subjects for the study.	['Insufficient_Enrollment']	['Neutral']
The study was terminated based on review of Phase 2 efficacy data	['Negative', 'Another_Study']	['Negative', 'Neutral']
PI left university, the grant could not be transferred, no data was collected	['Business_Administrative']	['Possibly_Negative']
PI no longer at facility.	['Study_Staff_Moved']	['Neutral']
Insufficient number of participants.	['Insufficient_Enrollment']	['Neutral']
Study has halted prematurely as we were not able to meet our target accrual.	['Insufficient_Enrollment']	['Neutral']
Terminated due to budgetary considerations and length of development.	['Business_Administrative']	['Possibly_Negative']
No further enrolled patients, Primary researcher left the institution	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
"The DSMB conducted an interim analysis on overall survival, which showed that the treatment arm
    did not demonstrate a sufficient improvement in OS vs. placebo."	['Negative']	['Negative']
Funding has been terminated for this study.	['Business_Administrative']	['Possibly_Negative']
Cannot find subjects to particpate	['Insufficient_Enrollment']	['Neutral']
Political unrest in study country	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
impossibility to find volunteers	['Insufficient_Enrollment']	['Neutral']
Lack of funds to continue and volunteer recruitment member left position	['Business_Administrative']	['Possibly_Negative']
The efficacy on CSF biomarkers failed to reach criteria for continuation of the trial	['Negative']	['Negative']
Enrollment goals not met	['Insufficient_Enrollment']	['Neutral']
No patients enrolled during 2 years	['Insufficient_Enrollment']	['Neutral']
"Before we could start the study, we realized that many of the patients were already getting
    ergocalciferol. Therefore, the study was closed."	['Safety_Sideeffects', 'Logistics_Resources', 'Endpoint_Met']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Failure to mobilize adequate CD34+ stem cells for minimum study treatment dose.	['Insufficient_Enrollment']	['Neutral']
Strategic Business Decision	['Business_Administrative']	['Possibly_Negative']
difficulty in subject recruitment	['Insufficient_Enrollment']	['Neutral']
"The study was terminated due to difficulties with finding sites and subjects willing to
    participate."	['Insufficient_Enrollment']	['Neutral']
"Overall profile of the compound does not offer significant clinical advantage to patients over
    currently available lipid lowering agents"	['Negative']	['Negative']
slow recruitment of the study subjects	['Insufficient_Enrollment']	['Neutral']
Poor accrual, patients were followed until completion of 5 yrs treatment	['Insufficient_Enrollment']	['Neutral']
"This study would be conducted by a master course student, nevertheless, she was unable to go
    forward with it."	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Covid-19	['Covid19']	['Neutral']
Study was terminated due to high heterogeneity of enrolled patients	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
An external board recommended to close the study for futility after the interin analysis	['Negative']	['Negative']
The collaborator, Genentech, stopped supplying the study drug to the site.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
recruitment problem-covid-	['Covid19']	['Neutral']
Statistical analysis of interim data showed no advantage of colchicine	['Negative']	['Negative']
"Stopped early due to inadequate separation on primary efficacy endpoint at Week 12 according to
    Interim Analysis conducted on the first 274 (50%) patients."	['Negative']	['Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Based on interim analysis for futility and given an enrolment rate almost nil	['Negative']	['Negative']
researchers delay	['Interim_Analysis', 'Logistics_Resources', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Could not enroll subjects who met the stringent inclusion/exclusion criteria.	['Insufficient_Enrollment']	['Neutral']
FB ATG is now a standard for sib allo MDS patients	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Investigator left site	['Study_Staff_Moved']	['Neutral']
technical problem	['Logistics_Resources']	['Neutral']
Closed due to slow enrollment.	['Insufficient_Enrollment']	['Neutral']
Enrollment hold	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Study has expired with the IRB	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Insufficient staff	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"The standard of care for the patient population changed and we were unable to accrue any
    longer."	['Insufficient_Enrollment']	['Neutral']
The study was stopped due to challenges recruiting eligible patients.	['Insufficient_Enrollment']	['Neutral']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Inability to recruit / logistic problems.	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
"Study was stopped due to perceived futility because the baseline pain score in first 40
    patients was too low to be able demonstrate an improvement"	['Negative']	['Negative']
Study suspended	['Invalid_Reason']	['Invalid_Reason']
Study was not activated	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Principal Investigator (Dr. Guardino) left Stanford	['Study_Staff_Moved']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Interim analysis showed no difference between groups	['Negative']	['Negative']
"Investigators and Ethic Committee endorsed early suspension of the protocol because of
    superiority and safety. For the interim analysys, the statistical methodology presented by
    Pocock was followed."	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Grant application to fund this work was not funded. We won't be posting data for this study.	['Business_Administrative']	['Possibly_Negative']
lack of study recruitment	['Insufficient_Enrollment']	['Neutral']
Requested by PI	['Study_Staff_Moved', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
"Issues with development and supply of infusion system for delivery of IMP. Prolonged approval
    process for the clinical study sNN0031-004."	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
See termination reason in detailed description	['No_Context']	['Invalid_Reason']
no patient accrual	['Insufficient_Enrollment']	['Neutral']
The study has been stopped for strategic and business reasons.	['Business_Administrative']	['Possibly_Negative']
no patient accrual	['Insufficient_Enrollment']	['Neutral']
Unable to recruit any subjects	['Insufficient_Enrollment']	['Neutral']
The study was terminated prematurely by the sponsor due to slow recruitment.	['Insufficient_Enrollment']	['Neutral']
"Because PD-1 antibodies had been proved to be a standard second-line treatment in esophageal
    cancer, the potential benefit of present intervention is under re-evaluation."	['Success', 'No_Context', 'Logistics_Resources']	['Success', 'Invalid_Reason', 'Neutral']
Study logistics proved difficult and enrollment never moved beyond the pilot phase.	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Difficulties in recruiting process	['Insufficient_Enrollment']	['Neutral']
The study was withdrawn by the sponsor.	['Business_Administrative']	['Possibly_Negative']
New method of pain control pushed by surgeons.	['Study_Design']	['Neutral']
Decided not tostart study because of unavailability of staff	['Logistics_Resources']	['Neutral']
No data so far	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Company decision due to enrollment challenges.	['Business_Administrative']	['Possibly_Negative']
Lack of efficacy	['Negative']	['Negative']
Intraoperative recording could not be maintained for required period	['Logistics_Resources']	['Neutral']
Could not get drug	['Logistics_Resources']	['Neutral']
Sponsor decision, not safety related.	['Business_Administrative']	['Possibly_Negative']
Coronavirus (COVID-19)-related pause on all clinical research studies.	['Covid19']	['Neutral']
IRB Decision	['Regulatory', 'Invalid_Reason', 'Negative']	['Neutral', 'Invalid_Reason', 'Negative']
"The Enterprise decided to stop the production of the catheter used for the clinical indicated
    renal denervation"	['Logistics_Resources']	['Neutral']
PI departure, slow recruitment	['Insufficient_Enrollment']	['Neutral']
For logistic reasons in the department and due to very low inclusion rates.	['Insufficient_Enrollment']	['Neutral']
Significant differences observed between groups.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Decision to change the study design	['Study_Design']	['Neutral']
Pharmaceutical co- re aligned their specialties- no longer will fund H&N ca	['Business_Administrative']	['Possibly_Negative']
Viokase was taken off market during study and remained off over a year.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
"Business objectives have changed, slow accrual, the standard of care for the patient population
    changed and we were unable to accrue any longer."	['Business_Administrative']	['Possibly_Negative']
"The PI and co-investigators would like to terminate the study given challenges with patient
    enrollment."	['Insufficient_Enrollment']	['Neutral']
The study was terminated due to low enrollment because inclusion criteria are obsolete.	['Insufficient_Enrollment']	['Neutral']
Low enrolment	['Insufficient_Enrollment']	['Neutral']
Study abandoned	['Invalid_Reason']	['Invalid_Reason']
"Post Market Study terminated early due to the launch and subsequent incorporation of the study
    into the Terumo Aortic Endovascular Registry (TiGER-001)."	['No_Context', 'Regulatory', 'Endpoint_Met']	['Invalid_Reason', 'Neutral', 'Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Business decision	['Business_Administrative']	['Possibly_Negative']
poor accrual	['Insufficient_Enrollment']	['Neutral']
difficult to enroll subjects	['Insufficient_Enrollment']	['Neutral']
The study was terminated on 23AUG2018 for safety reasons.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
IRB Approval lapsed	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
study was stopped for business/administrative reasons and not for patient safety concerns	['Business_Administrative']	['Possibly_Negative']
Low enrollment, funding withdrawn	['Business_Administrative']	['Possibly_Negative']
Minimally invasive surgical methods have ceased enrollment	['Study_Design']	['Neutral']
Study was terminated by investigator	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Development in prostate cancer indication halted	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
insufficient suitable drug supply	['Logistics_Resources']	['Neutral']
Analysis of initial sample shows negative results.	['Negative']	['Negative']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
"Recruitment was not on target, evised AAP guidelines may have contributed to the decrease in
    the number of potential participants"	['Insufficient_Enrollment']	['Neutral']
The investigators decided not to move forward with this study at this time.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
The steering committee of the TRIO014 study has taken the decision to stop the TRIO014 trial.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Poor enrollment, lack of feasibility	['Insufficient_Enrollment']	['Neutral']
"Study enrollment was terminated due to a corporate strategic decision unrelated to patient
    safety."	['Business_Administrative']	['Possibly_Negative']
Insufficient staff	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"This non-therapeutic study was registered in error. The PRS team doesn't delete studies once
    registered, so they recommended changing the status to Withdrawn"	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
lack of FDA approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Recruitment issues due to competing studies. Higher than expected PVI on first pass. Sample
    would have to be increased which was not feasible."	['Insufficient_Enrollment']	['Neutral']
"Adjustments to ensure clear outcomes and scientific merit integrated. Study closed at 14
    subjects. New protocol submitted to IRB."	['Study_Design']	['Neutral']
Insufficient	['No_Context', 'Logistics_Resources', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
Lack of funding and support staff.	['Business_Administrative']	['Possibly_Negative']
Molecule development was terminated	['Business_Administrative']	['Possibly_Negative']
Budget Allocation Decision by Sponsor	['Business_Administrative']	['Possibly_Negative']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
This study was stopped because of insufficient enrollment.	['Insufficient_Enrollment']	['Neutral']
Protocol study design was re-worked in collaboration with CMS	['Study_Design']	['Neutral']
Management Decision	['Business_Administrative']	['Possibly_Negative']
Study was terminated. P.I. left the institution before completing study	['Study_Staff_Moved']	['Neutral']
Too small included patients and, not enough cost for PTNS and biofeedback.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Participants no longer receiving intervention	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
Terminated due to lack of funding	['Business_Administrative']	['Possibly_Negative']
"AZD1704 has essentially similar PK profile in Japanese subjects as in Caucasians. One of the
    main purposes of the study has thereby been achieved."	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
"The standard of care had changed during our wait for the Program Letter of Agreement between
    Phoenix Children's Hospital and Banner to administering IV glucose in the newborn nursery so we
    weren't able to meet our objective."	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
low enrollment rate	['Insufficient_Enrollment']	['Neutral']
Low recruitment rate	['Insufficient_Enrollment']	['Neutral']
"The study was prematurely terminated because the emerging benefit:risk ratio did not justify
    continuing dosing patients."	['Negative']	['Negative']
Extremely slow enrollment	['Insufficient_Enrollment']	['Neutral']
"Due to the publication of significant literature in this area since commencement of the project
    which has now rendered the project unnecessary."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Our study hasn't been funded so far, but we will continue this study in the future.	['Business_Administrative']	['Possibly_Negative']
The NAVIGATE study has been terminated due to non-safety related reasons.	['Safety_Sideeffects', 'Logistics_Resources', 'Study_Design']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Study did not start due to investigator time constraints	['Business_Administrative']	['Possibly_Negative']
Inadequate Enrolment	['Insufficient_Enrollment']	['Neutral']
The study costed more than expected, so the investigators decided to end it.	['Business_Administrative']	['Possibly_Negative']
Large phase II opened to accue same patients	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
The development program has been terminated	['Business_Administrative']	['Possibly_Negative']
Inability to recruit subjects	['Insufficient_Enrollment']	['Neutral']
low recruitment	['Insufficient_Enrollment']	['Neutral']
Principal investigator has left the Institution	['Study_Staff_Moved']	['Neutral']
The study team decided not to pursue this study.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Terminated due to sibutramine being withdrawn from the market.	['Covid19', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Funding unavailable	['Business_Administrative']	['Possibly_Negative']
"The study has never been opened to accrual at COH. Study to be closed at COH due to the lack of
    qualified robotic colorectal surgeons."	['Insufficient_Enrollment']	['Neutral']
PI change in institution	['Study_Staff_Moved']	['Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
"On 3/15/2020 study visits were suspended due to COVID-19 pandemic. With safety concerns
    surrounding COVID-19 and difficulty recruiting, the investigators decided to close enrollment
    10/16/2020 after interim data were reviewed by the DSMB and NIH."	['Covid19']	['Neutral']
Collected study data was not usable due to process miscommunications	['Logistics_Resources']	['Neutral']
Strategic priorities impacted study	['Business_Administrative']	['Possibly_Negative']
Drug no longer being supplied by sponsor	['Logistics_Resources']	['Neutral']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
Per PI on 12/9/15 - No patients were ever enrolled in this study	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
issue concerning safety of elastography during pregnancy	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
funding	['Business_Administrative']	['Possibly_Negative']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
"Overall clinical activity (ORR) for oleclumab + durvalumab is minimal across tumor types and
    does not support further evaluation of this doublet."	['Negative']	['Negative']
low recruitment rate	['Insufficient_Enrollment']	['Neutral']
Device Review performed by Sponsor	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Business decision because enrollment was slower than expected	['Business_Administrative']	['Possibly_Negative']
"Our center had adopted a new detection method for anti-PLA2R antibodies in all membranous
    nephropathy patients."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
"Study terminated for re-design. A new IND study (US FDA, July 2009) will be conducted in US and
    Taiwan. Termination not related to safety concerns."	['Study_Design']	['Neutral']
Study halted prematurely and will not resume	['Invalid_Reason']	['Invalid_Reason']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Terminated due to very slow enrollment	['Insufficient_Enrollment']	['Neutral']
Difficult subject recruitment	['Insufficient_Enrollment']	['Neutral']
Failure to recruit the planned number of participants	['Insufficient_Enrollment']	['Neutral']
Sponsor terminated the study	['Business_Administrative']	['Possibly_Negative']
No recruitment	['Insufficient_Enrollment']	['Neutral']
Difficult to recruit participants	['Insufficient_Enrollment']	['Neutral']
Lack of sufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Required number of subjects to be included could not be accomplished	['Insufficient_Enrollment']	['Neutral']
Enrollment not feasible	['Insufficient_Enrollment']	['Neutral']
Study medication without approval and stop of financial support	['Business_Administrative']	['Possibly_Negative']
Device provider has requested withdrawal citing modifications needed for study integrity.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
This study was withdrawn prior to patient enrollment	['Invalid_Reason']	['Invalid_Reason']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Withdrawn due to poor accrual	['Insufficient_Enrollment']	['Neutral']
Stent taken off market due to safety concerns	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"no physiotherapist available for treatment of patients during trial, difficulties with
    recruitment"	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Due to preliminary efficacy results from an influenza challenge trial	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
"With change of personnel and lab resources, this study was not feasible without independent
    funding"	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Reassessment of study feasibility	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
"Recommended by DMEC. Poor recruitment, changes in current clinical management of Vit D
    deficiency. Research question no longer relevant"	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
poor recruitment	['Insufficient_Enrollment']	['Neutral']
IRB approved but never implemented	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study population difficult to recruit	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Withdrew IRB application, never approved and no subjects enrolled	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
not enough patients	['Insufficient_Enrollment']	['Neutral']
Study was never implemented.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
"Big delay on study activation (approval procedures by IRBs, hospitals contract negotiation) and
    on enrolment deadline due to CoViD-19; Placebo stock expires November 2021 and new batch not be
    available for at least one year"	['Covid19']	['Neutral']
Treatment ineffective	['Negative']	['Negative']
Unable to recruit enough subjects to attain the minimum sample size.	['Insufficient_Enrollment']	['Neutral']
Futility analysis undertaken, determined that study was underpowered.	['Negative']	['Negative']
Investigator Left Institution	['Study_Staff_Moved']	['Neutral']
Principal investigator (Dr. Sporn) left the sponsoring institution.	['Study_Staff_Moved']	['Neutral']
Insufficient funding to complete with low enrollment rate	['Business_Administrative']	['Possibly_Negative']
Poor patient enrollment due to logistical issues.	['Insufficient_Enrollment']	['Neutral']
Funding no longer available	['Business_Administrative']	['Possibly_Negative']
Unsatisfactory patient accrual	['Insufficient_Enrollment']	['Neutral']
Inadequate funds allocated for study completion	['Business_Administrative']	['Possibly_Negative']
Unable to enroll appropriate patients	['Insufficient_Enrollment']	['Neutral']
PI left the medical center, no replacement assigned	['Study_Staff_Moved']	['Neutral']
inactivity	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Funding agency withdrew funding due to slow recruitment	['Business_Administrative']	['Possibly_Negative']
"The funding agency (Administration of Children and Families, US Department of Health and Human
    Services) discontinued the local evaluation"	['Business_Administrative']	['Possibly_Negative']
Covid	['Covid19']	['Neutral']
Substudy 001B is not required at this stage of the PIP	['Covid19', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Inclusion difficulties, Investigator lack of time for the study completion	['Insufficient_Enrollment']	['Neutral']
No patients enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Lack of available personnel to conduct data acquisition and analysis	['Logistics_Resources']	['Neutral']
The Principal Investigator left the institution.	['Study_Staff_Moved']	['Neutral']
Organ transplant criteria made recruitment difficult. Closed with IRB 10/09/2015.	['Insufficient_Enrollment']	['Neutral']
"Combination slow recruitment, short shelf life for placebo and insufficient funding for further
    drug production (probably anyway sufficient number included)."	['Business_Administrative']	['Possibly_Negative']
Most of our patients had no willingness to participate in the survey	['Insufficient_Enrollment']	['Neutral']
IP change Hospital	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
Recruitment	['Insufficient_Enrollment']	['Neutral']
Recruitment proved to be extremely difficult.	['Insufficient_Enrollment']	['Neutral']
study closed due to recruitment problems	['Insufficient_Enrollment']	['Neutral']
DSMB recommendation based on programmed interim analysis.	['Negative']	['Negative']
Lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
A planned interim-analysis revealed increased number of infections in the intervention arm.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"Given the length of time data was collected (i.e. 5 1/3 years), we do not anticipate a change
    any potential conclusions by completing the final survey."	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Unable to recruit subjects.	['Insufficient_Enrollment']	['Neutral']
problems in funding	['Business_Administrative']	['Possibly_Negative']
"Due to slow rate of enrollment, which compromised the ability to meet study objectives in a
    timely manner."	['Insufficient_Enrollment']	['Neutral']
Study was terminated after the low dose cohort had been enrolled	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Protocol currently reviewed for updating	['Study_Design']	['Neutral']
We were not able to enroll patients.	['Insufficient_Enrollment']	['Neutral']
Efficacy rates did not show large enough differences between treatments	['Negative']	['Negative']
Not able to enroll the amount required.	['Insufficient_Enrollment']	['Neutral']
Due to funding - project never enrolled	['Business_Administrative']	['Possibly_Negative']
Funding withdrawn	['Business_Administrative']	['Possibly_Negative']
Sponsor discontinued providing study drug.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Approval lapse	['Regulatory', 'Invalid_Reason', 'Negative']	['Neutral', 'Invalid_Reason', 'Negative']
due to recruitment problems / based on recommendation of Independent Review Board	['Insufficient_Enrollment']	['Neutral']
Maintenance phase outcome unattenable	['Logistics_Resources']	['Neutral']
completed recruitment of patients on 15 december 2010	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Logistic reasons associated with the FDA-imposed clinical hold.	['Logistics_Resources']	['Neutral']
Futility	['Negative']	['Negative']
This study was terminated early due to recruitment difficulties. There were no safety concerns.	['Insufficient_Enrollment']	['Neutral']
Due to concerns about potential liver safety (See Detailed Description)	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
"The study was terminated on June 23, 2015 due to the company's change in prioritization for the
    portfolio and is not due to any safety concerns."	['Business_Administrative']	['Possibly_Negative']
Per PI	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
The study was stopped after interim analysis due to futility.	['Negative']	['Negative']
Due to low recruitment	['Insufficient_Enrollment']	['Neutral']
CMS disapproval, no alternative for sites/patient, risk of financial burden.	['Business_Administrative']	['Possibly_Negative']
"End of the inclusion period. A late start of inclusions and reduced scanner availability meant
    that the number of 45 participants could not be reached."	['Insufficient_Enrollment']	['Neutral']
"The study was not terminated for safety reasons. The sponsor was released from the
    postmarketing requirement to conduct the study"	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Due to an insufficient number of participants enrolled.	['Insufficient_Enrollment']	['Neutral']
On hold due to COVID-19 outbreak	['Covid19']	['Neutral']
PI left institution.	['Study_Staff_Moved']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
collaborator Kinemend closed due to finances	['Business_Administrative']	['Possibly_Negative']
Business Decision	['Business_Administrative']	['Possibly_Negative']
Converting from Exploratory IND to Full IND	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
The study was closed due to the slow enrollment rate.	['Insufficient_Enrollment']	['Neutral']
Senior managemnt decision	['Business_Administrative']	['Possibly_Negative']
No participants	['Insufficient_Enrollment']	['Neutral']
Study is no longer required by Brazil health authority.	['Interim_Analysis', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Provider of drug decided to discontinue study.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
project weill not be realized for organisational reasons	['Business_Administrative']	['Possibly_Negative']
Sponsor withdrew support.	['Business_Administrative']	['Possibly_Negative']
Principal Investigator Left University	['Study_Staff_Moved']	['Neutral']
No inclusion	['Insufficient_Enrollment']	['Neutral']
insufficient patient recruitment	['Insufficient_Enrollment']	['Neutral']
"We were unable to recruit sufficient numbers of patients and decided that the study protocol
    was not feasible to implement"	['Insufficient_Enrollment']	['Neutral']
Unable to enroll any patients in the study due to other on-going studies.	['No_Context', 'Insufficient_Enrollment', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
Corona	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Re-evaluation of protocol by Company	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"The study has ceased recruiting as Ethics approval has lapsed and the investigator availability
    reduced."	['Business_Administrative']	['Possibly_Negative']
Results with 4 subjects suggest a redesign of Compression system is required.	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Full clinical hold from FDA	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
this study was suspended for futility	['Negative']	['Negative']
"COVID pandemic disrupted subject recruitment and primary investigator no longer with our
    university; no additional interest in continuing the study."	['Covid19']	['Neutral']
funding period ended	['Business_Administrative']	['Possibly_Negative']
COVID 19	['Covid19']	['Neutral']
Unacceptable incidence of wound dehiscence in the PDS group	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
no paticipants enrolled	['Insufficient_Enrollment']	['Neutral']
Sponsor decision to terminate the study because subject enrollment was difficult.	['Insufficient_Enrollment']	['Neutral']
Company went out of business	['Business_Administrative']	['Possibly_Negative']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Terminated due to non clinical toxicology findings and reduced safety margins.	['Safety_Sideeffects', 'Endpoint_Met', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Social distancing regulations related to COVID19.	['Covid19']	['Neutral']
Study was not feasible as designed to allow for appropriate completion	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
"After an interim analysis the Company providing the product decided not to continue with the
    study"	['Negative', 'Business_Administrative']	['Negative', 'Possibly_Negative']
Drug Supply No Longer Available	['Logistics_Resources']	['Neutral']
The study was started before the official request for protocol registration	['Business_Administrative']	['Possibly_Negative']
Inability to recruit number of planned patients	['Insufficient_Enrollment']	['Neutral']
study sponsors withdrew support for the study drug.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study stopped due to difficulty recruiting	['Insufficient_Enrollment']	['Neutral']
No enrollment	['Insufficient_Enrollment']	['Neutral']
Suspended due to COVID-19	['Covid19']	['Neutral']
Principal Investigator is leaving Moffitt	['Study_Staff_Moved']	['Neutral']
Change of practice in the department	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"The trial prematurely terminated on November 1, 2010, due to healthy volunteer participants
    experiencing non-serious fosamprenavir-related skin rash."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Interim Analysis and review by Data Safety Monitoring Board	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
"Low likelihood to usedrug in clinic practice based on emergining AE profile and data from front
    line clinical trials"	['Negative', 'Another_Study']	['Negative', 'Neutral']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
Due to fatal occurrence (pneumonitis) attributed to one of the study drugs.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Study terminated early as per request by sponsor, Zila Biotechnology, Inc.	['Business_Administrative']	['Possibly_Negative']
RECRUITMENT DIFFICULTIES	['Insufficient_Enrollment']	['Neutral']
Due to funding	['Business_Administrative']	['Possibly_Negative']
no more interested in this issue	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
0	['No_Context', 'Insufficient_Enrollment', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
Administrative reasons	['Business_Administrative']	['Possibly_Negative']
Issues with PK detection limits and compliance to protocol at the analytical site.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Not enough subjects.	['Insufficient_Enrollment']	['Neutral']
Halozyme halted development of PEGPH20 following Phase 3 failure.	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
New protocol developed for recruitment of children for all child studies	['Study_Design']	['Neutral']
Planning new study protocol	['Study_Design']	['Neutral']
This study has been cancelled prior to FSFV due to business reasons	['Business_Administrative']	['Possibly_Negative']
"The study was terminated prior to enrolling patients as we were unable to secure enough funding
    to complete the study."	['Business_Administrative']	['Possibly_Negative']
Rarity of disease and current practice in the field made enrollment challenging.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Did not enroll	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
New data published showing EPO to be ineffective in TBI	['Negative', 'Another_Study']	['Negative', 'Neutral']
Inability to obtain drugs from supplier.	['Logistics_Resources']	['Neutral']
Unable to recruit patients in the 6 month extension allowed.	['Insufficient_Enrollment']	['Neutral']
Unable to improve on poor accrual to study.	['Insufficient_Enrollment']	['Neutral']
"considering the limited clinical activity observed with LTT462, the decision was made to not
    open the dose expansion phase of the study"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Dose limiting toxicity at the lowest planned dose level.	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
GA101-CHOP not advantage from rituximab-CHOP	['Negative']	['Negative']
IRB approval terminated	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
low enrollment	['Insufficient_Enrollment']	['Neutral']
Halted early for futility.	['Negative']	['Negative']
Interim analysis indicated treatment unlikely effective;slow recruitment	['Negative']	['Negative']
"De-identified PSGs were to be scored by a vendor prior to being sent to the sponsor. Issues
    occurred with vendor and no PSGs were analyzed by the sponsor."	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Lack of efficacy	['Negative']	['Negative']
Insufficient Recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of subject enrollment	['Insufficient_Enrollment']	['Neutral']
Withdrawal of pharmaceutical company support for the investigational drug	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"principle investigator moved, new investigators will join, insurance expired - project needs to
    be re-examined by an ethic committee"	['Business_Administrative']	['Possibly_Negative']
No accrual	['Insufficient_Enrollment']	['Neutral']
No participants enrolled.	['Insufficient_Enrollment']	['Neutral']
Withdrawn: Business decision (no enrollment)	['Business_Administrative']	['Possibly_Negative']
no participants enrolled	['Insufficient_Enrollment']	['Neutral']
Adjusting minor software glitches	['Logistics_Resources']	['Neutral']
Funding for the study was not received. No recruitment ever occurred.	['Business_Administrative']	['Possibly_Negative']
The sponsor decided to withdraw study drug from market	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Information of other studies with Abseb bioresorbable scaffolds showed a higher thrombotic risk
    than before, the risk for the Patients is estimated too high"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Sponsor withdrew support	['Business_Administrative']	['Possibly_Negative']
"The trial was terminated because it was determined that the usability of the MIND1 System in
    the intended population was necessary before conducting this trial."	['Interim_Analysis', 'Logistics_Resources', 'Negative']	['Neutral', 'Neutral', 'Negative']
Another phase 2 randomized study has been started by other investigators.	['Negative', 'Another_Study']	['Negative', 'Neutral']
PI left Abramson Cancer Center and study never opened at Moffitt Cancer Center.	['Study_Staff_Moved']	['Neutral']
Low accrual rate	['Insufficient_Enrollment']	['Neutral']
"The study was terminated based on the results of a planned interim analysis that showed
    futility of efficacy."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Phophoral was no longer used as a preparation before coloscopies at OUH	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Study terminated due to low patient enrollment.	['Insufficient_Enrollment']	['Neutral']
Extremely slow enrollment	['Insufficient_Enrollment']	['Neutral']
Administrative	['Business_Administrative']	['Possibly_Negative']
"Due to the lack of enrolment and complexity of design, this study in asthma was terminated. No
    subjects have been dosed for this study."	['Study_Design']	['Neutral']
no need to include more patients for analysis. 40 patients initially (36 actual)	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
"A pre-planned futility analysis indicated lack of efficacy in study NCT03039686 and led to
    discontinuation of both ongoing studies in DMD."	['Negative', 'Another_Study']	['Negative', 'Neutral']
0 ACTUAL Enrollment must have Overall Recruitment Status	['Insufficient_Enrollment']	['Neutral']
Preclinical finding	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
Sponsor has discontinued the development of emricasan	['Business_Administrative']	['Possibly_Negative']
Study was halted to make device updates	['Covid19', 'Interim_Analysis', 'Logistics_Resources']	['Neutral', 'Neutral', 'Neutral']
no eligible patients can be found	['Insufficient_Enrollment']	['Neutral']
Slow rate of participant's enrollment	['Insufficient_Enrollment']	['Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Difficulty to include patients	['Insufficient_Enrollment']	['Neutral']
"The study terminated on 19-Jan-2011 due to insufficient recruitment of patients. No safety
    reasons contributed to the termination of the study."	['Insufficient_Enrollment']	['Neutral']
enrollment problem	['Insufficient_Enrollment']	['Neutral']
The study was designed again in compliance with the regulatory agency.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
under enrollment	['Insufficient_Enrollment']	['Neutral']
"Recruitment challenges and results of interim futility analysis, which showed less than likely
    to achieve primary endpoint goal-length of hospital stay."	['Negative']	['Negative']
Technical difficulties have caused this study to be terminated	['Logistics_Resources']	['Neutral']
"Study halted prematurely and will not resume; participants are no longer being examined or
    receiving intervention. There is no data collected"	['Invalid_Reason']	['Invalid_Reason']
Cancelled due to Sponsor's decision	['Business_Administrative']	['Possibly_Negative']
Injection site reaction met protocol-defined stopping criteria.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
No local inclusions	['Insufficient_Enrollment']	['Neutral']
Temporary halt, whilst results reviewed and methodological changes made.	['Study_Design']	['Neutral']
Difficulty recruiting patients	['Insufficient_Enrollment']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
No available device in the hospital to complete study	['Logistics_Resources']	['Neutral']
recruitment has ended	['Invalid_Reason']	['Invalid_Reason']
"The reason for this decision is that this study is being merged with a larger multi-centre
    study using the same agent in the same population."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Lack of eligible patient recruitment	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Unable to recruit	['Insufficient_Enrollment']	['Neutral']
Stopeed due to lack of recruitment	['Insufficient_Enrollment']	['Neutral']
"The main sponsor of this multi-center trial has submitted this protocol. A single participating
    site should not register this study."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Withdrawal of sponsor support	['Business_Administrative']	['Possibly_Negative']
Insufficient expected benefit risk	['Negative']	['Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
"Intervention and and final data collection point was not completed due to coronavirus school
    closures in March 2020."	['Logistics_Resources', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Not subsidized, will not start in the near future	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
COVID	['Covid19']	['Neutral']
PR104 plus sorafenib was poorly tolerated in patients with advanced HCC	['Negative']	['Negative']
DMC recommended stop	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
patients with neurological disease not included	['Insufficient_Enrollment']	['Neutral']
Sponsor decision - not related to safety	['Business_Administrative']	['Possibly_Negative']
Terminated early due to lack of clinical response.	['Negative', 'Business_Administrative']	['Negative', 'Possibly_Negative']
Not enough enrollment, study needs to be revised	['Insufficient_Enrollment']	['Neutral']
sponsor funding shortage	['Business_Administrative']	['Possibly_Negative']
Lack of patient availability and expiration of study drug	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Not enough participants	['Insufficient_Enrollment']	['Neutral']
Enrolling participants has halted prematurely due to a low recruitment rate.	['Insufficient_Enrollment']	['Neutral']
"Study team submitted IRAS form and the ethic committee advised that this pilot study is more
    service evaluation and no REC ethical approval was required."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Lack of efficacy	['Negative']	['Negative']
PI decided not to open study	['Invalid_Reason']	['Invalid_Reason']
due to lack of finance	['Business_Administrative']	['Possibly_Negative']
The sponsor and hospital did not reach agreement	['Business_Administrative']	['Possibly_Negative']
no patients could be recruited	['Insufficient_Enrollment']	['Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Safety concerns from other studies.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Withdrawn due to lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
Could not enroll enough participants, and lost funding.	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
lack of enrolment	['Insufficient_Enrollment']	['Neutral']
Strategy change	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
The study was interrupted prematurely because of the low rate of recruitment.	['Insufficient_Enrollment']	['Neutral']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
"Enrollment to the study was terminated on 11Nvo2014 due to slow recruitment. There were no
    safety or efficacy issues that contributed to this decision."	['Insufficient_Enrollment']	['Neutral']
Patient compliance issues	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Due to lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
administrative delays too long	['Business_Administrative']	['Possibly_Negative']
One treatment policy showed an advantage at a very high significance level.	['Success', 'Endpoint_Met', 'Negative']	['Success', 'Neutral', 'Negative']
Failed funding application.	['Business_Administrative']	['Possibly_Negative']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
The study stopped due to unforeseen circumstances.	['Invalid_Reason']	['Invalid_Reason']
Logistics	['Logistics_Resources']	['Neutral']
Due to recruitment issues	['Insufficient_Enrollment']	['Neutral']
Slow Recruitment and Re-prioritizing of Sponsor-funding	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
elected not to proceed with the study	['Invalid_Reason']	['Invalid_Reason']
"The study was prematurely stopped due to extremely low recruitment and lack of feasibility to
    continue."	['Insufficient_Enrollment']	['Neutral']
Delay in IRB approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
NIH decision	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
This study was terminated due to failure to enroll, a low volume of patients met criteria.	['Insufficient_Enrollment']	['Neutral']
"A planned interim analysis led to the trial being stopped early based on the observed size
    effect and power analysis."	['Negative']	['Negative']
Expired with IRB.	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Insufficient or untimely patient recruitment	['Insufficient_Enrollment']	['Neutral']
Low inclusion rate	['Insufficient_Enrollment']	['Neutral']
Lack of available patients	['Insufficient_Enrollment']	['Neutral']
Concern for cross contamination in weighing tree nuts in facility with peanuts	['Safety_Sideeffects', 'Logistics_Resources']	['Safety_Sideeffects', 'Neutral']
Concerns for safety	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
The study couldn't be initiated as we did not secure funding.	['Business_Administrative']	['Possibly_Negative']
Unable to recruit participants from recruiting sites.	['Insufficient_Enrollment']	['Neutral']
Funding was terminated	['Business_Administrative']	['Possibly_Negative']
terminated	['Invalid_Reason']	['Invalid_Reason']
This study was terminated due to unanticipated recruitment difficulties.	['Insufficient_Enrollment']	['Neutral']
Inability to enroll subjects and changes in standard of care for PCI	['Study_Design']	['Neutral']
Loss of funding	['Business_Administrative']	['Possibly_Negative']
AstraZeneca withdrew support for the study.	['Business_Administrative']	['Possibly_Negative']
"We did not enroll any subjects because we realized we needed to establish the technique more
    definitively before proceeding to human testing."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
"PI/study coordinator retired due to personal family health matters; study sponsor withdrew
    funding. Study terminated and no data collected or analyzed"	['Business_Administrative']	['Possibly_Negative']
No subjects indentifiable	['Insufficient_Enrollment']	['Neutral']
Inability to recruit and adequate number of participants	['Insufficient_Enrollment']	['Neutral']
sufficient POC to switch development from bovine AP to recombinant AP	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
DSMB recommended termination because TI was safe but not durable.	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
drug no longer available in canada	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
unable to obtain funding to conduct study	['Business_Administrative']	['Possibly_Negative']
Unable to recruit sufficient study subjects	['Insufficient_Enrollment']	['Neutral']
"It was unlikely that the primary endpoint would be reached based on the fifth interim analysis
    results."	['Negative']	['Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Administratively Suspended	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
"Participants experienced data collection issues when using the eDiary, these issues increased
    the burden and lowered compliance. Updates to the eDiary were unsuccessful at resolving the
    issues so the decision was taken to terminate the Investigation."	['Logistics_Resources', 'Endpoint_Met', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
The study was never started	['Invalid_Reason']	['Invalid_Reason']
Finalizing recruitment strategies.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Due to COVID-19 all research activities including recruitment have been paused.	['Covid19']	['Neutral']
Lack of efficacy	['Negative']	['Negative']
Investigator left the institution	['Study_Staff_Moved']	['Neutral']
Patients recruitment and analysis were terminated	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
based on outcome of trial NCT01656889.	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Suspended pending internal review/direction of the company's focus. No sites ever engaged or
    collected data."	['Business_Administrative']	['Possibly_Negative']
The study goals were accomplished by a similar study at UAMS. (W.J. Evans)	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study was not funded.	['Business_Administrative']	['Possibly_Negative']
Drug was pulled from the market.	['Logistics_Resources']	['Neutral']
Slow accrual; study terminated.	['Insufficient_Enrollment']	['Neutral']
data insignificant, study terminated	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
"Study was withdrawn prior to patient enrollment due to COVID-19, funding termination and lack
    of eligible study participants."	['Covid19']	['Neutral']
After interim analysis, IRB recommend termination.	['Interim_Analysis', 'Regulatory', 'Negative']	['Neutral', 'Neutral', 'Negative']
Product no more sold	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Poor patient recruitment	['Insufficient_Enrollment']	['Neutral']
The PI has left Stanford University.	['Study_Staff_Moved']	['Neutral']
Recruitment in study could not be reached after 8 yrs of recruiting	['Insufficient_Enrollment']	['Neutral']
poor recruitment due to change of surgical technique	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
65 patients were included after 2 years instead of 140	['Insufficient_Enrollment']	['Neutral']
Study was not funded.	['Business_Administrative']	['Possibly_Negative']
Slow accrual and COVID-19 restrictions	['Covid19']	['Neutral']
Financial and organisational reasons	['Business_Administrative']	['Possibly_Negative']
No IRB approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Interim analysis indicated recruitment was necessary beyond study capabilities.	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
"A sample size recalculation indicated an increase from 154 to 1500 subjects was required so the
    study stopped as new target was considered unfeasible."	['Insufficient_Enrollment']	['Neutral']
"unable to recruit. Projected completion was 2018 however, enrollment and recruitment were
    difficult. The study was terminated due to inability to enroll."	['Insufficient_Enrollment']	['Neutral']
inadequate sample population	['Insufficient_Enrollment']	['Neutral']
the change of clinical development plan	['Business_Administrative']	['Possibly_Negative']
Slow recruitment, high drop-out	['Insufficient_Enrollment']	['Neutral']
Drug unavailable	['Logistics_Resources']	['Neutral']
It was suspendend because the protocol and the aims were modified	['Study_Design']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Final enrollment on hold until May 2021 pending peptide synthesis.	['Interim_Analysis', 'Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
drug is no longer manufactured	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
Lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
Withdrawn, no patients included	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Re-evaluate inclusion/exclusion criteria	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Problems in recruiting	['Insufficient_Enrollment']	['Neutral']
Novartis terminated this study due to internal, strategic decisions.	['Business_Administrative']	['Possibly_Negative']
The study stopped because it was difficult to recruit the 130 expected patients	['Insufficient_Enrollment']	['Neutral']
The business decided not to pursue the study at this time.	['Business_Administrative']	['Possibly_Negative']
Sponsor decision based on business reasons, unrelated to safety	['Business_Administrative']	['Possibly_Negative']
Funding problems	['Business_Administrative']	['Possibly_Negative']
no participants enrolled	['Insufficient_Enrollment']	['Neutral']
Feasibility concerns due to changes in standard of care	['Study_Design']	['Neutral']
PROBLEM of inclusion	['Insufficient_Enrollment']	['Neutral']
"Study halted prior to enrollment of first participant. (It has been determined on 2018 May 15
    that the NCT03275558 study will be stopped by sponsor decision)"	['No_Context', 'Regulatory', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
Principal Investigator has left the Institution	['Study_Staff_Moved']	['Neutral']
technical problems with equipment from the main outcome	['Logistics_Resources']	['Neutral']
No funding available	['Business_Administrative']	['Possibly_Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Recruitment/enrollment took too long	['Insufficient_Enrollment']	['Neutral']
Insufficient accrual and no funding	['Insufficient_Enrollment']	['Neutral']
Patients did not respond to therapy	['Negative']	['Negative']
Accrual terminated early because of poor accrual	['Insufficient_Enrollment']	['Neutral']
Terminated: recruiting or enrolling participants has halted prematurely	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Poor inclusion rate & lack of funding	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Patient population not available	['Insufficient_Enrollment']	['Neutral']
benefits of treatment less than expected	['Negative']	['Negative']
Study stopped due to low enrollment	['Insufficient_Enrollment']	['Neutral']
Funding no longer available	['Business_Administrative']	['Possibly_Negative']
poor recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of efficacy - Inability to meet the primary response endpoint	['Negative']	['Negative']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
The study was withdrawn prior to patients enrolment due to sponsor's decision	['Business_Administrative']	['Possibly_Negative']
Study plan was changed, this project would not be in progress	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
PI is leaving the University of Miami	['Study_Staff_Moved']	['Neutral']
Study was terminated due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Meeting enrolment target (81 pat) will not be feasible within reasonable time.	['Insufficient_Enrollment']	['Neutral']
Terminated by sponsor	['Business_Administrative']	['Possibly_Negative']
Results did not meet study requirements.	['Negative']	['Negative']
"Study terminated due to changes in government restrictions. Collected data to be presented as a
    pilot study."	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
No funding obtained	['Business_Administrative']	['Possibly_Negative']
Study never began	['Invalid_Reason']	['Invalid_Reason']
Unable to enroll adequate number of patients.	['Insufficient_Enrollment']	['Neutral']
Terminated 4/17/07. Drug sponsor withdrew.	['Business_Administrative']	['Possibly_Negative']
Principal Investigator resigned from institution	['Study_Staff_Moved']	['Neutral']
PI left the institution before all data analysis was completed	['Study_Staff_Moved']	['Neutral']
No recruitment	['Insufficient_Enrollment']	['Neutral']
Principal Investigator left the institution requested study terminated.	['Study_Staff_Moved']	['Neutral']
study did not move forward due to change in clinical strategy	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Patient population was not available	['Insufficient_Enrollment']	['Neutral']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
"Large sample size and change in Orthopaedic practice to use of CCPM in conjunction with
    Clinical Monitoring rendered project less timely."	['Study_Design']	['Neutral']
No appreciable difference noted between methods of delivery	['Negative']	['Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Low pregnancy rates in both groups	['Insufficient_Enrollment']	['Neutral']
funding unavailable	['Business_Administrative']	['Possibly_Negative']
The study has been terminated as a result of low enrollment.	['Insufficient_Enrollment']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Study failed to recruit in sufficient numbers and was determined to not be feasible.	['Insufficient_Enrollment']	['Neutral']
"Principal investigator moved, and the study should have been taken out of UNN Clincaltrial.gov
    account 5-6 years back in time."	['Study_Staff_Moved']	['Neutral']
Business decision, no safety concerns	['Business_Administrative']	['Possibly_Negative']
No active study enrollment for a 2 years.	['Insufficient_Enrollment']	['Neutral']
we don't have enough research funding.	['Business_Administrative']	['Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
Low recruitment rate, parent study has ended	['Insufficient_Enrollment']	['Neutral']
It was discovered that the patient population would not be large enough to adequately recruit.	['Insufficient_Enrollment']	['Neutral']
Insufficient staff	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Recruitment was very low	['Insufficient_Enrollment']	['Neutral']
Due to limited resources available to conduct study	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
FDA Approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Redirect focus of the indication	['Study_Design']	['Neutral']
The sponsor decided to withdraw the study for funding reasons.	['Business_Administrative']	['Possibly_Negative']
no patient enroled	['Insufficient_Enrollment']	['Neutral']
Ibuprofen is not prescribed during coronavirus pandemic, so the study is stopped	['Covid19', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
"Enrollment terminated after 13 patients (14 planned); further patients did not meet eligibility
    criteria to receive autologous IMP"	['Insufficient_Enrollment']	['Neutral']
no enrolled participants	['Insufficient_Enrollment']	['Neutral']
due lack of subjects	['Insufficient_Enrollment']	['Neutral']
Break in funding	['Business_Administrative']	['Possibly_Negative']
"This study was prematurely discontinued because the program for progressive supranuclear palsy
    was discontinued due to lack of efficacy."	['Negative']	['Negative']
Contractual/Funding/Accrual	['Business_Administrative']	['Possibly_Negative']
"For administrative reasons. Enrollment was sufficient to have statistical power without
    compromising the integrity of the study data"	['Business_Administrative']	['Possibly_Negative']
After meeting with the FDA, SPARC concludes a BE study will not be required	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
poor accrual	['Insufficient_Enrollment']	['Neutral']
Unable to enroll patients that met enrollment criteria.	['Insufficient_Enrollment']	['Neutral']
date: August 2006. No annual renewal	['Regulatory', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Participants are no longer being examined or treated.	['Invalid_Reason']	['Invalid_Reason']
Study design will be reformulated	['Study_Design']	['Neutral']
not enough subjects recruited	['Insufficient_Enrollment']	['Neutral']
investigator left the institution	['Study_Staff_Moved']	['Neutral']
Wound dehiscence on tissue adhesive side of 1 wound which developed an infection.	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Sponsor decision; unexpectedly high sham response at primary outcome time point.	['Negative']	['Negative']
the study was closed early due to competing trials	['Negative', 'Another_Study']	['Negative', 'Neutral']
poor accrual	['Insufficient_Enrollment']	['Neutral']
Military collaborator sample supplier was transferred, no samples obtained	['Logistics_Resources']	['Neutral']
grant was not approved, no subjects enrolled	['Business_Administrative']	['Possibly_Negative']
AG-1749 superior to Gefarnate in ulcer prevention	['Negative']	['Negative']
Terminated due to lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
Lost sponsorship for study drug	['Business_Administrative']	['Possibly_Negative']
Analysis of data from 104RA203 failed to meet primary endpoint.	['Negative']	['Negative']
Safety review	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Amended and merged with AHEAD-EU study	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
A business decision was made to not initiate this study.	['Business_Administrative']	['Possibly_Negative']
Others	['Covid19', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Not enough patients to enroll.	['Insufficient_Enrollment']	['Neutral']
one of site was not able to get an approval from the national regulatory authority.	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Business reasons	['Business_Administrative']	['Possibly_Negative']
Recruitment problems	['Insufficient_Enrollment']	['Neutral']
Protocol not activated.	['Study_Design']	['Neutral']
Company decision	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
"Due to study design limitations, this study has been discontinued and will not proceed with the
    2nd cohort as contemplated in the original protocol."	['Study_Design']	['Neutral']
Not enough patients	['Insufficient_Enrollment']	['Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Compliance unacceptably low.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The study was not started due to the lack of funding.	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
Study supporter (Takeda) ended study drug for prostate cancer; enrollment ended prematurely.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Consequences of failing to include.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
not enough recruits	['Insufficient_Enrollment']	['Neutral']
concern patients in oral cleaout arm had worse outcome	['Safety_Sideeffects', 'Negative']	['Safety_Sideeffects', 'Negative']
Funding was discontinued.	['Business_Administrative']	['Possibly_Negative']
Due to results from other studies regarding efficacy of pemirolast	['Negative', 'Another_Study']	['Negative', 'Neutral']
"we submitted an amendment. The study was stopped because this amendment raised the complexity
    of the study."	['Study_Design']	['Neutral']
It wasn't possible to recruit the desired number of patients.	['Insufficient_Enrollment']	['Neutral']
Dificulties in the recruitment of patients.	['Insufficient_Enrollment']	['Neutral']
Clinical studies are stopped, pending funding	['Business_Administrative']	['Possibly_Negative']
Efficacy not evident in this population.	['Negative']	['Negative']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Not started	['Invalid_Reason']	['Invalid_Reason']
PharmaMar has decided to end this study due to the slow recruitment rate of the trial	['Insufficient_Enrollment']	['Neutral']
Technical problem with one of the medical device used for the study.	['Logistics_Resources']	['Neutral']
"The DSMC decided it appeared futile to attempt to demonstrate non-inferiority of
    povidone-iodine to Natamycin."	['Negative']	['Negative']
No participants were recruited and study has been closed.	['Insufficient_Enrollment']	['Neutral']
Unable to recruit study participants	['Insufficient_Enrollment']	['Neutral']
need additional funding	['Business_Administrative']	['Possibly_Negative']
Samples lost during Hurricane Sandy. Study now taking place at other medical centers.	['Success', 'Safety_Sideeffects', 'Logistics_Resources']	['Success', 'Safety_Sideeffects', 'Neutral']
Cancelled due to low enrollment	['Insufficient_Enrollment']	['Neutral']
Closed early for business reasons (not safety reasons)	['Business_Administrative']	['Possibly_Negative']
Concept is withdrawn and a different concept will be submitted the near future.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"AZ decision to discontinue fostamatinib development in RA; rights to fostamatinib returned to
    Rigel Pharmaceuticals."	['Business_Administrative']	['Possibly_Negative']
"A review of blinded data indicates that the number of participant exposures needed to reach ICH
    standards has been met"	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
"The parent study did not meet its primary or secondary efficacy endpoints and therefore Sponsor
    decision to discontinue development in this indication."	['Negative']	['Negative']
"Slow inclusions due in part to a change in practices. The first chemotherapy become a standard
    for patients with NSCL with asymptomatic brain metastases."	['Study_Design']	['Neutral']
Slow enrollment; Lack of support and equipoise	['Insufficient_Enrollment']	['Neutral']
no enrollment	['Insufficient_Enrollment']	['Neutral']
PI- Dr. Jellish passed away. The study was terminated with the IRB	['Study_Staff_Moved']	['Neutral']
Due to SARS-CoV2 (Covid-19) pandemia and its implications for outcomes bias.	['Covid19']	['Neutral']
Study funding discontinued	['Business_Administrative']	['Possibly_Negative']
Lack of efficacy	['Negative']	['Negative']
Stopped by the Sponsor due to their change in product development priorities.	['Business_Administrative']	['Possibly_Negative']
low recruitment rate	['Insufficient_Enrollment']	['Neutral']
Study closed due to lack of participants	['Insufficient_Enrollment']	['Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
Expiration of National Cancer Institute (NCI) funding of the study.	['Business_Administrative']	['Possibly_Negative']
"The trial was stopped before the targeted number of patients was reached due to lack of
    support."	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Standard of care changed	['Study_Design']	['Neutral']
No approval from EC obtained. More details for study were required by EC.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
PI decided not to enroll	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Futility at the interim analysis.	['Negative']	['Negative']
no patients randomized after more than one year sponsor decided to withdrawn the study.	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Insufficient dermatitis was seen in the controls to allow any determination of protection by
    Difinsa53"	['Interim_Analysis', 'Safety_Sideeffects', 'Regulatory']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Not practical to continue due interim results	['Negative']	['Negative']
Low inclusion rate	['Insufficient_Enrollment']	['Neutral']
Publication of guidelines advising against the use of ethanol locks.	['Study_Design']	['Neutral']
Investigator left institution	['Study_Staff_Moved']	['Neutral']
Low qualified candidate enrollment	['Insufficient_Enrollment']	['Neutral']
Poor patient recruitment. Vast majority of the patients have exclusions criteria	['Insufficient_Enrollment']	['Neutral']
Healthy volonteers study results show that the device is not enough reliable	['Negative']	['Negative']
PI discretion	['Study_Staff_Moved', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Promoter's change	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Because of the product recall 2005/2006.	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Colonoscope being used in study not repairable at economic cost.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
impossibility to include patients in the study	['Insufficient_Enrollment']	['Neutral']
Because of poor inclusion difficulties to find patient	['Insufficient_Enrollment']	['Neutral']
Primary investigator left program: unable to recruit a replacement	['Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Collaborator withdrew support due to a drug supply interruption.	['Logistics_Resources']	['Neutral']
recruiting failed	['Insufficient_Enrollment']	['Neutral']
Recruiting at schools was slower than planned. Missing data higher than acceptable.	['No_Context', 'Insufficient_Enrollment', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
The CIHR Financial support was withdrawn because of insufficient recruitment	['Business_Administrative']	['Possibly_Negative']
"The sponsor felt enough information was available for the exploratory assessment of the effect
    of treatment with FBT on pain anxiety"	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Terminated due to slow recruitment	['Insufficient_Enrollment']	['Neutral']
COVID-19 pandemic	['Covid19']	['Neutral']
"Accrual was halted on the basis of the Data and Safety Monitoring Board review of a futility
    analysis."	['Negative']	['Negative']
test drug showed lack of benefit at interim analysis	['Negative']	['Negative']
Recruitment difficulties. Reframed as pilot study	['Insufficient_Enrollment']	['Neutral']
"Based on analysis of results and consideration of available treatments, the overall benefit to
    risk profile of ocrelizumab was not favorable in RA."	['Negative']	['Negative']
"Majority of patients (62%) had been treated with next line therapies, including new highly
    effective therapies confounding the interpretation of the OS results."	['Endpoint_Met', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
It was decided to discontinue the development in consideration of the results of a P1 study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"A pre-planned interim analysis indicated the trial was unlikely to meet the pre-specified
    efficacy criteria. The decision was not based on any safety concerns."	['Negative']	['Negative']
Logistics unresolved at the IRB at Elmhurst Hospital	['Logistics_Resources']	['Neutral']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
Sponsor decision for business purposes	['Business_Administrative']	['Possibly_Negative']
Company decision	['Business_Administrative']	['Possibly_Negative']
Protocol replaced with combination therapy adding KEYTRUDA (pembrolizumab)	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Unable to enroll significant number of patients.	['Insufficient_Enrollment']	['Neutral']
Funding and staffing	['Business_Administrative']	['Possibly_Negative']
"Following the termination of development and commercialization agreement for S-1 with Taiho
    Pharmaceutical"	['Business_Administrative']	['Possibly_Negative']
Business decision	['Business_Administrative']	['Possibly_Negative']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Low recruitment in final grant year, halted on-site research due to COVID-19 during NCE year.	['Covid19']	['Neutral']
No consensus among trial centers regarding protocol	['Interim_Analysis', 'Regulatory', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Study terminated due to low enrollment	['Insufficient_Enrollment']	['Neutral']
alll patients have been included	['Invalid_Reason']	['Invalid_Reason']
Sloww accrual and COVID-19 related problems (impossible to perform LPs)	['Covid19']	['Neutral']
The study sponsor was acquired by a company that focuses on chronic wounds	['Business_Administrative']	['Possibly_Negative']
Lack of accrual.	['Insufficient_Enrollment']	['Neutral']
Decision not to proceed with Study	['Invalid_Reason']	['Invalid_Reason']
The study was stopped due to lack of funding.	['Business_Administrative']	['Possibly_Negative']
study merged with another study	['Negative', 'Another_Study']	['Negative', 'Neutral']
"The study was withdrawn prior to enrollment after a comprehensive review of the biosimilars
    market and the company's global manufacturing network."	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Terminated by IRB	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"GSK investigating manufacturing site malfunction and assessing impact; Study 209713 Early
    Terminated due to risk of potential contamination of study tablets."	['Covid19', 'Interim_Analysis', 'Safety_Sideeffects']	['Neutral', 'Neutral', 'Safety_Sideeffects']
Insufficient Recruitment	['Insufficient_Enrollment']	['Neutral']
AstraZeneca halted funding; patent expired for Seroquel (Quetiapine) in 2012	['Business_Administrative']	['Possibly_Negative']
The study was terminated early due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
No enrollment because of war in the study country.	['Insufficient_Enrollment']	['Neutral']
Business Decision	['Business_Administrative']	['Possibly_Negative']
"Unfortunately we had unforeseen difficulty recruiting to this study. Therefore we have decided
    to halt the study and not publish the results."	['Insufficient_Enrollment']	['Neutral']
Difficulty recruiting	['Insufficient_Enrollment']	['Neutral']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
"The DSMB recommended that the study be stopped as a result of concerns regarding safety and
    intolerability and insufficient evidence of efficacy."	['Negative']	['Negative']
"Temporarily paused due to COVID-19 and expected to resume. This is not a suspension of IRB
    approval."	['Covid19']	['Neutral']
Sponsor stopped study for business reasons; not for clinical or clinical outcomes reasons.	['Business_Administrative']	['Possibly_Negative']
Terminated due to safety concerns.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
resources not available	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"high discontinuation rates mainly due to GI tolerability and implementation of risk mitigation
    plan to address hypersensitivity reactions"	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
recruitment is finished	['Invalid_Reason']	['Invalid_Reason']
Planned immunogenicity outcomes not reached	['Negative']	['Negative']
03/01/2009,due to date close to termination of this funding/study period	['Business_Administrative']	['Possibly_Negative']
Study was terminated due to low enrollment	['Insufficient_Enrollment']	['Neutral']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Necessary equipment to perform the study arms was removed by the medical center administration.	['Logistics_Resources']	['Neutral']
There are not enough patients enrolled.	['Insufficient_Enrollment']	['Neutral']
Discontinued development of Sym004 in combination with FOLFIRI	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
This study was withdrawn due to competing research interests and slow recruitment.	['Insufficient_Enrollment']	['Neutral']
COVID -19 HOLD	['Covid19']	['Neutral']
Unable to enroll more patients	['Insufficient_Enrollment']	['Neutral']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
Patients are currently being operated in the robot instead due to logistics	['Logistics_Resources']	['Neutral']
adverse events was observed in all of them, with intense neck pain and ulcer evelopment	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Coronavirus pandemic halted in-unit enrolment and participation	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Entry criteria were changed, investigator have registrated a new trials.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
The study was terminated prematurely on 16 May 2014 due to a safety concern.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
has not demonstrated efficacy in primary goal	['Negative']	['Negative']
Safety reason	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
The trial was terminated early due to inadequate study design.	['Study_Design']	['Neutral']
Study terminated-Sponsor's decision	['Business_Administrative']	['Possibly_Negative']
discontinued funding	['Business_Administrative']	['Possibly_Negative']
PI decision	['Invalid_Reason']	['Invalid_Reason']
"The study protocol was changed because of too few eligible participants. A registration with
    revised protocol can be found by ClinicalTrials.gov ID NCT03681054."	['Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral']
insufficient enrollment and retention	['Insufficient_Enrollment']	['Neutral']
Strategic changes regarding the product development	['Business_Administrative']	['Possibly_Negative']
Withdrawn due to medication withdrawal from the EMEA	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Never opened to accrual, a GOG working number, not developed into a clinical trial.	['Insufficient_Enrollment']	['Neutral']
Data safety monitoring board recommended due to low recruitment yield.	['Insufficient_Enrollment']	['Neutral']
Lack of subject enrollment over the past two years.	['Insufficient_Enrollment']	['Neutral']
Covid19 sanitary crisis	['Covid19']	['Neutral']
COVID-19	['Covid19']	['Neutral']
It was felt that a sufficient number of subjects were enrolled.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
The single patient enrolled began hemodialysis treatments.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Due to staff departures we were unable to execute this study	['Logistics_Resources', 'Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Unable to reach the target recruitment within timeline	['Insufficient_Enrollment']	['Neutral']
Study was terminated as per BARDA decision to terminate contract.	['Business_Administrative']	['Possibly_Negative']
"Ganaxolone missed its primary endpoint in the double-blind portion of the 1042-0603 study. Due
    to this outcome Marinus discontinued this extension study."	['Negative', 'Another_Study']	['Negative', 'Neutral']
The risk/benefit profile no longer indicated continued development.	['Negative']	['Negative']
Sponsor decided to stop the study due to commercial reasons.	['Business_Administrative']	['Possibly_Negative']
Principal Investigator is Moving Institutions	['Study_Staff_Moved']	['Neutral']
Company closure	['Business_Administrative']	['Possibly_Negative']
Protocol no longer meeting sponsor objectives	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Organisational changes at primary care units.	['Logistics_Resources', 'Study_Staff_Moved', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Sponsor funding	['Business_Administrative']	['Possibly_Negative']
no inclusion	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
The study was terminated due to results in another study (NCT00878501).	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study stopped due to similar case control study already completed	['Negative', 'Another_Study']	['Negative', 'Neutral']
The objective of the study has been achieved with fewer subjects than planned.	['Insufficient_Enrollment']	['Neutral']
No patients enrolled.	['Insufficient_Enrollment']	['Neutral']
new data makes this trial unethical	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"Study terminated 26 June 2015 due to changes in the drug development portfolio. This study was
    not terminated for reasons of safety and/or efficacy"	['Business_Administrative']	['Possibly_Negative']
interim analysis of efficacy completed and termination recommended	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
Slow recruitment rate	['Insufficient_Enrollment']	['Neutral']
accrual too difficult to meet	['Insufficient_Enrollment']	['Neutral']
new regulatory requirements will require funding for restart as a new study	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
This infrastructure project has been taken over by another study.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Sponsoring and Screening of first patients was not sufficient	['Business_Administrative']	['Possibly_Negative']
terminated	['Invalid_Reason']	['Invalid_Reason']
Study enrollment did not meet expected goals	['Insufficient_Enrollment']	['Neutral']
Safety	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
not funded	['Business_Administrative']	['Possibly_Negative']
project not initiated	['Invalid_Reason']	['Invalid_Reason']
Decided not to pursue study	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
No funding, lost support staff, no data collected/processed	['Business_Administrative']	['Possibly_Negative']
No inclusion	['Insufficient_Enrollment']	['Neutral']
No more inclusions	['Insufficient_Enrollment']	['Neutral']
"Low implant success rate(46%). For the successfull implants, 3month FU and available electrical
    data showed an increase in threshold values for the left atrium"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Dysfonction of the device	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Other - Pending amendment to address FDA comments	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
"The affiliated study SAMMPRIS (Stenting and Aggressive Medical Management for Preventing
    Recurrent stroke in Intracranial Stenosis) has stopped enrollment."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Study terminated due to lack of accrual/enrollment	['Insufficient_Enrollment']	['Neutral']
GS-9131 did not meet the targeted antiviral response	['Negative']	['Negative']
No participants recruited. Not able to recruit due to COVID 19.	['Covid19']	['Neutral']
Study was terminated due to a re-prioritization of ongoing studies.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Difficulty in patient recruitment	['Insufficient_Enrollment']	['Neutral']
Closed due to low accrual	['Insufficient_Enrollment']	['Neutral']
Covid-19 pandemic	['Covid19']	['Neutral']
All trials ojectives were met	['Invalid_Reason', 'Study_Design']	['Invalid_Reason', 'Neutral']
business decision	['Business_Administrative']	['Possibly_Negative']
Terminated due to lack of funding and support staff	['Business_Administrative']	['Possibly_Negative']
Production of the medical device was stopped	['Logistics_Resources']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Funding unavailable	['Business_Administrative']	['Possibly_Negative']
Funding has expired	['Business_Administrative']	['Possibly_Negative']
Competing Departmental Studies	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Based on the previous study results, inactivated EV71 vaccine with aluminum adjuvant was
    elected to be used for the efficacy Phase III study."	['Negative', 'Another_Study']	['Negative', 'Neutral']
FDA approved agent for this indication during enrollment	['No_Context', 'Regulatory', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
We didn't start the study	['Invalid_Reason']	['Invalid_Reason']
Funding stopped	['Business_Administrative']	['Possibly_Negative']
The exclusion criteria were stringent and enrollment was slow.	['Insufficient_Enrollment']	['Neutral']
loss of funding	['Business_Administrative']	['Possibly_Negative']
"Study stopped due to a change in the Sponsor's overall development strategy from treatment of
    chronic disease to finite, curative treatments, and is based partially on the advice and
    feedback from experts and regulators."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Investigator left institution	['Study_Staff_Moved']	['Neutral']
Lack of funding and clinical resources	['Business_Administrative']	['Possibly_Negative']
Drug supply	['Logistics_Resources']	['Neutral']
"Several analytical laboratories failed to develop and validate a suitable assay of urine
    fumonisin (the primary endpoint) up to date. Because of missing alternatives for an analytical
    laboratory the objective of the study cannot be met."	['Logistics_Resources']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Finished	['Invalid_Reason']	['Invalid_Reason']
Manufacturer discontinued drug development.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Recruitment challenges	['Insufficient_Enrollment']	['Neutral']
Side effect can increase the risk of the research	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
Data on initial patients sufficient	['Invalid_Reason']	['Invalid_Reason']
Because the PI left the institution.	['Study_Staff_Moved']	['Neutral']
The study was terminated due to insufficient subject enrollment and very slow enrollment.	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Challenges recruiting healthy, sedentary 65-75 year old males	['Insufficient_Enrollment']	['Neutral']
Application for regulatory approval withdrawn	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Sponsor has designed another study with different endpoint to replace the current study	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Too difficult to select patient according to the investigator	['Insufficient_Enrollment']	['Neutral']
Due to the COVID-19 outbreak and the overall low recruitment	['Covid19']	['Neutral']
Business decision outlined by the corporation.	['Business_Administrative']	['Possibly_Negative']
slow/insufficient accrual	['Insufficient_Enrollment']	['Neutral']
difficulties recruiting	['Insufficient_Enrollment']	['Neutral']
Suspended due to COVID	['Covid19']	['Neutral']
funding	['Business_Administrative']	['Possibly_Negative']
"Due to study design (and toxicity), this trial closed to accrual prior to opening the phase II
    portion."	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
More possibly treatment-related deaths on tasisulam-sodium arm.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"The study is prematurely terminated due to bad inclusion and the fact that examinations are
    already being used in standard care."	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Vaccinations paused to update guidance for investigators and participants.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Data source became unavailable	['Logistics_Resources']	['Neutral']
No progression of Phase 1 trial to Phase 2.	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
Due to COVID-19, this pilot study ended prematurely.	['Covid19']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Study terminated due to low enrollment	['Insufficient_Enrollment']	['Neutral']
Scans showed no visual difference between affected subjects & healthy volunteers	['Negative']	['Negative']
poor accrual	['Insufficient_Enrollment']	['Neutral']
Funding issues	['Business_Administrative']	['Possibly_Negative']
Emergence of FOLFIRINOX and slow recruitment	['Insufficient_Enrollment']	['Neutral']
"The Study halted prematurely because the potential for recruitment into the associated center
    was reached."	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Study was prematurely terminated due to administrative and strategic reasons	['Business_Administrative']	['Possibly_Negative']
Dr. Ralph Hoffman unexpectedly passed away.	['Study_Staff_Moved']	['Neutral']
COVID-19 pandemic	['Covid19']	['Neutral']
Suspended due to COVID-19	['Covid19']	['Neutral']
"Recruitment issues: Restrictions associated with the COVID-19 pandemic have made much of the
    research procedures unfeasible due to organizational and safety issues (for both staff and
    patient protection)."	['Covid19']	['Neutral']
Inadequate enrollment without results or statistics being calculated.	['Insufficient_Enrollment']	['Neutral']
"This study was closed earlier than planned because targeted participant recruitment is not
    smooth."	['Insufficient_Enrollment']	['Neutral']
Interim analysis results showed futility	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Increased recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Study was closed by the Cancer Therapy Evaluation Program (CTEP)	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
logistic problems	['Logistics_Resources']	['Neutral']
Could not recruit participants	['Insufficient_Enrollment']	['Neutral']
Early findings showed trial was not feasible	['Negative', 'Another_Study']	['Negative', 'Neutral']
Prematurely halted after interim data analysis	['Interim_Analysis', 'Negative']	['Neutral', 'Negative']
Terminated for insufficient accrual.	['Insufficient_Enrollment']	['Neutral']
Medtronic terminated the study since Foretevo product was no longer marketed	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Unable to recruit prescription opioid abusers; ultimately no potential POA recruit passed the
    pre-screening process"	['Insufficient_Enrollment']	['Neutral']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
major difficulties recruiting patients	['Insufficient_Enrollment']	['Neutral']
insufficient efficacy	['Negative']	['Negative']
"A total of three parts were planned for this study. The sponsor funded only Part 1, so that
    neither Part 2 nor Part 3 of this study has been conducted."	['Business_Administrative']	['Possibly_Negative']
The study was not approved by the Human Studies Subcommittee.	['Interim_Analysis', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Impossibility to accomplish the sample size in assigned time.	['Insufficient_Enrollment']	['Neutral']
Funding ended early	['Business_Administrative']	['Possibly_Negative']
Recruitment too low	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
"A feasibility study will be conducted to assess the online administration of the cognitive
    remediation program CIRCuiTS."	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
"The study was truncated due to the long period of enrollment and the collection of a sufficient
    amount of data that allowed the scientific objectives to be met"	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Safety issues related to outpatient intravenous infusion in India	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Observed lower cure rates and higher mortality rates in one of the treatment groups.	['Safety_Sideeffects', 'Negative', 'Another_Study']	['Safety_Sideeffects', 'Negative', 'Neutral']
Poor recruiting status	['Insufficient_Enrollment']	['Neutral']
"A 300 patient safety analysis by the Data Monitoring Committee showed a trend towards higher
    mortality in the treatment group."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Rising costs have made continuing the study untenable	['Business_Administrative']	['Possibly_Negative']
COVID-19 outbreak	['Covid19']	['Neutral']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
transitioning from 361 HCT/P Tissue to a Biologic (BLA)	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Low recruitment rate	['Insufficient_Enrollment']	['Neutral']
study is classified as ancillary / correlative	['Interim_Analysis', 'Safety_Sideeffects', 'Endpoint_Met']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Difficulty in accruing subjects	['Insufficient_Enrollment']	['Neutral']
Poor accrual rate	['Insufficient_Enrollment']	['Neutral']
Not feasible to recruit and follow-up subjects due to the pandemic	['Insufficient_Enrollment']	['Neutral']
Company has ceased operation	['Business_Administrative']	['Possibly_Negative']
"Because of dynamics in the field of minimal invasive mitral repair and the development of newer
    devices"	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
no patients enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Key personnel were reassigned to different project	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
Insufficient patient population & problems with device use in subjects enrolled.	['Insufficient_Enrollment']	['Neutral']
poor case accrual	['Insufficient_Enrollment']	['Neutral']
Terminated by sponsor	['Business_Administrative']	['Possibly_Negative']
No started, lack of funding	['Business_Administrative']	['Possibly_Negative']
Reduced enrollment rate for SV patients due to high competition for studies	['Insufficient_Enrollment']	['Neutral']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
"The Dopamine transporter brain imaging trial is terminated due to a company decision to return
    all rights for Safinamide back to Newron Pharmaceuticals"	['Business_Administrative']	['Possibly_Negative']
Early termination resulted from interim analysis of the ALTITUDE trial	['Success', 'No_Context', 'Logistics_Resources']	['Success', 'Invalid_Reason', 'Neutral']
Investigator choice	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
"Overall clinical activity (ORR) for oleclumab + durvalumab is minimal across tumor types and
    does not support further evaluation of this doublet."	['Negative']	['Negative']
Investigator decided to not go forward with the study.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
On Internal Hold	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Decision to stop study due to low recruitment.	['Insufficient_Enrollment']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Closed by Sponsor/Data Safety monitoring Board/IRB	['Interim_Analysis', 'Regulatory', 'Negative']	['Neutral', 'Neutral', 'Negative']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Change in priority of interventional protocols	['Study_Design']	['Neutral']
PI left Stanford	['Study_Staff_Moved']	['Neutral']
Low/slow accrual	['Insufficient_Enrollment']	['Neutral']
low enrollment	['Insufficient_Enrollment']	['Neutral']
Decommissioned due to not enough staff across the study to adequately support it.	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Business Decision (please see below)	['Business_Administrative']	['Possibly_Negative']
Difficulties in enrolling patients	['Insufficient_Enrollment']	['Neutral']
"Preliminary efficacy seen to date following treatment with AUTO2 has been determined not
    sufficient to warrant further development"	['Negative']	['Negative']
principal Investigator left institution	['Study_Staff_Moved']	['Neutral']
Insufficient inclusion of subjects	['Insufficient_Enrollment']	['Neutral']
Unable to recruit subjects	['Insufficient_Enrollment']	['Neutral']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
couldn't recruit patients	['Insufficient_Enrollment']	['Neutral']
Study stopped before enrollment due to non-safety related corporate decision.	['Business_Administrative']	['Possibly_Negative']
"PI has left the institution. We are unable to locate any study records to determine if subjects
    were enrolled."	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
Very slow accrual because sites have few open colorectal surgery	['Insufficient_Enrollment']	['Neutral']
"Interim analysis suggested that the trial, as designed, was not adequately powered to detect a
    therapeutic effect."	['Negative']	['Negative']
"The study design was changed to a prospective cohort study due to difficulties in using a
    randomized approach in an emergency setting"	['Study_Design']	['Neutral']
Lack of patient population	['Insufficient_Enrollment']	['Neutral']
Personnel involved in this protocol are no longer associated with this study	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
COVID19 restrictions and study personnel retirement	['Covid19']	['Neutral']
lack of budget and failure to reach milestones	['Business_Administrative']	['Possibly_Negative']
The study is terminated due to expiration of study materials.	['Logistics_Resources']	['Neutral']
Inability to meet protocol objectives	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
decision of the promoter	['Business_Administrative']	['Possibly_Negative']
The incidence of AEs was higher than the IB reported.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Funding was not available from company	['Business_Administrative']	['Possibly_Negative']
recruitment challenges	['Insufficient_Enrollment']	['Neutral']
Lack of patients eligible for the study.	['Insufficient_Enrollment']	['Neutral']
"We are closing this study due to the focus on other research projects and there is no time or
    personnel tofurther pursue the completion of this project"	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
medical decision	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
have difficulty finding eligible participants	['Insufficient_Enrollment']	['Neutral']
Increased LFTs	['Negative', 'Another_Study']	['Negative', 'Neutral']
Data Safety Monitoring Committee recommended stopping the trial due to futility.	['Negative']	['Negative']
"Due to staffing changes in the hospital, we will be unable to complete this study for the
    requested 84 subjects. As such, we have decided to close this study."	['Logistics_Resources']	['Neutral']
"Due to the departure of study staff and lack of interest by potential subjects and the sponsor,
    the investigators decided to end the study."	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
higher occurrence of complication than expected for both groups	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Due to the relative low incidence of severe malaria in Southeast Asia.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
This study was cancelled before any data collection due to business reasons.	['Business_Administrative']	['Possibly_Negative']
Covid-19 pandemic mandated suspension of research	['Covid19']	['Neutral']
"The trial was prematurely terminated on Dec 9, 2010, due to safety concerns, specifically new
    emerging evidence of hepatic injury."""	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
FDA Clinical Hold	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Terminated per PI's request	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Difficulty in participant recruitment	['Insufficient_Enrollment']	['Neutral']
data collection completed	['Invalid_Reason']	['Invalid_Reason']
Difficulty with recruitment - few eligible for enrolment.	['Insufficient_Enrollment']	['Neutral']
Need for evaluation of emerging pre-clinical toxicology findings	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Due to lack of accrual for this study. PI decided to close the study.	['Insufficient_Enrollment']	['Neutral']
Development Halted	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Investigator left institution	['Study_Staff_Moved']	['Neutral']
study design changed due to COVID-19	['Covid19']	['Neutral']
Loss of study site	['Logistics_Resources']	['Neutral']
Terminated due to COVID-19	['Covid19']	['Neutral']
End of the study	['Invalid_Reason']	['Invalid_Reason']
Enrollment issues.	['Insufficient_Enrollment']	['Neutral']
Inability to identify eligible patients	['Insufficient_Enrollment']	['Neutral']
Temporarily interrupted due to lack of funding: will re-open in the near future	['Business_Administrative']	['Possibly_Negative']
No statistical differences on study endpoints between groups.	['Negative']	['Negative']
lack of funding	['Business_Administrative']	['Possibly_Negative']
BIIB092 program discontinued	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
The investigator left the institution	['Study_Staff_Moved']	['Neutral']
Study was never initiated	['Invalid_Reason']	['Invalid_Reason']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
release of other trial indicating futility of this study after recruitment of 1 patient	['Negative', 'Another_Study']	['Negative', 'Neutral']
Due to more robust long-term data generated in other active-controlled studies	['Negative', 'Another_Study']	['Negative', 'Neutral']
redesign	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Insufficient accrual rate	['Insufficient_Enrollment']	['Neutral']
The study will not be conducted	['Invalid_Reason']	['Invalid_Reason']
DSMB estimated futility of the trial and safety risk	['Negative']	['Negative']
COVID-19 general concerns	['Covid19']	['Neutral']
"Enrollment challenges due to changes in standards of care resulted in premature termination. No
    safety or efficacy events factored into this action."	['Study_Design']	['Neutral']
Laboratory change, stem cell circuit on standby	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
"Enrollment was terminated early due to a change in practice on the obstetrical side that
    included administering azithromycin to women with preterm labor."	['Study_Design']	['Neutral']
The development program has been terminated	['Business_Administrative']	['Possibly_Negative']
due to failure to recruit subjects	['Insufficient_Enrollment']	['Neutral']
"The Study could not be done for every potential participant as planned in the protocol for
    organizational reasons."	['Business_Administrative']	['Possibly_Negative']
Difficulties for enrollment	['Insufficient_Enrollment']	['Neutral']
Investigator requested to close, lack of equipment available.	['Logistics_Resources']	['Neutral']
Inadequate number of records screened; primary investigator left institution.	['Insufficient_Enrollment']	['Neutral']
"Merck (supplier of study drug & funding) has undergone a large reprioritization, in which they
    had to terminate many oncology trials, including this one."	['Business_Administrative']	['Possibly_Negative']
logistical issues with coordinating the clinical and testing areas	['Logistics_Resources']	['Neutral']
lack of inclusions, sudden withdrawal of study coordinator	['Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
"This decision was based upon strategic considerations impacting the clinical development of
    olaparib in this indication."	['Business_Administrative']	['Possibly_Negative']
The trial has been enhanced, a new NCT(NCT03893799) listing was created.	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
The study was terminated due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
This study competed with another VICC study	['Negative', 'Another_Study']	['Negative', 'Neutral']
No subjects enrolled	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Lack of financial support. Study criteria severly limited enrollment.	['Business_Administrative']	['Possibly_Negative']
FDA and IRB recommended different mode of medication administration	['No_Context', 'Regulatory', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
In the process of transferring IRB to PI's current institution.	['Study_Staff_Moved']	['Neutral']
closed by sponser	['Business_Administrative']	['Possibly_Negative']
slow recruiting	['Insufficient_Enrollment']	['Neutral']
Covid-19	['Covid19']	['Neutral']
lack of access to study drug	['Logistics_Resources']	['Neutral']
Lack of funding.	['Business_Administrative']	['Possibly_Negative']
Withdrawn due to lack of accrual per Center DSMP, with PI concurrence	['Insufficient_Enrollment']	['Neutral']
Drug combination is no longer pursued	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Sponsor's decision	['Business_Administrative']	['Possibly_Negative']
Not adequate number of staff to continue study at the moment.	['Insufficient_Enrollment']	['Neutral']
The planned 15-month recruitment period was completed.	['Invalid_Reason']	['Invalid_Reason']
safety concerns regarding use of rosiglitazone	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Project not funded	['Business_Administrative']	['Possibly_Negative']
Problems with FMISO supply	['Logistics_Resources']	['Neutral']
Study was stopped as the sponsor is no longer funding this project	['Business_Administrative']	['Possibly_Negative']
Rationalization of the Silent Hip Prosthesis for business reasons only	['Business_Administrative']	['Possibly_Negative']
The development program has been terminated	['Business_Administrative']	['Possibly_Negative']
Study redesign	['Study_Design']	['Neutral']
Study was dropped at site before participation	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Too low inclusion rate	['Insufficient_Enrollment']	['Neutral']
Study not started due to the Regulatory and administrative issues of Universities in Vietnam	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of participants to enroll.	['Insufficient_Enrollment']	['Neutral']
The study was incorporated in another study.	['Negative', 'Another_Study']	['Negative', 'Neutral']
COVID-19	['Covid19']	['Neutral']
The enrollment process is too difficult to complete	['Insufficient_Enrollment']	['Neutral']
Study was closed permanently before the accrual goal was met due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Sponsorship for trial was halted after company acquisition	['Business_Administrative']	['Possibly_Negative']
Ulipristal Acetate was recalled	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
The sponsor is currently focusing on different indications	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Due to lack of supply of the investigational product.	['Logistics_Resources']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Protocol modification	['Study_Design']	['Neutral']
On clinical hold with the FDA. Insufficient funds to conduct the study	['Business_Administrative']	['Possibly_Negative']
Study terminated by PI	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
lack of funding	['Business_Administrative']	['Possibly_Negative']
"Saturation of a particular breast cancer treatment regimen enrolled. We will need to reexamine
    inclusion/exclusion criteria in future studies."	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
lack of accrual	['Insufficient_Enrollment']	['Neutral']
The required data was obtained and there was no need to collect further data	['Interim_Analysis', 'Success', 'Logistics_Resources']	['Neutral', 'Success', 'Neutral']
the study was terminated due to medication supply issue from current manufacturer	['Logistics_Resources']	['Neutral']
funding not secured	['Business_Administrative']	['Possibly_Negative']
Clinical hold for safety	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
Slow enrolment & potential regulatory changes for allograft in cartilage repair	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
Modified dose schedule presented no advantage over previously studied schedule	['Negative']	['Negative']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
No enrollment	['Insufficient_Enrollment']	['Neutral']
"Sponsor decision to discontinue the SHP647 (ontamalimab) clinical trial development program for
    inflammatory bowel diseases (IBD) early."	['Business_Administrative']	['Possibly_Negative']
The study stopped because of delays in the development of the smartphone app intervention	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
Protocol undergoing additional revisions.	['Study_Design']	['Neutral']
Low accrual rate	['Insufficient_Enrollment']	['Neutral']
there is a problem in recruting the paricipents	['Insufficient_Enrollment']	['Neutral']
Development project stopped	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Due to changes in the surgical technique, no potential subjects anymore	['Study_Design']	['Neutral']
due to lack of accrual	['Insufficient_Enrollment']	['Neutral']
"Trial suspended on 26 February, following the publication of a trial with negative results (Ann
    Intern Med 146(4), 2007). Pending ethics committee re-approval."	['Negative', 'Another_Study']	['Negative', 'Neutral']
"The decision of terminate the study was reached due to difficulties surrounding recruitment and
    enrollment of subjects since the inception of the study."	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
no participants were recruited,study stopped	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Study not started due to Sponsor decision to not move forward with compound.	['Business_Administrative']	['Possibly_Negative']
Preliminary results indicated that this test had a number of false-negative results.	['Negative', 'Another_Study']	['Negative', 'Neutral']
"There was a software server issue. Investigators were no longer able to sign patients up to the
    software program."	['Logistics_Resources']	['Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Terminated	['Invalid_Reason']	['Invalid_Reason']
Similar study has revealed result of no benefit for participants	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Preliminary results were promising when interim analysis performed but terminated due to
    primary investigators left recruitment site."	['Negative']	['Negative']
Lack of adequate enrollment	['Insufficient_Enrollment']	['Neutral']
No subjects were enrolled and the sponsor suspended support at this time	['Business_Administrative']	['Possibly_Negative']
Device was modified and no longer available to investigator	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Study site change to Thailand	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Funding shortage	['Business_Administrative']	['Possibly_Negative']
Were not able to conduct the intervention.	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
As recruitment rate was lower than anticipated	['Insufficient_Enrollment']	['Neutral']
Lack of patients meeting the defined primary obj. (50% decline in M-protein).	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Difficulties in logistics handling the very severe patients (travel, hospital stay, follow-up)	['Logistics_Resources']	['Neutral']
administrative reasons (slow patient enrollment)	['Business_Administrative']	['Possibly_Negative']
"A similar publication has been released, suggesting a beneficial effect of sartans, and only 15
    patients remained to be seen for their visit at 36 months."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Funding withdrawn	['Business_Administrative']	['Possibly_Negative']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Business Reasons	['Business_Administrative']	['Possibly_Negative']
survival advantage demonstrated	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
"Interim analysis indicated that sample size of study patients had to be highly increased to
    obtain significant outcomes."	['Negative']	['Negative']
"A post-PMA begun in 1998; enrollment halted in 2000 due to an anomaly in one study arm. The
    protocol required annual study visits after 2000."	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Invalid_Reason']	['Safety_Sideeffects', 'Neutral', 'Invalid_Reason']
Study terminated due to poor subject compliance.	['Study_Design']	['Neutral']
Study terminated due to reproducibility issues with genomics prediction model.	['Negative']	['Negative']
Halted after 3 years because of a persistent decline in enrollment	['Insufficient_Enrollment']	['Neutral']
"Poor recruitment and some centers were not able to secure ethics approval/exemption. The study
    will be repeated all over again with additional centers, secured approvals/exemptions, and when
    things are ready"	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Study stopped due to COVID-19	['Covid19']	['Neutral']
The number of subjects in this study was overestimated in the initial assessment.	['Insufficient_Enrollment']	['Neutral']
Never recruited/started study	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Third dose group not recruited due to slow enrollment.	['Insufficient_Enrollment']	['Neutral']
Enrollments slowed down significantly, despite several attempts to re-launch.	['Insufficient_Enrollment']	['Neutral']
Unanticipated delays due to sterilization/stabilization testing of GLP-1.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
"Early termination was approved due to compelling efficacy of LCZ696 in patients with HF &
    reduced EF after final pre-specified interim analysis 28-Mar-2014."	['Negative', 'Another_Study']	['Negative', 'Neutral']
The study was stopped prematurely due to slow enrolment without code breaking.	['Insufficient_Enrollment']	['Neutral']
Expiration of the placebo patch	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
"The study was terminated due to time constraints and the withdrawal of Stress Control from the
    NHS Greater Glasgow and Clyde services."	['Business_Administrative']	['Possibly_Negative']
participants are no longer being examined or treated	['Invalid_Reason']	['Invalid_Reason']
low recruitment	['Insufficient_Enrollment']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Recommendation from an independent data monitoring committee (DMC) and accepted by AstraZeneca.	['Interim_Analysis', 'Regulatory', 'Negative']	['Neutral', 'Neutral', 'Negative']
Protocol Amendment	['Study_Design']	['Neutral']
Recruitment no longer feasible	['Insufficient_Enrollment']	['Neutral']
"Given the extensive time projected to conclude the study hypothesis, it is no longer feasible
    to include this study of TP-0903."	['Success', 'No_Context', 'Logistics_Resources']	['Success', 'Invalid_Reason', 'Neutral']
"The new pain protocols imposed by the HAS make it difficult to include new patients in the
    study"	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
PI decision	['Invalid_Reason']	['Invalid_Reason']
Study was cancelled due to lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Due to lack of enrollment	['Insufficient_Enrollment']	['Neutral']
"The study was terminated due to inability to recruit subjects. A total of 2/100 anticipated
    were radomized."	['Insufficient_Enrollment']	['Neutral']
Operational barriers at the site.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Optimal response: 63% nomogram, 42% controls, overcoming the stopping rule for interim analysis	['Negative']	['Negative']
Early end of enrolment with regards to difficulty met to enrol patients.	['Insufficient_Enrollment']	['Neutral']
Administrative	['Business_Administrative']	['Possibly_Negative']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Gastrointestinal safety findings	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
"Study was stopped shortly after initiation due to change in strategic direction of the company;
    no safety concerns were observed that impacted this decision."	['Business_Administrative']	['Possibly_Negative']
Trial not initiated	['Invalid_Reason']	['Invalid_Reason']
After a discussion, we decided to withdraw the study.	['Invalid_Reason']	['Invalid_Reason']
Study was redesigned in collaboration with CMS before it started.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
due to the lack of funding to continue	['Business_Administrative']	['Possibly_Negative']
Low recruitment rate - >70% of colorectal procedures are done laparoscopically	['Insufficient_Enrollment']	['Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Difficulty in recruiting and maintenance of blinding necessary for the trial	['Logistics_Resources']	['Neutral']
"Diclofenac is no longer recommend for intramuscular administration by the Medical Council of
    Thailand"	['Interim_Analysis', 'Regulatory', 'Negative']	['Neutral', 'Neutral', 'Negative']
transfer of funding	['Business_Administrative']	['Possibly_Negative']
Funding ended	['Business_Administrative']	['Possibly_Negative']
Pharmaceutical and financial difficulties	['Business_Administrative']	['Possibly_Negative']
Study never officially opened	['Invalid_Reason']	['Invalid_Reason']
Sponsor pulled funding secondary to economy issues	['Business_Administrative']	['Possibly_Negative']
insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
"The study was stopped before the first patient was enetered due to logistical issues and lack
    of funding."	['Business_Administrative']	['Possibly_Negative']
Poor patient recruitment	['Insufficient_Enrollment']	['Neutral']
PI is no longer here.	['Study_Staff_Moved']	['Neutral']
Futility	['Negative']	['Negative']
Completion of cohort 3, safety concerns	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
The study was terminated due to withdrawal of institutional support, Phase II never began.	['Business_Administrative']	['Possibly_Negative']
Due to difficulty in patient recruitment	['Insufficient_Enrollment']	['Neutral']
Wireless connectivity challenges with device and mobile app	['Logistics_Resources']	['Neutral']
The reason was the fact that the ProCore needle was removed from clinical use	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Per Investigator study was terminated prematurely	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
COVID-19 policy of the University of Surrey	['Covid19']	['Neutral']
Too few patients completed the study once enrolled.	['Insufficient_Enrollment']	['Neutral']
No enrollments	['Insufficient_Enrollment']	['Neutral']
Problem with patient recruitment	['Insufficient_Enrollment']	['Neutral']
Change of Institutional Affliation & Funding Changes	['Business_Administrative']	['Possibly_Negative']
The study was withdrawn prior to enrollment of first participant.	['Invalid_Reason']	['Invalid_Reason']
Limited eligible sample size for study outcomes	['Insufficient_Enrollment']	['Neutral']
The enzymatic assay was not sensitive nor spesific for the test.	['Interim_Analysis', 'Logistics_Resources', 'Endpoint_Met']	['Neutral', 'Neutral', 'Neutral']
PI leaving institution	['Study_Staff_Moved']	['Neutral']
Difficulty with patient recruitment	['Insufficient_Enrollment']	['Neutral']
Per sponsor advice	['Business_Administrative']	['Possibly_Negative']
no funding	['Business_Administrative']	['Possibly_Negative']
Due to difficulties in recruiting the subjects.	['Insufficient_Enrollment']	['Neutral']
sponsor having financial difficulties	['Business_Administrative']	['Possibly_Negative']
"The futility analysis of study NCT00910091 in patients with endometrial cancer shows that the
    primary endpoint will not be reached."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsor Termination	['Business_Administrative']	['Possibly_Negative']
Raw ingredient shortage. Future study start date - TBD	['Logistics_Resources']	['Neutral']
Difficulty in Recruitment	['Insufficient_Enrollment']	['Neutral']
No funding.	['Business_Administrative']	['Possibly_Negative']
Inadequate enrollment	['Insufficient_Enrollment']	['Neutral']
Decision of sponsor	['Business_Administrative']	['Possibly_Negative']
No enough recruited cases	['Insufficient_Enrollment']	['Neutral']
Interim results showed high futility to continue	['Negative']	['Negative']
Because of difficulties on recruiting participants	['Insufficient_Enrollment']	['Neutral']
Recruiting was halted due to methodology issues	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Insufficient Funds and Inadequate Subject Recruitment	['Business_Administrative']	['Possibly_Negative']
"interim analysis incidence primary endpoint lower than anticipated. Sigicant finding based on
    secondary endpoint."	['Negative']	['Negative']
The study was terminated on completion of the Pilot Study phase.	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
Study suspended due to operational impediments imposed by COVID-19	['Covid19']	['Neutral']
No participants enrolled.	['Insufficient_Enrollment']	['Neutral']
Fail of applying funding	['Business_Administrative']	['Possibly_Negative']
Suspended to accrual due to COVID-19	['Covid19']	['Neutral']
Study under review. Temporarily suspended	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Terminated due to a distribution issue with the trial medication	['Logistics_Resources']	['Neutral']
poor accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Insufficient rate of volunteer accrual.	['Insufficient_Enrollment']	['Neutral']
Insufficient resources to evaluate pilot, second to shift in research priorities	['Business_Administrative']	['Possibly_Negative']
All prick tests are positive	['Endpoint_Met', 'Negative']	['Neutral', 'Negative']
Loss of cGMP facility to manufacture product used in clinical trial.	['Logistics_Resources']	['Neutral']
"Celgene terminated its collaboration agreement with MethylGene for the development of MGCD0103.
    All Celgene-sponsored trials with MGCD0103 with be closed."	['Business_Administrative']	['Possibly_Negative']
closed due to lack of interest and enrollment	['Insufficient_Enrollment']	['Neutral']
Study terminated due to a technical issue (randomization error).	['Logistics_Resources']	['Neutral']
"in accordance with the request to close study EP00-402 ""EMEA/H/C/000607/MEA 10.2"" submitted and
    adopted by the EMA"	['Covid19', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
PI has left UHN. This study is no longer running at UHN.	['Study_Staff_Moved']	['Neutral']
Sub-Investigator left U of C	['Study_Staff_Moved']	['Neutral']
Decreased Influenza activity; thus decrease/no eligible patient to recruit	['Insufficient_Enrollment']	['Neutral']
Due to the technical problem in the laser device,it has not started.	['Logistics_Resources']	['Neutral']
lack of accural	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
The study was terminated early at the sponsor's discretion.	['Business_Administrative']	['Possibly_Negative']
Insufficient enrollment.	['Insufficient_Enrollment']	['Neutral']
sponsor decision	['Business_Administrative']	['Possibly_Negative']
Inadequate enrollment	['Insufficient_Enrollment']	['Neutral']
terminated due to low staffing	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
The study was stopped after the first Interim Analysis due to futility.	['Negative']	['Negative']
Interim efficacy analysis indicated it would be futile to continue study.	['Negative']	['Negative']
Company decision taken in light of demands by certain national health authorities	['Business_Administrative']	['Possibly_Negative']
data suggesting pudendal artery stenosis rarely being cause of ED	['Negative', 'Another_Study']	['Negative', 'Neutral']
Extremely low enrollment and very little follow-up for meaningful data	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Inadequate enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Study drug could not be re-supplied	['Logistics_Resources']	['Neutral']
Study team missed continuing review and study lapsed with out recruiting any subjects.	['Insufficient_Enrollment']	['Neutral']
Administrative	['Business_Administrative']	['Possibly_Negative']
Recruitment efforts were not effective.	['Insufficient_Enrollment']	['Neutral']
Product discontinued in November 2014	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Decline in enrollment, lack of efficacy, and completion of funding accrual	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
delay in recruitment	['Insufficient_Enrollment']	['Neutral']
Difficulty enrollment; higher than planned patient attrition and data attrition	['Insufficient_Enrollment']	['Neutral']
Inability to analyze collected samples due to no funds.	['Business_Administrative']	['Possibly_Negative']
No funding	['Business_Administrative']	['Possibly_Negative']
Administratively closed early	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Product availability	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Angioscanners in excess of the SNA group because of use of thiopental	['Logistics_Resources']	['Neutral']
Study terminated due to inadequate recruitment	['Insufficient_Enrollment']	['Neutral']
Unable to obtain 3D TTE to complete study procedure.	['Logistics_Resources']	['Neutral']
Funding not available to continue with study.	['Business_Administrative']	['Possibly_Negative']
no patients enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Original sponsor withdrew funding.	['Business_Administrative']	['Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
Not enough sugjects enrolled before funding ran out	['Business_Administrative']	['Possibly_Negative']
difficult to patient inclusion	['Insufficient_Enrollment']	['Neutral']
Sponsor decision not related to patient safety	['Business_Administrative']	['Possibly_Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Logistical issues	['Logistics_Resources']	['Neutral']
The stereotaxis can be threatful for the patients because of respiratory insufficiency	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Halted due to funding issues.	['Business_Administrative']	['Possibly_Negative']
Withdrawn for administrative reasons	['Business_Administrative']	['Possibly_Negative']
Study did not get started.	['Invalid_Reason']	['Invalid_Reason']
stopped prematurely	['Invalid_Reason']	['Invalid_Reason']
Recruitment challenges	['Insufficient_Enrollment']	['Neutral']
Difficulty in enrolling patients	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Trial suspended due to COVID-19.	['Covid19']	['Neutral']
Unable to obtain IRB approval at all sites	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
the study was terminated early due to poor enrollment	['Insufficient_Enrollment']	['Neutral']
Device has been FDA approved.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Study TLK199.2102 was terminated for lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
Due to portfolio/business decisions by the sponsor	['Business_Administrative']	['Possibly_Negative']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
PI decision to close study early	['Invalid_Reason']	['Invalid_Reason']
The study was early terminated due to slow and difficult recruitment	['Insufficient_Enrollment']	['Neutral']
CorAssist believes that certain improvements are needed to the device	['Study_Design']	['Neutral']
Requested by PI during yearly Continuing Review	['Interim_Analysis', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Principal investigator left institution	['Study_Staff_Moved']	['Neutral']
The study was stopped due to slow patient recruitment and insufficient patient compliance.	['Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral']
PI transferred to another institution and did not take this study with him.	['Study_Staff_Moved']	['Neutral']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
Only 5 caregivers decided to participate	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
PI wanted to discontinue study.	['Invalid_Reason']	['Invalid_Reason']
No participants	['Insufficient_Enrollment']	['Neutral']
Sponsor due to COVID-19	['Covid19']	['Neutral']
"First the study failed to recruit the required sample size. Second, we no longer have acess to
    the clinics, due to the coronavirus outbreak"	['Insufficient_Enrollment']	['Neutral']
"Study approved with treatment regimen based on current guidelines. However, reimbursement of
    IMP was not feasible."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Temporarily paused due to COVID-19 and expected to resume. This is not a suspension of IRB
    approval."	['Covid19']	['Neutral']
Study terminated due to futility	['Negative']	['Negative']
Majority of enrolled patients have withdrawn.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Ran out of funding	['Business_Administrative']	['Possibly_Negative']
Due to suggestions of IRB committee in our institution	['Interim_Analysis', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
No recruitment.	['Insufficient_Enrollment']	['Neutral']
Lower prevalence than expected and the inclusion was difficult.	['Insufficient_Enrollment']	['Neutral']
Not developing product	['Business_Administrative']	['Possibly_Negative']
Signing a contract with the company owning the equipment	['Business_Administrative']	['Possibly_Negative']
Principal Investigator decided not to pursue enrollment due to changes in standard of care.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Low rate of recruitment (only one patient up to May 2014)	['Insufficient_Enrollment']	['Neutral']
enrollment terminated, analysis ongoing	['Invalid_Reason']	['Invalid_Reason']
sponsor decision	['Business_Administrative']	['Possibly_Negative']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Pilot study determined that this study would not be feasible.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Unable to recruit patients	['Insufficient_Enrollment']	['Neutral']
The study was not started due to a re-evaluation of the istaroxime development program	['Business_Administrative']	['Possibly_Negative']
Lack of volunteers who would consent to participate and lack of funding	['Business_Administrative']	['Possibly_Negative']
the chief of GS left the hopsital and the successor did't want to keep on this study	['Study_Staff_Moved']	['Neutral']
Primary endpoint not achieved	['Negative']	['Negative']
Failure to enroll adequate patient numbers due to small number of eligible patients	['Insufficient_Enrollment']	['Neutral']
too few patients participated	['Insufficient_Enrollment']	['Neutral']
"Dr. Milla has left University of Minnesota. The study is no longer being conducted at this
    site."	['Study_Staff_Moved']	['Neutral']
"After treatment of 7 patients, it was decided that the handling characteristics of the test
    device should be upgraded before continuing the trial as planned."	['Logistics_Resources']	['Neutral']
"We believe regional anesth better for TKR,90% patients got epidural. Last year we started
    spinal morphine one shot, and found it very promissing."	['Negative']	['Negative']
Closed by sponsor. Lack of funding.	['Business_Administrative']	['Possibly_Negative']
Due to lack of funding provided for Phase II portion of trial	['Business_Administrative']	['Possibly_Negative']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Study was terminated early due to slow recruitment.	['Insufficient_Enrollment']	['Neutral']
PI left institute	['Study_Staff_Moved']	['Neutral']
"The recruitment into DIAS4 has been stopped as the result of DIAS 3 indicates that the study is
    unlikely to reach its primary endpoint with the current protocol"	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Staffing changes precluded sleep study interpretation	['Logistics_Resources']	['Neutral']
"The trial has been terminated earlier following the company decision to discontinue the
    clinical development of Evofosfamide"	['Business_Administrative']	['Possibly_Negative']
Independent Data Monitoring Committee recommendation	['Negative']	['Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
"Per protocol, Phase II is to be terminated early if a less than 5% of the Phase II participants
    observe a Very Good Partial Response or Better in the first 23 participants enrolled to Phase
    II."	['Negative']	['Negative']
difficulty in recruitment	['Insufficient_Enrollment']	['Neutral']
"Due to budgetary concerns, the TSC decided it best to adjust sample size as there was
    sufficient data to assess feasibility. Recruitment was terminated early."	['Business_Administrative']	['Possibly_Negative']
New Safety Information	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Never activated.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Study terminated due to LBH589 toxicity.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
lack of personnel to continue	['Logistics_Resources']	['Neutral']
Grant expired	['Business_Administrative']	['Possibly_Negative']
Trial stopped early for poor accrual.	['Insufficient_Enrollment']	['Neutral']
Grant application for study was rejected	['Business_Administrative']	['Possibly_Negative']
Patient inclusion has stopped after interim analysis.	['Negative']	['Negative']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Terminated by Sponsor	['Business_Administrative']	['Possibly_Negative']
No participant enrolled	['Insufficient_Enrollment']	['Neutral']
Administrative decision	['Business_Administrative']	['Possibly_Negative']
"Lack of clarity regarding the PMS study requirement from the RA and Ethics committee hence it
    was concluded GSK will submit local PSURs."	['Interim_Analysis', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
This study was terminated due to the limited enrollment.	['Insufficient_Enrollment']	['Neutral']
Study was terminated early due to lack of experimental medication (supply issues)	['Logistics_Resources']	['Neutral']
The study terminated early due to the difficulty of recruiting candidates.	['Insufficient_Enrollment']	['Neutral']
feasibility reasons.	['Logistics_Resources']	['Neutral']
Study was suspended due to lack of resources.	['Logistics_Resources']	['Neutral']
Recruitment challenges	['Insufficient_Enrollment']	['Neutral']
IND has been withdrawn and the study is closed.	['Regulatory', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Additional funding was not secured	['Business_Administrative']	['Possibly_Negative']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
This study was stopped by the sponsor based on a non-safety related corporate decision	['Business_Administrative']	['Possibly_Negative']
Organizational reasons and lack of enrollment	['Business_Administrative']	['Possibly_Negative']
Funding withdrawn	['Business_Administrative']	['Possibly_Negative']
"The study was terminated on August 6, 2012, because 2 large Phase 3 studies showed no clinical
    benefit. This decision was not based on any new safety concerns."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Business decision to stop the program.	['Business_Administrative']	['Possibly_Negative']
Business decision based on funding	['Business_Administrative']	['Possibly_Negative']
investigator choice	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
COVID related termination	['Covid19']	['Neutral']
Low Recruitment	['Insufficient_Enrollment']	['Neutral']
Insufficient resources to complete study requirements	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
PI left the department; protocol transfer did not take place.	['Study_Staff_Moved']	['Neutral']
Unable to sufficiently enroll or collect follow-up	['Insufficient_Enrollment']	['Neutral']
This trial was a duplicate entry. Recruitment was never open and no participants were enrolled.	['Insufficient_Enrollment']	['Neutral']
Low enrollment; Physician practice relocating	['Insufficient_Enrollment']	['Neutral']
poor accrual	['Insufficient_Enrollment']	['Neutral']
Study stopped for administrative reasons.	['Business_Administrative']	['Possibly_Negative']
COVID prevented accruals	['Covid19']	['Neutral']
Lack of Funding	['Business_Administrative']	['Possibly_Negative']
sufficient data collected for significant study results	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
PI has left the study institution.	['Study_Staff_Moved']	['Neutral']
Lack of resources	['Logistics_Resources']	['Neutral']
Low Accrual.	['Insufficient_Enrollment']	['Neutral']
"Study was completed with 69 subjects enrolled due to difficult enrolment and adequate biomarker
    data was avaible with 69 subjects in the study."	['Insufficient_Enrollment']	['Neutral']
COVID-19 Interruption	['Covid19']	['Neutral']
Sponsor decided to discontinue study drug development.	['Business_Administrative']	['Possibly_Negative']
"The external funding (pharmaceutical company) was stopped and could not be substituded by
    internal funding."	['Business_Administrative']	['Possibly_Negative']
Investigator left institution	['Study_Staff_Moved']	['Neutral']
Investigator no longer actively pursuing this study.	['Business_Administrative']	['Possibly_Negative']
Investigator has retired.	['Study_Staff_Moved']	['Neutral']
Negative efficacy results of the MAESTRO-01 trial	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study drug not available at this time	['Logistics_Resources']	['Neutral']
Funding stopped	['Business_Administrative']	['Possibly_Negative']
This program was terminated for financial reasons	['Business_Administrative']	['Possibly_Negative']
Funding complete	['Business_Administrative']	['Possibly_Negative']
Study withdrawn due to corporate business decision	['Business_Administrative']	['Possibly_Negative']
Study objectives were considered as obsolete regarding the new AAD arrival	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Only two subjects were enrolled and completed the trial and enrollment of additional subjects
    was too slow. Accordingly, it was decided to terminate the study."	['Insufficient_Enrollment']	['Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Administrative reasons	['Business_Administrative']	['Possibly_Negative']
The study was stopped early due to futility.	['Negative']	['Negative']
Unable to perform the ultrasound.	['Logistics_Resources']	['Neutral']
PI moving to another institution	['Study_Staff_Moved']	['Neutral']
re-written and submitted as a new study	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
The study was stopped march 2009 due to recruitment problems.	['Insufficient_Enrollment']	['Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
"This study was stopped before any subjects were treated, consequently there are no results for
    the study."	['Negative', 'Another_Study']	['Negative', 'Neutral']
See Detailed Description	['No_Context']	['Invalid_Reason']
"The FDA advised of a possible health risk associated with lorcaserin and the drug is being
    withdrawn."	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Lab Staff that was required left the institution, therefore accrual closed prematurely	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
recruitment target not obtained	['Insufficient_Enrollment']	['Neutral']
Terminated	['Invalid_Reason']	['Invalid_Reason']
Decision was made to suspend enrollment until further notice.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Terminated due to insufficient efficacy	['Negative']	['Negative']
This study did not meet the efficacy objective	['Negative']	['Negative']
poor accrual	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Investigator departure (and wish not set up study)	['Study_Staff_Moved']	['Neutral']
difficulty in finding eligible subjects	['Insufficient_Enrollment']	['Neutral']
Terminated to initiate FDA IND-cleared study protocol	['No_Context', 'Regulatory', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
new methods of treatment, no more patients appilicable for study	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Insufficient Enrollment	['Insufficient_Enrollment']	['Neutral']
"The laboratory's partner on this study decides to terminate the contract with the CHRU Brest,
    because of the difficulty of the recruitment."	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The original PI, Alexander Neumeister, left NYULMC. No data was analyzed.	['Study_Staff_Moved']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Study did not pass Stage 1 interim analysis.	['Negative']	['Negative']
"Unable to reliably reproduce, visualize, or quantify microvascular flow in the subcutaneous
    tissue, the skeletal muscle or peri-adventitia"	['Logistics_Resources', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Financial problem (not enough budget to continue the study)	['Business_Administrative']	['Possibly_Negative']
Funding unavailable	['Business_Administrative']	['Possibly_Negative']
Ingenol mebutato discontinued in Brazil.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Temporary halt of the trial due to COVID-19 crisis related delays	['Covid19']	['Neutral']
Refer to statement in Summary Section/Detailed Description	['No_Context']	['Invalid_Reason']
due to futility	['Negative']	['Negative']
This study was not enrolled completely and was terminated.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
due to lack of supply of medication and technical problems with the MRI	['Logistics_Resources']	['Neutral']
All investigators/co-investigators relocating to other institutions.	['Study_Staff_Moved']	['Neutral']
"Sponsor withdrew funding du to lack of enrollment. Lack of enrollment was due to decrease in
    number of islet transplant procedures"	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
study not accruing	['Insufficient_Enrollment']	['Neutral']
Safety	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"Study no longer needed because eligible subjects may receive treatment with cobomarsen in a
    crossover arm of the SOLAR clinical trial (NCT03713320)"	['Negative', 'Another_Study']	['Negative', 'Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
terminated by PI	['No_Context', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
resubmission planned	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
started a NIH study that is competing for same subjects	['Negative', 'Another_Study']	['Negative', 'Neutral']
very slow recruitment and treatments beyond expiry date	['Insufficient_Enrollment']	['Neutral']
LAIV was no longer recommended by ACIP	['Regulatory', 'Ethical_Reason', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
pending protocol/funding review	['Business_Administrative']	['Possibly_Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Terminated early due to lack of study feasibility and poor patient recruitment	['Insufficient_Enrollment']	['Neutral']
lack of efficacy and lack of funding	['Business_Administrative']	['Possibly_Negative']
Business decision	['Business_Administrative']	['Possibly_Negative']
Parastomal Parietex withdrawn from market by the manufacturer.	['Covid19', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
COVID Restrictions in a vulnerable population.	['Covid19']	['Neutral']
The benefit/risk profile does not support continuation of this study.	['Negative']	['Negative']
"Clinical practice had changed between time of initial protocol development and subject
    recruitment. We were not able to find eligible patients."	['Insufficient_Enrollment']	['Neutral']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Inadequate patient accrual	['Insufficient_Enrollment']	['Neutral']
Terminated by pharmaceutical sponsor - no accrual	['Insufficient_Enrollment']	['Neutral']
No efficacy (interim.analysis)	['Negative']	['Negative']
Study terminated due to sponsor decision	['Business_Administrative']	['Possibly_Negative']
prematurely terminated due to loss of interest	['Business_Administrative']	['Possibly_Negative']
challenges in recruitment due to covid-19	['Covid19']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
terminated due to futility after interim analysis	['Negative']	['Negative']
Lack of financial support	['Business_Administrative']	['Possibly_Negative']
No funding	['Business_Administrative']	['Possibly_Negative']
accrual of evaluable subjects too low	['Insufficient_Enrollment']	['Neutral']
"Interim analysis of the present study showed a significant decrease in mortality rate (p= 0.04)
    as well as in the number of days at the ICU p=0.0002."	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Business decision to focus on other studies. No safety concern.	['Business_Administrative']	['Possibly_Negative']
On reviewing of new data	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Withdrawn by drug manufacturer	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Results obtained are sufficient for a publication.	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Only recruitment temporarily paused due to Covid-19	['Covid19']	['Neutral']
Strategic considerations	['Business_Administrative']	['Possibly_Negative']
MRI perfusion techniques development took longer than expected.	['Logistics_Resources']	['Neutral']
IRB requirements to start study could not be met in a timely manner	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
"A company's strategic decision to focus on areas whereit believes it can be competitive and
    decided to exit Oncology"	['Business_Administrative']	['Possibly_Negative']
Interim analysis results indicated need to recruit beyond scope of budget.	['Business_Administrative']	['Possibly_Negative']
Timeframe of the IMI project couldn't be expended	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The study was terminated due to change in focus of the development program	['Business_Administrative']	['Possibly_Negative']
Withdrawal of institutional support	['Business_Administrative']	['Possibly_Negative']
Due to COVID this study was never started.	['Covid19']	['Neutral']
Study terminated early 22Feb2010 with only 4 participants due to business reasons.	['Business_Administrative']	['Possibly_Negative']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
The data did not show clear results	['Negative']	['Negative']
Study stopped following management decision	['Business_Administrative']	['Possibly_Negative']
"Slow enrolment over the last 2 years with none in the past 1 year. No increase in the number of
    completed subjects for 1 year and no more ongoing study subjects"	['Insufficient_Enrollment']	['Neutral']
"Due to an SAE, Regeneron has decided to temporarily suspend all dosing and enrollment of new
    subjects at this time. Patients currently enrolled will not receive additional treatment on
    study and will be monitored for safety."	['Covid19', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
"South African Health Authorities now promote that HIV positive mothers should receive
    anti-retroviral drugs and breastfeed their infants."	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
PI left the institution	['Study_Staff_Moved']	['Neutral']
"This study was terminated before the planned sample size was enrolled because results indicated
    that a higher dose was necessary to elicit an efficacy effect."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
No coordinator available to work on study.	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Study was not started due to lack of funding	['Business_Administrative']	['Possibly_Negative']
"Due to inability of patient enrollment, decision taken to terminate in the interests of
    patients and later Malaysia is incorporated into global Phase 3 trial."	['Insufficient_Enrollment']	['Neutral']
"Target study population was extremely difficult to recruit and planned study budget was
    exceeded"	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The PI requested to terminate due to his schedule	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Study subjects were not enrolled.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
lack of resources	['Logistics_Resources']	['Neutral']
Feasibility/pilot study of 5 subjects registration not required	['Logistics_Resources', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
"The PI decided to close the study early as patients with diffused macular oedema without any
    previous treatment are uncommon."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Because we dont have the necessary technology anymore	['Logistics_Resources']	['Neutral']
Study Suspended 06Feb2020 per FDA Request	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Low inclusion rate	['Insufficient_Enrollment']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Insufficient efficacy in Phase 1 dose-escalation portion of study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of enrollment and limited funding	['Business_Administrative']	['Possibly_Negative']
Study never started. Operational issues prevented study from rolling out	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
There was a high drop-out rate and we were unable to recruit new subjects.	['Insufficient_Enrollment']	['Neutral']
due to other priorities	['Business_Administrative']	['Possibly_Negative']
None of the screened subjects were interested / eligible for enrollment.	['Insufficient_Enrollment']	['Neutral']
Difficult to recruit severely affected patients with fecal incontinence	['Insufficient_Enrollment']	['Neutral']
"Inability of the ETOLYA's manufacturer to furnish the promised functionalities as those which
    had to be recorded for assessment of the study's end points"	['Logistics_Resources']	['Neutral']
Due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
No participants were enrolled.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
The site decided not to proceed with the protocol.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Safety profile was not satisfying with sevolflurane	['Safety_Sideeffects', 'Logistics_Resources', 'Endpoint_Met']	['Safety_Sideeffects', 'Neutral', 'Neutral']
"The initial plan was 2 years but due to slow recruitment. We were able to screen 635 patients
    in 4 years and recruited only 127 patients."	['Insufficient_Enrollment']	['Neutral']
Not enough data.	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Sample was under-powered	['Logistics_Resources']	['Neutral']
PI Left Institution	['Study_Staff_Moved']	['Neutral']
Manufacturer of Alvimopam closed the study due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
Investigator Preference.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Due to slow accrual, study team has decided to end the study early.	['Insufficient_Enrollment']	['Neutral']
recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
"This study was combined with another CIHR funded study (NCT02078635). Both studies involve the
    same dietary portfolio and the same study population."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Withdrawn for business reasons	['Business_Administrative']	['Possibly_Negative']
PI was away on sabbatical for 2 years.Protocol is being revised before starting the study.	['Study_Design']	['Neutral']
Lack of resources	['Logistics_Resources']	['Neutral']
Study stopped per Novartis request due to futility from another study.	['Negative', 'Another_Study']	['Negative', 'Neutral']
difficulty of inclusion	['Insufficient_Enrollment']	['Neutral']
"The study was terminated under the political pressure of the Federal Security Service of the
    Russian Federation (FSB) and the Russian Society of Cardiology"	['Ethical_Reason', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
The protocol finished.	['Invalid_Reason']	['Invalid_Reason']
recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Study was terminated due to poor accrual.	['Insufficient_Enrollment']	['Neutral']
Boston Scientific has decided to close the Study.	['Business_Administrative']	['Possibly_Negative']
Company decision taken in light of demands by certain national health authorities	['Business_Administrative']	['Possibly_Negative']
Could not recruit any more people.	['Insufficient_Enrollment']	['Neutral']
(suspension)	['Interim_Analysis', 'Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
The study was terminated early due to slow enrollment and difficulties with long-term follow-up	['Insufficient_Enrollment']	['Neutral']
funding exhausted	['Business_Administrative']	['Possibly_Negative']
Recruitment halted by DSMB following interim analysis.	['Negative']	['Negative']
test device not approved to be used	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
Recruitment delayed, trial medication no loner available	['Insufficient_Enrollment']	['Neutral']
"Based on the developments in the treatment of recurrent metastatic renal cancer, the study
    treatment is no longer considered to be the best treatment option"	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Enrolment halted by Steering Committee on advice from Data Monitoring Committee.	['Negative']	['Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Continued effort did not successfully increase recruitment into the study.	['Insufficient_Enrollment']	['Neutral']
very slow recruitment	['Insufficient_Enrollment']	['Neutral']
Low recruitment due to few eligible participants.	['Insufficient_Enrollment']	['Neutral']
Sponsor business decision, not based on safety or efficacy data.	['Business_Administrative']	['Possibly_Negative']
No participants enrolled.	['Insufficient_Enrollment']	['Neutral']
The study was halted prior to enrollment of first participant due to non funding and recourses.	['Business_Administrative']	['Possibly_Negative']
Low participant enrollment rates. Significant comparative data not obtained.	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
No patients enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
is finish	['Invalid_Reason']	['Invalid_Reason']
Patient enrolment proved to be more difficult than foreseen and was stopped at 46 inclusions.	['Insufficient_Enrollment']	['Neutral']
"The study was terminated due to an unexpected preliminary result obtained from the study with
    CR8020."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Premature discontinuation of inclusions by the sponsor for low inclusion	['Insufficient_Enrollment']	['Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
PI is moving the a new institution and ended the study early.	['Study_Staff_Moved']	['Neutral']
Insufisciency of recruitment	['Insufficient_Enrollment']	['Neutral']
Difficulty enrolling patients and PI moved institutions.	['Insufficient_Enrollment']	['Neutral']
"reaching of step 1 (recruitment of 8 patients) per protocol -> risk assessment -> termination
    because of occurance of toxicity Grade 3 and 4"	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Logistics failure and staff/scanner shortage	['Logistics_Resources']	['Neutral']
Other	['Logistics_Resources', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
"Patient accrual is slow and software renewal is costly and beyond our allocated fund for this
    study."	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
COVID-19 pandemic	['Covid19']	['Neutral']
Unable to achieve enrollment goal.	['Insufficient_Enrollment']	['Neutral']
clinical myalgia	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Study not started, no subjects recruited.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
written here by mistake	['Covid19', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Study did not receive IRB approval.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
There was no patient accrual nor study activity due to inability to fund PFTs.	['Insufficient_Enrollment']	['Neutral']
Safety issues from trials in CLL	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Absence of positive results	['Negative']	['Negative']
Please see Detailed Description for termination reason.	['No_Context']	['Invalid_Reason']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
"This study terminated on April 8, 2015 due to a corporate decision and not related to the
    safety or efficacy of the protocol."	['Business_Administrative']	['Possibly_Negative']
Withdrawn study.	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Low efficacy rates	['Negative']	['Negative']
The study was not activated.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Lack of efficacy of the drug; no safety concern	['Negative']	['Negative']
drug now on market	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Protocol Amendment in process, pending reengineering of intruments	['Study_Design']	['Neutral']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
the study had to be stopped because the period of the Financial contract was over	['Business_Administrative']	['Possibly_Negative']
Protocol redesign	['Study_Design']	['Neutral']
Lack of financial resources	['Business_Administrative']	['Possibly_Negative']
Study stopped due to business reasons, following full enrollment of the first dose cohort.	['Business_Administrative']	['Possibly_Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
It wasn't possible to recruit the desired number of patients.	['Insufficient_Enrollment']	['Neutral']
"Third group realisation has not been necessary regarding the results of the first two groups
    (no sufficient modifications in the immune response)"	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Based upon preliminary safety and efficacy results from a similar study.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Change in excimer laser systems prior to completion of study	['Covid19', 'Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Futility analysis suggested termination	['Negative']	['Negative']
Terminated due to futility and less subjects meeting entry criteria	['Negative']	['Negative']
Lack of funds	['Business_Administrative']	['Possibly_Negative']
Subjects did not meet inclusion criteria	['Insufficient_Enrollment']	['Neutral']
To many infants in the experimental group developed hypertriglyceridemia	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Funding did not come through as the product was sold to another company.	['Business_Administrative']	['Possibly_Negative']
the fellow interested in this project left the institution	['Study_Staff_Moved']	['Neutral']
Trial cancelled before First Patient First Visit (no patient enrolled)	['Invalid_Reason']	['Invalid_Reason']
Based on a business decision unrelated to any safety concerns.	['Business_Administrative']	['Possibly_Negative']
Insufficient time for study extenuating personal circumstances of PI	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
"Given the infeasibility to achieve the study population together with the loss of originality
    in the scientific rationale, it was considered to cancel the study"	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"After recommendation because of the impossibility to end study with 1 center only. Outcomes of
    patients already included will be evaluated."	['No_Context', 'Safety_Sideeffects', 'Logistics_Resources']	['Invalid_Reason', 'Safety_Sideeffects', 'Neutral']
PI Request	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
The available study medication reached expiry (logistics).	['Logistics_Resources']	['Neutral']
Human metabolite not yet covered sufficiently by nonclinical data	['Negative']	['Negative']
per protocol design	['Study_Design']	['Neutral']
This study was terminated due to expired drug with possibility of re-starting in the future.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
The funder never paid for the study.	['Business_Administrative']	['Possibly_Negative']
Research fellow left institution	['Study_Staff_Moved']	['Neutral']
Terminated due to slow enrollment.	['Insufficient_Enrollment']	['Neutral']
COVID	['Covid19']	['Neutral']
poor enrolment	['Insufficient_Enrollment']	['Neutral']
"The study was never started by the responsible party (medical student who is no longer at the
    institution)."	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Temporarily paused due to COVID-19 and expected to resume.	['Covid19']	['Neutral']
Difficulty in finding suitable patients	['Insufficient_Enrollment']	['Neutral']
AVE5530 in hypercholesterolemia was stopped due to insufficient efficacy	['Negative']	['Negative']
"We decided to terminate recruit earlier because patient recruiting was not active as expected
    at the beginning of the study."	['Insufficient_Enrollment']	['Neutral']
sponsor determined study design would not produce useful results	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Inadequate enrollment	['Insufficient_Enrollment']	['Neutral']
This study was prematurely terminated due to low enrollment and not for safety reasons.	['Insufficient_Enrollment']	['Neutral']
Safety	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
The study was not feasible to conduct in the US and abroad.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
no funding	['Business_Administrative']	['Possibly_Negative']
"Data from a recently completed Phase I trial of enzalutamide and rucaparib is being reviewed to
    determine the need for the PK substudy"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Change in the development plan for the anti-OX40 antibody.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Further screening, enrollment, and dosing of subjects was suspended due to a clinical stock
    recovery action."	['Endpoint_Met', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
budget	['Business_Administrative']	['Possibly_Negative']
Support withdrawn due to slow accrual	['Insufficient_Enrollment']	['Neutral']
2017 business decision to cease GEN-003 spending.	['Business_Administrative']	['Possibly_Negative']
Due to low inclusion rate we terminated this study with n=20 participants instead of n=50.	['Insufficient_Enrollment']	['Neutral']
Terminated due to low enrollment because of decrease in DVT rates.	['Insufficient_Enrollment']	['Neutral']
"APPRISE closure prompted by SWOG S0205 not meeting primary endpoint-improving OS. APPRISE
    enrollment closure due to similar design;no unexpected safety data"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Unable to enroll	['Insufficient_Enrollment']	['Neutral']
Not enough subjects.	['Insufficient_Enrollment']	['Neutral']
Study was terminated in order to examine study data.	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
FDA sent letter to IRB stating it should be done under new drug application	['Covid19', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
Oxford BioMedica halted TroVax injections	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Unable to recruit study participants	['Insufficient_Enrollment']	['Neutral']
"Study was withdrawn due to delay in timelines. There were no safety concerns regarding the
    study or the compound in the decision to withdraw the trial."	['Interim_Analysis', 'Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
PI moving outside VA- grant not transferable	['Business_Administrative']	['Possibly_Negative']
No funding	['Business_Administrative']	['Possibly_Negative']
lack of data	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Business reasons	['Business_Administrative']	['Possibly_Negative']
unable to recruit	['Insufficient_Enrollment']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
DSMB recommended closure of the protocol due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
Trial not started due to accumulating evidence against HCQ for COVID	['Covid19']	['Neutral']
closed in agreement of the sponsor and institution due to lack of patient accrual.	['Insufficient_Enrollment']	['Neutral']
substance discontinued	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
lack of participants	['Insufficient_Enrollment']	['Neutral']
unable to obtain contract with sponsor	['Business_Administrative']	['Possibly_Negative']
the study was stopped because of lack of interest	['Business_Administrative']	['Possibly_Negative']
This trial discontinued March 7,2009 due to high screen failure rate.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
COVID	['Covid19']	['Neutral']
Insufficient accrual	['Insufficient_Enrollment']	['Neutral']
"Sufficient information was gathered from cohort 1 to terminate the study without proceeding to
    optional cohort 2."	['Success', 'No_Context', 'Endpoint_Met']	['Success', 'Invalid_Reason', 'Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Poor Enrollment	['Insufficient_Enrollment']	['Neutral']
"The study was terminated due to the interim Analysis results indicating a weaker correlation
    than anticipated and reported by other study groups."	['Negative']	['Negative']
Slow enrollment and administrative reasons	['Business_Administrative']	['Possibly_Negative']
Strategic decision unrelated to safety or efficacy	['Business_Administrative']	['Possibly_Negative']
Sponsor's decision	['Business_Administrative']	['Possibly_Negative']
Sterility problems in DepoCyte production	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
HLT determined that design changes are necessary before reopening a study	['Study_Design']	['Neutral']
Enrolling failure (lack of participants)	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
"It was decided by Sponsor on 13 January 2014 to terminate study early at primary efficacy
    endpoint as part of a decision to modify drug development plan."	['Business_Administrative']	['Possibly_Negative']
poor accrual	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
No patient met the criteria for inclusion in the study.	['Insufficient_Enrollment', 'Negative']	['Neutral', 'Negative']
The study was terminated for business reasons and not due to safety concerns.	['Business_Administrative']	['Possibly_Negative']
Study was terminated due to serious adverse event (SAE)	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Administrative reasons, and did not meet sample size requirements	['Business_Administrative']	['Possibly_Negative']
Adjustment of company focus due to acquision by Valeant Pharmaceuticals	['Business_Administrative']	['Possibly_Negative']
Sponsor's Decision	['Business_Administrative']	['Possibly_Negative']
Investigator's decision.	['Invalid_Reason']	['Invalid_Reason']
COVID-19 continues to prevent recruitment of people over the age of 65 years.	['Covid19']	['Neutral']
Withdrawn. Unable to set up appropriate infrastructure to support study.	['Logistics_Resources']	['Neutral']
Incyte has suspended development of the compound.	['Business_Administrative']	['Possibly_Negative']
Due to MOH request.	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Study never activated/opened as funding source and other support not available.	['Business_Administrative']	['Possibly_Negative']
PI left institution	['Study_Staff_Moved']	['Neutral']
Sponsor recalled the study	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
no subject met enrollment criteria	['Insufficient_Enrollment']	['Neutral']
Due to lack of availability of study participants to accommodate the study design	['Insufficient_Enrollment']	['Neutral']
COVID-19 and re-organisation at the hospital	['Covid19']	['Neutral']
PI resignation	['Study_Staff_Moved']	['Neutral']
Strategic decision	['Business_Administrative']	['Possibly_Negative']
Feasibility issues require solutions.	['Logistics_Resources']	['Neutral']
reorganization proceedings with a potential risk of company liquidation	['Business_Administrative']	['Possibly_Negative']
the physician responsable for this protocol left our hospital	['Study_Staff_Moved']	['Neutral']
Insufficient accrual	['Insufficient_Enrollment']	['Neutral']
Unable to obtain IND currently	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Principal investigator left the institution.	['Study_Staff_Moved']	['Neutral']
Low Recruitment	['Insufficient_Enrollment']	['Neutral']
Limiting funding sources forced us to withdraw the study.	['Business_Administrative']	['Possibly_Negative']
Re-prioritization lead to study cancellation.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Stop production PRB kit	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Due to termination of clinical program for Parkinson's Disease	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Funding unavailable	['Business_Administrative']	['Possibly_Negative']
Study drug not available.	['Logistics_Resources']	['Neutral']
Not enough patients	['Insufficient_Enrollment']	['Neutral']
End of production	['Invalid_Reason']	['Invalid_Reason']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
"More favorable safety profile was observed in QD schedule, therefore further enrollment in QW
    schedule was terminated."	['Endpoint_Met', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
No Participants Registered	['Insufficient_Enrollment']	['Neutral']
slow enrollment, lack of funding	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
transferred to different institution	['Study_Staff_Moved']	['Neutral']
IND voluntarily withdrawn, without prejudice	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Restrictive inclusion criteria/limited pool of suitable subjects with SFN.	['Insufficient_Enrollment']	['Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
waiting for the ethics approval of collaborator affiliation	['Logistics_Resources', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Recruiting or enrolling participants has halted and will not resume	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
No funding	['Business_Administrative']	['Possibly_Negative']
PI does not wish to move forward with the Study	['Study_Staff_Moved', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
"The funding sponsor decided to move in a different direction and terminated the study before
    site began patient recruitment."	['Business_Administrative']	['Possibly_Negative']
Lack of feasibility.	['Logistics_Resources']	['Neutral']
OPTION pilot trial merged with the new NCT03782818 - OPTION multicenter trial	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Inability to enroll subjects	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Recruitment Completed	['Invalid_Reason']	['Invalid_Reason']
data was received from another source, therefore phlebotomy was not necessary	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Removing from ClinicalTrials.gov as this is not really a clinical trial.	['Covid19', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Project terminated due to insufficient resources for recruitment.	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
"logistic issues - no available scans for participants at the moment need to postponed starting
    dates"	['Logistics_Resources']	['Neutral']
Funding no longer available and PI no longer working at the institution	['Business_Administrative']	['Possibly_Negative']
Terminated prior to enrollment goals due to difficulty with recruiting subjects	['Insufficient_Enrollment']	['Neutral']
enrollment default	['Insufficient_Enrollment']	['Neutral']
Study was closed due to recommendations of performing a PK study first.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
No study subjects enrolled, Investigator decided to cancel the project	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Monitor manufacturer stopped marketing plan for the product.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Study never went beyond FDA application for an IND #. FDAA required institutional DSMC which
    this institution then lacked."	['Regulatory', 'Ethical_Reason', 'Negative']	['Neutral', 'Neutral', 'Negative']
unable to recruit subjects for study.Collaborator stopped funding for study as of 3/31/2010	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Change in priorities occurred	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
The company has decided not to conduct the study	['Business_Administrative']	['Possibly_Negative']
Poor recruitment due to rare targeted population	['Insufficient_Enrollment']	['Neutral']
Sponsor terminated	['Business_Administrative']	['Possibly_Negative']
Issues with application of Clozex intervention	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
"The study was terminated early because of significant efficacy results for the primary endpoint
    in favor of benazepril/amlodipine treatment."	['Endpoint_Met', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Poor Accrual	['Insufficient_Enrollment']	['Neutral']
Unable to recruit large enough sample; large expectancy effects but no adverse events	['Insufficient_Enrollment']	['Neutral']
Terminated (Business Decision to pursue other indications)	['Business_Administrative']	['Possibly_Negative']
Due to an atypical health scenario caused by the COVID-19 pandemic	['Covid19']	['Neutral']
Due to covid-19	['Covid19']	['Neutral']
protocol qualifies as not human subjects research	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
COVID	['Covid19']	['Neutral']
other drugs other studies	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
The study stopped due to futility.	['Negative']	['Negative']
Interim Analysis ongoing	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
Futility	['Negative']	['Negative']
"The study was terminated prior to the planned final on-treatment efficacy assessments due to
    commercial availability of tocilizumab in Russia and Poland."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Challenges with recruitment	['Insufficient_Enrollment']	['Neutral']
The study did not meet endpoint.	['Negative']	['Negative']
organizational problems	['Business_Administrative']	['Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
"Study was terminated due to the inability to enroll a sufficient number of the required subject
    population"	['Insufficient_Enrollment']	['Neutral']
Unfavourable opinion of ethical comittee for Amendment Nr 3	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Internal desicions	['Logistics_Resources', 'Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
"The study was withdrawn due to change of ownership of the study drug maralixibat. Future
    studies of maralixibat will be posted by Mirum Pharmaceuticals."	['Business_Administrative']	['Possibly_Negative']
Business objectives have changed	['Business_Administrative']	['Possibly_Negative']
This was the cross over study for 09-1 which was terminated early	['Success', 'No_Context', 'Endpoint_Met']	['Success', 'Invalid_Reason', 'Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Decision was made to not go forward with the study	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Sponsor decided not to move forward	['Business_Administrative']	['Possibly_Negative']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Principal Investigator relocated; Study may resume in Fl Hosp. for Children, Orlando FL	['Study_Staff_Moved']	['Neutral']
Study stopped early due to the COVID-19 pandemic	['Covid19']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Industry sponsor withdrew financial support as well as the testing equipment.	['Business_Administrative']	['Possibly_Negative']
Pause due to COVID-19 Pandemic	['Covid19']	['Neutral']
"The Chief Investigator and the Sponsor have concluded that it will not be possible to complete
    the enrolment in any meaningful timeframe."	['Insufficient_Enrollment']	['Neutral']
Primary endpoint voided. Dosimeters did not capture radiation dose as expected.	['Interim_Analysis', 'Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
"Pilot study with sumatriptan found no significant changes in the primary outcome parameter
    (change in CBF)"	['Negative']	['Negative']
Ran out of funding	['Business_Administrative']	['Possibly_Negative']
Initial main phase completed but recruitment rate was too slow to continue.	['Insufficient_Enrollment']	['Neutral']
Study terminated due to business realignment	['Business_Administrative']	['Possibly_Negative']
0	['No_Context', 'Insufficient_Enrollment', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
sponsor decision	['Business_Administrative']	['Possibly_Negative']
Unrelated serious adverse events involving one of the proposed medications	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
The enrollment has been terminated by the NHLBI for administrative reasons.	['Business_Administrative']	['Possibly_Negative']
Inadequate funding	['Business_Administrative']	['Possibly_Negative']
SARS-CoV2 pandemic	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
"The termination was due to business reasons. No safety or efficacy concerns contributed to the
    termination of the study"	['Business_Administrative']	['Possibly_Negative']
No Interest. Investigator was unable to enroll any participants on study.	['Insufficient_Enrollment']	['Neutral']
Changed regulations of culture procedure	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Funding was not available	['Business_Administrative']	['Possibly_Negative']
PI left institution	['Study_Staff_Moved']	['Neutral']
See termination reason in detailed description	['No_Context']	['Invalid_Reason']
FDA approval was not obtained until adult trial completes accrual	['Regulatory', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
slow enrollment due to change in worldwide scaffold usage	['Insufficient_Enrollment']	['Neutral']
Very low enrollment	['Insufficient_Enrollment']	['Neutral']
"Because of the lack of the candidates and because of restrictions of denervation at the
    completion date."	['Insufficient_Enrollment']	['Neutral']
"The trial was terminated early due to slow enrollment. It was determined that the planned
    sample size of 300 could not be achieved."	['Insufficient_Enrollment']	['Neutral']
Funding completed	['Business_Administrative']	['Possibly_Negative']
Slow inclusion	['Insufficient_Enrollment']	['Neutral']
Principal Investigator moving out of state, no other staff to lead research.	['Study_Staff_Moved']	['Neutral']
Unsuccessful recruitment	['Insufficient_Enrollment']	['Neutral']
low enrollment	['Insufficient_Enrollment']	['Neutral']
Development of glembatumumab vedotin was discontinued	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
The Principal Investigator is leaving Johns Hopkins.	['Study_Staff_Moved']	['Neutral']
Insufficient recruitment.	['Insufficient_Enrollment']	['Neutral']
Sponsor has decided to not proceed with this study.	['Business_Administrative']	['Possibly_Negative']
no personnel available to enroll patients- decision made to not complete study	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
We did not accrue as much as anticipated and the PI (Dabaja) is no longer at Weill Cornell.	['Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Sponsor terminated the study	['Business_Administrative']	['Possibly_Negative']
Sub par recruitment performance	['Insufficient_Enrollment']	['Neutral']
funding difficulty	['Business_Administrative']	['Possibly_Negative']
Due to preliminary results of Altitude Trial.	['Negative', 'Another_Study']	['Negative', 'Neutral']
The study was prematurely terminated due to strategic reasons.	['Business_Administrative']	['Possibly_Negative']
No eligible subject enrolled	['Insufficient_Enrollment']	['Neutral']
Loss of funding before enrollment.	['Business_Administrative']	['Possibly_Negative']
Terminated per PI's request	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"Sponsor the return rights of the compound to the collaboration partner for further clinical
    development"	['Business_Administrative']	['Possibly_Negative']
"Study withdrawn without starting or enrolling subjects due to a business decision to not
    proceed with the project."	['Business_Administrative']	['Possibly_Negative']
The study did not open to accrual. No start date and no completion dates.	['Insufficient_Enrollment']	['Neutral']
Due to poor accrual	['Insufficient_Enrollment']	['Neutral']
"Study is a commitment for license renew, we target on Apr19 submission, considering timeline, a
    cut off should be scheduled in Apr18."	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The Sponsor decided to stop further manufacture the study drug 'Linsitinib' in Nov 2015.	['Covid19', 'Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
financial reasons / insufficient enrollment activity	['Business_Administrative']	['Possibly_Negative']
PI has left Riley Anesthesia. Lack of staff for continued recruitment	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
There were no eligible patients in the paticipated centers.	['Insufficient_Enrollment']	['Neutral']
Non-favorable risk/benefit profile with studied dosing regimen	['Negative']	['Negative']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
"Redundant in-clinic visits increased the workload in virtual follow-up group. An interim
    analysis showed that the study would not support the primary hypothesis"	['Negative']	['Negative']
PK portion will be included in a future protocol	['Negative', 'Another_Study']	['Negative', 'Neutral']
Sponosor's decision	['Business_Administrative']	['Possibly_Negative']
Business objectives have changed	['Business_Administrative']	['Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
Sponsor closed study	['Business_Administrative']	['Possibly_Negative']
Study closed due to poor accrual.	['Insufficient_Enrollment']	['Neutral']
"This is quality improvement review and should not have been registered. No participants were
    enrolled"	['Interim_Analysis', 'Regulatory', 'Negative']	['Neutral', 'Neutral', 'Negative']
Study suspended due to company decision prior to enrollment.	['Business_Administrative']	['Possibly_Negative']
The study needed to be stopped due to the COVID-19 pandemic.	['Covid19']	['Neutral']
Due to poor enrollment, this study was withdrawn/ terminated.	['Insufficient_Enrollment']	['Neutral']
"This study was structured in 2 phases, and was stopped after the first phase. The collected
    data will be used to improve the device and prepare future studies."	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
"The manufacturer of the device has pending modifications to the device. Enrollment will resume
    once the revised devices are received at the site"	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
terminatedd due to insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Unforeseen reduction of recruitment resource.	['Insufficient_Enrollment']	['Neutral']
No more data collected.	['Invalid_Reason']	['Invalid_Reason']
"This study is being closed prematurely due to resource availability and agreement constraints
    with the collaborating research site."	['Business_Administrative']	['Possibly_Negative']
Unable to get the vaccine on time to offer it to the study population.	['Logistics_Resources']	['Neutral']
Military related changes led to to no initiation of recruitment.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
"Due to an unsatisfactory benefit/risk ratio, as specified in & 14.8.1 of the protocol, Sanofi
    decided to stop enrollment and terminate ACT14596 prematurely"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Unable to recruit to study due to limited number of patients with ADH	['Insufficient_Enrollment']	['Neutral']
Other strategies followed	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Trial not initiated	['Invalid_Reason']	['Invalid_Reason']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Our physician researcher left WCM after the trial was approved.	['Study_Staff_Moved']	['Neutral']
"The principal investigator is leaving Yale University and will not be continuing the work at
    her new institution."	['Study_Staff_Moved']	['Neutral']
Sponsor chose to change the study design.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Pending Amendment	['Study_Design']	['Neutral']
Institutional Review Board requested termination - all patients deceased and no new accrual.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
The study was withdrawn based on new efficacy data from another study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Business Decision	['Business_Administrative']	['Possibly_Negative']
IRB AND FDA REVIEWS DEFERRED	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Participant enrolment was lower than expected	['Insufficient_Enrollment']	['Neutral']
The study never started due to the Principal Investigator leaving the institution	['Study_Staff_Moved']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Study never funded	['Business_Administrative']	['Possibly_Negative']
when realized that the target 60% of patients with SVR was no more achievable	['Negative']	['Negative']
No funding to start project.	['Business_Administrative']	['Possibly_Negative']
Study terminated due to FDA alert regarding Fleet phosphosoda	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
No Enrollment	['Insufficient_Enrollment']	['Neutral']
The study has been terminated due to difficulties in gathering the patient samples.	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Study logistics	['Logistics_Resources']	['Neutral']
poor accrual	['Insufficient_Enrollment']	['Neutral']
"There was an unexpected toxicology finding observed in the 39 week monkey study. Dosing was
    suspended, the study was put on hold and eventually terminated."	['Safety_Sideeffects', 'Study_Design', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
A company in China has decided to license the product	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Difficulty recruiting. Objectives from this protocol added to another protocol collecting the
    same information."	['Insufficient_Enrollment', 'Study_Design', 'Another_Study']	['Neutral', 'Neutral', 'Neutral']
"No participants enrolled in this trial could receive the SMO antagonist as a recommended phase
    2 dose was not determined by a different, concurrently-run trial."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Enrollment challenging during the pandemic COVID 19	['Covid19']	['Neutral']
sufficient data	['Invalid_Reason']	['Invalid_Reason']
Study was not approved by Health Surveillance Agency	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Terminated early at the Sponsor's discretion, not due to safety concerns.	['Interim_Analysis', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Funding unavailable	['Business_Administrative']	['Possibly_Negative']
Deficient Inclusions	['Insufficient_Enrollment']	['Neutral']
Temporary on hold.	['Invalid_Reason']	['Invalid_Reason']
"Due to the strict in- and exclusion criteria only few patients could be enrolled into the
    study."	['Insufficient_Enrollment']	['Neutral']
Scheduled Interim Monitoring	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Sponsor decision, unrelated to safety	['Business_Administrative']	['Possibly_Negative']
Sponsor opened Phase 2 Study.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Due to COVID-19 lockdown	['Covid19']	['Neutral']
Redesigned sensor to be subjected to a new protocol	['Study_Design']	['Neutral']
decided not to do study. This will be run as a service evaluation instead	['Invalid_Reason', 'Study_Design', 'Another_Study']	['Invalid_Reason', 'Neutral', 'Neutral']
The study team decided not to pursue this study.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Unanticipated slow enrollment	['Insufficient_Enrollment']	['Neutral']
Principal Investigator was leaving the institution.	['Study_Staff_Moved']	['Neutral']
Principal Investigator	['Study_Staff_Moved']	['Neutral']
Additional long-term safety data no longer needed	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Low recruitment rate	['Insufficient_Enrollment']	['Neutral']
Study suspended because of Covid-19 - there are no vaccinations in schools	['Covid19']	['Neutral']
Business Objectives Changed	['Business_Administrative']	['Possibly_Negative']
Low accrual; target accrual not met	['Insufficient_Enrollment']	['Neutral']
The trial was terminated for strategic reasons following the emergence of new data.	['Business_Administrative']	['Possibly_Negative']
accrual goal met	['Invalid_Reason']	['Invalid_Reason']
no accrual	['Insufficient_Enrollment']	['Neutral']
Very slow enrollment.Study entry criteria not in line w/local standards of care	['Insufficient_Enrollment']	['Neutral']
Sponsor decision due to product manufacturing and redesign of clinical trial.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
The study was withdrawn due to many implementation difficulties.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
No longer target indication	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
The Relamorelin program is being terminated solely based on a business decision.	['Business_Administrative']	['Possibly_Negative']
full accrual met	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
drug withdrawn from market	['Study_Design']	['Neutral']
COVID-19	['Covid19']	['Neutral']
The research project has been cancelled before any participants were enrolled.	['Invalid_Reason']	['Invalid_Reason']
Insufficient number of patients	['Insufficient_Enrollment']	['Neutral']
We didn't have enough financial support	['Business_Administrative']	['Possibly_Negative']
Closed: logistical problems that could not be resolved.	['Logistics_Resources']	['Neutral']
pharmaceutical company closed study because the treatment was not effective	['Negative']	['Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
PI decided to terminate the study at this time	['Invalid_Reason']	['Invalid_Reason']
IDMC recommendation for safety concerns	['Covid19', 'Safety_Sideeffects', 'Regulatory']	['Neutral', 'Safety_Sideeffects', 'Neutral']
There is no funding to proceed.	['Business_Administrative']	['Possibly_Negative']
Some patients experienced asymptomatic, transient elevations in liver transaminases	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Inclusion curve too slow.	['Insufficient_Enrollment']	['Neutral']
The study was terminated because of difficulties recruiting subjects.	['Insufficient_Enrollment']	['Neutral']
Recruitment targets were unachievable in the currently available population.	['Insufficient_Enrollment']	['Neutral']
COVID-19 Pandemic made participant recruitment nonfeasible.	['Covid19']	['Neutral']
"Based on Data Monitoring Committee's recommendation on February 3, 2021, the study was stopped
    due to futility."	['Negative']	['Negative']
Funding, portfolio re-prioritization	['Business_Administrative']	['Possibly_Negative']
problems with planned computer	['Logistics_Resources']	['Neutral']
Withdrawn: study halted prematurely, prior to enrollment of first participant	['Invalid_Reason']	['Invalid_Reason']
Per PI due to poor/inadequate accrual.	['Insufficient_Enrollment']	['Neutral']
Not sure if we are going to do this study now.	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
See termination reason in detailed description	['No_Context']	['Invalid_Reason']
Company providing catheter bought out, funding and supplies terminated	['Business_Administrative']	['Possibly_Negative']
Study was withdrawn by PI due to decision to study a different medication.	['Study_Design']	['Neutral']
Subject recruitment was slow, so enrollment has been closed.	['Insufficient_Enrollment']	['Neutral']
Failure to enroll enough participants	['Insufficient_Enrollment']	['Neutral']
Enrollment Difficulties	['Insufficient_Enrollment']	['Neutral']
low rate of covid patients	['Covid19']	['Neutral']
"FDA recommendations to not use outside of the hospital setting or in a clinical trial due to
    the risk of cardiac arrhythmias"	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
COVID-19	['Covid19']	['Neutral']
"The insufficient development of connection networks limit the teleconsultation deployment in
    the Grenoble metropolitan area"	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Low patient accrual	['Insufficient_Enrollment']	['Neutral']
Not able to enroll patient	['Insufficient_Enrollment']	['Neutral']
Unable to access components necessary to be able to run the study.	['Logistics_Resources']	['Neutral']
The study was stopped early due to lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
Collaborating site had difficulty with approval	['Business_Administrative']	['Possibly_Negative']
Airvo 2 not suitable for CO2 clearance, awaiting Optiflow THRIVE machine	['Logistics_Resources']	['Neutral']
studien skjuts p framtiden	['Covid19', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Study did not receive IRB approval, so did not start	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Unable to get the correct software.	['Logistics_Resources']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Device used for eye-blinks did not work as performed.	['Logistics_Resources']	['Neutral']
Enrollment proceeded to slowly	['Insufficient_Enrollment']	['Neutral']
sponsor withdrew support	['Business_Administrative']	['Possibly_Negative']
Study stopped prior to Patient Enrollment	['Invalid_Reason']	['Invalid_Reason']
Futility criteria, unable for Phase 2 of study, & phase 1 was terminated.	['Negative']	['Negative']
Interim analysis did not reveal of anticipated benefits of intervention	['Negative']	['Negative']
The study was prematurely terminated due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
The study was not started due to a re-evaluation of the istaroxime development program	['Business_Administrative']	['Possibly_Negative']
Company ended operations in January 2011	['Business_Administrative']	['Possibly_Negative']
Seeking additional funds	['Business_Administrative']	['Possibly_Negative']
Business Reasons	['Business_Administrative']	['Possibly_Negative']
The study was stopped after 69 subjects were enrolled because of poor accrual.	['Insufficient_Enrollment']	['Neutral']
Funding shortfall	['Business_Administrative']	['Possibly_Negative']
"Infusion reactions during re-induction cycles after a period of no treatment in another study
    [P04563, NCT0358670]"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Took too long to accrue participants, stopped for feasibility concerns	['Insufficient_Enrollment']	['Neutral']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Resources	['Logistics_Resources']	['Neutral']
"Other clinical trails probed that the use of convalescent plasma for patients with COVID-19 is
    safe ."	['Covid19']	['Neutral']
"Withdrawn [COVID restrictions prevent patient enrollment or treatment. Clinical Trial facility
    is being closed due to viral limitations and loss of staff to perform]"	['Covid19']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
High incidence of biloma and liver abscess after TACE	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Terminated prior to completion of accrual per corporate decision.	['Business_Administrative']	['Possibly_Negative']
"Numerically modest lowering of HbA1c with canakinumab in combination with metformin was
    inadequate to continue patients with T2DM into Period IV of this study."	['Negative']	['Negative']
Study has been stopped by sponsor decision	['Business_Administrative']	['Possibly_Negative']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
not enough patients consented during the funding period	['Business_Administrative']	['Possibly_Negative']
"The study was stopped by DSMB based on high treatment failure rate in placebo compared to
    active drug."	['Negative']	['Negative']
Safety concerns, apparent futility and protracted recruitment	['Negative']	['Negative']
Decision of the Sponsor for Early Benefits	['Business_Administrative']	['Possibly_Negative']
"Based on the observed safety profile of COVA322, the sponsor decided to stop the clinical
    study."	['Covid19', 'Safety_Sideeffects', 'Insufficient_Enrollment']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Insuficcient recruiting	['Insufficient_Enrollment']	['Neutral']
"Sponsor decided to prematurely terminate the study and not to pursue marketing approval for the
    indication of malignant glioma."	['Business_Administrative']	['Possibly_Negative']
"The epidemic of COVID-19 has been controlled well in China, no eligible patients can be
    enrolled at present."	['Covid19']	['Neutral']
Terminated early because no patients were further enrolled since mid-Apr 2020.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"security concerns based on preliminary results from preceding CYCOV-I-study suggesting higer
    mortality in cytokine adsorption group"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Due to potential concerns about liver safety (See Detailed Description)	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Low accrual--unable to meet accrual goals	['Insufficient_Enrollment']	['Neutral']
Principal investigator left institution.	['Study_Staff_Moved']	['Neutral']
Problems to recruit patients due to exclusion criteria	['Insufficient_Enrollment']	['Neutral']
Withdrawn due to PI leaving the institution prior to any participants enrolling	['Study_Staff_Moved']	['Neutral']
"Study was terminated based on the findings of primary analysis at 18 months post-RAI treatment.
    Patients pending 3 year follow up had end of study phone call."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Methods unexpectedly required additional refinement that precluded subject enrollment.	['Study_Design']	['Neutral']
Study halted prematurely, prior to enrollment of first participant.	['Invalid_Reason']	['Invalid_Reason']
"Terminated: Study halted prematurely and will not resume; participants are no longer being
    examined or receiving intervention"	['Invalid_Reason']	['Invalid_Reason']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Principal Investigator left the institution	['Study_Staff_Moved']	['Neutral']
Lack of patients and some progressed disease soon after surgery	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
Study halted permanently participants are not being enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Unable to recruit enough eligible subjects	['Insufficient_Enrollment']	['Neutral']
IRB suspension, did not resume	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Primary Endpoint not met	['Negative']	['Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
Study was not funded	['Business_Administrative']	['Possibly_Negative']
"This study was terminated prior to its planned enrollment due to low recruitment rates at the
    time that the funding for the study was completed."	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The study was never started.	['Invalid_Reason']	['Invalid_Reason']
Safety concerns	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Sponsor has designed another study with different endpoint to replace the current study	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Business Decision	['Business_Administrative']	['Possibly_Negative']
Results from other studies did not support continuation of this trial	['Negative', 'Another_Study']	['Negative', 'Neutral']
Insufficient sample number	['Insufficient_Enrollment']	['Neutral']
Feasibility Issues	['Logistics_Resources']	['Neutral']
No inclusion	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Scans showed no visual difference between affected subjects & healthy volunteers	['Negative']	['Negative']
Business Decision	['Business_Administrative']	['Possibly_Negative']
"Only one subject was enrolled and that subject was Lost to Follow Up. Decision was made to
    terminate the study."	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Evaluating potential amendments to the study	['Study_Design']	['Neutral']
No patient enrolled	['Insufficient_Enrollment']	['Neutral']
The trial was stopped after 7 months for lack of recruitment.	['Insufficient_Enrollment']	['Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Inability to recruit sufficient no. of subjects over an acceptable time period	['Insufficient_Enrollment']	['Neutral']
Study discontinued due to administrative reasons unrelated to safety	['Business_Administrative']	['Possibly_Negative']
FDA approval received for product, no additional study subjects required.	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Reached the sample size	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Required contrast media (Vasovist) withdrawn from market	['Logistics_Resources']	['Neutral']
"OvaScience, Inc. is no longer study sponsor as it is undergoing a merger. Follow-up will be
    conducted by sponsor-investigator Dr. Bob Casper."	['Business_Administrative']	['Possibly_Negative']
Internal Study team decision not to proceed.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
study drug unavailable	['Logistics_Resources']	['Neutral']
"Due to restrictions related to COVID the sponsor has decided not to move forward with this
    study"	['Covid19']	['Neutral']
The IRB which was overseeing the study stopped overseeing it	['Regulatory', 'Study_Staff_Moved', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
study did not reach benchmark efficacy rule at 16 subjects	['Negative']	['Negative']
Study stopped due to administrative reasons	['Business_Administrative']	['Possibly_Negative']
Lack of resources	['Logistics_Resources']	['Neutral']
The sponsor terminated the study prior to data analysis for financial reasons.	['Business_Administrative']	['Possibly_Negative']
Please see Detailed Description for termination reason.	['No_Context']	['Invalid_Reason']
terminated due to low enrollment rate	['Insufficient_Enrollment']	['Neutral']
As of 2017 study was terminated since investigators retired. No subjects recruited.	['Insufficient_Enrollment']	['Neutral']
Slow enrollment and financial issues	['Business_Administrative']	['Possibly_Negative']
Could not acquire data	['Logistics_Resources']	['Neutral']
Lack of Recruitment	['Insufficient_Enrollment']	['Neutral']
The trial was stopped based on information from the global phase 3 studies.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Difficulties in finding enough study participants.	['Insufficient_Enrollment']	['Neutral']
Some concerns arose for the accumulation of radioactivity in liver and spleen.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
poor accrual	['Insufficient_Enrollment']	['Neutral']
It was decided by the sponsor to not proceed.	['Business_Administrative']	['Possibly_Negative']
Study was not funded and therefore never began.	['Business_Administrative']	['Possibly_Negative']
devices malfunctioned	['Logistics_Resources']	['Neutral']
Sponsor's decision to withdraw study.	['Business_Administrative']	['Possibly_Negative']
Only patient enrolled on study died -the cause of death not study related	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"No participants were enrolled in the pilot phase of the study due to lack of interest from
    parents. Completion dates reflect the end of funding for the study."	['Business_Administrative']	['Possibly_Negative']
Enrollment underperformance.	['Insufficient_Enrollment']	['Neutral']
"Early termination is a sponsor decision. No new safety signal or serious adverse event has been
    observed."	['Covid19', 'Safety_Sideeffects', 'Regulatory']	['Neutral', 'Safety_Sideeffects', 'Neutral']
This study was terminated early due to poor recruitment.	['Insufficient_Enrollment']	['Neutral']
withdrawn	['Invalid_Reason']	['Invalid_Reason']
Withdrew study	['Invalid_Reason']	['Invalid_Reason']
This study was cancelled.	['Invalid_Reason']	['Invalid_Reason']
Study never initiated	['Invalid_Reason']	['Invalid_Reason']
Sponsor decision based on portfolio prioritization	['Business_Administrative']	['Possibly_Negative']
"Logistical difficulties in recruiting patients led to slower than expected recruitment.
    Recruitment was completely suspended during Covid and will not be restarted."	['Covid19', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
This study was not intended to be published as a trial.	['Invalid_Reason']	['Invalid_Reason']
"This study was stopped by the sponsor before enrollment based on a non-safety related corporate
    decision."	['Business_Administrative']	['Possibly_Negative']
Site selection	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
PI left institution	['Study_Staff_Moved']	['Neutral']
PI leaving institution	['Study_Staff_Moved']	['Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
Grant ended before study could be initiated	['Business_Administrative']	['Possibly_Negative']
treatment strategy changed	['Study_Design']	['Neutral']
This study was terminated by the Principal Investigator	['No_Context', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
"Sponsor decision to terminate the study because the study did not achieve the primary efficacy
    objective."	['Negative']	['Negative']
recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Temporarily paused due to COVID 19 and expected to resume	['Covid19']	['Neutral']
Development of next-generation device	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
low recruitment	['Insufficient_Enrollment']	['Neutral']
study not executed	['Invalid_Reason']	['Invalid_Reason']
no funding	['Business_Administrative']	['Possibly_Negative']
Insufficient rate of accrual	['Insufficient_Enrollment']	['Neutral']
The protocol was modified substantially and will be resubmitted to Clinical Trial	['Study_Design']	['Neutral']
"Due to COVID-19, recruitment and enrollment was suspended and never resumed. COVID-related
    changes have been made to the clinical program which houses our intervention, and we could not
    compare new participants with our previous cohort."	['Covid19']	['Neutral']
Unavailability of study article	['Logistics_Resources']	['Neutral']
No patients exhibited natural killer cell expansion (primary endpoint).	['Negative']	['Negative']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
Poor accrual and funding ended	['Insufficient_Enrollment']	['Neutral']
logistics	['Logistics_Resources']	['Neutral']
funding was not granted	['Business_Administrative']	['Possibly_Negative']
Lack of feasibility	['Logistics_Resources']	['Neutral']
It wasn't possible to recruit the desired number of patients.	['Insufficient_Enrollment']	['Neutral']
Human subjects protection's soubmission denied	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
"Development of JCAR015 has been discontinued. No subjects were enrolled/treated under protocol
    JCAR015-ALL-001"	['Invalid_Reason', 'Study_Design', 'Another_Study']	['Invalid_Reason', 'Neutral', 'Neutral']
Novartis decided to stop the marketing of BEZ235	['Business_Administrative']	['Possibly_Negative']
"Approval of several new agents for the treatment of HCV infection would mitigate the future
    need for interferon HCV treatment"	['Study_Design']	['Neutral']
PI left	['Study_Staff_Moved']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
PI left the institution.	['Study_Staff_Moved']	['Neutral']
PI left the institution	['Study_Staff_Moved']	['Neutral']
unable to recruit subjects given short length of stay in hospital	['Insufficient_Enrollment']	['Neutral']
Due to COVID this trial never got up and running.	['Covid19']	['Neutral']
PI Leaving Site	['Study_Staff_Moved']	['Neutral']
Funding was canceled and no resources are available.	['Business_Administrative']	['Possibly_Negative']
no funding	['Business_Administrative']	['Possibly_Negative']
Capacity problems	['Logistics_Resources']	['Neutral']
Institutional issues Institution issues	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
IDE approval received for larger Pivotal Study	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Lack of patients	['Insufficient_Enrollment']	['Neutral']
enlarged sample	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
This study was closed early by the DSMB due to increased toxicity.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Replaced it with another clinical trial	['Negative', 'Another_Study']	['Negative', 'Neutral']
End of commercialization of the medical device	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Following recommendation by SOLAR Study IDMC, Astellas closed enrollment in ASP8273 studies.	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Invalid_Reason']	['Safety_Sideeffects', 'Neutral', 'Invalid_Reason']
Subject Recruitment	['Insufficient_Enrollment']	['Neutral']
"One subject's HIV RNA rebounded at week 12. A repeat PhenoSense GT combination resistance assay
    at week 12 revealed evolution in protease inhibitor resistance."	['Endpoint_Met', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Termination due to acquisition of PEAK Surgical by Medtronic	['Business_Administrative']	['Possibly_Negative']
difficulty in recruiting parients	['Insufficient_Enrollment']	['Neutral']
Enrollment target not met due to high number of disqualified studies.	['Insufficient_Enrollment']	['Neutral']
"Lack of sufficient participants meeting the eligibility criteria to complete study in proposed
    and acceptable time frame."	['Insufficient_Enrollment']	['Neutral']
The longitudinal goal could not be completed due to CT scans not being performed at baseline.	['Logistics_Resources']	['Neutral']
No funding to hire staff, could not find student to do project	['Business_Administrative']	['Possibly_Negative']
not enough time to complete trial;covid	['Covid19']	['Neutral']
Due to logistic reason	['Logistics_Resources']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
feasibility and low enrollment	['Insufficient_Enrollment']	['Neutral']
"The study achieved the stated objective to record pre & post operative outcomes at a minimum 5
    years."	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Did not receive funding	['Business_Administrative']	['Possibly_Negative']
"The study was terminated early by the sponsor on 13 January 2014 due to a decision to modify
    the drug development plan."	['Business_Administrative']	['Possibly_Negative']
PI left institution	['Study_Staff_Moved']	['Neutral']
Change in benefit/risk profile.	['Negative']	['Negative']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
Did not want to expose additional subjects to Arterial Line placement	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
due to multiple subjects reporting pain and burning at the phlebotomy sites after 38hr	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Recruitment issues	['Insufficient_Enrollment']	['Neutral']
No enrolled patients received the second surgery.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
lack of accrual	['Insufficient_Enrollment']	['Neutral']
No participants enrolled. Study terminated at PI's discretion	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
investigation of adverse events	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Continuing IRB review was not submitted. Study was inactivated with the institutional IRB.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The study was terminated early because there were other competing protocols.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Low or No Enrollment	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
The study was suspended indefinitely because of Covid-19.	['Covid19']	['Neutral']
Logistics and lack of funding	['Business_Administrative']	['Possibly_Negative']
Withdrawn from IRB	['Regulatory', 'Ethical_Reason', 'Negative']	['Neutral', 'Neutral', 'Negative']
Unable to recruit participants	['Insufficient_Enrollment']	['Neutral']
SAEs with n=1 serotonin syndrome, n=2 SAEs after sertraline interruption.	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
The trial was stopped due to no recruitment	['Insufficient_Enrollment']	['Neutral']
Not enough participants recruited	['Insufficient_Enrollment']	['Neutral']
Slow enrollment and unable to meet enrollment targets	['Insufficient_Enrollment']	['Neutral']
Principal investigator terminated study due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Early study termination occurred due to inability to secure funding	['Business_Administrative']	['Possibly_Negative']
disengagement of the sponsor Alexion Pharmaceuticals	['Business_Administrative']	['Possibly_Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Logistically unable to recruit subjects	['Insufficient_Enrollment']	['Neutral']
Low accrual and loss of funding	['Insufficient_Enrollment']	['Neutral']
Low incidence of delirium.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
unable to enroll	['Insufficient_Enrollment']	['Neutral']
No patients were recruited over a 12 month period	['Insufficient_Enrollment']	['Neutral']
"recruiting or enrolling participants has halted prematurely and will not resume; participants
    are no longer being examined or treated"	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
No funding	['Business_Administrative']	['Possibly_Negative']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Dr. Hladky died Sept 2006 prior to study completion	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Recruitment has been suspended due to the COVID pandemic.	['Covid19']	['Neutral']
Focusing on observational cohort study due to limited enrollment in trial	['Insufficient_Enrollment']	['Neutral']
Concluded - Terminated by PI	['No_Context', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
"Toxicity in an independent study IMEX. The trial was subsequently terminated (54 pts instead of
    140) despite safety analyses showing no excess of toxicity"	['Negative', 'Another_Study']	['Negative', 'Neutral']
personnel shortage	['Logistics_Resources']	['Neutral']
Lack of funding.	['Business_Administrative']	['Possibly_Negative']
Interim analysis declared futility.	['Negative']	['Negative']
logistic and financial accounting reasons	['Business_Administrative']	['Possibly_Negative']
Toxic Epidermal Necrolysis	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Recruitment difficulties and toxicity	['Insufficient_Enrollment']	['Neutral']
"Study recruitment was terminated on 14 June 2016 due to a Pfizer business decision. This study
    was not terminated for reasons of safety."	['Business_Administrative']	['Possibly_Negative']
No additional patients fulfilling the inclusion criteria	['Insufficient_Enrollment']	['Neutral']
Study cancelled. Different direction pursued by Rhythm AI.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
No subject accrual.	['Insufficient_Enrollment']	['Neutral']
Investigational device changes	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Difficulty in finding patients with complex retinal pathology to enroll in this study.	['Insufficient_Enrollment']	['Neutral']
Study was closed to accrual for safety related to the frequency of BK infections.	['Insufficient_Enrollment']	['Neutral']
Study objectives achieved	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Study was stopped due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
data not as expected	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
COVID-19	['Covid19']	['Neutral']
Unable to meet all criteria as outlined for participants	['Insufficient_Enrollment', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Resident physician decided not to proceed with study	['Interim_Analysis', 'Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral', 'Neutral']
the study was closed early due to competing trials	['Negative', 'Another_Study']	['Negative', 'Neutral']
Part I completed. Part 2 will not be done due to sponsor decision.	['Business_Administrative']	['Possibly_Negative']
problems in funding	['Business_Administrative']	['Possibly_Negative']
"Difficult recruitment, and investigators did not want to extend the recruitment period, so
    study stopped at theoretical date but number of subjects not reached"	['Insufficient_Enrollment']	['Neutral']
Study re-designed	['Study_Design']	['Neutral']
It was not possible to recruite sufficient number of participants	['Insufficient_Enrollment']	['Neutral']
Terminated due to low 5 year completer number and not meeting primary objective.	['Insufficient_Enrollment']	['Neutral']
Scheduled Interim Monitoring	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Recruitment not feasible	['Insufficient_Enrollment']	['Neutral']
The study was conducted in the context of a medical thesis with a deadline.	['No_Context', 'Logistics_Resources', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
Results of preliminary analyses showed no reason to continue the study	['Negative']	['Negative']
Lack of benefit on efficacy	['Negative']	['Negative']
Funding suspended prior to completing enrollment of all participants.	['Business_Administrative']	['Possibly_Negative']
Decision made by the Principal Investigator	['Invalid_Reason']	['Invalid_Reason']
no college athlete availability	['Insufficient_Enrollment']	['Neutral']
"This observational study was stopped after 140 patients were enrolled, no more funds available
    to continue."	['Business_Administrative']	['Possibly_Negative']
patients could not be recuited within study duration	['Insufficient_Enrollment']	['Neutral']
No data are available for this study as the PI has left the institution.	['Study_Staff_Moved']	['Neutral']
"Unique provision in the American Recovery and Reinvestment Act prevented approval of second
    year no-cost-extension in which completion of analyses were planned."	['Regulatory', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Investigator decision	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Program discontinued to persue alternate indications.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
An one-month follow-up was completed after the treatment.	['Interim_Analysis', 'Endpoint_Met', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
"The study was terminated prematurely by the IRB due to data integrity and protocol compliance
    issues"	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
We decided to stopped the study because we have difficulties in recruiting subjects phase.	['Insufficient_Enrollment']	['Neutral']
The development was stopped due to company's strategy consideration	['Business_Administrative']	['Possibly_Negative']
it's too slow to enroll suitable patients into this study	['Insufficient_Enrollment']	['Neutral']
Not able to recruit enough patients	['Insufficient_Enrollment']	['Neutral']
could not recruit	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Study was halted prematurely due to lack of efficacy.	['Negative']	['Negative']
The sponsor decides withdrawn this study.	['Business_Administrative']	['Possibly_Negative']
Limited budget to continue this study	['Business_Administrative']	['Possibly_Negative']
Understaffing and inadequate funding	['Business_Administrative']	['Possibly_Negative']
Very poor recruitment	['Insufficient_Enrollment']	['Neutral']
funding pending	['Business_Administrative']	['Possibly_Negative']
Difficulty accruing subjects the study accrual was closed	['Insufficient_Enrollment']	['Neutral']
Unable to enroll patients	['Insufficient_Enrollment']	['Neutral']
withdrawn due to contractual issues	['Business_Administrative']	['Possibly_Negative']
Funding withdrawn	['Business_Administrative']	['Possibly_Negative']
Difficulty recruiting eligible participants; study medication was expiring.	['Insufficient_Enrollment']	['Neutral']
Lack of Patient accrual	['Insufficient_Enrollment']	['Neutral']
due to non-feasibility	['Logistics_Resources']	['Neutral']
Due to the impact of COVID-19	['Covid19']	['Neutral']
Study design changes.	['Study_Design']	['Neutral']
Study halted due to low investigator involvement; no patients enrolled in study.	['Insufficient_Enrollment']	['Neutral']
PI Request	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"If </= 5 of the initial 18 patients had a CR, the study would be stopped. Only 5 patients (21%)
    of 24 enrolled patients had a CR so the study was terminated."	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
"Difficulties in including Mild Traumatic Brain Injury (mTBI) group despite an extended
    inclusion period of an additional 12 months"	['Insufficient_Enrollment']	['Neutral']
Due to other Phase 3 trial failure to meet primary endpoint	['Negative', 'Another_Study']	['Negative', 'Neutral']
Not enough facilities to study	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
BMS decision	['Regulatory', 'Invalid_Reason', 'Negative']	['Neutral', 'Invalid_Reason', 'Negative']
"Because at the interim analysis the pre-specified stopping boundary for an overwhelming benefit
    had been crossed."	['Interim_Analysis', 'Endpoint_Met', 'Negative']	['Neutral', 'Neutral', 'Negative']
Lack of financial support	['Business_Administrative']	['Possibly_Negative']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
No funding available	['Business_Administrative']	['Possibly_Negative']
Delayed initiation	['Insufficient_Enrollment', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
The company did not provide the study product	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Slow/Insufficient accrual/COVID-19 pandemic	['Covid19']	['Neutral']
Investigator transferred to the University of Wisconsin - Madison	['Study_Staff_Moved']	['Neutral']
Data from other trials failed to demonstrate meaningful survival advantage	['Negative', 'Another_Study']	['Negative', 'Neutral']
Drug Supply Issue	['Logistics_Resources']	['Neutral']
Terminated due to insufficient efficacy over placebo in Study ATL1251/038/CL.	['Negative', 'Another_Study']	['Negative', 'Neutral']
"The number of patients with COVID-19 in Singapore was coming down for the community and the
    concerns about the potential side effects particularly when the baseline ECG and serum
    electrolytes was not proposed."	['Covid19']	['Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Business decision	['Business_Administrative']	['Possibly_Negative']
Changing study design. Will replace with a different protocol.	['Study_Design']	['Neutral']
Failed to meet recruitment goal and lost study staff due to COVID-19	['Covid19']	['Neutral']
Safety concerns (IgM Flare)	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Unable to provide OBGYN to assist with study for IRB approval	['Regulatory', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Lack of inclusions	['Insufficient_Enrollment']	['Neutral']
Interim Analysis / Resource Availability	['Logistics_Resources']	['Neutral']
Study was terminated early due to prolonged recruitment period.	['Insufficient_Enrollment']	['Neutral']
This study was combined with another trial that was on-going.	['Negative', 'Another_Study']	['Negative', 'Neutral']
The sponsor is focusing on prospective randomized studies	['Success', 'Endpoint_Met', 'Study_Design']	['Success', 'Neutral', 'Neutral']
Loss of funding	['Business_Administrative']	['Possibly_Negative']
See Detailed Description	['No_Context']	['Invalid_Reason']
"The study was terminated prematurely on May 16, 2013, for futility. No new or unexpected safety
    issues were identified."	['Negative']	['Negative']
No patient enrolled during the authorized period	['Insufficient_Enrollment']	['Neutral']
no patients enrolled.	['Insufficient_Enrollment']	['Neutral']
inability to recruit participants despite numerous attempts	['Insufficient_Enrollment']	['Neutral']
insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Working on getting accurate information for patients interested in the study.	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
The study was closed prematurely due to slow recruitment	['Insufficient_Enrollment']	['Neutral']
slow/insufficient accrual.	['Insufficient_Enrollment']	['Neutral']
Futility analysis by DSMC recommended termination.	['Negative']	['Negative']
"Recruitement did not meet expectations. Prev. differentiation of RAS-wild-type and mutated RAS
    are not in accordance with the scientific rank anymore."	['Insufficient_Enrollment']	['Neutral']
no accrual	['Insufficient_Enrollment']	['Neutral']
slow recruitment and change of faculty	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
No longer willing to continue clinical trials	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Lack of volunteers	['Insufficient_Enrollment']	['Neutral']
Low response	['Insufficient_Enrollment']	['Neutral']
Sponsor	['Business_Administrative']	['Possibly_Negative']
poor accrual	['Insufficient_Enrollment']	['Neutral']
Funding stopped, company closed	['Business_Administrative']	['Possibly_Negative']
Study Timing	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Study unable to enroll patients	['Insufficient_Enrollment']	['Neutral']
No Study Enrollment	['Insufficient_Enrollment']	['Neutral']
No significant results during interim analysis	['Negative']	['Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Stafit Acetabular System not CE marked anymore	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Administrative Reason	['Business_Administrative']	['Possibly_Negative']
The study population is smaller than expected. No subjects were included.	['Insufficient_Enrollment']	['Neutral']
Study never initiated	['Invalid_Reason']	['Invalid_Reason']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
no participants	['Insufficient_Enrollment']	['Neutral']
"Study has been terminated due linability to recruit the targeted participants. Aimed for 300
    participants and only 4 were enrolled after 1 year."	['Insufficient_Enrollment']	['Neutral']
study not initiated	['Invalid_Reason']	['Invalid_Reason']
Funding was withdrawn.	['Business_Administrative']	['Possibly_Negative']
the study was stopped due to non-availability of 4mg	['Logistics_Resources']	['Neutral']
Sites were unable to recruit participants	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Company Decision	['Business_Administrative']	['Possibly_Negative']
Medication removed from the U.S. market by the The Food and Drug Administration	['Covid19', 'Interim_Analysis', 'Logistics_Resources']	['Neutral', 'Neutral', 'Neutral']
Difficulty with enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsor's decision to halt the study.	['Business_Administrative']	['Possibly_Negative']
Organisation problem	['Business_Administrative']	['Possibly_Negative']
We recruited a target number (740 patients) earlier than the expected day of copletion	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
No patients	['Insufficient_Enrollment']	['Neutral']
Study was terminated early due to enrollment challenges	['Insufficient_Enrollment']	['Neutral']
Business decision	['Business_Administrative']	['Possibly_Negative']
for treatment amendment	['Study_Design']	['Neutral']
Medication removed from the U.S. market by the The Food and Drug Administration	['Covid19', 'Interim_Analysis', 'Logistics_Resources']	['Neutral', 'Neutral', 'Neutral']
unrealizable wishes of national authorities	['Business_Administrative']	['Possibly_Negative']
study withdrawn due to lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Consensus RAFT-LVendo Steering Committee to terminate.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Covid	['Covid19']	['Neutral']
"Difficulty finding eligible sites/patients; current situation in health policy cause negative
    effect on existing/planned contracts for integrated care program"	['Insufficient_Enrollment']	['Neutral']
Funding ended when only one subject enrolled and subject withdrew early.	['Business_Administrative']	['Possibly_Negative']
Low accrual rate.	['Insufficient_Enrollment']	['Neutral']
Clinical studies stopped, pending funding	['Business_Administrative']	['Possibly_Negative']
Screening discontinued early due to slow patient enrollment	['Insufficient_Enrollment']	['Neutral']
"AVANCE (Grantee and Implementing Agency) relinquished funding. Subsequently, both program and
    evaluation were terminated prematurely."	['Business_Administrative']	['Possibly_Negative']
Supply Omega-3 Fatty Acids expired and supplier no longer made same composition.	['Logistics_Resources']	['Neutral']
The study has proven to be infeasible.	['Logistics_Resources', 'Endpoint_Met', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
sponsor decision	['Business_Administrative']	['Possibly_Negative']
FDA changed classification of device and no longer requires this type of clinical data	['No_Context', 'Regulatory', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
No enrollment	['Insufficient_Enrollment']	['Neutral']
Investigator no longer at LU.	['Study_Staff_Moved']	['Neutral']
low enrollment	['Insufficient_Enrollment']	['Neutral']
Discontinued due to significant delays in the expected availability of data.	['Logistics_Resources']	['Neutral']
no funding	['Business_Administrative']	['Possibly_Negative']
Terminated due to low enrollment	['Insufficient_Enrollment']	['Neutral']
no participation over the long period	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lock down due to COVID-19 pandemic.	['Covid19']	['Neutral']
Difficulty in selecting the sample and follow-up lost.	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Enrollment issues	['Insufficient_Enrollment']	['Neutral']
Due to inadequate accrual, study was terminated and limited outcome data was reported.	['Insufficient_Enrollment']	['Neutral']
Difficulty to recruit patients fulfilling inclusion criteria	['Insufficient_Enrollment']	['Neutral']
Study stopped due to business reasons.	['Business_Administrative']	['Possibly_Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Treatment toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
lower than expected enrollment	['Insufficient_Enrollment']	['Neutral']
Because of small number of enrolled patients, we terminated this study.	['Insufficient_Enrollment']	['Neutral']
patients had to be converted to the other study arm	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
Study never started due to change in standard of care guideline	['Study_Design']	['Neutral']
Change in standard of care, no possibility of recruitment	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
slow recruitment rate	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
FDA and IRB directive to temporarily close to enrollment due to important safety findings	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Low recruitment in spite of strategies implemented	['Insufficient_Enrollment']	['Neutral']
Fail to sort out the logistics of study drugs due to funding problems	['Business_Administrative']	['Possibly_Negative']
Unknown, PI has left the institution. There was no enrollment.	['No_Context', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
Business Decision	['Business_Administrative']	['Possibly_Negative']
Sponsor decision stopped in June 2017	['Business_Administrative']	['Possibly_Negative']
Lack of Efficacy	['Negative']	['Negative']
"The study was terminated on 21-Sept-2011 due to the emergent safety concern of sensory
    symptoms."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
due to COVID-19	['Covid19']	['Neutral']
PI left the institution before any participants were enrolled.	['Study_Staff_Moved']	['Neutral']
Due to business considerations; not due to toxicities or adverse events.	['Business_Administrative']	['Possibly_Negative']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Difficulties in recruiting patients	['Insufficient_Enrollment']	['Neutral']
Sponsor decision.	['Business_Administrative']	['Possibly_Negative']
No patients dosed	['Invalid_Reason']	['Invalid_Reason']
NW Center for Reproductive Sciences was sold and is no longer open	['Logistics_Resources', 'Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
"The trial has been terminated per Sponsor direction due to longer than expected clinical and
    regulatory approvals."	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
The patient population changed. Unable to find patients that meet study criteria	['Insufficient_Enrollment']	['Neutral']
The efficacy failed to meet the primary efficacy endpoint	['Negative']	['Negative']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Slow recruitment and small observed effect size	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Invalid_Reason']	['Safety_Sideeffects', 'Neutral', 'Invalid_Reason']
COVID lack of cases/recruitment	['Covid19']	['Neutral']
never started	['Invalid_Reason']	['Invalid_Reason']
Suspended to recruitment following TSC review on efficacy and toxicities	['Negative']	['Negative']
Closed due to inability to enroll	['Insufficient_Enrollment']	['Neutral']
"Sponsor/PI voluntarily paused and stopped study after observing several Grade 2 and Grade 3
    redness local reactogenicity reactions at 10E8VLS injection sites"	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Principle Investigator went into maternity leave until August 2020	['Study_Staff_Moved']	['Neutral']
Unable to recruit eligible participants	['Insufficient_Enrollment']	['Neutral']
Due to COVID-19, effective 3/19/2020 recruitment is halted until further notice	['Covid19']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
"Data collection suggested that more work was needed to validate the theoretical connections
    between the constructs of interest, before doing a treatment trial."	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Lack of human ressources	['Logistics_Resources']	['Neutral']
interim analysis suggests futility	['Negative']	['Negative']
Never initiated due to lack of funding and IRB Approval	['Business_Administrative']	['Possibly_Negative']
"Study protocol needs to be amended. Recruitment is halted until amendment is completed and
    approved by IRB."	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Researcher performing the study is temporarily working outside the study center.	['Study_Staff_Moved']	['Neutral']
Loss of staff	['Logistics_Resources']	['Neutral']
"The Sponsor voluntarily recalled SD-101 and terminated the study due to GMP deficiencies
    identified during an FDA inspection at the site of the manufacturer."	['Regulatory', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
Accrual factor	['Insufficient_Enrollment']	['Neutral']
Unable to recruit suitable patients	['Insufficient_Enrollment']	['Neutral']
Not able to enroll enough patients in this study	['Insufficient_Enrollment']	['Neutral']
"A Phase 3 study recently reported and demonstrated that the dose of otelixizumab in OTX113390
    is not effective."	['Negative', 'Another_Study']	['Negative', 'Neutral']
The site is unable to recruit patients.	['Insufficient_Enrollment']	['Neutral']
low enrollment	['Insufficient_Enrollment']	['Neutral']
few delirious patients were enrolled.	['Insufficient_Enrollment']	['Neutral']
Too few participants recruited within timeframe	['Insufficient_Enrollment']	['Neutral']
Protocol Under Review	['Regulatory']	['Neutral']
poor accrual	['Insufficient_Enrollment']	['Neutral']
SARS epidemic in Asia and Canada	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
termination due to futility (very slow patient enrollment)	['Negative']	['Negative']
The perceived risk-benefit ratio for individuals with early active RA	['Negative']	['Negative']
terminated	['Invalid_Reason']	['Invalid_Reason']
Insufficient Enrollment	['Insufficient_Enrollment']	['Neutral']
unable to enroll adequate subjects	['Insufficient_Enrollment']	['Neutral']
due to lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Number included has been reached	['Invalid_Reason']	['Invalid_Reason']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
Not meeting accrual target.	['Insufficient_Enrollment']	['Neutral']
"Introduction of National Mass Drug Administration Campaign and failure to identify appropriate
    participants."	['Insufficient_Enrollment']	['Neutral']
low recruitment	['Insufficient_Enrollment']	['Neutral']
Study is closed as the PI transferred to another institution.	['Study_Staff_Moved']	['Neutral']
DSMB recommendation to stop	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Difficulty of inclusions and a sufficient number of relevant clinical information	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Unable to recruit	['Insufficient_Enrollment']	['Neutral']
"1. The simulator lacked the fidelity required to meet training needs of the novices, 2.
    Recruitment of novice anesthetists more difficult than anticipated"	['Logistics_Resources']	['Neutral']
"Due to the inclusion of an IMid in combination with pembrolizumab, Study Sponsor terminated the
    study."	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
The study was completely redesigned	['Study_Design']	['Neutral']
1) Policy change affecting C&Cs; 2) interm analysis revealing overt differences	['Interim_Analysis', 'Regulatory', 'Negative']	['Neutral', 'Neutral', 'Negative']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Hard to enroll	['Insufficient_Enrollment']	['Neutral']
failure of supply of test product	['Logistics_Resources']	['Neutral']
Due tot he Pandemic we decided to terminate this project.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Terminated due to recruitment challenges.	['Insufficient_Enrollment']	['Neutral']
Impossible patient inclusion due to the COVID-10 pandemic	['Covid19']	['Neutral']
"We have discovered a too low prevalence of Patent Foramen Ovale compared to the theoretical %
    of around 20-25%."	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Temporarily stopped due to COVID-19 and expected to resume.	['Covid19']	['Neutral']
due to slow patient recruitement.	['Insufficient_Enrollment']	['Neutral']
Study experienced delays due to site recruitment. Funder terminated contract.	['Business_Administrative']	['Possibly_Negative']
Lack of efficacy	['Negative']	['Negative']
Funds for study ended September 30, 2008.	['Business_Administrative']	['Possibly_Negative']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Loss of funding	['Business_Administrative']	['Possibly_Negative']
Difficulty with recruitment	['Insufficient_Enrollment']	['Neutral']
insufficient patient numbers have been recruited	['Insufficient_Enrollment']	['Neutral']
Halted prematurely due to lack of funding.	['Business_Administrative']	['Possibly_Negative']
Due to difficulty in finalizing the contract	['Business_Administrative']	['Possibly_Negative']
Program terminated	['Invalid_Reason']	['Invalid_Reason']
Industry funding not received. No subjects enrolled.	['Business_Administrative']	['Possibly_Negative']
Low inclusion rate; Change of position of principal investigator.	['Insufficient_Enrollment']	['Neutral']
Potential safety issue of second primary malignancies in patients treated with lenalidomide.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Company discontinued study and closed. No participants were enrolled.	['Business_Administrative']	['Possibly_Negative']
Difficulty recruiting patient. Lack of research assistant.	['Insufficient_Enrollment']	['Neutral']
No subjects were ever enrolled. This study was closed at the IRB.	['Invalid_Reason']	['Invalid_Reason']
Study never opened.	['Invalid_Reason']	['Invalid_Reason']
lack of efficacy	['Negative']	['Negative']
personnel change, unable to continue study	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Sufficient enrollments under current protocol for further development & studies	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Difficulty of inclusion of patients, impossible to reach the expected number	['Insufficient_Enrollment']	['Neutral']
The principal investigator decided to close this study site.	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Administrative	['Business_Administrative']	['Possibly_Negative']
The study was terminated early due to enrollment challenges.	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
This study has been terminated.	['Invalid_Reason']	['Invalid_Reason']
Administrative status of active ingredient anatabine	['Business_Administrative']	['Possibly_Negative']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
Sponsor decided to develop the product in collaboration	['Business_Administrative']	['Possibly_Negative']
"Novartis has acquired the rights to ofatumumab and terminated the OPV116910 and OPV117059
    studies. This decision is not linked to any safety consideration."	['Business_Administrative']	['Possibly_Negative']
Recruitment problematic	['Insufficient_Enrollment']	['Neutral']
No patients could be recruited	['Insufficient_Enrollment']	['Neutral']
Sponsor withdrew study for business reasons	['Business_Administrative']	['Possibly_Negative']
Decision made by B&L to cancel the study, no subjects enrolled.	['Business_Administrative']	['Possibly_Negative']
"The trial was closed early as the result of the impact of COVID-19 on trial-related activities.
    The study was not terminated due to any safety issues or concerns. The objectives of the study
    were successfully met."	['Covid19']	['Neutral']
Participants are no longer being examined and receiving intervention.	['Invalid_Reason', 'Study_Design', 'Another_Study']	['Invalid_Reason', 'Neutral', 'Neutral']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
Lack of Funding	['Business_Administrative']	['Possibly_Negative']
due to less patient the study was suspended	['Insufficient_Enrollment']	['Neutral']
It was determined that the volume imaging was not working.	['Interim_Analysis', 'Logistics_Resources', 'Negative']	['Neutral', 'Neutral', 'Negative']
key investigator relocated.	['Study_Staff_Moved']	['Neutral']
Lack of response	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Invalid_Reason']	['Safety_Sideeffects', 'Neutral', 'Invalid_Reason']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Administrative delay	['Business_Administrative']	['Possibly_Negative']
The single Quinacrine manufacture facility in the US was shut down by the FDA	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Further software development is required.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Not NIH defined clinical trial study.	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
PI has left University of Minnesota.	['Study_Staff_Moved']	['Neutral']
Study was terminated due to slow subject accrual	['Insufficient_Enrollment']	['Neutral']
Terminated due to lack of enrollment	['Insufficient_Enrollment']	['Neutral']
It was decided to change the study from a cohort to a randomized controlled trial.	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
Due to a change in the development strategy	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
study no longer consistent with current clinical practice	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
for futility	['Negative']	['Negative']
No arms are currently open to patient registration	['Regulatory', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
"Due to company decision to focus resources on the finalisation of three ongoing studies in the
    region"	['Negative', 'Another_Study']	['Negative', 'Neutral']
change in donor site care protocol; donor site healing is a study endpoint	['Study_Design']	['Neutral']
This study was terminated due slow accrual.	['Insufficient_Enrollment']	['Neutral']
Withdrawn for lack of funding and accrual	['Business_Administrative']	['Possibly_Negative']
We did not receive proper funding to complete this study.	['Business_Administrative']	['Possibly_Negative']
after original approval, IRB closed enrollment; major revisions required to re-open.	['No_Context', 'Regulatory', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
Clinic management decided to cancel the study for priority reasons	['Business_Administrative']	['Possibly_Negative']
Administratively inactivated	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Study not started due to administrative reasons.	['Business_Administrative']	['Possibly_Negative']
Diffculties to recruit anticipated study size, now analysis	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
The employe for the study quit and a new grant proposal was not financed	['Business_Administrative']	['Possibly_Negative']
Study was cancelled prior to any enrollment	['Invalid_Reason']	['Invalid_Reason']
Due to no accrual.	['Insufficient_Enrollment']	['Neutral']
Discontinued PB127 development program for business reasons	['Business_Administrative']	['Possibly_Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Study was stoped according to preliminary analysis.	['Negative']	['Negative']
"Unique provision in the American Recovery and Reinvestment Act prevented approval of second
    year no-cost-extension in which completion of analyses were planned."	['Regulatory', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Discontinuation of drug supply from Astellas.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The Cediranib producer laboratory decided to stop the development of this product.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Sponsor business decision unrelated to clinical performance.	['Business_Administrative']	['Possibly_Negative']
Unable to get required research materials	['Logistics_Resources']	['Neutral']
The trail end was achived according to the definition in the trial protocol	['Invalid_Reason']	['Invalid_Reason']
Study never moved past ideation phase	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Study permanently closed due to low accrual	['Insufficient_Enrollment']	['Neutral']
The study was stopped prematurely due to the COVID-19 pandemic	['Covid19']	['Neutral']
Data required further pilot work to be undertaken.	['No_Context', 'Endpoint_Met', 'Study_Design']	['Invalid_Reason', 'Neutral', 'Neutral']
"The study was terminated on May 5, 2011, due to methodological issues. The decision to
    terminate the study was not based on any safety or efficacy concerns."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"This study was terminated early based on an interim analysis of 14 subjects, which demonstrated
    a favorable safety and tolerability profile."	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
eIRB closed, no patient enrolled	['Regulatory', 'Insufficient_Enrollment', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
The accrual was very slow and there were many competing studies ongoing/initiated .	['Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral']
"Study terminated early based upon development of another anti-IL17 fully human monoclonal
    antibody with better potential for treating MS patients"	['Negative', 'Another_Study']	['Negative', 'Neutral']
strategic reasons (not due to lack of efficacy or safety issues)	['Business_Administrative']	['Possibly_Negative']
not enough pts for available to reach goal	['Insufficient_Enrollment']	['Neutral']
Funding was not available.	['Business_Administrative']	['Possibly_Negative']
Funding terminated by funding source.	['Business_Administrative']	['Possibly_Negative']
Stopped due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Company decided not to move forward with further accrual.	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Lack of efficacy	['Negative']	['Negative']
Did not meet enrollment requirements with limited funding	['Business_Administrative']	['Possibly_Negative']
No subjects were enrolled on this study, so study was closed and IND withdrawn.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Inability to recruit patients.	['Insufficient_Enrollment']	['Neutral']
The sponsor failed to provide financial support as promised.	['Business_Administrative']	['Possibly_Negative']
Company Decision	['Business_Administrative']	['Possibly_Negative']
"temporary hold in May 2010 due to an emerging PK profile that could not be aligned to the known
    pharmaceutical properties of the IMP (AZD6553)."	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Phase II recruitment unsuccesful, phase III lacking personnel resources	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Slow Enrollment	['Insufficient_Enrollment']	['Neutral']
Preliminary data showed [123I] MNI-308 not a useful tool in detection of AD.	['Negative']	['Negative']
Did not get enough patients	['Insufficient_Enrollment']	['Neutral']
Administrative reason by Sponsor.	['Business_Administrative']	['Possibly_Negative']
Principal Investigator is leaving institution.	['Study_Staff_Moved']	['Neutral']
Part1,double blind portion of the trial did not meet the primary end points	['Negative']	['Negative']
Denied by Human Subjects Protection Board	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of funding and personnel	['Business_Administrative']	['Possibly_Negative']
"Awaiting National Pharmaceutical Pricing Authority (NPPA) review of ceiling prices for
    innovative products in India."	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
The manufacturer discontinued necessary reagents.	['Logistics_Resources']	['Neutral']
The study was terminated due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
Bexxar isn't being produced by the manufacturer as of Feb. 2014	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
pending amendment	['Study_Design']	['Neutral']
Were not able to enroll enough participants due to shortage of study staff	['Insufficient_Enrollment']	['Neutral']
The stopping rule was applied because of low response rates.	['Negative']	['Negative']
Study was not funded	['Business_Administrative']	['Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
Lack of funding caused us to cancel the study.	['Business_Administrative']	['Possibly_Negative']
Sub-Site IRB suspension due to IDE for Optune	['No_Context', 'Regulatory', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
The PI retired/left the institution. Efforts were made to contact the PI but were unsuccessful.	['Study_Staff_Moved']	['Neutral']
Study terminated due to low enrollment making it unlikely to meet recruitment goals.	['Insufficient_Enrollment']	['Neutral']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
Company decision to discontinue trial	['Business_Administrative']	['Possibly_Negative']
"Further recruitment not possible due to COVID 19 impact. Hence a decision to close study was
    taken at the antifungal CDT in Aug 2020."	['Covid19']	['Neutral']
Observational Study should not be in CT.gov	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
No enrollment in the study	['Insufficient_Enrollment']	['Neutral']
Lack of Accrual	['Insufficient_Enrollment']	['Neutral']
MOR106 clinical development in atopic dermatitis was stopped for futility	['Negative']	['Negative']
"temporarily paused due to Covid-19 and expected to to resume, this is not a suspension of IRB
    approval."	['Covid19']	['Neutral']
recruitment challenges	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Due to efficacy results of interim analysis	['Negative']	['Negative']
"Study was stopped by sponsor prior to first patient assignment to groups due to operational
    reasons."	['Business_Administrative']	['Possibly_Negative']
Placebo cannot be prepared	['Logistics_Resources']	['Neutral']
New data; the study was terminated based on new efficacy data	['Negative', 'Another_Study']	['Negative', 'Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Insufficient numbers of participating sites and hip surgery cases.	['Insufficient_Enrollment']	['Neutral']
The study was terminated early due to company decision	['Business_Administrative']	['Possibly_Negative']
Project end after 3 years; prolongation was rejected	['Invalid_Reason']	['Invalid_Reason']
Major planned study protocol modifications	['Study_Design']	['Neutral']
PI's response to ePAAC, has withdrawn the protocol acknowledging the PI's action.	['Logistics_Resources', 'Study_Staff_Moved', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
poor recruitment	['Insufficient_Enrollment']	['Neutral']
Tecnical problem	['Logistics_Resources']	['Neutral']
"The study was closed due to a shift in research priorities and a lack of resources available
    for the project."	['Business_Administrative']	['Possibly_Negative']
Difficulty recruiting study subjects	['Insufficient_Enrollment']	['Neutral']
Patient inclusion cannot be reached within timelimits	['Insufficient_Enrollment']	['Neutral']
No subjects were enrolled in this protocol	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Poor rate of eligible subject enrollment	['Insufficient_Enrollment']	['Neutral']
Manufacturing stopped	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
"Conducting an interim analysis that allowed with the number of patients included of 150 to meet
    the objectives of this research"	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Sponsor is focusing on studies which can enable registration of duvelisib.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
study closed due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Profissional reasons, not related with the study	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of recruitment and the company's decision to de-prioritize 5584 development	['Business_Administrative']	['Possibly_Negative']
Equipment to run the study was not available	['Logistics_Resources']	['Neutral']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
low enrollment and high participant withdraw	['Insufficient_Enrollment']	['Neutral']
Difficulties recruiting participant	['Insufficient_Enrollment']	['Neutral']
wothdrawal of sponsor	['Business_Administrative']	['Possibly_Negative']
Business objectives have changed.	['Business_Administrative']	['Possibly_Negative']
Sponsor Decision based on strategic considerations	['Business_Administrative']	['Possibly_Negative']
New sponsor's existing product under evaluation for this indication	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
no efficacy	['Negative']	['Negative']
AMAG not continuing with Combidex, the study drug	['Business_Administrative']	['Possibly_Negative']
Inadequate accrual	['Insufficient_Enrollment']	['Neutral']
Because of the problem with Cilotax stent permission	['Logistics_Resources']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
funding difficulty	['Business_Administrative']	['Possibly_Negative']
Reconsidered significance in light of newly published in vitro data.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Participants were not able to stay for two weeks near our center.	['Insufficient_Enrollment']	['Neutral']
The study was stopped due to difficulty in identifying potential patients.	['Insufficient_Enrollment']	['Neutral']
lake of efficiency and poor tolerance of endoscopic technique	['Logistics_Resources', 'Endpoint_Met', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
The study was early terminated due to insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Study halted prematurely but potentially will resume	['Invalid_Reason']	['Invalid_Reason']
"The cyclotron in our hospital has a serious malfunction and can not be repaired. It will take a
    long time to purchase and install the new cyclotron."	['Logistics_Resources']	['Neutral']
no patient met inclusion criteria	['Insufficient_Enrollment']	['Neutral']
Unable to align the study questions with a complementary trial	['Negative', 'Another_Study']	['Negative', 'Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Unable to recruit sufficient participants	['Insufficient_Enrollment']	['Neutral']
"Estimated sample size not achieved due to decline in number of eligible patients and difficulty
    recruiting and retaining research staff."	['Insufficient_Enrollment']	['Neutral']
the study was terminated due to participant drop out	['Insufficient_Enrollment']	['Neutral']
Unexpected toxicities, likely due to TIL/IL-12 & low % of durable responses.	['Negative']	['Negative']
lack of support	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"All analysis with identifiable specimens/data is complete or site has no identifiers linked to
    the specimens/data"	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
We were unable to enroll a sufficient number of patients due to manpower.	['Insufficient_Enrollment']	['Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Low rate of subject accrual	['Insufficient_Enrollment']	['Neutral']
Competitive trials and slow recruitment rate	['Insufficient_Enrollment']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Terminated due to poor accrual.	['Insufficient_Enrollment']	['Neutral']
COVID-19 Pandemic	['Covid19']	['Neutral']
Recruitment Issues	['Insufficient_Enrollment']	['Neutral']
"After 148 patients enrolled, interim analysis revealed positive results in regard to primary
    hypothesis."	['Endpoint_Met', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"The decision to stop the trial was based on efficacy results in the overall schizophrenia
    participant population."	['Success', 'Endpoint_Met', 'Negative']	['Success', 'Neutral', 'Negative']
Primary endpoint did not reach statistical significance	['Negative']	['Negative']
Interim analysis: patients treated with SCD had higher incidence of DVT.	['Negative']	['Negative']
"This study met a protocol defined futility criterion and will be terminated following
    completion of the Follow Up Visit on the last subject randomised."	['Negative']	['Negative']
Treatment failure on study medication observed	['Safety_Sideeffects', 'Logistics_Resources', 'Endpoint_Met']	['Safety_Sideeffects', 'Neutral', 'Neutral']
"Planned interim analysis did not show the expected benefit of intervention A over B (effect
    size <0.2)."	['Negative']	['Negative']
The number of patients is suffisant to answer to the primary outcome	['Negative']	['Negative']
Covid-19 pandemic, aerosol generating procedures	['Covid19']	['Neutral']
COVID-19 caused shutdown of all human research	['Covid19']	['Neutral']
Due to recruitment problems	['Insufficient_Enrollment']	['Neutral']
Withdrawn due to protocol amendment	['Study_Design']	['Neutral']
Recruitment very slow - study could not be enrolled	['Insufficient_Enrollment']	['Neutral']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
"Withdrawn due to ""toxicity"" problems"	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Decision of the Independent Review Committee	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Inability to enroll	['Insufficient_Enrollment']	['Neutral']
Funding complications coupled with competing scientific objectives	['Business_Administrative']	['Possibly_Negative']
Recent FDA approval of a new drug for the same patient population	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Major inclusion difficulties	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
stopped because of a business decision	['Business_Administrative']	['Possibly_Negative']
Inability to recruit sufficient number of patients	['Insufficient_Enrollment']	['Neutral']
Insufficient Data Collected	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Not IRB approved	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Sponsor elected to terminate the study prior to subject treatment.	['Business_Administrative']	['Possibly_Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
"The decision to stop the trial was based on efficacy results in the overall schizophrenia
    participant population."	['Success', 'Endpoint_Met', 'Negative']	['Success', 'Neutral', 'Negative']
Recruitment	['Insufficient_Enrollment']	['Neutral']
Investigator decision	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
IRB Approval withdrawn	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Enrollment failed	['Insufficient_Enrollment']	['Neutral']
Funding was not received.	['Business_Administrative']	['Possibly_Negative']
Unable to recruit volunteers	['Insufficient_Enrollment']	['Neutral']
No Funding	['Business_Administrative']	['Possibly_Negative']
Unable to find subjects that met inclusion/exclusion criteria.	['Insufficient_Enrollment']	['Neutral']
This study was prematurely terminated due to delayed patient enrollment.	['Insufficient_Enrollment']	['Neutral']
did not move forward with IRB approval, competing study	['No_Context', 'Regulatory', 'Study_Design']	['Invalid_Reason', 'Neutral', 'Neutral']
focus resources in the allogeneic platform and provide optimal value for patients	['Interim_Analysis', 'Logistics_Resources', 'Endpoint_Met']	['Neutral', 'Neutral', 'Neutral']
Strategic Business Decision	['Business_Administrative']	['Possibly_Negative']
not enough enrollement	['Insufficient_Enrollment']	['Neutral']
Study is replaced by MI-CP198 per CPM.	['Negative', 'Another_Study']	['Negative', 'Neutral']
default inclusion	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Slow enrollment rate	['Insufficient_Enrollment']	['Neutral']
poor recruitment	['Insufficient_Enrollment']	['Neutral']
Study drug supplier withdrew support for the study. Study was withdrawn from the Duke IRB.	['Logistics_Resources']	['Neutral']
Technical problems with POC	['Logistics_Resources']	['Neutral']
interim analysis, closed for additional product development	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Halted enrollment due to COVID-19	['Covid19']	['Neutral']
conduct (recruitment) not feasible within timeframe	['Insufficient_Enrollment']	['Neutral']
Problems with including patients	['Insufficient_Enrollment']	['Neutral']
Difficulty finding the required patient population	['Insufficient_Enrollment']	['Neutral']
Lack of recruitment and no resources	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Closed by sponsor.	['Business_Administrative']	['Possibly_Negative']
Due to bankruptcy of the CRO company	['Business_Administrative']	['Possibly_Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Study design improvements.	['Study_Design']	['Neutral']
This study was terminated due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
"The sensitivity and specificity were not able to be assessed in this study due to the poor
    image quality."	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Trial not initiated	['Invalid_Reason']	['Invalid_Reason']
Management Decision	['Business_Administrative']	['Possibly_Negative']
Only 1 participant enrolled since the beginning of this study	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Low Accural Rate	['Insufficient_Enrollment']	['Neutral']
difficulted recruiting	['Insufficient_Enrollment']	['Neutral']
NYU 03-67 reached accrual prior to this study opening.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Insufficient on-site staff to manage study	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The IDMC recommended to stop the study prematurely due to a lack of efficacy.	['Negative']	['Negative']
"The study was terminated prematurely after futility criterion was met at planned interim
    analysis of 41 patients."	['Negative']	['Negative']
Study was never approved by the IRB	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Manufacturer recently halted production of gadofosveset.	['Covid19', 'Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Insufficient staff and equipment challenges	['Logistics_Resources']	['Neutral']
Safety	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Not possible to recruit	['Insufficient_Enrollment']	['Neutral']
Stopped prematurely in 2008 due to IONSYS withdrawal off the market globally	['Covid19', 'Interim_Analysis', 'Safety_Sideeffects']	['Neutral', 'Neutral', 'Safety_Sideeffects']
unable to enroll patients for randomization	['Insufficient_Enrollment']	['Neutral']
Business reasons	['Business_Administrative']	['Possibly_Negative']
Continuation of the trial cannot serve a scientific purpose, no safety concerns identified	['Interim_Analysis', 'Logistics_Resources', 'Endpoint_Met']	['Neutral', 'Neutral', 'Neutral']
Terminated because of insufficient number of subjects included.	['Insufficient_Enrollment']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Futility in enrollment as of May 31, 2011	['Negative']	['Negative']
Lack of enrollment and loss of co-investigator.	['Insufficient_Enrollment']	['Neutral']
Mobile-bearing insert dislocation	['Safety_Sideeffects', 'Logistics_Resources']	['Safety_Sideeffects', 'Neutral']
Study terminated due to COVID-19 pandemic.	['Covid19']	['Neutral']
study was not funded	['Business_Administrative']	['Possibly_Negative']
Low accrual.	['Insufficient_Enrollment']	['Neutral']
Study assessment tool development delayed.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Drs Okunieff and ODell have left the University of Rochester	['Study_Staff_Moved']	['Neutral']
Funding was never received so no patients were enrolled.	['Business_Administrative']	['Possibly_Negative']
data did not indicate any meaningful information	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Study withdrawn due to lack of study population.	['Insufficient_Enrollment']	['Neutral']
"Dr Obel is deceased and no other investigators on study to provide information. old record, IRB
    has no information; outside of retention period."	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
No recruitment	['Insufficient_Enrollment']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Changes in pipeline	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Trial withdrawn due to COVID-19.	['Covid19']	['Neutral']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
Primary endpoint was not met	['Negative']	['Negative']
Difficulties in recruiting patient	['Insufficient_Enrollment']	['Neutral']
Retinal vascular occlusion in 2 patients	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Study not feasible or convenient for the subject	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Interruption of COVID 19 pandemic	['Covid19']	['Neutral']
Sponsor preferred a better study design	['Study_Design']	['Neutral']
2010 represented complications recruiting. The team suffered from sick-leave.	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Difficulty recruiting and retaining participants	['Insufficient_Enrollment']	['Neutral']
unable to enroll	['Insufficient_Enrollment']	['Neutral']
Scheduled Interim Monitoring	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
"Experimental procedure did not induce sufficient craving to determine any possible effect of
    medication."	['Negative']	['Negative']
Study Cancelled before enrollment	['Invalid_Reason']	['Invalid_Reason']
Study was terminated due to cease in manufacturing of study drug.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Withdrawn [This study was terminated early by Wyeth, prior to dosing any subjects, for business
    reasons not related to safety."	['Business_Administrative']	['Possibly_Negative']
"The study cannot recruit the expected number of participants. Only 19 participants were
    recruited and no more new participant was recruited after that."	['Insufficient_Enrollment']	['Neutral']
Recruitment was early terminated due to slow recruitment. Not linked to any safety concern.	['Insufficient_Enrollment']	['Neutral']
"The PI resigned the institute. The rest investigators at the institute decided to terminate the
    study."	['Study_Staff_Moved']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
PI left	['Study_Staff_Moved']	['Neutral']
due to COVID-19	['Covid19']	['Neutral']
"Intended as multi-center. 1 of 2 sites could not participate. Enrollment discontinued after
    50/100. Subjects followed per protocol."	['Insufficient_Enrollment']	['Neutral']
Low enrollment.	['Insufficient_Enrollment']	['Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Low recruit rate	['Insufficient_Enrollment']	['Neutral']
Study has concluded.	['Invalid_Reason']	['Invalid_Reason']
Not enough staff to collect data	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
PhIII program revised; TMC207-C210 cancelled	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Difficulty enrolling eligible subjects	['Insufficient_Enrollment']	['Neutral']
Insufficient subject accrual rate	['Insufficient_Enrollment']	['Neutral']
Study never started and was abandoned.	['Invalid_Reason']	['Invalid_Reason']
Low rate of recruitment.	['Insufficient_Enrollment']	['Neutral']
Reactogenicity met study halting criteria	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Low accrual.	['Insufficient_Enrollment']	['Neutral']
Lack of Funds.	['Business_Administrative']	['Possibly_Negative']
No further patient enrollment	['Insufficient_Enrollment']	['Neutral']
Trial was stopped early due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
No subjects were enrolled here or at UCSF.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"because of the presence of unexpected administrative barrier to interfere the collection of
    case"	['Business_Administrative']	['Possibly_Negative']
Patients from this study were rolled into RAP-MD-99.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
COVID-19 Pandemic	['Covid19']	['Neutral']
Due to COVID-19 pandemic	['Covid19']	['Neutral']
"The number of actual events was extremely low. We extended the study period, but it was still
    not enough. Also, many patients were loss of follow up."	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Research cancelled	['Invalid_Reason']	['Invalid_Reason']
More delayed type hypersensitivity responses (DTH) observed than anticipated.	['Negative']	['Negative']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
"The study was discontinued early due to inadequate patient enrollment. No patients were
    enrolled."	['Insufficient_Enrollment']	['Neutral']
inadequate patient number	['Insufficient_Enrollment']	['Neutral']
No capacity to conduct the study	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
No funding	['Business_Administrative']	['Possibly_Negative']
All potential participants opt to a simultaneous pharmacological clinical trial	['No_Context', 'Invalid_Reason', 'Study_Design']	['Invalid_Reason', 'Invalid_Reason', 'Neutral']
Reached scientific goals, further recruitment would not further advance the findings of study.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Lack of human ressources	['Logistics_Resources']	['Neutral']
Insufficient enrollment, lack of funding to continue	['Business_Administrative']	['Possibly_Negative']
Lack of Enrollment	['Insufficient_Enrollment']	['Neutral']
Due to reorganization.	['Business_Administrative']	['Possibly_Negative']
"Trial terminated Feb '15. Interim analysis results missed primary endpoint, intended signal not
    delivered in Tx arm, sham results as expected. No safety issues."	['Negative']	['Negative']
Unable to meet projected enrollment	['Insufficient_Enrollment']	['Neutral']
Business decision due to slow enrollment	['Business_Administrative']	['Possibly_Negative']
"Regulatory approval was not obtained for drisapersen, hence BioMarin is stopping the
    development of all exon skipping oligonucleotides in DMD."	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"The research project was terminated due to lower than projected patient recruitment within the
    period of time allowed for the study."	['Insufficient_Enrollment']	['Neutral']
Ethical commentate has not be obtained by the institution.	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
"Discontinued cystitis study due to poor recruitment. To continue the trial under these
    circumstances is considered non-viable."	['Insufficient_Enrollment']	['Neutral']
low participation and retention rates	['Insufficient_Enrollment']	['Neutral']
Hyperintensities of unclear etiology on brain MRI. Follow up revealed no progression.	['Negative']	['Negative']
Adverse events related to drug lot	['Logistics_Resources']	['Neutral']
"Unique provision in the American Recovery and Reinvestment Act prevented approval of second
    year no-cost-extension in which completion of analyses were planned."	['Regulatory', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
See detailed description	['No_Context']	['Invalid_Reason']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
"Higher incidence of cardiovascular events in the testosterone arm of the trial. Decision taken
    by the DSMB on December 31st, 2009."	['Safety_Sideeffects', 'Endpoint_Met', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
"After initiation of study many studies reported an equivalence of SNB and ALND which led to
    widespread adoption of the former as standard procedure."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Toxicity/Side Effects	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
very low enrolled participants	['Insufficient_Enrollment']	['Neutral']
"Lack of enrollment due to the availability of other novel salvage therapies for
    relapsed/refractory B-ALL."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
PI has left the institution	['Study_Staff_Moved']	['Neutral']
Enrollment below goal.	['Insufficient_Enrollment']	['Neutral']
The study was terminated due to the termination of the clinical development program.	['Business_Administrative']	['Possibly_Negative']
Enrollment suspended; follow up continue	['Invalid_Reason']	['Invalid_Reason']
"Recruitment stalled. Study terminated before inclusion of sufficient number of participants
    included"	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Closed due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Too slow recruitment	['Insufficient_Enrollment']	['Neutral']
"Study terminated because of differences in the participant population under study compared with
    indicated Zinbryta use in most countries."	['Negative']	['Negative']
Primary Analysis and study completed. Not stopped due to safety concerns.	['Safety_Sideeffects', 'Endpoint_Met', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
"The study was terminated due to marginal efficacy and change in sponsor prioritization. The
    combination had a manageable safety profile."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
no personnel for recruitment	['Insufficient_Enrollment']	['Neutral']
Imbalance in the efficacy and safety endpoints between treatment arms in favor of comparator	['Negative']	['Negative']
Recruitment challenges.	['Insufficient_Enrollment']	['Neutral']
Safety	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Study sponsor terminated study due to AE's reported with valsartan and aliskiren	['Business_Administrative']	['Possibly_Negative']
Study site compliance	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Investigator left the institution	['Study_Staff_Moved']	['Neutral']
"This study was terminated on 10 December 2012 due to low enrollment. The decision to terminate
    the study was not based on safety or efficacy issues."	['Insufficient_Enrollment']	['Neutral']
Study closed due to positive interim results.	['Negative']	['Negative']
The study could not be performed.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Closed due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Difficulty recruiting, only one participant in 18 months, rarity of event	['Insufficient_Enrollment']	['Neutral']
European Medicines Agency issued a drug/drug interaction: sofosbuvir/modafinil	['Covid19', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
financial constraints	['Business_Administrative']	['Possibly_Negative']
Terminated due to the inability to enroll and carry out study intervention.	['Insufficient_Enrollment']	['Neutral']
Funding withdrawn	['Business_Administrative']	['Possibly_Negative']
Technical difficulties	['Logistics_Resources']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Restrictions due to COVID-19	['Covid19']	['Neutral']
Business Decision	['Business_Administrative']	['Possibly_Negative']
There is no longer a plan to pursue an approval of lampalizumab.	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Business Decision (see below)	['Business_Administrative']	['Possibly_Negative']
Due to financial issues of Restora spacer company.	['Business_Administrative']	['Possibly_Negative']
No subjects were able to be recruited for the study.	['Insufficient_Enrollment']	['Neutral']
lack of recruitment.	['Insufficient_Enrollment']	['Neutral']
No participant enrollment, funding withdrawn.	['Business_Administrative']	['Possibly_Negative']
This study of the overall grant was not pursued as the aims were changed	['Business_Administrative']	['Possibly_Negative']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
"Results obtained on the first 8 patients shown an expected glandular membrane specific labeling
    associated with non-specific labeling of fibro-muscular tissue."	['Success', 'No_Context', 'Safety_Sideeffects']	['Success', 'Invalid_Reason', 'Safety_Sideeffects']
Financial Sponsor requested termination	['Business_Administrative']	['Possibly_Negative']
No enough fund or cases	['Business_Administrative']	['Possibly_Negative']
failure to recruit patients	['Insufficient_Enrollment']	['Neutral']
Study design changes were needed based on GIPF-001 results	['Negative', 'Another_Study']	['Negative', 'Neutral']
deficient inclusion	['Insufficient_Enrollment']	['Neutral']
"The study was terminated early due to difficulty in enrollment and lack of clinical study drug
    access."	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Closed due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
"Difficult to enroll; since a similar research project on a different population showed no
    significance the study has been closed."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Contract could not be agreed on.	['Business_Administrative']	['Possibly_Negative']
Study closed after it became too difficult to interest patients in participating.	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Business decision to Cancel	['Business_Administrative']	['Possibly_Negative']
The investigator left the institution so the study was terminated.	['Study_Staff_Moved']	['Neutral']
Persistent low enrollment made study continuation no longer feasible	['Insufficient_Enrollment']	['Neutral']
Pharmaceutical company sponsor withdrew support prior to enrollment of subjects.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
"The withdrawal is due to a strategic realignment and is not related to any particular safety or
    efficacy concern."	['Business_Administrative']	['Possibly_Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
"The NEVO stent will not be commercialized. Cordis decided to close the study after 1 years.
    This decision took the absence of safety signals into account."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Funder terminated.	['Business_Administrative']	['Possibly_Negative']
Not meeting enrollment goals	['Insufficient_Enrollment']	['Neutral']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Other new drugs	['Study_Design']	['Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsor's decision to revisit the development approach for prostate cancer.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"The decision not to progress the planned Phase 3 studies is a business decision based on the
    need to prioritise and focus resources within GSK."	['Business_Administrative']	['Possibly_Negative']
Local IRB required us to submit amendment as a separate study.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Funding period expired before all subjects could be recrutied	['Business_Administrative']	['Possibly_Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Doxil is currently unavailable	['Logistics_Resources']	['Neutral']
Ethical approval declined	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Unable to enroll patients in this study	['Insufficient_Enrollment']	['Neutral']
No candidates during recruiting time. There were no candidates meeting the inclusion criteria	['Insufficient_Enrollment']	['Neutral']
Insufficient resources to meet enrollment target	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Major change in protocol anticipated	['Study_Design']	['Neutral']
The development program has been terminated	['Business_Administrative']	['Possibly_Negative']
Study recruitment was suspended due to lack of funding	['Business_Administrative']	['Possibly_Negative']
Study never started and will never be started	['Invalid_Reason']	['Invalid_Reason']
Enrollment not continued	['Insufficient_Enrollment']	['Neutral']
Decision by Sponsor	['Business_Administrative']	['Possibly_Negative']
Study was terminated because of conflicting results from intermediate analysis.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
"Similar large international competing trial with results of strong positive statistically
    benefit"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of efficacy	['Negative']	['Negative']
Per CTEP, Martha Khrum this study is withdrawn. Changing status to update CT.gov	['Covid19', 'No_Context', 'Invalid_Reason']	['Neutral', 'Invalid_Reason', 'Invalid_Reason']
Slow recruitment over 3 yrs (n=47). No chance to reach sample size (n=~160).	['Insufficient_Enrollment']	['Neutral']
closed due to slow accrual	['Insufficient_Enrollment']	['Neutral']
The principal investigator left the institution.	['Study_Staff_Moved']	['Neutral']
Lack of enrolment	['Insufficient_Enrollment']	['Neutral']
Study didn't materialize for various reasons.	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
The study was terminated on October 29, 2010 due to gastrointestinal adverse events.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"Pilot study initiated to provide support data for main grant GCO 06-0217 funded. only baseline
    characteristic data collected. no results for this study."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
the Cypher SES is now withdrawing in China market	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
"two other institutions that were in the center thought they weren't going to be able to recruit
    enough patients"	['Insufficient_Enrollment']	['Neutral']
insufficient recruitment: 142 patients instead of 2,220 planned	['Insufficient_Enrollment']	['Neutral']
Enrollment was more challenging than anticipated.	['Insufficient_Enrollment']	['Neutral']
No subjects enrolled	['Insufficient_Enrollment']	['Neutral']
Difficulty with patient enrollment	['Insufficient_Enrollment']	['Neutral']
"Study was discontinued due to FDA recommendations of the potential toxicities of the
    combination of drugs."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
This study was prematurely terminated on June 25, 2014 due to lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
not recruiting, awaiting for changes in IRB	['Interim_Analysis', 'Regulatory', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Closed due to poor accrual	['Insufficient_Enrollment']	['Neutral']
Inadequate patient enrollment	['Insufficient_Enrollment']	['Neutral']
Terminated due to warning letters issued regarding paclitaxel	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Ended prematurely	['Invalid_Reason']	['Invalid_Reason']
protocol change	['Study_Design']	['Neutral']
Difficulty in recruiting	['Insufficient_Enrollment']	['Neutral']
Business decision.	['Business_Administrative']	['Possibly_Negative']
Study terminated for commercial reasons	['Business_Administrative']	['Possibly_Negative']
"recruitment difficulties (few patients meeting inclusion criteria, refusal of patients to stop
    sport activities during 6 weeks,...)"	['Insufficient_Enrollment']	['Neutral']
"Insufficient funding for enrollment of patients. The invesitgators realized the study could not
    be performed."	['Business_Administrative']	['Possibly_Negative']
No suitable patient found	['Insufficient_Enrollment']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
No patients were enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Insufficient recruitment.	['Insufficient_Enrollment']	['Neutral']
Low/no enrollment. No subjects were enrolled over the past year.	['Insufficient_Enrollment']	['Neutral']
no accrual	['Insufficient_Enrollment']	['Neutral']
PI decided to terminate due to low/slow accrual	['Insufficient_Enrollment']	['Neutral']
"At the request of the study site, this study has been closed and access to study-related data
    is unavailable. We are unable to submit the results-data."	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
study no longer at pittsburgh	['Study_Staff_Moved']	['Neutral']
Study terminated due to poor accrual	['Insufficient_Enrollment']	['Neutral']
Accrual problems	['Insufficient_Enrollment']	['Neutral']
Per sponsor decision to stop the development of the study device	['Business_Administrative']	['Possibly_Negative']
difficulty in recruiting	['Insufficient_Enrollment']	['Neutral']
Trial not initiated	['Invalid_Reason']	['Invalid_Reason']
Enrollment too slow to complete the trial in a reasonable amount of time.	['Insufficient_Enrollment']	['Neutral']
"drug company withdrew support following re-examination of benefit-risk assessment for the
    investigational use of imetelstat in this population"	['Interim_Analysis', 'Regulatory', 'Negative']	['Neutral', 'Neutral', 'Negative']
Inability to obtain patients	['Insufficient_Enrollment']	['Neutral']
"Data did not show that the two biologic treatments impacted PMR disease activity to the same
    degree as steroid treatment within a 2-week treatment period."	['Negative']	['Negative']
Low accrual rate	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
study no longer required in current format	['Study_Design']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
This study was terminated for low accrual.	['Insufficient_Enrollment']	['Neutral']
Insufficient Resources	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study terminated for safety and the FDA put the study on hold for safety.	['Regulatory']	['Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Study was stopped to pursue a new treatment plan with a new study.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
funding	['Business_Administrative']	['Possibly_Negative']
Terminated by Sponsor	['Business_Administrative']	['Possibly_Negative']
Closed by investigator	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
funding withdrawn	['Business_Administrative']	['Possibly_Negative']
Data Safety and Monitoring Board 's request	['Interim_Analysis', 'Regulatory', 'Negative']	['Neutral', 'Neutral', 'Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Due to cranial nerve palsies observed	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
This study was terminated due to lack of funding.	['Business_Administrative']	['Possibly_Negative']
difficulty in recruiting participants to the study	['Insufficient_Enrollment']	['Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
PI retired, study never opened.	['Study_Staff_Moved']	['Neutral']
"With vaccination efforts ongoing, a feasibility survey indicated there would be inadequate
    recruitment"	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Terminated based on interim review	['Interim_Analysis', 'Regulatory', 'Negative']	['Neutral', 'Neutral', 'Negative']
"Due to low patient enrollment was stopped. Only one patient could be enrolled. 37 patients were
    pre-screened, but not into the inclusion criteria (wt-EGFR)"	['Insufficient_Enrollment']	['Neutral']
"Patients were transferred to designated hospitals for treatment as needed, the clinical trials
    cannot be conducted."	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Inability to recruit subjects at the study site.	['Insufficient_Enrollment']	['Neutral']
Company went out of business.	['Business_Administrative']	['Possibly_Negative']
FDA released Fresenius Kabi from this post marketing requirement on 07/16/2019.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Slow accrual to part 2 of the study. Accrual to part 1 is complete.	['Insufficient_Enrollment']	['Neutral']
Part B of the study no longer required due to new information on the study drug.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Recruitment no longer viable as spinal classes were stopped due to the COVID-19 situation.	['Covid19']	['Neutral']
Business decision (no safety or efficacy concerns)	['Business_Administrative']	['Possibly_Negative']
Logistics reason at the data collection site	['Logistics_Resources']	['Neutral']
investigators changed jobs, no longer affiliated with institution	['Study_Staff_Moved']	['Neutral']
Changes of usual clinical practices	['Study_Design']	['Neutral']
COVID-19	['Covid19']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
"Enrollment stopped after CDRH Advisory Panel (Nov 20, 2008) recommended NAVISTAR THERMOCOOL
    catheter approval."	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Project was not funded by FDA	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
"The primary investigator moved from academic practice to join a private group, and could not
    get any one to take over as PI for the study."	['Study_Staff_Moved']	['Neutral']
"Due to high number of patients terminating study early, low patient enrollment and difficulty
    in patient/investigator willingness for randomization"	['Insufficient_Enrollment']	['Neutral']
Study halted prematurely due to low accrual.	['Insufficient_Enrollment']	['Neutral']
"Organizational changes in health care made further recruitment to the treatment options
    unpossible."	['Business_Administrative']	['Possibly_Negative']
Gadolinium attenuation in vitro inadequate	['Negative']	['Negative']
closed by IRB	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
A number of issues which impact on the ability to recruit patients to the study	['Insufficient_Enrollment']	['Neutral']
PI left site.	['Study_Staff_Moved']	['Neutral']
Sponsor decision to prematurely stop the study, not linked to any safety concern.	['Business_Administrative']	['Possibly_Negative']
Strategic decision	['Business_Administrative']	['Possibly_Negative']
PI has left the institution.	['Study_Staff_Moved']	['Neutral']
"Recent similar studies have been completed and published showing no benefit to the
    intervention."	['Negative', 'Another_Study']	['Negative', 'Neutral']
no enrollment	['Insufficient_Enrollment']	['Neutral']
departure of one of the investigator	['Study_Staff_Moved']	['Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
New studies available with immunotherapy so recruitment is no longer acceptable.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Lack of Funding	['Business_Administrative']	['Possibly_Negative']
PI no longer at this facility	['Study_Staff_Moved']	['Neutral']
business decision	['Business_Administrative']	['Possibly_Negative']
Funding was terminated	['Business_Administrative']	['Possibly_Negative']
The study was terminated due to low enrollment	['Insufficient_Enrollment']	['Neutral']
low participation rate	['Insufficient_Enrollment']	['Neutral']
The project was not announced to the field and it was not funded.	['Business_Administrative']	['Possibly_Negative']
Recruitment problems	['Insufficient_Enrollment']	['Neutral']
Inability to enroll within funding period	['Business_Administrative']	['Possibly_Negative']
Accrual was terminated for lack of a clinical benefit.	['Negative']	['Negative']
Difficulty in recruiting patients for the study	['Insufficient_Enrollment']	['Neutral']
Company no longer has funding for the study.	['Business_Administrative']	['Possibly_Negative']
difficulty enrolling additional patients	['Insufficient_Enrollment']	['Neutral']
poor recruitment	['Insufficient_Enrollment']	['Neutral']
Drug manufacturer could not supply study drug.	['Logistics_Resources']	['Neutral']
Terminated because of futility to continue, after planned interim analysis.	['Negative']	['Negative']
Slow accrual of subject enrollment.	['Insufficient_Enrollment']	['Neutral']
Not pursuing the study due to funding issues	['Business_Administrative']	['Possibly_Negative']
Inadequate support to conduct the study	['Business_Administrative']	['Possibly_Negative']
Business Reasons	['Business_Administrative']	['Possibly_Negative']
Due to unforeseen circumstances this study will not now start.	['Invalid_Reason']	['Invalid_Reason']
Atypically high dropout rate.	['Insufficient_Enrollment']	['Neutral']
Unable to enroll patients	['Insufficient_Enrollment']	['Neutral']
not appropriate to carry on the study	['Invalid_Reason']	['Invalid_Reason']
Funding	['Business_Administrative']	['Possibly_Negative']
Mutual agreement between Sponsor and Investigator.	['Business_Administrative']	['Possibly_Negative']
recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Expired IRB application	['Business_Administrative']	['Possibly_Negative']
Study was terminated due to safety reason.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Lack of additional funding	['Business_Administrative']	['Possibly_Negative']
terminated	['Invalid_Reason']	['Invalid_Reason']
Terminated at continuing review	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Low accrual rate	['Insufficient_Enrollment']	['Neutral']
Decision of Study Principal Investigator	['Study_Staff_Moved', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Study is terminated due to lack of efficacy	['Negative']	['Negative']
As advised by the DSMB the study was stopped due to slow recruitment.	['Insufficient_Enrollment']	['Neutral']
Recruitment is temporarily suspended due to COVID. Will resume when appropriate.	['Covid19']	['Neutral']
Recruitment Challenges	['Insufficient_Enrollment']	['Neutral']
Reviewing data	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
"No activity was observed. BRAFi-nave participants should have received triple combination
    treatment (including MEK inhibitor). Continuation was not justified."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Submission discarded. Study never enrolled subjects.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
PI left	['Study_Staff_Moved']	['Neutral']
No subjects enrolled and PI went to another facility	['Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Participant enrollment was not feasible	['Insufficient_Enrollment']	['Neutral']
Study cancelled due to sponsor's decision to redesign the study	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Insufficient clinical activity	['Negative', 'Another_Study']	['Negative', 'Neutral']
difficulty to recruit patients	['Insufficient_Enrollment']	['Neutral']
No in-person testing is permitted at Ryerson University due to COVID-19.	['Covid19']	['Neutral']
Study never began	['Invalid_Reason']	['Invalid_Reason']
due to toxicity of cyclophosphamide	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Principal investigator left the institution and study was not transferred to anyone else.	['Study_Staff_Moved']	['Neutral']
Lack of patient enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
unable to recruit patients for study	['Insufficient_Enrollment']	['Neutral']
No funding obtained.	['Business_Administrative']	['Possibly_Negative']
Completed	['Invalid_Reason']	['Invalid_Reason']
departmental financial support withdrawn	['Business_Administrative']	['Possibly_Negative']
Study discontinued due to low accrual.	['Insufficient_Enrollment']	['Neutral']
Due to the discontinuation of compound development, this study has been terminated.	['Business_Administrative']	['Possibly_Negative']
Slow accruals	['Insufficient_Enrollment']	['Neutral']
End of the period of inclusion, NSN not achieved	['Regulatory', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
As a result of a pre-planned interim analysis for futility	['Negative']	['Negative']
lack of funding	['Business_Administrative']	['Possibly_Negative']
No participants were enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
A new alternative treatment caused the decrease in the rhythm of recruitment.	['Study_Design']	['Neutral']
Women's confinement for COVID-19 pandemic and changes on prenatal care.	['Covid19']	['Neutral']
Data collection was terminated due to unavailability of additional participants.	['Insufficient_Enrollment']	['Neutral']
"The study was terminated by Takeda due to the discomfort observed in the study participants
    from the CSF collection procedure in Part 3 of the study."	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
CPP requalification	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Study has withdrawn.	['Invalid_Reason']	['Invalid_Reason']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
1 patient died of uncertain cause but possibly related to drug.	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Physician is no longer associated with the Univ. of Michigan Medical Center	['Study_Staff_Moved']	['Neutral']
change in procedure	['Study_Design']	['Neutral']
"Sufficient data regarding the dose-response to MK-0893 had been obtained from the first cohort
    of the study to assess the safety and efficacy"	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Business decision	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Limited enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
no participants enrolled	['Insufficient_Enrollment']	['Neutral']
Study was terminated due to low accrual.	['Insufficient_Enrollment']	['Neutral']
"Two subjects finally recruited 11/17, but not enough time to complete their studies before the
    funding terminated on November 30, 2017"	['Business_Administrative']	['Possibly_Negative']
competing studies did not allow enrollment	['Insufficient_Enrollment', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
"There seemed to be no uptake of the ligand in the areas of the brain expected for subjects with
    amyloid."	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Limited participants for enrollment	['Insufficient_Enrollment']	['Neutral']
Difficulty of realization of the study	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
PI decided to end the study	['Invalid_Reason']	['Invalid_Reason']
No funding ever received	['Business_Administrative']	['Possibly_Negative']
Investigator Decision	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
difficulty in setting up the study in the investigator site	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
On the request of the investigational drug provider	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Drug Supply Shortage	['Logistics_Resources']	['Neutral']
FDA didn't approve the design of the protocol so we didn't start the study	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"This study has been withdraw from the IRB. The PI has transferred to another university. The
    IND was transferred."	['Study_Staff_Moved']	['Neutral']
Due to inability to recruit sufficient sample size in reasonable time frame.	['Insufficient_Enrollment']	['Neutral']
FDA Clinical Hold	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
enrollment	['Insufficient_Enrollment']	['Neutral']
"The last remaining subject withdrew consent because the collaborator Genentech stopped
    supplying study drug."	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of efficacy. Stopped at first interim evaluation point	['Negative']	['Negative']
no participants enrolled	['Insufficient_Enrollment']	['Neutral']
"Sponsor(Bayer)did not wish to continue with study due to slow accrual. Therefore, there is
    insufficient data and will not be any study results/outcomes."	['Insufficient_Enrollment']	['Neutral']
"The study never opened due to technical upgrades that were needed for the SHUTi computer
    system."	['Logistics_Resources']	['Neutral']
Low Enrollment	['Insufficient_Enrollment']	['Neutral']
few patient feedback and principal investigator disponibility	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Study terminated by sponsor	['Business_Administrative']	['Possibly_Negative']
Updating protocol and consents	['Study_Design']	['Neutral']
Failure of subject recruitment	['Insufficient_Enrollment']	['Neutral']
The study was suspended after a suspected unexpected serious adverse event.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Technical issues preventing recruitment.	['Logistics_Resources']	['Neutral']
study terminated due to slow accrual	['Insufficient_Enrollment']	['Neutral']
"After careful review of new data on GSK2245035, GlaxoSmithKline has decided to cancel this
    study."	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
not funded	['Business_Administrative']	['Possibly_Negative']
Enrollment considerations and current status of the clinical study	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
"Several therapeutic have been developed making more difficult the eligibility of patients -
    Recruitment of new centers wasn't possible due to competing trials"	['Insufficient_Enrollment', 'Study_Design', 'Another_Study']	['Neutral', 'Neutral', 'Neutral']
Futility for enrollment	['Negative']	['Negative']
proof of mechanism achieved with fewer subjects than anticipated	['Negative']	['Negative']
Program refocus	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
funding withdrawn due to fellow's departure from VICC	['Business_Administrative']	['Possibly_Negative']
"The study was terminated because of slow enrollment. The decision to terminate the trial was
    not based on any safety or efficacy concerns."	['Insufficient_Enrollment']	['Neutral']
Low Recruitment	['Insufficient_Enrollment']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Recruiting was not as anticipated.	['Insufficient_Enrollment']	['Neutral']
Non-safety related business decision to combine special population protocols	['Business_Administrative']	['Possibly_Negative']
Due to COVID-19 and the decrease in surgical cases, sufficient patients were not available.	['Covid19']	['Neutral']
Genzyme discontinued Funding	['Business_Administrative']	['Possibly_Negative']
stopped because of competing studies	['Negative', 'Another_Study']	['Negative', 'Neutral']
The progress of enrollment is too slow.	['Insufficient_Enrollment']	['Neutral']
Delayed/poor inclusion rate.	['Insufficient_Enrollment']	['Neutral']
Halted due to COVID 19; we believe we have adequate data for analysis	['Covid19']	['Neutral']
"EC did not accept measurement of patient's activity for the primary end-point with a
    non-validated activity tracking device"	['Logistics_Resources', 'Negative']	['Neutral', 'Negative']
IMP no longer available	['Covid19', 'Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Business Decision	['Business_Administrative']	['Possibly_Negative']
Structural changes that stopped the type of operations used in the study	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Funding has become unavailable	['Business_Administrative']	['Possibly_Negative']
This study was withdrawn due to study agent availability.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Unknown Reason	['No_Context', 'Logistics_Resources', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
"slow enrollment in one site and withdrawal of the second site prior to enrollment of first
    participant;"	['Insufficient_Enrollment']	['Neutral']
Clinic visits stopped due to COVID19	['Covid19']	['Neutral']
methodological problems	['Logistics_Resources']	['Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
low-rate of enrollment	['Insufficient_Enrollment']	['Neutral']
Change in design to observational study	['Study_Design']	['Neutral']
Recruitment almost complete, has been slow and challenging	['Insufficient_Enrollment']	['Neutral']
The study was terminated based on an interim assessment of immunogenicity	['Safety_Sideeffects', 'Negative']	['Safety_Sideeffects', 'Negative']
Study terminated early due to lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
Management Decision	['Business_Administrative']	['Possibly_Negative']
difficult to include patients	['Insufficient_Enrollment']	['Neutral']
Due to ongoing vaccination efforts, feasibility for recruitment is low	['Insufficient_Enrollment']	['Neutral']
Limited subject enrollment	['Insufficient_Enrollment']	['Neutral']
Drug provider withdrew support	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
for business reasons	['Business_Administrative']	['Possibly_Negative']
Due to lack of funding and a primary co-investigator of the trial leaving the institution.	['Business_Administrative']	['Possibly_Negative']
unable to enroll subjects meeting Eligibility criteria	['Insufficient_Enrollment']	['Neutral']
Per protocol, the study was terminated based on interim analysis results	['Interim_Analysis', 'Endpoint_Met', 'Negative']	['Neutral', 'Neutral', 'Negative']
lack of adequate recruitment	['Insufficient_Enrollment']	['Neutral']
Subject Recruitment	['Insufficient_Enrollment']	['Neutral']
Due to departure of PI from St. Jude	['Study_Staff_Moved']	['Neutral']
Coordinating site change	['Logistics_Resources', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
not recruiting	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Based on interim review and decision to re-design the study.	['Study_Design']	['Neutral']
"The study was terminated as it was determined to not be feasible to complete enrollment and the
    study within the required timeline and budget."	['Business_Administrative']	['Possibly_Negative']
"Dr. Rabheru left VCH last year and the study was cancelled according to his research
    coordinator."	['Study_Staff_Moved']	['Neutral']
"In view of outcome of RELAX-AHF-2 trial, the entire RLX030A project was decided to be
    terminated."	['Negative', 'Another_Study']	['Negative', 'Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Trial has been suspended due to lack of resource and staff	['Logistics_Resources']	['Neutral']
"In consequence of termination of ALTITUDE. A number of studies were continued in consultation
    with the Altitude Data Monitoring Committee."	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Interim analyses showed statistically and clinically significant results.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Trial discontinued prior to starting Phase II portion due to low accrual.	['Insufficient_Enrollment']	['Neutral']
Funding withdrawn	['Business_Administrative']	['Possibly_Negative']
Business objectives have changed.	['Business_Administrative']	['Possibly_Negative']
Study was terminated due to funding issues.	['Business_Administrative']	['Possibly_Negative']
study was terminated due to poor enrollment	['Insufficient_Enrollment']	['Neutral']
"Ultrasound machine was no longer approved for use by Health Canada therefore study was closed
    prior to patients being enrolled on study."	['Logistics_Resources']	['Neutral']
Protocol was withdrawn from IND	['Regulatory', 'Insufficient_Enrollment', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
PK results suggested product did not meet requirement for further development.	['Negative']	['Negative']
"The study ended prematurely due to the low accrual rate (24% of the expected accrual rate) in
    the first two years of patients enrolment"	['Insufficient_Enrollment']	['Neutral']
"We completed One group intervention but the COVID Pandemic forced us to pause the research. We
    have preliminary data from 18 participants."	['Covid19']	['Neutral']
Adverse change in the risk/benefit	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Competing studies	['Negative', 'Another_Study']	['Negative', 'Neutral']
Corporate decision	['Business_Administrative']	['Possibly_Negative']
Investigator left the university prior to study approval, no patients enrolled	['Study_Staff_Moved']	['Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Funding withdrawn.	['Business_Administrative']	['Possibly_Negative']
"Protocol pre-specified interim analysis showed that difference between groups was too small to
    reach significance."	['Negative']	['Negative']
recruitment for the substudy did not meet the goals	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Due to funding	['Business_Administrative']	['Possibly_Negative']
Terminated early due to a lack of efficacy	['Negative']	['Negative']
Study not conducted	['Invalid_Reason']	['Invalid_Reason']
Potential hepatic safety signal	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Closure was recommended by CTEP due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
Funding withdrawn based on unacceptably slow recruitment rate.	['Business_Administrative']	['Possibly_Negative']
Costs for antibody production rose; supplemental funding request not approved.	['Business_Administrative']	['Possibly_Negative']
Protocol suspended prior to patient enrollment	['Invalid_Reason']	['Invalid_Reason']
As a result of change of clinical development plan.	['Business_Administrative']	['Possibly_Negative']
Recently published BOTOX efficacy data and study design deficits.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
challenges encountered in the methodology and concerns with the gold standard of treatment	['Logistics_Resources', 'Endpoint_Met', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
The study is terminated early due to unavailability of investigational product.	['Logistics_Resources']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Lack of human ressources	['Logistics_Resources']	['Neutral']
IRB had concerns about study; terminated	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Insufficient efficacy of drug; no safety concern	['Negative']	['Negative']
Not enought inclusion	['Insufficient_Enrollment']	['Neutral']
Midterm analysis showed negative results.	['Negative']	['Negative']
Early closure due to low accrual	['Insufficient_Enrollment']	['Neutral']
Early termination due to lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Closed due to continued slow enrollment.	['Insufficient_Enrollment']	['Neutral']
no IRB approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
This study was not approved by the Ethics Committee	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
PI no longer available, not able to find replacement. 2 patients, lost to follow-up.	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
Unable to find further eligible participants	['Insufficient_Enrollment']	['Neutral']
Very few children and adolescents identified who met intake criteria.	['Insufficient_Enrollment']	['Neutral']
Study supply issues	['Logistics_Resources']	['Neutral']
"All enrolled participants completed the study protocol but the study was terminated prior to
    the goal number of participants due to low recruitment"	['Insufficient_Enrollment']	['Neutral']
Manufacturer of the investigational device has ceased all business activities	['Business_Administrative']	['Possibly_Negative']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
Difficulty in recruitment	['Insufficient_Enrollment']	['Neutral']
Cancelled according to PhD-protocol with insufficient time to complete the study	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Small number of subjects	['Insufficient_Enrollment']	['Neutral']
The mobile phone app upon which the study was based was not available.	['Logistics_Resources']	['Neutral']
sufficient enrollment	['Insufficient_Enrollment']	['Neutral']
The study is going to open in a new site	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
PI left institution prior to receiving funding	['Business_Administrative']	['Possibly_Negative']
Researcher deployed before approval	['Logistics_Resources', 'Study_Staff_Moved', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Number of patients to meet individual IDE requirements was not obtained.	['Insufficient_Enrollment']	['Neutral']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
The phase II portion was not conducted due to funding issue.	['Business_Administrative']	['Possibly_Negative']
Inadequate recruitment	['Insufficient_Enrollment']	['Neutral']
"Investigators and resources are no longer available for completion of the study due to
    retirements, relocations and reassignments."	['Logistics_Resources', 'Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
Sponsor decision not to enroll cohorts of combined SGN-35 and gemcitabine therapy.	['Business_Administrative']	['Possibly_Negative']
"""Tapering doses"" protocol arm was not effective for treatment retention outcome."	['Negative']	['Negative']
Follow-up end in 1999	['Invalid_Reason']	['Invalid_Reason']
Safety reasons	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Prevalence of infection for screened population too low (<7%) to enroll anyone.	['Insufficient_Enrollment']	['Neutral']
Study terminated/withdrawn	['Invalid_Reason']	['Invalid_Reason']
"Recruiting target patients is intermittent making it impracticable to enroll the required study
    sample. The administrative responsibilities have been met with extraordinary challenges.
    Current funding does not match the incurring costs."	['Business_Administrative']	['Possibly_Negative']
See Detailed Description	['No_Context']	['Invalid_Reason']
Head of the study has left the institution. Study never started.	['Study_Staff_Moved']	['Neutral']
The study was stopped early for futility reasons.	['Negative']	['Negative']
"This study should be terminated as the study has been closed for years and the investigator has
    since retired. No records are available.

    Thank you, Marlene"	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
End of the recruitment	['Invalid_Reason']	['Invalid_Reason']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Business Decision; No Safety Concerns.	['Business_Administrative']	['Possibly_Negative']
SERVE-HF results showed ASV increased CV mortality in patients with reduced LVEF	['Success', 'Logistics_Resources', 'Endpoint_Met']	['Success', 'Neutral', 'Neutral']
Per PIs request	['Study_Staff_Moved', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Due to financial reasons.	['Business_Administrative']	['Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
"Due to defunding of USAID project that supported the majority of the sites selected in the
    randomization."	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
no differences between the groups at the interim analysis	['Negative']	['Negative']
Recruitment on hold - COVID-19	['Covid19']	['Neutral']
"Recruitment, intervention implementation and data collected stopped in February, 2021 due to
    the COVID-19 pandemic. Recruitment is anticipated to resume in summer of 2021."	['Covid19']	['Neutral']
Problems with recruitment	['Insufficient_Enrollment']	['Neutral']
Cost prohibitive and company withdrew support.	['Business_Administrative']	['Possibly_Negative']
no accrual	['Insufficient_Enrollment']	['Neutral']
Principal investigator wishes to revisit design and start a new study	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
recruitment issues, critical investigators left institution	['Study_Staff_Moved']	['Neutral']
PI departure from institution	['Study_Staff_Moved']	['Neutral']
Withdrawn due to logistic reasons	['Logistics_Resources']	['Neutral']
terminated early due to non-safety related DMC recommendations	['Safety_Sideeffects', 'Regulatory', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Funding loss	['Business_Administrative']	['Possibly_Negative']
As of November 4, 2019 the study was halted prematurely and will not resume.	['Invalid_Reason']	['Invalid_Reason']
PI departure - study not conducted.	['Study_Staff_Moved']	['Neutral']
Terminated	['Invalid_Reason']	['Invalid_Reason']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Inadequate/low enrollment	['Insufficient_Enrollment']	['Neutral']
The trial was ended prematurely because of a poor accrual rate	['Insufficient_Enrollment']	['Neutral']
The medical device has been withdrawn from the market due to technical issues.	['Logistics_Resources']	['Neutral']
no enrollment	['Insufficient_Enrollment']	['Neutral']
"We are working on updating the study due to low enrollment and potentially looking at a
    different primary objective"	['Study_Design']	['Neutral']
Extenuating circumstances	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Inclusion problems	['Insufficient_Enrollment']	['Neutral']
"Since AZD0328 is unlikely to meet the current Target Product Profile, Astrazeneca decided to
    stop further development of AZD0328"	['Regulatory', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Developing new formulation of study drug. New study to open next year under a new protocol.	['Study_Design']	['Neutral']
Completion not feasible. THERE ARE NO RESULTS FROM THIS TRIAL	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"The study was closed prior to enrollment of any subjects. No subjects were enrolled in this
    study."	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
insufficient data	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
- Interest in the use of HCQ is controversial.	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Recruitment challenges and lack of funding caused an early end to this study	['Business_Administrative']	['Possibly_Negative']
Sponsors pulled out of the study	['Business_Administrative']	['Possibly_Negative']
Closed by the research committee	['Interim_Analysis', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
terminated due to low enrollment rate	['Insufficient_Enrollment']	['Neutral']
FDA Partial Clinical Hold	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Due to the COVID-19 pandemic	['Covid19']	['Neutral']
COVID-19	['Covid19']	['Neutral']
Competing study to be started in November 2018	['Negative', 'Another_Study']	['Negative', 'Neutral']
"nump

    acceptence by patient too low"	['Negative']	['Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Interim analysis completed and decided to terminate and proceed to Phase 3 trial.	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
Difficulty in recruiting	['Insufficient_Enrollment']	['Neutral']
inadequate recruitment	['Insufficient_Enrollment']	['Neutral']
"Imaging results were not sufficient or of good quality; therefore, we will not move further
    with the project."	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
investigator choice	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Study Ended May 1, 2020 with no enrollment	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
investigator institution change	['Study_Staff_Moved']	['Neutral']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
No patient recruited due to current guidelines for the pain related to burn	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
inadequate enrollment	['Insufficient_Enrollment']	['Neutral']
Study recruitment has been suspended.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Unable to complete subject recruitment	['Insufficient_Enrollment']	['Neutral']
"Aspirin added to chemoradiotherapy was safe but did not improve response to total neoadjuvant
    treatment. The study was closed due absence of benefit."	['Negative']	['Negative']
significant conclusive data has been collected	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
unable to allocate sufficient resources in setting of pandemic	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Suspended due to COVID-19.	['Covid19']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
High number of screen failures	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Recruitment and enrollment are suspended due to COVID-19.	['Covid19']	['Neutral']
Enrollment is suspended due to COVID-19	['Covid19']	['Neutral']
One of the investigators went abroad	['Study_Staff_Moved']	['Neutral']
protocol was never implemented as procedures became standard of care	['Study_Design']	['Neutral']
Study sponsor ended trial due to low recruitment	['Insufficient_Enrollment']	['Neutral']
The PI decided.	['Invalid_Reason']	['Invalid_Reason']
Sponsor no longer pursuing Epilepsy development.	['Business_Administrative']	['Possibly_Negative']
Higher than anticipated rate of Hepatic abscess (N=7)	['Safety_Sideeffects', 'Endpoint_Met', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
changed research plan	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Administrative reasons.	['Business_Administrative']	['Possibly_Negative']
study terminated due to low accrual	['Insufficient_Enrollment']	['Neutral']
Per protocol intermediate analyses of 76 patients and enrollment difficulties.	['Insufficient_Enrollment']	['Neutral']
low recruitment	['Insufficient_Enrollment']	['Neutral']
Due to insufficient research institution participation and patient enrollment	['Insufficient_Enrollment']	['Neutral']
difficulties of recruitement	['Insufficient_Enrollment']	['Neutral']
Temozolomide does not favour immune response; secondary GBM to be excluded	['Negative']	['Negative']
"The grant for this project wasn't funded, so there has been no enrollment. We are still hopeful
    that the project will go forward some day, but not now."	['Business_Administrative']	['Possibly_Negative']
Difficult enrollment, no subjects identified to enroll	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Technique no longer available	['Study_Design']	['Neutral']
Study withdrawn prior to initiation	['Invalid_Reason']	['Invalid_Reason']
Further development needed to facilitate easier polypectomy - device improvement	['Study_Design']	['Neutral']
Predefined termination criterion of > 10 patients without CR or PR was matched.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Inadequate number of patients whou could meet inclusion criteria.	['Insufficient_Enrollment']	['Neutral']
Study closed due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor discontinued IPF Program on 23-Oct. 2017 based on POC studies	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Difficulty with recruitment and therefore funding has been pulled.	['Business_Administrative']	['Possibly_Negative']
Company decision	['Business_Administrative']	['Possibly_Negative']
Difficulty in recruitment.	['Insufficient_Enrollment']	['Neutral']
University shutdown due to COVID	['Covid19']	['Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Terminated Per PIs request due to low accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Difficulties in getting suitable applicators for biodegradable stents.	['Logistics_Resources']	['Neutral']
Device voluntarily withdrawn from commercial use by manufacturer	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The funding sponsor elected to terminate the study.	['Business_Administrative']	['Possibly_Negative']
Unavailability of PI and Deputy	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
Slow Enrollment	['Insufficient_Enrollment']	['Neutral']
"Lack of enrollment during Covid pandemic, however sufficient data gathered for assessment of
    primary outcome"	['Covid19']	['Neutral']
Feasibility	['Logistics_Resources']	['Neutral']
enrollment challenges	['Insufficient_Enrollment']	['Neutral']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Study on-hold before first recruitment	['Invalid_Reason']	['Invalid_Reason']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
The DSMB supported termination of the trial due to slow recruitment.	['Insufficient_Enrollment']	['Neutral']
Administrative re-organization of the department. Referent physician left the hospital.	['Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
due to administrative reasons not related to efficacy or safety.	['Business_Administrative']	['Possibly_Negative']
due to a development decision by the funder	['Business_Administrative']	['Possibly_Negative']
Specialised equipment required withdrawn from market	['Logistics_Resources']	['Neutral']
Preliminary results indicated no measurable benefit.	['Negative']	['Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Adverse events	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Lack of Enrollment	['Insufficient_Enrollment']	['Neutral']
Due to the changes of standard of care and the slow recruitment of participants.	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"The study was terminated under the political pressure of the Federal Security Service of the
    Russian Federation (FSB) and the Russian Society of Cardiology"	['Ethical_Reason', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
No accrual	['Insufficient_Enrollment']	['Neutral']
FDA indicated the same study could not be conducted under multiple INDs	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
No participants were enrolled.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Insufficient recruitment rate	['Insufficient_Enrollment']	['Neutral']
Study halted prematurely and will not resume	['Invalid_Reason']	['Invalid_Reason']
New studies are being offered	['Negative', 'Another_Study']	['Negative', 'Neutral']
"This action was a business decision & not related to any efficacy, safety or clinical concerns
    with lesinurad."	['Business_Administrative']	['Possibly_Negative']
Change in business strategy	['Business_Administrative']	['Possibly_Negative']
Rescheduled Study	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Business decision	['Business_Administrative']	['Possibly_Negative']
Investigator moved to another institution.	['Study_Staff_Moved']	['Neutral']
PIs were unable to recruit any participants	['Insufficient_Enrollment']	['Neutral']
Study is complete Analysis is complete	['Invalid_Reason']	['Invalid_Reason']
This condition can now be managed in the office with an injection of Lucentis.	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Study was not accruing	['Insufficient_Enrollment']	['Neutral']
the study has recently ended, all information gathred as planed	['Invalid_Reason']	['Invalid_Reason']
because the study is very complicated and cannot be performed in the practice	['No_Context', 'Logistics_Resources', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
Analysis of cell phenotypes was not possible	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Recruitment and organizational difficulties	['Business_Administrative']	['Possibly_Negative']
problems obtaining the investigational agent, Allogenix(TM) Plus	['Logistics_Resources']	['Neutral']
Due to inability to demonstrate benefit in this patient population.	['Negative']	['Negative']
"In >9 months only 1 patient enrolled. Study stopped because design was too cumbersome and
    subjects not willing to participate"	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study could not be re-supplied with study medication in a timely manner.	['Logistics_Resources']	['Neutral']
business decision due to low subject recruitment	['Business_Administrative']	['Possibly_Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
"The study was terminated before the primary endpoint (determination of MTD) was reached because
    the OPC form is to be replaced with the newly developed capsule form in all subsequent clinical
    trials."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
COVID-19. Recruitment never began.	['Covid19']	['Neutral']
slow accrual rate	['Insufficient_Enrollment']	['Neutral']
Study never officially began	['Invalid_Reason']	['Invalid_Reason']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
No further contact with the site	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
"The Government of Tamil Nadu decided not to proceed with implementation of fortified rice
    through the Public Distribution (per the original study protocol)"	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Study was terminated due to closure of study arms following futility analysis and difficulty in
    enrolling participants due to evolving treatment landscape"	['Negative']	['Negative']
strategic reasons	['Business_Administrative']	['Possibly_Negative']
difficult to enroll, Pi decision to closed	['Insufficient_Enrollment']	['Neutral']
funding was withdrawn	['Business_Administrative']	['Possibly_Negative']
"Due to a lack of IP supply and then terminated because they were combined into one new study
    with the new IP formulation."	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
New coordinating center has been defined (Massachusetts General Hospital)	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
COVID-19 Pandemic. Update in-process.	['Covid19']	['Neutral']
Covid-19 pandemic	['Covid19']	['Neutral']
No research resources to complete study	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"The study was terminated prematurely due to difficulties in patient recruitment and associated
    potential for selection bias."	['Insufficient_Enrollment']	['Neutral']
Study was not funded and PI has left the institution	['Study_Staff_Moved', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Study never got underway due to sponsor re-organization.	['Business_Administrative']	['Possibly_Negative']
Too slow recruitment and no staff availability	['Insufficient_Enrollment']	['Neutral']
Recruitment Fulfilled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Funding lost and study never started	['Business_Administrative']	['Possibly_Negative']
Unable to meet enrollment goal	['Insufficient_Enrollment']	['Neutral']
Enrollment expectations were not met	['Insufficient_Enrollment']	['Neutral']
Only enrolled 10 participants over 9 months which is less then anticipated (75).	['Insufficient_Enrollment']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
PI and study coordinator both left the institution.	['Study_Staff_Moved']	['Neutral']
Poor enrollment of study population	['Insufficient_Enrollment']	['Neutral']
Technical difficulties (reduced staff plus university strike)	['Logistics_Resources']	['Neutral']
Original study purpose accomplished	['Invalid_Reason', 'Study_Design', 'Another_Study']	['Invalid_Reason', 'Neutral', 'Neutral']
Lack of participants	['Insufficient_Enrollment']	['Neutral']
difficulty in recruiting patients	['Insufficient_Enrollment']	['Neutral']
PI choose to close the study	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Original investigator left the NIH and the primary outcome was not reached	['Logistics_Resources', 'Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
funding ended	['Business_Administrative']	['Possibly_Negative']
Difficulty with enrollment.	['Insufficient_Enrollment']	['Neutral']
Slow accrual, and revised power calculation for primary end-points	['Insufficient_Enrollment']	['Neutral']
Sponsor terminated study due to inability to enroll subjects.	['Insufficient_Enrollment']	['Neutral']
"In a Phase II study in HIV-infected patients there were a number of seizures, although exact
    causality could not be assessed phase 1 activity was terminated."	['Negative', 'Another_Study']	['Negative', 'Neutral']
PI has re-located. PI terminated FDA IND # and closed study.	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
Lack of efficacy	['Negative']	['Negative']
Study stopped due to insufficient personnel required to conduct trial.	['Logistics_Resources']	['Neutral']
PI left center	['Study_Staff_Moved']	['Neutral']
poor recruitment	['Insufficient_Enrollment']	['Neutral']
number of enrolled individuals after 5 years still off the estimated sample size	['Insufficient_Enrollment']	['Neutral']
Terminated due to the change of supplier and sponsor	['Logistics_Resources']	['Neutral']
Funding withdrawn	['Business_Administrative']	['Possibly_Negative']
Funding expired	['Business_Administrative']	['Possibly_Negative']
Terminated due to slow accrual	['Insufficient_Enrollment']	['Neutral']
"the actual primary goal - establishment of an approved tissue biobank - was reached. 1000
    tissue samples were collected. No motivation at this time for continuation as originally
    planned"	['Business_Administrative']	['Possibly_Negative']
Accrual too slow; grant renewal unlikely; AAI as effective as BiV in Phase III	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
Enrolling of participants has halted and the results are being gathered	['Invalid_Reason']	['Invalid_Reason']
Lack of feasibility secondary to slow accrual	['Insufficient_Enrollment']	['Neutral']
Trial terminated strategically due to poor accrual.	['Insufficient_Enrollment']	['Neutral']
"insufficient recruitment of patients and high costs associated with the purchase and blinding
    of study medication"	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
recruitment issues	['Insufficient_Enrollment']	['Neutral']
PI left	['Study_Staff_Moved']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Because of researcher foreign training	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
insufficient accrual	['Insufficient_Enrollment']	['Neutral']
The study was not started due to the sponsor choosing to not fund the trial.	['Business_Administrative']	['Possibly_Negative']
"The study was not withdrawn for safety reasons. The sponsor received approval for the treatment
    of partial-onset seizures in patients 4 years of age and older"	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
staff change and lack of ressources	['Logistics_Resources']	['Neutral']
Sponsor Request- Global low enrollment	['Insufficient_Enrollment']	['Neutral']
Difficulties recruiting patients	['Insufficient_Enrollment']	['Neutral']
The risk benefit in the study population does not favor continuation of the study	['Negative']	['Negative']
Terminated due to poor recruitment	['Insufficient_Enrollment']	['Neutral']
Failure to recruit.	['Insufficient_Enrollment']	['Neutral']
The Relamorelin program is being terminated solely based on a business decision.	['Business_Administrative']	['Possibly_Negative']
The study was terminated early by the Sponsor due to lack of efficacy.	['Negative']	['Negative']
The recruitment was discontinued because of failure to meet expected enrolment goals	['Insufficient_Enrollment']	['Neutral']
Interest in this study changed and it was decided to end enrollment early	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Not a clinical trial study.	['Invalid_Reason']	['Invalid_Reason']
due to poor accrual	['Insufficient_Enrollment']	['Neutral']
"After a review of status, request of investigators & since similar data was available from
    other sources"	['Success', 'Negative', 'Another_Study']	['Success', 'Negative', 'Neutral']
Not completed	['Invalid_Reason']	['Invalid_Reason']
Terminated due to poor accrual	['Insufficient_Enrollment']	['Neutral']
Enrollment pace was far below target.	['Insufficient_Enrollment']	['Neutral']
Low Recruitment and Enrollment	['Insufficient_Enrollment']	['Neutral']
due to poor response	['Insufficient_Enrollment']	['Neutral']
PDOL request	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
poor accrual	['Insufficient_Enrollment']	['Neutral']
Unable to isolate sufficient cells from the skin biopsy to perform study experiments.	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
never initiated, did different study	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
Internal business decision not to move forward with study	['Business_Administrative']	['Possibly_Negative']
"A decision was made to discontinue the study due to a change in the strategic direction of the
    company."	['Business_Administrative']	['Possibly_Negative']
Due to low accrual	['Insufficient_Enrollment']	['Neutral']
no enrollment	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Other - Protocol moved to Disapproved	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Study completed	['Invalid_Reason']	['Invalid_Reason']
We did not get adequate referrals.	['Insufficient_Enrollment']	['Neutral']
Currently suspended due to Covid-19 policies.	['Covid19']	['Neutral']
Decided not to pursue at UPCI	['Business_Administrative']	['Possibly_Negative']
Objectives of study could not be met within a reasonable timeframe.	['Study_Design']	['Neutral']
Funding from the NIH ended and not all patients had been accrued	['Business_Administrative']	['Possibly_Negative']
Dosing stopped	['Invalid_Reason']	['Invalid_Reason']
Funding was not secured	['Business_Administrative']	['Possibly_Negative']
Study was withdrawn due to unanticipated hassle in patient recruitment.	['Insufficient_Enrollment']	['Neutral']
"Due to the action to withdraw the Foradil Aerolizer NDA in US; study was discontinued. This was
    a commercial reason and not due to any change in benefit-risk."	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"ITF2357 (Givinostat) was well tollerated but had limited activity against refractory/relapsed
    HL"	['Negative']	['Negative']
enrollment moved very slowly which was not anticipated, and, funding issues	['Business_Administrative']	['Possibly_Negative']
Principal investigator has decided not to continue her PhD studies.	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Study stopped at the end of the first step	['Invalid_Reason']	['Invalid_Reason']
"Due to ""early stopping rule"" as defined in the study protocol"	['Negative']	['Negative']
slow inclusion rate	['Insufficient_Enrollment']	['Neutral']
Accrual goals could not be met within a timely manner	['Insufficient_Enrollment']	['Neutral']
Logistics	['Logistics_Resources']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
The Swissmedic agency released Gilead from this post marketing requirement.	['Business_Administrative']	['Possibly_Negative']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
no accrual	['Insufficient_Enrollment']	['Neutral']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Sponsor withdrew request to conduct study	['Business_Administrative']	['Possibly_Negative']
Unable to accrue subjects.	['Insufficient_Enrollment']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Due to logistical issues the study as designed was determined to not be feasible.	['Logistics_Resources']	['Neutral']
PI leaving institution	['Study_Staff_Moved']	['Neutral']
change of sponsor	['Business_Administrative']	['Possibly_Negative']
study never got off the ground, no pts ever recruited	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Sponsor decision.	['Business_Administrative']	['Possibly_Negative']
"Inadequate recruitment resulting in a too low patient number for collection of long term
    efficacy data."	['Insufficient_Enrollment']	['Neutral']
recruitment was not going well.	['Insufficient_Enrollment']	['Neutral']
Investigator no longer at Cleveland Clinic	['Study_Staff_Moved']	['Neutral']
Study was terminated early for administrative reasons.	['Business_Administrative']	['Possibly_Negative']
We were not able to recruit enough participants during the funding period.	['Business_Administrative']	['Possibly_Negative']
Business objectives have changed	['Business_Administrative']	['Possibly_Negative']
Not able to secure funding	['Business_Administrative']	['Possibly_Negative']
Suspension of use of medicine containing Pioglitazone by French regulatory agency	['Regulatory']	['Neutral']
Study enrollment not initiated due to institutional delays	['Insufficient_Enrollment']	['Neutral']
The study was never initiated by sponsor. Patients where never recruited.	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
There is no fund to support it	['Business_Administrative']	['Possibly_Negative']
accrual criteria being reviewed	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
investigator choice	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
No patients recruited	['Insufficient_Enrollment']	['Neutral']
Favourable ethical opinion not obtained	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
"Because the principle investigator will participate a visiting scholar program for one year in
    other country, this study has been terminated."	['No_Context', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
Principal Investigator is leaving university and halting studies	['Study_Staff_Moved']	['Neutral']
It was found that the devices were not suitable for the application.	['Logistics_Resources']	['Neutral']
ITI-007 approved by FDA	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Early termination for discouraging results	['Negative']	['Negative']
Device modifications	['Study_Design']	['Neutral']
Due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
The study was terminated early due to insufficient evidence of clinical benefit.	['Negative']	['Negative']
"Funding was not secured for the project as expected, so we were unable to proceed with the
    project."	['Business_Administrative']	['Possibly_Negative']
Difficulty of recruiting patients and cost limitations.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
"Termination of study enrolment to Part C, Cohort 3 (08 July 2013) was based on the analysis of
    data from Study D2610C00004.

    Data were available from 33 patient"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Management Decision	['Business_Administrative']	['Possibly_Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
Data safety monitoring board decision	['Negative']	['Negative']
Efficacy issues on test arm	['Negative']	['Negative']
Study never started	['Invalid_Reason']	['Invalid_Reason']
enrollment halted in order to have all patients complete follow-up by Jan 2011	['Invalid_Reason']	['Invalid_Reason']
Subjects which fit the strict inclusion criteria were not found.	['Insufficient_Enrollment']	['Neutral']
Financing and re-organization	['Business_Administrative']	['Possibly_Negative']
Major technical hindrance in recruitment.	['Logistics_Resources']	['Neutral']
Lack of enrolment	['Insufficient_Enrollment']	['Neutral']
Accrual factor	['Insufficient_Enrollment']	['Neutral']
Drug dose became unavailable	['Logistics_Resources']	['Neutral']
Due to complexity and cost of study (no outside funding)	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
"Sponsor decision: priority change (Study approved by ethics committee and Swedish competent
    authority)"	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Terminated due to poor enrollment and grade 3 toxicities noted during an interim analysis.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
unable to recruit patients	['Insufficient_Enrollment']	['Neutral']
It was not possible to recruit enough patients with obstructive sleep apnea.	['Insufficient_Enrollment']	['Neutral']
Non availability of funding	['Business_Administrative']	['Possibly_Negative']
Delay in recruitment	['Insufficient_Enrollment']	['Neutral']
COVID-19 Restrictions for in-person study procedures	['Covid19']	['Neutral']
Protracted enrollment and limited efficacy in the first three subjects	['Negative']	['Negative']
DSMB decision based upon noted lack of efficacy in manufacturers pivotal trials.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Changing staff	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Study due for continuing review	['Regulatory']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
company dissolved	['Business_Administrative']	['Possibly_Negative']
Slow accrual in the high BMI group	['Insufficient_Enrollment']	['Neutral']
Study was stopped due to low enrollment and lack of clinical activity.	['Insufficient_Enrollment']	['Neutral']
Not enough participants to validate study.	['Insufficient_Enrollment']	['Neutral']
Difficulty obtaining enrollment	['Insufficient_Enrollment']	['Neutral']
Suspended (Due to Covid-19)	['Covid19']	['Neutral']
Lack of funds	['Business_Administrative']	['Possibly_Negative']
More than 100 invasive and non-invasive QpQs data were collected	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
"Drug exposure of retaspimycin HCl was superior to IPI-493, Infinity will focus on Retaspimycin
    HCL"	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"Based on available data, UCB has decided to stop development of padsevonil as adjunctive
    treatment of focal-onset seizures"	['Regulatory', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Per recommendation from DRT	['Interim_Analysis', 'Regulatory', 'Negative']	['Neutral', 'Neutral', 'Negative']
Low accrual rate	['Insufficient_Enrollment']	['Neutral']
Further evaluation of phase I dosing	['Negative', 'Another_Study']	['Negative', 'Neutral']
sponsor decision due to low recruitment	['Insufficient_Enrollment']	['Neutral']
Due to slow enrollment and not being able to reach the primary endpoint	['Insufficient_Enrollment']	['Neutral']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
not enough patients to e recruited, problems with the conductance catheter	['Insufficient_Enrollment']	['Neutral']
IDMC recommendation for safety concerns	['Covid19', 'Safety_Sideeffects', 'Regulatory']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Development program terminated.	['Business_Administrative']	['Possibly_Negative']
Study terminated as a result of the dissolution of the Sponsor.	['Business_Administrative']	['Possibly_Negative']
insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Redirection of company goals	['Business_Administrative']	['Possibly_Negative']
This study has been terminated, without having enrolled any participants	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Sponsor	['Business_Administrative']	['Possibly_Negative']
no funding	['Business_Administrative']	['Possibly_Negative']
Study terminated early due to business reasons	['Business_Administrative']	['Possibly_Negative']
Difficulties in recruiting.	['Insufficient_Enrollment']	['Neutral']
"Terminated for site documentation and monitoring issues - not safety, study drug, or adverse
    event issues."	['Business_Administrative']	['Possibly_Negative']
The study was terminated due to difficulty in recruiting participants.	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
withdrawn by industry	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
extended beyond completion date; chose to close out rather than renew IRB review	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Study withdrawn due to business decisions. No subjects were treated.	['Business_Administrative']	['Possibly_Negative']
Interruption of financial support	['Business_Administrative']	['Possibly_Negative']
Low rythm of inclusions	['Insufficient_Enrollment']	['Neutral']
The study terminated for safety reasons	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"The study was terminated due to insufficient evidence for Fexofenadine efficacy to treat GERD
    symptoms after the interim analysis."	['Negative']	['Negative']
No subjects enrolled	['Insufficient_Enrollment']	['Neutral']
The key elements of this study were incorporated into another study.	['Negative', 'Another_Study']	['Negative', 'Neutral']
due to coronavirus pandemic	['Covid19', 'Safety_Sideeffects', 'Insufficient_Enrollment']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Covid 19 and subsequent cancellation of all meeting activity	['Covid19']	['Neutral']
"This study's genetic testing laboratory has suspended operations pending discussions with the
    FDA concerning clinical interpretation of pharmacogenomics tests."	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
This study was a doctorate thesis and student changed the subject of her thesis.	['No_Context', 'Study_Staff_Moved', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
Lack of personnel available to complete study.	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
BioInceptdecided not to pursue this drug target at this time.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study Partner Left. Samples degraded before analysis.	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
"All patients during the study period were subjected to peripheral blocks or were excluded from
    the study due to exclusion criteria"	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
PI left the NIH	['Study_Staff_Moved']	['Neutral']
Enrollment problem	['Insufficient_Enrollment']	['Neutral']
"Enrollment took longer than anticipated; it was financially and logistically impossible to
    recruit the final cohort (G6PDd 0.4mg/kg PQ)."	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Difficulties to recruit on time the required patient population.	['Insufficient_Enrollment']	['Neutral']
PI left University	['Study_Staff_Moved']	['Neutral']
"We have recruited some patients, but we haven't found any significant result by bronchoscopy in
    the high risk population."	['Negative']	['Negative']
Did not go forward with study.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Changes to cardiac surgery program	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Emerging GSK1322322 pre-clinical data ID'd potentially reactive metabolites previously not seen
    that changed the risk: benefit profile and led to a termination"	['Success', 'Endpoint_Met', 'Negative']	['Success', 'Neutral', 'Negative']
participants are no longer receiving intervention due to clinical logistics	['Logistics_Resources']	['Neutral']
Drug is backordered;	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Standard of care changed to FOLFIRINOX; poor accrual.	['Insufficient_Enrollment']	['Neutral']
Error in randomization resulted in early study termination.	['No_Context', 'Logistics_Resources', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
"Stopped prior to last subject's last extended follow-up visit (78 weeks) due to lack of
    efficacy at the primary study endpoint (26 weeks)"	['Negative']	['Negative']
"not move forward with the commercialization of this product based on marketing needs and there
    is not a known safety issue or concern"	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Company ended operations January 2011	['Business_Administrative']	['Possibly_Negative']
Study drug was not longer available in our country.	['Logistics_Resources']	['Neutral']
The publication of a national guideline on NPPV precluded further recruitment.	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Financial Constraints	['Business_Administrative']	['Possibly_Negative']
Difficulty recruiting subjects	['Insufficient_Enrollment']	['Neutral']
Slow recruitment rate and consequent financial exhaustion.	['Business_Administrative']	['Possibly_Negative']
Insufficient patient participation	['Insufficient_Enrollment']	['Neutral']
Data Safety Monitoring Board (DSMB) recommended stopping study due to futility	['Negative']	['Negative']
Study completed	['Invalid_Reason']	['Invalid_Reason']
Study was stopped after pre-definied interim analysis because of no effects	['Negative']	['Negative']
Sponsor decision to close study	['Business_Administrative']	['Possibly_Negative']
Logistic reasons, financial contrastraints	['Business_Administrative']	['Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Per interim analysis, for futility.	['Negative']	['Negative']
"A business decision not to continue with Phase 2b based on non-safety observations during proof
    of concept phase."	['Business_Administrative']	['Possibly_Negative']
Difficulty in recruiting patients	['Insufficient_Enrollment']	['Neutral']
the study failed to enroll any patient and sponsor wished to stop.	['Insufficient_Enrollment']	['Neutral']
Futility by interim analysis	['Negative']	['Negative']
Drug support withdrawn	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
New requirements for study approval with the Swedish Medical Products Agency	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Halted by the Management Committee after the publication of the ART Trial	['Business_Administrative']	['Possibly_Negative']
Decision by Sponsor	['Business_Administrative']	['Possibly_Negative']
Due to potential concerns about liver safety (See Detailed Description)	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Did not meet predetermined primary endpoint	['Negative']	['Negative']
Company decision	['Business_Administrative']	['Possibly_Negative']
Enrollment and study visits are temporarily suspended due to COVID-19.	['Covid19']	['Neutral']
"The trial was closed as part of the out-licensure of the drug to Boston Pharmaceuticals, which
    will continue further clinical development of LYS228/BOS-228"	['Business_Administrative']	['Possibly_Negative']
Enrollment challenges/ slow enrollment.	['Insufficient_Enrollment']	['Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Adverse events of the first patient	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Expired with the IRB	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Not enough volunteer recruited before funding could be secured.	['Business_Administrative']	['Possibly_Negative']
Difficulties of enrollment	['Insufficient_Enrollment']	['Neutral']
"Technical difficulties with ambulatory equipment led to unacceptably high levels of data loss.
    As we would have had to suspend data collection under Covid precautions in any case, we decided
    to terminate in March of this year."	['Covid19', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
The study has been terminiated due to minimal subject recruitment	['Insufficient_Enrollment']	['Neutral']
Study withdrawn prior to enrollment of first subject	['Invalid_Reason']	['Invalid_Reason']
small number of utero death, mothers refused to participate	['Insufficient_Enrollment']	['Neutral']
The company no longer provided the device.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"The preliminary data do not support the expected sustainable blood levels of triptorelin for a
    duration of 4 months in all patients."	['Logistics_Resources']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Covid-19	['Covid19']	['Neutral']
lack of activity and G3-4 toxicity at interim analysis	['Safety_Sideeffects', 'Endpoint_Met', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Failure of recruitment	['Insufficient_Enrollment']	['Neutral']
funding not available	['Business_Administrative']	['Possibly_Negative']
Pentostatin/alemtuzumab regimen had greater risk of graft failure.	['Negative']	['Negative']
Study accrual stopped due to poor accrual.	['Insufficient_Enrollment']	['Neutral']
Efficacy demonstrated on a preliminary analysis	['Success', 'No_Context', 'Logistics_Resources']	['Success', 'Invalid_Reason', 'Neutral']
"Due to COVID-19 safety precautions and public health guidelines, the study was terminated
    early."	['Covid19']	['Neutral']
corporate decision	['Business_Administrative']	['Possibly_Negative']
"The study was closed due to low patient enrollment and the Sponsor's decision to include
    patients with squamous NSCLC into the GO29431 study, NCT02409342."	['Insufficient_Enrollment']	['Neutral']
Interim analysis showed greater variablility in NT-proBNP findings than anticipated.	['Negative']	['Negative']
Low levels of recruitment	['Insufficient_Enrollment']	['Neutral']
Study was unable to accrue subjects	['Insufficient_Enrollment']	['Neutral']
Not a clinical trial study.	['Invalid_Reason']	['Invalid_Reason']
drug supply issues	['Logistics_Resources']	['Neutral']
Inability to complete the recruitment.	['Insufficient_Enrollment']	['Neutral']
Sponsor withdrew support; Study did not progress to Phase II.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Funding not yet achieved	['Business_Administrative']	['Possibly_Negative']
Per PI Request	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Not enough participants	['Insufficient_Enrollment']	['Neutral']
The study was closed prematurely due to poor accrual.	['Insufficient_Enrollment']	['Neutral']
Recruitment was taking longer than originally anticipated.	['Insufficient_Enrollment']	['Neutral']
Change in benefit/risk profile	['Negative']	['Negative']
"Donor site material (scarlet red ) came back on the market, therefore new treatements for donor
    sites was not needed."	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
difficult to recruit patients	['Insufficient_Enrollment']	['Neutral']
Lower than anticipated recruitment	['Insufficient_Enrollment']	['Neutral']
Unfavorable results	['Insufficient_Enrollment', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
"Due to significantly slower than expected enrollment, the Sponsor decided to terminate the
    study."	['Insufficient_Enrollment']	['Neutral']
PI left institution. Insufficient enrollment for analysis.	['Insufficient_Enrollment']	['Neutral']
Not a clinical trial study	['Invalid_Reason']	['Invalid_Reason']
PI Decision	['Invalid_Reason']	['Invalid_Reason']
Lack of study patients	['Insufficient_Enrollment']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
No chance to meet the foreseen target of patients with study endpoint	['Negative']	['Negative']
Slow recruitment; Study did not address safety concern raised by European Medicines Agency	['Insufficient_Enrollment']	['Neutral']
Identical study Biomed 777-CLP-029 did not meet superiority endpoint	['Negative', 'Another_Study']	['Negative', 'Neutral']
Enrollment challenges	['Insufficient_Enrollment']	['Neutral']
Study terminated due to lack of funding.	['Business_Administrative']	['Possibly_Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
No recruitment since initiation	['Insufficient_Enrollment']	['Neutral']
difficult recruitment curve	['Insufficient_Enrollment']	['Neutral']
This study was terminated prematurely by the Sponsor for business reasons only.	['Business_Administrative']	['Possibly_Negative']
Original PI left institution	['Study_Staff_Moved']	['Neutral']
program discontinued	['Invalid_Reason']	['Invalid_Reason']
Coordinator departure	['Study_Staff_Moved']	['Neutral']
Study was terminated early due to low patient accrual.	['Insufficient_Enrollment']	['Neutral']
poor recruitment & retention	['Insufficient_Enrollment']	['Neutral']
All 3 participants receiving intervention in assessment phase developed seromas	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Unable to effective arrange trial logistics	['Logistics_Resources']	['Neutral']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
Poor patient accrual	['Insufficient_Enrollment']	['Neutral']
Lack of efficacy to proceed to Phase 2	['Negative']	['Negative']
"Enrollment is temporarily paused due to COVID-19 and is expected to resume in the future. This
    is not a suspension of IRB approval."	['Covid19']	['Neutral']
PI request	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Competing clinical trial priorities	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Business reasons	['Business_Administrative']	['Possibly_Negative']
"This registry was planned to report on the Phase II portion of the study. NSABP decided not to
    proceed with the Phase II portion of the study."	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
difficulties of enrollment	['Insufficient_Enrollment']	['Neutral']
No eligible subjects identified	['Insufficient_Enrollment']	['Neutral']
Never funded	['Business_Administrative']	['Possibly_Negative']
Dosing cohort (650mg) exceeded current 350mg dosing in other trials.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
No data. Study never completed.	['Success', 'No_Context', 'Logistics_Resources']	['Success', 'Invalid_Reason', 'Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Recruitment challenges	['Insufficient_Enrollment']	['Neutral']
"CHU Lyon will join as a participating center (and as national French coordinator) as a part of
    the BEV-IP study ongoing study EudraCT-number 2014-004257-14."	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
Study stopped due to increased cardiovascular risks associated with Celebrex	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Could not find subjects who met all the enrollment criteria so the study was stopped.	['Insufficient_Enrollment']	['Neutral']
Recruitment was stopped before the target sample size was achieved.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"The study was discontinued due to slow recruitment and subjects not completing follow up
    period."	['Insufficient_Enrollment']	['Neutral']
Changed study to an observational study	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Lack of funding, PI left the institution, poor enrollment	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Current protocol is not optimal/feasible	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
retirement of faculty PI	['Study_Staff_Moved']	['Neutral']
Subject accrual was prematurely terminated due slow enrollment.	['Insufficient_Enrollment']	['Neutral']
"none participant has been enrolled and recruited during the first year after competent autority
    autorisation."	['Insufficient_Enrollment']	['Neutral']
could not recruit	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
lack of recruitment/patient population	['Insufficient_Enrollment']	['Neutral']
protocol changed	['Study_Design']	['Neutral']
Bad design.	['Study_Design']	['Neutral']
"The PI is no longer with Kentuckiana Cancer Institute. All current subjects completed. No
    further subjects will be enrolled. Terminated with IRB."	['Study_Staff_Moved']	['Neutral']
Recruitment has been halted until further funding is secured.	['Business_Administrative']	['Possibly_Negative']
Lack of inclusion	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
The study was not activated.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
"interim analysis revealed no significant difference between study groups & increased sample
    size required to gain significance."	['Negative']	['Negative']
Inadequate accrual rate	['Insufficient_Enrollment']	['Neutral']
Administratively Terminated	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Combined into an international study (CAR-BHA-I21)	['Negative', 'Another_Study']	['Negative', 'Neutral']
Sponsor determined study is not required according to PFDA Circular 2013-004	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Business decision to stop the program.	['Business_Administrative']	['Possibly_Negative']
Due to company strategic decision	['Business_Administrative']	['Possibly_Negative']
"No participants were recruited at this study site. Study has been conducted and monitored at
    ClinicalTrials.gov ID: NCT01044563."	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Decided to participate in a multicenter trial researching the same issue	['Negative', 'Another_Study']	['Negative', 'Neutral']
Low enrollment.	['Insufficient_Enrollment']	['Neutral']
COVID-19	['Covid19']	['Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
FDA determined study device is significant risk. Study will not seek IDE.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
the number of patients needed for the study have been collected	['Invalid_Reason']	['Invalid_Reason']
Study termination by the Sponsor	['Business_Administrative']	['Possibly_Negative']
Lost funding	['Business_Administrative']	['Possibly_Negative']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
Study not started due to lack of recruitment potential.	['Insufficient_Enrollment']	['Neutral']
Study on enrollment hold, may potentially resume. No active subjects on trial.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Specimens are now collected through the BRS protocol.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Due to the bankruptcy of FITBiotech, the provider of the GTU DNA vaccine.	['Business_Administrative']	['Possibly_Negative']
Temporary halt due to adverse events	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Logistics reason at the data collection site	['Logistics_Resources']	['Neutral']
Protocol-defined outcome in terms of efficacy would not be achieved.	['Negative']	['Negative']
unexpected level of toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Business decision to withdraw trial	['Business_Administrative']	['Possibly_Negative']
Never funded or completed	['Business_Administrative']	['Possibly_Negative']
too much variability in the TMS measures	['Logistics_Resources', 'Endpoint_Met', 'Insufficient_Data']	['Neutral', 'Neutral', 'Neutral']
Rejected ethics approval in UK and Holland	['Interim_Analysis', 'Success', 'Logistics_Resources']	['Neutral', 'Success', 'Neutral']
Recruitment issues	['Insufficient_Enrollment']	['Neutral']
Difficult recruitment	['Insufficient_Enrollment']	['Neutral']
This study stopped due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
difficult enrollment	['Insufficient_Enrollment']	['Neutral']
no interest to develop the product	['Business_Administrative']	['Possibly_Negative']
inadequate enrollment.	['Insufficient_Enrollment']	['Neutral']
"This study has been temporarily suspended to accrual by the Data Review Committee due to a
    protocol violation that recently occurred. The study will resume to accrual after the protocol
    has been amended and approved by the IRB and DRC."	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Study is officially cancelled bevore FPFV.	['Interim_Analysis', 'Regulatory', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
The study did not meet efficacy end point and did not enroll patients in the randomized phase.	['Negative']	['Negative']
Minimal to no inclusion.	['Insufficient_Enrollment']	['Neutral']
"Significant changes to protocol and study design, study stopped to further enrollment and new
    study designed."	['Study_Design']	['Neutral']
Study was halted due to lack of funding.	['Business_Administrative']	['Possibly_Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor withdrew support	['Business_Administrative']	['Possibly_Negative']
"This study was terminated due to treatment stop resulting in an inability to draw conclusions
    from the data. Evaluation of nonclinical rat findings is ongoing."	['Logistics_Resources', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"Efficacy seen in the solid tumour patient population was not sufficient to continue research
    with AZD1152 monotherapy in solid tumors at that time."	['Negative']	['Negative']
Lack of enrollment and staff availability to administer treatment.	['Insufficient_Enrollment']	['Neutral']
No particapnt recruitment.	['Insufficient_Enrollment']	['Neutral']
poor tolerability at highest dose	['Safety_Sideeffects', 'Endpoint_Met', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Participant accrual low and the study was closed	['Insufficient_Enrollment']	['Neutral']
Others	['Covid19', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
"B7911002 was prematurely discontinued due to a safety concern that led to decision to terminate
    the study on 10 Nov 2014"	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Study not progressing	['Invalid_Reason']	['Invalid_Reason']
unable to obtain funding	['Business_Administrative']	['Possibly_Negative']
Recruitment problems, patients refused to participate	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Investigator choice	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Difficult to identify subjects who meet enrollment criteria.	['Insufficient_Enrollment']	['Neutral']
Database change	['Business_Administrative']	['Possibly_Negative']
"Due to staff departures unable to execute this study so requested closure. There were no study
    procedures performed & no participants enrolled."	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Funding was not received for this study.	['Business_Administrative']	['Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
PI left the Institution.	['Study_Staff_Moved']	['Neutral']
"There will be no opportunity to recruit patients during the pandemic of COVID-19 and possibly
    even post-pandemic"	['Covid19']	['Neutral']
The study was withdrawn from the IRB	['Interim_Analysis', 'Regulatory', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
unable to recruit enough candidates	['Insufficient_Enrollment']	['Neutral']
Poor enrollment.	['Insufficient_Enrollment']	['Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
Due to poor compliance of patients in the study.	['Study_Design']	['Neutral']
Lack of enrollment/lack of potential subjects fitting criteria	['Insufficient_Enrollment']	['Neutral']
Lack of subject enrollment.	['Insufficient_Enrollment']	['Neutral']
Lack of resources.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Sponsor (Masimo) suspended trial due to change in corporate ownership	['Business_Administrative']	['Possibly_Negative']
Device currently not available	['Logistics_Resources']	['Neutral']
unable to launch the study due to lack of participation with Autism Clinic	['Business_Administrative']	['Possibly_Negative']
very slow recruitment, no sufficient results	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
PI no longer at institution	['Study_Staff_Moved']	['Neutral']
lack of accrual	['Insufficient_Enrollment']	['Neutral']
Suspended due to COVID-19	['Covid19']	['Neutral']
enrollment was too slow	['Insufficient_Enrollment']	['Neutral']
Unacceptable high drop-out rate.	['Insufficient_Enrollment']	['Neutral']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Based on interim analysis study felt unlikely to reach the primary aim	['Negative']	['Negative']
Risk/benefit ratio did not indicate further study would be useful, or fair to future subjects.	['Negative']	['Negative']
No recruitment	['Insufficient_Enrollment']	['Neutral']
Unable to recruit enough patients to continue on with the study.	['Insufficient_Enrollment']	['Neutral']
sponsor funding	['Business_Administrative']	['Possibly_Negative']
Insufficient cell mobilization for tandem transplants	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
low enrollment	['Insufficient_Enrollment']	['Neutral']
New department chairman instructed PI to discontinue study.	['Study_Staff_Moved', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
"Due to the recent COVID-19 surge the majority of our staff was pulled from sleep care to
    inpatient care. Thus, we have had to temporarily pause in-lab studies until our staff returns.
    We hope to proceed with recruitment as soon as possible."	['Covid19']	['Neutral']
Not sufficient time to conduct the study	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Terminated prior to planned completion date due to lack of efficacy.	['Negative']	['Negative']
Inadequate patient recruitment	['Insufficient_Enrollment']	['Neutral']
"Study termination due to negative Phase III of another study product from same technology
    platform."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
The trial closed for emerging safety profile and futility analysis and will not resume.	['Negative']	['Negative']
"Study termination due to negative Ph III of another study product from same technology
    platform."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Unable to reach recruitment target	['Insufficient_Enrollment']	['Neutral']
Solanezumab did not meet the study's primary endpoint.	['Negative']	['Negative']
Very few patients met eligibility criteria, none of whom elected to enroll.	['Insufficient_Enrollment']	['Neutral']
Inconsistent and unpredictable exposures were observed. Drug needed to be reformulated.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Device incorrect colour-coded classification of fast breathing for RR	['Study_Design']	['Neutral']
"The PERTH RCT was nested within the MAASTHI birth cohort. PERTH study was stopped as MAASTHI
    has completed it's recruitment."	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
study population limited	['Insufficient_Enrollment']	['Neutral']
"Based on results from the pilot phase, the study is terminated. No safety events leading to
    discontinuation were reported"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Not enough responses to continue treatment.	['Insufficient_Enrollment']	['Neutral']
Only observational retrospective study performed. No enrollees collected.	['No_Context', 'Endpoint_Met', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
poor accrual	['Insufficient_Enrollment']	['Neutral']
"For the last patient still on treated nominal therapeutic use of the Milciclib was approved at
    INT Milano."	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Deadline of the end date of the inclusions	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
interim results concluded no added value of additional inclusion	['Negative']	['Negative']
recruitment and pilot funding issues	['Business_Administrative']	['Possibly_Negative']
Study has been halted due to safety reasons	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Did not meet recruitment goals	['Insufficient_Enrollment']	['Neutral']
The study was withdrawn, because no participants were enrolled in two years.	['Insufficient_Enrollment']	['Neutral']
The emergence of SARS-CoV-2 required a temporary hold of recruitment	['Covid19', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
No patients	['Insufficient_Enrollment']	['Neutral']
Recruitment is complete however study suspended due to COVID 19	['Covid19']	['Neutral']
Study stopped by the company funding the study	['Business_Administrative']	['Possibly_Negative']
secondary to funding issues and low enrollment	['Business_Administrative']	['Possibly_Negative']
PI's add. responsibilities and time commitment prevent him from completing trial	['Logistics_Resources', 'Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
We didn't receive the expected funding to support the study.	['Business_Administrative']	['Possibly_Negative']
The scientific commitee decided to stop the inclusions and exploit the results.	['Invalid_Reason']	['Invalid_Reason']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
funding was withdrawn	['Business_Administrative']	['Possibly_Negative']
Company decided to discontinue	['Business_Administrative']	['Possibly_Negative']
Closed study as requested by PI due to lack of accruals	['Insufficient_Enrollment']	['Neutral']
Terminated due to low accrual	['Insufficient_Enrollment']	['Neutral']
abandoned project	['Invalid_Reason']	['Invalid_Reason']
Due to interim analysis' results and definitions fixed in protocol	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
Recruitment slow and administrative reasons	['Business_Administrative']	['Possibly_Negative']
The study was discontinued prematurely by the sponsor due to non-medical reasons	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Funding ceased	['Business_Administrative']	['Possibly_Negative']
Principle investigator left the institution	['Study_Staff_Moved']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Trial experienced funding issues, was never opened to accrual.	['Business_Administrative']	['Possibly_Negative']
To pursue other indications	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Difficulty to keep children in randomly assigned groups.	['Insufficient_Enrollment']	['Neutral']
Difficulty recruiting patients	['Insufficient_Enrollment']	['Neutral']
Terminated due to lagging follow-up	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
Technical problems with data acquisition and interpretation; problems with recruitment	['Logistics_Resources']	['Neutral']
Inability to recruit	['Insufficient_Enrollment']	['Neutral']
Organizational Issues.	['Business_Administrative']	['Possibly_Negative']
No accrual	['Insufficient_Enrollment']	['Neutral']
By recommendation from the Data and safety monitoring board	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
The hospital was converte to attend only COVID19 patiens	['Covid19']	['Neutral']
Administrative reasons	['Business_Administrative']	['Possibly_Negative']
"Study is withdrawn before recruting participants, new trial will be multi centre, sponsored by
    different organisation."	['Invalid_Reason', 'Study_Design', 'Another_Study']	['Invalid_Reason', 'Neutral', 'Neutral']
decision of the investigator	['Invalid_Reason']	['Invalid_Reason']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
for difficulty to enroll patients in the study	['Insufficient_Enrollment']	['Neutral']
No more inclusions since august 2013	['Insufficient_Enrollment']	['Neutral']
The principal investigator terminated the study due to inactivity and low enrollment	['Insufficient_Enrollment']	['Neutral']
The Sponsor (Amicus Therapeutics) terminated this study for logistical reasons.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Company decision	['Business_Administrative']	['Possibly_Negative']
Study has been stopped after reviewing PK and safety results	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Manufacturer discontinued drug before any participants could be enrolled.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
protocol revisions were deemed unable to be completed by 8/2007	['Study_Design']	['Neutral']
New treatments available, which prevents additional recruitment.	['Insufficient_Enrollment']	['Neutral']
poor subject recruitment	['Insufficient_Enrollment']	['Neutral']
low enrollment	['Insufficient_Enrollment']	['Neutral']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
Not possible to complete the sample within the estimated time by the use of new antifungals	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Study was terminated due to insufficient data and lack of patient follow-up	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Measurement devices unavailable at this time.	['Logistics_Resources']	['Neutral']
because of withdrawal of Avandia sale due to its risks outweigh its benefits	['Logistics_Resources', 'Regulatory', 'Negative']	['Neutral', 'Neutral', 'Negative']
"Cardiac Catheterization no longer part of the anesthesia department A (no belonging to cardiac
    anesthesia, which is a different department)"	['Covid19', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
"The production of the device was stopped due to economic reasons. Basic post-market
    surveillance activities will be continued."	['Business_Administrative']	['Possibly_Negative']
grant funding no longer available	['Business_Administrative']	['Possibly_Negative']
Repros stopped the study for safety and FDA put the study on hold for safety.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Terminated per PI's request at the time of CR. Study was closed due to low/slow accrual due to
    other competing studies."	['Insufficient_Enrollment']	['Neutral']
Feasibility issues	['Logistics_Resources']	['Neutral']
No participants were enrolled. The PI left the institution.	['Study_Staff_Moved']	['Neutral']
Interim analysis showed that there was no difference between the two drugs	['Negative']	['Negative']
Due to a slow recruitment rate	['Insufficient_Enrollment']	['Neutral']
It was difficult to secure enrollment of the targeted number of subjects.	['Insufficient_Enrollment']	['Neutral']
"Protocol opened to recruitment in Nov 2009. No potential subjects identified in 5 years;
    therefore, study was terminated in Jul 2014 due to lack of feasibility"	['Insufficient_Enrollment']	['Neutral']
PI left site	['Study_Staff_Moved']	['Neutral']
Lack of sufficient recruitment, other priorities	['Insufficient_Enrollment']	['Neutral']
In ability to obtain Indian governmental approval from the study from NACO	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Terminated 25Sep17 due to parent study insufficient efficacy. Not due to safety	['Negative', 'Another_Study']	['Negative', 'Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Temporary enrollment hold due to COVID	['Covid19']	['Neutral']
Permanently Closed Due to Poor Accrual	['Insufficient_Enrollment']	['Neutral']
Principal Investigator left the institution	['Study_Staff_Moved']	['Neutral']
Statistical futility; totality of evidence suggests study unlikely to meet endpoint	['Negative']	['Negative']
enrollment proceeding too slowly	['Insufficient_Enrollment']	['Neutral']
"The low recruitment of patients will not allow to complete the study with the required number
    of patients within reasonable time."	['Insufficient_Enrollment']	['Neutral']
PI moved to new institution, unable to complete study	['Study_Staff_Moved']	['Neutral']
No possibilty to receive all plened patients for this study	['Insufficient_Enrollment']	['Neutral']
Toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Product availability	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Preliminary analysis of data showed no significant findings	['Negative']	['Negative']
PI no longer at Emory; no participants enrolled, study not conducted	['Study_Staff_Moved']	['Neutral']
Study was terminated in anticipation of transfer of ownership to Avid Radiopharmaceuticals.	['Business_Administrative']	['Possibly_Negative']
Business reasons	['Business_Administrative']	['Possibly_Negative']
See Detailed Description for termination reason.	['No_Context']	['Invalid_Reason']
Drug no longer available by manufacturer	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Withdrawn (No Participants Enrolled)	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Occurrence of severe respiratory depression in the remifentanil group.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Interim analysis indicated that endpoints can not be analysed with current dataset.	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Study stopped by local authorities	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
lack of accrual	['Insufficient_Enrollment']	['Neutral']
There were technical difficulties and the study was terminated in 2008	['Logistics_Resources']	['Neutral']
Patients fulfilling the criteria could not be found.	['Insufficient_Enrollment']	['Neutral']
sufficient data has been collected for significant conclusion	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Limited operating room availability	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Study drug became unaffordable for the purposes of the research.	['Logistics_Resources']	['Neutral']
Difficulty enrolling patients	['Insufficient_Enrollment']	['Neutral']
This study was stopped due to low recruitment.	['Insufficient_Enrollment']	['Neutral']
PI left the institution	['Study_Staff_Moved']	['Neutral']
"An IDMC validated the premature termination of the study on 19/02/2016 for lack of inclusion,
    with continuation of the FU initially planned for women included"	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
Low enrollment due to COVID-19	['Covid19']	['Neutral']
Lack of patient compliance	['Study_Design']	['Neutral']
This study was terminated early due to lower than expected enrollment rates.	['Insufficient_Enrollment']	['Neutral']
Temporarily halted due to COVID-19	['Covid19']	['Neutral']
Withdrawn due to poor accrual/lack of funding	['Insufficient_Enrollment']	['Neutral']
Principal investigator decided not to pursue trial	['Study_Staff_Moved', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
"Enrollment/interactions/interventions are temporarily paused due to COVID-19 and are expected
    to resume in the future. This is not a suspension of IRB approval."	['Covid19']	['Neutral']
Funding was withdrawn due to insufficient accrual	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Technical difficulties perfecting laboratory test used on blood samples.	['Logistics_Resources']	['Neutral']
lack of accrual	['Insufficient_Enrollment']	['Neutral']
"There was no indication that long-term follow-up would differ between any of the studies that
    have evaluated devices within the 410 Style Matrix."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Too many patients withdrew/lost to follow up	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Futility	['Negative']	['Negative']
Unable to complete agreement with sponsor	['Business_Administrative']	['Possibly_Negative']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Patient withdrawal symptoms unblinded the study	['Safety_Sideeffects', 'Logistics_Resources', 'Endpoint_Met']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Low recruitment. Pilot trial.	['Insufficient_Enrollment']	['Neutral']
failure to enroll	['Insufficient_Enrollment']	['Neutral']
The study was an inpatient, but PI left inpatient at MGH on July 1, 2012	['Study_Staff_Moved']	['Neutral']
PI left NIH	['Study_Staff_Moved']	['Neutral']
Poor accrual related to rarity of Diamond-Blackfan anemia (DBA)	['Insufficient_Enrollment']	['Neutral']
Low accrual; 4 patients enrolled between 2008-2015	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
"The early termination is due to the results obtained from the sister study, SAPPHIRE
    (CLS1003-301), which did not meet the 8-week primary efficacy endpoint."	['Negative', 'Another_Study']	['Negative', 'Neutral']
COVID-19	['Covid19']	['Neutral']
due to slow enrollment. United Therapeutics and Dr. Bajwa MD decided to terminate study	['Insufficient_Enrollment']	['Neutral']
Terminated due to lack of funding.	['Business_Administrative']	['Possibly_Negative']
"This study has temporarily held recruitment activities to perform a pre-planned interim
    analysis. Other elements of this study are still ongoing."	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
"Due to the COVID-19 pandemic, the recruitment of new subjects was temporarily halted in March
    2020. The study was permanently discontinued in December 2020."	['Covid19']	['Neutral']
Merged with the study NCT00307268	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study withdrawn as it no longer is deemed necessary per project status.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Awaiting additional safety data	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Study was closed early due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
The study was terminated based results of other studies and use of the new vaccine.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Slow inclusion rate. Awaiting results from NCT02132416.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Insufficient resources to support study	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
NCI approval withdrawn	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Terminated Chikungunya diseases has regressed and no more patients was suffering	['Insufficient_Enrollment']	['Neutral']
default inclusion	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
On hold for toxicitiy	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
The study was terminated because of difficulty in completing the study as originally planned	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
"FDA's draft guidance (March 2015) provided option of in-vitro or in-vivo studies for
    bioequivalence. Small study size resulted in negative culture rates."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Interim data analysis showed no effect between treatment groups	['Negative']	['Negative']
No subjects were enrolled and the grant period is ending.	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Sponsor's decision	['Business_Administrative']	['Possibly_Negative']
STUDY LOOKING AT SAMPLES ONLY, NO PARTICIPANT ENROLMENT REQUIRED	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Low Enrollment	['Insufficient_Enrollment']	['Neutral']
investigator choice	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Lack of Funding	['Business_Administrative']	['Possibly_Negative']
"The study is no longer feasible due to the restrictions placed on access to potential
    participants during the COVID-19 pandemic."	['Covid19']	['Neutral']
To few patients recruited to allow for study completion within ph.d. project.	['Insufficient_Enrollment']	['Neutral']
Problem with MRI interpretation	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
Not possible to include participants	['Insufficient_Enrollment']	['Neutral']
Inconsistent results in pilot phase	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Failure to enroll	['Insufficient_Enrollment']	['Neutral']
"This was a research project that was conducted by a visiting scholar and his time for departure
    came earlier than the study completion."	['No_Context', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
not enough subjects	['Insufficient_Enrollment']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Study was started but closed prior to completion because we could not meet enrollment numbers	['Insufficient_Enrollment']	['Neutral']
"DSMB recommended termination on the basis of poor accrual rate. We will transition to a
    prospective observational (non-randomized) study design."	['Insufficient_Enrollment']	['Neutral']
unable to recruit enough patients	['Insufficient_Enrollment']	['Neutral']
Insufficient recruitment.	['Insufficient_Enrollment']	['Neutral']
Difficulty in enrollment	['Insufficient_Enrollment']	['Neutral']
low enrollment	['Insufficient_Enrollment']	['Neutral']
"As of November 2013, the security situation in rural Northern Mozambique is no longer suitable
    for this clinical trial."	['Logistics_Resources']	['Neutral']
Enrollment issues	['Insufficient_Enrollment']	['Neutral']
Terminated	['Invalid_Reason']	['Invalid_Reason']
After March 2015, unable to enroll due to patients meeting exclusion criteria.	['Insufficient_Enrollment']	['Neutral']
Insufficient funding.	['Business_Administrative']	['Possibly_Negative']
PI left the institution. No subjects screened or enrolled.	['Study_Staff_Moved']	['Neutral']
Due to poor patient recruitment, a decision was made to terminate this trial.	['Insufficient_Enrollment']	['Neutral']
Not enough patients	['Insufficient_Enrollment']	['Neutral']
for administrative reasons	['Business_Administrative']	['Possibly_Negative']
Physician's chose to not follow through with the study.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Insufficient recruitment to meet aims.	['Insufficient_Enrollment']	['Neutral']
Please see detailed description for reason why study was terminated.	['No_Context']	['Invalid_Reason']
Withdrawal of medication and funding support by Sponsor	['Business_Administrative']	['Possibly_Negative']
Futility	['Negative']	['Negative']
COVID-19 pandemic	['Covid19']	['Neutral']
DMC recommendation, no efficacy	['Negative']	['Negative']
"For safety reasons the recruitment was halted prematurely. Patients on the trial continute to
    receive treatment and are being followed up as part the protocol."	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Change the sample size due to smaller variance than expected	['Negative']	['Negative']
Stopped by the DSMB for lack of effect per interim stopping rule.	['Negative']	['Negative']
"Inadequate retention of GHD adults to maintain power to study the effect of GH on fibrinolysis.
    A comparison between GHD adults and controls was completed."	['Insufficient_Enrollment']	['Neutral']
This study was prematurely terminated due to low enrollment	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Sponsor decision, unrelated to safety	['Business_Administrative']	['Possibly_Negative']
See termination reason in detailed description	['No_Context']	['Invalid_Reason']
Study terminated for administrative reasons.	['Business_Administrative']	['Possibly_Negative']
Novartis ended all studies regarding Aliskiren.	['Business_Administrative']	['Possibly_Negative']
"The study was terminated October 23, 2015 as pre-specified, interim analysis futility criteria
    were met. The termination was not due to safety concerns."	['Negative']	['Negative']
Development of tasquinimod in prostate cancer discontinued	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
failure to recruit enough number of participants	['Insufficient_Enrollment']	['Neutral']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Doctoral students on project defended their thesis.	['Success', 'No_Context', 'Logistics_Resources']	['Success', 'Invalid_Reason', 'Neutral']
replaced by a new study	['Negative', 'Another_Study']	['Negative', 'Neutral']
On hold due to COVID-19 pandemic.	['Covid19']	['Neutral']
Pending IRB Approval of new protocol and DSMB	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Principal Investigator left institution and not enough resources to support at MTF	['Logistics_Resources', 'Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
We did not receive funding	['Business_Administrative']	['Possibly_Negative']
The drug will no longer be available in the United States.	['Logistics_Resources']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
COVID-19	['Covid19']	['Neutral']
Collaborator/corporate sponsor withdrew funding and permission to continue.	['Business_Administrative']	['Possibly_Negative']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
funding available	['Business_Administrative']	['Possibly_Negative']
Study stopped prior to initiation due to COVID-19 complications	['Covid19']	['Neutral']
Not possible to include patients.	['Insufficient_Enrollment']	['Neutral']
Study on enrollment hold as a precaution per the pharmaceutical company.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
no focus on this topic	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Following difficulties in patient recruitment, we were forced to stop the study prematurely.	['Insufficient_Enrollment']	['Neutral']
Funding exhausted. Sufficient data already collected.	['Business_Administrative']	['Possibly_Negative']
Lack of effect in interim analysis	['Negative']	['Negative']
Difficulty in enrollment	['Insufficient_Enrollment']	['Neutral']
Organisational changes in hospital which changed recruitment rates	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Feasibility	['Logistics_Resources']	['Neutral']
No longer acruing data for this study.	['Invalid_Reason']	['Invalid_Reason']
The results of the interim analysis showed that the primary endpoint was not met	['Negative']	['Negative']
Recruitment not successful due to overly restrictive inclusion/exclusion criteria.	['Insufficient_Enrollment']	['Neutral']
This study was Cancelled Before Active	['Invalid_Reason']	['Invalid_Reason']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
ALX-0171 development program was stopped	['Business_Administrative']	['Possibly_Negative']
Slow accrual, competing studies, and lack of efficacy	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Troubles recruiting patients	['Insufficient_Enrollment']	['Neutral']
Difficulty Enrolling	['Insufficient_Enrollment']	['Neutral']
Extreme toxicity of Pertuzumab and Erlotinib combination	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Substance discontinued.	['Logistics_Resources', 'Endpoint_Met', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
"Some subjects could not complete the second crossover period due to COVID-19-related site
    closure. The study was closed to allow analysis of all collected data."	['Covid19']	['Neutral']
Cohort 2 not going forward. Manadate changes in Company	['Logistics_Resources', 'Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Trial withdrawn due to inability to meet the trial objectives (Pilot).	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Patients corresponding to the inclusion/exclusion criteria not found.	['Insufficient_Enrollment']	['Neutral']
Due to high mortality	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
low enrollment	['Insufficient_Enrollment']	['Neutral']
Modified study; created new study as a result of these modifications	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
The study will be rewritten as a data registry study	['No_Context', 'Study_Design', 'Another_Study']	['Invalid_Reason', 'Neutral', 'Neutral']
The study was terminated early due to poor subject enrollment.	['Insufficient_Enrollment']	['Neutral']
The study is not eligible at present.	['Insufficient_Enrollment']	['Neutral']
due to slow accrual (only 1 patient entered)	['Insufficient_Enrollment']	['Neutral']
COVID-19 pandemic and potential risks to study participants and study staff.	['Covid19']	['Neutral']
enrollment futility	['Negative']	['Negative']
Internal decision	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Accrual lower than anticipated and not expected to improve	['Insufficient_Enrollment']	['Neutral']
Study was not approved by research ethics board.	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
"study ended prior enrollment of the first patient because of unexpected issues in the
    manufacturing process prevented production of adequate clinical batches"	['Logistics_Resources']	['Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
Responsible Investigator left institution	['Study_Staff_Moved']	['Neutral']
Repros stopped study for safety and FDA put study on hold.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"The sponsor terminated the trial early because there was sufficient data to make a decision
    about SD-101 in the lymphoma development program."	['Business_Administrative']	['Possibly_Negative']
PI/Sponsor mutual agreement due to poor enrollment	['Insufficient_Enrollment']	['Neutral']
Stopped with Patients	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
The study was withdrawn prior to enrollment due to corporate decision.	['Business_Administrative']	['Possibly_Negative']
No enrollment was achieved	['Insufficient_Enrollment']	['Neutral']
Research activity paused for COVID-19	['Covid19']	['Neutral']
Inadequate Accrual	['Insufficient_Enrollment']	['Neutral']
Negative Efficacy Results from the recently completed Phase 3 study 104-201506	['Negative', 'Another_Study']	['Negative', 'Neutral']
Sponsor terminated	['Business_Administrative']	['Possibly_Negative']
sponsor decision: not enough inclusion	['Business_Administrative']	['Possibly_Negative']
The study was unable to enroll efficiently despite trying various technique.	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Funding Ended	['Business_Administrative']	['Possibly_Negative']
Not IRB approved	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
Suspended awaiting Ministry of Defence ethics approval.	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Currently in the process of submitting IDE to the FDA	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
CPP	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Study closed at Mayo prior to completion	['Invalid_Reason']	['Invalid_Reason']
Study closed by institutional review board	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
closed due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Study drugs (Oseltamivir suspension from Roche) were unavailable	['Logistics_Resources']	['Neutral']
The sponsor determined that one study (PRO-010) was sufficient	['Negative', 'Another_Study']	['Negative', 'Neutral']
Closure of main community treatment center	['Logistics_Resources', 'Study_Staff_Moved', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Funding allocation to different clinical trials.	['Business_Administrative']	['Possibly_Negative']
Safety concerns	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
Bb	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
"This study was terminated early due to neuropsychiatric serious adverse events reported by 2
    participants."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Practically difficult to inroll the number of patients anticipated	['Insufficient_Enrollment']	['Neutral']
change study sites	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
study was closed	['Invalid_Reason']	['Invalid_Reason']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
payments stopped by grant provider	['Business_Administrative']	['Possibly_Negative']
slow enrollment , interim analysis conducted.	['Insufficient_Enrollment']	['Neutral']
Difficulties in field coordination	['Logistics_Resources']	['Neutral']
insufficient eligable subjects and new data on BVS	['Success', 'No_Context', 'Logistics_Resources']	['Success', 'Invalid_Reason', 'Neutral']
study withdrawn from IRB	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
interim analysis indicates statistical futility for primary outcomes	['Negative']	['Negative']
Conflict with another study that was opened to recruitment	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Study closed with no subjects accrued. PI decided to stop study.	['Insufficient_Enrollment']	['Neutral']
Pfizer has terminated the execution of this protocol	['Business_Administrative']	['Possibly_Negative']
Terminated due to low accrual.	['Insufficient_Enrollment']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Funding was removed.	['Business_Administrative']	['Possibly_Negative']
Terminated new protocol developed which incorporated Pharmacokinetics	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Recruitment promlems	['Insufficient_Enrollment']	['Neutral']
Investigator left site	['Study_Staff_Moved']	['Neutral']
Insufficient funding	['Business_Administrative']	['Possibly_Negative']
Sponsor discontinued development of CO-1686 for NSCLC.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Due to COVID-19 all research activities including recruitment have been paused.	['Covid19']	['Neutral']
The main investigators are no longer working at the center.	['Study_Staff_Moved']	['Neutral']
COVID-19 global pandemic, and study funding period ended 7/31/2020.	['Covid19']	['Neutral']
Enrollment Goals not met	['Insufficient_Enrollment']	['Neutral']
Study terminated prematurely by sponsor for business reason. One patient was enrolled.	['Business_Administrative']	['Possibly_Negative']
Study was withdrawn because the university wanted to bill study patients for use of the laser.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
The DSAEK procedure was discontinued as the standard of care for the intended cohort.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"IRB delayed their review for an extensive period of time. Funding for this protocol is no
    longer available."	['Business_Administrative']	['Possibly_Negative']
No longer recruiting: participants are no longer being recruited or enrolled	['Invalid_Reason']	['Invalid_Reason']
"Based on our latest research results, we will revise the protocol and design a better study.
    Since no participants are enrolled till now, we withdraw this study."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Postmarket study terminated as the SN6AD3 is no longer promoted.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
number included	['Invalid_Reason']	['Invalid_Reason']
"The trial was closed because the changing standard of care landscape, making this trial not
    impactful anymore."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study is closed early due to withdrawal of funding. No study procedures were implemented.	['Business_Administrative']	['Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
Slow enrollment, lack of follow up	['Insufficient_Enrollment']	['Neutral']
Discontinuation of development for this indication	['Regulatory', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Funding unavailable	['Business_Administrative']	['Possibly_Negative']
Investigator has left the university	['Study_Staff_Moved']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Closed due to no accrual	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
"This study never started, did not receive IRB approval and was closed administratively at the
    site. Therefore, no subjects were recruited or enrolled."	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Company was dissolved.	['Business_Administrative']	['Possibly_Negative']
Expiration of funding	['Business_Administrative']	['Possibly_Negative']
Loss of Funding	['Business_Administrative']	['Possibly_Negative']
Study never started. No patients were enrolled.	['Invalid_Reason']	['Invalid_Reason']
Evidence of very low probability to success. No safety issues.	['Negative']	['Negative']
Lack of patient accrual	['Insufficient_Enrollment']	['Neutral']
Protocol failed to accrue sufficient subject to complete meaningful analysis.	['Insufficient_Enrollment']	['Neutral']
The study has been suspended because COVID pandemic.	['Covid19']	['Neutral']
pending amendment approval	['Study_Design']	['Neutral']
"The recruitment was much slower than expected and the COVID pandemic added new barriers to
    recruitment."	['Covid19']	['Neutral']
Ran out of funding	['Business_Administrative']	['Possibly_Negative']
Feasibility - unable to recruit therapists to enter the study	['Insufficient_Enrollment']	['Neutral']
No patient wants to be recruited.	['Insufficient_Enrollment']	['Neutral']
Study stopped due to lack of efficacy in first 6 patients	['Negative']	['Negative']
Business decision.	['Business_Administrative']	['Possibly_Negative']
Closed due to no enrollment	['Insufficient_Enrollment']	['Neutral']
Researcher stopped activity at institution	['Study_Staff_Moved']	['Neutral']
The study activities are suspended due to COVID-19 pandemic	['Covid19']	['Neutral']
Expected inability to recruit study participants in a reasonable amount of time.	['Insufficient_Enrollment']	['Neutral']
Low recruitment rate	['Insufficient_Enrollment']	['Neutral']
Study was not started due to PI concentrating on other studies	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
"Due to new scientific evidence assessment, the study design was revised before the study
    started recruitment"	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Withdrawn due to funding issues	['Business_Administrative']	['Possibly_Negative']
Lack of agreement between the participants and lack og funding	['Business_Administrative']	['Possibly_Negative']
The results were not significant, therfore the study ended prematurily	['Negative', 'Business_Administrative']	['Negative', 'Possibly_Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
investigators decided not to move forward with project	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
shortstaff at sleep lab	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
Terminated early due to low enrollment	['Insufficient_Enrollment']	['Neutral']
Study terminated due to low accrual.	['Insufficient_Enrollment']	['Neutral']
Covid-19 pandemic	['Covid19']	['Neutral']
"This study terminated 27Apr2010 due to slow recruitment and the need to use the existing
    information to determine dosing for another study."	['No_Context', 'Insufficient_Enrollment', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
slow accrual	['Insufficient_Enrollment']	['Neutral']
"UT-IRB insists on protocol design change -Not rel to any pt. safety/non-compliance-Recruiting
    halted at UT/MHHS but may resume at FLHosp for Children-OrlandoFL"	['Study_Design']	['Neutral']
Sponsor withdrew funding	['Business_Administrative']	['Possibly_Negative']
Due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
"In a communication dated June 12, 2019 the FDA has released Pfizer from the Postmarketing
    Commitment (PMC 2767-2) that was associated with study B3031003."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Funding for project was withdrawn	['Business_Administrative']	['Possibly_Negative']
Pediatric development program terminated by sponsor	['Business_Administrative']	['Possibly_Negative']
Study was terminated due to a business decision to cancel the entire project.	['Business_Administrative']	['Possibly_Negative']
Company strategic decision	['Business_Administrative']	['Possibly_Negative']
the study was completed	['Invalid_Reason']	['Invalid_Reason']
"Terminated due to a high number of protocol deviations secondary to non-study approved opioid
    administration."	['Study_Design']	['Neutral']
study coordinator left / no other current resources to complete	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Manufacturer asked to close study due to AEs experienced by subjects in other studies.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Drug supply issues	['Logistics_Resources']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
terminated early, due to toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
study completed	['Invalid_Reason']	['Invalid_Reason']
Lack of eligible patients	['Insufficient_Enrollment']	['Neutral']
Study was terminated early for strategic reasons. Only Part I of the study was completed.	['Business_Administrative']	['Possibly_Negative']
Study was halted due to poor subject accrual.	['Insufficient_Enrollment']	['Neutral']
Sponsor's Decision	['Business_Administrative']	['Possibly_Negative']
lack of investigators	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
no eligible subjects located	['Insufficient_Enrollment']	['Neutral']
Funding Unavailable	['Business_Administrative']	['Possibly_Negative']
no participants enrolled	['Insufficient_Enrollment']	['Neutral']
Trial was terminated by investigators due to equipment difficulties	['Logistics_Resources']	['Neutral']
commitment completed	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Unable to obtain FDA exemption	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Funding	['Business_Administrative']	['Possibly_Negative']
Sponsor strategy change	['Business_Administrative']	['Possibly_Negative']
Funding withdrawn	['Business_Administrative']	['Possibly_Negative']
Lack of novelty of study	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Lack of recruiting at primary study site	['Insufficient_Enrollment']	['Neutral']
Study enrollment and goals unable to be reached.	['Insufficient_Enrollment']	['Neutral']
Sponsor termination	['Business_Administrative']	['Possibly_Negative']
Due to a lack of laboratory resources, the study was abandoned.	['Logistics_Resources']	['Neutral']
Never received funding	['Business_Administrative']	['Possibly_Negative']
The PI has relocated and the study has been closed.	['Study_Staff_Moved']	['Neutral']
Lacking algorithms led to abortion of project	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
In 14 participants who had LP, very low level viremia was found in only 1	['Safety_Sideeffects', 'Endpoint_Met', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Low enrolment	['Insufficient_Enrollment']	['Neutral']
The study was halted prematurely due to poor recruitment	['Insufficient_Enrollment']	['Neutral']
NIH funding resulted in new clinical trial	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Logistical factors affecting recruitment	['Logistics_Resources']	['Neutral']
PI no longer at institution	['Study_Staff_Moved']	['Neutral']
too few candidates for enrollment	['Insufficient_Enrollment']	['Neutral']
Technical complications.	['Safety_Sideeffects', 'Logistics_Resources']	['Safety_Sideeffects', 'Neutral']
IND required by the FDA for all future FMTs.	['Regulatory']	['Neutral']
The CDC indicated nasal spray flu vaccine should not be used during 2016-2017	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
PI moving to Southern Illinois University to start new protocol	['Study_Staff_Moved']	['Neutral']
IND application was withdrawn, and therefore study listing is being withdrawn.	['Regulatory', 'Invalid_Reason', 'Negative']	['Neutral', 'Invalid_Reason', 'Negative']
Study site did not have sufficient subjects for the case group	['Insufficient_Enrollment']	['Neutral']
protocol not approved by VA R&D	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Terminated early due to administrative reasons unrelated to efficacy or safety.	['Business_Administrative']	['Possibly_Negative']
The study was terminated based on review of Phase 2 efficacy data	['Negative', 'Another_Study']	['Negative', 'Neutral']
Enrollment was halted early because of low adherence to the intervention.	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"AML assess. of response in Part B patients find treatment failure in all 8 evaluable for marrow
    response following a maximum of 2 induction courses of therapy"	['Negative']	['Negative']
Protocol was cancelled by company based on overall efficacy, no safety concern	['Negative']	['Negative']
Unexpected non-serious adverse events	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"This protocol terminated prematurely on July 8, 2013 due to slow enrollment, not because of any
    safety issues or concerns."	['Insufficient_Enrollment']	['Neutral']
"In October 2015 ICU's setting completely changed from an open concept 8-beds unit to a single
    bed isolated room."	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
The study was terminated due to a change in sponsor prioritization.	['Business_Administrative']	['Possibly_Negative']
Without recruitment	['Insufficient_Enrollment']	['Neutral']
Difficulty in recruiting eligible patients	['Insufficient_Enrollment']	['Neutral']
The team decided to close this study since we are not recruiting and collecting any data.	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Sponsor proceeded with a phase III study for same indication.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Due to pandemic COVID-19	['Covid19']	['Neutral']
no fund	['Business_Administrative']	['Possibly_Negative']
Repros stopped the study for safety and FDA put the study on hold for safety.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
slow recruitment - unable to meet enrollment goals	['Insufficient_Enrollment']	['Neutral']
Terminated due to sponsor desicioun	['Business_Administrative']	['Possibly_Negative']
New study with a similar endpoint/protocol was developed (see NCT03103061).	['Negative', 'Another_Study']	['Negative', 'Neutral']
This study was terminated early due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
Due to slow recruitment the study was terminated	['Insufficient_Enrollment']	['Neutral']
Other - Nearing the protocol-specified maximum enrollment	['Insufficient_Enrollment']	['Neutral']
IND was withdrawn	['Regulatory', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
No eligible patient was enrolled.	['Insufficient_Enrollment']	['Neutral']
No eligible patients were found, the study stopped without including any patients	['Insufficient_Enrollment']	['Neutral']
Due to COVID-19 Pandemic	['Covid19']	['Neutral']
Challenges with funding and very low incidence of COVID-19 at Irish study site	['Covid19']	['Neutral']
Lack of insurance coverage for proton beam treatment	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"The study was terminated because BioMarin decided to end the overall development program based
    on competing corporate priorities."	['Business_Administrative']	['Possibly_Negative']
Funding unavailable	['Business_Administrative']	['Possibly_Negative']
Business Decision	['Business_Administrative']	['Possibly_Negative']
Due to business reasons, not safety issues	['Business_Administrative']	['Possibly_Negative']
Due very high screen fail rate, pre study feasibility not consistent with screened population.	['Logistics_Resources', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Business decision	['Business_Administrative']	['Possibly_Negative']
Terminated due to low accrual	['Insufficient_Enrollment']	['Neutral']
COVID	['Covid19']	['Neutral']
There was no clear benefit but numerous side effects.	['Safety_Sideeffects', 'Endpoint_Met', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
"Sponsor stopped development of the MedTone inhaler in favor of an improved device (Gen2
    inhaler)"	['Study_Design']	['Neutral']
Study terminated due to adverse events related to the combination therapy	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
The protocol was amendment to be stopped after phase I (phase 2 removed from protocol)	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Inconsistent data taken from Phase I cohort	['Negative', 'Another_Study']	['Negative', 'Neutral']
Please see explanation in the Detailed Description field.	['No_Context']	['Invalid_Reason']
Funding was not obtained for this study and no participants were enrolled.	['Business_Administrative']	['Possibly_Negative']
withdrawn during planning stages	['Business_Administrative']	['Possibly_Negative']
Change in clinical plan and drug supply	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Study halted prematurely, prior to enrollment of first participant	['Invalid_Reason']	['Invalid_Reason']
Trial closure due to NCI NCTN transition	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Investigator has relocated to MD Anderson	['Study_Staff_Moved']	['Neutral']
unable to identify a third subject	['Insufficient_Enrollment']	['Neutral']
Funding was not obtained	['Business_Administrative']	['Possibly_Negative']
Sponsor no longer funding study.	['Business_Administrative']	['Possibly_Negative']
See Detailed Description	['No_Context']	['Invalid_Reason']
higher mortality in another published study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Poor enrolment	['Insufficient_Enrollment']	['Neutral']
end of the follow-up period	['Invalid_Reason']	['Invalid_Reason']
Lack of funding; not subjects enrolled	['Business_Administrative']	['Possibly_Negative']
The study is no longer required	['Invalid_Reason']	['Invalid_Reason']
Withdrawn because study never opened to accrual	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
device was stolen	['Logistics_Resources']	['Neutral']
Study drug expiry date not extended	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
poor enrollment (31 of a planned 114 subjects were randomized and evaluable)	['Insufficient_Enrollment']	['Neutral']
"Decision taken to halt progression of mefloquine as a potential partner for OZ439 as a single
    dose cure due to low probability of success"	['Negative']	['Negative']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
"Interim analysis showed early evidence of futility of sirolimus. Trial stopped per DSMB
    recommendation."	['Negative']	['Negative']
Grant ended and faculty has left the institution	['Business_Administrative']	['Possibly_Negative']
Low dose radiation treatment was not appropriate for these patients.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Investigator left institution for private practice	['Study_Staff_Moved']	['Neutral']
The study stopped as the performance of the study showed insufficient patient recruitment.	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
"Subject withdrawals after temporal suspension of the trial (for personal, logistic reasons). At
    time of reinitiation the number of enrolled subjects did not meet the predefined threshold for
    continuation of the trial."	['Insufficient_Enrollment']	['Neutral']
Difficulties in recruiting participants	['Insufficient_Enrollment']	['Neutral']
IND issues	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Research question was integrated in other study protocol	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"We decided to close this study. We are unable to perform this study due to the current
    pandemic."	['Covid19', 'Logistics_Resources', 'Endpoint_Met']	['Neutral', 'Neutral', 'Neutral']
Further internal evaluation of the device was required.	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
"indirect calorimetry no longer employed at the institution; calorimeter is not
    accurate/reliable"	['Logistics_Resources']	['Neutral']
"The study was terminated due to challenges with patient eligibility; the decision to terminate
    was not based on any safety concerns"	['Insufficient_Enrollment']	['Neutral']
Main cooperator finished cooperation	['Business_Administrative']	['Possibly_Negative']
Staffing changes at site. No longer feasible at site.	['Logistics_Resources']	['Neutral']
Study was not initiated. No subjects were screened or enrolled.	['Invalid_Reason']	['Invalid_Reason']
investigator wish	['Study_Staff_Moved', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Participant withdrew consent	['Business_Administrative']	['Possibly_Negative']
Accrual rate to date was too low to finish the trial in a reasonable timeframe	['Insufficient_Enrollment']	['Neutral']
No accrual. New study opening with modified technique.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
"DSPD focusing on Study 301 to confirm the clinical profile before proceeding. Daiichi Sankyo
    Pharma Development terminated this study on 23 Apr 2008 because of changes in the clinical
    development plan with 94 of 2600 planned, randomized participants."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"Following an internal portfolio review, Ipsen has made the decision to terminate study
    D-US-60090-001. Ipsen would like to highlight that early termination was not due to any safety
    or tolerability issues with IPN60090"	['Business_Administrative']	['Possibly_Negative']
The study was terminated prematurely because of difficulty with recruiting.	['Insufficient_Enrollment']	['Neutral']
Inadequate subject recruitment	['Insufficient_Enrollment']	['Neutral']
Failure to recruit	['Insufficient_Enrollment']	['Neutral']
Study was terminated based on the interim results of a futility test.	['Negative']	['Negative']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Withdrawn due to toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
PI left institution and study is being transferred.	['Study_Staff_Moved']	['Neutral']
This study was not conducted as the Principal Investigator left the institution	['Study_Staff_Moved']	['Neutral']
Development program terminated	['Business_Administrative']	['Possibly_Negative']
Difficulties to recruit patients	['Insufficient_Enrollment']	['Neutral']
"The study was terminated after Merck Serono had taken the decision not to pursue the
    development of AS900672-enriched in ovulation induction"	['Business_Administrative']	['Possibly_Negative']
The study was cancelled prior to the enrollment of any participants.	['Invalid_Reason']	['Invalid_Reason']
Enrollment discontinued after second cohort completed.	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
This study doesn't meet NIH criteria of clinical trial study	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Incomplete data set & analysis	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Competing clinical trials and slower than expected patient enrollment	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Lack of Recruitment	['Insufficient_Enrollment']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
required catheters not available	['Logistics_Resources']	['Neutral']
Withdrawal of pharmaceutical support from Novartis - no participants randomized	['Business_Administrative']	['Possibly_Negative']
Low patient compliance and dropout during the period defined for the study	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Sponsor decision not to start trial	['Business_Administrative']	['Possibly_Negative']
Lack of participations (8 of 25)	['Insufficient_Enrollment']	['Neutral']
recruitment problem	['Insufficient_Enrollment']	['Neutral']
The company decided to cancel this study in conformity with PH FDA Circular 2013-004	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
due to sponsor decision	['Business_Administrative']	['Possibly_Negative']
expired study	['Business_Administrative']	['Possibly_Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
No enrollment	['Insufficient_Enrollment']	['Neutral']
Slow accrual; did not meet accrual goal	['Insufficient_Enrollment']	['Neutral']
limited qualifying patient population	['Insufficient_Enrollment']	['Neutral']
Anticipation of inadequate recruitment according to current format.	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Data analysis revealed sufficient data for safety and efficacy	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Study Design changed and will be resubmitted as a new study	['Study_Design']	['Neutral']
sponsors	['Business_Administrative']	['Possibly_Negative']
Discontinued due to non-enrollment.	['Insufficient_Enrollment']	['Neutral']
Lack of patients	['Insufficient_Enrollment']	['Neutral']
This project is no longer active with DVA.	['Business_Administrative']	['Possibly_Negative']
PI left the university	['Study_Staff_Moved']	['Neutral']
Study will not be conducted due to lack of funding	['Business_Administrative']	['Possibly_Negative']
Very low accrual rate.	['Insufficient_Enrollment']	['Neutral']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
IRB approval expired	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The investigator has left the institution (UCSF) prior to study start-up	['Study_Staff_Moved']	['Neutral']
Business decision non-safety related.	['Business_Administrative']	['Possibly_Negative']
"Sponsor and Principle Investigator mutually agreed to terminate study and patients are no
    longer examined/treated"	['Business_Administrative']	['Possibly_Negative']
insufficient recruitment of control and study patients	['Insufficient_Enrollment']	['Neutral']
At end of Phase 1 excessive high pill burden (18 capsules/day)	['Safety_Sideeffects', 'Logistics_Resources', 'Endpoint_Met']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Business objectives have changed	['Business_Administrative']	['Possibly_Negative']
the PI is no longer work at Hadassah	['Study_Staff_Moved']	['Neutral']
"Cancelled due to changes in the scientific landscape. Decision was made after thorough
    evaluation of of pros&cons, ethical as well as regulatory consideration"	['Interim_Analysis', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
"The early termination was NOT due to safety reasons, terminated because of the very slow
    recruitment and problematic access to the study medication in Europe"	['Insufficient_Enrollment']	['Neutral']
Not due to safety but due to a lack of efficacy at the 5 mg azeliragon dose.	['Negative']	['Negative']
Shift in department's research interest	['Logistics_Resources', 'Study_Staff_Moved', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
"This study was a companion study to another one. The other study closed early so this one did
    as well."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study terminated due to safety assessment of the study product	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
No study recruitment due to time constraints and lack of support.	['Business_Administrative']	['Possibly_Negative']
"Slow accrual 5 patients out of 25 expected. Primary objectives could not be met without
    recruiting more patients."	['Insufficient_Enrollment']	['Neutral']
PI went for a post-doc course and when he came back he moved for another job	['Study_Staff_Moved']	['Neutral']
study approval lapsed	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Physician deceased	['Study_Staff_Moved']	['Neutral']
Nonapplicable clinical trial	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
IRB recommended change to registry study or quality improvement project status	['Regulatory', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Device Withdrawn from market	['Study_Design']	['Neutral']
Low accrual.	['Insufficient_Enrollment']	['Neutral']
Management decision not to conduct an additional efficacy study.	['Business_Administrative']	['Possibly_Negative']
Difficulty in recruiting subjects.	['Insufficient_Enrollment']	['Neutral']
The trial was terminated for scientific reasons.	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Inability to recruit patients	['Insufficient_Enrollment']	['Neutral']
"All consented subjects tested negative for the BRCA2 mutation, therefore, did not meet criteria
    to start the study, resulting in withdrawal by PI"	['Negative']	['Negative']
Accrual insufficient to complete study in a feasible time frame	['Insufficient_Enrollment']	['Neutral']
slow accrual made study completion unfeasible	['Insufficient_Enrollment']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
"Sponsor has decided there is not a business need for this study and is not required to
    complete."	['Business_Administrative']	['Possibly_Negative']
study changed waiting renew	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
PI Left institution	['Study_Staff_Moved']	['Neutral']
Data collection requirment complete	['Invalid_Reason']	['Invalid_Reason']
No funding	['Business_Administrative']	['Possibly_Negative']
No patients recruited	['Insufficient_Enrollment']	['Neutral']
insufficient resources to conduct study	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Art gallery dissembled- no research goals with new art.	['Logistics_Resources', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
failure to recruit	['Insufficient_Enrollment']	['Neutral']
No patients enrolled, sponsor refused to pay site invoices.	['Business_Administrative']	['Possibly_Negative']
Enrollment rate insufficient to fully enroll study within the planned timeline.	['Insufficient_Enrollment']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
PI no longer practicing at Methodist HF	['Study_Staff_Moved']	['Neutral']
Study withdrawn due to inability to enroll subjects.	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Due to an adverse event revelation.	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Genitope suspend drug development by decision made by the FDA March 6, 2008.	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Low eligibility rate	['Insufficient_Enrollment']	['Neutral']
Not funded	['Business_Administrative']	['Possibly_Negative']
study terminated by sponsor decision	['Business_Administrative']	['Possibly_Negative']
Study terminated due to insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
as per GCP sponsor/company decision	['Business_Administrative']	['Possibly_Negative']
Very few subjects were enrolled. Therefore, the study was terminated.	['Insufficient_Enrollment']	['Neutral']
Study team plans to revise one of the agents used in the treatment plan of the study.	['Study_Design']	['Neutral']
The study was terminated early due to company decision.	['Business_Administrative']	['Possibly_Negative']
Enrollment was slow and we decided to refocus our efforts on other studies	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Company decision	['Business_Administrative']	['Possibly_Negative']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Insufficient drug supply	['Logistics_Resources']	['Neutral']
Pilot feasibility for full trial: NCT03737799	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Stage 1 interim analysis of efficacy met the criteria for early trial termination (futility).
    The trial was terminated at Stage 1; did not proceed to Stage 2."	['Negative']	['Negative']
Insufficient interest and recruitment - study ended prematurely by investigators	['Insufficient_Enrollment']	['Neutral']
At time of pre-specified 2nd interim analysis	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
"Closed by US IRB due to lack of an adequate system for continuing review by the Indian IRB. No
    subjects enrolled in US."	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Unable to enrol enough people to achieve the full sample size	['Insufficient_Enrollment']	['Neutral']
(suspension)	['Interim_Analysis', 'Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Internal Business Decision	['Business_Administrative']	['Possibly_Negative']
Due to slow recruitment and an interim analysis showing no benefit of occlusion.	['Negative']	['Negative']
IND required	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
No funding, move to expanded access	['Business_Administrative']	['Possibly_Negative']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
Terminated in view of the C107 findings demonstrating efficacy at doses of 90 and 30 minutes	['Negative', 'Another_Study']	['Negative', 'Neutral']
Due to lack of volunteer facilitators to deliver the intervention	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Lack of efficacy data from the Phase 3 clinical study (AC-054-301; CONSCIOUS-2)	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Never activated	['Invalid_Reason']	['Invalid_Reason']
Low accrual.	['Insufficient_Enrollment']	['Neutral']
Difficulty in recruiting patients	['Insufficient_Enrollment']	['Neutral']
slow patient accrual	['Insufficient_Enrollment']	['Neutral']
PI left JHU	['Study_Staff_Moved']	['Neutral']
MyVax did not meet its primary endpoints	['Negative']	['Negative']
Enrollment	['Insufficient_Enrollment']	['Neutral']
SOF/VEL/VOX will not be evaluated in younger age groups.	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Sponsor bankruptcy	['Business_Administrative']	['Possibly_Negative']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Per Sponsor Request; nonACT	['Business_Administrative']	['Possibly_Negative']
Unable to recruit eligible subjects; no data analyzed	['Insufficient_Enrollment']	['Neutral']
Study registered to wrong sponsor.	['Business_Administrative']	['Possibly_Negative']
Recruitment futile	['Insufficient_Enrollment']	['Neutral']
Company decision	['Business_Administrative']	['Possibly_Negative']
Sponsor and investigator's decision	['Business_Administrative']	['Possibly_Negative']
Recruitment was not as expected.	['Insufficient_Enrollment']	['Neutral']
Inadequate rate of enrollment	['Insufficient_Enrollment']	['Neutral']
"Dr. Jorizzo has decided to withdraw from this study due to the time it is taking to get the
    study started."	['Business_Administrative']	['Possibly_Negative']
"Stopped randomization in June 2019 due to local community concerns about all waiver of consent
    research."	['Interim_Analysis', 'Regulatory', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Available MRI scan unable to collect required data elements.	['Logistics_Resources']	['Neutral']
staffing resources	['Logistics_Resources']	['Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Study Terminated by Sponsor	['Business_Administrative']	['Possibly_Negative']
Principal Investigator left Moffitt and study had low accrual.	['Insufficient_Enrollment']	['Neutral']
"The study was terminated due to the COVID-19 pandemic as no in-person study visits were
    permitted."	['Covid19']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Based on a business decision unrelated to any safety concerns.	['Business_Administrative']	['Possibly_Negative']
insufficient enrollment rate	['Insufficient_Enrollment']	['Neutral']
Expired experimental study agent, no additional supply available.	['Logistics_Resources']	['Neutral']
For business reasons	['Business_Administrative']	['Possibly_Negative']
"All analysis with identifiable specimens/data is complete or site has no identifiers linked to
    the specimens/data"	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
"Only half recruitment : restrictive respiratory mechanics group not achievable for technical
    problems"	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Safety	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Study prematurely terminated upon recommendation of IDMC due to lack of efficacy.	['Negative']	['Negative']
Due to slow/insufficient accrual and Principal Investigator left the NIH	['Insufficient_Enrollment']	['Neutral']
competing priorities at the organization	['Business_Administrative']	['Possibly_Negative']
sufficient data gathered to support hypothesis	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
FDA Clinical Hold	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Business decision - product discontinued	['Business_Administrative']	['Possibly_Negative']
Suspended trial was not restarted.	['Invalid_Reason']	['Invalid_Reason']
not enough patients enrolled	['Insufficient_Enrollment']	['Neutral']
Slow accrual, PI left the institution	['Insufficient_Enrollment']	['Neutral']
Corporate decision	['Business_Administrative']	['Possibly_Negative']
The study was terminated for business reasons.	['Business_Administrative']	['Possibly_Negative']
This study was withdrawn for administrative reasons. There were no safety concerns.	['Business_Administrative']	['Possibly_Negative']
Medtronic acquisition of Restore Medical, business decision	['Business_Administrative']	['Possibly_Negative']
Recruitment too low for power analysis	['Insufficient_Enrollment']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Change to study design.	['Study_Design']	['Neutral']
bad recruitment of suitable participants, just 4 patients in one year	['Insufficient_Enrollment']	['Neutral']
No patients enrolled and funding has been withdrawn.	['Business_Administrative']	['Possibly_Negative']
"Terminated for Commercial Reasons. There were no safety issues involved in the decision to
    terminate the study."	['Business_Administrative']	['Possibly_Negative']
Difficulty Enrolling	['Insufficient_Enrollment']	['Neutral']
Investigator is leaving the university	['Study_Staff_Moved']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Terminated due to clinical trial material production delays	['Logistics_Resources']	['Neutral']
Funding for the study ended with one subject consented, but not randomized	['Business_Administrative']	['Possibly_Negative']
Early termination due to slower than anticipated recruitment.	['Insufficient_Enrollment']	['Neutral']
Celgene would no longer supply lenalidomide for the study	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The preliminary analysis is in progress. Sample size will be revised after data analysis.	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
Satisfactory results, in terms of both clinical and statistical, were achieved.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
"Early termination was granted by FDA based on study results meeting the post approval
    requirements."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Lack of funding to continue the study	['Business_Administrative']	['Possibly_Negative']
Problems of recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
"Enrollment and interactions/interventions are paused due to COVID-19 and are expected to resume
    in the future. This is not a suspension of IRB approval."	['Covid19']	['Neutral']
lack of participation or interest in other sites.	['Business_Administrative']	['Possibly_Negative']
The drop-out rate was too high.	['Insufficient_Enrollment']	['Neutral']
Poor Accrual	['Insufficient_Enrollment']	['Neutral']
Technical & Logistical issues	['Logistics_Resources']	['Neutral']
Couldn't offer patients a high/low fat meal plan because food service changes	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Sponsor's decision	['Business_Administrative']	['Possibly_Negative']
Enrolled too slow	['Insufficient_Enrollment']	['Neutral']
Unable to obtain funding	['Business_Administrative']	['Possibly_Negative']
echo contrast agents no longer allowed in CAD patients.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Occurrence of 2 dose-limiting toxicities at the initial dose level (60 mg/m2) in Part I.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Lack of funding. Changed design.	['Business_Administrative']	['Possibly_Negative']
Funding not received.	['Business_Administrative']	['Possibly_Negative']
Upon DSMC suggestion due to a too low enrollment rate.	['Insufficient_Enrollment']	['Neutral']
"Study closed at Principal Investigator's request (study initiated, but not complete). Only 6
    subjects had been recruited. The same study was just published."	['Negative', 'Another_Study']	['Negative', 'Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
COVID-19 pandemic makes it unsafe for older adults to participate in the study	['Covid19']	['Neutral']
Low accrual due to competing trial.	['Insufficient_Enrollment']	['Neutral']
PI decision to terminate. No usable data collected	['Interim_Analysis', 'Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral', 'Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
"Pfizer has decided to perform the pre-specified final analysis at the current enrollment using
    a re-estimation of the sample size."	['Interim_Analysis', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
failed to enroll patients	['Insufficient_Enrollment']	['Neutral']
Loss of funding	['Business_Administrative']	['Possibly_Negative']
Study never got started.	['Invalid_Reason']	['Invalid_Reason']
The Initial Phase 3 Study (NCTO1281189) did not meet its primary efficacy endpoint.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Slow accrual in North America	['Insufficient_Enrollment']	['Neutral']
Due to unforeseen circumstances, the funder decided to discontinue all funding.	['Business_Administrative']	['Possibly_Negative']
This study was stopped due to time and budgetary constraints.	['Business_Administrative']	['Possibly_Negative']
Due to COVID-19	['Covid19']	['Neutral']
FMT for study indication has been permitted by Israeli Ministry of Health	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Investigator departed organization	['Study_Staff_Moved']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
No participants enrolled.	['Insufficient_Enrollment']	['Neutral']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
"Lack of new inclusions due to a significant change in surgery technique. An endoscopic
    a-traumatic coronary artery bypass (endo-ACAB) approach is now used."	['Study_Design']	['Neutral']
Few participants enrolled	['Insufficient_Enrollment']	['Neutral']
withdrawn study from IRB	['Regulatory', 'Ethical_Reason', 'Negative']	['Neutral', 'Neutral', 'Negative']
No satisfactory acrual	['Insufficient_Enrollment']	['Neutral']
"Patients with permanent AF are seldomly symptomatic enough to justify intervention. We decided
    to stop inclusion due to low recruitment rate."	['Insufficient_Enrollment']	['Neutral']
"The study was discontinued due to low enrollment. A survey has been implemented in place of a
    formal study."	['Insufficient_Enrollment']	['Neutral']
Dr. Sirgusson moved to another institution = Florida Institute of Technology in June 2013	['Study_Staff_Moved']	['Neutral']
Study was never activated	['Invalid_Reason']	['Invalid_Reason']
Lack of Funding	['Business_Administrative']	['Possibly_Negative']
"The Phase 3 PolarisDMD trial did not meet the primary endpoint. As a result, activities related
    to the development of edasalonexent have stopped including the CAT-1004-302 Open-Label Study of
    Edasalonexent in Boys With Duchenne Muscular Dystrophy"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Insufficient funding	['Business_Administrative']	['Possibly_Negative']
Study stopped to await new generation of device anticipated to be released 2018.	['Study_Design']	['Neutral']
Study was withdrawn due to lack of patient enrollment.	['Insufficient_Enrollment']	['Neutral']
Funding withdrawn by sponsor	['Business_Administrative']	['Possibly_Negative']
PI failed to file continuation report.	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
It wasn't possible to recruit the desired number of patients.	['Insufficient_Enrollment']	['Neutral']
No Accrual	['Insufficient_Enrollment']	['Neutral']
Closed due to low enrollment	['Insufficient_Enrollment']	['Neutral']
Protocol changed to meet IRB requirements for patient safety	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The prevalence of worm infections in the site is significantly lower than expected	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
No patients are enrolled in any studies conducted under this IND	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Study halted prematurely as investigator left the institution.	['Study_Staff_Moved']	['Neutral']
"Novartis decided not to pursue further development of buparlisib program (assessment of
    moderate PFS benefit with know, but manageable, buparlisib profile)."	['Negative', 'Business_Administrative']	['Negative', 'Possibly_Negative']
Lack of drug supply	['Logistics_Resources']	['Neutral']
"In light of the evolving Covid19 pandemic ongoing study recruitment was felt to pose an
    unacceptable risk to patient safety."	['Covid19']	['Neutral']
Management decision; not patient safety related	['Business_Administrative']	['Possibly_Negative']
Due to budgetary issues, the company has decided to focus on other applications at this stage.	['Business_Administrative']	['Possibly_Negative']
Sponsor dissolved before study started	['Business_Administrative']	['Possibly_Negative']
Sponsor decision due to low recruitment	['Insufficient_Enrollment']	['Neutral']
"Study is permanently closed to enrollment .Collection of private identifiable information is
    complete Analysis of private identifiable information is complete"	['Invalid_Reason']	['Invalid_Reason']
Due to VTI-208 results, the ELAD clinical plan is being re-evaluated.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Converted from a pilot into a larger study which we will enter as a new protocol	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
UNDER RECRUITMENT	['Insufficient_Enrollment']	['Neutral']
This study was Cancelled Before Active	['Invalid_Reason']	['Invalid_Reason']
Terminated by Investigator due to lack of eligible subjects.	['Insufficient_Enrollment']	['Neutral']
The control product was recalled.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
lack of interest by sponsor	['Business_Administrative']	['Possibly_Negative']
The company decided not to start the study.	['Business_Administrative']	['Possibly_Negative']
Judicial liquidation of the society providing dietary supplementation.	['Business_Administrative']	['Possibly_Negative']
No activties have occurred and no participants have enrolled in this protocol	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
low enrollment rate	['Insufficient_Enrollment']	['Neutral']
Poor enrollment/suspended to accrual; will close per AstraZeneca request	['Insufficient_Enrollment']	['Neutral']
Failure to enroll sufficient patients by expected deadline.	['Insufficient_Enrollment']	['Neutral']
stopped for futility	['Negative']	['Negative']
Unable to identify qualified subjects willing to participate in this study	['Insufficient_Enrollment']	['Neutral']
Reallocation of funding.	['Business_Administrative']	['Possibly_Negative']
Study was not initiated; no subjects were consented or enrolled	['Invalid_Reason']	['Invalid_Reason']
Closed early due to difficulties in enrolling the target number of 10 surgical procedures.	['Insufficient_Enrollment']	['Neutral']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Difficulty in enrolling patients	['Insufficient_Enrollment']	['Neutral']
Research Cancelled	['Invalid_Reason']	['Invalid_Reason']
Departure of PI	['Study_Staff_Moved']	['Neutral']
The target cannot be achieved within timeline due to delay of ethics approval	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Terminated due to unacceptable toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Local regulations	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Difficulty with enrollment	['Insufficient_Enrollment']	['Neutral']
scarce enrolment and presentation of positive results of similar study in June 2012.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Slow recruitment therefore study was stopped after 95% volunteers were enrolled.	['Insufficient_Enrollment']	['Neutral']
Sufficient patient population achieved; decision not due to product complaints.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Study suspended because of COVID 19	['Covid19']	['Neutral']
Insufficient resources necessary for completion.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The double-blind primary endpoint was not met. Open Label Extension period halted as a result.	['Negative']	['Negative']
Futility	['Negative']	['Negative']
the study has never started. The sponsor has decided to not move forward	['Business_Administrative']	['Possibly_Negative']
The study did not receive IRB approval and was withdrawn by the PI on April 9, 2020.	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Insufficient Recruitment	['Insufficient_Enrollment']	['Neutral']
Production of biomarker test discontinued by manufacturer	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Accrual too slow	['Insufficient_Enrollment']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Internal decision	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
"This study was closed to enrollment as of 13 May 2011 due to business reasons. Premature
    closure was not prompted by any safety or efficacy concerns."	['Business_Administrative']	['Possibly_Negative']
The early report didn't show any benefit.	['Negative']	['Negative']
Lack of participant recruitment.	['Insufficient_Enrollment']	['Neutral']
Recruitment of this population in the hospital setting not practical.	['Insufficient_Enrollment']	['Neutral']
The study was terminated due to lack of clinically meaningful benefit	['Negative']	['Negative']
"Study was terminated early by the Sponsor due to unblinding between study drug and placebo
    groups at the subject, site and Sponsor levels."	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Closed early due to lack of funding	['Business_Administrative']	['Possibly_Negative']
"USC has an ICOI because the university owns the patent of the interventional dietary
    supplement."	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Due to inability to meet accrual goals within the funding period.	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
accrual too slow, insufficient patients	['Insufficient_Enrollment']	['Neutral']
Closed due to poor accrual	['Insufficient_Enrollment']	['Neutral']
Withdrawn by investigators	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Released from PMR	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Lundbeck withdrew committment - expiring patents and prolonged inactivity	['Business_Administrative']	['Possibly_Negative']
Low enrollment rate	['Insufficient_Enrollment']	['Neutral']
"Comply with competent authority requirement to halt recruitment once 50% of subjects enrolled
    to allow for interim analysis completion (to resume once complete)"	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
No longer any benefit in collecting data since retigabine has been withdrawn from market.	['Negative']	['Negative']
"Operational difficulties related to medical staff turnover (investigators departure and
    sickness leave)."	['Logistics_Resources', 'Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Investigator left University of Michigan	['Study_Staff_Moved']	['Neutral']
"No safety concerns, the study was terminated due to slow enrollment. All enrolled patients were
    followed per protocol."	['Insufficient_Enrollment']	['Neutral']
Samples were not needed for test development, therefore subjects were not recruited or enrolled	['Insufficient_Enrollment']	['Neutral']
Multi phase study did not progress to Phase II. Phase I registered as NCT00734526.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Lack of feasiability	['Safety_Sideeffects', 'Negative']	['Safety_Sideeffects', 'Negative']
Major difficulties recruiting participants	['Insufficient_Enrollment']	['Neutral']
Could not recruit patients - modifying protocol and plan resubmission to our IRB	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
I am changing locations to Johns Hopkins Medical Center	['Study_Staff_Moved']	['Neutral']
Investigator left institution	['Study_Staff_Moved']	['Neutral']
difficulty with accrual	['Insufficient_Enrollment']	['Neutral']
Enrollment not initiated	['Insufficient_Enrollment']	['Neutral']
We were not successful in raising money for this project	['Business_Administrative']	['Possibly_Negative']
Unable to build the app for the clinical trial	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
lack of accrual	['Insufficient_Enrollment']	['Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
PI cited personal reasons	['Logistics_Resources', 'Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Corona	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Reassess safety risks and benefits	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Phase I/II study halted as Phase I, Low Response Rate	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
feasibility	['Logistics_Resources']	['Neutral']
Failure to achieve one of the primary endpoints.	['Negative']	['Negative']
Enrollment not started	['Insufficient_Enrollment']	['Neutral']
A corporate decision to terminate the study	['Business_Administrative']	['Possibly_Negative']
Withdrawal of IMP from the market. Data on risk-benefit ratio pending.	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Competitive studies were conducted at the same time, and enrollment was suspended.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
NEOD001 program terminated due to lack of clinical benefit	['Negative']	['Negative']
Investigator retierment	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Principal no longer interested in conducting study	['Logistics_Resources', 'Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Sponsor decided to stop enrollment	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Upon interim analysis, sponsor's decision due to absence of demonstration of efficacy.	['Negative']	['Negative']
Drug safety concerns	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Early termination for discouraging results	['Negative']	['Negative']
company decision	['Business_Administrative']	['Possibly_Negative']
Study was not successful at recruiting particpants	['Insufficient_Enrollment']	['Neutral']
low patient accrual	['Insufficient_Enrollment']	['Neutral']
Low recruitment rate	['Insufficient_Enrollment']	['Neutral']
Noted increased risks, greater than expected for standard of care therapy.	['Interim_Analysis', 'Safety_Sideeffects', 'Endpoint_Met']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
terminated for business reasons; study closed.	['Business_Administrative']	['Possibly_Negative']
"This was an observational study. The owners of the data refused to give us the data so we could
    not proceed with the analyses."	['Logistics_Resources', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Low interest	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study is being redesigned and submitted as a new study.	['Study_Design']	['Neutral']
Sponsor terminated trial	['Business_Administrative']	['Possibly_Negative']
Study is postponed	['Invalid_Reason']	['Invalid_Reason']
Met criteria for study futility at interim analysis	['Negative']	['Negative']
terminated	['Invalid_Reason']	['Invalid_Reason']
Inadequate Patient Recruitment.	['Insufficient_Enrollment']	['Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Training protocol with no research objectives	['Study_Design']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Lack of regulatory approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
due to lack of suitable patient population	['Insufficient_Enrollment']	['Neutral']
key study staff left foundation	['Study_Staff_Moved']	['Neutral']
Ineffective Recruitment (Business Decision)	['Business_Administrative']	['Possibly_Negative']
Due to Interim Analysis and business concerns	['Business_Administrative']	['Possibly_Negative']
The study was terminated early due to business reasons	['Business_Administrative']	['Possibly_Negative']
The screening service moved to a pan-London service and the trial was not able to be continued.	['Covid19', 'Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
PI voluntary closure due to low accrual	['Insufficient_Enrollment']	['Neutral']
The Study will be conducted in another research center. The Sponsor has changed.	['Business_Administrative']	['Possibly_Negative']
PI left the institution	['Study_Staff_Moved']	['Neutral']
Reduce COVID-19 risk to research personnel until safe to resume.	['Covid19']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Funding not secured	['Business_Administrative']	['Possibly_Negative']
Inability to recruit participants	['Insufficient_Enrollment']	['Neutral']
No patients randomised	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Loss of funding	['Business_Administrative']	['Possibly_Negative']
Unable to recruit adequately	['Insufficient_Enrollment']	['Neutral']
Lack of human ressources	['Logistics_Resources']	['Neutral']
Funding limit reached due to slower then anticipated recruitment.	['Business_Administrative']	['Possibly_Negative']
Unable to recruit patients to continue on with the study.	['Insufficient_Enrollment']	['Neutral']
Withdrawn	['Invalid_Reason']	['Invalid_Reason']
Closed early due to increased hematologic toxicity and possible reduced efficacy	['Negative']	['Negative']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
study never started	['Invalid_Reason']	['Invalid_Reason']
low recruitment numbers	['Insufficient_Enrollment']	['Neutral']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Difficulty in recruiting the selected subjects	['Insufficient_Enrollment']	['Neutral']
study closed to accrual due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Terminated due to sponsor decision.	['Business_Administrative']	['Possibly_Negative']
"Higher incidence of hospitalization for congestive heart failure in pioglitazone-treated
    subjects compared to glyburide treated subjects."	['Negative']	['Negative']
Resources not available for the study	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Trial not initiated	['Invalid_Reason']	['Invalid_Reason']
The researcher Left the organization	['Study_Staff_Moved']	['Neutral']
no patient accruals	['Insufficient_Enrollment']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
At the request of the PI	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
"The study was terminated and recruitment was capped because of the new changes in hepatitis C
    market"	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Unsuccessful recruiting patients, never got beyond pilot testing of patients	['Insufficient_Enrollment']	['Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Recruitment issues	['Insufficient_Enrollment']	['Neutral']
Abandoned following local ethics review.	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Telaprevir will not be used in NL, no more inclusions are expected.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Enrollment and study activities are temporarily suspended due to COVID-19.	['Covid19']	['Neutral']
Study Design was changed - no longer prospectively assigning participants	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Sponsor decision to withdraw study at this time.	['Business_Administrative']	['Possibly_Negative']
Study was terminated due to difficulty with reaching enrollment goals	['Insufficient_Enrollment']	['Neutral']
Study was closed due to lack of personnel for recruitment/enrollment purposes.	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Study was never initiated due to company decision. No study subjects were ever enrolled or
    treated."	['Business_Administrative']	['Possibly_Negative']
Trial closed early because, during an interim analysis, the primary endpoint fell short.	['Negative']	['Negative']
"Further development of this compound with ipilimumab in the treatment of melanoma is no longer
    being pursued."	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Could not obtain funding.	['Business_Administrative']	['Possibly_Negative']
Terminated at the request of the financial sponsor.	['Business_Administrative']	['Possibly_Negative']
Funding not obtained.	['Business_Administrative']	['Possibly_Negative']
Because of COVID pandemic	['Covid19']	['Neutral']
Preliminary analysis showed not clinically significant. Study ended and closed 1/11/2018	['Negative']	['Negative']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
PI left university. Did not start study	['Study_Staff_Moved']	['Neutral']
It was determined not to be needed based on the clinical development plan of Tykerb.	['Business_Administrative']	['Possibly_Negative']
Protracted recruitment of patients	['Insufficient_Enrollment']	['Neutral']
Sponsor did not have funds to continue study	['Business_Administrative']	['Possibly_Negative']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Due to poor accrual	['Insufficient_Enrollment']	['Neutral']
Lack of participants	['Insufficient_Enrollment']	['Neutral']
Terminated due to low accrual	['Insufficient_Enrollment']	['Neutral']
The sponsors want to stop the study.	['Business_Administrative']	['Possibly_Negative']
"Medarex (supplier of BsAb) stopped study due to toxicities experienced at other sites on
    unrelated trials halting manufacturing of BsAb"	['Covid19', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Supply issues from Sponsor	['Logistics_Resources']	['Neutral']
Not enough participating centres to complete recruitment in a timely manner.	['Insufficient_Enrollment']	['Neutral']
Time and resource constraints	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
The Sponsor terminated the study.	['Business_Administrative']	['Possibly_Negative']
early termination due to poor recruitment	['Insufficient_Enrollment']	['Neutral']
Premature closure as study drug is no longer available from the manufacturer.	['Business_Administrative']	['Possibly_Negative']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
no subjects enrolled	['Insufficient_Enrollment']	['Neutral']
Study never started due to COVID-19 pandemic	['Covid19']	['Neutral']
never started	['Invalid_Reason']	['Invalid_Reason']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
"Enrollment is temporarily paused due to COVID-19 and plan to resume in the future. IRB approval
    is not suspended"	['Covid19']	['Neutral']
Budget Constraints	['Business_Administrative']	['Possibly_Negative']
Data Monitoring Committee recommendation	['Negative']	['Negative']
Sponsor Decision- Financial Considerations	['Business_Administrative']	['Possibly_Negative']
Implantation rate significantly lower in treatment group than Controls.	['Negative']	['Negative']
The study is closed early due to lck of enrollment.	['Insufficient_Enrollment']	['Neutral']
Difficulty in enrolling participants	['Insufficient_Enrollment']	['Neutral']
Target accrual not met	['Insufficient_Enrollment']	['Neutral']
financial reasons	['Business_Administrative']	['Possibly_Negative']
No participants volunteered despite two recruitment rounds.	['Insufficient_Enrollment']	['Neutral']
Due to low enrollment	['Insufficient_Enrollment']	['Neutral']
Unexpected difficulties recruiting and following patients	['Insufficient_Enrollment']	['Neutral']
Study wasn't stopped. It wasn't started. Funding.	['Business_Administrative']	['Possibly_Negative']
We change the study protocal	['Study_Design']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
PI at new institution and no further enrollment to take place.	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Investigator decided not to pursue.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Lack of eligible patient	['Insufficient_Enrollment']	['Neutral']
Seeking further funding	['Business_Administrative']	['Possibly_Negative']
Insufficient investigational product	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Completion after 2 patients then stop due to end of validity of vaccine peptide	['Negative']	['Negative']
Termination due to poor accrual.	['Insufficient_Enrollment']	['Neutral']
Project has been withdrawn from funding consideration	['Business_Administrative']	['Possibly_Negative']
This study was suspended due to additional time needed for method development.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
PI dropped the study	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"On 12/16/19, a termination request was sent to CMS to end Kentucky HEALTH by the new
    administration."	['Business_Administrative']	['Possibly_Negative']
Lack of funds	['Business_Administrative']	['Possibly_Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Terminated as marketing of this product will be discontinued	['Business_Administrative']	['Possibly_Negative']
PI leaving institution: Will not continue study.	['Study_Staff_Moved']	['Neutral']
Sponsor financial has been stopped.	['Business_Administrative']	['Possibly_Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
Higher toxicity rate than observed in studies in Rheumatoid arthritis	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
This study was stopped because of an inadequate rate of enrollment.	['Insufficient_Enrollment']	['Neutral']
Celgene withdrew the support for this study (Durvalumab cannot be provided)	['Business_Administrative']	['Possibly_Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Enrollment feasibility issues, new study in design	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
There were not enough number of patients recruited till DEC 31th in 2012.	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Department chair choose not to participate	['Study_Staff_Moved', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
FDA Hold May 2007	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Safety Issue: The trial was prematurely terminated on Dec 9, 2010, due to safety concerns,
    specifically new emerging evidence of hepatic injury."	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
The study was limited to IRB Exempt chart review; not an applicable trial.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"This study was terminated early as a result of regulatory action suspending tegaserod use in
    2007"	['Regulatory']	['Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Optimization of protocol	['Study_Design']	['Neutral']
Reassessment of strategic direction	['Business_Administrative']	['Possibly_Negative']
enrollment rate	['Insufficient_Enrollment']	['Neutral']
Audit pre regulatory inspection	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Slow Recruitment and supply of Investigational Medicinal Product Issues	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Slow recruitment of target subjects and difficulty registering subjects	['Insufficient_Enrollment']	['Neutral']
This study was halted prematurely by UNC for low accrual.	['Insufficient_Enrollment']	['Neutral']
Clovis Oncology discontinued rociletinib.	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Protocol did not continue once Investigator relocated to another institution	['Study_Staff_Moved']	['Neutral']
enrollment	['Insufficient_Enrollment']	['Neutral']
Study being rewritten	['Study_Design']	['Neutral']
Drug development stopped	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Investigator terminated study due to low enrollment of eligible subjects	['Insufficient_Enrollment']	['Neutral']
Zero accrual	['Insufficient_Enrollment']	['Neutral']
Not progressing toward scientific goals	['Logistics_Resources', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Unexpected dose production issues prevented study start up	['Logistics_Resources']	['Neutral']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
PI no longer at Institution	['Study_Staff_Moved']	['Neutral']
Sluggish enrollment	['Insufficient_Enrollment']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Temporarily closed for interim data analysis.	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
"Intermediate results have shown a significant difference in the outcome of ablation and
    non-ablation patients. Therefore, the study was stopped."	['Success', 'Logistics_Resources', 'Endpoint_Met']	['Success', 'Neutral', 'Neutral']
The study never launched due to several COVID-19 related barriers.	['Covid19']	['Neutral']
low enrollment	['Insufficient_Enrollment']	['Neutral']
"Collection of long term lead performance is being transferred to an alternate data collection
    methodology."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Insufficient funds available	['Business_Administrative']	['Possibly_Negative']
Study stopped prior to enrollment.	['Invalid_Reason']	['Invalid_Reason']
unable to reach planned recruitment	['Insufficient_Enrollment']	['Neutral']
"Study vaccinations and blood draws were halted due to adequacy of a smaller dataset and study
    feasibility issues. It was not based on any safety concerns."	['Logistics_Resources', 'Negative']	['Neutral', 'Negative']
"Enrollment period not extended and screening stopped for slow recruitment and in accordance
    with provisions of the protocol. Not linked to any safety concern"	['Insufficient_Enrollment']	['Neutral']
Safety concern in a similar trial enrolling the same patient population	['Negative', 'Another_Study']	['Negative', 'Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Technical/operational issues	['Logistics_Resources']	['Neutral']
Clinical Hold FDA	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Could not enroll enough patients and ran out of $$ to manufacture more devices	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Interim analysis showed no significant difference between study arms.	['Negative']	['Negative']
Study ws terminated because of a too low recruitment rate.	['Insufficient_Enrollment']	['Neutral']
It is difficult to recruit patients.	['Insufficient_Enrollment']	['Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Device needs modifications	['Study_Design']	['Neutral']
Principle Investigator left the institution.	['Study_Staff_Moved']	['Neutral']
We were unable to procure the supplement for this study.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Funding problems, slow recruitment, PI location change	['Business_Administrative']	['Possibly_Negative']
Difficulty recruiting.	['Insufficient_Enrollment']	['Neutral']
Study was terminated due to the death of the PI.	['Study_Staff_Moved']	['Neutral']
Temporarily paused due to COVID-19, expected to resume, IRB not suspended.	['Covid19']	['Neutral']
Due to complex study protocol, no patients have been enrolled in the study.	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
No effect of the ACE inhibitor evaluated halfway in the study	['Negative']	['Negative']
"Abbott has suspended enrollment of the SHIELD II IDE study after a report of decreased impeller
    speed at the end of a procedure."	['Covid19', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Hurricane- terminated study due to skin bank being destroyed	['Logistics_Resources']	['Neutral']
Difficulty recruiting	['Insufficient_Enrollment']	['Neutral']
Study has been put on clinical hold by FDA	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Actual sample size of 156 was sufficient to estimate the clinical outcomes.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
The investigators failed to recruit participants as originally projected.	['Insufficient_Enrollment']	['Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
Business reasons	['Business_Administrative']	['Possibly_Negative']
Research priorities and focus have shifted	['Business_Administrative']	['Possibly_Negative']
futility	['Negative']	['Negative']
We enrolled only 53 patients	['Insufficient_Enrollment']	['Neutral']
IRB approval canceled	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Recruitment was so slow, that it made the study impossible. Organizational changes made it
    impossible for recruiting centers to continue recruitment"	['Business_Administrative']	['Possibly_Negative']
investigator took study to university hospital duesseldorf	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
"After critique raised by peers there was a risk that the study could be interpreted as a
    marketing tool for a specific product more than a scientific study."	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Insufficient Accrual	['Insufficient_Enrollment']	['Neutral']
"The study is terminated prematurely as the sponsor decided to discontinue program of NHS-IL2
    [MSB0010445]"	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
For administraive reasons	['Business_Administrative']	['Possibly_Negative']
Safety concerns	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"Delayed recruitment mainly due to a screening to inclusion rate much lower than expected. Due
    to the delayed recruitment IMP reached the end of its shelf life."	['Insufficient_Enrollment']	['Neutral']
End of funding	['Business_Administrative']	['Possibly_Negative']
"Part A, the dose escalation and primary objective of the study, was completed. Part B, the dose
    expansion, was not conducted due to a business decision."	['Business_Administrative']	['Possibly_Negative']
All investigators have moved to different oranizations	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Lack of efficacy	['Negative']	['Negative']
The PI left the institution and closed the study prior to enrolling any participants	['Study_Staff_Moved']	['Neutral']
Sponsor decision to terminate the study because the study did not meet the primary endpoint.	['Negative']	['Negative']
The study was terminated due to recruitment slower than anticipated	['Insufficient_Enrollment']	['Neutral']
Trial was rewritten and will no longer focus on the link between smoking and depression.	['Study_Design']	['Neutral']
Unable to recruit sufficient number of subjects in required timeline.	['Insufficient_Enrollment']	['Neutral']
Treatment ineffective	['Negative']	['Negative']
Lack of staff	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
After over a year no subjects were identified	['Insufficient_Enrollment']	['Neutral']
interim analysis found no difference in LB rate and lower than expected event rate	['Negative']	['Negative']
Due to the enrollment was slow and exceeded the expected enrollment time	['Insufficient_Enrollment']	['Neutral']
Trial not initiated	['Invalid_Reason']	['Invalid_Reason']
Study terminated due to unacceptable pharmacokinetic (PK) profile.	['Negative']	['Negative']
Business Decision	['Business_Administrative']	['Possibly_Negative']
"After data review of enrolled pts, it was determined that initial study objectives would not be
    met w/ continuation of enrollment"	['Negative']	['Negative']
"After discussion with the Data Safety Monitoring Board and NIH, the randomized clinical trial
    involving metformin vs. placebo is terminated due to slow enrollment in the setting of the
    COVID-19 pandemic."	['Covid19']	['Neutral']
"Due to the delay in the study shceduled, due to the start of competitive study and the approval
    of Durvalumab from the Ministry of Food and Drug Safety, it was judged that it was difficult to
    enroll subjects."	['Regulatory', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
skin irritation caused by device	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Slow enrollment due to strict eligibility criteria	['Insufficient_Enrollment']	['Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
No subjects enrolled	['Insufficient_Enrollment']	['Neutral']
Lack of efficacy	['Negative']	['Negative']
Low enrollment due to difficult eligibility criteria and participant prep logistics	['Insufficient_Enrollment']	['Neutral']
The collaborator lost interest in a clinical study.	['Logistics_Resources', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
did not have resources to continue this study	['Business_Administrative']	['Possibly_Negative']
Complications encountered with biopsy in first 6 patients	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
low enrollment - data was not analyzed for this study	['Insufficient_Enrollment']	['Neutral']
PI made decision	['Invalid_Reason']	['Invalid_Reason']
"Recently published data that has shown HCQ to be safe when combined with chemo and or radiation
    at even higher doses than what is used in this study."	['Success', 'Negative', 'Another_Study']	['Success', 'Negative', 'Neutral']
Cancelled Before Enrollment	['Invalid_Reason']	['Invalid_Reason']
study not started due to lack of resources	['Logistics_Resources']	['Neutral']
Recruitment of subjects was not successful.	['Insufficient_Enrollment']	['Neutral']
Accrual goals not met	['Insufficient_Enrollment']	['Neutral']
"The study was terminated prematurely on 05May 2015 because of the unavailability of study
    devices."	['Logistics_Resources']	['Neutral']
Administrative reasons	['Business_Administrative']	['Possibly_Negative']
Change in practice patterns	['Study_Design']	['Neutral']
Poor recruit rate	['Insufficient_Enrollment']	['Neutral']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Study stopped due to business decision to not continue to gather clinical evidence on product	['Business_Administrative']	['Possibly_Negative']
recruitment difficulty	['Insufficient_Enrollment']	['Neutral']
poor overall accrual	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
"The study was prematurely terminated because of unavailibility of Methylnaltrexone in the
    region"	['Logistics_Resources']	['Neutral']
slow recruitment and poor follow up	['Insufficient_Enrollment']	['Neutral']
the support group need to have some change	['Logistics_Resources', 'Study_Staff_Moved', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
"Withdrawn due to operational issues. The study was withdrawn early, before enrolling its first
    participant."	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Study was terminated early do to a business decision by sponsor and lack of ability to recruit
    the needed number of participants."	['Business_Administrative']	['Possibly_Negative']
COVID-19 paused study temporarily due to no clinical encounters	['Covid19']	['Neutral']
Due to insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
"Due to COVID-19, we have been unable to recruit to this study given the reconfiguration and
    prioritisation of services and workforce. This has been the case since March 2020 and
    unfortunately continues to be the case. Chief investigator is aware."	['Covid19']	['Neutral']
Data Safety Monitoring Board recommendation	['Negative']	['Negative']
Poor accrual of eligible patients	['Insufficient_Enrollment']	['Neutral']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
study is ended	['Invalid_Reason']	['Invalid_Reason']
Accrual difficulties	['Insufficient_Enrollment']	['Neutral']
Lack of funding for company	['Business_Administrative']	['Possibly_Negative']
The overall profile does not support development for obesity	['Negative']	['Negative']
Due to the achievement of minimum required sample size and new changes in local regulations.	['Regulatory', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
accrual goal not met	['Insufficient_Enrollment']	['Neutral']
insufficient inclusions	['Insufficient_Enrollment']	['Neutral']
Because of reconsideration of using erlotinib(EGFR Tyrosine kinase inhibitor) as adjuvant aim	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Study terminated prematurely.	['Invalid_Reason']	['Invalid_Reason']
the princcipal investigator went abroad	['Study_Staff_Moved']	['Neutral']
Recruitment and follow-up has been completed.	['Invalid_Reason']	['Invalid_Reason']
stopped on Data Safety and Monitoring Board 's request	['Interim_Analysis', 'Safety_Sideeffects', 'Negative']	['Neutral', 'Safety_Sideeffects', 'Negative']
Limitations in timing and personnel	['Logistics_Resources']	['Neutral']
Sponsor Terminated	['Business_Administrative']	['Possibly_Negative']
Difficulties of recruitment	['Insufficient_Enrollment']	['Neutral']
Temporarily closed to accrual due to COVID-19 pandemic.	['Covid19']	['Neutral']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
sufficient volunteer recruited for the moment. Study may be re-opened at a later date	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Terminated due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
The study was terminated after the planned interim analysis.	['Negative']	['Negative']
Study suspended due to COVID-19 restrictions.	['Covid19']	['Neutral']
No accrual in initial period, PI decided to close study.	['Insufficient_Enrollment']	['Neutral']
Sufficient samples collected when 73% of target enrollment was reached.	['Invalid_Reason']	['Invalid_Reason']
Never start	['Invalid_Reason']	['Invalid_Reason']
Poor enrollment.	['Insufficient_Enrollment']	['Neutral']
Difficulty meeting patient accrual goals	['Insufficient_Enrollment']	['Neutral']
Unable to recruit patients	['Insufficient_Enrollment']	['Neutral']
Principal Investigator left institution	['Study_Staff_Moved']	['Neutral']
20131209 Regulatory authorization is currently blocked at the ANSM.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
companion study to CALGB-9781 which closed administratively due to poor accrual	['Insufficient_Enrollment']	['Neutral']
Due to lack of funding	['Business_Administrative']	['Possibly_Negative']
"CliniMACS CD34 Reagent System was FDA approved for clinical use; therefore, patients were
    treated clinically."	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Unrelated to trial	['Invalid_Reason', 'Study_Design', 'Another_Study']	['Invalid_Reason', 'Neutral', 'Neutral']
Insufficient recruitment in a reasonable time + expiration of study medication	['Insufficient_Enrollment']	['Neutral']
"Overall profile of the compound does not offer significant clinical advantage to patients over
    currently available lipid lowering agents"	['Negative']	['Negative']
PI decision	['Invalid_Reason']	['Invalid_Reason']
PI Change	['Study_Staff_Moved']	['Neutral']
sponsor stopped	['Business_Administrative']	['Possibly_Negative']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
"Issues with development and supply of infusion system for delivery of IMP. Prolonged approval
    process for the clinical study sNN0031-004."	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Difficulties in recruitment due to a change in the nature of practice.	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Enrollment and data collection insufficient to continue study.	['Insufficient_Enrollment']	['Neutral']
All data collection has completed.	['Invalid_Reason']	['Invalid_Reason']
Due to Sponsor's decision, only 12 patients were randomized & completed study.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Study was discontinued.	['Invalid_Reason']	['Invalid_Reason']
Research personal no longer available	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Insufficient accrual	['Insufficient_Enrollment']	['Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor has decided to close study.	['Business_Administrative']	['Possibly_Negative']
recruitment defect	['Insufficient_Enrollment']	['Neutral']
"The study was interrupted early and terminated when only 26 out of 80 patients were enrolled
    due to new clinical study results indicating that the current study would not be informative."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Withdrawn	['Invalid_Reason']	['Invalid_Reason']
"The DSMB recommended stopping the study because of concerns about the dismal recruitment, the
    drain on network resources, and the need for a study redesign."	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Study discontinued	['Invalid_Reason']	['Invalid_Reason']
Principle Investigator was unable to fulfill responsibilities.	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
"This protocol was terminated not for safety reasons, but because Pfizer decided to return the
    worldwide rights for Exubera to Nektar, on 18 October 2007."	['Business_Administrative']	['Possibly_Negative']
There were no patients enrolled on this study.	['Insufficient_Enrollment']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Unresolvable inability to recruit the patients.	['Insufficient_Enrollment']	['Neutral']
"Results from previous study DFA102 demonstrated neutralizing activity to metreleptin in invitro
    assay in 2 participants."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study was cancelled before enrollment for reasons not related to safety and performance.	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Business reasons	['Business_Administrative']	['Possibly_Negative']
Efficacy signals were insufficiently strong to justify recruitment of additional patients.	['Negative']	['Negative']
Poor enrolment	['Insufficient_Enrollment']	['Neutral']
Loss of funding	['Business_Administrative']	['Possibly_Negative']
The sponsor decided not to proceed with Part B for business reasons.	['Business_Administrative']	['Possibly_Negative']
PI left institution	['Study_Staff_Moved']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
"Positive FAIR-HF study data are available, this study is identical as EFFICACY-HF. Due to low
    recruitment in EFFICACY-HF the decision was made to terminate it."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Withdrawal of funding by sponsor	['Business_Administrative']	['Possibly_Negative']
Business decision	['Business_Administrative']	['Possibly_Negative']
Problems with biosensor not working properly and not functional for study	['Logistics_Resources']	['Neutral']
The resident graduated.	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Funding was not received	['Business_Administrative']	['Possibly_Negative']
"Based on the outcome of a planned interim analysis, the study was stopped early due to
    futility."	['Negative']	['Negative']
catheters no longer available - difficult to recruit subjects	['Insufficient_Enrollment']	['Neutral']
Difficultly in enrolling	['Insufficient_Enrollment']	['Neutral']
Lack of interest	['Business_Administrative']	['Possibly_Negative']
No funding	['Business_Administrative']	['Possibly_Negative']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Sponsor's consideration of product development strategies	['Business_Administrative']	['Possibly_Negative']
Lack of qualified and willing volunteers.	['Insufficient_Enrollment']	['Neutral']
Slow recruitment of participants	['Insufficient_Enrollment']	['Neutral']
Patients noncompliant with instructions and follow ups could not be completed.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Recruitment too low	['Insufficient_Enrollment']	['Neutral']
Difficulty recruiting	['Insufficient_Enrollment']	['Neutral']
Budget issue.	['Business_Administrative']	['Possibly_Negative']
Decision was made not to attempt a lower dose	['Study_Design']	['Neutral']
Temporary suspension of all study activities due to COVID-19.	['Covid19']	['Neutral']
PATH withdrew IRB approval	['Regulatory', 'Ethical_Reason', 'Negative']	['Neutral', 'Neutral', 'Negative']
Study Manager could not embark on it during the timeline.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
COVID19	['Covid19']	['Neutral']
Head of project stopped	['No_Context', 'Study_Staff_Moved', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
Due to fewer than expected children enrolled and lower than expected overall mortality rate.	['Insufficient_Enrollment']	['Neutral']
Stopped enrolling subjects due to challenge of identifying eligible participants	['Insufficient_Enrollment']	['Neutral']
Covid-19: participants is a population at risk	['Covid19']	['Neutral']
Schedule issue	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Baxter has terminated the study for inadequate enrollment rate accrual.	['Insufficient_Enrollment']	['Neutral']
Business development reasons.	['Business_Administrative']	['Possibly_Negative']
Insufficient recruits	['Insufficient_Enrollment']	['Neutral']
No further funding	['Business_Administrative']	['Possibly_Negative']
Business decision with all subjects completing at least 1 year follow-up	['Business_Administrative']	['Possibly_Negative']
Terminated	['Invalid_Reason']	['Invalid_Reason']
no participant enrollment	['Insufficient_Enrollment']	['Neutral']
company stopped production of study drug due to excessive toxicities, lack of efficacy	['Negative']	['Negative']
Loss of funding and personnel	['Business_Administrative']	['Possibly_Negative']
NuvOx Pharma suspended the clinical program related to this study.	['Business_Administrative']	['Possibly_Negative']
Due to the KoreaFDA issue	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
principal investigator decision	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Slow recruitment, high drop-out rate in both arms	['Insufficient_Enrollment']	['Neutral']
"Our Co sources were in a state of advanced decay. That prolonged our surgical procedures,
    making them inconveniently and perhaps dangerously long (> 12 hours)"	['Logistics_Resources']	['Neutral']
Trial terminated following Dutch DSMB recommendation for their Study	['Negative', 'Another_Study']	['Negative', 'Neutral']
"My post-doctoral fellow did not return from her mat leave and I have no other students to take
    on this project."	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Scan results to date did not show reason to continue with study	['Negative']	['Negative']
"Study required back-to-back physical therapy (PT) and TMS Experimental sessions; as our
    practice move to another building, away from PT"	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
company decision to terminate	['Business_Administrative']	['Possibly_Negative']
"The study sponsor requested the study be terminated as the existing study design did not meet
    their needs."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study was withdrawn from the IRB and never opened. No subjects were enrolled.	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Conflict with funding	['Business_Administrative']	['Possibly_Negative']
Terminated due to enrollment failure	['Insufficient_Enrollment']	['Neutral']
Due to technical issues relating to the Electronic diary data.	['Logistics_Resources']	['Neutral']
AstraZeneca sponsored trials of AZD8931 have been halted	['Business_Administrative']	['Possibly_Negative']
Discontinuation of the experimental treatment being tested	['Invalid_Reason']	['Invalid_Reason']
"It became unlikely to achieve the study objective of 50% reduction over published inhibitor
    rates. The Data Monitoring Committee supported this decision."	['Negative']	['Negative']
Study was stopped due to lack of resources on part of investigators.	['Logistics_Resources']	['Neutral']
poor recruitment	['Insufficient_Enrollment']	['Neutral']
Investigator considered the device with no clinical utility.	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
PI stopped study due to inability to accrue.	['Insufficient_Enrollment']	['Neutral']
"Abbott received FDA approval to transition the ongoing Brady MRI PAS study to EP a new
    EP-Passion Real World Evidence methodology"	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Study is withdrawn due to company decision.	['Business_Administrative']	['Possibly_Negative']
"EMD Serono voluntarily decided to terminate this trial after observing increased MS disease
    activity in trial 28063 ATAMS [Please refer to ATAMS]"	['Negative', 'Another_Study']	['Negative', 'Neutral']
The graduate student quit.	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Company suspended development of product.	['Business_Administrative']	['Possibly_Negative']
"the article is not a clinical trial but is a hospital based randomized comparative study. This
    was inadvertently uploaded."	['Success', 'No_Context', 'Insufficient_Data']	['Success', 'Invalid_Reason', 'Neutral']
"The study was terminated early as the results did not support study objectives and were not as
    significant as expected."	['Negative']	['Negative']
COVID-19 seriously affected the study execution as required by the protocol	['Covid19']	['Neutral']
Please see detailed description for termination reason.	['No_Context']	['Invalid_Reason']
Because of the obsolescence of the study	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Lack of support with enrollment.	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Decision from Sanofi to withdraw on a worldwide basis the Marketing Authorisation Applications
    for Semuloparin sodium in the adult indication"	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Loss of funding support	['Business_Administrative']	['Possibly_Negative']
The study was terminated due to the current COVID-19 pandemic.	['Covid19']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Refusal by the ethics committee	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Neuronavigation system equipment failure caused unreliable data	['Logistics_Resources']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Futility	['Negative']	['Negative']
"The recruitment of the study was prematurely stopped in July 2014 for the following reason; no
    more study medication."	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Terminated for futility.	['Negative']	['Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Difficulty in recruiting subjects	['Insufficient_Enrollment']	['Neutral']
slow accrual in experiment arm	['Insufficient_Enrollment']	['Neutral']
PI has left institution	['Study_Staff_Moved']	['Neutral']
Abbott funding allocated to a different project.	['Business_Administrative']	['Possibly_Negative']
Funding not acquired	['Business_Administrative']	['Possibly_Negative']
This study is currently suspended due to transition of the investigator.	['Study_Staff_Moved']	['Neutral']
Authorization denied	['Regulatory', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Dr. Holguin is relocating.	['Study_Staff_Moved']	['Neutral']
"COVID-19 pandemic impacted the BE assessment of the trial. The clinical team decided to
    terminate the trial in order to start a new pivotal BE trial"	['Covid19']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Project terminated due to revision of local regulations	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Study stopped due to low accrual.	['Insufficient_Enrollment']	['Neutral']
Due to staff shortages we are closing the study.	['Logistics_Resources']	['Neutral']
The robot was no longer available to the study.	['Logistics_Resources']	['Neutral']
Insufficient number of subjects meeting inclusion criteria	['Insufficient_Enrollment']	['Neutral']
"Data Safety Monitoring Board is in agreement with the study findings so far and the stopping
    rule has been met, which suspends the study treatment arms."	['Endpoint_Met', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"Study was prematurely stopped due to slow recruitment after 17 of 32 anticipated patients were
    recruited."	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Lack of funds	['Business_Administrative']	['Possibly_Negative']
Protocol showed to be inappropriate for the evaluation of the selected patients	['Study_Design']	['Neutral']
We did not see any effect of Palifermin on benign or malignant tumor growth	['Negative']	['Negative']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
"First subject over five years after the transplant. The second subject is not in compliance
    with follow ups. We do not plan to enroll more subjects."	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
COVID-19	['Covid19']	['Neutral']
Not enough volunteer recruited before funding could be secured.	['Business_Administrative']	['Possibly_Negative']
lack of efficacy	['Negative']	['Negative']
"Further investigations would require changes in study design; the use of different endpoints, a
    different IL-17 antibody or a different patient population."	['Study_Design']	['Neutral']
Insufficient funding	['Business_Administrative']	['Possibly_Negative']
project opened under new PI	['Study_Staff_Moved']	['Neutral']
This study was terminated due to lack of efficacy.	['Negative']	['Negative']
"The single site that was deemed appropriate for this study was unable to enroll patients.
    Closed due to slow accrual."	['Insufficient_Enrollment']	['Neutral']
due to COVID-19	['Covid19']	['Neutral']
Study halted due to Covid-19 precautions	['Covid19']	['Neutral']
Manufacturer changed device so no study will be done; ie it was never started	['Study_Design']	['Neutral']
Sponsor	['Business_Administrative']	['Possibly_Negative']
New Safety Information	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Primary Investigator passed away.	['Study_Staff_Moved']	['Neutral']
DSMB recommended termination based on interim outcomes analysis	['Negative']	['Negative']
Too much difficulties to includ patient	['Insufficient_Enrollment']	['Neutral']
No enrollment in past year, lack of interest	['Insufficient_Enrollment']	['Neutral']
Due to ethical concerns regard to the results from the WHI study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Enrollment was not feasible	['Insufficient_Enrollment']	['Neutral']
low recruitement rate	['Insufficient_Enrollment']	['Neutral']
"The study was terminated due to challenges recruiting subjects with fibrotic interstitial lung
    disease associated with a connective tissue disease for Part D"	['Insufficient_Enrollment']	['Neutral']
Study closed due to funding before accrual was met	['Business_Administrative']	['Possibly_Negative']
Rare tumor type, patients eligible via expanded access.	['Insufficient_Enrollment']	['Neutral']
Due to administrative reasons	['Business_Administrative']	['Possibly_Negative']
Study was cancelled before patient enrollment	['Invalid_Reason']	['Invalid_Reason']
Insufficient accrual rate	['Insufficient_Enrollment']	['Neutral']
Covid-19	['Covid19']	['Neutral']
Lack of resources to perform the study	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Difficulty with enrolled patients to complete trial.	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
not funded	['Business_Administrative']	['Possibly_Negative']
Too low inclusion rate and several sites did not comply	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Significant Toxicities Experienced	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
PI left U of C	['Study_Staff_Moved']	['Neutral']
The decision to terminate was completely related to efficacy and there were no safety concerns.	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
the study did not start due to a lack of staff	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
None patient was enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
injection site reaction burden	['Safety_Sideeffects', 'Logistics_Resources']	['Safety_Sideeffects', 'Neutral']
Study was never initiated and internal decision to discontinue initiation process	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
See termination reason in detailed description	['No_Context']	['Invalid_Reason']
Closed for low enrollment and the inability to complete the study.	['Insufficient_Enrollment']	['Neutral']
Inadequate resources.	['Logistics_Resources']	['Neutral']
Early termination due to insufficient enrollment.	['Insufficient_Enrollment']	['Neutral']
"The study was stopped after a pause due to COVID-19 policies and new published evidence about
    the effectiveness of the interventon."	['Covid19']	['Neutral']
Assessment of daptomycin concentrations with microdialysis technically not feasible	['Interim_Analysis', 'Logistics_Resources', 'Endpoint_Met']	['Neutral', 'Neutral', 'Neutral']
The study has been closed due to lack of accrual	['Insufficient_Enrollment']	['Neutral']
Difficulty in recruiting patients	['Insufficient_Enrollment']	['Neutral']
Funding withdrawn.	['Business_Administrative']	['Possibly_Negative']
unexpectedly slow recruitment	['Insufficient_Enrollment']	['Neutral']
"Due to the slow recruitment process and the progress of newer cell types we decided to stop the
    trial after the phase 1 (after 10 patients included)"	['Insufficient_Enrollment']	['Neutral']
Difficulty with recruitment	['Insufficient_Enrollment']	['Neutral']
"Unfortunately the recruitment process appeared to be very difficult. No participants could be
    recruited."	['Insufficient_Enrollment']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Due to lack of recruitment and loss of the French principal investigator.	['Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Safety considerations	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Study suspended due to low enrollment	['Insufficient_Enrollment']	['Neutral']
GSK received exemption from PDFDA on conduct of this post-marketing surveillance (PMS) study.	['No_Context', 'Regulatory', 'Study_Design']	['Invalid_Reason', 'Neutral', 'Neutral']
This study was terminated early due to poor recruitment	['Insufficient_Enrollment']	['Neutral']
Due to funding source and lack of accrual	['Business_Administrative']	['Possibly_Negative']
Withdrawal of pharma support prior to opening to recruitment	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Results were not promising	['Negative']	['Negative']
DSMB recommendation	['Regulatory', 'Negative']	['Neutral', 'Negative']
Terminated after 86 pt included, because of recruitment problems	['Insufficient_Enrollment']	['Neutral']
Failure of recruitment	['Insufficient_Enrollment']	['Neutral']
Pharmaceutical company no longer manufacturing investigational product.	['Logistics_Resources']	['Neutral']
"We were unable to recruit the appropriate numbers as parents did not want to randomize their
    child for the treatments options."	['Insufficient_Enrollment']	['Neutral']
Study reevaluation	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Results of interim efficacy analysis showed results were not promising.	['Negative']	['Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Terminated due to slow recruitment. 41 of 50 participants had enrolled at time of termination.	['Insufficient_Enrollment']	['Neutral']
Funding unavailable	['Business_Administrative']	['Possibly_Negative']
"No participants satisfied eligibility criteria and were enrolled into the study since July
    2008."	['Insufficient_Enrollment']	['Neutral']
"Company decision has been taken in light of recent demands by certain national health
    authorities"	['Business_Administrative']	['Possibly_Negative']
Study should not have been listed on ClinicalTrials.gov	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
not enough accrual	['Insufficient_Enrollment']	['Neutral']
Study was not initiated and has been withdrawn due to lack of appropriate cases	['Insufficient_Enrollment']	['Neutral']
Lower than expected accrual	['Insufficient_Enrollment']	['Neutral']
Withdrawal of funding	['Business_Administrative']	['Possibly_Negative']
Due to slow accrual, the investigator decided to close the study.	['Insufficient_Enrollment']	['Neutral']
No patients enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Study stopped due to low enrollment	['Insufficient_Enrollment']	['Neutral']
Loss of funding	['Business_Administrative']	['Possibly_Negative']
New data: The study was terminated based on new efficacy data from another study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Protocol's modifications requested by IRB weren't feasible to continue the study	['Study_Design']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Study stopped and data not analyzed	['Invalid_Reason']	['Invalid_Reason']
No enrollment.	['Insufficient_Enrollment']	['Neutral']
Terminated on 14 Sep 2010 due to strategic considerations	['Business_Administrative']	['Possibly_Negative']
Due to lack of clinical benefit in the 17 subjects enrolled in the trial to date	['Negative']	['Negative']
Support funding of the regional health authority stopped	['Business_Administrative']	['Possibly_Negative']
The study was stopped due to futility	['Negative']	['Negative']
Study terminated due to reproducibility issues with genomics prediction model	['Negative']	['Negative']
Results did not show reason to continue with study.	['Negative']	['Negative']
"This trial was terminated based on an interim analysis as BEZ235 did not demonstrate a
    progression free survival advantage to everolimus treatment."	['Negative']	['Negative']
Unable to recruit	['Insufficient_Enrollment']	['Neutral']
contract issues	['Business_Administrative']	['Possibly_Negative']
Difficulty recruiting subjects	['Insufficient_Enrollment']	['Neutral']
Current study design couldn't support futher development on this indication	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
COVID-19	['Covid19']	['Neutral']
"Merck has decided to discontinue all studies with extended-release niacin/laropiprant.because
    the HPS2-THRIVE did not meet its primary endpoint"	['Negative']	['Negative']
Lack of effect in initial subjects	['Negative']	['Negative']
Device sponsor no longer in business.	['Business_Administrative']	['Possibly_Negative']
Did not meet enrollment goals	['Insufficient_Enrollment']	['Neutral']
The study was discontinued due to unfavorable interim analysis	['Negative']	['Negative']
Investigator left University 04/2010	['Study_Staff_Moved']	['Neutral']
Phase II not initiated due to cancellation of supply of Poly E by collaborator.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
lack or enrollment, funding depletion	['Business_Administrative']	['Possibly_Negative']
Change in staffing and not able to do study	['Logistics_Resources']	['Neutral']
Terminated at time of CR - 3.26.2019 - JA	['No_Context', 'Regulatory', 'Endpoint_Met']	['Invalid_Reason', 'Neutral', 'Neutral']
Lack of efficacy	['Negative']	['Negative']
Trial was not started due to lack of funding and nobody received an intervention.	['Business_Administrative']	['Possibly_Negative']
Accrual factor	['Insufficient_Enrollment']	['Neutral']
The fellow conducting the recruitment and screening left the institution	['Study_Staff_Moved']	['Neutral']
No eligible candidates in 2 years of recruiting	['Insufficient_Enrollment']	['Neutral']
"The study was suspended due to the COVID-19 pandemic. The study was then terminated to prevent
    inconsistencies in baseline anxiety for patients enrolled before vs after the COVID-19
    pandemic."	['Covid19']	['Neutral']
"Principle Investigator is moving to another institution and plans to restart this proctocol in
    the new location."	['Study_Staff_Moved']	['Neutral']
science has moved forward and there is no intent to complete the study	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Subjects not interested	['Insufficient_Enrollment']	['Neutral']
No more potentiel patients for study	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Lack of personnel to complete trial	['Logistics_Resources']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Study already undertaken at another centre	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"Low enrollment & superior treatments available for diabetic macular edema including anti-VEFG
    therapies such as bevacizumab and ranibizumab."	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Withdrawal of funding	['Business_Administrative']	['Possibly_Negative']
Covid-pandemic	['Covid19']	['Neutral']
"Patients are not compliant to the daily logbook exercises before surgery. Most will only
    perform once during training or maximum twice."	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Study terminated early due to ligistic reasons with study staff	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Study was terminated due to inadequate enrolment	['Insufficient_Enrollment']	['Neutral']
Enrollment never initiated, study withdrawn.	['Insufficient_Enrollment']	['Neutral']
Extreme toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Slow and poor recruitment.	['Insufficient_Enrollment']	['Neutral']
EC withdrawal with termination of the NB contract	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
Due to poor patient recruitment and insufficient financing.	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Terms could not be met with the FDA.	['Regulatory', 'Ethical_Reason', 'Negative']	['Neutral', 'Neutral', 'Negative']
Abbott Molecular stopped funding of study	['Business_Administrative']	['Possibly_Negative']
Insufficient funds	['Business_Administrative']	['Possibly_Negative']
Due to potential concerns about liver safety (See Detailed Description)	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Lack of interest with investigators - no subjects enrolled	['Insufficient_Enrollment']	['Neutral']
Trial suspended due to drug product manufacturer not GMP compliant	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Sponsor's decision to terminate the study	['Business_Administrative']	['Possibly_Negative']
NHLBI has suggested the company focus on the other two ongoing trials	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
no funding	['Business_Administrative']	['Possibly_Negative']
Withdrawn per sponsor and Investigator	['Business_Administrative']	['Possibly_Negative']
patient recruitment is difficult	['Insufficient_Enrollment']	['Neutral']
No funding secured.	['Business_Administrative']	['Possibly_Negative']
We need somebody to replace the principal inestigator.	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
Study stopped due to the outbreak of the covid-19 pandemic.	['Covid19']	['Neutral']
no participant enrolled	['Insufficient_Enrollment']	['Neutral']
"The PI of this study is leaving the institution and enrollment was progressing slowly so we
    decided to close the study."	['Study_Staff_Moved']	['Neutral']
interim assessment by sponsor	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
The PI decided to stop.	['Invalid_Reason']	['Invalid_Reason']
Sponsor decision based on portfolio prioritization	['Business_Administrative']	['Possibly_Negative']
Sage Therapeutics has decided not to proceed with this study at this time	['Business_Administrative']	['Possibly_Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Due to low recruitment rate the sponsor decided to discontinue the study.	['Insufficient_Enrollment']	['Neutral']
Due to the high rate of morbidity and mortality	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
This study was discontinued prematurely due to difficulty in participant recruitment.	['Insufficient_Enrollment']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Suspended [COVID-19 outbreak and to promote social distancing]	['Covid19']	['Neutral']
Business Decision	['Business_Administrative']	['Possibly_Negative']
no value in finding efficacy	['Negative']	['Negative']
Dr. Rahma decided to run the study through a different group	['Study_Staff_Moved', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Portfolio consolidation.	['Business_Administrative']	['Possibly_Negative']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Principal Investigator retiring	['Study_Staff_Moved']	['Neutral']
Requested by PI during yearly Continuing Review	['Interim_Analysis', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Unable to generate MD's and patients for this study	['Insufficient_Enrollment']	['Neutral']
Investigators decided not to begin the study.	['Invalid_Reason']	['Invalid_Reason']
PI moved. Unable to recruit	['Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Limited staff and operating resources	['Logistics_Resources']	['Neutral']
This study was closed early due to poor accrual	['Insufficient_Enrollment']	['Neutral']
"Emerging GSK1322322 pre-clinical data ID'd potentially reactive metabolites previously not seen
    that changed the risk: benefit profile and led to a termination"	['Success', 'Endpoint_Met', 'Negative']	['Success', 'Neutral', 'Negative']
change of technique	['Study_Design']	['Neutral']
Treatment Ineffective	['Negative']	['Negative']
Investigators chose to discontinue the study based on interim findings	['Negative']	['Negative']
Preliminary findings did not support purpose.	['Negative']	['Negative']
No patients registered; study terminated.	['Insufficient_Enrollment']	['Neutral']
Business decision	['Business_Administrative']	['Possibly_Negative']
the research data is not statistically significant	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
There was a change in the Sponsor's research strategy; safety concerns were not a factor.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
difficulty in the recruitment of patients	['Insufficient_Enrollment']	['Neutral']
Feasibility and Recruitment problems	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
"An independent assessment concluded the trial was not likely to meet the primary endpoint upon
    completion and therefore, trial stopped for futility."	['Negative']	['Negative']
Sponsor withdrew support after no patients enrolled	['Business_Administrative']	['Possibly_Negative']
Trial was terminated due to low recruitment rate	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Stopped by the sponsor due to discrepancies in the recruitment process.	['Insufficient_Enrollment']	['Neutral']
No accrual	['Insufficient_Enrollment']	['Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
New trial with same indication initiated	['Negative', 'Another_Study']	['Negative', 'Neutral']
Failed to recruit sufficient numbers of patients in the funded period	['Insufficient_Enrollment']	['Neutral']
Regulatory requirement. A phase III study is being designed.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
study do not start due to concurrential trial	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
"Trial temporarily halted to conduct additional device testing to verify cooling data. This
    temporary halt is NOT due to a potential risk to subject safety."	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Funding Ended	['Business_Administrative']	['Possibly_Negative']
Low accrual rate not allowing planned sample size leads to a futility condition	['Insufficient_Enrollment']	['Neutral']
difficulty in recruiting	['Insufficient_Enrollment']	['Neutral']
The overall profile does not support development for obesity	['Negative']	['Negative']
Enrolling participants has halted due to lack of investigator.	['Insufficient_Enrollment']	['Neutral']
Low enrollment and follow-up data on enrolled patients.	['Insufficient_Enrollment']	['Neutral']
Replaced by another study.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Principal Investigator left institution.	['Study_Staff_Moved']	['Neutral']
Inadequate funding	['Business_Administrative']	['Possibly_Negative']
Withdrawn because study never enrolled patients	['Insufficient_Enrollment']	['Neutral']
Study/financial issues	['Business_Administrative']	['Possibly_Negative']
limited resources	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsor chose to close	['Business_Administrative']	['Possibly_Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
"According to new guidelines, the use of vasopressors to force the MAP during CPB at values
    higher than 80 mmHg is not recommended."	['Safety_Sideeffects', 'Endpoint_Met', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Inacceptable oxygen saturation values in one study group	['Negative']	['Negative']
Study ended because recruitment goals unmet and further funding unlikely	['Business_Administrative']	['Possibly_Negative']
Unable to recruit participants.	['Insufficient_Enrollment']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Significant difference at interim analysis	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
no collaboration	['Business_Administrative']	['Possibly_Negative']
The study was terminated early based on the results of the planned interim analysis.	['Negative']	['Negative']
Current study design couldn't support futher development on this indication.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Difficulties arouse in recruiting new patients	['Insufficient_Enrollment']	['Neutral']
Study has been terminated due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
"This study was terminated early as a result of regulatory action suspending tegaserod use in
    2007"	['Regulatory']	['Neutral']
The bowel was not clean when the colonoscopy was performed	['Covid19', 'Interim_Analysis', 'Safety_Sideeffects']	['Neutral', 'Neutral', 'Safety_Sideeffects']
SNUH-NM-333 ligand effect was judged to be insufficient.	['Negative']	['Negative']
"The DSMB concluded that the findings regarding the primary analysis would persist and that no
    additional study goals would be achieved by continuing the study."	['Negative']	['Negative']
Study has been withdrawn.	['Invalid_Reason']	['Invalid_Reason']
Unanticipated staff changes are preventing completion within funding period.	['Business_Administrative']	['Possibly_Negative']
"The study was terminated early as it did not meet the Primary efficacy objective after primary
    analysis."	['Negative']	['Negative']
"1. Most patients with liver cirrhosis already use PPI and NSBB 2. 90 % Peptic ulcer size is
    smaller than 5cm"	['Safety_Sideeffects', 'Logistics_Resources', 'Endpoint_Met']	['Safety_Sideeffects', 'Neutral', 'Neutral']
"Assessment of data shows inadequate brain uptake, suggesting the tracer is inadequate as an
    imaging biomarker of brain amyloid."	['Interim_Analysis', 'Logistics_Resources', 'Negative']	['Neutral', 'Neutral', 'Negative']
Slow recruitment pace	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Enrollment too slow	['Insufficient_Enrollment']	['Neutral']
Study enrollment was halted due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
Study never initiated.	['Invalid_Reason']	['Invalid_Reason']
lack of patients	['Insufficient_Enrollment']	['Neutral']
Closed early for futility.	['Negative']	['Negative']
Amgen made a business decision not to proceed with Phase 2.	['Business_Administrative']	['Possibly_Negative']
Poor patient enrollment due to logistical issues	['Insufficient_Enrollment']	['Neutral']
safety issues	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
terminated due to PI lab/duties affected by natural disaster.	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
Lack of subject enrollment and the eczema season has completed	['Insufficient_Enrollment']	['Neutral']
PI left the institution	['Study_Staff_Moved']	['Neutral']
Terminated at 50% enrollment due to recent concerns about rosiglitazone	['Negative', 'Another_Study']	['Negative', 'Neutral']
Aim to assess feasibility achieved, larger project starting earlier than anticipated	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
"After analysis of the existing data, it was determined that additional skin biopsy samples
    would not be required to determine study outcome."	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Lack of Response	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Invalid_Reason']	['Safety_Sideeffects', 'Neutral', 'Invalid_Reason']
number of enrollments not reached in the estimated time	['Insufficient_Enrollment']	['Neutral']
Did not recruit	['Invalid_Reason']	['Invalid_Reason']
sufficient data was collected	['Invalid_Reason']	['Invalid_Reason']
Adequate statistical power at 92 dosed pts to meet study objectives.	['Negative']	['Negative']
No patients enrolled for 6 months.	['Insufficient_Enrollment']	['Neutral']
DSMB recommendation following interim analysis	['Negative']	['Negative']
Sponsor withdrew support	['Business_Administrative']	['Possibly_Negative']
Enrollment closed 10/15/2008 based on data about KRAS.	['No_Context', 'Safety_Sideeffects', 'Logistics_Resources']	['Invalid_Reason', 'Safety_Sideeffects', 'Neutral']
"Ethics approval is expected from the pharmaceutical institution for the study which has
    received the local ethics committee approval."	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
Investigator Decision	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Funding support withdrawn (much slower than expected enrollment)	['Business_Administrative']	['Possibly_Negative']
no funding	['Business_Administrative']	['Possibly_Negative']
The study stopped because the the project was abandoned.	['Invalid_Reason']	['Invalid_Reason']
Study did not enroll any subjects.	['Insufficient_Enrollment']	['Neutral']
Unable to recruit patient due to surgical case type. Not worth continuing study.	['Insufficient_Enrollment']	['Neutral']
The company that provided the intervention shut down & withdrew the intervention	['Business_Administrative']	['Possibly_Negative']
New data was published in the literature	['Success', 'No_Context', 'Logistics_Resources']	['Success', 'Invalid_Reason', 'Neutral']
Not enough could be recruted	['Insufficient_Enrollment']	['Neutral']
The study was terminated prior to enrollment	['Invalid_Reason']	['Invalid_Reason']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
Decision to discontinue patient follow-up at 2 years.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Slow recruitment pace	['Insufficient_Enrollment']	['Neutral']
Sponsor withdrew financial support	['Business_Administrative']	['Possibly_Negative']
"Clinical study in Graves' ophthalmopathy terminated until there is a better understanding of an
    efficacious dose with Otelixizumab from other clinical studies."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Business decision to end study due to limited enrollment and study population	['Business_Administrative']	['Possibly_Negative']
The maximum of inclusions was reached	['Invalid_Reason']	['Invalid_Reason']
Business Decision	['Business_Administrative']	['Possibly_Negative']
excessive protocol deviations due to strict nature of diet requirements	['Study_Design']	['Neutral']
Unable to recruit sufficient participants due to lack of funding; PI has left the institution.	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Delivery of equipment. PI not had any further interaction with the company so closed study.	['Logistics_Resources', 'Study_Staff_Moved', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Not able to recruit the estimated number of patients	['Insufficient_Enrollment']	['Neutral']
"IDMC decision - recommended on basis of results from other relevant clinical trials, there were
    not safety concerns"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Not enough recruitment Lack of funding CR	['Business_Administrative']	['Possibly_Negative']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
No subjects enrolled, bio equivalence study, canceled before active.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Due to COVID-19	['Covid19']	['Neutral']
This study has been transfered from a sponsored trial to an investigator initiated trial.	['Negative', 'Another_Study']	['Negative', 'Neutral']
"The study was a post-marketing commitment requested by the PEI and is no longer required as the
    Optivate German license will be allowed to expire in Sep-2017."	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Suspended due to Primary Investigator's decision	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Poor participant compliance	['Study_Design']	['Neutral']
funding issues	['Business_Administrative']	['Possibly_Negative']
IRB request	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Nonapplicable clinical trial	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"This study was stopped due to an internal reconsideration of priorities of the product
    portfolio."	['Business_Administrative']	['Possibly_Negative']
Lack of Funding	['Business_Administrative']	['Possibly_Negative']
Study objective and design change	['Study_Design']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Unable to recruit sufficient numbers of patinets in the time available	['Insufficient_Enrollment']	['Neutral']
Stopped after safety analysis because of significant benefit of intervention.	['Success', 'No_Context', 'Safety_Sideeffects']	['Success', 'Invalid_Reason', 'Safety_Sideeffects']
PI left institution.	['Study_Staff_Moved']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Low accrual.	['Insufficient_Enrollment']	['Neutral']
Business decision	['Business_Administrative']	['Possibly_Negative']
The study was withdrawn due to a change in company strategy.	['Business_Administrative']	['Possibly_Negative']
no candidats	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
national study, local site not responsible for any analysis/results/etc	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Non applicable clinical trial	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Closed by Sponsor	['Business_Administrative']	['Possibly_Negative']
low recruitment	['Insufficient_Enrollment']	['Neutral']
"We had many issues related to recruitment. After many attempts we want to suspend the study
    with 13 patients."	['Insufficient_Enrollment']	['Neutral']
"Given enrollment challenges, partly attributable to the constantly changing COVID-19 treatment
    landscape, the trial has been suspended."	['Covid19']	['Neutral']
principle investigator decision due to many adverse events in patients	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
low recruitment	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Integral investigator left study; could not continue recruiting.	['Study_Staff_Moved']	['Neutral']
COVID-19	['Covid19']	['Neutral']
"the interim results suggest that it is unlikely that the primary objective will be achieved at
    the final analysis"	['Negative']	['Negative']
Study stopped due to low accrual	['Insufficient_Enrollment']	['Neutral']
low recruitment rate	['Insufficient_Enrollment']	['Neutral']
Technology licensed to third party. Sponsor did not proceed with study.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
PI's request	['Study_Staff_Moved', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Due to unforeseen delays and funding issues	['Business_Administrative']	['Possibly_Negative']
Due to restrictions related to patient care secondary to covid pandemic.	['Covid19']	['Neutral']
Recruitment too slow; study completion not possible within frame	['Insufficient_Enrollment']	['Neutral']
Funding ended.	['Business_Administrative']	['Possibly_Negative']
Low accrual.	['Insufficient_Enrollment']	['Neutral']
PI changed institutions	['Study_Staff_Moved']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Practical issues	['Logistics_Resources']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Due to frequent turnover of research coordinators and thus poor study accrual.	['Insufficient_Enrollment']	['Neutral']
Poor accural	['Insufficient_Enrollment']	['Neutral']
Interim analysis showed no difference in outcome between treatment groups.	['Negative']	['Negative']
Please see Detailed Description for the termination reason.	['No_Context']	['Invalid_Reason']
funding	['Business_Administrative']	['Possibly_Negative']
Additional data may be required once preliminary data is analyzed.	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
The suppliers were unable to provide the investigational medicinal product (IMP)	['Logistics_Resources']	['Neutral']
study was withdrawn before any participants were recruited and enrolled	['Invalid_Reason']	['Invalid_Reason']
This sub-study was not done because main study results reached significance.	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
It is no longer practicable to complete the trial	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Insufficient study personnel	['Logistics_Resources']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
terminated	['Invalid_Reason']	['Invalid_Reason']
Study terminated early due to low accrual.	['Insufficient_Enrollment']	['Neutral']
Not enough inclusion	['Insufficient_Enrollment']	['Neutral']
"Study halted due to low recruitment. The 3 participants at time of termination transferred into
    study P04538 (NCT00727077). See NCT00727077 for details/results."	['Insufficient_Enrollment']	['Neutral']
Absence of BReg Lymphocytes in peritoneum	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
No individuals met eligibility or were enrolled.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Continued recruitment of study participants was not feasible	['Insufficient_Enrollment']	['Neutral']
"Sponsor closed study due to low enrollment

    Sponsor closed study due to low enrollment

    Sponsor closed study due to low enrollment."	['Insufficient_Enrollment']	['Neutral']
difficulty enrollment, no patients received treatment	['Insufficient_Enrollment']	['Neutral']
Business decision; No Safety or Efficacy Concerns	['Business_Administrative']	['Possibly_Negative']
Company discontinued further development of study drug for this indication	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Protocol stopping criteria (safety) were met.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Research cancelled following interim analysis	['Negative']	['Negative']
sponsor decision	['Business_Administrative']	['Possibly_Negative']
"An interim analysis demonstrated no benefit of high dose vitamin D when compared to standard
    dose vitamin D in the reduction or prevention of arthralgia"	['Negative']	['Negative']
Funding	['Business_Administrative']	['Possibly_Negative']
Lack of Enrollment	['Insufficient_Enrollment']	['Neutral']
funding not available	['Business_Administrative']	['Possibly_Negative']
Interim power analysis was prohibitive to continuing the study	['Interim_Analysis', 'Logistics_Resources', 'Negative']	['Neutral', 'Neutral', 'Negative']
Terminated due to lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Recruitment rates reduced during non-Strep season	['Insufficient_Enrollment']	['Neutral']
Funding exhausted	['Business_Administrative']	['Possibly_Negative']
"Recent studies suggest that cyclosporine A has a very sharp biphasic dose-response problem that
    is going to make further clinical translation difficult."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Company withdrew funding/sponsorship	['Business_Administrative']	['Possibly_Negative']
"Problem with obtaining microarrays, which are essential components needed to conduct this
    study."	['Logistics_Resources']	['Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
Completed stage I without pursuing stage II	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
Principal Investigator left institution	['Study_Staff_Moved']	['Neutral']
Superiority of iv omeprazole to ranitidine has already been proven by others.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Strategic considerations	['Business_Administrative']	['Possibly_Negative']
Slow Enrollment	['Insufficient_Enrollment']	['Neutral']
COVID-19	['Covid19']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Low Accrual.	['Insufficient_Enrollment']	['Neutral']
Planned interim analysis showed study was underpowered	['Negative']	['Negative']
Project not funded - withdrawn by VA	['Business_Administrative']	['Possibly_Negative']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
The study data to date show the required primary study endpoint will not be met.	['Negative']	['Negative']
Inadequate resources to start the study at this site.	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Completion of follow-up period	['Invalid_Reason']	['Invalid_Reason']
Study not IRB approved.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Business decision related to efficacy rather than tolerability limitations, not stopped for any
    safety reasons."	['Business_Administrative']	['Possibly_Negative']
Co-Investigators left the Institution.	['Study_Staff_Moved']	['Neutral']
Discontinued	['Invalid_Reason']	['Invalid_Reason']
Development of dovitinib was stopped.	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
This trial discontinued on 2 May 2008 due to lack of enrolment	['Insufficient_Enrollment']	['Neutral']
Not able to recruit qualified patents	['Insufficient_Enrollment']	['Neutral']
LEEP-COVID study (NCT04350073) initiation enables inclusion of COVID-positive subjects	['Covid19']	['Neutral']
This study was withdrawn due to low accrual.	['Insufficient_Enrollment']	['Neutral']
unable to secure funding	['Business_Administrative']	['Possibly_Negative']
Protocol Modification is pending	['Study_Design']	['Neutral']
EEG data collection instrument unavailable	['Logistics_Resources']	['Neutral']
Centers recruited poorly	['Insufficient_Enrollment']	['Neutral']
Due to lower than anticipated enrollment	['Insufficient_Enrollment']	['Neutral']
Inclusion curve too slow.	['Insufficient_Enrollment']	['Neutral']
Administrative decision	['Business_Administrative']	['Possibly_Negative']
Protocol is withdrawn due to inadequate accrual	['Insufficient_Enrollment']	['Neutral']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Lower than expected enrollment	['Insufficient_Enrollment']	['Neutral']
unable to recruit	['Insufficient_Enrollment']	['Neutral']
no accrual	['Insufficient_Enrollment']	['Neutral']
No fund no enough recruiting centers	['Business_Administrative']	['Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Tightly defined inclusion criteria were making recruitment very slow.	['Insufficient_Enrollment']	['Neutral']
"Phase 2 part of the trial will no longer continue since the protocol competes with another
    TPI287 protocol in outside institution supported by the sponsor."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Unable to enroll patients into study.	['Insufficient_Enrollment']	['Neutral']
Per NIH request	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Closed early due to poor accrual.	['Insufficient_Enrollment']	['Neutral']
Primary investigator left the institution.	['Study_Staff_Moved']	['Neutral']
insufficient staff	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Principal Investigator decided to withdraw.	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
After 3 years of recruitment, the study was stopped due to time constraints.	['Business_Administrative']	['Possibly_Negative']
criteria for continuing enrollment in Phase 2 portion was not met	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
"The study was terminated early by the sponsor due to the discontinuation of clinical
    development for rufinamide."	['Business_Administrative']	['Possibly_Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Insufficient equipment	['Logistics_Resources']	['Neutral']
After inclusion of four patients, two experienced moderate worsening of symptoms	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
"Independent steering committee has stopped the trial based on results of a prespecified,
    blinded interim analysis. It was not stopped due to safety concerns."	['Negative']	['Negative']
Lack of efficacy	['Negative']	['Negative']
COVID-19	['Covid19']	['Neutral']
zero accrual	['Insufficient_Enrollment']	['Neutral']
Business Decision	['Business_Administrative']	['Possibly_Negative']
"Terminated because primary efficacy parameter failed to demonstrate statistically significant
    difference between memantine and placebo in controlled trials"	['Negative']	['Negative']
Study Site Ceased all Business Operations	['Business_Administrative']	['Possibly_Negative']
"Lack of product due to industrial changes in the manufacturing process altering the final
    product."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Safety issues	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
due to difficulties recruiting patients and therefore too slow progress	['Insufficient_Enrollment']	['Neutral']
Unable to collect data due to COVID19	['Covid19']	['Neutral']
lack of accrual	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
not progressing as anticipated	['Invalid_Reason']	['Invalid_Reason']
never started	['Invalid_Reason']	['Invalid_Reason']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Due to cancellation of elective surgery (Covid-19)	['Covid19']	['Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Business objectives have changed	['Business_Administrative']	['Possibly_Negative']
"The patient population in RACU has changed significantly, we can not find potential subjects to
    recruit. The enrollment rate has reached zero."	['Insufficient_Enrollment']	['Neutral']
This trial was terminated due to low recruitment	['Insufficient_Enrollment']	['Neutral']
Due to adverse events	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
We were unable to recruit sufficient numbers of participants to complete the study.	['Insufficient_Enrollment']	['Neutral']
Change of MRI mode	['Study_Design']	['Neutral']
Study Investigator has suddenly died, study has no results.	['Negative']	['Negative']
Study is not funded	['Business_Administrative']	['Possibly_Negative']
Study closed due to lack of enrollment; challenging patient population.	['Insufficient_Enrollment']	['Neutral']
insufficient number of patient charts to support hypothesis	['No_Context', 'Logistics_Resources', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
Start of a new study concerning the same patients	['Negative', 'Another_Study']	['Negative', 'Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Terminated	['Invalid_Reason']	['Invalid_Reason']
Business reasons	['Business_Administrative']	['Possibly_Negative']
No recruitment.	['Insufficient_Enrollment']	['Neutral']
"Company's desire to allocate more research and development resources to other clinical
    programs. Decision not driven by any safety concerns."	['Business_Administrative']	['Possibly_Negative']
The Hospital had the Unit of Stem cells Tranplantion suspended	['Logistics_Resources']	['Neutral']
Investigators opted to change the design of the study.	['Study_Design']	['Neutral']
PI left institute	['Study_Staff_Moved']	['Neutral']
Not enough enrollees to obtain a valid conclusion	['Insufficient_Enrollment']	['Neutral']
Company stopped selling BVS	['Business_Administrative']	['Possibly_Negative']
"An interim analysis revealed a significantly higher persistence/recurrence of complications of
    portal hypertension in the 8 mm-stent group."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
GangTrainer GT1 is not state of the art anymore for the principal Invesigator	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
"After enrolling 3 participants the safety and efficacy of the planned treatment is
    questionable, thus we decided to terminate the study."	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
decided not to go ahead with study	['Invalid_Reason']	['Invalid_Reason']
slow accrual	['Insufficient_Enrollment']	['Neutral']
No IND submitted to the FDA	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study initiation has been delayed due to Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Enrollment too slow given study timeline	['Insufficient_Enrollment']	['Neutral']
"Patients did not consent to randomization in any study center, since they preferred endoscopic
    surgery. The recruitment of patients was impossible."	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Due to lack of funding, phase II of study was not completed.	['Business_Administrative']	['Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
collected data showed significant difference in two groups.	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Difficulty in recruiting suitable patients at centre	['Insufficient_Enrollment']	['Neutral']
"The site did not have enough funds to complete study arrengments and start to enrolling. The
    site was not able to enroll subjects."	['Business_Administrative']	['Possibly_Negative']
3Dtransvaginal probe is not available at this time	['Logistics_Resources']	['Neutral']
"Difficulty recruiting; Funding ended; interim analysis provided sufficient data for
    interpretation."	['Business_Administrative']	['Possibly_Negative']
Re-definition of MIRA technology goals.	['Study_Design']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Failed to meet target enrollment	['Insufficient_Enrollment']	['Neutral']
safety issue	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Not enough patients meeting criteria to enroll in the time period	['Insufficient_Enrollment']	['Neutral']
per Data Monitoring Committee recommendation	['Negative']	['Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
"The treatment landscape for NSCLC has evolved in the past year. An additional NSCLC arm will be
    added to the IOV-COM-202 study using TIL + pembrolizumab."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Another regulatory way was defined.	['Study_Design']	['Neutral']
Terminated by DSMB; futility analysis showing Mg treatment not efficacious	['Negative']	['Negative']
extremely slow enrollment	['Insufficient_Enrollment']	['Neutral']
difficulties of recruitment	['Insufficient_Enrollment']	['Neutral']
Not active	['Invalid_Reason']	['Invalid_Reason']
COVID-19	['Covid19']	['Neutral']
Recruitment goal not met	['Insufficient_Enrollment']	['Neutral']
"Few patients, time consuming to find suiting blood bags with the ""right"" weight."	['Logistics_Resources']	['Neutral']
Investigator's decision:Did not open to enrollment	['Invalid_Reason']	['Invalid_Reason']
PI LEFT THE DEPARTMENT	['Study_Staff_Moved']	['Neutral']
Modifying the clinnicaltrials	['Study_Design']	['Neutral']
The study was terminated early due to slow recruitment.	['Insufficient_Enrollment']	['Neutral']
Sponsor review of initial results demonstrates a non-favourable risk benefit	['Negative']	['Negative']
Beacuse of unexpected administrative barriers, only 5 cases were enrolled in a year.	['Business_Administrative']	['Possibly_Negative']
No additional enrollment	['Insufficient_Enrollment']	['Neutral']
No recruitment	['Insufficient_Enrollment']	['Neutral']
Departure of PI	['Study_Staff_Moved']	['Neutral']
Due to drug unavailability	['Logistics_Resources']	['Neutral']
"Study terminated by sponsor (29 Sep 2010). Subjects eligible to continue mepolizumab treatment
    were transferred into the compassionate use program (MHE104317)"	['Regulatory', 'Insufficient_Enrollment', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Common comorbidities of Veterans precluded sufficient recruitment and enrollment.	['Insufficient_Enrollment']	['Neutral']
Sponsor decision to not initiate part 2 due to slow enrollment and competing trials.	['Insufficient_Enrollment']	['Neutral']
Study is temporarily paused because of COVID-19	['Covid19']	['Neutral']
COVID-19 lockdown and halt of clinical trials	['Covid19']	['Neutral']
The study did not receive funding.	['Business_Administrative']	['Possibly_Negative']
Due to Poor accrual	['Insufficient_Enrollment']	['Neutral']
Administrative reason	['Business_Administrative']	['Possibly_Negative']
Problem to recruit sufficient patient number	['Insufficient_Enrollment']	['Neutral']
all participants finished the trial	['Invalid_Reason']	['Invalid_Reason']
covid-19 lock down	['Covid19']	['Neutral']
inability to meet enrollment goals in this subject population	['Insufficient_Enrollment']	['Neutral']
Difficulties of recruitement	['Insufficient_Enrollment']	['Neutral']
toxicities	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
We are now considering revision of the IND to determine maximum tolerated dose	['Study_Design']	['Neutral']
The study was not providing useful information.	['Logistics_Resources', 'Insufficient_Data', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Re-assessment of study	['Study_Design']	['Neutral']
This study was completed.	['Invalid_Reason']	['Invalid_Reason']
Difficult to recruit eligible subjects	['Insufficient_Enrollment']	['Neutral']
Ethics approval denied	['Interim_Analysis', 'Success', 'Logistics_Resources']	['Neutral', 'Success', 'Neutral']
Lack of efficacy	['Negative']	['Negative']
"The collaborating pharmaceutical company will not wish to continue with the trial due to the
    internal issues in the company."	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Never Started	['Invalid_Reason']	['Invalid_Reason']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
eIRB withdrew study for concerns	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
The PI retired	['Study_Staff_Moved']	['Neutral']
"An interim analysis revealed the study was unlikely to attain a positive outcome for the
    efficacy analysis. No safety concerns were detected."	['Negative']	['Negative']
NOT A CLINICAL TRIAL	['Invalid_Reason']	['Invalid_Reason']
Patient recruitment was not sufficient to achieve the needed patient numbers.	['Insufficient_Enrollment']	['Neutral']
Due to low accrual	['Insufficient_Enrollment']	['Neutral']
no enrollment	['Insufficient_Enrollment']	['Neutral']
no participant enrolled	['Insufficient_Enrollment']	['Neutral']
Inability to recruit adequate number of participants	['Insufficient_Enrollment']	['Neutral']
study progress and recruitment rate too low	['Insufficient_Enrollment']	['Neutral']
we didnt recieved the medicine	['Logistics_Resources']	['Neutral']
Lack of funding for the company has resulted in termination of the study.	['Business_Administrative']	['Possibly_Negative']
Stopped by sponsor. No interest in continuing trial due to business changes.	['Business_Administrative']	['Possibly_Negative']
Slow enrollment [HIGH SCREEN FAILURE RATE]	['Insufficient_Enrollment']	['Neutral']
Diakron Pharmaceuticals couldn't fulfill the financial responsibility of the study	['Business_Administrative']	['Possibly_Negative']
The study treminated early according to DSMB recommendantions	['Negative']	['Negative']
Interim futility analyses identified a lack of SYNB1020 efficacy.	['Negative']	['Negative']
Publication of a similar study. Not ethical to continue.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Interim analysis shows results opposite of hypothesized.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Few biopsies showed the expected pattern We suspect erroeneous method.	['Negative']	['Negative']
due to inability to recruit sufficient sample size in reasonable time frame.	['Insufficient_Enrollment']	['Neutral']
"Due to results of conditional power analysis performed at the first interim analysis and due to
    observed spectrum of adverse events."	['Negative']	['Negative']
change of funding leading to major redesign	['Business_Administrative']	['Possibly_Negative']
Not able to recruit	['Insufficient_Enrollment']	['Neutral']
Company decision to discontinue trial	['Business_Administrative']	['Possibly_Negative']
"Due to portfolio and logistical issues, this study will not be re-started at the present time.
    The study is not being terminated for safety reasons."	['Business_Administrative']	['Possibly_Negative']
Unfavorable opinion of IRB/IEC	['Regulatory', 'Ethical_Reason', 'Negative']	['Neutral', 'Neutral', 'Negative']
Study protocol under revision.	['Study_Design']	['Neutral']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
COVID delay and subsequent unavailability of staff.	['Covid19', 'Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
PI is leaving the institution	['Study_Staff_Moved']	['Neutral']
Accrual not met	['Insufficient_Enrollment']	['Neutral']
toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Participant enrollment was much more challenging than anticipated.	['Insufficient_Enrollment']	['Neutral']
Local PI did not submit annual renewal, still active in Detroit, not recruiting.	['Study_Staff_Moved']	['Neutral']
insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
No accrual	['Insufficient_Enrollment']	['Neutral']
The requiered sample were not recruited due to COVID-19 pandemic	['Covid19']	['Neutral']
Study discontinued. Superseded by NCT02973893 VF00102.	['Negative', 'Another_Study']	['Negative', 'Neutral']
This study has been terminated early due to slow enrolment.	['Insufficient_Enrollment']	['Neutral']
Clinicians were not offering the study to eligible potential subjects.	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Proposed comparison (RetCam vs. COSMOS) was unfeasible. Device is now licensed in Canada.	['Study_Design']	['Neutral']
GID terminated the Registry due to evolving registry requirements	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
results of the SYMPLICITY HTN 3 trial	['Negative', 'Another_Study']	['Negative', 'Neutral']
slow patient recruitment	['Insufficient_Enrollment']	['Neutral']
COVID-19	['Covid19']	['Neutral']
Closed due to poor accrual	['Insufficient_Enrollment']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
"Sister trial has SAE investigation underway - sponsor elected to withdraw as study expected to
    be repeated later"	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Discontinuation of product development	['Business_Administrative']	['Possibly_Negative']
no patients enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
No patient enrolled as new similar study will be in system within 3 months	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Not enough viable subjects	['Insufficient_Enrollment']	['Neutral']
Funding not received	['Business_Administrative']	['Possibly_Negative']
suspended due to COVID-19, will resume	['Covid19']	['Neutral']
higher incidence of pain related sexual dysfunction in the TO arm	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
No enrollment.	['Insufficient_Enrollment']	['Neutral']
Difficulty recruiting patients	['Insufficient_Enrollment']	['Neutral']
Unable to get MRI of patients within reasonable time on a local hospital.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Futility suggested by DSMC	['Negative']	['Negative']
"Observational study that DSMB placed on hold (withdrew 4 subjects). Protocol revised and
    received IND to become interventional PK study (no subjects enrolled)."	['Study_Design']	['Neutral']
Accrual is very poor	['Insufficient_Enrollment']	['Neutral']
Study was completed.	['Invalid_Reason']	['Invalid_Reason']
"Due to the COVID19 pandemic, as of March 14, 2020, all nursing homes in New York were on
    lockdown, as a result, all of the recruitment efforts have been on pause until further notice."	['Covid19']	['Neutral']
Regulatory decision not to proceed	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Concerns over standard of care and recruiting process. Investigator left UAMS, therefore study
    halted immediately"	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
Enrollment goals not met in efficient timeframe.	['Insufficient_Enrollment']	['Neutral']
poor recruitment	['Insufficient_Enrollment']	['Neutral']
Pilot study protocol terminated to begin expanded study.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Funding for this study has ended and we were unable to enroll any subjects	['Business_Administrative']	['Possibly_Negative']
Late approval by the Secretariat of Health, and expiration of vaccine	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Change in guidelines favouring newer antiplatelet drugs in ACS	['Study_Design']	['Neutral']
"Study halted prematurely and will not resume; participants are no longer being examined or
    receiving intervention."	['Invalid_Reason']	['Invalid_Reason']
Business decision	['Business_Administrative']	['Possibly_Negative']
no subjects were found who met criteria	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Lack of financial support	['Business_Administrative']	['Possibly_Negative']
"The top-line results from the Part 1 did not meet the pre-specified primary endpoint nor the
    key secondary endpoints. The decision to discontinue study 215MS202 Part 2 was not based on
    safety concerns."	['Negative', 'Another_Study']	['Negative', 'Neutral']
The study was terminated due to slow recruitment.	['Insufficient_Enrollment']	['Neutral']
Not reaching recruitment and endpoint goals	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Inadequate enrollment	['Insufficient_Enrollment']	['Neutral']
"Due to COVID-19, Radial slowed their operations. Hence the investigational device is not
    available."	['Covid19']	['Neutral']
Problem on the app, questioned the feasability of the study	['Logistics_Resources']	['Neutral']
poor enrollment, unable to meet recruitment goals	['Insufficient_Enrollment']	['Neutral']
Study closed & recruitment will not recommence	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Renal toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Stopped due to feasibility	['Logistics_Resources']	['Neutral']
Recruitment temporarily held for site retraining	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
"Exhaustion of subject population pool, greater than expected drop-out rates . Data analysis
    approved by DMC for study completions"	['Insufficient_Enrollment']	['Neutral']
Low enrollment rate.	['Insufficient_Enrollment']	['Neutral']
Slow subject enrollment and contracting issues; sponsor decided to abort study	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
5 immune related serious adverse events in Phase 1 study	['Negative', 'Another_Study']	['Negative', 'Neutral']
toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
COVID-19 pandemic	['Covid19']	['Neutral']
"No participants enrolled. PI/Sponsor left UPitt. IND withdrawn & revised protocol submitted
    through the new institution. New study recruiting under NCT03488667."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Low accrual(4 completed subjects over 2 months)& inconclusive nasal wash assays.	['Insufficient_Enrollment']	['Neutral']
the study terminated last week	['Invalid_Reason']	['Invalid_Reason']
The COVID-19 pandemic required that we discontinue the study.	['Covid19']	['Neutral']
Study was closed due to Sponsor switched to Longeveron. New Identifier is NTC03525418	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Unable to obtain a timely newly requested IDE	['Logistics_Resources', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
"The extension study was terminated early after the results of the core study showed the study
    did not meet primary endpoint; confirmed disability progression"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Terminated to allow continued optimization of the product.	['Study_Design']	['Neutral']
Poor accrual and change of SOC (FOLFIRINOX in adjuvant setting)	['Insufficient_Enrollment']	['Neutral']
Low accrual rate.	['Insufficient_Enrollment']	['Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
No agreement between investigator and sponsor	['Business_Administrative']	['Possibly_Negative']
PI leaving institution	['Study_Staff_Moved']	['Neutral']
"The SARS-CoV-2 pandemic delayed recruitment for but also provided an opportunity to apply
    findings from the rapid development of a ChAdOx1-vectored vaccine against SARS-CoV-2 to the
    further development of the MERS vaccine"	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
ORIGIO a/s acquired by Cooper Surgical Inc. who decided to withdraw from the project	['Business_Administrative']	['Possibly_Negative']
slow recruitment, internal problems with the study protocol	['Insufficient_Enrollment']	['Neutral']
Sponsor stopped the study due to poor enrollment	['Insufficient_Enrollment']	['Neutral']
Failure to recruit	['Insufficient_Enrollment']	['Neutral']
"Company decision to discontinue the AVE1642 development program, not due to any safety or
    efficacy concerns"	['Business_Administrative']	['Possibly_Negative']
"A significant reduction in head injuries coupled with more frequent use of crainectomy reduced
    the number of potential subjects."	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Study closed for PI failure to submit renewal paperwork	['Business_Administrative']	['Possibly_Negative']
Study met safety endpoints	['Covid19', 'Interim_Analysis', 'Safety_Sideeffects']	['Neutral', 'Neutral', 'Safety_Sideeffects']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Abandoned	['Invalid_Reason']	['Invalid_Reason']
Study moved to British Columbia	['Study_Staff_Moved']	['Neutral']
Did not support the planned development of DCCR in the new indication	['Regulatory', 'Insufficient_Enrollment', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
"The interim analysis suggested that low dose lisinopril given to be tube fed older patients
    with neuroligical dysphagia had increased mortality."	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
study cancelled	['Invalid_Reason']	['Invalid_Reason']
"The hospitals could not enroll any patients. Therefore, the authors decided to withdraw the
    study."	['Insufficient_Enrollment']	['Neutral']
Trend toward increased readmissions in the auto-delivery arm.	['Negative']	['Negative']
Interim futility analysis results	['Negative']	['Negative']
Insufficient subject enrollment	['Insufficient_Enrollment']	['Neutral']
Funds for this project have been spent, and it is thereby terminated.	['Business_Administrative']	['Possibly_Negative']
Due to poor enrollment	['Insufficient_Enrollment']	['Neutral']
This study was early terminated due to insufficient enrollment required for hypothesis testing.	['Insufficient_Enrollment']	['Neutral']
Terminated due to low accrual	['Insufficient_Enrollment']	['Neutral']
The Phase I of the study was completed, but Phase 2 has not been activated	['Invalid_Reason', 'Study_Design', 'Another_Study']	['Invalid_Reason', 'Neutral', 'Neutral']
See Detailed Description	['No_Context']	['Invalid_Reason']
FDA Hold May 2007	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Slow enrollment rate. Low scientific value	['Insufficient_Enrollment']	['Neutral']
practicality reasons; recruitment slower than expected	['Insufficient_Enrollment']	['Neutral']
no patient enrollment	['Insufficient_Enrollment']	['Neutral']
low accruals--2 patients were enrolled in over a year	['Insufficient_Enrollment']	['Neutral']
Study procedures were not feasible.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Field Safety Notice related to potential ventricular oversensing associated to the PhD feature
    on Paradym ICDs"	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Unable to acquire additional funding needed to continue this study.	['Business_Administrative']	['Possibly_Negative']
Protocol revision	['Study_Design']	['Neutral']
"The study was terminated following an internal review of the company's current research and
    development portfolio."	['Business_Administrative']	['Possibly_Negative']
It was hard to find suitable subject due to strict enrollment criteria.	['Insufficient_Enrollment']	['Neutral']
competing studies	['Negative', 'Another_Study']	['Negative', 'Neutral']
Sponsor Corporate Business Decision	['Business_Administrative']	['Possibly_Negative']
no participants enrolled	['Insufficient_Enrollment']	['Neutral']
Slow recruitment, interim analysis	['Insufficient_Enrollment']	['Neutral']
Difficulties with recruitment during the internal pilot phase	['Insufficient_Enrollment']	['Neutral']
Slow accrual. 100 patients included	['Insufficient_Enrollment']	['Neutral']
"As most HER2+ patient develop brain mets while on/after having received TDM1, it has proven to
    be an insurmountable challenge to recruit patients"	['Insufficient_Enrollment']	['Neutral']
Investigator Decision due to insufficient accrual.	['Insufficient_Enrollment']	['Neutral']
slowly recruitment rate	['Insufficient_Enrollment']	['Neutral']
Subjects could not be recruited	['Insufficient_Enrollment']	['Neutral']
Sponsor's decision	['Business_Administrative']	['Possibly_Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
No participants met eligibility requirements	['Insufficient_Enrollment']	['Neutral']
Never received funding	['Business_Administrative']	['Possibly_Negative']
sponsor asked site to suspend study.	['Business_Administrative']	['Possibly_Negative']
Administrative problems makes changes in hospital staff New clinical research team will restart	['Business_Administrative']	['Possibly_Negative']
Study terminated with IRB on 20Feb2019 due to lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
DSMB determined, due to higher than expected risk/safety concerns, study should be closed.	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Financial problem	['Business_Administrative']	['Possibly_Negative']
was terminated due to meeting a priori stopping rule set by DSMB	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
"The Omega arm of this study was stopped for futility. The EDEN arm continues to recruit
    patients as a separate independent study."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Unable to enroll breast cancer patients with current I/E criteria.	['Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
lack of clinical cases	['Insufficient_Enrollment']	['Neutral']
There is no longer a plan to pursue an approval of lampalizumab.	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
PI left University	['Study_Staff_Moved']	['Neutral']
contract not executed	['Business_Administrative']	['Possibly_Negative']
Due to limited pool of eligble WNV patients	['Insufficient_Enrollment']	['Neutral']
Difficulty with recruiting sujects and subjects complying with the protocol	['Insufficient_Enrollment']	['Neutral']
Administrative reasons	['Business_Administrative']	['Possibly_Negative']
Non Applicable clinical trial	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Protocol expired; PI retired	['Study_Staff_Moved']	['Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Pandemic context.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
left institution protocol closed	['Study_Staff_Moved']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
PI has decided to close the study.	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"The COVID19 outbreak began March 2020 in Jamaica. Associated risks, prohibitive cost of
    mitigating those risks for study participants and locally enacted legislation militated against
    further recruitment and intervention activities."	['Covid19']	['Neutral']
Analysis of data from 104RA202 failed to meet primary endpoint	['Negative']	['Negative']
Patients failed to be enrolled because of tight exclusion criteria.	['Insufficient_Enrollment']	['Neutral']
Since reorganization of the institute, this study is aborted. No patient was recruited.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Funding ended	['Business_Administrative']	['Possibly_Negative']
The study was terminated due to enrollment challenges and the COVID-19 pandemic.	['Covid19']	['Neutral']
"As vaccine coverage rates have drastically improved in Venezuela, the study lost its objective
    to show positive impact of the vaccine to stimulate higher usage"	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
The proposed work could not be completed.	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Sponsor put plans on hold	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Manufacturer of the investigational device has ceased all business activities	['Business_Administrative']	['Possibly_Negative']
"Clinical benefit was noted in the earlier portion of the trial; hence, participants were not
    enrolled in 2 expansion cohorts and the study was terminated early."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Terminated	['Invalid_Reason']	['Invalid_Reason']
The PI has left Duke-the primary study site and the sponsor retreat the support	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
We came across unexpected difficulty with recruitment.	['Insufficient_Enrollment']	['Neutral']
The Investigator decided not to pursue this study.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Terminated due to limited enrollment and follow up.	['Insufficient_Enrollment']	['Neutral']
"Did not obtain Health Canda approval for drug use in reasonable time and moved onward to new
    trial"	['Regulatory', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Not reached the statistical hypothesis at the interim analysis	['Negative']	['Negative']
slow recruitment and no further drug supply	['Insufficient_Enrollment']	['Neutral']
refusal of the ansm	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Lack of enrollment & funding	['Business_Administrative']	['Possibly_Negative']
"in the absence of benefits and because of a statistically significant excess mortality in the
    group of patients receiving active stimulation."	['Negative']	['Negative']
"This study was terminated based on Pfizer's change in clinical development strategy not related
    to safety and efficacy."	['Business_Administrative']	['Possibly_Negative']
Subject accrual too difficult	['Insufficient_Enrollment']	['Neutral']
Failure of accrual achievement	['Insufficient_Enrollment']	['Neutral']
Lost funding from sponsor	['Business_Administrative']	['Possibly_Negative']
did not receive funding to conduct study	['Business_Administrative']	['Possibly_Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
Study terminated by sponsor	['Business_Administrative']	['Possibly_Negative']
Change in referral pattern changed the population we were studying	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Sponsor withdrew funding	['Business_Administrative']	['Possibly_Negative']
Sponsor pulled funding related to enrollment pace.	['Business_Administrative']	['Possibly_Negative']
"Sponsor terminated RRMS studies as sufficient long term clinical data was collected for the
    study drug in the relevant dose."	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Illness of PI forced termination.	['Study_Staff_Moved']	['Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
there was no percipitant enrolled	['Insufficient_Enrollment']	['Neutral']
We could not get physicians in the ED to enroll patients.	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Difficulty in Recruitment due to lack of investigators and suitable patients	['Insufficient_Enrollment']	['Neutral']
Recruitment challenges. Extensive remedial recruitment strategies unsuccessful	['Insufficient_Enrollment']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
High patient withdrawal rate	['Insufficient_Enrollment']	['Neutral']
No pt enrolled	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
funding discontinued by sponsor	['Business_Administrative']	['Possibly_Negative']
Company dissolved, no study devices available anymore	['Business_Administrative']	['Possibly_Negative']
"Clinical Team decision to terminate the study after the results from Cohort 1 did not support
    conducting Cohort 2."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Analysis of 99 subjects showed no significant benefits of the novel diabetic foot education.	['Negative']	['Negative']
"The clinical phase of the study (from FSFV to LSLV) was never initiated due to the sponsor's
    decision."	['Business_Administrative']	['Possibly_Negative']
"Study was withdrawn prior to the first subject being enrolled due to the Co-Investigator
    leaving the university"	['Study_Staff_Moved']	['Neutral']
Company decision not to start the study	['Business_Administrative']	['Possibly_Negative']
"The study was terminated voluntarily by the sponsor due to changes in clinical development
    strategy."	['Business_Administrative']	['Possibly_Negative']
No longer viable	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
Recruitment was very low.	['Insufficient_Enrollment']	['Neutral']
study was never started due to regional geopolitical conflict	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Procedure protocol improved - study protocol became obsolete	['Study_Design']	['Neutral']
Unable to meet enrollment goals	['Insufficient_Enrollment']	['Neutral']
Policy changes have contributed to the failure to carry out smoothly	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Study product is no longer being considered for further development.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"RCT with same hypothesis ended and showed a superiority for protective ileostomy after lower
    anterior rectum resection."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Modified insurance requests by a new law released after its approval.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Very slow enrollment of target patient population	['Insufficient_Enrollment']	['Neutral']
The company providing study IMP was unable to supply further batches of IMP.	['Logistics_Resources']	['Neutral']
This study is temporarily suspended due to COVID-19 pandemic.	['Covid19']	['Neutral']
The principal investigator decided to stop the research.	['Invalid_Reason']	['Invalid_Reason']
Subcutaneous administration of RRx-001 is no longer of interest.	['Interim_Analysis', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
VTL-308 failed to meet its primary endpoint, all follow up studies were terminated	['Negative']	['Negative']
Sponsor Decision to withdraw study (comparative product withdrawn from the market)	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Lack of recruitment from different study sites and due to structural changes in the included
    centers"	['Insufficient_Enrollment']	['Neutral']
Due to covid-19 restrictions on recruiting	['Covid19']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
New enrollment has been suspended, currently following previously enrolled participants	['Insufficient_Enrollment']	['Neutral']
protocol violation	['Study_Design']	['Neutral']
No funds	['Business_Administrative']	['Possibly_Negative']
modified formulation under investigation	['Study_Design']	['Neutral']
"The clinical study has been terminated based on difficulties to enroll eligible subjects per
    protocol inclusion and exclusion criteria."	['Insufficient_Enrollment']	['Neutral']
Poor accrual. Investigator decision.	['Insufficient_Enrollment']	['Neutral']
"On April 15, 2019, BIOTRONIK received FDA approval to transition the ongoing Protego DF4 Post
    Approval Registry to a new EP PASSION real-world data methodology."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Lack of funding and resources	['Business_Administrative']	['Possibly_Negative']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
It was determined that one member of the team had falsified data.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Difficulty in recruiting patients	['Insufficient_Enrollment']	['Neutral']
The company decided to cancel this study in conformity with Philippines FDA Circular 2013-004	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
At the request of the Principal Investigator	['Study_Staff_Moved', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Safety reasons, though no safety issues arose.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Too slow recruitment rate	['Insufficient_Enrollment']	['Neutral']
sponsor has decided not to support this study.	['Business_Administrative']	['Possibly_Negative']
no patients were enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"At the request of the study site, this study has been closed and access to study-related data
    is unavailable. We are unable to submit the results-data."	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Terminated due to bevacizumab and chemoradiotherapy toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Never started.	['Invalid_Reason']	['Invalid_Reason']
no patients recruited	['Insufficient_Enrollment']	['Neutral']
lack of patient enrollment	['Insufficient_Enrollment']	['Neutral']
unable to accrue patients	['Insufficient_Enrollment']	['Neutral']
"Results from pre-specified criteria in study NCT01499355 (211LE201) did not demonstrate
    sufficient efficacy to warrant continuation of the study"	['Negative', 'Another_Study']	['Negative', 'Neutral']
"A similar study had already been conducted, therefore pursuing this trial would have been
    unethical"	['Negative', 'Another_Study']	['Negative', 'Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Study is unfunded and lack of resources	['Business_Administrative']	['Possibly_Negative']
"As enrollment began external studies called into question the safety and efficacy of
    hydroxychloroquine as a treatment which resulted in controversy. The timing of the controversy
    significantly impacted our ability to enroll and retain participants."	['Safety_Sideeffects', 'Logistics_Resources', 'Endpoint_Met']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Terminated due to poor recruitment	['Insufficient_Enrollment']	['Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Slow recruitment of patients	['Insufficient_Enrollment']	['Neutral']
Difficulty in enrolling patients	['Insufficient_Enrollment']	['Neutral']
Difficulty recruiting patients due to logistics	['Insufficient_Enrollment']	['Neutral']
Logistics and financial	['Business_Administrative']	['Possibly_Negative']
low enrollment rate	['Insufficient_Enrollment']	['Neutral']
"Recruitment challenging: lack of suitable pts; recruiting so soon after diagnosis; competing
    studies. Funding ended despite extensions to grant."	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
no participants recruded.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"Well tolerated but failed to demonstrate significant activity. So it did not meet its primary
    endpoint or key secondary endpoints."	['Negative']	['Negative']
Prevention of COVID-19 spread	['Covid19']	['Neutral']
Unable to enroll subjects	['Insufficient_Enrollment']	['Neutral']
The study was withdrawn because of problems found with the baseplate	['Logistics_Resources']	['Neutral']
"36 cases were included and the 4 centers and they are unable to increase their recruitment to
    obtain the 400 cases necessary to reach statistical significance."	['Insufficient_Enrollment']	['Neutral']
Changes to the overall development program for the study medication	['Business_Administrative']	['Possibly_Negative']
"The study was closed early due to low enrollment and new information regarding the benefit of
    the study regimen."	['Negative', 'Another_Study']	['Negative', 'Neutral']
no more inclusions	['Insufficient_Enrollment']	['Neutral']
Business decision	['Business_Administrative']	['Possibly_Negative']
Principal investigator left institution.	['Study_Staff_Moved']	['Neutral']
Could not receive facility approval	['Business_Administrative']	['Possibly_Negative']
Difficult to recruit patients	['Insufficient_Enrollment']	['Neutral']
Insufficient resources available to complete the study	['Business_Administrative']	['Possibly_Negative']
Low accrual.	['Insufficient_Enrollment']	['Neutral']
Lack of funding/patient availability	['Business_Administrative']	['Possibly_Negative']
drug issues	['Logistics_Resources']	['Neutral']
Nationwide shortage of study meds in 2013 loss of funding & competing studies	['Business_Administrative']	['Possibly_Negative']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Due to slow accrual	['Insufficient_Enrollment']	['Neutral']
No more funding	['Business_Administrative']	['Possibly_Negative']
No patient enter this study.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Could not recruit adequate number of subjectsa	['Insufficient_Enrollment']	['Neutral']
Difficulty to include patients	['Insufficient_Enrollment']	['Neutral']
Ende of part 1. Only few patients in part 2 enrolled	['Insufficient_Enrollment']	['Neutral']
Protocol revision necessary.	['Study_Design']	['Neutral']
No patients met eligibility.	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
"Termination was due to identified errors in data management handling after an internal audit by
    the sponsor performed by third party."	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
"Mitra is temporarily suspending enrollment in the ANCERS-2 clinical utility study due to
    unexpected test performance results, to analyze the test performance."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
No enrollment and competing studies	['No_Context', 'Logistics_Resources', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Not enough patient	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
New study written	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
Sponsor discretion	['Business_Administrative']	['Possibly_Negative']
Currently not moving forward with the study	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Unsufficient referrals for recruitment	['Insufficient_Enrollment']	['Neutral']
Investigators decision	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
recruitment issues	['Insufficient_Enrollment']	['Neutral']
PI leaving institution; closing trial and reopening at another site; no accruals.	['No_Context', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
low enrollment	['Insufficient_Enrollment']	['Neutral']
Study was withdrawn due to technical limitations to the device	['Logistics_Resources']	['Neutral']
"The PI resigned the institute, and the rest investigators at the institute decided to terminate
    the study."	['Study_Staff_Moved']	['Neutral']
"We are unable to find a clip used to stabilize the epidural needle on the ultrasound probe to
    allow adequate epidural catheter placement."	['Logistics_Resources']	['Neutral']
Withdrawn: Study halted prior to enrollment of first participant	['Invalid_Reason']	['Invalid_Reason']
Shortfall in funding	['Business_Administrative']	['Possibly_Negative']
Study has been cancelled and it has not been initiated.	['Invalid_Reason']	['Invalid_Reason']
Study not approved by BfARM	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
FDA hold and toxicity associated with study drug	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
This study will not be proceeding due to lack of funding from anticipated sources	['Business_Administrative']	['Possibly_Negative']
Sponsor decision to not to proceed	['Business_Administrative']	['Possibly_Negative']
Unable to recruit patients who had not had MRI first.	['Insufficient_Enrollment']	['Neutral']
Due to slow enrollment the study was stopped prematurely.	['Insufficient_Enrollment']	['Neutral']
"The trial was halted because of unanticipated nonrespiratory adverse events related to
    dexamethasone therapy."	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
"This study had an major amendment in 12/2006 introducing risk stratified sequential treatment
    (RSST). The modified protocol is registered with NCT00590447."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Due to insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
did not receive funding	['Business_Administrative']	['Possibly_Negative']
Trial terminated early per business decision	['Business_Administrative']	['Possibly_Negative']
Primary endpoint (Safety) has been achieved	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
no patient included after 6 month of enrollement	['Insufficient_Enrollment']	['Neutral']
enrollment was too slow	['Insufficient_Enrollment']	['Neutral']
equipments and staff are unavailable.	['Logistics_Resources']	['Neutral']
"No patients were enrolled in this study. The study onset was delayed due to problems with drug
    acquisition."	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Difficulty Recruiting subjects	['Insufficient_Enrollment']	['Neutral']
Unable to obtain funding source	['Business_Administrative']	['Possibly_Negative']
Company decision taken in light of demands by certain national health authorities	['Business_Administrative']	['Possibly_Negative']
delay in enrollment	['Insufficient_Enrollment']	['Neutral']
"Strict study protocol and lack of participant reimbursement was not advantageous and feasible
    as evidenced by the high rate of attrition."	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Failed to recruit sufficient subjects	['Insufficient_Enrollment']	['Neutral']
Unable to reach target goal	['Insufficient_Enrollment']	['Neutral']
Sorafenib ineffective for tx of recurrent or progressive PLGA	['Negative']	['Negative']
"New enrollment and collection of blood samples paused while IRB reviews use of the
    investigational assay involved."	['Study_Design']	['Neutral']
Insufficient funding	['Business_Administrative']	['Possibly_Negative']
Safety reasons	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
no recruitment	['Insufficient_Enrollment']	['Neutral']
No accrual to the study	['Insufficient_Enrollment']	['Neutral']
pilot data to be used for upcoming larger trial.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
administrative reasons	['Business_Administrative']	['Possibly_Negative']
Strategic considerations	['Business_Administrative']	['Possibly_Negative']
Due to stringent inclusion/exclusion criteria, study investigator deemed it not feasible.	['Insufficient_Enrollment']	['Neutral']
Investigator left the institution and decided not to continue with the study.	['Study_Staff_Moved']	['Neutral']
Difficulties in recruitment - will require longer time to achieve sample size	['Insufficient_Enrollment']	['Neutral']
"In accordance with the protocol, following the occurrence of two SUSARs, the TOTEM trial was
    stopped early for safety reasons."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
early termination due to loss of interest and low enrollment of patient	['Insufficient_Enrollment']	['Neutral']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
"Cohort 1: slow accrual Cohort 2: Other studies showed no benefit Cohort 3: Study met
    pre-specificied futility analysis at planned second interim analysis"	['Negative', 'Another_Study']	['Negative', 'Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
low inclusion rate	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Administrative decision of the company	['Business_Administrative']	['Possibly_Negative']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Formula Reformulation	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Interim analysis found study had achieved primary objective	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
The institution transitioned from open surgical procedure to Robotic procedure	['Study_Design']	['Neutral']
Site non-compliance to GCP (No safety concerns. See detailed description)	['Covid19', 'No_Context', 'Insufficient_Enrollment']	['Neutral', 'Invalid_Reason', 'Neutral']
Insufficient, delayed recruitment of participants	['Insufficient_Enrollment']	['Neutral']
due to release of competing App	['Covid19', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
No participants were enrolled in the study.	['Insufficient_Enrollment']	['Neutral']
Principal Investigator is deceased	['Study_Staff_Moved']	['Neutral']
PI retired prior to final N number reached	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
The PI decided to withdraw the study. No patient interaction took place.	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Resource constraints at participating sites	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Due to COVID 19 restrictions and protocol could not to be implemented safely for participants
    and researchers."	['Covid19']	['Neutral']
Principal Investigator departed for another position.	['Study_Staff_Moved']	['Neutral']
"Due to FDA constraints on the off label use of the medications we will not be able to conduct
    this evaluation."	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
Decided to do studies in patients with AMD	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"The trial was terminated due to an out-licensing agreement after the new sponsor did not wish
    to continue the trial"	['Business_Administrative']	['Possibly_Negative']
funding	['Business_Administrative']	['Possibly_Negative']
Lack of recruitment/participants	['Insufficient_Enrollment']	['Neutral']
New data; the study was terminated based on new efficacy data from another study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Most pts requested to be treated with versed. It was difficult to randomize pts.	['Insufficient_Enrollment']	['Neutral']
Difficulty in recruitment of study participants in alloted time and funding	['Business_Administrative']	['Possibly_Negative']
"Due to enrollment challenges resulting in changing treatment patterns, the study has been
    terminated. No patients remain on study."	['Insufficient_Enrollment']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
terminated due to the low conditional power for a positive study	['Negative']	['Negative']
"This study was terminated when the accrual goal for the low/intermediate grade stratum was
    reached. The high grade stratum was closed due to slow accrual."	['Insufficient_Enrollment']	['Neutral']
Study withdrawn at PI's request. no patients enrolled.	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Unable to recruit participants before funding period ended.	['Business_Administrative']	['Possibly_Negative']
"109MS415 ImPROve study was terminated due to patient enrollment challenges and feasibility .
    The decision was not a result of safety concerns."	['Logistics_Resources', 'Endpoint_Met', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Trial not initiated	['Invalid_Reason']	['Invalid_Reason']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Insufficient patient enrollment	['Insufficient_Enrollment']	['Neutral']
Unable to recruit adequate number of subjects	['Insufficient_Enrollment']	['Neutral']
DSMB recommendation (futility)	['Negative']	['Negative']
"Unforeseen feasibility issues arose that meant the study did not seem viable in the current
    form."	['Logistics_Resources']	['Neutral']
PI withdrew from study protocol participation	['Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
protocol has not been used for many years and has outlived it utility	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Hampering patient enrolment after registration of first line pembrolizumab	['Covid19', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
It has been put on hold for the moment due to logistic problems	['Logistics_Resources']	['Neutral']
"MTD was established and patients completed 16 months safety f-up and response assessments. It
    is considered of limited value to follow patients for 3 years."	['Interim_Analysis', 'Logistics_Resources', 'Endpoint_Met']	['Neutral', 'Neutral', 'Neutral']
"Change in Investigational Drug Service policies resulting in the need to change the operational
    design of the overall protocol."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Unable to achieve device(s) which will be used in this study.	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Low enrollment due to inclusion/exclusion criteria	['Insufficient_Enrollment']	['Neutral']
Poor accrual due to change in standard of care procedure.	['Insufficient_Enrollment']	['Neutral']
Research activities suspended March 2020 due to COVID-19 pandemic.	['Covid19']	['Neutral']
Did not reach the enrollment goal.	['Insufficient_Enrollment']	['Neutral']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Unable to attain funding	['Business_Administrative']	['Possibly_Negative']
"Difficulties experienced in identifying participants who meet the eligibility criteria of the
    trial."	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
unable to enroll sufficient number of participants	['Insufficient_Enrollment']	['Neutral']
Due to fundamental changes in procedures design no patients have been enrolled	['Study_Design']	['Neutral']
"Results to date adequately demonstrated user preference and recovery time. Time to target (Part
    II) was not studied. ."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Enrollment Completed	['Invalid_Reason']	['Invalid_Reason']
Change of location for Investigators	['Study_Staff_Moved']	['Neutral']
Inability to recruit	['Insufficient_Enrollment']	['Neutral']
investigator choice	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
study did never start, may be deleted from clinicaltrials.gov if possible	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Temporary Restrictions on in-person contact due to COVID-19	['Covid19']	['Neutral']
Difficulties patient recruitment	['Insufficient_Enrollment']	['Neutral']
Insufficient recruitment leading to selection bias and insufficient data	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Change to investigator's research affiliation and other employment.	['Study_Staff_Moved']	['Neutral']
"Recruitment not started at Loyola, PI leaving Loyola, PI may resume at next affiliating
    instituation."	['Study_Staff_Moved']	['Neutral']
Due to other trials in the department	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Due to lack of funding	['Business_Administrative']	['Possibly_Negative']
Amendment pending	['Study_Design']	['Neutral']
paused temporarily due to covid-19	['Covid19']	['Neutral']
The study was discontinued prematurely due to early stopping rules.	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
Insufficient enrollment.	['Insufficient_Enrollment']	['Neutral']
Planned Future Study	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
Slow Accrual.	['Insufficient_Enrollment']	['Neutral']
Sponsor is focusing on studies which can enable registration of duvelisib	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Study terminated due to slow enrollment.	['Insufficient_Enrollment']	['Neutral']
Loss of interest	['Business_Administrative']	['Possibly_Negative']
Delay in setting up the study.	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Stopped by data safety monitoring board	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
"As no safety warnings were detected,Interim analysis from the first 40 patients reccomends to
    stop the trial for futility"	['Negative']	['Negative']
No satisfactory acrual	['Insufficient_Enrollment']	['Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
No patients enrolled.	['Insufficient_Enrollment']	['Neutral']
Lack of ethical approval in Ethiopia	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
We did not receive funding to conduct the study	['Business_Administrative']	['Possibly_Negative']
The study was not carried out due to lack of funding and budget problems	['Business_Administrative']	['Possibly_Negative']
"In HPS2-THRIVE, MK-0524A did not meet the primary efficacy objective and there was a
    significant increase in incidence of some types of non-fatal SAEs"	['Negative']	['Negative']
Difficulty recruiting patients	['Insufficient_Enrollment']	['Neutral']
Funds needed to carry on the project were not secured.	['Business_Administrative']	['Possibly_Negative']
Low recruitment rate. Lack of interest of the sponsor.	['Insufficient_Enrollment']	['Neutral']
due to poor patient recruitment	['Insufficient_Enrollment']	['Neutral']
Product manufacturing issues.	['Logistics_Resources']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
failure to accrue projected number of patients	['Insufficient_Enrollment']	['Neutral']
Registration trial did not meet the primary end points	['Insufficient_Enrollment', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
"Although the relevance of this study remains, the recruitment was too slow (4 patients in 2
    years)."	['Insufficient_Enrollment']	['Neutral']
Design modification	['Study_Design']	['Neutral']
"Study team has decided not to rework the trial to correct inconsistencies and will resubmit to
    IRB as a new study at a later date."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
limited number of recruited patients	['Insufficient_Enrollment']	['Neutral']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
COVID pandemic	['Covid19']	['Neutral']
Difficulty obtaining advanced notification of who was wanting to use nitrous	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Funding withdrawn due to drug unavailability	['Business_Administrative']	['Possibly_Negative']
Funding Period Ended	['Business_Administrative']	['Possibly_Negative']
"Study funding was withdrawn by the sponsor following agreement that slow patient recruitment
    warranted a new approach."	['Insufficient_Enrollment']	['Neutral']
Unexpected side-effects: reversible and mild to moderate neurological impairment	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Difficulties surrounding recruiting patients	['Insufficient_Enrollment']	['Neutral']
No longer a sub-study - Changing to an independent parallel study	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Study suspended because of safety reasons	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Study did not start. Another protocol is being developed. Recruitment on hold.	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
insufficient inclusion rate	['Insufficient_Enrollment']	['Neutral']
Patients did not want to be randomized in their procedure.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
See detailed description	['No_Context']	['Invalid_Reason']
This is not a clinical trials study	['Invalid_Reason']	['Invalid_Reason']
The study was withdrawn due to budgetary and other constraints.	['Business_Administrative']	['Possibly_Negative']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
"This was planned as a phase I/II study originally, but due to a lack of funding, the phase II
    portion was never conducted."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Corporate decision	['Business_Administrative']	['Possibly_Negative']
Terminated due to slow enrollment and change in business priority	['Business_Administrative']	['Possibly_Negative']
The study was prematurely terminated due to slow enrollment beyond the planned study timelines.	['Insufficient_Enrollment']	['Neutral']
Withdrawn due to low accrual	['Insufficient_Enrollment']	['Neutral']
"The study was stopped because based on the planned interim analysis of the data of Part 1,
    palatability of both pediatric formulations was not acceptable."	['Negative']	['Negative']
Principal investigator left the institution.	['Study_Staff_Moved']	['Neutral']
"The study was terminated early due to difficulty in enrollment and lack of clinical study drug
    access."	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
"Testing for this study remained in the pilot stages due to optimization of the tACS equipment.
    There are no clinical results to report."	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Company decision	['Business_Administrative']	['Possibly_Negative']
Reorganization proceedings of the sponsor	['Business_Administrative']	['Possibly_Negative']
Study closed for slow recruitment	['Insufficient_Enrollment']	['Neutral']
Inadequate response to Scientific Review Committee.	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
"Eligible subjects will be enrolled in Celgene's long-term follow-up protocol for subjects
    previously treated with a CAR T-cell product."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Preliminary data showed no survival benefit in the GV1001 group compared to the gemcitabine
    group."	['Negative']	['Negative']
PI decision	['Invalid_Reason']	['Invalid_Reason']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
"Pfizer Canada and the SMH ORA could not come into an agreement on responsibility to be the
    Importer of Record for the trial."	['Business_Administrative']	['Possibly_Negative']
Current lack of medication support.	['Logistics_Resources']	['Neutral']
"Study terminated as sufficient data was collected to determine if impedance measurements with
    the LINQ device could track body fluid changes."	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
This study was never started.	['Invalid_Reason']	['Invalid_Reason']
Student performing study left Mayo Clinic, no funds to continue study.	['Business_Administrative']	['Possibly_Negative']
Absence of key personnel to conduct study	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
grant was withdrawn no financial support to conduct the study.	['Business_Administrative']	['Possibly_Negative']
logistical difficulties	['Logistics_Resources']	['Neutral']
Principal Investigator has left study site	['Study_Staff_Moved']	['Neutral']
The technique has been approved and validated	['Study_Design']	['Neutral']
NIH funding ended prior to full enrollment in the clinical study	['Business_Administrative']	['Possibly_Negative']
New sponsor's decision to pursue a redesigned clinical study	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Primary (safety) endpoint reached	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Monocentric Study, Site reorganised, could no longer participate in study	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
One participant enrolled, study terminated .	['Insufficient_Enrollment']	['Neutral']
problems with subject accrual	['Insufficient_Enrollment']	['Neutral']
Software update needed	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
PI passed away	['Study_Staff_Moved']	['Neutral']
"Vandetanib is no longer available as Sanofi has decided not to provide additional drug. All
    subjects are off-study."	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"impossibility of supplying the medication in research of the study by the pharmaceutical
    company that gave it to the trial"	['Logistics_Resources']	['Neutral']
Publication of data from a similar study made the current study redundant.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
the Fellow conducting the study left the institution in 2009	['Study_Staff_Moved']	['Neutral']
Unable to enroll enough subjects to answer the research questions	['Insufficient_Enrollment']	['Neutral']
Recruitment terminated permanently due to limited resource to recruit.	['Insufficient_Enrollment']	['Neutral']
Portfolio re-prioritization	['Business_Administrative']	['Possibly_Negative']
funding lost	['Business_Administrative']	['Possibly_Negative']
LIFE Bronchoscopy equipment no longer functioning and cannot be repaired.	['Logistics_Resources']	['Neutral']
"A lot of patients recruited in our center were already on montelukast treatment. It was not
    possible to recruit sufficient patients for the study."	['Insufficient_Enrollment']	['Neutral']
Covid 19	['Covid19']	['Neutral']
Closed by pharmaceutical sponsor	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Need funding and scientific collaborator	['Business_Administrative']	['Possibly_Negative']
The study was terminated after all enrolled participants progressed.	['Invalid_Reason']	['Invalid_Reason']
Research Cancelled	['Invalid_Reason']	['Invalid_Reason']
PI is no longer at this University.	['Study_Staff_Moved']	['Neutral']
Phase II funding not available	['Business_Administrative']	['Possibly_Negative']
End point reached at interim analysis	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Study has been halted per PI and IRB recommendation	['Interim_Analysis', 'Regulatory', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Methodology applied did not meet all criteria required per guidelines	['Study_Design']	['Neutral']
project has been cancelled	['Invalid_Reason']	['Invalid_Reason']
Recent developments lead to re-evaluation of study.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
company dissolved	['Business_Administrative']	['Possibly_Negative']
Not renewed with IRB	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"The study ended early after encountering logistics challenges and difficulties with site
    recruitment."	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
This study was superseded by the subsequent study IRB-15919 (NCT01050764)	['Negative', 'Another_Study']	['Negative', 'Neutral']
Sufficient enrollment for Month 24 safety and efficacy endpoints	['Endpoint_Met', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"The enrollment was not done actively even though enrollment period was extended due to poor
    enrollment."	['Insufficient_Enrollment']	['Neutral']
Planned parent study never enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
No active recruitment at present due to COVID-19 pandemic	['Covid19']	['Neutral']
patients' reluctance	['Insufficient_Enrollment']	['Neutral']
Erroneously entered in ClinicalTrials.gov. Replacement submission has been approved.	['Regulatory', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
"The study was withdrawn for business reasons. The decision to stop the TECNERGY study was not a
    result of any safety or efficacy concerns."	['Business_Administrative']	['Possibly_Negative']
Insuffisent recruitment	['Insufficient_Enrollment']	['Neutral']
Terminated by sponsor	['Business_Administrative']	['Possibly_Negative']
PI no longer with the institution	['Study_Staff_Moved']	['Neutral']
"DePuy discontinued this product in 2013, the clinical program was reviewed and this Study was
    closed."	['Business_Administrative']	['Possibly_Negative']
Persantine is no longer being used at UCHC for pharmacological stress testing	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Modification to Clinical Development Plan	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Lack of funding.	['Business_Administrative']	['Possibly_Negative']
Retirement of former Qualified Investigator and lack of resources to complete study	['Logistics_Resources', 'Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Could not be completed due to technology problems and cost constraints	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
funding	['Business_Administrative']	['Possibly_Negative']
"The high recurrence rate and the findings during the reoperations were considered as serious
    adverse events and were the reason for study termination."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Because of results of Altitude trial, this trial was cancelled.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
No patients accrued since study opened	['Insufficient_Enrollment']	['Neutral']
This study was terminated for futility	['Negative']	['Negative']
VMS Medical went out of busainess	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The doses were not effective in maintaining testosterone suppression	['Negative']	['Negative']
Study withdrawn prior to enrollment due to AZ business decision unrelated to safety.	['Business_Administrative']	['Possibly_Negative']
Funding issues	['Business_Administrative']	['Possibly_Negative']
low patient recruitment	['Insufficient_Enrollment']	['Neutral']
No more enrollment	['Insufficient_Enrollment']	['Neutral']
Difficulty of patient enrollment	['Insufficient_Enrollment']	['Neutral']
PI decision	['Invalid_Reason']	['Invalid_Reason']
Study was never initiated	['Invalid_Reason']	['Invalid_Reason']
"Based on analysis of our data after the Symplicity-3 trial announcement, decision for study
    termination was done."	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
"Dr. Arnold assisted in designing and initiating study for a pharmacology PhD candidate. The
    candidate left the institution and study enrollment was terminated."	['Study_Staff_Moved']	['Neutral']
Amended clinical development plan.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Study is withdrawn due to the global impact of the COVID-19 pandemic.	['Covid19']	['Neutral']
Too narrow inclusion criteria. Impossible to recruit patients.	['Insufficient_Enrollment']	['Neutral']
Closed per Data Monitoring Committee due to lack of efficacy	['Negative']	['Negative']
Study was never started	['Invalid_Reason']	['Invalid_Reason']
"Due to an error in the implementation of the project, CDS was provided to all providers, rather
    than to the intended random sample of providers."	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
difficult to recruit subject	['Insufficient_Enrollment']	['Neutral']
Poor recruiting rate	['Insufficient_Enrollment']	['Neutral']
Recruitment for the study has been terminated due to poor enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsor Terminated	['Business_Administrative']	['Possibly_Negative']
Recruitment issues and interim results	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Study was ended due to low enrollment	['Insufficient_Enrollment']	['Neutral']
Study never initiated, PI left institution	['Study_Staff_Moved']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
"Reason for termination was challenge with enrollment and recruitment. A significant decrease in
    the eligible patient population was main driver."	['Insufficient_Enrollment']	['Neutral']
The Dm production has been stopped	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
the patient enrollment is too difficult	['Insufficient_Enrollment']	['Neutral']
"Sponsor decided to terminate the study early so they could begin a second dose-escalation study
    of EGEN-001 in combination with standard chemotherapy."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Former PI Left the Institution	['Study_Staff_Moved']	['Neutral']
Business decision, formulation will not be pursued.	['Business_Administrative']	['Possibly_Negative']
Problems in including patients in the study	['Insufficient_Enrollment']	['Neutral']
Sponsor decided against going forward with the study.	['Business_Administrative']	['Possibly_Negative']
Lead Researcher left the Department	['Study_Staff_Moved']	['Neutral']
Difficulty recruiting	['Insufficient_Enrollment']	['Neutral']
Lack of resource from collaborating organisation	['Business_Administrative']	['Possibly_Negative']
Difficulty recruiting	['Insufficient_Enrollment']	['Neutral']
loss of funding	['Business_Administrative']	['Possibly_Negative']
Study personnel left institution before study completion	['Study_Staff_Moved']	['Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
Data storage damage plus unexpected loss of funding	['Business_Administrative']	['Possibly_Negative']
Sponsor decided to discontinue study for business reasons.	['Business_Administrative']	['Possibly_Negative']
Modification to Clinical Development Plan	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
The original PI, Alexander Neumeister, left NYULMC. No data was analyzed.	['Study_Staff_Moved']	['Neutral']
Recruitment behind plan, no increase expected	['Insufficient_Enrollment']	['Neutral']
Study was closed due to the recent pandemic and enrollment challenges.	['Insufficient_Enrollment']	['Neutral']
Due to COVID-19 recruitment and enrollment of participants was halted	['Covid19']	['Neutral']
Original Principal Investigator, G. Ashmead, MD left the Institution	['Study_Staff_Moved']	['Neutral']
Covid-19 has shut the clinic indefinitely	['Covid19']	['Neutral']
To much effort needed, high costs for an academic study	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Unable to reach accrual target.	['Insufficient_Enrollment']	['Neutral']
"Shriner's Burn Hospital closed the study and access to study-related data is unavailable. We
    are unable to submit the additional information or results-data"	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Recruitment challenges	['Insufficient_Enrollment']	['Neutral']
"A planned interim analysis was performed after approx. 240 subjects completed the trial. The
    study was stopped, as permitted by protocol, after the analysis."	['Negative']	['Negative']
The trial started and halted due sponsor's considerations.	['Business_Administrative']	['Possibly_Negative']
"The study was terminated upon completion of escalation phase, prior to opening expansion
    cohorts"	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Interim Futility Analysis	['Negative']	['Negative']
Due to administrative reasons, it was not possible to enroll subjects.	['Business_Administrative']	['Possibly_Negative']
Organizational changes made recruitment no longer possible	['Business_Administrative']	['Possibly_Negative']
Study design required a change in device	['Study_Design']	['Neutral']
PI left	['Study_Staff_Moved']	['Neutral']
"The CYPRESS-1 trial was closed early after the planned primary analysis because the risk
    benefit ratio is unfavorable."	['Negative']	['Negative']
closed to enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of Funding	['Business_Administrative']	['Possibly_Negative']
Unable to enroll adequate participants	['Insufficient_Enrollment']	['Neutral']
Recruitment problems	['Insufficient_Enrollment']	['Neutral']
Enough surgeon use to validate the usefulness of the device	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Stopped for efficacy	['Negative']	['Negative']
enrollment criteria not met by PI patient population	['Insufficient_Enrollment']	['Neutral']
Temporarily suspended due to Pandemic.	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
"Since the conception of the study, the competitive environment has developed and as a result
    this study is no longer able to generate the necessary information."	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Under the discretion of the PI the study has been withdrawn.	['Study_Staff_Moved', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Futility	['Negative']	['Negative']
Funding for continuation was not received.	['Business_Administrative']	['Possibly_Negative']
Study halted prematurely due to COVID-19 pandemic but will resume	['Covid19']	['Neutral']
Not ever started	['Invalid_Reason']	['Invalid_Reason']
Study not required due to change in device	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"This study was terminated early due to lack of efficacy based on the results of Part I of the
    AURORA study."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Investigator terminated due to funding issues	['Business_Administrative']	['Possibly_Negative']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
The study was terminated due to results in another study (NCT00878501).	['Negative', 'Another_Study']	['Negative', 'Neutral']
The study is cancelled. FDA Circular 2013-004 mandates that PMSs like this are not required	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Difficulties with recruitment	['Insufficient_Enrollment']	['Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Unable to identify appropriate patients.	['Insufficient_Enrollment']	['Neutral']
Funding terminated	['Business_Administrative']	['Possibly_Negative']
difficulties for including diabetic patients	['Insufficient_Enrollment']	['Neutral']
Study was Terminated by PI due to low accrual	['Insufficient_Enrollment']	['Neutral']
"The low accrual rate of the study (30% of the expected accrual rate)/Low efficacy in both
    treatment arms."	['Insufficient_Enrollment']	['Neutral']
insufficient study staff	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Poor accrual and difficulty with multicenter logistics	['Insufficient_Enrollment']	['Neutral']
Sponsor Decision- Financial Considerations	['Business_Administrative']	['Possibly_Negative']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
"Researcher has quit. Question still unanswered. A related study (observational, not to be
    registered) has started recently."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of efficacy	['Negative']	['Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
Management decision to temporarily suspend enrollment while the program is reassessed	['Business_Administrative']	['Possibly_Negative']
no patient	['Insufficient_Enrollment']	['Neutral']
LOE	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
PI left	['Study_Staff_Moved']	['Neutral']
No response seen in patients	['Negative']	['Negative']
Enrolled requested number of patients and completed study. In analysis	['Invalid_Reason']	['Invalid_Reason']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
Covid-19	['Covid19']	['Neutral']
Scheduled Interim Monitoring	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
inability to find qualifying participants	['Insufficient_Enrollment']	['Neutral']
Insufficient accrual	['Insufficient_Enrollment']	['Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Research cancelled - no funding identified.	['Business_Administrative']	['Possibly_Negative']
choice of the principal investigator	['No_Context', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
"AZ decision to discontinue fostamatinib development in RA; rights to fostamatinib returned to
    Rigel Pharmaceuticals."	['Business_Administrative']	['Possibly_Negative']
Data obtained from the M11-428 study is not critical to the continued evaluation of ABT-126.	['Success', 'Negative', 'Another_Study']	['Success', 'Negative', 'Neutral']
Sponsor's decision to discontinue development of entospletinib.	['Business_Administrative']	['Possibly_Negative']
Access to the devices was halted by the sponsor	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"The Prematuration Culture With a Phosphodiesterase-3 Inhibitor (PDE3-I) has been replaced by a
    different formulation"	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Lack of subject interest due to study design	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"This study was stopped due to slow enrollment after enrolling only 12 of 80 patients over 14
    months time."	['Insufficient_Enrollment']	['Neutral']
Study was closed by PI because of low enrollment.	['Insufficient_Enrollment']	['Neutral']
Sponsor decision.	['Business_Administrative']	['Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
Slow Enrollment	['Insufficient_Enrollment']	['Neutral']
The DSMB felt the risks of the study now outweighed the potential benefits.	['Negative']	['Negative']
Covid-19	['Covid19']	['Neutral']
lack of effect at interims analysis	['Negative']	['Negative']
"Recruitment terminated on 3Apr2015 due to slow recruitment rate and lack of operational
    feasibility. Study was not terminated for reasons of safety/efficacy."	['Insufficient_Enrollment']	['Neutral']
"as the recruitment rate was very low, a futility study was conducted and it was decided to
    discontinue inclusions"	['Negative']	['Negative']
Biomet's focus has changed and we no longer expect further developments	['Business_Administrative']	['Possibly_Negative']
Low recruitment rate meaning unable to complete the study in a timely manner	['Insufficient_Enrollment']	['Neutral']
Failure to recruit	['Insufficient_Enrollment']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Funding Stopped	['Business_Administrative']	['Possibly_Negative']
An excess of all-cause acute health services utilization in the intervention arm	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The study is being terminated early as a result of the coronavirus (COVID-19) outbreak.	['Covid19']	['Neutral']
Sponsor elected not to continue with study	['Business_Administrative']	['Possibly_Negative']
Pharmaceutical company pulled support for the trial.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Covid-19. Relocation of trainee/investigator. Covid-19.	['Covid19']	['Neutral']
Decided not to pursue study at this time. Resources not available	['Business_Administrative']	['Possibly_Negative']
slow accrual, competing clinical trials	['Insufficient_Enrollment']	['Neutral']
Benefit/Risk Imbalance	['Interim_Analysis', 'Safety_Sideeffects', 'Endpoint_Met']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Withdrawn (No Participants Enrolled)	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
lack of accrual	['Insufficient_Enrollment']	['Neutral']
Internal Company Decision	['Business_Administrative']	['Possibly_Negative']
Sponsored withdrew	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Transition to a different immunotherapy strategy in the future at our institution	['Study_Design']	['Neutral']
Funds for study ended September 30, 2008.	['Business_Administrative']	['Possibly_Negative']
The study was proposed but never started due to other commitments	['Business_Administrative']	['Possibly_Negative']
"Difficulty was encountered with the subjects completing their required 20 intubations in
    patients with at least one predictor of difficult intubation."	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
terminated due to lorcaserin recall	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Insufficient Funding	['Business_Administrative']	['Possibly_Negative']
financial reasons	['Business_Administrative']	['Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
difficulty enrolling	['Insufficient_Enrollment']	['Neutral']
due to strong side effect	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Withdrawn due to change in plan for this study and not due to safety reasons.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Based on results of an interim analysis, the study was halted for futility	['Negative']	['Negative']
Insufficient evidence of the clinical effectiveness of cangrelor	['Negative']	['Negative']
Pilot deemed not feasible by Steering Committee due to recruitment rate.	['Insufficient_Enrollment']	['Neutral']
Permanently terminated due to halt of recruitment due to COVID-19 pandemic	['Covid19']	['Neutral']
"because in a preliminary analysis we would need 1000 patients per group to achieve
    significative differences in the main end point."	['Negative']	['Negative']
Commercial strategy	['Business_Administrative']	['Possibly_Negative']
We could not find any candidate eligible for recruitment	['Insufficient_Enrollment']	['Neutral']
withdrawn due to lack of funding	['Business_Administrative']	['Possibly_Negative']
Study halted early due to limited response.	['Insufficient_Enrollment']	['Neutral']
No patient accrual	['Insufficient_Enrollment']	['Neutral']
CTEP Initiated Action.	['Regulatory', 'Ethical_Reason', 'Negative']	['Neutral', 'Neutral', 'Negative']
Break in funding	['Business_Administrative']	['Possibly_Negative']
Inability to recruit enough participants	['Insufficient_Enrollment']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
lack of inclusion	['Insufficient_Enrollment']	['Neutral']
Trial stopped due to slow patient accrual.	['Insufficient_Enrollment']	['Neutral']
Difficulties to enrol patients	['Insufficient_Enrollment']	['Neutral']
Low accrual.	['Insufficient_Enrollment']	['Neutral']
"On 15 January 2019, the sponsor decided to stop the study prematurely due to lack of patient
    recruitment because of supply problems with 18 F-Florbetaben."	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Due to the rare patient population and challenges to enroll patients.	['Insufficient_Enrollment']	['Neutral']
"Recruiting problems because of the time expenditure required for participating and the strict
    criteria of inclusion and exclusion"	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
funding issues	['Business_Administrative']	['Possibly_Negative']
different protocol started, new registration	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Business decision due to enrollment challenges	['Business_Administrative']	['Possibly_Negative']
departure of the coordinating investigator from another institution	['Study_Staff_Moved']	['Neutral']
PI left university and study was halted prematurely. No data was analyzed.	['Study_Staff_Moved']	['Neutral']
FDA approval of supplementation to IDE to terminate subject long term follow up	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
poor recruitment at collaborating sites	['Insufficient_Enrollment']	['Neutral']
Due to poor compliance with study drug administration.	['Study_Design']	['Neutral']
"Based on the results of the Phase 1 data, the company decided not to pursue the development of
    this drug at this time."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
PI - lack of funding	['Business_Administrative']	['Possibly_Negative']
Since the project has been terminated and there is no funding to continue the clinical trial	['Business_Administrative']	['Possibly_Negative']
Not feasible to recruit and follow-up subjects due to the pandemic	['Insufficient_Enrollment']	['Neutral']
Interim analysis	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
"As the therapeutic landscape in renal cell carcinoma is changing, it has become apparent that
    information gained so far by CATChEz study is sufficient."	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Lack of funding.	['Business_Administrative']	['Possibly_Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
difficulty obtaining required data	['Logistics_Resources']	['Neutral']
Low Enrollment	['Insufficient_Enrollment']	['Neutral']
Not enough subjects enrolled to be able to analyze data.	['Insufficient_Enrollment']	['Neutral']
Study Termination	['Invalid_Reason']	['Invalid_Reason']
Terminated due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
Manufacturer ceased to produce vials used for this study.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Recruitment Status	['Insufficient_Enrollment']	['Neutral']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
Withdrawn prior to opening to enrollment	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Lack of available time	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Funding was stopped	['Business_Administrative']	['Possibly_Negative']
Due to poor accrual	['Insufficient_Enrollment']	['Neutral']
Inability to accrue due to changing treatment landscape (PD-1 approvals)	['Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral']
See detailed description for termination reason	['No_Context']	['Invalid_Reason']
Investigator left the insititution	['Study_Staff_Moved']	['Neutral']
no longer interest from medical community	['Business_Administrative']	['Possibly_Negative']
Study timing was poor.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
COVID-19 Pandemic	['Covid19']	['Neutral']
Low participant recruitment and retention	['Insufficient_Enrollment']	['Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
"Primary objective of the trial was not met and so there was no benefit in collecting further
    information"	['Logistics_Resources', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Never started	['Invalid_Reason']	['Invalid_Reason']
Principal Investigator has left institution. IND withdrawn.	['Study_Staff_Moved']	['Neutral']
1) Difficulties in recruiting veterans and 2) the funding was used up completely	['Business_Administrative']	['Possibly_Negative']
lack of efficacy	['Negative']	['Negative']
Per PI request	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
"Slow recruitment rate into this study with rare tumors of neuroendocrine origin (enrollment
    issues)"	['Insufficient_Enrollment']	['Neutral']
Business decision	['Business_Administrative']	['Possibly_Negative']
Slow Accrual, Initiating Principal Investigator (PI) left Moffitt	['Insufficient_Enrollment']	['Neutral']
no accrual	['Insufficient_Enrollment']	['Neutral']
Lack of efficacy.	['Negative']	['Negative']
Difficult to enroll patients for the study	['Insufficient_Enrollment']	['Neutral']
I discontinued this study because I transferred to another institution.	['Study_Staff_Moved']	['Neutral']
Funding for this project ended as of August 31, 2018	['Business_Administrative']	['Possibly_Negative']
Terminated: No longer recruiting.	['Invalid_Reason']	['Invalid_Reason']
Funding source for study ended.	['Business_Administrative']	['Possibly_Negative']
Funding withdrawn.	['Business_Administrative']	['Possibly_Negative']
"The study was terminated due to difficult recruitment and retention of subjects, these were
    attributed by subjects to conflict with their job schedule."	['Insufficient_Enrollment']	['Neutral']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Inadequate rate of enrollment	['Insufficient_Enrollment']	['Neutral']
Recruitment very difficult. Study drug expired so we have stopped the study.	['Insufficient_Enrollment']	['Neutral']
no potential participants met the inclusion criteria	['Insufficient_Enrollment']	['Neutral']
"Terminated ahead of schedule after completion of the 3-year follow-up time point due to Sponsor
    decision."	['Business_Administrative']	['Possibly_Negative']
No financial support aproved	['Business_Administrative']	['Possibly_Negative']
"State of Mass. tightened regulations for making intravenous solutions for research subjects.
    Study was withdrawn and no participants were enrolled."	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
"The study was discontinued early because the Sponsor de-prioritized development of
    mocetinostat. The decision to stop was not due to any patient safety issues."	['Business_Administrative']	['Possibly_Negative']
Terminated based on safety results from another trial	['Negative', 'Another_Study']	['Negative', 'Neutral']
lack of timely recruitment of subjects	['Insufficient_Enrollment']	['Neutral']
Per PI Request	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
The study terminated early due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
Drug not available.	['Logistics_Resources']	['Neutral']
COVID-19 Pandemic	['Covid19']	['Neutral']
Company decision	['Business_Administrative']	['Possibly_Negative']
Due to overall benefit/risk profile	['Safety_Sideeffects', 'Endpoint_Met', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
IRB closed study: irregularities in documentation of informed consent, HIPAA	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of subjects	['Insufficient_Enrollment']	['Neutral']
Low enrollment and Pi had no time.	['Insufficient_Enrollment']	['Neutral']
Study terminated as CE marks of the devices used have not been renewed.	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Difficulty in recruiting patients	['Insufficient_Enrollment']	['Neutral']
Dose escalation ended after Cohort B1, RUX 10 mg BID - GCSF in October 2014.	['Negative', 'Another_Study']	['Negative', 'Neutral']
funding issues and Principal Investigator leaving the institution	['Business_Administrative']	['Possibly_Negative']
Not enough patients to recruite.	['Insufficient_Enrollment']	['Neutral']
"Main investigators (Pieters/van Zundert) changed institutions. Therefore, they were not able to
    start the study and decided to withdraw the study for now."	['Study_Staff_Moved']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
"Celgene terminated its collaboration agreement with MethylGene for the development of MGCD0103.
    All Celgene-sponsored trials with MGCD0103 will be closed."	['Business_Administrative']	['Possibly_Negative']
notification from sponsor	['Business_Administrative']	['Possibly_Negative']
Lack of efficacy.	['Negative']	['Negative']
Sponsor elected not to continue with study.	['Business_Administrative']	['Possibly_Negative']
Study treatment did not show clinical activity.	['Negative']	['Negative']
participants were not recruited enough	['Insufficient_Enrollment']	['Neutral']
Low recruiting rate and fulfill requirements	['Insufficient_Enrollment']	['Neutral']
Tredaptive has been suspended worldwide	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Technology has advanced beyond the applicability of the study	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
poor recruitment	['Insufficient_Enrollment']	['Neutral']
PI did not want to go forward with study at this time	['Study_Staff_Moved', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
"From Sept./08 to April/09 only 30 subjects were recruited. It has proved extremely difficult to
    recruit subjects."	['Insufficient_Enrollment']	['Neutral']
Difficulty in recruitment. Funding issues.	['Business_Administrative']	['Possibly_Negative']
decision of the investigator in the face of new scientific knowledge	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Pre-specified response criteria not met to proceed to next stage of study.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Terminated due to nonclinical findings	['Safety_Sideeffects', 'Negative']	['Safety_Sideeffects', 'Negative']
Surgeon refuse the proposal, so we can's enroll the patients	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
PI no longer at institution and no subjects enrolled	['Study_Staff_Moved']	['Neutral']
Lack of time to enroll due to additional responsibilities of the PI and research coordinator.	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
Sponsor withdrew IND from FDA	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Compound development discontinued	['Business_Administrative']	['Possibly_Negative']
due to lack of recruitment	['Insufficient_Enrollment']	['Neutral']
The study stopped due to a lack of recruitment	['Insufficient_Enrollment']	['Neutral']
No participants enrolled, study will not be conducted.	['Insufficient_Enrollment']	['Neutral']
difficulty enrolling patients into this study	['Insufficient_Enrollment']	['Neutral']
"Patient number to be enrolled not reachable in prospected time frame, decision to stop the
    study prematurely was made."	['Insufficient_Enrollment']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Grant Funding Ended	['Business_Administrative']	['Possibly_Negative']
Enrollment futility	['Negative']	['Negative']
Difficulty with patient recruitment	['Insufficient_Enrollment']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Due to inadequate recruitment	['Insufficient_Enrollment']	['Neutral']
prematurely terminated because of low recruitment	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
not recruiting, awaiting for changes in IRB	['Interim_Analysis', 'Regulatory', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Sanitary crisis du to Covid-19	['Covid19']	['Neutral']
Investigational product unavailable due to manufacturing issues	['Logistics_Resources']	['Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
study not funded	['Business_Administrative']	['Possibly_Negative']
Accrual incomplete/Investigator left institution	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
"Therapy for carotid disease has recently changed. Carotid stenting is now restricted to high
    risk patients that are not eligible for the study."	['Study_Design']	['Neutral']
Discontinued due to favorable results	['Negative', 'Another_Study']	['Negative', 'Neutral']
insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Enrollment did not progress as anticipated. No participants enrolled.	['Insufficient_Enrollment']	['Neutral']
Merck's decision for early termination of the data	['Business_Administrative']	['Possibly_Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
No efficacy could be demonstrated, sponsor decided to prematurely end the study.	['Negative']	['Negative']
deficient inclusion	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Difficulty identifying and enrolling eligible patients	['Insufficient_Enrollment']	['Neutral']
Inadequate accrual rate	['Insufficient_Enrollment']	['Neutral']
study terminated 12Feb09 due to low recruitment	['Insufficient_Enrollment']	['Neutral']
See Detailed Description for termination reason.	['No_Context']	['Invalid_Reason']
"No more information will be given. No consequences on security and treatment of patients:
    standard therapy is already performed for all patients."	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Changes in treatment plans affecting drug therapy choices	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
PI left JHU and is not able to be reached for updates	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
This study did not meet the efficacy objective	['Negative']	['Negative']
Development program terminated	['Business_Administrative']	['Possibly_Negative']
PI is no longer here.	['Study_Staff_Moved']	['Neutral']
"In November 2012, this study was permanently closed to new accrual at the request of the drug
    manufacturer (BMS), who decided not to pursue additional research activity in this patient
    population."	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Lack of funding availability to complete project	['Business_Administrative']	['Possibly_Negative']
This prodect will be transferred to another company.	['Business_Administrative']	['Possibly_Negative']
No authorization from CLSA database scientific committee	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
COVID-19 Risk	['Covid19']	['Neutral']
Investigational products has been suspended from the US market	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
PI relocated and reopened trial in new university	['Study_Staff_Moved']	['Neutral']
No patients	['Insufficient_Enrollment']	['Neutral']
"The study was terminated by the IRB and the Institutional Official after the MOPH and WCMQ
    audits"	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Slow accrual over 6 year period	['Insufficient_Enrollment']	['Neutral']
Data presented at SABCS 2010 showing that dual blockade is superior to monotherapy	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Due to the pandemic, enrollment was halted and patients were not coming to clinic. 40 of 100
    patients were randomized."	['Insufficient_Enrollment']	['Neutral']
No eligible subjects were identified.	['Insufficient_Enrollment']	['Neutral']
There is no fund to support	['Business_Administrative']	['Possibly_Negative']
Terminated due to completion of competing study.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
Drug logistics	['Logistics_Resources']	['Neutral']
Due to the results of interim analysis at the time 44 patients were recruited.	['Negative']	['Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
"The goal of collecting proof-of-concept information was met through additional modeling
    studies, new published evidence and information collected from the study"	['Another_Study']	['Neutral']
No enrolled participants	['Insufficient_Enrollment']	['Neutral']
"This study was terminated due to COVID-19 pandemic-related halting of recruitment in the
    context of an upcoming replacement of the study MRI scanner."	['Covid19']	['Neutral']
"Due to Health Canada losartan recall, a new formulation being added to the protocol/ temporary
    suspension"	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of enrollment. No new subjects had been enrolled for nearly a year.	['Insufficient_Enrollment']	['Neutral']
Strategic considerations	['Business_Administrative']	['Possibly_Negative']
Canceled.	['Invalid_Reason']	['Invalid_Reason']
Low study accrual caused the study to be ended early.	['Insufficient_Enrollment']	['Neutral']
"Enrollment was closed after the open label stage due to poor recruitment rate (randomized stage
    never opened)."	['Insufficient_Enrollment']	['Neutral']
"PI no longer has an appointment and has seperated from Hines VAH and project was not
    transferred to another PI?"	['Study_Staff_Moved']	['Neutral']
Successful proof of concept study after 1 subject.	['No_Context', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
Lead researcher left the Department	['Study_Staff_Moved']	['Neutral']
Recommendations changing	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"results obtained at interrim analysis after 12 patients would not be changed by recruiting
    another twelwe participants"	['Negative']	['Negative']
Study drug became commercially available.	['Logistics_Resources', 'Study_Design', 'Another_Study']	['Neutral', 'Neutral', 'Neutral']
Study closed per the request of PI due to lack of participant accrual	['Insufficient_Enrollment']	['Neutral']
lack of patients who meet inclusion criteria; there was one screen failure	['Insufficient_Enrollment']	['Neutral']
The PI left the institution	['Study_Staff_Moved']	['Neutral']
"At the end of the inclusion period, the observed correlations were much lower than expected.
    Thus, it did not seem relevant to prolong the inclusions."	['Negative']	['Negative']
"Sponsor decided to terminate the entire project, and therefore there was no use for the samples
    collected in the study."	['Business_Administrative']	['Possibly_Negative']
Difficulty with recruitment	['Insufficient_Enrollment']	['Neutral']
the human resources in the organisation are to limited to do the trial	['Logistics_Resources']	['Neutral']
Study team not ready to start enrolling and unsure of when this may happen.	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
The study was stopped due to the judicial liquidation of the CRO in charge of this study.	['Business_Administrative']	['Possibly_Negative']
Funding has been pulled	['Business_Administrative']	['Possibly_Negative']
The IND was withdrawn.	['Regulatory', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
"This study was unsuccessful in enrolling the target number of subjects during the funding
    period."	['Business_Administrative']	['Possibly_Negative']
Due to enrollment challenges	['Insufficient_Enrollment']	['Neutral']
Sponsor decision to discontinue the study.	['Business_Administrative']	['Possibly_Negative']
PI's clinical privileges at MedStar Washington Hospital Center have expired	['Study_Staff_Moved']	['Neutral']
Study not going forward at this time.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
"Due to the reason that not all participants agree to have anesthesia and postoperative
    management at the same time"	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Due to poor accrual	['Insufficient_Enrollment']	['Neutral']
Withdrawn study	['Invalid_Reason']	['Invalid_Reason']
were not able to enroll patients to a satisfactory level	['Insufficient_Enrollment']	['Neutral']
inclusion was too slow	['Insufficient_Enrollment']	['Neutral']
"Clinical changes: graft to fistula first; enrollment of 46/132 planned. NIH approved animal
    model: supplemental oxygen/AV fistula."	['Study_Design']	['Neutral']
Data obtained from the M11-427 study is not critical to the continued evaluation of ABT-126.	['Success', 'Endpoint_Met', 'Insufficient_Data']	['Success', 'Neutral', 'Neutral']
Study funding has not been established	['Business_Administrative']	['Possibly_Negative']
Study has been terminated	['Invalid_Reason']	['Invalid_Reason']
Per protocol stopping rules	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Funding was withdrawn as number of subjects enrolled did not meet expectation	['Business_Administrative']	['Possibly_Negative']
Study terminated due to lack of response at the first efficacy analysis	['Negative']	['Negative']
Revised study design.	['Study_Design']	['Neutral']
Unable to enroll sufficient subjects	['Insufficient_Enrollment']	['Neutral']
Lack of drug efficacy	['Negative']	['Negative']
Data not useful	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Personnel unavailable to run the study	['Logistics_Resources']	['Neutral']
Terminated due to low recruitment.	['Insufficient_Enrollment']	['Neutral']
pts. will be captured in core	['Interim_Analysis', 'Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral', 'Neutral']
impossibility to recruit in the BAT arm	['Insufficient_Enrollment']	['Neutral']
See termination reason in the below Purpose statement	['No_Context']	['Invalid_Reason']
Program was terminated for business reasons	['Business_Administrative']	['Possibly_Negative']
"Administrative challenges made it impossible to recruit enough subjects to achieve the study
    goals."	['Business_Administrative']	['Possibly_Negative']
Due to reorganisation in the hospital structure	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
poor recruitment	['Insufficient_Enrollment']	['Neutral']
No patients recruited	['Insufficient_Enrollment']	['Neutral']
No accrual	['Insufficient_Enrollment']	['Neutral']
inability to reach a satisfactory endpoint with respect to adequate recruitment	['Insufficient_Enrollment']	['Neutral']
Insufficient enrollment in Pancreatic & Biliary arm	['Insufficient_Enrollment']	['Neutral']
Terminated due to insufficient funding	['Business_Administrative']	['Possibly_Negative']
Device revised	['Study_Design']	['Neutral']
"Interim data analysis indicated too many variables prevented the ability to drawn conclusive
    evidence the devices affected falls."	['Negative']	['Negative']
No recruitment	['Insufficient_Enrollment']	['Neutral']
Did not reach enrollment goals	['Insufficient_Enrollment']	['Neutral']
Early termination due to efficacy	['Negative']	['Negative']
Data from the Actigraph devices could no longer be read/analyzed	['Logistics_Resources']	['Neutral']
Another study enrolling the similar group of patient are ongoing	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Study enrollment was withdrawn as it is no longer the sponsor's intention to study this
    indication under this protocol."	['Business_Administrative']	['Possibly_Negative']
The rate of subject recruitment is too slow.	['Insufficient_Enrollment']	['Neutral']
Medacta GMK PS is not in use anymore	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
"Based interim analysis results, Data Monitoring Committee did not believe the primary efficacy
    endpoint would be met. No patient safety concerns."	['Negative']	['Negative']
Investigator left the NIH.	['Study_Staff_Moved']	['Neutral']
Technical reasons- unable to process samples therefore did not recruit	['Logistics_Resources']	['Neutral']
Difficult to recruit participant	['Insufficient_Enrollment']	['Neutral']
Difficulty recruiting adequate enrollment	['Insufficient_Enrollment']	['Neutral']
The study was discontinued by the sponsor. No results to report	['Interim_Analysis', 'Logistics_Resources', 'Insufficient_Data']	['Neutral', 'Neutral', 'Neutral']
Hologic made business decision to no longer sell or manufacture Adiana device.	['Business_Administrative']	['Possibly_Negative']
no subjects recruited	['Insufficient_Enrollment']	['Neutral']
The study chair changed his employment, the realization of the study was not possible	['Study_Staff_Moved']	['Neutral']
Funding was denied.	['Business_Administrative']	['Possibly_Negative']
The study was stopped due to lack of funding	['Business_Administrative']	['Possibly_Negative']
Under internal considerations	['Business_Administrative']	['Possibly_Negative']
PIs will not pursue trial due to staff and time constraints	['Business_Administrative']	['Possibly_Negative']
Recruitment challenges	['Insufficient_Enrollment']	['Neutral']
Recruitment challenges and unforseen costs to continue	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Study was completed but there were no participants. It was completed as a theoretical study.
    Requests for final progress report can be sent to Dr. Liu."	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Funds ended.	['Business_Administrative']	['Possibly_Negative']
Subjects preferred the 5 night overnight system in terms of ease of use.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
Issue regarding the stent design	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Treatment ineffective	['Negative']	['Negative']
Study stopped due to safety concerns in both study arms	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
PI left institution prior to enrollment	['Study_Staff_Moved']	['Neutral']
Difficulty enrolling patients with elevated triglycerides under statin treatment	['Insufficient_Enrollment']	['Neutral']
Inadequate enrollment	['Insufficient_Enrollment']	['Neutral']
"B5301001 study did not meet its predefined efficacy endpoints, the long term follow up study
    B5301012 was terminated in 1/6/2015. No safety concerns identified."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Not enough study participants	['Insufficient_Enrollment']	['Neutral']
New evidence and trouble recruiting	['Negative', 'Another_Study']	['Negative', 'Neutral']
results from interim analysis conducted to study interruption	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Lack of eligible participants and failure to meeting study enrollment.	['Insufficient_Enrollment']	['Neutral']
Change of practice in the department (Nerve stimulation technique abandoned)	['Study_Design']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Requested by PI during yearly Continuing Review	['Interim_Analysis', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Safety	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
The study terminated prematurely due to insufficient recruitment.	['Insufficient_Enrollment']	['Neutral']
Due to the fact data results were statistically significant among the two groups	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
The study device became unavailable for use.	['Logistics_Resources']	['Neutral']
The study was ultimately not funded by the sponsor. No subjects were enrolled.	['Business_Administrative']	['Possibly_Negative']
Due to change in the national policy of medications	['Regulatory', 'Insufficient_Enrollment', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
The trial end was achieved according to the definition in the trial protocol	['Invalid_Reason']	['Invalid_Reason']
Principal Investigator left institution	['Study_Staff_Moved']	['Neutral']
A higher rate of late rejection was seen in the low tacrolimus arm.	['Safety_Sideeffects', 'Negative']	['Safety_Sideeffects', 'Negative']
Unable to recruit any subjects for this study	['Insufficient_Enrollment']	['Neutral']
Funding for the study withdrawn by sponsor after baseline data collected	['Business_Administrative']	['Possibly_Negative']
difficulty to include enough subjects	['Insufficient_Enrollment']	['Neutral']
Original PI left the institution, and lack of funding.	['Business_Administrative']	['Possibly_Negative']
Difficulty recruit pts with PSHF HR > 70 & high BNP.	['Insufficient_Enrollment']	['Neutral']
withdrawal by sponsor	['Business_Administrative']	['Possibly_Negative']
Results of primary outcome are not satisfactory in terms of RNA quality	['Negative']	['Negative']
Study terminated by sponsor for commercial reasons	['Business_Administrative']	['Possibly_Negative']
Inadequate recruitment	['Insufficient_Enrollment']	['Neutral']
Interim analysis shows harma to one of the study arms.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
slow accrual	['Insufficient_Enrollment']	['Neutral']
"study procedures have become standard of care as patients seeking Model for End-Stage Liver
    Disease (MELD) exception points for cholangiocarcinoma"	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Difficulty finding eligible sites/patients:current situation in health policy cause negative
    effects on existing/planned contracts for integrated care programs"	['Insufficient_Enrollment']	['Neutral']
poor accrual	['Insufficient_Enrollment']	['Neutral']
The study was not completed, the funding sponsor lost interest.	['Business_Administrative']	['Possibly_Negative']
The development program has been terminated	['Business_Administrative']	['Possibly_Negative']
Financial/Business Reasons	['Business_Administrative']	['Possibly_Negative']
Current treatment regimen of 3 procedures considered acceptable.	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Premature closure due to slow/insufficient accrual.	['Insufficient_Enrollment']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
The study was terminated due to insufficient efficacy in a separate phase III study	['Negative', 'Another_Study']	['Negative', 'Neutral']
terminated due to administrative reasons.	['Business_Administrative']	['Possibly_Negative']
Study was stopped early due to lack of efficacy signal and safety concerns	['Negative']	['Negative']
Enrollment discontinued based on mutually agreed upon decision by PI and funding sponsor	['Business_Administrative']	['Possibly_Negative']
Lack of patients, PI left	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
The enrollment of the study is much slower than expected.	['Insufficient_Enrollment']	['Neutral']
The study closed prematurely due to discontinuation of drug supply.	['Logistics_Resources']	['Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
Insufficient on-site staff to manage study	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The population of target indication is small and screening is difficult.	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Trial prematurely discontinued due to slow recruitment	['Insufficient_Enrollment']	['Neutral']
Low recruitment numbers	['Insufficient_Enrollment']	['Neutral']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Contract not negotiated.	['Business_Administrative']	['Possibly_Negative']
logistics	['Logistics_Resources']	['Neutral']
Unable to meet enrollment and follow up criteria	['Insufficient_Enrollment']	['Neutral']
The study was terminated and the PI has left the institution.	['Study_Staff_Moved']	['Neutral']
"GSK has elected to terminate development principally as a result of the statin drug-drug
    interaction (DDI) study."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Feasibility Period ended.	['Logistics_Resources', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
"AZ decision to discontinue fostamatinib development in RA; rights to fostamatinib returned to
    Rigel Pharmaceuticals."	['Business_Administrative']	['Possibly_Negative']
COVID-19 pandemic	['Covid19']	['Neutral']
Sponsor discontinued funding of the study	['Business_Administrative']	['Possibly_Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
PI requested	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Sponsor decision to terminate study.	['Business_Administrative']	['Possibly_Negative']
Company decision taken in light of demands by certain national health authorities	['Business_Administrative']	['Possibly_Negative']
Difficulty recruiting participants.	['Insufficient_Enrollment']	['Neutral']
Excess risk in rectal bleeding of first 10 patients	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
waiting for ethic board approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Subject recruitment is too difficult and we foresee that this will not improve	['Insufficient_Enrollment']	['Neutral']
insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
there are not enough participants enrolled	['Insufficient_Enrollment']	['Neutral']
European drug approval.	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
Pilot study superseded by a larger NHMRC funded trial	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study stopped due to issues surrounding development and formulation of olaparib	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
We screened over 200 patients but were ultimately unable to enroll anyone	['Insufficient_Enrollment']	['Neutral']
Decision by NIH	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study was not approved by the institution's scientific committee.	['Regulatory', 'Ethical_Reason', 'Negative']	['Neutral', 'Neutral', 'Negative']
Change in scientific information obtained resulting in early cessation of protocol.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
PI terminated the study prior to enrolling any participants.	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
no fund	['Business_Administrative']	['Possibly_Negative']
Enrollment was too low.	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Study never undertaken	['Invalid_Reason']	['Invalid_Reason']
Step 1 enrollment complete.	['Invalid_Reason']	['Invalid_Reason']
Funding not available	['Business_Administrative']	['Possibly_Negative']
The study was terminated early due to low accrual.	['Insufficient_Enrollment']	['Neutral']
A new study will be initiated in order to specifically investigate cardiac safety	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Business reasons	['Business_Administrative']	['Possibly_Negative']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
Insufficient accrual	['Insufficient_Enrollment']	['Neutral']
no financial support	['Business_Administrative']	['Possibly_Negative']
Drug provider decided not to move forward with the study.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
Personnel changes; insufficient resources to continue	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Unable to recruit	['Insufficient_Enrollment']	['Neutral']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Early indication of an unfavorable risk/benefit ratio.	['Negative']	['Negative']
Completed	['Invalid_Reason']	['Invalid_Reason']
"COVID-19 pandemic prevented further enrollment. Interim analysis showed adequate power
    achieved."	['Covid19']	['Neutral']
"PI left institution,inability to enroll and analyze data due to software/technical limitations,
    pt enrollment terminated early with no data generated"	['Logistics_Resources']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Difficulty recruiting participants and lost personnel.	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Due to COVID 19.	['Covid19']	['Neutral']
Inability to recruit patients sufficiently	['Insufficient_Enrollment']	['Neutral']
Inability to supply and maintain treatment device. No safety concerns occurred.	['Logistics_Resources']	['Neutral']
Competing study opened	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study sponsor discontinued support	['Business_Administrative']	['Possibly_Negative']
New protocol to start with improved product	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Never started	['Invalid_Reason']	['Invalid_Reason']
Funding Discontinued due to low accrual rate	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
no subject	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Study may continue	['Invalid_Reason']	['Invalid_Reason']
Decision not to go forth with study.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Closed early due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
Change in business priorities.	['Business_Administrative']	['Possibly_Negative']
Research cancelled	['Invalid_Reason']	['Invalid_Reason']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
Unable to enroll	['Insufficient_Enrollment']	['Neutral']
Study withdrawn by Investigator	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Pending FDA approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Study prematurely discont'd 20-Apr-2006 after interim analysis suggested sample size could be
    reduced without losing power. No safety concerns led to decision."	['Invalid_Reason']	['Invalid_Reason']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
"Fisher & Paykel Healthcare placed an administrative hold on the Simplus and Eson Non-Invasive
    Ventilation Evaluation study being conducted at Charite, Berlin"	['Business_Administrative']	['Possibly_Negative']
No participants were recruited over the course of the study time period	['Insufficient_Enrollment']	['Neutral']
PI left the institution	['Study_Staff_Moved']	['Neutral']
Pandemic preventing recruitment due to regulations limiting personnel in clinical spaces.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
enrollment constraints	['Insufficient_Enrollment']	['Neutral']
Difficult recruitment	['Insufficient_Enrollment']	['Neutral']
Due to administrative issues, the study was withdrawn.	['Business_Administrative']	['Possibly_Negative']
Lack of financial support	['Business_Administrative']	['Possibly_Negative']
The study was terminated early based on the results of a planned interim analysis.	['Negative']	['Negative']
We were unable to recruit a sufficient number of participants	['Insufficient_Enrollment']	['Neutral']
Evotec has indicated that this study was discontinued due to a clinical hold issued by the FDA	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
"Another surveillance protocol was initiated by the OFSEP (OFSEP cohort) which allows to follow
    all the patients, whatever their treatment."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
There could not be enough patients recruited	['Insufficient_Enrollment']	['Neutral']
Novartis is ending their research program for Nilotinib in GIST.	['Business_Administrative']	['Possibly_Negative']
Study medication was no longer available for study	['Logistics_Resources']	['Neutral']
Difficulty enrolling patients	['Insufficient_Enrollment']	['Neutral']
Enrollment suspended by Sponsor.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
planned to design a prospective study	['Study_Design']	['Neutral']
not enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Other more favorable treatments are now available.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Drug Shortage	['Logistics_Resources']	['Neutral']
Trial stopped June 2007	['Invalid_Reason']	['Invalid_Reason']
Sponsor/ PI leaving institution, no plans to continue this research at this time	['Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"On 3/4/20 a federal judge ruled the HMP work requirement unlawful, thereby ending it and
    suspending implementation of this RCT. This is not an IRB suspension."	['Regulatory', 'Ethical_Reason', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Patient inclusion cannot be completed within time limits	['Insufficient_Enrollment']	['Neutral']
Lack of adherence and huge loss of follow up.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
The study interest was reached	['Invalid_Reason']	['Invalid_Reason']
Low Recruitment	['Insufficient_Enrollment']	['Neutral']
"Terminated for non-safety reasons when Sponsor felt that sufficient long-term safety data was
    obtained."	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
"development program of study drug volasertib was stopped by Boehringer Ingelheim due to
    manufacturing problems"	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Investigators decided not to continue	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Organisational/Recruitment Issues	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Lack of patients and no longer influenza vaccine season.	['Insufficient_Enrollment']	['Neutral']
"The Sponsor decided to discontinue ALX-0171 development (due to insufficient evidence of
    efficacy). As a result, the ALX0171-C203 study was early terminated."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Unable to meet accrual due to changing practice patters	['Insufficient_Enrollment']	['Neutral']
Business decision brand strategy; no patients enrolled	['Business_Administrative']	['Possibly_Negative']
Changes in availability of study personnel	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Investigator left the Institution	['Study_Staff_Moved']	['Neutral']
"Due to the outbreak of the SARS-CoV-2 pandemic in Argentina and the lack of information about
    the potential risks of contamination from extubation and aerosolization, we stopped recruiting
    patients before achieving the predefined sample size."	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
no participants enrolled	['Insufficient_Enrollment']	['Neutral']
Low recruitment rate	['Insufficient_Enrollment']	['Neutral']
Manufacturer unwilling to provide information needed for IND application.	['Business_Administrative']	['Possibly_Negative']
PI has left institution	['Study_Staff_Moved']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Decreasing interest in using samples; department infrastructure waned	['Logistics_Resources']	['Neutral']
Study closed due to slow/low enrollment; no subjects were enrolled.	['Insufficient_Enrollment']	['Neutral']
Exploratory pre-study demonstrated participants unwilling to be randomized to control arm.	['Insufficient_Enrollment']	['Neutral']
Because of the difficulties of participant enrollment.	['Insufficient_Enrollment']	['Neutral']
recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Terminated due to results of interim analysis	['Interim_Analysis', 'Endpoint_Met', 'Negative']	['Neutral', 'Neutral', 'Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
protocol withdrawn	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
could not meet enrollment goal	['Insufficient_Enrollment']	['Neutral']
"Enrolment was suspended on 22may2020, after Mehra et al (Lancet 2020) then stopped due to lack
    of Covid19 cases."	['Covid19']	['Neutral']
problem with the candidate (investigator)	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
Enough data has been collected to allow analysis of safety profile and risk-benefit.	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Unable to recruit subjects	['Insufficient_Enrollment']	['Neutral']
This study has been withdrawn prior to enrollment	['Invalid_Reason']	['Invalid_Reason']
insufficient funding	['Business_Administrative']	['Possibly_Negative']
Sponsor withdrew funds	['Business_Administrative']	['Possibly_Negative']
PI relocated	['Study_Staff_Moved']	['Neutral']
"recruiting or enrolling participants has halted prematurely and will not resume; participants
    are no longer being examined or treated"	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
The acquisition sequence was incompatible with MRI hardware	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
Slow Enrollment	['Insufficient_Enrollment']	['Neutral']
"Slow patient enrollment and new molecules for chronic lymphoid leukemia, have importantly
    reduced the interest of conducting the phase II of this study."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Terminated to initiate FDA IND-cleared study protocol	['No_Context', 'Regulatory', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
This study not get the approval by the drug company	['Business_Administrative']	['Possibly_Negative']
Delayed inclusion	['Insufficient_Enrollment']	['Neutral']
Enrollment not achieved succesfully	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Issues with tetramer staining	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Study design changed to clinical database only with no research question to be studied.	['Study_Design']	['Neutral']
change in company plans	['Business_Administrative']	['Possibly_Negative']
Study was withdrawn due to PI decision	['Invalid_Reason']	['Invalid_Reason']
"Study terminated due to an unexpected prominent effect of entecavir alone in this patient
    population."	['Success', 'No_Context', 'Safety_Sideeffects']	['Success', 'Invalid_Reason', 'Safety_Sideeffects']
"After reports of turbidity in urine in 4 of 8 volunteers in the 4th cohort, the study was
    halted temporarily."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Unable to recruit during COVID-19 epidemic restrictions on associated clinical practice	['Covid19']	['Neutral']
Difficulties with patients recruitment, study acceptance and protocol implementation.	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Insufficient evidence of the clinical effectiveness of cangrelor	['Negative']	['Negative']
Trial did not activate	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
insufficient support	['Business_Administrative']	['Possibly_Negative']
enough patients have been enrolled for the statistic analysis	['Invalid_Reason']	['Invalid_Reason']
"unfortunately, the trial couldn't take place as planned as the investigators didn't manage to
    recruit a sufficient number of participants."	['Insufficient_Enrollment']	['Neutral']
Inadequate recruitment due to COVID-19 restrictions.	['Covid19']	['Neutral']
"The investigator conducting the study determined that the entry criteria for the proposed
    subjects was too difficult to determine in a retrospective review."	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
No participant were enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Research plan changed; no longer conducting clinical trial.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
The second intermediary analysis showed no significant difference between both arms	['Negative']	['Negative']
Company no longer pursing indication	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Recruitment delay	['Insufficient_Enrollment']	['Neutral']
Technical difficulty with sending device home with patients	['Logistics_Resources']	['Neutral']
Never started	['Invalid_Reason']	['Invalid_Reason']
Recruitment difficulty	['Insufficient_Enrollment']	['Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Inclusion curve too slow.	['Insufficient_Enrollment']	['Neutral']
No approval CA (MPA) of protocol amendment	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
PI moved from Hadassah	['Study_Staff_Moved']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Permanently Closed Due to Poor Accrual	['Insufficient_Enrollment']	['Neutral']
No participant enrolled for three years. No plan to continue study.	['Insufficient_Enrollment']	['Neutral']
Lack of Accrual and Inadequate Funding	['Insufficient_Enrollment']	['Neutral']
Strategic considerations	['Business_Administrative']	['Possibly_Negative']
"SPD489 failed to demonstrate a benefit as adjunctive treatment to antidepressants. Termination
    was not related to any new safety findings."	['Negative']	['Negative']
The study was stopped, as the another multicentre-RCT on the same patients started.	['Negative', 'Another_Study']	['Negative', 'Neutral']
The principal investigator decided to stop the study.	['Invalid_Reason']	['Invalid_Reason']
IMP management difficulties	['Business_Administrative']	['Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
Study not performed	['Invalid_Reason']	['Invalid_Reason']
Study discontinued due to difficulty in enrolling eligible subjects	['Insufficient_Enrollment']	['Neutral']
Difficulty in recruiting eligible subjects	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
"Due to lack of resources (insufficient personnel) and due to technical problems with
    measurement of primary and secondary outcomes."	['Logistics_Resources']	['Neutral']
stopped after planned interim analysis for lack of efficacy	['Negative']	['Negative']
Study was set up by an MSc student who left her post.	['Study_Staff_Moved']	['Neutral']
Lack of efficacy	['Negative']	['Negative']
Study was closed to accrual because imaging agent was no longer available.	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Early termination due to only 2 subjects completing trial.	['Insufficient_Enrollment']	['Neutral']
DRC recommended stopping study as it had missed its primary endpoint	['Negative']	['Negative']
Due to the achievement of minimum required sample size and new changes in local regulations.	['Regulatory', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Study tracer can no longer be obtained at our institution	['Logistics_Resources']	['Neutral']
IND application withdrawn	['Regulatory', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Replaced by a global study protocol NST-CA004	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
slow recruitment and adverse events	['Insufficient_Enrollment']	['Neutral']
Poor Accural	['Insufficient_Enrollment']	['Neutral']
"COVID19 pandemic: national lockdown imposed and study centre diverted all trauma cases to
    surrounding hospitals"	['Covid19']	['Neutral']
low enrollment rate	['Insufficient_Enrollment']	['Neutral']
Issues w/ sponsor and recruitment	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Difficulty in enrolling patients	['Insufficient_Enrollment']	['Neutral']
Business Decision	['Business_Administrative']	['Possibly_Negative']
Lack of patient accruals.	['Insufficient_Enrollment']	['Neutral']
Increased rate of bacterial infections	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
PI left institution; Data collected from 45 participants, but no results are available.	['Study_Staff_Moved']	['Neutral']
Sponsor's Decision	['Business_Administrative']	['Possibly_Negative']
Study was stopped by sponsers internal reason.	['Business_Administrative']	['Possibly_Negative']
Lack of feasibility	['Logistics_Resources']	['Neutral']
insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
"Subjects' not-well compliance due to diarrhea and softening stool after taking PerOx Quench 4
    sachets a day."	['Safety_Sideeffects', 'Logistics_Resources', 'Endpoint_Met']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Low accrual. No Analyses were performed	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor decided to terminate the project due to low multi-center enrollment.	['Insufficient_Enrollment']	['Neutral']
An industry-wide, alternative, post-market study has been initiated	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor decided to discontinue study drug development.	['Business_Administrative']	['Possibly_Negative']
Study stopped because of study personel movement to another institution.	['Logistics_Resources', 'Study_Staff_Moved', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Low enroll rate	['Insufficient_Enrollment']	['Neutral']
Covid-19	['Covid19']	['Neutral']
Due to low enrollment	['Insufficient_Enrollment']	['Neutral']
Patient inclusion was very tedious and slower than expected. (7 patients in 5 years)	['Insufficient_Enrollment']	['Neutral']
lack of potential patients	['Insufficient_Enrollment']	['Neutral']
Terminated early, Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
Study terminated due to corporate decision.	['Business_Administrative']	['Possibly_Negative']
Slow Accruals	['Insufficient_Enrollment']	['Neutral']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Clinical investigations have been discontinued and transfer to BMS 3/24/2015	['Invalid_Reason', 'Study_Design', 'Another_Study']	['Invalid_Reason', 'Neutral', 'Neutral']
Principal Investigator left the University of Louisville.	['Study_Staff_Moved']	['Neutral']
Insufficient recruitment and enrollment. Reduction in study personnel capacity.	['Insufficient_Enrollment']	['Neutral']
study device was recalled.	['Logistics_Resources']	['Neutral']
Too few participants	['Insufficient_Enrollment']	['Neutral']
On partial hold for clinical investigation into AE and SAE reported.	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Lack of enrollment, many screen failures and non eligible study participants	['Insufficient_Enrollment']	['Neutral']
Study stopped prematurely to test a new formulation of Exendin (9-39)	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Not able meet target enrollment.	['Insufficient_Enrollment']	['Neutral']
Provider of product no longer wished to continue with site. No data available.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Needed equipment failed before the study was started.	['Logistics_Resources']	['Neutral']
Due to discussion regarding the design of the study.	['Study_Design']	['Neutral']
Unable to enroll	['Insufficient_Enrollment']	['Neutral']
Funding Discontinued	['Business_Administrative']	['Possibly_Negative']
Changes in funding.	['Business_Administrative']	['Possibly_Negative']
Poor accrual (inability to enroll participants)	['Insufficient_Enrollment']	['Neutral']
Business reason	['Business_Administrative']	['Possibly_Negative']
Accrual terminated as recommended by the data and safety monitoring board.	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Futility reason, no difference between study groups	['Negative']	['Negative']
Insufficient separation in session duration between randomized treatment groups	['Insufficient_Enrollment']	['Neutral']
"This study served its purpose in providing considerable safety data. The decision to terminate
    the studies was not based on any new or emerging safety concern."	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Issues in reserving MRI scanner	['Logistics_Resources']	['Neutral']
Dr. Bavry is recruiting the same patients for a NIH trial.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
difficulty of enrolling patients	['Insufficient_Enrollment']	['Neutral']
Study terminated due to low accrual	['Insufficient_Enrollment']	['Neutral']
Limited funding support	['Business_Administrative']	['Possibly_Negative']
Study stopped due to a competing trial.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Because of very slow rate of enrollement	['Insufficient_Enrollment']	['Neutral']
Due to COVID-19 all research activities including recruitment have been paused.	['Covid19']	['Neutral']
Recruitment too low	['Insufficient_Enrollment']	['Neutral']
unable to rectuir	['Logistics_Resources']	['Neutral']
Sponsor cancelled the study	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Outbreak of COVID-19.	['Covid19']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Business decision	['Business_Administrative']	['Possibly_Negative']
The study was terminated because of lack of resources to complete it.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Sponsor decision; not due to any safety concerns related to DTX101.	['Covid19', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Stopped before approval due to ineffective drug	['Negative']	['Negative']
"The logistics of this trial (incl. supply of tracer) in connection with the patients' treatment
    course caused the inclusion rate to be very slow."	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Product was not developed and study was cancelled	['Business_Administrative']	['Possibly_Negative']
Lack of funding support for continued recruitment, enrollment, treatment	['Business_Administrative']	['Possibly_Negative']
Inability to enroll subjects who were willing to be randomized to control group	['Insufficient_Enrollment']	['Neutral']
Restructuring and refocus of company.	['Business_Administrative']	['Possibly_Negative']
PI left	['Study_Staff_Moved']	['Neutral']
Loss of interest in the subject	['Business_Administrative']	['Possibly_Negative']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
This study was suspended due to insufficient subject accrual.	['Insufficient_Enrollment']	['Neutral']
Business purposes	['Business_Administrative']	['Possibly_Negative']
Recruitment slower than expected.	['Insufficient_Enrollment']	['Neutral']
Lack of accruals	['Insufficient_Enrollment']	['Neutral']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Trial was terminated due to the impact of COVID-19 on trial activities.	['Covid19']	['Neutral']
Lost funding for Phase II portion of study	['Business_Administrative']	['Possibly_Negative']
Unable to accrue patients due to change in standard CLL therapy	['Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral']
All AstraZeneca sponsored clinical trials of AZD8931 have been halted	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
lack of recruitment due to changed therapy options	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Terminated (failure to enroll)	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Not enough subjects have been recruited in the expected period.	['Insufficient_Enrollment']	['Neutral']
Drug Supply Issues	['Logistics_Resources']	['Neutral']
Delay in the R&D stage	['Business_Administrative']	['Possibly_Negative']
Study never opened due to lack of funds.	['Business_Administrative']	['Possibly_Negative']
"Preliminary results of MK-5172 PN003 (NCT01353911) suggested a possible dose relationship to
    elevated transaminase levels in treatment with grazoprevir."	['Success', 'Negative', 'Another_Study']	['Success', 'Negative', 'Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
No patients were enrolled. Study terminated for portfolio reasons.	['Business_Administrative']	['Possibly_Negative']
Major challenge for enrollment of participants.	['Insufficient_Enrollment']	['Neutral']
This study has closed to accrual early due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
"Decision to modify the product under study as a result of feedback regarding subjective feeling
    during installation procedure. For more info, see brief summary."	['Study_Design']	['Neutral']
DSMB recommended stopping the trial because of lack of effect.	['Negative']	['Negative']
No Participant Enrolled	['Insufficient_Enrollment']	['Neutral']
unable to meet enrollment projections	['Insufficient_Enrollment']	['Neutral']
Interim results suggested a concern for patient outcomes and safety	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Slow recruitment rate	['Insufficient_Enrollment']	['Neutral']
PI Left Institution prior to reaching accrual goal and analyzing data.	['Study_Staff_Moved']	['Neutral']
"Study stopped early as AZ have re-prioritised to focus on research to help bring existing and
    innovative medicines to more patients with asthma and COPD."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
question was no longer committee priority	['Business_Administrative']	['Possibly_Negative']
Due to limited staff resources, we were unable to start enrolling participants.	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Study site collaborators withdrew from participating due to time constraints.	['Business_Administrative']	['Possibly_Negative']
Termination of collaboration	['Business_Administrative']	['Possibly_Negative']
Enrollment was stopped based on the Data Monitoring Committee's recommendation.	['Negative']	['Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Enrollment rate too low; rate much under estimation of sponsor and investigators	['Insufficient_Enrollment']	['Neutral']
Difficulties to include patients	['Insufficient_Enrollment']	['Neutral']
No possibility to recruit.	['Insufficient_Enrollment']	['Neutral']
Company went out of business	['Business_Administrative']	['Possibly_Negative']
Low Study Accrual	['Insufficient_Enrollment']	['Neutral']
The inclusion rate was too low, due to the exclusion criteria.	['Insufficient_Enrollment']	['Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Results of interim analysis	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
Unable to recruit subjects	['Insufficient_Enrollment']	['Neutral']
funding	['Business_Administrative']	['Possibly_Negative']
Not enough paticipants enroll in this study.	['Insufficient_Enrollment']	['Neutral']
"Guillaume Grenier, principal investigator is no longer working at the lab. The lab is now
    closed."	['Study_Staff_Moved']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Commercial distribution of the remed System stopped by LivaNova.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Very important delay in the pace of inclusions. Likely overestimation of the potential for
    inclusion. Lack of involvement of some health professionals."	['Insufficient_Enrollment']	['Neutral']
Interim analysis shows no efficacy	['Negative']	['Negative']
Safety issues in the LDFD-group (higher heart rate with dopamine)	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"Considering the life-threatening risk posed by COVID-19 disease to a fragile population, the
    Sponsor concluded that the benefit of continuing the study does not outweigh the risk to the
    safety of patients & site staffs."	['Covid19']	['Neutral']
Low accrual rate	['Insufficient_Enrollment']	['Neutral']
Funding withdrawn.	['Business_Administrative']	['Possibly_Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Study was dropped prior to opening.	['Invalid_Reason']	['Invalid_Reason']
Cardiac safety finding	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Futility	['Negative']	['Negative']
FDA recommendation	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
The study was terminated early due to sponsors decision	['Business_Administrative']	['Possibly_Negative']
No participants enrolled-slow accrual	['Insufficient_Enrollment']	['Neutral']
broken equipment	['Logistics_Resources']	['Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Study not feasible - very low recruitment rate	['Insufficient_Enrollment']	['Neutral']
PI decided to terminate study	['Invalid_Reason']	['Invalid_Reason']
poor patient recrutment	['Insufficient_Enrollment']	['Neutral']
Not enough patients/ ethical concerns	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Off study clinical use of Y90 glass microspheres (TheraSphere)	['Logistics_Resources', 'Endpoint_Met', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
"No evidence of a physiological response; no significant safety concerns; post 24-month
    follow-up; Data Monitoring Committee agreed"	['Negative']	['Negative']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
A new registration has been submitted due to a redesign of the study protocol.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Low recruitment status	['Insufficient_Enrollment']	['Neutral']
Lack of Funding	['Business_Administrative']	['Possibly_Negative']
Trial stopped: A SAE has occured. As a measure of precaution, the trial has been stopped.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
No participants	['Insufficient_Enrollment']	['Neutral']
"The study was terminated due to the discontinuation of the tralokinumab asthma program (as per
    the results of the Phase III study [D2210C00008])"	['Negative', 'Another_Study']	['Negative', 'Neutral']
"No safety signals were noted. The study was stopped because it was no longer consistent with
    the company's scientific and strategic focus."	['Business_Administrative']	['Possibly_Negative']
Not authorized by Regulatory agencies - new protocol phase 1a in progress	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Insufficient patient recruitment	['Insufficient_Enrollment']	['Neutral']
Temporarily suspended due to COVID-19	['Covid19']	['Neutral']
Due to COVID-19	['Covid19']	['Neutral']
Terminated due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
Funding was not received for this study.	['Business_Administrative']	['Possibly_Negative']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Unfavourable Pharmakokinetics	['Negative']	['Negative']
study abandoned for funding issues	['Business_Administrative']	['Possibly_Negative']
lack of funding/ benefit	['Business_Administrative']	['Possibly_Negative']
feasibility /drug availability issues - No study drug sources available	['Logistics_Resources']	['Neutral']
"Enrollment and other trial activities have temporarily paused due to COVID-19 and are expected
    to resume in the future; This is not a suspension of IRB approval"	['Covid19']	['Neutral']
The study was closed to accrual due to very poor enrollment.	['Insufficient_Enrollment']	['Neutral']
Funding restrictions - study never opened to recruitment	['Business_Administrative']	['Possibly_Negative']
The study was terminated due to satisfaction of post-marketing commitments	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Study Investigator/Sponsor decided to end enrollment earlier.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
no subjects enrolled,study never started	['Insufficient_Enrollment']	['Neutral']
Slow enrolment and Covid19	['Covid19']	['Neutral']
Closed due to lack of drug availability.	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Study terminated due to low accrual.	['Insufficient_Enrollment']	['Neutral']
Study has been closed due to no accrual.	['Insufficient_Enrollment']	['Neutral']
Similar studies already published by other researchers	['Negative', 'Another_Study']	['Negative', 'Neutral']
Internal reassessment of the medicinal product development strategy by Sponsor	['Business_Administrative']	['Possibly_Negative']
Investigator moved to new institution	['Study_Staff_Moved']	['Neutral']
due to COVID-19	['Covid19']	['Neutral']
Reccomended by DSMB after review of planned interim analyses.	['Negative']	['Negative']
The investigator abandoned the project.	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Study not to be initiated	['Invalid_Reason']	['Invalid_Reason']
"Key aspects linked to sample management and analysis were not met during feasibility assessment
    limiting the ability of the study to reach its objectives."	['Logistics_Resources']	['Neutral']
too few patients meeting current eligibility criteria	['Insufficient_Enrollment']	['Neutral']
Amgen decision	['Business_Administrative']	['Possibly_Negative']
Extremely low enrollment rate	['Insufficient_Enrollment']	['Neutral']
Data Monitoring Committee cited poor accrual.	['Insufficient_Enrollment']	['Neutral']
Sponsor and facility unable to reach agreement before study timeline expired	['Business_Administrative']	['Possibly_Negative']
Few prevalence of liver fibrosis in subjects	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
"The study ethics committee recommended concluding the study for longer crying time with
    benzocaine and very short crying time in all participants."	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
The study was cancelled due to change in food registration regulations in China.	['No_Context', 'Regulatory', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
Slow accrual due to restrictive eligibility criteria	['Insufficient_Enrollment']	['Neutral']
Business Reasons (No safety concerns)	['Business_Administrative']	['Possibly_Negative']
lack of funds	['Business_Administrative']	['Possibly_Negative']
Regulatory timelines for approval expired	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Low enrollment.	['Insufficient_Enrollment']	['Neutral']
short of euqitments	['Negative', 'Business_Administrative']	['Negative', 'Possibly_Negative']
completed patient rectuitment	['Invalid_Reason']	['Invalid_Reason']
Inclusion according to criteria was not practical in our setting.	['Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral']
"Phase III study results for the drug Tesquinimod were not promising so it was a drug
    development decision to stop using the drug"	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Business Objectives Have Changed	['Business_Administrative']	['Possibly_Negative']
Clinical department where study was held was unable to continue collaboration	['Business_Administrative']	['Possibly_Negative']
Study terminated due to Medtronic acquisition	['Business_Administrative']	['Possibly_Negative']
the CELLVIZIO device required to analyse biopsy is available until september 2020	['Logistics_Resources']	['Neutral']
end of inclusion period without patient enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Withdrawal of sponsor support	['Business_Administrative']	['Possibly_Negative']
Strategic decision by Sponsor	['Business_Administrative']	['Possibly_Negative']
"Study terminated as enrolled patients rolled over into a large international study in the same
    indication"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Suspended due to Covid-19	['Covid19']	['Neutral']
Lagging enrollment	['Insufficient_Enrollment']	['Neutral']
Safety concerns	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Scheduled Interim Monitoring	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
standard of care has changed	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Change in strategy regarding the product by the company	['Business_Administrative']	['Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
The dataset was not strong enough to do NLP analysis.	['Interim_Analysis', 'Logistics_Resources', 'Negative']	['Neutral', 'Neutral', 'Negative']
due to poor recrutment	['Insufficient_Enrollment']	['Neutral']
GeneSearch BLN Assay has been voluntarily withdrawn from the US market.	['Business_Administrative']	['Possibly_Negative']
Lactic and metabolic acidosis of OPB-51602 is not tolerable	['Safety_Sideeffects', 'Logistics_Resources', 'Endpoint_Met']	['Safety_Sideeffects', 'Neutral', 'Neutral']
"Recommendation from the DSMB following recurrent DVT in 3/4 participants who underwent the
    thrombectomy procedure."	['Safety_Sideeffects', 'Negative', 'Another_Study']	['Safety_Sideeffects', 'Negative', 'Neutral']
Investigator (Dr Amit) not interested to carry out the study	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
"Due to inclusion problems (not recruting enough participants) recruiting participants has
    halted prematurely and will not resume."	['Insufficient_Enrollment']	['Neutral']
insufficient participant population per COVID-19	['Covid19']	['Neutral']
Trouble enrolling patients	['Insufficient_Enrollment']	['Neutral']
Study will not be conducted due to changes related to the investigational agent.	['Study_Design']	['Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
insufficient accrual	['Insufficient_Enrollment']	['Neutral']
Safety	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Early termination of patient enrollment based on business decision	['Business_Administrative']	['Possibly_Negative']
Due to Covid-19, fnding period expired and Phase 2 was not possible.	['Covid19']	['Neutral']
PI left University of Florida	['Study_Staff_Moved']	['Neutral']
Due to low enrollment of participants meeting eligibility criteria	['Insufficient_Enrollment']	['Neutral']
Insufficient Patient Population	['Insufficient_Enrollment']	['Neutral']
"The results of the dose escalation phase did not identify a well-tolerated dose that would
    permit further study in Phase 2."	['Negative']	['Negative']
Lack of suitable patients for recruitment	['Insufficient_Enrollment']	['Neutral']
Due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Unable to enroll	['Insufficient_Enrollment']	['Neutral']
Failed to meet enrollment goals	['Insufficient_Enrollment']	['Neutral']
No participants ever enrolled.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Unable to recruit; all patients interested simply wanted to stop medication	['Insufficient_Enrollment']	['Neutral']
Original principal investigator left institution	['Study_Staff_Moved']	['Neutral']
"Project Never Initiated - no human subjects were enrolled and no data regarding humans was
    collected or studied"	['Invalid_Reason']	['Invalid_Reason']
Terminated for slow enrollment.	['Insufficient_Enrollment']	['Neutral']
Never initiated	['Invalid_Reason']	['Invalid_Reason']
Replaced with updated protocol as H16-02361	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Study was terminated due to futility.	['Negative']	['Negative']
Re-manufacture of drug supply	['Logistics_Resources']	['Neutral']
Pharmacokinetic stopping criteria for the study were met.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Treatment with thymic shielding found safe, another study started.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Withdrawn by Investigator, protocol in revision	['Study_Design']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor halted study.	['Business_Administrative']	['Possibly_Negative']
no accrual for over 12 months	['Insufficient_Enrollment']	['Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Pediatric enrollment very slow.	['Insufficient_Enrollment']	['Neutral']
"UACC-PHX is no longer able to support the study and Novartis is unable to provide drug beyond
    December 2019."	['Business_Administrative']	['Possibly_Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Study closed due to slow accrual and lack of efficacy.	['Insufficient_Enrollment']	['Neutral']
Study endpoint in preceding base study M10-855 not met.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Protocol needed major revisions; lack of money to institute changes	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study never started, no subjects enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Delay in recruitment as per last protocol amendment due to Covid-19	['Covid19']	['Neutral']
"The pharmaceutical company (BMS) would no longer provide nivolumab for the study, so the study
    was terminated early."	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
terminated due to diminishing frequency of thorocotomies and slow enrollment	['Insufficient_Enrollment']	['Neutral']
Study closed	['Invalid_Reason']	['Invalid_Reason']
Incidence of abnormalities of liver function tests is higher than expected in this population.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Due to poor accrual	['Insufficient_Enrollment']	['Neutral']
due to slow accrual and withdrawal of funding	['Insufficient_Enrollment']	['Neutral']
Difficulty in recruiting subjects who meet the inclusion/exclusion criteria	['Insufficient_Enrollment']	['Neutral']
Sponsor administrative decision	['Business_Administrative']	['Possibly_Negative']
Recruitment suspended secondary to social distancing directive associated with Covid-19	['Covid19']	['Neutral']
funding sequestered	['Business_Administrative']	['Possibly_Negative']
Drug was discontinued by manufacturer	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
drug not available	['Logistics_Resources']	['Neutral']
New study initiated	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Loss of funding	['Business_Administrative']	['Possibly_Negative']
Sponsor seeking additional financial support before starting the study	['Business_Administrative']	['Possibly_Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
IRB approval lapsed	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
A corporate decision to suspend development of DiaPep277	['Business_Administrative']	['Possibly_Negative']
COVID-19 Restrictions	['Covid19']	['Neutral']
not enough participants	['Insufficient_Enrollment']	['Neutral']
We were unable to recruit any suitable patients to this study	['Insufficient_Enrollment']	['Neutral']
Principal Investigator Changed	['Study_Staff_Moved']	['Neutral']
Slow recruitment and high dropout rates	['Insufficient_Enrollment']	['Neutral']
"COVID-19 caused the group format to shift, therefore the intervention was not delivered in the
    same manner as the one described in the proposal. The study was stopped as the intervention may
    not be delivered as planned even following COVID-19."	['Covid19']	['Neutral']
Study was stopped due to slower than expected recruitment.	['Insufficient_Enrollment']	['Neutral']
The response rate (5/8) had reached a statistical significant endpoint.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Change of design consideration	['Study_Design']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Volume resuscitation procotol has changed around 2017/2018 to less volume/more vasopressors.	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Uptake of drug into the tumour lesion was negligible	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Insufficient recruitment over time.	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
This study was withdrawn until the evaluation of the nonclinical rat findings is complete.	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Till IRB renewal	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Company no longer operational	['Business_Administrative']	['Possibly_Negative']
"Merck has decided to not pursue phase 3 development of ceralifimod (ONO-4641). The decision was
    not related to any safety and efficacy findings"	['Business_Administrative']	['Possibly_Negative']
The ICTuS 2 portion of the trial has been halted and data will be analyzed.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
"Due to COVID-19 - recruitment suspended since March 2020 in line with guidance from the
    UCLH/UCL Joint Research Office"	['Covid19']	['Neutral']
budget issues	['Business_Administrative']	['Possibly_Negative']
due to the pandemic	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
study never started because of safety alerts in literature regarding the topic to be examined	['No_Context', 'Safety_Sideeffects', 'Study_Design']	['Invalid_Reason', 'Safety_Sideeffects', 'Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Poor enrolment	['Insufficient_Enrollment']	['Neutral']
"The study has been terminated due to difficulties in recruiting subjects into Part C. No safety
    concerns contributed to the termination of the study"	['Insufficient_Enrollment']	['Neutral']
Slow accrual, closed in Phase I.	['Insufficient_Enrollment']	['Neutral']
Sponsor decision (due to low subject enrollment)	['Insufficient_Enrollment']	['Neutral']
Study withdrawn due to business decisions. No subjects were treated.	['Business_Administrative']	['Possibly_Negative']
Excess toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
protocol deviations	['Study_Design']	['Neutral']
financial causes, and the study will be continued within days.	['Business_Administrative']	['Possibly_Negative']
No Participants enrolled	['Insufficient_Enrollment']	['Neutral']
Terminated due to Osimertinib approval	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
sufficient data gathered to support conclusion	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Business reasons	['Business_Administrative']	['Possibly_Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
lack of efficacy	['Negative']	['Negative']
"This study is recruiting under a different title - ""Genotype-Phenotype Correlation of Multiple
    Hereditary Exostoses: Multicentre Project"" NCT00474331"	['Negative', 'Another_Study']	['Negative', 'Neutral']
lack of participation	['Insufficient_Enrollment']	['Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Low cure rate in the study (fluconazole) group	['Negative']	['Negative']
Per PI termination request, no patients enrolled	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
PI left institution	['Study_Staff_Moved']	['Neutral']
Technical difficulty and feasibility issues	['Logistics_Resources']	['Neutral']
"There was toxicity in higher dose groups and a therapeutic dose level was not found in lower
    dose groups."	['Safety_Sideeffects', 'Negative']	['Safety_Sideeffects', 'Negative']
In most sites had difficult to recruitting subjects.	['Insufficient_Enrollment']	['Neutral']
Deemed not human subjects research	['Invalid_Reason']	['Invalid_Reason']
Terminated due to commercial considerations with no patient safety reasons.	['Business_Administrative']	['Possibly_Negative']
funding issues	['Business_Administrative']	['Possibly_Negative']
The study was terimnated - low rate of cases	['Insufficient_Enrollment']	['Neutral']
Enrollment too slow	['Insufficient_Enrollment']	['Neutral']
reprioritization of indications	['Regulatory', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
No funding for the study	['Business_Administrative']	['Possibly_Negative']
No patients enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
COVID restrictions	['Covid19']	['Neutral']
"The study has been stopped for logistic reasons not related to the safety or efficacy of the
    vaccine."	['Logistics_Resources']	['Neutral']
Low patient enrollment	['Insufficient_Enrollment']	['Neutral']
Study terminated by University of Miami Institutional Review Board	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Did not meet target patient accrual goals	['Insufficient_Enrollment']	['Neutral']
DSMB recommended closing the study and publishing the results	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
Male subjects were terminated due to an imbalance in prostate cancer events	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Not enough research staff	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
[Sponsors decision]	['Business_Administrative']	['Possibly_Negative']
Unable to adequatly recruit	['Insufficient_Enrollment']	['Neutral']
Case numbers not enough, however, the funding is over	['Business_Administrative']	['Possibly_Negative']
Study was never open due to lack of funding	['Business_Administrative']	['Possibly_Negative']
Insufficient enrollment.	['Insufficient_Enrollment']	['Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
"Study withdrawn before active to fully evaluate impact of changing practice in target
    population."	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
recruitment rate	['Insufficient_Enrollment']	['Neutral']
2 DLTs had been reported from first 4 patients on lowest possible dose cohort.	['Negative']	['Negative']
Lack of Enrollment	['Insufficient_Enrollment']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Unable to recruit patients	['Insufficient_Enrollment']	['Neutral']
"Terminated October 2009 (in 4th year) due to low enrollment and anticipated drug expiration
    November 2009."	['Insufficient_Enrollment']	['Neutral']
Concerns about safety at the first interim analysis	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Funder and IMP manufacturer withdrew support	['Business_Administrative']	['Possibly_Negative']
Insufficient Patient Recruitment	['Insufficient_Enrollment']	['Neutral']
COVID-19; unable to continue to enroll due to pandemic	['Covid19']	['Neutral']
Recruitment difficult and enrolment low: decision was made to stop the study.	['Insufficient_Enrollment']	['Neutral']
Study closed out due to recruitment complications.	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
no available participants	['Insufficient_Enrollment']	['Neutral']
Unanswered questions regarding indications for device.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
"The study was terminated early by the sponsor on 13 January 2014 due to a decision to modify
    the drug development plan."	['Business_Administrative']	['Possibly_Negative']
Review of new pre-clinical data	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Analysis of designed comparison groups not viable	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Terminated Phase I due to slow accrual without progression to Phase II.	['Insufficient_Enrollment']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Interim analysis (n=52) with significantly differences in primary outcome (LOS)	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
PI and lab have re-located study to The Ohio State University	['Study_Staff_Moved']	['Neutral']
The study was stopped due to inadequate efficacy after 13 patients were evaluated.	['Negative']	['Negative']
lack of recrutment	['Insufficient_Enrollment']	['Neutral']
"recruiting or enrolling participants has halted prematurely by Life-Moms Consortium and will
    not resume; participants are no longer being examined or treated."	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Funder withdrew funding after not accruing any subjects after 1 year.	['Business_Administrative']	['Possibly_Negative']
loss of funding	['Business_Administrative']	['Possibly_Negative']
Practical difficulties in starting active recruitment.	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Unable to meet recruitment goals.	['Insufficient_Enrollment']	['Neutral']
"This study was for National Science Council project. The study was not funded, so the study was
    withdrawn."	['Business_Administrative']	['Possibly_Negative']
No eligible patients could be recruited.	['Insufficient_Enrollment']	['Neutral']
Withdrawn due to lack of eligible participants	['Insufficient_Enrollment']	['Neutral']
slow accrual rate	['Insufficient_Enrollment']	['Neutral']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
"The study was scheduled for completion February 2013. Because of difficulties encountered in
    completing the trial the study was terminated by sponsor June 2013."	['Business_Administrative']	['Possibly_Negative']
Failure to enroll subjects due to change in referral policy.	['Insufficient_Enrollment']	['Neutral']
Study did not reach primary objective; study did not accrue enough patients.	['Insufficient_Enrollment']	['Neutral']
Inadequate accrual rate	['Insufficient_Enrollment']	['Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Unable to meet enrollment milestones	['Insufficient_Enrollment']	['Neutral']
"Per DSMB, study fiber had given subjects more adverse events and made their IBS symptoms worse
    than the psyllium group."	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
COVID-19	['Covid19']	['Neutral']
not yet started	['Invalid_Reason']	['Invalid_Reason']
Awaiting additional funding	['Business_Administrative']	['Possibly_Negative']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Change in study design to be a pilot with no randomization to intervention/control	['Study_Design']	['Neutral']
"The study was terminated early due to difficulties in recruiting subjects, not following
    concerns for the safety or absence of clinical activity in patients."	['Insufficient_Enrollment']	['Neutral']
recruitement difficulty	['Insufficient_Enrollment']	['Neutral']
stopping the marketing of BMP7	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
"Follow up period after primary analysis was prematurely stopped because more mature data will
    not impact the study outcome"	['Negative']	['Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Insufficient recruitmen	['Insufficient_Enrollment']	['Neutral']
study not feasible due to too slow recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of funds	['Business_Administrative']	['Possibly_Negative']
The study was terminated before reaching the estimated sample size because of trial fatigue.	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Study voluntarily stopped by Principal Investigator due to lack of accrual.	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
due to slow recruitment of patients	['Insufficient_Enrollment']	['Neutral']
Non-safety device related issues	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Loss of Funding	['Business_Administrative']	['Possibly_Negative']
unable to validate analytical method	['Logistics_Resources', 'Endpoint_Met', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
"Enrollment was terminated in June 2008 due to market withdrawal of the NexStent Carotid Stent
    System."	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
No patients enrolled. Study did not start.	['Insufficient_Enrollment']	['Neutral']
The study was discontinued prematurely on December 18 2008 due to slow recruitment	['Insufficient_Enrollment']	['Neutral']
Difficulties in recruiting patients	['Insufficient_Enrollment']	['Neutral']
Did not continue with development of DCCR in Very High Triglycerides	['Interim_Analysis', 'Logistics_Resources', 'Endpoint_Met']	['Neutral', 'Neutral', 'Neutral']
Bupivacaine has recently been shown to inhibit osteoclast formation in vitro.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study was never initiated	['Invalid_Reason']	['Invalid_Reason']
10/2005 PI assigned duties as trauma physician in addition other duties	['Study_Staff_Moved']	['Neutral']
Lack of Patient Accrual	['Insufficient_Enrollment']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Patients did not meet inclusion criteria.	['Insufficient_Enrollment']	['Neutral']
Slow patient enrollment and study discontinued after 14 patients enrolled	['Insufficient_Enrollment']	['Neutral']
Not recruiting	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Will re-open at another time	['Invalid_Reason']	['Invalid_Reason']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
"Interim analyses produced signal of intervention efficacy for primary outcomes and weaker
    signal of increased exposure to violence. Therefore, DSMC recommended stopping recruitment in
    May 2018. Enrolled participants completed intervention by Aug 2018"	['Negative']	['Negative']
Phase I completed. Phase II is cancelled.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Patients were not willing to be randomized and therefore recruitment could not continue.	['Insufficient_Enrollment']	['Neutral']
IMP will not be further developed	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Standard of care for dressing changes at the institution now includes treatment intervention	['Study_Design']	['Neutral']
Difficulty controlling for confounding factors	['Safety_Sideeffects', 'Logistics_Resources', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
"Recruitment did not take place for this research due to several delays and then one of the PIs
    moved out of the country and the project was closed"	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
insufficient staff to enroll	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
unable to recruit participants.	['Insufficient_Enrollment']	['Neutral']
Funding was not able to be secured for the study and no participants enrolled.	['Business_Administrative']	['Possibly_Negative']
Lack of support.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Arm C rolled into parallel study; Arms A and B halted for greater efficacy in Arm C	['Negative', 'Another_Study']	['Negative', 'Neutral']
PI made the decision to not continue the study. It was at the Health Canada review stage.	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Teh Priincipal investigator responsible for the trial no longer employed at the study site.	['Study_Staff_Moved']	['Neutral']
Difficulty in recruiting	['Insufficient_Enrollment']	['Neutral']
Business reasons	['Business_Administrative']	['Possibly_Negative']
Closed to accrual before all 12 planned patients were enrolled.	['Insufficient_Enrollment']	['Neutral']
funding terminated	['Business_Administrative']	['Possibly_Negative']
Safety concerns in the treatment arm	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Difficulties for inclusions	['Insufficient_Enrollment']	['Neutral']
failure to enroll	['Insufficient_Enrollment']	['Neutral']
Efficacy study indicated that further study is not warranted	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study was completed at other sites	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"Enrollment was more difficult than expected. It was mutually agreed upon that we would close
    the study. No results to report."	['Insufficient_Enrollment']	['Neutral']
Safety concerns	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
It doesn't meet the requirements of randomized trials	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Inclusion rate not as expected. Not financially possible to involve other centres.	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Reassessing corporate priorities.	['Business_Administrative']	['Possibly_Negative']
Grant application was not funded	['Business_Administrative']	['Possibly_Negative']
no longer interested in doing the study	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Poor Accrual	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Change in trial design	['Study_Design']	['Neutral']
"The pharmaceutical collaborator filed for bankruptcy and as a result, the study was unable to
    move into the phase II portion."	['Business_Administrative']	['Possibly_Negative']
On hold due to Covid-19 restrictions on Site	['Covid19']	['Neutral']
due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Early Stopping Rule: Would not meet interim analysis goal to proceed with enrollment	['Negative']	['Negative']
terminated due to low enrollment rate	['Insufficient_Enrollment']	['Neutral']
lack of funding and staff to conduct the study	['Business_Administrative']	['Possibly_Negative']
Loss of Personnel	['Logistics_Resources']	['Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
No subjects were ever recruited and enrolled.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Funding exhausted	['Business_Administrative']	['Possibly_Negative']
PI left the University	['Study_Staff_Moved']	['Neutral']
Unable to get accurate measurements with existing technology	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
COVID-19 precautions	['Covid19']	['Neutral']
low participant accrual	['Insufficient_Enrollment']	['Neutral']
Insurance now covers post-op HA injections, drastically decreasing enrollment.	['Insufficient_Enrollment']	['Neutral']
"Study design change required protocol/ICF changes, deemed more appropriate to terminate study
    and apply knowledge gained to potential future study design"	['Study_Design']	['Neutral']
The trial was stopped for efficacy futility	['Negative']	['Negative']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Principal Investigator no longer at institution	['Study_Staff_Moved']	['Neutral']
results were not as hypothesized	['Negative']	['Negative']
The number of subjects did not meet the requirements	['Insufficient_Enrollment']	['Neutral']
Difficult to enroll subjects	['Insufficient_Enrollment']	['Neutral']
Due to lack of manpower at the various study sites	['Insufficient_Enrollment']	['Neutral']
Study was stopped due to inability to accrue patients because of competing trials.	['Insufficient_Enrollment']	['Neutral']
Futility	['Negative']	['Negative']
Primary objective not obtained after interim analysis	['Interim_Analysis', 'Negative']	['Neutral', 'Negative']
PI changed institutions and accrual was not completed.	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Not active	['Invalid_Reason']	['Invalid_Reason']
Inclusion rythm too slow.	['Insufficient_Enrollment']	['Neutral']
Difficulties with enrollment.	['Insufficient_Enrollment']	['Neutral']
The trial was terminated early due to futility in reaching the primary endpoint.	['Negative']	['Negative']
PI left institution	['Study_Staff_Moved']	['Neutral']
Data was inconclusive	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Behind enrollment targets	['Insufficient_Enrollment']	['Neutral']
Medtronic Business Decision	['Business_Administrative']	['Possibly_Negative']
PI left the institution	['Study_Staff_Moved']	['Neutral']
Changes in treatment paradigm resulted in a lower than expected rate of accrual.	['Insufficient_Enrollment']	['Neutral']
Because of the impact of COVID-19 pandemic	['Covid19']	['Neutral']
Study never recruited subjects	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
No funding was obtained.	['Business_Administrative']	['Possibly_Negative']
Unable to determine a suitable placebo.	['Logistics_Resources']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Principal Investigator left	['Study_Staff_Moved']	['Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
Slow recruitment caused rethink on the study design	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Lack of Enrollment	['Insufficient_Enrollment']	['Neutral']
Terminated due to pipeline prioritization	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Aim 1 enrollment and study activities have been completed. Aim 2 anticipated start date is
    3/2021."	['Invalid_Reason']	['Invalid_Reason']
Toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
The number and speed of enrollment were significantly less than expected.	['Insufficient_Enrollment']	['Neutral']
enrollment to slow, insufficient funds	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
CDC's decision to down-select vaccine development to single candidate, ACAM2000	['Business_Administrative']	['Possibly_Negative']
due to COVID-19 and lack of financial means to continue	['Covid19']	['Neutral']
Business decision (not for safety reasons)	['Business_Administrative']	['Possibly_Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Unable to enroll participants	['Insufficient_Enrollment']	['Neutral']
"The institutional review board recommended the study stop enrollment prior to achieving its
    initial sample size for patient safety."	['Interim_Analysis', 'Regulatory', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Slow recruitment and lack of time to product launch	['Insufficient_Enrollment']	['Neutral']
This study was terminated early due to futility.	['Negative']	['Negative']
See Detailed Description for termination reason.	['No_Context']	['Invalid_Reason']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
The pharmaceutical company did not want to follow through with support for the study.	['Business_Administrative']	['Possibly_Negative']
accrual	['Insufficient_Enrollment']	['Neutral']
because of the coronavirus (COVID-19), the endoscopy was forbidden	['Covid19']	['Neutral']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Early Phase I study of [123I]MNI-340 did not evidence as marker of disease	['Negative', 'Another_Study']	['Negative', 'Neutral']
Insufficient # subjects available for 2nd group; evaluating alternate study site	['Insufficient_Enrollment']	['Neutral']
"Temporarily paused due to COVID-19 and expected to resume. This is not a suspension of IRB
    approval."	['Covid19']	['Neutral']
Technical issues & lack of funds	['Business_Administrative']	['Possibly_Negative']
PI left institution	['Study_Staff_Moved']	['Neutral']
recruitment problem	['Insufficient_Enrollment']	['Neutral']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Low patient recruitment	['Insufficient_Enrollment']	['Neutral']
recruitment failure	['Insufficient_Enrollment']	['Neutral']
Change in guidelines	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
No participants were enrolled, no funding obtained to perform study	['Business_Administrative']	['Possibly_Negative']
Another institution performed the study	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
Organisatory reason	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Failure to meet pre-specified endpoint for the day 28 cure rate	['Negative']	['Negative']
The study expired at the IRB	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Change in PI and funding	['Business_Administrative']	['Possibly_Negative']
"Very slow accrual; terminated to allow resources to be utilized more effectively on other
    studies. No data analysis completed, nor any conclusions reached."	['Insufficient_Enrollment']	['Neutral']
The study was terminated based on interim analysis. See detailed description.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Awaiting FDA approval to continue	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The sponsor decided to terminate the study due to slow enrollment.	['Insufficient_Enrollment']	['Neutral']
Due to enrollment difficulties compounded by the COVID pandemic.	['Covid19']	['Neutral']
Research question answered by another group of researchers (Sviggum et al)	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Staffing changes resulted in the expiration of IRB approval (2/15/12), and recruitment halted
    (n=84). IRB approval is now current for retrospective analysis."	['Interim_Analysis', 'Regulatory', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
"Because of unexpectedly reduced disease prevalence in the study area, a pragmatic decision was
    taken to terminate recruitment in March 2003."	['Insufficient_Enrollment']	['Neutral']
Low enrollment.	['Insufficient_Enrollment']	['Neutral']
This study has been terminated because of insufficient patient recruitment.	['Insufficient_Enrollment']	['Neutral']
Low pool of subjects	['Insufficient_Enrollment']	['Neutral']
evidence showed chloroquine is not effective against COVID-19	['Covid19']	['Neutral']
Business decision: no safety or efficacy concerns	['Business_Administrative']	['Possibly_Negative']
Study was terminated after enrollment of 3 participants due to recruitment difficulties.	['Insufficient_Enrollment']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
subject recruitment not feasible due to standard care changes	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
study completed	['Invalid_Reason']	['Invalid_Reason']
Sponsor terminated study.	['Business_Administrative']	['Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Study was prematurely terminated due to poor recruitment.	['Insufficient_Enrollment']	['Neutral']
Testing of combination no longer relevant	['Study_Design']	['Neutral']
The study has been terminated due to changed clinical conditions and too few patients available	['Insufficient_Enrollment']	['Neutral']
Insufficient funding	['Business_Administrative']	['Possibly_Negative']
Study in competition with another so it was decided to stop recruitment	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
sufficient data collected	['Invalid_Reason']	['Invalid_Reason']
Our fellow completed the program before we were able to start the study	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
sponsor decision	['Business_Administrative']	['Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Original Principal Investigator left the institution.	['Study_Staff_Moved']	['Neutral']
Termination Date: 30Aug2018; Reason for termination: Lack of Efficacy	['Negative']	['Negative']
reduced ability to recruit sufficient number of patients	['Insufficient_Enrollment']	['Neutral']
Trial was prematurely terminated due to enrollment challenges.	['Insufficient_Enrollment']	['Neutral']
Modifying procedure.	['Study_Design']	['Neutral']
"investigator letter from drug manufacturer stating animal studies showed increased risk of
    cancer which was an unknown adverse event"	['Success', 'Endpoint_Met', 'Study_Design']	['Success', 'Neutral', 'Neutral']
Low patient accrual	['Insufficient_Enrollment']	['Neutral']
At sponsor's discretion	['Business_Administrative']	['Possibly_Negative']
Inadequate recruitment.	['Insufficient_Enrollment']	['Neutral']
Poor Accrual	['Insufficient_Enrollment']	['Neutral']
"Inability to recruit subjects at our hospital due to change in surgical patient population. Not
    worth to continue."	['Insufficient_Enrollment']	['Neutral']
Terminated [Sponsor decision to terminate the study]	['Business_Administrative']	['Possibly_Negative']
"Cystic Fibrosis (CF) data from the double-blind CF Study PTC124-GD-021-CF did not meet
    endpoints."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Drug not being developed for this indication	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Unfortunately, the co-PI and lead community partner relocated out of the target area.
    Therefore, recruiting participants from the target area was not feasible."	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
failure to enroll	['Insufficient_Enrollment']	['Neutral']
low enrollment	['Insufficient_Enrollment']	['Neutral']
This study was stopped due to poor enrollment numbers	['Insufficient_Enrollment']	['Neutral']
Study will not have power to show a difference between groups.	['Negative']	['Negative']
No study drug available. Same concept with new study drug will be explored in M19TGA study	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Study approval deferred by the IRB.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Too few patients included	['Insufficient_Enrollment']	['Neutral']
"On 25April2014, study was terminated before any dosing due to an AE of safety concern that
    occurred in protocol B1731003 with the same drug."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Investigator left institution prior to enrollment of study participants	['Study_Staff_Moved']	['Neutral']
"Mahnaz Kazemipoor has not handed over human subject review board approval letter to her
    colleague."	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Nature of study was changed from ACT to retrospective chart review	['Covid19', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Recruitment by GPs proved to be impossible	['Insufficient_Enrollment']	['Neutral']
decrease in number of eligible patients	['Insufficient_Enrollment']	['Neutral']
key personnel left institution	['Study_Staff_Moved']	['Neutral']
Technical Issues with intervention	['Logistics_Resources']	['Neutral']
"The study stopped prematurely due to and administrative reasons, not based on grounds of
    safety."	['Business_Administrative']	['Possibly_Negative']
SE system by Spirus Medical withdrawn from market in 2011	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
due to administrative issue and financial sponsor decision to suspend ovarian cancer studies	['Business_Administrative']	['Possibly_Negative']
too slow of recruitmentc	['Insufficient_Enrollment']	['Neutral']
exhausted personel after a long recruiting period	['Logistics_Resources']	['Neutral']
Withdrawn per Bayer	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
"Of 36 participants only 8 participants able to fully complete the study procedures. At this
    time, the study will be closed due to poor enrollment numbers."	['Insufficient_Enrollment']	['Neutral']
Slow inclusion	['Insufficient_Enrollment']	['Neutral']
Study cancelled as of 9/12/15. 0 subjects enrolled.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
no patient enrollment	['Insufficient_Enrollment']	['Neutral']
Business objectives have changed	['Business_Administrative']	['Possibly_Negative']
"Due to the high number of multiples pregnancies in the double embryo transfer group, we have
    decided to stop the enrollment of patients at 07/31/2012"	['Insufficient_Enrollment']	['Neutral']
Business Decision	['Business_Administrative']	['Possibly_Negative']
Issues with recruitment.	['Insufficient_Enrollment']	['Neutral']
FDA reclassified so all 522 studies were stopped,	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
No COVID-19 in EU countries - Sponsor withdraw in regulatory stage	['Covid19']	['Neutral']
lack of efficacy	['Negative']	['Negative']
Low enrollment rate	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
The project leader has left the institution	['Study_Staff_Moved']	['Neutral']
No subjects were enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Poor Enrollment	['Insufficient_Enrollment']	['Neutral']
COVID-19 pandemic has halted all recruitment and pushed back the anticipated study start date.	['Covid19']	['Neutral']
Study was expanded and included in another study.	['Negative', 'Another_Study']	['Negative', 'Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
inclusion default	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
"Enrollment was stopped after the sponsor's decision not to pursue the development of lirilumab
    for myeloid malignancies."	['Business_Administrative']	['Possibly_Negative']
"The trial was discontinued due to a lower than anticipated recruitment rate. The decision has
    not been made due to any safety reasons."	['Insufficient_Enrollment']	['Neutral']
Study terminated due to treatment-emergent serious adverse events	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Institutional RDRC dissolved	['Interim_Analysis', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
due to financial problems	['Business_Administrative']	['Possibly_Negative']
Sponsor	['Business_Administrative']	['Possibly_Negative']
Sponsor can not supply drugs anymore.	['Logistics_Resources']	['Neutral']
Conflicting interim data	['Interim_Analysis', 'Logistics_Resources', 'Endpoint_Met']	['Neutral', 'Neutral', 'Neutral']
Recruitment Status	['Insufficient_Enrollment']	['Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
Funding declined. Study never initiated.	['Business_Administrative']	['Possibly_Negative']
Difficulty in recruitment	['Insufficient_Enrollment']	['Neutral']
Awaiting local ethics approval	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Withdrawn due to lack of resources	['Logistics_Resources']	['Neutral']
Difficulties in recruitment	['Insufficient_Enrollment']	['Neutral']
"The study was halted due to futility concerns based on the unmet benchmarks as specified in the
    pilot study protocol."	['Negative']	['Negative']
PI left institution	['Study_Staff_Moved']	['Neutral']
slow accrual rate	['Insufficient_Enrollment']	['Neutral']
Closed due to slow accrual	['Insufficient_Enrollment']	['Neutral']
This study will be terminated due to poor patient recruitments.	['Insufficient_Enrollment']	['Neutral']
Sponsor withdrew support	['Business_Administrative']	['Possibly_Negative']
Company no longer operational	['Business_Administrative']	['Possibly_Negative']
The current protocol did not satisfy IRB requirements	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Data collected under different protocol; funding exhuasted	['Business_Administrative']	['Possibly_Negative']
No inclusions.	['Insufficient_Enrollment']	['Neutral']
Not enough subjects interested in this study	['Insufficient_Enrollment']	['Neutral']
Unexpected difficult recruitment. Study drug expired	['Insufficient_Enrollment']	['Neutral']
Unable to obtain varenicline to provide to participants	['Logistics_Resources']	['Neutral']
Data review showed that the study was underpowered to draw clear conlcusions	['Negative']	['Negative']
Due to unforseen recruiting difficulties, the study was closed.	['Insufficient_Enrollment']	['Neutral']
Insufficient Accrual	['Insufficient_Enrollment']	['Neutral']
Only 1 patient recruited and deemed ineligible.	['Insufficient_Enrollment']	['Neutral']
Unforeseen cost restrictions of the drug halted the execution of this study altogether.	['Business_Administrative']	['Possibly_Negative']
Funding limits exceeded prior to complete enrollment.	['Business_Administrative']	['Possibly_Negative']
"Study terminated due to low probability of achieving a positive outcome on the primary
    endpoint."	['Negative']	['Negative']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
"Study B7601011 was terminated on 29 Jan 2018 due to lack of efficacy in moderate/advanced
    Parkinson's disease."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Not due to safety reasons	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
We were not able to recruit participants.	['Insufficient_Enrollment']	['Neutral']
Study stopped due to lack of patient inclusion	['Insufficient_Enrollment']	['Neutral']
Difficulty in enrolling participants	['Insufficient_Enrollment']	['Neutral']
Unable to begin study due to funding. PI has left organization.	['Business_Administrative']	['Possibly_Negative']
Difficulty in enrolling eligible patients	['Insufficient_Enrollment']	['Neutral']
Futility	['Negative']	['Negative']
Principal Investigator left institution	['Study_Staff_Moved']	['Neutral']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Investigator Left Institution	['Study_Staff_Moved']	['Neutral']
failure to enroll additional subjects	['Insufficient_Enrollment']	['Neutral']
Inadequate enrollment prior to expiration date of unreplaceable blinded investigational product	['Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral']
the study was stopped because the sample size was very difficult to achieve.	['Insufficient_Enrollment']	['Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
"Based on input from regulatory agencies, it is not necessary to conduct this study. An ongoing
    study was sufficient for regulatory purposes."	['Negative', 'Another_Study']	['Negative', 'Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Could not complete study due to administrative challenges	['Business_Administrative']	['Possibly_Negative']
PI no longer at site. Data was not collected	['Study_Staff_Moved']	['Neutral']
Nonapplicable clinical trial	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Low enrolment rate	['Insufficient_Enrollment']	['Neutral']
Lack of equipoise	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Low recruitment rate	['Insufficient_Enrollment']	['Neutral']
funding to support alternate feasible recruitment strategy was not acquired	['Business_Administrative']	['Possibly_Negative']
overweight of hard-ware removals in the Dynaloc group	['Logistics_Resources']	['Neutral']
Withdrawal of funding support	['Business_Administrative']	['Possibly_Negative']
Closed due to futility with only 1 patient accrued	['Insufficient_Enrollment']	['Neutral']
Study personnel left institution before study completion.	['Study_Staff_Moved']	['Neutral']
We cannot enroll enough participants.	['Insufficient_Enrollment']	['Neutral']
Institutional decision	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Due to lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
Withdrawn	['Invalid_Reason']	['Invalid_Reason']
The study was cancelled prior to the enrollment of any participants.	['Invalid_Reason']	['Invalid_Reason']
Study was terminated after completion of Part 1, because Part 2 was no longer appropriate.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
The investigational devices need alterations before validation	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Funding	['Business_Administrative']	['Possibly_Negative']
Poor enrolment	['Insufficient_Enrollment']	['Neutral']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Preparing for Phase II.	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Suspended Development Program	['Business_Administrative']	['Possibly_Negative']
"The study was terminated early due to pre-clinical toxicity data that became available after
    start of trial"	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Lack of eligible subjects, lack of staffing	['Insufficient_Enrollment']	['Neutral']
Technical probelms led to inadequate randomization, and thus the project was terminated.	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
no funding	['Business_Administrative']	['Possibly_Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Trial was never activated	['Invalid_Reason']	['Invalid_Reason']
"lost funding; Shriner Burn Hosp has revoked access to study records. No updates or results can
    be submitted"	['Business_Administrative']	['Possibly_Negative']
Low recruiting rate	['Insufficient_Enrollment']	['Neutral']
Study timeline delay, low site feasibility and delay concerns due to COVID-19.	['Covid19']	['Neutral']
Slow enrollment, access to devices	['Insufficient_Enrollment']	['Neutral']
Study terminated due to too slow enrollment	['Insufficient_Enrollment']	['Neutral']
difficulty enrolling patients	['Insufficient_Enrollment']	['Neutral']
due to low enrollment	['Insufficient_Enrollment']	['Neutral']
This study has never been started	['Invalid_Reason']	['Invalid_Reason']
No active recruitment	['Insufficient_Enrollment']	['Neutral']
ran out of money	['Business_Administrative']	['Possibly_Negative']
"Sites have adjusted their participation priorities due to the pandemic. Not enough site
    interest at this current time to initiate the study."	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study will not be intiated	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Business decision not to continue development	['Business_Administrative']	['Possibly_Negative']
Low recruitment rate. with the final sample primary endpoint could be assessed.	['Insufficient_Enrollment']	['Neutral']
The number of participants needed for this study has been met.	['Invalid_Reason']	['Invalid_Reason']
"Terminated: Study halted prematurely and will not resume; participants are no longer being
    examined or receiving intervention"	['Invalid_Reason']	['Invalid_Reason']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
Closed to accrual in March 2009 for slow accrual.	['Insufficient_Enrollment']	['Neutral']
Principal Investigator left the institution requested termination	['Study_Staff_Moved']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
New Safety Information	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
difficulty with enrollment of subjects	['Insufficient_Enrollment']	['Neutral']
Not enough recruitment during the proposed period.	['Insufficient_Enrollment']	['Neutral']
"No participants enrolled since this study open. The Primary research member (medical school
    student) is no longer available to do this study"	['Insufficient_Enrollment']	['Neutral']
Recruitment target not obtained	['Insufficient_Enrollment']	['Neutral']
Planned recruitment of 630 patients was not possible to achieve within the given time frame	['Insufficient_Enrollment']	['Neutral']
Enrolling participants has halted prematurely and will not resume	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Difficulty enrolling patients as patients wanted articulating spacers.	['Insufficient_Enrollment']	['Neutral']
prototype catheter never delivered	['Logistics_Resources']	['Neutral']
Business reason	['Business_Administrative']	['Possibly_Negative']
The study was suspended because the oncology service decided to adopt the procedure in routine	['Study_Design']	['Neutral']
"Because of many competing trials using the same mechanism of action, but being further advanced
    in development"	['Negative', 'Another_Study']	['Negative', 'Neutral']
No patients recruited. Study didn't get off the ground. PI left.	['No_Context', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
Recruitment challenges despite several attenpts to increase enrollment	['Insufficient_Enrollment']	['Neutral']
Business decision	['Business_Administrative']	['Possibly_Negative']
Enrollment goals were not able to be met	['Insufficient_Enrollment']	['Neutral']
no budget	['Business_Administrative']	['Possibly_Negative']
Study has been terminated due to poor accrual.	['Insufficient_Enrollment']	['Neutral']
Met primary endpoint	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Sufficient clinical results obtained to support study endpoints.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Difficult to obtain informed consent	['Logistics_Resources', 'Regulatory', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Recruitment was stopped, due to slow recruitment rate	['Insufficient_Enrollment']	['Neutral']
We determined that the results would not be worth reporting.	['Logistics_Resources', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Pending COVID-19 pandemic; pending status of product development	['Covid19']	['Neutral']
The DSMB recommended stopping the study due to safety concerns.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
poor patient accrual	['Insufficient_Enrollment']	['Neutral']
Termination due to acquisition of PEAK Surgical by Medtronic	['Business_Administrative']	['Possibly_Negative']
Ran out of drug	['Logistics_Resources']	['Neutral']
Awaiting further funding for study agents	['Business_Administrative']	['Possibly_Negative']
Unable to meet enrollment goals	['Insufficient_Enrollment']	['Neutral']
terminated	['Invalid_Reason']	['Invalid_Reason']
the recently feasibility study shows that the number of patients is insufficient in the centers	['Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral']
Could not recruit total numbers needed	['Insufficient_Enrollment']	['Neutral']
recruiting difficulties	['Insufficient_Enrollment']	['Neutral']
Recruitment was stopped due to lack of funding.	['Business_Administrative']	['Possibly_Negative']
Only the first part of the study was done.	['Invalid_Reason']	['Invalid_Reason']
Principal investigator departure	['Study_Staff_Moved']	['Neutral']
budget constraints	['Business_Administrative']	['Possibly_Negative']
Due to low recruiment rate, the study design is chanced to a feasibility study	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
The study was terminated due to slow enrollment.	['Insufficient_Enrollment']	['Neutral']
Recruiting slower than expected.	['Insufficient_Enrollment']	['Neutral']
Business Reasons	['Business_Administrative']	['Possibly_Negative']
PI Decision	['Invalid_Reason']	['Invalid_Reason']
Negative efficacy results of the MAESTRO-01 study	['Negative', 'Another_Study']	['Negative', 'Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Funding stopped	['Business_Administrative']	['Possibly_Negative']
Budgetary Issues	['Business_Administrative']	['Possibly_Negative']
Funding fell through	['Business_Administrative']	['Possibly_Negative']
"The study was closed due to investigator discretion based on the lack of perceived clinical
    activity observed in the study."	['Negative', 'Business_Administrative']	['Negative', 'Possibly_Negative']
Sponsor terminated study before enrollment Sponsor terminated study before enrollment	['Business_Administrative']	['Possibly_Negative']
This study was withdrawn for business reasons.	['Business_Administrative']	['Possibly_Negative']
Revisiting product options	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Due to poor accrual	['Insufficient_Enrollment']	['Neutral']
Maximum tolerated dose not able to be determined	['Negative']	['Negative']
PI left Massachusetts General Hospital Inpatient service	['Study_Staff_Moved']	['Neutral']
unable to complete due to lack of funding	['Business_Administrative']	['Possibly_Negative']
Sponsor financial decision stemming from low recruitment	['Business_Administrative']	['Possibly_Negative']
problem in funding which will be solved by the end of August	['Business_Administrative']	['Possibly_Negative']
The research protocol was completely changed.	['Study_Design']	['Neutral']
Low enrollment rate, voluntary study suspension of the study	['Insufficient_Enrollment']	['Neutral']
No Patient recruitment	['Insufficient_Enrollment']	['Neutral']
Lucentis, a treatment superior to PDT, has become available i Sweden.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Enrollment Goals not met	['Insufficient_Enrollment']	['Neutral']
Resources can be better spent on higher enrolling studies	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
study was suspended because of difficluty maintaining equipment	['Logistics_Resources']	['Neutral']
Big difficulties to enroll patients	['Insufficient_Enrollment']	['Neutral']
Insufficient sample size to complete study and merged with parent grant funded study	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
No subjects recruited	['Insufficient_Enrollment']	['Neutral']
Could not recruit participants for the study	['Insufficient_Enrollment']	['Neutral']
Study stopped due to lagging enrolment.	['Insufficient_Enrollment']	['Neutral']
Pharmaceutical collaborator pulled funding.	['Business_Administrative']	['Possibly_Negative']
The study did not receive funding.	['Business_Administrative']	['Possibly_Negative']
unable to perform refinement of study procedures to better capture information needed	['Study_Design']	['Neutral']
Challenging Enrollment	['Insufficient_Enrollment']	['Neutral']
Investigator left Institution	['Study_Staff_Moved']	['Neutral']
PI decided to end the study	['Invalid_Reason']	['Invalid_Reason']
Time and resource constraints	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Replaced by another protocol	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Lack of patients	['Insufficient_Enrollment']	['Neutral']
Enrollment on hold due to funding.	['Business_Administrative']	['Possibly_Negative']
At sponsor's decision	['Business_Administrative']	['Possibly_Negative']
The project was not funded	['Business_Administrative']	['Possibly_Negative']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
HRI no longer conducting research.	['Business_Administrative']	['Possibly_Negative']
"Collecting data for the population involved was very difficult. Over 3 years, only 19
    participants were recruited."	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
"low recruitment rate exacerbated by manufacturing shortage and price increase of
    hydroxychloroquine."	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Lack of feasibility due to low recruitment	['Insufficient_Enrollment']	['Neutral']
Study to be redesigned.	['Study_Design']	['Neutral']
COVID-19 pandemic related enrollment pause	['Covid19']	['Neutral']
Program de-prioritized	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
COVID-19 study status being reviewed on an ongoing basis.	['Covid19']	['Neutral']
No inclusion	['Insufficient_Enrollment']	['Neutral']
Business decision	['Business_Administrative']	['Possibly_Negative']
Increased use of commercial product; less eligible patients & poor enrollment.	['Insufficient_Enrollment']	['Neutral']
"Difficulty in recruitment. Mothers of infants preferred to take probiotics bought
    over-the-counter over the possibility of being in a placebo group"	['Insufficient_Enrollment']	['Neutral']
"Due to COVID-19 pandemic and change in the clinical development strategy for the GB1211
    compound"	['Covid19']	['Neutral']
Withdrawn (Study was withdrawn by Sponsor because of change in regulatory strategy.)	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Pediatric development program terminated by sponsor	['Business_Administrative']	['Possibly_Negative']
Terminated per PI's request	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
ran out of funding	['Business_Administrative']	['Possibly_Negative']
Change in clinical development plan	['Business_Administrative']	['Possibly_Negative']
Safety concerns	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Difficulty in enrollment	['Insufficient_Enrollment']	['Neutral']
The trial was prematurely closed due to lack of accrual	['Insufficient_Enrollment']	['Neutral']
Investigator left the institution prior to enrollment of the first participant.	['Study_Staff_Moved']	['Neutral']
Expiration of study funds.	['Business_Administrative']	['Possibly_Negative']
Slow recruitment rate	['Insufficient_Enrollment']	['Neutral']
Study was terminated based on results from pivotal adult AHF study CRLX030A2301	['Negative', 'Another_Study']	['Negative', 'Neutral']
The project was not funded.	['Business_Administrative']	['Possibly_Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Equipment malfunction.	['Logistics_Resources']	['Neutral']
accrual was slow	['Insufficient_Enrollment']	['Neutral']
Primary study team member left organization, study was not completed.	['Study_Staff_Moved']	['Neutral']
Difficulty in finding staff to help with study	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Recruitment Difficulties and Financing Limited and exhausted	['Business_Administrative']	['Possibly_Negative']
Terminated early due to administrative reasons not related to safety.	['Business_Administrative']	['Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Inactive	['Invalid_Reason']	['Invalid_Reason']
Implementation issues	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
Study terminated for reasons unrelated to safety or efficacy.	['Safety_Sideeffects', 'Logistics_Resources', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Due to pending COI review, expected to resume once this is completed	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Business Decision (no enrollment)	['Business_Administrative']	['Possibly_Negative']
Business reasons	['Business_Administrative']	['Possibly_Negative']
Lack of enrolment	['Insufficient_Enrollment']	['Neutral']
Study terminated due to slow accrual with no expansion to additional phase.	['Insufficient_Enrollment']	['Neutral']
Treatment with Chrysalin did not demonstrate benefit compared to placebo.	['Negative']	['Negative']
"The project was stopped by 31-May-2017 because of internal owner decision from out of balance
    enrollment from two groups."	['Business_Administrative']	['Possibly_Negative']
PI decided not to pursue study	['Study_Staff_Moved', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
FDA needs more information from the manufacturing company of the supplements.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Lack of feasibility for completion of the trial within a reasonable time frame.	['Logistics_Resources']	['Neutral']
Study never activated to enrollment.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
See termination reason in detailed description	['No_Context']	['Invalid_Reason']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
based on IDMC decision	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Investigator left Northwestern University	['Study_Staff_Moved']	['Neutral']
Study never opened	['Invalid_Reason']	['Invalid_Reason']
no enough fund	['Business_Administrative']	['Possibly_Negative']
Not able to enroll patients	['Insufficient_Enrollment']	['Neutral']
Coronavirus pandemic	['Covid19', 'Safety_Sideeffects', 'Insufficient_Enrollment']	['Neutral', 'Safety_Sideeffects', 'Neutral']
difficulties to include patients	['Insufficient_Enrollment']	['Neutral']
Slowly recruitment rate. Intermediate analysis	['Negative']	['Negative']
not enough patients enrolled	['Insufficient_Enrollment']	['Neutral']
insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
"higher than anticipated rate of increased post-void residual in subjects who received botulinum
    toxin A injection"	['Safety_Sideeffects', 'Negative']	['Safety_Sideeffects', 'Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
"The study was terminated early for futility according to the stopping rule of the Simon 2-stage
    design."	['Negative']	['Negative']
Change of organizational circumstances.	['Business_Administrative']	['Possibly_Negative']
change in the therapeutic indication	['Study_Design']	['Neutral']
confounding factors impacted the ability to fully complete the aims of this study	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
Company decision to not conduct study	['Business_Administrative']	['Possibly_Negative']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
no participants enrolled	['Insufficient_Enrollment']	['Neutral']
"Study is suspended due to COVID-19 pandemic as a result of recruitment challenges and the
    inability to conduct all study procedures (e.g., bronchoscopy) per protocol."	['Covid19']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Feeder cohort study closed.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Business decision by sponsor	['Business_Administrative']	['Possibly_Negative']
The patient population was not enough to complete enrollment	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
had been finished	['Invalid_Reason']	['Invalid_Reason']
The Silent Hip has been rationalized for business reasons only	['Business_Administrative']	['Possibly_Negative']
FDA and Sponsor closed trial. New post-marketing approval trial in development.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
departure of the principal investigator and nobody else was able to continue this study.	['Study_Staff_Moved']	['Neutral']
Pilot data suggested the paradigm would need significant revision.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Terminated	['Invalid_Reason']	['Invalid_Reason']
CCX872-B will not be available in sufficient quantity to conduct the study.	['Logistics_Resources', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
The study did not recruit/no study activity occurred.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Funding Expiration	['Business_Administrative']	['Possibly_Negative']
Lack of funding/ PI leaving institution	['Business_Administrative']	['Possibly_Negative']
There were no objective responses by patient 7.	['Negative']	['Negative']
premature closure due to lack of accrual	['Insufficient_Enrollment']	['Neutral']
because the study had to be redesigned and restarted as clinical device study	['Study_Design']	['Neutral']
"No one is currently receiving treatment and enrollment is of course on hold. Subjects being
    unblinded to perform interim analysis."	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
A competing trial has been initiated.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Enough data has been collected to allow analysis of the safety profile and risk-benefit.	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
The study was terminated due to slow enrollment.	['Insufficient_Enrollment']	['Neutral']
Unable to enroll	['Insufficient_Enrollment']	['Neutral']
Difficult recruitment	['Insufficient_Enrollment']	['Neutral']
Difficulty recruiting subjects	['Insufficient_Enrollment']	['Neutral']
COVID-19 HOLD	['Covid19']	['Neutral']
"Due to the sale of Cardene IV, the sponsor has stopped enrollment and withdrawn the study. No
    safety issues were identified."	['Business_Administrative']	['Possibly_Negative']
Unable to fulfill recruitment	['Insufficient_Enrollment']	['Neutral']
Insufficient Fund	['Business_Administrative']	['Possibly_Negative']
COVID-19 Research Restrictions	['Covid19']	['Neutral']
COVID precautions	['Covid19']	['Neutral']
Study stopped early due to staffing changes at the site.	['Logistics_Resources']	['Neutral']
Development of SRM003 was discontinued based on portfolio prioritization.	['Business_Administrative']	['Possibly_Negative']
Study halted by sponsor for business reasons	['Business_Administrative']	['Possibly_Negative']
"There were no safety or effectiveness concerns. There were concerns about completing enrollment
    due to a competitive device's potential approval."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Safety Issue: The trial was prematurely terminated on Dec 9, 2010, due to safety concerns,
    specifically new emerging evidence of hepatic injury."	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Unable to recruit the adequate number of subjects	['Insufficient_Enrollment']	['Neutral']
Efficacy was not cleared at US study	['Negative']	['Negative']
"Following the DSMB recommendation. Study population being insufficiently symptomatic to enable
    differentiation between treatment and placebo. No safety concerns"	['Negative']	['Negative']
Slow patients recruitment	['Insufficient_Enrollment']	['Neutral']
study was terminated by investigator due to low enrollment	['Insufficient_Enrollment']	['Neutral']
COVD-19	['Covid19']	['Neutral']
Study closed to accrual after the company chose to stop development of the drug.	['Insufficient_Enrollment']	['Neutral']
Not IRB approved	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
inadequate methodology to determine primary outcome	['Negative', 'Another_Study']	['Negative', 'Neutral']
non-compliance issues	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Study was terminated early due to Sponsor decision and not reflective of adverse safety
    findings."	['Safety_Sideeffects', 'Endpoint_Met', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Sponsor request	['Business_Administrative']	['Possibly_Negative']
Change in treatment priorities for these disease types as well as staffing concerns.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
lack of accrual	['Insufficient_Enrollment']	['Neutral']
Study no longer at LU.	['Study_Staff_Moved']	['Neutral']
"The Coherence Therapy intervention could not be delivered in a reliable and valid way for a
    variety of reasons."	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Unable to recruit any subjects	['Insufficient_Enrollment']	['Neutral']
Expired with IRB (2/2/2019).	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Local authorities no longer require routine PMS studies; GSK does not believe the study would
    add meaningfully to the safety data already available for MMRV."	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Study was terminated due to low accrual.	['Insufficient_Enrollment']	['Neutral']
no funding	['Business_Administrative']	['Possibly_Negative']
Duplicate Study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study was stopped due to slow recruitment	['Insufficient_Enrollment']	['Neutral']
Feasibility issues	['Logistics_Resources']	['Neutral']
"The study is closed to accrual. Enrollment of new patients stopped at the request of CUBIST
    Pharmaceuticals due to slow rate of enrollment."	['Insufficient_Enrollment']	['Neutral']
Sponsor terminated study for business reasons.	['Business_Administrative']	['Possibly_Negative']
Change in the number of approved drugs for metastatic melanoma	['Regulatory', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
"The sponsor decided to terminate study after 70% of participants had experienced a
    progression-free survival event."	['Negative']	['Negative']
The study was terminated due to the slow recruitment rate.	['Insufficient_Enrollment']	['Neutral']
Study was terminated by principal investigator	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
This study was withdrawn for lack of progress. No subjects were recruited.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
This record should not have been created for this study. It is under another sponsor's account.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
All the patients were included	['Invalid_Reason']	['Invalid_Reason']
Change in protocol and delay in study initiation led to new study submission	['Study_Design']	['Neutral']
Funding ended	['Business_Administrative']	['Possibly_Negative']
Not yet submitted, unclear timelines	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
difficult getting subjects	['Insufficient_Enrollment']	['Neutral']
"BMS withdrew support and required this trial to stop enrolling; Phase II portion never began,
    only a Phase I trial."	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
Trial not initiated	['Invalid_Reason']	['Invalid_Reason']
Investigator completing residency program and leaving for a new job	['Study_Staff_Moved']	['Neutral']
"Interim Analysis result indicated the study will not show a significant benefit of the study
    medication on the primary endpoint."	['Negative']	['Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
COVID-19	['Covid19']	['Neutral']
Minimal recruitment. very few patients available with eligibility criteria	['Insufficient_Enrollment']	['Neutral']
One of the study medications, tacrine, is no longer clinically available	['Logistics_Resources']	['Neutral']
Review Board stopped the study after interim analysis reaching stopping rule for efficacy.	['Negative']	['Negative']
The introduction of oral propranolol as a highly efficacious agent for infantile hemangiomas	['Logistics_Resources', 'Endpoint_Met', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Inclusion stopped due to COVID-19	['Covid19']	['Neutral']
Contract terminated	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
The study was stopped by the sponsor based on a non-safety related business priority decision	['Business_Administrative']	['Possibly_Negative']
lack of accrual reevaluating feasibility	['Insufficient_Enrollment']	['Neutral']
Study cancelled because recruitment rate was too slow	['Insufficient_Enrollment']	['Neutral']
Company Decision	['Business_Administrative']	['Possibly_Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Results of 5 first patients show that chips' cauterization interferes the signal	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
No Participants Enrolled	['Insufficient_Enrollment']	['Neutral']
Protocol was withdrawn and closed by IRB in April, 2018 prior to enrollment of first patient	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Enrollment stopped prior to Phase 1b, change in strategic focus	['Business_Administrative']	['Possibly_Negative']
Study will be redesigned.	['Study_Design']	['Neutral']
"Due to extremely slow recruitment, infrequent use of combination triple therapy (MMF,
    cyclosporine, steroids), study was discontinued; Part 2 was not conducted."	['Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Interruption of business relations between Study Sponsor and Device Manufacturer	['Business_Administrative']	['Possibly_Negative']
Recruitment issues	['Insufficient_Enrollment']	['Neutral']
"extended obligations of amended medical device law in Germany 2010 did not allow to continue
    and complete the trial due to budget limitation"	['Business_Administrative']	['Possibly_Negative']
Investigator is no longer at study site	['Study_Staff_Moved']	['Neutral']
data submitted for Food and Drug Administration (FDA) approval	['Interim_Analysis', 'Regulatory', 'Negative']	['Neutral', 'Neutral', 'Negative']
Study data no longer needed	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
PI leaving institution	['Study_Staff_Moved']	['Neutral']
Low subject accrual	['Insufficient_Enrollment']	['Neutral']
Intended number of patients reached	['Invalid_Reason']	['Invalid_Reason']
Poor Accrual	['Insufficient_Enrollment']	['Neutral']
Adult patient population barriers.	['Insufficient_Enrollment']	['Neutral']
Insufficient number of patient records met inclusion criteria	['Insufficient_Enrollment']	['Neutral']
The Study was terminated due to lack of efficacy.	['Negative']	['Negative']
The sponsor have not enough money to support this trial	['Business_Administrative']	['Possibly_Negative']
Study initiation delayed due to COVID 19	['Covid19']	['Neutral']
Inconsistent training status of sniffer dogs	['No_Context', 'Logistics_Resources', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
Participant lost to followup	['No_Context', 'Logistics_Resources', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
See Detailed Description	['No_Context']	['Invalid_Reason']
no accrual	['Insufficient_Enrollment']	['Neutral']
Terminated to focus on comparable trial, CLOMDS02507	['Negative', 'Another_Study']	['Negative', 'Neutral']
PI chose not to conduct the study; no data collected.	['Invalid_Reason']	['Invalid_Reason']
insufficient accrual	['Insufficient_Enrollment']	['Neutral']
"PI permanently closed accrual for the study based on FDA warning issued in April 2014. Study is
    closed"	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Sara Cheng, MD has left the University of Colorado and we have closed this study.	['Study_Staff_Moved']	['Neutral']
The study was stopped due to patient enrollment challenges.	['Insufficient_Enrollment']	['Neutral']
The study had been revised and made a new application.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Study withdrawn from IRB approval process by PI	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Business Reasons	['Business_Administrative']	['Possibly_Negative']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
challenge in recruitment	['Insufficient_Enrollment']	['Neutral']
limited recruitment within study timeline	['Insufficient_Enrollment']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
"Since only 1 of the first 10 subjects responded to the study treatment, it was decided to stop
    the trial due to lack of efficacy ."	['Negative']	['Negative']
Longer than expected recruitment period.	['Insufficient_Enrollment']	['Neutral']
Temporary pause on non-COVID clinical trial recruitment at study site	['Covid19']	['Neutral']
Technology used to obtain/measure cerebral state index is no longer manufactured	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
Stopped after the outcome of cabozantinib Phase 3 CRPC study XL184-307.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Low accrual rate	['Insufficient_Enrollment']	['Neutral']
"Initial number of 250 was not based on sample size. Most airway studies use n=100 therefore
    trial stopped when 120 children recruited"	['No_Context', 'Logistics_Resources', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
Enrollment Difficulty	['Insufficient_Enrollment']	['Neutral']
PI relocated to another Institution	['Study_Staff_Moved']	['Neutral']
Due to low enrollment	['Insufficient_Enrollment']	['Neutral']
All patients were started on HCV treatment	['No_Context', 'Logistics_Resources', 'Endpoint_Met']	['Invalid_Reason', 'Neutral', 'Neutral']
Due to poor enrollment rate	['Insufficient_Enrollment']	['Neutral']
The study failed to recruit within the permitted timeframe	['Insufficient_Enrollment']	['Neutral']
Study terminated early based on Adult AHF study CRLX030A2301 results	['Negative', 'Another_Study']	['Negative', 'Neutral']
Difficulty with patient recruitment.	['Insufficient_Enrollment']	['Neutral']
"This study has been terminated early as the esreboxetine development program is being
    discontinued. There are no safety or efficacy concerns."	['Business_Administrative']	['Possibly_Negative']
Difficulty recruiting subjects.	['Insufficient_Enrollment']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
terminated ( Halted prematurely,expiration of investigationnal product)	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Stopped by DSMB due to increased wound infection rate.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Grant application was not funded	['Business_Administrative']	['Possibly_Negative']
Administratively Complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Sponsor decision to stop the study	['Business_Administrative']	['Possibly_Negative']
The trial did not show any positive effects.	['Negative']	['Negative']
Sponsor terminated study prior to initiation.	['Business_Administrative']	['Possibly_Negative']
Product Enhancements completed	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Sponsor Discretion	['Business_Administrative']	['Possibly_Negative']
Corporate decision	['Business_Administrative']	['Possibly_Negative']
methodological difficulties	['Logistics_Resources']	['Neutral']
FDA determination of Fox software as class III medical device, not CDSS.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Site was unable to reach Sponsor recruitment goals.	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
adverse effect	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Similar study published results	['Negative', 'Another_Study']	['Negative', 'Neutral']
Institution required IND, although FDA did not, so institution did not allow enrollment	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
This study has been difficult to recruit.	['Insufficient_Enrollment']	['Neutral']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
No funding available.	['Business_Administrative']	['Possibly_Negative']
Futility boundary at interim analysis not met	['Negative']	['Negative']
not recruiting patients.	['Insufficient_Enrollment']	['Neutral']
"This study was prematurely discontinued because no improvement was observed in the 800mg dose
    compared to 400mg dose"	['Negative']	['Negative']
The study was terminated by Merck USA. The company did not supply drugs for the study.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Sponsor terminated protocol	['Business_Administrative']	['Possibly_Negative']
slow enrollment, funding ended	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
CPP requalification	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Covid-19	['Covid19']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Low levels of recruitment	['Insufficient_Enrollment']	['Neutral']
Sponsor changed their study product and halted study.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Slow accrual and changes in clinical practice	['Insufficient_Enrollment']	['Neutral']
PI left organization	['Study_Staff_Moved']	['Neutral']
The recruitment rate for the study was inadequate to achieve its enrollment goals.	['Insufficient_Enrollment']	['Neutral']
due to COVID-19	['Covid19']	['Neutral']
never started	['Invalid_Reason']	['Invalid_Reason']
This study was stopped due to insufficient recruitment.	['Insufficient_Enrollment']	['Neutral']
The study was terminated because it is very difficult to recruit more patients.	['Insufficient_Enrollment']	['Neutral']
due to low recruitment rate secondary to very stringent inclusion criteria	['Insufficient_Enrollment']	['Neutral']
The recruitment rate slowed considerably	['Insufficient_Enrollment']	['Neutral']
because of safety problem, this trial was stopped in the hospital	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Problems with recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of efficacy - Futility endpoint reached	['Negative']	['Negative']
"The study was terminated on 02-Jun-2014 due to slow enrollment. The study was not terminated
    for reasons of either safety or efficacy."	['Insufficient_Enrollment']	['Neutral']
Lack of efficacy after interim analysis	['Negative']	['Negative']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Study was terminated as Eisai agreed to voluntarily withdraw Belviq XR from US market.	['Business_Administrative']	['Possibly_Negative']
poorly recruiting	['Insufficient_Enrollment']	['Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
no funding	['Business_Administrative']	['Possibly_Negative']
Study no longer required	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Stopped due to the formation of injection site skin nodules.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Based on results from SYMPLICITY HTN-3	['Negative', 'Another_Study']	['Negative', 'Neutral']
No longer proceeding with application	['Business_Administrative']	['Possibly_Negative']
Low Enrollment	['Insufficient_Enrollment']	['Neutral']
Terminated due to lack of funding required to continue the study.	['Business_Administrative']	['Possibly_Negative']
Lack of recruitment during COVID	['Covid19']	['Neutral']
COVID-19 - To resume most likely in 2021	['Covid19']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
funding for study stopped	['Business_Administrative']	['Possibly_Negative']
"The study was prematurely terminated by S+N due to business reasons. After an extensive review
    of all ongoing studies with the focus on which studies are still required for regulatory
    obligations S+N took the decision to close the REDAPT 15 study."	['Business_Administrative']	['Possibly_Negative']
"Study suspended due to civil unrest and corresponding safety concerns and logistical
    challenges."	['Logistics_Resources']	['Neutral']
PI is leaving institution	['Study_Staff_Moved']	['Neutral']
No Current Funding	['Business_Administrative']	['Possibly_Negative']
Enrollment rate was too slow.	['Insufficient_Enrollment']	['Neutral']
Suspended failure to follow Conflict of Interest Management Plan	['Business_Administrative']	['Possibly_Negative']
lack of Funding	['Business_Administrative']	['Possibly_Negative']
Gallium is no longer available for the conduct of this study.	['Logistics_Resources']	['Neutral']
Enrollment proceeded too slowly to conduct study as RCT.	['Insufficient_Enrollment']	['Neutral']
"The sponsor-investigator relocated to a different institution and was not able to continue the
    study."	['Study_Staff_Moved']	['Neutral']
SWOG eliminated its head and neck committee	['Regulatory', 'Study_Staff_Moved', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Study finished enrollment but data was never sent for publishing.	['Logistics_Resources', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
No funding stopped recruitment march 2014 with only 14 enrolled	['Business_Administrative']	['Possibly_Negative']
Pending Organization approval	['Business_Administrative']	['Possibly_Negative']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
the PI is no longer work at Hadassah	['Study_Staff_Moved']	['Neutral']
Slow to enroll.	['Insufficient_Enrollment']	['Neutral']
Withdrawn studies.	['Invalid_Reason']	['Invalid_Reason']
Too difficult to recruit given new Crohn's medications approved	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Sponsor decision to terminate the study because the study did not meet the primary endpoint.	['Negative']	['Negative']
Protocol is being reevaluated by sponsor	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Superiority of one imaging method	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Significant recruitment delay in POC part	['Insufficient_Enrollment']	['Neutral']
recruitment was not sufficient.	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
low enrollment	['Insufficient_Enrollment']	['Neutral']
was not approved by the ministry of health	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"In view of recent approval of NS5A inhibitors for treatment of hepatitis C such as Declatasvir
    and Ledipasvir which have proven better efficacy in the HCV cure"	['Negative', 'Another_Study']	['Negative', 'Neutral']
D Hardin not at institution, IRB has no record, no other investigators for study information	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
PI chose not to continue with this unfunded study	['Business_Administrative']	['Possibly_Negative']
Restructuring Cell Lab	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study Terminated due to lack of Funding	['Business_Administrative']	['Possibly_Negative']
Study suspended due to Covid-19 pandemic.	['Covid19']	['Neutral']
Outbreak COVID 19	['Covid19']	['Neutral']
Results from similar research were already published	['Negative', 'Another_Study']	['Negative', 'Neutral']
Terminated by IRB for non-compliance with human subject regulations.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
financial support withdrawn	['Business_Administrative']	['Possibly_Negative']
Investigator left institution	['Study_Staff_Moved']	['Neutral']
Intolerable high amount of adverse events	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"Please see 'Further study details as provided by Acorda Therapeutics' for explanation of why
    study stopped."	['Covid19', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
Sponsor's decision not to pursue further development of the combination in DLBCL	['Business_Administrative']	['Possibly_Negative']
Product no longer on the market	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
PI	['Study_Staff_Moved']	['Neutral']
Business decision	['Business_Administrative']	['Possibly_Negative']
Terminated for administrative reasons and becuase there were no enrollments	['Business_Administrative']	['Possibly_Negative']
Company decision taken in light of demands by certain national health authorities	['Business_Administrative']	['Possibly_Negative']
Loss of funding from sponsor	['Business_Administrative']	['Possibly_Negative']
Principal Investigator left institution; did not complete the study	['Study_Staff_Moved']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
"Future development of AZD1236 is currently under review by the project team and no new studies
    will be started until this review is completed."	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
Technical issues with catheter placement; researcher left institution	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
"research project has been abandoned primarily because of the excessive delays associated with
    past challenges in obtaining approval from Health Canada"	['Business_Administrative']	['Possibly_Negative']
PMA withdrawn	['Regulatory', 'Invalid_Reason', 'Negative']	['Neutral', 'Invalid_Reason', 'Negative']
recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Slow recruitment in pilot phase. A follow-up trial is launched (NCT03796650).	['Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral']
Unrelated to trial	['Invalid_Reason', 'Study_Design', 'Another_Study']	['Invalid_Reason', 'Neutral', 'Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
removal of the Phd student due to not obtaining financing	['Business_Administrative']	['Possibly_Negative']
"CFDA announced Xi'An Risperdal as reference drug, no need for this BE trial from both
    scientific and ethical perspective."	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Due to internal reasons study was not performed.	['Invalid_Reason']	['Invalid_Reason']
unable to enroll subjects into the study	['Insufficient_Enrollment']	['Neutral']
Discontinuation of clinical investigation with NMS-1116354	['Negative', 'Another_Study']	['Negative', 'Neutral']
Blinded interim analysis resulted in early termination of the study.	['Negative']	['Negative']
Study data is currently under review.	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
project progression decision was able to be made with the data already gathered	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
Very low enrollment and follow-up, cannot meet study objectives	['Insufficient_Enrollment']	['Neutral']
Due to the small number of patients, none could be included in the study.	['Insufficient_Enrollment']	['Neutral']
IRB Closure	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"The European Medical Agency granted a Paediatric Investigational Product-specific waiver on the
    grounds that idelalisib is likely to be unsafe in paediatrics"	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Higher hemorrhage rates of Abciximab in ABESST II trial	['Negative', 'Another_Study']	['Negative', 'Neutral']
Initial difficulties recruiting + main researcher had to withdraw from the study	['Insufficient_Enrollment']	['Neutral']
Lack of timely patient accrual	['Insufficient_Enrollment']	['Neutral']
The results from the interim analysis were not favorable to continue this trial.	['Negative']	['Negative']
Pending internal study review and potential protocol modification	['Study_Design']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
The study could not be conducted since funding was not obtained.	['Business_Administrative']	['Possibly_Negative']
Enrollments closed after former PI Eric Hollander left institution. There are no results.	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
The PI was leaving Pennington	['Study_Staff_Moved']	['Neutral']
Investigators moved to other institutions	['Study_Staff_Moved']	['Neutral']
"Lack of resources and not because of any concern with the safety or effectiveness of the
    procedures studied."	['Logistics_Resources']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Efficacy did not meet the continuance criteria and DMC recommended to stop enrollment.	['Negative']	['Negative']
Researcher left University	['Study_Staff_Moved']	['Neutral']
"due to recent release reports from CDC about lung injury due to vaping, the PI and IRB decided
    to terminate the study"	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
lack of response	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Invalid_Reason']	['Safety_Sideeffects', 'Neutral', 'Invalid_Reason']
lack of recrutment	['Insufficient_Enrollment']	['Neutral']
"temporarily paused due to COVID-19 and expected to resume in the future; This is not a
    suspension of IRB approval"	['Covid19']	['Neutral']
Business Decision	['Business_Administrative']	['Possibly_Negative']
Withdrawn because protocol has been discontinued. It was never opened.	['Invalid_Reason']	['Invalid_Reason']
"Sponsor decision to end development of RP103 for mitochondrial disease due to lack of efficacy
    demonstrated in base study RP103-MITO-001."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Protocol was deem insufficient to answer research question	['Logistics_Resources', 'Study_Design', 'Another_Study']	['Neutral', 'Neutral', 'Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
The DMC detected an imbalance in safety outcomes between the two groups.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
0 subjects enrolled	['Insufficient_Enrollment']	['Neutral']
Enrollment goals were not met.	['Insufficient_Enrollment']	['Neutral']
lack of inclusion	['Insufficient_Enrollment']	['Neutral']
Enrolment rate	['Insufficient_Enrollment']	['Neutral']
Support issue.	['Logistics_Resources']	['Neutral']
Inadequate funding	['Business_Administrative']	['Possibly_Negative']
Preliminary data analysis	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
Terminated due to inadequate enrollment	['Insufficient_Enrollment']	['Neutral']
insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Unable to achieve accrural within anticipated timeframe	['Insufficient_Enrollment']	['Neutral']
Suboptimal recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of financial support	['Business_Administrative']	['Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Stopped by the sponsor	['Business_Administrative']	['Possibly_Negative']
The study never started	['Invalid_Reason']	['Invalid_Reason']
Lack of participants	['Insufficient_Enrollment']	['Neutral']
Site did not meet recruitment goals and target numbers	['Insufficient_Enrollment']	['Neutral']
"Due to the arrival of DAAs replacing standard of care for genotype 1 patients the VIRID study
    had to be terminated."	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Submission converted to 510(k)	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
lack of efficacy	['Negative']	['Negative']
Due to lack of recruitment of eligible participants	['Insufficient_Enrollment']	['Neutral']
"This study was terminated because of an interim analysis suggesting futility of papillary
    epinephrine spraying in PEP prevention."	['Negative']	['Negative']
Funding withdrawn due to insufficient enrollment rate	['Business_Administrative']	['Possibly_Negative']
Low rate of enrollment, in conjunction with inability of continuation of funding	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study terminated due to slow recruitment and funding ended.	['Business_Administrative']	['Possibly_Negative']
Not enough participants	['Insufficient_Enrollment']	['Neutral']
Due to slow accrual	['Insufficient_Enrollment']	['Neutral']
One of the 2 nutritional products is reformulated and withdrawn from the market	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Enrollment suspended due to low drug exposure.	['Study_Design']	['Neutral']
Decided to stop drug development	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Poor patient enrollment due to logistical issues	['Insufficient_Enrollment']	['Neutral']
Study withdrawn and combined with a new protocol	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Insufficient accrual of population likely to benefit; progression in 6 patients	['Insufficient_Enrollment']	['Neutral']
efalizumab was withdrawn from market; full 2 years follow-up only 14 patients	['Safety_Sideeffects', 'Negative', 'Another_Study']	['Safety_Sideeffects', 'Negative', 'Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Terminating study as sponsor has sold the drug to another company	['Business_Administrative']	['Possibly_Negative']
For technical reasons	['Logistics_Resources']	['Neutral']
Lack of interest in participation by patients locally and lack of funding.	['Business_Administrative']	['Possibly_Negative']
TV-4710/201 did not meet its primary endpoints in patients with SLE	['Negative']	['Negative']
Terminated: We are no longer recruiting.	['Invalid_Reason']	['Invalid_Reason']
Because there was no funding	['Business_Administrative']	['Possibly_Negative']
Sufficient evidence of efficacy not met. Discontinuation not based on any safety concerns.	['Negative']	['Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
No accrual interest	['Insufficient_Enrollment']	['Neutral']
Lead site preference	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Difficult enrollment	['Insufficient_Enrollment']	['Neutral']
Terminated by sponsor due to low enrollment; see details below	['Insufficient_Enrollment']	['Neutral']
"The study was ended for strategic reasons and changes in the external environment.

    The safety profile and risk benefit ratio for PF-0674775 remained unchanged."	['Business_Administrative']	['Possibly_Negative']
Primary Investigator is no longer employed at LLU as of 02/29/12.	['Study_Staff_Moved']	['Neutral']
insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
"Low accrual of subjects primarily attributable to the low uptake of Cervarix in the US and
    Canada in women aged 15 to 25 years of age."	['Insufficient_Enrollment']	['Neutral']
low qualified candidate enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
The trial was terminated as the participant withdrew from the trial.	['Invalid_Reason']	['Invalid_Reason']
"In the context of the World Health Organization's (WHO) Phase 6 pandemic influenza declaration
    the conduct of the study was deemed no longer feasible"	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Investigator left institution	['Study_Staff_Moved']	['Neutral']
Withdrawn because of lack of approvement from local medical authorities	['Regulatory', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Unable to complete a contract with the Sponsor	['Business_Administrative']	['Possibly_Negative']
Study withdrawn for business reasons prior to screening or enrolling any subjects.	['Business_Administrative']	['Possibly_Negative']
There is no possibility to reach the target patient number within the set time frame	['Insufficient_Enrollment']	['Neutral']
"Approval of adjuvant durvalumab after RT-CT (not anticipated in the study design) and small
    number of stage III NSLCL patients with peripheral tumor accessible to SBRT"	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
"It was decided on 9/21/2016 to terminate this study early because LogPad devices the patients
    used to record their injection data was flawed"	['Logistics_Resources']	['Neutral']
Inability to recruit patients	['Insufficient_Enrollment']	['Neutral']
Technical limitations encountered with the remote monitoring platform	['Logistics_Resources']	['Neutral']
funding unavailable	['Business_Administrative']	['Possibly_Negative']
Negative interim analysis.	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
Recruiting issues and limited personel ressources	['Logistics_Resources']	['Neutral']
we need more participants to complete the research	['Insufficient_Enrollment']	['Neutral']
The study was terminated on 31 May, 2011, due to strategic considerations.	['Business_Administrative']	['Possibly_Negative']
Financial concerns with device manufacturer.	['Business_Administrative']	['Possibly_Negative']
discontinued due to change in operating plans prior to study initiation and enrollment	['Business_Administrative']	['Possibly_Negative']
ViewRay maintenance	['Logistics_Resources']	['Neutral']
Difficulty recruiting	['Insufficient_Enrollment']	['Neutral']
Funding ran out	['Business_Administrative']	['Possibly_Negative']
never started	['Invalid_Reason']	['Invalid_Reason']
Difficulty with enrollment.	['Insufficient_Enrollment']	['Neutral']
PI Left Moffitt	['Study_Staff_Moved']	['Neutral']
Trial completed prematurely.	['Invalid_Reason']	['Invalid_Reason']
Study cancelled	['Invalid_Reason']	['Invalid_Reason']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Study was terminated due to difficulty in recruiting subjects.	['Insufficient_Enrollment']	['Neutral']
No patients were enrolled on the study	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"It has been determined on June 10th that the 205165 study will not progress. This decision has
    been made prior to study start, no patients were screened."	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Patients refuse randomization.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Sponsor decision to terminate the study	['Business_Administrative']	['Possibly_Negative']
Data review	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
Change in study consent process at study site so that study had to be terminated	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
No subjects enrolled	['Insufficient_Enrollment']	['Neutral']
Aim 1 was stopped by DSMB. Aim 2 was stopped due to ending of funding.	['Business_Administrative']	['Possibly_Negative']
Lack of personnel/research time to recruit participants.	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Insufficient accrual	['Insufficient_Enrollment']	['Neutral']
Enrollment and study activities are temporarily suspended due to COVID-19.	['Covid19']	['Neutral']
Participant enrolment was lower than expected	['Insufficient_Enrollment']	['Neutral']
Unable to successfully recruit participants using current study design.	['Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral']
Study Never Initiated due to Impact approval from institution not being obtinaed	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Study is no longer necessary given the safety and efficacy of emflaza in this age range has
    already been established after review of already available data."	['Interim_Analysis', 'Endpoint_Met', 'Negative']	['Neutral', 'Neutral', 'Negative']
Very poor recruitment in the Part 4 of the study	['Insufficient_Enrollment']	['Neutral']
lack of funds	['Business_Administrative']	['Possibly_Negative']
Research Cancelled	['Invalid_Reason']	['Invalid_Reason']
low enrollment	['Insufficient_Enrollment']	['Neutral']
The principal investigator decided to stop the study.	['Invalid_Reason']	['Invalid_Reason']
very difficult recruitment	['Insufficient_Enrollment']	['Neutral']
Poor accrual resulted in lack of feasibility to evaluate endpoints.	['Insufficient_Enrollment']	['Neutral']
Covid-19	['Covid19']	['Neutral']
Low enrollment.	['Insufficient_Enrollment']	['Neutral']
No participants found	['Insufficient_Enrollment']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
"Based on a strategic decision, the application for the trial has been withdrawn before
    initiation."	['Business_Administrative']	['Possibly_Negative']
Business reasons	['Business_Administrative']	['Possibly_Negative']
Cancelled before first patient enrolled	['Invalid_Reason']	['Invalid_Reason']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Difficulty with enrollment and then Covid pandemic	['Covid19']	['Neutral']
"Change in ER rules (no longer allowed endoscopies in ER) prevented ability to perform study
    according to protocol"	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Protocol changed to use subcutaneous rather than intravenous daratumumab.	['Study_Design']	['Neutral']
changing indication from breast cancer to metastatic colorectal cancer	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
"The immune monitoring data failed to demonstrate an improvement in any biologic endpoint with
    denileukin diftitox."	['Negative']	['Negative']
Lack of eligible patients willing and able to participate	['Insufficient_Enrollment']	['Neutral']
No recruitment of patients	['Insufficient_Enrollment']	['Neutral']
Lack of recruitment - only 2 patients recruited.	['Insufficient_Enrollment']	['Neutral']
Evaluating outcomes of current subjects pre further enrollment/dose reduction.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Per sponsor	['Business_Administrative']	['Possibly_Negative']
Recruiting sufficient number of qualified subjects proved impossible.	['Insufficient_Enrollment']	['Neutral']
Total enrollment number is being lowered	['Insufficient_Enrollment']	['Neutral']
Recruitment paused	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Recruiting or enrolling participants has halted prematurely and will not resume.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Low recruitment rate	['Insufficient_Enrollment']	['Neutral']
Study has been cancelled and it has not been initiated.	['Invalid_Reason']	['Invalid_Reason']
"Study was discontinued based on futility analysis done and not based on safety concerns.
    Follow-up visits and closing out study activities are completed"	['Negative']	['Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Decision of the Sponsor	['Business_Administrative']	['Possibly_Negative']
This study was terminated early due to lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
Was unable to recruit subjects	['Insufficient_Enrollment']	['Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Terminated due to poor accrual	['Insufficient_Enrollment']	['Neutral']
Funding and study drugs unavailable	['Business_Administrative']	['Possibly_Negative']
lack of recruitement	['Insufficient_Enrollment']	['Neutral']
It has been decided by the Sponsor not to conduct the trial.	['Business_Administrative']	['Possibly_Negative']
insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Enrollment criteria was too challenging and Investigators changed Institutions	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"FDA recall - Canadian system did voluntary suspension of study; Investigators subsequently
    decided to terminate the study"	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Insufficient research manpower	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
Investigator Decision	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
"This Phase I study was permanently closed to patient accrual on February 23, 2011, due to the
    discontinuation of support from MERCK."	['Business_Administrative']	['Possibly_Negative']
Site never got up and running due to institutional issues	['Logistics_Resources', 'Study_Staff_Moved', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
COVID19-related suspension, recruitment goal cannot be met within time limit of funders	['Covid19']	['Neutral']
Expected mortality rates in placebo and treatment groups lower than predicted	['Safety_Sideeffects', 'Logistics_Resources', 'Endpoint_Met']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Insufficient recruitment rate	['Insufficient_Enrollment']	['Neutral']
Negativity of the first results of in vivo binding of 18F-PBR06	['Negative', 'Another_Study']	['Negative', 'Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
No enrollment	['Insufficient_Enrollment']	['Neutral']
major amendments in progress	['Study_Design']	['Neutral']
The study was stopped early due to slow enrollment.	['Insufficient_Enrollment']	['Neutral']
terminated due to poor accrual	['Insufficient_Enrollment']	['Neutral']
Due to study plan	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Recruitment goals could not be met.	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
did not apply for ethics renewal	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
study drug not available in time	['Logistics_Resources']	['Neutral']
Principal Investigator left the institution in August, 2016;	['Study_Staff_Moved']	['Neutral']
Recruiting patients difficulties	['Insufficient_Enrollment']	['Neutral']
Sponsor decision based off site/PI feedback about	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
PI has encountered recruitment challenges.	['Insufficient_Enrollment']	['Neutral']
Pandemia of the Covid-19	['Covid19']	['Neutral']
Recruitment slow due to improved extravasation rate.	['Insufficient_Enrollment']	['Neutral']
Insufficient recruitment over time	['Insufficient_Enrollment']	['Neutral']
poor enrolment	['Insufficient_Enrollment']	['Neutral']
defect of inclusion	['Insufficient_Enrollment']	['Neutral']
Enrollment and data collection insufficient to continue study.	['Insufficient_Enrollment']	['Neutral']
A cluster of deaths in the BCG-arm compared with controls	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
PI Left	['Study_Staff_Moved']	['Neutral']
Study funding has been withdrawn. No adverse safety issues.	['Business_Administrative']	['Possibly_Negative']
Study follow-up activities affected by COVID-19	['Covid19']	['Neutral']
Withdrawal of support.	['Business_Administrative']	['Possibly_Negative']
lack of efficacy	['Negative']	['Negative']
Could not get an approval from Department Reviewer for the study continuation.	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Unable to find patients matching inclusion criteria	['Insufficient_Enrollment']	['Neutral']
recruitment was stopped as consequence of cessation of funding (economic crisis)	['Business_Administrative']	['Possibly_Negative']
Primary investigator is taking a leave of absence	['Study_Staff_Moved']	['Neutral']
recommendation by Data Monitoring Committee	['Negative']	['Negative']
"The study was extended for 2.5 years. A further extension could not be funded. When the study
    was halted in June 2012, 47 subjects were included."	['Business_Administrative']	['Possibly_Negative']
PI no longer wishes to conduct the study. No participants were enrolled.	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Business Decision; No Safety Or Efficacy Concerns	['Business_Administrative']	['Possibly_Negative']
Due to lack of funding	['Business_Administrative']	['Possibly_Negative']
not enough recruitment	['Insufficient_Enrollment']	['Neutral']
At this time it is felt that we will not gain further information from an additional patients.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Site dropped study	['Invalid_Reason']	['Invalid_Reason']
"Study was terminated due to data from another study showing no efficacy. There were no safety
    issues of concern."	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Phase 3 clinical trial of somavaratan in PGHD did not meet its primary endpoint of
    non-inferiority"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
The study was stopped by the sponsor based on a non-safety related business priority decision.	['Business_Administrative']	['Possibly_Negative']
Funding source unavailable	['Business_Administrative']	['Possibly_Negative']
unexpected histological findings in a phase 2 study in NASH patients CB8025-21730	['Negative', 'Another_Study']	['Negative', 'Neutral']
The study was terminated due to low accrual.	['Insufficient_Enrollment']	['Neutral']
Termination due to incomplete enrollment; planned data analysis not performed	['Insufficient_Enrollment']	['Neutral']
COVID-19 pandemic and related school policies.	['Covid19']	['Neutral']
"All recruitment activities for this study (with acutely ill inpatients with dementia) stopped
    due to the COVID pandemic."	['Covid19']	['Neutral']
Patients meeting inclusion criteria was low, and PI went to another institution.	['Insufficient_Enrollment']	['Neutral']
the study is withdrawn due to low and unexpected enrollment rate	['Insufficient_Enrollment']	['Neutral']
Funding issues	['Business_Administrative']	['Possibly_Negative']
Sponsor business decision not to proceed with the AMG 424 asset.	['Business_Administrative']	['Possibly_Negative']
This study was terminated due to lack of funding.	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Study temporarily suspended until funding can be secured.	['Business_Administrative']	['Possibly_Negative']
Low enrollment.	['Insufficient_Enrollment']	['Neutral']
production of adjuvant to be used with vaccine was discontinued by sponsor	['Logistics_Resources']	['Neutral']
Submitted, denied (too much steps; project to be cut in several projects)	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
"The data from participants with sBCCs showed insufficient efficacy with current formulation and
    treatment conditions."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Due to SARS-CoV2 (Covid-19) pandemia	['Covid19']	['Neutral']
Pandemic response invalidated long-term outcome data collection	['Negative']	['Negative']
The trial is terminated due to re-evaluation of the compound	['Study_Design']	['Neutral']
Device manufacturer no longer supports implant covered under the IDE.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Difficulty in recruiting participants.	['Insufficient_Enrollment']	['Neutral']
"Physicians/audiologists preferred to manage patients with BPPV immediately rather than
    enrolling in study except for difficult to treat cases."	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
IRB approval expired.	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Due to COVID-19 situation IPV is no longer allowed in the center	['Covid19']	['Neutral']
Enrollment was feasibly not going to be reached.	['Insufficient_Enrollment']	['Neutral']
Industry Funding Withdrawn	['Business_Administrative']	['Possibly_Negative']
Terminated at request of sponsor.	['Business_Administrative']	['Possibly_Negative']
"Based on other clinical trial results it was unlikely the study would meet the efficacy
    endpoints"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Non applicable clinical trial	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"Recruitment was fully completed for this study; however, the study was terminated during
    conduct after the primary endpoint analysis was completed."	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Due to slow recruitment, study was stopped before target enrollment was achieved	['Insufficient_Enrollment']	['Neutral']
IND has been closed.	['Regulatory', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Substance discontinued	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Suspended due to lack of funding	['Business_Administrative']	['Possibly_Negative']
Enrollment goals unable to be reached.	['Insufficient_Enrollment']	['Neutral']
Principal Investigator left the university.	['Study_Staff_Moved']	['Neutral']
For Business Reasons	['Business_Administrative']	['Possibly_Negative']
"Study withdrawn for financial problems. We didnwt get a grant we needed for purchesing the
    medication for the study."	['Business_Administrative']	['Possibly_Negative']
"Inadequate enrolment, protocol too challenging for participants, lack of observable benefit
    after analysis of 6 patients."	['Negative']	['Negative']
"The patient recruitment was behind target, no successful completion of the planned patient
    numbers within trial period could be expected"	['Insufficient_Enrollment']	['Neutral']
Funding withdrawn	['Business_Administrative']	['Possibly_Negative']
failure to recruit more patients and lack of supporting personnel.	['Insufficient_Enrollment']	['Neutral']
"Stopped by DSMB for overwhelming benefit of indomethacin (unethical to withhold indomethacin
    from patients)"	['Negative']	['Negative']
low incidence	['Insufficient_Enrollment']	['Neutral']
Study was terminated due to low recruitment.	['Insufficient_Enrollment']	['Neutral']
unable to recruit	['Insufficient_Enrollment']	['Neutral']
Study completed	['Invalid_Reason']	['Invalid_Reason']
Sponsor stopped program]	['Business_Administrative']	['Possibly_Negative']
Replaced by another study.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Inadequate recruitment	['Insufficient_Enrollment']	['Neutral']
Sponsors decision	['Business_Administrative']	['Possibly_Negative']
Investigator elected to end the study	['Invalid_Reason']	['Invalid_Reason']
Did not enroll, PI decided not to proceed.	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
issues with obtaining study product	['Logistics_Resources']	['Neutral']
"Enrollments were suspended due to delta-V2 Env unavailability, following the
    EMA/CHMP/BWP/534898/2008 guideline, not allowing the use of a retest date"	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Unsatisfactory enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of funding to complete subject recruitment and testing	['Business_Administrative']	['Possibly_Negative']
No results are avaialble as the study did not complete according to the protocol	['Negative']	['Negative']
"Primarily due to insufficient recruitment (n = 2 instead of n = 30), the study was prematurely
    discontinued for feasibility reasons. Neither any meaningful results on safety nor on efficacy
    can be reported."	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
study is merged with CONTESSA study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
Study closed by sponsor	['Business_Administrative']	['Possibly_Negative']
"The Pi has estimated that he has received sufficiently biological samples and associated data.
    it's no longer worth following up."	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Extended Carboplatin Infusion did not Reduce Frequency of Hypersensitivity Reactions	['Negative']	['Negative']
Primary endpoint not met	['Negative']	['Negative']
Slow accrual and futility	['Insufficient_Enrollment']	['Neutral']
Unable to recruit patients meeting the inclusion criteria	['Insufficient_Enrollment']	['Neutral']
Recruiting halted prematurely and will not resume. New study to open soon.	['Invalid_Reason']	['Invalid_Reason']
Unable to recruit a sufficient amount of subjects	['Insufficient_Enrollment']	['Neutral']
Withdrawn because SWOG no longer pursuing this study at this time	['Business_Administrative']	['Possibly_Negative']
Research question no longer useful/feasible due to shifts in standards of care	['Study_Design']	['Neutral']
Withdrawn due to other initiatives	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Haven't enrolled participants since 2010	['Insufficient_Enrollment']	['Neutral']
Business decision	['Business_Administrative']	['Possibly_Negative']
Logistical Issues	['Logistics_Resources']	['Neutral']
This study is temporarily suspended due to COVID-19 pandemic	['Covid19']	['Neutral']
Product not available, study withdrawn	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Not enough patients in the follow-up period	['Insufficient_Enrollment']	['Neutral']
Shortage of Increlex supply	['Logistics_Resources']	['Neutral']
Insufficient biological material for analysis	['Logistics_Resources']	['Neutral']
closed due to new safety concerns of subcutaneous buprenorphine in pregnant patients	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
due to new safety information	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"Unable to record n95 pERG peak (primary measure), as LHON subjects are unable to focus on
    target."	['Negative']	['Negative']
"Tecentriq label restriction for first line limited the patient population and scientific
    question could not be answered in an appropriate time."	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Surgical access not facilitated- residues of hydrogel.	['Logistics_Resources']	['Neutral']
Postponed due to COVID-19 pandemic	['Covid19']	['Neutral']
COVID-19	['Covid19']	['Neutral']
The PI decided to not proceed with the trial due to lack of funding.	['Business_Administrative']	['Possibly_Negative']
Risk/benefit determination showed study revealed negative safety issues.	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
low enrollment	['Insufficient_Enrollment']	['Neutral']
(due to change in the post-marketing requirement to assess alirocumab during pregnancy)	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Program Cancelled.	['Invalid_Reason']	['Invalid_Reason']
Unable to recruit adaquate number of GHB dependent subjects	['Insufficient_Enrollment']	['Neutral']
Decision by Sponsor not to continue with the trial.	['Business_Administrative']	['Possibly_Negative']
Resource and time constraints were encountered by product manufacturer and study team.	['Business_Administrative']	['Possibly_Negative']
No eligible patient was enrolled.	['Insufficient_Enrollment']	['Neutral']
Unable to enroll sufficient participants	['Insufficient_Enrollment']	['Neutral']
Due to an administrative reason	['Business_Administrative']	['Possibly_Negative']
Limited interest from colleagues/time constraints	['Business_Administrative']	['Possibly_Negative']
Scientific rationale is deemed obsolete. Funders lost interest in the trial.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
study deemed non-essential under COVID-19 pandemic	['Covid19']	['Neutral']
lack of drug	['Logistics_Resources']	['Neutral']
Limited subjects, patient compliance	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
No participants enrolled.	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Administratively withdrawn by the IRB prior to IRB approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Inability to recruit adequate number of patients within the specified time period.	['Insufficient_Enrollment']	['Neutral']
Device development not completed	['Business_Administrative']	['Possibly_Negative']
Student study which ended at the end of their course.	['Invalid_Reason']	['Invalid_Reason']
Study terminated early as a result of the outcome of the pre-planned Interim Analysis	['Negative']	['Negative']
Failure to achieve primary objective	['Negative']	['Negative']
Current program is on hold, not for safety reason	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Inadequate recruitment	['Insufficient_Enrollment']	['Neutral']
Terminated due to concerns about adverse events in separate study.	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Stopped due to an inability to recruit eligible subjects.	['Insufficient_Enrollment']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Product is no longer being manufactured and marketed.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Investigator is revising protocol.	['Study_Design']	['Neutral']
"Following the COVID-related health crisis, nasofibroscopic sampling could no longer be carried
    out"	['Covid19']	['Neutral']
Problem negotiating other sites	['Logistics_Resources']	['Neutral']
MFR's business decision to d/c TSO production -unrelated to any safety concern.	['Business_Administrative']	['Possibly_Negative']
difficulty with recruitment, PI left the institution	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Due to Covid19 pandemic at this time we are on pause	['Covid19']	['Neutral']
Sponsor elected not to continue with study.	['Business_Administrative']	['Possibly_Negative']
Recruitment	['Insufficient_Enrollment']	['Neutral']
The Covid-19 pandemic that made it impossible to conduct within the timeframe.	['Covid19']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
No patients enrolled. Also, impacted of COVID on enrolling subjects hindered recruitment.	['Covid19']	['Neutral']
Volasertib no longer available	['Safety_Sideeffects', 'Logistics_Resources', 'Regulatory']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Trial was stopped after non-response to treatment.	['Negative']	['Negative']
Negative Efficacy Results from the recently completed Phase 3 study 104-201506	['Negative', 'Another_Study']	['Negative', 'Neutral']
The PI is no longer working at UniNove	['Study_Staff_Moved']	['Neutral']
"The study was truncated due to the long period of enrollment and the collection of a sufficient
    amount of data that allowed the scientific objectives to be met"	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsor is not proceeding with USA human trial at this time	['Business_Administrative']	['Possibly_Negative']
Per Sponsor	['Business_Administrative']	['Possibly_Negative']
Study was stopped due to the expected introduction of a next product generation.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Inadequate support to complete recruitment/data analysis.	['Business_Administrative']	['Possibly_Negative']
"No one recruited due to resource limitations. Issues with how complicated the study could be
    for patients so the study was later modified and turned into a different study."	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Due to slow enrolment.	['Insufficient_Enrollment']	['Neutral']
insufficient enrollment numbers	['Insufficient_Enrollment']	['Neutral']
Interim evaluation of data after internal safety report from sponsor.	['Interim_Analysis', 'Endpoint_Met', 'Negative']	['Neutral', 'Neutral', 'Negative']
Investigator was not able to maintain IRB approval. Study never accrued subjects.	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Funding delayed beyond acceptable start date	['Business_Administrative']	['Possibly_Negative']
Principal Investigator left institution	['Study_Staff_Moved']	['Neutral']
Low recruitment of patients	['Insufficient_Enrollment']	['Neutral']
feasibility of population needed to complete study	['Logistics_Resources']	['Neutral']
"Study stopped for operational futility. Due to very small numbers of subjects, insufficient
    data was available for results to provide meaningful conclusions."	['Negative']	['Negative']
Difficulty finding eligible participants and lack of funding.	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
See termination reason in detailed description	['No_Context']	['Invalid_Reason']
Combined with NCT03266107	['Negative', 'Another_Study']	['Negative', 'Neutral']
low enrolment	['Insufficient_Enrollment']	['Neutral']
"Study halted for efficacy following the results of the interim analysis provided for in the
    protocol on 20 patients."	['Negative']	['Negative']
Unable to Recruit Participants	['Insufficient_Enrollment']	['Neutral']
"Inclusion of the study didn't go as fast as expected. Expect: 234 patients in 1 year in 2
    centers. After 1,5 year only 147 patients were recruited."	['Insufficient_Enrollment']	['Neutral']
No longer have access to equipment used for functional data collection	['Logistics_Resources']	['Neutral']
Investigator elected not to proceed with project	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
It was decided that it was not feasible to continue this study.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Withdrawn	['Invalid_Reason']	['Invalid_Reason']
never initiated; did not recruit patients	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Funding Issue	['Business_Administrative']	['Possibly_Negative']
Poor recruitment, high drop out rate	['Insufficient_Enrollment']	['Neutral']
Enrollment was very slow. Hope to reopen as multi-site study	['Insufficient_Enrollment']	['Neutral']
Toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
COVID-19 Pandemic	['Covid19']	['Neutral']
Preliminary results providing sufficient data	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Drug Recall	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Funding issues	['Business_Administrative']	['Possibly_Negative']
unavailability of the investigational device	['Logistics_Resources']	['Neutral']
"The DSMB committee recommended closing the trial because of the COVID-19 risk in this ""at-risk""
    oGVHD population if they came for study visits."	['Covid19']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Lack of enrollement	['Insufficient_Enrollment']	['Neutral']
Study was not approved for the IRB; we then had no funds to reapply	['Business_Administrative']	['Possibly_Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Funding unavailable	['Business_Administrative']	['Possibly_Negative']
Limited number of subjects	['Insufficient_Enrollment']	['Neutral']
The study was suspended due to organizational problems	['Business_Administrative']	['Possibly_Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
The study was terminated for logistic reasons	['Logistics_Resources']	['Neutral']
PI left institution and loss of funding	['Business_Administrative']	['Possibly_Negative']
insufficient efficacy	['Negative']	['Negative']
Company closed	['Business_Administrative']	['Possibly_Negative']
lack of patient	['Insufficient_Enrollment']	['Neutral']
inability to recruit subjects	['Insufficient_Enrollment']	['Neutral']
No potential participants met entry criteria	['Insufficient_Enrollment']	['Neutral']
"Terminated: recruiting or enrolling participants has halted prematurely and will not resume;
    participants are no longer being examined or treated"	['Invalid_Reason']	['Invalid_Reason']
Study was stopped following interim analysis.	['Negative']	['Negative']
Over budget, slow recruitment, and personnel change	['Business_Administrative']	['Possibly_Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Difficulty in participant recruitment	['Insufficient_Enrollment']	['Neutral']
Difficulties with participant recruitment.	['Insufficient_Enrollment']	['Neutral']
Funding issues	['Business_Administrative']	['Possibly_Negative']
Poor Enrollment	['Insufficient_Enrollment']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Lack of inclusion due to changed medical practice	['Study_Design']	['Neutral']
no new location to open	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
Lead researcher completed fellowship and never got study off ground	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Too few interns willing to consent to wear the actigraph watches.	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
PI decision	['Invalid_Reason']	['Invalid_Reason']
"Study was stopped due to poor enrollment on 28 Feb 2012. Reason for termination was not due to
    safety concerns."	['Insufficient_Enrollment']	['Neutral']
Administrative Decision	['Business_Administrative']	['Possibly_Negative']
Low patient accrual	['Insufficient_Enrollment']	['Neutral']
Drug supplier did not come through.	['Logistics_Resources']	['Neutral']
Inability to recruit subjects	['Insufficient_Enrollment']	['Neutral']
Sponsor request	['Business_Administrative']	['Possibly_Negative']
due to lack of interest	['Business_Administrative']	['Possibly_Negative']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Not enough patients enrolling	['Insufficient_Enrollment']	['Neutral']
Terminated due to lack of assistance and time to carry out the research.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Few subject enrolled	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
accrual	['Insufficient_Enrollment']	['Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
"The BfArM (CA)approved the trial in Nov 2008. However, the responsible EC refused approval in
    March 2009."	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study terminated due to poor patient recruitment.	['Insufficient_Enrollment']	['Neutral']
Study terminated	['Invalid_Reason']	['Invalid_Reason']
Transfer of IND to new marketing authorization holder	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Superceded by a larger trial by the pharmaceutical company	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"The study treatment failed to demonstrate efficacy in target population in two other clinical
    studies (CAFQ056B2214 and CAFQ056A2212)."	['Negative', 'Another_Study']	['Negative', 'Neutral']
No additional efficacy seen with REGN2176-3 over aflibercept alone	['Negative']	['Negative']
The Principal Investigator left the site.	['Study_Staff_Moved']	['Neutral']
Closed due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Very slow recruitment	['Insufficient_Enrollment']	['Neutral']
"The study was terminated on 24JUN15 due to change in strategy of PF-03084014 development.No
    safety/efficacy concerns were behind the reason of trial termination"	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
This study is terminated due to COVID-19 pandemic	['Covid19']	['Neutral']
Inability to recruit patients	['Insufficient_Enrollment']	['Neutral']
Study revised significantly. New trial to be launched.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Poor enrollment numbers of patients	['Insufficient_Enrollment']	['Neutral']
enrollment was completed	['Invalid_Reason']	['Invalid_Reason']
PI Left University	['Study_Staff_Moved']	['Neutral']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
no funding available	['Business_Administrative']	['Possibly_Negative']
poor enrollment and lack of funding	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study was discontinued as it did not achieve functional secondary endpoints.	['Negative']	['Negative']
"to carry out the rest of the study with new CRO and modified protocol as a multi-regional
    study."	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Slow enrollment rate.	['Insufficient_Enrollment']	['Neutral']
Joined another larger group of same study	['Negative', 'Another_Study']	['Negative', 'Neutral']
We decided to alter the intervention.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Low accrual and funding term ended	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Due to protocol feasibility given the rapid evolution of medical practice for spinal procedure.
    Data from approximately 65 FUSION study subjects will be analyzed with the intent to create
    either a future study or registry for this patient population."	['Study_Design']	['Neutral']
Study was terminated due to delay in enrollment.	['Insufficient_Enrollment']	['Neutral']
Recruitment stopped at the end of the recruitment timeframe	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
New study in planning	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Low recruitment rate, bibliographic evidence of lack of efficacy	['Negative']	['Negative']
Too frequent grade 3-4 toxicities	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Due to prohibitively high drug cost, physicians were not prescribing the drug.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
The study was terminated due to lack of adequate patient enrollment into trial.	['Insufficient_Enrollment']	['Neutral']
"This study is on hold due to toxicity findings in a pre-clinical asset with the same mode of
    action as GSK'899. We are assessing the impact of these findings."	['Success', 'Negative', 'Another_Study']	['Success', 'Negative', 'Neutral']
not enough enrollment	['Insufficient_Enrollment']	['Neutral']
Components were recalled by Depuy	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Low patient enrolment during the recruiting period	['Insufficient_Enrollment']	['Neutral']
Suspension of the study upon the decision of the notified body	['Regulatory', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
"Study was terminated in March 2012 due to lack of eficacy in a seperate Phase II study in
    patients."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Komen Foundation Funding Terminated	['Business_Administrative']	['Possibly_Negative']
"Study was prematurely terminated due to difficulties experienced in recruiting patients in a
    reasonable timeframe."	['Insufficient_Enrollment']	['Neutral']
The sponsor was no longer in a position to sponsor a CTIMP. Study did not open.	['Business_Administrative']	['Possibly_Negative']
PI terminated employment with the University	['Study_Staff_Moved']	['Neutral']
new safety concerns which emerged about pioglitazone during the trial	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
"Study funding period reached conclusion. Sample size sufficient to complete the analysis on
    benzodiazepines."	['Business_Administrative']	['Possibly_Negative']
COVID pandemic. Recruited 31 out of target 40 patients.	['Covid19']	['Neutral']
Lack of patient recruitment.	['Insufficient_Enrollment']	['Neutral']
Lack of subjects	['Insufficient_Enrollment']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
"This study was terminated earlier due to a phase III study that showed this drug inferior to
    sorafenib"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Terminated due to lack of eligible patients.	['Insufficient_Enrollment']	['Neutral']
The inclusion/Exclusion criteria was too strict which restricted recruitment	['Insufficient_Enrollment']	['Neutral']
sufficient info	['Invalid_Reason']	['Invalid_Reason']
No enrollment	['Insufficient_Enrollment']	['Neutral']
PI chose to close the study	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Study withdrawn as technology already proven with data no longer needed.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
Low accruals	['Insufficient_Enrollment']	['Neutral']
Resignation of critical volunteer staff and lack of funding	['Business_Administrative']	['Possibly_Negative']
Drug supply unavailable.	['Logistics_Resources']	['Neutral']
study completed	['Invalid_Reason']	['Invalid_Reason']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
The study was terminated due to poor enrollment	['Insufficient_Enrollment']	['Neutral']
Clinical studies stopped, pending funding	['Business_Administrative']	['Possibly_Negative']
never approved	['Interim_Analysis', 'Regulatory', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Funding not received	['Business_Administrative']	['Possibly_Negative']
Costs of study procedures has changed and escalated and became prohibitive.	['Business_Administrative']	['Possibly_Negative']
"Since schools are closed due to the current corona virus situation, the study cannot be
    continued."	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Limited resources	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Interim analysis showed significant results, thus study was stopped	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
"Study was terminated by sponsor due to market authorization of tocilizumab for the study
    population."	['No_Context', 'Regulatory', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
Loss of staff combined with low study enrollment and a change in lab/PI priorities	['Insufficient_Enrollment']	['Neutral']
A strong primary outcome crosses the efficacy boundary at the interim analysis	['Endpoint_Met', 'Negative']	['Neutral', 'Negative']
The study was terminated due to enrolment challenges	['Insufficient_Enrollment']	['Neutral']
PI changed subspecialties and no longer had access to main study population	['Study_Staff_Moved']	['Neutral']
Lack of patient responding to criteria	['Insufficient_Enrollment', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Sponsor closed enrollment early based on interim data from the PRISM US Pivotal Study.	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Owing to the Covid-19 epidemics, investigators have decided to suspend inclusion on Monday 16
    march 2020 for an undetermined period of time"	['Covid19']	['Neutral']
Poor enrolment; only 6 subjects enrolled and they were all screen failures.	['Insufficient_Enrollment']	['Neutral']
PI left Moffitt	['Study_Staff_Moved']	['Neutral']
"Due to the COVID-19 pandemic the financial sponsor of the trial suspended the study funding due
    to funding limitations and based on various considerations, including the uncertainties of
    conducting the study in the volatile scenario of this pandemic."	['Covid19', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Unable to complete enrollment due lack of family interest.	['Insufficient_Enrollment']	['Neutral']
"The biological effect seen with natalizumab was not sufficient to warrant further development
    in RA."	['Negative']	['Negative']
Study was terminated due to futility	['Negative']	['Negative']
recruitment difficulty	['Insufficient_Enrollment']	['Neutral']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
Stop inclusions for insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Due to strict inclusion and exclusion criteria no subjects were enrolled	['Insufficient_Enrollment']	['Neutral']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
Unable to renegotiate an expired contract w/sponsor providing study med	['Business_Administrative']	['Possibly_Negative']
Change in study design	['Study_Design']	['Neutral']
Not enrolling subjects in the study.	['Insufficient_Enrollment']	['Neutral']
Study drug no longer being clinically developed by manufacturer	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Lack of patients for recruitment	['Insufficient_Enrollment']	['Neutral']
Company decision to pursue alternative clinical trial	['Business_Administrative']	['Possibly_Negative']
The study pharmacodynamic stopping criteria were met after the first dosing group	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
PI left National Jewish Health	['Study_Staff_Moved']	['Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Study was terminated as enrollment rate did not meet the requirement of the Sponsor.	['Insufficient_Enrollment']	['Neutral']
Budgetary and Timing Constraints	['Business_Administrative']	['Possibly_Negative']
slow enrollment, lack of patients	['Insufficient_Enrollment']	['Neutral']
Study re-design	['Study_Design']	['Neutral']
Study was terminated early for business reasons (not safety reasons).	['Business_Administrative']	['Possibly_Negative']
NCI stopped supplying fenretinide in November of 2012.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
Accrual slower than anticipated	['Insufficient_Enrollment']	['Neutral']
Difficulties with recruitment	['Insufficient_Enrollment']	['Neutral']
Due to slow, insufficient accrual.	['Insufficient_Enrollment']	['Neutral']
Significant difference not reached on interim analysis	['Negative']	['Negative']
Lost Funding	['Business_Administrative']	['Possibly_Negative']
Data has been published on this study (this would have been a duplicate study)	['Negative', 'Another_Study']	['Negative', 'Neutral']
The foundations of our pilotstudy planning has changed.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
"Study paused per DSMB pending investigation of Adverse Event occurrence in an unrelated gene
    therapy study involving sickle cell patients."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Difficult to find patients that accepted the study	['Insufficient_Enrollment']	['Neutral']
Study has been termination early due to financial constraints.	['Business_Administrative']	['Possibly_Negative']
Unable to recruit and enroll eligible subjects.	['Insufficient_Enrollment']	['Neutral']
due to organisational changes	['Business_Administrative']	['Possibly_Negative']
Lack of efficacy	['Negative']	['Negative']
difficulty with enrollment	['Insufficient_Enrollment']	['Neutral']
"Sponsor decision due to the protocol-defined stopping boundary for futility was met based on
    the interim OS data."	['Negative']	['Negative']
Slow accrual; recommended by DSMB.	['Insufficient_Enrollment']	['Neutral']
Temporarily paused due to COVID-19 and expected to resume.	['Covid19']	['Neutral']
Business Decision	['Business_Administrative']	['Possibly_Negative']
Study never started - halted by funder	['Business_Administrative']	['Possibly_Negative']
A preliminary analysis of data from this trial failed to demonstrate any signal of activity.	['Negative']	['Negative']
No enrollment and PI requested study termination per IRB system.	['Insufficient_Enrollment']	['Neutral']
Poor recruitment.	['Insufficient_Enrollment']	['Neutral']
See detailed description	['No_Context']	['Invalid_Reason']
Interim analysis results, study terminated 5/2010	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Difficulty getting parents to complete follow-up assessments	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
"Study objectives were considered as absolete regarding the arrival of new antiviral drugs in
    Egypt."	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
for lack of recruitment	['Insufficient_Enrollment']	['Neutral']
"Recruitment was only stopped after the statistical power of the study was reached and the study
    objectives could be met despite the premature discontinuation."	['Endpoint_Met', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Due to the COVID-19 Pandemic.	['Covid19']	['Neutral']
recruitment slower than expected	['Insufficient_Enrollment']	['Neutral']
Lack of financing of the study drug. Not sufficient financial support.	['Business_Administrative']	['Possibly_Negative']
The trial is not being done at this time	['Invalid_Reason']	['Invalid_Reason']
"All Amgen sponsored AMG102 clinical studies were terminated following a pre-planned Data
    Monitoring Committee safety review of study 20070622."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Temporary hold on recruitment during staff changes at the site	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
Withdrawn by PI	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Strategic decision by Sponsor	['Business_Administrative']	['Possibly_Negative']
This study was stopped due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Inability to recruit patients	['Insufficient_Enrollment']	['Neutral']
PI changed institution and impossible to solve problem with contract's sites	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Not enough number of enrolling patient	['Insufficient_Enrollment']	['Neutral']
"Evolving data with Ipatasertib that changes the known risk / benefit background in pursuing
    future studies."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Cancer Therapy Evaluation Program's (CTEP's) termination of drug supply	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
could not find eligible patients	['Insufficient_Enrollment']	['Neutral']
Responsible party left the university of kentucky without enrolling any participants	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
Study submitted in error	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
"Surgeon team were not happy with the study protocol, the periarticular injection of local
    anesthetics"	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
See Termination Reason in Detailed Description.	['No_Context']	['Invalid_Reason']
Not enough patients eligible for recruitment.	['Insufficient_Enrollment']	['Neutral']
"Too slow recruitment rate. The study has been terminated and will be re-started with an
    improved and more suitable study design."	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"The decision to terminate the trial was based on the slow rate of recruitment across the
    programme of studies"	['Insufficient_Enrollment']	['Neutral']
insufficient accrual/funding withdrawn	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Terminated due to low accrual.	['Insufficient_Enrollment']	['Neutral']
"Recovery Trial showed no convincing evidence that further recruitment would provide conclusive
    proof of worthwhile benefit for the evaluation of Colchicine in patients with Covid-19."	['Covid19', 'No_Context', 'Negative']	['Neutral', 'Invalid_Reason', 'Negative']
Insufficient subject enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of patients	['Insufficient_Enrollment']	['Neutral']
Study did not start	['Invalid_Reason']	['Invalid_Reason']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Temporary halt due to COVID-19 pandemic	['Covid19']	['Neutral']
The study was stopped due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
"The device often failed to detect hypoglycemic episodes in glycogen storage disease patients
    and the rate of false positive alarms was high."	['Safety_Sideeffects', 'Negative']	['Safety_Sideeffects', 'Negative']
Investigator left institution	['Study_Staff_Moved']	['Neutral']
Janssen business decision	['Business_Administrative']	['Possibly_Negative']
Absence of equipoise on the basis of predetermined stopping rules.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Considering more robust design.	['Study_Design']	['Neutral']
Negative Efficacy Results from the recently completed Phase 3 study 104-201506	['Negative', 'Another_Study']	['Negative', 'Neutral']
unable to recruit participants due to political issues	['Insufficient_Enrollment']	['Neutral']
Lack of Enrollment	['Insufficient_Enrollment']	['Neutral']
poor recruitment and no student currently interested in working on this project.	['Insufficient_Enrollment']	['Neutral']
"The study was discontinued early, owing to difficulties in recruiting the target sample after
    seven patients had been recruited."	['Insufficient_Enrollment']	['Neutral']
There was a lack of business need to continue this data collection.	['Business_Administrative']	['Possibly_Negative']
decision of investigator	['Invalid_Reason']	['Invalid_Reason']
Low accrual	['Insufficient_Enrollment']	['Neutral']
terminated due to lack of accrual	['Insufficient_Enrollment']	['Neutral']
Recruitment has been temporarily closed due to COVID-19	['Covid19']	['Neutral']
The trial was terminated due to lack of compliance with GCP regulations.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Time limitation for recruitment exceeded. 72 of 90 estimated sample recruited.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"Terminated due to lack of efficacy demonstrated in relevant participant population in other
    clinical trials."	['Negative', 'Another_Study']	['Negative', 'Neutral']
In response to COVID-19	['Covid19']	['Neutral']
Funds depleted and Ilness of Principal Investigator	['Business_Administrative']	['Possibly_Negative']
Withdrawn: It was decided not to proceed with the study at this time.	['Invalid_Reason']	['Invalid_Reason']
"Azidus, the CRO hired for this study by Prevent Senior has lost the interest to conduct this
    study."	['Logistics_Resources', 'Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Closed at PI discretion	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"The unpromising experience of the French group with topotecan given at a dosage of 0.4
    mg/m2/day over 30 mins w/in 1 hr of radiation (Cancer 2005; 104: 2792)."	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Inclusion rate insufficient	['Insufficient_Enrollment']	['Neutral']
Not able to recruit participants	['Insufficient_Enrollment']	['Neutral']
"we arrived to the end of the inclusion and only 1 patient was recruited. We will submit an
    amendement"	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
External information	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
The study was withdrawn due to an internal decision.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Could not meet enrollment requirement.	['Insufficient_Enrollment']	['Neutral']
Not enough participants - only 5 since the study started	['Insufficient_Enrollment']	['Neutral']
Due to an unfavorable benefit/risk ratio.	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Excess of mortality in the treatment group created safety concerns.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Difficulty in Recruitment	['Insufficient_Enrollment']	['Neutral']
Inability to recruit patients	['Insufficient_Enrollment']	['Neutral']
Replaced by another protocol	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Very slow recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of Enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsor could not fund.	['Business_Administrative']	['Possibly_Negative']
Funding withdrawn	['Business_Administrative']	['Possibly_Negative']
Lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
study to reopen with additional enrollment	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
changes were made to the which needed an entireley new submission	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
"Agios is no longer developing its second pyruvate kinase-R (PKR) activator, AG-519, and
    withdrew its investigational new drug (IND) application in December 2016"	['Business_Administrative']	['Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
Didn't have the resources necessary to carry out the study	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
"Enrollment has temporarily paused due to COVID-19 and is expected to resume in the future; This
    is not a suspension of IRB approval"	['Covid19']	['Neutral']
Timeline to consent prior to intervention start was unfeasible.	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Sponsor suspended study do to funding	['Business_Administrative']	['Possibly_Negative']
"Interaction term analysis result was not significant and thus comparative effectiveness for
    primary and secondary outcomes could not be considered per protocol."	['Negative']	['Negative']
Study transferred out of McGill because PI relocted to another insitution.	['Study_Staff_Moved']	['Neutral']
The study is terminated due to feasibility in recruitment.	['Insufficient_Enrollment']	['Neutral']
insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Principal investigator has left the Institution	['Study_Staff_Moved']	['Neutral']
lack of Financial support	['Business_Administrative']	['Possibly_Negative']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
Recruitment problems	['Insufficient_Enrollment']	['Neutral']
Due to positive preliminary results from other palifermin studies.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of efficacy	['Negative']	['Negative']
study terminated prematurely for financial reasons and Covid-19 pandemic	['Covid19']	['Neutral']
"Encountered significant recruitment challenges, and it was decided to terminate the study
    without recruiting participants."	['Insufficient_Enrollment']	['Neutral']
No participants were enrolled.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Logistic reasons	['Logistics_Resources']	['Neutral']
funding unavailable	['Business_Administrative']	['Possibly_Negative']
"PIs agreed no safety signals were shown, drug did not appear to lessen the risk of preventing
    GVHD no further patients would be enrolled"	['Negative']	['Negative']
Principal Investigator's Request	['Study_Staff_Moved', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
PI transferred to new institution.	['Study_Staff_Moved']	['Neutral']
Low rate of accrual	['Insufficient_Enrollment']	['Neutral']
Lost funding due to low enrollment	['Business_Administrative']	['Possibly_Negative']
insufficient patient recruitment and ECP capacity	['Insufficient_Enrollment']	['Neutral']
"The pilot study demonsttated some new concerns about methodology. So we decided to suspended
    temporarily to added new settings to study design."	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
European reports of liver toxicity from kava meant that the study had to stop	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Unable to recruit adequate number of subjects	['Insufficient_Enrollment']	['Neutral']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
Company Decision	['Business_Administrative']	['Possibly_Negative']
"Ancef (Cefazolin) became the new standard of care (instead of Vancomycin) for GBS prophylaxis
    if the patient is allergic to penicillin."	['Endpoint_Met', 'Study_Design', 'Another_Study']	['Neutral', 'Neutral', 'Neutral']
we were not able to work through the logistics of the study to support enrolment in ER	['Logistics_Resources']	['Neutral']
The risk of donor blood transfusion was unacceptably high in the Short Duration Group	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Funding unavailable	['Business_Administrative']	['Possibly_Negative']
The study was prematurely terminated due to insufficient recruitment.	['Insufficient_Enrollment']	['Neutral']
"Prematurely unblinded based on outcome in other trial. 2 out of 3 particpants in one arm had
    clinically elevated fasting insulin. Adverse event was reported."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Drug became available with insurance reimbursement	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
PI moved to different institution. Decided to concentrate on different studies.	['Study_Staff_Moved']	['Neutral']
Business Decision: No Safety or Efficacy Concerns	['Business_Administrative']	['Possibly_Negative']
"The study was terminated as relationship between GSK3335065 and ventricular tachycardia could
    not be excluded."	['Negative']	['Negative']
Inclusion rate too slow / infeasible.	['Insufficient_Enrollment']	['Neutral']
PI change and no enrollment ever, therefore no data available.	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
Funding problem; trial abandoned.	['Business_Administrative']	['Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
Investigational product needs improvements	['Study_Design']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
MI-CP177 study closed per sponsor decision.	['Business_Administrative']	['Possibly_Negative']
The study was terminated prematurely due to poor recruitment.	['Insufficient_Enrollment']	['Neutral']
created a new protocol with a new study design	['Study_Design']	['Neutral']
Low accrual, unable to meet endpoint in timely manner	['Insufficient_Enrollment']	['Neutral']
participants lost to follow-up;	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Business Decision	['Business_Administrative']	['Possibly_Negative']
Number of included patients is sufficient.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
No participants met the inclusion criteria in an exted period of time.	['Insufficient_Enrollment']	['Neutral']
The PI decided.	['Invalid_Reason']	['Invalid_Reason']
Covid 19 pandemic	['Covid19']	['Neutral']
Recruitment was problematic	['Insufficient_Enrollment']	['Neutral']
"Study was terminated early (10 July 2015) based on preliminary analysis of pharmacokinetic
    data."	['Interim_Analysis', 'Endpoint_Met', 'Negative']	['Neutral', 'Neutral', 'Negative']
Competing studies	['Negative', 'Another_Study']	['Negative', 'Neutral']
The number of inclusion was reached normally	['Invalid_Reason']	['Invalid_Reason']
recruitment difficulty	['Insufficient_Enrollment']	['Neutral']
low recruitment	['Insufficient_Enrollment']	['Neutral']
never been started	['Invalid_Reason']	['Invalid_Reason']
"temporarily paused due to COVID-19 and expected to resume in the future; This is not a
    suspension of IRB approval"""	['Covid19']	['Neutral']
Difficult (slow) Enrollment	['Insufficient_Enrollment']	['Neutral']
no funding available to continue	['Business_Administrative']	['Possibly_Negative']
Not enough subjects enrolled	['Insufficient_Enrollment']	['Neutral']
Lack of patients eligible for the study	['Insufficient_Enrollment']	['Neutral']
Major inclusion difficulties	['Insufficient_Enrollment']	['Neutral']
"Study halted prematurely and will not resume; participants are no longer being examined or
    receiving intervention. Low enrollment and PI leaving institution"	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Study never started	['Invalid_Reason']	['Invalid_Reason']
"enrollment ""0"""	['Insufficient_Enrollment']	['Neutral']
Trial terminated prematurely due to slow recruitment.	['Insufficient_Enrollment']	['Neutral']
"No diagnosis of visceral lesion was placed on 18 included patients. The study is thus stopped
    prematurely for ethical reasons."	['Interim_Analysis', 'Success', 'Logistics_Resources']	['Neutral', 'Success', 'Neutral']
end-point reached	['Invalid_Reason']	['Invalid_Reason']
Decision to stop development of AZD1480	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Study terminated due to business realignment	['Business_Administrative']	['Possibly_Negative']
Discontinued due to non-enrollment.	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
The study is being terminated due to no enrollment in over one year in the control arm	['Insufficient_Enrollment']	['Neutral']
Study was halted due to challenges with recruitment and enrollment.	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Widespread use firstline Pemetrexed; slow recruitment; funding withdrawn..	['Business_Administrative']	['Possibly_Negative']
"This study was discontinued due to an interim analysis in the BN29552 study, which indicated
    that Crenezumab was unlikely to meet its primary endpoint."	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
a lack of a potential patient.	['Insufficient_Enrollment']	['Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Clinical development plans and strategy for RT-100 being re-evaluated	['Business_Administrative']	['Possibly_Negative']
Study terminated due to low recruitment (funding agency halted study).	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Early closure based on audit by study investigators after 3 patients died on study.	['Safety_Sideeffects', 'Negative', 'Another_Study']	['Safety_Sideeffects', 'Negative', 'Neutral']
"DSMB stopped the study based on conclusion of likely futility of treatment on the primary
    outcome."	['Negative']	['Negative']
"The study was discontinued due to the death of a co-investigator and a second co-investigator
    leaving the institution."	['Study_Staff_Moved']	['Neutral']
Insufficient recruitment rate	['Insufficient_Enrollment']	['Neutral']
This study has been merged with 1553 SPECTA, in which brain patients are enrolled	['Negative', 'Another_Study']	['Negative', 'Neutral']
Not initiated	['Invalid_Reason']	['Invalid_Reason']
funding discontinued	['Business_Administrative']	['Possibly_Negative']
Study withdrawn due to personnel limitations.	['Logistics_Resources']	['Neutral']
"Study terminated by Sponsor as a result of a business decision to discontinue the development
    program for MK-8342B for reasons unrelated to safety or efficacy."	['Business_Administrative']	['Possibly_Negative']
Unable to accrue as planned for optional biopsies	['Insufficient_Enrollment']	['Neutral']
Study did not get started.	['Invalid_Reason']	['Invalid_Reason']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
poor accrual	['Insufficient_Enrollment']	['Neutral']
Not feasable due to logistics	['Logistics_Resources']	['Neutral']
due to significant decrease of perinatal mortality in the cerclage group	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Discontinued development of G3139 (oblimersen)	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Too difficult to enroll according to inclusion/exclusion criteria	['Insufficient_Enrollment']	['Neutral']
Due to out-of-date design and non-compliance.	['Study_Design']	['Neutral']
due to slow recruitment and budgetary restraints study was prematurely terminated	['Business_Administrative']	['Possibly_Negative']
"Company decision has been taken in light of recent demands by certain national health
    authorities"	['Business_Administrative']	['Possibly_Negative']
Support withdrawn - Study continued by NCI - see record NCT00006981	['Another_Study', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
COVID 19 restrictions	['Covid19']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Overlapping study, PI preferred to enroll in alternate trial.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Funding issues	['Business_Administrative']	['Possibly_Negative']
Recruitment halted: Failed to achieve efficacy	['Negative']	['Negative']
Due to budget limitations as allocated for a given period.	['Business_Administrative']	['Possibly_Negative']
No Enrollments	['Insufficient_Enrollment']	['Neutral']
Terminated due to a distribution issue with the trial medication	['Logistics_Resources']	['Neutral']
PI is moving to a different institution.	['Study_Staff_Moved']	['Neutral']
Because of a very slow patient recruitment.	['Insufficient_Enrollment']	['Neutral']
Not funded	['Business_Administrative']	['Possibly_Negative']
investigator has left UCSF	['Study_Staff_Moved']	['Neutral']
Obstacles with recruitment	['Insufficient_Enrollment']	['Neutral']
poor accrual	['Insufficient_Enrollment']	['Neutral']
"The study was terminated on August 6, 2012, because 2 large Phase 3 studies showed no clinical
    benefit. This decision was not based on any new safety concerns."	['Negative', 'Another_Study']	['Negative', 'Neutral']
COVID-19 Pandemic	['Covid19']	['Neutral']
discontinued in favor of more promising directions that may benefit patients	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"the manufacturer of the device has been bought and the new company does not want to continue
    the study anymore"	['Business_Administrative']	['Possibly_Negative']
Strategic considerations	['Business_Administrative']	['Possibly_Negative']
Use of Formocresol for pulpotomies ws discontinued.	['Interim_Analysis', 'Logistics_Resources', 'Endpoint_Met']	['Neutral', 'Neutral', 'Neutral']
recruitment not possible	['Insufficient_Enrollment']	['Neutral']
Pharmaceutical company request.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Not able to include enough participants.	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Please see Detailed Description for termination reason.	['No_Context']	['Invalid_Reason']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Attending surgeon on the project is moving to a different facility	['Study_Staff_Moved']	['Neutral']
Low study enrollment; re-evaluating study protocol and study selection criteria.	['Study_Design']	['Neutral']
no participants enrolled	['Insufficient_Enrollment']	['Neutral']
due to weak accrual	['Insufficient_Enrollment']	['Neutral']
Two step study, step two was not feasible based on results from phase one.	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Recent analysis of Phase II balovaptan data in paediatric ASD did not support the continuation
    of this study. No new safety concerns were identified."	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
DSMB decision	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
change in clinical practice- both surgeons have left the institution	['Study_Staff_Moved']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
study never started	['Invalid_Reason']	['Invalid_Reason']
Sponsor decision to not pursue epilepsy development.	['Business_Administrative']	['Possibly_Negative']
Negative results in a similar study	['Negative', 'Another_Study']	['Negative', 'Neutral']
no finance	['Business_Administrative']	['Possibly_Negative']
Recruitment not currently possible owing to current ongoing COVID-19 pandemic.	['Covid19']	['Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
stopped because of a business decision	['Business_Administrative']	['Possibly_Negative']
Difficulty accruing subjects the study accrual was closed	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor stops to provide the study drug.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
No funding obtained	['Business_Administrative']	['Possibly_Negative']
Slow recruitment rate	['Insufficient_Enrollment']	['Neutral']
Sponsor decision based on portfolio prioritization	['Business_Administrative']	['Possibly_Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
"This study was terminated prematurely due to lack of sufficient exposure following single- and
    repeat-dosing."	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
Following recommendation by SOLAR Study IDMC, Astellas closed enrollment in ASP8273 studies.	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Invalid_Reason']	['Safety_Sideeffects', 'Neutral', 'Invalid_Reason']
Other and future studies on lipiview in pterygium will cover this current trial sufficiently.	['Negative', 'Another_Study']	['Negative', 'Neutral']
COVID-19	['Covid19']	['Neutral']
slow enrollment, study device unavailable ( CoreValve)	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Due to covid	['Covid19']	['Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
"25 patients have been recruited and it was considered that further recruitment would add no
    extra PK information"	['No_Context', 'Logistics_Resources', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
Lack of efficacy	['Negative']	['Negative']
"Phase 2 was not conducted due to a change in the standard of care for newly diagnosed,
    unresectable Stage III NSCLC"	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Slow accrural to study.	['Insufficient_Enrollment']	['Neutral']
Phycisican decided to terminate study due to slow patient accrual.	['Insufficient_Enrollment']	['Neutral']
No participant enrolled	['Insufficient_Enrollment']	['Neutral']
Difficulty in enrolling subjects in the proposed crossover study design	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Unable to recruit individuals for the study	['Insufficient_Enrollment']	['Neutral']
Due to an incompatibility with the local procedures	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
similar study data published	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study terminated due to protocol deficiencies.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
change in clinical practice that led to ability to recruit subjects	['Study_Design']	['Neutral']
absorption of oral sildenafil not consistent	['Negative']	['Negative']
Unable to enroll due to protocol exclusion criteria and participant population pool	['Insufficient_Enrollment']	['Neutral']
Single subject remained on study - transferred to compassionate use	['Covid19', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Termination of funding from sponsor.	['Business_Administrative']	['Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Combination of chemotherapy and Immunotherapy is a new Standard of care	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Optimization of protocol	['Study_Design']	['Neutral']
no enrollments	['Insufficient_Enrollment']	['Neutral']
Study subjects were not able to be recruited	['Insufficient_Enrollment']	['Neutral']
The study have been stoped because the protocol is going to be modify.	['Study_Design']	['Neutral']
Inclusion rate insufficint	['Insufficient_Enrollment']	['Neutral']
Insufficient Data Collected	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
The study was closed due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
Negative clinical outcomes	['Negative']	['Negative']
Outbreak COVID 19	['Covid19']	['Neutral']
Study never initiated. PI withdrew protocol with the IRB.	['Study_Staff_Moved']	['Neutral']
Slower than expected recruitment rate, and larger than expected required sample.	['Insufficient_Enrollment']	['Neutral']
Recruitment was too slow due to strict inclusion criteria.	['Insufficient_Enrollment']	['Neutral']
difficulties of enrollement	['Insufficient_Enrollment']	['Neutral']
"Closed by sponsor of the study; PI has left the institution and Columbia is now the sponsor of
    the record"	['Logistics_Resources', 'Study_Staff_Moved', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
"B2341002 was terminated on 26-OCT-2017 for strategic reasons. The decision to terminate the
    trial was not based on any safety concerns."	['Business_Administrative']	['Possibly_Negative']
low recruitment rate	['Insufficient_Enrollment']	['Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
Lack of study recruitment	['Insufficient_Enrollment']	['Neutral']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
"(""Trial terminated (recruitment delays)"")"	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Safety of patients	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
withdrawn because the research efforts at that time followed another path	['Invalid_Reason', 'Study_Design', 'Another_Study']	['Invalid_Reason', 'Neutral', 'Neutral']
Global recall of Hemospray	['Interim_Analysis', 'Regulatory', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
interim analysis does not show good results	['Negative']	['Negative']
Futility	['Negative']	['Negative']
Too low enrolment rate	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment and patient interest in study	['Insufficient_Enrollment']	['Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
Study team felt toxicity of study regimen outweighed potential benefit.	['Negative']	['Negative']
The smartwatches we planned to use were discontinued.	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Covid-19 and we failed to submit annual report for 2017 and 2018	['Covid19']	['Neutral']
"Blinded interim analysis Recommendation, submitted April 1, 2014, was early termination for
    futility."	['Negative']	['Negative']
Study terminated due to financial status of sponsor.	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
treatment was not working	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
There was more benefit from the infusion arm compared to the bolus arm.	['Negative']	['Negative']
Poor patient enrollment from clinic secondary to investigator illness.	['Insufficient_Enrollment']	['Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Closed due to lack of enrollment	['Insufficient_Enrollment']	['Neutral']
"The decision to close the NN2211-3619 trial was based on the very low recruitment rate as well
    as challenges relating to trial execution and study completion."	['Insufficient_Enrollment']	['Neutral']
PI Law left Geisinger-study terminated prematurely - 4 patients enrolled	['Study_Staff_Moved']	['Neutral']
"Temporarily paused due to COVID-19, will resume based on guidance of public health authorities.
    This is not a suspension of IRB approval."	['Covid19']	['Neutral']
"With the determination of the RD and a well established understanding of the safety and
    tolerability profile, the main endpoints of the study have been met."	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Stopped due to COVID-19 pandemic.	['Covid19']	['Neutral']
Due to COVID-19 virus	['Covid19']	['Neutral']
"Study was terminated due to sponsor's decision to not pursue further development of
    andecaliximab in oncology"	['Business_Administrative']	['Possibly_Negative']
The investigational drug celgosivir will not be developed due to lack of VC funding.	['Business_Administrative']	['Possibly_Negative']
INHERENT MODIFICATIONS NEEDED BEFORE PROCEEDING	['Study_Design']	['Neutral']
Study never started and therefore terminated.	['Invalid_Reason']	['Invalid_Reason']
Because of logistic and practical reasons.	['Logistics_Resources']	['Neutral']
Study to be revised. Future plans to be determined.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Study was cancelled before enrolment for reasons not related to vaccine safety or efficacy.	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
PI Leaving Site	['Study_Staff_Moved']	['Neutral']
"Study reached halfway point in approximately one year time period and was halted to analyze
    data."	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
No enrolled patients received the second surgery.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Safety issue	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
low enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of funding.	['Business_Administrative']	['Possibly_Negative']
IRB needs updated	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Per PI's request	['Study_Staff_Moved', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
study will be started under a new modified protocol	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
because a significant decrease of viable candidates for the study.	['Insufficient_Enrollment', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
"The supply of BL22 has expired and MedImmune the sponsor is not interested in producing any new
    supply."	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Suspended due to COVID19	['Covid19']	['Neutral']
Schering-Plough discontinued supplying study drug.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Business decision	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Due to Chief Investigator relocating out of the United Kingdom.	['Study_Staff_Moved']	['Neutral']
Issues with Recruitment.	['Insufficient_Enrollment']	['Neutral']
Lack of eligible patients	['Insufficient_Enrollment']	['Neutral']
Poor accrural	['Insufficient_Enrollment']	['Neutral']
PI left institution prior to completion of study. Data unavailable..	['Study_Staff_Moved']	['Neutral']
Decision to terminate recruitment based on lack of efficacy	['Negative']	['Negative']
not enough inclusion	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
COVID pandemic	['Covid19']	['Neutral']
Tthe study is in the approval phase by local regulatory authorities	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
the study was halted prematurely due to slow recruitment and expiration of funding	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Trial discontinued due to apparent lack of response in psoriasis measures. No safety concerns
    were present"	['Negative']	['Negative']
The study was stopped before reaching its accrual goal due to slow accrual	['Insufficient_Enrollment']	['Neutral']
This study was terminated for futility.	['Negative']	['Negative']
enrollment is difficult and pilot nature of this study	['Insufficient_Enrollment']	['Neutral']
Safety reasons	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Study halted prematurely, prior to enrollment of first participant.	['Invalid_Reason']	['Invalid_Reason']
PI left UF	['Study_Staff_Moved']	['Neutral']
Did not find interested patients.	['Insufficient_Enrollment']	['Neutral']
Due to COVID-19 pandemic, we will not be pursuing this study	['Covid19']	['Neutral']
Terminated to initiate FDA IND-cleared study protocol	['No_Context', 'Regulatory', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
Low Recruitment	['Insufficient_Enrollment']	['Neutral']
Not enough interested participants	['Insufficient_Enrollment']	['Neutral']
Slow Recruitment	['Insufficient_Enrollment']	['Neutral']
Terminated prematurely due to indication change.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Poorly recruiting	['Insufficient_Enrollment']	['Neutral']
Study was transferred to Epizyme under NCT04762160 and new study number EZH-1401	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"CI of study retired on 6.10.2020 and there will be no further efforts to apply for an extension
    in order to recruit to this study."	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Study restarted under new study number 18987	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
Change in cryopreservation protocol	['Study_Design']	['Neutral']
Delay during study initiation. Change of MitraClip design in meantime.	['Study_Design']	['Neutral']
The sponsor of this study has terminated the study due to poor enrollment.	['Insufficient_Enrollment']	['Neutral']
Pre-hypertension no longer exists	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Under additional IRB Review	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The scientific director decided to terminate: low priority study with slow accrual	['Insufficient_Enrollment']	['Neutral']
Preliminary analysis of the results showed no statistically significant difference	['Negative']	['Negative']
Due to the business issues. Manufacturer has been acquired by other company.	['Business_Administrative']	['Possibly_Negative']
"The sctrict inclusion and exclusion criteria made the study unfeasible. No patients were
    enrolled."	['Insufficient_Enrollment']	['Neutral']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Lack of participants	['Insufficient_Enrollment']	['Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Doctoral student running the study left for internship and did not finish the study	['Study_Staff_Moved']	['Neutral']
Ethics board said the study could not be fully justified.	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Company dissolved	['Business_Administrative']	['Possibly_Negative']
Study was terminated early to allow subjects to roll over to study NCT02102204.	['No_Context', 'Insufficient_Enrollment', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
"FDA/IRB approved but hospital administration vetoed the study fearing litigation of a preterm
    birth though the electrical uterine pacemaker/EI is not the cause."	['Regulatory', 'Ethical_Reason', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
The study was terminated due to low accrual.	['Insufficient_Enrollment']	['Neutral']
Funding was pulled after unsuccessful pilot study	['Business_Administrative']	['Possibly_Negative']
The study was never initiated.	['Invalid_Reason']	['Invalid_Reason']
The Relamorelin program is being terminated solely based on a business decision.	['Business_Administrative']	['Possibly_Negative']
funding source ended earlier than anticipated	['Business_Administrative']	['Possibly_Negative']
Management Decision	['Business_Administrative']	['Possibly_Negative']
Protocol halted due to less than anticipated recruitment.	['Insufficient_Enrollment']	['Neutral']
Sponsor chose not to continue	['Business_Administrative']	['Possibly_Negative']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Study halted prematurely and will not resume due to the COVID-19 pandemic.	['Covid19']	['Neutral']
non-accrual	['Insufficient_Enrollment']	['Neutral']
Unable to enroll patients for the trial.	['Insufficient_Enrollment']	['Neutral']
Study was never initiated.	['Invalid_Reason']	['Invalid_Reason']
"Naloxone became unavailable due to manufacturing shortatges requiring the study to be
    terminated."	['Logistics_Resources']	['Neutral']
"DSMB recommended termination due to lower survival to discharge in primary population and worse
    discharge CPC scores in the treatment arm than control arm."	['Negative']	['Negative']
Due to slow recruitment, the study had to be terminated prematurely.	['Insufficient_Enrollment']	['Neutral']
Lack of sufficient enrollment	['Insufficient_Enrollment']	['Neutral']
AbbVie decided to stop trial involving Venetoclax for safety measures needed	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Other projects took precedence, no mechanism of funding establed	['Business_Administrative']	['Possibly_Negative']
Recruitment was not achieved as expected	['Insufficient_Enrollment']	['Neutral']
lack of efficacy	['Negative']	['Negative']
"Due to the ubiquitous use of ICS in the treatment of COPD in 2012, it was hard to find the
    study population."	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Lack of patient enrollment	['Insufficient_Enrollment']	['Neutral']
Study halted temporarily due to COVID-19	['Covid19']	['Neutral']
Temporary suspension due to Covid-19 policies.	['Covid19']	['Neutral']
Sponsor decision due to clinical strategy changes	['Business_Administrative']	['Possibly_Negative']
Scheduled Interim Monitoring	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Recruitment method is no longer active.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
PI withdrew the submission to the IRB	['Ethical_Reason', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Unexpected low recruitment rate	['Insufficient_Enrollment']	['Neutral']
Terminated prior to randomised phase	['Invalid_Reason']	['Invalid_Reason']
The study was stopped for feasibility (i.e., low recruitment)	['Insufficient_Enrollment']	['Neutral']
TECHNICAL ISSUES	['Logistics_Resources']	['Neutral']
Accrual goal for interventional part not achievable	['Insufficient_Enrollment']	['Neutral']
Trial stopped early for futility	['Negative']	['Negative']
DSMC closed due to patient deaths	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Change in drug product development strategy	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Sponsor's decision	['Business_Administrative']	['Possibly_Negative']
"The CYPRESS-2 trial was closed early after the planned final analysis because the risk benefit
    ratio is unfavorable."	['Negative']	['Negative']
due to low follow up	['Negative', 'Business_Administrative']	['Negative', 'Possibly_Negative']
Nephrotoxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Company funding	['Business_Administrative']	['Possibly_Negative']
PI Relocation	['Study_Staff_Moved']	['Neutral']
Insufficient personnel	['Logistics_Resources']	['Neutral']
Unable to move forward due to funding	['Business_Administrative']	['Possibly_Negative']
Enough inclusions for interpretation	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"Poor recruitment, Interim analysis: The rates of pts who reached primary and secondary
    endpoints were lower than expected."	['Insufficient_Enrollment']	['Neutral']
transfer to another sponsor	['Business_Administrative']	['Possibly_Negative']
Surgical approach changed therefore subject enrollment not possible.	['Study_Design']	['Neutral']
"This study was withdrawn to further optimize the device. No patients were enrolled in the
    trial."	['Study_Design']	['Neutral']
Due to logistical purposes	['Logistics_Resources']	['Neutral']
Enrollment did not meet expectations	['Insufficient_Enrollment']	['Neutral']
institutional conflict of interest	['Logistics_Resources', 'Regulatory', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Slow enrollment, issues with inclusion/exclusion and choice of control	['Insufficient_Enrollment']	['Neutral']
Sponsor closed the trial	['Business_Administrative']	['Possibly_Negative']
Unavailability of the medication	['Logistics_Resources']	['Neutral']
Paused until further notice due to COVID-19 restrictions	['Covid19']	['Neutral']
no enough partcipants enrolled in the 1 year planned for recruitment	['Insufficient_Enrollment']	['Neutral']
Data collection has been halted. We are not recruiting any more subjects.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Study was not producing meaningful data.	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Ended follow-up after four years	['Invalid_Reason']	['Invalid_Reason']
"The implementation of the tool has been delayed due to technology governance issues and
    requests for changes in the end user design."	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
"The risk-benefit ratio for patients has changed since we initiated the study, and that the
    study in its current form cannot be justified"	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Higher drop out than expected. Lower Statistical Power.	['Insufficient_Enrollment']	['Neutral']
Study terminated by study partners	['Invalid_Reason']	['Invalid_Reason']
Never initiated. Withdrawn by sponsor.	['Business_Administrative']	['Possibly_Negative']
Internal competitive study that is open	['Business_Administrative']	['Possibly_Negative']
Inadequate accrural rates	['Insufficient_Enrollment']	['Neutral']
Sites not recruiting	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Grade 3 elevation in liver function tests	['Interim_Analysis', 'Safety_Sideeffects', 'Endpoint_Met']	['Neutral', 'Safety_Sideeffects', 'Neutral']
"PI has let the institution. We are unable to locate any study documents that would indicate
    study enrollment"	['Logistics_Resources', 'Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Due to lack of follow-up information	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Insufficient enrollment (no subjects were enrolled)	['Insufficient_Enrollment']	['Neutral']
Follow new disciplines on disease control from government	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
"Study was stopped due to restrictions in labeling for the subcutaneous route of administration
    of EPREX."	['Regulatory']	['Neutral']
Study proved difficult to recruit	['Insufficient_Enrollment']	['Neutral']
"Internal sponsor decision to terminate project in Crohn's disease due to potential narrow
    therapeutic window. No subjects were enrolled"	['Study_Design', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
because bone osteointegration is completed	['Invalid_Reason']	['Invalid_Reason']
Company merger resulted in business decision to terminate the study.	['Business_Administrative']	['Possibly_Negative']
Development of Current Formulation has Ceased	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Enrollment hold to limit exposure to COVID-19	['Covid19']	['Neutral']
On 05/08/12, team working on revising protocol and re-open study under version 2.0	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
"inability to achieve recruitment goals at a single center and given the current pandemic
    conditions"	['Insufficient_Enrollment']	['Neutral']
"The Philips Minicare has been taken off the market due to financial company issues that have
    nothing to do with the safety of the Minicare or the URGENT trial."	['Business_Administrative']	['Possibly_Negative']
Study stopped, recruitment difficult, subject compliance very difficult.	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Calculated sample size not achieved	['Insufficient_Enrollment']	['Neutral']
Aim 1a completed. Aim 1B is being developed	['Covid19', 'Endpoint_Met', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
only 2 patients inclued and Study Principal Investigator has left the hospital	['Study_Staff_Moved']	['Neutral']
"Strategic decision - to understand data from psoriasis study - NCT02129777 and wait for results
    of formal proof of concept study - NCT02379091."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Retrospective study from December 2007 to May 2010	['Success', 'No_Context', 'Endpoint_Met']	['Success', 'Invalid_Reason', 'Neutral']
Initial Principal Investigator left Moffitt	['Study_Staff_Moved']	['Neutral']
Company decision	['Business_Administrative']	['Possibly_Negative']
due to lack resources	['Logistics_Resources']	['Neutral']
Not enough interest in enrollment	['Insufficient_Enrollment']	['Neutral']
The study was terminated as per the Sponsor's decision.	['Business_Administrative']	['Possibly_Negative']
Primary endpoint measure not suitable for evaluation	['Interim_Analysis', 'Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Intermediary analysis showing increased morbidity in the delayed group	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
supply issues with the formulation of fenofibrate that was used.	['Logistics_Resources']	['Neutral']
PI is no longer at the University of Minnesota	['Study_Staff_Moved']	['Neutral']
"Due to a lack of resources and the principal investigator leaving the institution, we stopped
    the study prior to reaching enrollment target."	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
pursuing IND	['Regulatory', 'Invalid_Reason', 'Negative']	['Neutral', 'Invalid_Reason', 'Negative']
Withdrawn prior to participant enrollment due to funding status	['Business_Administrative']	['Possibly_Negative']
Study interest shifted	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
"The study was prematurely discontinued due to slow enrollment during the 2019/2020 cold season.
    No safety or efficacy concerns led to the decision to terminate"	['Insufficient_Enrollment']	['Neutral']
Study design changed, no longer a randomized trial design	['Study_Design']	['Neutral']
Both sponsor and UCSF decided this study was not clinical relevant at this time	['Business_Administrative']	['Possibly_Negative']
"The study has been terminated due to a change in internal prioritization and not due to any
    safety concerns."	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Funding was not recieved	['Business_Administrative']	['Possibly_Negative']
Study stopped due to low accrual	['Insufficient_Enrollment']	['Neutral']
Interim analysis indicated accuracy unchanged from previous versions	['Success', 'No_Context', 'Logistics_Resources']	['Success', 'Invalid_Reason', 'Neutral']
slow recruitment, no funding	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
PI has left the University	['Study_Staff_Moved']	['Neutral']
Issues with patient recruitment.	['Insufficient_Enrollment']	['Neutral']
"Terminated due to low accrual. Study was closed to accrual prematurely and did not continue on
    to Phase II."	['Insufficient_Enrollment']	['Neutral']
inactive	['Invalid_Reason']	['Invalid_Reason']
"the only reason is that recruitment was not sufficient to meet the planned patient numbers,
    because complete remissions are still infrequent."	['Insufficient_Enrollment']	['Neutral']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Slow Recruitment	['Insufficient_Enrollment']	['Neutral']
"The study was closed due to investigator discretion based on the lack of ability to recruit
    patients and research goals of the program."	['Insufficient_Enrollment']	['Neutral']
VA never granted approval following suspension of enrollment.	['Regulatory', 'Ethical_Reason', 'Negative']	['Neutral', 'Neutral', 'Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
after 90 charts reviewed, insufficient data to support conclusion	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Difficult to enroll eligible subjects.	['Insufficient_Enrollment']	['Neutral']
Replaced by another study	['Negative', 'Another_Study']	['Negative', 'Neutral']
The study funder retracted their grant funding offer before contract signed.	['Business_Administrative']	['Possibly_Negative']
Business decision	['Business_Administrative']	['Possibly_Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
Because of Covid-19	['Covid19']	['Neutral']
Enrollment below the target goal; statistical analysis unable to be completed.	['Insufficient_Enrollment']	['Neutral']
insufficient recruitment rate	['Insufficient_Enrollment']	['Neutral']
Need for re-formulation	['Study_Design']	['Neutral']
Study terminated early due to slow recruitment of patients.	['Insufficient_Enrollment']	['Neutral']
Based on PK data, product did not meet requirement for further development.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"Participant recruitment due to high rates of staff turn over at three of the four recruitment
    sites"	['Insufficient_Enrollment']	['Neutral']
company policy	['Business_Administrative']	['Possibly_Negative']
No accrual; No patients enrolled	['Insufficient_Enrollment']	['Neutral']
Inability to enroll subjects.	['Insufficient_Enrollment']	['Neutral']
Primary Investigator resigned from hospital	['Study_Staff_Moved']	['Neutral']
Did not pursue study	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
insufficient accrual	['Insufficient_Enrollment']	['Neutral']
Principal Investigator withdrew from the study.	['Study_Staff_Moved']	['Neutral']
"The parents of two patients enrolled who died, presented a claim against the hospital and the
    study was halted."	['Ethical_Reason', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Equipment Failure	['Logistics_Resources']	['Neutral']
"Due to the withdrawal of Gore Korea Co.Ltd., manufacturer of medical device, it is impossible
    to supply the medical device(C-TAG)."	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Difficulty with enrollment and change in available study resources	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
development of product discontinued	['Business_Administrative']	['Possibly_Negative']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
Drug toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Study was terminated due to cardiac toxicities in the subjects	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Replaced with new observational study design	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
"""Enrollment is temporarily paused due to COVID-19 and is expected to reopen in the future. This
    is not a suspension of IRB approval."""	['Covid19']	['Neutral']
No participant were enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
No additional funding is available to continue this pilot study at this time.	['Business_Administrative']	['Possibly_Negative']
data was not collected accurately	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Original study product (VSL #3) became unavailable; change in study Collaborator and product	['Study_Design']	['Neutral']
Exclusion criteria prevented enrollment of adequate # of participants	['Insufficient_Enrollment']	['Neutral']
"Two patients developed corneal laceration and hence study re-reviewed by IEC and decided to
    terminate the study prematurely"	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Change strategy	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
can not meet enrollment	['Insufficient_Enrollment']	['Neutral']
Study was halted for lack of accrual	['Insufficient_Enrollment']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
Feasibility	['Logistics_Resources']	['Neutral']
Participants never enrolled, study never started.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"Genzyme will no longer supply the study drug for this trial as it does not believe the study
    will not fully enroll within an appropriate time frame."	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Protocol redundancy	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
No epidemic of Men C in 2019	['Insufficient_Enrollment']	['Neutral']
COVID	['Covid19']	['Neutral']
Slow accrual; funding stopped	['Insufficient_Enrollment']	['Neutral']
Due to lack of funds to continue this study.	['Business_Administrative']	['Possibly_Negative']
Change in personnel	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Because of the SARS-COV2 pandemic. Recruitment stopped at 48 patients	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
no patients enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
The study has been stopped because no one is	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
Company turnover	['Business_Administrative']	['Possibly_Negative']
Support for investigational products has been withdrawn.	['Business_Administrative']	['Possibly_Negative']
PI left the institution	['Study_Staff_Moved']	['Neutral']
Recruitment base changed due to change in clinical acquisition procedures	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
inability to enroll adequate number of patients	['Insufficient_Enrollment']	['Neutral']
unable to enroll	['Insufficient_Enrollment']	['Neutral']
Clinical study terminated due to preclinical safety findings in non-human primates.	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Withdrawn because Ablatherm devices were not available anymore at trial centers	['Logistics_Resources']	['Neutral']
Personal reasons	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
patient population	['Insufficient_Enrollment']	['Neutral']
decision made not to proceed -- no subjects were ever enrolled	['Invalid_Reason']	['Invalid_Reason']
No eligible patient was enrolled.	['Insufficient_Enrollment']	['Neutral']
The study has been stopped due to technical difficulties.	['Logistics_Resources']	['Neutral']
This study was terminated based on results of interim analysis.	['Interim_Analysis', 'Negative']	['Neutral', 'Negative']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Study was cancelled prior to enrolling any subjects.	['Invalid_Reason']	['Invalid_Reason']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Problems recruting patients	['Insufficient_Enrollment']	['Neutral']
The study was terminated on May 17, 2006 due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
Changes in corporate business environment	['Business_Administrative']	['Possibly_Negative']
no funding was awarded	['Business_Administrative']	['Possibly_Negative']
Low enrollment & subjects didn't survive to study end due to cancer progression.	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
funding terminated	['Business_Administrative']	['Possibly_Negative']
Paused for Covid-19	['Covid19']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
low recruitment rate	['Insufficient_Enrollment']	['Neutral']
funding became unavailable	['Business_Administrative']	['Possibly_Negative']
"New record created in clinical trials due to company re-branding, and inability to list new
    name as the sponsor."	['Business_Administrative']	['Possibly_Negative']
PI leaving the laboratory	['Study_Staff_Moved']	['Neutral']
Principle Investigator left the institution	['Study_Staff_Moved']	['Neutral']
due to lack of funding	['Business_Administrative']	['Possibly_Negative']
futility: low conditional power to demonstrate benefit of progesterone	['Negative']	['Negative']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Study design no longer relevant and no patients were recruited.	['Study_Design']	['Neutral']
Budgetary Issues	['Business_Administrative']	['Possibly_Negative']
Funding stopped	['Business_Administrative']	['Possibly_Negative']
Due to poor accrual	['Insufficient_Enrollment']	['Neutral']
Difficulty in identifying subjects satisfying the inclusion criteria.	['Insufficient_Enrollment']	['Neutral']
Inadequate Recruitment	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
IDMC recommendation	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
withdrawn	['Invalid_Reason']	['Invalid_Reason']
Severe side effects & lack of target engagement	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
No usable data were obtained. Therefore, the study was terminated.	['Interim_Analysis', 'Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Study was suspended due to current COVID 19 research curtailment	['Covid19']	['Neutral']
Unable to find sufficient drug naive patients	['Insufficient_Enrollment']	['Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
the company does not want to proceed yet with the study	['Business_Administrative']	['Possibly_Negative']
PI is retiring from Center. Research will not continue with a new PI.	['Study_Staff_Moved']	['Neutral']
"The study was terminated during dose escalation after a determination was made that the
    risk:benefit ratio no longer favored continued evaluation."	['Negative']	['Negative']
Recruitment did not accrue as expected.	['Insufficient_Enrollment']	['Neutral']
This study was terminated early due to funding issues prior to completion of phase I	['Business_Administrative']	['Possibly_Negative']
the manufacturing of preservative free ketorolac (Acular-PF) was discontinued	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Investigator Decision	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Replaced by US RCT	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
poor recruitment, no participants enrolled	['Insufficient_Enrollment']	['Neutral']
The study was terminated prematurely after three influenza seasons.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Futility	['Negative']	['Negative']
Investigator left institution. No data analysis completed.	['Study_Staff_Moved']	['Neutral']
Sponsor withdrew funding	['Business_Administrative']	['Possibly_Negative']
Investigator transferred to the University of Wisconsin - Madison	['Study_Staff_Moved']	['Neutral']
The recuiting was to slow to complete the study	['Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral']
The PI leaves the study institution.	['Study_Staff_Moved']	['Neutral']
Extended study timelines and additional budget could no longer be supported.	['Business_Administrative']	['Possibly_Negative']
PI no longer at sight. Results not collected	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Sponsor decision to not initiate clinical trial at this time	['Business_Administrative']	['Possibly_Negative']
Recruitment/Financial Issues	['Business_Administrative']	['Possibly_Negative']
"Based on analysis of results and consideration of available treatments, the overall benefit to
    risk profile of ocrelizumab was not favorable in RA."	['Negative']	['Negative']
Futility	['Negative']	['Negative']
Preliminary results showed increased intraventricular hemorrhage (IVH) in experimental arm	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
four adverse events encountered	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
not sufficiently staff available to perform trial	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Due to poor enrollment this study was terminated prematurely.	['Insufficient_Enrollment']	['Neutral']
Inability to enroll subjects	['Insufficient_Enrollment']	['Neutral']
Results unlikely to impact treatment patterns. Time to complete not justified.	['Negative']	['Negative']
Not possible to conduct study	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Investigator decision	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
The study was discontinued due to low recruitment.	['Insufficient_Enrollment']	['Neutral']
Competent Authority's decision	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Recruitment insufficient	['Insufficient_Enrollment']	['Neutral']
We didn't use this tech in patient.	['Logistics_Resources']	['Neutral']
terminated study	['Invalid_Reason']	['Invalid_Reason']
Sponsor is no longer interested in funding the study	['Business_Administrative']	['Possibly_Negative']
interventional radiologist suffered stroke and unable to perform RFA procedure	['Logistics_Resources']	['Neutral']
Patient population limited	['Insufficient_Enrollment']	['Neutral']
No eligible patient was enrolled.	['Insufficient_Enrollment']	['Neutral']
OMP-59R5 did not improve PFS.	['Negative']	['Negative']
"Due to the Covid-19 pandemic, Saint Louis University suspended human research studies that did
    not meet specific criteria, which this study did not meet."	['Covid19']	['Neutral']
The study was not able to be completed due to the COVID-19 pandemic.	['Covid19']	['Neutral']
Sponsor decision, not safety related	['Business_Administrative']	['Possibly_Negative']
Delays in start date led to termination of the study prior to recruitment of participants.	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
"No safety signals were noted. The study completed the main phase, additional potential study
    cohorts not required."	['Invalid_Reason']	['Invalid_Reason']
"initially cessation due to covid, then fellow doing the study graduated with no time to
    complete the study; will take up again if a current fellow takes on the project"	['Covid19']	['Neutral']
Technical problem	['Logistics_Resources']	['Neutral']
participants are no longer being examined or receiving intervention	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
Insufficient funding	['Business_Administrative']	['Possibly_Negative']
Administrative decision	['Business_Administrative']	['Possibly_Negative']
Not subjects enrolled	['Insufficient_Enrollment']	['Neutral']
This study has been terminated due to lack of availability of investigational product.	['Logistics_Resources']	['Neutral']
Unable to recruit	['Insufficient_Enrollment']	['Neutral']
The primary endpoint was not met on the double blind data	['Negative']	['Negative']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
Study stopped	['Invalid_Reason']	['Invalid_Reason']
Sponsor Decision (No safety or efficacy concerns)	['Business_Administrative']	['Possibly_Negative']
Needed PET facility closed	['Logistics_Resources', 'Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
Unrelated to trial	['Invalid_Reason', 'Study_Design', 'Another_Study']	['Invalid_Reason', 'Neutral', 'Neutral']
The study crossed the prospective futility boundary of primary endpoint	['Negative']	['Negative']
Trial was redesigned as a new trial	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Per stopping rule if 12 patients underwent immune response analysis after 6 vaccinations and
    none developed a response, the protocol would stop accrual."	['Negative']	['Negative']
"Effective August 13, 2004: Unanticipated high incidence of post-transplant lymphoproliferative
    disorder"	['Safety_Sideeffects', 'Negative', 'Another_Study']	['Safety_Sideeffects', 'Negative', 'Neutral']
Futility	['Negative']	['Negative']
PI no longer at institution	['Study_Staff_Moved']	['Neutral']
Not enough patient volume to continue the study.	['Insufficient_Enrollment']	['Neutral']
Study was terminated for business reasons.	['Business_Administrative']	['Possibly_Negative']
"Changes to the HIFU-SURG-FA study protocol, a number of centers have decided not to continue
    the study, including our national coordinating center."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Funding changes.	['Business_Administrative']	['Possibly_Negative']
Due to poor accrual	['Insufficient_Enrollment']	['Neutral']
Refer to Detailed Description for documentaion of Termination Statement.	['No_Context']	['Invalid_Reason']
Terminated early due to low accrual.	['Insufficient_Enrollment']	['Neutral']
Terminated early due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
to include required number of patients took too much time	['Insufficient_Enrollment']	['Neutral']
Sponsor decision to terminate the study	['Business_Administrative']	['Possibly_Negative']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
Difficulties in recruiting participants.	['Insufficient_Enrollment']	['Neutral']
Toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Study published rendering this protocol/study obsolete.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
COVID-related delays.	['Covid19']	['Neutral']
Parent protocol (SWOG S0816 / AMC-073) discontinued	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Significant result achieved after enrollment of 31 of planned 50 subjects.	['Logistics_Resources', 'Endpoint_Met', 'Negative']	['Neutral', 'Neutral', 'Negative']
loss of support	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
Recruitment temporarily suspended due to COVID-19 pandemic	['Covid19']	['Neutral']
Patient enrollment goal will not be met	['Insufficient_Enrollment']	['Neutral']
Project not initiated	['Invalid_Reason']	['Invalid_Reason']
Suspended enrollment due to pandemic, follow-up visits still ongoing.	['Covid19', 'Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Recruitment has been suspended in order to perform interim data analysis.	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
limited funding	['Business_Administrative']	['Possibly_Negative']
"The study was terminated for business reasons and not due to any safety or efficacy concerns
    related to omarigliptin"	['Business_Administrative']	['Possibly_Negative']
Recruiting of the whole study population not possible.	['Insufficient_Enrollment']	['Neutral']
Other- Protocol moved to Disapproved	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Enrollment and data collection insufficient to continue study.	['Insufficient_Enrollment']	['Neutral']
Unable to obtain sufficient funding.	['Business_Administrative']	['Possibly_Negative']
"The study was stopped for futility based on efficacy results at the interim analysis; no
    unexpected safety findings were observed."	['Negative']	['Negative']
Lack of participant enrolment	['Insufficient_Enrollment']	['Neutral']
P.I. left	['Study_Staff_Moved']	['Neutral']
Patient recruitment slow	['Insufficient_Enrollment']	['Neutral']
Funding unavailable	['Business_Administrative']	['Possibly_Negative']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Unfunded	['Business_Administrative']	['Possibly_Negative']
Study closed to recruitment early as endpoints were reached on several participants	['Insufficient_Enrollment', 'Invalid_Reason', 'Negative']	['Neutral', 'Invalid_Reason', 'Negative']
company dissolution	['Business_Administrative']	['Possibly_Negative']
We terminated the study due to problems recruiting alcoholic subjects with HIV.	['Insufficient_Enrollment']	['Neutral']
Results did not clearly support continuing development in recurrent GBM	['Negative']	['Negative']
pts. will be captured in core	['Interim_Analysis', 'Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral', 'Neutral']
Temporary suspension of recruitment and research activities due to COVID-19	['Covid19']	['Neutral']
technician left institution	['Study_Staff_Moved']	['Neutral']
Data Monitoring Committee recommended closure due to poor accrual.	['Insufficient_Enrollment']	['Neutral']
autorities vorbidden this dispositif in other trial	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Enrollment in the clinical trial was stopped for futility	['Negative']	['Negative']
Study sponsor withdrew support.	['Business_Administrative']	['Possibly_Negative']
Study was terminated early based on emerging data with epacadostat and pembrolizumab.	['Negative', 'Another_Study']	['Negative', 'Neutral']
study closed due to low enrollment	['Insufficient_Enrollment']	['Neutral']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
Poor Recruitment prior to end of funding timelines.	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Difficulty in patient enrollment	['Insufficient_Enrollment']	['Neutral']
2 complications with midazolam	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Terminated for administrative reasons not related to safety or efficacy	['Business_Administrative']	['Possibly_Negative']
Study stopped due to lack of efficacy.	['Negative']	['Negative']
difficulty in recruitment	['Insufficient_Enrollment']	['Neutral']
Study revised to use a different study medication and patient population.	['Study_Design']	['Neutral']
No participants were enrolled as schedule.	['Insufficient_Enrollment']	['Neutral']
PI stopped study to make a more substantial database.	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Unable to obtain funding for this research.	['Business_Administrative']	['Possibly_Negative']
"The duration of the study is longer than 5 years and we can not recruit the participants to the
    target number."	['Insufficient_Enrollment']	['Neutral']
lack of enrollment; terminated by the Principal Investigator	['Insufficient_Enrollment']	['Neutral']
lack of patient population - slow accrual	['Insufficient_Enrollment']	['Neutral']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
Trial was withdrawn for drug availability issues.	['Logistics_Resources']	['Neutral']
it was logistically difficult to obtain the drug needed to conduct the study	['Logistics_Resources']	['Neutral']
recruitment lower than estimated	['Insufficient_Enrollment']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
This study will not be conducted. A new study is replacing this one.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Business decision to end program	['Business_Administrative']	['Possibly_Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Due to lower than expected recruitment since the start of study	['Insufficient_Enrollment']	['Neutral']
This study was withdrawn until the evaluation of the nonclinical rat findings is complete.	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Unexpected adverse event	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Study closed due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
Study halted by Sponsor	['Business_Administrative']	['Possibly_Negative']
patients insurance would not cover the cost of the study procedures	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
This study is temporarily suspended due to COVID-19	['Covid19']	['Neutral']
Please see Brief Summary for Termination Reason.	['No_Context']	['Invalid_Reason']
Business decision non-safety related.	['Business_Administrative']	['Possibly_Negative']
Local pharmacy unwilling to comply with study protocol	['Study_Design']	['Neutral']
Lack of efficacy determined at interim analysis	['Negative']	['Negative']
Did not have the research staff necessary to follow through with this study.	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Difficulties in the organisation	['Business_Administrative']	['Possibly_Negative']
Insufficient recruitment, funding terminated from sponsor	['Business_Administrative']	['Possibly_Negative']
Poor accrual. Patients were reluctant to agree if they would need tube feeding for a month.	['Insufficient_Enrollment']	['Neutral']
This study was halted prior to enrolling.	['Invalid_Reason']	['Invalid_Reason']
inability to enroll	['Insufficient_Enrollment']	['Neutral']
Terminated due to slow participant accrual	['Insufficient_Enrollment']	['Neutral']
Business purposes.	['Business_Administrative']	['Possibly_Negative']
Due to restrictions pertaining to COVD study has been halted	['Covid19', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
lack of funding	['Business_Administrative']	['Possibly_Negative']
poor recruitment	['Insufficient_Enrollment']	['Neutral']
poor accrual	['Insufficient_Enrollment']	['Neutral']
No Financial Support	['Business_Administrative']	['Possibly_Negative']
"Patients did not want to take part in the experimental arm of the study as all have opted for
    the current standard of care procedure."	['Study_Design']	['Neutral']
Sponsor	['Business_Administrative']	['Possibly_Negative']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
unable to enroll expected number of subjects	['Insufficient_Enrollment']	['Neutral']
PI moved to a different institution.	['Study_Staff_Moved']	['Neutral']
Failure to recruit	['Insufficient_Enrollment']	['Neutral']
Business Reasons	['Business_Administrative']	['Possibly_Negative']
The study enrollment was prematurely halted due to safety reasons.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
This study was closed prematurely due study team travel restrictions.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
No effect of carnitine on lipid induced insulin resistance after n=8 (p=1.00)	['Negative']	['Negative']
Company decision to withdraw the study	['Business_Administrative']	['Possibly_Negative']
Trial terminated early per business decision.	['Business_Administrative']	['Possibly_Negative']
COVID-19 Impacted Service Delivery and Research Infrastructure	['Covid19']	['Neutral']
The study was stopped for business reasons. No safety issues were reported.	['Business_Administrative']	['Possibly_Negative']
Animal Safety Data	['Negative', 'Another_Study']	['Negative', 'Neutral']
Didn't enroll enough subjects	['Insufficient_Enrollment']	['Neutral']
07/27/2017 Unable to contact research team to confirm reason for withdrawing study.	['Business_Administrative']	['Possibly_Negative']
Lack of available clinical drug supply	['Logistics_Resources']	['Neutral']
"Analysis after 20 patients was convincing for a negative result for the primary outcome, so the
    study was stopped."	['Negative']	['Negative']
The protocol was not funded by the NCI	['Business_Administrative']	['Possibly_Negative']
Presumed loss of clinical equipoise between the agents being investigated	['Logistics_Resources']	['Neutral']
"Recruitment for trial stopped early due to limitations from COVID-19, additionally changes in
    the standard of care for CF patients during the study period resulted in confounding of the
    primary endpoint."	['Covid19']	['Neutral']
Abandoned	['Invalid_Reason']	['Invalid_Reason']
MOR106 clinical development in atopic dermatitis was stopped for futility	['Negative']	['Negative']
The bioassay development is too difficult.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Difficulty enrolling	['Insufficient_Enrollment']	['Neutral']
Covid-19. No in-person study procedures are currently allowable by the overseeing IRB.	['Covid19']	['Neutral']
PI no longer at site and he does	['Study_Staff_Moved']	['Neutral']
Trial terminated because of lack of efficacy in the short term acute phase	['Negative']	['Negative']
"Study closed due to limited availability of eligible subjects and competition by for enrollment
    by other studies"	['Insufficient_Enrollment']	['Neutral']
drug supply was no longer available	['Logistics_Resources']	['Neutral']
No participants were successfully enrolled.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Insufficient recruitment and end of funding	['Business_Administrative']	['Possibly_Negative']
Safety reasons	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Study terminated due to low accrual and the investigator left the NIH.	['Insufficient_Enrollment']	['Neutral']
Due to reported toxicity of Celecoxib at high doses	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Not enough patient enrollment and lack of staffing	['Insufficient_Enrollment']	['Neutral']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Business reasons	['Business_Administrative']	['Possibly_Negative']
CI left the country so study has never opened	['Study_Staff_Moved']	['Neutral']
The PI has left UCLA and we do not plan to pursue this study.	['Study_Staff_Moved']	['Neutral']
"Sponsor decisionbased on adverse events limiting administration of higher doses required to
    achieve myeoblative conditioning necessary in this population"	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Revised project	['Study_Design']	['Neutral']
Permanent closure of trial to further accrual based on IDE disapproval	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
12/15/2008 Voluntarily placed on inactive status-requested by the PI	['Invalid_Reason']	['Invalid_Reason']
sitaxentan is not commercialized anymore	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
A 30% decrease in opioid use was obeserved in the paravertebral analgesia group.	['Negative']	['Negative']
PI is requesting termination (closure) of this study.	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Not authorized by Cofepris (Mexico Competent Regulatory Authority)	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The study was terminated because of immunogenicity and business decision.	['Business_Administrative']	['Possibly_Negative']
Lack of participant recruitment	['Insufficient_Enrollment']	['Neutral']
"According to the NIH definition of clinical trial studies, this study does not meet requirement
    to be a clinical trial study."	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
experimental treatment not Superior to standard - no need to continue the follow-up	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"It was no longer possible to include patients due to logistic challanges occuring during the
    Covid-19 pandemic"	['Covid19']	['Neutral']
Drugs unavailable	['Logistics_Resources']	['Neutral']
Premature termination due to insufficient patient recruitement..	['Insufficient_Enrollment']	['Neutral']
Insufficient enrollment.	['Insufficient_Enrollment']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
"A substantial decrease in refugee arrivals in Virginia didn't allow the investigator to
    continue the study as planned."	['Insufficient_Enrollment']	['Neutral']
Investigator leaving institution	['Study_Staff_Moved']	['Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Recruitment issues	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
"Unplanned interim analysis by DSMB indicated possible reduced response rate with the addition
    of Ca/Mg in pooled population. Further analysis pending."	['Negative']	['Negative']
"The sponsor required early termination of the economic agreement due to a supposed extension of
    the enrollment period for bureaucracy reasons and for the concomitant Covid -19 Pandemic"	['Covid19']	['Neutral']
The Clinical Development Program for MGCD0103 is being re-evaluated	['Business_Administrative']	['Possibly_Negative']
Study design changed to clinical database only with no research question to be studied.	['Study_Design']	['Neutral']
Study temporarily on hold due to COVID19	['Covid19']	['Neutral']
Business Reasons	['Business_Administrative']	['Possibly_Negative']
Lack of efficacy	['Negative']	['Negative']
Terminated early due to poor enrollment	['Insufficient_Enrollment']	['Neutral']
The study was deemed unfeasible to complete.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Project canceled due to the implementation of IMRT, fewer patients reporting xerostomia.	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Study_Design']	['Safety_Sideeffects', 'Neutral', 'Neutral']
No participants enrolled.	['Insufficient_Enrollment']	['Neutral']
Sponsor encountered funding issues for this study.	['Business_Administrative']	['Possibly_Negative']
Nonapplicable clinical trial	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
After a recruitment of more than 2 years, only 8 patients have been registered.	['Insufficient_Enrollment']	['Neutral']
Lost funding source	['Business_Administrative']	['Possibly_Negative']
The study was not funded	['Business_Administrative']	['Possibly_Negative']
Lack of new studies contributing subjects to this study	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Enrollment lasted longer than expected and expected number of patients could not be matched in
    time."	['Insufficient_Enrollment']	['Neutral']
"The number of participants included and especially who connected to the application (less than
    50% of the target) does not meet the objective set by the study."	['Insufficient_Enrollment']	['Neutral']
Low enrollment rate	['Insufficient_Enrollment']	['Neutral']
Difficulties in recruiting enough subjects	['Insufficient_Enrollment']	['Neutral']
IMP expired prior to completion of recruitment	['Business_Administrative']	['Possibly_Negative']
Slow progress in recruiting study patients	['Insufficient_Enrollment']	['Neutral']
The study was withdrawn.	['Invalid_Reason']	['Invalid_Reason']
Insufficient recruitment rate	['Insufficient_Enrollment']	['Neutral']
"The study was terminated at 2 years as investigators were unable to continue participation in
    the study."	['Business_Administrative']	['Possibly_Negative']
The termination criteria of the protocol was met during dose escalation.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Study wasn't started.	['Invalid_Reason']	['Invalid_Reason']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Due to slow enrolment.	['Insufficient_Enrollment']	['Neutral']
"Need for improvement of study medication. Safety data collected sufficient. No further gain in
    knowledge expected."	['Logistics_Resources', 'Endpoint_Met', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Stringent eligibility criterion caused difficulties in recruiting patients.	['Insufficient_Enrollment']	['Neutral']
The research never began.	['Invalid_Reason']	['Invalid_Reason']
Poor response rate on follow up of patients	['Insufficient_Enrollment']	['Neutral']
technical issues	['Logistics_Resources']	['Neutral']
Practice patterns with pemetrexed have evolved.	['Study_Design']	['Neutral']
not enough patients meeting criteria	['Insufficient_Enrollment']	['Neutral']
Difficulty recruiting and follow-up due to the epidemic context of COVID19	['Covid19']	['Neutral']
Incomplete Follow-up	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
New regulatories of the peptides by the pharmaceutical company (the seller)	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"It was decided that data from this study are no longer required and therefore it is not
    necessary to expose patients to the study medication"	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
slow inclusion rate	['Insufficient_Enrollment']	['Neutral']
"Amgen decided to terminate the study early to be able to meet US regulatory timelines fo
    filing. Subjects in treatment were rolled over to the 20140159 study."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Poor recruitment due to new treatments becoming available.	['Insufficient_Enrollment']	['Neutral']
"At the request of the study site, this study has been closed and access to study-related data
    is unavailable. We are unable to submit the results-data."	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
NIH did not fund the study so it never started	['Business_Administrative']	['Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
Company decided to remove CLIA test from Market.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Enough patients has been enrolled.	['Invalid_Reason']	['Invalid_Reason']
"A planed interim analysis shows no benefits, but higher adverse event rates for the
    experimental arm."	['Negative']	['Negative']
Study not feasible with current resources.	['Logistics_Resources']	['Neutral']
"The Sponsor voluntarily recalled SD-101 and terminated the study due to GMP deficiencies
    identified during an FDA inspection at the site of the manufacturer."	['Regulatory', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
This study is currently terminated due to low recruitment rate.	['Insufficient_Enrollment']	['Neutral']
never opened	['Invalid_Reason']	['Invalid_Reason']
Primary Investigator Retired.	['Study_Staff_Moved']	['Neutral']
The study was terminated because it was not enrolling at the expected rate	['Insufficient_Enrollment']	['Neutral']
PI deceased; study did not start.	['Study_Staff_Moved']	['Neutral']
"The study was terminated due to the unavailability of Continuous Glucose Monitoring sensors
    (CGMS) which were required to assess the primary end-point."	['Logistics_Resources']	['Neutral']
recruitment difficulty	['Insufficient_Enrollment']	['Neutral']
Withdrawn by PI	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
PI leaving institution	['Study_Staff_Moved']	['Neutral']
Lack of efficacy	['Negative']	['Negative']
Enrolment issues	['Insufficient_Enrollment']	['Neutral']
Accrual limitations	['Insufficient_Enrollment']	['Neutral']
"The surgeon changed pain control protocol for all patients. Continued enrollment impossible
    under approved protocol."	['Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
"Study was terminated at the request of the company due to the recall of marketed product in
    Europe."	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
staff shortage	['Logistics_Resources']	['Neutral']
Inability to meet protocol objectives.	['Insufficient_Enrollment', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
insufficient inclusions	['Insufficient_Enrollment']	['Neutral']
Slow enrollment of patients.	['Insufficient_Enrollment']	['Neutral']
Study halted prematurely due to some difficulties in recruitment of patients	['Insufficient_Enrollment']	['Neutral']
Analysis was frustrated by inadequate PhD's....	['Logistics_Resources', 'Insufficient_Data', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Low accrual and early termination	['Insufficient_Enrollment']	['Neutral']
Not enough patients to conclude	['Insufficient_Enrollment']	['Neutral']
Study terminated by sponsor	['Business_Administrative']	['Possibly_Negative']
"The response rate observed in the phase 1 portion of the study did not merit further evaluation
    in phase 2 portion of the study."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Investigator Retired.	['Study_Staff_Moved']	['Neutral']
Study was never started	['Invalid_Reason']	['Invalid_Reason']
Expected technology was not available.	['Logistics_Resources']	['Neutral']
Images not adequate to visualize catheter penetration or obtain measurements	['Interim_Analysis', 'Logistics_Resources', 'Insufficient_Data']	['Neutral', 'Neutral', 'Neutral']
A new protocol was written to replace this protocol.	['Study_Design']	['Neutral']
NHS service understaffing which made study unable to begin.	['Logistics_Resources']	['Neutral']
"The original PI moved on from this facility as did other key personnel. The current PI decided
    to discontinue the study."	['Study_Staff_Moved']	['Neutral']
Investigator transferred to the University of Wisconsin - Madison	['Study_Staff_Moved']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Investigator Left university	['Study_Staff_Moved']	['Neutral']
Reagent shortage	['Logistics_Resources']	['Neutral']
Insufficient patient accrual	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Study withdrawn before enrolling first patient	['Invalid_Reason']	['Invalid_Reason']
Unable to recruit adequate number of participants in required time frame.	['Insufficient_Enrollment']	['Neutral']
stopping rule	['Negative']	['Negative']
Did not initiate study intervention.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
"No safety concerns, study terminated due to lack of primary endpoint cases in 2009-2010 Flu
    season (coincided with H1N1 Pandemic) Subjects followed per-protocol"	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
safety reason	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
PI Left Institution	['Study_Staff_Moved']	['Neutral']
Trouble recruiting	['Insufficient_Enrollment']	['Neutral']
Unable to enroll due to Pandemic	['Insufficient_Enrollment']	['Neutral']
investigator decision	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Due to COVID-19 lockdown	['Covid19']	['Neutral']
Unable to locate grant funding.	['Business_Administrative']	['Possibly_Negative']
"Because of delay in approval of the protocol by a number of Ethics Commitees the trial was
    terminated on March 4, 2010. No patient had received any study drug."	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Study was terminated based on the results of analyses performed as planned at Month 12.	['Endpoint_Met', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
low inclusion rate	['Insufficient_Enrollment']	['Neutral']
Phase I portion completed. Phase II will open pending amendment approval.	['Study_Design']	['Neutral']
Impossible to start to the study.	['Insufficient_Enrollment']	['Neutral']
Due to difficulty with enrollment of subjects	['Insufficient_Enrollment']	['Neutral']
Recruitment was terminated due to elevated levels of hypoglycaemia	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Patient's disease progressed and Vision Dropped which led to exit from the study	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
"The Sponsor voluntarily terminated this trial because compliance to strict Good Clinical
    Practice (GCP) requirements was not ensured - No safety concerns"	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
IDMC decision due to accrual issue (82 pts accrued / 120 expected)	['Insufficient_Enrollment']	['Neutral']
COVID-19	['Covid19']	['Neutral']
"Interim analysis did not reveal any safety concerns by the DSMB, but unblinded data did not
    provide support to continue. Event rate did not meet projected magnitude; given low recruitment
    potential, it is unlikely that a positive result will occur."	['Interim_Analysis', 'Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
COVID-19 pandemic	['Covid19']	['Neutral']
"The study was terminated because of the availability of alternate therapies for primary biliary
    cholangitis (PBC)."	['Logistics_Resources', 'Study_Design', 'Another_Study']	['Neutral', 'Neutral', 'Neutral']
impossible to recruit participants due to organization changes	['Insufficient_Enrollment']	['Neutral']
Difficulty to identify eligible patients: 8 centers contributed 54 patients in 6 months.	['Insufficient_Enrollment']	['Neutral']
terminated for logistical reasons	['Logistics_Resources']	['Neutral']
Principal Investigator has left the Institution	['Study_Staff_Moved']	['Neutral']
Too low effect on the output and low rate of responders	['Negative']	['Negative']
Phase 2 study results	['Negative', 'Another_Study']	['Negative', 'Neutral']
Slow recruitment, stopped after 4 years	['Insufficient_Enrollment']	['Neutral']
Discontinued early due to enrollment challenges and changes in treatment standards	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
overload costs	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
IT was impossible to find patients	['Insufficient_Enrollment']	['Neutral']
Not enough subject enrolled	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
The design of the MagPEP trial is no longer in compliance with the current state of science.	['Study_Design']	['Neutral']
"Withdrawn [COVID restrictions prevent patient enrollment or treatment. Clinical Trial facility
    is being closed due to viral limitations and loss of staff to perform]"	['Covid19']	['Neutral']
Project was withdrawn and never began at Loyola University Medical Center.	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Institutional implementation of a same day discharge pathway	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Revision of recruitment strategies due to difficulties in recruitment	['Insufficient_Enrollment']	['Neutral']
Difficulties with the patient recruitment	['Insufficient_Enrollment']	['Neutral']
Problems with IRB	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
IRB terminated study due to non compliance with continuing review date.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Lack of efficacy	['Negative']	['Negative']
Funding	['Business_Administrative']	['Possibly_Negative']
lack of accrual	['Insufficient_Enrollment']	['Neutral']
"Because of technical and feasibility issues with InterACTION, the study to investigate the
    system for individuals following ACL reconstruction was terminated."	['Logistics_Resources']	['Neutral']
Lack of personnel	['Logistics_Resources']	['Neutral']
Has been terminated before FSFV.	['Interim_Analysis', 'Regulatory', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Funding ran out_difficulties with study product (delays in authorization).	['Business_Administrative']	['Possibly_Negative']
Resourcing issues impacted by COVID-19 pandemic.	['Covid19']	['Neutral']
Design changed to observational, not RCT. PI left USF; study closed.	['Study_Staff_Moved']	['Neutral']
Study never started, PI relocation	['Study_Staff_Moved']	['Neutral']
Do not have a sutable subjects.	['Insufficient_Enrollment']	['Neutral']
"an additional intervention, amendet to the study (3rd arm, not described here), has not
    received clearance by regulatory authorities"	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Slow enrollment, feasibility issues	['Insufficient_Enrollment']	['Neutral']
New data in public domain suggested continuing study not ethical	['Negative', 'Another_Study']	['Negative', 'Neutral']
Business objectives have changed	['Business_Administrative']	['Possibly_Negative']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
18 or 20 enrolled, stopped due to paucity of available participants	['Insufficient_Enrollment']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Business Decision	['Business_Administrative']	['Possibly_Negative']
"Study FP1039-002 was not feasible. The original assumption was at least 5% of patients screened
    would qualify, but after screening 70 patients, none qualified."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study was terminated due to lack of funding	['Business_Administrative']	['Possibly_Negative']
Withdrawn due to lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Enrollment was stopped and will not resume. Participants are no longer being examined.	['Invalid_Reason']	['Invalid_Reason']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Inclusion period finished	['Invalid_Reason']	['Invalid_Reason']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Abandoned study	['Invalid_Reason']	['Invalid_Reason']
contract issues	['Business_Administrative']	['Possibly_Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
The study protocol will be updated (major updates), following Health Canada request	['Study_Design']	['Neutral']
Sponsor decided not to go forward with the study.	['Business_Administrative']	['Possibly_Negative']
slow recruitment; local new isseus with CMR after study start	['Insufficient_Enrollment']	['Neutral']
COVID-19	['Covid19']	['Neutral']
Sub-investigator left facility prior to study initiation	['Study_Staff_Moved']	['Neutral']
Primary outcome was met in the 16 patients that completed the study per protocol	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Study blind compromised.	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Lost funding	['Business_Administrative']	['Possibly_Negative']
1 consented patient never started on study drug, lost to follow up	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
suspeded due to slow recruitment, terminated due to interim analysis	['Insufficient_Enrollment']	['Neutral']
original PI left institute, no plan to continue using samples	['Study_Staff_Moved']	['Neutral']
resident left and no one to take over	['Study_Staff_Moved']	['Neutral']
DSMB terminated the trial for futility.	['Negative']	['Negative']
insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
"This trial discontinued on 20 JUN 2008 because the interim immunogenicity results do not
    justify these formulations as pandemic vaccine candidates"	['Negative']	['Negative']
Poor recruitment and follow up	['Insufficient_Enrollment']	['Neutral']
Study activities are suspended due to COVID-19	['Covid19']	['Neutral']
Inadequate recruitment	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
Coronavirus	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Less inclusions than expected with the given criteria	['Insufficient_Enrollment']	['Neutral']
poor accrual	['Insufficient_Enrollment']	['Neutral']
Difficulties at recruiting enough participants for this study	['Insufficient_Enrollment']	['Neutral']
investigator decision	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Lack of enrollment of suitable candidates	['Insufficient_Enrollment']	['Neutral']
Protocol no longer meets sponsor objectives	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
No patients Enrollment	['Insufficient_Enrollment']	['Neutral']
Interim Analysis for Feasibility	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Issues with Manufacturing	['Logistics_Resources']	['Neutral']
funding problems	['Business_Administrative']	['Possibly_Negative']
Enrollment terminated due to not having any other eligible participants.	['Insufficient_Enrollment']	['Neutral']
difficulties in patients enrolment	['Insufficient_Enrollment']	['Neutral']
Recruitment challenges.	['Insufficient_Enrollment']	['Neutral']
Study not started for administrative reasons	['Business_Administrative']	['Possibly_Negative']
No funding	['Business_Administrative']	['Possibly_Negative']
"1. Very low enrollment rate.

      2. Recent studies question the effect of adding panitumumab in this category of patients.

      3. Too high toxicity rate"	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
temporarily suspended recruitment due to COVID-related social distancing requirements	['Covid19']	['Neutral']
Principal Investigator left the institution before subjects were enrolled	['Study_Staff_Moved']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Lead Investigator no longer with institution	['Study_Staff_Moved']	['Neutral']
investigators have decided not to continue with the study	['Invalid_Reason']	['Invalid_Reason']
FDA clinical hold, IND withdrawn.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Altered research priorities	['Business_Administrative']	['Possibly_Negative']
No relevant data	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
insufficient population, unable to recruit	['Insufficient_Enrollment']	['Neutral']
"AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in
    preventing primary outcome events."	['Negative']	['Negative']
Promotor decision	['Business_Administrative']	['Possibly_Negative']
Entry were insufficient as expected.	['Insufficient_Enrollment']	['Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Funding not renewed	['Business_Administrative']	['Possibly_Negative']
No funding for the project	['Business_Administrative']	['Possibly_Negative']
study closed prematurely	['Invalid_Reason']	['Invalid_Reason']
"-  slower than anticipated rate of enrollment

      -  need to obtain safety and efficacy data in a timely manner

      -  pending expiry of manufacturing materials/reagents"	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
The study did not achieve the statistical success to continue.	['Negative']	['Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
not i	['Invalid_Reason']	['Invalid_Reason']
Practical circumstances made it too difficult to carry out as planned.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Lost funding due to low enrollment.	['Business_Administrative']	['Possibly_Negative']
Recruitment problems	['Insufficient_Enrollment']	['Neutral']
Reassessing study feasibility	['Logistics_Resources']	['Neutral']
Because the study has not yet sponsorship.	['Business_Administrative']	['Possibly_Negative']
Lack of recruitment.	['Insufficient_Enrollment']	['Neutral']
"Benefit of duodenal exclusion alone less than expected for treatment of type 2 diabetes; an
    additional effect of combination with omentectomy not observed"	['Negative']	['Negative']
Difficulty in recruitment and funding.	['Business_Administrative']	['Possibly_Negative']
Termination of the development project for Neladenoson bialanate	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
unavailability of study drug and matching placebo	['Logistics_Resources']	['Neutral']
"The study was terminated prematurely for logistic reasons, not related to safety or efficacy of
    the vaccine."	['Logistics_Resources']	['Neutral']
Researcher left University	['Study_Staff_Moved']	['Neutral']
"This study was terminated due to the lack of efficacy of GSK1605786A in Crohn's disease based
    on the results of Study CCX114151."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Due to change in available resources	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Difficulty in identifying interested subjects.	['Insufficient_Enrollment']	['Neutral']
Program discontinued for business reasons (not safety).	['Business_Administrative']	['Possibly_Negative']
"12 SCI volunteers completed the study. As the data analysis was negative, the decision was made
    not to proceed with MS recruitment."	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
"Feasibility issues with the study treatment (in-person CBT) resulted in the study ending
    earlier than anticipated."	['Logistics_Resources']	['Neutral']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
Due to slow recruitment and sponsor request study ended early	['Insufficient_Enrollment']	['Neutral']
unresolved issues with a collaborator.	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
Discontinuation of development of device.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Trial stopped for administrative reasons prior to official determination of MTD.	['Business_Administrative']	['Possibly_Negative']
Study results were too significant	['Negative', 'Another_Study']	['Negative', 'Neutral']
Decision was made not to start the study before it was initiated.	['Invalid_Reason']	['Invalid_Reason']
"Regulatory approval was not obtained for drisapersen, hence BioMarin is stopping the
    development of all exon skipping oligonucleotides in DMD."	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Difficulty of inclusion	['Insufficient_Enrollment']	['Neutral']
"The study was terminated because the dense treatment schedule precluded successful recruitment
    of study participants."	['Insufficient_Enrollment']	['Neutral']
target population is insufficient	['Insufficient_Enrollment']	['Neutral']
No subjects were enrolled in this study. Funding ran out.	['Business_Administrative']	['Possibly_Negative']
Low patient accrual	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Business Reasons	['Business_Administrative']	['Possibly_Negative']
The parent trials did not meet the primary endpoints of reduction in motor and phonic tics.	['Negative', 'Another_Study']	['Negative', 'Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
No enrollment.	['Insufficient_Enrollment']	['Neutral']
Enrollment was halted prematurely due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
The project is suspended temporarily due to lack of funding.	['Business_Administrative']	['Possibly_Negative']
insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Study was stopped due to approved label expansion of alglucosidase alfa.	['Covid19', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
Due to lack of eligible patients.	['Insufficient_Enrollment']	['Neutral']
Low enrollment/ expiration of the grant	['Insufficient_Enrollment']	['Neutral']
MTD determined sub-optimal as efficacious treatment for renal cell carcinoma.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Business Reasons	['Business_Administrative']	['Possibly_Negative']
Inability to reach statistical significance toward primary endpoint	['Negative']	['Negative']
eyes that received gel had slightly thinner than intended flaps	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Lack of Efficacy	['Negative']	['Negative']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Low enrolment rate	['Insufficient_Enrollment']	['Neutral']
Study not being conducted	['Invalid_Reason']	['Invalid_Reason']
Could not make FDA required changes	['No_Context', 'Regulatory', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
No participants enrolled per PI discretion	['Insufficient_Enrollment']	['Neutral']
high relapse rate	['Negative']	['Negative']
"The decision is based on a change in the benefit risk assessment of this drug for the lupus
    population targeted in this study."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Poor accrual of subjects onto study	['Insufficient_Enrollment']	['Neutral']
Due to recently published research, this is no longer a novel study.	['Negative', 'Another_Study']	['Negative', 'Neutral']
sponsor's decision	['Business_Administrative']	['Possibly_Negative']
Never received final IRB approval for amendments, so never opened officially	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Sponsor - Confluent Surgical terminated study re: surgical techniques Letter dated 4/31/2008	['Business_Administrative']	['Possibly_Negative']
did not enroll enough subjects in the 2017/2018 cold season, so the study was terminated	['Insufficient_Enrollment']	['Neutral']
The study was stopped due to poor accrual and lack of funding.	['Insufficient_Enrollment']	['Neutral']
due to slow accrual	['Insufficient_Enrollment']	['Neutral']
poor accrual	['Insufficient_Enrollment']	['Neutral']
"The decision to end the study was made for GSK portfolio reasons. No subjects were randomised
    into the study."	['Business_Administrative']	['Possibly_Negative']
The study was terminated early due to insufficient recruitment.	['Insufficient_Enrollment']	['Neutral']
Could not get participants	['Insufficient_Enrollment']	['Neutral']
Unable to recruit subjects	['Insufficient_Enrollment']	['Neutral']
Temporarily suspended due to COVID-19	['Covid19']	['Neutral']
Failure to include	['Insufficient_Enrollment']	['Neutral']
Unable to include the number of patients	['Insufficient_Enrollment']	['Neutral']
PI didn't have time to finish approval process	['Business_Administrative']	['Possibly_Negative']
Pre-Clinical Safety Tox Findings	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Planned number of 30 subjects could not be recruited during recruitment phase.	['Insufficient_Enrollment']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
"protocol underwent significant revisions, decision made to terminate study and open as new
    study listed NCT00849459"	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Sufficient findings to draw conclusions	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
CI no longer wishes to complete this study due to Covid-19	['Covid19']	['Neutral']
Slow accrual; drug availability	['Insufficient_Enrollment']	['Neutral']
Withdrawn for problem of logistics with the associated laboratories	['Logistics_Resources']	['Neutral']
No reduction in hair loss 1 month after treatment	['Negative']	['Negative']
No further enrollment after two patients	['Insufficient_Enrollment']	['Neutral']
Closed due to competing protocols	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
The study was stopped because of safety concerns	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
"Data from the 12 patients recruited has now been analysed, and it has been determined that it
    is sufficient to meet the study objectives."	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
No further funding available, remaining visits halted due to threat of Covid 19	['Covid19']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Unavailability of study drug.	['Logistics_Resources']	['Neutral']
Research direction changed	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Closed prematurely due to emerging data on toxicity and competing trials.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Due to difficulty in recruitment	['Insufficient_Enrollment']	['Neutral']
Roche decided to prematurely terminate study.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Low recruitment, sponsor withdrew funding.	['Insufficient_Enrollment']	['Neutral']
Upon interim analysis, sufficient data was accrued to assess study hypotheses.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Study never started - transferred to Array.	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
Challenging data collection	['Logistics_Resources']	['Neutral']
Steering Committee decision in accordance with stopping rule 1: Emergence of new data	['Negative', 'Another_Study']	['Negative', 'Neutral']
Unable to complete enrollment due to newly approved treatment options.	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Study terminated due to reproducibility issues with genomics prediction model.	['Negative']	['Negative']
Funding support unavailable	['Business_Administrative']	['Possibly_Negative']
Study terminated early due to low enrollment. No data collected.	['Insufficient_Enrollment']	['Neutral']
Results of interim analysis indicate lack of efficacy when compared to placebo.	['Negative']	['Negative']
Difficulty in recruiting patients for the study.	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
"This study was halted prematurely due to the COVID-19 pandemic, resulting in the inability to
    enroll participants. Funding for this project has also ended."	['Covid19']	['Neutral']
Study never began	['Invalid_Reason']	['Invalid_Reason']
Funding ended	['Business_Administrative']	['Possibly_Negative']
Study prematurely terminated due to safety concerns leading to clinical hold	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Study will not be conducted	['Invalid_Reason']	['Invalid_Reason']
"Difficult to enroll. The blood sugar status of the two enrolled subjects was not evaluable due
    to multiple hospital admissions."	['Insufficient_Enrollment']	['Neutral']
"Based on interim Analysis outcome being futile for FLZ3001; decision was taken to stop (early
    terminate) both FLZ3001/3002. There was no safety concern."	['Negative']	['Negative']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Covid19 pandemia	['Covid19']	['Neutral']
principal criteria was achieved with the intermediate statistical analysis	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
"Inability for further recruitment, change of position of the principal investigator, COVID-19
    pandemic"	['Covid19']	['Neutral']
"Study early termination was due to slow recruitment and difficulties at achieving the required
    enrolment for the study."	['Insufficient_Enrollment']	['Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
"LFG316, had been studied in seven patients with transplantation-associated microangiopathy. Due
    to low confidence of clinical benefit, this study was closed."	['Negative']	['Negative']
no participants enrolled	['Insufficient_Enrollment']	['Neutral']
"the study was halted after an interim analysis perfomed for a perceived excess of target vessel
    revascularization in the DEB+BMS arm"	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
The pharmaceutical company sold the compound and pulled out.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
The study was terminated early by the sponsor.	['Business_Administrative']	['Possibly_Negative']
Funding was not acquired	['Business_Administrative']	['Possibly_Negative']
Manufacturing shortage of both Diftitox and Doxil	['Logistics_Resources']	['Neutral']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
The study was withdrawn due to change of the study product formulation.	['Study_Design']	['Neutral']
medical center difficulties in recruiting patients for the study in a timely fashion	['Insufficient_Enrollment']	['Neutral']
Insufficient recruitment.	['Insufficient_Enrollment']	['Neutral']
"The centers have no longer patients. In September 2018, set up of a competitive international
    study."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Lack of interest in pool of potential participants	['Insufficient_Enrollment']	['Neutral']
sponsor withdrawal	['Business_Administrative']	['Possibly_Negative']
Lidocaine injection group showed significant improvement in pain	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Failed to include the required number of participants	['Insufficient_Enrollment']	['Neutral']
"Enrollment prematurely discontinued due to program prioritization & not due to any safety
    concerns."	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Business decision	['Business_Administrative']	['Possibly_Negative']
Unable to meet recruitment target	['Insufficient_Enrollment']	['Neutral']
Insufficient enrollment, investigator left institution	['Insufficient_Enrollment']	['Neutral']
No resources available at the clinic	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Redundant with another study	['Negative', 'Another_Study']	['Negative', 'Neutral']
low accrual rate; the only participant withdrew after signing consent	['Insufficient_Enrollment']	['Neutral']
Unable to recruit enough patients	['Insufficient_Enrollment']	['Neutral']
Inadequate enrollment	['Insufficient_Enrollment']	['Neutral']
Principal Investigator relocated to Orlando, Florida.	['Study_Staff_Moved']	['Neutral']
Study enrollment was no adequate.	['Insufficient_Enrollment']	['Neutral']
"Study discontinued based on planned interim analysis of the primary endpoint. Not linked to any
    safety concern."	['Interim_Analysis', 'Negative']	['Neutral', 'Negative']
lack of performance	['Logistics_Resources', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Study terminated due to lack of efficacy of GSK2798745 in chronic cough.	['Negative']	['Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Study closed without enrollment .	['Insufficient_Enrollment']	['Neutral']
Study funding	['Business_Administrative']	['Possibly_Negative']
Principal Investigator passed away.	['Study_Staff_Moved']	['Neutral']
The development program has been terminated	['Business_Administrative']	['Possibly_Negative']
slow enrollement unavailable technology	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Low recruitment rate	['Insufficient_Enrollment']	['Neutral']
Unacceptable frequency of hypoglycemia observed at and above 200 ug/kg/day	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Insufficient staff to continue pursuing project	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
PI left institution	['Study_Staff_Moved']	['Neutral']
Withdrawn from the IRB	['Interim_Analysis', 'Regulatory', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Funding was not received	['Business_Administrative']	['Possibly_Negative']
insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Unable to enroll the required number of subjects	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Administrative	['Business_Administrative']	['Possibly_Negative']
Couldnt find sponor for this study	['Logistics_Resources']	['Neutral']
Leak of research funding	['Business_Administrative']	['Possibly_Negative']
low enrollment	['Insufficient_Enrollment']	['Neutral']
Study Stopped	['Invalid_Reason']	['Invalid_Reason']
Departure of the coordinating investigator	['Study_Staff_Moved']	['Neutral']
No subject accrual	['Insufficient_Enrollment']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
The PI is leaving the University of Florida.	['Study_Staff_Moved']	['Neutral']
"The study was allowed to expire due to changes in standard care for the patient population
    within the NCH institution."	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsor lack of funding	['Business_Administrative']	['Possibly_Negative']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
Slow accrual, PI left instituion	['Insufficient_Enrollment']	['Neutral']
loss of funding support	['Business_Administrative']	['Possibly_Negative']
Study no longer being conducted.	['Invalid_Reason']	['Invalid_Reason']
"Study was terminated due to slow enrolment with no reasonable expectation of attaining a
    meaningful sample size"	['Insufficient_Enrollment']	['Neutral']
Difficult recruiting participants	['Insufficient_Enrollment']	['Neutral']
Study terminated early due to Aralast being phased out of the market.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
required license	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
IRB's initial review of this study was not completed and study was withdrawn	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Enrollment halted prematurely due to the Covid-19 pandemic	['Covid19']	['Neutral']
The investigators did not find suiable patients	['Insufficient_Enrollment']	['Neutral']
For various reasons.	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
"The study was never started because the sponsor decided not to manufacture the investigational
    product."	['Business_Administrative']	['Possibly_Negative']
Due to safety concerns re: the concomitant use of aliskiren with an ACEi or ARB.	['Safety_Sideeffects', 'Endpoint_Met', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Toxic Epidermal Necrolysis	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"The results concerning amniotic membrane transplantation (n=7) and robot-assisted pterygium
    surgery (n=5) were conclusive"	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Temporarily suspended due to pandemic	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Lack of patient enrollment	['Insufficient_Enrollment']	['Neutral']
"This trial was supporting the development of an asset which was terminated, thus the data from
    the study were no longer required."	['Business_Administrative']	['Possibly_Negative']
Funding c hange	['Business_Administrative']	['Possibly_Negative']
Terminated by the sponsor in the context of COVID-19 pandemia	['Covid19']	['Neutral']
Business reasons	['Business_Administrative']	['Possibly_Negative']
Due to COVID-19 lockdown	['Covid19']	['Neutral']
Withdrawal of funding from primary sponsor	['Business_Administrative']	['Possibly_Negative']
recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
"TRIAL STOPPED due to a change in standard of care and the required patient numbers could no
    longer be achieved"	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
COVID19 pandemic closed in-person clinics temporarily	['Covid19']	['Neutral']
"insufficient numbers of eligible patients as laparscopic surgery increased and open surgery
    decreased."	['Insufficient_Enrollment']	['Neutral']
Recruitment challenges	['Insufficient_Enrollment']	['Neutral']
"Closure of Gait Analysis Laboratory - unable to set up alternative gait laboratory in time for
    funders"	['Business_Administrative']	['Possibly_Negative']
lack of patient inclusion	['Insufficient_Enrollment']	['Neutral']
"The decision to terminate the trial was based on the slow rate of recruitment across the
    programme of studies]"	['Insufficient_Enrollment']	['Neutral']
The study was never approved by the IRB and the PI left the VA	['Study_Staff_Moved']	['Neutral']
Difficulty with participant recruitment and retainment	['Insufficient_Enrollment']	['Neutral']
Company strategic decision	['Business_Administrative']	['Possibly_Negative']
Temporarily paused due to COVID-19, expected to resume, IRB not suspended.	['Covid19']	['Neutral']
delays in obtaining study materials	['Logistics_Resources']	['Neutral']
Inclusion criteria not met at preoperative clinic visit screening. No eligible participants.	['Insufficient_Enrollment']	['Neutral']
No Further Funding	['Business_Administrative']	['Possibly_Negative']
study terminated due toTechnical issue pre -recruiting	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
In interim analysis, this study met the primary hypothesis.	['Negative']	['Negative']
Withdrawn by Sponsor	['Business_Administrative']	['Possibly_Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
"we collected data of a total of 19 patients for an interim analysis. but there are less than 7
    responses out of the initial 19 patients."	['Negative']	['Negative']
drug supply issues	['Logistics_Resources']	['Neutral']
"PI moving to another university--study will not be done at UK; Coronavirus pandemic will likely
    delay start at University of Texas at Arlington"	['Study_Staff_Moved']	['Neutral']
"Study initially suspended recruitment due to COVID-19. Study withdrawn due to PI leaving
    institution in early 2021."	['Covid19']	['Neutral']
Non applicable clinical trial	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Low accrual.	['Insufficient_Enrollment']	['Neutral']
Sponsor terminated study	['Business_Administrative']	['Possibly_Negative']
Due to a change in the development program, the study was closed prematurely.	['Business_Administrative']	['Possibly_Negative']
Company Decision	['Business_Administrative']	['Possibly_Negative']
insufficent enrollment	['Insufficient_Enrollment']	['Neutral']
Early analysis showed negative results. It was decided to halt the study.	['Negative']	['Negative']
Study did not occur	['Invalid_Reason']	['Invalid_Reason']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Study was halted permanently due to enrollment and logistic issues.	['Logistics_Resources']	['Neutral']
Discontinuation of clinical investigation with NMS-1116354	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Completion of MK-0431A-235 was rendered unnecessary, as the local oversight authority accepted
    in its stead the results of another study [MK-0431-234]."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Business Objectives Changed	['Business_Administrative']	['Possibly_Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Principal Investigator terminated study	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"Due to the outbreak of the COVID-19 pandemic in the USA on March 2020, all study sites stopped
    enrolling patients to the study"	['Covid19']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
The results of leading Phase 2 trials did not meet all desired endpoints	['Negative', 'Another_Study']	['Negative', 'Neutral']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
"Initial version of the protocol not submitted and new version approved has a new sponsor and it
    has been added into Clinicaltrials by the new sponsor"	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Slow, insufficient accrual.	['Insufficient_Enrollment']	['Neutral']
"The PI resigned the institute, and the rest investigators at the institute decided to terminate
    the study."	['Study_Staff_Moved']	['Neutral']
sponsor funding	['Business_Administrative']	['Possibly_Negative']
funding and manpower unavailable, completion within a reasonable timeframe not possible.	['Business_Administrative']	['Possibly_Negative']
"Following a recommendation from the Data and Safety Monitoring Board (DSMB), the study was
    stopped early for futility. There were no safety concerns raised."	['Negative']	['Negative']
Study never started, and there are no plans to initiate.	['Invalid_Reason']	['Invalid_Reason']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
Prior to start up, study was discontinued for feasibility reasons	['Logistics_Resources']	['Neutral']
Lost funding prior to study commencing	['Business_Administrative']	['Possibly_Negative']
No participants enrolled, study terminated.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Product unavailability	['Logistics_Resources']	['Neutral']
difficult enrollment after the primary investigator left the centre	['Insufficient_Enrollment']	['Neutral']
Low recruitment rate	['Insufficient_Enrollment']	['Neutral']
Unconfirmed research expenses	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Pfizer made a business-related decision on 04May2017 to terminate study based on change in
    portfolio prioritization, and is not due to safety or efficacy."	['Business_Administrative']	['Possibly_Negative']
Due to budget limitations, the company decided to withdraw this study.	['Business_Administrative']	['Possibly_Negative']
The sponsor decided to postpone the performance of this study to after phase 3	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
lack of efficacy	['Negative']	['Negative']
Taiwan FDA asked for seperating this protocol into one disease site per protocol.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Only recruitment temporarily paused due to Covid-19.	['Covid19']	['Neutral']
Sponsor Strategic/Business Decision	['Business_Administrative']	['Possibly_Negative']
Adverse Event	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
change in the development strategy	['Business_Administrative']	['Possibly_Negative']
IRB terminated due to no continuation request.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
No grant funding for this trial.	['Business_Administrative']	['Possibly_Negative']
Site unable to enrol recruited subjects	['Insufficient_Enrollment']	['Neutral']
"no participants could be recruited who were eager to donate blood for bioavailability despite
    prolongation of the study period."	['Insufficient_Enrollment']	['Neutral']
"Due to the COVID-19 pandemic. With a second wave just beginning, and considering that we are
    testing an immunosuppressant in patients with high risk for COVID-19 complications, we would
    not be able to re-start recruitment safely in the near future."	['Covid19']	['Neutral']
Device was sunset from the market in May2015. No longer need for long term data.	['Interim_Analysis', 'Logistics_Resources', 'Endpoint_Met']	['Neutral', 'Neutral', 'Neutral']
Study could not get funding; research never initiated.	['Business_Administrative']	['Possibly_Negative']
insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
"Batch recall for Misago Terumo self-expanding peripheral stent systems.(withdrawal from the
    market)"	['Covid19', 'Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
"The trial is terminated before investigation of repeat escalating doses as these will be
    conducted with the new formulation instead."	['Study_Design']	['Neutral']
unable to be funded	['Business_Administrative']	['Possibly_Negative']
Slow Enrollment	['Insufficient_Enrollment']	['Neutral']
lack of financial support	['Business_Administrative']	['Possibly_Negative']
Unable to find eligible participants to participate in the study.	['Insufficient_Enrollment']	['Neutral']
Closed, never started.	['Invalid_Reason']	['Invalid_Reason']
Unable to enrol patients	['Insufficient_Enrollment']	['Neutral']
Phase II: no scientific interests are given anymore	['Business_Administrative']	['Possibly_Negative']
Company decision	['Business_Administrative']	['Possibly_Negative']
Funding was lost due to the COVID19 Pandemic	['Covid19']	['Neutral']
additional enrolment criteria made patients' recruitment not feasible anymore	['Insufficient_Enrollment']	['Neutral']
See 'Limitations and Caveats' section	['Covid19', 'No_Context', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Recruiting difficulties	['Insufficient_Enrollment']	['Neutral']
Study discontinued due to business decisions.	['Business_Administrative']	['Possibly_Negative']
Study stopped due to low enrollment	['Insufficient_Enrollment']	['Neutral']
In light of the ongoing COVID-19 pandemic and its impact on clinical trials	['Covid19']	['Neutral']
"Enrollment challenges - Single participant discontinued after placebo, no relevant outcome
    measure data was recorded."	['Negative']	['Negative']
Low drop-out rate and slow recruitment rate	['Insufficient_Enrollment']	['Neutral']
Study withdrawn.	['Invalid_Reason']	['Invalid_Reason']
Due to administrative difficulties caused by PI change.	['Business_Administrative']	['Possibly_Negative']
This study was terminated for administrative reasons. There were no safety concerns.	['Business_Administrative']	['Possibly_Negative']
Insufficient accrual	['Insufficient_Enrollment']	['Neutral']
Principal investigator left the study institution.	['Study_Staff_Moved']	['Neutral']
Unable to recruit patients due to technical issues following submission	['Insufficient_Enrollment']	['Neutral']
Failure to recruit adequate patients	['Insufficient_Enrollment']	['Neutral']
Change of dose regimen (new protocol)	['Study_Design']	['Neutral']
safety	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
No enrollements for more than 6 months in Phase II	['Insufficient_Enrollment']	['Neutral']
Stopped due to a non-safety-related issue with the beverage (test vehicle).	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
it's too slow to enroll suitable patients into this study	['Insufficient_Enrollment']	['Neutral']
lack of efficacy	['Negative']	['Negative']
"Due to SARS-CoV-2 pandemic research restrictions placed by university, unable to collect data
    at this time"	['Covid19', 'Logistics_Resources', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Extreme toxicity of Pertuzumab and Erlotinib combination	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Senior management decision	['Business_Administrative']	['Possibly_Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Because of logistic problems, we could not recruit any patient.	['Insufficient_Enrollment']	['Neutral']
"Enrollment and interactions/interventions temporarily paused due to COVID-19 & will resume in
    the future. No suspension of IRB approval."	['Covid19']	['Neutral']
Administrative issues precluded conducting the study.	['Business_Administrative']	['Possibly_Negative']
Hoag Hospital ceased support.	['Business_Administrative']	['Possibly_Negative']
Terminated per PI's request due to competing priorities.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
The paclitaxel-albumin halt production.	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
"Recruitment was slower than anticipated. Insufficient funding to expand to multi-centered
    trial."	['Business_Administrative']	['Possibly_Negative']
"Pilot study showed recruitment rates were lower than expected,and number of losses to
    follow-up, much higher."	['No_Context', 'Insufficient_Enrollment', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
"Today Entresto treatment has marketing authorization and is available for all patients, that is
    the reason why study was halted prematurely."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lacking effect of treatment	['Negative']	['Negative']
It was not possible to get insurance companies to cover bevacizumab.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
IRB expired	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Business decision	['Business_Administrative']	['Possibly_Negative']
Trial will not meet CTEP Early Phase Trial Slow Accrual Guidelines	['Insufficient_Enrollment']	['Neutral']
This study was terminated for business reasons.	['Business_Administrative']	['Possibly_Negative']
Sponsor decided to terminate the study due to business reasons	['Business_Administrative']	['Possibly_Negative']
Resources no longer available	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
temporarily closed to enrollment due to COVID	['Covid19']	['Neutral']
Difficulty in enrolling participants	['Insufficient_Enrollment']	['Neutral']
Slow/Insufficient accrual	['Insufficient_Enrollment']	['Neutral']
Logistic reasons associated with the FDA-imposed clinical hold.	['Logistics_Resources']	['Neutral']
"Single agent phase completed, insufficient supportive preclinical data to proceed with
    combination phase"	['Logistics_Resources', 'Insufficient_Data', 'Negative']	['Neutral', 'Neutral', 'Negative']
"Study was suspended until FDA approved the IND. Study has since been terminated and a new
    screening process has been implemented."	['Regulatory', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Lack of funding and staffing	['Business_Administrative']	['Possibly_Negative']
Waiting for annual IRB progress report to be reviewed and approved	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Study discontinued due to lack of study funding.	['Business_Administrative']	['Possibly_Negative']
Low accrual, study terminated.	['Insufficient_Enrollment']	['Neutral']
Insuffisient recruitment	['Insufficient_Enrollment']	['Neutral']
This trial was terminated due to low recruitment	['Insufficient_Enrollment']	['Neutral']
The study was stopped because the research team was unable to enroll any participants	['Insufficient_Enrollment']	['Neutral']
Failure to recruit subjects	['Insufficient_Enrollment']	['Neutral']
materials incomplete	['Logistics_Resources']	['Neutral']
Difficulty finding the required patient population	['Insufficient_Enrollment']	['Neutral']
"The clinical phase of the study (from FSFV to LSLV) was never initiated due to the sponsor's
    decision."	['Business_Administrative']	['Possibly_Negative']
3rd party proprietary software issue	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
difficult to register	['Insufficient_Enrollment']	['Neutral']
Funding not obtained	['Business_Administrative']	['Possibly_Negative']
After feasibility assessment and due to delays in data receipt study was terminated	['Logistics_Resources']	['Neutral']
"Temporarily paused due to COVID-19 and expected to resume. This is not a suspension of IRB
    approval."	['Covid19']	['Neutral']
problems with the stability of samples collected	['Logistics_Resources']	['Neutral']
Study did not open	['Invalid_Reason']	['Invalid_Reason']
Terminated by Funder	['Business_Administrative']	['Possibly_Negative']
Sponsor decision to withdraw	['Business_Administrative']	['Possibly_Negative']
Study closed by sponsor. Funding ended.	['Business_Administrative']	['Possibly_Negative']
Low recruitment of patients	['Insufficient_Enrollment']	['Neutral']
Our PI left our institutions as we could not longer continue.	['Study_Staff_Moved']	['Neutral']
Change of study design	['Study_Design']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Lack of availability of IV ibuprofen as of 8/10 due to a manufacturer's recall	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
The unexpected increase in morbidity of the hemoclip group	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Insufficient on-site staff to manage study	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Change of device used for dual energy computed tomography with Xenon	['Study_Design']	['Neutral']
Low enrollment rate.	['Insufficient_Enrollment']	['Neutral']
Poor inclusion	['Insufficient_Enrollment']	['Neutral']
Difficulty obtaining enrollment	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Slow enrolment	['Insufficient_Enrollment']	['Neutral']
The study has been terminated, due to technically difficulties.	['Business_Administrative']	['Possibly_Negative']
Coe terminated due to lack of efficacy	['Negative']	['Negative']
Part 1 completed successfully. Part 2 not conducted.	['Invalid_Reason']	['Invalid_Reason']
PI moved to different institution	['Study_Staff_Moved']	['Neutral']
No accrual	['Insufficient_Enrollment']	['Neutral']
Not funded	['Business_Administrative']	['Possibly_Negative']
Lack of accrual. We were unable to enroll enough participants to have meaningful results.	['Insufficient_Enrollment']	['Neutral']
Unable to recruit participants	['Insufficient_Enrollment']	['Neutral']
Poor trial recruitment	['Insufficient_Enrollment']	['Neutral']
Expired IRB	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Inadequate toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Awaiting supply of peptide from a different company	['Logistics_Resources']	['Neutral']
for technical reasons	['Logistics_Resources']	['Neutral']
Investigators prefer to pursue other studies	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Never started	['Invalid_Reason']	['Invalid_Reason']
Study was terminated in August 2016 due to replacement by a new study.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Research Cancelled	['Invalid_Reason']	['Invalid_Reason']
Sponsor withdrew PMA	['Business_Administrative']	['Possibly_Negative']
Enrollment did not meet anticipated goals. Eligibility was a challenge.	['Insufficient_Enrollment']	['Neutral']
The image-guidance system became commercially available	['Covid19', 'Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Completed	['Invalid_Reason']	['Invalid_Reason']
Sponsor cancelled study	['Business_Administrative']	['Possibly_Negative']
Study was never opened	['Invalid_Reason']	['Invalid_Reason']
"No participants were recruited at this study site. Study has been conducted and monitored with
    ClinicalTrials.gov ID: NCT01044563."	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
There were no funds for the study.	['Business_Administrative']	['Possibly_Negative']
Closed early due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
FDA released from conducting	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of patients in the trial population from which to recruit and lack of funding	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
PI left the institute and the funding expired.	['Business_Administrative']	['Possibly_Negative']
"This study was terminated due to the efficacy results from an interim analysis (at the end of
    treatment epoch) of the Phase II study CQGE031B2201 (NCT01716754)."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Poor accrual, no data to analyze	['Insufficient_Enrollment']	['Neutral']
due to dose re-selection	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Expected futility in reaching the primary endpoint	['Negative']	['Negative']
No funding	['Business_Administrative']	['Possibly_Negative']
It was not possible to recruit patients	['Insufficient_Enrollment']	['Neutral']
COVID-19	['Covid19']	['Neutral']
Due to Inadequate patient recruitment	['Insufficient_Enrollment']	['Neutral']
feasibility; challenges with recruitment	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Under enrollment and IP supply expiring.	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Insufficient recruitment of physicians to participate to the study.	['Insufficient_Enrollment']	['Neutral']
Terminated early due to slow accrual	['Insufficient_Enrollment']	['Neutral']
The Study was not recruiting	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
COVID-19	['Covid19']	['Neutral']
Start-up and enrolling activities have been temporatily suspended due to the COVID-19 pandemic.	['Covid19']	['Neutral']
PI has left institution after losing funding for this PI-initiated study	['Business_Administrative']	['Possibly_Negative']
Study has been suspended due to reconsideration of study design.	['Study_Design']	['Neutral']
difficulty in enrolling patients	['Insufficient_Enrollment']	['Neutral']
unable to secure additional funding	['Business_Administrative']	['Possibly_Negative']
Business decision to not continue this study (only few subjects were screened).	['Business_Administrative']	['Possibly_Negative']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
scope has a new modification. Waiting on product delivery	['Study_Design']	['Neutral']
"Ph I completed. Funding became unavailable causing Ph II to cease after two patients were
    enrolled."	['Business_Administrative']	['Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
Difficulty recruiting subjects to dosing cohort 5.	['Insufficient_Enrollment']	['Neutral']
Due to slow recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of sufficient funding	['Business_Administrative']	['Possibly_Negative']
The Study has been officially closed with the IRB	['Regulatory', 'Ethical_Reason', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Due to the current pandemic situation, recruitment has been disrupted by the inability to
    recruit more patients"	['Insufficient_Enrollment']	['Neutral']
Change in company strategy	['Business_Administrative']	['Possibly_Negative']
Low enrollment numbers	['Insufficient_Enrollment']	['Neutral']
Terminated due to logistical barriers to cell processing and poor enrollment	['Insufficient_Enrollment']	['Neutral']
PI is relocating to another institution.	['Study_Staff_Moved']	['Neutral']
May 2007: No annual renewal	['Regulatory', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Change in strategy	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Business objectives have changed.	['Business_Administrative']	['Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Study device is incorrect size for pediatric patients	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
"Study product voluntarily recalled by sponsor. Listeria identified at the manufacturing
    facility (not in tested finished product)."	['Safety_Sideeffects', 'Logistics_Resources', 'Endpoint_Met']	['Safety_Sideeffects', 'Neutral', 'Neutral']
"The alternative laparoscopic chole, has so little morbidity very few patients opt for a
    transvaginal approach when presented with the alternative"	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
The participating site went broke and no new participating sites have been found	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Unable to recruit enough participants	['Insufficient_Enrollment']	['Neutral']
Dose limiting adverse effects	['Safety_Sideeffects', 'Negative']	['Safety_Sideeffects', 'Negative']
Due to lack of recruitment	['Insufficient_Enrollment']	['Neutral']
The study was not executed. No subjects were enrolled.	['Invalid_Reason']	['Invalid_Reason']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
low recruitment rate	['Insufficient_Enrollment']	['Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Sponsor decided not to go forward with study for FDA submission.	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
"The study was terminated because the lead-in study (14571A) in elderly was terminated; see
    Detailed Description."	['No_Context', 'Negative', 'Another_Study']	['Invalid_Reason', 'Negative', 'Neutral']
Enrollment not initiated	['Insufficient_Enrollment']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
After primary completition date, experimental drug was no longer available	['Logistics_Resources', 'Negative']	['Neutral', 'Negative']
This study was closed due to lack of enrollment (only one subject enrolled)	['Insufficient_Enrollment']	['Neutral']
Temporarily suspended due to Pandemic	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
"To the impossibility to visit patients at the hospital by COVID-19.When the situation
    stabilizes, we will start the study again."	['Covid19']	['Neutral']
COVID-19, followed by PI leaving institution.	['Covid19']	['Neutral']
Not enough patients for study arms	['Insufficient_Enrollment']	['Neutral']
Dose levels were determined to be subtherapeutic	['Negative']	['Negative']
The study met a pre-defined protocol study stopping criteria	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Due to considerations regarding the appropriate therapeutic regimen for these patients.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Support withdrawn - Study continued by NCI - see record NCT00006981	['Another_Study', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
terminated, due to lack enrollment,	['Insufficient_Enrollment']	['Neutral']
Personnel and funding was no longer available	['Business_Administrative']	['Possibly_Negative']
The study sponsor found the trial to be not viable.	['Business_Administrative']	['Possibly_Negative']
PI is leaving UCSD	['Study_Staff_Moved']	['Neutral']
Technical difficulty with Endo-PAT machine	['Logistics_Resources']	['Neutral']
Enrollment difficulties and drop outs	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment (and due to pandemic)	['Insufficient_Enrollment']	['Neutral']
This is a rare disease, and enrollment was poor.	['Insufficient_Enrollment']	['Neutral']
"Due to the regulatory approval of the product in this indication, a large portion of the study
    becomes unnecessary."	['No_Context', 'Regulatory', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
Problems with the number of participants	['Insufficient_Enrollment']	['Neutral']
See reason for termination in detailed description.	['No_Context']	['Invalid_Reason']
Don't have enough funding to finish the project.	['Business_Administrative']	['Possibly_Negative']
Study terminated due to low accrual and change in research focus.	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
"COVID restrictions prevent patient enrollment or treatment. Clinical Trial facility is being
    closed due to viral limitations and loss of staff to perform]]"	['Covid19']	['Neutral']
Treatment was ineffective	['Negative']	['Negative']
doesnt meet criteria for clinical trial reporting	['Negative']	['Negative']
The hospital was convert to attend only COVID19	['Covid19']	['Neutral']
Funding unavailable	['Business_Administrative']	['Possibly_Negative']
Lead Research left the Institute	['Study_Staff_Moved']	['Neutral']
Slow enrollment of patients	['Insufficient_Enrollment']	['Neutral']
Phase I/II study that did not progress to Phase II	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
unavailable recording device and difficulty of patient inclusions	['Logistics_Resources']	['Neutral']
"Study was stopped 04.10.2014 prematurly after recruitment of HCC and RCC patients. NSCLC (2 of
    10 patients planned) and CRC patients recruitment was stopped"	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"Terminated due to low enrollment and unclear pharmacologic effect in available pharmacodynamic
    data (not due to any safety concerns)."	['Negative']	['Negative']
"The study was closed prior to enrollment of Cohort 2 due to a non-safety related sponsor
    decision."	['Business_Administrative']	['Possibly_Negative']
"Study was a F32 Fellowship. Trial was proposed however Principle Investigator does not believe
    trial took place."	['Logistics_Resources', 'Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Inability to meet target enrollment prior to ending of network in March 2011.	['Insufficient_Enrollment']	['Neutral']
PI no longer at institution	['Study_Staff_Moved']	['Neutral']
Interim analysis did not show sufficient immunogenicity of IMP compared to placebo	['Negative']	['Negative']
The study had poor efficacy.	['Negative']	['Negative']
This study was terminated due to low recruitment	['Insufficient_Enrollment']	['Neutral']
Sponsor	['Business_Administrative']	['Possibly_Negative']
due to financial problems	['Business_Administrative']	['Possibly_Negative']
Due to competing studies no further subjects could be recruited.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
due to COVID-19 outbreak	['Covid19']	['Neutral']
Lack of funding for researchers	['Business_Administrative']	['Possibly_Negative']
See detailed description	['No_Context']	['Invalid_Reason']
results of interim analysis (not safety relevant)	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
The study was treminated because of low accural	['Insufficient_Enrollment']	['Neutral']
major difficulties in training investigators in other centers	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
PI left the Institution; No replacement PI identified;	['Study_Staff_Moved']	['Neutral']
positive results from a larger study with same regimen was released.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Very low recruitment rate	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Collaborator no longer interested, short of funds	['Business_Administrative']	['Possibly_Negative']
Sponsor Decision.	['Business_Administrative']	['Possibly_Negative']
grunnet COVID-19 pandemien d vi haft hg drop-out og vanskelig att rekruttere	['Covid19']	['Neutral']
Completion not feasible due to lack of eligible subjects.	['Insufficient_Enrollment']	['Neutral']
There was insufficient enrollment of subjects.	['Insufficient_Enrollment']	['Neutral']
"Boston Scientific acquisition of BTG/Galil Medical - business decision made to stop follow-up
    early"	['Business_Administrative']	['Possibly_Negative']
PI no longer at NYUMC	['Study_Staff_Moved']	['Neutral']
Lack of subjects	['Insufficient_Enrollment']	['Neutral']
Decided not to perform the pilot phase	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
recruiting of patients difficult combined by lack of money	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Treatment ineffective	['Negative']	['Negative']
lack of enrollment/drug shortages	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
"Overall profile of the compound does not offer significant clinical advantage to patients over
    currently available lipid lowering agents"	['Negative']	['Negative']
Slow accrual to some cohorts	['Insufficient_Enrollment']	['Neutral']
due lack of funds	['Business_Administrative']	['Possibly_Negative']
Failure to recruit patients meeting inclusion criteria.	['Insufficient_Enrollment']	['Neutral']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
"The PI left Indiana University. The findings served as preliminary data for a recently awarded
    NIH R01 grant."	['Logistics_Resources', 'Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
We do not have the funding or resources to complete the study at this time	['Business_Administrative']	['Possibly_Negative']
No participants enrolled.	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Slow enrollement, Low Follow-up rate	['Insufficient_Enrollment']	['Neutral']
Slow enrollment and Covid-19	['Covid19']	['Neutral']
This was an inpatient study, but PI left inpatient service at MGH	['Study_Staff_Moved']	['Neutral']
Not enough study participants	['Insufficient_Enrollment']	['Neutral']
Terminated due to awaiting data from Phase II study.	['Negative', 'Another_Study']	['Negative', 'Neutral']
poor recruitment	['Insufficient_Enrollment']	['Neutral']
No patients were eligible to receive the experimental component of the protocol therapy.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
logistical difficulties	['Logistics_Resources']	['Neutral']
Expected PK&no safety issues in 1B.1Cwon't proceed due to lack of 1Befficacy	['Safety_Sideeffects', 'Logistics_Resources', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
"Multiparas study terminated due to poor recruitment. Randomization revealed only after decision
    recorded on clinicaltrials.gov"	['Insufficient_Enrollment']	['Neutral']
"-  Interim analysis on 60 randomized subjects showed significant result for the main outcome
         (VT1)

      -  Enrollment difficulty"	['Success', 'No_Context', 'Logistics_Resources']	['Success', 'Invalid_Reason', 'Neutral']
"Due to the COVID-19 pandemic, this health department-based trial ended early to limit utilizing
    clinic services and resources and to ensure participant and staff safety. This termination
    primarily affected the 12-month follow-up appointments."	['Covid19']	['Neutral']
Lack of randomized participants	['Insufficient_Enrollment']	['Neutral']
Study withdrawn due to staff unavailability and limited resources	['Logistics_Resources']	['Neutral']
Limited numbers of patients qualified for trial	['Insufficient_Enrollment']	['Neutral']
Logistical reasons (institutional reorganization of ambulatory surgery)	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Due to administrative reasons	['Business_Administrative']	['Possibly_Negative']
Not able to recruit patients	['Insufficient_Enrollment']	['Neutral']
Enrollment halted during phase 2 to reformulate the investigational product	['Study_Design']	['Neutral']
"Amgen decided to terminate the study early to be able to meet US regulatory timelines fo
    filing. Subjects in treatment were rolled over to the 20140159 study."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
End of research time, time-resources	['Logistics_Resources']	['Neutral']
problem of enrollment	['Insufficient_Enrollment']	['Neutral']
Covid-19 disruption of team	['Covid19']	['Neutral']
we change the study protocol	['Study_Design']	['Neutral']
Poor patient accrual	['Insufficient_Enrollment']	['Neutral']
Received funding for the next phase of the study	['Business_Administrative']	['Possibly_Negative']
Recruitment failure.	['Insufficient_Enrollment']	['Neutral']
Recruitement problems as single centre study	['Insufficient_Enrollment']	['Neutral']
High number of withdrawals, appt. no-shows, or those lost to follow-up.	['Insufficient_Enrollment']	['Neutral']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of study staff.	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
sponsor funding	['Business_Administrative']	['Possibly_Negative']
"Inadequate recruitment rate combined with a high rate of patients dropping in to the treatment
    group from standard care"	['Insufficient_Enrollment']	['Neutral']
"Based on analysis of results and consideration of available treatments, the overall benefit to
    risk profile of ocrelizumab was not favorable in RA."	['Negative']	['Negative']
Different study will be conducted	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
refocusing of research priorities	['Business_Administrative']	['Possibly_Negative']
Funding duration ended.	['Business_Administrative']	['Possibly_Negative']
sponsor decision	['Business_Administrative']	['Possibly_Negative']
Sanitary context (COVID19)	['Covid19']	['Neutral']
review the study concept	['Study_Design']	['Neutral']
Gemcitabine is not the first choice for most pancreatic cancer patients nowdays	['Logistics_Resources']	['Neutral']
This study has closed due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
To assess product performance (test and reference products), move into further testing.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
This study never started due to delays in medication development	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Not enough sample list at participating healthcare facility.	['Insufficient_Enrollment']	['Neutral']
Not required to be registered	['Regulatory', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Camera for study is being repaired	['Logistics_Resources']	['Neutral']
Unable to secure drug.	['Logistics_Resources']	['Neutral']
"Study failed to accrue any patients due to regulatory issues with PR1 vaccine and T cell
    production."	['Insufficient_Enrollment']	['Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
Study was halted due to suspected liver injury in another study with Inarigavir	['Negative', 'Another_Study']	['Negative', 'Neutral']
Withdrawn due to low accrual	['Insufficient_Enrollment']	['Neutral']
Funds no longer available	['Business_Administrative']	['Possibly_Negative']
Recommended by DSMB due to lack of accrual	['Insufficient_Enrollment']	['Neutral']
Due to findings in the preclinical carcinogenicity studies for vilaprisan (BAY1002670)	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Lack of Accrual/Enrollment	['Insufficient_Enrollment']	['Neutral']
Terminated due to difficulty enrolling subjects.	['Insufficient_Enrollment']	['Neutral']
Finally it was decided not to initiate the study due to logistical issues	['Logistics_Resources']	['Neutral']
Study stopped due to difficulty recruiting patients	['Insufficient_Enrollment']	['Neutral']
loss of research support	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Principle Investigator left institution	['Study_Staff_Moved']	['Neutral']
Device no longer available in Singapore	['Covid19', 'Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Withdrawn by funding source	['Business_Administrative']	['Possibly_Negative']
Development strategy reasons	['Business_Administrative']	['Possibly_Negative']
investigator decision	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
The whole project was discontinued within GSK, hence this study was cancelled before enrolment.	['Business_Administrative']	['Possibly_Negative']
"Due to unproven issues associated with hydroxychloroquine use and safety, further complicated
    by media and political misinformation which in effect rendered all global studies on HCQ to
    stop enrolling participants."	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Business decision	['Business_Administrative']	['Possibly_Negative']
Donor altered priorities for available funding and eliminated the project	['Business_Administrative']	['Possibly_Negative']
"Study stopped early based on interim results of another trial, showing inferior activity of
    pemetrexed/carboplatin compared to etoposide/carboplatin in SCLC."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Business objectives have changed	['Business_Administrative']	['Possibly_Negative']
Difficulties in recruiting patients;	['Insufficient_Enrollment']	['Neutral']
COVID-19 social distancing restrictions--temp halt of recruitment & intervention	['Covid19']	['Neutral']
Sponsor terminated.	['Business_Administrative']	['Possibly_Negative']
Study terminated due to lack of resources.	['Logistics_Resources']	['Neutral']
Strategic Considerations	['Business_Administrative']	['Possibly_Negative']
Closed prior to completion secondary to surgeon leaving UCLA	['Study_Staff_Moved']	['Neutral']
Insufficient resources	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
low enrollment	['Insufficient_Enrollment']	['Neutral']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
Poor recruitment.	['Insufficient_Enrollment']	['Neutral']
The trial was stopped because of slow recruitment.	['Insufficient_Enrollment']	['Neutral']
The study has not started, the device is not ready so the study will be delayed	['Logistics_Resources']	['Neutral']
"The study was terminated. Six subjects were consented & all were withdrawn before any study
    activities took place."	['Invalid_Reason']	['Invalid_Reason']
Errors in study conception, e.g. sample size calculation.	['No_Context', 'Logistics_Resources', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
Early stopping point based on 2nd interim analysis (planned per protocol)	['Endpoint_Met', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
In response to COVID-19	['Covid19']	['Neutral']
We can not get enough sample size.	['Insufficient_Enrollment']	['Neutral']
IRB approval expired	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study was never initiated	['Invalid_Reason']	['Invalid_Reason']
Enrollment difficulties	['Insufficient_Enrollment']	['Neutral']
The clinical team couldn't recruit patients who met the criteria for enrollment	['Insufficient_Enrollment']	['Neutral']
No patients enrolled.	['Insufficient_Enrollment']	['Neutral']
Unable to recruit sufficient patients within reasonable timeframe	['Insufficient_Enrollment']	['Neutral']
Study was terminated due to lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Subject passed away prior to enrollment	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
A corporate decision to terminate the study	['Business_Administrative']	['Possibly_Negative']
"Study A6181120 was prematurely discontinued due to futility on 27 September 2010. No new or
    unexpected safety issues were identified."	['Negative']	['Negative']
Sponsor request	['Business_Administrative']	['Possibly_Negative']
"The paper is about to publish on the same subject abroad, so the investigator decieded to
    stopped the study."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
It was decided not to proceed with the study at this time.	['Invalid_Reason']	['Invalid_Reason']
Negative Efficacy Results from the recently completed Phase 3 study 104-201506	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lagging enrollment	['Insufficient_Enrollment']	['Neutral']
low enrolment rate	['Insufficient_Enrollment']	['Neutral']
No funding available	['Business_Administrative']	['Possibly_Negative']
Study termination due to insufficient efficacy.	['Negative']	['Negative']
Trial did not meet primary efficacy endpoint for double blind phase.	['Negative']	['Negative']
Difficulty recruiting patients, company closed down	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
The study was early terminated prior to part 2 because of slow accrual.	['Insufficient_Enrollment']	['Neutral']
"Study was terminated because dramatic benefits seen during the first 24 hours of drug
    administration combined with COVID restrictions on research activities suggested it was both
    unethical and unnecessary to complete the planned enrollment"	['Covid19', 'Study_Design']	['Neutral', 'Neutral']
Study protocol amended to a new treatment regimen: study DAVFU-006.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
"Study activity has initially suspended due to COVID-19 restrictions, but it will not resume due
    to the confounding influence of the pandemic on the study outcomes. The feasibility of the
    study protocol is limited with restrictions from the pandemic."	['Covid19']	['Neutral']
Study was not conducted, no subjects recruited.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
The sponsor will no longer develop the experimental drug.	['Business_Administrative']	['Possibly_Negative']
Electrodes required gas sterilization before re-use which was not feasible	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
terminated for not meeting enrollment goals	['Insufficient_Enrollment']	['Neutral']
the PI is no longer work at Hadassah	['Study_Staff_Moved']	['Neutral']
"SARS-CoV-2 has been detected in fecal material. Although FMT is screened for SARS-CoV-2, the
    team decided to end the study to minimize risk to participants."	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
"Vaccines safe but not immunogenic in 8 participants; trial closed to further recruitment by the
    protocol steering committee & DSMB."	['Logistics_Resources', 'Negative']	['Neutral', 'Negative']
problems with recruitment	['Insufficient_Enrollment']	['Neutral']
Enrollment temporarily suspended due to COVID-19.	['Covid19']	['Neutral']
One subject enrolled and completed this study. The study was stopped due to poor recruitment.	['Insufficient_Enrollment']	['Neutral']
COVID-19	['Covid19']	['Neutral']
"This was a strategic decision for business planning purposes and not out of concern for patient
    safety."	['Business_Administrative']	['Possibly_Negative']
Sub investigator is working no longer in the hospital. No participants were enrolled.	['Study_Staff_Moved']	['Neutral']
Personelle changes mandated suspension.	['Logistics_Resources']	['Neutral']
This study has been terminated for administrative reasons only.	['Business_Administrative']	['Possibly_Negative']
Poor Accrual.	['Insufficient_Enrollment']	['Neutral']
Company decision	['Business_Administrative']	['Possibly_Negative']
The study has now a correlational design: no participant recruitment is needed.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
"The US FDA and the EU CHMP provided guidance indicating preference for intereferon-free
    regimens in pediatric studies of HCV infection."	['Covid19', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
Difficulty in recruitment	['Insufficient_Enrollment']	['Neutral']
No interest from school district	['Business_Administrative']	['Possibly_Negative']
Changes in standards of care	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of Funding	['Business_Administrative']	['Possibly_Negative']
"Recruiting or enrolling participants has halted prematurely and will not resume; participants
    are no longer being examined or treated."	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Financing and re-organization	['Business_Administrative']	['Possibly_Negative']
Difficulty recruiting patients	['Insufficient_Enrollment']	['Neutral']
Stopped for one complication event (arterial occlusion)	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Investigator decision - clinical practice change	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
"The ongoing COVID-19 pandemic has forced the sponsor to temporally halt enrollment of patients
    and stop all the further investigations."	['Covid19']	['Neutral']
"The study was stopped prior to recruitment due to logistical issues with the company in which
    it was going to be run."	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Closure of long term follow up (LTFU) and study earlier than previously outlined in the
    protocol as no beneficial information gained from continuing LTFU."	['Negative']	['Negative']
Lack of funding and personnel to conduct study.	['Business_Administrative']	['Possibly_Negative']
Time and funding ran out prior to full recruitment	['Business_Administrative']	['Possibly_Negative']
Terminated with partial enrollment completed	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Principal Investigator is making changes to the protocol.	['Study_Design']	['Neutral']
See termination reason in detailed description	['No_Context']	['Invalid_Reason']
final study report has been completed and submitted	['Invalid_Reason']	['Invalid_Reason']
insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Contamination of the Piti-Salptrire biotherapy laboratory	['Safety_Sideeffects', 'Logistics_Resources']	['Safety_Sideeffects', 'Neutral']
Interim analysis showed a significant reduction in the pain scores	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
The benefit/ risk profile does not support continuation of this study.	['Negative']	['Negative']
Unable to recruit enough patients at a single center.	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
product no longer on market	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Insufficient enrollment numbers	['Insufficient_Enrollment']	['Neutral']
"The investigators concluded that it is not feasible due to the lack of participation and
    difficulty in recruiting patients."	['Insufficient_Enrollment']	['Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
PI Retired and no data was collected	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
No patients	['Insufficient_Enrollment']	['Neutral']
no eligible subjects were enrolled	['Insufficient_Enrollment']	['Neutral']
Extremely difficult recruitment. Preliminary analysis showed no effect of the intervention.	['Negative']	['Negative']
"The study was terminated on August 6, 2012, because 2 large Phase 3 studies showed no clinical
    benefit. This decision was not based on any new safety concerns."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
IND was terminated for being inactive for more than five years	['Regulatory', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Could not make FDA required changes	['No_Context', 'Regulatory', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
reports indicating that increased folic acid intake may increase colin cancer	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study withdrawn.	['Invalid_Reason']	['Invalid_Reason']
no participants	['Insufficient_Enrollment']	['Neutral']
"The study did not start recruiting as albiglutide would have been withdrawn from the market
    prior to study end."	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
No patients enrolled in the study	['Insufficient_Enrollment']	['Neutral']
Transfer of management of study	['Business_Administrative']	['Possibly_Negative']
Study was registered but never started.	['Invalid_Reason']	['Invalid_Reason']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Funding agency no longer provide support.	['Business_Administrative']	['Possibly_Negative']
CI left institution	['Study_Staff_Moved']	['Neutral']
New funding sources being sought	['Business_Administrative']	['Possibly_Negative']
Negative Efficacy Results from the recently completed Phase 3 study 104-201506	['Negative', 'Another_Study']	['Negative', 'Neutral']
Slow inclusion	['Insufficient_Enrollment']	['Neutral']
Terminated due to unachievable sample size and lack of resource availability	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
No EC approval obtained	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Slow enrollment; study terminated.	['Insufficient_Enrollment']	['Neutral']
The development program has been terminated	['Business_Administrative']	['Possibly_Negative']
Pilot study is finished, multi centered is awaiting funding	['Business_Administrative']	['Possibly_Negative']
At 6 months 1 participant recruited. Study deemed not feasible and discontinued.	['Insufficient_Enrollment']	['Neutral']
Immunotherapy approved for NSCLC in the first line setting	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Sponsor business decision	['Business_Administrative']	['Possibly_Negative']
The study was closed early due to weak accrual on June 26, 2012.	['Insufficient_Enrollment']	['Neutral']
safety risks to youth in the study required early termination of the study	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Difficulty recruiting and consenting participants	['Insufficient_Enrollment']	['Neutral']
Study completed by another institution prior to enrollment of first subject.	['Invalid_Reason']	['Invalid_Reason']
See Detailed Description	['No_Context']	['Invalid_Reason']
"Terminated due to, licensing agreement granting exclusive rights of research, development,
    manufacture and marketing of Eisai's E7046 to Adlai Nortye Biopharma."	['Business_Administrative']	['Possibly_Negative']
"Loss of resources due to COVID-19 resulted in insufficient funds to complete the trial as
    planned. However, sufficient data was collected to fulfill the aims of the trial.
    Discontinuation is not related to the drug, its use, or adverse events."	['Covid19']	['Neutral']
No participants were recruited	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Due to the low recruitment rate and the large number lost to follow-up	['Insufficient_Enrollment']	['Neutral']
Lack of financial support	['Business_Administrative']	['Possibly_Negative']
Insufficient number of participants	['Insufficient_Enrollment']	['Neutral']
PI decided to terminate study.	['Invalid_Reason']	['Invalid_Reason']
Funding terminated	['Business_Administrative']	['Possibly_Negative']
problem of recruitment	['Insufficient_Enrollment']	['Neutral']
Funding struggles, may resume recruitment if funding problems resolve	['Business_Administrative']	['Possibly_Negative']
The study was stopped due to insufficient enrollment.	['Insufficient_Enrollment']	['Neutral']
Conduct of the first analyses	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Investigator changed jobs	['Study_Staff_Moved']	['Neutral']
Study is temporarily suspended until resources are put in place for enrollment	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Unable to recruit the projected patient number. All analyses are descriptive, only.	['Insufficient_Enrollment']	['Neutral']
"This study was prematurely terminated as 2 patients were recruited and both of them withdrawn
    from the study before reaching the primary end point."	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Occurrence of unacceptable adverse events.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
COVID-19 pandemic	['Covid19']	['Neutral']
Subject recruitment was unsuccessful.	['Insufficient_Enrollment']	['Neutral']
due to an altered benefit/risk assessment.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Slow accrual led to early study termination.	['Insufficient_Enrollment']	['Neutral']
Study expired; PI failed to submit study to IRB for continuing review	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Futility	['Negative']	['Negative']
Unable to obtain supplement for this study. Unable to recruit.	['Insufficient_Enrollment']	['Neutral']
Lack of eligible subjects.	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Recruitment	['Insufficient_Enrollment']	['Neutral']
Terminated prematurely due to high incidence of postoperative atrial fibrillation.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
This study has been withdrawn because the drug would not meet trial criteria for efficacy	['Negative']	['Negative']
No recruitment	['Insufficient_Enrollment']	['Neutral']
PI decision	['Invalid_Reason']	['Invalid_Reason']
Lack of administrative support	['Business_Administrative']	['Possibly_Negative']
Few subjects recruited, sponsor withdrew support.	['Insufficient_Enrollment']	['Neutral']
No participants enrolled, per PI discretion	['Insufficient_Enrollment']	['Neutral']
Because of many unseen obstacles resulted in poor accrual, study is terminated.	['Insufficient_Enrollment']	['Neutral']
Lack of efficacy	['Negative']	['Negative']
The study activities are on hold due to COVID-19	['Covid19']	['Neutral']
"After interim statistical analysis, a statistician reccommended to stop study, because results
    are significant and in favour of POC approach."	['Negative']	['Negative']
Preliminary exploration of research concept did not prove to be viable.	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
unable to meet enrollment goal	['Insufficient_Enrollment']	['Neutral']
Secondary to other study results, suspended for a scientific review	['Success', 'No_Context', 'Logistics_Resources']	['Success', 'Invalid_Reason', 'Neutral']
"Due to GSK concerns that the data collected in this study could not support reliable
    interpretation of assessments and conclusions on the primary objectives."	['Logistics_Resources', 'Negative']	['Neutral', 'Negative']
poor recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of Efficacy	['Negative']	['Negative']
FDA withdrew requirement to complete study	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Insufficient patient eligible for recruitment	['Insufficient_Enrollment']	['Neutral']
Slow accrual, study terminated.	['Insufficient_Enrollment']	['Neutral']
Failure to meet primary endpoint	['Negative']	['Negative']
Study did not enroll participants is being withdrawn from the system.	['Insufficient_Enrollment']	['Neutral']
small number of patients got recruited	['Insufficient_Enrollment']	['Neutral']
Grant funding expired, poor patient enrollment	['Business_Administrative']	['Possibly_Negative']
Insufficient recruitment of participants	['Insufficient_Enrollment']	['Neutral']
Competing studies	['Negative', 'Another_Study']	['Negative', 'Neutral']
Terminated due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
"The research was terminated because the recruitment of the study subjects was not smooth and
    the overseas training of the investigator was scheduled."	['Insufficient_Enrollment']	['Neutral']
COVID-19 pandemic	['Covid19']	['Neutral']
Lack of internal resources	['Logistics_Resources']	['Neutral']
no funding	['Business_Administrative']	['Possibly_Negative']
No funding	['Business_Administrative']	['Possibly_Negative']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
underfunding	['Business_Administrative']	['Possibly_Negative']
Problems with accrual	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
End date of epidemic	['Invalid_Reason']	['Invalid_Reason']
Funding withdrawn by sponsor	['Business_Administrative']	['Possibly_Negative']
Manufacturer of the MFI QRS Fragmentation Systems used in the study, has filed for insolvency	['Business_Administrative']	['Possibly_Negative']
No subjects are willing to participating.	['Insufficient_Enrollment']	['Neutral']
Study is no longer funded.	['Business_Administrative']	['Possibly_Negative']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
"The Brazilian regulatory agency - ANVISA has requested the cancellation of the phase 3 study
    for conducting a phase 1 study first."	['No_Context', 'Regulatory', 'Endpoint_Met']	['Invalid_Reason', 'Neutral', 'Neutral']
"After an interim analysis, it was decided to discontinue the study after a stochastic
    curtailment analysis."	['Negative']	['Negative']
enrollment goal not met in allotted recruitment period	['Insufficient_Enrollment']	['Neutral']
Study group showed better results. Poor Accrual.	['Insufficient_Enrollment']	['Neutral']
The researcher couldnt handle it	['Logistics_Resources']	['Neutral']
"Previous study DSC/08/2357/36 did not show efficacy for Givinostat in JIA. Sponsor decision to
    stop development of Givinostat in polyarticular course Juvenile Idiopathic Arthritis wasn't
    related to any tolerability concerns."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Difficulty recruiting patients	['Insufficient_Enrollment']	['Neutral']
Primary endpoint reached, slow accrual, leakage around	['Insufficient_Enrollment']	['Neutral']
study halted prematurely before enrollment of first patient	['Invalid_Reason']	['Invalid_Reason']
Inclusion curve too slow.	['Insufficient_Enrollment']	['Neutral']
A new coordinating center has been defined (Massachusetts General Hospital)	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
"EMD Serono voluntarily decided to terminate this trial after observing increased MS disease
    activity in trial 28063 ATAMS [Please refer to ATAMS]"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
No participants enrolled for more than 1 year.	['Insufficient_Enrollment']	['Neutral']
Out of funding, no differences between groups	['Business_Administrative']	['Possibly_Negative']
Enrollment delays, business re-allocation of resources	['Business_Administrative']	['Possibly_Negative']
Company decision taken in light of demands by certain national health authorities	['Business_Administrative']	['Possibly_Negative']
"Sponsor will amend study design by incorporating reconfirmation of coagulopathy following
    discussion with FDA regarding findings from SCARLET1 study."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
No site recruitment due to Covid-19	['Covid19']	['Neutral']
No participants were enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Funding withdrawn	['Business_Administrative']	['Possibly_Negative']
NIAID terminated the study due to low subject enrollment	['Insufficient_Enrollment']	['Neutral']
"project was only internally funded and would complete for subjects with 2 newer externally
    funded projects"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
No eligible patient was enrolled.	['Insufficient_Enrollment']	['Neutral']
Recruitment problems	['Insufficient_Enrollment']	['Neutral']
sponsor and investigator 's decision	['Business_Administrative']	['Possibly_Negative']
Material needed for study was not available	['Logistics_Resources']	['Neutral']
no participants enrolled	['Insufficient_Enrollment']	['Neutral']
This study was closed earlier than planned because of lack of research staff.	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
No enrollment to study, study closed	['Insufficient_Enrollment']	['Neutral']
REAL trial showed a significant difference in OS for reduced EOX and standard EOX	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Sponsor decision to not renew CE mark on product. Therefore study not needed.	['Business_Administrative']	['Possibly_Negative']
PI Decision	['Invalid_Reason']	['Invalid_Reason']
PI closing his lab	['Study_Staff_Moved']	['Neutral']
Enrollment was significantly under target.	['Insufficient_Enrollment']	['Neutral']
"DSMB reviewed data of 1st 10 subjects; determined no safety concerns. Efficacy as a single
    agent in this patient population was unlikely. Voluntary Termination"	['Negative']	['Negative']
Not meeting enrollment goals.	['Insufficient_Enrollment']	['Neutral']
Terminated due to lack of patient recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of patient enrollment	['Insufficient_Enrollment']	['Neutral']
Substantial amendment to be implemented using another device	['Study_Design']	['Neutral']
due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
DSMB	['Negative']	['Negative']
Primary investigator relocated	['Study_Staff_Moved']	['Neutral']
Inability to recruit further.	['Insufficient_Enrollment']	['Neutral']
IND is withdrawn - study is will not restart	['Regulatory', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Due to poor accrual	['Insufficient_Enrollment']	['Neutral']
Gilead decision to terminate	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
"The technology showed rapid acceptance in the general population and we halted our feasibility
    demonstration study."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
the study has never started. my grant request was denied.	['Business_Administrative']	['Possibly_Negative']
"DSMB recommended stopping the study after an interim analysis of the primary endpoint revealed
    that futility criteria were met."	['Negative']	['Negative']
protocol completed	['Invalid_Reason']	['Invalid_Reason']
enrollment too slow	['Insufficient_Enrollment']	['Neutral']
By sponsor decision due to difficulty of recruitment	['Insufficient_Enrollment']	['Neutral']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Dendreon was sold and new company decided not to fund study.	['Business_Administrative']	['Possibly_Negative']
Data inconclusive.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Terminated upon recommendation of the Data Safety Monitoring Board (DSMB)	['Interim_Analysis', 'Regulatory', 'Negative']	['Neutral', 'Neutral', 'Negative']
lack of accrual	['Insufficient_Enrollment']	['Neutral']
Recruitment too slow	['Insufficient_Enrollment']	['Neutral']
Study terminated due to unacceptable frequency of drug related adverse events	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Did not enroll as planned	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Participants were not able to stay near our center for two weeks	['Insufficient_Enrollment']	['Neutral']
"Participating site withdrew prior to any enrollment and lead site with slow enrollment. Not
    expected to meet enrollment goals."	['Insufficient_Enrollment']	['Neutral']
Collaborative decision between study PI and sponsor.	['Business_Administrative']	['Possibly_Negative']
Changes in departmental staff have led to a cut in research alotments.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Difficulty recruiting subjects	['Insufficient_Enrollment']	['Neutral']
poor accrual	['Insufficient_Enrollment']	['Neutral']
Recruitment futility	['Negative']	['Negative']
"Recruitment problems has forced us to change the design of this study from a clinical trial to
    a comparative study of 3 different groups of patients."	['Study_Design']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
The recruitment period has finished without reaching sample size	['Insufficient_Enrollment']	['Neutral']
The sponsor stopped the study.	['Business_Administrative']	['Possibly_Negative']
Enrollement target could not be achieved, study will not resume	['Insufficient_Enrollment']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Most OSA patients were not obese and/or admitted over night so the study was not feasible.	['Insufficient_Enrollment']	['Neutral']
Change in strategy.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Change in available resources for study procedures	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Discontinued program	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
CRx-102-006 study results, negative	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
Lack of funding available	['Business_Administrative']	['Possibly_Negative']
Sponsor withdrew funding.	['Business_Administrative']	['Possibly_Negative']
Terminated	['Invalid_Reason']	['Invalid_Reason']
"Interim data indicated this vaccine will not meet the protocol criteria for a good vaccine
    candidate."	['Negative']	['Negative']
This protocol was closed and will be redesigned and submitted as a new protocol.	['Study_Design']	['Neutral']
Based on the tolerabilty challenges of the combination	['Logistics_Resources']	['Neutral']
"The reason for the discontinuation of the study is difficulty with recruitment and timely
    enrolment and is not related to safety concerns"	['Insufficient_Enrollment']	['Neutral']
Orthopedic surgeon that does our knee surgeries moved to a different location	['Study_Staff_Moved']	['Neutral']
Development of BAY1000394 has been terminated by Bayer.	['Business_Administrative']	['Possibly_Negative']
Study closed early without enrollment.	['Insufficient_Enrollment']	['Neutral']
Enough information was gathered in order to answer the primary research question	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Study closed; recruitment problems	['Insufficient_Enrollment']	['Neutral']
The sample size should be re-calculated based on the first 20 cases.	['Interim_Analysis', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Because of Covid-19, in-person visits were halted and telemedicine was used.	['Covid19']	['Neutral']
Not a Clinical Trial requirement per VA HSR&D	['Regulatory', 'Ethical_Reason', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Business/Operational issues	['Business_Administrative']	['Possibly_Negative']
No recruitment.	['Insufficient_Enrollment']	['Neutral']
Safety	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
insufficient enrolment	['Insufficient_Enrollment']	['Neutral']
Investigator Non Compliance	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Inadequate enrollment	['Insufficient_Enrollment']	['Neutral']
COVI-19 Pandemic	['Covid19']	['Neutral']
Poor recruitment.	['Insufficient_Enrollment']	['Neutral']
COVID-19 pandemic meant continuation of the study was unfeasible at this time.	['Covid19']	['Neutral']
Recruition too slow	['Insufficient_Enrollment']	['Neutral']
FDA placed on partial hold due to additional data	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
low recruitment	['Insufficient_Enrollment']	['Neutral']
Funding for the study was withdrawn, no participants were ever recruited.	['Business_Administrative']	['Possibly_Negative']
PI moved out of state.	['Study_Staff_Moved']	['Neutral']
Could not find a Sponsor for the study	['Business_Administrative']	['Possibly_Negative']
The PI left this institution, and the study was closed.	['Study_Staff_Moved']	['Neutral']
"This study was terminated after enrolling five subjects due to staff turnover and its effects
    on quality of data collection."	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Withdrawal of the administrative reason	['Business_Administrative']	['Possibly_Negative']
"Currently, almost no patients admitted to Dutch hospitals. If any effect of HCQ is to be
    expected we need more than 1000 inclusions"	['Negative']	['Negative']
not enough patients	['Insufficient_Enrollment']	['Neutral']
Difficulty in patient recruitment	['Insufficient_Enrollment']	['Neutral']
"Results from futility analysis conducted at planned interim time-point did not meet the study
    criteria for continuation."	['Negative']	['Negative']
"Diagnostic platform no longer under development; study termination not related to any safety
    issues"	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Termination of study due to low enrollment. There were no safety issues.	['Insufficient_Enrollment']	['Neutral']
the chosen intervention was obviously ineffective	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Terminated due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
The study was stopped because of slow accrual	['Insufficient_Enrollment']	['Neutral']
Investigator who manufactured the vaccine left the university.	['Study_Staff_Moved']	['Neutral']
Rare aneurysms. No patient enrolled at site.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
IRB decision	['Regulatory', 'Invalid_Reason', 'Negative']	['Neutral', 'Invalid_Reason', 'Negative']
funding withdrawn	['Business_Administrative']	['Possibly_Negative']
Alternative trial planned	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Preliminary results showed that the use of the cloths helped prevent infections.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
"Statistical analysis of 153 enrolled Phase 1 patients showed that specific patients could not
    be targeted for medication histories by discipline."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Unable to identify study population to achieve number expected	['Insufficient_Enrollment']	['Neutral']
Business decision pending resolution of clinical hold with FDA	['Business_Administrative']	['Possibly_Negative']
internal practice and policy limitations including time commitment / workflow issues	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Slow enrollment decreased sample size No unexpected safety issues.	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Manufacturing of the AGS-004 HIV vaccine by Argos could no longer be provided.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Very low patient recruitment, changed insurance requirements	['Insufficient_Enrollment']	['Neutral']
This study was withdrawn (see NCT00181753).	['No_Context', 'Negative', 'Another_Study']	['Invalid_Reason', 'Negative', 'Neutral']
Primary investigator transferred in another hospital; ongoing pandemic;	['Study_Staff_Moved']	['Neutral']
The study terminated early due to weak accrual.	['Insufficient_Enrollment']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
This protocol was replaced with a different one and therefore discontinued.	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
The study was terminated by Sponsor due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
This study is being closed because it is unworkable.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Not meeting enrollment goals.	['Insufficient_Enrollment']	['Neutral']
Recruitment terminated prematurely due to SARS-CoV-2 pandemic	['Covid19', 'No_Context', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
withdrawn prior to IRB approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study halted by drug manufacturer	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"PI is working on getting funding for the study and wishes to withdraw the study until that
    funding is secured."	['Business_Administrative']	['Possibly_Negative']
"The termination of the study is not linked to a product recall or result of any safety signal.
    Rather it was sponsor's commercial decision to withdraw the MA"	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Interim analysis did not show good results for main objective	['Negative']	['Negative']
failure to enroll	['Insufficient_Enrollment']	['Neutral']
No patients were enrolled. No data & no study results to report.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Study should not have been listed on ClinicalTrials	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
Cancelled before Active	['Invalid_Reason']	['Invalid_Reason']
"This study is terminated due to a business decision not to pursue INCB059782 in Sickle Cell
    Disease indication."	['Business_Administrative']	['Possibly_Negative']
For strategic buisness reasons.	['Business_Administrative']	['Possibly_Negative']
"Study terminated on 15DEC2016 due to study A8241021 showing no significant difference on
    primary endpoint between PF-02545920 & placebo. No safety concerns."	['Negative', 'Another_Study']	['Negative', 'Neutral']
departure without replacement of the principal investigator	['Study_Staff_Moved']	['Neutral']
The company is no longer pursuing this study.	['Business_Administrative']	['Possibly_Negative']
The sponsor is no longer developing this program and therefore has withdrawn the funding.	['Business_Administrative']	['Possibly_Negative']
The study was terminated based on results of an interim analysis for futility.	['Negative']	['Negative']
Stopped for futility by DSMB	['Negative']	['Negative']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
The PI changed institutions	['Study_Staff_Moved']	['Neutral']
Close-out of the grant - study ceased on 1/1/2010	['Business_Administrative']	['Possibly_Negative']
completed	['Invalid_Reason']	['Invalid_Reason']
Financial considerations	['Business_Administrative']	['Possibly_Negative']
Study stopped due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
Too low inclusion rate. Only 4 patients included over 16 months	['Insufficient_Enrollment']	['Neutral']
"251PP301(NCT03068468) primary endpoint was not met;further development of Gosuranemab BIIB092
    in progressive supranuclear palsy will not be pursued."	['Negative']	['Negative']
IRB did not approve	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
This study was terminated due to insufficient recruitment.	['Insufficient_Enrollment']	['Neutral']
Company Assets Being Sold	['Business_Administrative']	['Possibly_Negative']
Safety concerns with approved medication identified in an unrelated trial	['Negative', 'Another_Study']	['Negative', 'Neutral']
Phase I analysis	['No_Context', 'Endpoint_Met', 'Study_Design']	['Invalid_Reason', 'Neutral', 'Neutral']
Interim analysis results were not supportive of primary endpoint	['Negative']	['Negative']
Drugs unavailable. Study did not progress to Phase 2.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Competing studies	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Study was closed to enrollment when it became clear that enrollment was too slow to complete
    full enrollment target within time frame allowed."	['Insufficient_Enrollment']	['Neutral']
Sponsor's decision	['Business_Administrative']	['Possibly_Negative']
Investigator Moved Institutions	['Study_Staff_Moved']	['Neutral']
Funding inadequate	['Business_Administrative']	['Possibly_Negative']
insufficient recruitment, a lot of premature study discontinuations	['Insufficient_Enrollment']	['Neutral']
Study pulled due to a grant disagreement between the U of M and SMDC	['Business_Administrative']	['Possibly_Negative']
PI is leaving UCSD	['Study_Staff_Moved']	['Neutral']
Study design was amended to include a control - reregistered as NCT02465775	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Sponsor withdrew funding	['Business_Administrative']	['Possibly_Negative']
Personal changes in the company	['Business_Administrative']	['Possibly_Negative']
Problems in organization	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Too many barriers to enroll participants.	['Insufficient_Enrollment']	['Neutral']
The study was stopped due to other research priorities.	['Business_Administrative']	['Possibly_Negative']
Business decision	['Business_Administrative']	['Possibly_Negative']
Company Decision	['Business_Administrative']	['Possibly_Negative']
Researchers leading this study have left BMC	['Study_Staff_Moved']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Inadequate enrollment	['Insufficient_Enrollment']	['Neutral']
difficulty of recrutement	['Insufficient_Enrollment']	['Neutral']
no additional funding	['Business_Administrative']	['Possibly_Negative']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
IMP new owner decision	['Business_Administrative']	['Possibly_Negative']
FDA has withdrawn the IND application- requesting protocol changes	['No_Context', 'Regulatory', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
The PI moved to another city and position	['Study_Staff_Moved']	['Neutral']
The study has been terminated due to key change of protocol	['Study_Design']	['Neutral']
difficult to achieve the sufficient subjects	['Insufficient_Enrollment']	['Neutral']
recruitment infeasible	['Insufficient_Enrollment']	['Neutral']
principal investigator has left the institution	['Study_Staff_Moved']	['Neutral']
Enrollment suspended due to COVID-19	['Covid19']	['Neutral']
Study sponsor decided to withdraw the current study prior to enrollment of first participant.	['Business_Administrative']	['Possibly_Negative']
No subject enrolled since 2009	['Insufficient_Enrollment']	['Neutral']
Required by the investigator. The site could not recruit patients anymore.	['Insufficient_Enrollment']	['Neutral']
suboptimal recruitment	['Insufficient_Enrollment']	['Neutral']
"The study was terminated because the Study Chair/IDE Sponsor and Novocure determined that
    conducting this trial was not feasible without CMS approval."	['Business_Administrative']	['Possibly_Negative']
No participants were enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Couldn't sign the contract	['Business_Administrative']	['Possibly_Negative']
The study was never started as a result of change of personnel and funding	['Business_Administrative']	['Possibly_Negative']
Study never opened; never enrolled participants	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"Withdrawn [COVID restrictions prevent patient enrollment or treatment. Clinical Trial facility
    is being closed due to viral limitations and loss of staff to perform]"	['Covid19']	['Neutral']
"Loss of equipoise among enrolling clinicians, as well as emergence of external literature
    showing safety of nasogastric tube (NGT) feeds."	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Difficulty recruiting	['Insufficient_Enrollment']	['Neutral']
"The NPs that we have been buying from a vendor show lot to lot variation. We are making our own
    NPs, need to characterize them before we enroll new patients."	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
inability to complete recruitment as planned	['Insufficient_Enrollment']	['Neutral']
"AZ decision to discontinue fostamatinib development in RA; rights to fostamatinib returned to
    Rigel Pharmaceuticals."	['Business_Administrative']	['Possibly_Negative']
Principal Investigator surrendered funding and left institution.	['Business_Administrative']	['Possibly_Negative']
The study was closed due to poor enrollment and lack of interest.	['Insufficient_Enrollment']	['Neutral']
halted prematurely.	['Invalid_Reason']	['Invalid_Reason']
IRB not approved	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Department difficulties	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
The study was terminated due to a company decision following completion of Part A.	['Business_Administrative']	['Possibly_Negative']
inadequate data	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Study subject enrollment difficulties	['Insufficient_Enrollment']	['Neutral']
Funding ended	['Business_Administrative']	['Possibly_Negative']
Covid-19	['Covid19']	['Neutral']
"Due to slow enrollment and lack of response observed during the enrollment period, the Sponsor
    decided to close study enrollment early on 28 January 2015"	['Insufficient_Enrollment']	['Neutral']
"Study recruitment was stopped due to difficulty in enrolling the targeted number of
    participants."	['Insufficient_Enrollment']	['Neutral']
Funding problems	['Business_Administrative']	['Possibly_Negative']
unable to enroll participants who meet the criteria	['Insufficient_Enrollment']	['Neutral']
poor accrual	['Insufficient_Enrollment']	['Neutral']
Unable to enroll subjects	['Insufficient_Enrollment']	['Neutral']
"Due to reasons unrelated to safety. However, a primary efficacy endpoint signal was seen during
    a pre-specified interim analysis."	['Negative']	['Negative']
Business decision	['Business_Administrative']	['Possibly_Negative']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Failed to enroll patients. There is no data or results for this study.	['Insufficient_Enrollment']	['Neutral']
al study sites stoped on 15/05/2012 because of insufficient recrutement.	['Insufficient_Enrollment']	['Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Study terminated due to slow enrollment. There were no safety concerns.	['Insufficient_Enrollment']	['Neutral']
Unexpected culture contamination potentially due to a testing error	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Lack of observed efficacy	['Negative']	['Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
"No patients were enrolled because the company that pledged the drug does not yet have it
    available."	['Business_Administrative']	['Possibly_Negative']
Protocol required revisions and application was withdrawn from the IRB.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of financial support	['Business_Administrative']	['Possibly_Negative']
Half of DM patients had EEG changes and therefore were excluded.	['Safety_Sideeffects', 'Logistics_Resources', 'Endpoint_Met']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Too slow recruitment rate	['Insufficient_Enrollment']	['Neutral']
Withdrawn due to business reasons	['Business_Administrative']	['Possibly_Negative']
Study was redesigned based on FDA feedback.	['Covid19', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
Uterine contractility not possible to visualize with our ultrasound machines	['Logistics_Resources']	['Neutral']
"The company determined that continued exposure of these high-risk PH patients to clinic or
    in-person visits during the COVID pandemic presented an unacceptable risk."	['Covid19']	['Neutral']
No patients Enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
"The original sponsor was acquired by a new company and has elected to end funding for all
    Investigator Sponsored Trials (ISTs)"	['Business_Administrative']	['Possibly_Negative']
"The department in charge of this research is no longer able to follow this project. Only two
    inclusions this study is close"	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
Challenges with participant recruitment as a result of COVID-19 pandemic	['Covid19']	['Neutral']
Not NIH defined clinical trial study.	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
"Due to lack of funds, the study has been terminated upon recruiting less than desired number of
    subjects"	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Inadequate recruitment	['Insufficient_Enrollment']	['Neutral']
Terminated per PI's request at the time of continuing review	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
This protocol was never officially opened and no patients were recruited.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Terminated due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
loss of support	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
Study cancelled: Withdrawn before enrollment of any participants	['Invalid_Reason']	['Invalid_Reason']
Study personnel diverted to other activities and the study was not commenced	['Logistics_Resources', 'Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Time restrictions on leading investigator	['Logistics_Resources', 'Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
The study was terminated due to low accrual.	['Insufficient_Enrollment']	['Neutral']
Weak enrollment rate and sanitary situation	['Insufficient_Enrollment']	['Neutral']
Lack of funding to complete trial. A lead member of research team retired.	['Business_Administrative']	['Possibly_Negative']
Study has been terminated due to lack of financial support	['Business_Administrative']	['Possibly_Negative']
The study was withdrawn for administrative reason	['Business_Administrative']	['Possibly_Negative']
Problem with medical device provider	['Logistics_Resources']	['Neutral']
Extended study duration	['No_Context', 'Logistics_Resources', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
"Study was terminated due to commercial considerations and potential patient attrition at 3
    years. There were no patient safety or procedure efficacy reasons."	['Business_Administrative']	['Possibly_Negative']
"one PI (BM) no longer felt he had clinical equipoise regarding the intervention. No adverse
    events."	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
no participant recruited	['Insufficient_Enrollment']	['Neutral']
No safety reasons. Low recruitment.	['Insufficient_Enrollment']	['Neutral']
"Coronary flow by echo Doppler was obtainable in about 50% of subjects. The study was stopped
    early because of insufficient sample size to achieve adequate power"	['Negative']	['Negative']
"The study was terminated early (following completion of SAD Cohort 3; 80 mg) based on PK/PD
    modelling which demonstrated the medicine's intended target profile was not achievable."	['Negative']	['Negative']
"There was a delay in getting protocol approvals and hence the study would not be completed in
    time."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Results of the phase III RTOG0525 trial made the manufacturer of cilengitide decide to end
    their support to the trial"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Based on analyses in Phase I, the study did not advance to Phase II.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Results were not accurate; despite multiple efforts to troubleshoot.	['Negative']	['Negative']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Temporarily suspending due to the impact of COVID-19 on practices.	['Covid19']	['Neutral']
Recent publication makes current study obsolete.	['Another_Study']	['Neutral']
recruiting problems	['Insufficient_Enrollment']	['Neutral']
Study terminated due to an unfavorable risk-benefit analysis	['Negative']	['Negative']
Use of bupropion with counseling works better to help patients quit smoking.	['No_Context', 'Logistics_Resources', 'Endpoint_Met']	['Invalid_Reason', 'Neutral', 'Neutral']
Study was terminated early due to low enrollment numbers.	['Insufficient_Enrollment']	['Neutral']
Investigator initiated suspension to focus on other studies.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Due to decreased case volume due to COVID-19 enrollment has stopped.	['Covid19']	['Neutral']
Subject Research)	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
Change in supply of study medication	['Logistics_Resources']	['Neutral']
Funding for project not secured	['Business_Administrative']	['Possibly_Negative']
Terminated due to the fact that the required number of trial subjects was not met.	['Insufficient_Enrollment']	['Neutral']
too few participants enrolled and few interested patients in three years	['Insufficient_Enrollment']	['Neutral']
PI left Institution	['Study_Staff_Moved']	['Neutral']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Closed per local IRB due to advancements in standard ovarian cancer screening.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Study withdrawn due to hospital emphasis on funded studies.	['Business_Administrative']	['Possibly_Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
PI decision due to funding support	['Business_Administrative']	['Possibly_Negative']
Modifications were made to protocol, new IRB pending	['Study_Design']	['Neutral']
Another study has been started in other country.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study drug is no longer supplied by grantor.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study stopped due to lack of efficacy & funding.	['Business_Administrative']	['Possibly_Negative']
Difficulty recruiting	['Insufficient_Enrollment']	['Neutral']
Product received Approval for Commercial Distribution	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
PI returned to her home country of Japan	['Study_Staff_Moved']	['Neutral']
We switched this study design to another study per IEC's recommendations.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
the team has changed. the new team did not have the perosnnel to set up the study	['Logistics_Resources', 'Study_Staff_Moved', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
IRB withheld the data due to inadequate supporting documentation	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
This study never initiated.	['Invalid_Reason']	['Invalid_Reason']
Business Priorities	['Business_Administrative']	['Possibly_Negative']
Difficulty to recruit patients due to pandemic	['Insufficient_Enrollment']	['Neutral']
faillure to obtain insurance because of refusal from insurance companies	['Business_Administrative']	['Possibly_Negative']
sponsor funding	['Business_Administrative']	['Possibly_Negative']
problem due to new regulations for CE-marking of implants; lack of funding	['Business_Administrative']	['Possibly_Negative']
PI Decision	['Invalid_Reason']	['Invalid_Reason']
Sponsor decision (due to low subject recruitment)	['Insufficient_Enrollment']	['Neutral']
Funding Unavailable	['Business_Administrative']	['Possibly_Negative']
Temporarily suspended due to Pandemic	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Delayed recruitment, unable to meet calculated sample size	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Unable to recruit/enroll subjects for study.	['Insufficient_Enrollment']	['Neutral']
Withdrawn due to no accrual	['Insufficient_Enrollment']	['Neutral']
Study terminated due to COVID-19 restrictions	['Covid19']	['Neutral']
3/7 subjects experienced hypotension. Study was terminated.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"This study was stopped because ustekinumab did not achieve key endpoints in a related study.
    The safety profile was consistent with past ustekinumab studies."	['Negative', 'Another_Study']	['Negative', 'Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
"Simplicity HTN 3 trial did meet safety endpoint, but did not meet efficacy endpoint and
    withdrew support for their catheter in 2014."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
This trial was terminated early based on the lack of sufficient clinical efficacy observed.	['Negative']	['Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
No participants were enrolled.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Trial was stopped due to difficult enrolment	['Insufficient_Enrollment']	['Neutral']
Transient adverse events observed	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Recruitement was much slower than anticipated.	['Insufficient_Enrollment']	['Neutral']
Substance discontinued	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
failed to recruit eligible subjects	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
The study closed primarily due to weak accrual, as well as study design limitations.	['Insufficient_Enrollment']	['Neutral']
It was impossible for us to include patients	['Insufficient_Enrollment']	['Neutral']
Changing priorities	['Business_Administrative']	['Possibly_Negative']
There were IP availability issues due to which the study could not be started.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Pending Interim Analysis	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
never approved by IRB	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Slow enrollment combined with positive preliminary results	['Negative', 'Another_Study']	['Negative', 'Neutral']
"We observed reduced intake by the fifth week, so we are shortening the study and simplifying it
    by using a complete factorial design with four conditions."	['Study_Design']	['Neutral']
Product development cancelled.	['Business_Administrative']	['Possibly_Negative']
Schools opening remotely has prevented recruitment	['Insufficient_Enrollment']	['Neutral']
Administrative Reasons	['Business_Administrative']	['Possibly_Negative']
Logistic reasons associated with the FDA-imposed clinical hold.	['Logistics_Resources']	['Neutral']
PI departed study site. Study closed.	['Study_Staff_Moved']	['Neutral']
"At the request of the study site, this study has been closed and access to study-related data
    is unavailable. We are unable to submit the results-data."	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study not started	['Invalid_Reason']	['Invalid_Reason']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Lack of resources and COVID-related closure in 2020.	['Covid19']	['Neutral']
Lack of Efficacy	['Negative']	['Negative']
Withdrawal of support of the drug company for drug and placebo	['Business_Administrative']	['Possibly_Negative']
CLML134X2201 was terminated due to business reasons and not to safety findings	['Business_Administrative']	['Possibly_Negative']
Recruitment was unsuccessful	['Insufficient_Enrollment']	['Neutral']
low detection of the SN in patients included so far (n=11)	['Negative']	['Negative']
Low recruitment of patients.	['Insufficient_Enrollment']	['Neutral']
Lead was recalled and manufacturing halted	['Logistics_Resources']	['Neutral']
Covid-19	['Covid19']	['Neutral']
difficulties to include patients	['Insufficient_Enrollment']	['Neutral']
Recruitment difficulty	['Insufficient_Enrollment']	['Neutral']
withdrawn as MSU approval obained	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study terminated due to low accrual.	['Insufficient_Enrollment']	['Neutral']
Commercial reasons	['Business_Administrative']	['Possibly_Negative']
Inadequate enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of response to recruitment	['Insufficient_Enrollment']	['Neutral']
At the request of the PI	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Study was not opened at site.	['Invalid_Reason']	['Invalid_Reason']
Futility analysis	['Negative']	['Negative']
Erroneously duplicated study	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Business Objectives Have Changed	['Business_Administrative']	['Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Considiering to change the Chemotherapy into Gefitinib	['Study_Design']	['Neutral']
Reliable and consistent method of UV Tattoo application was not able to be achieved.	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Business decision	['Business_Administrative']	['Possibly_Negative']
Non-protocol feasibility	['Logistics_Resources']	['Neutral']
Principal Investigator left the study site on December 28, 2012.	['Study_Staff_Moved']	['Neutral']
Decision by company to cease development of dovitinib	['Business_Administrative']	['Possibly_Negative']
program has been put on hold by the sponsor	['Business_Administrative']	['Possibly_Negative']
"Due to a financial business decision by the company supporting the research study (Indivior).
    The decision was not due to adverse events, safety reasons, or scientific reasons, but was a
    business decision."	['Business_Administrative']	['Possibly_Negative']
Business decision	['Business_Administrative']	['Possibly_Negative']
primary investigator left institution; not enough patients	['Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Study had to be withdrawn because financial support was cancelled.	['Business_Administrative']	['Possibly_Negative']
Abnormal distribution and lack of tumor targeting were observed.	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Due to inability to recruit participants.	['Insufficient_Enrollment']	['Neutral']
"All Amgen sponsored AMG102 clinical studies were terminated following a pre-planned Data
    Monitoring Committee safety review of study 20070622."	['Negative', 'Another_Study']	['Negative', 'Neutral']
No need	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
recruitment numbers lower than expected	['Insufficient_Enrollment']	['Neutral']
Study terminated due to lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
Study was never started	['Invalid_Reason']	['Invalid_Reason']
Sponsor decision to terminate after 3 dosing groups	['Business_Administrative']	['Possibly_Negative']
Feasibility	['Logistics_Resources']	['Neutral']
Low subject accrual	['Insufficient_Enrollment']	['Neutral']
delayed recruitment	['Insufficient_Enrollment']	['Neutral']
Continuation was futile per calculation recommend by data & safety monitoring committee	['Negative']	['Negative']
PI obtained outside employment that was not compatible with this award	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
"Final protocol and ICF has not been approved by local IRB. No subjects have been enrolled.
    Study will not be pursued due to current COVID-19 pandemic."	['Covid19']	['Neutral']
no longer had funding to continue	['Business_Administrative']	['Possibly_Negative']
IMP supply	['Logistics_Resources']	['Neutral']
Slow Accrual.	['Insufficient_Enrollment']	['Neutral']
moved to new institution	['Study_Staff_Moved']	['Neutral']
Slow recruitment. No safety concerns during this study.	['Insufficient_Enrollment']	['Neutral']
Verified with former investigator that recruitment activity did not take place	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Business Decision	['Business_Administrative']	['Possibly_Negative']
Investigators are no longer considering FMT product development for C. difficile.	['Business_Administrative']	['Possibly_Negative']
Sponsor-Investigator left the institution	['Study_Staff_Moved']	['Neutral']
Logistics	['Logistics_Resources']	['Neutral']
No funding was obtained.	['Business_Administrative']	['Possibly_Negative']
"Difficulties to recruit participants A similar Canadian multicentric study started at about the
    same."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Study never moved forward with accrual.	['Insufficient_Enrollment']	['Neutral']
Covid19, not able to finish recruitment	['Covid19']	['Neutral']
Unable to recruit adequate numbers for study	['Insufficient_Enrollment']	['Neutral']
low enrollment potential in local community	['Insufficient_Enrollment']	['Neutral']
This study had to be suspended due to COVID-19 Pandemic.	['Covid19']	['Neutral']
Replaced by another study.	['Negative', 'Another_Study']	['Negative', 'Neutral']
insufficient accrual	['Insufficient_Enrollment']	['Neutral']
no patient accrual	['Insufficient_Enrollment']	['Neutral']
This study has been terminated because of insufficient patient recruitment.	['Insufficient_Enrollment']	['Neutral']
Defect of recruitment	['Insufficient_Enrollment']	['Neutral']
Low recruitment rate; high proportion of screening failures.	['Insufficient_Enrollment']	['Neutral']
Could not recruit	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Principal investigator took a position at another institution. No subjects enrolled.	['Study_Staff_Moved']	['Neutral']
Funding ended	['Business_Administrative']	['Possibly_Negative']
"We observed that using the Suprathel dressing required additional treatment of the wound and
    had a longer healing time than the standard of care Xeroform dressing; it did not dry the wound
    out properly to promote healing."	['Logistics_Resources', 'Endpoint_Met', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
The device did not work well enough in its current form to continue the study.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"The study was halted prematurely at 90 of 105 planned patients due to the beneficial results of
    embolectomy clinical trials."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Two cohorts successfully completed; further cohorts not needed; no safety issue!	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
at sponsor's discretion : Benefit is not guaranteed	['Business_Administrative']	['Possibly_Negative']
Decision based on strategic determination; not safety.	['Business_Administrative']	['Possibly_Negative']
Others	['Covid19', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
H1N1 pandemic concluded in early 2010	['Safety_Sideeffects', 'Endpoint_Met', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Primary endpoint (safety) has been achieved	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Trial was terminated to allow sponsors to evaluate the future development of the drug program	['Business_Administrative']	['Possibly_Negative']
Study enrollment significantly below protocol expectation	['Insufficient_Enrollment']	['Neutral']
"In collaboration with community partners, we determined that the reading level required for the
    intervention did not make it suitable for the adolescents."	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Unable to recruit participants	['Insufficient_Enrollment']	['Neutral']
Insufficient findings for data analysis	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Funding unavailable	['Business_Administrative']	['Possibly_Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
interim analysis showed significant differences between two treatment groups	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
COVID-19 pandemic	['Covid19']	['Neutral']
Covid-19	['Covid19']	['Neutral']
Patients were not interested in enrolling	['Insufficient_Enrollment']	['Neutral']
Bradykinin Shortage, SCCOR expired prior to BK availability, lack of enrollment.	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Kadmon has made a business decision to terminate the study due to slow enrollment. Note the
    decision to terminate the study was not related to safety issues"	['Business_Administrative']	['Possibly_Negative']
Haluted due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Not able to recruit patients	['Insufficient_Enrollment']	['Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
For business reasons / product no longer available from Sponsor	['Business_Administrative']	['Possibly_Negative']
The study was not developed due to the cessation of IONSYS marketing	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Management decision	['Business_Administrative']	['Possibly_Negative']
Sponsor decision, not safety related	['Business_Administrative']	['Possibly_Negative']
study drug unavailable	['Logistics_Resources']	['Neutral']
CA approval not obtained	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Imbalance in the # graft infections between the tx's (graft vs. graft + wrap)	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
PI's Request	['Study_Staff_Moved', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Determined feasibility was needed before conducting this trial	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Interim analysis showed significant effect in favour of full-dose atorvastatin.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Terminated by Sponsor	['Business_Administrative']	['Possibly_Negative']
Sponsor decision not related to patient safety	['Business_Administrative']	['Possibly_Negative']
Terminated due to medical supplies shortages due to the 2017 hurricane season.	['Logistics_Resources']	['Neutral']
catheter occlusion events during the study drug infusion	['Safety_Sideeffects', 'Logistics_Resources']	['Safety_Sideeffects', 'Neutral']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
The study was stopped due to resourcing issues.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Principal Investigator left the Hospital and did not transfer the study	['Study_Staff_Moved']	['Neutral']
Study currently suspended due to a lack of available funding.	['Business_Administrative']	['Possibly_Negative']
"Due to the current COVID-19 pandemic, the recruitment of new subjects is temporarily
    discontinued. Ongoing, randomised patients are managed per Trial Protocol."	['Covid19']	['Neutral']
terminated	['Invalid_Reason']	['Invalid_Reason']
PI was unable to enroll anyone.	['Insufficient_Enrollment']	['Neutral']
This study was terminated early for administrative reasons.	['Business_Administrative']	['Possibly_Negative']
"The decision was taken solely for business/administrative reasons, no safety considerations
    entered into this. Ongoing randomized patients to complete."	['Business_Administrative']	['Possibly_Negative']
Subject changed	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Due to low recruitment numbers, the study was terminated.	['Insufficient_Enrollment']	['Neutral']
Severe allergic reaction in one patient	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
PI has left the UMDNJ but may resume the study in her new place of employment.	['Study_Staff_Moved']	['Neutral']
Study is terminated due to administrative reasons.	['Business_Administrative']	['Possibly_Negative']
during anticipated study duration trial power was not attained.	['Negative']	['Negative']
Study recruitment temporarily suspended due to COVID-19 pandemic.	['Covid19']	['Neutral']
Terminated- Study halted due to low recruitment.	['Insufficient_Enrollment']	['Neutral']
Safety data review	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
"A publication released shortly after start indicating intervention not always beneficial. Fewer
    surgical cased thereafter."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Subject recuitment halted and won't resume; subjects are no longer being treated.	['Invalid_Reason']	['Invalid_Reason']
Loss of team members.	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
"The number of patients registered for the study was low and it was expected to be difficult to
    derive the study results."	['Insufficient_Enrollment']	['Neutral']
"Suggested by IRB after the Principal Investigator has amended the study title, study protocol
    and increased sample size, the original study has to be withdrawn and apply as a new study."	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Lack of quality data	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
"Steering Committee decision after inclusion of 74 patients after 6 years and very slow
    inclusion rate"	['Insufficient_Enrollment']	['Neutral']
To high rejection rate in CsA withdrawal arm	['Negative']	['Negative']
the PROTECT study is being transitioned to ACTIV4 ACUTE anticoagulation inpatient study	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Insufficient funds	['Business_Administrative']	['Possibly_Negative']
Funding ended and fewer than required number of patients enrolled.	['Business_Administrative']	['Possibly_Negative']
No enrollment as this was a retrospective review, not a clinical trial.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Decision to prematurely close the trial was made because of poor recruitment.	['Insufficient_Enrollment']	['Neutral']
Poor accrual.	['Insufficient_Enrollment']	['Neutral']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Covid-19	['Covid19']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Based on data collected, the combination appeared to be poorly tolearated.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Enrollment too difficult	['Insufficient_Enrollment']	['Neutral']
The data showed that pain was higher for our standardized method of sampling	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Some sites withdrew because no contract with insulin pump supplier	['Business_Administrative']	['Possibly_Negative']
Not activated at Duke	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
This study was stopped as no patient asked to participate was prepared to do so	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Expiration of MEDI-507	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Study enrollment was prematurely stopped for business reasons.	['Business_Administrative']	['Possibly_Negative']
This study was terminated early due to administrative reasons.	['Business_Administrative']	['Possibly_Negative']
Study never started	['Invalid_Reason']	['Invalid_Reason']
never enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Difficulty in recruitment	['Insufficient_Enrollment']	['Neutral']
Covid 19 pandemic	['Covid19']	['Neutral']
Funding could not be secured	['Business_Administrative']	['Possibly_Negative']
"Unfortunately, other Phase III clinical Study (GEM+S-1 vs GEM vs S-1) have been started in
    Japan.

    h"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Reduced acceptance of IMP	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
PI has left institution	['Study_Staff_Moved']	['Neutral']
Suspended for protocol revisions	['Study_Design']	['Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
"The clinical study is closed to further enrolment based on the lack of perceived need to
    compare the study device with the control device."	['Study_Design', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Business decision by the sponsor during Phase 1.	['Business_Administrative']	['Possibly_Negative']
"Imbalance in deaths favoring control arm; deaths not attributed to treatment by the blinded
    external medical monitor."	['Covid19', 'Interim_Analysis', 'Safety_Sideeffects']	['Neutral', 'Neutral', 'Safety_Sideeffects']
The study was stopped on november 2006 after inclusion was fulfilled	['Invalid_Reason']	['Invalid_Reason']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
"Based on recent publications, determination of natalizumub washout period was no longer
    relevant."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Not enough confirmed responses to continue treatment.	['Insufficient_Enrollment', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
The trial was ended per sponsor due to slow accrual rates.	['Insufficient_Enrollment']	['Neutral']
Drug receive FDA approval	['No_Context', 'Regulatory', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
difficult to enrol and as a pilot study sample size was not powered anyway	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
No funding obtained	['Business_Administrative']	['Possibly_Negative']
Study has been suspended due to clinical hold.	['Invalid_Reason']	['Invalid_Reason']
Business reason unrelated to product safety	['Business_Administrative']	['Possibly_Negative']
never started	['Invalid_Reason']	['Invalid_Reason']
Participants are no longer being examined or treated.	['Invalid_Reason']	['Invalid_Reason']
"Recent advances in the treatment of B cell malignancies resulting in new treatments being
    approved for marketing and many others in late stage development"	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Poor enrollment. No apparent treatment effect.	['Negative']	['Negative']
"Expectation that within the set time period insufficient patients will be included, so
    endpoints will not be achieved"	['Insufficient_Enrollment']	['Neutral']
Did not meet target enrollment deadlines.	['Insufficient_Enrollment']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Following Regulator inspection in 2009, study terminated as inadequate approvals were in place	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Terminated based on mutual agreement between PI and sponsor (Glaxo Smith Kline)	['Business_Administrative']	['Possibly_Negative']
Recruitment Issues - Lack of target population	['Insufficient_Enrollment']	['Neutral']
The study never started.	['Invalid_Reason']	['Invalid_Reason']
logistic reasons; amendment pending with IRB	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Interim analysis determined that the study should be concluded for futility.	['Negative']	['Negative']
"The FDA determined that there is not adequate safety information to continue clinical
    investigations using ANS-6637 and Amygdala Neurosciences, the product company of ANS-6637, is
    no longer pursuing research with this compound."	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
No man power	['Logistics_Resources']	['Neutral']
"Further data are no longer required to support an application for use in pediatric patients.
    The decision to terminate was not based on any new safety findings"	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
Funding did not allow for completion of game programming	['Business_Administrative']	['Possibly_Negative']
Secondary to safety concerns plus change in Campath (alemtuzumab) availability.	['Safety_Sideeffects', 'Logistics_Resources', 'Endpoint_Met']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Preliminary results did not support the utility of combining selegeline + NRT.	['Negative']	['Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Difficulty recruiting appropriate participants	['Insufficient_Enrollment']	['Neutral']
Did not obtain an IND.	['Regulatory', 'Invalid_Reason', 'Negative']	['Neutral', 'Invalid_Reason', 'Negative']
Recruitment inadequate and investigators leaving the study institution for new positions.	['Insufficient_Enrollment']	['Neutral']
no enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsor cancelled the study	['Business_Administrative']	['Possibly_Negative']
Industry won't be moving forward with production of bococizumab	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Shortage of potassium acetate for study intravenous fluids	['Logistics_Resources']	['Neutral']
"The trial was terminated after an interim analysis of efficacy and safety data did not warrant
    continuation of the trial."	['Negative']	['Negative']
Per study sponsor decision.	['Business_Administrative']	['Possibly_Negative']
Due to logistical concerns	['Logistics_Resources']	['Neutral']
Pharmaceutical company decision	['Business_Administrative']	['Possibly_Negative']
"Recruitment was prematurely stopped due to difficulty of recruitment encountered by the
    experimental centers"	['Insufficient_Enrollment']	['Neutral']
Lost funding/staff	['Business_Administrative']	['Possibly_Negative']
Change in procedure.US technically challenging.	['Study_Design']	['Neutral']
Slow enrollment and administrative reasons	['Business_Administrative']	['Possibly_Negative']
was not able to recruit participants	['Insufficient_Enrollment']	['Neutral']
The study was terminated because of high dropout rate.	['Insufficient_Enrollment']	['Neutral']
Formulation issues.	['Logistics_Resources']	['Neutral']
Early closure of study due to poor response	['Insufficient_Enrollment', 'Negative']	['Neutral', 'Negative']
Recruitment was early terminated due to slow recruitment. Not linked to any safety concern.	['Insufficient_Enrollment']	['Neutral']
Withdrawal of analysis study Partner.	['Logistics_Resources', 'Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Increased mortality in the intervention arm at 50% enrolment	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Lack of funding and recruitment.	['Business_Administrative']	['Possibly_Negative']
Due to the recent change in standard of care for hepatitis C.	['Study_Design']	['Neutral']
no funding	['Business_Administrative']	['Possibly_Negative']
lack of recruitement	['Insufficient_Enrollment']	['Neutral']
"Study stopped early after review of safety and efficacy demonstrated efficacy proof-of-concept
    and need for dose reduction."	['Success', 'No_Context', 'Logistics_Resources']	['Success', 'Invalid_Reason', 'Neutral']
This study was terminated for administrative reasons	['Business_Administrative']	['Possibly_Negative']
This study was cancelled before any data collection due to business reasons.	['Business_Administrative']	['Possibly_Negative']
no accrual	['Insufficient_Enrollment']	['Neutral']
Investigator decided it was not feasible to conduct this study	['Study_Design']	['Neutral']
Lack of efficacy	['Negative']	['Negative']
Study closed Nov 2000 by Amgen, who stopped drug delivery	['Business_Administrative']	['Possibly_Negative']
Study halted prematurely prior to enrollment of first participant.	['Invalid_Reason']	['Invalid_Reason']
Study never started	['Invalid_Reason']	['Invalid_Reason']
Business decision to stop the program.	['Business_Administrative']	['Possibly_Negative']
"Study device no longer manufactured by Sonendo. Total enrollment for the study was 20 subjects,
    only 3 subjects were enrolled and treated."	['Covid19', 'Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
lack of time	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Sangart ceased operations	['Business_Administrative']	['Possibly_Negative']
Study principal investigator left the organization	['Study_Staff_Moved']	['Neutral']
"Primary endpoints would be unlikely to be met based on the unplanned interim assessment on the
    first 20 efficacy evaluable patients."	['Negative']	['Negative']
study was abandoned and a new study was written to replace this one	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
inability to recruit due to administrative difficulties at the site	['Business_Administrative']	['Possibly_Negative']
Enrollment lower than anticipated	['Insufficient_Enrollment']	['Neutral']
Development of tasquinimod in prostate cancer discontinued	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
"In a pre-planned interim analysis, OSI-774-205 met futility for efficacy with no safety
    concerns. As a result, the companion trial, OSI-774-206 has been stopped"	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
Pending further equipment and staff	['Logistics_Resources']	['Neutral']
Termination of [18F]Fluciclatide production	['Interim_Analysis', 'Safety_Sideeffects', 'Regulatory']	['Neutral', 'Safety_Sideeffects', 'Neutral']
The sponsor decided to terminate the study.	['Business_Administrative']	['Possibly_Negative']
No one met the inclusion/exclusion criteria	['Insufficient_Enrollment']	['Neutral']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
difficult recruiting	['Insufficient_Enrollment']	['Neutral']
Withdrawn by PI	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"The patient was ""lost to follow-up"" and the PI left the institution."	['Study_Staff_Moved']	['Neutral']
Recruitment difficulties.	['Insufficient_Enrollment']	['Neutral']
Covid-19	['Covid19']	['Neutral']
Recruiting of family doctors below our goal	['Insufficient_Enrollment']	['Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
inability to recruit	['Insufficient_Enrollment']	['Neutral']
Insufficient enrollment, question addressed by other researchers	['Insufficient_Enrollment']	['Neutral']
production of IMP has stopped	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Withdrawal of study support.	['Business_Administrative']	['Possibly_Negative']
Business decision: Protocol efficacy futility met	['Business_Administrative']	['Possibly_Negative']
Lack of funding.	['Business_Administrative']	['Possibly_Negative']
Study stopped due to business decision	['Business_Administrative']	['Possibly_Negative']
Study halted prematurely but potentially will resume	['Invalid_Reason']	['Invalid_Reason']
No patient follow-up	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Low recruitment rate and expiration of the study drug	['Insufficient_Enrollment']	['Neutral']
"Randomization was stopped early because a significant beneficial effect of nutritional
    intervention was found in the interim analysis"	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Decision not to pursue as single agent in the study population.	['Business_Administrative']	['Possibly_Negative']
"Data Monitoring Committee concluded after a planned interim analysis that aflibercept added to
    gemcitabine would be unable to demonstrate improved survival"	['Negative']	['Negative']
Low subject recruitment	['Insufficient_Enrollment']	['Neutral']
insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
"The PI resigned the institute, and the rest investigators at the institute decided to terminate
    the study."	['Study_Staff_Moved']	['Neutral']
the research is on susoension beacause the lack of manpower	['Logistics_Resources']	['Neutral']
In the intermediate analysis, no effect could be shown, not even a tendency.	['Negative']	['Negative']
Alternative product is now approved and available for use.	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Difficulties encountered with patients inclusion and femtolaser availability	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Protocol expired with IRB.	['Regulatory', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
No funding for the project	['Business_Administrative']	['Possibly_Negative']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Update to clinical strategy - COVID impact	['Covid19']	['Neutral']
Poor retention and recruitment,changes need to be made to the program	['Insufficient_Enrollment']	['Neutral']
Recruitment Target not met	['Insufficient_Enrollment']	['Neutral']
Abbott (drug manufacturer) discontinued manufacture of ABT-627	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
study was never started and no patients were ever enrolled	['Invalid_Reason']	['Invalid_Reason']
This study is temporarily suspended due to COVID-19 pandemic	['Covid19']	['Neutral']
Molecule Development was Terminated	['Business_Administrative']	['Possibly_Negative']
See Detailed Description field	['No_Context']	['Invalid_Reason']
delayed funding	['Business_Administrative']	['Possibly_Negative']
Lack of recruitment.	['Insufficient_Enrollment']	['Neutral']
The study never officially funded and therefore never began.	['Business_Administrative']	['Possibly_Negative']
"There were no subjects enrolled locally on this study since it opened. Local IRB closure has
    been requested."	['Regulatory', 'Insufficient_Enrollment', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
We did not receive proper funding to complete this study	['Business_Administrative']	['Possibly_Negative']
Revising Protocol Based on Expert Feedback	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
"After an extensive review,the ASPIRE in CKD study was terminated because it was not possible to
    complete the study in an appropriate time frame."	['Logistics_Resources']	['Neutral']
Recruitment issues	['Insufficient_Enrollment']	['Neutral']
Sponsors	['Business_Administrative']	['Possibly_Negative']
"The tracker application has been withdrawn by developer and no other suitable tracker
    application has been identified to replace it."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
the study stopped because we could not recruit enough patients.	['Insufficient_Enrollment']	['Neutral']
Study was not initiated because we could not secure funding.	['Business_Administrative']	['Possibly_Negative']
Business decision to perform a market withdrawal of the product	['Business_Administrative']	['Possibly_Negative']
Study was not feasible	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
lack of Financial support	['Business_Administrative']	['Possibly_Negative']
"Unfavourable opinion from NHS ethics. Due to low recruitment from NHS sources in another study,
    it was decided not to reapply but to withdraw the study."	['Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral']
low accrual not allowing site to meeting statistical endpoints	['Insufficient_Enrollment']	['Neutral']
Request of Indian Health Service Leadership	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Program terminated	['Invalid_Reason']	['Invalid_Reason']
Potential for immune stimulation to interfere with further dose escalation.	['Negative']	['Negative']
"PI changed affiliation not beening allowed to continue the trial in further cooperation. The
    sub-investigators did not see any option to continue the trial and made the decision to
    terminate the study."	['Study_Staff_Moved', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Development of other studies led to termination without recruitment.	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Insufficient patient accrual.	['Insufficient_Enrollment']	['Neutral']
poor enrollment (only one subject enrolled)	['Insufficient_Enrollment']	['Neutral']
Final analysis done, follow-up of patients no more necessary	['Interim_Analysis', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
incomplete enrollment	['Insufficient_Enrollment']	['Neutral']
COVID-19 pandemic	['Covid19']	['Neutral']
Sponsor requested termination due to low recruitment numbers	['Insufficient_Enrollment']	['Neutral']
Unable to recruit participants	['Insufficient_Enrollment']	['Neutral']
Other stimulation target (slMFB) more efficacious, unethical to continue with Nucleus Accumbens	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
COVID pandemic	['Covid19']	['Neutral']
Sponsor decision based on portfolio prioritization	['Business_Administrative']	['Possibly_Negative']
Enrollment too slow.	['Insufficient_Enrollment']	['Neutral']
IMP will not be further developed	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Not participants inclusion	['Insufficient_Enrollment']	['Neutral']
business reasons	['Business_Administrative']	['Possibly_Negative']
Sponsor's decision not to pursue development of uPLi for vascular conditions.	['Business_Administrative']	['Possibly_Negative']
Changes in the lab's focus and needs	['Logistics_Resources', 'Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
unable to hire qualified personnel to run the study	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Unable to recruit enough study participants	['Insufficient_Enrollment']	['Neutral']
"This study was suspended by principal investigator's decision. All the sites were not opened,
    and the recruitment was so slow."	['Insufficient_Enrollment']	['Neutral']
Lack of funding.	['Business_Administrative']	['Possibly_Negative']
Slow enrollment &Study Drug Expiration (Target: 40 randomized participants /arm)	['Insufficient_Enrollment']	['Neutral']
This study was terminated early due to poor recruitment.	['Insufficient_Enrollment']	['Neutral']
"Study did not meet Phase Ib primary objective to establish the maximum tolerated
    dose/recommended dose for Phase II"	['Negative']	['Negative']
Recruitment for the study was terminated due to slow recruitment	['Insufficient_Enrollment']	['Neutral']
3 unexpected Serious Adverse Events (veno-occlusive disease (VOD))	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of efficacy	['Negative']	['Negative']
Compounding facility to submit quality update before they can manufacture 18F-DCFPyL	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
The study was stopped prematurally due to low recruiting	['Insufficient_Enrollment']	['Neutral']
Study subjects were not compliant with study protocols.	['Study_Design']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Lab close down	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Investigator decided not to proceed in Australia at this stage.	['Invalid_Reason']	['Invalid_Reason']
PennState would not allow the study to move forward	['Business_Administrative']	['Possibly_Negative']
the study was not feasible	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
due to safety concerns and lack of efficacy	['Negative']	['Negative']
A similar study was conducted and subsequently published in Italy.	['Negative', 'Another_Study']	['Negative', 'Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
"Following a pre-specified interim analysis and Data Monitoring Committee recommendation due to
    insufficient level of efficacy"	['Negative']	['Negative']
"Low intervention uptake, lack of substitution of video for home visits, and study sites'
    decision to expand telehealth use in response to payment changes"	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
IRB is reviewing all studies at the institution and are on hold	['Interim_Analysis', 'Regulatory', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Site unable to complete full data collection/protocol	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Study was terminated due to a business decision to cancel the entire project.	['Business_Administrative']	['Possibly_Negative']
Very Low recruitment rate	['Insufficient_Enrollment']	['Neutral']
due to celecoxib safety issues	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Lack of funding and low accrual.	['Insufficient_Enrollment']	['Neutral']
Did not pass the Stage 1 interim analysis.	['Negative']	['Negative']
Lack of subject population for PI	['Insufficient_Enrollment']	['Neutral']
Site no longer met criteria	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Problem with recruitment of patients meeting the inclusion criteria.	['Insufficient_Enrollment']	['Neutral']
IRB request IRB request	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The drug was ineffective in improving function in Pompe's disease	['Negative']	['Negative']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
regulatory reasons	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Recruitment rate, lower than expected. Organizational changes made it impossible for recruiting
    centers to continue"	['Business_Administrative']	['Possibly_Negative']
Interim analysis showed inadequate efficacy of bifeprunox	['Negative']	['Negative']
Business reasons	['Business_Administrative']	['Possibly_Negative']
It was a business decision to cancel this study in Aug. 2012.	['Business_Administrative']	['Possibly_Negative']
COVID-19 and Funding	['Covid19']	['Neutral']
PI resigned from faculty position and K23 award was terminated early	['Study_Staff_Moved']	['Neutral']
Difficulty in recruiting	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
difficulties recruiting this population for study population	['Insufficient_Enrollment']	['Neutral']
OHSU IRB closed study to further enrollment 2/17/2006	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Unable to recruit more than 2 subjects	['Insufficient_Enrollment']	['Neutral']
poor accrual of eligible patients	['Insufficient_Enrollment']	['Neutral']
Sample size too small for data analysis.	['Insufficient_Enrollment']	['Neutral']
Closed by Sponsor	['Business_Administrative']	['Possibly_Negative']
Because one of the drugs Valdecoxib was withdrawn due to safety concerns.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
The ET catheters were outdated.	['Logistics_Resources']	['Neutral']
"slow recruitment and recent concerns of safety of Paclitaxel coated balloons and associated
    increased risk death"	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Study location changed	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
IND approval for naive T-cell depletion not obtained	['Interim_Analysis', 'Regulatory', 'Negative']	['Neutral', 'Neutral', 'Negative']
Blood drawing protocol for RUH/ADARC. ADARC ceasing operations at RUH	['Study_Design']	['Neutral']
first postponed then cancelled as national drug authority changed requirements	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Not able to run research in the service. Research terminated.	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Problems with availability of study medicine in clinical center	['Logistics_Resources']	['Neutral']
No funding obtained	['Business_Administrative']	['Possibly_Negative']
"Optimal histolgic verification support such as whole mount analysis could not be made
    available."	['Logistics_Resources']	['Neutral']
"Difficulties in reaching the desired number of patients and intermediate analysis leading to
    discontinuation of the study."	['Insufficient_Enrollment']	['Neutral']
Business Reasons	['Business_Administrative']	['Possibly_Negative']
No data because of ECG equipment malfunctioned and all data unusable	['Logistics_Resources']	['Neutral']
Unable to secure product from international source, low recruitment rate.	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
The study was closed as the data received to date did not support continuation of the study.	['Negative']	['Negative']
Roche has withdrawn support	['Business_Administrative']	['Possibly_Negative']
insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Principal Investigator left the organization and took the IDE/Study with him	['Study_Staff_Moved']	['Neutral']
Difficulties identifying subjects who were qualified to participate in the study	['Insufficient_Enrollment']	['Neutral']
Resident Project which was not followed through after graduation	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Too slow recruitment	['Insufficient_Enrollment']	['Neutral']
Prevalence of H Pylori in the study population was much lower than anticipated	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Slow/insufficient accrual	['Insufficient_Enrollment']	['Neutral']
"Dr. Levy terminated from IU in December 2009. Indiana University has no record that this study
    was initiated prior to his termination."	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Low probability of positive outcome	['Negative']	['Negative']
Due to potential concerns about liver safety (See Detailed Description)	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
"This study was terminated on August 29th, 2014 due to a business decision by the Sponsor. The
    study was not terminated due to a safety reason."	['Business_Administrative']	['Possibly_Negative']
The trial was stopped at the first stage due to futility	['Negative']	['Negative']
We anticipated that we could not complete this study.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
PI left the institution	['Study_Staff_Moved']	['Neutral']
Company Decision	['Business_Administrative']	['Possibly_Negative']
Study has been stopped by sponsor decision	['Business_Administrative']	['Possibly_Negative']
The intervention (PulsePoint application) could not be implemented in Toronto as planned	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Lack of inclusion	['Insufficient_Enrollment']	['Neutral']
Funding timeline completed	['Business_Administrative']	['Possibly_Negative']
lack of appropriate funding	['Business_Administrative']	['Possibly_Negative']
Awaiting for funding	['Business_Administrative']	['Possibly_Negative']
Competing studies	['Negative', 'Another_Study']	['Negative', 'Neutral']
Resources were refocused into another project preventing this project from starting	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
termination of funding by sponsors	['Business_Administrative']	['Possibly_Negative']
drug procurement issues	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Concerns about post VTP MRI results being conclusive	['Negative']	['Negative']
Low accruals	['Insufficient_Enrollment']	['Neutral']
Poor enrollment, much data was missing as patients were lost to follow up	['Insufficient_Enrollment']	['Neutral']
The trial was halted prematurely due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
"The researchers were unable to answer the study question by utilizing the insurance claims
    database."	['Logistics_Resources']	['Neutral']
Terminated following interim analysis	['Interim_Analysis', 'Endpoint_Met', 'Negative']	['Neutral', 'Neutral', 'Negative']
There were not patients that meet inclusion/exclusion criteria. Site decided to close study.	['Insufficient_Enrollment']	['Neutral']
Study stopped prematurely because of multiple logistic difficulties	['Logistics_Resources']	['Neutral']
At the first prespecified interim analysis	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
Accrual stopped	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
No participants	['Insufficient_Enrollment']	['Neutral']
franchise closed; no safety concerns	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Due to difficulty enrolling patients	['Insufficient_Enrollment']	['Neutral']
Market dynamics including other technologies made the project not viable.	['Business_Administrative']	['Possibly_Negative']
Protocol modification	['Study_Design']	['Neutral']
COVID-19	['Covid19']	['Neutral']
Performance did not meet sponsor requirements.	['Study_Design', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Because there were no responses	['Insufficient_Enrollment']	['Neutral']
IRB haulted the study there was no evidence that the probiotic would benefit the patient	['Negative']	['Negative']
Study no longer funded	['Business_Administrative']	['Possibly_Negative']
Awaiting advice from R&D regarding recruitment	['Business_Administrative']	['Possibly_Negative']
failing of recruitment	['Insufficient_Enrollment']	['Neutral']
Enrollment	['Insufficient_Enrollment']	['Neutral']
Due to lack of funds	['Business_Administrative']	['Possibly_Negative']
'Sponsor decision following recruitment issues, not related to any safety concerns in the study	['Business_Administrative']	['Possibly_Negative']
difficulty to recrut patients	['Insufficient_Enrollment']	['Neutral']
Study not started	['Invalid_Reason']	['Invalid_Reason']
Business reasons	['Business_Administrative']	['Possibly_Negative']
No patients have been enrolled, and will not.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Change in company strategy	['Business_Administrative']	['Possibly_Negative']
Protocol proved too cumbersome. Consequently, only one one patient enrolled, and completed.	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
An arm closed due to lack of efficacy	['Negative']	['Negative']
difficulties to recruit planned numbers of patients within reasonable time frame	['Insufficient_Enrollment']	['Neutral']
Study was terminated early because of slow recruitment	['Insufficient_Enrollment']	['Neutral']
stopped for operational reasons	['Business_Administrative']	['Possibly_Negative']
Change of Research Objectives for Grant Funded Study	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Recruitment barriers.	['Insufficient_Enrollment']	['Neutral']
The study design was changed and this clinical trial will not be conducted.	['Study_Design']	['Neutral']
this is not a clinical trial and does not require registration	['Business_Administrative']	['Possibly_Negative']
Due to inability to enroll patients	['Insufficient_Enrollment']	['Neutral']
Study halted in line with slowdown in flu season.	['Insufficient_Enrollment']	['Neutral']
Decision was made by Sponsor to stop the trial.	['Business_Administrative']	['Possibly_Negative']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Dose specified in protocol was not adequate to achieve optimal resolution.	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Positive Predictive value not related to follow up duration.	['Negative']	['Negative']
Temporarily suspended due to COVID-19	['Covid19']	['Neutral']
The sponsor have not enough money to support this trial	['Business_Administrative']	['Possibly_Negative']
Only 1 participant recruited to study. Qs addressed in other ongoing studies.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Scientific	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Experience gained from this study is sufficient to design and facilitate the follow-on study.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
finding it difficult to recruit.	['Insufficient_Enrollment']	['Neutral']
Funding expired	['Business_Administrative']	['Possibly_Negative']
Limitations to recruitment related to COVID	['Covid19']	['Neutral']
Sponsor decision to stop study due to COVID-19 pandemic	['Covid19']	['Neutral']
Suspended due to the covid-19 pandemic.	['Covid19']	['Neutral']
"Study has been halted after completing Stage 1, for corporate reasons. No future patients will
    be enrolled or treated."	['Business_Administrative']	['Possibly_Negative']
recruiting or enrolling participants has halted prematurely and will not resume	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Study stopped 10/24/13 secondary to lack of patients/slow enrollment	['Insufficient_Enrollment']	['Neutral']
Insufficient Enrollment	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
PI is leaving the University of Florida	['Study_Staff_Moved']	['Neutral']
Study halted prematurely but potentially will resume, the protocol will be amended	['Study_Design']	['Neutral']
Low Accrual.	['Insufficient_Enrollment']	['Neutral']
Study enrollment halted due to COVID-19	['Covid19']	['Neutral']
low accrual made the study no longer feasible/decision not related to safety and efficacy	['Insufficient_Enrollment']	['Neutral']
Problems with ensuring patient examinations defined in the protocol of the study	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Experimental arm (induction + low dose tacrolimus) not effective.	['Negative']	['Negative']
insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Resources unavailable to continue study follow-up.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Temporarily suspended due to COVID-19 precautions	['Covid19']	['Neutral']
Administratively closed prior to subject enrollment	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"Inappropriate therapy associated with certain right ventricular (RV) lead complications may
    occur more frequently if the Respiratory Sensor is programmed On"	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
No enrollment	['Insufficient_Enrollment']	['Neutral']
administrative issues	['Business_Administrative']	['Possibly_Negative']
Drug shortage	['Logistics_Resources']	['Neutral']
temporarily on hold	['Invalid_Reason']	['Invalid_Reason']
no patients enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
No eligible patient was enrolled.	['Insufficient_Enrollment']	['Neutral']
"Primary efficacy analysis at Week 48 did not demonstrate non-inferiority of raltegravir 800 mg
    once daily versus raltegravir 400 mg twice daily"	['Negative']	['Negative']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Study was not funded	['Business_Administrative']	['Possibly_Negative']
why study stopped	['Invalid_Reason']	['Invalid_Reason']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
no accrual	['Insufficient_Enrollment']	['Neutral']
IDE was withdrawn. Veniti no longer owns the rights to this device.	['Business_Administrative']	['Possibly_Negative']
Very poor enrollment	['Insufficient_Enrollment']	['Neutral']
compound terminated	['Invalid_Reason']	['Invalid_Reason']
lack of activity, Primary researcher moved to another institution	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
Study recruitment temporarily suspended due to COVID-19 pandemic.	['Covid19']	['Neutral']
Sponsor was impacted by COVID-19 and did not have sufficient funds to continue.	['Covid19']	['Neutral']
PI move	['Study_Staff_Moved']	['Neutral']
Lack of Funding	['Business_Administrative']	['Possibly_Negative']
no accrual rate	['Insufficient_Enrollment']	['Neutral']
Sponsor could no longer support; enrollment stopped August 2008.	['Business_Administrative']	['Possibly_Negative']
Sponsor withdrew drug.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Did not receive funding	['Business_Administrative']	['Possibly_Negative']
Change of inlay from no bevel to bevel design	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
lack of surgical controls	['Logistics_Resources']	['Neutral']
PI returned to India	['Study_Staff_Moved']	['Neutral']
low enrollment	['Insufficient_Enrollment']	['Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
Student no longer enrolled in program.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Closed by the Sponsor/DSMB/IRB	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Slow Accruals	['Insufficient_Enrollment']	['Neutral']
This study was not funded and is not going to be done.	['Business_Administrative']	['Possibly_Negative']
No participants and no longer working with off shore center	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Study procedures and time not feasible due to patient schedule	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Sponsor decision based on portfolio prioritization	['Business_Administrative']	['Possibly_Negative']
This study was terminated for reasons not related to efficacy or safety	['Negative']	['Negative']
Early detection of the purpose of the study.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Study was not able to be completed, no results analyzed.	['Interim_Analysis', 'Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
An alternative Biobank Project was initiated.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Interim analysis, revealed no additional effect of proactive over reactive service.	['Negative']	['Negative']
Difficulty to include patients	['Insufficient_Enrollment']	['Neutral']
IRB Disapproval	['Regulatory', 'Ethical_Reason', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
lack of funding	['Business_Administrative']	['Possibly_Negative']
No subjects enrolled	['Insufficient_Enrollment']	['Neutral']
Lack of interest by Investigators	['Business_Administrative']	['Possibly_Negative']
Company has fulfilled post-marketing requirements	['Business_Administrative']	['Possibly_Negative']
negative endpoint study resulting in withdrawal of study drug	['Negative']	['Negative']
change of study structure and resource allocation	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"This study is terminated as a result of data from a study that showed increased mortality in
    stroke patients."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study terminated due to lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
low accrual-no data available	['Insufficient_Enrollment']	['Neutral']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
Interim analysis showed no differences between groups	['Negative']	['Negative']
Inefficacy	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
"study team will review the collected data and make any necessary changes to the educational
    tool."	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
"Interim data indicated that subjects exhibited no meaningful allergic disease during the first
    ragweed season, making it impossible to measure treatment effect."	['Negative']	['Negative']
Adverse Event issues.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Strategic reasons of the company	['Business_Administrative']	['Possibly_Negative']
study was not started due to an administrative reason on the part of the local Health Authority	['Business_Administrative']	['Possibly_Negative']
COVID-19 Closure	['Covid19']	['Neutral']
The Competent Authority did not give the authorization to start the study.	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Only 5 individuals were able to be recruited.	['Insufficient_Enrollment']	['Neutral']
No longer sponsor of trial	['Business_Administrative']	['Possibly_Negative']
Low enrollment. 1 pt. enrolled & withdrew at 6 wk follow-up. No further enrollment	['Insufficient_Enrollment']	['Neutral']
Logistical challenges; no safety concerns	['Logistics_Resources']	['Neutral']
Mutual decision of sponsor and investigator due to logistical challenges	['Logistics_Resources']	['Neutral']
no funding	['Business_Administrative']	['Possibly_Negative']
"An unexpected Zika outbreak prevented recruitment of study participants. The samples collected
    were subsequently destroyed and not analyzed."	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
not able to find enough participants for this study	['Insufficient_Enrollment']	['Neutral']
Researchers left institution	['Study_Staff_Moved']	['Neutral']
"Recruitment has been poor. Study drug is being offered as part of standard care of women
    carrying a pregnancy diagnosed with CCAM"	['Insufficient_Enrollment']	['Neutral']
Local circumstances & difficulties in site access has prevented continuation	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Scientific Director request to use resources for other studies	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Incyte (supporter of the study) is no longer going to support the study.	['Business_Administrative']	['Possibly_Negative']
Program Restructured	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Challenges associated with study enrollment due to stress test, study terminated	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
The first phase was completed	['Invalid_Reason']	['Invalid_Reason']
Closed due to no response from PI to IRB	['Insufficient_Enrollment', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
the company suspended the persecution of this combination	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
The surgeon decided not permit we to follow recruiting his patients to study.	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Study terminated as a result of interim analysis not meeting predetermined criteria.	['Negative']	['Negative']
Inability to recruit enough eligible participants at study site.	['Insufficient_Enrollment']	['Neutral']
no enrollment	['Insufficient_Enrollment']	['Neutral']
Inability to complete enrollment due to difficulty in finding subjects	['Insufficient_Enrollment']	['Neutral']
Following recommendation by SOLAR Study IDMC, Astellas closed enrollment in ASP8273 studies.	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Invalid_Reason']	['Safety_Sideeffects', 'Neutral', 'Invalid_Reason']
withdrawn studies	['Invalid_Reason']	['Invalid_Reason']
The study was stopped after 4 years of recruitment difficulties.	['Insufficient_Enrollment']	['Neutral']
The study was terminated for logistic reasons not related to safety or efficacy of the vaccine.	['Logistics_Resources']	['Neutral']
The study was withdrawn due to lack of an appropriate patient population.	['Insufficient_Enrollment']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Safety results (applied in METIV-HCC trial) have led early termination	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of definitive clinical results.	['Negative']	['Negative']
Sponsoring company declared bankrupty	['Business_Administrative']	['Possibly_Negative']
investigator decision	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
with 2/3 of the data collected, we had to terminate the study because of COVID19.	['Covid19']	['Neutral']
difficulties with the center	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
early discontinuation based on strategic sponsor decision not driven by any safety concern	['Business_Administrative']	['Possibly_Negative']
Study was stopped after interim analysis and slow enrollment.	['Insufficient_Enrollment']	['Neutral']
The study was not activated.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Insufficient Data Collected	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
The Study was terminated because there was insufficient data to complete the study objectives	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Not NIH defined clinical trials.	['Interim_Analysis', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Research cancelled because of inadequate staffing.	['Logistics_Resources']	['Neutral']
"The study was put on clinical hold by the sponsor since Feb 9th 2016, and was later decided not
    to re-open due to financial constraints."	['Business_Administrative']	['Possibly_Negative']
This study was terminated due to lack of clinical activity and not due to safety reasons.	['Negative']	['Negative']
Participant numbers too low. Could not ingest required fat.	['Insufficient_Enrollment']	['Neutral']
The COVID-19 pandemic made the recruitment and follow-up of this study impractical.	['Covid19']	['Neutral']
According to retired PI, resident graduated and next resident never carried it to fruition.	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Due to low recruitment rate	['Insufficient_Enrollment']	['Neutral']
No subjects consented for enrollment on this study.	['Insufficient_Enrollment']	['Neutral']
difficulty of carrying out the analysis and low recruitment	['Insufficient_Enrollment']	['Neutral']
Inufficient IMD supply due to manufacturing issue	['Logistics_Resources']	['Neutral']
Administrative	['Business_Administrative']	['Possibly_Negative']
Contract issues	['Business_Administrative']	['Possibly_Negative']
No more patients to include	['Insufficient_Enrollment']	['Neutral']
recruitment feasability	['Insufficient_Enrollment']	['Neutral']
No enrollment due to difficulty in recruitment of study sites	['Insufficient_Enrollment']	['Neutral']
Extreme toxicity in Phase I, study did not proceed to Phase II	['Covid19', 'Safety_Sideeffects', 'Endpoint_Met']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Cardica has terminated the development of the product for Business Reason.	['Business_Administrative']	['Possibly_Negative']
In compliance with research restrictions imposed due to the COVID-19 pandemic.	['Covid19']	['Neutral']
PI changed institution	['Study_Staff_Moved']	['Neutral']
Initial PI left, study not continued	['Study_Staff_Moved']	['Neutral']
Several sites did not manage to recruit patients.	['Insufficient_Enrollment']	['Neutral']
protocol development and Amended protocol revision	['Study_Design']	['Neutral']
Trial not progressing toward scientific goals	['Logistics_Resources', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
(suspension)	['Interim_Analysis', 'Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Proof of principle was achieved after inclusion of 7 patients	['Success', 'No_Context', 'Logistics_Resources']	['Success', 'Invalid_Reason', 'Neutral']
Management decision	['Business_Administrative']	['Possibly_Negative']
PI/Project director no longer at facility	['Study_Staff_Moved']	['Neutral']
difficult to enroll targeted participants	['Insufficient_Enrollment']	['Neutral']
Unable to recruit subjects at our site within the past year.	['Insufficient_Enrollment']	['Neutral']
AZ discontinued study	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Difficulty of participant enrollment.	['Insufficient_Enrollment']	['Neutral']
Core study unsuccessful	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Difficulty in patient recruitment	['Insufficient_Enrollment']	['Neutral']
Terminated by the IRB	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Study terminated for technical feasibility, operational considerations and futility in line
    with pre-specified criteria."	['Interim_Analysis', 'Logistics_Resources', 'Negative']	['Neutral', 'Neutral', 'Negative']
"Helical CT scans at our institution preclude the necessity for diagnostic laparoscopy in most
    cases at our institution."	['Interim_Analysis', 'Logistics_Resources', 'Endpoint_Met']	['Neutral', 'Neutral', 'Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Pharmaceutical company purchased by another company and funding was terminated.	['Business_Administrative']	['Possibly_Negative']
The study is closed due to lack of funding to support the study.	['Business_Administrative']	['Possibly_Negative']
Others	['Covid19', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Ebola epidemic in N-Kivu has ended	['Covid19', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Zero accrual and failure to generate multicenter interest.	['Insufficient_Enrollment']	['Neutral']
Study terminated due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
Sponsor decided not to run this study.	['Business_Administrative']	['Possibly_Negative']
"Enrollment and other trial activities have temporarily paused due to COVID-19 and are expected
    to resume in the future; This is not a suspension of IRB approval"	['Covid19']	['Neutral']
No patient accruals	['Insufficient_Enrollment']	['Neutral']
study not required for development	['Business_Administrative']	['Possibly_Negative']
suboptimal enrollment after 18 months.	['Insufficient_Enrollment']	['Neutral']
The primary efficacy endpoint was not met	['Negative']	['Negative']
Closed due to slow patient accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor stoppage of recruitment	['Business_Administrative']	['Possibly_Negative']
The study was never approved by CTEP neither was it ever activated	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
logistic reasons, patients could not be recruited	['Insufficient_Enrollment']	['Neutral']
Business Objectives Changed	['Business_Administrative']	['Possibly_Negative']
This study was merged into HOWTO-BRS study.	['Negative', 'Another_Study']	['Negative', 'Neutral']
"The study stopped because after monitoring visits and data analysis we noticed a high number of
    protocol deviation that made impossible the results analysis."	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Other - to update dosing schedule	['Study_Design']	['Neutral']
"Further evaluation determined it was not feasible to enroll the post-partum tubal ligation
    group at our facility"	['Insufficient_Enrollment']	['Neutral']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
Company decision taken in light of demands by certain national health authorities	['Business_Administrative']	['Possibly_Negative']
The primary objective of PFS did not meet pre-specified criteria.	['Negative']	['Negative']
Based on DMC recommendation to discontinue EG-01-1962-03	['No_Context', 'Regulatory', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
Interim Assessment: Lack of Efficacy	['Negative']	['Negative']
the study PI left the university of iowa	['Study_Staff_Moved']	['Neutral']
Enrollment never started	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
No positive results were detected	['Negative']	['Negative']
The company changed the strategy.	['Business_Administrative']	['Possibly_Negative']
COVID 19 pandemic	['Covid19']	['Neutral']
No accrual	['Insufficient_Enrollment']	['Neutral']
Corporate decision, priority change	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
combination arm delevelped significant poor prognosis	['Negative']	['Negative']
Study funding was completed.	['Business_Administrative']	['Possibly_Negative']
Terminated (halted prematurely)	['Invalid_Reason']	['Invalid_Reason']
"Company restructured and protocol restructured. Resubmitted with IDE approval under new company
    name-Exalenz"	['Business_Administrative']	['Possibly_Negative']
Study Completed	['Invalid_Reason']	['Invalid_Reason']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor/ PI leaving institution, no plans to continue this research at this time	['Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Difficulty in patient enrollment	['Insufficient_Enrollment']	['Neutral']
the study was terminated due to the primary end point being met.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
"The Principal investigator retired without replacement. Only one patient was enrolled and
    completed the entire study without adverse events."	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
"In HPS2-THRIVE, MK-0524A did not meet the primary efficacy objective and there was a
    significant increase in incidence of some types of non-fatal SAEs"	['Negative']	['Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Slow enrollment and therefore not possible to reach the estimated enrollment	['Insufficient_Enrollment']	['Neutral']
Very low recruitment. During COVID-19 pandemic these are patients of high risk.	['Covid19']	['Neutral']
Conflicting recruitment with PERISCOPE II study (NCT03348150)	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Distancing and movement restrictions of the COVID-19 emergency response made continuation of
    clinic-based and field entomological trial activities infeasible"	['Covid19']	['Neutral']
The study was stopped for feasibility (low enrollment)	['Insufficient_Enrollment']	['Neutral']
Recruitment rythm not sufficent to reach the simple size needed.	['Insufficient_Enrollment']	['Neutral']
Planned interim analysis showed worse outcomes in experimental group	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Because there was no longer an active laboratory component to this study.	['Logistics_Resources', 'Study_Staff_Moved', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Data Safety Monitoring Board concerning of the participants' safety	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
"At the request of the study site, this study has been closed and access to study-related data
    is unavailable. We are unable to submit the results-data."	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
study never opened	['Invalid_Reason']	['Invalid_Reason']
Low enrollment and limited research staffing	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description	['No_Context']	['Invalid_Reason']
Lack of ressources	['Logistics_Resources']	['Neutral']
The study was stopped due to insufficient accrual	['Insufficient_Enrollment']	['Neutral']
Study has been terminated due to lack of accrual.	['Insufficient_Enrollment']	['Neutral']
IP breach	['Covid19', 'Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral', 'Neutral']
Sponsor Decision to discontinue long-term follow-up	['Business_Administrative']	['Possibly_Negative']
Unable to successfully recruit patients for study.	['Insufficient_Enrollment']	['Neutral']
The study closed because of inadequate early activity.	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
sponsor decision	['Business_Administrative']	['Possibly_Negative']
due to technical issues	['Logistics_Resources']	['Neutral']
Business decision.	['Business_Administrative']	['Possibly_Negative']
Did not enroll	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
low accrual	['Insufficient_Enrollment']	['Neutral']
Study sites were closed in March 2020, due to COVID-19	['Covid19']	['Neutral']
Lack of efficacy	['Negative']	['Negative']
Study is not realised.	['Invalid_Reason']	['Invalid_Reason']
terminated early due to lack of recruitment [only 3 of 207 subjects were enrolled]	['Insufficient_Enrollment']	['Neutral']
This study has been terminated due to poor accrual	['Insufficient_Enrollment']	['Neutral']
Change in research direction	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Funding for the CALM-PD Cohort Study was terminated by sponsor.	['Business_Administrative']	['Possibly_Negative']
No patients enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Insys Therapeutics filed Chapter 11 and terminated all studies.	['Business_Administrative']	['Possibly_Negative']
trial handovered to another sponser.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Sponsor decided to terminate the study and not proceed to Phase 2.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
"Unable to accrue subjects to the study after 2 years - closed per request by Data Monitoring
    Committee."	['Insufficient_Enrollment']	['Neutral']
"Steven Johnson's Syndrome (SJS) and Toxic Epidermal Necrolysis Syndrome (TENS) are rare (~3 in
    1 million). No eligible subjects have been identified."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Grant was not funded	['Business_Administrative']	['Possibly_Negative']
Evidence of bad outcome after interims analysis	['Negative']	['Negative']
It doesn't meet the requirements of randomized trials	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Lack of participant enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
the study was stopped for lack of inclusion	['Insufficient_Enrollment']	['Neutral']
Unable to enroll and study intended patient population.	['Insufficient_Enrollment']	['Neutral']
recruiting or enrolling participants has halted prematurely and will not resume	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Similar study has been published.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Early termination d/t overlap with a new, extended protocol study.	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Results from pre-specified criteria did not demonstrate sufficient efficacy to warrant
    continuation of the study."	['Negative']	['Negative']
Low Accural	['Insufficient_Enrollment']	['Neutral']
too slow enrollment	['Insufficient_Enrollment']	['Neutral']
No Funding	['Business_Administrative']	['Possibly_Negative']
No participants recruited, IRB closed	['Insufficient_Enrollment']	['Neutral']
Inability to accrue	['Insufficient_Enrollment']	['Neutral']
lower than anticipated recruitment rate	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Representativeness and results about treatment and health condition available	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
COVID pandemic	['Covid19']	['Neutral']
No Inclusion potentiel	['Insufficient_Enrollment']	['Neutral']
It was stopped due to a lack of recruitment after 48 patients included	['Insufficient_Enrollment']	['Neutral']
"The study was prematurely interrupted because patients randomized to CPAP reached the endpoint
    quicker than anticipated in the protocol"	['Negative']	['Negative']
Cytosponge device availability	['Logistics_Resources']	['Neutral']
Primary objective has been met; safety and pharmacokinetics have been characterized.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Study terminated by the DSMB due to low recruitment	['Insufficient_Enrollment']	['Neutral']
Sponsor prematurely withdrew financial support.	['Business_Administrative']	['Possibly_Negative']
Not completed its inspection.(CSR completed)	['Interim_Analysis', 'Regulatory', 'Negative']	['Neutral', 'Neutral', 'Negative']
"PMCF data, originally planned to be collected withthis study, are collected using another
    methodology"	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Poor enrollment.	['Insufficient_Enrollment']	['Neutral']
low recruitment rate	['Insufficient_Enrollment']	['Neutral']
investigator no longer available on site	['Study_Staff_Moved']	['Neutral']
Coronavirus Pandemic	['Covid19', 'Safety_Sideeffects', 'Insufficient_Enrollment']	['Neutral', 'Safety_Sideeffects', 'Neutral']
"AWD arm was completed. ADF diarrhea arm was unable to fill completely and there are no funds
    remaining to continue recruiting/enrolling."	['Business_Administrative']	['Possibly_Negative']
"Due to slow recruitment the study was terminated prematurely by the Sponsor after 30 subjects
    had been included"	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
failure to recruit	['Insufficient_Enrollment']	['Neutral']
Core study in non-infectious active uveitis was terminated	['Success', 'No_Context', 'Safety_Sideeffects']	['Success', 'Invalid_Reason', 'Safety_Sideeffects']
PI relocated to a different country and coI moved to a different lab.	['Study_Staff_Moved']	['Neutral']
Requested by PI during yearly Continuing Review	['Interim_Analysis', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Management Decision	['Business_Administrative']	['Possibly_Negative']
Trial was not funded	['Business_Administrative']	['Possibly_Negative']
Study design was changed to the study was changed to Insulin, hypotension and sarcopenia.	['Study_Design']	['Neutral']
recent research indicates Lucentis to be an effictive treatment	['Negative', 'Another_Study']	['Negative', 'Neutral']
Enrollment criteria met	['Invalid_Reason']	['Invalid_Reason']
The study is not a clinical trial.	['Invalid_Reason']	['Invalid_Reason']
Lack of efficacy	['Negative']	['Negative']
Due to PI leaving the institution	['Study_Staff_Moved']	['Neutral']
It has been decided to improve the inclusion criteria for better study outcome	['Endpoint_Met', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Not enough patients in time period allotted for study	['Insufficient_Enrollment']	['Neutral']
Material sponsor withdrew support	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Insufficient Accrual	['Insufficient_Enrollment']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
"Futility analysis revealed that the primary endpoint is unlikely to be met. There were no
    safety concerns observed with fremanezumab treatment in the trial."	['Negative']	['Negative']
Withdrawn prior to recruitment for business reasons.	['Business_Administrative']	['Possibly_Negative']
Due to no enrollment.	['Insufficient_Enrollment']	['Neutral']
No patients met eligibility criteria. The study has been closed.	['Insufficient_Enrollment']	['Neutral']
Study was not initiated	['Invalid_Reason']	['Invalid_Reason']
A consequence of the results of the ENTHUSE phase III study program	['Negative', 'Another_Study']	['Negative', 'Neutral']
low enrollment	['Insufficient_Enrollment']	['Neutral']
Low Patient Recruitment	['Insufficient_Enrollment']	['Neutral']
Insufficient patient volume	['Insufficient_Enrollment']	['Neutral']
lack of funding due to Celgene administrative decision	['Business_Administrative']	['Possibly_Negative']
The institution was requiring extensive changes to the protocol	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study not started, investigator left the institution	['Study_Staff_Moved']	['Neutral']
Did not obtain IND or IRB approval to initiate study.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
closed by PI and FDA	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study closed due to feasability	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Interim analysis unfavorable to continue the study	['Negative']	['Negative']
Lack of funding.	['Business_Administrative']	['Possibly_Negative']
Unexpected toxicity (2 early deaths)	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Symphogen made a business decision to no longer perform the clinical study	['Business_Administrative']	['Possibly_Negative']
Terminated [See Detailed Description for Termination Reason.]	['No_Context']	['Invalid_Reason']
Slow accrual; no further funding	['Insufficient_Enrollment']	['Neutral']
Recruitment issues	['Insufficient_Enrollment']	['Neutral']
Insufficient funding	['Business_Administrative']	['Possibly_Negative']
Low Accrual.	['Insufficient_Enrollment']	['Neutral']
"CMS questions to assess patient satisfaction of pain control were removed from the HCAHPS
    survey, leaving the study without intervention assessment."	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
This project currently does not have any subjects enrolled due to other PI priorities.	['Insufficient_Enrollment']	['Neutral']
Difficulties with recruitment	['Insufficient_Enrollment']	['Neutral']
"The probe could not be anchored in place and would rotate about its axis, thus comparison was
    difficult."	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Not able to finalize funding	['Business_Administrative']	['Possibly_Negative']
Terminated due to low accrual	['Insufficient_Enrollment']	['Neutral']
Study stopped due to organization reasons.	['Business_Administrative']	['Possibly_Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
"This study was stopped due to slow enrollment after enrolling only 9 of 80 patients over 14
    months time."	['Insufficient_Enrollment']	['Neutral']
Negative study; Principal Investigator chose to prematurely terminate the study.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
No further subjects will be enrolled due to adverse events.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Because of lack of participants and funds	['Business_Administrative']	['Possibly_Negative']
Shortage of required study drug.	['Logistics_Resources']	['Neutral']
Change in commercial strategy	['Business_Administrative']	['Possibly_Negative']
difficulty meeting enrollment goals	['Insufficient_Enrollment']	['Neutral']
Before enrollment, suspended due to changing insurance coverage of study drugs.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Modifying the clinnicaltrials	['Study_Design']	['Neutral']
company withdrawal of the drug	['Business_Administrative']	['Possibly_Negative']
Patient Toxicities	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
This study was terminated because of recruitment difficulties.	['Insufficient_Enrollment']	['Neutral']
Measurement device not performing to standard in study environment	['Logistics_Resources']	['Neutral']
Study was withdrawn prior to patient dosing based on a business decision.	['Business_Administrative']	['Possibly_Negative']
failure to recruit	['Insufficient_Enrollment']	['Neutral']
Recruitment and retention difficulties	['Insufficient_Enrollment']	['Neutral']
This was a follow-on study to Biomed 777-CLP-029 which did not meet superiority endpoint	['Negative', 'Another_Study']	['Negative', 'Neutral']
Corporate decision	['Business_Administrative']	['Possibly_Negative']
unable to find appropriate candidates	['Insufficient_Enrollment']	['Neutral']
Study terminated due to withdrawal of pharmaceutical funding	['Business_Administrative']	['Possibly_Negative']
The study did not receive IRB approval and was withdrawn	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Replaced by a study with a similar design.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Withdrawn due to poor/low accrual	['Insufficient_Enrollment']	['Neutral']
Unable to meet the study's recruitment goals	['Insufficient_Enrollment']	['Neutral']
No patients were enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
The trial was terminated per protocol because of lack of feasibility.	['Logistics_Resources']	['Neutral']
Insufficient Accrual	['Insufficient_Enrollment']	['Neutral']
Investigator left NIH	['Study_Staff_Moved']	['Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
The Investigator decided not to pursue this study.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
The study has concluded normally	['Invalid_Reason']	['Invalid_Reason']
Terminated due to lack of efficacy and safety concerns.	['Negative']	['Negative']
The study was terminated due to low accrual.	['Insufficient_Enrollment']	['Neutral']
PI left	['Study_Staff_Moved']	['Neutral']
Withdrawal of drug supply.	['Logistics_Resources']	['Neutral']
"Primary investigator changed. Study protocol may under go change with addition of new
    investigators."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
New protocol was developed based on preliminary results from this study.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
"After recruiting just over 50% of target an interim review conclude a larger sample size was
    highly unlikely to alter the study outcomes"	['Negative']	['Negative']
"Slow progress despite recruitment boosting efforts e.g., expert advice obtained from leading
    study center Investigators; decision thus made to terminate."	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
device not available	['Logistics_Resources']	['Neutral']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
This study has never actually started as waiting on funding	['Business_Administrative']	['Possibly_Negative']
"Closed short of the enrollment goal, due to slow enrollment and adequate data to address
    endpoints"	['Insufficient_Enrollment']	['Neutral']
Strategic business decision	['Business_Administrative']	['Possibly_Negative']
Study sponsor sold and the new company would not support the study.	['Business_Administrative']	['Possibly_Negative']
No longer following patient and no plans to publish.	['Study_Staff_Moved', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
The investigator abandoned the project.	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Concluded study following COVID19 outbreak and inability to complete study as designed.	['Covid19']	['Neutral']
shelf life of investigational drug ran out before 90 patients could be included	['Logistics_Resources']	['Neutral']
Study closed to accrual due unfavorable interim analysis	['Insufficient_Enrollment']	['Neutral']
Study did not meet first stage requirements of interim analysis	['Negative']	['Negative']
Interim analysis demonstrated significant benefit in intervention arm	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Online program required re-design	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Drug sponsor stopped drug manufacture due to toxicity issues from other studies	['Negative', 'Another_Study']	['Negative', 'Neutral']
lack of eligible participants to enrol	['Insufficient_Enrollment']	['Neutral']
Protocol-defined criterion of macitentan availability achieved.	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Inadequate recruitment	['Insufficient_Enrollment']	['Neutral']
PI left the institution.	['Study_Staff_Moved']	['Neutral']
This study was closed to enrollment prematurely due to sub-optimal accrual.	['Insufficient_Enrollment']	['Neutral']
sponsor discretion	['Business_Administrative']	['Possibly_Negative']
The physician in charge is leaving the University of Florida	['Study_Staff_Moved']	['Neutral']
PI has left Institution	['Study_Staff_Moved']	['Neutral']
"The funding agency, DoD, determined that the study could not meet its enrollment numbers by the
    end of the grant."	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The hypothesis that probiotics would reduce hepatic steatosis in humans was not supported	['Negative']	['Negative']
on hold indefinitely due to lack of funding	['Business_Administrative']	['Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
The study was withdrawn due to administrative reason	['Business_Administrative']	['Possibly_Negative']
Company decision: No Safety or Efficacy Concerns	['Business_Administrative']	['Possibly_Negative']
Business Decision; No Safety Or Efficacy Concerns	['Business_Administrative']	['Possibly_Negative']
Suspended due to COVID-19 risks	['Covid19']	['Neutral']
Unable to meet accrual goals	['Insufficient_Enrollment']	['Neutral']
Drug manufacturer no longer could supply for study	['Logistics_Resources']	['Neutral']
Terminated by financier due to low accrual & high number of protocol deviations.	['Insufficient_Enrollment']	['Neutral']
"The study could not be completed as the company producing this product interrupted their supply
    of this medication"	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Low accrual and no funding	['Insufficient_Enrollment']	['Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
DSMB	['Negative']	['Negative']
Investigator no longer at site to enroll patients or write up data	['Study_Staff_Moved']	['Neutral']
Internal problems	['Logistics_Resources']	['Neutral']
Sponsor discontinued the Argus II product	['Covid19', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
recruitment problems	['Insufficient_Enrollment']	['Neutral']
The study was terminated early due to shortage of drug supply.	['Logistics_Resources']	['Neutral']
The ACT was re-designed per physician feedback and patient compliance & not because of safety.	['Study_Design']	['Neutral']
finally it was decided not to initiate the study due to logistical issues	['Logistics_Resources']	['Neutral']
Study terminated as principal investigator [PI] left the university.	['Study_Staff_Moved']	['Neutral']
due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Study stopped due to early stopping rule	['Negative']	['Negative']
funding terminated	['Business_Administrative']	['Possibly_Negative']
Study stopped for business reasons and not for any safety reasons.	['Business_Administrative']	['Possibly_Negative']
Support Staff Left Institution	['Study_Staff_Moved']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of Funds	['Business_Administrative']	['Possibly_Negative']
Did not have time to complete this study	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Other published trials showed definitive expected superiority of Group 1	['Negative', 'Another_Study']	['Negative', 'Neutral']
FDA issued a clinical hold as pacritinib had increased side effects	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
The study was discontinued prematurely at the end of March 2007 due to slow enrolment.	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
host site logistical problems	['Logistics_Resources']	['Neutral']
Parent sponsor company (Baxter Healthcare) company cut funding	['Business_Administrative']	['Possibly_Negative']
Unable to recruit necessary sample size	['Insufficient_Enrollment']	['Neutral']
data collection ended	['Invalid_Reason']	['Invalid_Reason']
Reclassification by Ethics Committee	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
Principal investigator leaving study site; no replacement PI will be sought	['Study_Staff_Moved']	['Neutral']
"Recruitment was so slow, that it made the study impossible. Organizational changes made it
    impossible for recruiting centers to continue recruitment"	['Business_Administrative']	['Possibly_Negative']
lack of participants fulfilling inclusion criteria	['Insufficient_Enrollment']	['Neutral']
study drug (Ontak) no longer available	['Logistics_Resources']	['Neutral']
Study terminated for business reasons	['Business_Administrative']	['Possibly_Negative']
Device failure	['Logistics_Resources']	['Neutral']
Principal Investigator (Dr. Peiris) is retiring	['Study_Staff_Moved']	['Neutral']
Drug supply unavailable	['Logistics_Resources']	['Neutral']
"Institution decided on starting a new protocol of sedation, with another methods and thats why
    this study has not started."	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Sponsor decision to not initiate study due to sufficient bioavailability information	['Interim_Analysis', 'Logistics_Resources', 'Negative']	['Neutral', 'Neutral', 'Negative']
The study was terminated as the PI left the institution.	['Study_Staff_Moved']	['Neutral']
high rate of drop-out	['Insufficient_Enrollment']	['Neutral']
Considering new technology for product.	['Study_Design']	['Neutral']
Criterion according study protocol to end study prematurely was fulfilled.	['Invalid_Reason']	['Invalid_Reason']
"This study was terminated on April 8, 2011 as Pfizer Canada could no longer supply study drug.
    No efficacy or safety concerns factored into this decision."	['Business_Administrative']	['Possibly_Negative']
Sponsor terminated due to signif. difficulty with pilot investigation enrollment	['Insufficient_Enrollment']	['Neutral']
The ethics committee did not approve the pharmacokinetic part of the study.	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
"Study suspended due to the occurrence of a SUSAR. During suspension, no enrollment, new
    mobilization, cell collection, conditioning or bb1111 infusion will be initiated. Subjects who
    have been treated will continue to be followed per study protocol."	['Safety_Sideeffects', 'Logistics_Resources', 'Endpoint_Met']	['Safety_Sideeffects', 'Neutral', 'Neutral']
"Triggering of futility rule; Interim analysis suggested no statistical superiority over
    historic controls"	['Negative']	['Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Annual accrual goal not met	['Insufficient_Enrollment']	['Neutral']
"We exhausted potential candidates before reaching goal of 70; recruited 29, 13 completed the
    study"	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Phase 1 (Feasibility) completed. Currently no funding to launch Phase 2 (RCT).	['Business_Administrative']	['Possibly_Negative']
Closed this protocol due to autoimmune toxicity.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"Ofatumumab IV trials in RA were prematurely terminated because GSK refocused clinical
    development of autoimmune indications on the subcutaneous delivery."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
enrolment difficulties	['Insufficient_Enrollment']	['Neutral']
"Interim assessment performed after 14 patients provided evidence that further enrollment was
    not required to achieve intended endpoints of the study."	['Negative']	['Negative']
difficult recruitment	['Insufficient_Enrollment']	['Neutral']
Business Decision; No Safety Or Efficacy Concerns.	['Business_Administrative']	['Possibly_Negative']
The study was terminated on 16JUN2017 for safety reasons	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Drug intervention no longer relevant for the proposed population	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
opposite result	['Negative']	['Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Insufficient enrollment to justify keeping open.	['Insufficient_Enrollment']	['Neutral']
Curtailment of funding by sponsor	['Business_Administrative']	['Possibly_Negative']
Enrollment goals not being met	['Insufficient_Enrollment']	['Neutral']
Terminated early due to slow recruitment	['Insufficient_Enrollment']	['Neutral']
Interim analysis to assess concern for spinal anesthesia and increased cesarean delivery rate.	['Interim_Analysis', 'Safety_Sideeffects', 'Endpoint_Met']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Investigator found that a new study drug that is FDA approved would be superior to melatonin	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Company/Sponsor has discontinued business	['Business_Administrative']	['Possibly_Negative']
Difficulties with the recruitment	['Insufficient_Enrollment']	['Neutral']
Poor recruitment. Funding expired.	['Business_Administrative']	['Possibly_Negative']
Slow patient recruitment	['Insufficient_Enrollment']	['Neutral']
Study protocol was changed.	['Study_Design']	['Neutral']
Upon recommendation of DSMB	['Regulatory', 'Negative']	['Neutral', 'Negative']
not enough interest	['Business_Administrative']	['Possibly_Negative']
Local IRB decision due to poor accrual	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
No longer pursuing study at our site.	['Study_Staff_Moved', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
9/12/12 FDA stopped enrollment pending device exemption(IDE)application.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Study halted prematurely and will not resume; participants are no longer being examined or
    receiving intervention."	['Invalid_Reason']	['Invalid_Reason']
Initially suspended due to COVID-19 policies, it will not be possible to restart.	['Covid19']	['Neutral']
Study halted due to slow recruitment	['Insufficient_Enrollment']	['Neutral']
Enrollment was slower than anticipated.	['Insufficient_Enrollment']	['Neutral']
Delayed due to Covid-19	['Covid19']	['Neutral']
Logistic reasons	['Logistics_Resources']	['Neutral']
No patients were successfully recruited	['Insufficient_Enrollment']	['Neutral']
Recruitment did not meet sponsors timeline	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study temporarily suspended due to COVID-19 pandemic	['Covid19']	['Neutral']
The stopping rule for incidence of acute rejection was met.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Slow enrollment decreased sample size; No unexpected safety issues.	['Insufficient_Enrollment']	['Neutral']
Analysis showed no clinically or statistically significant effects	['Negative']	['Negative']
The study was terminated to be redesigned for a trial according to EMA proposal.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
difficulty in subject recruitment	['Insufficient_Enrollment']	['Neutral']
abandoned	['Invalid_Reason']	['Invalid_Reason']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
delayed recruitment as compared to that expected	['Insufficient_Enrollment']	['Neutral']
Partly due to financial issues and changes in study staff work placements	['Business_Administrative']	['Possibly_Negative']
Study was never started.	['Invalid_Reason']	['Invalid_Reason']
No participants were recruited due to a lack of referrals.	['Insufficient_Enrollment']	['Neutral']
Investigator decision	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Challenges to recruit qualified participants	['Insufficient_Enrollment']	['Neutral']
Due to delay in site initiation and funding considerations	['Business_Administrative']	['Possibly_Negative']
FDA agreed to early termination due to difficulties enrolling patients.	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Recruitment not satisfactory	['Insufficient_Enrollment']	['Neutral']
funding term ended	['Business_Administrative']	['Possibly_Negative']
Low accrual not allowing to support statistical endpoints	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Pending funding	['Business_Administrative']	['Possibly_Negative']
"Study end date exceeded and insufficient number of subjects needed for analysis. 11 patients
    included / 70 theoretical patients"	['Insufficient_Enrollment']	['Neutral']
Was not able to recruit the total anticipated number of subjects	['Insufficient_Enrollment']	['Neutral']
Operational feasibility with low recruitment due to changing epidemiology of disease	['Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral']
Lack of personnel/research time	['Logistics_Resources']	['Neutral']
interim analysis	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
COVID-19	['Covid19']	['Neutral']
We did not found voluntary subjects	['Insufficient_Enrollment']	['Neutral']
Poor case accrual	['Insufficient_Enrollment']	['Neutral']
Not enough participants enrolled	['Insufficient_Enrollment']	['Neutral']
Study site change	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Drug availability	['Logistics_Resources']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
No subjects were recruited at the Weill Cornell site.	['Insufficient_Enrollment']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Due to futility	['Negative']	['Negative']
Terminated: higher rate of acute rejection in the Cyclosporin A group	['Negative']	['Negative']
Low enrollment rates	['Insufficient_Enrollment']	['Neutral']
Lack of proposed funding.	['Business_Administrative']	['Possibly_Negative']
due to unexpectedly high rate of relapse in the active comparator arm.	['Negative']	['Negative']
Funding withdrawn	['Business_Administrative']	['Possibly_Negative']
The study protocol has been replaced with a two-glove protocol NCT02026245	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
logistics	['Logistics_Resources']	['Neutral']
sponsor and investigator's decision	['Business_Administrative']	['Possibly_Negative']
Termination of study funding	['Business_Administrative']	['Possibly_Negative']
Inclusion of patients was slow. Could not reach the target within the studyperiod.	['Insufficient_Enrollment']	['Neutral']
Difficulty with enrollment	['Insufficient_Enrollment']	['Neutral']
"Study was discontinued due to non-safety related business prioritization decisions. No subjects
    were randomized."	['Business_Administrative']	['Possibly_Negative']
lack of funds	['Business_Administrative']	['Possibly_Negative']
Due to COVID-19	['Covid19']	['Neutral']
Funding not secured	['Business_Administrative']	['Possibly_Negative']
Per recommendation of the PI; slow accrual	['Insufficient_Enrollment']	['Neutral']
finish study as protocol	['Invalid_Reason']	['Invalid_Reason']
"Enrollment was much slower than anticipated, leading to a decision to terminate the study early
    for enrollment futility."	['Negative']	['Negative']
The recruitment of subject is very difficult	['Insufficient_Enrollment']	['Neutral']
Inadequate enrollment	['Insufficient_Enrollment']	['Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
Business decision due to low subject recruitment and enrollment	['Business_Administrative']	['Possibly_Negative']
Validation study suspended due to Covid-19 restrictions-will resume when able	['Covid19']	['Neutral']
retirement of PI	['Study_Staff_Moved']	['Neutral']
Sponsor terminated due to business reasons	['Business_Administrative']	['Possibly_Negative']
"All analysis with identifiable specimens/data is complete or site has no identifiers linked to
    the specimens/data. The one enrolled pt has been taken off study"	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
This study was terminated after 6 patients due to loss of funding	['Business_Administrative']	['Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
unable to complete statistical analysis	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
PI no longer with institution	['Study_Staff_Moved']	['Neutral']
Unable to obtain approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"1 patient has been enrolled. No complications reported. The research team decided to terminate
    the clinical trial due to insufficient patients' accrual."	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
The study was combined with our Urine and Stool Study (NCT01637506).	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study has been abandoned for lack of available funding.	['Business_Administrative']	['Possibly_Negative']
Efficiency and safety reasons	['Logistics_Resources']	['Neutral']
no enrollment	['Insufficient_Enrollment']	['Neutral']
PI left the institution	['Study_Staff_Moved']	['Neutral']
Terminated by the sponsor due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsors decision	['Business_Administrative']	['Possibly_Negative']
treatments are no longer proposed to this type of patients	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Insufficient Data Collected	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Competing studies	['Negative', 'Another_Study']	['Negative', 'Neutral']
Due to business reasons	['Business_Administrative']	['Possibly_Negative']
Closed at a planned interim analysis by meeting a predefined toxicity endpoint	['Safety_Sideeffects', 'Negative']	['Safety_Sideeffects', 'Negative']
Change in clinical strategy	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
The safety profile of combination therapy became unacceptable.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of available participants that meet criteria	['Insufficient_Enrollment']	['Neutral']
The study withdrawn due to lack financial support	['Business_Administrative']	['Possibly_Negative']
Funding withdrawn	['Business_Administrative']	['Possibly_Negative']
Slow Enrollment	['Insufficient_Enrollment']	['Neutral']
"Reports of significant laboratory abnormalities and adverse events in a number of clinical
    study participants."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
The trial is postponed pending the completion of other ongoing pre-clinical and clinical work.	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Unable to recruit/maintain participants for intervention	['Insufficient_Enrollment']	['Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Difficulties with patient recruitement	['Insufficient_Enrollment']	['Neutral']
Study redesigned and re-submitted to UAMS IRB under different study title and IRB number.	['Study_Design']	['Neutral']
PI decided to use another product	['Study_Design']	['Neutral']
Low Recruitment	['Insufficient_Enrollment']	['Neutral']
Recruitment difficulty due to eligibility criteria.	['Insufficient_Enrollment']	['Neutral']
Recuritment Challenges	['Insufficient_Enrollment']	['Neutral']
Due to company resource constraints	['Business_Administrative']	['Possibly_Negative']
Slow accrual and lack of study drug	['Insufficient_Enrollment']	['Neutral']
Unavailability of clarithromycin 250 mg in the market	['Logistics_Resources']	['Neutral']
"The complexity of the study and the recent slow down situation hampered the ability to recruit
    CAD patients therefore the study has been terminated."	['Insufficient_Enrollment']	['Neutral']
"The trial was terminated early as the objective of the Aripiprazole Pediatric Investigational
    Plan was met and provided 2 years of safety data."	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Technical failure	['Logistics_Resources']	['Neutral']
"No patients populations included ==> could not be recruited in meaningful numbers to allow
    conclusions."	['Insufficient_Enrollment']	['Neutral']
"Study was discontinued due to non-safety related business prioritization decisions. No subjects
    were randomized."	['Business_Administrative']	['Possibly_Negative']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
This study is delayed. It was not funded.	['Business_Administrative']	['Possibly_Negative']
"A decision was made to terminate the study due to the changing treatment landscape for the
    development of new agents in combination in Hodgkin lymphoma."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
To be replaced with a randomized placebo-controlled study.	['Negative', 'Another_Study']	['Negative', 'Neutral']
recrutment difficulty	['Insufficient_Enrollment']	['Neutral']
Slow subject enrollment	['Insufficient_Enrollment']	['Neutral']
Funding was terminated early due to slow recruitment.	['Business_Administrative']	['Possibly_Negative']
Study was not initiated	['Invalid_Reason']	['Invalid_Reason']
"Project was discontinued. Ran into difficulties with purification at the protein production
    stage"	['Logistics_Resources']	['Neutral']
"Business decision was made to remove the CE mark from this product, thus prompting the closing
    of this study."	['Business_Administrative']	['Possibly_Negative']
Due to issues with study design	['Study_Design']	['Neutral']
Difficulty in recruitment and change in study site protocols.	['Insufficient_Enrollment']	['Neutral']
Study was terminated due to lack of efficacy	['Negative']	['Negative']
Resources unavailable to continue study follow-up.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
No new participants enrolled. Protocol has been superseded	['Study_Design']	['Neutral']
Study was closed due to loss of industry sponsorship	['Business_Administrative']	['Possibly_Negative']
Study closed because of low enrolment	['Insufficient_Enrollment']	['Neutral']
PI left the institution	['Study_Staff_Moved']	['Neutral']
Study was closed early due to poor accrual.	['Insufficient_Enrollment']	['Neutral']
The principal investigator left the organization	['Study_Staff_Moved']	['Neutral']
Research cancelled; equipment broke	['Logistics_Resources']	['Neutral']
Funding not available	['Business_Administrative']	['Possibly_Negative']
Company Decision	['Business_Administrative']	['Possibly_Negative']
reassessment of phase 2 study indication	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
investigator graduated and is not longer at this institution	['Study_Staff_Moved']	['Neutral']
No funding support and not adequate number of subjects are recruited for the study	['Business_Administrative']	['Possibly_Negative']
License termination.	['Business_Administrative']	['Possibly_Negative']
Study has never enrolled any subjects	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Lack of Resources and Personnel	['Logistics_Resources']	['Neutral']
Discontinued early due to local tolerance expectations not being met.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Number of eligible patients too low	['Insufficient_Enrollment']	['Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
No subjects meeting study inclusion were enrolled.	['Insufficient_Enrollment']	['Neutral']
Study never began	['Invalid_Reason']	['Invalid_Reason']
lack of funds	['Business_Administrative']	['Possibly_Negative']
"Study terminated on Nov 7, 2008 as a result of poor recruitment and changes in business
    priorities. The decision was not based on safety concerns."	['Business_Administrative']	['Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
Slow Enrollment	['Insufficient_Enrollment']	['Neutral']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
unable to meet recruitment goal	['Insufficient_Enrollment']	['Neutral']
The study was terminated due to program discontinuation.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
"To ensure the safety of participants during the COVID-19 pandemic, this clinical trial is
    suspended until further notice"	['Covid19']	['Neutral']
(Expected) side effects	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Delays in IND approval caused a lack of funding to conduct the trial.	['Business_Administrative']	['Possibly_Negative']
"Limited time between the beginning and the end of the inclusions, only 7 high level rowers
    available within the time compatible with research realization"	['Insufficient_Enrollment']	['Neutral']
The study was terminated after determination of the RP2D, prior to opening expansion cohorts)	['Negative']	['Negative']
low incidence of primary endpoint	['Negative']	['Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Principal investigator's decision due to lack of resources	['Logistics_Resources']	['Neutral']
Different study initiation	['Study_Design']	['Neutral']
Very low recruitment rates	['Insufficient_Enrollment']	['Neutral']
Loss of study staff	['Logistics_Resources']	['Neutral']
"An interim review of the data revealed that there was broad inter-participant variability.The
    study was stopped due to futility."	['Negative']	['Negative']
Change in medical practice on the management of the eligible population	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Funding ran out before study started, prior PI left institution.	['Business_Administrative']	['Possibly_Negative']
See Detailed Description	['No_Context']	['Invalid_Reason']
Terminated due to insufficient inclusion rate.	['Insufficient_Enrollment']	['Neutral']
Reorganization of personnel forced termination.	['Business_Administrative']	['Possibly_Negative']
Requested by surgeons to pursue new study	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"During the execution time foreseen in the project, the expected number of patients was not
    reached."	['Insufficient_Enrollment']	['Neutral']
no EC approval obtained	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Unable to meet enrollment numbers	['Insufficient_Enrollment']	['Neutral']
recruitment too slow	['Insufficient_Enrollment']	['Neutral']
Slow Enrollment	['Insufficient_Enrollment']	['Neutral']
Closed to accrual to allow enrollment on another more promising trial.	['Insufficient_Enrollment']	['Neutral']
Planned recruitment target not reached	['Insufficient_Enrollment']	['Neutral']
The trial was terminated in 2010 due to lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
Due to changes in Hospital Protocols and COVID-19	['Covid19']	['Neutral']
Three subjects were enrolled and all three subjects withdrew.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Insufficient enrollment (Terminated due to lack of patient recruitment)	['Insufficient_Enrollment']	['Neutral']
Inability to recruit the number of patients established in the study protocol (34 of 40)	['Insufficient_Enrollment']	['Neutral']
The development program has been terminated	['Business_Administrative']	['Possibly_Negative']
Sponsor pulled funding and low accrual	['Insufficient_Enrollment']	['Neutral']
Insufficient accrual to meet analysis goals	['Insufficient_Enrollment']	['Neutral']
Availabe time for inclusion ended (master thesis)	['Invalid_Reason']	['Invalid_Reason']
Difficulty with patient recruitment due to COVID-19 pandemic	['Covid19']	['Neutral']
Unable to meet recruitment numbers, lack of participation	['Insufficient_Enrollment']	['Neutral']
Primary Investigator left UT Southwestern and was not replaced.	['Study_Staff_Moved']	['Neutral']
Difficulty enrolling patients	['Insufficient_Enrollment']	['Neutral']
The study was targeted to accrue 130 patients, but closed early for futility.	['Negative']	['Negative']
Study was prematurely discontinued due to unacceptable toxicity.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Study Never Initiated	['Invalid_Reason']	['Invalid_Reason']
Terminated at request of PI as study was outdated.	['Logistics_Resources', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Company Decision	['Business_Administrative']	['Possibly_Negative']
"Sponsor's decision due to absence of demonstration of efficacy of volinanserin in primary
    insomnia with predominant sleep maintenance problems"	['Negative']	['Negative']
Decision of Sponsor	['Business_Administrative']	['Possibly_Negative']
There was not enough manpower to complete the study.	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
NO PARTICIPANTS ENROLLED	['Insufficient_Enrollment']	['Neutral']
Withdrawn for business reasons	['Business_Administrative']	['Possibly_Negative']
PI no longer at institution. Study terminated prior to enrolling subjects.	['Study_Staff_Moved']	['Neutral']
too many side-effects	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Difficulties finding subjects meeting enrollment criteria	['Insufficient_Enrollment']	['Neutral']
Insufficient accruals	['Insufficient_Enrollment']	['Neutral']
Funding and logistical difficuties resulted in the withdrawl of the study.	['Business_Administrative']	['Possibly_Negative']
Closed early due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
The study required more participants than anticipated for statistical significance.	['Negative']	['Negative']
Corporate reasons unrelated to safety and efficacy	['Business_Administrative']	['Possibly_Negative']
Feasibility of the clinical trial could not be confirmed at the different sites.	['Logistics_Resources']	['Neutral']
PI left the institution	['Study_Staff_Moved']	['Neutral']
Local problems with BIS monitor, we wont have it anymore.	['Logistics_Resources']	['Neutral']
Please see Detailed Description for termination reason.	['No_Context']	['Invalid_Reason']
MEDI-551 removed from oncology by pharmaceutical company due to change in research target.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Insufficient funding available to complete study.	['Business_Administrative']	['Possibly_Negative']
Clinical Hold	['Invalid_Reason']	['Invalid_Reason']
Poor recruiting	['Insufficient_Enrollment']	['Neutral']
Study PI has moved institutions	['Study_Staff_Moved']	['Neutral']
sponsor decision	['Business_Administrative']	['Possibly_Negative']
sponsor closed study due to poor enrollment	['Insufficient_Enrollment']	['Neutral']
No patients enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Early termination due to inability to meet enrollment for >350lb weight class	['Insufficient_Enrollment']	['Neutral']
Student related research project. Completion of allotted time.	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Due to low enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsor decided to discontinue study drug development	['Business_Administrative']	['Possibly_Negative']
lack of eligible participant	['Insufficient_Enrollment']	['Neutral']
due to COVID-19	['Covid19']	['Neutral']
no participants	['Insufficient_Enrollment']	['Neutral']
Insufficient data to continue. Study will not resume.	['Success', 'No_Context', 'Logistics_Resources']	['Success', 'Invalid_Reason', 'Neutral']
Inability to recruit required number of subjects.	['Insufficient_Enrollment']	['Neutral']
company focus on other projects	['Business_Administrative']	['Possibly_Negative']
Insufficient patients who met inclusion criteria	['Insufficient_Enrollment']	['Neutral']
Company closed	['Business_Administrative']	['Possibly_Negative']
- Interest in the use of HCQ is controversial.	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
This study has been terminated due to poor participant recruitment	['Insufficient_Enrollment']	['Neutral']
IND not approved	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Funding ended	['Business_Administrative']	['Possibly_Negative']
Suspended due to COVID	['Covid19']	['Neutral']
New technique for administration of drug, this is the old technique of administration.	['Study_Design']	['Neutral']
failed to achive funding	['Business_Administrative']	['Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
Insufficient study participants	['Insufficient_Enrollment']	['Neutral']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
Not more patient with lateral deviation	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Study_Design']	['Safety_Sideeffects', 'Neutral', 'Neutral']
We terminated this trial and initiated a new one including pertuzumab.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"Termination of the study was made after a full review of program data and assessment of the
    current risk-benefit profile."	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Lorcaserin removed from market	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
business reasons	['Business_Administrative']	['Possibly_Negative']
Participant attrition before final follow-up visit was greater than anticipated.	['Insufficient_Enrollment']	['Neutral']
Closed due to early stopping rule	['Negative']	['Negative']
"For futility reasons and potential ""loss of chance"" for MD 3511356 group"	['Negative']	['Negative']
The number of anticipated participants was not achieved	['Insufficient_Enrollment']	['Neutral']
Feasibility issues	['Logistics_Resources']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
"Drug exposure of retaspimycin HCl was superior to IPI-493, Infinity will focus exclusively on
    retaspimycin"	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"Unexpected discordant results between the KOH microscopy and mycological culture tests at three
    study sites in the UK."	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Interim analysis showed that the tested protocol did not improve treatment	['Negative']	['Negative']
recrutment	['Insufficient_Enrollment']	['Neutral']
Unable to enroll into study.	['Insufficient_Enrollment']	['Neutral']
Study was stopped due to difficulty in patient enrollment	['Insufficient_Enrollment']	['Neutral']
"Due to a problem with the supply and demand of the stent used in the study, it is difficult to
    register the target so the study ends early."	['Logistics_Resources']	['Neutral']
Funding was never obtained	['Business_Administrative']	['Possibly_Negative']
Recruitment problems; insufficient number of new recruits	['Insufficient_Enrollment']	['Neutral']
Too difficult to enroll patients.	['Insufficient_Enrollment']	['Neutral']
"Investigator judged that this study can not be maintained because participant registration rate
    is low."	['Insufficient_Enrollment']	['Neutral']
Change company strategy	['Business_Administrative']	['Possibly_Negative']
Study closed due to insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
evaluating feasibility	['Logistics_Resources']	['Neutral']
CoStar Stent IDE failed to meet primary endpoint	['Negative']	['Negative']
Trial terminated early due to results from a similar study.	['Negative', 'Another_Study']	['Negative', 'Neutral']
We do not have active funding at this time.	['Business_Administrative']	['Possibly_Negative']
poor recruitment	['Insufficient_Enrollment']	['Neutral']
funding and recruiting problems	['Business_Administrative']	['Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
it was not possible to recruit new patients anymore	['Insufficient_Enrollment']	['Neutral']
Investigator leaving the institution	['Study_Staff_Moved']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
"The French medicines agency did not allow the continuation of the study (no patient enrolled in
    this study)"	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
"Recruitment is suspended while the study site is being transitioned from Beth Israel Deaconess
    Medical Center to Boston Medical Center. Once IRB approval is obtained at Boston Medical
    Center, recruitment will resume."	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Risk-benefit analysis	['Negative']	['Negative']
Statistical analysis at interim analysis determined futility in continuing.	['Negative']	['Negative']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Administrative - change in development strategy	['Business_Administrative']	['Possibly_Negative']
"Temporarily paused due to COVID-19 and will resume based on guidance of public health
    authorities. This is not a suspension of IRB approval."	['Covid19']	['Neutral']
Due to company resource constraints	['Business_Administrative']	['Possibly_Negative']
This study has suspended participant recruitment.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Study did not meet pre-specified objectives.	['Study_Design', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
The study never started due to administrative reasons.	['Business_Administrative']	['Possibly_Negative']
insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
The patient's study enrollment was too low.	['Insufficient_Enrollment']	['Neutral']
low recruitment rate	['Insufficient_Enrollment']	['Neutral']
recruitment challenges	['Insufficient_Enrollment']	['Neutral']
All enrolled participants were screen failures, no data were collected for outcome measures.	['Negative']	['Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
"The Data Safety Monitoring Board (DSMB) recommended study termination for slow accrual and
    futility."	['Insufficient_Enrollment']	['Neutral']
Investigator choice	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Lack of efficacy	['Negative']	['Negative']
Could not secure funding to complete the study.	['Business_Administrative']	['Possibly_Negative']
Due to a lack of a referal base, study was terminated.	['Insufficient_Enrollment']	['Neutral']
Enrollment was too slow, so no participants were ever enrolled.	['Insufficient_Enrollment']	['Neutral']
Leakage	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Equality of results between the two groups at interim analysis	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Early termination due to COVID19; preliminary data can be considered significant	['Covid19']	['Neutral']
study no longer required	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Drug contract timelines and inadequate enrollment	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
We terminated the study because the Pain Management Program closed in January 2018.	['Business_Administrative']	['Possibly_Negative']
"This study was terminated on November 20, 2003 because of poor recruitment. This study was not
    terminated due to safety/efficacy."	['Insufficient_Enrollment']	['Neutral']
excessive dropout	['Insufficient_Enrollment']	['Neutral']
"due to a change in surgical personnel, the operative technique changed, precluding the
    examination of bypass-related bi-hemispheric saturation differences."	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Repositioning of target indication.	['Study_Design']	['Neutral']
Therapy shown effective by larger studies	['Negative', 'Another_Study']	['Negative', 'Neutral']
Difficulty recruiting enough patients	['Insufficient_Enrollment']	['Neutral']
Funding exhausted.	['Business_Administrative']	['Possibly_Negative']
The sponsor stoppes the study for the security problem.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Difficulties for recruting patients	['Insufficient_Enrollment']	['Neutral']
funding was not secured	['Business_Administrative']	['Possibly_Negative']
Slow/insufficient accrual	['Insufficient_Enrollment']	['Neutral']
Investigator is leaving Dartmouth	['Study_Staff_Moved']	['Neutral']
Anticipated that results would not be conclusive	['Negative']	['Negative']
No enrollment.	['Insufficient_Enrollment']	['Neutral']
Terminiated for trial redesign	['Study_Design']	['Neutral']
No patients were enrolled and global prioritization of pipeline and research strategy	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Enrollment into study was slower than expected.	['Insufficient_Enrollment']	['Neutral']
Study expired; Investigator left facility.	['Study_Staff_Moved']	['Neutral']
A competing study made it challenging to enroll subjects.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
The Prinicipal Investigator left the organization and decided to close the trial	['Study_Staff_Moved']	['Neutral']
No participants enrolled.	['Insufficient_Enrollment']	['Neutral']
The objective response rate by more than two people are confirmed.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
"Development of JNJ-64041757 in combination with nivolumab discontinued due to lack of clinical
    benefit observed in the Phase 1b portion of the study"	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Due to the pursuit of other SARS-CoV-2-related research including alternative trials with
    tofacitinib, this trial was canceled prior to subject enrollment."	['Negative', 'Another_Study']	['Negative', 'Neutral']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Very slow recruitment rate. Only 6 infants were recruited over 2 years.	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Due to the pandemic we decided to terminate this project.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
No accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor has obtained sufficient case load prematurely.	['Business_Administrative']	['Possibly_Negative']
We stopped inserting BioFlo ports, no more patients to recruit	['Insufficient_Enrollment']	['Neutral']
Due to difficulties with enrollment, the study was terminated early.	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Adequate recruitment was not achieved in the time frame allowed.	['Insufficient_Enrollment']	['Neutral']
The study stopped due to marketing approval by the FDA.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
insufficient patient recruitment	['Insufficient_Enrollment']	['Neutral']
Insufficient enrollment numbers due to Covid-19 pandemic	['Covid19']	['Neutral']
"Considering the Thai FDA requirement, changes of Malaria cases in Thailand and EC
    recommendation, the decision to withdrawal the study was made."	['Regulatory', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Not enough recources.	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
No subjects have been enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Due to COVID-19	['Covid19']	['Neutral']
Funding was withdrawn for this study by the sponsor.	['Business_Administrative']	['Possibly_Negative']
Recruitment not reached	['Insufficient_Enrollment']	['Neutral']
A re-evaluation of research risks to participants were greater than originally anticipated	['Interim_Analysis', 'Endpoint_Met', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Study terminated early due to decision by sponsor	['Business_Administrative']	['Possibly_Negative']
difficulty in recruitment. lack of sponsorship	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
No documentation with MHRA to support clinical trial of a medicinal product.	['Business_Administrative']	['Possibly_Negative']
Insufficient study support	['Business_Administrative']	['Possibly_Negative']
Decision to change trial design.	['Study_Design']	['Neutral']
Reduction in funding.	['Business_Administrative']	['Possibly_Negative']
Adequate enrollment was not reached for this study.	['Insufficient_Enrollment']	['Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Funding ended and will not be renewed	['Business_Administrative']	['Possibly_Negative']
New compounds available in the indication (nivolumab/pembrolizumab), toxicity of ipilimumab	['Endpoint_Met', 'Study_Design', 'Another_Study']	['Neutral', 'Neutral', 'Neutral']
NDA #210565 did not trigger the need for a Pediatric Research Equity Act study.	['Business_Administrative']	['Possibly_Negative']
Per PI	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
Study never initiated.	['Invalid_Reason']	['Invalid_Reason']
"Study suspended due to the occurrence of a SUSAR. During suspension, no enrollment, new
    mobilization, cell collection, conditioning or bb1111 infusion will be initiated. Subjects who
    have been treated will continue to be followed per study protocol."	['Safety_Sideeffects', 'Logistics_Resources', 'Endpoint_Met']	['Safety_Sideeffects', 'Neutral', 'Neutral']
"The study was terminated early due to difficulty in recruiting subjects, and ran short of
    funds."	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Safety Issue: The trial was prematurely terminated on Dec 9, 2010, due to safety concerns,
    specifically new emerging evidence of hepatic injury."	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
guideline developed	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Low recruitment, scientific rationale not applicable anymore to all patients and possible
    induction of GvHD by the study drug"	['Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral']
"The study was not completed as planned and was terminated early with agreement from the
    European Medicines Agency (EMEA)"	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Change in hospital protocol	['Study_Design']	['Neutral']
Low accrual.	['Insufficient_Enrollment']	['Neutral']
The recruiting centre was no longer presenting new patients for inclusion	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
lack of enrollement	['Insufficient_Enrollment']	['Neutral']
Low participant accrual	['Insufficient_Enrollment']	['Neutral']
FDA Clinical Hold	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
acrrual target was not being met	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Enrolment difficulties.	['Insufficient_Enrollment']	['Neutral']
Uncertainty about funding	['Business_Administrative']	['Possibly_Negative']
trial design contingent on RFA optimization	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Stopped due to a business decision	['Business_Administrative']	['Possibly_Negative']
Existing trials demonstrate reduction in fluoroscopy with MediGuide	['Negative', 'Another_Study']	['Negative', 'Neutral']
No financial support	['Business_Administrative']	['Possibly_Negative']
Failing recruitement and more exclusions than anticipated.	['Insufficient_Enrollment']	['Neutral']
Withdrawn pending further review of clinical design.	['Study_Design']	['Neutral']
"The Sponsor decided to terminate the study early for several reasons (low enrollment, limited
    variety of surgery types, and available scientific data)."	['Insufficient_Enrollment']	['Neutral']
Expertise resigned	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
due to company decision	['Business_Administrative']	['Possibly_Negative']
Low accrual rate	['Insufficient_Enrollment']	['Neutral']
no patients included	['Insufficient_Enrollment']	['Neutral']
Lack of Accrual	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Poor enrollment and data collection	['Insufficient_Enrollment']	['Neutral']
Unable to recruit adequate trial participants	['Insufficient_Enrollment']	['Neutral']
company and Sheba did not reach an agreement	['Business_Administrative']	['Possibly_Negative']
"The study was terminated on 21 June 2010 due to results not meeting the primary endpoint. No
    safety reasons contributed to the termination of the study."	['Negative']	['Negative']
This study was terminated for reasons not related to efficacy or safety	['Negative']	['Negative']
Minimal enrollment	['Insufficient_Enrollment']	['Neutral']
PI left the institution	['Study_Staff_Moved']	['Neutral']
Resources allocated elsewhere.	['Business_Administrative']	['Possibly_Negative']
no funding	['Business_Administrative']	['Possibly_Negative']
No funding obtained to conduct study	['Business_Administrative']	['Possibly_Negative']
Sponsor discontinued funding due to higher than anticipated manufacturer costs	['Business_Administrative']	['Possibly_Negative']
Data Monitoring Committee decision on 22nd August 2011 for safety issues	['Safety_Sideeffects', 'Negative']	['Safety_Sideeffects', 'Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
The study activities are suspended due to COVID	['Covid19']	['Neutral']
Decision by Sponsor to to terminate the study early.	['Business_Administrative']	['Possibly_Negative']
Study was terminated due to futility	['Negative']	['Negative']
Terminated by Sponsor	['Business_Administrative']	['Possibly_Negative']
Patient enrolment issues	['Insufficient_Enrollment']	['Neutral']
"Only apx 1/3 of enrolled subjects (signed consent) participated. Futility analysis to show
    primary endpoint"	['Negative']	['Negative']
Study terminated due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
Business pivot caused termination of study before enrollment.	['Business_Administrative']	['Possibly_Negative']
"The study was terminated by Spiracur (original sponsor). Efforts were made to contact the
    PI/study team members, but were unsuccessful."	['Business_Administrative']	['Possibly_Negative']
sponsor stopped the study because of lack of elligible participants	['Insufficient_Enrollment']	['Neutral']
Low participant enrollment: 15 enrolled of 114 planned	['Insufficient_Enrollment']	['Neutral']
"Suspended for an interim review of (CAR) CD19 research strategy for the treatment of CD19
    positive ALL."	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Study was terminated due to withdrawal of CRADA partner.	['Business_Administrative']	['Possibly_Negative']
Slow inclusion rate	['Insufficient_Enrollment']	['Neutral']
The study Principal Investigator relocated and the grant funding the trial expired.	['Business_Administrative']	['Possibly_Negative']
Missing ressources. The study official has left and will not be replaced	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
Collaborator, MyndTec, withdrew from the study due to lack of resources	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
lack of recruitement	['Insufficient_Enrollment']	['Neutral']
This study was stopped prematurely due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
lack of resources; no patient enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of efficacy in European Phase 2 study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study design was inadequate and would not achieve study endpoints	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"The study was terminated prior to completing the planned cohorts and analysis because of
    problems with the infusion set resulting in inadequate insulin delivery"	['Logistics_Resources']	['Neutral']
Funding issues	['Business_Administrative']	['Possibly_Negative']
Study terminated due to strategic business decision by Eli Lilly and Company.	['Business_Administrative']	['Possibly_Negative']
The voluntary attendance rate for intervention is low.	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Slow subject enrollment, unable to complete trial in a timely manner	['Insufficient_Enrollment']	['Neutral']
no pts recruited	['Insufficient_Enrollment']	['Neutral']
inadequate recruitment	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Terminated due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
We were not able to accrue any participants.	['Insufficient_Enrollment']	['Neutral']
"Decision to discontinue the study based on broader development and strategic prioritisation.
    The Sponsor concludes there is no benefit-risk impact on the CO41863 study."	['Business_Administrative']	['Possibly_Negative']
No eligibles patients	['Insufficient_Enrollment']	['Neutral']
Original investigator has left the institution.	['Study_Staff_Moved']	['Neutral']
Slower than anticipated recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of Funding	['Business_Administrative']	['Possibly_Negative']
"Trial terminated after recruiting 172 patients but without proceeding to the highest dosing
    cohort as this no longer reflects common clinical practice"	['Study_Design']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
not funded	['Business_Administrative']	['Possibly_Negative']
The PI is deceased, decision was made to withdraw.	['Study_Staff_Moved']	['Neutral']
For poor enrollment	['Insufficient_Enrollment']	['Neutral']
Administrative barriers	['Business_Administrative']	['Possibly_Negative']
incorporated into other study	['Negative', 'Another_Study']	['Negative', 'Neutral']
due to poor enrollment	['Insufficient_Enrollment']	['Neutral']
inability to recruit participants despite numerous attempts	['Insufficient_Enrollment']	['Neutral']
Enrollment Challenges	['Insufficient_Enrollment']	['Neutral']
Business decision	['Business_Administrative']	['Possibly_Negative']
"After reevaluation of the benefit: risk profile of ezogabine/retigabine, GSK does not believe
    the early adjunctive treatment study population is appropriate."	['Negative']	['Negative']
No Funding	['Business_Administrative']	['Possibly_Negative']
PI moved to another institution	['Study_Staff_Moved']	['Neutral']
Patient recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
"Study was terminated in order to secure the data quality of the study in terms of follow-up
    rates and data completeness."	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Study PI resigned	['Study_Staff_Moved']	['Neutral']
Trial not initiated	['Invalid_Reason']	['Invalid_Reason']
Not enough tissue for analysis	['Logistics_Resources']	['Neutral']
study terminated due to slow accrual	['Insufficient_Enrollment']	['Neutral']
"Logistical challenges with research pharmacy prevented the dilution of the capsaicin. No
    participants were ever recruited, enrolled, or approached."	['Logistics_Resources']	['Neutral']
insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
"The termination of the study is not linked to a product recall or result of any safety signal.
    Rather it was sponsor's commercial decision to withdraw the MA"	['Business_Administrative']	['Possibly_Negative']
Funding no longer available	['Business_Administrative']	['Possibly_Negative']
Interim analysis showed a high likelihood of benefit in the endovascular group	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Sponsor decision due to commercial availability of ataluren.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
No patients were enrolled to trial	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
study stopped due to not meeting enrollment goal.	['Insufficient_Enrollment']	['Neutral']
Unable to recruit sufficient patients	['Insufficient_Enrollment']	['Neutral']
Accrual was not optimized	['Insufficient_Enrollment']	['Neutral']
No patients enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
18F-THK5351 was reported non-specific binding of MAO receptors.	['Negative']	['Negative']
Development terminated.	['Business_Administrative']	['Possibly_Negative']
drug has expired, no enrollments in study. Company pulled funding	['Business_Administrative']	['Possibly_Negative']
prolonged device failure after just 10 participants and too long to resume	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
recruiting or enrolling participants has halted prematurely and will not resume	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"The trial was terminated on May 2008 after inclusion of 10 patients due to low recruitment and
    patient compliance."	['Insufficient_Enrollment']	['Neutral']
poor accrual	['Insufficient_Enrollment']	['Neutral']
Lack of accrual.	['Insufficient_Enrollment']	['Neutral']
Lack of funds	['Business_Administrative']	['Possibly_Negative']
The study was terminated due to lack of efficacy.	['Negative']	['Negative']
This study was terminated due to low enrollment	['Insufficient_Enrollment']	['Neutral']
Not enough sites available to complete enrollment in a timely manner	['Insufficient_Enrollment']	['Neutral']
Departure of essential Co-Investigator from McLean Hospital	['Study_Staff_Moved']	['Neutral']
Pending financial support	['Business_Administrative']	['Possibly_Negative']
Business decision	['Business_Administrative']	['Possibly_Negative']
Unable to isolate sufficient cells from the skin biopsy to perform study related experiments	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Low accrual.	['Insufficient_Enrollment']	['Neutral']
because of lack of funding and recruitment problems the study has been closed.	['Business_Administrative']	['Possibly_Negative']
Lack of efficacy of the drug; no safety concern	['Negative']	['Negative']
Principal Investigator has left the Institution	['Study_Staff_Moved']	['Neutral']
not enough participants	['Insufficient_Enrollment']	['Neutral']
Recruitment halted due to COVID19; Study is in no-cost extension due to COVID.	['Covid19']	['Neutral']
Insufficient resources	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
FLT production not available	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
recruiting inadequate	['Insufficient_Enrollment']	['Neutral']
Sponsor is bankrupt	['Business_Administrative']	['Possibly_Negative']
Changes in study design	['Study_Design']	['Neutral']
Company decision	['Business_Administrative']	['Possibly_Negative']
See Detailed Description.	['No_Context']	['Invalid_Reason']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
Financial Reasons	['Business_Administrative']	['Possibly_Negative']
Terminated due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
Funding issues. 0 subjects enrolled	['Business_Administrative']	['Possibly_Negative']
Study was halted early after 63 subjects were enrolled due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
COVID-19	['Covid19']	['Neutral']
7% enrollment. Study terminated after a small number of recruited patients	['Insufficient_Enrollment']	['Neutral']
Sponsor decision to withdraw.	['Business_Administrative']	['Possibly_Negative']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Slow accrual, study terminated.	['Insufficient_Enrollment']	['Neutral']
Feasibility issues	['Logistics_Resources']	['Neutral']
This study was cancelled with no patients	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
No difference in outcome between the two groups	['Negative']	['Negative']
"Patient recruitment challenges, low enrolment, and a forecasted inability to complete the study
    in an acceptable timeframe"	['Insufficient_Enrollment']	['Neutral']
Due to COVID pandemic further recruitment of subjects was unethical.	['Covid19']	['Neutral']
The study was terminated because of recruitment challenges	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
funding not available	['Business_Administrative']	['Possibly_Negative']
Low enrollment.	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
"Study terminated due to change in clinical practice affecting recruitment. For majority of
    patients, NJ tubes are now used instead of NG tubes."	['Study_Design']	['Neutral']
"I did not pass the 2018 Ministry of Science and Technology research project subsidy, so I
    applied for the project to close the case."	['Business_Administrative']	['Possibly_Negative']
This study was halted prematurely by the NCI for low accrual.	['Insufficient_Enrollment']	['Neutral']
Funding will not be provided for the drug	['Business_Administrative']	['Possibly_Negative']
Enrollment never began.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Differences between BIS and Neurosense are important. This study can be terminated.	['Interim_Analysis', 'Endpoint_Met', 'Negative']	['Neutral', 'Neutral', 'Negative']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
Inability of site to recruit/enroll target population	['Insufficient_Enrollment']	['Neutral']
Conditions of recruitment changed	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
The study was stopped by insufficient funds	['Business_Administrative']	['Possibly_Negative']
"Perception of an increased incidence of C-Qur V-patch mesh infection, with need for removal,
    compared to other meshes used for umbilical hernia repair."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Due to a lack of funding	['Business_Administrative']	['Possibly_Negative']
insufficient subjects recruited in allotted time	['Insufficient_Enrollment']	['Neutral']
Safety concerns	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
No patients enrolled. Study withdrawn.	['Insufficient_Enrollment']	['Neutral']
No funding and data was not appropriate to consider continuing.	['Business_Administrative']	['Possibly_Negative']
Retirement of former Qualified Investigator and lack of resources to complete study	['Logistics_Resources', 'Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Product withdrawn from distribution	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
P.I. left	['Study_Staff_Moved']	['Neutral']
The principle investigator decided to change the protocol	['Study_Design']	['Neutral']
Study not funded.	['Business_Administrative']	['Possibly_Negative']
The principal investigator decide to stop the sudy.	['Invalid_Reason']	['Invalid_Reason']
PI request due to a lack of coordinator availability for study procedures.	['Logistics_Resources']	['Neutral']
"Planned interim analysis yielded different event rate affecting sample size and ability to
    recruit sufficient numbers within remaining trial time frame"	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
poor patient recruitment and limited resources	['Insufficient_Enrollment']	['Neutral']
no patient enrolled	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
24 months follow up completed without substantial change to the profile.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
"Drug sponsor has requested to keep this study open until a new study is initiated. The study is
    being suspended in the interim time period."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Principal Investigator left Institution	['Study_Staff_Moved']	['Neutral']
Pentaspan is no longer used at our institution. Pentaspan was an arm of the study	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
Early analysis indicated SRS not as beneficial post-op as pre-op	['Negative']	['Negative']
study drug was removed from the market and low enrollment.	['Insufficient_Enrollment']	['Neutral']
no responders/lack of efficacy	['Negative']	['Negative']
Very slow and infrequent recruitment, availability of the imaging procedure at Adult Centre	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Insufficient recruitment during the predefined time frame for the study	['Insufficient_Enrollment']	['Neutral']
Low participant enrollment, Insufficient findings for data analysis	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"Based on the independent Data Monitoring Committee's recommendation that all dosing be stopped
    and patients continue to be followed for safety and efficacy outcomes as per protocol, without
    study drug administration from 22 March 2021."	['Negative']	['Negative']
"Study recruitment was terminated before the planned number of subjects was enrolled in CAT-354
    10 mg/kg group due to the slow recruitment rate."	['Insufficient_Enrollment']	['Neutral']
Realized there was a design flaw.	['Study_Design']	['Neutral']
The study product was revised. PI withdrew the study without enrolling participants..	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Proof of principle established with completed SAD part	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
FSI delayed until 15 January 2013	['Regulatory', 'Invalid_Reason', 'Negative']	['Neutral', 'Invalid_Reason', 'Negative']
"Due to low enrollment, no participant had a dose limiting toxicity, therefore a maximum
    tolerated dose could not be established"	['Safety_Sideeffects', 'Endpoint_Met', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Study was not funded and pilot work proved impractical.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Resident research project limited by restrictions of residency program.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
"Study terminated early due to sample size, not possible to perform further statistical
    analysis."	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
HUAA study is terminated early due to a business decision.	['Business_Administrative']	['Possibly_Negative']
Logistical reasons	['Logistics_Resources']	['Neutral']
"Tezepelumab as a monotherapy in atopic dermatitis did not reach the targeted efficacy level
    pre-established for this patient population."	['Negative']	['Negative']
no patient recruiting	['Insufficient_Enrollment']	['Neutral']
Business decision	['Business_Administrative']	['Possibly_Negative']
Persisting recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Because of the expiration of the previous ethical approval documents	['Interim_Analysis', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Study withdrawn due to the company decision	['Business_Administrative']	['Possibly_Negative']
interim analysis shows futility	['Negative']	['Negative']
Funding unavailable	['Business_Administrative']	['Possibly_Negative']
Please see Purpose Statement below	['No_Context']	['Invalid_Reason']
Study was cancelled	['Invalid_Reason']	['Invalid_Reason']
Nonapplicable clinical trial	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Very low accrual rate	['Insufficient_Enrollment']	['Neutral']
Lack of patients	['Insufficient_Enrollment']	['Neutral']
No patients were enrolled, due to logistic difficulties, no funding was acquired.	['Business_Administrative']	['Possibly_Negative']
Study stopped due to poor enrollment.	['Insufficient_Enrollment']	['Neutral']
Futility criteria	['Negative']	['Negative']
"Due to recent strategic policy developments in the national vaccination program it is uncertain
    preadolescent girls will receive the HBV vaccin."	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Sponsor closed the study in order to review data from other ongoing tesevatinib oncology
    studies, and to determine feasibility of continuing this study"	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Clinical trial activity slowdown due to COVID-19 pandemic, high screen fail rate, and lack of
    enrollment led to the decision to withdraw the MARINA study."	['Covid19']	['Neutral']
no recruited patients	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
"Unsuccessful recruitment, failed training of the group leaders leading into lack of study
    groups"	['Insufficient_Enrollment']	['Neutral']
The study was terminated based on a business decision.	['Business_Administrative']	['Possibly_Negative']
No new participants	['Insufficient_Enrollment']	['Neutral']
Trial terminated for futility.	['Negative']	['Negative']
Stopped for futility	['Negative']	['Negative']
funding	['Business_Administrative']	['Possibly_Negative']
"The study was terminated at the interim point due to the covid-19 pandemic, which did not allow
    completing full recruitment in relevant timelines"	['Covid19']	['Neutral']
No patients could be recruited.	['Insufficient_Enrollment']	['Neutral']
Funding Withdrawn	['Business_Administrative']	['Possibly_Negative']
Study was withdrawn by the Sponsor prior to enrollment	['Business_Administrative']	['Possibly_Negative']
Update of the technical documentation of the device	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Study Was Terminated due to lack of Funding.	['Business_Administrative']	['Possibly_Negative']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
"Early termination due to significant lack of relevant patient data for evaluation of
    objectives."	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Low enrollment; Low clinical relevance: evidence for use of vancomycin powder	['Negative', 'Another_Study']	['Negative', 'Neutral']
The study was not approved by Hospital's Medical Ethics Committee.	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
unexpectedly slow recruitment rate	['Insufficient_Enrollment']	['Neutral']
Slow study enrollment	['Insufficient_Enrollment']	['Neutral']
due to loss of key personnel due to illness and sabbatical of thePI	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
Unable to recruit required sample size	['Insufficient_Enrollment']	['Neutral']
invalid data	['Success', 'No_Context', 'Logistics_Resources']	['Success', 'Invalid_Reason', 'Neutral']
Due to slow recruitment the study was stopped prematurely.	['Insufficient_Enrollment']	['Neutral']
PI left JHU	['Study_Staff_Moved']	['Neutral']
Slow enrollment resulted in withdraw of funding	['Insufficient_Enrollment']	['Neutral']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
This study was terminated early due to poor enrollment.	['Insufficient_Enrollment']	['Neutral']
Technical issues with the device under study. Sponsor terminated.	['Logistics_Resources']	['Neutral']
replaced by another study ; Trial re-written as MT2015-29	['Negative', 'Another_Study']	['Negative', 'Neutral']
As of 12/12/12 study closed to enrollment because study was determined to be ineffective.	['Negative']	['Negative']
statistical Significance was reached for primary outcome	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
lack of new patients	['Insufficient_Enrollment']	['Neutral']
Study was terminated due to cardiac toxicities in the subjects	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"Supported by preliminary interim analysis. Not based on any safety signals in study or any
    quality issues that could affect efficacy of the product."	['Negative']	['Negative']
"Based on available data, UCB has decided to stop development of padsevonil as adjunctive
    treatment of focal-onset seizures"	['Regulatory', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
no sufficient subjects	['Insufficient_Enrollment']	['Neutral']
research group's decision	['Business_Administrative']	['Possibly_Negative']
The reason for termination was lack of tolerability and efficacy of the combination treatment	['Negative']	['Negative']
The study was stopped due to a lack of additional subjects.	['Insufficient_Enrollment']	['Neutral']
because of difficulties for participants enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of patient accrual	['Insufficient_Enrollment']	['Neutral']
Recruitment became very slow.	['Insufficient_Enrollment']	['Neutral']
Unable to complete study	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Lack of feasibility	['Logistics_Resources']	['Neutral']
Efficacy was not seen after interim analysis	['Negative']	['Negative']
new safety data from another study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Sponsor decided to terminate the study due to budget consideration	['Business_Administrative']	['Possibly_Negative']
"Study was discontinued based on futility analysis conducted on Phase 3 trials (NCT02477800 and
    NCT02484547) and not based on safety concerns."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Recommendation by BfArM after interim analysis	['Regulatory', 'Negative']	['Neutral', 'Negative']
Enrollment was stopped after eighty patients were enrolled.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
This study did not receive the grant that was applied for to conduct the study.	['Business_Administrative']	['Possibly_Negative']
recruitment completed	['Invalid_Reason']	['Invalid_Reason']
staffing change and lack of resources to conduct the study.	['Logistics_Resources']	['Neutral']
Needed New IND per FDA	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Insufficient resources available to complete the study	['Business_Administrative']	['Possibly_Negative']
"The incidence of post-operative delirium observed from interim blinded data was significantly
    lower than the current literature in this population."	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
unable to reach enrollment goal	['Insufficient_Enrollment']	['Neutral']
Funding was unable to be secured for this study	['Business_Administrative']	['Possibly_Negative']
"The Sponsor decided to terminate this study in favor of development of subcutaneous
    administration."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
sponsor decision	['Business_Administrative']	['Possibly_Negative']
Due to results from the VTI-208 study, the ELAD plan is being re-evaluated.	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Due to SARS-Cov-2 emergency we were unable to recruit the expected number of children. We will
    analyze the available data"	['Insufficient_Enrollment']	['Neutral']
There was recruted subject	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Decision of the Sponsor, as the funding of the study was no longer guaranteed.	['Business_Administrative']	['Possibly_Negative']
recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Funding issue	['Business_Administrative']	['Possibly_Negative']
Study complexity, low study recruitment	['Insufficient_Enrollment']	['Neutral']
Study is being closed due to insufficient patient population for enrollment.	['Insufficient_Enrollment']	['Neutral']
Unable to execute contract	['Business_Administrative']	['Possibly_Negative']
lack of funding by company providing TPI-287	['Business_Administrative']	['Possibly_Negative']
Consenting participants entered tenofovir/emtricitabine oral prophylaxis trial	['Negative', 'Another_Study']	['Negative', 'Neutral']
physician's departure	['Study_Staff_Moved']	['Neutral']
Primary investigator has changed his employee and the country of residence.	['Study_Staff_Moved']	['Neutral']
Difficult enrollment	['Insufficient_Enrollment']	['Neutral']
This study was terminated early due to company decision. Part B was never conducted.	['Business_Administrative']	['Possibly_Negative']
Lack of Funding	['Business_Administrative']	['Possibly_Negative']
Clinical studies are stopped, pending funding.	['Business_Administrative']	['Possibly_Negative']
The study is being terminated early as a result of the coronavirus (COVID-19) outbreak.	['Covid19']	['Neutral']
Management Decision	['Business_Administrative']	['Possibly_Negative']
Based on a futility analysis, the data monitoring committee recommended to stop enrollment.	['Negative']	['Negative']
Low rate recruitment	['Insufficient_Enrollment']	['Neutral']
"As it is difficult to recruit any more subjects, the investigators decided to terminate the
    study."	['Insufficient_Enrollment']	['Neutral']
FDA advised that study is no longer required	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Insufficient number of participants	['Insufficient_Enrollment']	['Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
"The ARGX-113-1908 study will be replaced by a similar design with a subcutaneous formulation
    (ARGX-113-2004)"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Inclusion rate too low. Recruitment of further study centers too costly.	['Insufficient_Enrollment']	['Neutral']
Study was closed early due to low numbers of evaluable patients	['Insufficient_Enrollment']	['Neutral']
The study was terminated early during the phase II portion of the study due to slow enrollment.	['Insufficient_Enrollment']	['Neutral']
Absence of Co-investigator	['Study_Staff_Moved']	['Neutral']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
CGM Navigator isn't longer available (October 11, 2019)	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Principal Investigator leaving institution. 38 subjects were enrolled in Aim 1. Aim 2 was not
    initiated."	['Study_Staff_Moved']	['Neutral']
Unable to enroll r/t study design & staffing issues. The trial terminated.	['Logistics_Resources']	['Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Study was terminated due to administrative reasons.	['Business_Administrative']	['Possibly_Negative']
No participants were enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Another study with similar methods was recently published	['Negative', 'Another_Study']	['Negative', 'Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
"Sanofi ended collaboration with Lexicon for Sotagliflozin. In China no regulatory pathway to
    transfer sponsorship during the conduct of ongoing studies."	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Administrative reasons	['Business_Administrative']	['Possibly_Negative']
"We did not want to start a case series as we already finished a RCT...SO this study is now
    outdated"	['No_Context', 'Logistics_Resources', 'Insufficient_Data']	['Invalid_Reason', 'Neutral', 'Neutral']
No paritcipants enrolled	['Insufficient_Enrollment']	['Neutral']
We did not receive funding	['Business_Administrative']	['Possibly_Negative']
"The study was prematurely discontinued due to poor recruitment on 18th April 2013. There were
    no safety concerns that led to the decision to terminate."	['Insufficient_Enrollment']	['Neutral']
"A new scientific study shows that surgery with internal brace is worse than convensional
    surgery tecnic. This new knowledge stops this trial."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
patients enrolled got vaccinated vs COVID-19 and Influenza	['Covid19']	['Neutral']
Due to low patient recruitment	['Insufficient_Enrollment']	['Neutral']
too slow recruitment; lack of funding	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Original PI left institution and sponsor decided to end support.	['Study_Staff_Moved']	['Neutral']
"The study was prematurely terminated due to slow patient accrual and discontinuation of
    clinical development of MOXR0916 due to Sponsor's strategic priorities."	['Insufficient_Enrollment']	['Neutral']
Study terminated due to abnormal liver biochemical tests in some participants.	['Safety_Sideeffects', 'Logistics_Resources', 'Endpoint_Met']	['Safety_Sideeffects', 'Neutral', 'Neutral']
sponsor decision (confidential)	['Business_Administrative']	['Possibly_Negative']
Sponsor decision - sponsor will be initiating a phase 3 mid-2019	['Business_Administrative']	['Possibly_Negative']
Difficulty with enrollment	['Insufficient_Enrollment']	['Neutral']
Study terminated due to COVID-19 impact	['Covid19']	['Neutral']
Sponsor has withdrawn support for this study and it will not be performed	['Business_Administrative']	['Possibly_Negative']
Efficacy	['Negative']	['Negative']
Sponsor decision to cancel TRIAL, not related to safety concern	['Safety_Sideeffects', 'Business_Administrative']	['Safety_Sideeffects', 'Possibly_Negative']
The viability of the study is being analyzed	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Screenings yielded inadequate eligible subjects to enroll.	['Insufficient_Enrollment']	['Neutral']
"Analysis was not done because only 1 subject was able to come back for the 3 month follow up
    visit."	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Study halted due to low recruitment, unrelated to safety or efficacy reasons	['Insufficient_Enrollment']	['Neutral']
Follow up only	['Invalid_Reason', 'Study_Design', 'Another_Study']	['Invalid_Reason', 'Neutral', 'Neutral']
Company Decision	['Business_Administrative']	['Possibly_Negative']
Technical problems	['Logistics_Resources']	['Neutral']
not enough patients	['Insufficient_Enrollment']	['Neutral']
The investigator had no more scientific interest about this issue.	['Logistics_Resources', 'Study_Staff_Moved', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Responsible Party/PI passed away. All subjects enrolled completed study prior to termination.	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
This study is suspended secondary to staffing/PI availability until February 2021.	['Logistics_Resources']	['Neutral']
Not due to safety but due to a lack of efficacy at the 5 mg azeliragon dose.	['Negative']	['Negative']
This original design is no longer consistent with current clinical practice.	['Study_Design']	['Neutral']
Study never started	['Invalid_Reason']	['Invalid_Reason']
Study design was changed and is now InSite trial #1634 - See NCT00547378	['No_Context', 'Study_Design', 'Another_Study']	['Invalid_Reason', 'Neutral', 'Neutral']
Recruitment challenges	['Insufficient_Enrollment']	['Neutral']
investigator transferred institutions	['Study_Staff_Moved']	['Neutral']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
Futility of Primary Efficacy Endpoint	['Negative']	['Negative']
futility ground	['Negative']	['Negative']
unable to obtain IRB approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Recruitment was stopped early due to slow enrolment of this population. With no safety
    concerns, the study continued normally for subjects already recruited"	['Insufficient_Enrollment']	['Neutral']
The Sponsor decided to halt the development of GDC-0810, but not due to any safety concerns.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Greater differences between randomized patients than previously anticipated	['Negative']	['Negative']
"This study was terminated early as a result of regulatory action suspending tegaserod use in
    2007"	['Regulatory']	['Neutral']
Funding was withdrawn after only 10 participants were enrolled	['Business_Administrative']	['Possibly_Negative']
"investigator's decision : recruitment difficulties and lack of interest in the remote study of
    the crisis Levothyrox"	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Site did not want to pursue study	['Business_Administrative']	['Possibly_Negative']
Per protocol, study was terminated due to low rate of randomized patients.	['Insufficient_Enrollment']	['Neutral']
per sponsor decision	['Business_Administrative']	['Possibly_Negative']
other trials show no survival benefit of bexarotene with platinum-based chemo	['Negative', 'Another_Study']	['Negative', 'Neutral']
Insufficient accrual	['Insufficient_Enrollment']	['Neutral']
Study was terminated early due to significant enrollment challenges.	['Insufficient_Enrollment']	['Neutral']
Sponsor determination	['Business_Administrative']	['Possibly_Negative']
"Protocol planned interim analysis after two years showed very low recruitment in cohort 1 and
    low recruitment in cohort 2."	['Insufficient_Enrollment']	['Neutral']
Sponsor decision, unrelated to safety	['Business_Administrative']	['Possibly_Negative']
It has been impossible to achieve the number of patients defined by protocol	['Insufficient_Enrollment']	['Neutral']
Based on Independent Data Monitoring Committee (IDMC) recommendation.	['Negative']	['Negative']
Clinical trial from which subjects were recruited closed to enrollment	['Insufficient_Enrollment']	['Neutral']
Stopped before IRB approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Drug manufacturer - Amgen requested, per DSMB observation in POWER trial.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Sponsor's decision not to pursue development of uPLi for vascular conditions	['Business_Administrative']	['Possibly_Negative']
Loss of principal investigator	['Study_Staff_Moved']	['Neutral']
Investigator no longer interested in proceeding with study	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
actually limited personnel ressources	['Logistics_Resources']	['Neutral']
"Study was withdrawn due to 2 cases of agranulocytosis in a different clinical trial with this
    same drug."	['Negative', 'Another_Study']	['Negative', 'Neutral']
"COVID19 impact on this trial was evaluated and a delay of at least 6-9 months was expected. In
    parallel, the development of a new type of pen injector, which was an important part of the
    trial, was ceased and thus this trial was cancelled."	['Covid19']	['Neutral']
Closed due to lack of accrual	['Insufficient_Enrollment']	['Neutral']
"On May 30, 2014, study injections were discontinued at the request of the DSMC. No further
    recruitment will occur."	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
"by sponsor due to failure to recruit patients who had mild persistent asthma who were not
    already on Advair 250/50 or 500/50."	['Insufficient_Enrollment']	['Neutral']
"After review of safety events and have decided that further dose escalation of MEDI-507 as a
    single agent is not feasible."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
waiting on surgeon training	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
"Estimated Primary Completion Date: March 2017 (Final data collection date for primary outcome
    measure)"	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
scientific question reconsidered	['Ethical_Reason', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
CRP is no longer SOC - enrollment halted and will analyze available data.	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
lack of efficacy in Multiple myeloma	['Negative']	['Negative']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
"DSMC acknowledged no safety concerns with the trial, recommending that the trial be terminated
    due to slow enrollment"	['Insufficient_Enrollment']	['Neutral']
One of the investigators left the Institution	['Study_Staff_Moved']	['Neutral']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
The study was stopped due to low enrollment	['Insufficient_Enrollment']	['Neutral']
No patients have been recruited therefore study has been cancelled	['Insufficient_Enrollment']	['Neutral']
clinical trial have encountered difficulties enrolling a sufficient number of patients	['Insufficient_Enrollment']	['Neutral']
Enrollment is temporarily suspended due to COVID-19	['Covid19']	['Neutral']
Strategic decision unrelated to safety or efficacy	['Business_Administrative']	['Possibly_Negative']
Failure to recruit	['Insufficient_Enrollment']	['Neutral']
study on hold for an undetermined time	['Invalid_Reason']	['Invalid_Reason']
Lack of patient accruals.	['Insufficient_Enrollment']	['Neutral']
The development was stopped due to company's strategy consideration	['Business_Administrative']	['Possibly_Negative']
"Patient enrollment impacted by COVID-19 pandemic and other business challenges. Patient
    enrollment discontinued, but follow-ups will continue according to protocol."	['Covid19']	['Neutral']
This study was terminated due to the decrease in percentage of participants.	['Insufficient_Enrollment']	['Neutral']
Some of the researchers finished their participation in the study.	['Study_Staff_Moved', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Study was not renewed during annual Northwestern Cancer Center review.	['Interim_Analysis', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Contract issues	['Business_Administrative']	['Possibly_Negative']
Ran out of funding.	['Business_Administrative']	['Possibly_Negative']
The device did not provide sufficient quality of data	['Logistics_Resources']	['Neutral']
Slow recruitment; trial unlikely to reach completion	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
"Study had completed enrollment but drug injection was halted due to an unacceptable incidence
    of rash."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Withdrawn due to drug toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Enrollment was too slow.	['Insufficient_Enrollment']	['Neutral']
Logistic problems with adequately timely organ collection and transport	['Logistics_Resources']	['Neutral']
Funding ended for the study	['Business_Administrative']	['Possibly_Negative']
Interim analysis	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
Lack of patient recruitment.	['Insufficient_Enrollment']	['Neutral']
The corona virus pandemic_UK national lockdown	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
One grade 4 adverse event (AE) and common (47.2%) grade 3 AEs	['Safety_Sideeffects', 'Endpoint_Met', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Due to COVID-19	['Covid19']	['Neutral']
Study was not initiated.	['Invalid_Reason']	['Invalid_Reason']
new competing studies	['Negative', 'Another_Study']	['Negative', 'Neutral']
Interim analysis	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
unable to recruit sufficient patients to satisfy study protocols	['Insufficient_Enrollment']	['Neutral']
because of safety concerns the study was terminated prematurely	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Study termination due to efficacy results of another study	['Negative', 'Another_Study']	['Negative', 'Neutral']
The study itself was Disapproved on 04/20/2018 and will not be moving forward.	['Invalid_Reason']	['Invalid_Reason']
"Novartis has acquired the rights to ofatumumab and terminated the OPV116910 and OPV117059
    studies. This decision is not linked to any safety consideration."	['Business_Administrative']	['Possibly_Negative']
PI Left Insitution - study no RCT	['Study_Staff_Moved']	['Neutral']
No funding - program closure	['Business_Administrative']	['Possibly_Negative']
"The protocol has been completed prematurely (e.g., due to poor accrual, insufficient drug
    supply, IND closure)."	['Insufficient_Enrollment']	['Neutral']
Study drug supply expired and could not be renewed.	['Logistics_Resources']	['Neutral']
Primary endpoint could no longer be reached.	['Interim_Analysis', 'Logistics_Resources', 'Endpoint_Met']	['Neutral', 'Neutral', 'Neutral']
Regulatory Review needed	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
FDA hold on the project	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
PI left center	['Study_Staff_Moved']	['Neutral']
"The target population with available genotype traveled outside study area and study duration of
    19 weeks was long for some participants."	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Change in study design	['Study_Design']	['Neutral']
Funding was never granted for this study. No participants were ever enrolled.	['Business_Administrative']	['Possibly_Negative']
insufficient number of participants met the enrollment criteria.	['Insufficient_Enrollment']	['Neutral']
Loss of funding	['Business_Administrative']	['Possibly_Negative']
no regulatory approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
IND approval from FDA was rejected and IRB approval was never granted.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The patients were discharged on the day of the surgery.	['Invalid_Reason']	['Invalid_Reason']
Business Decision	['Business_Administrative']	['Possibly_Negative']
Rate of cure was higher than expected, IRB suspended for no additional benefit	['Negative']	['Negative']
affiliation's change of the principal investigator need a new review bord	['Logistics_Resources', 'Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
40 patients	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Enrolment difficulties	['Insufficient_Enrollment']	['Neutral']
No difference in primary outcomes at interim analysis.	['Negative']	['Negative']
insufficient funds	['Business_Administrative']	['Possibly_Negative']
"The study was terminated because preliminary PK and overall clinical data demonstrated
    compelling similarity between Western and Asian participant populations."	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
sufficient mature data to complete a final analysis	['Invalid_Reason']	['Invalid_Reason']
Withdrawn due to the local Radiation Safety Committee refusing to approve it.	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Inability to reach desired recruitment goal; Sponsor executed other RCTs	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
GLP-2 Drug product stability concerns	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Study terminated due to resources	['Logistics_Resources']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
PI left the institution	['Study_Staff_Moved']	['Neutral']
Investigator left NIH	['Study_Staff_Moved']	['Neutral']
Terminated due to poor accrual.	['Insufficient_Enrollment']	['Neutral']
Change of company's strategy	['Business_Administrative']	['Possibly_Negative']
Limited number of patients	['Insufficient_Enrollment']	['Neutral']
The grant application for this project was rejected.	['Business_Administrative']	['Possibly_Negative']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Closed due to low enrollment	['Insufficient_Enrollment']	['Neutral']
Due to the COVID-19 situation, it was not feasible to complete the study in our ICU.	['Covid19']	['Neutral']
Not active	['Invalid_Reason']	['Invalid_Reason']
The study is being terminated early as a result of the coronavirus (COVID-19) outbreak.	['Covid19']	['Neutral']
Insufficient accrual	['Insufficient_Enrollment']	['Neutral']
no Canadian centre interested in conducting study in a reasonable timeframe	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Not NIH defined clinical trial study	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
Inadequate recruitment of study subjects and inadequate retention.	['Insufficient_Enrollment']	['Neutral']
Company decided to discontinue trial to focus on development program next steps	['Business_Administrative']	['Possibly_Negative']
Initial results did not show benefit.	['Negative']	['Negative']
Bristol-Myers Squibb company terminated this study	['Business_Administrative']	['Possibly_Negative']
inclusion difficulty	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
recruitment problems	['Insufficient_Enrollment']	['Neutral']
Difficulty in enrolling patients	['Insufficient_Enrollment']	['Neutral']
"The target drug, dovitinib, failed as a single agent in prior studies in patients with heavily
    treated multiple myeloma."	['Negative', 'Another_Study']	['Negative', 'Neutral']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
short of enrollment	['Insufficient_Enrollment']	['Neutral']
"Microbiological findings of resistance on therapy in patients with complicated urinary tract
    infection"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Slow accrual rate	['Insufficient_Enrollment']	['Neutral']
Slow enrollment of eligible subjects	['Insufficient_Enrollment']	['Neutral']
PI Transferred	['Study_Staff_Moved']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Medtronic made a business decision to discontinue the study and withdraw the IDE.	['Business_Administrative']	['Possibly_Negative']
Lower than anticipated enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsor election	['Business_Administrative']	['Possibly_Negative']
Study completed	['Invalid_Reason']	['Invalid_Reason']
Logistics reason at the data collection site	['Logistics_Resources']	['Neutral']
Unable to recruit participants for this study	['Insufficient_Enrollment']	['Neutral']
Logistics	['Logistics_Resources']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
This study did not accrue any subjects and due to this will be closed.	['Insufficient_Enrollment']	['Neutral']
Principal Investigator has left the institution.	['Study_Staff_Moved']	['Neutral']
Pharmaceutical company did not decide to renew contract	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
no adequate recruitment	['Insufficient_Enrollment']	['Neutral']
Device for multi coil TMS no longer supported	['Covid19', 'Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Inability to achieve primary or secondary study objectives	['Negative']	['Negative']
"This is no longer considered a clinical trial as per the Kantonial Ethics Committee in Zurich,
    CH"	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
"uniQure, has decided not to renew the Marketing Authorization of Glybera in the EU. This
    decision is not related to any safety, efficacy or quality issue"	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Technical problems with protocol.	['Logistics_Resources']	['Neutral']
Lack of funding, departure of key personnel	['Business_Administrative']	['Possibly_Negative']
Investigator left institution	['Study_Staff_Moved']	['Neutral']
Difficulty recruiting qualified subjects.	['Insufficient_Enrollment']	['Neutral']
very poor enrollment	['Insufficient_Enrollment']	['Neutral']
36 months follow up without change to profile. No further studies planned.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
We did not receive proper funding to complete this study	['Business_Administrative']	['Possibly_Negative']
Slow enrolment and end of funding	['Insufficient_Enrollment']	['Neutral']
All Clinical Trials at Univ Oregon halted due to COVID-19 pandemic	['Covid19']	['Neutral']
Funding unavailable	['Business_Administrative']	['Possibly_Negative']
The study was stopped due to insufficient numbers of subjects to meet study design objectives.	['Insufficient_Enrollment']	['Neutral']
Lack of Enrollment	['Insufficient_Enrollment']	['Neutral']
Business objectives have changed	['Business_Administrative']	['Possibly_Negative']
too few participans available	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Study performed in alternative location (Beijing China)	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Study objectives met	['Invalid_Reason']	['Invalid_Reason']
Inability to complete study according to protocol	['Insufficient_Enrollment']	['Neutral']
The recruitment site changed their admission policy to only more severely affected patients.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Clinical evaluation plan outdated and obsolete due to altered clinical routine	['Study_Design']	['Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Study ended after review	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
The study was terminated early due to lack of accrual.	['Insufficient_Enrollment']	['Neutral']
Modifications will be necessary before full IRB approval will be secured.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Inability to timely enroll.	['Insufficient_Enrollment']	['Neutral']
The study was halted due to logistical reasons.	['Logistics_Resources']	['Neutral']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
not enough funding to complete the project as planned	['Business_Administrative']	['Possibly_Negative']
Logistics of study did not allow for consistent data collection	['Logistics_Resources']	['Neutral']
recruitment futility	['Negative']	['Negative']
Safety	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Funding ended prematurely	['Business_Administrative']	['Possibly_Negative']
Insufficient resources at test site for recruitment.	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Study was stopped terminated early due to low recruitment.	['Insufficient_Enrollment']	['Neutral']
due to COVID-19	['Covid19']	['Neutral']
former PI left institute	['Study_Staff_Moved']	['Neutral']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsor Withdrawal	['Business_Administrative']	['Possibly_Negative']
Not reveal any significant difference between the 2 treatment arms	['Negative']	['Negative']
Slow recruitment (preemptive treatment of gurglers, after association was published)	['Insufficient_Enrollment']	['Neutral']
recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Study was previously suspended and is now terminated	['Invalid_Reason']	['Invalid_Reason']
"Administrative closure 9/22/2006. Decline in enrollment at CHOP. due to competing protocols
    with new agents."	['Business_Administrative']	['Possibly_Negative']
No source of funding to implement the study.	['Business_Administrative']	['Possibly_Negative']
difficulty recruiting patients	['Insufficient_Enrollment']	['Neutral']
"PK results demonstrate low and variable plasma concentrations so that achieving therapeutic
    concentrations is unlikely."	['Negative']	['Negative']
No eligible participants were recruited	['Insufficient_Enrollment']	['Neutral']
Recruiting and financial constraints	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Protocol Expired. Terminated by IRB	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
PI not longer at site.	['Study_Staff_Moved']	['Neutral']
Due to the very low inlcusion rate and the current COVID-19 pandemic.	['Covid19']	['Neutral']
"Enrolment stopped on December 01, 2014 since after 3 years, only 13 patients were included
    (instead of 274) (Date of last visit last patient : October 3, 2013)."	['Insufficient_Enrollment']	['Neutral']
"To be compliant with the timelines as agreed with Paediatric Committee (PC) within the
    Paediatric Investigational Plan"	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Terminated early, endorsed by the FDA based on futility of continuation.	['Negative']	['Negative']
The study was terminated due to lack of recruitment.	['Insufficient_Enrollment']	['Neutral']
"""Owing to the Covid-19 epidemics and in the application of guidelines, inclusions have been
    suspended in the ROBOTNOL research on March 26th 2021 for an undetermined period of time."""	['Covid19']	['Neutral']
Delay in patient enrolment	['Insufficient_Enrollment']	['Neutral']
Futility in patient enrollment	['Negative']	['Negative']
personal changes in study team	['Study_Staff_Moved']	['Neutral']
Difficulties in recruiting	['Insufficient_Enrollment']	['Neutral']
Two authors changed their jobs.	['Study_Staff_Moved']	['Neutral']
"The correlation coefficient at the interim analysis with results for all three groups pooled,
    did not reach the level of statistical significance of (p<0.05)."	['Negative']	['Negative']
"Based on the outcome of the planned first interim analysis, it was decided not to continue the
    trial. No safety concerns were identified."	['Negative']	['Negative']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
PI left institution and no subjects enrolled.	['Study_Staff_Moved']	['Neutral']
Lack of efficacy	['Negative']	['Negative']
Staff no longer available.	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
"The decision to terminate has been taken by the Sponsor. The decision is not due to safety
    concerns but reflects business prioritizations of the company."	['Business_Administrative']	['Possibly_Negative']
We did not receive grant funding. We will reapply in June of 2020	['Business_Administrative']	['Possibly_Negative']
PI was unable to perform ultrasound of airway.	['Logistics_Resources']	['Neutral']
due to poor accrual	['Insufficient_Enrollment']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Due to potential concerns about liver safety (See Detailed Description)	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Recruitment was too difficult	['Insufficient_Enrollment']	['Neutral']
"Abbott has decided to stop selling the Absorb stent which was the product under evaluation in
    this study."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Funding was not approved	['Business_Administrative']	['Possibly_Negative']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
closed without enrollment	['Insufficient_Enrollment']	['Neutral']
Recruitment of participants did not commence due to lack of available staff to run the trial.	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
funding and personnel are lack.	['Business_Administrative']	['Possibly_Negative']
This study was terminated due to lack of efficacy	['Negative']	['Negative']
low enrollment; principal investigator left sponsoring institution	['Insufficient_Enrollment']	['Neutral']
poor recruitment	['Insufficient_Enrollment']	['Neutral']
Protocol changes	['Study_Design']	['Neutral']
Inability to recruit patients sufficiently	['Insufficient_Enrollment']	['Neutral']
Decision to not gather further data	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Sponsor decision to cancel TRIAL, not related to safety concern.	['Business_Administrative']	['Possibly_Negative']
Study ended due to difficulties in recruitment and low enrollment.	['Insufficient_Enrollment']	['Neutral']
Samuel Sigal no longer with NYU	['Study_Staff_Moved']	['Neutral']
"Withdrawn [COVID restrictions prevent patient enrollment or treatment. Clinical Trial facility
    is being closed due to viral limitations and loss of staff to perform]"	['Covid19']	['Neutral']
Final cost of study medication was significantly greater than initial estimate,	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Futility	['Negative']	['Negative']
Technical problems with the device	['Logistics_Resources']	['Neutral']
Change in availability of investigators/participants	['Insufficient_Enrollment']	['Neutral']
Trial never opened.	['Invalid_Reason']	['Invalid_Reason']
sponsor decides to suspend this trial	['Business_Administrative']	['Possibly_Negative']
"Study progress very slow therefore terminated as other projects underway to investigate the
    same research question which will deliver results earlier"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Decided not pursue the study	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Difficulty enrolling; competing industry-funded multi-center clinical trial	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
The study was stopped due to an unanticipated serious adverse event.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Study registered elsewhere and is not covered by FDA	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
No subjects were enrolled. Study team was not able to grow cell lines for the tumors.	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
insufficient number of eligible subjects	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Unexpected poor enrollment	['Insufficient_Enrollment']	['Neutral']
Inability to recruit eligible subjects	['Insufficient_Enrollment']	['Neutral']
difficulties to recruit patients	['Insufficient_Enrollment']	['Neutral']
Lack of efficacy with one month of treatement	['Negative']	['Negative']
Study was withdrawn due to challenges in site recruitment and lack of patient enrollment	['Insufficient_Enrollment']	['Neutral']
IDMC recommendation. Unexpectedly high use of concomitant corticosteroid treatment.	['Safety_Sideeffects', 'Study_Design', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Organization has withdrawn their 510k submission and stopped the study	['Business_Administrative']	['Possibly_Negative']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
"Due to instillation site of the cortisone and the development of the related SARS-Cov2
    infection, it was preferred to terminate the trial and develop it again without beclomethasone"	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
The study is out of date	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
P.I. left University. Study terminated	['Study_Staff_Moved']	['Neutral']
Suspended since april 2020 as the application is temporarily unavailable	['Business_Administrative']	['Possibly_Negative']
Renal denervation has not been used as clinical method in our hospital the last two years	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
"An interim analysis was conducted in May-2014. Upon review of the data, the committee
    recommended study termination due to futility."	['Negative']	['Negative']
because of a lack of funding	['Business_Administrative']	['Possibly_Negative']
Covid-19	['Covid19']	['Neutral']
Study is replaced by MI-CP198 per CPM.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Inability to recruit study participants	['Insufficient_Enrollment']	['Neutral']
"Change in benefit-risk profile for individuals with early sporadic Alzheimer Disease because of
    elevations in liver enzymes in subjects receiving atabecestat"	['Safety_Sideeffects', 'Negative']	['Safety_Sideeffects', 'Negative']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
"Sponsor made the decision to terminate the DUETTE study based on the interim analysis of the
    VIOLETTE study (NCT03330847) investigating the combination of ceralasertib and Olaparib, where
    study closure was recommended due to insufficient efficacy."	['Negative', 'Another_Study']	['Negative', 'Neutral']
change in the business strategy of the sponsor	['Business_Administrative']	['Possibly_Negative']
Not to expose the patients to subtherapeutic dose	['Study_Design']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
efficacy interim analysis as per protocol	['Negative']	['Negative']
exposure to radiation due to repetitive PET evaluation	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Closed by sponsor	['Business_Administrative']	['Possibly_Negative']
Funding issues meant that development of the study was halted.	['Business_Administrative']	['Possibly_Negative']
Unable to complete accrual; elected to close the study in April 2008.	['Insufficient_Enrollment']	['Neutral']
Changes in staffing, original PI no longer at our institution.	['Study_Staff_Moved']	['Neutral']
Lack of eligible patient recruits/feasibility considerations.	['Insufficient_Enrollment']	['Neutral']
Not adequate enrollment (sample size not possible to reach)	['Insufficient_Enrollment']	['Neutral']
Study halted due to futility	['Negative']	['Negative']
study protocol changed	['Study_Design']	['Neutral']
Re-evaluation of amount of T Cell collection needed.	['Interim_Analysis', 'Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Difficulties of recruitment	['Insufficient_Enrollment']	['Neutral']
The study closed because of shifting research priorities and interests.	['Business_Administrative']	['Possibly_Negative']
futilty of the treatment	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
PI leaving facility	['Study_Staff_Moved']	['Neutral']
"Slow enrolment process and COVID situation worsened the situation. SIFI has developed a new
    product with probably a better performance. SIFI changed its marketing strategy and decided
    that Eyestil Protection will be not marketed anymore"	['Covid19', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Decision was taken by Wyeth Sr. Management to early terminate the 3100N7-210 study (terminate
    enrollment but complete follow-up)."	['Business_Administrative']	['Possibly_Negative']
funding channel amended by UK department of health	['Business_Administrative']	['Possibly_Negative']
The study has been halted due to the low enrolment rate.	['Insufficient_Enrollment']	['Neutral']
Unable to continue study following Hurricane Ike.	['Covid19', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
The study terminated for safety reasons.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
due to futility	['Negative']	['Negative']
This study has been terminated because of insufficient patient recruitment.	['Insufficient_Enrollment']	['Neutral']
"The trial was comprised of two parts. After the first part we could repudiate our hypothesis.
    Thus, no reason to carry on with the second part of the trial."	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
Completed	['Invalid_Reason']	['Invalid_Reason']
all active subjects rolled into 209FX303/NCT01013480	['Invalid_Reason', 'Negative', 'Another_Study']	['Invalid_Reason', 'Negative', 'Neutral']
Study has not yet been approved by the local IRB in Guinea Bissau.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Inability to recruit patients meeting eligibilty criteria.	['Insufficient_Enrollment']	['Neutral']
slow enrollment, and unusable data	['No_Context', 'Logistics_Resources', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
recrution number was not reached	['Insufficient_Enrollment']	['Neutral']
COVID-19 - pause in in-person enrollment; follow-up by phone continuing	['Covid19']	['Neutral']
The study team was unable to secure sufficient funding and administrative support.	['Business_Administrative']	['Possibly_Negative']
Terminated	['Invalid_Reason']	['Invalid_Reason']
Sponsor elected not to conduct study at this time.	['Business_Administrative']	['Possibly_Negative']
Lack of interest and support	['Business_Administrative']	['Possibly_Negative']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
Poor recruitment, trial terminated	['Insufficient_Enrollment']	['Neutral']
protocol design	['Study_Design']	['Neutral']
End of Agreement between BMS and SGHL	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Shift in department's research interests	['Logistics_Resources', 'Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
No subjects were enrolled.	['Insufficient_Enrollment']	['Neutral']
The original PI, Alexander Neumeister, left NYULMC. No data was analyzed.	['Study_Staff_Moved']	['Neutral']
Lack of participants and funding support	['Business_Administrative']	['Possibly_Negative']
technical problem	['Logistics_Resources']	['Neutral']
High number of screen failures-couldn't find qualified subjects in timely manner	['Insufficient_Enrollment']	['Neutral']
Unable to recruit sufficient participants	['Insufficient_Enrollment']	['Neutral']
Principle Investigator retired, Resident moved away	['Study_Staff_Moved']	['Neutral']
Unable to enroll enough patients	['Insufficient_Enrollment']	['Neutral']
Inability to recruit adequate number of patients	['Insufficient_Enrollment']	['Neutral']
"The EC withdrawn the approval becuase of possible conflicts of interests between our Institute
    and Supporter (Celgene)"	['Business_Administrative']	['Possibly_Negative']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
Due to COVID-19	['Covid19']	['Neutral']
Slow accrual due to practice changes meant study would take too long to finish	['Insufficient_Enrollment']	['Neutral']
too few subjects enrolled	['Insufficient_Enrollment']	['Neutral']
Boehringer Ingelheim is discontinuing their volasertib development program	['Business_Administrative']	['Possibly_Negative']
No study funding available.	['Business_Administrative']	['Possibly_Negative']
Withdrawn due to poor/low accrual	['Insufficient_Enrollment']	['Neutral']
Personnel changes	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
the Principal Investigator left the institution	['Study_Staff_Moved']	['Neutral']
Site chose to close due to lack of enrollment	['Insufficient_Enrollment']	['Neutral']
DSMB recommendation; enrollment too slow	['Insufficient_Enrollment']	['Neutral']
PI left the University, sponsor pulled funding	['Business_Administrative']	['Possibly_Negative']
Technical problem with device in study	['Logistics_Resources']	['Neutral']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
On hold due to poor enrollment and high drop-out rate.	['Insufficient_Enrollment']	['Neutral']
No significant change for the primary objective at 12 months	['Negative']	['Negative']
Funding issues.	['Business_Administrative']	['Possibly_Negative']
Based on lack of efficacy in PAI2003, sponsor made the decision to discontinue the trial.	['Negative']	['Negative']
Difficult accrual	['Insufficient_Enrollment']	['Neutral']
Stopped for futility. Phase 3 studies not likely to meet primary endpoints.	['Negative']	['Negative']
not started due to regulatory reasons	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study was cancelled prior to enrolling any patients	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Unacceptable Neurotoxicity (2 cases)	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
lack of efficacy (intermediate analysis)	['Negative']	['Negative']
Study was recently terminated due to poor enrollment - never enrolled.	['Insufficient_Enrollment']	['Neutral']
procedure no longer being done	['Study_Design']	['Neutral']
"In accordance with protocol's predefined criteria and Data Monitoring Committee recommendation
    due to insufficient level of efficacy"	['Negative']	['Negative']
PI closed lab	['Study_Staff_Moved']	['Neutral']
PI left JHU and is not able to be reached for updates	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
Study was terminated according the study protocol end of 2007	['Invalid_Reason']	['Invalid_Reason']
poor enrollment, availability of more effective medications	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Slower than planned recruitement	['Insufficient_Enrollment']	['Neutral']
suspended pending data analysis	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
Another study has been planned, so we did not initiate this one.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Inability to recruit participants since H1N1 epidemic resolved.	['Insufficient_Enrollment']	['Neutral']
unable to enroll patient population	['Insufficient_Enrollment']	['Neutral']
See the termination reason in detailed description.	['No_Context']	['Invalid_Reason']
The study was discontinued prematurely by the sponsor due to a lack of recruitment.	['Insufficient_Enrollment']	['Neutral']
PI left JHU and is not able to be reached for updates	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
"Emerging GSK1322322 pre-clinical data ID'd potentially reactive metabolites previously not seen
    that changed the risk: benefit profile and led to a termination"	['Success', 'Endpoint_Met', 'Negative']	['Success', 'Neutral', 'Negative']
Investigator leaving institution	['Study_Staff_Moved']	['Neutral']
Zone Labs, Inc discontinue utilizing their fish oil supplement and frozen foods	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Low recruitment rate due to treatment regimen change	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
run out of independent funding	['Business_Administrative']	['Possibly_Negative']
Intepirdine did't meet primary efficacy endpoints in lead-in study RVT-101-3001	['Negative', 'Another_Study']	['Negative', 'Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Updating study protocol, consent form and study SOP's and personnel training	['Study_Design']	['Neutral']
Low rythm of inclusions, financial support terminated	['Business_Administrative']	['Possibly_Negative']
Sponsor terminated due to budgetary issue	['Business_Administrative']	['Possibly_Negative']
Covid restrictions	['Covid19']	['Neutral']
reason of halt prematurely: futility of the trial	['Negative']	['Negative']
Lack of efficacy on olaratumab	['Negative']	['Negative']
Study withdrawn due to lack of recruitment. No patients enrolled. No safety concerns.	['Insufficient_Enrollment']	['Neutral']
Slow accrual; resource re-allocation	['Insufficient_Enrollment']	['Neutral']
Terminated for lack of patient samples and funding	['Business_Administrative']	['Possibly_Negative']
"Stop date for randomization: 31/5/2012. Recruitment terminated due to lack of recruitment. No
    new safety issues were identified."	['Insufficient_Enrollment']	['Neutral']
Lost funding	['Business_Administrative']	['Possibly_Negative']
"Preliminary analysis of accrued data failed to indicate any meaningful pharmacodynamic
    response."	['Negative']	['Negative']
competitor study about to start	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Insufficient funding	['Business_Administrative']	['Possibly_Negative']
low recruitment	['Insufficient_Enrollment']	['Neutral']
Insufficient funding was available and the study could not be started.	['Business_Administrative']	['Possibly_Negative']
This study was never funded, never fully IRB approved, and thus never enrolled anyone.	['Business_Administrative']	['Possibly_Negative']
Investigator discretion due to lack of efficacy in three subjects enrolled	['Negative']	['Negative']
Inability to enroll patients at anticipated rate.	['Insufficient_Enrollment']	['Neutral']
Business Decision	['Business_Administrative']	['Possibly_Negative']
end of contract negociations	['Business_Administrative']	['Possibly_Negative']
"The study design will need to be changed completely becasue of the change of research interest.
    We have decided to withdraw the study."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The recruitment process is affected by the coronavirus pandemic.	['Covid19', 'Safety_Sideeffects', 'Insufficient_Enrollment']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Study on hold since 2009. Awaiting FDA approval of Sugammdex to complete second arm of study.	['No_Context', 'Regulatory', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
To focus on another clinical indication.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Safety Issue	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Changes in the sponsorship, design and locations of the study	['Business_Administrative']	['Possibly_Negative']
"This study was terminated due to slow enrollment, despite protocol amendments to change the
    entrance criteria."	['Insufficient_Enrollment']	['Neutral']
Completed very similar study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Subject withdrew	['Invalid_Reason']	['Invalid_Reason']
Lack of funds	['Business_Administrative']	['Possibly_Negative']
"Study overall progress behind of scheduled timeline. Study was terminated early due to company
    decision."	['Business_Administrative']	['Possibly_Negative']
"Unable to complete initial data collection due to tornado and then COVID-19 has limited in
    person data collection/intervention."	['Covid19']	['Neutral']
IRB disapproval	['Regulatory', 'Ethical_Reason', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
limited enrollment	['Insufficient_Enrollment']	['Neutral']
Temporarily suspended due to COVID-19	['Covid19']	['Neutral']
Lack of funds	['Business_Administrative']	['Possibly_Negative']
"The study was stopped early due to increased global access to genomic screening. It is no
    longer economical to continue with this particular single-gene screening protocol."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
images obtained were non-diagnostic	['Negative']	['Negative']
COVID-19 pandemic restrictions for data collection	['Covid19']	['Neutral']
"Collaboration with PI left university and study will potentially resume when collaborators are
    identified"	['Study_Staff_Moved']	['Neutral']
It's not possible to complete in our hospital.	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Halted because of slow accrual and lack of study funding	['Insufficient_Enrollment']	['Neutral']
safety and efficacy reason	['Interim_Analysis', 'Safety_Sideeffects', 'Endpoint_Met']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Sponsor decision.	['Business_Administrative']	['Possibly_Negative']
Unable to recruit eligible subjects for the trial.	['Insufficient_Enrollment']	['Neutral']
"This study was closed for the reason of slow recruitment with only 16% of the target subjects
    recruited over a 29 month period."	['Insufficient_Enrollment']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Study closed due to lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Due to on-going enrollment challenges	['Insufficient_Enrollment']	['Neutral']
Electrical device malfunction; recruitment was stopped.	['Logistics_Resources']	['Neutral']
Unable to receive additional approvals required	['Regulatory', 'Invalid_Reason', 'Negative']	['Neutral', 'Invalid_Reason', 'Negative']
Ran out of funds	['Business_Administrative']	['Possibly_Negative']
Futility	['Negative']	['Negative']
PI left the institution	['Study_Staff_Moved']	['Neutral']
Study was completed in another site	['No_Context', 'Insufficient_Enrollment', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
Failure to have funding to perform the trial	['Business_Administrative']	['Possibly_Negative']
Study could not be run for logistical reasons	['Logistics_Resources']	['Neutral']
Contract terminated with Site Management Organization	['Business_Administrative']	['Possibly_Negative']
termination because of low accrual; four subjects enrolled and four screen failures.	['Insufficient_Enrollment']	['Neutral']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
"Revisiting the availability of patients with Ph+ ALL that would meet the in-/exclusion criteria
    of the study led to the decision not to move forward."	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
"Novartis has have decided to terminate all clinical investigator-initiated research projects
    involving aliskiren"	['Business_Administrative']	['Possibly_Negative']
lapse in IRB review	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Didn't have funding to support the study design	['Business_Administrative']	['Possibly_Negative']
Never Activated	['Invalid_Reason']	['Invalid_Reason']
company decision to suspend project	['Business_Administrative']	['Possibly_Negative']
Awaiting funding	['Business_Administrative']	['Possibly_Negative']
BioIncept changed the focus of future drug development	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Insufficient enrollment.	['Insufficient_Enrollment']	['Neutral']
Not funded	['Business_Administrative']	['Possibly_Negative']
promoter decision	['Business_Administrative']	['Possibly_Negative']
Covid 19 pandemic, will restart in the future	['Covid19']	['Neutral']
Principal Investigator relocated to another institution	['Study_Staff_Moved']	['Neutral']
Difficulty getting radiation therapy for patients and Low enrollment number	['Insufficient_Enrollment']	['Neutral']
Due to slow recruitment and recent new published data	['Negative', 'Another_Study']	['Negative', 'Neutral']
Development of CDX-014 discontinued	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Business decision	['Business_Administrative']	['Possibly_Negative']
IRB expired	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
slow enrollment and change in product development strategy	['Insufficient_Enrollment']	['Neutral']
because of corona virus epidemic	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
The study was terminated early due to slow and insufficient total enrollment.	['Insufficient_Enrollment']	['Neutral']
No subject accrual	['Insufficient_Enrollment']	['Neutral']
"The study terminated before Phase 1 was completed. This study was reprioritized within the
    rociletinib development program."	['Business_Administrative']	['Possibly_Negative']
Device demonstrated to be less effective than the control mask in reducing leak	['Negative']	['Negative']
Participants were consented but registry was not developed due to low numbers	['Insufficient_Enrollment']	['Neutral']
Development of this compound was discontinued.	['Business_Administrative']	['Possibly_Negative']
sufficient data gathered to support conclusion	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Business Decision; Insufficient Enrollment	['Business_Administrative']	['Possibly_Negative']
Study halted prematurely, prior to enrollment of first participant	['Invalid_Reason']	['Invalid_Reason']
Data from other studies showed that study could not be completef successfully	['Negative', 'Another_Study']	['Negative', 'Neutral']
company decision	['Business_Administrative']	['Possibly_Negative']
Failure to meet enrollment	['Insufficient_Enrollment']	['Neutral']
Intepirdine did not meet its primary efficacy endpoints in the lead-in study RVT-101-2001.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Due to lack of sufficient efficacy.	['Negative']	['Negative']
The study was stopped due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
No adequate funding	['Business_Administrative']	['Possibly_Negative']
Enrollment Goal Not Met	['Insufficient_Enrollment']	['Neutral']
No funding obtained	['Business_Administrative']	['Possibly_Negative']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Funding constraints	['Business_Administrative']	['Possibly_Negative']
Enrolment slower than anticipated accrual.	['Insufficient_Enrollment']	['Neutral']
lack of resources	['Logistics_Resources']	['Neutral']
Trial operational issues.	['Logistics_Resources']	['Neutral']
"Study stopped to avoid treating enrolled subjects to hemoglobin levels higher than those
    specified in current labeling."	['Study_Design']	['Neutral']
low enrollment	['Insufficient_Enrollment']	['Neutral']
Terminated due to a lack of recruitment and decision by the PI not to continue.	['Insufficient_Enrollment']	['Neutral']
Management decision	['Business_Administrative']	['Possibly_Negative']
changes in study design by sponsor not acceptable for participating	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"The epidemic of COVID-19 has been controlled well at present, no eligible patients can be
    recruitted."	['Covid19']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
"BeiGene and Celgene Corporation terminated the parties' global collaboration for the compound,
    pending the acquisition of Celgene by Bristol Myers Squibb"	['Business_Administrative']	['Possibly_Negative']
"Anticipated number of patients not achieved. All Patients recruited in the study completed all
    study visits."	['Insufficient_Enrollment']	['Neutral']
strategy change	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
The study was stopped due to unbalanced side effects	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"In a pre-planned interim analysis, OSI-774-205 met futility for efficacy with no safety
    concerns. As a result, it has been stopped."	['Negative']	['Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
DSMB recommendation due to lack of efficacy. There were no safety signals.	['Negative']	['Negative']
equipment not functional	['Logistics_Resources']	['Neutral']
The study team decided not to pursue this study.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
on July 07, 2020 due to slow enrollment; there were no safety concerns.	['Insufficient_Enrollment']	['Neutral']
Study not funded	['Business_Administrative']	['Possibly_Negative']
Dr. Bello is no longer a PI at the institution. Data analysis was not completed.	['Study_Staff_Moved']	['Neutral']
Poor enrollment and advances in venoplasty only techniques of the femoral vein	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Very low recruitment	['Insufficient_Enrollment']	['Neutral']
Insufficient Recruitment	['Insufficient_Enrollment']	['Neutral']
Difficulty in recruiting patients who met the eligibility criteria.	['Insufficient_Enrollment']	['Neutral']
Based on interim analysis of results	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
withdrawal of support for drug supply	['Logistics_Resources']	['Neutral']
"Study was stopped early due to a greater than expected incidence of ocular AEs and analysis of
    the data from the first 4 subjects indicating that the likelihood of permanent remission with
    this therapy was low."	['Safety_Sideeffects', 'Endpoint_Met', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Principal Investigator Request	['Study_Staff_Moved', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Poor enrollment; PI left the institution	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description	['No_Context']	['Invalid_Reason']
Accrual too slow - would not enroll enough subjects to determine outcome	['Insufficient_Enrollment']	['Neutral']
Low accrual rate	['Insufficient_Enrollment']	['Neutral']
The 3rd interim analysis found superiority in the mesh reinforcement arm	['Success', 'No_Context', 'Logistics_Resources']	['Success', 'Invalid_Reason', 'Neutral']
Sponsor (Intelect Medical, Inc.) was acquired by Boston Scientific and study was canceled.	['Business_Administrative']	['Possibly_Negative']
The study design failed and the data was not able to be analyzed.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"At the end of the year 2002, Cameroon switched from chloroquine to amodiaquine as first-line
    therapy for of uncomplicated malaria."	['Study_Design']	['Neutral']
Never received funding.	['Business_Administrative']	['Possibly_Negative']
The study was stopped prior to 2nd stage.	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
Funding completed	['Business_Administrative']	['Possibly_Negative']
the pilot study (before the intervention) is completed.	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
Study futility with regards to recruitment	['Negative']	['Negative']
COVID-related restrictions on in-person participant contact	['Covid19']	['Neutral']
The ED physicians no longer prescribe opioids at discharge; not feasible to conduct the study	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Anticipated recruitment challenges	['Insufficient_Enrollment']	['Neutral']
it became clear that recruitment was infeasible	['Insufficient_Enrollment']	['Neutral']
Lack of study participants, no data published.	['Insufficient_Enrollment']	['Neutral']
Principal Investigator left the institution	['Study_Staff_Moved']	['Neutral']
Funding unavailable	['Business_Administrative']	['Possibly_Negative']
Trial terminated due to difficult recruitment	['Insufficient_Enrollment']	['Neutral']
"The protocol has undergone significant changes and the investigator feels that it is reasonable
    to submit a new protocol for review and approval."	['Study_Design']	['Neutral']
"Enrollment has temporarily paused due to COVID-19 and is expected to resume in the future; This
    is not a suspension of IRB approval"	['Covid19']	['Neutral']
Lack of efficacy	['Negative']	['Negative']
insufficient patient recruitement	['Insufficient_Enrollment']	['Neutral']
Per regulatory coordinator, the sponsor is no longer supporting the study.	['Business_Administrative']	['Possibly_Negative']
Unmasked without Sponsor's prior knowledge or authorization by the PI.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Inability to recruit patients into the study.	['Insufficient_Enrollment']	['Neutral']
side effect and poor clinical outcome	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Lack of recrual	['Insufficient_Enrollment']	['Neutral']
Study recruitment was suspended due to lack of funding	['Business_Administrative']	['Possibly_Negative']
Recruitment was stopped before the target sample size was achieved.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
COVID-19 Pandemic	['Covid19']	['Neutral']
No patients were enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"One of the both Funder partners decided to stop the study before the initiation : thus no
    product provided and no funding to realize the study"	['Business_Administrative']	['Possibly_Negative']
Study terminated due to tolerability issues.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"Outcome of EXPAND study (no benefit from adding cetuximab to the first-line chemotherapy in
    advanced gastric cancer in the overall patient population)"	['Negative', 'Another_Study']	['Negative', 'Neutral']
The lab was acquired by another company and has put this study's samples on hold.	['Business_Administrative']	['Possibly_Negative']
Terminated due to low enrollment	['Insufficient_Enrollment']	['Neutral']
Accrual issues - Low Accrual	['Insufficient_Enrollment']	['Neutral']
Parent Studies didn't meet their primary endpoint so study was terminated.	['Negative']	['Negative']
Overlapping with another danish questionnaire study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Low accrual.	['Insufficient_Enrollment']	['Neutral']
Business reasons not related to safety or trial conduct	['Business_Administrative']	['Possibly_Negative']
the Preliminary data, progress of this study and the adjustment of the pipeline and strategy .	['Interim_Analysis', 'Logistics_Resources', 'Endpoint_Met']	['Neutral', 'Neutral', 'Neutral']
due to irrelevancy of the idea given the advancement in the field and COVID-19 crisis	['Covid19']	['Neutral']
"Terminated early because similar study with Ataluren (PTC124-GD-007-DMD; NCT00592553) exhibited
    lack of efficacy at the high dose (not due to safety concerns)."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study did not open for enrollment.	['Insufficient_Enrollment']	['Neutral']
The study stopped early, before enrolling its first participant.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"In a pilot of early noninvasive positive pressure ventilation, the children did so well that
    early NPPV is now used in all children who meet criteria."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Not enough enrollment	['Insufficient_Enrollment']	['Neutral']
PI left the university.	['Study_Staff_Moved']	['Neutral']
Drugs unavailable	['Logistics_Resources']	['Neutral']
"This study has been terminated early as the esreboxetine development program is being
    discontinued. There are no safety or efficacy concerns."	['Business_Administrative']	['Possibly_Negative']
The study has stopped due to no patient enrollment unable to meet the study criteria	['Insufficient_Enrollment']	['Neutral']
"Results from trial in another population lead investigators to determine study outcome may not
    reach statistical significance."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Unable to commence study due to closure of hospital department.	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Unable to enroll subjects that fit study criteria.	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Ministry of Health in country did not authorized the conduct of the study	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
PI decided not to continue	['Invalid_Reason']	['Invalid_Reason']
decided not to go ahead with study at this time	['Invalid_Reason']	['Invalid_Reason']
To obtain funding for a larger study	['Business_Administrative']	['Possibly_Negative']
Loss of funding	['Business_Administrative']	['Possibly_Negative']
The study was closed due to the departure of several of the co-investigators.	['Study_Staff_Moved']	['Neutral']
The funding period ended.	['Business_Administrative']	['Possibly_Negative']
Sponsor business decision, not safety related	['Business_Administrative']	['Possibly_Negative']
There was no enrollment.	['Insufficient_Enrollment']	['Neutral']
Paused due to COVID-19. Expected to resume. Not a suspension of IRB approval.	['Covid19']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Slow Enrollment	['Insufficient_Enrollment']	['Neutral']
Unable to recruit due to COVID 19	['Covid19']	['Neutral']
Funding withdrawn; no participants enrolled.	['Business_Administrative']	['Possibly_Negative']
"Enrollment into this registry was not as robust as investigator envisioned. Thus, the registry
    was closed."	['Insufficient_Enrollment']	['Neutral']
Failure of Subject Recruitment	['Insufficient_Enrollment']	['Neutral']
Currently suspended due to Covid-19 policies.	['Covid19']	['Neutral']
Discontinued due to company's strategic reason	['Business_Administrative']	['Possibly_Negative']
interim analysis revealed it was futile, we would not reach an answer at N=60.	['Negative']	['Negative']
"The FDA changed the labeling for this agent, and we felt we could not offer it to patients on a
    non-surgical study."	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Lack of efficacy and enrollment	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
terminated due to failure to meet enrolment goals	['Insufficient_Enrollment']	['Neutral']
Recruitment failed	['Insufficient_Enrollment']	['Neutral']
Unable to meet enrollment goal	['Insufficient_Enrollment']	['Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
Slow enrollment, Feasibility issues	['Insufficient_Enrollment']	['Neutral']
PI Sabbatical	['Study_Staff_Moved']	['Neutral']
"Inability to recruit an adequate number of patients with stress urinary incontinence (based on
    inclusion / exclusion criteria) to participate in the study"	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
"Phase 1 completed. Phase 2 under consideration for commercial reasons (no safety related
    issues)"	['Business_Administrative']	['Possibly_Negative']
Measures are being taken to recruit a research scientist	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
"Due to recruiting problems and the introduction of new treatment strategies (ranibizumab and
    dexamethasone implant)."	['Study_Design']	['Neutral']
Logistical difficulties : protocol never finalized nor submitted	['Logistics_Resources']	['Neutral']
The study was terminated due to insufficient sample size and protocol compliance issue.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study terminated due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
stopped on Data Safety and Monitoring Board 's request	['Interim_Analysis', 'Safety_Sideeffects', 'Negative']	['Neutral', 'Safety_Sideeffects', 'Negative']
Difficulty recruiting subjects	['Insufficient_Enrollment']	['Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
No Accrual	['Insufficient_Enrollment']	['Neutral']
"Compound is not expected to change the current treatment practice or fill significant clinical
    need for patients in China over currently available EE agents."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Trial futility	['Negative']	['Negative']
Study was not funded, and therefore not conducted	['Business_Administrative']	['Possibly_Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Low Recruitment rate	['Insufficient_Enrollment']	['Neutral']
Early termination due to manufacturer discontinued supplying the product for the study.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
The person who started the study joined medical school	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Not feasible - RSA machine not available. RSA images needed for study endpoints	['Logistics_Resources']	['Neutral']
Not meeting primary objective of the study	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Business Decision; No Safety Concerns	['Business_Administrative']	['Possibly_Negative']
Similar study to be completd once kit for new formulation becomes available.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
Due to staff changes the study never started.	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
no patient accrual	['Insufficient_Enrollment']	['Neutral']
pts off study, PI left institute	['Study_Staff_Moved']	['Neutral']
Funding Issues	['Business_Administrative']	['Possibly_Negative']
no one enrolled; PI left institution	['Study_Staff_Moved']	['Neutral']
Resource allocation	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
We were unable to recruit participants to the study	['Insufficient_Enrollment']	['Neutral']
Insufficient recruitment/data collection	['Insufficient_Enrollment']	['Neutral']
due to a problem of device	['Logistics_Resources']	['Neutral']
Funding ended	['Business_Administrative']	['Possibly_Negative']
We could not find patients who agreed to enrolled this clinical study.	['Insufficient_Enrollment']	['Neutral']
The study was stopped because the study never received funding	['Business_Administrative']	['Possibly_Negative']
Registration is less	['Insufficient_Enrollment']	['Neutral']
Practices in surgery have evolved and the study has not interest yet	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Drug company decided to terminate all sponsored clinical studies involving rilotumumab.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
no funding	['Business_Administrative']	['Possibly_Negative']
Site was never activated by sponsor	['Business_Administrative']	['Possibly_Negative']
Insufficient dose for MRI scanning	['Logistics_Resources']	['Neutral']
"The study was terminated at median 46-48 months long term follow-up and mature overall survival
    follow-up data."	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Inclusion rate too low	['Insufficient_Enrollment']	['Neutral']
"Sponsor terminated RRMS studies as sufficient long term clinical data was collected for the
    study drug in the relevant dose"	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Covid-19	['Covid19']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Medication safety concern	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
none enrolled in second arm, therfore no analysis	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Logistic reasons associated with the FDA-imposed clinical hold.	['Logistics_Resources']	['Neutral']
Terminated due to lack of funding	['Business_Administrative']	['Possibly_Negative']
Part B was cancelled based on business decision	['Business_Administrative']	['Possibly_Negative']
The Sponsor has stopped responding to calls and emails	['Business_Administrative']	['Possibly_Negative']
Problem with IP supply	['Logistics_Resources']	['Neutral']
Funding ended	['Business_Administrative']	['Possibly_Negative']
PI decision	['Invalid_Reason']	['Invalid_Reason']
In agreement with FDA the study was terminated based on data available.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Terminated by sponsor due to general risk that aranesp caused tumor progression	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Too limited accrual	['Insufficient_Enrollment']	['Neutral']
Closed due to low enrollment	['Insufficient_Enrollment']	['Neutral']
Principal investigator was unable to fulfill his responsibilities.	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
This study was terminated after the sponsor withdrew our support	['Business_Administrative']	['Possibly_Negative']
Bayer Healthcare is no supplying the study drug	['Logistics_Resources']	['Neutral']
No recruitment	['Insufficient_Enrollment']	['Neutral']
due to COVID-19	['Covid19']	['Neutral']
MOR106 clinical development in atopic dermatitis was stopped for futility	['Negative']	['Negative']
Revision of study procedures	['Study_Design']	['Neutral']
Recruitment Rate too slow	['Insufficient_Enrollment']	['Neutral']
PI left University of Minnesota	['Study_Staff_Moved']	['Neutral']
COVID-19 pandemic	['Covid19']	['Neutral']
To rebalance the study plan because it is not desirable to set up comparators using placebo.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Poor recruitment and through put	['Insufficient_Enrollment']	['Neutral']
Recruitment problem	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
The post-treatment recurrence rate was expected to be different between two treatment groups.	['Safety_Sideeffects', 'Endpoint_Met', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
"Temporarily paused due to COVID-19 and expected to resume. This is not a suspension of IRB
    approval."	['Covid19']	['Neutral']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
Covid-19	['Covid19']	['Neutral']
"Due to poor enrollment sponsor terminated early after enrolling 9 in Cohort 1 and no enrollment
    in Cohorts 2 and 3."	['Insufficient_Enrollment']	['Neutral']
Subject population not available.	['Insufficient_Enrollment']	['Neutral']
Change of local requirements	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
"The technology planned to be used in the study got outdated and therefore the study will not be
    conducted according to the initial protocol."	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
study was not started	['Invalid_Reason']	['Invalid_Reason']
Lack of patients	['Insufficient_Enrollment']	['Neutral']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
"Substantial changes were made to the study protocol and a new ethics application will be
    submitted."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
feasability and recruitment issues	['Insufficient_Enrollment']	['Neutral']
Of the 8 histologically proven tumors, detection of PpIX proved to be ambiguous.	['Interim_Analysis', 'Safety_Sideeffects', 'Endpoint_Met']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Sponsor decision to end monotherapy development of the compound in breast cancer.	['Business_Administrative']	['Possibly_Negative']
Due to the investigator leaving the institution, the study was terminated	['Study_Staff_Moved']	['Neutral']
Withdrawn due to slow accrual	['Insufficient_Enrollment']	['Neutral']
DSMB recommendation for slow enrollment	['Insufficient_Enrollment']	['Neutral']
Withdrawn due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
Strategic decision unrelated to safety or efficacy	['Business_Administrative']	['Possibly_Negative']
PI left university	['Study_Staff_Moved']	['Neutral']
"financial assistance financial assistance financial assistance financial assistance financial
    assistance without financial assistance"	['Business_Administrative']	['Possibly_Negative']
"The data did not support study endpoints for acute cough, based on an interim efficacy
    analysis; not due to safety concerns."	['Negative']	['Negative']
Outcome measures for pre-intervention were much lower than anticipated.	['Negative']	['Negative']
Difficulty recruiting	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Sponsor decision for administrative reasons	['Business_Administrative']	['Possibly_Negative']
Study was never started because Dr. Hammerberg left before it could be started.	['Study_Staff_Moved']	['Neutral']
This study was suspended because there is no more funds to complete the study.	['Business_Administrative']	['Possibly_Negative']
Difficult to recruit participants	['Insufficient_Enrollment']	['Neutral']
"Edwards Lifesciences acquired Harpoon Medical in December 2017 and a decision has been made to
    close enrollment in the HMEFS-2000 protocol"	['Business_Administrative']	['Possibly_Negative']
Business decision to end study due to limited enrollment and study population	['Business_Administrative']	['Possibly_Negative']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
Doppler device company wanted hospital to stop recruiting	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Sponsor discretion determined no clinical benefit	['Negative', 'Business_Administrative']	['Negative', 'Possibly_Negative']
PI decided to revamp the protocol completely and will submit as new study.	['Study_Design']	['Neutral']
not able to recruit enough participants.	['Insufficient_Enrollment']	['Neutral']
study lacked funding to recruit	['Business_Administrative']	['Possibly_Negative']
"A significant local issue has to led to the suspension of recruitment, this study will be
    terminated in the coming months"	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Loss of funding	['Business_Administrative']	['Possibly_Negative']
Insufficient Accrual	['Insufficient_Enrollment']	['Neutral']
the study was early terminated due to lack of recruitment.	['Insufficient_Enrollment']	['Neutral']
Sponsor cancellation	['Business_Administrative']	['Possibly_Negative']
"Decision to discontinue due to challenges of trial design and constraints on enrolling eligible
    and consenting patients."	['Study_Design']	['Neutral']
Company decided not to pursue this study.	['Business_Administrative']	['Possibly_Negative']
Study was closed due to low accrual.	['Insufficient_Enrollment']	['Neutral']
Recuitment target non obtained	['Insufficient_Enrollment']	['Neutral']
Transitioned into a national study through ECOG	['Negative', 'Another_Study']	['Negative', 'Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
The present study was joining 2005-41-4933 into one study	['Negative', 'Another_Study']	['Negative', 'Neutral']
the PI is no longer work at Hadassah	['Study_Staff_Moved']	['Neutral']
funding application unsuccessful	['Business_Administrative']	['Possibly_Negative']
Principal investigator was unable to pursue research further due to time constraints.	['Business_Administrative']	['Possibly_Negative']
Resource availability	['Logistics_Resources']	['Neutral']
Study team was unable to effectively conduct the study.	['Logistics_Resources']	['Neutral']
"Budget not sufficient to cover the study scope proposed and recruitment rates expected to be no
    sufficient."	['Business_Administrative']	['Possibly_Negative']
low enrollment r/t requirement of prior treatment with denileukin diftitox	['Insufficient_Enrollment']	['Neutral']
Due to participant recruitment feasibility	['Insufficient_Enrollment']	['Neutral']
due to Sponsor's ongoing and upcoming projects and overall research priorities	['Business_Administrative']	['Possibly_Negative']
difficult recruitment and new black box warning for IVIG	['Insufficient_Enrollment']	['Neutral']
Study modified and has been running as CDR0000581286 instead.	['Covid19', 'Study_Design', 'Another_Study']	['Neutral', 'Neutral', 'Neutral']
Company decision to discontinue the study, not due to any safety or efficacy concerns	['Business_Administrative']	['Possibly_Negative']
Pre-specified futility boundary was reached.	['Negative']	['Negative']
drug cannot be prepared commercially	['Logistics_Resources']	['Neutral']
The supplies of study drug were halted by Gilead Sciences Ltd.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Compound recently partnered with another company for continued development.	['Business_Administrative']	['Possibly_Negative']
"Following the failure to demonstrate efficacy in EIG-UBX-001, the sponsor decided to terminate
    Study EIG-UBX-002."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Terminated by Sponsor	['Business_Administrative']	['Possibly_Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Temporarily paused due to COVID-19 and expected to resume. Not of IRB approval	['Covid19']	['Neutral']
A change in research priorities after a merger	['Business_Administrative']	['Possibly_Negative']
Moved to complete	['Invalid_Reason']	['Invalid_Reason']
Study was terminated due to difficulty in identifying eligible subjects	['Insufficient_Enrollment']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
PI no longer pursuing clinical trial	['Study_Staff_Moved', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Change in personnel leading to inability to conduct study.	['Logistics_Resources']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
"Covid 19 Break has caused the research to stop temporarily for safety of participants and
    conductors"	['Covid19']	['Neutral']
"The primary endpoint of non-inferiority to daily therapy in the pediatric Phase 3 study was not
    achieved"	['Negative']	['Negative']
"COVID-19 pandemic prevents patients from making in-hospital visits, which are mandatory to
    assessment of safety in this study"	['Covid19']	['Neutral']
Withdrawn: study halted prematurely, prior to enrollment of first participant	['Invalid_Reason']	['Invalid_Reason']
Withdrawn before IRB review. Investigator no longer working at facility.	['Study_Staff_Moved']	['Neutral']
no subjects enrolled	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
discontinuation of financial support	['Business_Administrative']	['Possibly_Negative']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Protocol not progressed. Study not implemented.	['Study_Design']	['Neutral']
Study had a high screen fail rate, enrollment was open over a year, only 3 completed.	['Insufficient_Enrollment']	['Neutral']
The patient's study enrollment was too low.	['Insufficient_Enrollment']	['Neutral']
Insufficient efficacy observed in study BCDM(NCT01198002) and BCDV(NCT01202773)	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study did not meet its primary objective	['Negative']	['Negative']
Two of the sites withdraw, did not have capacity to recruit patients	['Insufficient_Enrollment']	['Neutral']
Low accrual rate	['Insufficient_Enrollment']	['Neutral']
Souces of funding have been terminated	['Business_Administrative']	['Possibly_Negative']
"The study was terminated following assessment of the lack of efficacy of the study product by
    the Independent Data monitoring Committee for the study."	['Negative']	['Negative']
Terminated due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
COVID-19 pandemic	['Covid19']	['Neutral']
unable to develop a rapid & reliable assay to detect sulfide concentrations	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Team's request.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
PI left previous institution study will reopen at new institution.	['Study_Staff_Moved']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
"The primary trial was stopped. Since, a feasibility study showed that recruitment was not
    feasible. We obtain a recruitment rate of 15 %."	['No_Context', 'Logistics_Resources', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
difficultly recruiting	['Insufficient_Enrollment']	['Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Difficult accrual	['Insufficient_Enrollment']	['Neutral']
Administratively Complete	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor will discontinue further development of EMD 1201081	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"The device that was going to be studied was removed by Duke University shortly after the study
    was approved."	['Logistics_Resources', 'Study_Staff_Moved', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Study was discontinued due to lack of recruitment.	['Insufficient_Enrollment']	['Neutral']
Terminated due to study design changes; zero patients enrolled.	['Study_Design']	['Neutral']
Slow enrollment.	['Insufficient_Enrollment']	['Neutral']
no Financial agreement	['Business_Administrative']	['Possibly_Negative']
"This trial is being closed based on lack of substantive efficacy, slow accrual and overall
    tolerance in patients treated to date."	['Negative']	['Negative']
Interim analysis	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
No continued funding.	['Business_Administrative']	['Possibly_Negative']
This study never started enrolling participants due to lack of grant funding.	['Business_Administrative']	['Possibly_Negative']
Poor recruitment and change in development strategy	['Insufficient_Enrollment']	['Neutral']
Interim Analysis	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
"New data has caused the principal investigator to decide that the study no longer makes sense
    to conduct as it is designed. This is not a suspension of IRB approval."	['No_Context', 'Endpoint_Met', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
Principal Investigator left institution--no subjects completed the study	['Study_Staff_Moved']	['Neutral']
Sponsor terminated study due to lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Risk to benefit ratio is not acceptable	['Negative']	['Negative']
No actual DM	['Negative', 'Business_Administrative']	['Negative', 'Possibly_Negative']
no participants enrolled	['Insufficient_Enrollment']	['Neutral']
"The study was terminated by Spiracur (original sponsor). Efforts were made to contact the
    PI/study team members, but were unsuccessful."	['Business_Administrative']	['Possibly_Negative']
The study was discontinued early due to lack of funding and slow enrollment	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Decision not to pursue	['Business_Administrative']	['Possibly_Negative']
Principal Investigator left institution. IRB approval lapsed.	['Study_Staff_Moved']	['Neutral']
Low recruitment and difficulty in having study data	['Insufficient_Enrollment']	['Neutral']
Study abandoned.	['Invalid_Reason']	['Invalid_Reason']
COVID-19	['Covid19']	['Neutral']
administrative reason	['Business_Administrative']	['Possibly_Negative']
recruitment failure	['Insufficient_Enrollment']	['Neutral']
"we have found another marker (microRNA26) which is more sensitive to evaluate the effect of
    postoperative IFNa treatment in patients with HCC"	['Negative', 'Another_Study']	['Negative', 'Neutral']
delayed study start	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
major problems in recruiting patients due to very strict inclusion criteria	['Insufficient_Enrollment']	['Neutral']
Difficulty in accrual and by the order of the cancer center.	['Insufficient_Enrollment']	['Neutral']
pending expiration of the supply of study agent.	['Logistics_Resources']	['Neutral']
"Why study stopped revised to ""A program evaluation identified that the safety profile and
    pharmacokinetic (PK) characteristics of the formulation used in all oprozomib studies required
    further optimization and thus enrollment in OPZ009 was halted"	['Study_Design']	['Neutral']
The equipment to be used for the study was inoperable and not repairable.	['Logistics_Resources']	['Neutral']
company (Inovio) is no longer able to support the study	['Business_Administrative']	['Possibly_Negative']
The trial was terminated because of inability to recruit the needed number of participants	['Insufficient_Enrollment']	['Neutral']
Activation of a similar multicenter study for same population	['Negative', 'Another_Study']	['Negative', 'Neutral']
conclusions drawn, manuscript written	['Invalid_Reason']	['Invalid_Reason']
"Terminated: recruiting or enrolling participants has halted prematurely and will not resume;
    participants are no longer being examined or treated"	['Invalid_Reason']	['Invalid_Reason']
enrollment not met	['Insufficient_Enrollment']	['Neutral']
Negative results were obtained in all subjects that were analyzed (n=10)	['Endpoint_Met', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
lack of efficacy	['Negative']	['Negative']
Discontinuation of the development	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Discontinued by Investigator	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
The population described via ex- and inclusion criteria did not excisit	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
PI no longer at University of Minnesota	['Study_Staff_Moved']	['Neutral']
"Slow Accrual due to patients not wanting daily clinic administration of 5AZA and/or 6 months of
    treatment after surgery."	['Insufficient_Enrollment']	['Neutral']
Study was Suspended since 2018; PI decided to terminate.	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Currently closed for data analysis.	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
ECT equipment not available at study center	['Logistics_Resources']	['Neutral']
closure of radiolaboratory	['Logistics_Resources']	['Neutral']
Unable to enroll subjects.	['Insufficient_Enrollment']	['Neutral']
the study stopped due to the lack of inclusion.	['Insufficient_Enrollment']	['Neutral']
rate of inclusion too low	['Insufficient_Enrollment']	['Neutral']
Business decision	['Business_Administrative']	['Possibly_Negative']
Equipment changed	['Logistics_Resources']	['Neutral']
The investigators have decided not to go forward with this protocol	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Study stopped due to low enrollment	['Insufficient_Enrollment']	['Neutral']
Funding not secured.	['Business_Administrative']	['Possibly_Negative']
The study is not feasible with the number of subjects needed to complete it.	['Insufficient_Enrollment']	['Neutral']
We were unable to enroll any participants into this study.	['Insufficient_Enrollment']	['Neutral']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
Business reasons	['Business_Administrative']	['Possibly_Negative']
"Low enrolment and increasing COVID restrictions, following an earlier enrolment pause in April
    made it clear that completion of the study would not be feasible"	['Covid19']	['Neutral']
Lost many participants to follow-up.	['Insufficient_Enrollment']	['Neutral']
Closed due to slow patient accrual.	['Insufficient_Enrollment']	['Neutral']
This study was terminated early due to lack of adequate enrollment.	['Insufficient_Enrollment']	['Neutral']
Closed due to slowing enrollment and negative results of a phase III trial using cabozantinib.	['Negative', 'Another_Study']	['Negative', 'Neutral']
"English to Japanese translation issues caused enrollment of incorrect and unqualified subjects;
    error applied to all subjects enrolled prior to termination."	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Primary Investigator (AJN) left institution	['Study_Staff_Moved']	['Neutral']
difficulties with inclusion	['Insufficient_Enrollment']	['Neutral']
Lack of funds to cover the costs of the study medications	['Business_Administrative']	['Possibly_Negative']
PI left Emory	['Study_Staff_Moved']	['Neutral']
Registered and published incorrectly	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
slowdown due to covid	['Covid19']	['Neutral']
no funding	['Business_Administrative']	['Possibly_Negative']
Change in National PMTCT guidelines in Thailand	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"The study placed on temporarily hold to enrollment due to quality testing necessary for the
    study drug."	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
The results were disappointing.	['Negative', 'Business_Administrative']	['Negative', 'Possibly_Negative']
Study terminated early due to PI's extended medical leave.	['Study_Staff_Moved']	['Neutral']
Insuffisant personnel	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Strategic reasons. Seeking partner for future development.	['Business_Administrative']	['Possibly_Negative']
PI left institution	['Study_Staff_Moved']	['Neutral']
did not start RCT due to current concerns about vaping-related lung illness	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Lack of resources	['Logistics_Resources']	['Neutral']
Difficult eligibility and lack of funding	['Business_Administrative']	['Possibly_Negative']
Funding withdrawn due to inability to accrue	['Business_Administrative']	['Possibly_Negative']
PI decision was made to discontinue the study	['Invalid_Reason']	['Invalid_Reason']
"After consultation with a medical expert the Notified Body confirmed premature termination of
    the study."	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
PI decided to not initiate this study.	['Invalid_Reason']	['Invalid_Reason']
Slow enrollment and high number of screen failures	['Insufficient_Enrollment']	['Neutral']
Lack of patient accrual	['Insufficient_Enrollment']	['Neutral']
Study suspended until IRB continuing review approval.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Key personnel moving out	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Issues with data collection tool	['Logistics_Resources']	['Neutral']
"Ofatumumab IV trials in RA were prematurely terminated because GSK refocused clinical
    development of autoimmune indications on the subcutaneous delivery."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
The recruitment process was slower than expected.	['Insufficient_Enrollment']	['Neutral']
New relevant data published	['Success', 'No_Context', 'Endpoint_Met']	['Success', 'Invalid_Reason', 'Neutral']
Due to funding issues.	['Business_Administrative']	['Possibly_Negative']
On DSMB advice, trial recruitment has been halted for efficacy. F/U continues.	['Negative']	['Negative']
Collaborators left the institution.	['Study_Staff_Moved']	['Neutral']
Study was suspended before recruitment, due to logistic issues.	['Logistics_Resources']	['Neutral']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
"13 of 15 patients recruited.Study patients responded with no safety signals. Recruitment
    slow,timely end of study necessary to keep development timelines"	['Insufficient_Enrollment']	['Neutral']
Drug manufacturing issues	['Logistics_Resources']	['Neutral']
Lack of availibility of eligible subjects	['Insufficient_Enrollment']	['Neutral']
Due to Low Accrual	['Insufficient_Enrollment']	['Neutral']
Low recruitment of participants for the study	['Insufficient_Enrollment']	['Neutral']
Study did not meet statistical requirements to continue.	['Negative']	['Negative']
Difficulties in completing the required sample size	['Insufficient_Enrollment']	['Neutral']
Protocol expired and not renewed	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Study was ceased due to Covid-19 epidemia.	['Covid19']	['Neutral']
"Study had to be put on hold after the outbreak of Covid-19 in the participating countries and
    was terminated in September 2020 since a date for re-starting was not foreseeable."	['Covid19']	['Neutral']
"Considered not necessary to continue with this trial; recommended dose was reached in other
    phase I trials"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study was moved to another location with involvement of different researchers	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
This study has been placed on clinical hold by the sponsor due to operational reasons.	['Business_Administrative']	['Possibly_Negative']
"We strongly feel that the ability to recruit the required number of patients is very low and
    thus decided to stop the study."	['Insufficient_Enrollment']	['Neutral']
study withdrawn	['Invalid_Reason']	['Invalid_Reason']
Competing study was started.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Recruiting or enrolling participants has halted and will not resume	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
The Principal Investigator left the clinic and there was no one who could take over this study.	['Study_Staff_Moved']	['Neutral']
No patients recruited	['Insufficient_Enrollment']	['Neutral']
Funding not available	['Business_Administrative']	['Possibly_Negative']
Corporate decision to reformulate the investigational product.	['Business_Administrative']	['Possibly_Negative']
Satisfied a post-marketing commitment to Canadian Health Authorities.	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Tracer not available.	['Logistics_Resources']	['Neutral']
The planned number of enrolled patients was not reached.	['Insufficient_Enrollment']	['Neutral']
Study not initiated	['Invalid_Reason']	['Invalid_Reason']
low number of patients enrolled	['Insufficient_Enrollment']	['Neutral']
Funding not available to continue enrollment beyond study completion date.	['Business_Administrative']	['Possibly_Negative']
No longer could obtain clenbuterol	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Slow Enrollment	['Insufficient_Enrollment']	['Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
"Arm ""placement periph iv cath"" COMPLETED - Arm ""blood sampling"" : study will not be performed
    because of the results of the arm ""placement periph. iv cath"""	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
New data from another study show that a positive result is unlikely.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Time to engraftment would not be improved compared to historical controls.	['Logistics_Resources', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
No Funding Source and Competing Trials	['Business_Administrative']	['Possibly_Negative']
Study never started.	['Invalid_Reason']	['Invalid_Reason']
"Study halted permanently and will not resume; participants are no longer being examined or
    receiving intervention."	['Invalid_Reason']	['Invalid_Reason']
Data from first 12 subjects-primary endpoint not met. Data analysis underway.	['Negative']	['Negative']
DSMB stopped the study due to early effectiveness	['Negative']	['Negative']
Programmatic decision	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"COVID-19 caused the program to change in its delivery to virtual, therefore it no longer
    followed the intervention described in the protocol."	['Covid19']	['Neutral']
Number of patients willing to participate in the study too low	['Insufficient_Enrollment']	['Neutral']
funding	['Business_Administrative']	['Possibly_Negative']
Lack of enrolment	['Insufficient_Enrollment']	['Neutral']
Policy changes have contributed to the failure to carry out smoothly	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Insufficient findings for data analysis	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Withdrawn: study halted prematurely, prior to enrollment of first participant	['Invalid_Reason']	['Invalid_Reason']
Physician decided not to go through with study	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
PI decided to withdrawal study before recruitment started	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
"Unable to recruit additional patients due to transfer of surgical service (ortho sports
    medicine) and recruitable cases to another institution."	['Insufficient_Enrollment']	['Neutral']
Decision to change the study design	['Study_Design']	['Neutral']
patients should have assurance to attend this study, money is the main problem	['Business_Administrative']	['Possibly_Negative']
device failure	['Logistics_Resources']	['Neutral']
PI left the University; study will not continue.	['Study_Staff_Moved']	['Neutral']
Unable to enrolled in a timely manner.	['Insufficient_Enrollment']	['Neutral']
Change in clinical practice that logistically prevented this study from being engaged.	['Study_Design']	['Neutral']
Stopp because of FDA concrns regarding recruitment.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Business Decision	['Business_Administrative']	['Possibly_Negative']
Change of schedule	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
DSMB recommended study suspension slow accrual	['Insufficient_Enrollment']	['Neutral']
scheduling complexities	['Logistics_Resources']	['Neutral']
Enrollment terminated in 2005 to focus on Phase 3 study enrollment.	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
Recruiting or enrolling participants has halted prematurely and will not resume	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Study will need to be redesigned for improved efficacy.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Due to slow patient recruitment	['Insufficient_Enrollment']	['Neutral']
High attrition rate up to 37.7% at one year's follow-up	['Insufficient_Enrollment']	['Neutral']
pending clinical laboratory analyses	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Lack of success with recruitment	['Insufficient_Enrollment']	['Neutral']
IRB closed project as the continuing review was not submitted. PI has left WU.	['Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Funding unavailable - Company shutting down	['Business_Administrative']	['Possibly_Negative']
PI left	['Study_Staff_Moved']	['Neutral']
Study not initiated due to funding.	['Business_Administrative']	['Possibly_Negative']
"COVID restrictions prevent patient enrollment or treatment. Clinical Trial facility is being
    closed due to viral limitations and loss of staff to perform"	['Covid19']	['Neutral']
COVID 19 consequences	['Covid19']	['Neutral']
Withdrawn as the sponsor has stopped the drug for NSCLC population	['Business_Administrative']	['Possibly_Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Inadequate enrollment	['Insufficient_Enrollment']	['Neutral']
company dissolved	['Business_Administrative']	['Possibly_Negative']
Lower recruitment rate than expected	['Insufficient_Enrollment']	['Neutral']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Decision of the Steering Committee. Recruitment more difficult and slower than expected.	['Insufficient_Enrollment']	['Neutral']
"Key personnel moved to new location. Therefore, we had insufficient resources to initiate the
    trial."	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Not enough patients	['Insufficient_Enrollment']	['Neutral']
Insufficient efficacy observed in study BCDM(NCT01198002) and BCDV(NCT01202773).	['Negative', 'Another_Study']	['Negative', 'Neutral']
Terminated for lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Problems of drugs supply by the manufacturer	['Logistics_Resources']	['Neutral']
Unable to secure funding	['Business_Administrative']	['Possibly_Negative']
Study halted prematurely, prior to enrollment of first participant	['Invalid_Reason']	['Invalid_Reason']
The original PI, Alexander Neumeister, left NYULMC. No data was analyzed.	['Study_Staff_Moved']	['Neutral']
The study was terminated by the Sponsor due to insufficient enrollment.	['Insufficient_Enrollment']	['Neutral']
Treatment without success, low enrollment, one serious adverse event	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
The study was stopped due to carry over effect in the cross over study design.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
PI left facility	['Study_Staff_Moved']	['Neutral']
Decided not go move forward with this population as recruitment was difficult	['Insufficient_Enrollment']	['Neutral']
Company decision taken in light of demands by certain national health authorities	['Business_Administrative']	['Possibly_Negative']
Low enrollment.	['Insufficient_Enrollment']	['Neutral']
"The study closed to accrual before the planned accrual goal was attained due to the
    availability of newer directly-acting antiviral (DAA) treatments for HCV."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
this study was not initiated due to lack of funding	['Business_Administrative']	['Possibly_Negative']
End of the study because of the inclusions were too difficult	['Insufficient_Enrollment']	['Neutral']
Decided to do a different clinical trial opportunity.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
The sponsor determined that adequate data had been acquired.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Study cancelled: Withdrawn before enrollment of any participants	['Invalid_Reason']	['Invalid_Reason']
low enrollment	['Insufficient_Enrollment']	['Neutral']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
Futility - unable to secure sites and samples for participation	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Target of recruitment not reachable	['Insufficient_Enrollment']	['Neutral']
Stopped for futility. Phase 3 studies not likely to meet primary endpoints.	['Negative']	['Negative']
The risk benefit in relapsed refractory SCLC does not favor continuation of the study	['Negative']	['Negative']
low accrual rate	['Insufficient_Enrollment']	['Neutral']
deficient inclusions	['Insufficient_Enrollment']	['Neutral']
Futility	['Negative']	['Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Patients were consented to screening but none were enrolled and proceeded with transplant.	['Invalid_Reason']	['Invalid_Reason']
lack of accrual and PI left institution	['Insufficient_Enrollment']	['Neutral']
Withdrawn from IRB	['Regulatory', 'Ethical_Reason', 'Negative']	['Neutral', 'Neutral', 'Negative']
recruitment longer than expected and without the expected success	['Insufficient_Enrollment']	['Neutral']
Business decision and not a result of any patient or product safety issues.	['Business_Administrative']	['Possibly_Negative']
Interim analysis and potential modification	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Suspended by funder	['Business_Administrative']	['Possibly_Negative']
The study medication was no longer available in the market	['Logistics_Resources']	['Neutral']
Business decision to close study due to low and slow enrollment.	['Business_Administrative']	['Possibly_Negative']
Suspended pending internal review/direction of the company's focus.	['Business_Administrative']	['Possibly_Negative']
Surgeons change in preference for perioperative warming.	['Study_Design']	['Neutral']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
Determined not to be human subject reseach	['Regulatory', 'Insufficient_Enrollment', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Routine use of corticoids became standard therapy	['Endpoint_Met', 'Study_Design']	['Neutral', 'Neutral']
no enrollment	['Insufficient_Enrollment']	['Neutral']
No sufficient clinical or molecular signals for efficacy were observed.	['Negative']	['Negative']
French Agency for the Safety of Health Products refusal	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Closed early due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Strategic decision	['Business_Administrative']	['Possibly_Negative']
Lack of enrollment to the trial. Very difficult population to recruit.	['Insufficient_Enrollment']	['Neutral']
No patients recruited	['Insufficient_Enrollment']	['Neutral']
The study was terminated due to lack of subject recruitment	['Insufficient_Enrollment']	['Neutral']
low enrolling participants	['Insufficient_Enrollment']	['Neutral']
Difficulty accruing	['Insufficient_Enrollment']	['Neutral']
Unable to enroll patients	['Insufficient_Enrollment']	['Neutral']
Business and program changes	['Business_Administrative']	['Possibly_Negative']
Currently on partial clinical hold due to COVID-19 policies.	['Covid19']	['Neutral']
"PRIMARY EFFICACY OUTCOME MEASURE (MATURATION) WAS SIGNIFICANT, IN FAVOR OF THE TW0-STAGE
    PROCEDURE"	['Success', 'No_Context', 'Logistics_Resources']	['Success', 'Invalid_Reason', 'Neutral']
PI decided to terminate the study	['Invalid_Reason']	['Invalid_Reason']
due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Funding	['Business_Administrative']	['Possibly_Negative']
Extremely slow accural due to rarity of medical condition studied.	['Insufficient_Enrollment']	['Neutral']
The trial was revised to be two protocols, one Prevention, one Eradication Trials.	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
focus portfolio on immune-mediated diseases	['Business_Administrative']	['Possibly_Negative']
logistical problems	['Logistics_Resources']	['Neutral']
"The study was terminated after the second cohort had completed Part II due complex PK results.
    There were no safety concerns."	['Negative', 'Another_Study']	['Negative', 'Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
difficulty of recruitment	['Insufficient_Enrollment']	['Neutral']
Study redesigned into three separate trials.	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Slow to accrue, lack of qualified participants	['Insufficient_Enrollment']	['Neutral']
"DBS method not be validated against the standard of care venepuncture method due to quality of
    blood sample and variable tacrolimus extraction"	['Logistics_Resources', 'Endpoint_Met', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Safety reasons	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
"Development of JNJ-64041757 discontinued due to lack of efficacy. No further follow up data
    will be collected after October 22, 2018."	['Negative']	['Negative']
collaborator withdrew the study	['Logistics_Resources', 'Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
It ended early because it would not be possible to meet the target number.	['Insufficient_Enrollment']	['Neutral']
Study was stopped for slow enrollment - only 2 patients, no evaluable results	['Insufficient_Enrollment']	['Neutral']
Administrative	['Business_Administrative']	['Possibly_Negative']
Enrollment was stopped after the dose-limiting toxicity (DLT) evaluation phase of Cohort 2.	['Safety_Sideeffects', 'Endpoint_Met', 'Study_Design']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Unable to secure equipment to proceed	['Logistics_Resources']	['Neutral']
"slow subject recruitment and lack of medical and scientific merit due to change in new standard
    of therapy during that same period."	['Study_Design']	['Neutral']
PI has left Duke	['Study_Staff_Moved']	['Neutral']
Funding unavailable	['Business_Administrative']	['Possibly_Negative']
Budgetary	['Business_Administrative']	['Possibly_Negative']
This clinical trial was terminated early, due to slow recruitment and study drug shortages.	['Insufficient_Enrollment']	['Neutral']
PI departure from coordinating institution	['Study_Staff_Moved']	['Neutral']
Effects of aripiprazole was not obvious and showed adverse reaction obviously	['Safety_Sideeffects', 'Negative']	['Safety_Sideeffects', 'Negative']
Discontinued PB127 development program for business reasons	['Business_Administrative']	['Possibly_Negative']
Study tasks to difficult for subjects to complete.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Terminated for lack of resources to complete.	['Business_Administrative']	['Possibly_Negative']
Suspended because the lack of patients among the time this clinical trial was running.	['Insufficient_Enrollment']	['Neutral']
Difficulties in recruitment	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
"According to the study design, in the first step the number of responses was lower than the
    number required (< 7)."	['Insufficient_Enrollment']	['Neutral']
turnover in staff, to restart with new hire	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
"By DSMB on October 18, 2013 due to increased incidence of ARDS. See modified protocol
    [NCT02175225"	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Low accrual	['Insufficient_Enrollment']	['Neutral']
"The sponsor merged with another company and decided they did not want to continue with the
    study."	['Business_Administrative']	['Possibly_Negative']
The investigator resigned on February 28, 2014.	['Study_Staff_Moved']	['Neutral']
As a single center, it was not possible to recruit enough patients with pulmonary hypertension	['Insufficient_Enrollment']	['Neutral']
"The study was terminated. The data analysis was futile with only 3 accruals. PI opted to
    terminate with IRB and withdraw FDA IND."	['Insufficient_Enrollment']	['Neutral']
Lack of Enrollment	['Insufficient_Enrollment']	['Neutral']
The PI has determined not to continue the study.	['Invalid_Reason']	['Invalid_Reason']
Study stopped due to lack of efficacy.	['Negative']	['Negative']
The clinical trial did not receive any funding.	['Business_Administrative']	['Possibly_Negative']
"the DSMB stopped the trial due to unacceptable side effects in the experimental arm which has
    not yet been verified"	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Investigator's hospital sold and study cancelled	['Business_Administrative']	['Possibly_Negative']
"New ultra sound technology have made this present study design less relevant and force us to
    change the design of the study."	['Study_Design']	['Neutral']
PI left the Institution.	['Study_Staff_Moved']	['Neutral']
Inadequate recruitment	['Insufficient_Enrollment']	['Neutral']
failure to accrue	['Insufficient_Enrollment']	['Neutral']
IRB approval has lapsed.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
IRB determined need for an IDE, which was not approved	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Funding	['Business_Administrative']	['Possibly_Negative']
Study Team did not respond to requests for continuing review approval.	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Insufficient number of participants recruited	['Insufficient_Enrollment']	['Neutral']
This project was not a clinical trial requiring registration	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Investigator decision	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Primary endpoint of parent study AC-055-305/MAESTRO (NCT01743001) not met.	['Negative', 'Another_Study']	['Negative', 'Neutral']
The study was prematurely discontinued due to administrative reasons.	['Business_Administrative']	['Possibly_Negative']
System-wide implementation of intervention prevented randomized trial design	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Early end of enrolment with regards to difficulty met to enrol patients	['Insufficient_Enrollment']	['Neutral']
"The study was terminated on June 24th, 2015 due to change in strategy of PF-03084014
    development. There were no safety/efficacy concerns behind the decision."	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
Lack of Funding	['Business_Administrative']	['Possibly_Negative']
Project was stopped due to futility	['Negative']	['Negative']
Recruitment stopped due to time restrains	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Study was never activated at Fox Chase Cancer Center.	['Study_Staff_Moved', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Insufficient enrollment, no safety or efficacy concerns	['Insufficient_Enrollment']	['Neutral']
"Recruitment was slower than anticipated. Incomplete neuropsychological outcome measures
    obtained."	['Negative']	['Negative']
poor accrual	['Insufficient_Enrollment']	['Neutral']
"Interim analysis, infliximab did not reduce number of first relapses in GCA or cumulative
    glucocorticosteroid dosage"	['Negative']	['Negative']
Failure of funding	['Business_Administrative']	['Possibly_Negative']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Study was never published	['Invalid_Reason']	['Invalid_Reason']
Did not have funding or resources to carry out study	['Business_Administrative']	['Possibly_Negative']
lack of accrual	['Insufficient_Enrollment']	['Neutral']
no patient meet of criteria the trial	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
methodological concerns about study design	['Study_Design']	['Neutral']
Recruitment defect	['Insufficient_Enrollment']	['Neutral']
Poor accrual.	['Insufficient_Enrollment']	['Neutral']
Administrative reasons.	['Business_Administrative']	['Possibly_Negative']
Problems with the electronic data collection program	['Logistics_Resources']	['Neutral']
Difficulties of recrutment	['Insufficient_Enrollment']	['Neutral']
low recruitment	['Insufficient_Enrollment']	['Neutral']
Terminated due to lack of accrual	['Insufficient_Enrollment']	['Neutral']
Lack of resources	['Logistics_Resources']	['Neutral']
Slow recruitment and a lack of funding to complete further follow-up	['Business_Administrative']	['Possibly_Negative']
"Interim analysis revealed that no statistical difference will be identified after inclusion of
    the patient cohort as foreseen in the sample size calculation"	['Negative']	['Negative']
Unable to obtain study agent	['Logistics_Resources']	['Neutral']
Due to slow recruitment	['Insufficient_Enrollment']	['Neutral']
Change of strategic priorities in the sponsor's clinical development sector.	['Business_Administrative']	['Possibly_Negative']
lack of accrual	['Insufficient_Enrollment']	['Neutral']
FDA Hold May 2007	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Insufficient accrual rate: 14 participants enrolled (target of 30).	['Insufficient_Enrollment']	['Neutral']
Unable to begin study with drug provider	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"As a result of a slower inclusion rate than expected, competence of medical staff to work with
    the AVEA ventilator could no longer be guaranteed."	['Insufficient_Enrollment']	['Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
poor enrollment and study design	['Insufficient_Enrollment']	['Neutral']
Unable to recruit individuals for the study	['Insufficient_Enrollment']	['Neutral']
Relocation of PI	['Study_Staff_Moved']	['Neutral']
Pandemic of SARS-CoV2	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Study could not recruit any participant	['Insufficient_Enrollment']	['Neutral']
Recruitment on hold due to COVID 19 restrictions in hospital since March 2020.	['Covid19']	['Neutral']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
Stopped in December 2007	['Invalid_Reason']	['Invalid_Reason']
The study was prematurely terminated for strategic reasons, not for a safety concern.	['Business_Administrative']	['Possibly_Negative']
Pending more information from PI	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
COVID 19	['Covid19']	['Neutral']
The company currently does not have plans to conduct this study	['Business_Administrative']	['Possibly_Negative']
The study was terminated because the funding was withdrawn.	['Business_Administrative']	['Possibly_Negative']
Insufficient Accrual	['Insufficient_Enrollment']	['Neutral']
Funding ended	['Business_Administrative']	['Possibly_Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
poor recruitment and an unexpected low treatment rate	['Insufficient_Enrollment']	['Neutral']
Could not get teenagers to enroll	['Insufficient_Enrollment']	['Neutral']
Slow accrual and funding issues	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
No accrual	['Insufficient_Enrollment']	['Neutral']
end of funding granted	['Business_Administrative']	['Possibly_Negative']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Expiration of funding	['Business_Administrative']	['Possibly_Negative']
This study has been cancelled prior to enrollment.	['Invalid_Reason']	['Invalid_Reason']
Due to slow enrollment.	['Insufficient_Enrollment']	['Neutral']
"Livoletide did not result in a statistically significant improvement in hyperphagia and
    food-related behaviors"	['Negative']	['Negative']
The study was stopped because it was not approved for funding	['Business_Administrative']	['Possibly_Negative']
Inefficiency of treatment	['Negative']	['Negative']
"All Parkinson's disease patients have finished training. The MS and ECT groups have not
    finished as these groups had trouble including 20 patients."	['Insufficient_Enrollment']	['Neutral']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
No recruitment	['Insufficient_Enrollment']	['Neutral']
Due to numerous delays in study start-up process...	['Logistics_Resources']	['Neutral']
Interim analysis	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
Recruitment: Insufficient number of patients eligible for enrollment	['Insufficient_Enrollment']	['Neutral']
See detailed description for reason.	['No_Context']	['Invalid_Reason']
"Temporarily paused due to COVID-19 and will resume based on guidance of public health
    authorities. This is not a suspension of IRB approval."	['Covid19']	['Neutral']
Due to COVID-19	['Covid19']	['Neutral']
Drug development suspended	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Lack of enrollment. Futility.	['Insufficient_Enrollment', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Difficulties recruiting	['Insufficient_Enrollment']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Product Pre-Market Approval withdrawn	['Regulatory', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
lack of recruitment and follow up	['Insufficient_Enrollment']	['Neutral']
Sponsor's decision due to slow enrollment rate.	['Insufficient_Enrollment']	['Neutral']
No study population in Mexico (H1N1). Study withdrawn from IRB consideration.	['Insufficient_Enrollment']	['Neutral']
Sponsor decision to terminate study due to poor accrual	['Insufficient_Enrollment']	['Neutral']
Lack of inclusion	['Insufficient_Enrollment']	['Neutral']
Low enrollment and there is insufficient data to publish.	['No_Context', 'Logistics_Resources', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
"This study was discontinued due to an interim analysis in this study, which indicated that
    Crenezumab was unlikely to meet its primary endpoint."	['Negative']	['Negative']
"The study was terminated early because of a related decision to stop the development of
    ocrelizumab in rheumatoid arthritis."	['Regulatory', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Organizational problems, change of research priorities	['Business_Administrative']	['Possibly_Negative']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
difficulties to recruit patients who suffer from this pathology	['Insufficient_Enrollment']	['Neutral']
Lack of personnel	['Logistics_Resources']	['Neutral']
"After loss of orphan drug status in Korea, study was withdrawn due to Regulatory Authority
    request. Patients will be enrolled into NCT01075828 instead."	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Compound terminated	['Invalid_Reason']	['Invalid_Reason']
Re-submission Planned	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Terminated by Sponsor: see details below	['No_Context']	['Invalid_Reason']
Not able to recruit patients with the current enrollment criteria.	['Insufficient_Enrollment']	['Neutral']
No objective responses observed following completion of Phase 1 dose-escalation	['Negative']	['Negative']
Never initiated. PI has left the institution.	['Study_Staff_Moved']	['Neutral']
"SBI Biotech who provided the drug for this study has decided to no longer support the study or
    GNKG168."	['Business_Administrative']	['Possibly_Negative']
Repros stopped study for safety and FDA put study on hold because of safety.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Difficulty in participant recruitment	['Insufficient_Enrollment']	['Neutral']
Currently suspended due to COVID-19 policies.	['Covid19']	['Neutral']
Study is on hold due to significant impact of COVID pandemic	['Covid19']	['Neutral']
We have discontinued development of FPA008 in RA	['Logistics_Resources', 'Regulatory', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Logistical	['Logistics_Resources']	['Neutral']
poor recruitment and expiry of funding	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The protocol was cancelled becouse lack of funding	['Business_Administrative']	['Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Could not predict who would respond, relapse or go into remission	['Negative']	['Negative']
Unavailability of central lab	['Logistics_Resources']	['Neutral']
standard of care improved combination treatment of ipilimumab plus nivolumab.	['Endpoint_Met', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
We are closing the study because of lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
no subjects recruited	['Insufficient_Enrollment']	['Neutral']
Study is terminated because of administrative reasons.	['Business_Administrative']	['Possibly_Negative']
"Despite promising efficacy and a good tolerability profile in Part I, it was decided not to
    initiate Part II as the pre-specified boundary for efficacy was uncertain to be met in this
    heavily pre-treated population with significant co-morbidities"	['Negative']	['Negative']
PI left institution, study interest wained-so stopped.	['Study_Staff_Moved']	['Neutral']
never started several reasons	['Invalid_Reason']	['Invalid_Reason']
Enrollement failure	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment and discontinued funding	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
PI moving to a different institution.	['Study_Staff_Moved']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
At sponsor's discretion	['Business_Administrative']	['Possibly_Negative']
Difficulty in recruiting subjects who meet the inclusion/exclusion criteria	['Insufficient_Enrollment']	['Neutral']
low enrollment and loss of funding	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
NIH grant ended.	['Business_Administrative']	['Possibly_Negative']
AVE5530 in hypercholesterolemia was stopped due to insufficient efficacy	['Negative']	['Negative']
"after interims analysis standard errors for inflammatory and nutritional markers varied widely,
    that the power calculation required unattainable goals"	['Interim_Analysis', 'Logistics_Resources', 'Endpoint_Met']	['Neutral', 'Neutral', 'Neutral']
The trial was prematurely closed due to lack of accrual	['Insufficient_Enrollment']	['Neutral']
Principal investigator retired from the project	['Study_Staff_Moved']	['Neutral']
Limited viral load reduction in HCV subjects	['Negative']	['Negative']
Suspended pending funding and staffing.	['Business_Administrative']	['Possibly_Negative']
COVID-19 limitations on recruitment	['Covid19']	['Neutral']
no funding	['Business_Administrative']	['Possibly_Negative']
Due to slow accrual of patients	['Insufficient_Enrollment']	['Neutral']
Study Medication unavailable	['Logistics_Resources']	['Neutral']
Amendment changes were significant enough to warrant a new study.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"This study was terminated early due to lack of efficacy based on the results of the Week 48
    analysis as prespecified in the clinical study protocol."	['Negative']	['Negative']
lack of accrual	['Insufficient_Enrollment']	['Neutral']
Lack of efficacy	['Negative']	['Negative']
Deemed unable to enroll targeted participants in part due to COVID-19 shut downs	['Covid19']	['Neutral']
Company withdrew drug supply	['Logistics_Resources']	['Neutral']
insufficient study population to meet study objective	['Insufficient_Enrollment']	['Neutral']
potential harm of insulin infusion outweights the benefit.	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
"Factors that led to termination: recruitment challenges and a lower incidence of flares than
    estimated, causing a high risk of the study being underpowered."	['Insufficient_Enrollment']	['Neutral']
Principal Investigator was unable to fulfill his responsibilities.	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
Sponsor discretion (low recruitment rate)	['Insufficient_Enrollment']	['Neutral']
Strategy Change	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
The study did not recruit any participant.	['Insufficient_Enrollment']	['Neutral']
Study withdrawn.	['Invalid_Reason']	['Invalid_Reason']
Original principal investigator left the university before enrollment started	['Study_Staff_Moved']	['Neutral']
Early termination due to a suspension of financial support	['Business_Administrative']	['Possibly_Negative']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Recruiting complete and administrative termination	['Business_Administrative']	['Possibly_Negative']
"No patient enrolled on study. Did not get patients in timely fashion. All referrals for study
    when assessed were not eligible."	['Insufficient_Enrollment']	['Neutral']
Study not initiated	['Invalid_Reason']	['Invalid_Reason']
Canceled study due to delay of progress procedure and failure to obtain research funds.	['Business_Administrative']	['Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
The study was a retrospective chart review and was mistakenly registered in ClinicalTrials.gov	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
"The termination of the study is not linked to a product recall or result of any safety signal.
    Rather it was sponsor's commercial decision to withdraw the MA"	['Business_Administrative']	['Possibly_Negative']
The research project has been cancelled before any participants were enrolled.	['Invalid_Reason']	['Invalid_Reason']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
withdrawn, not funded	['Business_Administrative']	['Possibly_Negative']
Left Institution where study was approved	['Study_Staff_Moved']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
"Informed by manufacturer that CDB-2914 crosses blood-brain barrier invalidating Arm #3 of
    protocol."	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
PI leaving institution	['Study_Staff_Moved']	['Neutral']
"Study halted due to low recruitment. Reimbursement changes require a larger study with
    additional centers and therefore, a new study planned as replacement."	['Insufficient_Enrollment']	['Neutral']
Award was ended by NIH for parent study	['Regulatory', 'Ethical_Reason', 'Negative']	['Neutral', 'Neutral', 'Negative']
The study was terminated because of low accrual.	['Insufficient_Enrollment']	['Neutral']
The study was terminated early due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
the study has stopped due to no recruitment	['Insufficient_Enrollment']	['Neutral']
difficulty recruiting	['Insufficient_Enrollment']	['Neutral']
No support staff	['Logistics_Resources']	['Neutral']
We completed the 62% of the cases, enough data to get a conclusion of the study.	['Success', 'Invalid_Reason']	['Success', 'Invalid_Reason']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
Difficulty in recruitment	['Insufficient_Enrollment']	['Neutral']
Enrollment challenges	['Insufficient_Enrollment']	['Neutral']
Study published November 2010 and no further work will be done	['Invalid_Reason']	['Invalid_Reason']
Due to missing patient recruitment, the financial support was stopped.	['Business_Administrative']	['Possibly_Negative']
Low enrollment number	['Insufficient_Enrollment']	['Neutral']
"A program evaluation identified that the safety profile and pharmacokinetic (PK)
    characteristics of the formulation used in all oprozomib studies required further optimization
    and thus enrollment in OPZ003 was halted during dose-escalation."	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Device for multi coil TMS no longer supported	['Covid19', 'Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Termination due to acquisition of PEAK Surgical by Medtronic	['Business_Administrative']	['Possibly_Negative']
Met protocol stop rule [i.e., extreme toxicity]	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Business objectives have changed	['Business_Administrative']	['Possibly_Negative']
loss of funding	['Business_Administrative']	['Possibly_Negative']
"The study was terminated early due to challenges in recruitment. The decision to terminate the
    study was not related to any safety issues or concerns."	['Insufficient_Enrollment']	['Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
Not able to recruit any participants	['Insufficient_Enrollment']	['Neutral']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Study halted prematurely and will not resume; participants are no longer being examined	['Invalid_Reason']	['Invalid_Reason']
"Due to a strategic business decision Kura has stopped development of KO-947. Neither safety nor
    efficacy reasons were the cause of study termination."	['Business_Administrative']	['Possibly_Negative']
"Study is withdrawn due to unavailability of eligible subject population. We will request the
    sponsors to extend the time for enrollment."	['Insufficient_Enrollment']	['Neutral']
Study on hold	['Invalid_Reason']	['Invalid_Reason']
Terminated early dt acquisition of Sponsor and change in corporate priorities	['Business_Administrative']	['Possibly_Negative']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of patients with the right criteria for inclusion	['Insufficient_Enrollment']	['Neutral']
Retirement of former Qualified Investigator and lack of resources to complete study	['Logistics_Resources', 'Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
interaction with another study, not possible to include patients	['No_Context', 'Insufficient_Enrollment', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
Sponsor has withdrawn the funding	['Business_Administrative']	['Possibly_Negative']
"The One Hospital ClinicalService project involves the provision of services to hospitals, and
    is not a clinical study. As such, this service offering should not be listed on
    ClinicalTrials.gov."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Could not enroll enough patients	['Insufficient_Enrollment']	['Neutral']
Change in the company clinical trials priority	['Business_Administrative']	['Possibly_Negative']
This registration has moved to a local ICTRP (CRIS; https://cris.nih.go.kr, KCT0002565).	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
COVID	['Covid19']	['Neutral']
Per Investigator and sponsor decision	['Business_Administrative']	['Possibly_Negative']
Due to COVID-19 study inclusion was halted on March 16, 2020 after 309 days.	['Covid19']	['Neutral']
Change in local healthcare policies and practices	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Test lens did not meet near visual efficacy endpoints	['Negative']	['Negative']
Lab company that was to do testing was sold	['Business_Administrative']	['Possibly_Negative']
Could not recruit patients	['Insufficient_Enrollment']	['Neutral']
Study is no longer needed as recent data have answered the primary hypotheses for this study.	['Success', 'Negative', 'Another_Study']	['Success', 'Negative', 'Neutral']
Unusual high frequency of elevated liver function tests.	['Safety_Sideeffects', 'Endpoint_Met', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
PI has left UHN. This study is no longer running at UHN.	['Study_Staff_Moved']	['Neutral']
Please see Detailed Description for termination reason.	['No_Context']	['Invalid_Reason']
Unsuccessful enrollment	['Insufficient_Enrollment']	['Neutral']
This study was withdrawn prior to enrollment.	['Invalid_Reason']	['Invalid_Reason']
"Study stopped early due to investigational drug not meeting primary endpoint in the main study
    T-Force GOLD (NBI-98854-TS2003); no safety concerns identified."	['Negative', 'Another_Study']	['Negative', 'Neutral']
The study have difficulty in recruiting subjectes	['Insufficient_Enrollment']	['Neutral']
Difficult to recruit to due to conflicting trials recruiting similar participants.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
"FU for 3 years from randomization as initially planned is stopped as we do not expect any
    changes to the endpoints in the future after one year of FU."	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Study was not initiated, change in clinical development	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Based on preliminary parent study results	['Negative', 'Another_Study']	['Negative', 'Neutral']
Due to COVID pandemia enrolment was stopped on 20March2020	['Covid19']	['Neutral']
No participants enrolled. IND withdrawn.	['Insufficient_Enrollment']	['Neutral']
Loss of funding	['Business_Administrative']	['Possibly_Negative']
"Recruitment was suspended with the begin of the COVID-19 pandemic as this potentially has an
    incluence on our outcomes"	['Covid19']	['Neutral']
Staffing change	['Logistics_Resources']	['Neutral']
Insurance coverage reached	['Logistics_Resources', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Study was early terminated due to problems enrolling adequate number of patients	['Insufficient_Enrollment']	['Neutral']
Study was terminated for lack of recruitment.	['Insufficient_Enrollment']	['Neutral']
Unable to perform brain imaging	['Logistics_Resources']	['Neutral']
Lack of substantial evidence for immune responses in response to vaccination.	['Negative']	['Negative']
difficulty with equipment	['Logistics_Resources']	['Neutral']
company focus on other projects	['Business_Administrative']	['Possibly_Negative']
Business decision	['Business_Administrative']	['Possibly_Negative']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
compound no longer available	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
The device was under developed with some technical bugs.	['Logistics_Resources']	['Neutral']
No funding for study.	['Business_Administrative']	['Possibly_Negative']
Insufficient patient recruitment. Data lost following departure of key personnel	['Insufficient_Enrollment']	['Neutral']
DSMB decision to begin closeout process in view of April 2010 SA HAART guideline	['No_Context', 'Regulatory', 'Study_Design']	['Invalid_Reason', 'Neutral', 'Neutral']
Time and funding constraints	['Business_Administrative']	['Possibly_Negative']
Temporary clinical staffing issues	['Logistics_Resources']	['Neutral']
no IRB	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The study was terminated prematurely after ad-interim analysis for the primary outcome.	['Negative']	['Negative']
Study Withdrawn due to Investigator leaving	['Study_Staff_Moved']	['Neutral']
Due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Difficulty faced with enrollment in the study	['Insufficient_Enrollment']	['Neutral']
Changes in renal function parameters.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Changes made to device.	['Study_Design']	['Neutral']
administrative reasons.	['Business_Administrative']	['Possibly_Negative']
No accrual	['Insufficient_Enrollment']	['Neutral']
PI did not receive funding for this PI-initiated study. PI subsequently left the institution.	['Business_Administrative']	['Possibly_Negative']
DSMB stopped trial for futility	['Negative']	['Negative']
Break in funding	['Business_Administrative']	['Possibly_Negative']
Lack of funds	['Business_Administrative']	['Possibly_Negative']
"Principal investigator left lead institution and efforts to open the protocol at another
    institution were not successful."	['Study_Staff_Moved']	['Neutral']
Change in standard of care	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study Initiation delayed due to COVID 19	['Covid19']	['Neutral']
Multiple logistical challenges	['Logistics_Resources']	['Neutral']
Principal investigator is leaving the institution to obtain further training.	['Study_Staff_Moved']	['Neutral']
Per definition: study halted prematurely but potentially will resume pending COVID limitations	['Covid19']	['Neutral']
Difficulty in recruitment	['Insufficient_Enrollment']	['Neutral']
Saliva testing was not sensitive enough to correctly identify high risk patients	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
No funding secured	['Business_Administrative']	['Possibly_Negative']
Poor accrual and compliance	['Insufficient_Enrollment']	['Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
due to finalizing af phd project and fundings	['Business_Administrative']	['Possibly_Negative']
Safety Reasons	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
low recruitment	['Insufficient_Enrollment']	['Neutral']
No funding available.	['Business_Administrative']	['Possibly_Negative']
Sponsor has terminated trial to pursue other targets.	['Business_Administrative']	['Possibly_Negative']
Unsuccessful in recruiting appropriate subjects.	['Insufficient_Enrollment']	['Neutral']
Interim analysis was sufficient to demonstrate accuracy of the evaluated test	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
This indication is not being pursued at this point in time.	['Interim_Analysis', 'No_Context', 'Insufficient_Enrollment']	['Neutral', 'Invalid_Reason', 'Neutral']
Study never officially began	['Invalid_Reason']	['Invalid_Reason']
Drug supply unavailable	['Logistics_Resources']	['Neutral']
Study terminated due to no subject enrollment.	['Insufficient_Enrollment']	['Neutral']
The study was stopped due to safety concerns	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Replaced with another study	['Negative', 'Another_Study']	['Negative', 'Neutral']
lack of support	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Inability to recruit patients that meet inclusion criteria.	['Insufficient_Enrollment']	['Neutral']
Recruitment was stopped before start of the pollen season	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Company closed	['Business_Administrative']	['Possibly_Negative']
No accrual	['Insufficient_Enrollment']	['Neutral']
Study halted prematurely but potentially will resume	['Invalid_Reason']	['Invalid_Reason']
Inadequate enrollment	['Insufficient_Enrollment']	['Neutral']
Repros stopped the study for safety and FDA put the study on hold for safety.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Failure to recruit due to polypharmacy	['Insufficient_Enrollment']	['Neutral']
Terminated due to poor accrual.	['Insufficient_Enrollment']	['Neutral']
Business decision.	['Business_Administrative']	['Possibly_Negative']
"Due to a safety signal found at a planned interim safety review, further conduct of this safety
    study is not recommended hence the study was terminated."	['Safety_Sideeffects', 'Endpoint_Met', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Due to risk for covid-19 spreading, the study was suspended 12 march 2020.	['Covid19']	['Neutral']
"The futility analysis of study NCT00910091 in patients with endometrial cancer shows that the
    primary endpoint will not be reached."	['Negative', 'Another_Study']	['Negative', 'Neutral']
enrollment insufficient: lack of motivated patients	['Insufficient_Enrollment']	['Neutral']
Due to the voluntary recall of the study device (DLS 3.7mm and DLS 5.0mm)	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Incyte suspended development of the compound.	['Business_Administrative']	['Possibly_Negative']
This was a review of existing de-identified records	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
investigator choice	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Decision of Sponsor	['Business_Administrative']	['Possibly_Negative']
Principal investigator departure without possible replacement	['Study_Staff_Moved']	['Neutral']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
Study was closed due to logistical issues.	['Logistics_Resources']	['Neutral']
Policy changes have contributed to the failure to carry out smoothly	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Study stopped due to product discontinuation by manufacturer	['Business_Administrative']	['Possibly_Negative']
Major changes to protocol (new study design and comparator)	['Study_Design']	['Neutral']
"The buccal arm of the study was 30% less effective in stopping seizures within 10 minutes
    compared with the IV dose. This met a stopping rule for the study"	['Negative']	['Negative']
Failure to recruit	['Insufficient_Enrollment']	['Neutral']
Business decision to not perform this study.	['Business_Administrative']	['Possibly_Negative']
High recurrence of headache in SPG group.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Sponsor strategy change	['Business_Administrative']	['Possibly_Negative']
COVID19 changed the workflow within the department and the study is no longer feasible	['Covid19']	['Neutral']
Research site no longer available	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
A more highly selected protocol with ESO TCR opened for pts with melanoma	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
due to low accrual	['Insufficient_Enrollment']	['Neutral']
not enough patients	['Insufficient_Enrollment']	['Neutral']
Sponsor withdrew and updated study design. Refer to NCT03183895.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Could not achieve target enrollment	['Insufficient_Enrollment']	['Neutral']
IP unavailable at site.	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
"Low prevalence of malaria, high prevalence of reported allergy to sulphur drugs, high
    proportion of women not meeting the inclusion criterea."	['Insufficient_Enrollment']	['Neutral']
"Inclusion-rate does not seem feasible anymore to obtain te required number of patients before
    the end of the trial."	['Insufficient_Enrollment']	['Neutral']
Unable to meet study requirements	['Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral']
analysis at 50% inclusion showed 4 times larger reoperation rate in X-stop group	['Endpoint_Met', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
resource and prioritization change as Network transition to a new funding cycle	['Business_Administrative']	['Possibly_Negative']
Study never submitted to IND. Study is being sponsored by Johnson and Johnson in the EU only.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Sufficient clinical evidence was gathered	['Success', 'No_Context', 'Endpoint_Met']	['Success', 'Invalid_Reason', 'Neutral']
Study was changed to Insulin, hypotension and sarcopenia	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
This protocol is closed to further enrollment due to lack of study progress.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Unable to obtain FDA approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Sponsor decision not related to safety reasons	['Business_Administrative']	['Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Lack of efficacy	['Negative']	['Negative']
Merck requested to change MK-3475 dosing schedule; PI decided to close instead	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Per protocol - interim analysis showed no significant PSA declines among the first 12 patients
    after 3 cycles of treatment"	['Negative']	['Negative']
failure to recruit	['Insufficient_Enrollment']	['Neutral']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
organizationally not possible	['Business_Administrative']	['Possibly_Negative']
Logistical difficulties	['Logistics_Resources']	['Neutral']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
PI has relocated to another institution, no other site PI to take over	['Study_Staff_Moved']	['Neutral']
Withdrawals from study due to anticipated effects from study drugs	['Negative']	['Negative']
Our anesthesiologist was no longer available to assist.	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
The study stopped due to slow enrollment and low participant compliance.	['Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral']
Funding was never available to conduct the proposed series of experiments.	['Business_Administrative']	['Possibly_Negative']
Sponsor funding stopped	['Business_Administrative']	['Possibly_Negative']
Study is withdrawn because of administrative reasons	['Business_Administrative']	['Possibly_Negative']
per sponsor decision	['Business_Administrative']	['Possibly_Negative']
Business decision: no safety or efficacy concerns	['Business_Administrative']	['Possibly_Negative']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
poor recruitment	['Insufficient_Enrollment']	['Neutral']
Funding issues	['Business_Administrative']	['Possibly_Negative']
We don't have students/research staff who are able to continue data collection	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Lack of study personnel	['Logistics_Resources']	['Neutral']
Miscommunication with the CRO that was hired to help with the regulatory submission process	['Business_Administrative']	['Possibly_Negative']
Slow Enrollment	['Insufficient_Enrollment']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
The research team is exploring device optimization	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
no more subjects for recrutment	['Insufficient_Enrollment']	['Neutral']
Preliminary analysis showed little or no bioactivity.	['Negative']	['Negative']
lack of funding	['Business_Administrative']	['Possibly_Negative']
too slow recruitment; lack of resources	['Insufficient_Enrollment']	['Neutral']
Terminated due to dose limiting toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"The study was closed to accrual due to the end of the clinical development program with
    cixutumumab."	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Study terminated due to slow enrollment.	['Insufficient_Enrollment']	['Neutral']
Lack of efficacy caused enrollment to be stopped at the end of dose escalation	['Negative']	['Negative']
As per sponsor	['Business_Administrative']	['Possibly_Negative']
The study was terminated due to a considerably lower recruitment rate than anticipated	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Due to slow recruitment.	['Insufficient_Enrollment']	['Neutral']
Sponsor support withdrawn	['Business_Administrative']	['Possibly_Negative']
See Detailed Description	['No_Context']	['Invalid_Reason']
insufficient funding and resource	['Business_Administrative']	['Possibly_Negative']
Reprioritization of study programs	['Business_Administrative']	['Possibly_Negative']
Change in research focus	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Drugs unavailable- study terminated 1/2/18	['Logistics_Resources']	['Neutral']
Lack of patient population	['Insufficient_Enrollment']	['Neutral']
Decline of eligible participants	['Insufficient_Enrollment']	['Neutral']
29-Apr-14 UPENN IRB granted approval to close study due to lack of funding	['Business_Administrative']	['Possibly_Negative']
Investigator left institution	['Study_Staff_Moved']	['Neutral']
Sponsor decided to discontinue study drug development	['Business_Administrative']	['Possibly_Negative']
Contractual issues have halted study set up	['Business_Administrative']	['Possibly_Negative']
Terminated (Decision by the Sponsor. The study was not terminated due to a safety reason.)	['Safety_Sideeffects', 'Logistics_Resources', 'Endpoint_Met']	['Safety_Sideeffects', 'Neutral', 'Neutral']
"This study was terminated after a pre-specified interim analysis. Please see Detailed Study
    Description for further information."	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
Low recruitment rate.	['Insufficient_Enrollment']	['Neutral']
unable to recruit in suitable time frame	['Insufficient_Enrollment']	['Neutral']
Early termination due to slow enrollment and protocol-defined stopping rule.	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Invalid_Reason']	['Safety_Sideeffects', 'Neutral', 'Invalid_Reason']
Pending further safety information regarding polysaccharides and premature infants	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Study location changed	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
No update for several year, confermed ended by Odd Edvardsen i march 2020.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Strategic hold	['Business_Administrative']	['Possibly_Negative']
no longer RCT - same surgical technique and implant used	['Study_Design']	['Neutral']
Closure of Indiana University Health Proton Center in December 2014	['Logistics_Resources', 'Study_Staff_Moved', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
PI left University	['Study_Staff_Moved']	['Neutral']
Sponsoring company ceased business operations	['Business_Administrative']	['Possibly_Negative']
not funded	['Business_Administrative']	['Possibly_Negative']
"The trial was discontinued due to sponsor's decision and not a consequence of any safety
    concern."	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
"The decision to end the study was based on a change in GSK strategy. No subjects were enrolled
    into the study."	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
No accrual - closed by PRMC	['Insufficient_Enrollment']	['Neutral']
Difficulty in enrolling subjects	['Insufficient_Enrollment']	['Neutral']
IRB Study Closure	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Slow Recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Sponsor/funding source decided to not move forward.	['Business_Administrative']	['Possibly_Negative']
There was no participants enrolled in this clinical trial.	['Insufficient_Enrollment']	['Neutral']
"Due to the fact that we were unable to find subjects who met all inclusion and exclusion
    criteria it was determined to withdraw this study."	['Insufficient_Enrollment']	['Neutral']
Interim data was sufficient for study purpose	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Main investigator changed affiliation.	['Study_Staff_Moved']	['Neutral']
No member of staff available for active recruitment at the moment	['Insufficient_Enrollment']	['Neutral']
unable to recruit patients	['Insufficient_Enrollment']	['Neutral']
due to sample problem	['Insufficient_Enrollment']	['Neutral']
Randomization flawed. Results were poor in the innovative catheter group	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
"Due to company decision to focus resources on a larger, controlled study in this patient
    population."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
"Temporarily paused due to COVID-19 and expected to resume. This is not a suspension of IRB
    approval."	['Covid19']	['Neutral']
Sponsor's decision	['Business_Administrative']	['Possibly_Negative']
Initial Principal Investigator no longer at institution.	['Study_Staff_Moved']	['Neutral']
lack of consistent enrollment, follow up and results	['Insufficient_Enrollment']	['Neutral']
Difficult to recruit to.	['Insufficient_Enrollment']	['Neutral']
Sponsor decision; not safety related	['Business_Administrative']	['Possibly_Negative']
Insufficient Accrual	['Insufficient_Enrollment']	['Neutral']
Trial halted early due to limited ability to recruit participants	['Insufficient_Enrollment']	['Neutral']
Study stopped early due to investigator conflict of interest.	['Business_Administrative']	['Possibly_Negative']
failure to recruit enough patients	['Insufficient_Enrollment']	['Neutral']
changes in available treatments for melanoma	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Circumstances beyond the course of the trial have produced a change in the conditions of
    recruitment unacceptable to the ROMPA researchers"	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
ANX005 well tolerated at doses studied; study discontinued and initiated in patient population	['Negative']	['Negative']
No funding	['Business_Administrative']	['Possibly_Negative']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Withdrawn before recruitment started.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
"The manufacturer Arog Pharmaceuticals Inc has terminated the Agreement Concerning the Support
    of an Investigator Initiated Trial this became valid on 2020/03/09"	['Business_Administrative']	['Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
"Enrollment and interactions/interventions paused due to COVID-19. Expected to resume in the
    future. This is not a suspension of IRB approval"	['Covid19']	['Neutral']
Lack of patients, lack of funding for analysis	['Business_Administrative']	['Possibly_Negative']
PI closed study due to lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
the numbers of drop-out patients are more than we anticipate	['Insufficient_Enrollment']	['Neutral']
After enrollment of half the subjects, the trial was unlikely to yield results	['Negative']	['Negative']
Lack of timely accrual.	['Insufficient_Enrollment']	['Neutral']
Study terminated due to lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Slow accrual, closed by IRB	['Insufficient_Enrollment']	['Neutral']
Financial and administrative matters did not allow collaboration among centers.	['Business_Administrative']	['Possibly_Negative']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Terminated due to COVID-19	['Covid19']	['Neutral']
Year 1 of study completed. No enrollment planned for Year 2 of study.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
It was impossible to recruit the scheduled number of patients	['Insufficient_Enrollment']	['Neutral']
Grantor withdrew from study	['Business_Administrative']	['Possibly_Negative']
Sponsor decision - subjects rolled over to protocol 20101116	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Halted due to high incidence of veno-oclusive disease of the liver.	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Lack of funds	['Business_Administrative']	['Possibly_Negative']
Investigator left the institution	['Study_Staff_Moved']	['Neutral']
Study suspended due to logistical/personnel difficulties	['Logistics_Resources']	['Neutral']
"Based on results from an ALTITUDE study interim analysis, testing aliskiren concomitantly with
    an ACE inhibitor or ARB, in diabetics with renal impairment"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Toxicity. Only enrolled patients in phase I portion of trial.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Combination of no funding and time commitments on PI	['Business_Administrative']	['Possibly_Negative']
no patient uptake	['Insufficient_Enrollment', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
study terminated due to low accrual	['Insufficient_Enrollment']	['Neutral']
Study stopped due to lack of accrual	['Insufficient_Enrollment']	['Neutral']
Poor Response Rate	['Insufficient_Enrollment']	['Neutral']
Study concept was terminated.	['Invalid_Reason']	['Invalid_Reason']
Results of the interim analysis suggested no significant diff between study groups.	['Negative']	['Negative']
Intended length of study ended	['Invalid_Reason']	['Invalid_Reason']
Possible change in study protocol	['Study_Design']	['Neutral']
Futility interim analysis of the Induction Study HMPL-004-03.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
unacceptable toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Lack of budget	['Business_Administrative']	['Possibly_Negative']
Sponsor funding ended	['Business_Administrative']	['Possibly_Negative']
He could not be started due to lack of funds	['Business_Administrative']	['Possibly_Negative']
issue with project feasibility	['Logistics_Resources']	['Neutral']
Study changed to a placebo controlled trial of dextromethorphan	['Negative', 'Another_Study']	['Negative', 'Neutral']
study was on hold for protocol redesign; decided to not move forward with study.	['Study_Design']	['Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
"This complex study included a pilot and a main part. As the results of the pilot study were
    satisfying and conclusive, the main study was not performed."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Terminated because of slow recruitment and lack of funding support	['Business_Administrative']	['Possibly_Negative']
Manufacturer discontinued production of Amevive: business decision.	['Business_Administrative']	['Possibly_Negative']
Study funding ended before last round of data collection could be complete.	['Business_Administrative']	['Possibly_Negative']
Principal Investigator left the university	['Study_Staff_Moved']	['Neutral']
due to COVID19	['Covid19']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Due to resource problems in the clinic at University Hospital Odense	['Logistics_Resources']	['Neutral']
Lack of accrual - terminated	['Insufficient_Enrollment']	['Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Funding for the study fell through.	['Business_Administrative']	['Possibly_Negative']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
interrupted early due to the drastic reduction in the number of cases	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
No patients with renal failure	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
MTD not determined	['Interim_Analysis', 'Regulatory', 'Negative']	['Neutral', 'Neutral', 'Negative']
The sponsor's study closure justification addressed the 522 Order's questions.	['Business_Administrative']	['Possibly_Negative']
low enrollment	['Insufficient_Enrollment']	['Neutral']
side effect profile did not match expectations	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Company decision taken in light of demands by certain national health authorities	['Business_Administrative']	['Possibly_Negative']
The trial was terminated because of difficulties in recruitement.	['Insufficient_Enrollment']	['Neutral']
Study will not go forward	['Invalid_Reason']	['Invalid_Reason']
Study staff change.	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
delay in recruitment, lack of additional funding	['Business_Administrative']	['Possibly_Negative']
Recruitment problems due to change of patient population at site.	['Insufficient_Enrollment']	['Neutral']
Stopped with agreement from FDA.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Comparator was not available in the planned setting	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
unable to secure funding and long term follow up	['Business_Administrative']	['Possibly_Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Change of Focus for the company	['Business_Administrative']	['Possibly_Negative']
unable to find subjects meeting inclusion criteria	['Insufficient_Enrollment']	['Neutral']
"The Sponsor is terminating the study because the primary objective was achieved after 5 of the
    6 subjects were assessed in the final cohort."	['Interim_Analysis', 'Endpoint_Met', 'Negative']	['Neutral', 'Neutral', 'Negative']
drug supply became unavailable	['Logistics_Resources']	['Neutral']
Low enrollment. Treament no longer used by researchers.	['Insufficient_Enrollment']	['Neutral']
Safety issues/concerns per DF/HCC PI	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Drug was not sent	['Logistics_Resources']	['Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
lack of inclusion	['Insufficient_Enrollment']	['Neutral']
Closed to accrual 4/19/2006 / Study doesn't qualify for reporting.	['Insufficient_Enrollment']	['Neutral']
no open study	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
The study was terminated due to an unexpected toxicity finding.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Unable to enroll the appropriate number of subjects within a reasonable timeframe.	['Insufficient_Enrollment']	['Neutral']
Number of enrolled patients was insufficient during planned inclusion time.	['Insufficient_Enrollment']	['Neutral']
"Mandated by DSMB because of lack of protective effect of carrageenan, higher proportion of
    adverse events in the carrageenan compared to placebo arm, and low probability that continued
    accrual would lead to a significant protective effect."	['Negative']	['Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
no eligible patients; study stopped without inclusion	['Insufficient_Enrollment']	['Neutral']
Lack of patients	['Insufficient_Enrollment']	['Neutral']
This study was temporarily paused due to an unanticipated bioanalytical issue.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
enrollment much slower than anticipated, and, funding issues	['Business_Administrative']	['Possibly_Negative']
Terminated early due to discovery of new mechanism of activation.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
PI Left university	['Study_Staff_Moved']	['Neutral']
Difficulties for patients inclusion	['Insufficient_Enrollment']	['Neutral']
Lack of subject enrollment	['Insufficient_Enrollment']	['Neutral']
A funding mechanism is not identified at this time	['Business_Administrative']	['Possibly_Negative']
Insufficient number of adverse events	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
"Due to rare patient population, planned number of patients could not be recruited in a
    reasonable timeframe. Recruitment was stopped prematurely."	['Insufficient_Enrollment']	['Neutral']
Administrative	['Business_Administrative']	['Possibly_Negative']
At the discretion of the PI	['Study_Staff_Moved', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
low enrollment	['Insufficient_Enrollment']	['Neutral']
Inadequate clinical supplies and Emmaus business decision.	['Business_Administrative']	['Possibly_Negative']
"Conduct the randomized Phase 2 part not recommended due to the achieved MTD for pimasertib
    (45mg/day) in combination with FOLFIRI"	['Negative']	['Negative']
Lack of funding.	['Business_Administrative']	['Possibly_Negative']
PI left	['Study_Staff_Moved']	['Neutral']
Study was withdrawn due to a business decision.	['Business_Administrative']	['Possibly_Negative']
Statistical power could not be achieved due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Study objectives no longer met business need	['Business_Administrative']	['Possibly_Negative']
Clinical Trial Agreement not executed	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Poor patient recruitment	['Insufficient_Enrollment']	['Neutral']
Other researchers have published results on a similar trial	['Negative', 'Another_Study']	['Negative', 'Neutral']
Difficulty obtaining IDE by the FDA. Currently not worthwhile to pursue further.	['Business_Administrative']	['Possibly_Negative']
Withdrawn due to low accrual	['Insufficient_Enrollment']	['Neutral']
no approval by CA	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Never funded	['Business_Administrative']	['Possibly_Negative']
Study TLK199.2103 was terminated for business reasons.	['Business_Administrative']	['Possibly_Negative']
low enrollment, 2 pts enrolled no data every analyzed investigator left the institution	['Insufficient_Enrollment']	['Neutral']
Study will no longer take place, the study did not begin or accrue subjects.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Withdrawn as trial was never activated by SuperGen	['Business_Administrative']	['Possibly_Negative']
Inclusion stopped at 50% after interim analysis: primary efficacy endpoint not significant	['Negative']	['Negative']
The whole project was terminated	['Invalid_Reason']	['Invalid_Reason']
Unable to reach target enrollment of 60 subjects	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
No eligible patient.	['Insufficient_Enrollment']	['Neutral']
Sponsor stopped due to difficulties to recruit 130 patients required by protocol	['Insufficient_Enrollment']	['Neutral']
PI deparature and very low (<2%) accrual rate.(No results required)	['Insufficient_Enrollment']	['Neutral']
This study has been withdrawn prior to enrollment.	['Invalid_Reason']	['Invalid_Reason']
Lack of enrollment numbers - participants are no longer being examined	['Insufficient_Enrollment']	['Neutral']
Study terminated based on evaluation of safety data.	['Safety_Sideeffects', 'Endpoint_Met', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
"Unable to register Treatment IND with the US Food And Drug Administration's new process of
    establishing TLS encryption for email correspondence."	['Regulatory', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Suspended to determine if Mirena device could be charged to patient insurance	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Difficulties concerning the recruitment of participants	['Insufficient_Enrollment']	['Neutral']
"Given the number of toxicities seen and the difficulty with patient retention in the dose
    escalation portion, the sponsor decided to close the trial."	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Sponsor's decision	['Business_Administrative']	['Possibly_Negative']
change study design and funding	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The researcher had left the hospital and the project was stopped	['Study_Staff_Moved']	['Neutral']
IRB closed study due to no enrollment over 4 yrs	['Insufficient_Enrollment']	['Neutral']
Study was withdrawn from IRB review on 03/08/16	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Very limited enrollment	['Insufficient_Enrollment']	['Neutral']
"after 4 years of recruitment only 16 patients have been included. Due to this low rate of
    recruitment it was decided to stop the study"	['Insufficient_Enrollment']	['Neutral']
No longer active	['Invalid_Reason']	['Invalid_Reason']
company dissolved	['Business_Administrative']	['Possibly_Negative']
Enrollment difficulty	['Insufficient_Enrollment']	['Neutral']
Funding constraints	['Business_Administrative']	['Possibly_Negative']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Not funded	['Business_Administrative']	['Possibly_Negative']
This study was stopped early due to slow enrollment.	['Insufficient_Enrollment']	['Neutral']
COVID-19	['Covid19']	['Neutral']
Due to few capacities 2011 to 2016 the study was withdrawn.	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"This study was terminated at the recommendation of an independent Data Monitoring Committee.
    The decision was not based on any safety concerns."	['Negative']	['Negative']
slow enrollment and discontinued once original principal investigator left Emory	['Insufficient_Enrollment']	['Neutral']
Low enrollment and need to refine protocol	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
terminated after 2 patients due to difficulty in enrollment	['Insufficient_Enrollment']	['Neutral']
"Terminated due to slow enrollment and interim analysis showing no difference between treatment
    arms."	['Negative']	['Negative']
Interim results showed that the HATCP material was not non-inferior to the AUTO graft.	['Negative']	['Negative']
departure of the coordinating investigator from another institution	['Study_Staff_Moved']	['Neutral']
Manufacturer discontinued Sylatron	['Covid19', 'Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
Due to the covid-19 pandemic	['Covid19']	['Neutral']
"This study was terminated. An IT injection study of C. novyi-NT in patients with treatment
    refractory solid tumor malignancies may be viewed at NCT01924689."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Funding not available, study did not open to accrual and will not open in future	['Business_Administrative']	['Possibly_Negative']
Target sample size not reached for enrollment.	['Insufficient_Enrollment']	['Neutral']
recruitment not met	['Insufficient_Enrollment']	['Neutral']
Study was terminated due to lack of funding.	['Business_Administrative']	['Possibly_Negative']
The company DNage is in receivership and no longer functional	['Business_Administrative']	['Possibly_Negative']
low enrollment	['Insufficient_Enrollment']	['Neutral']
Difficulties for recruitment	['Insufficient_Enrollment']	['Neutral']
low inclusion rate	['Insufficient_Enrollment']	['Neutral']
Loss of finacial support	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Unavailability of Triembutine maleate	['Logistics_Resources']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
lack of sufficient accrual	['Insufficient_Enrollment']	['Neutral']
Funding issues	['Business_Administrative']	['Possibly_Negative']
"Recurrent equipment failures (used with custom EEG and ERP recording software) precluded timely
    data collection and analysis activities."	['Logistics_Resources']	['Neutral']
Due to the slow recruitment of patients	['Insufficient_Enrollment']	['Neutral']
Inclusion was difficult and to slow	['Insufficient_Enrollment']	['Neutral']
Difficulties of internal organization	['Business_Administrative']	['Possibly_Negative']
Difficulty in recruiting patients	['Insufficient_Enrollment']	['Neutral']
Ongoing insights required a different approach	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Funding cut, no patients enrolled	['Business_Administrative']	['Possibly_Negative']
Study was closed due to low accrual before the accrual goal was reached	['Insufficient_Enrollment']	['Neutral']
Low accrual.	['Insufficient_Enrollment']	['Neutral']
Study was discontinued prematurely due to funding insecurity	['Business_Administrative']	['Possibly_Negative']
Development of XL999 was stopped due to cardiac toxicities in the subjects	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"Study must be registered under the sponsor instead of the site, so we have created a new
    posting in the sponsor's account."	['Covid19', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Insufficient Subject Recruitment	['Insufficient_Enrollment']	['Neutral']
Principal investigator determination	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
amendment pending	['Study_Design']	['Neutral']
Covid halt in March; PI subsequently moved to another Institution	['Covid19']	['Neutral']
Administrative barriers	['Business_Administrative']	['Possibly_Negative']
Suspended (Pandemic caused by Coronavirus)	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Funding mechanism compromised	['Business_Administrative']	['Possibly_Negative']
"Not enough resources in place; COVID-19 pandemic impedes working on the project and travelling
    within the EU"	['Covid19']	['Neutral']
a new study has began recently	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Local authorities no longer require routine PMS studies;GSK does not believe the study would
    add meaningfully to the safety data already available for Synflorix"	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
not adequate resources	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Political Issues in Algeria and now Covod-19 lock-down	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Sufficient number of subjects accrued to conduct analysis	['Invalid_Reason']	['Invalid_Reason']
Lack of staff to enroll patients in this study	['Insufficient_Enrollment']	['Neutral']
Failed to recruit full number of patients	['Insufficient_Enrollment']	['Neutral']
The NHLBI BSMB recommended closure due to poor enrollment.	['Insufficient_Enrollment']	['Neutral']
Intermediate analysis	['Negative']	['Negative']
"It appeared to be impossible for the study centres to recruit the targeted number of patients,
    due to reduced incidence and reduced acceptance to IMP"	['Insufficient_Enrollment']	['Neutral']
Inadequate number of charts available for Test Group	['Logistics_Resources']	['Neutral']
study not funded	['Business_Administrative']	['Possibly_Negative']
To optimize device	['Study_Design']	['Neutral']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
Study was terminated due to sponsor's decision.	['Business_Administrative']	['Possibly_Negative']
No Participants Enrolled	['Insufficient_Enrollment']	['Neutral']
"Since no safety issues have been reported to date in association with TAG vaccine, no further
    survival follow-up will be done."	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Lack of patients	['Insufficient_Enrollment']	['Neutral']
Terminated by IRB	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Sponsor terminated RRMS studies as sufficient long term clinical data was collected for the
    study drug in the relevant dose."	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
financing delays	['Business_Administrative']	['Possibly_Negative']
Lack of Efficacy	['Negative']	['Negative']
PI decision	['Invalid_Reason']	['Invalid_Reason']
Sponsor's decision to terminate the study after Phase 1; will not proceed with Phase 2.	['Business_Administrative']	['Possibly_Negative']
"Although the defined success rate needed for continuation of the investigation was met, due to
    the overall low success rate; it was considered, particularly considering the ongoing pandemic,
    to discontinue the investigation prematurely."	['Negative', 'Business_Administrative']	['Negative', 'Possibly_Negative']
Toxicity and lack of efficacy	['Negative']	['Negative']
Insufficient number of subjects could be enrolled.	['Insufficient_Enrollment']	['Neutral']
No longer enrolling patients, not enough enrollment	['Insufficient_Enrollment']	['Neutral']
new study type, it will be re-organiZed as an Investigator Initiated Study (IIS)	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Enrollment slower than expected	['Insufficient_Enrollment']	['Neutral']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
"1. Slow recruitment; 2. Change to clinical environment reducing the pool of potentially
    eligible patients; 3. Availability of data from another similar study"	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Study facing recruitment difficulties related to stringent eligibility criteria	['Insufficient_Enrollment']	['Neutral']
End of support	['Business_Administrative']	['Possibly_Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Not enough inclusions	['Insufficient_Enrollment']	['Neutral']
Funding expired	['Business_Administrative']	['Possibly_Negative']
PI moving to another institution with NIH grant relinquished.	['Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The trial was prematurely terminated due to low recruitment	['Insufficient_Enrollment']	['Neutral']
unable to increase to target enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsor terminated study	['Business_Administrative']	['Possibly_Negative']
Enrollment stopped for chemistry work on investigational product.	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Administratively terminated.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
The recruitment rate was much slower than expected.	['Insufficient_Enrollment']	['Neutral']
new sponsor	['Business_Administrative']	['Possibly_Negative']
Optimize calibration	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
access to human body samples by another existing cohort	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Insuffisent recruitment	['Insufficient_Enrollment']	['Neutral']
Could not recruit eligible PhD-candidate to take on the project	['Insufficient_Enrollment']	['Neutral']
Business decision	['Business_Administrative']	['Possibly_Negative']
The study did not recruit any patients.	['Insufficient_Enrollment']	['Neutral']
"In HPS2-THRIVE, MK-0524A did not meet the primary efficacy objective and there was a
    significant increase in incidence of some types of non-fatal SAEs"	['Negative']	['Negative']
"The trial has terminated early due to the disruptions caused by the ongoing COVID-19 pandemic.
    The decision was not related to any efficacy, safety or clinical concerns regarding
    rVA576/Coversin."	['Covid19']	['Neutral']
The study was stopped for futility at the first interim analysis	['Negative']	['Negative']
Terminated due to lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Insys Therapeutics filed Chapter 11 and terminated all studies.	['Business_Administrative']	['Possibly_Negative']
PI relocated to a different country.	['Study_Staff_Moved']	['Neutral']
unknown - no record of study conduct in departmental archive	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
"Enrollment has been temporarily suspended by the Sponsor due to a shortage of drug supply
    resulting from a voluntary recall of ZERBAXA"	['Logistics_Resources']	['Neutral']
Facility where study was taking place closed.	['Logistics_Resources', 'Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Rate of enrollment too slow to allow completion in a reasonable timeframe	['Insufficient_Enrollment']	['Neutral']
the PI left our facility and the new staff prefer alternate excersises	['Study_Staff_Moved']	['Neutral']
PI discretion, low enrollment	['Insufficient_Enrollment']	['Neutral']
Strategic company decision	['Business_Administrative']	['Possibly_Negative']
This study was withdrawn due to business reasons.	['Business_Administrative']	['Possibly_Negative']
permanently closed per sponsor's request	['Business_Administrative']	['Possibly_Negative']
Withdrawn	['Invalid_Reason']	['Invalid_Reason']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Study dose changed based on recent publications	['Negative', 'Another_Study']	['Negative', 'Neutral']
Terminated due to withdrawal of support from our collaborator.	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Assay being revised and re-validated.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
This clinical trial was closed due to slow recruitment of patients.	['Insufficient_Enrollment']	['Neutral']
medical/ethical reasons	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Awaiting the results of interim data analysis.	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
The risk benefit in relapsed refractory AML does not favor continuation of the study.	['Negative']	['Negative']
Investigator left NIH	['Study_Staff_Moved']	['Neutral']
Sponsor decision to close trial	['Business_Administrative']	['Possibly_Negative']
low enrollment	['Insufficient_Enrollment']	['Neutral']
study stopped because patient access became extremely limited for the initial data entry point.	['Insufficient_Enrollment']	['Neutral']
Inadequate recruitment	['Insufficient_Enrollment']	['Neutral']
Efficacy was not cleared at US study	['Negative']	['Negative']
Study was closed prematurely due to slow and insufficient accrual.	['Insufficient_Enrollment']	['Neutral']
Study was completed	['Invalid_Reason']	['Invalid_Reason']
PI left institution	['Study_Staff_Moved']	['Neutral']
"No patient enrolled after 6 months from the start. The decision to withdraw the study was based
    on a feasibility reevaluation conducted with investigators."	['Study_Design']	['Neutral']
Reevaluation of development strategy	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Based on a consistently low enrolment rate and procedural challenges that were unknown at study
    start. It was not based on safety or efficacy concerns."	['Logistics_Resources']	['Neutral']
shortage of experienced health care personnel after reorganisation of units	['Logistics_Resources']	['Neutral']
Study was halted at this time due to other budgetary priorities.	['Business_Administrative']	['Possibly_Negative']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
The company pulled durvalumab from heme malignancies	['Logistics_Resources', 'Regulatory', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Study was terminated due to continued enrolment difficulties.	['Insufficient_Enrollment']	['Neutral']
Rate of recruitment	['Insufficient_Enrollment']	['Neutral']
Study stopping criteria was met	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
"It appears Dr. Vanderbrink left Nationwide Children's Hospital in 2011 and efforts to reach Dr.
    Vanderbrink have been unsuccessful."	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
no inclusions	['Insufficient_Enrollment']	['Neutral']
Funding ended	['Business_Administrative']	['Possibly_Negative']
Lack of funding and other logistic reasons	['Business_Administrative']	['Possibly_Negative']
"The Contract of K-haler products had been terminated between Mundipharma and provider.
    Therefore, this clinical trial was terminated early."	['Business_Administrative']	['Possibly_Negative']
lack of accrual	['Insufficient_Enrollment']	['Neutral']
Due to Poor Accrual	['Insufficient_Enrollment']	['Neutral']
Problems with inclusion, >80% of patients included	['Insufficient_Enrollment']	['Neutral']
COVID19 pandemic	['Covid19']	['Neutral']
The study was suspended since july 27th 2016 because of unavailability of Everolimus	['Logistics_Resources']	['Neutral']
Hospital had initiated a conflicting study, hence the study was terminated.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
study suspended while data is reviewed for safety and efficacy.	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
poor recruitment and reduction in CT surgery support	['Insufficient_Enrollment']	['Neutral']
The product company withdrawn interest in participation in this study	['Business_Administrative']	['Possibly_Negative']
Unafavourable toxicity profile	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Experimental pain model didn't work as anticipated.	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
study was never opened to accrual	['Insufficient_Enrollment']	['Neutral']
The study was terminated due to insufficient recruitment.	['Insufficient_Enrollment']	['Neutral']
Unable to enroll prospective subject for dose escalation	['Insufficient_Enrollment']	['Neutral']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
no Sponsor	['Business_Administrative']	['Possibly_Negative']
PI was transferred to another base. No one else available to serve as PI.	['Study_Staff_Moved']	['Neutral']
Sponsor decision to terminate study (not due to safety reasons)	['Business_Administrative']	['Possibly_Negative']
This study is non-funded study and experienced difficulty in recruitment.	['Insufficient_Enrollment']	['Neutral']
Study was not given ethical approval- a alternative protocol required	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"it is unethical to continue a study with deactivation of HM in the control arm although a
    reduced risk of all-cause death has been shown in previous trials"	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Due to poor accrual of the study	['Insufficient_Enrollment']	['Neutral']
"Study halted early due to no efficacy improvement over aspirin at an interim analysis and very
    little chance of showing overall benefit if study were completed"	['Negative']	['Negative']
The protocol has been withdrawn for re-evaluation.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Not human subject research	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Administrative	['Business_Administrative']	['Possibly_Negative']
Slow enrollment, feasibility issues	['Insufficient_Enrollment']	['Neutral']
Changes to surgical practices led to the loss of eligible patients	['Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral']
Another study published with similar results	['Negative', 'Another_Study']	['Negative', 'Neutral']
Funding cycle completed	['Business_Administrative']	['Possibly_Negative']
Due to low recruitment	['Insufficient_Enrollment']	['Neutral']
"Impossible to include patients at a correct rate; patients don't want to come back so they
    refuse participation."	['Insufficient_Enrollment']	['Neutral']
Stopped due to low recruitment.	['Insufficient_Enrollment']	['Neutral']
Recruitment Difficulties due to some factors	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Only 4 participants were recruited from 130 potential participants.	['Insufficient_Enrollment']	['Neutral']
"The study was discontinued due to slow recruitment and subjects not completing follow up
    period."	['Insufficient_Enrollment']	['Neutral']
New clinical finding with Celebrex and cardiac concerns.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Difficulty in patient recruitment	['Insufficient_Enrollment']	['Neutral']
has not begun yet.	['Invalid_Reason']	['Invalid_Reason']
Study completed	['Invalid_Reason']	['Invalid_Reason']
Due to slow enrollment the study was terminated early	['Insufficient_Enrollment']	['Neutral']
Terminated for convenience of the Government due to funding constraits	['Business_Administrative']	['Possibly_Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Inclusion and Exclusion criteria too stringent, no patient coluld be recruited	['Insufficient_Enrollment']	['Neutral']
Terminated due to lack of enrollment at target sites	['Insufficient_Enrollment']	['Neutral']
similar large study planned by NHLBI	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study was dropped and never started.	['Invalid_Reason']	['Invalid_Reason']
Slow subject recruitment.	['Insufficient_Enrollment']	['Neutral']
On hold due to COVID-19 outbreak	['Covid19']	['Neutral']
"The required number of banked samples could not be met due to limited availability. There is no
    realistic possibility to complete the study succesfully."	['Insufficient_Enrollment']	['Neutral']
The study was withdrawn due to an internal decision	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
"Decision to open a randomized controlled trial with two groups receiving different Botulinum
    Toxin in comparison to placebo group."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
The study has been terminated due to limited participant enrollment.	['Insufficient_Enrollment']	['Neutral']
COVID-19	['Covid19']	['Neutral']
lack of interest	['Business_Administrative']	['Possibly_Negative']
The trial was terminated due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
Principal Investigator left the institution	['Study_Staff_Moved']	['Neutral']
recruitement unsuccessful	['Insufficient_Enrollment']	['Neutral']
Difficulties for recruiting patients	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
Study concluded prematurly	['Invalid_Reason']	['Invalid_Reason']
Funding was withdrawn by Sponsor prior to start of study	['Business_Administrative']	['Possibly_Negative']
Original PI relocated to another institution	['Study_Staff_Moved']	['Neutral']
Unable to secure supply of the study medication	['Logistics_Resources']	['Neutral']
The development program has been terminated	['Business_Administrative']	['Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
study never started due to funding issues	['Business_Administrative']	['Possibly_Negative']
Inadequate funding to continue the study	['Business_Administrative']	['Possibly_Negative']
Slow enrolment	['Insufficient_Enrollment']	['Neutral']
Recruitment too slow and site decided to use hypothermia (exclusion criteria)	['Insufficient_Enrollment']	['Neutral']
(Non-safety reason, business objectives have changed)	['Business_Administrative']	['Possibly_Negative']
Enrollment completed. Outcomes measured after only 1 yr due to loss of funding.	['Business_Administrative']	['Possibly_Negative']
Difficulties in recruitment	['Insufficient_Enrollment']	['Neutral']
it is very difficult to recruit qualified patients	['Insufficient_Enrollment']	['Neutral']
No participants recruited, study discontinued.	['Insufficient_Enrollment']	['Neutral']
Study terminated early due to inability to enroll.	['Insufficient_Enrollment']	['Neutral']
The project was not funded.	['Business_Administrative']	['Possibly_Negative']
"In conjunction with the overall risk-benefit assessment, study was terminated prematurely due
    to safety concerns."	['Safety_Sideeffects', 'Endpoint_Met', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Reform CAR structure due to safety consideration	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"The study was closed by the Sponsor according to the protocol-specified minimum post-treatment
    follow-up period of 3 years."	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Low Recruitment	['Insufficient_Enrollment']	['Neutral']
Terminated at Continuing Review	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study not initiated at our site.	['Invalid_Reason']	['Invalid_Reason']
"Study halted prematurely and will not resume; participants are no longer being examined or
    receiving intervention"	['Invalid_Reason', 'Study_Design']	['Invalid_Reason', 'Neutral']
Patient compliance was low.	['Study_Design']	['Neutral']
Interim analysis concluded to futility	['Negative']	['Negative']
Unable reach recruitment	['Insufficient_Enrollment']	['Neutral']
Business decision	['Business_Administrative']	['Possibly_Negative']
Study closed early secondary to inability to obtain grant funding to conduct.	['Business_Administrative']	['Possibly_Negative']
"Not enough participants could be enrolled and so the PI decided to close the study. No
    participants completed the study"	['Insufficient_Enrollment']	['Neutral']
Lack of Recruitment	['Insufficient_Enrollment']	['Neutral']
Inadequate Recruitment	['Insufficient_Enrollment']	['Neutral']
No final agreement with sponsor	['Business_Administrative']	['Possibly_Negative']
low anticipated recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
First milestone was not met.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
The number of enrollment cases is too small.	['Insufficient_Enrollment']	['Neutral']
Not funded Administrative formalities not completed	['Business_Administrative']	['Possibly_Negative']
Sponsor terminated due to low accrual.	['Insufficient_Enrollment']	['Neutral']
Termination due to acquisition of PEAK Surgical by Medtronic	['Business_Administrative']	['Possibly_Negative']
Low recruitment rate	['Insufficient_Enrollment']	['Neutral']
not start in coming years	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Poor enrolment	['Insufficient_Enrollment']	['Neutral']
Study modified to a two-group crossover design and transferred to new location.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Sponsor's decision	['Business_Administrative']	['Possibly_Negative']
Recruitment very difficult; only preliminary data usable.	['Insufficient_Enrollment']	['Neutral']
decided not to proceed with study at this time	['Invalid_Reason']	['Invalid_Reason']
Significant changes have been made to the protocol.	['Study_Design']	['Neutral']
Failure to meet the schedule of patient recruitment	['Insufficient_Enrollment']	['Neutral']
This study was terminated due to limited enrollment.	['Insufficient_Enrollment']	['Neutral']
Dose limiting toxicities on lowest dose level	['Safety_Sideeffects', 'Endpoint_Met', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Enrollment and study activities are temporarily suspended due to COVID-19.	['Covid19']	['Neutral']
Changing conditions for the device in one of the participation companies	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Please see Detailed Description for termination reason.	['No_Context']	['Invalid_Reason']
Recruitment has been suspended during COVID19 Pandemic	['Covid19']	['Neutral']
end of study of this product	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
Sponsor decided to stop for lack of efficacy	['Negative']	['Negative']
PI had difficult enrollment.	['Insufficient_Enrollment']	['Neutral']
Logistic challenges	['Logistics_Resources']	['Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Study has been withdrawn as the H1N1 epidemic made this study redundant	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Poor accrual - terminated during Phase I; Phase II never started.	['Insufficient_Enrollment']	['Neutral']
Logistical problems prior to the recruitment phase.	['Logistics_Resources']	['Neutral']
Recruitment goal could not be achieved	['Insufficient_Enrollment']	['Neutral']
Essure no longer sold in the US after Dec 2018; Sponsor requested trial be ended	['Business_Administrative']	['Possibly_Negative']
Business decision not related to any safety or tolerability concern	['Business_Administrative']	['Possibly_Negative']
The program responsible for recruitment was dismantled in 2006.	['Logistics_Resources', 'Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
no participants enrolled	['Insufficient_Enrollment']	['Neutral']
logistics	['Logistics_Resources']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Difficulty in recruitment	['Insufficient_Enrollment']	['Neutral']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
slow accrual rate; interim accrual objective met	['Insufficient_Enrollment']	['Neutral']
PI moved from Hadassah	['Study_Staff_Moved']	['Neutral']
No accrual due to rarity of disease.	['Insufficient_Enrollment']	['Neutral']
Site decided not to open this study	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
scarce interest of centres	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Funding Horizon	['Business_Administrative']	['Possibly_Negative']
Stopped due to funding	['Business_Administrative']	['Possibly_Negative']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
Accrual goals were no longer feasible based on restrictions imposed by the DSMB.	['Insufficient_Enrollment']	['Neutral']
"The FDA IND application is paused due to additional required testing. The IRB protocol was
    closed prior to research starting."	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study terminated due to declining enrollment; data analysis proceeding.	['Insufficient_Enrollment']	['Neutral']
Accrual rate was too low	['Insufficient_Enrollment']	['Neutral']
Funder has not approved protocol	['Business_Administrative']	['Possibly_Negative']
Due to the ACIP guidelines halting the use of LAIV	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The study activities are suspended due to COVID	['Covid19']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Due to the situation of virus Covid-19, recruitment is paused from 7th April.	['Covid19']	['Neutral']
"Recruitment goals were not achieved. Extension of the trial concept had to be abjected due to
    methodological reasons."	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Eclipse Shoulder System received 510(k) clearance on July 26, 2019.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Terminated for administrative reasons before enrollment was complete.	['Business_Administrative']	['Possibly_Negative']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
FDA IND was not obtained	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
COVID-19 pandemic	['Covid19']	['Neutral']
Not enough participants enrolled	['Insufficient_Enrollment']	['Neutral']
Lack of effect	['Negative']	['Negative']
Interim analysis showed more LCFs in one of the treatment arms	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Unexpected events	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Study did not get funded	['Business_Administrative']	['Possibly_Negative']
the trial was discontinued for legislative reasons.	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
As of 31 JAN 2018, the study was terminated by the sponsor due to PK variability.	['Negative', 'Business_Administrative']	['Negative', 'Possibly_Negative']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
"Stopped before any site initiation or any recruitment due to change in overall product
    development plan"	['Business_Administrative']	['Possibly_Negative']
"Sponsor has determined that information it would have collected would not inform future
    development of a therapy with AXA 1957 for NAFLD"	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Study stopped due to lack of elegible patient enrollment	['Insufficient_Enrollment']	['Neutral']
"Given the strength of CYP3A4 inhibition observed in Cohort 1, there is no rationale to
    investigate higher doses of GSK2647544 in the following two cohorts"	['Negative', 'Another_Study']	['Negative', 'Neutral']
The study never started since our Medical Ethic Commeettee did not approved it	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Terminated by IRB for continuing review	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Terminated early due to regulatory action suspending tegaserod use in 2007	['Regulatory']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
FDA released requirement to complete study	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Enrollment stopped for safety issues	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Change of treatment landscape and evolving standard of care	['Study_Design']	['Neutral']
Terminated by Sponsor	['Business_Administrative']	['Possibly_Negative']
poor data collection	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Schools are in lockdown due to COVID-19 pandemic	['Covid19']	['Neutral']
"This study was never completed because the company was not able to support the trial with
    devices."	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study terminated due to business decision	['Business_Administrative']	['Possibly_Negative']
Impossible to get a written informed consent beforehand	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Surgical Unit closed and moved.	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
in preparation for an amendment	['Study_Design']	['Neutral']
Low accrual and lack of funding.	['Insufficient_Enrollment']	['Neutral']
"In view of the notices concerning hydroxychloroquine issued by the regulatory authorities, we
    withdraw the protocol"	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Unable to recruit subjects in timely fashion for the study	['Insufficient_Enrollment']	['Neutral']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
We achieved n=38, due to slow recruitment (=2/3 of target).	['Insufficient_Enrollment']	['Neutral']
COVID-19 pandemic	['Covid19']	['Neutral']
We did not get funding to develop the clinical trial.	['Business_Administrative']	['Possibly_Negative']
technical problems	['Logistics_Resources']	['Neutral']
Trial has been cancelled due to availability of new therapeutic options for patient population	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Terminated due to prolonged subject recruitment	['Insufficient_Enrollment']	['Neutral']
Change in clinical strategy	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Change in study design and inability to recruit participants	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Study Terminated per Principal Investigator's request	['Study_Staff_Moved', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Logistic reasons	['Logistics_Resources']	['Neutral']
"The Interim analysis (100 patients) revealed a possible harm to patients randomised to the
    fresh frozen plasma (FFP) treatment arm."	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
This study is temporarily suspended due to COVID-19 pandemic.	['Covid19']	['Neutral']
Study was put on hold then out of Medical Plan therefore cancelled	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Sanofi-Aventis wanted the study terminated.	['Business_Administrative']	['Possibly_Negative']
Higher hemorrhage rates of Abciximab in ABESST II trial	['Negative', 'Another_Study']	['Negative', 'Neutral']
The study is no longer required based on nonclinical drug data	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Vaccine sponsor ceased operations.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Funding	['Business_Administrative']	['Possibly_Negative']
"The planned enrollment was 130 patients and the study was halted prematurely due to lack of
    efficacy in both arms. Enrolled patients continued treatment."	['Negative']	['Negative']
An interim analysis did not warrant to continue enrollment	['Interim_Analysis', 'Negative']	['Neutral', 'Negative']
"Study was terminated due to positive results seen in statistical analysis. Adequate patient
    enrollment was achieved."	['Success', 'No_Context', 'Safety_Sideeffects']	['Success', 'Invalid_Reason', 'Safety_Sideeffects']
funding withdrawal	['Business_Administrative']	['Possibly_Negative']
To difficult to recruit patients in the acute setting	['Insufficient_Enrollment']	['Neutral']
Premature closure for lack of efficacy.	['Negative']	['Negative']
Enrollment.	['Insufficient_Enrollment']	['Neutral']
Not funded	['Business_Administrative']	['Possibly_Negative']
"Due to Medtronic's voluntary withdrawal of PMA P040001 for X-STOP systems; post-approval study
    costs outweighed business benefits for marketing X-STOP in US."	['Business_Administrative']	['Possibly_Negative']
"During a safety review of studies U2970g and U2971g, the Data Monitoring Committee recommended
    that enrollment in this extension trial be terminated."	['Negative', 'Another_Study']	['Negative', 'Neutral']
PI moved institutions and changed study protocol	['Study_Staff_Moved']	['Neutral']
Per recommendation of the NHLBI DSMB	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The study was never initiated at any sites.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"Because of slow recruitment; Despite the study was started long time ago (Oct 2004), we have
    not reached the projected number of patients (150 patients)"	['Insufficient_Enrollment']	['Neutral']
Changes in treatment plan affecting drug therapy choices	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
we use this data as a pilot study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Sample size calculation would have been overinflated; re-think study design	['Study_Design']	['Neutral']
could not find subject population	['Insufficient_Enrollment']	['Neutral']
Lack of funding.	['Business_Administrative']	['Possibly_Negative']
Enough samples were collected for data analysis.	['Invalid_Reason']	['Invalid_Reason']
no funding	['Business_Administrative']	['Possibly_Negative']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Unable to meet enrollment goal prior to PI transfer	['Insufficient_Enrollment']	['Neutral']
Evident advantages of one treatment (seton) over the other (Tissucol Glue)	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Higher then expected Gr3 GU/GI toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Low recruitment. No safety issue associated.	['Insufficient_Enrollment']	['Neutral']
Financial problem	['Business_Administrative']	['Possibly_Negative']
Dissatisfactory enrollment rate	['Insufficient_Enrollment']	['Neutral']
"Terminated: recruiting or enrolling participants has halted prematurely and will not resume;
    participants are no longer being examined or treated"	['Invalid_Reason']	['Invalid_Reason']
COVID19 epidemic, and institutional guidelines for halt of recruitment during epidemic	['Covid19']	['Neutral']
Terminated due to low accrual	['Insufficient_Enrollment']	['Neutral']
Per sponsor's decision	['Business_Administrative']	['Possibly_Negative']
Primary outcome evaluation determined lack of treatment group difference	['Negative']	['Negative']
Efforts at recruitment have halted as recruitment was poor	['Insufficient_Enrollment']	['Neutral']
Protocol changes underway. Trial never started	['Study_Design']	['Neutral']
Due to COVID-19 Pandemic	['Covid19']	['Neutral']
Business Decision to pursue other indications	['Business_Administrative']	['Possibly_Negative']
"The study completed the first phase and did not meet efficacy end point to enter into the
    randomized phase."	['Negative']	['Negative']
The funding ended before the study was completed.	['Business_Administrative']	['Possibly_Negative']
Dosing stopped	['Invalid_Reason']	['Invalid_Reason']
Investigator choice	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Problem with enrollment	['Insufficient_Enrollment']	['Neutral']
results did not show intervention was beneficial	['Negative']	['Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Lack of funding to progress the study	['Business_Administrative']	['Possibly_Negative']
insufficient recuritment due to covid	['Covid19']	['Neutral']
Closed by Investigator	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
lack of inclusion	['Insufficient_Enrollment']	['Neutral']
Poor accrual.	['Insufficient_Enrollment']	['Neutral']
terminated due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Termination of the clinical development program by the Sponsor	['Business_Administrative']	['Possibly_Negative']
"Low enrolllment was exacerbated by a covid policy related study suspension so the resarch was
    stopped."	['Covid19']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Pandemic (Covid 19)	['Covid19']	['Neutral']
The company decided to cancel this study in conformity with PH FDA Circular 2013-004	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Pending COVID-19 pandemic; pending product development	['Covid19']	['Neutral']
Low recruitment rate	['Insufficient_Enrollment']	['Neutral']
Budget issues	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
No funding to complete study	['Business_Administrative']	['Possibly_Negative']
"The study was terminated because the required sample size of 240-260 de novo senior renal
    transplant patients was not achieved within a reasonable time."	['Insufficient_Enrollment']	['Neutral']
Temporarily suspended due to equipment issues	['Logistics_Resources']	['Neutral']
"Definitive discontinuation according to safety monitoring of death from the 46th patient
    onwards."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Manufacturer of the device filed for bankruptcy	['Business_Administrative']	['Possibly_Negative']
"B2151007 was prematurely discontinued due to Pfizer's change in prioritization for the
    portfolio and is not due to any safety concerns or regulatory interaction"	['Business_Administrative']	['Possibly_Negative']
The same protocol has been launched in United States.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Sufficient enrollment achieved for outcome measures	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
low recruitment	['Insufficient_Enrollment']	['Neutral']
We no longer have the resources to complete enrollment	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Terminated for futility by sponsor after a pre-planned interim review of data	['Negative']	['Negative']
no recruitment	['Insufficient_Enrollment']	['Neutral']
to address inquiry.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Ongoing issues with the device and software that were provided by the sponsor.	['Logistics_Resources']	['Neutral']
"Study being continued as a multi centre MA3RS study.The patients will be followed up under
    MA3RS and AAA PET."	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
Termination of the clinical trial by sponsor.	['Business_Administrative']	['Possibly_Negative']
PI left institute and contacted IRB to close study.	['Study_Staff_Moved']	['Neutral']
"This action is an internal decision that was not made because of any pending regulatory action
    for these products."	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Live H1N1 vaccine expired and unable to get new supply	['Logistics_Resources']	['Neutral']
"this type of surgery is now performed with a surgical robot that no longer allows the
    realization of microdialysis"	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
This treatment is now considered standard of care	['Endpoint_Met', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
"low recruitment rate; difficulties to achieve planned number of participants within reasonable
    time frame"	['Insufficient_Enrollment']	['Neutral']
This study was registered with Clinical Trials.gov by mistake.	['Regulatory', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Study has been completed as planned	['Invalid_Reason']	['Invalid_Reason']
Institutional RDRC dissolved	['Interim_Analysis', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
"This study was stopped for slow enrollment after enrolling only 11 of 180 patients in six
    months time."	['Insufficient_Enrollment']	['Neutral']
Early termination of patient enrollment based on business decision	['Business_Administrative']	['Possibly_Negative']
Grant Ended	['Business_Administrative']	['Possibly_Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
"Study terminated on 13 April 2016 for business reasons. No safety and/or efficacy concerns
    contributed to the termination of the study"	['Business_Administrative']	['Possibly_Negative']
Enrollment incomplete by the end of the contracted enrollment period	['Insufficient_Enrollment']	['Neutral']
Closed early due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Terminated due to surgeon preferences	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Slow accrual, Funding stopped	['Insufficient_Enrollment']	['Neutral']
"Due to safety; specifically a higher rate of deaths, including fatal infections, in the SGN33A
    arm versus the control arm"	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Novel HCV DAA approved by FDA	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"Patient 2 suffered DLT post-vaccination. The vaccine manufacturers withdrew support for the
    study on commercial grounds."	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Logisitic problem	['Logistics_Resources']	['Neutral']
"A study start is currently not foreseeable for organizational reasons. Due to the delays,
    research has also been focused on new compounds, which has reduced the interest in the
    potential results of the above-mentioned clinical trial."	['Business_Administrative']	['Possibly_Negative']
Protracted recruitment timeline exacerbated by COVID-19 pandemic	['Covid19']	['Neutral']
PI health issues	['Study_Staff_Moved']	['Neutral']
Difficulty in recruiting	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Safety of patients : CSI recommandation and promotor decision	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
PI is away, will hopefully perform the study at another institution.	['Study_Staff_Moved']	['Neutral']
Regulatory approvals have not been obtained	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Difficulty in recruiting patients	['Insufficient_Enrollment']	['Neutral']
Business decision	['Business_Administrative']	['Possibly_Negative']
Lack of efficacy	['Negative']	['Negative']
Decreasing recruitment	['Insufficient_Enrollment']	['Neutral']
The principal investigator left the institution.	['Study_Staff_Moved']	['Neutral']
Patients pain was not regulated well with this product.	['Safety_Sideeffects', 'Logistics_Resources', 'Endpoint_Met']	['Safety_Sideeffects', 'Neutral', 'Neutral']
We stop because of problems such as insurance.	['Logistics_Resources']	['Neutral']
The surgical technique is no longer used	['Study_Design']	['Neutral']
A pending new protocol will replace this study.	['Study_Design']	['Neutral']
Sponsor did not fund the study	['Business_Administrative']	['Possibly_Negative']
No availability of investigational medication.	['Logistics_Resources']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
the manufacturer decided to halt manufacturing the vaccine	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Enrollment target has not achieved due to very slow and low recruitment rate	['Insufficient_Enrollment']	['Neutral']
IND holder relocated from the University of Utah	['Study_Staff_Moved']	['Neutral']
Study was terminated due to inability to recruit and collect follow up outcome data.	['Insufficient_Enrollment']	['Neutral']
Study terminated due to recruitment failure	['Insufficient_Enrollment']	['Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Recruitment due to CORONA	['Insufficient_Enrollment']	['Neutral']
Subject recruitment unable to be completed due to study feasibility issues.	['Insufficient_Enrollment']	['Neutral']
lack of funds	['Business_Administrative']	['Possibly_Negative']
Business Reasons	['Business_Administrative']	['Possibly_Negative']
Lack of funding for continuation.	['Business_Administrative']	['Possibly_Negative']
Co-PI Albert Chang relocating to UCLA. IND will transfer to UCLA. UCSF will not participate.	['Study_Staff_Moved']	['Neutral']
Company decision to terminate the trial	['Business_Administrative']	['Possibly_Negative']
Due to more robust long-term data generated in other active-controlled studies	['Negative', 'Another_Study']	['Negative', 'Neutral']
PI passed away unexpectedly	['Study_Staff_Moved']	['Neutral']
Study transferring to INOVA Health	['Business_Administrative']	['Possibly_Negative']
"It has been difficult to recruit participants meeting study entry criteria that are >65 years
    of age and not for any safety reasons."	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Unfavourable ethical opinion, principally on grounds of inadequate sample size	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
The trial was terminated due to insufficient enrollment.	['Insufficient_Enrollment']	['Neutral']
Study closed due to lack of recruitment	['Insufficient_Enrollment']	['Neutral']
The investigators left the institution.	['Study_Staff_Moved']	['Neutral']
Slow Enrollment	['Insufficient_Enrollment']	['Neutral']
technical issues	['Logistics_Resources']	['Neutral']
IRB suspended all of the PI's research activities; study was then closed	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
low patient number after 2 years recruiting	['Insufficient_Enrollment']	['Neutral']
Corporate decision	['Business_Administrative']	['Possibly_Negative']
The study never started due to zero enrolment	['Insufficient_Enrollment']	['Neutral']
greater mortality in intervention group	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"This potential study was held up at the level of the FDA as they wouldn't approve and IND for
    the dose of vitamin C we wanted to use."	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Study team decided not to move forward with study	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
"Carisbamate partial onset seizures studies lacked consistent efficacy data so trials in this
    indication were terminated."	['Negative']	['Negative']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Sponsor declined funding	['Business_Administrative']	['Possibly_Negative']
Recruitment rate was slow so we could not complete the study.	['Insufficient_Enrollment']	['Neutral']
Resources	['Logistics_Resources']	['Neutral']
The development program has been terminated	['Business_Administrative']	['Possibly_Negative']
The study was terminated early due to insufficient potential for recruitment.	['Insufficient_Enrollment']	['Neutral']
Difficulty with enrollment	['Insufficient_Enrollment']	['Neutral']
"it was felt by the sponsoring institution that the current standard of oversight expected by
    the Health Canada regulations, would not be possible to achieve"	['Study_Design', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Funding was withdrawn due to inadequete enrollment.	['Business_Administrative']	['Possibly_Negative']
Unable to obtain funding to initiate the study. No subjects were enrolled.	['Business_Administrative']	['Possibly_Negative']
The study was terminated due to funding constraints	['Business_Administrative']	['Possibly_Negative']
Study is not feasable yet, due to evolution in the patients' care	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Company decision to not fund further development of women's health new drug development
    programs."	['Business_Administrative']	['Possibly_Negative']
Lack of patient enrollment due to only one surgeon that was enrolling.	['Insufficient_Enrollment']	['Neutral']
Problems of the MST device	['Logistics_Resources']	['Neutral']
Investigator left organization prior to study initiation	['Study_Staff_Moved']	['Neutral']
Very difficult to recruit patients/slow recruitment(2 patients in nearly 2 years).	['Insufficient_Enrollment']	['Neutral']
PI relocated to another institution; study may be resubmitted at a later date.	['Study_Staff_Moved']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Study terminated per recommendation of Data Review Team	['Negative']	['Negative']
"DePuy discontinued this product in 4Q2009. At the time of this decision DePuy reviewed all
    clinical studies for this product and decided to close this Study."	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Difficulties in recruiting of volunteers with a BMI (Body Mass Index) between 30 and 35 kg/m2	['Insufficient_Enrollment']	['Neutral']
Funding problems	['Business_Administrative']	['Possibly_Negative']
"Study terminated early (date of study termination decision: 28 August 2020) as a result of the
    outcome of the pre-planned Interim Analysis."	['Negative']	['Negative']
Part B of the study was terminated early due to a lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
patients did not want to participate	['Insufficient_Enrollment']	['Neutral']
Sponsor's decision	['Business_Administrative']	['Possibly_Negative']
It is too difficult to recruit suitable patients.	['Insufficient_Enrollment']	['Neutral']
Study was not conducted. No participants were enrolled	['Invalid_Reason']	['Invalid_Reason']
Not possible to enroll enough patients in reasonable time.	['Insufficient_Enrollment']	['Neutral']
Funding pulled	['Business_Administrative']	['Possibly_Negative']
Funding not obtained. No subjects enrolled.	['Business_Administrative']	['Possibly_Negative']
funding	['Business_Administrative']	['Possibly_Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Terminated after FDA agreement.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
The clinical trial was terminated due to poor enrollment	['Insufficient_Enrollment']	['Neutral']
very slow enrollment. Only one patient enrolled. Termination by PI	['Insufficient_Enrollment']	['Neutral']
Recruitment for the study was limited.	['Insufficient_Enrollment']	['Neutral']
"Initial patients were seen at St Paul Hospital. Enrollment changes occurred with the move to
    Clements Hospital. We were unable to identify an infusion room at CUH despite an exhaustive
    search for alternatives and forced to terminate early."	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Sponsor's decision	['Business_Administrative']	['Possibly_Negative']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Life shirt technology no longer available	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
GPDC decided to terminate the study	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Study closed prematurely due to the end of the influenza (H1N1) 2009 pandemic	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
patients with inflammatory colitis not included	['Insufficient_Enrollment']	['Neutral']
ODEN trial stopped due to low enrollment & to focus on the PRESERVE Trial.	['Insufficient_Enrollment']	['Neutral']
Similar study already published	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study was not feasible to complete at study site	['Insufficient_Enrollment']	['Neutral']
It was difficult to recruit subjects.	['Insufficient_Enrollment']	['Neutral']
Device failure	['Logistics_Resources']	['Neutral']
The study design was revised so a new protocol will be opened.	['Study_Design']	['Neutral']
The development program has been terminated	['Business_Administrative']	['Possibly_Negative']
Continued development of technology	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Study termination due to negative Phase III of another study product from same technology
    platform."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"Enrollment suspended based upon interim analysis; subjects allowed to stay on study until
    disease progression."	['Negative']	['Negative']
MBX-102 did not meet the target efficacy profile of HbA1c change.	['Negative']	['Negative']
Terminated due to lack of recruitment	['Insufficient_Enrollment']	['Neutral']
"Recruitment for this study has ended and follow-up of enrolled participants is ongoing. For
    additional information contact the PIs."	['No_Context', 'Insufficient_Enrollment', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
"Participant Data obtained to 30Sep2015:

    Baseline data: 447 6 month data: 253 Program terminated: recruitment target not met. No
    analysis will be provided."	['No_Context', 'Insufficient_Enrollment', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
"Prematuration Culture With a Phosphodiesterase-3 Inhibitor (PDE3-I) has been replaced by other
    system"	['Endpoint_Met', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
The preliminary data from this pilot study did not indicate efficacy.	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Due to unforeseen slow enrollment and a shift in corporate resources due to the COVID-19
    impact."	['Covid19']	['Neutral']
Hypoglycaemia is significantly higher in TGC	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
concern regarding study design	['Study_Design']	['Neutral']
"This study was terminated early due to lack of efficacy based on the results of Part I of the
    AURORA study."	['Negative', 'Another_Study']	['Negative', 'Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Reclassification by Ethics Committee	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
This study was not activated, no data was collected.	['Invalid_Reason']	['Invalid_Reason']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Revision to improve cell recovery	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Funding and resource restrictions.	['Business_Administrative']	['Possibly_Negative']
"The study was terminated on June 22, 2007 for inability to enroll patients within an
    appropriate timeframe. There were no efficacy/safety concerns."	['Insufficient_Enrollment']	['Neutral']
Feasibility issues	['Logistics_Resources']	['Neutral']
Lack of efficacy in a preceding study.	['Negative', 'Another_Study']	['Negative', 'Neutral']
fewer tumors than expected expressed FGF-5, led to end of accrual to cohorts A&B	['Insufficient_Enrollment', 'Negative']	['Neutral', 'Negative']
Other - Assess strategies to improve accrual rate	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Inability to accrue additional sites and enroll an adequate number of subjects.	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Interim analysis suggested additional enrollment would not change outcomes	['Negative']	['Negative']
Due to business reasons.	['Business_Administrative']	['Possibly_Negative']
"Due to enrollment challenges and availability of other options for lung cancer patients. The
    termination is not a consequence of any safety concern."	['Insufficient_Enrollment']	['Neutral']
"Based on analysis of results and consideration of available treatments, the overall benefit to
    risk profile of ocrelizumab was not favorable in RA."	['Negative']	['Negative']
"Shortages of the active comparator drug (BCG) on the market worldwide and a growing uncertainty
    as to its future supply."	['Logistics_Resources']	['Neutral']
Change in Clinical Strategy	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Lack of Recruitment	['Insufficient_Enrollment']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
The study had accomplished its goal with the 6 patients who have been enrolled.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Lack of available funding.	['Business_Administrative']	['Possibly_Negative']
Lack of Enrollment	['Insufficient_Enrollment']	['Neutral']
Results from sister study at University of the Pacific were conclusive.	['Negative', 'Another_Study']	['Negative', 'Neutral']
no funding	['Business_Administrative']	['Possibly_Negative']
We failed to obtain study drugs from the company	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Low enrollment; investigator chose not to continue study	['Insufficient_Enrollment']	['Neutral']
The resident in charge of the project has graduated so we decided to close this study	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
primary site withdrew due to competing study: never enrolled any subjects.	['Insufficient_Enrollment']	['Neutral']
Repros stopped study for safety and the FDA put the study on hold for safety.	['Regulatory']	['Neutral']
Did not meet interim stopping criteria for continuation to the second stage.	['Negative']	['Negative']
"For this pilot, we constructed conditional power curves and noted that we would not
    substantially enhance power by enrolling additional participants."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Funding Depleted.	['Business_Administrative']	['Possibly_Negative']
physician departure	['Study_Staff_Moved']	['Neutral']
Not a clinical trial study	['Invalid_Reason']	['Invalid_Reason']
PI left the institution; no further accruals	['No_Context', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
"extremely poor recruitment & since the study was approved, medical practice has evolved to
    where cord milking is now common practice."	['Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral']
Lack of study subjects	['Insufficient_Enrollment']	['Neutral']
Insufficient accrual	['Insufficient_Enrollment']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Mediators of interest were not consistently detectable with the analytical methods employed.	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
funding issues	['Business_Administrative']	['Possibly_Negative']
Due to a lack of participants, this study has been closed.	['Insufficient_Enrollment']	['Neutral']
PI is leaving the institution	['Study_Staff_Moved']	['Neutral']
Data analysis was never performed by sub-investigator	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
no accrual	['Insufficient_Enrollment']	['Neutral']
revisions to original study protocol underway	['Study_Design']	['Neutral']
The grant application has not been approved	['Business_Administrative']	['Possibly_Negative']
"There were a number of bugs in the game that meant the participants were not getting the
    intended intervention."	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
Study terminated due to failure to meet sufficient enrollment for valid analysis	['Insufficient_Enrollment']	['Neutral']
Not enough patients	['Insufficient_Enrollment']	['Neutral']
Interim analysis of Primary Endpoint completed	['Invalid_Reason']	['Invalid_Reason']
PI is leaving the institution	['Study_Staff_Moved']	['Neutral']
Stopped early for funding and efficacy reasons.	['Business_Administrative']	['Possibly_Negative']
Investigator separated from institution	['Study_Staff_Moved']	['Neutral']
Low Enrollment	['Insufficient_Enrollment']	['Neutral']
Interim Analysis: Optimization of study design required.	['Study_Design']	['Neutral']
protocol change	['Study_Design']	['Neutral']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
due to business decisions	['Business_Administrative']	['Possibly_Negative']
Study closed prematurely.	['Invalid_Reason']	['Invalid_Reason']
The effect is poor	['Negative']	['Negative']
Due to major recruitment issues, a decision was made to terminate this trial	['Insufficient_Enrollment']	['Neutral']
concern of detrimental effect	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
THe study was terminated early due to a lack of accural	['Insufficient_Enrollment']	['Neutral']
The study was terminated due to poor enrollment.	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
delayed recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of Accrual	['Insufficient_Enrollment']	['Neutral']
"The interim analysis performed on 09 November 2018, showed the failure to achieve the primary
    objective of effectiveness of the experimental treatment."	['Negative']	['Negative']
Company closure due to lack of funding	['Business_Administrative']	['Possibly_Negative']
inadequate enrollment rate	['Insufficient_Enrollment']	['Neutral']
"While 33 people signed consent, no one was enrolled in the study, because none of these
    patients developed shoulder pain in the recovery room."	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
It was decided to not proceed with the study at this time.	['Invalid_Reason']	['Invalid_Reason']
Funding Discontinued	['Business_Administrative']	['Possibly_Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Loss of funding	['Business_Administrative']	['Possibly_Negative']
Change in subject population/ABLE POWER program	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Paused due to technical issues	['Logistics_Resources']	['Neutral']
This protocol was re-written and resubmitted under a different trial number again (NCT02980419)	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
IDMC recommendation for safety concerns	['Covid19', 'Safety_Sideeffects', 'Regulatory']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Only 32 patients included in 21 months	['Insufficient_Enrollment']	['Neutral']
No manpower to conduct the study further	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Due to COVID-19	['Covid19']	['Neutral']
Futility analysis failed to showed likelihoo of benefit of CoQ 2400 mg/day.	['Negative']	['Negative']
Toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Slow recruitment of eligible patients	['Insufficient_Enrollment']	['Neutral']
Study closed by Protocol Review Monitoring Committee because of lack of accrual	['Insufficient_Enrollment']	['Neutral']
poor recruitment	['Insufficient_Enrollment']	['Neutral']
Difficulty with recruiting	['Insufficient_Enrollment']	['Neutral']
COVID-19 Pandemic	['Covid19']	['Neutral']
Early termination due to change in recruitment site and search team members	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of enrollments	['Insufficient_Enrollment']	['Neutral']
Doxil Shortage	['Logistics_Resources']	['Neutral']
Inadequate participant recruitment	['Insufficient_Enrollment']	['Neutral']
Due to competing trials. Stopped before IRB approval.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Study terminated due to a change in the benefit-risk profile for danirixin in COPD.	['Negative']	['Negative']
Unable to recruit due to COVID limitiations	['Covid19']	['Neutral']
safety reasons	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Poor accural	['Insufficient_Enrollment']	['Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Recruitment and study progress halted by COVID-19	['Covid19']	['Neutral']
Difficulties of recruitment	['Insufficient_Enrollment']	['Neutral']
Problem of Investigational Products	['Logistics_Resources']	['Neutral']
"The safety committee found no safety issues but recommended halting the study based on a lack
    of efficacy in a similar trial. The sponsor terminated the trial."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of Efficacy	['Negative']	['Negative']
"The predecessor study A00309 (NCT00152464) did not show statistical significance in time to
    onset of asthma between the levocetirizine and placebo groups."	['Negative', 'Another_Study']	['Negative', 'Neutral']
seeking additional funding	['Business_Administrative']	['Possibly_Negative']
The randomization to the observational arm of the trial was no longer ethical	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
sufficient number to reach the primary endpoint and as planned	['Invalid_Reason']	['Invalid_Reason']
Lack of funding.	['Business_Administrative']	['Possibly_Negative']
accrual of subjects did not occur as anticipated	['Insufficient_Enrollment']	['Neutral']
Lack of continued funding	['Business_Administrative']	['Possibly_Negative']
was replaced by an other study	['Negative', 'Another_Study']	['Negative', 'Neutral']
too many side effect in the control arm (DMSO)	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Because a higher rate of virological failures in study versus control arm.	['Logistics_Resources', 'Negative']	['Neutral', 'Negative']
"The study was terminated as the asset was sold to another company who decided not to pursue
    this indication with this drug."	['Business_Administrative']	['Possibly_Negative']
Product no longer on the market	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Business decision	['Business_Administrative']	['Possibly_Negative']
"A delay in protocol approval and approval of laboratory sites in Salvador, Brazil left too
    little time for completion of enrollment into the study."	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
no patients enrolled. primary investigator never started study	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
primary endpoint missed	['Negative']	['Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Lack of funding to support clinical trial	['Business_Administrative']	['Possibly_Negative']
Program reprioritization	['Business_Administrative']	['Possibly_Negative']
Trial discontinued due to low enrollment	['Insufficient_Enrollment']	['Neutral']
not funded by NIH	['Business_Administrative']	['Possibly_Negative']
Low numbers of eligible patients and failure to successfully recruit them.	['Insufficient_Enrollment']	['Neutral']
Company decided to stop development of drug - 7/31/12	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
evolving standard of care and difficulties of enrolling participants	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Slow recruitment and increase in deployment overseas limiting follow up	['Insufficient_Enrollment']	['Neutral']
another design of protocole is submitted for approuval before the start date	['Study_Design']	['Neutral']
Study delayed indefinetly	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Difficult to enrollment patient	['Insufficient_Enrollment']	['Neutral']
Lack of recruitment, result of COVID-19 pandemic	['Covid19']	['Neutral']
Patient Safety	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
funding unavailable	['Business_Administrative']	['Possibly_Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
no participants enrolled	['Insufficient_Enrollment']	['Neutral']
Trials was stopped early due to lack of funding.	['Business_Administrative']	['Possibly_Negative']
Poor recruitment.	['Insufficient_Enrollment']	['Neutral']
Business Decision; Insufficient Enrollment	['Business_Administrative']	['Possibly_Negative']
"0 subjects completed all study visits. Due to noncompliance and recruitment difficulties study
    was terminated."	['Insufficient_Enrollment']	['Neutral']
Did not meet the expected enrollment rate.	['Insufficient_Enrollment']	['Neutral']
loss of research personnel	['Logistics_Resources']	['Neutral']
Study research team disintegration	['Logistics_Resources']	['Neutral']
GSK decision	['Business_Administrative']	['Possibly_Negative']
Accrual factor	['Insufficient_Enrollment']	['Neutral']
Felt not to show benefit over control per DMC and confirmed via futility analysis	['Negative']	['Negative']
recruitment goals met	['Invalid_Reason']	['Invalid_Reason']
"Study was discontinued based on futility analysis done and not based on safety concerns.
    Follow-up visits and closing out study activities are completed"	['Negative']	['Negative']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
Sponsor withdrew funding	['Business_Administrative']	['Possibly_Negative']
Poor recruition	['Insufficient_Enrollment']	['Neutral']
Resources limited secondary to COVID-19 pandemic.	['Covid19']	['Neutral']
No participants were enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Insufficient data collection	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Unable to recruit	['Insufficient_Enrollment']	['Neutral']
No benefit on primary end point (RFS); no rationale to collect survival data	['Negative', 'Business_Administrative']	['Negative', 'Possibly_Negative']
Study canceled	['Invalid_Reason']	['Invalid_Reason']
qualitative analysis of the study database	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
"B3301002 was discontinued on 18 April 2012 for strategic reasons.There were no safety concerns
    leading to discontinuation of this study."	['Business_Administrative']	['Possibly_Negative']
"We were unable to recruit any subjects into this study so no subjects completed the protocol.
    Therefore, we are unable to provide any conclusions."	['Insufficient_Enrollment']	['Neutral']
Lack of Funding/ Resident in charge graduated	['Business_Administrative']	['Possibly_Negative']
Terminated due to Enrollment futility	['Negative']	['Negative']
Sponsor decision due to lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
Two authors changed their jobs.	['Study_Staff_Moved']	['Neutral']
By Sponsor due to occurrences of incomplete study drug administration	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
No funding obtained.	['Business_Administrative']	['Possibly_Negative']
Investigator left Institution.	['Study_Staff_Moved']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
NO participants enrolled	['Insufficient_Enrollment']	['Neutral']
Limited Enrollment	['Insufficient_Enrollment']	['Neutral']
COVID-19	['Covid19']	['Neutral']
PI left UTMB	['Study_Staff_Moved']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Study design determined to be not likely feasible	['Study_Design']	['Neutral']
The study was halted due to low enrollment exacerbated by COVID-19.	['Covid19']	['Neutral']
"The study was closed due to investigator discretion based on the lack of ability to recruit
    patients and research goals of the program."	['Insufficient_Enrollment']	['Neutral']
The sponsor decided to stop the study prematurely because of financial issues	['Business_Administrative']	['Possibly_Negative']
no funding	['Business_Administrative']	['Possibly_Negative']
Unable to recruit enough subjects	['Insufficient_Enrollment']	['Neutral']
recruiting rate was to low	['Insufficient_Enrollment']	['Neutral']
Sponsor decided that the results were not significant enough to continue.	['Negative', 'Business_Administrative']	['Negative', 'Possibly_Negative']
Imaging temporarily on hold at site due to machine maintenance.	['Logistics_Resources']	['Neutral']
IRB did not approve this study.	['Regulatory', 'Ethical_Reason', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"The study was withdrawn as lesinurad was withdrawn from the market in Europe by the market
    authorization holder. Hence the commitment to do this PASS was removed by the European
    Medicines Agency."	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Unsatisfactory rate of recruitment	['Insufficient_Enrollment']	['Neutral']
The study was stopped due to efficacy reasons.	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Study was terminated after unplanned interim analysis of single centre data and results were
    reported"	['Interim_Analysis', 'Endpoint_Met', 'Negative']	['Neutral', 'Neutral', 'Negative']
Changed to a retrospective chart review	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
See termination reason in detailed description	['No_Context']	['Invalid_Reason']
"Trial was terminated early to analyze the accumulated data and evaluate the efficacy, safety
    and future of palovarotene in MO."	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
"6 out of 20 patients were included. The trend towards the treatment of severe asthma has
    meanwhile developed in a different direction, so that there is no longer any intention to
    pursue the study objective mentioned here."	['Study_Design']	['Neutral']
Discontinuation due to the high response rate at the 1st stage and slow accrual.	['Insufficient_Enrollment']	['Neutral']
Project Team decision	['Business_Administrative']	['Possibly_Negative']
Study not started	['Invalid_Reason']	['Invalid_Reason']
Diffic;ulty recruiting	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
study not feasible with low accrual. DSMB recommended closure	['Insufficient_Enrollment']	['Neutral']
Feasibility issues prevent completion of recruitment.	['Logistics_Resources']	['Neutral']
"IDMC made a recommendation to stop the trial as the target for continuing to the 2nd phase was
    not met."	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
It was not possible to recruit any patients at that time.	['Insufficient_Enrollment']	['Neutral']
senior coworker retired	['Study_Staff_Moved']	['Neutral']
Strategic business decision (not related to safety or efficacy concerns)	['Business_Administrative']	['Possibly_Negative']
PI left institution and unable to find new PI	['Study_Staff_Moved']	['Neutral']
PI left the institution.	['Study_Staff_Moved']	['Neutral']
Funders withdrew funding due to slow recruitment	['Business_Administrative']	['Possibly_Negative']
investigator withdrew	['Study_Staff_Moved']	['Neutral']
"Terminated prematurely due to issues with one of the data collection systems, no impact on
    subject safety"	['Logistics_Resources']	['Neutral']
Interim assessment provided sufficient data to answer study questions	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Unable to recruit required participants	['Insufficient_Enrollment']	['Neutral']
Recommendation of DMC	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The PI changed institutions	['Study_Staff_Moved']	['Neutral']
funding issue	['Business_Administrative']	['Possibly_Negative']
"Study population more infrequent than estimated. No study-related safety issues and no safety
    concerns were identified for the study."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Study terminated mutually by sponsor & PI due to no enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsor withdrew support for study due to reorganization and project prioritization	['Business_Administrative']	['Possibly_Negative']
No participants enrolled. Changed requirements for studying e-cigarettes.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
PI left institution, never submitted to IRB	['Study_Staff_Moved']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Inadequate resources	['Logistics_Resources']	['Neutral']
We are halting enrollment of this study.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Study terminated due to lack of feasibility of study design.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"A device would have had to be maintained. The maintenance company is insolvent; both another
    maintenance company and another serviced device were not available."	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"a pilot study of 7 patients did not reveal a temperature dependent difference in glycation
    rates"	['Negative', 'Another_Study']	['Negative', 'Neutral']
no further funding	['Business_Administrative']	['Possibly_Negative']
"Enrollment is temporarily paused due to COVID-19; interactions/interventions with current
    participants continue. This is not a suspension of IRB approval."	['Covid19']	['Neutral']
Lack of study funding	['Business_Administrative']	['Possibly_Negative']
few patients met all the inclusion criteria	['Insufficient_Enrollment']	['Neutral']
See Termination Reason in Detailed Description.	['No_Context']	['Invalid_Reason']
Phase I accrual goal met	['Invalid_Reason']	['Invalid_Reason']
Study terminated for lack of funds to initiate study	['Business_Administrative']	['Possibly_Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
The inclusion criteria for plasmapheresis is too stringent to get any potential subjects.	['Insufficient_Enrollment']	['Neutral']
recruiting problems	['Insufficient_Enrollment']	['Neutral']
following DSMB recommandation.	['Negative']	['Negative']
Unacceptable safety profile	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Insufficient funding	['Business_Administrative']	['Possibly_Negative']
Study was cancelled before enrolment for reasons not related to vaccine safety or efficacy.	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
"The dose limiting toxicity of cardiac QTc prolongation was identified and demonstrated unsafe
    to continue clinical development of this molecule."	['Safety_Sideeffects']	['Safety_Sideeffects']
PI left institution	['Study_Staff_Moved']	['Neutral']
"Study was terminated due to lack of efficacy, as a result, the stability program for the drug
    product was discontinued"	['Negative', 'Business_Administrative']	['Negative', 'Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
Terminated	['Invalid_Reason']	['Invalid_Reason']
Terminated due to financial reasons.	['Business_Administrative']	['Possibly_Negative']
the project could no longer be implemented effectively and with fidelity	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Study withdrawn due to slow accrual. No patients were enrolled.	['Insufficient_Enrollment']	['Neutral']
Feasability phase completed: Cost Evaluation	['Business_Administrative']	['Possibly_Negative']
Difficulty with enrollment	['Insufficient_Enrollment']	['Neutral']
Due to technical and logistical constraints and a change in the study team's focus of research	['Logistics_Resources']	['Neutral']
terminated	['Invalid_Reason']	['Invalid_Reason']
Unfunded	['Business_Administrative']	['Possibly_Negative']
Refer to Detailed Description.	['No_Context']	['Invalid_Reason']
Business decision to discontinue product development.	['Business_Administrative']	['Possibly_Negative']
The study never started due to problems with Laboratory facilities in collaborating center	['Logistics_Resources']	['Neutral']
"The 24-week analysis indicated no clinical or statistical benefit for the primary endpoint for
    the overall study population. No new safety concerns identified."	['Negative']	['Negative']
researcher left the institution study will not continue	['Study_Staff_Moved']	['Neutral']
COVID-19 related inability to complete study	['Covid19']	['Neutral']
On hold due to COVID-19 outbreak	['Covid19']	['Neutral']
Lack of efficacy	['Negative']	['Negative']
Difficulty identifying appropriate patients	['Insufficient_Enrollment']	['Neutral']
Sample size was not completed	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Insufficient subject recruitment	['Insufficient_Enrollment']	['Neutral']
Nexis Vision was unable to provide the shields to continue with the study.	['Logistics_Resources']	['Neutral']
The entire drug development program for this molecule was sold to another company.	['Business_Administrative']	['Possibly_Negative']
enrollment was too low	['Insufficient_Enrollment']	['Neutral']
Termination stopped due to low recruitment rates	['Insufficient_Enrollment']	['Neutral']
Safety concerns	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"Tech changes made it impossible to consent patients. Not a flaw in design, practice changes
    caused the study end."	['Study_Design']	['Neutral']
"No subjects have been accrued to this trial. The PI will no longer be at COH and requests a
    study withdrawal/closure."	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Enrollment process not efficient	['Insufficient_Enrollment']	['Neutral']
The study was a collaboration that could not be effectively run.	['Business_Administrative']	['Possibly_Negative']
Funding of study was exhausted prior to completion of study	['Business_Administrative']	['Possibly_Negative']
Suboptimal accrual	['Insufficient_Enrollment']	['Neutral']
Low enrollment so sponsor stopped funding the study (did not renew)	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study abandoned and was never started	['Invalid_Reason']	['Invalid_Reason']
"because the instruments for collecting the SPI data from the monitor (S5 collector) could not
    be imported due to the manufacturer's problem."	['Logistics_Resources']	['Neutral']
"The data of the paper referenced in the preparation of the protocols in this task were
    manipulated and the paper was withdrawn."	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
"We decided to complete our research in the 4th year, and publish the data. The data are under
    evaluation."	['Invalid_Reason']	['Invalid_Reason']
Recruitment was slower than expected and study drug reached expiry	['Insufficient_Enrollment']	['Neutral']
Study termination due to insufficient efficacy.	['Negative']	['Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Trial no longer feasible	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
program discontinued	['Invalid_Reason']	['Invalid_Reason']
Slow recruitment, cessation of funding	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Standard of Care changed due to COVID-19 and thus had to stop the study.	['Covid19']	['Neutral']
"Due to the number of competing trials at their site, the study team has closed enrollment and
    withdrawn this trial."	['Insufficient_Enrollment']	['Neutral']
Insufficient funding	['Business_Administrative']	['Possibly_Negative']
Large sample size	['Insufficient_Enrollment']	['Neutral']
The study was never initiated, no patients were enrolled. It has been closed with the IRB.	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
The study was stopped early due to low recruitment	['Insufficient_Enrollment']	['Neutral']
Hospital administrative problems	['Business_Administrative']	['Possibly_Negative']
General Informed Consent has been introduced at the Hospital, no need for study anymore	['Interim_Analysis', 'Regulatory', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Discrepancies in medication orders	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Missing financial sponsorship	['Business_Administrative']	['Possibly_Negative']
Lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
PI moved to a new facility	['Study_Staff_Moved']	['Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Withdrawn because treatment guidelines changed	['Study_Design']	['Neutral']
lack of accrual	['Insufficient_Enrollment']	['Neutral']
"The decision to stop the trial was based on efficacy results in the overall schizophrenia
    participant population."	['Success', 'Endpoint_Met', 'Negative']	['Success', 'Neutral', 'Negative']
Necessary equipment could not be obtained.	['Logistics_Resources']	['Neutral']
The study was stopped due to slow rate of recruitment.	['Insufficient_Enrollment']	['Neutral']
PI decided no longer to pursue	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
upon recommendation from the Data Monitoring Committee	['Regulatory', 'Negative']	['Neutral', 'Negative']
Due to slow inclusion of patients	['Insufficient_Enrollment']	['Neutral']
Study stopped because we could not recruit patients in the available time	['Insufficient_Enrollment']	['Neutral']
Administratively terminated per FDA recommendation	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The study was terminated early for business reasons, not for safety concerns.	['Business_Administrative']	['Possibly_Negative']
Insufficient staff and funding	['Business_Administrative']	['Possibly_Negative']
This study was stopped due to slow enrollment after enrolling 25 of 200 patients.	['Insufficient_Enrollment']	['Neutral']
replaced with other study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Futility and limited feasibility	['Negative']	['Negative']
Funding has ended prior to complete enrollment	['Business_Administrative']	['Possibly_Negative']
higher than projected discontinuation rate during Maintenance Phase	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Study_Design']	['Safety_Sideeffects', 'Neutral', 'Neutral']
PI relocated, unable to complete the study. No replacement PI identified.	['Study_Staff_Moved']	['Neutral']
low enrollment due to limited resources	['Insufficient_Enrollment']	['Neutral']
Administrative	['Business_Administrative']	['Possibly_Negative']
Study was terminated by sponsor decision	['Business_Administrative']	['Possibly_Negative']
Recent findings suggest that letrozole may be a superior Clomiphene Citrate.	['Negative', 'Another_Study']	['Negative', 'Neutral']
lack of accrual due to competing study	['Insufficient_Enrollment']	['Neutral']
Investigator left the institution	['Study_Staff_Moved']	['Neutral']
Another trial in the department directly competes for the the same patient population	['Negative', 'Another_Study']	['Negative', 'Neutral']
PI left and section closed.	['Study_Staff_Moved']	['Neutral']
The FB4 trial has been terminated due to COVID-19.	['Covid19']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
We are currently engaged in other behavioral study.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Sponsor decision.	['Business_Administrative']	['Possibly_Negative']
Study had to be terminated due to lack of funding	['Business_Administrative']	['Possibly_Negative']
No patients enrolled. Delay due to optimisation of drug product formulation.	['Study_Design']	['Neutral']
Feasibility issues.	['Logistics_Resources']	['Neutral']
Astora business is closing	['Business_Administrative']	['Possibly_Negative']
Lack of funding following full FDA clinical hold	['Business_Administrative']	['Possibly_Negative']
"Due to very specific inclusion criteria the anticipated number of patients was not reached.
    Inclusion stopped at N=26, allowing for analyzing primary outcomes."	['Insufficient_Enrollment']	['Neutral']
MnSOD longer available during Phase II	['Negative', 'Business_Administrative']	['Negative', 'Possibly_Negative']
Difficulties with recruitment and MRI scanner became unavailable.	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Funding withdrawn	['Business_Administrative']	['Possibly_Negative']
Blood withdrawal problems despite use of different catheters.	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
slow patient recruitment, low patient-commpliance, high dropout rates,	['Insufficient_Enrollment']	['Neutral']
Principal Investigator is no longer at this site	['Study_Staff_Moved']	['Neutral']
Study was cancelled before patient enrollment	['Invalid_Reason']	['Invalid_Reason']
Business considerations	['Business_Administrative']	['Possibly_Negative']
Study withdrawn by funding organization with no participants enrolled	['Business_Administrative']	['Possibly_Negative']
"Overall study status is changed to ""Terminated"" due to low enrollment"	['Insufficient_Enrollment']	['Neutral']
Due to the termination of the collaboration of ApiFix ltd. and the UMC Utrecht	['Business_Administrative']	['Possibly_Negative']
Study terminated due to expiration of IRB approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Incorporating the recommendations of the NIH-formed DSMB in the study procedures would make the
    project budget over the limit for this funding mechanism."	['Business_Administrative']	['Possibly_Negative']
Lack of recruitment.	['Insufficient_Enrollment']	['Neutral']
The trial prematurely terminated due to the loss of funding.	['Business_Administrative']	['Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
poor recruitment rate	['Insufficient_Enrollment']	['Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Sponsor withdrew study	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Please see ""Purpose"" statement below."	['No_Context']	['Invalid_Reason']
"The liquidation of our industrial partner NEOLYS Diagnostics, directly involved in the
    methodology of the study and a sub-optimal rate of inclusions which did not allow us to include
    all patient within the allotted time."	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
No ZIKA cases at study site	['Insufficient_Enrollment']	['Neutral']
Insufficient recruitment.	['Insufficient_Enrollment']	['Neutral']
"No enrollment, another competing study and difficult to find the right person to enroll on this
    study."	['Insufficient_Enrollment']	['Neutral']
Inability to recruit eligible subjects	['Insufficient_Enrollment']	['Neutral']
"Study terminated by Sponsor following a recommendation from external DMC based on lack of
    emerging benefit; there were no new emergent safety findings"	['Negative']	['Negative']
program discontinued based on GIPF-007 results	['Negative', 'Another_Study']	['Negative', 'Neutral']
preliminary analysis showed no difference	['Negative']	['Negative']
no eligible patient	['Insufficient_Enrollment']	['Neutral']
funding expired	['Business_Administrative']	['Possibly_Negative']
PI left MUSC, no patient enrollments	['Study_Staff_Moved']	['Neutral']
Limitations to recruitment due to COVID-19	['Covid19']	['Neutral']
Study never received IRB approval. Study was never pursued.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Inability to recruit any trial partcipants	['Insufficient_Enrollment']	['Neutral']
Insufficient Funding	['Business_Administrative']	['Possibly_Negative']
No funding.	['Business_Administrative']	['Possibly_Negative']
"At the direction of our IRB, this project was incorporated into an existing study, LU#200038,
    NCT#02925156"	['Negative', 'Another_Study']	['Negative', 'Neutral']
The study was stopped due to lack of meaningful enrollment due to the COVID-19 pandemic.	['Covid19']	['Neutral']
Funding expired; no subjects enrolled as this was a retrospective chart review	['Business_Administrative']	['Possibly_Negative']
Trial stopped due to futility.	['Negative']	['Negative']
Departure of study team	['Study_Staff_Moved']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Recruitment issues	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
The sponsor's clinical program for the agent used in this study was discontinued.	['Business_Administrative']	['Possibly_Negative']
Trial never initiated	['Invalid_Reason']	['Invalid_Reason']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
PI institutional transition prior to enrollment	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Funding withdrawn from funding source.	['Business_Administrative']	['Possibly_Negative']
No safety issues; change in innovation strategy	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
After 190 weeks [7 patients left] it was terminated for administrative reasons	['Business_Administrative']	['Possibly_Negative']
"Per IRB recommendation, a separate protocol will be prepared for retrospective data analysis.
    The current protocol does not have specific hypotheses."	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Study was completed, only life long extended follow-up phase was discontinued after 12 years.	['Invalid_Reason']	['Invalid_Reason']
The protocol design is being reconfigured in order to open a new study.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
study was cancelled	['Invalid_Reason']	['Invalid_Reason']
"Initiation of CMS BMT study for sickle-cell disease operating under NCT01166009 made further
    accrual to this study impossible."	['No_Context', 'Insufficient_Enrollment', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
no longer studying this disease site	['Invalid_Reason', 'Study_Design', 'Another_Study']	['Invalid_Reason', 'Neutral', 'Neutral']
Core study 12011.201 was terminated.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Less enrollment than expected. Would have been grossly underpowered	['Insufficient_Enrollment']	['Neutral']
Suspended due to COVID-19	['Covid19']	['Neutral']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
Investigator-initiated termination of approval due to problems with recruitment.	['Insufficient_Enrollment']	['Neutral']
Study product will not be commercialized.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
stopped for lack of efficacy	['Negative']	['Negative']
interim analysis proved that protocol intervention had no preventive effect	['Negative']	['Negative']
Company strategic decision	['Business_Administrative']	['Possibly_Negative']
Resources were not readily available to begin the study.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Internal	['Invalid_Reason']	['Invalid_Reason']
Closed due to insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
Inadequate numbers of babies enrolled and departure of co-investigator	['Insufficient_Enrollment']	['Neutral']
Only able to accrue just 18 of the 40 target & funds were limited.	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Enrollment at study center below rate compatible with study completion.	['Insufficient_Enrollment']	['Neutral']
Problems to recruit individuals with diaphragm paresis.	['Insufficient_Enrollment']	['Neutral']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Business Decision (no safety or efficacy concerns)	['Business_Administrative']	['Possibly_Negative']
Company decision. Non-safety related	['Business_Administrative']	['Possibly_Negative']
We will not be pursuing this study.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Administratively Complete	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Ameriscience went bankrupt.	['Business_Administrative']	['Possibly_Negative']
change in availability of study investigators	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Lack of participants	['Insufficient_Enrollment']	['Neutral']
"With the current health situation, we do not anticipate a significant resumption of recruitment
    for several months."	['Insufficient_Enrollment']	['Neutral']
Study was halted prematurely, prior to enrollment of first participant	['Invalid_Reason']	['Invalid_Reason']
Incomplete information	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Terminated for futility after review of first planned interim analysis.	['Negative']	['Negative']
"FDA request as study could not serve as the confirmatory trial as required under Subpart H
    approval."	['No_Context', 'Regulatory', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
Sponsor terminated study early to start a larger feasability study	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"Strong enrollment efforts resulted in few eligible subjects and high screen failures due to CKD
    patients with higher vitamin D levels than anticipated."	['Insufficient_Enrollment']	['Neutral']
difficulties of recruitment	['Insufficient_Enrollment']	['Neutral']
Feasibility of study. PI termination	['Logistics_Resources']	['Neutral']
funding for the study was terminated	['Business_Administrative']	['Possibly_Negative']
Slow enrollment,increased loss to follow-ups and general lack of interest.	['Insufficient_Enrollment']	['Neutral']
Sponsor requested termination.	['Business_Administrative']	['Possibly_Negative']
"Lack of resources and loss of personnel precluded study progress. No adverse events or
    unanticipated problems involving risks to subjects."	['Logistics_Resources']	['Neutral']
Scheduled Interim Monitoring	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Patient recruitment	['Insufficient_Enrollment']	['Neutral']
"DePuy discontinued this product in 4Q2009. At the time of this decision DePuy reviewed all
    clinical studies for this product and decided to close this Study"	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
The study sponsor was acquired by a company that focuses on chronic wounds.	['Business_Administrative']	['Possibly_Negative']
The total number of patients has been reached.	['Invalid_Reason']	['Invalid_Reason']
"Part II was not performed as we could not include enough patients fulfilling the inclusion
    criteria."	['Insufficient_Enrollment']	['Neutral']
"Study terminated as ongoing analysis suggested objectives not practical to achieve with study
    as implemented"	['Negative']	['Negative']
Failure to recruit patients further	['Insufficient_Enrollment']	['Neutral']
Study was not initiated as planned	['Invalid_Reason']	['Invalid_Reason']
enrollment closed due to lack of funding	['Business_Administrative']	['Possibly_Negative']
No suitable patients and many patients refused the study	['Insufficient_Enrollment']	['Neutral']
Project Cancelled	['Invalid_Reason']	['Invalid_Reason']
Insufficient patient recruitment	['Insufficient_Enrollment']	['Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
Study has been withdrawn from IRB review pending IND revision	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Study is suspended due to Abramson Cancer Center suspension of Observational research studies
    due to the COVID-19 Pandemic."	['Covid19']	['Neutral']
"For business reason unrelated to safety or tolerability,Tonix has discontinued the Fibromyalgia
    development with TNX102 SL."	['Business_Administrative']	['Possibly_Negative']
Company closed	['Business_Administrative']	['Possibly_Negative']
Project lacked funding.	['Business_Administrative']	['Possibly_Negative']
IND Inactive Status	['Regulatory', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Pi departure; service discontinued study	['Study_Staff_Moved']	['Neutral']
unable to accrue in subjects in a timely fashion	['Insufficient_Enrollment']	['Neutral']
"There is no participant enrolled in this study since developing this trial and other
    cholangiographic techniques are more available in our institute."	['Study_Design']	['Neutral']
Due to lack of mechanistic signal and competing industry studies	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Study was closed at the suggestion of DSMB prior to obtaining target enrollment	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Not due to safety reasons (sponsor decision).	['Business_Administrative']	['Possibly_Negative']
The study was terminated due to poor enrollment.	['Insufficient_Enrollment']	['Neutral']
Disease Site Team changed research focus unlikely to have sufficient support to complete study	['Logistics_Resources', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Principal Investigator left institution. Project never started.	['Study_Staff_Moved']	['Neutral']
Study was closed early due to slow accrual	['Insufficient_Enrollment']	['Neutral']
problems to include patients, patients not showing up at check-up	['Insufficient_Enrollment']	['Neutral']
Engagement issues, poor recruitment to study	['Insufficient_Enrollment']	['Neutral']
Reasons associated with COVID-19 pandemic led to cancellation of Phase 2	['Covid19']	['Neutral']
Investigators no longer interested in activating study	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Patient Recruitment	['Insufficient_Enrollment']	['Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Covid-19 quarantines and closures prevented recruitment and assessment of participants.	['Covid19']	['Neutral']
Poor recruitment, poor patient compliance, lack of funding	['Business_Administrative']	['Possibly_Negative']
Project cancellation	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Recruitment problems (not enough patients were found who met eligibility criteria)	['Insufficient_Enrollment']	['Neutral']
Not funded.	['Business_Administrative']	['Possibly_Negative']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
"The decision to stop the trial was based on efficacy results in the overall schizophrenia
    participant population."	['Success', 'Endpoint_Met', 'Negative']	['Success', 'Neutral', 'Negative']
Study withdrawn for financial issues	['Business_Administrative']	['Possibly_Negative']
Unable to recruit due to school closures in response to Covid-19	['Covid19']	['Neutral']
Low study participant enrollment.	['Insufficient_Enrollment']	['Neutral']
Due to a change of sponsor	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
not a required sutudy to be posted	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Evidence that the dose is insufficient.	['Negative']	['Negative']
There is no longer equipoise. DSMB recommended termination.	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
"The NEVO stent will not be commercialized. Cordis have decided to close the study after 3
    years. This decision took the absence of safety signals into account."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Business reason	['Business_Administrative']	['Possibly_Negative']
Study stopped for change in needle usage	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Business reasons	['Business_Administrative']	['Possibly_Negative']
Sponsor terminated open-label extension	['Business_Administrative']	['Possibly_Negative']
"This study has been suspended due to the COVID-19 epidemic. The study will resume once the
    epidemic has ended."	['Covid19']	['Neutral']
Company decision taken in light of demands by certain national health authorities	['Business_Administrative']	['Possibly_Negative']
Recruitment slow	['Insufficient_Enrollment']	['Neutral']
due to mycotoxin potential contamination of one lot of study drug	['Safety_Sideeffects', 'Logistics_Resources']	['Safety_Sideeffects', 'Neutral']
recruiting not successful, too few participants	['Insufficient_Enrollment']	['Neutral']
partial clinical hold per FDA	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
"The number of subjects were underestimated, which implies a reduction in the number of subjects
    required."	['Insufficient_Enrollment']	['Neutral']
Anticipated grant was withdrawn and additional funding was unable to be obtained	['Business_Administrative']	['Possibly_Negative']
Slow recruitment due to changes in standard of care	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
No funds	['Business_Administrative']	['Possibly_Negative']
"in view of the difficulties of inclusion in this study, it was decided not to extend this
    period"	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Trial reached a definitive answer ahead of full recruitment.	['Insufficient_Enrollment', 'Invalid_Reason', 'Negative']	['Neutral', 'Invalid_Reason', 'Negative']
no recruitment	['Insufficient_Enrollment']	['Neutral']
seeking funding	['Business_Administrative']	['Possibly_Negative']
Business decision	['Business_Administrative']	['Possibly_Negative']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Company decision taken in light of demands by certain national health authorities	['Business_Administrative']	['Possibly_Negative']
"The EC withdrawn the approval becuase of possible conflicts of interests between our Institute
    and Supporter (Celgene)"	['Business_Administrative']	['Possibly_Negative']
Protocol was changed to make it easier for treating doctors. No safety concerns	['Study_Design']	['Neutral']
COVID concerns	['Covid19']	['Neutral']
I am relocating to Johns Hopkins Medical Center	['Study_Staff_Moved']	['Neutral']
Sponsor elected not to continue with study	['Business_Administrative']	['Possibly_Negative']
Due to COVID 19 the Study did not start enrolling	['Covid19']	['Neutral']
Inadequate enrollment.	['Insufficient_Enrollment']	['Neutral']
Based on efficacy results from interim analysis	['Negative']	['Negative']
Insufficient number of participants	['Insufficient_Enrollment']	['Neutral']
"There was a change of sponsor. The new sponsor company did not wish to conduct the study after
    all."	['Business_Administrative']	['Possibly_Negative']
Due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor's decision due to negative result of Phase 3 study TH-CR-406/SARC021	['Negative', 'Another_Study']	['Negative', 'Neutral']
per PI: temporarily hold throughout month of Dec.	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
PI left institution.	['Study_Staff_Moved']	['Neutral']
"Low recruitment rate. In our center, open radical prostatectomies have been almost completely
    replaced by robotic prostatectomies."	['Insufficient_Enrollment']	['Neutral']
Agreement not executed between site and sponsor	['Business_Administrative']	['Possibly_Negative']
PK data from first 3 cohorts does not support study continuation.There was no safety concerns	['Negative']	['Negative']
"A futility analysis assessed that the study is highly unlikely to meet the pre-defined primary
    objective of the study. No new safety concerns were identified."	['Negative']	['Negative']
PI decision	['Invalid_Reason']	['Invalid_Reason']
No funding	['Business_Administrative']	['Possibly_Negative']
More preparation needed prior to collecting data.	['Interim_Analysis', 'Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
COVID-19 has halted recruitment	['Covid19']	['Neutral']
The toxicity seemed to outweigh the benefit.	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
our site was unable to enroll any qualified subjects	['Insufficient_Enrollment']	['Neutral']
Long process and due to strict deadline, project was stopped.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
low recruitement rates	['Insufficient_Enrollment']	['Neutral']
patient cohort consists of diabetic patients, which is a co-risk factor for covid-19	['Covid19']	['Neutral']
inability to retain study drug with comparable placebo.	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Study was unable to meet patient enrollment goals. PI chose to terminate the study early.	['Insufficient_Enrollment']	['Neutral']
Difficulties with patient inclusion	['Insufficient_Enrollment']	['Neutral']
Sponsor has suspended clinical development of MYDICAR for heart failure.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Due to the health crisis triggered by the COVID-19 pandemic and the consequent
    sanitary-organizational arrangements set up for its contrast it was necessary to interrupt the
    study before reaching the established sample size."	['Covid19']	['Neutral']
Sponsor Terminated	['Business_Administrative']	['Possibly_Negative']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
Ended enrollment not fully completed no data analysis planned	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"The Airways Biology Initiative closed in December, 2015. This study was closed with the Penn
    IRB at that time. No subjects were recruited for this trial."	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Deemed ineffective	['Negative']	['Negative']
"Data from Dose Groups 1,2 and other MN-221 studies resulted in the determination of a more
    appropriate dosing scheme for MN-221 in subjects with asthma."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Sufficient study funding was not obtained.	['Business_Administrative']	['Possibly_Negative']
PI left the institution	['Study_Staff_Moved']	['Neutral']
Cancelled before enrollment	['Invalid_Reason']	['Invalid_Reason']
Lack of financing	['Business_Administrative']	['Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Study Cancelled	['Invalid_Reason']	['Invalid_Reason']
Study suspended prior to enrollment	['Invalid_Reason']	['Invalid_Reason']
Design was not feasible	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
lack of study participants	['Insufficient_Enrollment']	['Neutral']
slow inclusion	['Insufficient_Enrollment']	['Neutral']
Company Decision	['Business_Administrative']	['Possibly_Negative']
"The study had poor enrollment with only 16 patients randomized across 19 study centers over an
    18-month period."	['Insufficient_Enrollment']	['Neutral']
PI left institution (there are no data results for this study)	['Study_Staff_Moved']	['Neutral']
Difficulties with recruitment	['Insufficient_Enrollment']	['Neutral']
"Study was terminated as a result of a pre-specified futility analysis at the interim of 150
    participants completing the efficacy analysis of the study."	['Negative']	['Negative']
Administrative hold	['Business_Administrative']	['Possibly_Negative']
"The study is being closed to accrual secondary to low accrual and an interest in opening up a
    different trial."	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Unable to maintain a waitlist long enough to serve as a control group.	['Insufficient_Enrollment']	['Neutral']
Patient recruitment insufficient	['Insufficient_Enrollment']	['Neutral']
No participants enrolled. Unable to enroll	['Insufficient_Enrollment']	['Neutral']
No longer practical to deliver treatment	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Slow enrolment.	['Insufficient_Enrollment']	['Neutral']
"The PI wanted to make additional changes to the hand held camera therefore he terminated the
    study rather than continue with an outdated camera design."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Difficulty accruing subjects the study accrual was closed	['Insufficient_Enrollment']	['Neutral']
Funding unavailable	['Business_Administrative']	['Possibly_Negative']
Due to budget limitations, the company decided to withdraw this study.	['Business_Administrative']	['Possibly_Negative']
Not enough eligible patients available	['Insufficient_Enrollment']	['Neutral']
Enrollment futility	['Negative']	['Negative']
no funding	['Business_Administrative']	['Possibly_Negative']
Slow patient accrual	['Insufficient_Enrollment']	['Neutral']
low enrollment	['Insufficient_Enrollment']	['Neutral']
Due to COVID-19 with temporary closure of recruitment sites	['Covid19']	['Neutral']
Grant not obtained	['Business_Administrative']	['Possibly_Negative']
Could not meet recruitment, technology advancement.	['Study_Design']	['Neutral']
Unable to collect data	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Study sponsor requested that the study be permanently closed by letter.	['Business_Administrative']	['Possibly_Negative']
sponsor withdraw from this study	['Business_Administrative']	['Possibly_Negative']
Too much difficulty recruiting and retaining patients, PI decided to stop.	['Insufficient_Enrollment']	['Neutral']
not possible to enroll during COVID pandemic	['Covid19']	['Neutral']
The former principal investigator left the institution.	['Study_Staff_Moved']	['Neutral']
"IMP used off label by phys. in pat. with PSP. Thus no more eligible patients were available for
    the study(pre-treatm.with Rasagiline=exclusion criterion"	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Study terminated due to the acquisition of PEAK Surgical by Medtronic	['Business_Administrative']	['Possibly_Negative']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
"Accrual was poor at two other sites and manuscript was published which describing another study
    which accomplished the goals of this project."	['Insufficient_Enrollment', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
"Change in FDA required patient population decision prior to study start, new protocol
    developed, this protocol withdrawn"	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Closed due to poor accrual	['Insufficient_Enrollment']	['Neutral']
Lack of efficacy	['Negative']	['Negative']
Not Awarded	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Due to nationwide shortage of Aminophylline.	['Logistics_Resources']	['Neutral']
Trial never received funding.	['Business_Administrative']	['Possibly_Negative']
Similar data obtained in another study [see NCT01085045], therefore study not implemented.	['Negative', 'Another_Study']	['Negative', 'Neutral']
"The study was terminated on June 24th, 2015 due to change in strategy of PF-03084014
    development. There were no safety/efficacy concerns behind the decision."	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
Covid-19	['Covid19']	['Neutral']
No patients were recruited. Treatment drug expired.	['Logistics_Resources']	['Neutral']
"Inclusion rate too low due to a lack of eligible patients and difficulties obtaining informed
    consent."	['Insufficient_Enrollment']	['Neutral']
not enough patients recruited	['Insufficient_Enrollment']	['Neutral']
Data from the C08 study and Avant study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Sponsor decision to terminate early	['Business_Administrative']	['Possibly_Negative']
PI left institution,replacement PI not able to do study.	['Study_Staff_Moved']	['Neutral']
Behavioral manipulation failed so the trial did not occur	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study was stopped due to insufficient efficacy and very slow accrual	['Insufficient_Enrollment']	['Neutral']
Unable to accrual total number of participants during study period.	['Insufficient_Enrollment']	['Neutral']
no treatment available	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Adverse events reported with beta-blockers as primary therapy.	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
First required to complete a proof of principle study for a new outcome measure.	['No_Context', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
Early termination for discouraging results	['Negative']	['Negative']
safety reasons	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Company decision to discontinue trial	['Business_Administrative']	['Possibly_Negative']
Terminated due to low subject accrual	['Insufficient_Enrollment']	['Neutral']
low inclusion rate	['Insufficient_Enrollment']	['Neutral']
Study completed and data was inconclusive.	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
PI withdrew the protocol	['No_Context', 'Study_Staff_Moved', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
"Melagatran/ximelagatran was withdrawn from the market and clinical development in February 2006
    in the interest of patient safety."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
Study terminated based on decision of Sponsor.	['Business_Administrative']	['Possibly_Negative']
no patient recruitment	['Insufficient_Enrollment']	['Neutral']
Study never reached the enrolling phase and PI has since relocated	['Study_Staff_Moved']	['Neutral']
"Study was terminated before the start of dosing due to a business decision and not due to
    safety or efficacy reasons."	['Business_Administrative']	['Possibly_Negative']
Lack of efficacy	['Negative']	['Negative']
Study Terminated - No enrollment, business decision.	['Business_Administrative']	['Possibly_Negative']
poor accrual rate	['Insufficient_Enrollment']	['Neutral']
Study stopped by promoter for lack of inclusion	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
COVID-19	['Covid19']	['Neutral']
The study was stopped because there were not enough eligible patients to complete the study.	['Insufficient_Enrollment']	['Neutral']
Change in personnel	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
PI time constraints	['Business_Administrative']	['Possibly_Negative']
difficulty in recruiting	['Insufficient_Enrollment']	['Neutral']
Supplement expired and unable to obtain more from company manufacturing	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
study halted prematurely, prior to enrollment of first participant	['Invalid_Reason']	['Invalid_Reason']
during the study	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Colaborator withdrew support.	['Business_Administrative']	['Possibly_Negative']
End of study time and budget permission	['Business_Administrative']	['Possibly_Negative']
Change in clinical strategy.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
There were no patient enrolled in this study at this site	['Insufficient_Enrollment']	['Neutral']
AVE5530 in hypercholesterolemia was stopped due to insufficient efficacy	['Negative']	['Negative']
Failure to recruit	['Insufficient_Enrollment']	['Neutral']
A major adverse event occured (pulsed biphasic waveform arm).	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
strategic decision	['Business_Administrative']	['Possibly_Negative']
Study was terminated due to lack of available funding.	['Business_Administrative']	['Possibly_Negative']
no subjects were enrolled, study was halted due to study staff departure	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
Unable to enroll to the randomized arm.	['Insufficient_Enrollment']	['Neutral']
No subjects accrued and no potential subjects were identified..	['Insufficient_Enrollment']	['Neutral']
Mutual decision between the investigators and the sponsor	['Business_Administrative']	['Possibly_Negative']
study was non-feasible per DSMB	['Negative', 'Another_Study']	['Negative', 'Neutral']
Co-investigator left facility. Decided not to enroll patients therefore.	['Study_Staff_Moved']	['Neutral']
Insufficient recruitment, too much selective inclusion criteria, feasibility problems	['Insufficient_Enrollment']	['Neutral']
funding ran out, poor accrual.	['Insufficient_Enrollment']	['Neutral']
Unable to sufficiently recruit candidates	['Insufficient_Enrollment']	['Neutral']
The study stopped prematurely due to the low accrual rate	['Insufficient_Enrollment']	['Neutral']
Recruitment of patients proved much too difficult based on the chosen criteria.	['Study_Design']	['Neutral']
"Synthesis of the chemical precursor for the neuroimaging radiotracer could not be produced in a
    stable fashion."	['Logistics_Resources']	['Neutral']
Difficulty meeting enrollment goal	['Insufficient_Enrollment']	['Neutral']
The study will not take place at the University of Pittsburgh	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
unable to enroll enough patients	['Insufficient_Enrollment']	['Neutral']
COVID-19 pandemic	['Covid19']	['Neutral']
"Issues with development and supply of infusion system for delivery of IMP. Lack of favorable
    benefit risk ratio in sNN0029-003 study (review of interim data)."	['Negative']	['Negative']
Study not funded.	['Business_Administrative']	['Possibly_Negative']
not funded	['Business_Administrative']	['Possibly_Negative']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
cancellation of funding contract	['Business_Administrative']	['Possibly_Negative']
The study was not activated.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
The reason is: emerging pre-clinical toxicology findings.	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
PI left the institution	['Study_Staff_Moved']	['Neutral']
Lack of Drug Supply	['Logistics_Resources']	['Neutral']
"Although not observed in our patients (4 enrolled), SAEs have been reported in other patients
    receiving the same product."	['Safety_Sideeffects', 'Negative', 'Another_Study']	['Safety_Sideeffects', 'Negative', 'Neutral']
Study ended due to lack of eligible subjects and funding not renewing	['Business_Administrative']	['Possibly_Negative']
low accrual; loss of funding	['Insufficient_Enrollment']	['Neutral']
Safety questions on patients with glaucoma are in discussion by our IRB	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Due to competing trials, this study is permanenlty closed to patient acrrual.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Difficult recruitment	['Insufficient_Enrollment']	['Neutral']
low recruitment	['Insufficient_Enrollment']	['Neutral']
Study terminated due to slow/insufficient accrual.	['Insufficient_Enrollment']	['Neutral']
low enrollment	['Insufficient_Enrollment']	['Neutral']
Due to recruiting issues	['Insufficient_Enrollment']	['Neutral']
Administrative reasons.	['Business_Administrative']	['Possibly_Negative']
No benefit of intravesical instillation of Hyaluronic Acid/Chondroitin Sulfate	['Negative']	['Negative']
low recruitment	['Insufficient_Enrollment']	['Neutral']
"Study must be registered under the sponsor instead of the site, so we have created a new
    posting in the sponsor's account."	['Covid19', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Study was not initiated	['Invalid_Reason']	['Invalid_Reason']
Slow Enrollment	['Insufficient_Enrollment']	['Neutral']
recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Slow enrollment and poor patient follow-up following enrollment	['Insufficient_Enrollment']	['Neutral']
Resident project--resident left institution and was not picked up by anyone else	['Study_Staff_Moved']	['Neutral']
Funding discontinued	['Business_Administrative']	['Possibly_Negative']
Sponsor's commercial decision	['Business_Administrative']	['Possibly_Negative']
Inadequate enrollment and decreased need for clinical data to support product	['No_Context', 'Logistics_Resources', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
Change in institutional policy. Change in resources available.	['Business_Administrative']	['Possibly_Negative']
Study was withdrawn before IRB approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Funding ended	['Business_Administrative']	['Possibly_Negative']
due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
Unfortunately we did not receive funding and therefore were not able to begin the trial.	['Business_Administrative']	['Possibly_Negative']
GeneSearch BLN Assay has been voluntarily withdrawn from the US market.	['Business_Administrative']	['Possibly_Negative']
Study never started.	['Invalid_Reason']	['Invalid_Reason']
Strategic considerations	['Business_Administrative']	['Possibly_Negative']
Inclusion criteria too strict making it difficult to recruit in primary care	['Insufficient_Enrollment']	['Neutral']
safety and efficacy after cohort 5 did not warrant further dose escalation	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study halted prematurely, prior to enrollment of first participant, for strategic reasons	['Business_Administrative']	['Possibly_Negative']
Waiting for funding	['Business_Administrative']	['Possibly_Negative']
The trial was halted by the DSMB.	['Interim_Analysis', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
The research could not be conducted as it was denied by the IRB.	['Interim_Analysis', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
the PI is no longer work at Hadassah	['Study_Staff_Moved']	['Neutral']
Terminated in lieu of similar,competing large, multi-site study.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Company decision to discontinue trial	['Business_Administrative']	['Possibly_Negative']
interim analysis showed that the trial will not meet the interim endpoint.	['Negative']	['Negative']
Low interest in study, slow recruitment	['Insufficient_Enrollment']	['Neutral']
Non significative preliminary data	['Negative']	['Negative']
Protocol Withdrawn	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Development program terminated	['Business_Administrative']	['Possibly_Negative']
Subjects did not receive Hope Pharmaceuticals' Sodium Thiosulfate Injection.	['Logistics_Resources']	['Neutral']
Study was discontinued due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
"Therapy of HER2+ patients according to protocol was no longer appropriate. Patient enrolment
    behind planned schedule and challenges of site performance"	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Study halted prematurely due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
OncoGel did not show any impact on overall tumor response	['Negative']	['Negative']
It was decided to discontinue the study due to insufficient recruitment.	['Insufficient_Enrollment']	['Neutral']
Technical issue	['Logistics_Resources']	['Neutral']
Following an interim data review, further investment in nevanimibe has been discontinued	['Business_Administrative']	['Possibly_Negative']
Preliminary analyses of data indicated study should be terminated for futility	['Negative']	['Negative']
Sangart ceased operations	['Business_Administrative']	['Possibly_Negative']
low enrollment	['Insufficient_Enrollment']	['Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
Inability to recruit patients	['Insufficient_Enrollment']	['Neutral']
No participants were recruited.	['Insufficient_Enrollment']	['Neutral']
Due to Covid, the study could not be initiated as planned.	['Covid19']	['Neutral']
"One of the investigators left the department, Master Degree in which this study was part of her
    thesis. No patients were enrolled."	['Study_Staff_Moved']	['Neutral']
Initial enrollment goal met. Pending funding to expand study.	['Business_Administrative']	['Possibly_Negative']
Funding expired	['Business_Administrative']	['Possibly_Negative']
FDA Contingencies unresolved	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study was terminated due to slow accrual rate.	['Insufficient_Enrollment']	['Neutral']
Lack of patient population	['Insufficient_Enrollment']	['Neutral']
Principal Investigator and Study Sponsor decided to terminate the study early	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
COVID19 pandemic. Cannot recruit from primary care during pandemic	['Covid19']	['Neutral']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
The study was terminated early due to difficulties with patient recruitment.	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
departure of PI from institution and poor population for study participation	['Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Unsuccessful attempts to recruit participants	['Insufficient_Enrollment']	['Neutral']
Concerned about the adverse effects of HCQ	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Varience of supply chain from that required by protocol	['Logistics_Resources']	['Neutral']
The PI closed this study and went to another institution.	['Study_Staff_Moved']	['Neutral']
Clinical trial was postponed as a result of restructured business priorities.	['Business_Administrative']	['Possibly_Negative']
Sopnsor decision	['Regulatory', 'Insufficient_Enrollment', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
inability to recruit patients	['Insufficient_Enrollment']	['Neutral']
No funding received.	['Business_Administrative']	['Possibly_Negative']
Slow patient recruitment	['Insufficient_Enrollment']	['Neutral']
"not ""applicable clinical trial"""	['Invalid_Reason']	['Invalid_Reason']
Study terminated by Sponsor before completion due to absence of significant safety findings.	['Safety_Sideeffects', 'Negative']	['Safety_Sideeffects', 'Negative']
Inclusion criteria were too strict and therefore we were not able to recruit more patients.	['Insufficient_Enrollment']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of Subject Recruitment	['Insufficient_Enrollment']	['Neutral']
PI said to close accrual do to funding	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
The study closed prior to enrolling any participants.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Difficulty in Recruiting Research Participants	['Insufficient_Enrollment']	['Neutral']
Due to personnel and organizational issues.	['Business_Administrative']	['Possibly_Negative']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Subjects declined enrollment; sponsor/PI elected to close study.	['Insufficient_Enrollment']	['Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Study never began because of withdrawal of the industrial partner	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
The study was withdrawn due to lack of patients.	['Insufficient_Enrollment']	['Neutral']
"Protocol objective could not be met. A new study with amended eligibility criteria will be
    developed."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
See Detailed Description	['No_Context']	['Invalid_Reason']
Unable to enroll any study participants.	['Insufficient_Enrollment']	['Neutral']
The original PI on this study left VICC, thus study was closed.	['Study_Staff_Moved']	['Neutral']
Could not resolve technical difficulties	['Logistics_Resources']	['Neutral']
Lack of enrollment due to strict inclusion/exclusion criteria. Bradykinin shortage	['Insufficient_Enrollment']	['Neutral']
Principal Investigator passed away.	['Study_Staff_Moved']	['Neutral']
Failure to meet primary objective	['Negative']	['Negative']
Lack of financial support	['Business_Administrative']	['Possibly_Negative']
"Study D2276C00001 was not started. No patients were enrolled. The sponsor decided to pursue an
    alternate design."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
PI moved to Oregon	['Study_Staff_Moved']	['Neutral']
Failure to secure funding	['Business_Administrative']	['Possibly_Negative']
Slow accrual, PI left institution	['Insufficient_Enrollment']	['Neutral']
Methods of activation timing measurements too imprecise	['No_Context', 'Logistics_Resources', 'Endpoint_Met']	['Invalid_Reason', 'Neutral', 'Neutral']
Poor efficacy of DHA-piperaquine due to likely drug resistance.	['Negative']	['Negative']
Investigator left the National Institutes of Health (NIH)	['Study_Staff_Moved']	['Neutral']
Could not get IMP	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
"It is considered non-achievable to recruit the target number of subjects in the short bowel
    group (n = 12). 10 participants were recruited."	['Insufficient_Enrollment']	['Neutral']
The principal investigator decided to stop the study.	['Invalid_Reason']	['Invalid_Reason']
recruition number was not reached	['Insufficient_Enrollment']	['Neutral']
the main research is no longer in the Institution	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
PI left Duke	['Study_Staff_Moved']	['Neutral']
FDA did not require a clinical trial for indication.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
not include patient anymore	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Interim analysis demonstrated the treatment was not effective	['Negative']	['Negative']
Inadequate enrolment and lack of resources	['Insufficient_Enrollment']	['Neutral']
Slower than anticipated recruitment	['Insufficient_Enrollment']	['Neutral']
This study was terminated early due to slow accrual of patients.	['Insufficient_Enrollment']	['Neutral']
COVID-19 pandemic	['Covid19']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Poor accrual of subjects and lack of funding	['Insufficient_Enrollment']	['Neutral']
Funding has run out but we are trying to secure more funding.	['Business_Administrative']	['Possibly_Negative']
loss of funding	['Business_Administrative']	['Possibly_Negative']
"Departure of psychologist in charge of questionnaires and scales administered to patients as
    part of the evaluation of primary endpoint"	['Study_Staff_Moved']	['Neutral']
No recruitment was achievable	['Insufficient_Enrollment']	['Neutral']
Business Decision (no enrollment)	['Business_Administrative']	['Possibly_Negative']
Inadequate resources to submit for approval	['Business_Administrative']	['Possibly_Negative']
"Following program review within Pfizer, decision was made not to go ahead with this study. This
    study is cancelled"	['Business_Administrative']	['Possibly_Negative']
"The trial prematurely terminated as recommended by the E-DMC because the boundary for futility
    has been crossed."	['Negative']	['Negative']
sponsor withdrew funding prior to patient enrollment	['Business_Administrative']	['Possibly_Negative']
"The company providing one of the study drugs withdrew its support due to low enrollment.
    Therefore, we had to close the study due to lack of funding."	['Business_Administrative']	['Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
The primary hypotheses were unsupported with half of the data collected.	['Logistics_Resources', 'Insufficient_Data', 'Negative']	['Neutral', 'Neutral', 'Negative']
Enrollment was completed with insufficient sample size for publishable results	['Insufficient_Enrollment']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Awaiting further funding	['Business_Administrative']	['Possibly_Negative']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Termination of study due to low enrollment. There were no safety issues.	['Insufficient_Enrollment']	['Neutral']
Sponsor decision because of to small enrollment	['Insufficient_Enrollment']	['Neutral']
Study never started as no longer novel	['Invalid_Reason', 'Study_Design']	['Invalid_Reason', 'Neutral']
study was discontinued	['Invalid_Reason']	['Invalid_Reason']
low enrollment	['Insufficient_Enrollment']	['Neutral']
financial issues	['Business_Administrative']	['Possibly_Negative']
Withdrawn due to no funding	['Business_Administrative']	['Possibly_Negative']
Slow enrollment and minimal preliminary biological and clinical efficacy.	['Negative']	['Negative']
Withdrawn due to lack of accrual	['Insufficient_Enrollment']	['Neutral']
Poor recruitment and terminated during COVID-19 pandemic	['Covid19']	['Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Difficulty of inclusion	['Insufficient_Enrollment']	['Neutral']
NIH Funded Grant Expired	['Business_Administrative']	['Possibly_Negative']
Insufficient recruitment.	['Insufficient_Enrollment']	['Neutral']
"An interim analysis found the study would not be able to reach significance without a large
    increase in subjects which was not feasible."	['Negative']	['Negative']
"The study was terminated by Spiracur. Efforts were made to contact the PI/study team members,
    but were unsuccessful."	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
No longer required study by FDA for NDA approval.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"pre-planned interim analysis of the Phase II/III CLARITY trial of BL-1020 indicate that the
    trial would not meet the pre-specified primary efficacy endpoint."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Difficult to recruit participants	['Insufficient_Enrollment']	['Neutral']
Study was withdrawn due to scientific and business considerations.	['Business_Administrative']	['Possibly_Negative']
We decided to close this study and come up with a new study design.	['Study_Design']	['Neutral']
Machine cannot provide	['Logistics_Resources']	['Neutral']
voluntarily by Sponsor to investigate an anticipated SAE	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
PI left the institution	['Study_Staff_Moved']	['Neutral']
Futility	['Negative']	['Negative']
This trial was halted prematurely for business reasons and low enrollment.	['Business_Administrative']	['Possibly_Negative']
PI is no longer at MCW, study has been closed	['Study_Staff_Moved']	['Neutral']
"The study group changed from patients to a healthy volunteers. A healthy-volunteer study is
    being planned to replace 213."	['Negative', 'Another_Study']	['Negative', 'Neutral']
lack of funding.	['Business_Administrative']	['Possibly_Negative']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Clinical Hold pending additional data review and protocol amendment	['Study_Design']	['Neutral']
The industry plant from which we should recruit was closed down.	['Logistics_Resources', 'Study_Staff_Moved', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Management decision	['Business_Administrative']	['Possibly_Negative']
unable to recruit participants	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Withdrawn due to change in standard of care - new protocol required	['Study_Design']	['Neutral']
Early termination because of insufficient accrual.	['Insufficient_Enrollment']	['Neutral']
Study recruitment of new participants was suspended during 2020 due to the Covid-19 pandemic.	['Covid19']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
Accrual issue	['Insufficient_Enrollment']	['Neutral']
The reason was the fact that the study was not clinically feasible.	['Logistics_Resources', 'Study_Design', 'Another_Study']	['Neutral', 'Neutral', 'Neutral']
After completing Phase 1, the Sponsor elected not to move forward with Phase 2.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
No subjects enrolled	['Insufficient_Enrollment']	['Neutral']
"Study halted prematurely and will not resume; participants are no longer being examined or
    receiving intervention. Low enrollment and PI leaving institution"	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Diminished rectruitment	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Poor inclusion rate.	['Insufficient_Enrollment']	['Neutral']
Recruitment time expired.	['Business_Administrative']	['Possibly_Negative']
The Study was terminated due to lack of efficacy.	['Negative']	['Negative']
"Scientific review positive from 3 manufacturers; internal committees did not support due to
    deploying new flu vaccines in HIV+ pregnant women in Kenya."	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
unexpected withdrawal of funding	['Business_Administrative']	['Possibly_Negative']
The owner of the algorithm does not wish that this study be undertaken	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Drug supply issue	['Logistics_Resources']	['Neutral']
Planned interim analysis-no statistical significance for the primary outcome.	['Negative']	['Negative']
Study was stopped prematurely due to the lack of eligible participants.	['Insufficient_Enrollment']	['Neutral']
Closed due to poor accrual.	['Insufficient_Enrollment']	['Neutral']
Please see Detailed Description for termination reason.	['No_Context']	['Invalid_Reason']
No participants were enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
No uptake from potential participants	['Insufficient_Enrollment']	['Neutral']
Investigator's perogative	['Safety_Sideeffects', 'Logistics_Resources', 'Study_Staff_Moved']	['Safety_Sideeffects', 'Neutral', 'Neutral']
end of recruitment period was reach	['Invalid_Reason']	['Invalid_Reason']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Unable to enroll subjects	['Insufficient_Enrollment']	['Neutral']
The study was withdrawn because it no longer fit the business need.	['Business_Administrative']	['Possibly_Negative']
NCT01318642: Planned independent DMC Interim review: ended for futility w/no safety concerns	['Negative']	['Negative']
Low accrual due to the approval of new drugs for use in Mantle cell lymphoma.	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Insufficient funding	['Business_Administrative']	['Possibly_Negative']
Study stopped due to low enrolment rate.	['Insufficient_Enrollment']	['Neutral']
Funding terminated by sponsor, insufficient data collection	['Business_Administrative']	['Possibly_Negative']
Study never accrued sufficient subjects	['Insufficient_Enrollment']	['Neutral']
Insufficient number of baseline eligible patient	['Insufficient_Enrollment']	['Neutral']
Sponsor related	['Business_Administrative']	['Possibly_Negative']
Enrollment finished and a paper was published.	['Success', 'No_Context', 'Insufficient_Data']	['Success', 'Invalid_Reason', 'Neutral']
Sponsor elected to not pursue this indication for the study device.	['Business_Administrative']	['Possibly_Negative']
The clinical use of Campath for transplant patients was temporarily suspended.	['Study_Design']	['Neutral']
Lack of feasibility	['Logistics_Resources']	['Neutral']
higher rate of post-operative infection in the Dermal Matrix arm of the study	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
"The study was never opened for enrollment; concept became irrelevant as other study results
    became available."	['Success', 'Insufficient_Data', 'Study_Design']	['Success', 'Neutral', 'Neutral']
Lack of study personnel	['Logistics_Resources']	['Neutral']
The recruitment process could not provide us with enough participants	['Insufficient_Enrollment']	['Neutral']
failed to meet enrollment goals	['Insufficient_Enrollment']	['Neutral']
Data collection ended due to COVID-19 (study site closed to in-person visits)	['Covid19']	['Neutral']
investigator and sponsor decided by mutual agreement to stop study prematurely	['Business_Administrative']	['Possibly_Negative']
no subjects enrolled	['Insufficient_Enrollment']	['Neutral']
Unable to recruit patients.	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Funding withdrawn before ethical approval granted	['Business_Administrative']	['Possibly_Negative']
Slow enrollment and lack of community enthusiasm	['Insufficient_Enrollment']	['Neutral']
Management Decision	['Business_Administrative']	['Possibly_Negative']
Terminated prematurely due to feasibility issues with rate of recruitment	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
"Due to the Covid-19 pandemic, face-to-face activities have been suspended since March 2020,
    making the research unfeasible."	['Covid19']	['Neutral']
Trial was Terminated prior to subjects receiving study drug; no trial results	['Negative', 'Another_Study']	['Negative', 'Neutral']
"The study was stopped due to methodological issues that require additional consideration prior
    to resuming the trial."	['Study_Design']	['Neutral']
recent publications have made this study obsolete	['Negative', 'Another_Study']	['Negative', 'Neutral']
stopped for futility	['Negative']	['Negative']
Research Changed Directions	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
"We observed >90 % efficacy in cyclophosphamide and Prednisolone group for treatment of
    anti-i-HuEpo associated PRCA"	['Success', 'Logistics_Resources', 'Endpoint_Met']	['Success', 'Neutral', 'Neutral']
Lack of sponsor support	['Business_Administrative']	['Possibly_Negative']
Trial cancelled before First Patient First Visit (no patient enrolled)	['Invalid_Reason']	['Invalid_Reason']
Unable to successfully recruit subjects to this study.	['Insufficient_Enrollment']	['Neutral']
Study was stopped before progressive disease or death of alive subjects.	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Difficulty recruiting subjects and loss of study physician for new job	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Recruitment was slow and subjects declined participation after signing the ICF.	['Insufficient_Enrollment']	['Neutral']
Regulatory	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
poor recruitment	['Insufficient_Enrollment']	['Neutral']
lack of funding and drug supply	['Business_Administrative']	['Possibly_Negative']
Business objective change, no safety or efficacy concerns	['Business_Administrative']	['Possibly_Negative']
Unspecified business decision/strategic reason.	['Business_Administrative']	['Possibly_Negative']
"Part 1 of the study was completed and the maximum tolerated dose determined. Part 2 of the
    study was terminated and will be conducted under a new protocol."	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Protocol updates resulted in new protocol/study	['Study_Design']	['Neutral']
failure to recruit	['Insufficient_Enrollment']	['Neutral']
Study team decision-impact(s) of change in hOKT31 (Ala-Ala) manufacturer during study.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
POZEN agreed with FDA to stop study due to low and inadequate enrollment	['Insufficient_Enrollment']	['Neutral']
Administrative issues	['Business_Administrative']	['Possibly_Negative']
FDA removal of drug from the market due to cancer risks	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Inadequate recruitment	['Insufficient_Enrollment']	['Neutral']
PI transferred to another institution and did not take this study with him.	['Study_Staff_Moved']	['Neutral']
High rate of early drop-outs	['Insufficient_Enrollment']	['Neutral']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
Slow inclusion	['Insufficient_Enrollment']	['Neutral']
Program discontinued	['Invalid_Reason']	['Invalid_Reason']
Poor patients' accrual	['Insufficient_Enrollment']	['Neutral']
Access to Speedlyte Product no longer available.	['Logistics_Resources']	['Neutral']
Protocol violation occurred frequently during the postoperative period.	['Study_Design']	['Neutral']
Drug supply issues	['Logistics_Resources']	['Neutral']
Withdrawal of support from sponsor	['Business_Administrative']	['Possibly_Negative']
As recommended by the study's independent Data and Safety Monitoring Board (DSMB)	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
Feasibility issues, only 1 patient recruited.	['Logistics_Resources']	['Neutral']
Sponsor decision based on slow recruitment and new emerging drug combinations	['Insufficient_Enrollment']	['Neutral']
Practical issues that could not be resolved resulting in recruitment difficulties at sites.	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Interim analysis showed sample size sufficient for final analysis	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Not funded - and PI left for another position in 2012	['Logistics_Resources', 'Study_Staff_Moved', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
No subjects recruited	['Insufficient_Enrollment']	['Neutral']
Unable to recruit subjects	['Insufficient_Enrollment']	['Neutral']
Ventricular rate during AF in CRT-patients much lower than expected	['Negative']	['Negative']
Financial/business decision by Sponsor to not proceed with this study	['Business_Administrative']	['Possibly_Negative']
terminated	['Invalid_Reason']	['Invalid_Reason']
Terms for legal agreements between institution and Sponsor could not be made.	['Business_Administrative']	['Possibly_Negative']
The study was terminated due to excessive toxicity and low compliance to the protocol scheme.	['Covid19', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Rofecoxib was withdrawn from the market due to safety concerns.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Unlikely to show statistical significance and slow recruitment.	['Insufficient_Enrollment', 'Invalid_Reason', 'Negative']	['Neutral', 'Invalid_Reason', 'Negative']
PI decided to not activate	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Principal Investigator decided to close the study early.	['Invalid_Reason']	['Invalid_Reason']
Following recommendation by SOLAR Study IDMC, Astellas closed enrollment in ASP8273 studies.	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Invalid_Reason']	['Safety_Sideeffects', 'Neutral', 'Invalid_Reason']
Covid	['Covid19']	['Neutral']
Inadequate accrual rate	['Insufficient_Enrollment']	['Neutral']
Could not recruit any subjects	['Insufficient_Enrollment']	['Neutral']
"Safety Issue: The trial was prematurely terminated on Dec 9, 2010, due to safety concerns,
    specifically new emerging evidence of hepatic injury"	['Success', 'No_Context', 'Safety_Sideeffects']	['Success', 'Invalid_Reason', 'Safety_Sideeffects']
Insufficient findings for data analysis	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
low rate of enrolment	['Insufficient_Enrollment']	['Neutral']
Study terminated due to strategic business decision by Eli Lilly and Company.	['Business_Administrative']	['Possibly_Negative']
Unable to recruit suitable subjects within a reasonable time period.	['Insufficient_Enrollment']	['Neutral']
Terminated	['Invalid_Reason']	['Invalid_Reason']
Majority of enrolled patients have withdrawn.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Sponsor's decision	['Business_Administrative']	['Possibly_Negative']
Enrollment difficulties	['Insufficient_Enrollment']	['Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
Corporate decision not to initiate the trial	['Business_Administrative']	['Possibly_Negative']
FDA alert regarding study drug safety	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Other - evaluation of current enrollments	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Problems with enrollement of patients, less patients than expected	['Insufficient_Enrollment']	['Neutral']
OCT cost is high	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
We are currently modifying the study	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Corona-Virus Lockdown (16th March in Switzerland)	['Covid19', 'Safety_Sideeffects', 'Insufficient_Enrollment']	['Neutral', 'Safety_Sideeffects', 'Neutral']
COVID-19	['Covid19']	['Neutral']
Decision of IP support organization	['Business_Administrative']	['Possibly_Negative']
This study was not feasible due to facility budget and contractual issues.	['Business_Administrative']	['Possibly_Negative']
Slow accrual of subjects. May take longer than expected to complete the trial.	['Insufficient_Enrollment']	['Neutral']
Based on data collected, the combination appeared to be poorly tolearated.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"It was not possible to recruit and include a sufficient number of patients within the
    timeframe."	['Insufficient_Enrollment']	['Neutral']
Suspended due to Covid-19	['Covid19']	['Neutral']
pandemic situation	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Response rate in placebo group for primary outcome was 100% on interim analysis.	['Negative']	['Negative']
not enough recruitment	['Insufficient_Enrollment']	['Neutral']
lack of accrual	['Insufficient_Enrollment']	['Neutral']
More progressive stroke in one arm	['Covid19', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
no funding	['Business_Administrative']	['Possibly_Negative']
"The funding agency, DoD, determined that the study could not meet its enrollment numbers by the
    end of the grant."	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Unable to find grant fundingsupport to continue builds the study device.	['Business_Administrative']	['Possibly_Negative']
Aripiprazole arm had obvious adverse reactions,especially akathisia.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Insys Therapeutics filed Chapter 11 and terminated all studies.	['Business_Administrative']	['Possibly_Negative']
Sponsor financial has been stopped	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
The study was terminated due to a small number of study participants.	['Insufficient_Enrollment']	['Neutral']
The study was withdrawn due to inability to enroll patients in a timely fashion.	['Insufficient_Enrollment']	['Neutral']
non-compliance with the protocol. Arrest requested by the Monitoring Safety committee	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Sponsor withdrew the study	['Business_Administrative']	['Possibly_Negative']
Lack of funding support	['Business_Administrative']	['Possibly_Negative']
Major changes in study required new IRB application and approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Financial issues (no participants enrolled)	['Business_Administrative']	['Possibly_Negative']
Slower than expected recruitment	['Insufficient_Enrollment']	['Neutral']
The IRB did not approve the study to be conducted at the home institution.	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
"Patients evaluated so far could not be enrolled because they did not meet the primary criterion
    of acute renal failure provided by the study protocol"	['Negative']	['Negative']
"Trial is terminated due to a company decision to return all rights for Safinamide back to
    Newron Pharmaceuticals"	['Business_Administrative']	['Possibly_Negative']
Italian Medicines Agency decision	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Protocol could not be carried out to achieve the aims of the study	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
unable to implement the intervention	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Principal Investigator Left Institution	['Study_Staff_Moved']	['Neutral']
Study stopped prior to subject enrollment.	['Invalid_Reason']	['Invalid_Reason']
FDA did not require a clinical trial for indication.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Terminated due to the limitations of accrual.	['Insufficient_Enrollment']	['Neutral']
PI decided to withdraw study	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Voluntarily terminated by PI due to lack of feasibility.	['Logistics_Resources']	['Neutral']
PI is no longer at institution. IRB closed study due to lack of response from PI	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
inadequate recruitment	['Insufficient_Enrollment']	['Neutral']
Sponsor and site were unable to complete a final contract to support the study	['Business_Administrative']	['Possibly_Negative']
no patients enrolled, decided not to pursue study	['Insufficient_Enrollment']	['Neutral']
Please see Detailed Description for termination reason.	['No_Context']	['Invalid_Reason']
Difficulty in enrolling participants	['Insufficient_Enrollment']	['Neutral']
Decided not to enroll	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Drugs unavailable	['Logistics_Resources']	['Neutral']
"Overall profile of the compound does not offer significant clinical advantage to patients over
    currently available lipid lowering agents"	['Negative']	['Negative']
"There was no indication that long-term follow-up would differ between any of the studies that
    have evaluated devices within the 410 Style Matrix."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"After completing the part of assessing lactobacilli transfer, it was decided not to proceed
    further with the masked part of the study."	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Low recruitment rate	['Insufficient_Enrollment']	['Neutral']
"Takeda submitted 900 patient years Interim Analysis to PRAC and requested study to be closed
    since primary objective had been fulfilled. PRAC agreed and on 17Sep2020 approved closure of
    EU-AIR Registry. Takeda announced study closure on 31Oct2020."	['Interim_Analysis', 'Regulatory', 'Negative']	['Neutral', 'Neutral', 'Negative']
Trial enrollment was prematurely terminated due to excessively slow patient recruitment	['Insufficient_Enrollment']	['Neutral']
COVID-19 disrupted interventions irrecoverably.	['Covid19']	['Neutral']
Cardiac surgery group could not be measured (technical monitoring problems)	['Logistics_Resources']	['Neutral']
Inadequate recruitment	['Insufficient_Enrollment']	['Neutral']
Trial Logistics	['Logistics_Resources']	['Neutral']
Early termination of the study due to lack of efficacy.	['Negative']	['Negative']
competing study was opened by the surgeon after this trial was opened	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study stopped early due to poor accrual.	['Insufficient_Enrollment']	['Neutral']
PI terminated the project prematurely	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Research Cancelled	['Invalid_Reason']	['Invalid_Reason']
Lack of recruitement	['Insufficient_Enrollment']	['Neutral']
Due to slow recruitment, the study was prematurely discontinued.	['Insufficient_Enrollment']	['Neutral']
"This observational study has been transitioned to a clinical trial and is now registered at
    (NCT04181112)."	['Success', 'Invalid_Reason', 'Study_Design']	['Success', 'Invalid_Reason', 'Neutral']
Changes in development plan	['Business_Administrative']	['Possibly_Negative']
Study was never started due to logistical issues.	['Logistics_Resources']	['Neutral']
"Study canceled based on results of different study with similar hypothesis, investigational
    agent, & patient"	['Negative', 'Another_Study']	['Negative', 'Neutral']
"No patients could be recruited and randomized due to other center offering backdoor for
    treatment."	['Insufficient_Enrollment']	['Neutral']
Suspended for potential change in protocol to include different imaging modalities	['Study_Design']	['Neutral']
Sponsor withdrew support	['Business_Administrative']	['Possibly_Negative']
Recommendation of DSMB for safety issue, increased mortality with study drug.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
"Terminated prematurely due to recruitment difficulties. Expansion to more study sites not
    planned."	['Insufficient_Enrollment']	['Neutral']
Competing clinical trial	['Negative', 'Another_Study']	['Negative', 'Neutral']
Too few of the invited subjects wanted to participate	['Insufficient_Enrollment']	['Neutral']
Terminated early in agreement with Health Authorities for feasibility reasons	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Sufficient data has been obtained to meet current objectives	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Did not achieve enrollment goal and decided to terminate early	['Insufficient_Enrollment']	['Neutral']
Temporarily paused due to COVID-19	['Covid19']	['Neutral']
"Based on data from pilot study, the PI and program officer have determined that this study was
    not feasible."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"Microbiological findings of resistance on therapy in patients with complicated urinary tract
    infection"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Due to financial reasons	['Business_Administrative']	['Possibly_Negative']
SP arms were stopped due to high levels of treatment failure.CD not available.	['Negative']	['Negative']
Sponsor decided not to continue with the development program	['Business_Administrative']	['Possibly_Negative']
"The study was closed to further enrollment due to the decision by the Sponsor to discontinue
    development of R1507."	['Business_Administrative']	['Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Lack of patient recruitment	['Insufficient_Enrollment']	['Neutral']
"When 9 subjects of targeted 12 subjects had been studied, no changes in plasma potassium were
    detected and it was deemed futile to continue with enrolment."	['Negative']	['Negative']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
no patients were enrolled. Study was closed prior to study start.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Study terminated by Sponsor for administrative reasons prior to completion	['Business_Administrative']	['Possibly_Negative']
Labortory focus was changed and study was not opened at all	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Due to limited support staff and time, study was unable to get started	['Logistics_Resources']	['Neutral']
No effect was found	['Negative']	['Negative']
Study team finished their analysis.	['Invalid_Reason']	['Invalid_Reason']
lack of funds	['Business_Administrative']	['Possibly_Negative']
"A competing trial was opened for patient population with combination of ribociclib and
    everolimus."	['Negative', 'Another_Study']	['Negative', 'Neutral']
REB decision	['Regulatory', 'Invalid_Reason', 'Negative']	['Neutral', 'Invalid_Reason', 'Negative']
"Study terminated due to change in benefit-risk ratio, driven by high incidence GI toxicity in
    absence of clinically significant anti-tumor efficacy."	['Negative']	['Negative']
"The benefit of halting the study to analyze the available data outweighs the benefit of
    delaying the analysis to include data from remaining treatment periods"	['Interim_Analysis', 'Endpoint_Met', 'Negative']	['Neutral', 'Neutral', 'Negative']
did not enroll a patient	['Insufficient_Enrollment']	['Neutral']
Slow accrual rate	['Insufficient_Enrollment']	['Neutral']
"Decision of independent monitoring committee after interim analysis: Risk of failure
    significantly higher in ceftazidime group."	['Negative']	['Negative']
Did not receive budget needed.	['Business_Administrative']	['Possibly_Negative']
Sponsor pulled funding	['Business_Administrative']	['Possibly_Negative']
insufficient number of subjects	['Insufficient_Enrollment']	['Neutral']
"The study was suspended because the PI was unable to get permission from his department to
    submit the protocol to the local IRB?"""	['Business_Administrative']	['Possibly_Negative']
Sponsor terminated open-label extension.	['Business_Administrative']	['Possibly_Negative']
Feasibility	['Logistics_Resources']	['Neutral']
"The study was closed prematurely due to low enrollment and anticipation of future barriers in
    enrollment"	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description	['No_Context']	['Invalid_Reason']
The original PI, Alexander Neumeister, left NYULMC. No data was analyzed.	['Study_Staff_Moved']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Resource constraints	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Never received IRB approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Competition with another study.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of Enrollment	['Insufficient_Enrollment']	['Neutral']
Study was terminated prematurely due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
the number of patients recruited at present is sufficient for analysis.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Clinical Hold for Safety	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Business Decision	['Business_Administrative']	['Possibly_Negative']
Sponsor's considerations	['Business_Administrative']	['Possibly_Negative']
Study stopped due to lack of efficacy.	['Negative']	['Negative']
The company currently does not have plans to conduct this study	['Business_Administrative']	['Possibly_Negative']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Study was stopped and not completed	['Invalid_Reason']	['Invalid_Reason']
Study stopped since it was considered that one of the pre-defined stopping criterion was met.	['Interim_Analysis', 'Endpoint_Met', 'Negative']	['Neutral', 'Neutral', 'Negative']
Too slow patient inclusion and superior effect of the injection	['Negative']	['Negative']
Project was suspended for personal issues	['Logistics_Resources', 'Study_Staff_Moved', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Study was never started. PI left our institution and no other PI was identified	['Study_Staff_Moved']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Manufacturer changed focus to cell therapy	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Illogistical results found in interim evaluation.	['Negative']	['Negative']
No participants enrolled for more than two years. No plan to continue study.	['Insufficient_Enrollment']	['Neutral']
Study no longer feasible	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Pandemic, researchers no longer have access to residents of assisted living.	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
"A program evaluation identified that the safety profile and pharmacokinetic (PK)
    characteristics of the formulation used in all oprozomib studies required further optimization
    and thus enrollment in OPZ007 was halted during dose-expansion."	['Logistics_Resources', 'Endpoint_Met', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
lack of eligible patients	['Insufficient_Enrollment']	['Neutral']
"- Study was terminated due to insufficient clinical efficacy observed in previous studies
    conducted in postherpetic neuralgia."	['Negative', 'Another_Study']	['Negative', 'Neutral']
investigator choice	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
"The trial was stopped due to the toxicities observed with the combination of pimasertib and
    temsirolimus."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Due to local restructering, further recruting was not possible	['Insufficient_Enrollment']	['Neutral']
"Study has been completed in terms of duration but no patient has been recruited during this
    time"	['Insufficient_Enrollment']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Study never started.	['Invalid_Reason']	['Invalid_Reason']
No patient could be recruited.	['Insufficient_Enrollment']	['Neutral']
"Although this study was approved at the Institutional Review Board, Korea Food & Drug
    Administration (KFDA) did not approve this study due to safety concern."	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
No subjects enrolled	['Insufficient_Enrollment']	['Neutral']
Unrelated to trial	['Invalid_Reason', 'Study_Design', 'Another_Study']	['Invalid_Reason', 'Neutral', 'Neutral']
Inability to recruit subjects	['Insufficient_Enrollment']	['Neutral']
Record owner left institution	['Logistics_Resources', 'Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Unable to fill cohort	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
This study was stopped 20 May 2010 due to strategic considerations	['Business_Administrative']	['Possibly_Negative']
on hold due to planned modifications to the test device	['Study_Design']	['Neutral']
No more inclusion	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Funding associated with enrollment milestones was withdrawn by Sponsor.	['Business_Administrative']	['Possibly_Negative']
COVID-19 hold	['Covid19']	['Neutral']
COVID-19 pandemic.	['Covid19']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Recruitment error; Inclusion criteria not met	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
not enough participants	['Insufficient_Enrollment']	['Neutral']
the study is discarded by the sponsor.	['Business_Administrative']	['Possibly_Negative']
"DLBCL and FL cohorts met the pre-specified futility criteria and will not proceed. The MCL
    cohort was terminated due to slow recruitment and aggressive disease."	['Negative']	['Negative']
PI left insitution	['Study_Staff_Moved']	['Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
"Study terminated on 7 April 2015 for business reasons. No safety and/or efficacy concerns
    contributed to the termination of the study"	['Business_Administrative']	['Possibly_Negative']
The main investigators are no longer working at the the center	['Study_Staff_Moved']	['Neutral']
Insulin-HF study was prematurely ended due principally to low recruitment rate.	['Insufficient_Enrollment']	['Neutral']
Suspended due to lack of funding.	['Business_Administrative']	['Possibly_Negative']
"This study was intended to produce pilot data for a center grant component that will no longer
    be conducted."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
The study has been withdrawn due to too few patients	['Insufficient_Enrollment']	['Neutral']
No funding or enrollment	['Business_Administrative']	['Possibly_Negative']
this study was terminated due to losing financial support, and enrollment challenges	['Business_Administrative']	['Possibly_Negative']
Inclusion, treatments and follow-up are finished	['Invalid_Reason']	['Invalid_Reason']
No participants were identified per inclusion/exclusion criteria	['Insufficient_Enrollment']	['Neutral']
Not enough participants. very slow and poor recruitment	['Insufficient_Enrollment']	['Neutral']
Study was not continued due to lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
research staffs unable to continue.	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
An interim data analysis found no significant difference between testing groups.	['Negative']	['Negative']
Company terminated drug support	['Business_Administrative']	['Possibly_Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Subjects were never screened/enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
PI leaving University	['Study_Staff_Moved']	['Neutral']
Contractual issues	['Business_Administrative']	['Possibly_Negative']
Delay in the R&D stage	['Business_Administrative']	['Possibly_Negative']
Completion of follow-up period	['Invalid_Reason']	['Invalid_Reason']
Funding ended	['Business_Administrative']	['Possibly_Negative']
This study is a retrospective chart review study, not a clinical trial.	['Success', 'No_Context', 'Insufficient_Data']	['Success', 'Invalid_Reason', 'Neutral']
Awaiting IRB approval of amendment	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
No medication	['Logistics_Resources']	['Neutral']
Study halted by the sponsor	['Business_Administrative']	['Possibly_Negative']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
all patients required included	['Invalid_Reason']	['Invalid_Reason']
investigator not available	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
hard to get an informed concent because of small number of indiaiton of surgery	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"In order to join forces with another study already running which aims to answer the same
    question."	['Negative', 'Another_Study']	['Negative', 'Neutral']
autistic recruitment problems	['Insufficient_Enrollment']	['Neutral']
Inclusion default	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
"Due to COVID-19 recruitement stopped since intended sample size was an estimation and not based
    on power calculation"	['Covid19']	['Neutral']
Investigator leaving institution	['Study_Staff_Moved']	['Neutral']
Inability to enroll adequate number of patients	['Insufficient_Enrollment']	['Neutral']
In-person visit restrictions due to COVID-19	['Covid19']	['Neutral']
Study canceled by decision strategically.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
investigator left Loyola	['Study_Staff_Moved']	['Neutral']
This study was terminated because the National Ethics Committee has not approved the protocol.	['Interim_Analysis', 'Regulatory', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
recruitment failure	['Insufficient_Enrollment']	['Neutral']
One investigator is out-of-service due to carrying out another task.	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
Slow recruitment rate	['Insufficient_Enrollment']	['Neutral']
low recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Cancellation of funding contract	['Business_Administrative']	['Possibly_Negative']
Inclusion difficulties, despite significant changes to inclusion criteria	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Investigator no longer at institution-no data analyzed	['Study_Staff_Moved']	['Neutral']
The company which holds the patent was not interested.	['Business_Administrative']	['Possibly_Negative']
At sponsor's discretion : The purpose of study is no longer maintained	['Business_Administrative']	['Possibly_Negative']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
lack of inclusion in the study	['Insufficient_Enrollment']	['Neutral']
"Due to COVID-19, recruitment was halted before we were able to enroll participants. Currently
    we are unable to resume recruitment due to study staff changes."	['Covid19']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Assay for stem cell analysis not available	['Logistics_Resources', 'Negative']	['Neutral', 'Negative']
The Study will be conducted in another research center. The Sponsor has changed.	['Business_Administrative']	['Possibly_Negative']
PI left institution, end of funding, clinic relocation, recruitment issues	['Business_Administrative']	['Possibly_Negative']
The study was terminated based on an interim assessment of immunogenicity.	['Safety_Sideeffects', 'Negative']	['Safety_Sideeffects', 'Negative']
Slower than anticipated enrollment	['Insufficient_Enrollment']	['Neutral']
"Slow recruitment, study stopped with only 13 of 70 patients included in second part of the
    study"	['Insufficient_Enrollment']	['Neutral']
The primary objective has already been answered with the number of recruited patients.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Regulatory issues	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The study was never started	['Invalid_Reason']	['Invalid_Reason']
"The study has been suspended because of COVID-19. We will resume as soon as COVID-19
    restrictions are lifted."	['Covid19']	['Neutral']
Methodology of subject enrollment would require significant modification.	['Study_Design']	['Neutral']
Primary Investigator is leaving host university (ETSU)	['Study_Staff_Moved']	['Neutral']
Study is temporarily suspended due to COVID-19	['Covid19']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Recruitment numbers could not at all been achieved in an acceptable period of time	['Insufficient_Enrollment']	['Neutral']
No participants were enrolled.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
End of drug development	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Contract not reached with sponsor	['Business_Administrative']	['Possibly_Negative']
Study closed due to low accrual.	['Insufficient_Enrollment']	['Neutral']
For financial and logistical reasons	['Business_Administrative']	['Possibly_Negative']
"Except in compulsory cases hospital admissions have been decreased significantly due to the
    pandemic. The study was terminated due to significant decrease in enrollment rate."	['Insufficient_Enrollment']	['Neutral']
Because of the very slow enrollment, this study was stopped.	['Insufficient_Enrollment']	['Neutral']
Insufficient accrual	['Insufficient_Enrollment']	['Neutral']
finances and feasibility	['Business_Administrative']	['Possibly_Negative']
CT scanner software incompatible	['Logistics_Resources']	['Neutral']
Corporate decision	['Business_Administrative']	['Possibly_Negative']
"-  Delay in enrolment (24% at 1 year)

      -  Lower than estimated prevalence of PAH (15% instead of 50%)

      -  Refusal of patients with PAH to participate"	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Significant Adverse Effects - Futility	['Negative']	['Negative']
low recruitment	['Insufficient_Enrollment']	['Neutral']
Recruitment challenges	['Insufficient_Enrollment']	['Neutral']
Lack of benefit and safety concern	['Safety_Sideeffects', 'Endpoint_Met', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Low rate of patient recruitment. Cannot achieve sample size.	['Insufficient_Enrollment']	['Neutral']
The study was stopped due to lack of funding.	['Business_Administrative']	['Possibly_Negative']
This study is coordinated by the Harms Study Group. It is already registered on this website	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Recruiting was not possible	['Insufficient_Enrollment']	['Neutral']
Antibody supply was discontinued by United Therapeutics Corporation.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Insufficient Enrollment	['Insufficient_Enrollment']	['Neutral']
Protocol drug change required new clinicaltrails.gov entry	['Study_Design']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
"Unique provision in the American Recovery and Reinvestment Act prevented approval of second
    year no-cost-extension in which completion of analyses were planned."	['Regulatory', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
"Terminated: Test article, Omontys, was recalled from the market; Enrollment has halted
    prematurely and will not resume; participants are no longer being treated"	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
No financial agreement	['Business_Administrative']	['Possibly_Negative']
slow accrual for Cohort II	['Insufficient_Enrollment']	['Neutral']
Unable to recruit any patients that fulfilled the narrow enrollment requirements	['Insufficient_Enrollment']	['Neutral']
Stopped due to concerns about interaction between St. John's wort and Tamoxifen.	['Covid19', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Dropout rate was too high	['Insufficient_Enrollment']	['Neutral']
Study closed. Difficult enrollment of patients with prostatitis.	['Insufficient_Enrollment']	['Neutral']
IND no longer available.	['Covid19', 'Regulatory', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Feasibility issues	['Logistics_Resources']	['Neutral']
sample size is too small to draw a conclusion	['Insufficient_Enrollment']	['Neutral']
Due to a radical change in postoperative care as well as surgical technique.	['Study_Design']	['Neutral']
Low accrual rate	['Insufficient_Enrollment']	['Neutral']
Sponsor determined there was sufficient material collected to answer the study questions.	['Interim_Analysis', 'Success', 'Logistics_Resources']	['Neutral', 'Success', 'Neutral']
No eligible participants left to approach/ recruit	['Insufficient_Enrollment']	['Neutral']
Sponsor discretion	['Business_Administrative']	['Possibly_Negative']
Alternate development strategy	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Because of inclusion delay	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
slow accrual	['Insufficient_Enrollment']	['Neutral']
See Detailed Description.	['No_Context']	['Invalid_Reason']
FDA approved Embospheres for prostate embolization, so IDE not needed	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Slower than expected tooth decay in placebo group and insufficient recruitment.	['Insufficient_Enrollment']	['Neutral']
Trial initiated, but data collection was inadequate. Analysis was terminated.	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Drug Product no longer available.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Lack of efficacy (stratum 2); slow accrual (stratum 1)	['Insufficient_Enrollment']	['Neutral']
"Due to staffing issues, we are unable to enroll patients at the clinical site assigned. The
    study is terminated."	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
lack of study personel	['Logistics_Resources']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Study was cancelled prior to enrolling any subjects	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
for inability to enroll subjects.	['Insufficient_Enrollment']	['Neutral']
"Abbott received FDA approval to transition the ongoing Optisure PAS to EP a new EP-PASSION Real
    World Evidence methodology"	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Business pivot caused termination of study before enrollment.	['Business_Administrative']	['Possibly_Negative']
Funding source withdrew funding	['Business_Administrative']	['Possibly_Negative']
Technical difficulties	['Logistics_Resources']	['Neutral']
Low or poor accrual	['Insufficient_Enrollment']	['Neutral']
no participants enrolled	['Insufficient_Enrollment']	['Neutral']
Terminated on 2/28/13, low enrollment; last participant med visit 5/13/13.	['Insufficient_Enrollment']	['Neutral']
This study was closed before accrual due to FDA recall of Medication	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
No subjects enrolled. Study was canceled before active	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
lack of accrual	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
lack of participants	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
"Sponsors Decision. The collected data are available in a significant proportion and
    sufficiently enough for an adequate analysis."	['Interim_Analysis', 'Success', 'Endpoint_Met']	['Neutral', 'Success', 'Neutral']
Study terminated due to funding issues	['Business_Administrative']	['Possibly_Negative']
"the study was started in the second half of the outbreak, and the number of qualifying COVID-19
    patients decreased with the control of the epidemic so that we had to stop our trial before
    reaching the predefined sample size."	['Covid19']	['Neutral']
Lack of People to follow up the study, work overload	['Insufficient_Enrollment']	['Neutral']
Device feasibility study, not clinical trial	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
No funding, study not done	['Business_Administrative']	['Possibly_Negative']
Funding not finalized	['Business_Administrative']	['Possibly_Negative']
Study withdrawn at sponsor request.	['Business_Administrative']	['Possibly_Negative']
"The study was terminated early due to lackluster pharmacodynamic data that showed no
    significant reduction of plasma kynurenine at steady state of M4112."	['Negative']	['Negative']
Product was discontinued.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Study was terminated for business reasons; not due to safety or efficacy concerns.	['Business_Administrative']	['Possibly_Negative']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
We need to revise and redesign the study	['Study_Design']	['Neutral']
DSMB halted the study due to futility as a result of lower than anticipated HIV incidence rates	['Negative']	['Negative']
No patients enrolled.	['Insufficient_Enrollment']	['Neutral']
Insufficient enrollment/retention	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment of eligible patients for randomization.	['Insufficient_Enrollment']	['Neutral']
Lower than anticipated rate of subject enrollment	['Insufficient_Enrollment']	['Neutral']
"Termination is due to a combination of a device defect potentially impacting the quality of the
    AD 923 IMP and a major change in corporate strategy."	['Business_Administrative']	['Possibly_Negative']
study terminated due to low recruitment	['Insufficient_Enrollment']	['Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
"Methodological problems/problems in the study design (competing pain and a placebo effect). No
    serious adverse events or other safety issues"	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
protocol never approved by local IRB	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The study plan is cancelled because of difficulties in the progress of the study.	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
lower than expected enrollment	['Insufficient_Enrollment']	['Neutral']
Reached power analysis goal and funds depleted	['Business_Administrative']	['Possibly_Negative']
"Recent improvements in clinical practice have reduced the apparent incidence of AMR in renal
    transplantation."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
default of inclusion	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Number of patients with a serum cortisol > 18 ng/ml reached	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Insufficient number of participants met the study eligibility criteria.	['Insufficient_Enrollment']	['Neutral']
recruitment rate too slow	['Insufficient_Enrollment']	['Neutral']
Due to current BVS safety issue	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
PI left study institution, declined to continue study at new institution	['Study_Staff_Moved']	['Neutral']
due to poor enrolled patients	['Insufficient_Enrollment']	['Neutral']
Study was terminated due to loss of funding.	['Business_Administrative']	['Possibly_Negative']
Too few acute stroke patients available to meet enrollment requirements.	['Insufficient_Enrollment']	['Neutral']
due to strategic reasons	['Business_Administrative']	['Possibly_Negative']
"Update on clinical development: after discussions with the drug manufacturer, the PI has
    decided to discontinue the trial."	['Business_Administrative']	['Possibly_Negative']
Insufficient no of patients eligible for enrollment.	['Insufficient_Enrollment']	['Neutral']
Enrollment rate was slower than anticipated.	['Insufficient_Enrollment']	['Neutral']
low recruitment	['Insufficient_Enrollment']	['Neutral']
Results showed statistically significant benefit in the experimental group	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
The development program has been terminated	['Business_Administrative']	['Possibly_Negative']
Departure of the principal investigator and lack of succession	['Study_Staff_Moved']	['Neutral']
DSMC recommended discontinuation for futility and feasibility	['Negative']	['Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Unable to get an IND from the FDA for the walnut powder	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Isotope (FMISO) production is no longer available in our country.	['Logistics_Resources']	['Neutral']
Interim analysis has shown that the objectives of this study can not be reached	['Negative']	['Negative']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Recruitment difficulties.	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Difficulty in enrolling suitable subjects	['Insufficient_Enrollment']	['Neutral']
Due to slow enrolment	['Insufficient_Enrollment']	['Neutral']
Unable to enroll	['Insufficient_Enrollment']	['Neutral']
insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Because the sample volume was completed during three years.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Low rate of recruitment.	['Insufficient_Enrollment']	['Neutral']
"After 5 patients, realized that the standard deviation of the measurements in real life was
    higher than the calculated difference."	['Interim_Analysis', 'Endpoint_Met', 'Negative']	['Neutral', 'Neutral', 'Negative']
Did not achieve statistical significance for primary endpoint	['Negative']	['Negative']
Insufficient power to show therapy difference at interim analysis.	['Negative']	['Negative']
Business Decision	['Business_Administrative']	['Possibly_Negative']
SWOG has decided to not pursue this trial	['Business_Administrative']	['Possibly_Negative']
Technical Issues	['Logistics_Resources']	['Neutral']
"Based on the totality of the generated combined safety and efficacy data in the interim period,
    the company decided to terminate the combination study in NSCLC patients. There are no subjects
    on study drug at this time or in the EOT Follow-up period."	['Negative']	['Negative']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
"PI transferred from Georgetown to Johns Hopkins University. No participants enrolled at either
    site. Funding lapsed."	['Business_Administrative']	['Possibly_Negative']
Sponsor decided to stop study early	['Business_Administrative']	['Possibly_Negative']
We expanded to a bigger, multi-site study & decided to close this study.	['Invalid_Reason', 'Study_Design', 'Another_Study']	['Invalid_Reason', 'Neutral', 'Neutral']
Scheduled Interim Monitoring	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
low accrual	['Insufficient_Enrollment']	['Neutral']
Terminated based on safety results from another trial	['Negative', 'Another_Study']	['Negative', 'Neutral']
For business reasons.	['Business_Administrative']	['Possibly_Negative']
The data that was critical to the study was not able to be obtained.	['Logistics_Resources']	['Neutral']
Very poor recruitment of patients to the study	['Insufficient_Enrollment']	['Neutral']
seeking research grant support	['Business_Administrative']	['Possibly_Negative']
No participant enrolled over five years. No plan to continue the study.	['Insufficient_Enrollment']	['Neutral']
Early end of enrolment with regards to difficulty met to enrol patients .	['Insufficient_Enrollment']	['Neutral']
only one patient enrolled	['Insufficient_Enrollment']	['Neutral']
COVID-19	['Covid19']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
COVID-19 safety restrictions	['Covid19']	['Neutral']
study completed as planned	['Invalid_Reason']	['Invalid_Reason']
Study medication no longer available at institution	['Logistics_Resources']	['Neutral']
Difficulty recruiting, funding lapsed	['Business_Administrative']	['Possibly_Negative']
Technical problems.	['Logistics_Resources']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
An endpoint difference between 3 energies was not observed at interim analysis	['Negative']	['Negative']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
End of commercialization of low polyamin diet	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
investigator choice	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
Preliminary analyses did not reveal significant associations.	['Negative']	['Negative']
Reactogenicity met study halting criteria	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
test	['Interim_Analysis', 'No_Context', 'Invalid_Reason']	['Neutral', 'Invalid_Reason', 'Invalid_Reason']
Recruitment problems	['Insufficient_Enrollment']	['Neutral']
COVID	['Covid19']	['Neutral']
the study stopped because the company's strategy.	['Business_Administrative']	['Possibly_Negative']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
lack of the subjects	['Insufficient_Enrollment']	['Neutral']
due to low study enrollment	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Study stopped because sufficient pilot data collected to proceed to next clinical trial.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
New power calculation (reduction of necessary patient number)	['Study_Design']	['Neutral']
"The analysis of the blood samples was much expensive than calculated. The recruitment had to be
    stopped after 36 study participants."	['Logistics_Resources']	['Neutral']
No funding for this study	['Business_Administrative']	['Possibly_Negative']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
There was a voluntary recall from the Habib EUS RFA device manufacturer	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Difficulty finding a monitor	['Logistics_Resources']	['Neutral']
PI left HMRI	['Study_Staff_Moved']	['Neutral']
Manufacturer will not be supporting this study	['Business_Administrative']	['Possibly_Negative']
Other - Revision to study design	['Study_Design']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Study was closed to accrual on January 15, 2020.	['Insufficient_Enrollment']	['Neutral']
No Enrollment	['Insufficient_Enrollment']	['Neutral']
"The risk of inhaled allergen challenge and anakinra treatment outweigh benefits to participants
    with allergic asthma due to the COVID-19 pandemic."	['Covid19']	['Neutral']
difficulty recruiting patients	['Insufficient_Enrollment']	['Neutral']
Study has been terminated due to small sample size	['Insufficient_Enrollment']	['Neutral']
Unexpected injection site reactions.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Investigator left institution	['Study_Staff_Moved']	['Neutral']
"This study was terminated due to treatment stop resulting in an inability to draw conclusions
    from the data. Evaluation of nonclinical rat findings is ongoing."	['Logistics_Resources', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"1) A delay in obtaining immunoassays to measure serum neopterin 2)altered relevance of the
    expected experimental results to clinical practice"	['Negative']	['Negative']
"The study was terminated by Spiracur (original sponsor). Efforts were made to contact the
    PI/study team members, but were unsuccessful."	['Business_Administrative']	['Possibly_Negative']
University decision.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Insufficient funding	['Business_Administrative']	['Possibly_Negative']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
On hold to determine chosen formulations	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Sponsor decision due to recommendation of the IDMC.	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
No enrollment	['Insufficient_Enrollment']	['Neutral']
Study stopped due to poor enrollment	['Insufficient_Enrollment']	['Neutral']
This study does not qualify as a clinical trial under current NIH guidelines.	['Interim_Analysis', 'Regulatory', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
limited enrollment	['Insufficient_Enrollment']	['Neutral']
difficult enrollment, focus of study no longer of interest	['Insufficient_Enrollment']	['Neutral']
"The manufacturing company of the Raindrop Corneal Inlay has stopped distribution or sales of
    the product."	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Withdrawn	['Invalid_Reason']	['Invalid_Reason']
Business reasons not related to safety	['Business_Administrative']	['Possibly_Negative']
"Withdrawn as the clinical development of ATN-224 was terminated by the drug company who was
    providing ATN-224 for the study"	['Business_Administrative']	['Possibly_Negative']
recruitment recruitment recruitment recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Equipment/software did not work as anticipated	['Logistics_Resources']	['Neutral']
Lack of patient population	['Insufficient_Enrollment']	['Neutral']
On hold: pending grant funding for further enrollment	['Business_Administrative']	['Possibly_Negative']
A larger study collecting the same outcomes is currently being conducted by the study team.	['Negative', 'Another_Study']	['Negative', 'Neutral']
a respiratory depression in remifentanyl group	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Protocol design under review.	['Regulatory']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
"At the interim analysis, the futility boundary was not met and the study was stopped due to
    insufficient efficacy."	['Negative']	['Negative']
IRB approval expired	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Mutual decision by site and sponsor because of difficulty recruiting Patients.	['Insufficient_Enrollment']	['Neutral']
"PI/study coordinator retired due to personal family health matters; study sponsor withdrew
    funding. Study terminated and no data collected or analyzed"	['Business_Administrative']	['Possibly_Negative']
Business decision	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
"The study was prematurely ended due to the modification of study requirements by the US Food
    and Drug Administration and the European Medicines Agency"	['Regulatory', 'Insufficient_Enrollment', 'Negative']	['Neutral', 'Neutral', 'Negative']
Difficulty recruiting; pill burden and nausea were barriers	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Not logistically feasible to continue enrolling patients.	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
"Corroboration of supporting in vitro data

    - Data successfully corroborated 2009"	['Negative', 'Another_Study']	['Negative', 'Neutral']
not feasible due to funding	['Business_Administrative']	['Possibly_Negative']
Logistical difficulties running the study	['Logistics_Resources']	['Neutral']
"Evolving standard of care practices in this disease setting was limiting enrolment and leading
    to a delay in delivering this study information to the public."	['Study_Design']	['Neutral']
Difficulty in recruiting	['Insufficient_Enrollment']	['Neutral']
difficult recruitment	['Insufficient_Enrollment']	['Neutral']
Technical issues with availability of relevant personnel	['Logistics_Resources']	['Neutral']
Due to financial reasons	['Business_Administrative']	['Possibly_Negative']
Study has been suspended due to clinical hold.	['Invalid_Reason']	['Invalid_Reason']
"Due to COVID19 hospital admissions by patients with moderate-severe bronchiolitis have
    drastically decreased from 02/2020 to date. Moreover, many centers that had initially joined
    the study project had great difficulties in the activation phase"	['Covid19']	['Neutral']
PI Withdrawal	['Study_Staff_Moved']	['Neutral']
COVID-19 outbreak	['Covid19']	['Neutral']
lack of pharmaceutical support	['Logistics_Resources']	['Neutral']
Study was terminated due to poor accrual.	['Insufficient_Enrollment']	['Neutral']
funding issues and procedural problems	['Business_Administrative']	['Possibly_Negative']
Lilly's decision to cancel this trial is due to regulatory uncertainty in China.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The enrollment period/study duration had exceeded The Alfred Mann Foundation's timeline.	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
due to technical issues	['Logistics_Resources']	['Neutral']
"Decision based on the low enrollment mainly due to high efficacy drugs available in 1st line
    ALK-positive NSCLC (eg alectinib), not due to any safety concerns"	['Negative']	['Negative']
Scheduled Interim Monitoring	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Transition to new position	['Study_Staff_Moved']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Business decision to discontinue development of this investigational device	['Business_Administrative']	['Possibly_Negative']
Lack of effect in Cohort 1	['Negative']	['Negative']
See Detailed Description	['No_Context']	['Invalid_Reason']
Difficulty of recruitment.	['Insufficient_Enrollment']	['Neutral']
Study terminated early due to slow accrual or other non-safety related issues	['Insufficient_Enrollment']	['Neutral']
temp suspend due to covid	['Covid19']	['Neutral']
"The low recruitment rate makes it very difficult to complete the study within a reasonable
    period of time."	['Insufficient_Enrollment']	['Neutral']
Inadequate enrollment. Key study personnel transitioned to a different role.	['Insufficient_Enrollment']	['Neutral']
Unforseen problems recruiting patients	['Insufficient_Enrollment']	['Neutral']
PI is leaving the institution	['Study_Staff_Moved']	['Neutral']
PI left the institution	['Study_Staff_Moved']	['Neutral']
See Detailed Description	['No_Context']	['Invalid_Reason']
Sponsor cancelled the study	['Business_Administrative']	['Possibly_Negative']
Difficulty in patient recruitment	['Insufficient_Enrollment']	['Neutral']
Study redesign	['Study_Design']	['Neutral']
The study was not initiated	['Invalid_Reason']	['Invalid_Reason']
Lack of efficacy	['Negative']	['Negative']
Trial was only opened at RCINJ for analysis of data, no patient enrollment took place here.	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
PI is no longer work at Hadassah	['Study_Staff_Moved']	['Neutral']
Sponsor closed the trial before it began	['Business_Administrative']	['Possibly_Negative']
unsatisfactory efficacy data from preceding trial	['Negative', 'Another_Study']	['Negative', 'Neutral']
Change in patient population no longer fit study criteria.	['Insufficient_Enrollment']	['Neutral']
"Based on business priorities. Not related to any safety or efficacy issue & took place before
    data were unblinded or analyzed"	['Business_Administrative']	['Possibly_Negative']
Funding	['Business_Administrative']	['Possibly_Negative']
Never started	['Invalid_Reason']	['Invalid_Reason']
Compound was sold by funder and development ceased.	['Business_Administrative']	['Possibly_Negative']
"The study was terminated due to the inability to enroll subjects. No subjects were or ever will
    be enrolled into this study."	['Insufficient_Enrollment']	['Neutral']
COVID-19	['Covid19']	['Neutral']
Per Data Monitoring Committee given the poor/inadequate accrual.	['Insufficient_Enrollment']	['Neutral']
Modifications are being made to protocol	['Study_Design']	['Neutral']
Permanently Closed Due to Poor Accrual	['Insufficient_Enrollment']	['Neutral']
Company decision	['Business_Administrative']	['Possibly_Negative']
Study halted prematurely, prior to enrollment of first participant.	['Invalid_Reason']	['Invalid_Reason']
Lack of funds for specimen management and data analysis	['Business_Administrative']	['Possibly_Negative']
Funding ended	['Business_Administrative']	['Possibly_Negative']
Enrollment was too slow	['Insufficient_Enrollment']	['Neutral']
Study stopped early due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
lack of recruitment at this site	['Insufficient_Enrollment']	['Neutral']
This study was terminated at the request of the drug manufacturer.	['Business_Administrative']	['Possibly_Negative']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Strategic Considerations	['Business_Administrative']	['Possibly_Negative']
DSMB reviewed interim analysis and terminated the study due to futility.	['Negative']	['Negative']
Study not funded	['Business_Administrative']	['Possibly_Negative']
high incidence of TTP, poor recrual	['Insufficient_Enrollment']	['Neutral']
funding	['Business_Administrative']	['Possibly_Negative']
Sponsor withdrew funding prior to study initiation	['Business_Administrative']	['Possibly_Negative']
Dovitinib Production stopped	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Biochemical measurement techniques were deemed insufficient to continue research	['Logistics_Resources']	['Neutral']
Patients would not take product	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of efficacy	['Negative']	['Negative']
Preliminary reports of this study was too bad.	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Terminated, prior to its planned completion as anticipated by the protocol.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
"determined not enough participants would be able to be enrolled and not enough data collected
    for good analyses"	['Insufficient_Enrollment']	['Neutral']
Sample size was re- calculated considering sucking pattern parameters	['No_Context', 'Endpoint_Met', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
Required number of participants were not able to be enrolled.	['Insufficient_Enrollment']	['Neutral']
Business Decision, No Safety or Efficacy Concerns	['Business_Administrative']	['Possibly_Negative']
Intervention was taken up as a standard of care.	['Endpoint_Met', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Break in funding	['Business_Administrative']	['Possibly_Negative']
Withdrawal of PhD	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
recruitment was unsuccesfull, only 7 patient have been included untill 2012	['Insufficient_Enrollment']	['Neutral']
not sufficiency recruitment	['Insufficient_Enrollment']	['Neutral']
PI unable to recruit appropriate patients	['Insufficient_Enrollment']	['Neutral']
PI left University	['Study_Staff_Moved']	['Neutral']
A pilot study is currently in progress.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
funding not available to continue	['Business_Administrative']	['Possibly_Negative']
"Stopped due to futility considerations:

    Sample size calculations have assumed smaller effect sizes than considered relevant now."	['Negative']	['Negative']
Difficulty in obtaining surrogate consent on critically ill subjects.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Funding obtained to conduct expanded study - to be posted to ClinicalTrials.gov.	['Business_Administrative']	['Possibly_Negative']
lacking recruitment	['Insufficient_Enrollment']	['Neutral']
"The study is stopped based upon strategic considerations impacting the clinical development of
    exenatide once-weekly suspension in China"	['Business_Administrative']	['Possibly_Negative']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
"Information was entered by mistake by a Research Assistant. Study never went beyond the initial
    discussion phase."	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
study stopped due to company strategic prioritization	['Business_Administrative']	['Possibly_Negative']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Slow enrollment - terminated for futility.	['Negative']	['Negative']
Study was suspended due to organisational difficulties.	['Business_Administrative']	['Possibly_Negative']
Similar study completed.	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Enrollment is temporarily paused due to COVID-19 and is expected to reopen in the future. This
    is not a suspension of IRB approval."	['Covid19']	['Neutral']
"The Data Safety Monitoring Board determined that the serious adverse event rate was higher
    among patients awaiting enrollment in the home-based primary care intervention compared to
    those who had initiated home-based primary care."	['Covid19', 'Safety_Sideeffects', 'Endpoint_Met']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Additional in-house analysis and development	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Slow enrollment and lack of interest	['Insufficient_Enrollment']	['Neutral']
Principal Investigator resigned from institution	['Study_Staff_Moved']	['Neutral']
safety issues (toxicity)	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Withdrawn from IRB before approval	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Business Decision	['Business_Administrative']	['Possibly_Negative']
"""Company is in a process of being taken over by another pharma and the new one has different
    ideas on how to pursue studies with this drug"""	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Study was terminated early because the site that administered the hyperbaric oxygen treatment
    closed and an alternative site could not be identified."	['Logistics_Resources']	['Neutral']
Funding ran out	['Business_Administrative']	['Possibly_Negative']
Low inclusion rate	['Insufficient_Enrollment']	['Neutral']
"The principal linvestigator decided not to continue the registry. No patient were enrolled.
    CLosure to the registry was done October 2014"	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Due to COVID-19 pandemic	['Covid19']	['Neutral']
Covid- 19 has shut the clinic	['Covid19']	['Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
too long inclusion phase due to difficulties to find eligible participants.	['Insufficient_Enrollment']	['Neutral']
Development in prostate cancer indication halted	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
funding	['Business_Administrative']	['Possibly_Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
the investigator left our institution	['Study_Staff_Moved']	['Neutral']
Terminated by sponsor.	['Business_Administrative']	['Possibly_Negative']
Cancelled by Sponsor	['Business_Administrative']	['Possibly_Negative']
Slow recruitment due to strict inclusion/exclusion criteria	['Insufficient_Enrollment']	['Neutral']
Site did not obtain LIRB approval due to medication usage.	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Administrative reasons	['Business_Administrative']	['Possibly_Negative']
"because 1 patient's scar becomes more severe than before, and most patient have satificated
    outcome"	['Negative']	['Negative']
Funding withdrawn	['Business_Administrative']	['Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
COVID-19 - unable to bring patients for intervention due to C-19 restrictions at present	['Covid19']	['Neutral']
Study was cancelled before enrolment for reasons not related to vaccine safety or efficacy.	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Low level of returning participants year by year.	['Insufficient_Enrollment']	['Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
Initiated a new randomized trial per discussion with FDA	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Lack of Recruitment	['Insufficient_Enrollment']	['Neutral']
Patient enrolment below planned schedule	['Insufficient_Enrollment']	['Neutral']
lost the recruiting source- no recruitment for the past 18months, PI moving	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
Failed to enroll any patients despite study modifications	['Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral']
No more funding	['Business_Administrative']	['Possibly_Negative']
too much cross over bias between small numbers of participants	['Insufficient_Enrollment']	['Neutral']
IP could not be made available in sufficient quantity for the expected enrollment	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Difficulty producing tracer	['Logistics_Resources']	['Neutral']
The study was terminated due to hepatoxicity of compound	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"The decision to stop the study was due to a lack of observed efficacy in a pre-specified
    interim analysis. The decision was not related to safety concerns."	['Negative']	['Negative']
Other competing clinical trials affecting enrollment	['Negative', 'Another_Study']	['Negative', 'Neutral']
Change plans and no longer testing these interventions	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Human Subjects Protection Review: submitted, denied	['Interim_Analysis', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Following DMC review, due to slow recruitment of evaluable patients.	['Insufficient_Enrollment']	['Neutral']
Study has never received funding and has never been initiated	['Business_Administrative']	['Possibly_Negative']
study cancelled prior to FSI	['Invalid_Reason']	['Invalid_Reason']
Primary goal not achievable	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
"The Data Monitoring Committee terminated the study on the basis of futility (insufficient
    clinical response)."	['Negative']	['Negative']
All research activities were suspended as a result of COVID-19.	['Covid19']	['Neutral']
decreased enrollment. (there are no data results for this study)	['Insufficient_Enrollment']	['Neutral']
Difficulty in patient recruitment	['Insufficient_Enrollment']	['Neutral']
Under evaluation for need for further enrollment	['Interim_Analysis', 'Regulatory', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Business decision	['Business_Administrative']	['Possibly_Negative']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
No enrollment	['Insufficient_Enrollment']	['Neutral']
Difference found in interim analysis, not ethical to continue	['Interim_Analysis', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
The field has changed, and we have decided to develop a PrEP program.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Closed due to issues encountered with meeting enrollment goals at our site.	['Insufficient_Enrollment']	['Neutral']
PI decided not to open study, following review of data collected in another study	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Company decided not to pursue the development of this drug in this patient population at this
    time"	['Business_Administrative']	['Possibly_Negative']
as specified in the protocol	['No_Context', 'Insufficient_Enrollment', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
Difficulties in recruitment	['Insufficient_Enrollment']	['Neutral']
Study terminated due to the Sponsor's decision.	['Business_Administrative']	['Possibly_Negative']
Financial issues	['Business_Administrative']	['Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Logistical and administrative issues	['Business_Administrative']	['Possibly_Negative']
Never started the study cause of the lack of funding	['Business_Administrative']	['Possibly_Negative']
Recruitment problems	['Insufficient_Enrollment']	['Neutral']
PI left University	['Study_Staff_Moved']	['Neutral']
Did not begin	['Invalid_Reason']	['Invalid_Reason']
recruitment challenges, device no longer available	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
recruitment problems in the controle group	['Insufficient_Enrollment']	['Neutral']
Strategic decision was made to terminate the AFM11 development	['Business_Administrative']	['Possibly_Negative']
Lack of efficacy	['Negative']	['Negative']
Slower than anticipated enrollment	['Insufficient_Enrollment']	['Neutral']
Per SAP	['Covid19', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
Preliminary data analysis showed insufficient efficacy to justify continuation.	['Negative']	['Negative']
Drug (Aflibercept) no longuer available for the study	['Logistics_Resources']	['Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Unable to continue to conduct study procedures due to pandemic	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Company decision taken in light of demands by certain national health authorities	['Business_Administrative']	['Possibly_Negative']
Terminated due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
Business reasons unrelated to product safety	['Business_Administrative']	['Possibly_Negative']
Full Clinical Hold	['Invalid_Reason']	['Invalid_Reason']
Lack of supply of comparator drug in country	['Logistics_Resources']	['Neutral']
Could not recruit ALS participants, hence ALS arm discontinued	['Insufficient_Enrollment']	['Neutral']
Principal Investigator unable to incorporate study and recruitments into clinical routines	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Data was inconclusive	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
"Cryoablation is no longer offered at our hospital, and likely won't be offered in the near
    future."	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Unable to secure funding.	['Business_Administrative']	['Possibly_Negative']
Project was never initiated.	['Invalid_Reason']	['Invalid_Reason']
COVID-19	['Covid19']	['Neutral']
The Outbreak of COVID-19.	['Covid19']	['Neutral']
no patient was recruited till 1/2008	['Insufficient_Enrollment']	['Neutral']
Symphogen made a business decision to no longer perform the clinical study.	['Business_Administrative']	['Possibly_Negative']
Patient safety - Unacceptable toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Insufficient subject recruitment.	['Insufficient_Enrollment']	['Neutral']
All subject enrollment/follow up is on hold due to COVID-19 pandemic	['Covid19']	['Neutral']
terminated because of enough case number	['Invalid_Reason']	['Invalid_Reason']
Covid-19 Pandemics	['Covid19']	['Neutral']
Limited efficacy response observed during interim analysis.	['Negative']	['Negative']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
insufficient institutional support	['Business_Administrative']	['Possibly_Negative']
this study has not finding place	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"Melagatran/ximelagatran was withdrawn from the market and clinical development in February 2006
    in the interest of patient safety."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Problem with recruiting	['Insufficient_Enrollment']	['Neutral']
"this study was ended prematurely by ethical committees with a reason of the final outcome was
    achieved with no longer recruitment was needed."	['Interim_Analysis', 'Logistics_Resources', 'Endpoint_Met']	['Neutral', 'Neutral', 'Neutral']
No Patients enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
PI left VICC	['Study_Staff_Moved']	['Neutral']
Change in strategy	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
"Enrollment and interactions/interventions are temporarily paused due to COVID-19 and are
    expected to resume. This is not a suspension of IRB approval."	['Covid19']	['Neutral']
The team wasn't able to work effectively with the social worker at the site	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
"Accrual temporarily suspended, followed by study closure due to technical problems with
    investigational camera."	['Logistics_Resources']	['Neutral']
"Early termination of IDX21459 was due to integration of Merck's HCV antiviral pipeline has
    resulted in revisions of the clinical development plan."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
PI decided not to proceed	['Invalid_Reason']	['Invalid_Reason']
feasibility of study recruitment	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
This project is no longer being adequately supported to allow completion	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
The sponsor withdrew support due to slow accrual of eligible subjects.	['Insufficient_Enrollment']	['Neutral']
PI resigned.	['Study_Staff_Moved']	['Neutral']
"The study will be part of a European multicenter trial (Infliximab Top-down Study in Kids with
    Crohn's disease)"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Due to institutions restrictions	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
bad recruitment	['Insufficient_Enrollment']	['Neutral']
Financial and Method issues suggesting that study is not feasible.	['Business_Administrative']	['Possibly_Negative']
Withdrawn as study never opened	['Invalid_Reason']	['Invalid_Reason']
Not enough patient enrolled in the study	['Insufficient_Enrollment']	['Neutral']
No Participants enrolled, per PI discretion	['Insufficient_Enrollment']	['Neutral']
The study was prematurely discontinued due to the low rate of enrollment.	['Insufficient_Enrollment']	['Neutral']
Study was terminated by Novartis	['Business_Administrative']	['Possibly_Negative']
Part 1 completed, part 2 not done due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
The study was terminated based on a non-safety related corporate decision.	['Business_Administrative']	['Possibly_Negative']
logistics	['Logistics_Resources']	['Neutral']
Study halted prior to enrollment of patients	['Invalid_Reason']	['Invalid_Reason']
due to business decision regarding the study drug.	['Business_Administrative']	['Possibly_Negative']
sponsor discontinues support	['Business_Administrative']	['Possibly_Negative']
Low recruitment rate	['Insufficient_Enrollment']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Did not enroll enough patients for study	['Insufficient_Enrollment']	['Neutral']
Not clinical trial	['Invalid_Reason']	['Invalid_Reason']
"This study is not feasible to conduct as functional brain imaging capability is inadequate.
    CIRB acknowledged in June 2016."	['Logistics_Resources', 'Negative']	['Neutral', 'Negative']
Safety. Devices explanted. 12m post-explant safety f/u as agreed with UK MHRA	['Covid19', 'Interim_Analysis', 'Safety_Sideeffects']	['Neutral', 'Neutral', 'Safety_Sideeffects']
Interferon use for hepatitis C plummeted, eliminating the need for study drug.	['Logistics_Resources']	['Neutral']
Early termination due to COVID-19	['Covid19']	['Neutral']
The protocol was cancelled due timelines be not compatible with business strategy in Colombia.	['Business_Administrative']	['Possibly_Negative']
Study design changed significantly; was submitted as a different protocol.	['Study_Design']	['Neutral']
Evaluating cohort for value	['Negative']	['Negative']
Did not receive funding for recruitment.	['Business_Administrative']	['Possibly_Negative']
Funding nonavailability and principal investigator move	['Business_Administrative']	['Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
no subjects enrolled	['Insufficient_Enrollment']	['Neutral']
Lack of participation	['Insufficient_Enrollment']	['Neutral']
Withdrawal of CircuLite Synergy from clinical use	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Lack of funding to complete the trial phase of the study.	['Business_Administrative']	['Possibly_Negative']
AVE5530 in hypercholesterolemia was stopped due to insufficient efficacy	['Negative']	['Negative']
Side effects	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
The trial failed to accrue	['Insufficient_Enrollment']	['Neutral']
Covid-19 pandemic	['Covid19']	['Neutral']
"As the guideline for the acute stroke endovascular treatment of the AHA/ASA was changed, DSMB
    recommended an end to the study."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Recruitment failure	['Insufficient_Enrollment']	['Neutral']
Prematurely Discontinued Amgen decision Amgen Decision	['Business_Administrative']	['Possibly_Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Low recruitment rate	['Insufficient_Enrollment']	['Neutral']
enrollment difficult due to inclusion/exclusion criteria/protocol requirements	['Insufficient_Enrollment']	['Neutral']
Dose over MTD reached	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Halted prematurely	['Invalid_Reason']	['Invalid_Reason']
No recruitment	['Insufficient_Enrollment']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
updating protocol	['Study_Design']	['Neutral']
Lack of Funding	['Business_Administrative']	['Possibly_Negative']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Unable to recruit participants	['Insufficient_Enrollment']	['Neutral']
No funding support	['Business_Administrative']	['Possibly_Negative']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
Poor patient recruitment	['Insufficient_Enrollment']	['Neutral']
Company manufacturing study drug was unable to continue production.	['Logistics_Resources']	['Neutral']
Recommendation of DMC - challenges recruiting, statistical considerations	['Logistics_Resources', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
lack of recruitement	['Insufficient_Enrollment']	['Neutral']
Organization and logistic problems due to COVID19 pandemy	['Covid19']	['Neutral']
"The recruitment of new subjects has been stopped with no intention of restarting the study
    before reaching the protocol specified End of Trial."	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"The delay between diagnosis and initiation of treatment was no longer consistent with standard
    of care"	['Study_Design', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
The project was not funded.	['Business_Administrative']	['Possibly_Negative']
Poor enrollment.	['Insufficient_Enrollment']	['Neutral']
"This study was terminated early because premedication with tocilizumab was unlikely to reduce
    the risk of IRR."	['Negative']	['Negative']
Study drug expired	['Logistics_Resources']	['Neutral']
"Registrational study did not meet endpoint so entire program (including CO-101-011) was
    terminated."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Principal Investigator left institution prior to subjects being enrolled	['Study_Staff_Moved']	['Neutral']
terminated	['Invalid_Reason']	['Invalid_Reason']
COVID-19 research restrictions	['Covid19']	['Neutral']
Insufficient patient enrolled	['Insufficient_Enrollment']	['Neutral']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
No participant enrolled	['Insufficient_Enrollment']	['Neutral']
funding not secured	['Business_Administrative']	['Possibly_Negative']
We need to make significant adjustments to proposed drug and its delivery method	['Study_Design']	['Neutral']
Lack of substantial enrollment	['Insufficient_Enrollment']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
"The study was prematurely terminated on May 18, 2012 due to slow enrollment. The study was not
    terminate due to any safety issues or concerns."	['Insufficient_Enrollment']	['Neutral']
The study was not approved by the Italian Medicines Agency (AIFA).	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Following review of results obtained from a pre-specified 6-month analysis of Part B data the
    study was terminated on the basis of futility."	['Negative']	['Negative']
We couldn't recruit the sample the we required	['Insufficient_Enrollment']	['Neutral']
"The computer is crushed and all data is lost (IT was not able to recover it. Last data was
    collected 6.17.14)"	['Logistics_Resources']	['Neutral']
Based on a business decision unrelated to any safety concerns.	['Business_Administrative']	['Possibly_Negative']
Principal investigator left the institution	['Study_Staff_Moved']	['Neutral']
recruitment issues	['Insufficient_Enrollment']	['Neutral']
unexpected histological findings	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Study terminated due to lack of funding.	['Business_Administrative']	['Possibly_Negative']
PI decided to stop due to divisional reorganization. No pts enrolled.	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Recruitment challenges	['Insufficient_Enrollment']	['Neutral']
Financial decision	['Business_Administrative']	['Possibly_Negative']
No participants were enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"Concerns about risk of bronchoscopy procedure in the selected patient population and frequency
    of SAEs observed to date."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
COVID-19	['Covid19']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Enrollment and study activities are temporarily suspended due to COVID-19.	['Covid19']	['Neutral']
Please see termination statement in the detailed description.	['No_Context']	['Invalid_Reason']
Insufficient funding and drug supply from manufacturer	['Business_Administrative']	['Possibly_Negative']
Early termination due to the inability to enroll (13 of 120 subjects enrolled)	['Insufficient_Enrollment']	['Neutral']
Unable to conduct study because of political issues in host country.	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
"We can't obtained the test drug (Vadenafil) from Bayer. They decided not to carry out this
    trail in Taiwan. Therefore this trail has never been started."	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Change in personnel	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Principal Investigator moved to Jacksonville, FL campus.	['Study_Staff_Moved']	['Neutral']
Unable to recruit required numbers for study.	['Insufficient_Enrollment']	['Neutral']
"2011 Thailand flooding led to loss of GMP pharmacy, project delays, and further regulatory
    challenges."	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
"Terminated for business reasons not due to scientific data. Sufficient data was acquired to
    transition program development to other technologies"	['Business_Administrative']	['Possibly_Negative']
Sponsor decision to terminate because limited investigational agent activity was observed.	['Negative']	['Negative']
Insufficient study participants enrolled	['Insufficient_Enrollment']	['Neutral']
"Enrollment paused due to COVID-19 and will resume in the future. This is not a suspension of
    IRB approval."	['Covid19']	['Neutral']
insufficient recruitment; sponsor-investigator has left the institution	['Insufficient_Enrollment']	['Neutral']
The investigators were not able to get grant funding for this study.	['Business_Administrative']	['Possibly_Negative']
"Study was terminated due to lack of interest from subjects and no funding, only 1 subject
    signed consent but did not participate."	['Business_Administrative']	['Possibly_Negative']
Company decision to terminate	['Business_Administrative']	['Possibly_Negative']
Study is no longer relevant	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
The principal investigator has left the hospital.	['Study_Staff_Moved']	['Neutral']
Strategic direction of the sponsor changed	['Business_Administrative']	['Possibly_Negative']
Unable to enroll enough study subjects. Study has been terminated	['Insufficient_Enrollment']	['Neutral']
"In Amendment 1 of P05319 [NCT 00779675], the option to enroll into this study, was discontinued
    due to low numbers of participants with suboptimal response."	['No_Context', 'Insufficient_Enrollment', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
Study objectives met so study concluded earlier than planned hence we terminated the study.	['Invalid_Reason']	['Invalid_Reason']
recruitment difficulty	['Insufficient_Enrollment']	['Neutral']
drug no longer available	['Logistics_Resources']	['Neutral']
"Lack of patients who are eligible for inclusion: less patients on treatment and not using
    epclusa."	['Insufficient_Enrollment']	['Neutral']
Study was closed June 23, 2008 due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
slow accrual & early closure	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
"The study was terminated based on interim results and all subjects were off study at that time.
    No major safety or tolerability concerns"	['Negative']	['Negative']
Difficult to obtain placebo	['Logistics_Resources']	['Neutral']
Sponsor Decision.	['Business_Administrative']	['Possibly_Negative']
We have closed the study because of slow inclusion of families	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
"After reviewing the interim analysis results the study was terminated as a bigger sample size
    was needed to find a significant difference between the groups."	['Interim_Analysis', 'Endpoint_Met', 'Negative']	['Neutral', 'Neutral', 'Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
Study was abandoned before opening to accrual. Replaced by another study.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Corporate re-prioritization	['Business_Administrative']	['Possibly_Negative']
NOL not obtained	['Regulatory', 'Invalid_Reason', 'Negative']	['Neutral', 'Invalid_Reason', 'Negative']
Difficulty in patient recruitment in the participating sites	['Insufficient_Enrollment']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Nonapplicable clinical trial	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Poor enrollment.	['Insufficient_Enrollment']	['Neutral']
The research project was changed.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Lack of trial population, unable to recruit subjects	['Insufficient_Enrollment']	['Neutral']
Insufficient funding	['Business_Administrative']	['Possibly_Negative']
Study revised to retrospective chart review	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Parent study (OSCILLATE) stopped by the Data Monitoring Committee	['Negative']	['Negative']
accrual was slow and sporadic so the study was closed	['Insufficient_Enrollment']	['Neutral']
Principal Investigator retired before study completed.	['Study_Staff_Moved']	['Neutral']
Inadequate recruitment	['Insufficient_Enrollment']	['Neutral']
Inclusion curve too slow.	['Insufficient_Enrollment']	['Neutral']
Replaced with an alternate study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Terminated due to low enrollment rate.	['Insufficient_Enrollment']	['Neutral']
Sponsor strategic decision based on preliminary results	['Business_Administrative']	['Possibly_Negative']
No Enrollment	['Insufficient_Enrollment']	['Neutral']
the clinical study was canceled by the sponsor due to logistics and programming	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Terminated due to low enrollment. No statistical analyses were performed.	['Insufficient_Enrollment']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Business reasons	['Business_Administrative']	['Possibly_Negative']
Funding used up	['Business_Administrative']	['Possibly_Negative']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Unable to recruit enough patients	['Insufficient_Enrollment']	['Neutral']
Preliminary analysis of 11 patients did not demonstrate the efficacy required.	['Negative']	['Negative']
Recruitment barriers	['Insufficient_Enrollment']	['Neutral']
per Pharma company	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"This study was terminated early due to response rates not meeting the anticipated minimum of
    30%."	['Insufficient_Enrollment']	['Neutral']
Protocol not feasible as written	['Study_Design']	['Neutral']
Main bedrest study moved to Texas. No enrollment at Cleveland Clinic.	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
A change in sponsor's developmental strategy	['Business_Administrative']	['Possibly_Negative']
inability to recruit subjects	['Insufficient_Enrollment']	['Neutral']
"Enrollment and other trial activities have temporarily paused due to COVID-19 and are expected
    to resume in the future; This is not a suspension of IRB approval"	['Covid19']	['Neutral']
Regulatory authorities did not allow the entrance of the study drug in the country	['Interim_Analysis', 'Regulatory', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Pending needed additional funding/resources	['Business_Administrative']	['Possibly_Negative']
Not enough patient	['Insufficient_Enrollment']	['Neutral']
Terminated Per PI	['Invalid_Reason']	['Invalid_Reason']
Poor initial results. Scans were of insufficient quality for study purpose.	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Lack of study participants.	['Insufficient_Enrollment']	['Neutral']
PI left the company	['Study_Staff_Moved']	['Neutral']
lack of funds to continue recruitment	['Business_Administrative']	['Possibly_Negative']
IRB determination	['Interim_Analysis', 'Regulatory', 'Negative']	['Neutral', 'Neutral', 'Negative']
Protocol was stopped due to the safety issue in Global	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
Pharmacy stopped dispensing study medication	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Study is withdrawn due to unavailability of eligible subject population. We will request the
    sponsors to extend the time for enrollment."	['Insufficient_Enrollment']	['Neutral']
enrollment difficulties	['Insufficient_Enrollment']	['Neutral']
"A program evaluation identified that the safety profile and pharmacokinetic (PK)
    characteristics of the formulation used in all oprozomib studies required further optimization
    and thus enrollment in 2011-001 was halted."	['Logistics_Resources', 'Endpoint_Met', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Interim analysis	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
Combination of futility analysis and poor accrual	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Withdrawn due to lack of participants.	['Insufficient_Enrollment']	['Neutral']
Funding issues	['Business_Administrative']	['Possibly_Negative']
Management Decision	['Business_Administrative']	['Possibly_Negative']
Study design has been substantially revised and a new registration will be made in the future.	['Study_Design']	['Neutral']
Due to a change in medication guidelines it became practically impossible to recruit patients	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Change in priority of interventional protocols	['Study_Design']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
change in study design.	['Study_Design']	['Neutral']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
Research never begun.	['Invalid_Reason']	['Invalid_Reason']
The study has been withdrawn due to organizational problems	['Business_Administrative']	['Possibly_Negative']
Protocol not feasible	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
because the sunitinib showed futility in anotehr trial	['Negative', 'Another_Study']	['Negative', 'Neutral']
"We could not achieve the number of participants necessary to continue with the study and
    limited money to continue with the study"	['Business_Administrative']	['Possibly_Negative']
Lack of support to complete	['Business_Administrative']	['Possibly_Negative']
"Sorafenib administered in the combination with pemetrexed-carboplatin appears to enhance
    thrombocytopenia compared to historical data."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Study was terminated due to low enrollment	['Insufficient_Enrollment']	['Neutral']
"The trial was terminated for several reasons, including complexities in development of
    LY2525623, but not because of safety concerns"	['Logistics_Resources']	['Neutral']
study intervention was approved by the FDA	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Lack of time and participation in the study	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Too few patients enrolling + laser no longer available	['Insufficient_Enrollment']	['Neutral']
Withdrawn prior to initiation.	['Invalid_Reason']	['Invalid_Reason']
Work has already been published by other groups	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Mutual Termination	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Sponsor withdrew support for the study	['Business_Administrative']	['Possibly_Negative']
New data: The study was terminated based on new efficacy data from another study	['Negative', 'Another_Study']	['Negative', 'Neutral']
"It is unrealistic to succeed with sufficient inclusion within the timeframe of the study, why
    it is terminated."	['Insufficient_Enrollment']	['Neutral']
"Because of Covid-19 pandemia, The cardiac rehabilitation unit in the hospital conducting the
    study has been closed for a while."	['Covid19']	['Neutral']
market demand from paclitaxel to sirolimus drug-eluting stent	['Covid19', 'Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Terminated due to inefficacy of the tested method	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Unable to locate the resources necessary to complete participant recruitment.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
an other study will start with new outcome measures	['Negative', 'Another_Study']	['Negative', 'Neutral']
Funding discontinued due to changes in corporate structures	['Business_Administrative']	['Possibly_Negative']
Study was stopped due to non-availability of the lidocaine placebo patches.	['Logistics_Resources']	['Neutral']
Due to inadequate enrollment.	['Insufficient_Enrollment']	['Neutral']
the project was never initiated and no participants were enrolled, it was closed permanently	['Invalid_Reason']	['Invalid_Reason']
Minimal enrollment	['Insufficient_Enrollment']	['Neutral']
futility of the sample	['Negative']	['Negative']
safety	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"Sponsor ceased sponsorship and terminated the research citing slow accrual of subjects in this
    clinical trial."	['Insufficient_Enrollment']	['Neutral']
investigator could not identify any patients	['Insufficient_Enrollment']	['Neutral']
prior to its planned completion as anticipated by the protocol due to lack of resources	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
This study is a retrospective chart review study, not a clinical trial.	['Success', 'No_Context', 'Insufficient_Data']	['Success', 'Invalid_Reason', 'Neutral']
The study was discontinued after the first 10 patients because of discouraging results.	['Negative']	['Negative']
Co-development decision	['Business_Administrative']	['Possibly_Negative']
poor accrual	['Insufficient_Enrollment']	['Neutral']
"Insufficient Recruitment. Findings of concurrent study in low risk population not supportive of
    hypotheses in this study."	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
DMC review concluded study has a low probability of meeting its primary endpoint	['Negative']	['Negative']
site terminated due to lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of statistical difference between both arms of the trial.	['Negative']	['Negative']
Lack of funds	['Business_Administrative']	['Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
No recruitment of patients	['Insufficient_Enrollment']	['Neutral']
No fundings	['Business_Administrative']	['Possibly_Negative']
difficult to find participants and no funding	['Business_Administrative']	['Possibly_Negative']
Technical Conflicts	['Logistics_Resources']	['Neutral']
Lack of subject enrollment	['Insufficient_Enrollment']	['Neutral']
Inability to recruit controls and limited research staff to complete project.	['Insufficient_Enrollment']	['Neutral']
Mutations found do not modify the ATM protein+ modifications of methodology would be necessary	['Study_Design']	['Neutral']
difficulty of recrutment	['Insufficient_Enrollment']	['Neutral']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Study has been termination early due to financial contraints.	['Business_Administrative']	['Possibly_Negative']
The study was terminated as we plan to start a competing study sponsored through VA CSP.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Unable to staff the project	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Company was sold and clinical trial was suspended then teminated	['Business_Administrative']	['Possibly_Negative']
The interim data analysis shows no significant difference between groups	['Negative']	['Negative']
Sponsor decision to terminate prior to completion to pursue combination therapies.	['Business_Administrative']	['Possibly_Negative']
Study Canceled	['Invalid_Reason']	['Invalid_Reason']
Technical problems	['Logistics_Resources']	['Neutral']
"KeraMed is being discontinued because it is no longer feasible due to the slow pace of
    recruitment and insufficient financial resources."	['Business_Administrative']	['Possibly_Negative']
"PI decided not to proceed with the major amendment and switching to the new generation of the
    device due to lack of funding."	['Business_Administrative']	['Possibly_Negative']
Study terminated due to safety issues.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"early efficacy review by the Independent Data Monitoring Committee indicated it was unlikely to
    meet its primary efficacy endpoints"	['Negative']	['Negative']
A study was published regarding the same question this study had.	['Negative', 'Another_Study']	['Negative', 'Neutral']
PI left hospital	['Study_Staff_Moved']	['Neutral']
Lack of sufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Sponsor's Decision	['Business_Administrative']	['Possibly_Negative']
IRB application withdrawn	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Monitoring Committee found significant & meaningful difference on main outcome	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Investigators perogative	['Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Recruitment finished earlier, because all 40 patients enrolled	['Invalid_Reason']	['Invalid_Reason']
Recruitment completed	['Invalid_Reason']	['Invalid_Reason']
Incomplete study enrollment prior to depletion of funding	['Business_Administrative']	['Possibly_Negative']
No resources available	['Business_Administrative']	['Possibly_Negative']
Study did not begin enrollment, multiple competing studies at same institution	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
The financial support was withdrawn.	['Business_Administrative']	['Possibly_Negative']
Funding discontinued	['Business_Administrative']	['Possibly_Negative']
"Sufficient acquisitions for DCE-MRI and 4D flow, but not for T1/T2-mapping due to lack of ILT
    in some participants."	['Business_Administrative']	['Possibly_Negative']
No funding available	['Business_Administrative']	['Possibly_Negative']
Recruitment not possible worldwide	['Insufficient_Enrollment']	['Neutral']
"The Sponsor's decision to terminate the SBC-103 program was reached after review of the data
    from all interventional clinical studies of SBC-103."	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
Lack of perceived need for domperidone in this population	['Business_Administrative']	['Possibly_Negative']
"The major and primary reason for the study termination is the observed reduced efficacy of
    CellCept compared to placebo."	['Negative']	['Negative']
Recruitment on hold for business reasons	['Business_Administrative']	['Possibly_Negative']
Funding not obtained	['Business_Administrative']	['Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Slow accruaL, lack of scientific progress	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
"This study was discontinued due to an interim analysis in the BN29552 study, which indicated
    that Crenezumab was unlikely to meet its primary endpoint."	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
Altitude trial which used similar drugs was terminated due to increased ADR.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Enrollment was stopped due to low recruitment and the PI's move to a different institution.	['Insufficient_Enrollment']	['Neutral']
The sponsor discontinued to support the study.	['Business_Administrative']	['Possibly_Negative']
Recruitment too slow	['Insufficient_Enrollment']	['Neutral']
Study stopped 12/2010 due to poor enrollment. Only 15 of 60 needed enrolled.	['Insufficient_Enrollment']	['Neutral']
Principle Investigator as left government service	['Study_Staff_Moved']	['Neutral']
Due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Major revisions needed in study	['Study_Design']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
"This study was halted prior to the start of enrollment due to the COVID-19 pandemic. The
    inability to conduct planned in-person intervention activities during the pandemic related to
    inherent risks of the virus necessitated withdrawal of the study."	['Covid19']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
LT-02 did not appear to help induce remission of UC	['Negative']	['Negative']
"Suspended due to non-essential research prohibitions at the study's recruitment and outcome
    assessment sites in the context of COVID-19."	['Covid19']	['Neutral']
PI left JHU	['Study_Staff_Moved']	['Neutral']
This study was cancelled due to COVID-19.	['Covid19']	['Neutral']
PI is no longer at this University.	['Study_Staff_Moved']	['Neutral']
no patients enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Coronavirus stay-at-home orders prevent in-person data collection	['Logistics_Resources']	['Neutral']
This study was stopped to allow initiation of a mult-center study	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
COVID-19 response	['Covid19']	['Neutral']
study is being rewritten for different disease population	['Study_Design']	['Neutral']
Lack of participant recruitment.	['Insufficient_Enrollment']	['Neutral']
Strategic considerations	['Business_Administrative']	['Possibly_Negative']
Enrollment was slower than anticipated.	['Insufficient_Enrollment']	['Neutral']
Did not obtain IRB approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Early termination following Trial Steering Committee recommendation	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
Study has been cancelled and it has not been initiated.	['Invalid_Reason']	['Invalid_Reason']
Recruitment slow	['Insufficient_Enrollment']	['Neutral']
Study was terminated due to lack of efficacy.	['Negative']	['Negative']
COVID-19	['Covid19']	['Neutral']
"Data collection could not be completed in time and it has not been possible to continue due to
    the pandemic. Since it is not yet known when the face-to-face classes will resume, we moved on
    to the data analysis phase with the existing data."	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Premature terminated at institution request	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Proposal will not be submitted and low accrual.	['Insufficient_Enrollment']	['Neutral']
Unable to recruit sufficient participants	['Insufficient_Enrollment']	['Neutral']
because of the COVID-19 pandemic.	['Covid19']	['Neutral']
unable to recruit enough subjects on CBD	['Insufficient_Enrollment']	['Neutral']
"Study temporarily paused due to COVID-19 and is expected to resume. This is not a suspension of
    IRB approval."	['Covid19']	['Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
The study was terminated due to the SARS-CoV-2 pandemic. Aim 1 was completed.	['Covid19', 'Study_Design']	['Neutral', 'Neutral']
"The funding source is not going to fund this anymore. Only two subjects completed the study
    therefore meaningful analysis not possible."	['Business_Administrative']	['Possibly_Negative']
reason	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
performance variability	['Negative']	['Negative']
COVID19-pandemic	['Covid19']	['Neutral']
Slow enrollment.	['Insufficient_Enrollment']	['Neutral']
Closed by CHUM REB for incomplete documentation of research activities.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Sponsor decision based on portfolio prioritization	['Business_Administrative']	['Possibly_Negative']
"The differences seen between treatments led to recalculation of the sample, unattainable in a
    reasonable time"	['Insufficient_Enrollment']	['Neutral']
"An independent assessment concluded the trial was not likely to meet the primary endpoint upon
    completion and therefore, trial stopped for futility"	['Negative']	['Negative']
due to poor recruitment	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
PI left	['Study_Staff_Moved']	['Neutral']
Study stopped due to investigational device deficiency	['Logistics_Resources']	['Neutral']
could not be obtained enough sperm RNA is highly fragmented and very difficult to purify.	['Logistics_Resources']	['Neutral']
Management decision	['Business_Administrative']	['Possibly_Negative']
Investigator has moved to other state.	['Study_Staff_Moved']	['Neutral']
Drug supply withdrawn	['Logistics_Resources']	['Neutral']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
No new investigational product can be delivered to the site.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Internal Issues	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
However, no intervention reduced the risk of major morbidity or 1 yr mortality	['Logistics_Resources', 'Endpoint_Met', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Unable to recruit subjects	['Insufficient_Enrollment']	['Neutral']
The study was discontinued prematurely on 25 February 2008 due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
Insufficient funding	['Business_Administrative']	['Possibly_Negative']
Low referral rate due to new therapeutic options.	['Study_Design']	['Neutral']
New efficacy data from another study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Music therapist left position.	['Study_Staff_Moved']	['Neutral']
The study got terminated based on result from primary endpoint analysis	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Terminated due to low accrual.	['Insufficient_Enrollment']	['Neutral']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
Terminated after placing the study on hold at the request of the FDA	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
kerasys had more erosions than tutoplast	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
inadequate recruitment	['Insufficient_Enrollment']	['Neutral']
Lead surgeon retired.	['Study_Staff_Moved']	['Neutral']
"For the 2 last patients still on treated nominal therapeutic use of the Milciclib was approved
    at INT Milano."	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Decision of the investigator	['Invalid_Reason']	['Invalid_Reason']
"The study stopped as the used needle was difficult to maneuver in the corkscrew method being
    studied so no more participants were included."	['Logistics_Resources']	['Neutral']
Lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
"Based on analyses of studies separately of the SCORE study, sponsor has decided to discontinue
    the Study. Data collected during the study will not be analyzed"	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"Limited beta-blocker naive participants among newly diagnosed heart failure participants, which
    led barrier to the recruitments."	['Insufficient_Enrollment']	['Neutral']
The study was terminated.	['Invalid_Reason']	['Invalid_Reason']
Trial terminated due to financial resource limitations	['Business_Administrative']	['Possibly_Negative']
This study was terminated due to limited efficacy and not due to safety reasons.	['Negative']	['Negative']
Decided not to participate in study per Leslie Padron-Massaro	['Covid19', 'Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Study was terminated early due to difficulties with patient recruitment	['Insufficient_Enrollment']	['Neutral']
COVID-19	['Covid19']	['Neutral']
Slow in patient enrollment	['Insufficient_Enrollment']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
drug and placebo unavailable	['Logistics_Resources']	['Neutral']
No funding obtained. The ABPM machines are being used for another project	['Business_Administrative']	['Possibly_Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Incomplete data	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Enrollment challenges prohibited study progression.	['Insufficient_Enrollment']	['Neutral']
low recruitment	['Insufficient_Enrollment']	['Neutral']
Sponsor decision.	['Business_Administrative']	['Possibly_Negative']
"Study recruitment has been halted due to the Pandemic. It is anticipated that recruitment will
    restart in March 2021."	['Covid19', 'Safety_Sideeffects', 'Insufficient_Enrollment']	['Neutral', 'Safety_Sideeffects', 'Neutral']
"The number of patients achieved is sufficient to evaluate the diagnostic performance of the
    test TRAP-myelin"	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Due to the low rate of recruitment.	['Insufficient_Enrollment']	['Neutral']
The investigator left the institution so the study was terminated.	['Study_Staff_Moved']	['Neutral']
Company decision	['Business_Administrative']	['Possibly_Negative']
A pilot study was negative.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study was stopped due to time dependent drug accumulation	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Determined not to be Human Subject Research	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
"The Data Monitoring Committee recommended to stop the trial based on the Recovery Trial
    results, which was accepted by the CoDEX Steering Committee."	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
Study initiation at this site fell through	['Invalid_Reason']	['Invalid_Reason']
Poor Recruitment	['Insufficient_Enrollment']	['Neutral']
Stopped prematurely because too few patients were recruited.	['Insufficient_Enrollment']	['Neutral']
Study was terminated prematurely due to insufficient enrolment.	['Insufficient_Enrollment']	['Neutral']
"Poor patient recruitment, necessary number of patients could not be included within the
    required time frame"	['Insufficient_Enrollment']	['Neutral']
study drug no longer available in the United States	['Logistics_Resources']	['Neutral']
funding withdrawn by sponsor	['Business_Administrative']	['Possibly_Negative']
Improving assay methods	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
A company decision was made not to proceed with the study.	['Business_Administrative']	['Possibly_Negative']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
Replace with a new trial	['Negative', 'Another_Study']	['Negative', 'Neutral']
Treatment now available commercially	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Mutual agreement between FDA closed the 522 postmarket surveillance Registry.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of funding and other logistical issues	['Business_Administrative']	['Possibly_Negative']
Due to DLTs/AEs safety profile considered challenging.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
PI resigned	['Study_Staff_Moved']	['Neutral']
Terminated by mutual agreement between the site and sponsor	['Business_Administrative']	['Possibly_Negative']
Slow enrollment and Natera is transitioning to a new PGS testing platform.	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
The study sponsor stopped the funding.	['Business_Administrative']	['Possibly_Negative']
Suspended due to lack of funding.	['Business_Administrative']	['Possibly_Negative']
Study was terminated due to under enrollment	['Insufficient_Enrollment']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Changes of the standard adjuvant treatment which does not allow an iterative PICC placement	['Study_Design']	['Neutral']
Seton IRB administratively closed this study on January 6, 2017	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
dexmedetomidine is unavailable in this time	['Logistics_Resources']	['Neutral']
Modifying procedure	['Study_Design']	['Neutral']
Low accrural	['Insufficient_Enrollment']	['Neutral']
PI moved from medical center	['Study_Staff_Moved']	['Neutral']
"The IRB has determined that the design of this trial should be changed to a randomized
    controlled trial. A new record will be created for the redesigned study."	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Limited regulatory value to uncontrolled trials. No safety/efficacy concerns.	['Study_Design']	['Neutral']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
COVID-19	['Covid19']	['Neutral']
Did not receive funding	['Business_Administrative']	['Possibly_Negative']
Edwards Lifesciences terminated the IDE associated with this study. No patients enrolled.	['Business_Administrative']	['Possibly_Negative']
The study was suspended due to lack of study drug	['Logistics_Resources']	['Neutral']
Sponsor stopped due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
"Halozyme isn't allowing this trial to move forward until their current clinical trial results
    are released."	['Negative', 'Business_Administrative']	['Negative', 'Possibly_Negative']
Insufficient accrual	['Insufficient_Enrollment']	['Neutral']
Safety: Stopping rule not met.	['Safety_Sideeffects', 'Endpoint_Met', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Blinded review of the data suggested no significant diferences in outcomes.	['Negative']	['Negative']
Potential participants with COPD/asthma unwilling to participate.	['Insufficient_Enrollment']	['Neutral']
A paper on the same topic came out just before we wanted to start our study.	['Negative', 'Another_Study']	['Negative', 'Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
no patients enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Terminated because sample size achieved	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Treatment ineffective; Extreme toxicity	['Safety_Sideeffects', 'Endpoint_Met', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
We unfortunately experienced recruitment difficulties with this study for the past few years.	['Insufficient_Enrollment']	['Neutral']
Evidence of liver injury in a separate Inarigavir study	['Negative', 'Another_Study']	['Negative', 'Neutral']
The quality of Limulus Amebocyte Lysate (LAL) test was poor.	['Safety_Sideeffects', 'Logistics_Resources']	['Safety_Sideeffects', 'Neutral']
Stage 1 terminated 6/1/18 prior to completion of Stage 1 due to low enrollment and efficacy	['Insufficient_Enrollment']	['Neutral']
Funding Stopped	['Business_Administrative']	['Possibly_Negative']
This study was terminated due to poor enrollment	['Insufficient_Enrollment']	['Neutral']
Covid-related	['Covid19']	['Neutral']
Lack of funding.	['Business_Administrative']	['Possibly_Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Investigator is no longer at Northwestern University.	['Study_Staff_Moved']	['Neutral']
unable to get adequate enrollment	['Insufficient_Enrollment']	['Neutral']
Unable to recruit adequate number of participants and high attrition rate	['Insufficient_Enrollment']	['Neutral']
study was never initiated, No participants enrolled	['Invalid_Reason']	['Invalid_Reason']
Request by sponsor due to no enrollment of participants on study	['Insufficient_Enrollment']	['Neutral']
"The Study was terminated on May 24th 2012 due to a slow recruitment rate. The study was not
    terminated for reasons of safety or efficacy."	['Insufficient_Enrollment']	['Neutral']
Pediatric development program terminated by sponsor	['Business_Administrative']	['Possibly_Negative']
Terminated early due to recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
High incidence of fraudulent enrollment.	['Insufficient_Enrollment']	['Neutral']
"The study is terminated prematurely as the sponsor decided to discontinue program with
    Tecemotide in NSCLC."	['Business_Administrative']	['Possibly_Negative']
difficulty for the patient recruiting	['Insufficient_Enrollment']	['Neutral']
Safety data on drug	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Study terminated (halted prematurely) as recomended by the drug supplier and medical agencies	['Logistics_Resources']	['Neutral']
The study was terminated because the preliminary data did not indicate efficacy.	['Negative']	['Negative']
Terminated for the safety of cystic fibrosis clinical trial subjects due to Covid-19.	['Covid19']	['Neutral']
Method development/validation	['Logistics_Resources', 'Study_Design', 'Another_Study']	['Neutral', 'Neutral', 'Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Too few patients who met enrollment criteria.	['Insufficient_Enrollment']	['Neutral']
No bone lesions detected and poor accrual	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Dosing stopped	['Invalid_Reason']	['Invalid_Reason']
Collaborator stopped study	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Withdrawal of the associated centers	['Logistics_Resources', 'Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
the doctor who ran this study, left	['Study_Staff_Moved']	['Neutral']
"No objective response was observed at the first step. The treatment was considered ineffective,
    with a complete clinical trial suspension."	['Negative']	['Negative']
Principal Investigator left the institution.	['Study_Staff_Moved']	['Neutral']
"Recruitment rate could not be met in the study period, review group was dissolved before
    regular end of study. Recruitment was therefore terminated."	['Insufficient_Enrollment']	['Neutral']
Study closed and subject follow-up completed following analysis of blinded study data.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Not enough funding	['Business_Administrative']	['Possibly_Negative']
Not enough patient	['Insufficient_Enrollment']	['Neutral']
"The study was prematurely terminated by S+N due to business reasons. After an extensive review
    of all ongoing studies with the focus on which studies are still required for regulatory
    obligations S+N took the decision to close the SMF S&E study."	['Business_Administrative']	['Possibly_Negative']
Study withdrawn before any enrollment (site's research goals adjustments).	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Investigator decided not to open study.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
No participant enrollment.	['Insufficient_Enrollment']	['Neutral']
One of the study drugs is not available.	['Logistics_Resources']	['Neutral']
Project terminated due to revision of local regulations	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Interim analysis showed that the primary endpoint would not be met.	['Negative']	['Negative']
Study design flaws; research design needed to be reconfigured	['Study_Design']	['Neutral']
The recruitment of subject is very difficult.	['Insufficient_Enrollment']	['Neutral']
Sponsor support withdrawn	['Business_Administrative']	['Possibly_Negative']
"Slow patient recruitment, not enough patients willing to participate within the prespecified
    time frame."	['Insufficient_Enrollment']	['Neutral']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
COVID19	['Covid19']	['Neutral']
Lack of efficacy and slow accrual	['Insufficient_Enrollment']	['Neutral']
The PI, who was sponsor got retired	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
Nonapplicable clinical trial	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
The decision to discontinue the study was based on business reasons.	['Business_Administrative']	['Possibly_Negative']
Poor enrollment, low recruitment.	['Insufficient_Enrollment']	['Neutral']
New information suggested a more effective treatment protocol.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Feasibility	['Logistics_Resources']	['Neutral']
Funding withdrawn by the funding agency; study could not be performed.	['Business_Administrative']	['Possibly_Negative']
Study IRB approval expired	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
This study was stopped 29OCT2009 due to strategic drug development considerations	['Business_Administrative']	['Possibly_Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Safety concerns with the COX-2 specific inhibitor class of drug.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Covid19 emergency	['Covid19']	['Neutral']
Poor accural	['Insufficient_Enrollment']	['Neutral']
Futility	['Negative']	['Negative']
Unable to implement the study due to delays from COVID-19 policies which postponed the start.	['Covid19']	['Neutral']
Study never started	['Invalid_Reason']	['Invalid_Reason']
Sponsor's considerations	['Business_Administrative']	['Possibly_Negative']
PI accepted a position at a new Institution and terminated the study at UIC.	['Study_Staff_Moved']	['Neutral']
Withdrawal of marketing autorization of efalizumab by the EMEA.	['Regulatory']	['Neutral']
No funding.	['Business_Administrative']	['Possibly_Negative']
Sponsor's decision	['Business_Administrative']	['Possibly_Negative']
Time and resource constraints	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
low response rate, no evidence of PFS or OS improved.	['Negative']	['Negative']
Lack of budget	['Business_Administrative']	['Possibly_Negative']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
The study was terminated due to difficulty of find eligible subjects	['Insufficient_Enrollment']	['Neutral']
Study personnel left institution	['Study_Staff_Moved']	['Neutral']
Study closed by sponsor prior to completing enrollment goal.	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
difficulty in recruiting elderly subjects	['Insufficient_Enrollment']	['Neutral']
"Study was terminated due to changing sponsor priorities, and was not based on safety or
    outcomes data."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Lack of budget	['Business_Administrative']	['Possibly_Negative']
Due to poor accrual	['Insufficient_Enrollment']	['Neutral']
Business Reasons	['Business_Administrative']	['Possibly_Negative']
Investigator left the site. Site closed.	['Study_Staff_Moved']	['Neutral']
insufficient number of eligible subjects	['Insufficient_Enrollment']	['Neutral']
Administrative	['Business_Administrative']	['Possibly_Negative']
It has come to our attention that the site was not necessary for our research project.	['Logistics_Resources', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Too slow recruitment.	['Insufficient_Enrollment']	['Neutral']
Not able to meet accrual	['Insufficient_Enrollment']	['Neutral']
Terminated by sponsor due to lack of funding	['Business_Administrative']	['Possibly_Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Halted Prematurely	['Invalid_Reason']	['Invalid_Reason']
"Problems with the Performance-Based Financing System in Cameroon, combined with the
    restrictions on movement brought on by the Covid-19 pandemic."	['Covid19']	['Neutral']
Study recruitment very slow.	['Insufficient_Enrollment']	['Neutral']
Suspended during COVID-19 outbreak, aim to re-start 2021	['Covid19']	['Neutral']
No new participants enrolled. Protocol superseded.	['Study_Design']	['Neutral']
change in development plan, not due to safety concerns.	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Due to business reasons, not safety issues.	['Business_Administrative']	['Possibly_Negative']
"The Principal Investigator left the institution so the study was stopped before completing
    enrollment."	['Study_Staff_Moved']	['Neutral']
Termininated for business reasons	['Business_Administrative']	['Possibly_Negative']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Due to lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
difficulty in recruiting patients	['Insufficient_Enrollment']	['Neutral']
Study terminated due to lack of eligible patients	['Insufficient_Enrollment']	['Neutral']
"Temporarily paused due to COVID-19 and will resume based on guidance of public health
    authorities. This is not a suspension of IRB approval."	['Covid19']	['Neutral']
Unable to find adequate funding	['Business_Administrative']	['Possibly_Negative']
Inadequate participant enrollment during recruitment period.	['Insufficient_Enrollment']	['Neutral']
insufficient recrutment	['Insufficient_Enrollment']	['Neutral']
The study never started.	['Invalid_Reason']	['Invalid_Reason']
not approved by sponsor	['Business_Administrative']	['Possibly_Negative']
"The PI resigned the institute, and the rest investigators at the institute decided to terminate
    the study."	['Study_Staff_Moved']	['Neutral']
Met study stopping rules	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
"Due to tolerability issues related to the dose titration, unexpected withdrawals were observed
    and it was unlikely for the trial to meet its objectives"	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Sponsor decided not to pursue market release of prototype device used in this study	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Due to a pre-specified imbalance of deaths between treatment groups, the DSMB recommended early
    termination of the trial"	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
No subjects enrolled	['Insufficient_Enrollment']	['Neutral']
Study put on clinical hold by FDA. Sponsor decided to no pursue the study.	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Due to increased rate of local injection site reactions in the DSJI group.	['Safety_Sideeffects', 'Endpoint_Met', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
high rate of medullar aplasia with infectious troubles.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Insufficient staff	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
lack of accrual	['Insufficient_Enrollment']	['Neutral']
Not funded at this time.	['Business_Administrative']	['Possibly_Negative']
Lack of resources has prevented the study from continuation.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
insufficient study staff	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
No avaliability of melphlan in mainland China	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
IRB issues	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
The data that would be generated is no longer clinically novel.	['Logistics_Resources', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
The protocol needs to be re-designed.	['Study_Design']	['Neutral']
COVID-19 Restrictions	['Covid19']	['Neutral']
"Investigation of ACE-083 for use in patients with CMT is being discontinued as it did not
    achieve functional secondary endpoints in the A083-03 trial."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Administrative reasons	['Business_Administrative']	['Possibly_Negative']
We had got enough data, therefore we stopped the study and published the data.	['Invalid_Reason']	['Invalid_Reason']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Recruitment was suboptimal	['Insufficient_Enrollment']	['Neutral']
no funding	['Business_Administrative']	['Possibly_Negative']
"Covidien is conducting a voluntary recall of DuetTRS use in the thoracic cavity. IFU is
    revised to contraindicate use in adult and pediatric thoracic surgeries"	['Covid19', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
Investigators are no longer at NYU Langone Health	['Study_Staff_Moved']	['Neutral']
Principal Investigator has left the institution	['Study_Staff_Moved']	['Neutral']
Study was terminated in anticipation of transfer of ownership to Avid Radiopharmaceuticals.	['Business_Administrative']	['Possibly_Negative']
COVID19 related	['Covid19']	['Neutral']
primary efficacy endpoint not attainable.	['Negative']	['Negative']
There were not participants to complete sample size	['Insufficient_Enrollment']	['Neutral']
sponsor withdrew study	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study has no principal investigator at the moment.	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
Drug supplier stopped funding due to loss of study drug (docetaxel) patent.	['Business_Administrative']	['Possibly_Negative']
"The study was terminated on August 6, 2012, because 2 large Phase 3 studies showed no clinical
    benefit. This decision was not based on any new safety concerns."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Terminated per the PI's request.	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Failure to meet primary endpoint	['Negative']	['Negative']
Hard to enroll participants	['Insufficient_Enrollment']	['Neutral']
Lacking of funding	['Business_Administrative']	['Possibly_Negative']
Terminated due to problems enrolling adequate number of patients.	['Insufficient_Enrollment']	['Neutral']
Recruitment problem-covid	['Covid19']	['Neutral']
Study ended early due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of funding required to enroll target subject number	['Business_Administrative']	['Possibly_Negative']
Myriad has discontinued the development of Flurizan.	['Business_Administrative']	['Possibly_Negative']
Recruitment impossible	['Insufficient_Enrollment']	['Neutral']
"As the feeder study (AZES) was stopped for futility after an independent assessment, this trial
    was also stopped."	['Negative']	['Negative']
Terminated	['Invalid_Reason']	['Invalid_Reason']
The study was stopped early due to successfully meeting the primary endpoint	['Negative', 'Another_Study']	['Negative', 'Neutral']
This study was never able to open due to lack of funding from the pharmaceutical company.	['Business_Administrative']	['Possibly_Negative']
Principle investigator is leaving institution.	['Study_Staff_Moved']	['Neutral']
The primary endpoint at 15 months was not met.	['Negative']	['Negative']
"With recommendation from IDMC, Steering Committee terminated this trial due to ethical concerns
    raised by J-ART study."	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Terminated due to funding loss.	['Business_Administrative']	['Possibly_Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Low accrual rate	['Insufficient_Enrollment']	['Neutral']
"have been published new studies that it showed the ineffectiveness of the treatments proposed
    in this study."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study stopped due to increased harm and slow progress in the intervention group.	['Negative']	['Negative']
Due to Covid - 19 pandemic	['Covid19']	['Neutral']
Large and sustained difference in pregnancy rate	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
not enough patients	['Insufficient_Enrollment']	['Neutral']
"Poor accrual, changes in management of newly diagnosed myeloma patients, new drugs/more
    effective regimens."	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
There were not enough eligible families and trained clinicians to conduct RCT.	['Insufficient_Enrollment']	['Neutral']
Withdrawn [Funding was never granted for this study. No participants were ever enrolled.]	['Business_Administrative']	['Possibly_Negative']
Abnormality prevalence revealed to be much lower than expected.	['Insufficient_Enrollment']	['Neutral']
low enrollment and difficulty recruiting eligible patients in adequate time	['Insufficient_Enrollment']	['Neutral']
no subject enrolled within one year following EC and IRB approvals.	['Regulatory', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Study withdrawn.	['Invalid_Reason']	['Invalid_Reason']
This study will now be conducted in healthy volunteers.	['No_Context', 'Invalid_Reason', 'Study_Design']	['Invalid_Reason', 'Invalid_Reason', 'Neutral']
difficulty recruiting and retaining participants	['Insufficient_Enrollment']	['Neutral']
"To unsuccessful recruitment of rare UM-genotype. All other planned genotype groups are
    completed (EM, IM and PM)."	['Insufficient_Enrollment']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Following DSMB advice after first interim analysis (n=174)	['Negative']	['Negative']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
Lack of patient enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
change sites	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Terminated after two years by CSRD	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Dr. Higgins does not have a sub-investigator that can complete the study.	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
slow recuritment	['Insufficient_Enrollment']	['Neutral']
Due to permanant change of stations of investigators.	['Logistics_Resources', 'Study_Staff_Moved', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Equipoise for hydroxychloquine was lost	['Logistics_Resources']	['Neutral']
Because funding was not secured, the study was never initiated. 0 subjects enrolled	['Business_Administrative']	['Possibly_Negative']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
St. Jude Medical business decision	['Business_Administrative']	['Possibly_Negative']
Lack of logistic capabilities at the study site	['Logistics_Resources']	['Neutral']
Failed to reach endpoints	['Negative']	['Negative']
Enrollment slower than usual.	['Insufficient_Enrollment']	['Neutral']
unable to secure funding for analysis of laboratory data.	['Business_Administrative']	['Possibly_Negative']
Due to COVID-19 restrictions, recruitment suspended until Spring 2021	['Covid19']	['Neutral']
Trial is no longer enrolling due to priority of other non-pharmacologic PTSD trials.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
The study was prematurely terminated because of slow recruitment	['Insufficient_Enrollment']	['Neutral']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
"In light of the cessation of non-essential clinical activities at CPU due to the COVID-19
    pandemic, the sponsor has determined to terminate the study early."	['Covid19']	['Neutral']
Study never started. Study suspended indefinitely.	['Invalid_Reason']	['Invalid_Reason']
PI Initiated study - PI left facility	['Study_Staff_Moved']	['Neutral']
The study was terminated and the PI has left the institution.	['Study_Staff_Moved']	['Neutral']
"The Sponsor's decision to terminate the SBC-103 program was reached after review of the data
    from all interventional clinical studies of SBC-103."	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
Program was discontinued.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
PI chose not to proceed with study.	['Invalid_Reason']	['Invalid_Reason']
Due to problems regarding methodology.	['Logistics_Resources', 'Study_Design', 'Another_Study']	['Neutral', 'Neutral', 'Neutral']
Study on hold, enrollment suspended at this time	['Invalid_Reason']	['Invalid_Reason']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
This record is an additional copy of the study listed above	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Poor return rate/high dropout rate requiring alteration to study methodology	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Study fatigue	['Safety_Sideeffects', 'Logistics_Resources', 'Endpoint_Met']	['Safety_Sideeffects', 'Neutral', 'Neutral']
to re-evaluate biomarker strategy for recruitment to Part 2	['Study_Design']	['Neutral']
Insufficient accrual	['Insufficient_Enrollment']	['Neutral']
very low rate of patient accrual	['Insufficient_Enrollment']	['Neutral']
Mycotoxin potential contamination of one lot of study drug	['Safety_Sideeffects', 'Logistics_Resources']	['Safety_Sideeffects', 'Neutral']
"It was determined that internal resources to support this population would be better utilized
    in other Injury and Violence Prevention Programs."	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The budget issues.	['Business_Administrative']	['Possibly_Negative']
DSMB Interim Analyses	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
replaced by other study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Limited funds available to complete full recruitment. Enrolment achieved: 90%.	['Business_Administrative']	['Possibly_Negative']
The study reach enough significance at the intermediary analysis	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
"Terminated by sponsor due to new unpublished data that rendered the current design of the study
    no longer clinically relevant. There were no safety concerns."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Safety concerns	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Risk to benefit ratio is not acceptable	['Negative']	['Negative']
No funding	['Business_Administrative']	['Possibly_Negative']
Site did not recruit any patients	['Insufficient_Enrollment']	['Neutral']
"Topline results from study M13-796 showed an overall lack of efficacy. There were no safety
    concerns."	['Negative', 'Another_Study']	['Negative', 'Neutral']
patient enrollment too slow	['Insufficient_Enrollment']	['Neutral']
Unable to obtain approval from FDA for use of chloral hydrate	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Study unable to recruit	['Insufficient_Enrollment']	['Neutral']
low enrollment rate	['Insufficient_Enrollment']	['Neutral']
PI was unable to continue to gather data during the trip during to medical illness	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
The trial could not be completed within the grant timeline.	['Business_Administrative']	['Possibly_Negative']
recruitment difficulties due to recently introduced new surgical procedure	['Study_Design']	['Neutral']
Needle production stopped	['Interim_Analysis', 'Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
resources limited due to COVID-19	['Covid19']	['Neutral']
Non applicable clinical trial	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
inability to recruiti a sufficient number of patients	['Insufficient_Enrollment']	['Neutral']
Difficulty finding the required subject population	['Insufficient_Enrollment']	['Neutral']
Terminated due to funding issues.	['Business_Administrative']	['Possibly_Negative']
Low enrollment rates.	['Insufficient_Enrollment']	['Neutral']
Withdrawn due to no accrual	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Slow accrual than anticipated.	['Insufficient_Enrollment']	['Neutral']
The trial was stopped for futility in view of the results of the anticipated analysis	['Negative']	['Negative']
Pending funding	['Business_Administrative']	['Possibly_Negative']
Lack of staff resources to properly consent and enroll patients into the study.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Funding was not obtained to complete study	['Business_Administrative']	['Possibly_Negative']
Temporary suspension due to COVID-19 pandemic	['Covid19']	['Neutral']
No patients enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Question raised by Ethics Committee	['Interim_Analysis', 'Success', 'Logistics_Resources']	['Neutral', 'Success', 'Neutral']
Interim analysis showed inadequate efficacy of bifeprunox	['Negative']	['Negative']
Grant proposal not funded, study has been withdrawn with IRB	['Business_Administrative']	['Possibly_Negative']
Interim analysis suggested futility.	['Negative']	['Negative']
Inadequate accrual rate	['Insufficient_Enrollment']	['Neutral']
"This small mechanistic pilot study was ended prior to first enrollment after considering
    factors related to feasibility (e.g., available time and resources)."	['Logistics_Resources']	['Neutral']
Suspended due to COVID-19 risks	['Covid19']	['Neutral']
Was not funded	['Business_Administrative']	['Possibly_Negative']
The trial was prematurely terminated on 01April2014 due to safety concerns.	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
"Interim analysis suggested a trend favoring ecallantide; observed response rate to placebo was
    substantially higher than described in medical literature."	['Negative']	['Negative']
This study was stopped because of insufficient enrollment.	['Insufficient_Enrollment']	['Neutral']
Unable to recruit sufficient number of participants in the time available.	['Insufficient_Enrollment']	['Neutral']
The study closed due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
due to low enrollment	['Insufficient_Enrollment']	['Neutral']
It was not feasible to enroll Emergency Department patients into this protocol	['Insufficient_Enrollment']	['Neutral']
too slow recruiting	['Insufficient_Enrollment']	['Neutral']
Investigator decision based on new device information.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
From preliminary imaging data, the study was stopped due to futility.	['Negative']	['Negative']
as of 4/23/97	['Invalid_Reason']	['Invalid_Reason']
See Detailed Description for termination reason.	['No_Context']	['Invalid_Reason']
Trial discontinued based on the results of an interim futility analysis.	['Negative']	['Negative']
Feasibility of study at single site; changes in clinical practice in opioid use	['Study_Design']	['Neutral']
Difficult recruitment, despite several interventions.	['Insufficient_Enrollment']	['Neutral']
RECOVERY Trial results - no efficacy	['Negative']	['Negative']
Insufficient rate of patient recruitment and treatment.	['Insufficient_Enrollment']	['Neutral']
low enrollment	['Insufficient_Enrollment']	['Neutral']
Business decision to discontinue development of this investigational device.	['Business_Administrative']	['Possibly_Negative']
Study terminated due to poor recruitment	['Insufficient_Enrollment']	['Neutral']
Merrimack Inc. terminated the trial early due to business decision	['Business_Administrative']	['Possibly_Negative']
Sufficient funding could not be secured for the study	['Business_Administrative']	['Possibly_Negative']
The study was prematurely closed due to unacceptable toxicity.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Business need changed.	['Business_Administrative']	['Possibly_Negative']
"The Thoracic Surgery Department has almost stopped completely its surgical activities and the
    completion of the study doesn't seem to be feasible."	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Slow enrollment, end of funding	['Insufficient_Enrollment']	['Neutral']
Halted due to zero accrual and lack of funding	['Insufficient_Enrollment']	['Neutral']
Participants couldn't be enrolled due to complain of frequent visit.	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Study was stopped early due to difficulty finding patients who met I/E criteria.	['Insufficient_Enrollment']	['Neutral']
Lack of improved efficacy compared to historical controls, competing studies	['Negative', 'Another_Study']	['Negative', 'Neutral']
Procedure has become standard of care - protocol is no longer necessary	['Study_Design']	['Neutral']
Trial did not move to Phase II portion due to poor tolerance of treatment	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
The sponsor has decided to stop the study	['Business_Administrative']	['Possibly_Negative']
COVID 19	['Covid19']	['Neutral']
Principle investigator (Sylvia Herbozo) left the university.	['Study_Staff_Moved']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
This trial discontinued on 30 JUN 2006 due to a lack of enrolment	['Insufficient_Enrollment']	['Neutral']
Funding ended and enrollment not completed within a certain time period	['Business_Administrative']	['Possibly_Negative']
Study terminated due to corporate decision.	['Business_Administrative']	['Possibly_Negative']
PI left the VA, per Central Office	['Study_Staff_Moved']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
The study drug delayed time of discharge which is clinically impracticable.	['Interim_Analysis', 'Logistics_Resources', 'Endpoint_Met']	['Neutral', 'Neutral', 'Neutral']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Failure to enroll	['Insufficient_Enrollment']	['Neutral']
Terminated due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
Study was stopped due to recruitment failure	['Insufficient_Enrollment']	['Neutral']
Study was stopped early due to inability to recruit additional participants	['Insufficient_Enrollment']	['Neutral']
IDE not submitted	['Regulatory', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
difficult to recruit	['Insufficient_Enrollment']	['Neutral']
COVID-19	['Covid19']	['Neutral']
problems with recruitment and funding	['Business_Administrative']	['Possibly_Negative']
Study site has terminated the study due to the complexity of the study	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Sponsor company was acquired and new owner chose not to proceed with clinical study	['Business_Administrative']	['Possibly_Negative']
Lack of Enrollment	['Insufficient_Enrollment']	['Neutral']
Primary investigator is no longer a part of the VA	['Study_Staff_Moved']	['Neutral']
accrual too slow	['Insufficient_Enrollment']	['Neutral']
inadequate enrollment, insufficient funds to continue enrollment	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
12-month assessment process has been stopped prematurely due to logistic reasons.	['Logistics_Resources']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of feasibility to accrue patients in allotted time.	['Insufficient_Enrollment']	['Neutral']
"Azidus, the CRO hired for this study by Prevent Senior has lost the interest to conduct this
    study."	['Logistics_Resources', 'Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
The study was stopped due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
Unfunded Pilot Study	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
There was a problem with funding and with the acquisition of the lab assays	['Business_Administrative']	['Possibly_Negative']
ethical issues of continuing control group without treatment	['Interim_Analysis', 'Success', 'Logistics_Resources']	['Neutral', 'Success', 'Neutral']
slow inclusion	['Insufficient_Enrollment']	['Neutral']
No participants were enrolled.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
IRB approval expired	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The renin laboratory used in the study is no longer available.	['Logistics_Resources']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Economic and business factors	['Business_Administrative']	['Possibly_Negative']
Not accruing patients quickly enough	['Insufficient_Enrollment']	['Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
"Temporarily paused due to COVID-19 and will resume based on guidance of public health
    authorities. This is not a suspension of IRB approval."	['Covid19']	['Neutral']
Low feasibility	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Stopped product production	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Patient population no longer available.	['Insufficient_Enrollment']	['Neutral']
Voluntary global product recall of Zerbaxa (ceftolozane and tazobactam) for injection (1.5g).	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
PI not planning to pursue this study and it was never IRB approved.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
closing due to low enrollment, no safety issues	['Insufficient_Enrollment']	['Neutral']
Slow Enrollment	['Insufficient_Enrollment']	['Neutral']
Grant ended/funding unavailable	['Business_Administrative']	['Possibly_Negative']
Study could not be initiated due to lack of research funding from the sponsors.	['Business_Administrative']	['Possibly_Negative']
Study lost access to ECGI	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
insufficent enrolement	['Insufficient_Enrollment']	['Neutral']
PI retired	['Study_Staff_Moved']	['Neutral']
Study stopping rules were met.	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
We were unable to enroll any patients into the study.	['Insufficient_Enrollment']	['Neutral']
"Novartis terminated all projects involving aliskiren. Findings of the DMC overseeing the
    ALTITUDE clinical trial found a higher incidence of adverse events."	['Covid19', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
No participants were enrolled and the study was never initiated.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Study was stopped because of safety concerns.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Company providing study drug terminated study due to lack of funds	['Business_Administrative']	['Possibly_Negative']
"Insufficient patients recruited due to a lack of GUCH patients enrolling in cardiac
    Rehabilitation."	['Insufficient_Enrollment']	['Neutral']
Because of low recruitment	['Insufficient_Enrollment']	['Neutral']
Very low recruitment rate	['Insufficient_Enrollment']	['Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
The study was cancelled before any patients were enrolled, due to operational reasons.	['Business_Administrative']	['Possibly_Negative']
Company closed May 1, 2019	['Business_Administrative']	['Possibly_Negative']
Not reached the primary endpoint target according to the statistical design	['Negative']	['Negative']
Principal Investigator left institution-study not continued	['Study_Staff_Moved']	['Neutral']
Inadequate number of eligible patients	['Insufficient_Enrollment']	['Neutral']
Recruitment	['Insufficient_Enrollment']	['Neutral']
small number of patients enrolled	['Insufficient_Enrollment']	['Neutral']
COVID-19	['Covid19']	['Neutral']
Change in goals of PI	['Study_Staff_Moved']	['Neutral']
"Remaining patients were offered a similar observational study (Alexion M11-001) to allow for
    robust, high quality data collection in a larger, single database"	['Negative', 'Another_Study']	['Negative', 'Neutral']
The study was withdrawn for administrative reasons	['Business_Administrative']	['Possibly_Negative']
Number of needed participants could not be obtained	['Insufficient_Enrollment']	['Neutral']
is involved in NIH study	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Due to a shift in primary responsibilities, the PI was not longer able to enroll subjects.	['Insufficient_Enrollment']	['Neutral']
"The study was terminated on August 6, 2012, because 2 large Phase 3 studies showed no clinical
    benefit. This decision was not based on any new safety concerns."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Please see Purpose Statement below	['No_Context']	['Invalid_Reason']
Inability to recruit subjects	['Insufficient_Enrollment']	['Neutral']
initial on hold due to space but now permanently suspended due to futility.	['Negative']	['Negative']
Sponsor's decision to deprioritize the program.	['Business_Administrative']	['Possibly_Negative']
PI left Health System	['Study_Staff_Moved']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
PI left the institution	['Study_Staff_Moved']	['Neutral']
Study stopped prematurely due to enrolment challenges.	['Insufficient_Enrollment']	['Neutral']
Trial met toxicity stopping rule	['Safety_Sideeffects', 'Endpoint_Met', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
"At 75% patient completion overall mortality was much lower than expected and without
    significant difference at day 90. No chance to reach the primary endpoint."	['Negative']	['Negative']
"Steering Committee accepted DSMB advise to terminate the study after review of data analysis at
    second interim analysis"	['Negative']	['Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Changes & upgrades in informatic infrastructure of the web-based intervention.	['Covid19', 'Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
The decision was made to prematurely discontinue this trial due to lack of efficacy.	['Negative']	['Negative']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
company strategic change	['Business_Administrative']	['Possibly_Negative']
Expiration of study supply	['Logistics_Resources']	['Neutral']
funding	['Business_Administrative']	['Possibly_Negative']
The underwriter stopped the funding	['Business_Administrative']	['Possibly_Negative']
Not started	['Invalid_Reason']	['Invalid_Reason']
Recruitment failure	['Insufficient_Enrollment']	['Neutral']
lack of data	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Change in research site	['Logistics_Resources', 'Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Investigator left the Institution.	['Study_Staff_Moved']	['Neutral']
The study closed due to poor accrual and difficulty with participant compliance.	['Insufficient_Enrollment']	['Neutral']
"Outcome of a planned interim analysis was that the sample size required to show superiority was
    too high to be feasible. Fresenius Kabi requested termination to the FDA on 17 Jan 2020. FDA
    accepted termination by written response on 16 Apr 2020."	['Regulatory', 'Negative']	['Neutral', 'Negative']
Low/inadequate rate of accrual.	['Insufficient_Enrollment']	['Neutral']
There was no enough subject	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Inadequate enrollment.	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
poor patient recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
PI left institution and terminated study	['Study_Staff_Moved']	['Neutral']
Study terminated by sponsor	['Business_Administrative']	['Possibly_Negative']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
No Funding	['Business_Administrative']	['Possibly_Negative']
Study never initiated	['Invalid_Reason']	['Invalid_Reason']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
Principal investigator left the institution	['Study_Staff_Moved']	['Neutral']
Study was stopped due to lack of resources (clinical dietitians)	['Logistics_Resources']	['Neutral']
recruiting problems	['Insufficient_Enrollment']	['Neutral']
End of promotion by the sponsor	['Business_Administrative']	['Possibly_Negative']
Unable to recruit subjects	['Insufficient_Enrollment']	['Neutral']
Inadequate recruitment numbers	['Insufficient_Enrollment']	['Neutral']
"New design was developed to better fit company strategy, a new study has replaced
    5413541TRD3011 study"	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
inadequate number of recruita	['Insufficient_Enrollment']	['Neutral']
Was never started	['Invalid_Reason']	['Invalid_Reason']
anticipated number of patients could not be reached	['Insufficient_Enrollment']	['Neutral']
Early termination due to increase in serum creatinine levels and minimal PD activity.	['Negative']	['Negative']
Unproven hypothesis	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
No funding	['Business_Administrative']	['Possibly_Negative']
"The study was terminated early by the Sponsor for reasons unrelated to patient safety or
    anti-tumor activity."	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Anticipated high risk of pancreatitis	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"Study stopped for Statistical Futility. Low rate of bleeding events made it unlikely there
    would be statistical power to show a difference in the 2 arms."	['Negative']	['Negative']
Withdrawn by PI due to insufficient accrual	['Insufficient_Enrollment']	['Neutral']
"Study halted prematurely, prior to enrollment of first participant due to PI not employment at
    University."	['Study_Staff_Moved']	['Neutral']
Lack of further funding.	['Business_Administrative']	['Possibly_Negative']
The study was stopped due to a non-clinical safety finding.	['Negative', 'Another_Study']	['Negative', 'Neutral']
low qualified candidate enrollment	['Insufficient_Enrollment']	['Neutral']
Suspended due to COVID-19 risks	['Covid19']	['Neutral']
No additional enrollment	['Insufficient_Enrollment']	['Neutral']
No recruitment of subjects	['Insufficient_Enrollment']	['Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Sufficient information gathered	['Invalid_Reason']	['Invalid_Reason']
Study not started	['Invalid_Reason']	['Invalid_Reason']
Principal Investigator Medical Leave	['Study_Staff_Moved']	['Neutral']
Stopped for futility by DSMB	['Negative']	['Negative']
intervention programming	['Logistics_Resources', 'Study_Design', 'Another_Study']	['Neutral', 'Neutral', 'Neutral']
"The results of a third interim analysis (ad hoc) indicated a lack of efficacy and futility in
    continuing the trial."	['Negative']	['Negative']
Due to time constraints, the study will not be able to be completed as outlined	['Business_Administrative']	['Possibly_Negative']
Not enough obese subjects could be recruited.	['Insufficient_Enrollment']	['Neutral']
Due to poor accrual and lack of peptide vaccine	['Insufficient_Enrollment']	['Neutral']
Not enough patients within the time frame to allow for a meaningful study.	['Insufficient_Enrollment']	['Neutral']
Slow recruitment and inability to extend funding.	['Business_Administrative']	['Possibly_Negative']
Study is completed and analysis completed	['Invalid_Reason']	['Invalid_Reason']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
The investigator decided to stop the trial due to a lack of inclusion.	['Insufficient_Enrollment']	['Neutral']
new studies were finding that Erbitux was not beneficial	['Negative', 'Another_Study']	['Negative', 'Neutral']
DSMB halted the study early due to futility. There were no safety concerns.	['Negative']	['Negative']
Failure to meet recruitment target during the recruitment period	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor decision to cancel TRIAL, not related to safety concern	['Safety_Sideeffects', 'Business_Administrative']	['Safety_Sideeffects', 'Possibly_Negative']
PI leaving institution/no funding	['Business_Administrative']	['Possibly_Negative']
Study withdrawn from ClinicalTrials.gov.	['Covid19', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
"The ART Trial was published suggesting harm by the intervention protocol, which was closely
    related to the protocol in this study, so the study was terminated."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Poor follow/up rates and data.	['Success', 'No_Context', 'Logistics_Resources']	['Success', 'Invalid_Reason', 'Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
Study never activated	['Invalid_Reason']	['Invalid_Reason']
The study was terminated early due to poor recruitment.	['Insufficient_Enrollment']	['Neutral']
Voluntary halt due to an FDA Clinical Hold issued in relation to DV2-HBV-10.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Withdrawn in October 2006, no longer of interest	['Business_Administrative']	['Possibly_Negative']
Investigator left institution	['Study_Staff_Moved']	['Neutral']
Unable to recruit/accrue adequate numbers of participants within funding period.	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of Funding	['Business_Administrative']	['Possibly_Negative']
There were problems with national reimbursement policies.	['Business_Administrative']	['Possibly_Negative']
Not able to find enough eligible patients (200) in last 4 years.	['Insufficient_Enrollment']	['Neutral']
We are underpowered to find a difference in the primary outcome.	['Negative']	['Negative']
large non-response rate	['Insufficient_Enrollment']	['Neutral']
IRB and institutional re-assessment	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
impossible enrollement	['Insufficient_Enrollment']	['Neutral']
competing protocol	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Funding source was terminated before enrollment of first subject	['Business_Administrative']	['Possibly_Negative']
Unable to enroll at rate anticipated, insufft low vitamin D in clin rem @ 5 sites	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Low rate of accrual	['Insufficient_Enrollment']	['Neutral']
We have recruited and treated 79 participants	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
early termination due to difficult collection of patients	['Insufficient_Enrollment']	['Neutral']
Due to insufficient patient recruitment and lack of funding	['Business_Administrative']	['Possibly_Negative']
The study was stopped due to low recruitment.	['Insufficient_Enrollment']	['Neutral']
Difficulty finding participants who fit all criteria	['Insufficient_Enrollment']	['Neutral']
Enrollment too slow.	['Insufficient_Enrollment']	['Neutral']
IRB approval expired and study ceased.	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Study was terminated due to poor accrual.	['Insufficient_Enrollment']	['Neutral']
Principal investigator [PI] has left institution.	['Study_Staff_Moved']	['Neutral']
510(K) Approval Gained for Product	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Study terminated due to corporate decision.	['Business_Administrative']	['Possibly_Negative']
This study was stopped due to low inclusion	['Insufficient_Enrollment']	['Neutral']
The trial was prematurely stopped due to slow patient enrolment.	['Insufficient_Enrollment']	['Neutral']
Discontinuation of program	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
"Based on newly available preclinical data we changed the CAR construct to a more effective
    version and will now study that product on a different protocol."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Participants are no longer being examined. The results are published 2016 Anticancer Research
    36: 6431-6438"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of eligible patients	['Insufficient_Enrollment']	['Neutral']
Funding for the study finished before anticipated participants enrolled	['Business_Administrative']	['Possibly_Negative']
Lack of patient accrual	['Insufficient_Enrollment']	['Neutral']
Difficulty recruiting patients	['Insufficient_Enrollment']	['Neutral']
COVID-19	['Covid19']	['Neutral']
We decided to go to another direction.	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
No participants shared	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Ongoing challenges to successfully recruit the required number of subjects	['Insufficient_Enrollment']	['Neutral']
Sponsor could not fund	['Business_Administrative']	['Possibly_Negative']
because of low rate recruitment and the inability to reach the target expected	['Insufficient_Enrollment']	['Neutral']
"No safety reasons. Interim analysis shows that the hypothesis superiority of the experimental
    arm over the control arm- would not be confirmed."	['Negative']	['Negative']
Investigator left institution	['Study_Staff_Moved']	['Neutral']
Lack of eligible participants	['Insufficient_Enrollment']	['Neutral']
Study terminated due to inadequate funding.	['Business_Administrative']	['Possibly_Negative']
Recruitment and organisational difficulties	['Business_Administrative']	['Possibly_Negative']
Study was not activated at Fox Chase Cancer Center	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Funding for the study was not renewed	['Business_Administrative']	['Possibly_Negative']
Study terminated due to lack of care guidelines in the protocol.	['Study_Design']	['Neutral']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
organizational reasons at sites: low recruitment	['Business_Administrative']	['Possibly_Negative']
Patient numbers estimated to be too low to complete the trial in less than 10 years	['Insufficient_Enrollment']	['Neutral']
No patients enrolled. A pilot study variation of this study was done instead.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Publication of recent trials showing no effect of EPO in TBI.	['Negative', 'Another_Study']	['Negative', 'Neutral']
The Relamorelin program is being terminated solely based on a business decision.	['Business_Administrative']	['Possibly_Negative']
Data for Study Devices vs. Predicate not within allowable ranges.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Investigator left institution	['Study_Staff_Moved']	['Neutral']
acrual too slow	['Insufficient_Enrollment']	['Neutral']
Prematurely terminated due to poor accrual	['Insufficient_Enrollment']	['Neutral']
Insufficient number of eligible and interested partients	['Insufficient_Enrollment']	['Neutral']
Suspended for indetermined period.	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
It was not possible within the time frame to recruit the planned no. of patients.	['Insufficient_Enrollment']	['Neutral']
Unable to recruit needed participants	['Insufficient_Enrollment']	['Neutral']
Poor subject enrollment	['Insufficient_Enrollment']	['Neutral']
"The sole investigative site refused to accept the amended protocol and declined to continue the
    study. There was no safety signal nor any other reason."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
PI Request	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Not sufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Elevation of ALT and AST in some patients.	['Safety_Sideeffects', 'Negative']	['Safety_Sideeffects', 'Negative']
No enrollment	['Insufficient_Enrollment']	['Neutral']
Study was stopped due to non-enrollment of subjects due to rarity of disease.	['Insufficient_Enrollment']	['Neutral']
Loss of funding.	['Business_Administrative']	['Possibly_Negative']
"Study was activated initially. However, the necessary resources were not available to complete
    the research."	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Funding was inadequate to continue; Companies requested closure.	['Business_Administrative']	['Possibly_Negative']
Necessity of major revision of the protocol	['Study_Design']	['Neutral']
Unexpected toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
PI has passed away. Requested by department to terminate study.	['Study_Staff_Moved']	['Neutral']
Sponsor decision to not proceed with study - no subjects enrolled	['Business_Administrative']	['Possibly_Negative']
No patients willing to join	['Insufficient_Enrollment']	['Neutral']
Program was terminated for business reasons	['Business_Administrative']	['Possibly_Negative']
Unable to provide study medications due to cost.	['Logistics_Resources']	['Neutral']
Futility	['Negative']	['Negative']
Lower enrollment than Sponsor expected - Sponsor stopped study	['Insufficient_Enrollment']	['Neutral']
Original P.I. left the institution	['Study_Staff_Moved']	['Neutral']
futility	['Negative']	['Negative']
not funded	['Business_Administrative']	['Possibly_Negative']
"On April 15, 2019, BIOTRONIK received FDA approval to transition the ongoing SIELLO Post
    Approval Registry to a new EP PASSION real-world data methodology."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Cooperation stooped with PI	['Logistics_Resources', 'Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
unable to gather sufficient data	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
The Relamorelin program is being terminated solely based on a business decision	['Business_Administrative']	['Possibly_Negative']
Study stopped due to lack of volunteer patients.	['Insufficient_Enrollment']	['Neutral']
Study withdrawn due to difficulties in recruiting patients	['Insufficient_Enrollment']	['Neutral']
Internal decision, study will be replaced with a larger monotherapy trial	['Negative', 'Another_Study']	['Negative', 'Neutral']
Positive results at interim analysis	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Rate of recruitment deemed insufficient by study sponsor	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
"The study was withdrawn due to the CE mark of the device was not yet granted during the
    specified period."	['Interim_Analysis', 'Regulatory', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Study has been updated with a new protocol number	['Study_Design']	['Neutral']
Funding revoked	['Business_Administrative']	['Possibly_Negative']
Financial hardship	['Business_Administrative']	['Possibly_Negative']
Terminated early due to futility.	['Negative']	['Negative']
Unable to recruit targeted #	['Insufficient_Enrollment']	['Neutral']
Lack of efficacy	['Negative']	['Negative']
Unable to recruit a sufficient number of subjects.	['Insufficient_Enrollment']	['Neutral']
we decided not to go on treatment phase	['Invalid_Reason']	['Invalid_Reason']
Terminated due to approved label expansion	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
difficulty recruiting	['Insufficient_Enrollment']	['Neutral']
Futility	['Negative']	['Negative']
Changed the direction and aims of the study	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Slow subject enrollment; study to be obtained is no longer required.	['Insufficient_Enrollment']	['Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
"There is a lower recruitment rate than projected. Patients are being screened to participate in
    another study and with held from our recruitment."	['Insufficient_Enrollment']	['Neutral']
Terminated due to lack of funding. Follow-up completed for all enrolled subjects.	['Business_Administrative']	['Possibly_Negative']
"The risk-benefit ratio for the use of onercept in this condition was not sufficiently favorable
    to justify continued development"	['Negative']	['Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Primary objective reached	['Interim_Analysis', 'Success', 'Endpoint_Met']	['Neutral', 'Success', 'Neutral']
Recruitment was not sufficient to complete the study	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
The study was terminated early due to business reasons.	['Business_Administrative']	['Possibly_Negative']
Study drug production halted.	['Logistics_Resources', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Company no longer interested in supporting this trial	['Business_Administrative']	['Possibly_Negative']
Closed 2017 for low accrual. Last data for primary outcome on 02Feb2015.	['Insufficient_Enrollment']	['Neutral']
Transfer of grant to new institution	['Business_Administrative']	['Possibly_Negative']
Unable to recruit sufficient number of subjects	['Insufficient_Enrollment']	['Neutral']
Business Decision; there were no safety issues	['Business_Administrative']	['Possibly_Negative']
lack of inclusions	['Insufficient_Enrollment']	['Neutral']
"The study was terminated early to roll over participants to open label extension study
    NCT02594124."	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Preliminary data run on rat samples showed that this study question and design would not
    produce conclusive results. The PI decided not to carry out the study."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
PI no longer at institution	['Study_Staff_Moved']	['Neutral']
Business Reasons	['Business_Administrative']	['Possibly_Negative']
enrollment failure (only 29 patients were enrolled during the study period)	['Insufficient_Enrollment']	['Neutral']
No funding available for the activity	['Business_Administrative']	['Possibly_Negative']
Sponsor decided to stop enrollment to review data.	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
unable to recruit participants	['Insufficient_Enrollment']	['Neutral']
The study never screened or enrolled any subjects due to stalled recruitment efforts.	['Insufficient_Enrollment']	['Neutral']
Unlikely to achieve targeted accrual	['Insufficient_Enrollment']	['Neutral']
"The study was terminated early, due to the poor feasibility and sustainability, leading to slow
    recruitment rate."	['Insufficient_Enrollment']	['Neutral']
Respond was to low.	['Insufficient_Enrollment']	['Neutral']
Unable to identify and recruit suitable study subjects	['Insufficient_Enrollment']	['Neutral']
R and D approval not forthcoming	['Business_Administrative']	['Possibly_Negative']
"recruiting or enrolling participants has halted prematurely and will not resume; participants
    are no longer being examined or treated"	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Lack of Enrollement	['Insufficient_Enrollment']	['Neutral']
"As similar local evidence recently available, present study will not add new information; no
    ethical justification exists to continue study procedures."	['Negative', 'Another_Study']	['Negative', 'Neutral']
PI left the institution	['Study_Staff_Moved']	['Neutral']
"Prematurely due to slow recruitment (07/08/2013). Newly defined study end=LPLV=05/11/2013.
    ABCSG guaranteed completed treatment period for ethical reasons."	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
slow accrual	['Insufficient_Enrollment']	['Neutral']
The study was stopped for not meeting the primary endpoint for PFS.	['Negative']	['Negative']
Despite a large number of patients screened, very few met eligibility guidelines.	['Insufficient_Enrollment']	['Neutral']
Recruitment problems	['Insufficient_Enrollment']	['Neutral']
Never received necessary funding.	['Business_Administrative']	['Possibly_Negative']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
See detailed description for termination reason	['No_Context']	['Invalid_Reason']
"Stopped prematurely by Company due to decision to terminate all CTEP supplied drug for further
    development of RO4929097."	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
No accrual.	['Insufficient_Enrollment']	['Neutral']
This study has been temporarily suspended due to COVID-19.	['Covid19']	['Neutral']
Grant not approved	['Business_Administrative']	['Possibly_Negative']
This trial was terminated early due to lack of recruitment.	['Insufficient_Enrollment']	['Neutral']
not enough patients	['Insufficient_Enrollment']	['Neutral']
No Participants enrolled; slow accrual	['Insufficient_Enrollment']	['Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
hurricane caused closure of hospital with PI not associated with Shriners Hospital for children	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
"An interim analysis revealed the study was unlikely to attain a positive outcome for the
    efficacy analysis. No safety concerns were detected"	['Negative']	['Negative']
"Because previous studies had found no difference, and one recent study even reported a higher
    incidence of PEP in treatment arm"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Difficulty with recruiting willing participants.	['Insufficient_Enrollment']	['Neutral']
Funding not obtained	['Business_Administrative']	['Possibly_Negative']
Abandoned project	['Invalid_Reason']	['Invalid_Reason']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
Insufficient funding	['Business_Administrative']	['Possibly_Negative']
lack of efficacy	['Negative']	['Negative']
Due to difficulties in recruiting frail subjects.	['Insufficient_Enrollment']	['Neutral']
Funding stopped	['Business_Administrative']	['Possibly_Negative']
Slow accrual of patients.	['Insufficient_Enrollment']	['Neutral']
"Study stopped early following termination of associated clinical development program (due to
    lack of efficacy)"	['Negative', 'Business_Administrative']	['Negative', 'Possibly_Negative']
departure of the investigator coordinator into other country	['Study_Staff_Moved']	['Neutral']
Enrollment was paused due to the COVID-19 pandemic and switching of PI	['Covid19']	['Neutral']
"Recruitment was stopped with the begin of the COVID-19 pandemic as this potentially has an
    incluence on our outcomes"	['Covid19']	['Neutral']
Business Decision	['Business_Administrative']	['Possibly_Negative']
Canceled by Immunoscore's manufacturer	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Closed prematurely due to toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
The PI has left the project and the VA, as of 3/2011	['Study_Staff_Moved']	['Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
End of allotted time for subject recruiting.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Investigators don't want to conduct this study as time is limited.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Closed due to slow accrual prior to interim analysis.	['Insufficient_Enrollment']	['Neutral']
Closed early due to poor accrual.	['Insufficient_Enrollment']	['Neutral']
Very poor enrollment	['Insufficient_Enrollment']	['Neutral']
The study was terminated due to lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
Investigational device changes; adequate enrollment achieved	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
The study was withdrawn due to lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Regulatory strategy	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Prematurely terminated based on interim study analysis	['Interim_Analysis', 'Negative']	['Neutral', 'Negative']
Interim analysis results	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
Enrollment problem	['Insufficient_Enrollment']	['Neutral']
"The principal investigator suspended the study temporarily because of the COVID pandemic. We do
    not want patients to attend their follow-up visits at this time unless absolutely necessary."	['Covid19']	['Neutral']
cancelled before initiation	['Invalid_Reason']	['Invalid_Reason']
New intraocular steroid in the market. Recruitment no longer ethical.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
No funding	['Business_Administrative']	['Possibly_Negative']
"This was a dosing study to determine acceptability. Participants found protocol burdensome and
    so we terminated."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Study terminated due to no apparent benefit.	['Negative']	['Negative']
Finances	['Business_Administrative']	['Possibly_Negative']
initial results suggest no significant trends will be observed with completion of study	['Negative']	['Negative']
Recruitment problems making the study completion unlikely	['Insufficient_Enrollment']	['Neutral']
insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
No need	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Expired study materials; low subject recruitment	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
"Study was pending major changes and was on hold, pending activation; administratively
    withdrawn; will be submitted as a new protocol if study is revised."	['Study_Design']	['Neutral']
Unable to access EMR for patients enrolled prior to 8/2015 for data collection	['Logistics_Resources']	['Neutral']
Low recruitment rate	['Insufficient_Enrollment']	['Neutral']
complete per PI	['Invalid_Reason']	['Invalid_Reason']
loss of interest before enrolment started	['Business_Administrative']	['Possibly_Negative']
Trial has failed to meet primary - and major secondary endpoints	['Negative']	['Negative']
Study no longer has an active IDE	['Covid19', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Please see Detailed Description below for termination reason.	['No_Context']	['Invalid_Reason']
No enrollment.	['Insufficient_Enrollment']	['Neutral']
Lack of Efficacy	['Negative']	['Negative']
Study investigator retired and study not funded	['Business_Administrative']	['Possibly_Negative']
Withdrawal of sponsorship	['Business_Administrative']	['Possibly_Negative']
"Due to study design challenges including DMC enrollment suspension as required by the protocol
    stopping rules and recommended changes to the surgical technique"	['Study_Design']	['Neutral']
Low enrollment, incomplete participant data, and follow-up information	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
PI left institution	['Study_Staff_Moved']	['Neutral']
The study ended early due to budgetary issues	['Business_Administrative']	['Possibly_Negative']
The study stopped after been paused (the patients were switched in the meantime)	['Invalid_Reason']	['Invalid_Reason']
Funding withdrawal and COVID-19 environment.	['Covid19']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
"Difficulty in recruitment. PDCO in the Day 30 summary report agrred to remove the PK study in
    children <1 year of age."	['Insufficient_Enrollment']	['Neutral']
The enrollment in the study was too limited for meaningful data analysis.	['Insufficient_Enrollment']	['Neutral']
study failed to recruit	['Insufficient_Enrollment']	['Neutral']
"The results of a same study design have shown low response with important side effects.
    Accordingly & ethicly, the study has been stopped."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Investigator left institution and no PI has been found to continue the study	['Study_Staff_Moved']	['Neutral']
PI left institution.	['Study_Staff_Moved']	['Neutral']
Difficulties to enroll patients	['Insufficient_Enrollment']	['Neutral']
inadequate number of patients, study completed with normal subjects	['Insufficient_Enrollment']	['Neutral']
Study is not feasible	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Study was terminated due to patient complications unrelated to study drugs	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
lack of accrual	['Insufficient_Enrollment']	['Neutral']
There was insuficient recruitment in two centers	['Insufficient_Enrollment']	['Neutral']
Cancelled due to financial reasons	['Business_Administrative']	['Possibly_Negative']
MTD determined	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Sponsor terminated due to no enrollments within last 4 months.	['Insufficient_Enrollment']	['Neutral']
Business decision to move away from this study	['Business_Administrative']	['Possibly_Negative']
Due to funding	['Business_Administrative']	['Possibly_Negative']
"It was decided to prematurely terminate the GENTLE-UF registry as a parallel study conducted
    with the same device has been prematurely terminated due to low recruitment."	['No_Context', 'Insufficient_Enrollment', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
Difficulty collecting	['Insufficient_Enrollment']	['Neutral']
The study was not activated.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
lack of funding	['Business_Administrative']	['Possibly_Negative']
No funding	['Business_Administrative']	['Possibly_Negative']
transferred study sponsor	['Business_Administrative']	['Possibly_Negative']
The study site was closed down	['Study_Staff_Moved', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
No patients recruited into study.	['Insufficient_Enrollment']	['Neutral']
low enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
Based upon results of interim data analysis	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Expired for lack of continuing review	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
DSMB recommendation to suspend trial due to control device	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Study closed due to low enrollment	['Insufficient_Enrollment']	['Neutral']
Final contract negotiations	['Business_Administrative']	['Possibly_Negative']
Slow accrual; closed by funder	['Insufficient_Enrollment']	['Neutral']
Unable to maintain a functional laser in the environment	['Logistics_Resources']	['Neutral']
termination of the trial after interim analysis. the main criterion could not be reached	['Negative']	['Negative']
Study closed early, because of low enrollment.	['Insufficient_Enrollment']	['Neutral']
"COVID-19: protocol requires a large number (20+) of specifically timed visits. Because a
    mistimed visit would disqualify a participant, we have suspended until travel and data
    collection can be assured."	['Covid19']	['Neutral']
COVID-19	['Covid19']	['Neutral']
"Trial OT left post due to significant personal circumstances. Study team unable to recruit new
    OT to post in time frame available."	['Insufficient_Enrollment']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Logistical reasons	['Logistics_Resources']	['Neutral']
Recruiting/enrolling participants halted prematurely but potentially will resume	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Principal Investigator and sponsor agreed to termination.	['Business_Administrative']	['Possibly_Negative']
"Sponsor decided to stop commercialization of QTERNMet/Qtrilmet and to stop all related ongoing
    activities/studies for business reasons."	['Business_Administrative']	['Possibly_Negative']
PI relocated to new university	['Study_Staff_Moved']	['Neutral']
Lack of Accrual	['Insufficient_Enrollment']	['Neutral']
Decision made to stop study following availability of results from another study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Very slow enrollment	['Insufficient_Enrollment']	['Neutral']
Protocol would not be able to reach stated accrual.	['Insufficient_Enrollment']	['Neutral']
"Phase 1b portion completed. Sponsor decided not to proceed with P2 portion of study.
    Vecabrutinib was very well tolerated, there was insufficient evidence of activity at the doses
    tested in the Phase 1b to advance to Phase 2."	['Negative']	['Negative']
Halted for convenience due to COVID19 challenges.	['Covid19']	['Neutral']
Failure to enroll a suitable number of qualified subjects.	['Insufficient_Enrollment']	['Neutral']
IP Change Hospital	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
"Due to late study start, the possibility to enroll enough subjects dropped below the limit to
    provide scientifically acceptable data, hence study was cancelled."	['Insufficient_Enrollment']	['Neutral']
Terminated due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
Main reason: negative echo in the literature after the first publications.	['Negative']	['Negative']
Budgetary restrictions	['Business_Administrative']	['Possibly_Negative']
Study Terminated - Company decision	['Business_Administrative']	['Possibly_Negative']
Development program of JNJ-4178 was discontinued.	['Business_Administrative']	['Possibly_Negative']
Acquired asset	['Business_Administrative']	['Possibly_Negative']
Project plan changed, study conduct was no longer needed.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Industry support and funding not forthcoming	['Business_Administrative']	['Possibly_Negative']
Incidence of GI Perforation	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
The study was terminated due to a change in sponsor prioritization.	['Business_Administrative']	['Possibly_Negative']
slow recruitment and treatments beyond expiry date	['Insufficient_Enrollment']	['Neutral']
PI relocated	['Study_Staff_Moved']	['Neutral']
Study stopping criteria has been reached	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Recruitment failure	['Insufficient_Enrollment']	['Neutral']
Limitted financial resources	['Business_Administrative']	['Possibly_Negative']
COVID-19 restrictions on research at University	['Covid19']	['Neutral']
Inadequate Recruitment	['Insufficient_Enrollment']	['Neutral']
"Issues with recruitment and enrollment made the trial impossible or highly impracticable.
    Termination of this trial was not due to safety reasons."	['Insufficient_Enrollment']	['Neutral']
Study was terminated due to poor enrollment.	['Insufficient_Enrollment']	['Neutral']
Closed due to internal and external factors.	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Failure to recruit.	['Insufficient_Enrollment']	['Neutral']
technical and funding issues	['Business_Administrative']	['Possibly_Negative']
Most study procedures incorporated into NCT01144741, some in NCT01306994	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Study suspended as a precautionary measure, due to COVID-19, as the outbreak poses an increased
    risk to participants, due to potential exposure to the virus through attendance for study
    visits."	['Covid19']	['Neutral']
Closed due to achievement of primary study endpoint	['Negative']	['Negative']
investigator	['Study_Staff_Moved']	['Neutral']
A cluster of adverse events in everolimus arm was noted.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Funding for study is currently unavailable.	['Business_Administrative']	['Possibly_Negative']
Difficulty recruiting due to parent declining feeding strategy	['Insufficient_Enrollment']	['Neutral']
Study was terminated by sponsor without any AEs to review the device design.	['Interim_Analysis', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
The study was terminated by the sponser due to low study enrollment.	['Insufficient_Enrollment']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
"For business reason unrelated to safety or tolerability,Tonix has discontinued the Fibromyalgia
    development with TNX102 SL."	['Business_Administrative']	['Possibly_Negative']
COVID-19 Pandemic	['Covid19']	['Neutral']
ENT surgery stopped at the recruiting hospital	['Invalid_Reason']	['Invalid_Reason']
Study was halted prematurely for futility after an intermediate analysis	['Negative']	['Negative']
Business Decision; No Safety Or Efficacy Concerns	['Business_Administrative']	['Possibly_Negative']
Investigaotr no longer at LU.	['Logistics_Resources', 'Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
subject accrual and data analysis is completed.	['Invalid_Reason']	['Invalid_Reason']
"Change in clinical practice allowing chronic therapy at 6 weeks of age, incompatible with
    possibility of placebo beyond 6 weeks of age on study protocol"	['Study_Design']	['Neutral']
Problems to recruit the needed number of patients in the planned time	['Insufficient_Enrollment']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
The study was terminated early due to a business decision and not for safety reasons.	['Business_Administrative']	['Possibly_Negative']
Business decision	['Business_Administrative']	['Possibly_Negative']
"interim review of the data indicated that the hypothesis put forth on the efficacy of a 3 day
    regimen was not met."	['Negative']	['Negative']
"The study was terminated for business planning purposes. Assessments of APOCIIIRx in this
    population will be explored in a larger efficacy study"	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Insufficient recruitment to complete study	['Insufficient_Enrollment']	['Neutral']
The study was not meeting recruitment goals.	['Insufficient_Enrollment']	['Neutral']
Trial was stopped early for futility	['Negative']	['Negative']
Not yet IRB approved and PI will be leaving institution in September.	['Study_Staff_Moved']	['Neutral']
Another treatment found efficacious	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Lack of budget	['Business_Administrative']	['Possibly_Negative']
Business Decision; Terminated due to futility, with no safety concerns (see below)	['Business_Administrative']	['Possibly_Negative']
Funding issue	['Business_Administrative']	['Possibly_Negative']
Study Funding Terminated	['Business_Administrative']	['Possibly_Negative']
"Due to the significantly lower than expected accrual it was impossible to evaluate the endpoint
    in a timely fashion."	['Insufficient_Enrollment']	['Neutral']
Sub-Investigator reloacted to another institution	['Study_Staff_Moved']	['Neutral']
Study was terminated because of poor enrollment.	['Insufficient_Enrollment']	['Neutral']
Institution converted to an alternative strategy for pain control	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Lack of efficacy	['Negative']	['Negative']
Difficulties in recrutment	['Insufficient_Enrollment']	['Neutral']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Enzon Pharmaceuticals decided to end its development of EZN-3042.	['Business_Administrative']	['Possibly_Negative']
Insufficient Resources	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The study was terminated because of slower than anticipated enrollment	['Insufficient_Enrollment']	['Neutral']
difficulties in recruiting patients	['Insufficient_Enrollment']	['Neutral']
We have finally no financial support and any patients have been included.	['Business_Administrative']	['Possibly_Negative']
competent authority decision	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Difficulty with enrollment	['Insufficient_Enrollment']	['Neutral']
Terminated due to slow accrual, PI left NIH and primary endpoint not met.	['Insufficient_Enrollment']	['Neutral']
The study was stopped prematurely due to insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
The trial was terminated due to slow accrual	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Recruitment concerns	['Insufficient_Enrollment']	['Neutral']
Primary care physicians began prescribing antacid therapy for chronic cough	['Logistics_Resources', 'Endpoint_Met', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Technique failed	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
slow recruitment (only 8 patients recruited and treated until 12/2012)	['Insufficient_Enrollment']	['Neutral']
Lack of efficacy	['Negative']	['Negative']
"Most patients completed only the primary objective (PET) and not went throught the secondary
    outcome (efficacy phase) of 8wks period."	['Negative']	['Negative']
Company decision	['Business_Administrative']	['Possibly_Negative']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
intermediary analysis was performed and significant results were found for the main objective	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Interim analysis showed no added value of second look endoscopy	['Negative']	['Negative']
Enrollment problems	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Stop recommended following the last sequential analysis	['Negative']	['Negative']
"Due to lack of funding and issues with ability to complete all procedures, it was decided that
    this study could not be carried out and therefore withdrawn."	['Business_Administrative']	['Possibly_Negative']
inclusion speed	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Closed due to poor accrual.	['Insufficient_Enrollment']	['Neutral']
Some capsules used in this study were been found to be cracked and leaking.	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
For scientific, logistic, and administrative reasons.	['Business_Administrative']	['Possibly_Negative']
Study terminated owing to challenges posed by the COVID-19 situation.	['Covid19']	['Neutral']
Resident graduated; faculty mentor retired	['Study_Staff_Moved']	['Neutral']
Problems with samples handling	['Logistics_Resources']	['Neutral']
The investigator left the research center and the study was not carried out	['Study_Staff_Moved']	['Neutral']
Based on futility analysis, study would not meet primary endpoint.	['Negative']	['Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
poor accrual	['Insufficient_Enrollment']	['Neutral']
"Project Never Initiated - no human subjects were enrolled and no data regarding humans was
    collected or studied"	['Invalid_Reason']	['Invalid_Reason']
Poor enrollment.	['Insufficient_Enrollment']	['Neutral']
GCP issues.	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Inadequate enrollment and lack of funds.	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study was terminated due to sponsor portfolio decision.	['Business_Administrative']	['Possibly_Negative']
Terminated due to lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Due to potential competition with a post-marketing study requested by FDA	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
problem of accrual	['Insufficient_Enrollment']	['Neutral']
Inability to recruit additional subjects.	['Insufficient_Enrollment']	['Neutral']
Reformulation	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Company decision not related to safety.	['Business_Administrative']	['Possibly_Negative']
Decision by Sponsor	['Business_Administrative']	['Possibly_Negative']
"The maximal dose and schedule attained with GSK2816126 has shown insufficient evidence of
    clinical activity, and does not justify further clinical investigation"	['Negative']	['Negative']
Due to poor accrual	['Insufficient_Enrollment']	['Neutral']
No advantage seen during continued animal studies. Difficult recruitment.	['Negative']	['Negative']
Study was terminated due to animal toxicity data	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
recruitment difficulties, high postoperative drop-out rate	['Insufficient_Enrollment']	['Neutral']
Funding Goals changed	['Business_Administrative']	['Possibly_Negative']
Lack of subject enrollment	['Insufficient_Enrollment']	['Neutral']
Study closed prior to enrolling patients	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Low accrual, small patient population at center.	['Insufficient_Enrollment']	['Neutral']
Alternative data published	['Negative', 'Another_Study']	['Negative', 'Neutral']
Was not financed, Sponsor withdrawn	['Business_Administrative']	['Possibly_Negative']
"The study was terminated after approximately 3 years due to future clinical development plans,
    including ethical considerations."	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Slow accrual was the reason for study termination.	['Insufficient_Enrollment']	['Neutral']
the investigator left the institution	['Study_Staff_Moved']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor withdrawing the subject IND	['Business_Administrative']	['Possibly_Negative']
Participant enrollment is much delayed. The whole design needs to be revised.	['Study_Design']	['Neutral']
Inclusion speed too slow, no longer relevant and takeover	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Seven years of follow-up & final analysis done in Dec 2012.	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
low recruitment rate	['Insufficient_Enrollment']	['Neutral']
Internal protocol review	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
company decision	['Business_Administrative']	['Possibly_Negative']
"Study was withdrawn because of a problem with the software used for generating the aftercare
    summary."	['Logistics_Resources']	['Neutral']
company dissolved	['Business_Administrative']	['Possibly_Negative']
Site investigator decided to not move forward with study.	['Study_Staff_Moved', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
unable to recruit	['Insufficient_Enrollment']	['Neutral']
Inability to enrole subjucts.	['Insufficient_Enrollment']	['Neutral']
Temporary lack of funding	['Business_Administrative']	['Possibly_Negative']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Poor recruitment	['Insufficient_Enrollment']	['Neutral']
Change in Belgian law on the use of hMG in IUI	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Terminated early due to slow accrual as Phase I dose escalation study.	['Insufficient_Enrollment']	['Neutral']
Business decision of the sponsor	['Business_Administrative']	['Possibly_Negative']
Business Reasons	['Business_Administrative']	['Possibly_Negative']
Covid19	['Covid19']	['Neutral']
Lack of accrual and low efficacy	['Insufficient_Enrollment']	['Neutral']
The study was terminated for logistic reasons not related to safety or efficacy of the vaccine.	['Logistics_Resources']	['Neutral']
Evaluating potential amendments to the study	['Study_Design']	['Neutral']
Sponsor's decision	['Business_Administrative']	['Possibly_Negative']
drug development plan has been updated	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The PI discontinued the evaluation study.	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Covid pandemia. Is one temporal decision.	['Covid19']	['Neutral']
no longer interest / resources to start study	['Business_Administrative']	['Possibly_Negative']
insufficient funding	['Business_Administrative']	['Possibly_Negative']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
PI leaving VICC, low future accrual predicted, continued funding improbable,	['Business_Administrative']	['Possibly_Negative']
unsuccessful recruitment	['Insufficient_Enrollment']	['Neutral']
Administratively closed by the IRB	['Regulatory', 'Ethical_Reason', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Due to insufficient interest in the study and enrollment has been closed	['Insufficient_Enrollment']	['Neutral']
Due to safety-relevant aspects with regard to internal processes of the sponsor	['Logistics_Resources', 'Ethical_Reason', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor decision to terminate study.	['Business_Administrative']	['Possibly_Negative']
low recruitment	['Insufficient_Enrollment']	['Neutral']
Commercial considerations relating to required device modifications.	['Business_Administrative']	['Possibly_Negative']
"New prepositioned protocol being developed to optimize its use in the disaster setting and
    broaden its reach."	['Study_Design']	['Neutral']
Couldn't accrue patients	['Insufficient_Enrollment']	['Neutral']
"Institution changed surgical method to small-incision lenticule extraction. Study never
    started."	['Study_Design']	['Neutral']
"The study was terminated following an internal review of the company's research and development
    portfolio"	['Business_Administrative']	['Possibly_Negative']
Lack of efficacy	['Negative']	['Negative']
Recruitment rate is unexpectedly too low (insufficient number of eligible patients).	['Insufficient_Enrollment']	['Neutral']
Withdrawn by PI	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
The study was terminated due to poor enrollment.	['Insufficient_Enrollment']	['Neutral']
Lack of Patient Enrollment	['Insufficient_Enrollment']	['Neutral']
Due to lack of activity and slow accrual	['Insufficient_Enrollment']	['Neutral']
Unable to enroll participants. Sponsor requested study closure.	['Insufficient_Enrollment']	['Neutral']
No subjects enrolled	['Insufficient_Enrollment']	['Neutral']
Combination formulation concerns	['Logistics_Resources', 'Endpoint_Met', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Poor recruitment.	['Insufficient_Enrollment']	['Neutral']
Not enough subjects to reach accrual goals.	['Insufficient_Enrollment']	['Neutral']
No enrollment	['Insufficient_Enrollment']	['Neutral']
"Co-investigator left the university and another co-investigator died several years ago, making
    it impossible to complete the study as planned."	['Study_Staff_Moved']	['Neutral']
the preliminary analysis of study result did not show significant benefit that was anticipate	['Negative']	['Negative']
sufficient data collected for significant conclusive results	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Failed to accrue	['Insufficient_Enrollment']	['Neutral']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
Trial cancelled	['Invalid_Reason']	['Invalid_Reason']
"We have decided to withdraw the study prior to enrollment of the first participant in order to
    pursue other research studies."	['Invalid_Reason']	['Invalid_Reason']
lack of patient intube more than 5 days	['Insufficient_Enrollment']	['Neutral']
no enrollment	['Insufficient_Enrollment']	['Neutral']
Study terminated per Ongoing Care Solutions, Inc.	['Business_Administrative']	['Possibly_Negative']
Study discontinued.	['Invalid_Reason']	['Invalid_Reason']
Recruitment problems	['Insufficient_Enrollment']	['Neutral']
IND moved to sponsor.	['Business_Administrative']	['Possibly_Negative']
COVID-19 Pandemic	['Covid19']	['Neutral']
Inability to attain sufficient numbers of subjects	['Insufficient_Enrollment']	['Neutral']
The speed of recruitment was slower than anticipated.	['Insufficient_Enrollment']	['Neutral']
No participants recrui	['Insufficient_Enrollment']	['Neutral']
Unable to recruit patients	['Insufficient_Enrollment']	['Neutral']
Study is terminated as per Sponsor's Decision.	['Business_Administrative']	['Possibly_Negative']
Celgene unable to continue funds.	['Business_Administrative']	['Possibly_Negative']
No patients enrolled.	['Insufficient_Enrollment']	['Neutral']
national study, local site not responsible for results/analysis	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
The study was terminated prematurely because of difficulty with recruiting.	['Insufficient_Enrollment']	['Neutral']
Insufficient Accrual	['Insufficient_Enrollment']	['Neutral']
Funding period expired before reaching recruitment goal.	['Business_Administrative']	['Possibly_Negative']
"The study was terminated after a pre-planned futility analyses showed an insufficient level of
    efficacy in the study population to warrant continuation."	['Negative']	['Negative']
Human resource change in Research investigators and Seoul Fire Department	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
PI left Institution	['Study_Staff_Moved']	['Neutral']
Due to overall benefit/risk profile	['Safety_Sideeffects', 'Endpoint_Met', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
incomplete data	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
"The required number of endpoints will be obtained with a sample size lower than initially
    planned."	['Insufficient_Enrollment']	['Neutral']
Recruiting difficulties	['Insufficient_Enrollment']	['Neutral']
The remaining eligible participants declined to participate.	['Insufficient_Enrollment']	['Neutral']
Suspended due to cessation of funding	['Business_Administrative']	['Possibly_Negative']
IRB violations	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Stopped early due to low enrollment	['Insufficient_Enrollment']	['Neutral']
"The principal investigator withdrew from the study. The study was withdrawn because a qualified
    replacement was not available."	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
"This study was unable to overcome IT and contracting barriers which prevented the study's data
    collection system from being implemented."	['Logistics_Resources']	['Neutral']
Closed after complete treatment of 32 patients after 21 months' recruitment.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"Following an SAE, study was put on hold. After performing preclinical follow-up studies,
    volunteers were no longer available for continuation."	['Insufficient_Enrollment']	['Neutral']
"The study is on hold due to stopping of the Autism Spectrum Disorder program with balovatpan,
    the study drug."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
Need to obtain IND approval.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study was stopped due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
An analysis demonstrated that running the final participants was unnecessary.	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
study temporarily paused due to an Amendment request	['Study_Design']	['Neutral']
Not able to get enough participants	['Insufficient_Enrollment']	['Neutral']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Sponsor withdrew support	['Business_Administrative']	['Possibly_Negative']
Poor recruitment.	['Insufficient_Enrollment']	['Neutral']
IRB study closure by investigator due to low enrollment	['Insufficient_Enrollment']	['Neutral']
IP received FDA clearance for use in PAE as treatment for BPH.	['No_Context', 'Regulatory', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
closure due to failure to recruit any patients that met study criteria	['Insufficient_Enrollment']	['Neutral']
We terminated the study after enrolling 580/900 patients due to a slow accrual	['Insufficient_Enrollment']	['Neutral']
Trial was stopped early due to low enrollment	['Insufficient_Enrollment']	['Neutral']
Nonapplicable clinical trial	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
The current rate of recruitment is insufficient.	['Insufficient_Enrollment']	['Neutral']
Study was not feasible.	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Logistics	['Logistics_Resources']	['Neutral']
Pandemic caused by Coronavirus.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
The overall profile does not support development for obesity	['Negative']	['Negative']
Study was terminated as per sponsor's decision	['Business_Administrative']	['Possibly_Negative']
COVID-19 pandemic	['Covid19']	['Neutral']
Failure to accrue	['Insufficient_Enrollment']	['Neutral']
The study was terminated due to low recruitment	['Insufficient_Enrollment']	['Neutral']
"This study was halted as the preliminary analysis revealed that the numbers were too low to
    warrant continuing the project"	['Insufficient_Enrollment']	['Neutral']
The study sponsor canceled the study.	['Business_Administrative']	['Possibly_Negative']
Study closed following Phase I portion, insufficient activity to continue to Phase II.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"Prohibitively expensive and efficacy of tranexamic acid rendered topic clinically less
    relevant."	['Logistics_Resources']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
low enrollment	['Insufficient_Enrollment']	['Neutral']
slow recruitment: stopped early	['Insufficient_Enrollment']	['Neutral']
". The trial would be continued if there was a difference of 3 % between trial arms. However,
    the difference between ongoing pregnancy rates was <1 %"	['Negative']	['Negative']
Due to poor accrual	['Insufficient_Enrollment']	['Neutral']
It is on hold given changes planned for the protocol.	['Study_Design']	['Neutral']
New PI discovered that some of previously collected data may not be accurate	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
study entered twice, please see protocol 0120110047	['Negative', 'Another_Study']	['Negative', 'Neutral']
Closed by CHUM REB for lack of documentation related to the recruitment of participants.	['Business_Administrative']	['Possibly_Negative']
Terminated early due to change in practice.	['Study_Design']	['Neutral']
Due to very low enrollment rate the study was terminated.	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
"Data from the CALAVI Phase II trials for Acalabrutinib in patients hospitalized with COVID-19
    did not meet their primary efficacy endpoints.

    Based on this higher management made the decision to prematurely terminate the D822FC00005 PK
    study."	['Covid19']	['Neutral']
Study concept was not approved by NCI. Study was never activated. No enrollment	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Interim analysis showed no difference between either arm of the intervention.	['Negative']	['Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Study was never opened due to lack of funding	['Business_Administrative']	['Possibly_Negative']
Administrative reason by Sponsor.	['Business_Administrative']	['Possibly_Negative']
Change of practice made further recruitment impossible	['Study_Design']	['Neutral']
Lack of study funding & resources	['Business_Administrative']	['Possibly_Negative']
Performing Interim Analysis	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
no accrual, PI left institution	['Insufficient_Enrollment']	['Neutral']
Lead acquisition from company & COVID-19 restrictions	['Covid19']	['Neutral']
This study was suspended because that few participants was enrolled.	['Insufficient_Enrollment']	['Neutral']
Difficult patient recruitment	['Insufficient_Enrollment']	['Neutral']
Researcher changed jobs. Unable to carry out the project	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
unexpected low willingness of patient to participate on the study	['Insufficient_Enrollment']	['Neutral']
"The FDA did not accept the sponsor's additional animal toxicology data to support the proposed
    dosing in this protocol."	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Covid19 pandemic prevented continuation of study visits	['Covid19']	['Neutral']
The study terminated due to low enrollment.	['Insufficient_Enrollment']	['Neutral']
"The study was terminated because of Early Treatment Failure in child.The justification for this
    decision are concerns about safety of children."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Study terminated due to change in sponsorship	['Business_Administrative']	['Possibly_Negative']
Interim results of another trial showed inferior activity of treatment	['Negative', 'Another_Study']	['Negative', 'Neutral']
Study is withdrawn before recruitment begun.	['Invalid_Reason']	['Invalid_Reason']
The Sponsor decided to halt the development of GDC-0810, but not due to any safety concerns.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Difficulty with recruitment.	['Insufficient_Enrollment']	['Neutral']
Closed due to poor accrual and lack of feasibility to finish study per DSMB	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor decision to withdraw study to pursue others.	['Business_Administrative']	['Possibly_Negative']
Lack of funding to recruit target sample size	['Business_Administrative']	['Possibly_Negative']
Study will not be initiated as planned.	['Invalid_Reason']	['Invalid_Reason']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
PI failed to submit study for continuing review by IRB	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The study drugs are not covered anymore by insurance.	['Logistics_Resources']	['Neutral']
expected accrual not reached	['Insufficient_Enrollment']	['Neutral']
Strategic business decision (not related to safety or efficacy concerns)	['Business_Administrative']	['Possibly_Negative']
"Interim analysis results revealed substantial increase of patient number, with unfeasible study
    prolongation."	['Insufficient_Enrollment']	['Neutral']
Unable to abstract pulmonary function and some other data from medical records.	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Masked independent interim analysis: completion of the trial was unlikely.	['Negative']	['Negative']
Insecticidal treatment of school uniforms did not last through a dengue season	['Logistics_Resources']	['Neutral']
Limited staff available for enrollment and limited availability of drug	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Investigators left the institution for unrelated reasons	['Study_Staff_Moved']	['Neutral']
No patient enrolled	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Financial sponsor difficulties	['Business_Administrative']	['Possibly_Negative']
PI and main Co-I (Dr Edwards) relocated locations	['Study_Staff_Moved']	['Neutral']
Study ending due to lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
"Interim analysis suggested that size of benefit anticipated from continued participation of
    patients in Part B no longer supported trial extension beyond Part A"	['Negative', 'Another_Study']	['Negative', 'Neutral']
unable to find patients meeting inclusion/exclusion criteria	['Insufficient_Enrollment']	['Neutral']
Trial terminated - Nanoscale Company out of business	['Business_Administrative']	['Possibly_Negative']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
problems with including patients and a large multicenter Trial is now starting as follow-up	['Negative', 'Another_Study']	['Negative', 'Neutral']
Low accrual.	['Insufficient_Enrollment']	['Neutral']
"The study was terminated early due to slow enrollment and limited numbers of viable tissue
    samples."	['Insufficient_Enrollment']	['Neutral']
COVID-19 general concerns	['Covid19']	['Neutral']
Poor recruitment rate.	['Insufficient_Enrollment']	['Neutral']
Due to inability to get support for the study	['Business_Administrative']	['Possibly_Negative']
"This study was stopped after Part 1 completed and was terminated because the predefined
    criteria of efficacy was not reached ( >50% better then placebo)"	['Negative']	['Negative']
Research staff decision	['Business_Administrative']	['Possibly_Negative']
Unable to continue research due to time constraints	['Business_Administrative']	['Possibly_Negative']
Closed due to very slow accrual	['Insufficient_Enrollment']	['Neutral']
The study has been terminated because of operational reasons.	['Business_Administrative']	['Possibly_Negative']
"Staff constraints made it impossibile to enroll consecutive patients, making the sample not
    representative of the true cancer population"	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Unable to enroll sufficient number of subjects	['Insufficient_Enrollment']	['Neutral']
Recruitment under target, Finding	['Insufficient_Enrollment']	['Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
"The study has shown futility and the objectives could not be reached without enrolling a very
    large number of subjects."	['Negative']	['Negative']
Unable to recruit sufficient numbers of patients.	['Insufficient_Enrollment']	['Neutral']
slow enrollment, outcome measures collected but actual enrollment is below target enrollment	['Insufficient_Enrollment']	['Neutral']
lost funding, limited eligibility due to pre-existing vitamin D supplementation	['Business_Administrative']	['Possibly_Negative']
unresolved budget issues	['Business_Administrative']	['Possibly_Negative']
The study was stopped due to time constraints and resources	['Business_Administrative']	['Possibly_Negative']
Slow recruitment.	['Insufficient_Enrollment']	['Neutral']
Product development project closed prematurely	['Business_Administrative']	['Possibly_Negative']
Original subject recruitment goal was unrealistic. Study was terminated at N=19.	['Insufficient_Enrollment']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
"The funding withdrawal and early termination of the trial is based upon lack of suitable
    recruitment figures in order to reach the required trial endpoints."	['Business_Administrative']	['Possibly_Negative']
Ketamine shortage during the funding period of the trial	['Business_Administrative']	['Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
PI left university	['Study_Staff_Moved']	['Neutral']
It wasn't possible to recruit the desired number of patients.	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
The study was not started and prematurely closed.	['Invalid_Reason']	['Invalid_Reason']
seeking funding	['Business_Administrative']	['Possibly_Negative']
UPenn suspended production of the ligand necessary to produce the tracer TRODAT.	['Interim_Analysis', 'Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor decision based on portfolio prioritization	['Business_Administrative']	['Possibly_Negative']
The study was discontinued following product approval.	['No_Context', 'Regulatory', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
Change to study required.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
critical low recruitment rate	['Insufficient_Enrollment']	['Neutral']
Study never started	['Invalid_Reason']	['Invalid_Reason']
"This low-interventional study (involving no study drug) has been terminated early due to the
    COVID-19 pandemic, and not for any safety or efficacy reasons."	['Covid19']	['Neutral']
"Because the conditional power was 0.083, the Data and Safety Monitoring Board recommended
    halting the study due to futility after the 1st interim analysis."	['Negative']	['Negative']
We were unable to get additional funding to complete study.	['Business_Administrative']	['Possibly_Negative']
funding not available	['Business_Administrative']	['Possibly_Negative']
Sponsor withdrew due to funding issues	['Business_Administrative']	['Possibly_Negative']
PI has left institution	['Study_Staff_Moved']	['Neutral']
Loss of funding	['Business_Administrative']	['Possibly_Negative']
Study was not a good fit for the patient population seen at this hospital.	['Insufficient_Enrollment']	['Neutral']
The researcher quit the study	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
The study funding was dropped with no patients enrolled	['Business_Administrative']	['Possibly_Negative']
Study was terminated due to company decision after Part A. Part B was never conducted	['Business_Administrative']	['Possibly_Negative']
failure to recruit 83/99	['Insufficient_Enrollment']	['Neutral']
I withdrew from this study	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
IRB lapsed, currently in process of re-submitting	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
due to COVID-19	['Covid19']	['Neutral']
Unable to accrue patients at a reasonable rate	['Insufficient_Enrollment']	['Neutral']
Economic and business reasons	['Business_Administrative']	['Possibly_Negative']
No patients enrolled in study	['Insufficient_Enrollment']	['Neutral']
The trial was permanently halted due to futility concerns.	['Negative']	['Negative']
Unable to recruit to enrollment target	['Insufficient_Enrollment']	['Neutral']
The results of the interim analysis showed significant results.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Temporarily paused due to COVID-19 and expected to resume.	['Covid19']	['Neutral']
Preliminary data suggested a better approach available	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Primary investigator moved to different university	['Study_Staff_Moved']	['Neutral']
unable to enroll	['Insufficient_Enrollment']	['Neutral']
"Closed based on the lack of perceived clinical activity observed from a different study
    treating a similar patient population with same study agent."	['Negative', 'Another_Study']	['Negative', 'Neutral']
The Sponsor stopped the study due to a change in study plans	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
unable to recruit patients due to competing studies	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Change in research plan.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Interim analysis indicated study should be terminated	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Sponsor decided not to initiate the study for alternate commercial strategy	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Not enough staff	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Terminated due to sponsor decision	['Business_Administrative']	['Possibly_Negative']
terminated due to failure to enroll patients after two years of approval	['Insufficient_Enrollment']	['Neutral']
The study activities are on hold due to COVID	['Covid19']	['Neutral']
The study was cancelled due to budget limitations	['Business_Administrative']	['Possibly_Negative']
Data analysis	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Iterim analysis did not detect a clinically meaningful change in the primary endpoint	['Negative']	['Negative']
Sponsor business decision, not based on safety or efficacy data	['Business_Administrative']	['Possibly_Negative']
"The study was terminated early due to slow recruitment and inability to recruit patients during
    the Covid-19 situation."	['Covid19']	['Neutral']
Emerging evidence made the trial unnecessary.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Stopped due to COVID-19 pandemic	['Covid19']	['Neutral']
Study was not initiated	['Invalid_Reason']	['Invalid_Reason']
Slow Accruals	['Insufficient_Enrollment']	['Neutral']
Insufficient funding	['Business_Administrative']	['Possibly_Negative']
PI Retired study unfunded	['Logistics_Resources', 'Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Lack of Funding	['Business_Administrative']	['Possibly_Negative']
Research stopped after lab-based data using mouse model did not support use of technology.	['Negative']	['Negative']
Lack of participants	['Insufficient_Enrollment']	['Neutral']
Study recruitment temporarily suspended due to COVID-19 pandemic.	['Covid19']	['Neutral']
IRB protocol violations	['Regulatory', 'Ethical_Reason', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Slow recruitment and sufficient data available to analyse	['Insufficient_Enrollment']	['Neutral']
data collection sufficient	['Invalid_Reason']	['Invalid_Reason']
Low recruitment due to change in standard of care	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Inability to recruit participants	['Insufficient_Enrollment']	['Neutral']
"Due to new respiratory quality control initiative introduced in the NICU, recruitment for the
    study was stopped."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
See Detailed Description for Termination Reason	['No_Context']	['Invalid_Reason']
The study is stopped due to very modest activity compared to competitors	['Negative']	['Negative']
Slow patient accrual and plans to perform multi-center study	['Insufficient_Enrollment']	['Neutral']
Company decision	['Business_Administrative']	['Possibly_Negative']
"Enrollment and interventions are temporarily paused due to COVID-19 and are expected to resume
    in the future.This is not a suspension of IRB approval."	['Covid19']	['Neutral']
We had a change in staffing that precluded pursing this project	['Logistics_Resources']	['Neutral']
Could not enroll enough patients.	['Insufficient_Enrollment']	['Neutral']
"The study was halted prematurely due to low enrollment and anticipation of future barriers to
    enrollment."	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description	['No_Context']	['Invalid_Reason']
lack of cooperation and compliance	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Logistical problems	['Logistics_Resources']	['Neutral']
Recommendation of the Data Safety Monitoring Committee	['Negative']	['Negative']
Insufficient Accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor never funded study.	['Business_Administrative']	['Possibly_Negative']
"We recruited 25 of the 40 participants from intended study population. Recruitment in new
    populations requires an METC amendment."	['Study_Design']	['Neutral']
Sponsor's decision	['Business_Administrative']	['Possibly_Negative']
Study was terminated due to PI leaving the institution	['Study_Staff_Moved']	['Neutral']
Inadequate enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsor Withdrew	['Business_Administrative']	['Possibly_Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Extreme toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
numbers recruited to show adequate association but not primary outcome	['Negative']	['Negative']
Study transferring to another facility	['Study_Staff_Moved']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Previous studies have been done regarding same condition	['Negative', 'Another_Study']	['Negative', 'Neutral']
Administrative closure	['Business_Administrative']	['Possibly_Negative']
"Study team has decided to close enrollment, and all subjects are being rolled into a different
    clinical trial: Total Cancer Care"	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
No funding source	['Business_Administrative']	['Possibly_Negative']
Terminated due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
study never started	['Invalid_Reason']	['Invalid_Reason']
The cessation of the development project for neladenoson bialanate.	['Business_Administrative']	['Possibly_Negative']
Computers/hardware for data collection/storage are outdated and unserviceable.	['Logistics_Resources']	['Neutral']
Day is not required for Anticipated dates.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Study stopped d/t lack of enrollment and no compelling data.	['Success', 'No_Context', 'Logistics_Resources']	['Success', 'Invalid_Reason', 'Neutral']
"Inability to enroll due to the widespread use of both classes of drugs in patients with T2DM,
    including those on concomitant insulin therapy."	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
lack of efficacy	['Negative']	['Negative']
COVID-19	['Covid19']	['Neutral']
"Flavoprotein fluorescence machine for the trial is not working so the trial was terminated. No
    study data was collected prior to termination."	['Logistics_Resources']	['Neutral']
Amendment to study compound development programme	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Related to COVID-19, we are continuing data analysis at this time	['Covid19']	['Neutral']
Other - Protocol moved to Disapproved	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"The results did not demonstrate sufficient clinical benefit induced specifically by the active
    treatment to justify continuation of the trial."	['Negative']	['Negative']
Slow recruitment and lack of efficacy despite the completion of several dose steps.	['Negative']	['Negative']
low accrual rate	['Insufficient_Enrollment']	['Neutral']
Business decision, not safety related	['Business_Administrative']	['Possibly_Negative']
Difficulty in recruiting, many patients with exclusion criteria	['Insufficient_Enrollment']	['Neutral']
"The study recruitment was terminated based on strategic considerations after 8 patients were
    enrolled."	['Business_Administrative']	['Possibly_Negative']
sponsor has decide to pospone this study	['Business_Administrative']	['Possibly_Negative']
Study discontinued - testing of highest dose obsolete	['Study_Design']	['Neutral']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Infeasibility to continue study.	['Safety_Sideeffects', 'Logistics_Resources', 'Regulatory']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Unable to find eligible subjects- study closed	['Insufficient_Enrollment']	['Neutral']
Preliminary analysis	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
Please Detailed Description for termination reason.	['No_Context']	['Invalid_Reason']
Lack of adequate funding	['Business_Administrative']	['Possibly_Negative']
Sponsor's decision to terminate the study after Phase 1; will not proceed with Phase 2.	['Business_Administrative']	['Possibly_Negative']
"The COVID-19 pandemic in China has ended completely. As a result, patient recruiting is
    impossible in China."	['Covid19']	['Neutral']
Terminated	['Invalid_Reason']	['Invalid_Reason']
Low rate of enrollment	['Insufficient_Enrollment']	['Neutral']
Limited scanner availability	['Logistics_Resources']	['Neutral']
Poor study patient recruitment	['Insufficient_Enrollment']	['Neutral']
"Enrollment stopped prior to reaching expected number of patients, study had accumulated
    sufficient data to allow a registration study in PTCL (PXD101-CLN-19)"	['Success', 'Insufficient_Enrollment', 'Invalid_Reason']	['Success', 'Neutral', 'Invalid_Reason']
"The termination was result of GSK business considerations and not due to quality, safety or
    efficacy concerns with any albiglutide formulations or study conduct"	['Business_Administrative']	['Possibly_Negative']
Limited enrollment	['Insufficient_Enrollment']	['Neutral']
Because of the difficulty of research operation, we changed to another research design.	['Study_Design']	['Neutral']
For slow accrual	['Insufficient_Enrollment']	['Neutral']
Slow Recruitment of eligible patients	['Insufficient_Enrollment']	['Neutral']
insufficient inclusion rate	['Insufficient_Enrollment']	['Neutral']
The Sponsor changed R&D strategy and priority.	['Business_Administrative']	['Possibly_Negative']
Study has been terminated for inadequate results	['Negative', 'Another_Study']	['Negative', 'Neutral']
No participants found	['Insufficient_Enrollment']	['Neutral']
Never IRB approved, no intention to proceed with the study	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
The sponsor did not provide the equipment needed to do study.	['Logistics_Resources']	['Neutral']
Difficult recruitment and end of funding.	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
barriers to accrual: delay until surgery and additional pre-operative visits	['Insufficient_Enrollment']	['Neutral']
data analysis showed insufficient drug efficacy	['Negative']	['Negative']
Terminated due to low accrual.	['Insufficient_Enrollment']	['Neutral']
"The intervention could not be successfully carried out in the SADP setting because of issues
    independent of the cognitive training intervention."	['Study_Design']	['Neutral']
Investigator transferred to the University of Wisconsin - Madison	['Study_Staff_Moved']	['Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
No participant enrolled	['Insufficient_Enrollment']	['Neutral']
The study was terminated for lack of efficacy after an interim analysis was performed	['Negative']	['Negative']
"This study has been terminated. (Interim analysis of preliminary results indicated the need for
    protocol re-design)."	['Study_Design']	['Neutral']
Business Decision; no human safety concern; evaluating preclinical toxicology finding	['Business_Administrative']	['Possibly_Negative']
Lack of recruitment of subjects.	['Insufficient_Enrollment']	['Neutral']
High flow oxygen therapy became available as standard care	['Study_Design']	['Neutral']
One of the intravenous lipid emulsions was retired from the market	['Logistics_Resources']	['Neutral']
PI left Stanford	['Study_Staff_Moved']	['Neutral']
Difficulty with recruitment and agreed with Sponsor to report completed data as case reports	['Insufficient_Enrollment']	['Neutral']
Sample too small in retrospective chart review to conduct analysis	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Closed by IRB	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"The study was terminated early on July 8, 2016 due to business priorities regarding study
    execution."	['Business_Administrative']	['Possibly_Negative']
Study was never initiated due to lack of funding support.	['Business_Administrative']	['Possibly_Negative']
Trial was closed due to poor accrual.	['Insufficient_Enrollment']	['Neutral']
lack of sufficient population for recruitment	['Insufficient_Enrollment']	['Neutral']
New data does not support a role of vitamin E in LCHAD associated neuropathy.	['Negative']	['Negative']
Due to lack of funding and necessary personnel we determined that the study could not be done.	['Business_Administrative']	['Possibly_Negative']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
patient's recruitment too difficult	['Insufficient_Enrollment']	['Neutral']
was not possible to measure LBP levels because we cannot found the kit	['Logistics_Resources']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
PI has requested for this study be closed due to technical issues	['Logistics_Resources']	['Neutral']
Negative data from another trial led to termination of this trial by sponsor.	['Negative', 'Another_Study']	['Negative', 'Neutral']
lack of subject enrollment	['Insufficient_Enrollment']	['Neutral']
This study was terminated early due to slow enrollment.	['Insufficient_Enrollment']	['Neutral']
implementation issues	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
Slow Accrual.	['Insufficient_Enrollment']	['Neutral']
"Time table was unfulfilled due to incompetent research coordinator. Inaccurate results and No
    conclusions can be withdrawn"	['Logistics_Resources', 'Study_Staff_Moved', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Closed due to prolonged enrollment timelines	['Insufficient_Enrollment']	['Neutral']
Due to lack of financial support	['Business_Administrative']	['Possibly_Negative']
no patient recruitment	['Insufficient_Enrollment']	['Neutral']
Lack of efficacy based on the interim analysis in the 17972A study	['Negative', 'Another_Study']	['Negative', 'Neutral']
To enable development of an enhanced version of the vaccine.	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
"Terminated: recruiting or enrolling participants has halted and will not resume because low
    protein diet is not feasible nor efficious."	['Negative']	['Negative']
Lead Investigator no longer at Institution	['Study_Staff_Moved']	['Neutral']
Terminated due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
Business Decision	['Business_Administrative']	['Possibly_Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
No financial support	['Business_Administrative']	['Possibly_Negative']
Inability to meet protocol objectives	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Study Withdrawn	['Invalid_Reason']	['Invalid_Reason']
No patient included at target sample sizes	['Insufficient_Enrollment']	['Neutral']
drug-related harm	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Business decision	['Business_Administrative']	['Possibly_Negative']
slow enrollment and lack of continuing funds	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
recruitment temporarily suspended due to COVID-19	['Covid19']	['Neutral']
PI decided to withdraw study	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"The inclusion of proposed sample turned to be infeasible due to Ethical Non-approval of 2
    research sites and another site no transplant activity since 2012."	['Logistics_Resources', 'Regulatory', 'Study_Staff_Moved']	['Neutral', 'Neutral', 'Neutral']
"The company that was contracted to conduct study specific testing was sold and new management
    chose to pursue interests other than CMV."	['Business_Administrative']	['Possibly_Negative']
Low participant enrolment	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Funding ended.	['Business_Administrative']	['Possibly_Negative']
Safety data review	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Enrollment target could not be achieved.	['Insufficient_Enrollment']	['Neutral']
SAE- risk of overall protocol treatment outweighs benefits	['Safety_Sideeffects', 'Negative']	['Safety_Sideeffects', 'Negative']
Insufficient accrual	['Insufficient_Enrollment']	['Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
Recruitment difficulities	['Insufficient_Enrollment']	['Neutral']
"The study upon which this project depended for subjects and the intervention was terminated
    prematurely due to lack of funds."	['Business_Administrative']	['Possibly_Negative']
Staffing and departmental changes at our site made it difficult to enroll subjects.	['Logistics_Resources']	['Neutral']
Study team had difficulties recruiting and enrolling patients into this study.	['Insufficient_Enrollment']	['Neutral']
Funding withdrawn	['Business_Administrative']	['Possibly_Negative']
Recruitment and subject study compliance was difficult	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Sponsor cancelled the development program, and never conducted the study.	['Business_Administrative']	['Possibly_Negative']
Terminated due to nonclinical safety findings	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
HandyLab device did not work for the science	['Logistics_Resources']	['Neutral']
Medtronic support terminated	['Logistics_Resources']	['Neutral']
"prematurely discontinued after results of the EORTC phase-3 study defined the SOC for newly
    diagnosed GMB pts as RT plus concomitant and adjuvant TMZ"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Budgetary	['Business_Administrative']	['Possibly_Negative']
Enrollment goals unable to be reached.	['Insufficient_Enrollment']	['Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
problems with enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsoring company ceased business operations.	['Business_Administrative']	['Possibly_Negative']
Not feasible in inpatient setting	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Business Decision	['Business_Administrative']	['Possibly_Negative']
"The study was discontinued after the first pre-planned interim analysis due to insufficient
    response rates."	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Invalid_Reason']	['Safety_Sideeffects', 'Neutral', 'Invalid_Reason']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
Samus is focusing all of their efforts in myelofibrosis on the new oral formulation of PU-H71.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Study never began.	['Invalid_Reason']	['Invalid_Reason']
study was terminated because study conclusions varied.	['Negative']	['Negative']
"The ASCEND Study did not achieve statistical significance on the primary or secondary
    endpoints."	['Negative']	['Negative']
Study was closed because of slow accrual	['Insufficient_Enrollment']	['Neutral']
There is no longer any funding to support the study	['Business_Administrative']	['Possibly_Negative']
The investigator left the institution so the study was terminated.	['Study_Staff_Moved']	['Neutral']
Poor accrual, change in standard of care.	['Insufficient_Enrollment']	['Neutral']
Sponsor's decision.	['Business_Administrative']	['Possibly_Negative']
Poor enrollment due to insufficient study support.	['Insufficient_Enrollment']	['Neutral']
Sponsor's decision	['Business_Administrative']	['Possibly_Negative']
Funding ceased	['Business_Administrative']	['Possibly_Negative']
This study was never initiated.	['Invalid_Reason']	['Invalid_Reason']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor's decision	['Business_Administrative']	['Possibly_Negative']
missed endpoint of meaningful clinical benefit, compared to prednisolone 2.7mg	['Negative']	['Negative']
This study was stopped due to lack of evidence for clinical efficacy.	['Negative']	['Negative']
Business decision to discontinue development of the IsoPSA assay.	['Business_Administrative']	['Possibly_Negative']
Interim analysis-DSMB stated good safety profile but lack of efficacy	['Negative']	['Negative']
Recommended Phase II dose determined	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Protocol modification	['Study_Design']	['Neutral']
"The study was closed after we determined that this albuterol/NAC regimen may be associated with
    excessive bronchoconstriction."	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Termination due to acquisition of PEAK Surgical by Medtronic	['Business_Administrative']	['Possibly_Negative']
Low accrual rate.	['Insufficient_Enrollment']	['Neutral']
Suspended by sponsor, pending investigation of abnormal laboratory values in patients with NASH	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Incidence of AE	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"Study was prematurely discontinued as it was unethical to continue based on a change in
    ranibizumab (RFB) marketing authorization."	['Regulatory', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Dose limiting tox is observed. Study put on full clinical hold.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Difficulties with subject enrolment.	['Insufficient_Enrollment']	['Neutral']
Halted prematurely	['Invalid_Reason']	['Invalid_Reason']
Sponsor decided to discontinue study drug development.	['Business_Administrative']	['Possibly_Negative']
Withdrawn due to toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
No participant enrolled more than two years. No plan to continue study.	['Insufficient_Enrollment']	['Neutral']
Trial was terminated early due to slow enrollment.	['Insufficient_Enrollment']	['Neutral']
Administratively inactivated by IRB due to no response for Continuing Review	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
As recruitment rate was lower than anticipated	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
It was repeated with other studies in the same department	['Negative', 'Another_Study']	['Negative', 'Neutral']
Slow accrual and anticipated loss of funding	['Insufficient_Enrollment']	['Neutral']
Due to poor accrual	['Insufficient_Enrollment']	['Neutral']
Objectives not met.	['Logistics_Resources', 'Endpoint_Met', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
no participants enrolled	['Insufficient_Enrollment']	['Neutral']
IDMC recommendation	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Low inclusion rate	['Insufficient_Enrollment']	['Neutral']
Due to FDA comments, protocol changed; new trial will be proposed shortly	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Inadequate funds	['Business_Administrative']	['Possibly_Negative']
Study stopped based on the recommendation of the IDMC after a planned Interim Analysis	['Interim_Analysis', 'Regulatory', 'Negative']	['Neutral', 'Neutral', 'Negative']
COVID-19	['Covid19']	['Neutral']
"After 2 patients it was concluded that a large change in exclusion criteria and study design
    was needed to obtain the ojective for the study"	['Study_Design']	['Neutral']
PI withdrew study	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Unable to recruit sufficient number of patients	['Insufficient_Enrollment']	['Neutral']
"researchers did not find participants to meet the inclusion and exclusion criteria for the
    testing protocols"	['Insufficient_Enrollment']	['Neutral']
No participants recruited	['Insufficient_Enrollment']	['Neutral']
The Imiquimod 3.75% was ineffective	['Negative']	['Negative']
poor accrual	['Insufficient_Enrollment']	['Neutral']
Terminated early for poor study design.	['Study_Design']	['Neutral']
Could not reach recruitment goal	['Insufficient_Enrollment']	['Neutral']
None enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"Company stopped making product for cosmetic use. All consented subjects withdrew before any
    study interventions were performed."	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
The local authorities did not authorize the use of biofreeze in Chile.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
"A separate study (similar subjects) identified transfusion-associated microchimerism only
    rarely, making this observational study impractical to conduct."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Changes in funding decision	['Business_Administrative']	['Possibly_Negative']
No need for a pilot study. New study will be opened.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"Primary endpoint (HSP) could not be analyzed with the specified method in the planned interim
    analysis; a method of increased sensitivity had to be established."	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
"inability to promptly see local allergists as part of medical maximization which lead to delays
    in care for these patients"	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Ethics Committee concerns.	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Only 1 inclusion in 2,5 years	['Insufficient_Enrollment']	['Neutral']
this pilot project is no longer funded	['Business_Administrative']	['Possibly_Negative']
Funding	['Business_Administrative']	['Possibly_Negative']
Advisor left the university and student moved to a clinical track	['Study_Staff_Moved']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Dr. Sigal no longer with NYUMC	['Study_Staff_Moved']	['Neutral']
This study was stopped because of difficulties of supplying the drug.	['Logistics_Resources']	['Neutral']
"This is not a human subject's study. Protocol registered in error. This protocol studied
    nursing homes as a unit."	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
"The study was stopped because there was a technical problem with the ultrasound used in the
    trial."	['Logistics_Resources']	['Neutral']
Sponsor made a business decision to discontinue the study due to low accrual.	['Insufficient_Enrollment']	['Neutral']
Researcher left	['Study_Staff_Moved']	['Neutral']
Investigational device not available anymore.	['Logistics_Resources']	['Neutral']
Terminated due to PI leaving institution	['Study_Staff_Moved']	['Neutral']
Pending funding	['Business_Administrative']	['Possibly_Negative']
The study was terminated early by the Sponsor for business reasons.	['Business_Administrative']	['Possibly_Negative']
"Drug related AEs observed upon repeat dosing that with longer treatment duration could become
    worse. Required action on some biomarkers not observed."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Recruitment failed due to lack of subjects meeting the eligibility criteria	['Insufficient_Enrollment']	['Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
Study has been stopped by sponsor decision.	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Failure to recruit enough subjects	['Insufficient_Enrollment']	['Neutral']
Failed primary endpoint	['Negative']	['Negative']
COVID-19	['Covid19']	['Neutral']
"Study assessments for patients recruited continuing per protocol so patients receive a minimum
    of 6 months follow up. No safety concerns have been raised."	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Unable to recruit patients in a timely fashion and unable to recruit sufficient patients	['Insufficient_Enrollment']	['Neutral']
Lack of efficacy	['Negative']	['Negative']
The trial was ended prematurely due to low recruitment/enrolment.	['Insufficient_Enrollment']	['Neutral']
Lack of funding.	['Business_Administrative']	['Possibly_Negative']
End of funding	['Business_Administrative']	['Possibly_Negative']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
due to low accrual rate	['Insufficient_Enrollment']	['Neutral']
"The study was terminated due to lack of efficacy of single agent LBH589 in the 4 month open
    label core phase and due to enrollment difficulties."	['Negative']	['Negative']
Internal data analysis	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
toxicities required dose reduction compromising effectiveness and PI left Moffitt	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
"struggled to recruit and the synovial tissue samples obtained were so poor that we had to end
    the study prematurely without data from the primary outcomes"	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
difficulties acquiring the drug and funding for the drug	['Business_Administrative']	['Possibly_Negative']
Loss of participants to follow-up	['Insufficient_Enrollment']	['Neutral']
"Prematurely stopped, as no beneficial effect was evident for bilateral stimulation after
    interim analysis of the first 20 patients."	['Negative']	['Negative']
Cases of hepatotoxicity under investigation	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Study is withdrawn and no one enrolled due to changes in personnel	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Study was terminated due to increased PVR in one subject from T0-T1 reaching the level of a
    predetermined stopping rule"	['Negative']	['Negative']
"Enrollment did not reach our intended sample size due to availability of CTR with MANOS outside
    of the study."	['Insufficient_Enrollment']	['Neutral']
"it was decided that due to lack of accrual on the trial, and low potential for accruing over
    the near future, the trial will be shut down."	['Insufficient_Enrollment']	['Neutral']
Study was never opened	['Invalid_Reason']	['Invalid_Reason']
Low recruitment, lack of efficacy and increased adverse events in investigational arm.	['Insufficient_Enrollment', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Lack of participants that fit inclusion criteria	['Insufficient_Enrollment']	['Neutral']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Difficult to recruit due to protocol requirements - participant burden.	['Insufficient_Enrollment']	['Neutral']
Pre-Clinical Toxicology Findings	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
COVID-19	['Covid19']	['Neutral']
Covid-19	['Covid19']	['Neutral']
internal organizational problem and dysfunction of study material	['Business_Administrative']	['Possibly_Negative']
FDA did not provide approval of the use of the drug for the study	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study not being pursued	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Enrollment and study activities are temporarily suspended due to COVID-19.	['Covid19']	['Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Due to several intracranial hemorrhages and recommendation by the PBTC DSMB.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
"Merck Sharp & Dohme Corp (MSD) received exemption from PFDA on conduct of post-marketing
    surveillance (PMS) study"	['Business_Administrative']	['Possibly_Negative']
Lack of funds	['Business_Administrative']	['Possibly_Negative']
Principal Investigator is leaving the UMDNJ	['Study_Staff_Moved']	['Neutral']
PI left UNMC	['Study_Staff_Moved']	['Neutral']
No patients enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Other - Randomized data no longer support continuation	['Negative']	['Negative']
Advice from DSMB	['Interim_Analysis', 'Regulatory', 'Negative']	['Neutral', 'Neutral', 'Negative']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Study cancelled prior to start due to change in company priorities.	['Business_Administrative']	['Possibly_Negative']
Trial closure for NCI NCTN Transition	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Decision made by Sponsor	['Business_Administrative']	['Possibly_Negative']
slow recruitment, lack of funding and PI transferred	['Business_Administrative']	['Possibly_Negative']
"few eligible patients, dialysate drainage problem, measurement bias : not all currently
    marketed laboratory instruments are able to dose peritoneal dialysate"	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Terminated by the local IRB	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
enrollment goals not met	['Insufficient_Enrollment']	['Neutral']
withdrawn	['Invalid_Reason']	['Invalid_Reason']
"Unique provision in the American Recovery and Reinvestment Act prevented approval of second
    year no-cost-extension in which completion of analyses were planned."	['Regulatory', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Study not funded	['Business_Administrative']	['Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
"stopped due to limited enrollment. 2 subjects were enrolled. There was NO enrollment after
    November 2007."	['Insufficient_Enrollment']	['Neutral']
Recruitment was below expectation	['Insufficient_Enrollment']	['Neutral']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Enrollment goal not met in allotted recruitment period	['Insufficient_Enrollment']	['Neutral']
Funding	['Business_Administrative']	['Possibly_Negative']
Temporarily suspended due to Pandemic	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Recruitment for other joints is suspended until analysis is complete for the hip participants.	['Interim_Analysis', 'Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral', 'Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
terminated	['Invalid_Reason']	['Invalid_Reason']
Study cancelled: Withdrawn before enrollment of any participants	['Invalid_Reason']	['Invalid_Reason']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
low accrual	['Insufficient_Enrollment']	['Neutral']
PI, Dr. Josh Gaston, left the institution and the study has been stopped.	['Study_Staff_Moved']	['Neutral']
We have decided not to pursue the study	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
The study was stopped prematurely due to lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Lack of Participants	['Insufficient_Enrollment']	['Neutral']
Insufficient resources.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study closed because of new overlapping study with ribavirin.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Risk-benefit ratio	['Negative']	['Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Too challenging to recruit appropriate participants at an acceptable speed.	['Insufficient_Enrollment']	['Neutral']
The estimated number of patients could not be recorded in this study	['Insufficient_Enrollment']	['Neutral']
"An alternative joint industry effort will provide information on combination versus single
    agent therapy for treatment of aspergillosis"	['Negative', 'Another_Study']	['Negative', 'Neutral']
We are closing the study because of lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
Other - Protocol moved to Withdrawn	['Study_Design']	['Neutral']
This study was prematurely terminated due to low enrollment	['Insufficient_Enrollment']	['Neutral']
We did not have sufficient funds to conduct the study.	['Business_Administrative']	['Possibly_Negative']
Lack of Funds	['Business_Administrative']	['Possibly_Negative']
Did not obtain funding to proceed with study	['Business_Administrative']	['Possibly_Negative']
"An interim analysis, planned because of the influence of the COVID-lockdown, showed the LCM
    mouthwash did not affect the incidence of Ng, Ct and syphilis."	['Covid19']	['Neutral']
Terminated early due to futility	['Negative']	['Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Discontinued prematurely due to low enrollment	['Insufficient_Enrollment']	['Neutral']
PI lapsed institutional training	['Logistics_Resources', 'Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
grant funding ended and lack of sufficient participants to complete trial	['Business_Administrative']	['Possibly_Negative']
insufficient for the fund	['Business_Administrative']	['Possibly_Negative']
Unfavourable Risk-Benefit-Ratio	['Negative']	['Negative']
Extensive changes to the watch design would be needed to produce a robust device.	['Study_Design']	['Neutral']
decision to stop the study because of enrollment difficulties.	['Insufficient_Enrollment']	['Neutral']
Insufficient funds to complete study.	['Business_Administrative']	['Possibly_Negative']
"A decision was made to not move forward with the study. No participants were enrolled or
    treated."	['Invalid_Reason']	['Invalid_Reason']
We failed to recruit patients	['Insufficient_Enrollment']	['Neutral']
Trial not initiated	['Invalid_Reason']	['Invalid_Reason']
Sponsor decision based on portfolio prioritization	['Business_Administrative']	['Possibly_Negative']
"primary efficacy analysis at Week 24 did not demonstrate non-inferiority of raltegravir versus
    lopinavir (+) ritonavir"	['Negative']	['Negative']
Revision to over all corporate strategy	['Business_Administrative']	['Possibly_Negative']
Logistical problems meant that the study was no longer feasible.	['Logistics_Resources']	['Neutral']
Temporarily suspended due to Pandemic	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
PI on an extended leave of absence.	['Study_Staff_Moved']	['Neutral']
Unavailable to recruit patients.	['Insufficient_Enrollment']	['Neutral']
Record created in error - not a research study	['No_Context', 'Logistics_Resources', 'Endpoint_Met']	['Invalid_Reason', 'Neutral', 'Neutral']
Due to restricted and new rules for data protection, the use of an app could not be approved	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
End of inclusion period	['Invalid_Reason']	['Invalid_Reason']
Protocol being re-written to allow inclusion of more patients	['Study_Design']	['Neutral']
Unable to meet accrual goals.	['Insufficient_Enrollment']	['Neutral']
Investigator moved locations.	['Study_Staff_Moved']	['Neutral']
Apellis concluded that sufficient data were collected to meet the study objectives.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Stopped due to low enrollment	['Insufficient_Enrollment']	['Neutral']
Substance was withdrawn from further development.	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
"The CARE Network DSMB recommended to the NHLBI that the MARS trial be terminated, based on a
    futility analysis with 55 randomized children."	['Negative']	['Negative']
Adequate subjects numbers not enrolled in study timeframe.	['Insufficient_Enrollment']	['Neutral']
Not a Clinical trial. Retrospective Data review only.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
"The study was terminated as the Prinicipal Investigator left the site- all previous subjects
    enrolled are deceased"	['Study_Staff_Moved']	['Neutral']
Funding not secured	['Business_Administrative']	['Possibly_Negative']
Sponsor decision to not initiate the trial	['Business_Administrative']	['Possibly_Negative']
Poor Accrual	['Insufficient_Enrollment']	['Neutral']
Study terminated for business reasons	['Business_Administrative']	['Possibly_Negative']
not able to be completed	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
No participants were enrolled. Therefore, we stop this study, prematurely.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
PI left University no data available	['Study_Staff_Moved']	['Neutral']
Due to surgeons' unwillingness to randomize patients into different treatments	['Insufficient_Enrollment']	['Neutral']
Low patient enrollment is the primary reason	['Insufficient_Enrollment']	['Neutral']
Study catheter manufacturing issues. Poor enrollment.	['Insufficient_Enrollment']	['Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
Parent trial (ProTECT III) stopped for futility	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
Study was terminated early as per sponsor decision due to unexpectedly slow enrollment.	['Insufficient_Enrollment']	['Neutral']
Inability to enroll subjects.	['Insufficient_Enrollment']	['Neutral']
Unable to obtain QP release certification from the manufacturer (VSL3) for shipment of IMP	['Interim_Analysis', 'Regulatory', 'Negative']	['Neutral', 'Neutral', 'Negative']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
Extreme Toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Study was terminated due to inability to recruit patients.	['Insufficient_Enrollment']	['Neutral']
Investigator decision to close study	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
"This study was terminated before any participants were enrolled due to unforseen problems with
    participant enrollment and study design."	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Due to issues with the study, we did not proceed with enrolling participants in the trial.	['Insufficient_Enrollment']	['Neutral']
Because patient enrollment is so difficult.	['Insufficient_Enrollment']	['Neutral']
"Investigator did not start the project in time; study team decided it was not feasible to begin
    study as resident was soon graduating. No patients enrolled."	['Insufficient_Enrollment']	['Neutral']
Due to slow recruitment and a delay in reaching the recruitment target.	['Insufficient_Enrollment']	['Neutral']
Study was stopped due to lack of funding	['Business_Administrative']	['Possibly_Negative']
Objective of study achieved after interim analysis.	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Study was stopped due to slow accrual of patients.	['Insufficient_Enrollment']	['Neutral']
"Study was put on clinical hold on 30 Jan 2013 following a subject fatality. Study was never
    restarted and was closed."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Negative interim analysis	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Re-eval of patient population	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
difficulties in the department	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
Departure of the PhD in charge of the study	['Study_Staff_Moved']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
This study never started, no funding.	['Business_Administrative']	['Possibly_Negative']
Phase I was conducted Australia. Phase II not conducted and no US pts enrolled.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
This study is a retrospective chart review study, not a clinical trial.	['Success', 'No_Context', 'Insufficient_Data']	['Success', 'Invalid_Reason', 'Neutral']
Principle Investigator was not able to proceed with the study	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Due to low accrual	['Insufficient_Enrollment']	['Neutral']
investigateur decision	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Terminated due to unfavorable human pharmacokinetic properties	['Negative']	['Negative']
"Few patients would like to participate ,since CIK cell transfusion was a new treatment and its
    efficacy was doubted."	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Sponsor withdrew funding	['Business_Administrative']	['Possibly_Negative']
The study was terminated due to lack of efficacy in Cohorts 1 and 2.	['Negative']	['Negative']
UNABLE TO PROCEED WITH STUDY DUE TO STAFFING OF COLLABORATIVE INVESTIGATORS	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
PI left the NIH	['Study_Staff_Moved']	['Neutral']
Study terminated due to slow acrual	['Insufficient_Enrollment']	['Neutral']
Covid-19	['Covid19']	['Neutral']
This was an exploratory open-label study and has met its initial objectives	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Doesn't meet NIH clinical trial definition.	['Interim_Analysis', 'Regulatory', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Not enough inclusions	['Insufficient_Enrollment']	['Neutral']
recruiting/enrolling participants has halted prematurely but potentially will resume Oct	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Due to inability to meet accrual goals within the funding period	['Insufficient_Enrollment']	['Neutral']
Others	['Covid19', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Decision by sponsor, development stopped.	['Business_Administrative']	['Possibly_Negative']
Safety reasons	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Difficulty in with enrollment of patient	['Insufficient_Enrollment']	['Neutral']
New study planned.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Met protocol defined stopping rule for futility	['Negative']	['Negative']
patients do not want to participate	['Insufficient_Enrollment']	['Neutral']
PI has left institution	['Study_Staff_Moved']	['Neutral']
"This study was terminated early as a result of regulatory action suspending tegaserod use in
    2007"	['Regulatory']	['Neutral']
withdrawn by industry	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
"Following extensive efforts to increase recruitment, it will not be possible to complete the
    study protocol within a reasonable time"	['Insufficient_Enrollment']	['Neutral']
Funding period completed.	['Business_Administrative']	['Possibly_Negative']
unavailability of the investigator due to an overloaded planning	['Logistics_Resources']	['Neutral']
Funding withdrawn	['Business_Administrative']	['Possibly_Negative']
Refusal of CPP to extend the period of inclusion	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
due to COVID-19 outbreak	['Covid19']	['Neutral']
funding loss, no data was ever collected	['Business_Administrative']	['Possibly_Negative']
Unsatisfactory filter deployment in several cases	['Logistics_Resources']	['Neutral']
Funding Withdrawn	['Business_Administrative']	['Possibly_Negative']
funding was withdrawn	['Business_Administrative']	['Possibly_Negative']
withdrawn before IRB approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Sponsor's decision to not pursue uPLi for vascular conditions including DVT.	['Business_Administrative']	['Possibly_Negative']
No patients were enrolled.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Pilot results in change to protocol, new study needed.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
The laser is currently being worked on	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
sponsor terminated study	['Business_Administrative']	['Possibly_Negative']
Subjects on drug were more likely to have severe pain crises requiring hospitalization.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Not stated by Pharmaceutical Company	['Business_Administrative']	['Possibly_Negative']
Contract negotiations were terminated and study never started.	['Business_Administrative']	['Possibly_Negative']
no funding	['Business_Administrative']	['Possibly_Negative']
The PI left the university	['Study_Staff_Moved']	['Neutral']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
Accrual Goal Met	['Invalid_Reason']	['Invalid_Reason']
Study not activated.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
not funded	['Business_Administrative']	['Possibly_Negative']
During interim analysis, it appeared there were no difference in groups	['Negative']	['Negative']
Difficulty enrolling participants due to exclusion and inclusion criteria	['Insufficient_Enrollment']	['Neutral']
"Stopped by the DSMB due to a trend toward more adverse events in the higher hemoglobin (Hb) arm
    and <5% chance that the study would show benefit for higher Hb."	['Safety_Sideeffects', 'Negative']	['Safety_Sideeffects', 'Negative']
funding ended due to recruitment delays	['Business_Administrative']	['Possibly_Negative']
"Institutional ORE decision to stop community based research in response to COVID emergency and
    need to socially distance"	['Covid19']	['Neutral']
Unable to enroll subjects by sponsor deadline	['Insufficient_Enrollment']	['Neutral']
PI is no longer at institution	['Study_Staff_Moved']	['Neutral']
Due to lack of feasibility of enrolling participants, the study was terminated early.	['Insufficient_Enrollment']	['Neutral']
Slow enrollment and lack of funds.	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Departure of the PhD in charge of the study	['Study_Staff_Moved']	['Neutral']
"B1411001 was terminated after completion of 4 cohorts of the multiple ascending dose phase, as
    additional data were deemed unnecessary. No safety concerns."	['Success', 'No_Context', 'Logistics_Resources']	['Success', 'Invalid_Reason', 'Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
"Study terminated in line with Biogen decision to withdraw Zinbryta from the market and not to
    pursue further studies of daclizumab in MS."	['Business_Administrative']	['Possibly_Negative']
Difficulties of recruitment in a randomization arm	['Insufficient_Enrollment']	['Neutral']
"This study was terminated early by the sponsor on the recommendation of an independent data
    safety monitoring board following review of unblinded data from the Phase 3 studies
    E2609-G000-301 (NCT02956486) and E2609-G000-302 (NCT03036280)."	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Study was never initiated due to company decision. No study subjects were ever enrolled or
    dosed."	['Business_Administrative']	['Possibly_Negative']
Job change of responsible investigators	['Study_Staff_Moved']	['Neutral']
Funding and proposal withdrawn	['Business_Administrative']	['Possibly_Negative']
The study was withdrawn after 18 months due to lack of recruitment.	['Insufficient_Enrollment']	['Neutral']
Only 5 subjects could be enrolled. Sample of 25 pat. not be achieved (rare disease).	['Insufficient_Enrollment']	['Neutral']
Difficulties in recruiting	['Insufficient_Enrollment']	['Neutral']
Change in business need.	['Business_Administrative']	['Possibly_Negative']
patient recruitment	['Insufficient_Enrollment']	['Neutral']
"As the study progressed, the intervention became more of a standard of care, thus the study has
    stalled and been aborted."	['Study_Design']	['Neutral']
Protocol amended to NCT01549366 and participants rolled into study	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Investigator left institution	['Study_Staff_Moved']	['Neutral']
Trial closed due to additional safety information.	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
"After the investigators and experts in the field imput it became apparent that the protocol was
    not reflective of clinical reality. No safety issues reported."	['Study_Design']	['Neutral']
We had low accrual and given PORTEC3 results, the study is no longer valid.	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Study data collection was terminated due to COVID-19 pandemic and will not resume.	['Covid19']	['Neutral']
Study cancelled.	['Invalid_Reason']	['Invalid_Reason']
Lack of efficacy / adverse events	['Negative']	['Negative']
Insufficient patient material	['Logistics_Resources']	['Neutral']
Patient Safety Concerns	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Recruitment rates too low	['Insufficient_Enrollment']	['Neutral']
Only one patient included as per Feb. 4, 2008.	['Insufficient_Enrollment']	['Neutral']
"Following an interim analysis the study team felt that there was enough data that showed no
    significant difference."	['Negative']	['Negative']
"Study was a pilot and after recruitment started it was determined to not be feasible. Therefore
    study protocol will be reviewed to adjust for changes."	['Study_Design']	['Neutral']
The trial was terminated at the request of the Data and Safety Monitoring Board.	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Enrollment did not progress as anticipated	['Insufficient_Enrollment']	['Neutral']
recruiting centers do not have the patient potential	['Insufficient_Enrollment']	['Neutral']
Difficult enrollment	['Insufficient_Enrollment']	['Neutral']
Inadequate recruitment	['Insufficient_Enrollment']	['Neutral']
the observed event rate is lower than expected by the protocol hypothesis.	['Negative']	['Negative']
Local IRB recommended IND exemption from FDA, study timeline not able to be met.	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Unable to obtain adequate recruitment	['Insufficient_Enrollment']	['Neutral']
low accrual rate	['Insufficient_Enrollment']	['Neutral']
Stopped due to published data regarding THK-5351 non-specificity in Tau imaging	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
sponsor decided to discontinue development of the study drug.	['Business_Administrative']	['Possibly_Negative']
Please see Detailed Description for termination reason.	['No_Context']	['Invalid_Reason']
Study not initiated	['Invalid_Reason']	['Invalid_Reason']
Enrollment terminated pending additional Phase 1 data	['Negative', 'Another_Study']	['Negative', 'Neutral']
For administrative reasons, we started a new study	['Business_Administrative']	['Possibly_Negative']
Technical issues impeded recruitment.	['Logistics_Resources']	['Neutral']
the data collected are enough to obtain a qualitative analysis.	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Difficulties in recruiting appropriate participants to the study	['Insufficient_Enrollment']	['Neutral']
sponsor internal decision	['Business_Administrative']	['Possibly_Negative']
Change in procedure.	['Study_Design']	['Neutral']
Because the inclusion rate was lower than expected.	['Insufficient_Enrollment']	['Neutral']
Could not recruit any participants	['Insufficient_Enrollment']	['Neutral']
Study has been terminated due low recruitment of participant population.	['Insufficient_Enrollment']	['Neutral']
Insufficient Enrollment	['Insufficient_Enrollment']	['Neutral']
"The study was terminated prematurely when the decision was made that ocrelizumab was not likely
    to benefit this patient population."	['Negative']	['Negative']
No enrollment. Unable to recruit due to lack of eligible patients.	['Insufficient_Enrollment']	['Neutral']
Business reasons	['Business_Administrative']	['Possibly_Negative']
Key investigator resigned	['Study_Staff_Moved']	['Neutral']
Primary objective reached	['Interim_Analysis', 'Success', 'Endpoint_Met']	['Neutral', 'Success', 'Neutral']
Investigator Resigned	['Study_Staff_Moved']	['Neutral']
Change in clinical strategy	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Member of staff moved on to training post. Trial halted and terminated	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Inadequate enrollment	['Insufficient_Enrollment']	['Neutral']
Incomplete effect	['Negative']	['Negative']
Study did not get funded. Study never started	['Business_Administrative']	['Possibly_Negative']
No funds to complete study as anticipated, preliminary data used for future grant	['Business_Administrative']	['Possibly_Negative']
Statistical interim analysis showed valid and significant results	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
No funding from the sponsor	['Business_Administrative']	['Possibly_Negative']
Because of safety issues/support concerning the multispecies probiotic mixture	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
"Proposed doses were too large, bolus oxytocin may cause cases of arrythmias, and some even
    advocate slowing down the infusion rates that are currently used."	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Standard clinical practice at site caused unforeseen issues for the use of the ACM	['Study_Design']	['Neutral']
never started	['Invalid_Reason']	['Invalid_Reason']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
The study was terminated due to subject recruitment problems.	['Insufficient_Enrollment']	['Neutral']
Recruitment not being met	['Insufficient_Enrollment']	['Neutral']
"The COVID-19 pandemic impacted study methods. Therefore, the study team opted not to conduct
    this study as written. The study never started and no participants were enrolled."	['Covid19']	['Neutral']
IRB application expired.	['Business_Administrative']	['Possibly_Negative']
insufficient patient recruiting	['Insufficient_Enrollment']	['Neutral']
Primary Investigator is no longer employeed by the VA	['Study_Staff_Moved']	['Neutral']
Difficulties in recruiting patients	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Study was administratively withdrawn by the IRB; no subjects were enrolled	['Insufficient_Enrollment', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
"Our study stopped before it could begin because of the Covid-19 pandemic. We revised the study
    so that it could be performed virtually, but the revised study isn't a clinical trial."	['Covid19']	['Neutral']
negative study outcome from Complexa's multicenter clinical trial; no safety concerns	['Negative', 'Another_Study']	['Negative', 'Neutral']
Funding expired due to grant for new project (NCT03851302)	['Business_Administrative']	['Possibly_Negative']
Lack of dedicated resources at this time.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
(suspension)	['Interim_Analysis', 'Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
low enrollment	['Insufficient_Enrollment']	['Neutral']
Ran out of time/ funding	['Business_Administrative']	['Possibly_Negative']
Achieving site readiness and enrolling the trial within a reasonable time	['Insufficient_Enrollment']	['Neutral']
Major structural and organizational changes at the NICU	['Business_Administrative']	['Possibly_Negative']
Low Enrollment	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
There were no subjects ever enrolled. Study was closed at the IRB.	['Invalid_Reason']	['Invalid_Reason']
The study is suspended because of the COVID-19 pandemic	['Covid19']	['Neutral']
DSMB recommendation of stopping the trial after reviewing the interim data	['Negative']	['Negative']
"It was not possible to perform 2 MRI studies in each patient due to practical problems. The
    study was not suspended due to safety issues."	['Logistics_Resources']	['Neutral']
"The Independent Data Monitoring Committee (IDMC) concluded that the probability that the study
    will meet its primary objective is low."	['Negative']	['Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor decision to temporarily suspend enrollment while the program is reassessed.	['Business_Administrative']	['Possibly_Negative']
Anticipated non-feasibility of recruitment objectives	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
no funding	['Business_Administrative']	['Possibly_Negative']
Investigator left institution	['Study_Staff_Moved']	['Neutral']
Unable to find participants who met inclusion/exclusion criteria	['Insufficient_Enrollment']	['Neutral']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
withdrawn due to internal reasons	['Study_Staff_Moved', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
The tests have been completed	['Invalid_Reason']	['Invalid_Reason']
Business decision	['Business_Administrative']	['Possibly_Negative']
Study no longer met business objectives	['Business_Administrative']	['Possibly_Negative']
Low accrual and PI left the institution	['Insufficient_Enrollment']	['Neutral']
Lack of patients with a condition of interest that resulted in failure to recruit	['Insufficient_Enrollment']	['Neutral']
insufficient enrollment rate	['Insufficient_Enrollment']	['Neutral']
PI left the institution and was no funding to continue study.	['Business_Administrative']	['Possibly_Negative']
No accrual	['Insufficient_Enrollment']	['Neutral']
low enrollment	['Insufficient_Enrollment']	['Neutral']
"Study stopped due to non-approval of IEC to proposed change in locations. Study discontinuation
    not due to safety/efficacy reasons related to the vaccine."	['Regulatory', 'Insufficient_Enrollment', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
The study was stopped due to poor enrollment.	['Insufficient_Enrollment']	['Neutral']
Business decision (no safety or efficacy concerns)	['Business_Administrative']	['Possibly_Negative']
Funding for staff no longer available	['Business_Administrative']	['Possibly_Negative']
recruiting subjects did not start.	['Insufficient_Enrollment']	['Neutral']
Enrollment taking longer than expected.	['Insufficient_Enrollment']	['Neutral']
"Following a pre-scheduled interim analysis performed by the DMC, it was determined that the
    study met the pre-specified criteria for futility."	['Negative']	['Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Difficulties with recruitment.	['Insufficient_Enrollment']	['Neutral']
Unlikely to recruit the adequate number of patients within a reasonable timeline	['Insufficient_Enrollment']	['Neutral']
Due to Corona Virus guidelines, we have decided to withdraw the study.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
no personnel available to enroll in study- decision made to not complete	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
No enrollment	['Insufficient_Enrollment']	['Neutral']
Business decision due to slow enrollment	['Business_Administrative']	['Possibly_Negative']
Study TLK199.2108 was terminated for business reasons.	['Business_Administrative']	['Possibly_Negative']
no particpants enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
sufficient participants for analysis	['Invalid_Reason']	['Invalid_Reason']
PI left the institution	['Study_Staff_Moved']	['Neutral']
Study never initiated	['Invalid_Reason']	['Invalid_Reason']
Placebo was better than active drug.	['Negative']	['Negative']
STUDY WAS NOT STARTED	['Invalid_Reason']	['Invalid_Reason']
Recruitment was too slow and data collected would not add to already published studies.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Investigator Decision - Insufficient Accrual	['Insufficient_Enrollment']	['Neutral']
funding issues	['Business_Administrative']	['Possibly_Negative']
no change in primary endpoint at week 48	['Negative']	['Negative']
Business decision. No patients were enrolled	['Business_Administrative']	['Possibly_Negative']
Sponsor met enroll. need for planned second study before meeting enroll. ceiling in protocol	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Terminated due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
Slow accrual and company withdrawing support to supply the drug	['Insufficient_Enrollment']	['Neutral']
No funding obtained to support patient recruitment	['Business_Administrative']	['Possibly_Negative']
Slow, insufficient accrual.	['Insufficient_Enrollment']	['Neutral']
low recruitment with registration denosumab	['Insufficient_Enrollment']	['Neutral']
Recruitment and follow up concerns during Covid-19 pandemic	['Covid19']	['Neutral']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
Enough data for a publication, decision of Sponsor-PI	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
"Based on the data collected, the combination of bevacizumab and sunitinib appeared to be poorly
    tolerated."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
at request of funding group because of failure to enroll more than one patient	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Ethics application has not been completed yet	['Business_Administrative']	['Possibly_Negative']
Sponsor voluntarily terminated study	['Business_Administrative']	['Possibly_Negative']
Lack of funding/support	['Business_Administrative']	['Possibly_Negative']
"There was no enrolment of participants.Unscheduled Clinical Study Closure - Eisai Network
    Company Decision, November 12, 2020."	['Business_Administrative']	['Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Due to other phase 3 trial failure to meet primary endpoint	['Negative', 'Another_Study']	['Negative', 'Neutral']
Logistic reasons associated with the FDA-imposed clinical hold.	['Logistics_Resources']	['Neutral']
The study was prematurely discontinued since study medication was no longer available.	['Logistics_Resources']	['Neutral']
Not enough patients recruited	['Insufficient_Enrollment']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Drug unavailable	['Logistics_Resources']	['Neutral']
"Enrollment and other trial activities have temporarily paused due to COVID-19 and are expected
    to resume in the future; This is not a suspension of IRB approval"	['Covid19']	['Neutral']
study no longer required in current format	['Study_Design']	['Neutral']
two key faculty members are no longer part of the study and institution	['Study_Staff_Moved']	['Neutral']
Due to uveitis specialist leaving our University	['Study_Staff_Moved']	['Neutral']
"The sponsor permanently suspended new enrollment into the trial and discontinued the study;
    which was not related to any concerns over product safety."	['Regulatory', 'Insufficient_Enrollment', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Treatment ineffective	['Negative']	['Negative']
No suitable patients could be recruited in the available time period	['Insufficient_Enrollment']	['Neutral']
Lack of efficacy of the drug; no safety concern	['Negative']	['Negative']
"On 25April2014, study was terminated before any dosing due to an AE of safety concern that
    occurred in protocol B1731003 with the same drug."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
patients did not want to participate	['Insufficient_Enrollment']	['Neutral']
The enrollment was not achieved within proposed timeframe.	['Insufficient_Enrollment']	['Neutral']
We must delay the study for some financial reasons	['Business_Administrative']	['Possibly_Negative']
reprioritization of company activities	['Business_Administrative']	['Possibly_Negative']
Evidence that HCQ ineffective, loss of HCW interest,	['Negative']	['Negative']
"1.) Not possible to recruit the planned number of patients during the planned study period; 2.)
    ""Dexamethason"" was included in the standard of care for the study population during the course
    of the study and inclusion criteria could no longer be met."	['Insufficient_Enrollment']	['Neutral']
GI Intolerability	['Safety_Sideeffects', 'Endpoint_Met', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
COVID-19	['Covid19']	['Neutral']
Funding support for the study was terminated	['Business_Administrative']	['Possibly_Negative']
Slow recruitment rate	['Insufficient_Enrollment']	['Neutral']
"Significant challenges recruiting a difficult patient population with most surgeries occurring
    out of hours"	['Insufficient_Enrollment']	['Neutral']
"Because GSK concluded that it was impossible to recruit sufficient participants within a
    reasonable timeframe."	['Insufficient_Enrollment']	['Neutral']
Delays caused by Covid-19	['Covid19']	['Neutral']
IRB temporarily suspended study due to COVID-19	['Covid19']	['Neutral']
"The protocol was terminated early (prior to complete enrollment) after interim analysis proved
    data to be statistically insignificant"	['Negative']	['Negative']
Study terminated due to insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Poor enrollment; PI left the institution	['Insufficient_Enrollment']	['Neutral']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
slow inclusion	['Insufficient_Enrollment']	['Neutral']
Early study closure due to limited internal resources to continue enrollment.	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Revised study design.	['Study_Design']	['Neutral']
Study withdrawn with intent of persuing larger, multi-site study.	['Study_Design']	['Neutral']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
PI left institution	['Study_Staff_Moved']	['Neutral']
Our local committee has denied the approval request	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Duplicate listing	['Covid19', 'No_Context', 'Insufficient_Enrollment']	['Neutral', 'Invalid_Reason', 'Neutral']
"Pharmaceutical company supplying the drug withdraw financial support. PI has decided to close
    study prior to enrollment of any patients."	['Business_Administrative']	['Possibly_Negative']
"Study was terminated due to an imbalance of serious and opportunistic infections in the
    ocrelizumab treated patients versus the placebo arm."	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"Sponsor cancelled the study as real life impact data has already shown the value of HepA
    vaccination & as no critical need to gather additional data in Israel."	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Enrollment temporarily stopped	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Difficulty in obtaining specific isotope tracer	['Logistics_Resources']	['Neutral']
Inadequate enrollment	['Insufficient_Enrollment']	['Neutral']
Regulatory authority approval for the initial study design could not be obtained	['No_Context', 'Regulatory', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
Unable to continue recruit subjects	['Insufficient_Enrollment']	['Neutral']
Sponsor is re-evaluating the clinical development path	['Business_Administrative']	['Possibly_Negative']
"This trial was terminated due to slow accrual and the drug supply of Obatoclax during the phase
    I; therefore, the phase II portion will never open."	['Insufficient_Enrollment']	['Neutral']
Data for the primary objectives is complete and the MTD identified in Stratum II.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Unrelated to Trial	['Invalid_Reason', 'Study_Design', 'Another_Study']	['Invalid_Reason', 'Neutral', 'Neutral']
Management decision	['Business_Administrative']	['Possibly_Negative']
"Safety Issue: The trial was prematurely terminated on Dec 9, 2010, due to safety concerns,
    specifically new emerging evidence of hepatic injury."	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
COVID	['Covid19']	['Neutral']
"Registry was built to handle Medicare coverage decision on NGS, but CMS decided to not require
    data."	['Business_Administrative']	['Possibly_Negative']
multidisciplinary participation could not be overcome.	['Insufficient_Enrollment']	['Neutral']
Due to high incidence of neurological complication in those with ilioinguinal block	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Because of technical problems (researcher moved to different city).	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
sufficient enrollment reached	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
low accrual	['Insufficient_Enrollment']	['Neutral']
Toxicity and efficacy data from another trial	['Negative', 'Another_Study']	['Negative', 'Neutral']
Investigational Medicinal Product Supplies	['Logistics_Resources']	['Neutral']
Decision of the investigator	['Invalid_Reason']	['Invalid_Reason']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Principal Investigator no longer at Site	['Study_Staff_Moved']	['Neutral']
PI left Loyola and Sub-I graduated.	['Study_Staff_Moved']	['Neutral']
Business Reasons	['Business_Administrative']	['Possibly_Negative']
The study was terminated because the rate of prothesis dislocation was too high.	['Logistics_Resources']	['Neutral']
"The study was never initiated because of lack of funding and research priorities have been
    shifted elsewhere."	['Business_Administrative']	['Possibly_Negative']
This study was terminated due to some challenges in recruitment process	['Insufficient_Enrollment']	['Neutral']
"The study is terminated prematurely as the sponsor decided to discontinue program with
    Tecemotide in NSCLC."	['Business_Administrative']	['Possibly_Negative']
See Detailed Description field.	['No_Context']	['Invalid_Reason']
terminated after participants were enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Vaccine unavailable.	['Logistics_Resources']	['Neutral']
This study was canceled before enrollment due to a decision by the Sponsor	['Business_Administrative']	['Possibly_Negative']
The interest of potential centers is very limited.	['Insufficient_Enrollment']	['Neutral']
Due to COVID 19 Pandemic	['Covid19']	['Neutral']
Stopping rule-acute rejection threshold-was met based on local biopsy results	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
"The study was terminated at the time of interim analysis since none of the participants showed
    a PSA response."	['Negative']	['Negative']
research cancelled	['Invalid_Reason']	['Invalid_Reason']
PI has been having difficulties obtaining ICG for this project.	['Business_Administrative']	['Possibly_Negative']
Change in clinical practice since the start of the trial in 2011 (phenylephrine superior)	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
Slow rate of enrollment	['Insufficient_Enrollment']	['Neutral']
change in design	['Study_Design']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
"The study was stopped after the interim analysis based on lack of sufficient efficacy. There
    were no safety concerns."	['Negative']	['Negative']
Indeterminate performance during the first half of the trial.	['Insufficient_Enrollment', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Insufficient patient recruitment	['Insufficient_Enrollment']	['Neutral']
The study was closed due to accrual futility there were only a total of 8 subjects enrolled.	['Insufficient_Enrollment']	['Neutral']
poor recruitment	['Insufficient_Enrollment']	['Neutral']
Investigator relocation	['Study_Staff_Moved']	['Neutral']
Non adequation between the medical device and the study population	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Facilities for the exercise training program were not available for the study.	['Logistics_Resources']	['Neutral']
Parallel IW-3718 Phase III trial did not meet pre-specified criteria.	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Study was terminated because of delays in sourcing replacement Investigational Medicinal
    Product for the study due to manufacturing delays."	['Logistics_Resources']	['Neutral']
Difficulty recruiting patient population.	['Insufficient_Enrollment']	['Neutral']
"Study discontinued based on planned interim analysis of the primary endpoint. Not linked to any
    safety concern."	['Interim_Analysis', 'Negative']	['Neutral', 'Negative']
Finished	['Invalid_Reason']	['Invalid_Reason']
PI decided to not proceed with study	['Invalid_Reason']	['Invalid_Reason']
Resources to conduct study withdrawn	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"The trial was terminated on 08FEB2018. Pfizer has decided to withdraw the New Drug Application
    and has notified FDA. There are no efficacy or safety concerns."	['Business_Administrative']	['Possibly_Negative']
Study was terminated due to lack of adherence to the protocol in the intervention arm.	['Study_Design']	['Neutral']
Safety concerns	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Continuing beyond the pilot phase of the trial was deemed unfeasible	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
did not accrue enough patients.	['Insufficient_Enrollment']	['Neutral']
Low accrual, funding withdrawn by AstraZeneca, and change in clinical practice	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study goals rolled into a broader study	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Study was stopped due to inadequate accrual.	['Insufficient_Enrollment']	['Neutral']
This protocol was determined to be not human subjects research.	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Termination of study due to low enrollment	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
sufficient data gathered for study conclusion	['Invalid_Reason']	['Invalid_Reason']
Enrollment was too slow and principal investigator moved to another country	['Insufficient_Enrollment']	['Neutral']
"Our RCT recently started. The RCT is similar to the feasibility trial, so it was terminated to
    avoid 2 trials running simultaniously."	['No_Context', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
No metabolic disordered ID'd by TMS in either control/test group at >50%enrolled	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Insufficient population of eligible patients; none enrolled	['Insufficient_Enrollment']	['Neutral']
closed due to futility	['Negative']	['Negative']
Unable to enroll subjects	['Insufficient_Enrollment']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
"More patients in Cohort 1 than Cohort 2 demonstrated a clinically meaningful reduction of
    seizure count. Given this, enrollment of Cohort 3 was discontinued."	['Success', 'No_Context', 'Safety_Sideeffects']	['Success', 'Invalid_Reason', 'Safety_Sideeffects']
"Due to ""prolonged low participant recruitment"""	['Insufficient_Enrollment']	['Neutral']
Altered biodistribution in investigational images versus standard images.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Sponsor stopped due to difficulties to recruit 402 patients required by protocol	['Insufficient_Enrollment']	['Neutral']
Recruitment goals not met	['Insufficient_Enrollment']	['Neutral']
Funding not available, PI left institution	['Business_Administrative']	['Possibly_Negative']
not able to recruit participants	['Insufficient_Enrollment']	['Neutral']
Trial would not be completed in a reasonable timeframe per CTEP guidelines	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
Proved difficult to consent patient population due to comorbidities	['Insufficient_Enrollment']	['Neutral']
Enrollment, study-design and execution challenges.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Preliminary data from study NCT00994214 do not support expected inhibition of GH and IGF-1	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Based on recent input from FDA, the pre-specified final analysis will be performed at the
    current enrollment using a re-estimation of the sample size."	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
The Sponsor has no interest in continuing the study.	['Business_Administrative']	['Possibly_Negative']
Early termination due to lack of efficacy (overall response)	['Negative']	['Negative']
The IND has been withdrawn from FDA	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
NINDS/NIH-DSMB recommended halting trial due to futility, no safety concerns.	['Negative']	['Negative']
Due to changes within the research program this study is not feasible at this time	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Due to the COVID global pandemic Sponsor has not received the economic support necessary for
    the study conduction."	['Covid19', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
grant was not approved.	['Business_Administrative']	['Possibly_Negative']
Logistical problems	['Logistics_Resources']	['Neutral']
Study was closed due to poor accrual.	['Insufficient_Enrollment']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
change in practice occured	['Study_Design']	['Neutral']
PI leaving institution	['Study_Staff_Moved']	['Neutral']
Safety analysis showed increased grade 5 toxicity in experimental arm.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Evaluation halted	['Invalid_Reason']	['Invalid_Reason']
Terminated due to lack of drug efficacy. 2017 study did not show benefit.	['Negative']	['Negative']
No financial support	['Business_Administrative']	['Possibly_Negative']
Business reasons	['Business_Administrative']	['Possibly_Negative']
due to COVID-19	['Covid19']	['Neutral']
sponsor decision	['Business_Administrative']	['Possibly_Negative']
Terminated due to slow enrollment.	['Insufficient_Enrollment']	['Neutral']
no further funding available for recruiting and testing participants	['Business_Administrative']	['Possibly_Negative']
"Study was terminated early for business purposes and as a result of a strategic decision to
    shift focus to another indication."	['Business_Administrative']	['Possibly_Negative']
Poor recruitment of fast and slow acetylators	['Insufficient_Enrollment']	['Neutral']
"Recruitment potential impaired by shift in clinical care whereby practically all HIV patients
    receive standard treatment as soon as possible after HIV diagnosis"	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Key study team members working on the study are leaving the institution.	['Study_Staff_Moved']	['Neutral']
"Key samples protocols will be provided by a collaborator and we were not able to produce IPS
    lines from human fibroblasts."	['Logistics_Resources']	['Neutral']
"Funding Period ended, did not reach full sample size due to limited numbers of eligible
    patients"	['Business_Administrative']	['Possibly_Negative']
Lack of Accrual	['Insufficient_Enrollment']	['Neutral']
The study was terminated due to safety reasons	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"Lack of enrollment - since the start of the study in 2013, only 17 subjects have consented. Of
    those, only 8 completed the study."	['Insufficient_Enrollment']	['Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
This study was stopped prematurely due to lack of efficacy.	['Negative']	['Negative']
Sponsor's business decision	['Business_Administrative']	['Possibly_Negative']
Insufficient funding	['Business_Administrative']	['Possibly_Negative']
Study was canceled	['Invalid_Reason']	['Invalid_Reason']
"Recruitment stopped due to slow accrual and lack of evidence of need for further continuation
    of protocol in inpatient setting."	['Insufficient_Enrollment']	['Neutral']
Target enrollment not met within specific time period.	['Insufficient_Enrollment']	['Neutral']
Explanation provided in detailed descriptiong section of record.	['No_Context']	['Invalid_Reason']
"The gynecological laparoscopic surgery transition to day surgery made following the study
    protocol not possible."	['Study_Design']	['Neutral']
"not ""applicable clinical trial"""	['Invalid_Reason']	['Invalid_Reason']
Interim analysis recommended terminating the study	['Interim_Analysis', 'Safety_Sideeffects', 'Regulatory']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Study was terminated due to poor accrual	['Insufficient_Enrollment']	['Neutral']
PI leaving institution, slow enrollment	['Insufficient_Enrollment']	['Neutral']
"GSK has merged all individual pregnancy registries, which are terminated, for its seasonal
    influenza vaccines into one combined registry, EPI-FLU-039 VS US PR."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Not enough recruitment	['Insufficient_Enrollment']	['Neutral']
Sponsor-PI left Switzerland	['Logistics_Resources', 'Study_Staff_Moved', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Competing trials	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of funding.	['Business_Administrative']	['Possibly_Negative']
Collaborator withdrew closing the study prematurely with no participants enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Due to inadequate supply of drug	['Logistics_Resources']	['Neutral']
Low accrual and loss of funding.	['Insufficient_Enrollment']	['Neutral']
Study was withdrawn due to scientific and business considerations.	['Business_Administrative']	['Possibly_Negative']
unexpectedly low screening results leading to poor accrual	['Insufficient_Enrollment']	['Neutral']
Sponsorship change	['Business_Administrative']	['Possibly_Negative']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
investigator changed location, requires new training effort	['Logistics_Resources', 'Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Sponsor funding limitations	['Business_Administrative']	['Possibly_Negative']
Study discontinued due to funding.	['Business_Administrative']	['Possibly_Negative']
One of the study products is no longer available for clinical trial use.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Funding not obtained.	['Business_Administrative']	['Possibly_Negative']
It was hard to recruit patients	['Insufficient_Enrollment']	['Neutral']
Insufficient accrual	['Insufficient_Enrollment']	['Neutral']
"We were unable to secure funding for the triaging experiment. The participatory design process
    ran its course as intended."	['Business_Administrative']	['Possibly_Negative']
Company Decision	['Business_Administrative']	['Possibly_Negative']
This study was discontinued due to a shown lack of efficacy in the investigational agent	['Negative']	['Negative']
"251PP301(PASSPORT) primary endpoint was not met;Biogen decision to close the study early. There
    were no safety concerns with the PASSPORT study."	['Negative']	['Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
PI left the university	['Study_Staff_Moved']	['Neutral']
The study was terminated per PI decision.	['Invalid_Reason']	['Invalid_Reason']
This study was terminated early in May 2006 due to low patient enrollment	['Insufficient_Enrollment']	['Neutral']
Interim analysis: safety without efficacy ODSH in patients with acute COPD.	['Negative']	['Negative']
Study has never started	['Invalid_Reason']	['Invalid_Reason']
"Neurogen acquired by Ligand Pharmaceuticals - no further support for study. No safety concerns
    identified."	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Replaced by a different study	['Negative', 'Another_Study']	['Negative', 'Neutral']
No MEC approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Inability to recruit sufficient number of patients	['Insufficient_Enrollment']	['Neutral']
Alternate study design for ovarian cancer under discussion	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Recruiting Issue	['Insufficient_Enrollment']	['Neutral']
Unable to enroll eligible participants	['Insufficient_Enrollment']	['Neutral']
Difficulty in recruitment	['Insufficient_Enrollment']	['Neutral']
no staff available to do the research	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Study may not be clinically relevant at this time.	['No_Context', 'Logistics_Resources', 'Ethical_Reason']	['Invalid_Reason', 'Neutral', 'Neutral']
Study completed at site, no active participants. IDE open for future enrollment	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Test ingredient production did not meet specification	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
"Strategic decision to discontinue further development of investigational compounds for the
    treatment of hepatitis C."	['Business_Administrative']	['Possibly_Negative']
the study has concluded normally;	['Invalid_Reason']	['Invalid_Reason']
Funding not received	['Business_Administrative']	['Possibly_Negative']
Toxicity and Lack of Efficacy	['Negative']	['Negative']
Insufficient staff	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Business Reasons	['Business_Administrative']	['Possibly_Negative']
unable to enrollment subjects due to early departure of study personele	['Insufficient_Enrollment']	['Neutral']
Nottingham PCT withdrew for financial reasons	['Business_Administrative']	['Possibly_Negative']
Study terminated due to PI leaving the institution.	['Study_Staff_Moved']	['Neutral']
Difficulty to include patient	['Insufficient_Enrollment']	['Neutral']
Low recruitment rates and timeline viability analysis.	['Interim_Analysis', 'Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Designed a new modified/simplified protocol see NCT 03180489	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Due to difficulties in recruitment and academic time constrains we terminated the study after
    60 participants instead of 90 as planned."	['Insufficient_Enrollment']	['Neutral']
Low accrual rate	['Insufficient_Enrollment']	['Neutral']
Unexpectedely high rates of treatment-failure	['Negative']	['Negative']
This study was canceled for operational reasons.	['Business_Administrative']	['Possibly_Negative']
"Overall profile of the compound does not offer significant clinical advantage to patients over
    currently available lipid lowering agents"	['Negative']	['Negative']
"We designed a different pilot trial based on data obtained after this study started - the 2
    studies were too overlapping to continue both."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Recruitment was stopped after an interim analysis of the parent GS39684 study.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Futility found by interim analysis	['Negative']	['Negative']
"Poor compliance with returning of logbooks by families. Two patients were enrolled. Only one
    returned the logbook and therefore not analyzed"	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
"Company decision to discontinue the AVE1642 development program, not due to any safety or
    efficacy concerns"	['Business_Administrative']	['Possibly_Negative']
Difficult to enroll, parents/subjects prefer to choose type of anesthetic block.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Research was competing with other projects in the department, and no patients were recruited.	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
study never start	['Invalid_Reason']	['Invalid_Reason']
Subjects were enrolled into a different Phase 2 study (PVO-1A-202, NCT02279095).	['Negative', 'Another_Study']	['Negative', 'Neutral']
Sponsor request	['Business_Administrative']	['Possibly_Negative']
Project development priorities changed	['Business_Administrative']	['Possibly_Negative']
IRB Study Closure	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Secondary to third interim analysis by the study DSMB.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Could not get funding	['Business_Administrative']	['Possibly_Negative']
due to low enrollment, participants are no longer being examined or treated	['Insufficient_Enrollment']	['Neutral']
recruitment has been put on hold until a future date	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
no participants enrolled	['Insufficient_Enrollment']	['Neutral']
supporting company (Eisai) withdrew their interest	['Business_Administrative']	['Possibly_Negative']
"Site Principal Investigator became seriously ill, so study abandoned before the start of
    recruitment"	['Study_Staff_Moved']	['Neutral']
Principal Investgator leaving institution	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
slow patient enrollment	['Insufficient_Enrollment']	['Neutral']
Scheduling and recruitment difficulties	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Accrual rate remaining too low	['Insufficient_Enrollment']	['Neutral']
Business strategy decision	['Business_Administrative']	['Possibly_Negative']
The study direction does not longer aligns the sponsor's strategy	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Investigator's decision (departure from institution)	['Study_Staff_Moved']	['Neutral']
Disparate corneal thickness readings from two measurement techniques employed.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Administrative reasons	['Business_Administrative']	['Possibly_Negative']
sponsor decision	['Business_Administrative']	['Possibly_Negative']
Could not obtain appropriate funding or standardized manufacturing for cinnamon tablets	['Business_Administrative']	['Possibly_Negative']
PI determined not enough clinical staff support for project.	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
"Was not possible to enroll sufficient number of subjects to draw any worthwhile conclusions
    from the study."	['Insufficient_Enrollment']	['Neutral']
Dr. Vindas completed his fellowship + low enrollment	['Insufficient_Enrollment']	['Neutral']
funding lapse; enrollment difficulty	['Business_Administrative']	['Possibly_Negative']
This study is terminated because of problems wtih the society responsible of the data base.	['Logistics_Resources', 'Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Funding	['Business_Administrative']	['Possibly_Negative']
the lung transplantation program at the site is on hold	['Logistics_Resources', 'Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Not achieved the objective till 4 mg single dose	['Negative']	['Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
administrative reasons	['Business_Administrative']	['Possibly_Negative']
funding not available	['Business_Administrative']	['Possibly_Negative']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Not enough patient population according to selection criteria to complete the study	['Insufficient_Enrollment']	['Neutral']
Terminated due to difficuly recruiting participants	['Insufficient_Enrollment']	['Neutral']
"No patients recruited due to decreased levels of patients requiring non-invasive ventilation
    during the study."	['Insufficient_Enrollment']	['Neutral']
Study cancelled.	['Invalid_Reason']	['Invalid_Reason']
study did not start	['Invalid_Reason']	['Invalid_Reason']
Poor patient accrual. Attempts to open at other sites unsuccessful.	['Insufficient_Enrollment']	['Neutral']
The study was terminated by the sponsor due to budgetary issues	['Business_Administrative']	['Possibly_Negative']
"Adequate safety data has been accumulated and the # of patients meeting inclusion criteria has
    diminished."	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Difficulty in recruitment.	['Insufficient_Enrollment']	['Neutral']
No further local interest in pursuing the study.	['Business_Administrative']	['Possibly_Negative']
Population of eligible patients smaller than anticipated	['Insufficient_Enrollment']	['Neutral']
Risk to benefit ratio not acceptable	['Negative']	['Negative']
recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
sponsor decided they are not interested in the study due to finacial reasons	['Business_Administrative']	['Possibly_Negative']
"Anticipated nr of 25 probands was not reached in terms of full data sets (missing data, low
    fMRI data quality), but time frame for recruitment ended."	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Change of protocol title	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Principal Investigator left facility	['Study_Staff_Moved']	['Neutral']
Not enough participants enrolled in the study	['Insufficient_Enrollment']	['Neutral']
Terminated by sponsor	['Business_Administrative']	['Possibly_Negative']
"This study was withdrawn for administrative reasons. The dose ranging plan for the program was
    revised""."	['Business_Administrative']	['Possibly_Negative']
Not funded	['Business_Administrative']	['Possibly_Negative']
Internal decision	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Study abandoned before any submission (foreseeable organizational difficulties)	['Business_Administrative']	['Possibly_Negative']
unsufficient recruitment	['Insufficient_Enrollment']	['Neutral']
The PI has requested to close this study.	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
lack of PSG	['Logistics_Resources', 'Regulatory', 'Negative']	['Neutral', 'Neutral', 'Negative']
Lack of funds	['Business_Administrative']	['Possibly_Negative']
Could not perform accurate measures due to equipment and sensor issues.	['Logistics_Resources']	['Neutral']
Failure to recruit people with very late onset schizophrenia like psychosis	['Insufficient_Enrollment']	['Neutral']
Competition from other studies and initiation of a larger multi center trial	['Negative', 'Another_Study']	['Negative', 'Neutral']
The study was stopped due to lack of adequate enrollment.	['Insufficient_Enrollment']	['Neutral']
only recruited 5 patients at this location	['Insufficient_Enrollment']	['Neutral']
"This study was stopped for business and program changes. At no time was the safety of any
    participants at risk."	['Business_Administrative']	['Possibly_Negative']
No funding and exclusion criteria were to stringent.	['Business_Administrative']	['Possibly_Negative']
"It was not possible to enroll the planned amount of subjects. Many patients with chronic
    obstructive pulmonary disease already took large doses of vitamin D."	['Insufficient_Enrollment']	['Neutral']
Withdrawn by sponsor	['Business_Administrative']	['Possibly_Negative']
"Poor accrual and limited target patient population for future accrual. Did not complete the
    Phase 1 portion of the trial."	['Insufficient_Enrollment']	['Neutral']
Data from MSK-IMPACT is sufficient for relevant analyses going forward	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
"We at the Sunshine Coast University Hospital are unable to cope with the extra effort/time
    needed to complete this trial properly."	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
lack of acurral	['Insufficient_Enrollment']	['Neutral']
Study DAR-312 did not meet primary co-endpoints	['Negative']	['Negative']
Enrollment discontinued due to rare medical condition in the age group 0 to 2 months	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Study was closed due to low enrollment numbers.	['Insufficient_Enrollment']	['Neutral']
Insufficient Accrual	['Insufficient_Enrollment']	['Neutral']
Ended the recruitment in June 2012 for low enrollement accrual	['Insufficient_Enrollment']	['Neutral']
Limited recruitment	['Insufficient_Enrollment']	['Neutral']
Study did not get started. Investigator is no longer at this institution	['Study_Staff_Moved']	['Neutral']
Lack of funds	['Business_Administrative']	['Possibly_Negative']
Study stopped for procedural difficulties and lack of personnel	['Logistics_Resources']	['Neutral']
Leaving of the person responsible for the data collection	['Study_Staff_Moved']	['Neutral']
recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
"Study halted prematurely and will not resume; participants are no longer receiving intervention
    due to coronavirus pandemic and unexpected enrollment delays."	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Study_Design']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Update of the technical documentation of the device	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
PI left NIH. No subjects enrolled.	['Study_Staff_Moved']	['Neutral']
Contract ended	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
insufficient rate of accrual	['Insufficient_Enrollment']	['Neutral']
Administrative reasons	['Business_Administrative']	['Possibly_Negative']
inability to recruit subjects	['Insufficient_Enrollment']	['Neutral']
No patients recruited	['Insufficient_Enrollment']	['Neutral']
Required revisions were unable to be made to protocol.	['Study_Design']	['Neutral']
business reason	['Business_Administrative']	['Possibly_Negative']
Patient recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Expiration of IRB Approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"Study is unlikely to be feasible given the evolving ovarian cancer landscape and alternative
    studies have the potential to meet future clinical demand."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
unable to enroll	['Insufficient_Enrollment']	['Neutral']
Strategic considerations	['Business_Administrative']	['Possibly_Negative']
Study never initiated. IND placed on Hold	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Stopped by Principal Investigator decision	['Invalid_Reason']	['Invalid_Reason']
No Funding was acquired.	['Business_Administrative']	['Possibly_Negative']
Unable to enroll	['Insufficient_Enrollment']	['Neutral']
Terminated for futility on 11/30/09 based on the recommendation of the DSMB	['Negative']	['Negative']
Due to delays with logistics and protocol revision not viable to continue.	['Logistics_Resources']	['Neutral']
interim analysis suggested no differences with whole sample	['Negative']	['Negative']
"Study stopped due to study enrollment challenges that impacted the feasibility of conducting
    the study."	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
No funding	['Business_Administrative']	['Possibly_Negative']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
"Decision was made to terminate the project due to slower than anticipated recruitment and many
    of the investigators no longer being available."	['Insufficient_Enrollment']	['Neutral']
Closed due to funding and never enrolled a subject	['Business_Administrative']	['Possibly_Negative']
lack of funding	['Business_Administrative']	['Possibly_Negative']
It was decided to use a different protocol with a different radioligand	['Study_Design']	['Neutral']
Difficulty in recruiting participants	['Insufficient_Enrollment']	['Neutral']
Could not meet primary and secondary outcome measures	['Negative']	['Negative']
Study enrollment rate was far slower than anticipated. Study was stopped for business purposes.	['Business_Administrative']	['Possibly_Negative']
Ethic Comitte (CONEP) determinated the prematurely terminated.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Slow/low enrollment	['Insufficient_Enrollment']	['Neutral']
study suspended due to staff indisposition	['Logistics_Resources']	['Neutral']
The study stopped due to lack of efficacy.	['Negative']	['Negative']
Study was terminated due to low enrollment	['Insufficient_Enrollment']	['Neutral']
Withdrawn due to lack of study participants	['Insufficient_Enrollment']	['Neutral']
setup activities were suspended due to COVID	['Covid19']	['Neutral']
Terminated due to limited enrollment (non-safety related decision)	['Insufficient_Enrollment']	['Neutral']
company dissolved	['Business_Administrative']	['Possibly_Negative']
Insufficient funding	['Business_Administrative']	['Possibly_Negative']
Protocol modification	['Study_Design']	['Neutral']
Funding terminated	['Business_Administrative']	['Possibly_Negative']
Sponsoring company ceased business operations.	['Business_Administrative']	['Possibly_Negative']
Administrative reasons and Overall Study PI moved to another institution.	['Business_Administrative']	['Possibly_Negative']
no patients completed	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Recruiting problems.	['Insufficient_Enrollment']	['Neutral']
no patients enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
LOGISTIC DIFFICULTIES	['Logistics_Resources']	['Neutral']
Trial stopped for futility	['Negative']	['Negative']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
The patient pathway changed resulting in less admissions for this condition.	['Insufficient_Enrollment']	['Neutral']
"The study had to be stopped due to the COVID-19 pandemic. The University has been closed since
    the beginning of the pandemic until the present date (02/2021) due to the social distance
    imposed by the government."	['Covid19']	['Neutral']
Project Cancelled	['Invalid_Reason']	['Invalid_Reason']
Lack of accrual	['Insufficient_Enrollment']	['Neutral']
study director job transfer in another departement	['Study_Staff_Moved']	['Neutral']
Insufficient resources to complete study	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Internal staffing issues	['Logistics_Resources']	['Neutral']
Lack of successful recruiting, budget cuts, and potential study flaws.	['Business_Administrative']	['Possibly_Negative']
no suitable patients	['Insufficient_Enrollment']	['Neutral']
no funding	['Business_Administrative']	['Possibly_Negative']
Trial met primary efficacy endpoint target. No additional subjects necessary.	['No_Context', 'Endpoint_Met', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
Business objectives have changed.	['Business_Administrative']	['Possibly_Negative']
Seems to have simply stopped.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
Resensitization or clinical benefit was not observed	['Negative']	['Negative']
Methodologicals and logistics issues.	['Logistics_Resources']	['Neutral']
Insufficient accrual rate	['Insufficient_Enrollment']	['Neutral']
COVID-19 Pandemic	['Covid19']	['Neutral']
Study termination due to insufficient efficacy.	['Negative']	['Negative']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
"Study stopped for scientific reasons. Another study with a new design is in course of
    authorization and implementation"	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Study closed by PI due to lower than expected accrual.	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
No Patients enrolled; sponsor not providing devices anymore	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Very slow recruitment.	['Insufficient_Enrollment']	['Neutral']
According to the Recommendation of the Indipendent Data Monitoring Committee	['Negative']	['Negative']
Study was terminated early due to slow recruitment rate.	['Insufficient_Enrollment']	['Neutral']
Halted due to lack of statistical power. No safety concerns identified.	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
increased number of patients death	['Insufficient_Enrollment']	['Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
American Society of Reproductive Medicine guidelines, October 2012.	['No_Context', 'Regulatory', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
low enrollment	['Insufficient_Enrollment']	['Neutral']
"Enrollment and other trial activities have temporarily paused due to COVID-19 and are expected
    to resume in the future; This is not a suspension of IRB approval"	['Covid19']	['Neutral']
No enrolement	['Insufficient_Enrollment']	['Neutral']
PI left hospital	['Study_Staff_Moved']	['Neutral']
Change of Institutional Affiliation & Funding	['Business_Administrative']	['Possibly_Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
NOT A CLINICAL TRIAL	['Invalid_Reason']	['Invalid_Reason']
No financing possible	['Business_Administrative']	['Possibly_Negative']
App stopped development before minimum viable product created	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
the study is publiched	['Invalid_Reason']	['Invalid_Reason']
Non-compliance	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
PI left the institution	['Study_Staff_Moved']	['Neutral']
Not feasable at this site	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
DSMB suggested closure due to low enrollment	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Study was closed due to administrative decision	['Business_Administrative']	['Possibly_Negative']
Problems with drug supply	['Logistics_Resources']	['Neutral']
Enrollment difficulties	['Insufficient_Enrollment']	['Neutral']
Contract with drug supplier expired and was not renewed.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
PI decision due to low accrual and lack of funding	['Insufficient_Enrollment']	['Neutral']
poor recruitment	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Study is on hold until pilot study is completed.	['Invalid_Reason', 'Study_Design', 'Another_Study']	['Invalid_Reason', 'Neutral', 'Neutral']
Low inclusion rate.	['Insufficient_Enrollment']	['Neutral']
This study put on inactive status due to no identifiable subjects to enter the protocol.	['Insufficient_Enrollment']	['Neutral']
primary outcome measure not met	['Negative']	['Negative']
closed due to toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Business Reasons	['Business_Administrative']	['Possibly_Negative']
terminated due to very low recruitment rate (27 June 2006)	['Insufficient_Enrollment']	['Neutral']
Due to organisational issues, the study had to be completed prematurely.	['Business_Administrative']	['Possibly_Negative']
New data show no effect of dose escalation and also poor recruitment	['Negative', 'Another_Study']	['Negative', 'Neutral']
Recruitment problems in Denmark and Norway	['Insufficient_Enrollment']	['Neutral']
Organizational changes and lack of resources	['Business_Administrative']	['Possibly_Negative']
"We encounter technical problems to continue with the study. (Notably difficulty in teaching the
    patients to use the dressing set involved in the study.)"	['Logistics_Resources']	['Neutral']
study was not ethically acceptable to continue and therefore it was finally stopped	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
Lack of efficacy	['Negative']	['Negative']
not enough particpants	['Logistics_Resources']	['Neutral']
PI no longer at institution	['Study_Staff_Moved']	['Neutral']
"Company decision to modify the ferroquine development strategy; discontinuation not due to
    safety or activity unexpected findings"	['Business_Administrative']	['Possibly_Negative']
Evidence of thrombectomy for acute stroke was established	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
recruitment problems	['Insufficient_Enrollment']	['Neutral']
Staffing and space deficiencies prevented completion of the study.	['Logistics_Resources']	['Neutral']
FDA Clinical hold	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Recruitment difficulties and stopped funding	['Business_Administrative']	['Possibly_Negative']
The study was stopped due to an administrative decision not safety.	['Business_Administrative']	['Possibly_Negative']
technical difficulties	['Logistics_Resources']	['Neutral']
"devices applied in the study were no more available in the market, and medical intervention
    section was completed."	['Logistics_Resources']	['Neutral']
Pending enrollment of new subjects if new funding obtained	['Business_Administrative']	['Possibly_Negative']
Inclusion/Exclusion criteria was too stringent to enroll patients at this site.	['Insufficient_Enrollment']	['Neutral']
"This study was stopped after larger studies published in the NEJM failed to show a benefit in
    treating ADPKD"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Inadequate patient population	['Insufficient_Enrollment']	['Neutral']
Recruiting Difficulty	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
due to slow accrual and lack of funding	['Insufficient_Enrollment']	['Neutral']
Stopped accordining to early stopping rule for futility	['Negative']	['Negative']
"after interim analysis it was determined that the risks were too great in comparision to the
    results"	['Interim_Analysis', 'Safety_Sideeffects', 'Endpoint_Met']	['Neutral', 'Safety_Sideeffects', 'Neutral']
The study was terminated in the interest of patient safety.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
No IND Serial #	['No_Context', 'Insufficient_Enrollment', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
Terminated due to nonclinical safety findings	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Market reasons	['Business_Administrative']	['Possibly_Negative']
Study was discontinued due to lack of accrual.	['Insufficient_Enrollment']	['Neutral']
Recruitment and enrollment currently suspended due to COVID-19	['Covid19']	['Neutral']
Due to specimen collection difficulties; this study has been terminated	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Business Decision; No Safety Or Efficacy Concerns.	['Business_Administrative']	['Possibly_Negative']
Business decision	['Business_Administrative']	['Possibly_Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
Regulatory approvals not received	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
The research is permanently closed to enrollment.	['Insufficient_Enrollment']	['Neutral']
"Interim analysis indicated significant additional subjects needed to demonsate statistical
    difference in primary outcome."	['Interim_Analysis', 'Endpoint_Met', 'Negative']	['Neutral', 'Neutral', 'Negative']
Lack of inclusion	['Insufficient_Enrollment']	['Neutral']
Unable to accrue the projected number of patients required.	['Insufficient_Enrollment']	['Neutral']
Termination Date 30AUG2018: Reason for termination: Lack of Efficacy	['Negative']	['Negative']
ROS1 in IHC and gene rearrangement result can not matchNo tumor response	['Negative']	['Negative']
The investigator moved to another institution, therefore the study was never initiated.	['Study_Staff_Moved']	['Neutral']
Recruitment slow, funding ended.	['Business_Administrative']	['Possibly_Negative']
"Trial will not complete until at least 2025 and evolution of immunosuppressant therapy has made
    it unlikely that patients will convert from Modigraf to Prograf."	['Study_Design']	['Neutral']
Study was terminated early for strategic reasons. Only Part I of the study was completed.	['Business_Administrative']	['Possibly_Negative']
Insufficient patient participation	['Insufficient_Enrollment']	['Neutral']
Lack of cooperation by the participants	['Business_Administrative']	['Possibly_Negative']
Low recruitment rate	['Insufficient_Enrollment']	['Neutral']
COVID-19 institutional restrictions on screening colonoscopies	['Covid19']	['Neutral']
See Termination Statement in the Detailed Description below	['No_Context']	['Invalid_Reason']
The study was prematurely terminated on 17th December 2014 due to safety concerns.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
The investigators hadn't got funding to support the study	['Business_Administrative']	['Possibly_Negative']
"The study was terminated because of difficulty in completing the study as originally planned
    and loss of extra-funding."	['Business_Administrative']	['Possibly_Negative']
Sponsor determined this trial does not support their anticipated clinical development program.	['Business_Administrative']	['Possibly_Negative']
Limited efficacy response observed at 1/3 enrollment at investigated dosage.	['Negative']	['Negative']
Funding not awarded	['Business_Administrative']	['Possibly_Negative']
No accrual	['Insufficient_Enrollment']	['Neutral']
sample size was not enrolled	['Insufficient_Enrollment']	['Neutral']
Business decision: no safety or efficacy concerns.	['Business_Administrative']	['Possibly_Negative']
temporary closing per study design	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Due to unavailability of the drug.	['Logistics_Resources']	['Neutral']
Research idea tabled at this point.	['No_Context', 'Invalid_Reason', 'Study_Design']	['Invalid_Reason', 'Invalid_Reason', 'Neutral']
Software issues not resolved.	['Logistics_Resources']	['Neutral']
slow accrual - the 1 patient accrued did not go on treatment	['Insufficient_Enrollment']	['Neutral']
Sponsor's decision	['Business_Administrative']	['Possibly_Negative']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
Due to poor accrual this study is being closed to accrual	['Insufficient_Enrollment']	['Neutral']
Terminated due to no patient enrollment.	['Insufficient_Enrollment']	['Neutral']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
Discontinued	['Invalid_Reason']	['Invalid_Reason']
It was not feasible to recruit required sample size from two clinical sites.	['Insufficient_Enrollment']	['Neutral']
study was stopped after enrolment of about 200 patients for slow recruitment	['Insufficient_Enrollment']	['Neutral']
COVID-19 restrictions	['Covid19']	['Neutral']
Expired IRB approval since 05/07/2020	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Not enough resources to start the study	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Business decision	['Business_Administrative']	['Possibly_Negative']
Due to Corona/Covid19 pandemic	['Covid19']	['Neutral']
PI left University	['Study_Staff_Moved']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Difficult Recruitment	['Insufficient_Enrollment']	['Neutral']
"The study was terminated by the Sponsor for administrative reasons and not due to any safety
    concerns."	['Business_Administrative']	['Possibly_Negative']
Coronavirus Pandemic	['Covid19', 'Safety_Sideeffects', 'Insufficient_Enrollment']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Institutions issue	['Logistics_Resources']	['Neutral']
EMEA recommendation to suspend Acomplia marketing authorisation	['Regulatory', 'Insufficient_Enrollment', 'Negative']	['Neutral', 'Neutral', 'Negative']
insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Study never officially opened for enrollment	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
PI left institution	['Study_Staff_Moved']	['Neutral']
Fewer patients than anticipated were referred	['Insufficient_Enrollment']	['Neutral']
Study being redesigned in anticipation of new study protocol.	['Study_Design']	['Neutral']
Changes in personnel at Institution.	['Logistics_Resources', 'Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
lack of sufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Company decision to not initiate trial	['Business_Administrative']	['Possibly_Negative']
drug toxicity	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"EMA/PDCO acknowledged that available results from this study do not support further clinical
    studies in relapsed/refractory AML paediatric patients."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Sponsor withdrawl prior to study completion.	['Business_Administrative']	['Possibly_Negative']
Enrollment has been halted	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Changes of SoC for third line therapy resulting in poor recruitment	['Insufficient_Enrollment']	['Neutral']
Inclusion rhythm too slow	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
The study was stopped early due to recruitment challenges	['Insufficient_Enrollment']	['Neutral']
Lack of efficacy and funding to continue investigation	['Business_Administrative']	['Possibly_Negative']
Lack of staff, time, and resources	['Logistics_Resources']	['Neutral']
poor recruitment, no patients were enrolled	['Insufficient_Enrollment']	['Neutral']
Analyzing data	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
Study no longer relevant based on change in regulatory pathway for TFV 1% gel	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Insufficient rate of patient enrollment/accrual.	['Insufficient_Enrollment']	['Neutral']
FDA approval not obtained.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
This study was prematurely terminated (26 June 2009) due to slow recruitment	['Insufficient_Enrollment']	['Neutral']
Inadequate accrual rate	['Insufficient_Enrollment']	['Neutral']
Poor recruitment rate due to difficulties in identifying suitable patients	['Insufficient_Enrollment']	['Neutral']
Researcher performing the study is temporarily working outside the study center.	['Study_Staff_Moved']	['Neutral']
moved study to USA	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
company decision	['Business_Administrative']	['Possibly_Negative']
Enrollment target not reached	['Insufficient_Enrollment']	['Neutral']
Replacing this trial with a new trial.	['Negative', 'Another_Study']	['Negative', 'Neutral']
"The study was not feasible to perform at one institution with the amount of subjects that were
    needed to complete it."	['Insufficient_Enrollment']	['Neutral']
study diet is no longer available to match with the previous participants.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Due to low accrual	['Insufficient_Enrollment']	['Neutral']
The trial has been terminated due to difficulties with recruitment.	['Insufficient_Enrollment']	['Neutral']
No patients enrolled.	['Insufficient_Enrollment']	['Neutral']
"Because of negative results of the sister study NAK-06 and the low overall response rate at
    week 24."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Protocol was closed due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
Withdrawal of research institution from participating	['Business_Administrative']	['Possibly_Negative']
"Study design changes were needed due to change of protocol to a multisite trial and updated set
    up"	['Study_Design']	['Neutral']
"Study closed by IRB because a Continuing Review and/or Close-Out have not been submitted.

    Study closed by IRB"	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
It is difficult to recruit enough participants	['Insufficient_Enrollment']	['Neutral']
change in surgical implant use, loss of subinvestigator	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
The patients eligible for this trial do not exist anymore due to change in procedures.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Based on overall benefit-risk assessment.	['Negative']	['Negative']
COVID-19 and Personnel changes	['Covid19']	['Neutral']
low recruitment	['Insufficient_Enrollment']	['Neutral']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
Enrollment challenges	['Insufficient_Enrollment']	['Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
terminated	['Invalid_Reason']	['Invalid_Reason']
Numer of eligible patients markedly decreased since the initiation of the study.	['Insufficient_Enrollment']	['Neutral']
we terminated the study before enrolling 303/560 due to a slow accrual	['Insufficient_Enrollment']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor wanted study rewritten	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Xoma to no longer supply drug for the study	['Logistics_Resources']	['Neutral']
Insufficient recruitment	['Insufficient_Enrollment']	['Neutral']
Study never initiated; withdrawn prior to receiving IRB approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Due to concern for high systemic drug levels that could exceed levels in toxicology studies.	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
"Key aspects linked to sample management and analysis were not met during feasibility assessment
    limiting the ability of the study to reach its objectives."	['Logistics_Resources']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
PI left and closed study at Hackensack went to RUTGERS	['Study_Staff_Moved']	['Neutral']
Logistics reason at the data collection site	['Logistics_Resources']	['Neutral']
Interim analysis showed efficacy less than 2.5%.	['Negative']	['Negative']
Closed early due to slow patient accrual and sponsor's withdrawal of support.	['Insufficient_Enrollment']	['Neutral']
Temporarily closed to accrual by IRB	['Insufficient_Enrollment']	['Neutral']
Study conduct does not meet corporate objectives of sponsor	['Business_Administrative']	['Possibly_Negative']
The study was stopped for recruitment defect	['Insufficient_Enrollment']	['Neutral']
feasibility issues	['Logistics_Resources']	['Neutral']
Study terminated early due to difficulties in subject recruitment	['Insufficient_Enrollment']	['Neutral']
Since the published data resolved the study goals we decided not to start it	['Invalid_Reason']	['Invalid_Reason']
not patient recruitment	['Insufficient_Enrollment']	['Neutral']
Expired IRB approval	['Business_Administrative']	['Possibly_Negative']
5 patients on tivicay had virological failure	['Safety_Sideeffects', 'Logistics_Resources', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
The study had been cancelled and replaced with protocol 20130250.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
The trial was prematurely terminated due to slow recruitment.	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Poor patient accrual	['Insufficient_Enrollment']	['Neutral']
The device is undergoing further study in China, per FDA requirements.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Intervention not implemented as planned	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
amendment pending	['Study_Design']	['Neutral']
Never able to get any subjects enrolled	['Insufficient_Enrollment']	['Neutral']
Sponsor withdrew funds	['Business_Administrative']	['Possibly_Negative']
Investigator is no longer employed in study site	['Study_Staff_Moved']	['Neutral']
logistical challenges	['Logistics_Resources']	['Neutral']
Product class one recall	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Trial closed due to low accrual	['Insufficient_Enrollment']	['Neutral']
safety issues	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"A strategic restructuring including the planned conclusion of clinical oncology development
    programs and no further sponsoring of the development of SD-101."	['Business_Administrative']	['Possibly_Negative']
Terminated due to no new subject enrollment during the last 3 year period.	['Insufficient_Enrollment']	['Neutral']
Poor recruitment, strong evidence from larger trials of no therapeutic benefit	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of funds	['Business_Administrative']	['Possibly_Negative']
Failure to recruit.	['Insufficient_Enrollment']	['Neutral']
Study enrollment was prematurely stopped.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Research cancelled	['Invalid_Reason']	['Invalid_Reason']
CE mark will not be renewed, PMCF data no longer required	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Primary endpoint reached futility boundary	['Endpoint_Met', 'Negative']	['Neutral', 'Negative']
"Study terminated per recommendation of iDMC. On iDMC request, protocol amended to include
    4-month safety follow-up for patients after withdrawal of riociguat."	['Regulatory', 'Insufficient_Enrollment', 'Negative']	['Neutral', 'Neutral', 'Negative']
PI decided not to pursue this study.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Lack of subjects	['Insufficient_Enrollment']	['Neutral']
COVID-19 Control Measures	['Covid19']	['Neutral']
Unable to accrue subjects to the study.	['Insufficient_Enrollment']	['Neutral']
Lack of Enrollment	['Insufficient_Enrollment']	['Neutral']
Low Accrual Rate	['Insufficient_Enrollment']	['Neutral']
FDA has placed the trial on full clinical hold.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
funding not available	['Business_Administrative']	['Possibly_Negative']
failed recruitment efforts	['Insufficient_Enrollment']	['Neutral']
there was no eligible patients	['Insufficient_Enrollment']	['Neutral']
Interim Analysis results	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
Insufficient recruitment pace	['Insufficient_Enrollment']	['Neutral']
"Change of PI. Former PI changed from Research Center and Promoter obliged unexpectedly to
    change the PI."	['Study_Staff_Moved']	['Neutral']
Study was terminated by the sponsor for lack of evidence of superiority and slow study accrual.	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Recruitment target could not be met	['Insufficient_Enrollment']	['Neutral']
closed early with no results/no data collected.	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Recruitment Difficulty	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
FDA approved synovial biopsy device unavailable	['Interim_Analysis', 'Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Recruitment slow as single center conducting in rare disease	['Insufficient_Enrollment']	['Neutral']
Inability to meet the accrual target of 213.	['Insufficient_Enrollment']	['Neutral']
Slow patient enrolment	['Insufficient_Enrollment']	['Neutral']
funding ceased	['Business_Administrative']	['Possibly_Negative']
Due to poor accrual	['Insufficient_Enrollment']	['Neutral']
insufficient number of inclusion	['Insufficient_Enrollment']	['Neutral']
The study PI left the institution in early 2015.	['Study_Staff_Moved']	['Neutral']
The study was closed due to poor accrual. No patients were enrolled.	['Insufficient_Enrollment']	['Neutral']
This study was never funded therefore no patients were enrolled.	['Business_Administrative']	['Possibly_Negative']
"Financial support of the Study withdrawn by Nuvolase, Inc ( PinPointe FootLaser) due to delayed
    start of the Study and inadequate subjects enrolled"	['Business_Administrative']	['Possibly_Negative']
Terminated due to poor accrual	['Insufficient_Enrollment']	['Neutral']
Study halted prematurely and will not resume; participants are no longer being examined.	['Invalid_Reason']	['Invalid_Reason']
Planning for randomized phase III trial for this issue.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
no more patient	['Insufficient_Enrollment']	['Neutral']
Investigator on medical leave, and difficult recruitment	['Insufficient_Enrollment']	['Neutral']
Change of research focus	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
The study met the pre-specified criteria for stopping the trial	['Interim_Analysis', 'No_Context', 'Regulatory']	['Neutral', 'Invalid_Reason', 'Neutral']
Equipment failure	['Logistics_Resources']	['Neutral']
The project has ended prior to beginning.	['Invalid_Reason']	['Invalid_Reason']
The study has been suspended for slower than anticipated enrollment to date.	['Insufficient_Enrollment']	['Neutral']
Trial no longer occurring.	['Invalid_Reason']	['Invalid_Reason']
Stopped at interim analyses phase due to lack of efficacy	['Negative']	['Negative']
Sponsor's decision	['Business_Administrative']	['Possibly_Negative']
Unfavourable benefit:risk	['Negative']	['Negative']
PI moved to a different institution	['Study_Staff_Moved']	['Neutral']
Original PI left institution.	['Study_Staff_Moved']	['Neutral']
Researcher leading the study moved institutions study not feasible	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
The study never started since it did not receive IRB approval	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study termination by the Sponsor	['Business_Administrative']	['Possibly_Negative']
insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
this study does not need to get a clinicaltrials number	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"Many study exits (many deaths, aggravations) that we had anticipated (but not enough). The
    patients did not stay long enough in the department to complete the protocol (many study exits
    that we had not anticipated)."	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
insufficient accrual	['Insufficient_Enrollment']	['Neutral']
Study did not start.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
We found out that there is another study on the same issue	['Negative', 'Another_Study']	['Negative', 'Neutral']
Failure to enroll/recruit	['Insufficient_Enrollment']	['Neutral']
short of participants	['Insufficient_Enrollment']	['Neutral']
Study was combined with Mayo protocol 07-003476	['Negative', 'Another_Study']	['Negative', 'Neutral']
Accrual factor	['Insufficient_Enrollment']	['Neutral']
Sponsor decision due to change in strategy	['Business_Administrative']	['Possibly_Negative']
"The study is cancelled due to reassessment of the medical need for the vaccine in India.
    Cancellation is not related to vaccine's safety and/or efficacy."	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
On hold due to COVID-19 outbreak	['Covid19']	['Neutral']
found not enough centers for recruitment	['Insufficient_Enrollment']	['Neutral']
Study was not funded	['Business_Administrative']	['Possibly_Negative']
Unable to find enough patients who accept randomization of surgical procedures.	['Insufficient_Enrollment']	['Neutral']
Inadequate accrual rate	['Insufficient_Enrollment']	['Neutral']
insufficient data	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
"Revised protocol to such a significant degree that we simply closed this study and started a
    new study."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Low recruitment	['Insufficient_Enrollment']	['Neutral']
Superiority was no longer attainable	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
No subjects enrolled and no ongoing funding.	['Business_Administrative']	['Possibly_Negative']
Closed by study sponsor; PI left the institution; responsible party changed to Columbia	['Study_Staff_Moved']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsor's decision (non-safety related)	['Business_Administrative']	['Possibly_Negative']
Contract Issues	['Business_Administrative']	['Possibly_Negative']
"This study has been cancelled before initiation due to company's prioritisation decisions
    linked to resources restrictions."	['Business_Administrative']	['Possibly_Negative']
Not funded	['Business_Administrative']	['Possibly_Negative']
not meeting enrollment criteria	['Insufficient_Enrollment']	['Neutral']
Study not initiated	['Invalid_Reason']	['Invalid_Reason']
Terminated because preliminary data suggested no difference in the strategies.	['Negative']	['Negative']
Study recruitment completed.	['Invalid_Reason']	['Invalid_Reason']
Lack of financial support	['Business_Administrative']	['Possibly_Negative']
Principal Investigator has relocated.	['Study_Staff_Moved']	['Neutral']
USAF Regulatory Concerns	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Main investigator has left the department and therefore the study had ended	['Study_Staff_Moved']	['Neutral']
Availability of Investigational agent	['Logistics_Resources']	['Neutral']
Study cancelled without recruitment	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
insufficient staff to complete recruitment	['Insufficient_Enrollment']	['Neutral']
Enrollment lower than expected	['Insufficient_Enrollment']	['Neutral']
Because the rate of recruitment was very slow	['Insufficient_Enrollment']	['Neutral']
"Wk 52 primary endpoint results would be unaffected by follow-up data so trial was discontinued
    prior to wk 104. No safety data was collected after wk 52."	['Endpoint_Met', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Protocol stopping criteria (safety) were met.	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Never started or submitted to IRB	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Collaborator was not clear on how best to proceed with this project.	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Terminated due to low accrual. No data analyzed.	['Insufficient_Enrollment']	['Neutral']
Competition with other ongoing projects with this population.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
"The study did not demonstrate evidence of efficacy on the primary or secondary efficacy
    variables"	['Negative']	['Negative']
"First two patients enrolled after trial reopened, developed grade III-IV acute GVHD and
    subsequently passed away."	['Safety_Sideeffects', 'Endpoint_Met', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
"Device superceded by next generation device. Enrollment stopped, long term follow up was
    completed in August of 2004."	['Study_Design']	['Neutral']
"We chose to maximize this iterative treatment development study by terminating the pilot RCT in
    favor of enhancing an initial open trial (increased N 12 to 14)"	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
An alternative smoking cessation study received funding and will be completed instead	['Business_Administrative']	['Possibly_Negative']
Study terminated due to insufficient subject participation	['Insufficient_Enrollment']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Request for the study waived by Indian Health Authorities	['Regulatory', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
Lack of subject response	['Insufficient_Enrollment', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Technical issues	['Logistics_Resources']	['Neutral']
funding for project discontinued	['Business_Administrative']	['Possibly_Negative']
Project did not receive funding	['Business_Administrative']	['Possibly_Negative']
Due to COVID-19	['Covid19']	['Neutral']
PI deceased	['Study_Staff_Moved']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Difficulties to recruit the patients following the inclusion criteria	['Insufficient_Enrollment']	['Neutral']
Barrel shaped interdental brush went out of production	['Logistics_Resources']	['Neutral']
We have decided not to test the newly designed TENS device	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Due to enrollment challenges. The termination is not a consequence of any safety concern.	['Insufficient_Enrollment']	['Neutral']
inclusion difficult	['Insufficient_Enrollment']	['Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
This study will be incorporated into another study.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Difficulty Enrolling	['Insufficient_Enrollment']	['Neutral']
Corporate decision	['Business_Administrative']	['Possibly_Negative']
The study was not activated	['Invalid_Reason']	['Invalid_Reason']
product development was cancelled	['Business_Administrative']	['Possibly_Negative']
"The study was terminated prematurely due to the COVID-19 pandemic creating uncertainty
    impacting trial progress and costs."	['Covid19']	['Neutral']
Failure to recruit designed nuimebrt of subjects	['Insufficient_Enrollment']	['Neutral']
"Drug sold to Sanofi-Aventis who sold it to GSK; OBS no longer owns study and does not have
    data."	['Business_Administrative']	['Possibly_Negative']
poor recruitment	['Insufficient_Enrollment']	['Neutral']
Withdrawn due to poor accrual	['Insufficient_Enrollment']	['Neutral']
The study was terminated because of lack of funding.	['Business_Administrative']	['Possibly_Negative']
Funding ended	['Business_Administrative']	['Possibly_Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
Financial decision	['Business_Administrative']	['Possibly_Negative']
difficulties in recruiting study participants	['Insufficient_Enrollment']	['Neutral']
Study was prematurely terminated because of missing data collection.	['Logistics_Resources', 'Insufficient_Enrollment', 'Insufficient_Data']	['Neutral', 'Neutral', 'Neutral']
Slow recruitment, schanges in standard treatment	['Insufficient_Enrollment']	['Neutral']
The study was closed before 2017 due to inconclusive results from Lab	['Negative', 'Another_Study']	['Negative', 'Neutral']
The primary investigator moved.	['Study_Staff_Moved']	['Neutral']
Study underwent major protocol changes prior to planned enrollment	['Study_Design']	['Neutral']
PI (Prof. Slavin) not longer work at Hadassah	['Study_Staff_Moved']	['Neutral']
"Stopped for benefit of the MPFL reconstruction arm and due to safety concerns of the medial
    reefing arm."	['Interim_Analysis', 'Safety_Sideeffects', 'Endpoint_Met']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Study stopped due to business reasons.	['Business_Administrative']	['Possibly_Negative']
Policy changes have contributed to the failure to carry out smoothly	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Slow recruitment rate	['Insufficient_Enrollment']	['Neutral']
Primary endpoint showed no stat significant difference. FU > M12 terminated.	['Negative']	['Negative']
Lack of funds	['Business_Administrative']	['Possibly_Negative']
Administrative	['Business_Administrative']	['Possibly_Negative']
Drug company withdrawal of support for investigational agent in this indication.	['Business_Administrative']	['Possibly_Negative']
Temporarily suspended due to Pandemic.	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Principal investigator left institution.	['Study_Staff_Moved']	['Neutral']
"This basic science study was using a microelectrode array device for scientific purposes only.
    This study does not meet the definition of a ACT under 42 CFR 11.22. The PI has decided to
    discontinue the study."	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Low accrual rate	['Insufficient_Enrollment']	['Neutral']
Investigator terminated trial pursuant to research contract rights.	['Business_Administrative']	['Possibly_Negative']
Increased number of oxygen desaturation in tilt down position	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Poor enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment interest.	['Insufficient_Enrollment']	['Neutral']
Principal investigator left the National Institutes of Health (NIH).	['Study_Staff_Moved']	['Neutral']
Not able to recruit any subjects for the study and was closed in February 2008	['Insufficient_Enrollment']	['Neutral']
withdrew due to funding	['Business_Administrative']	['Possibly_Negative']
feasibility issues	['Logistics_Resources']	['Neutral']
"On the basis of published results of SMART study, it has been observed that the results are
    worse in patients who have interrupted their treatments."	['Negative', 'Another_Study']	['Negative', 'Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
Lack of Subject enrollment	['Insufficient_Enrollment']	['Neutral']
KaloBios to Wind Down Operations	['Business_Administrative']	['Possibly_Negative']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
PI pulled the study. No participants.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Recruit completed	['Invalid_Reason']	['Invalid_Reason']
PI left the institution	['Study_Staff_Moved']	['Neutral']
"Interim Analysis showed that study continuation was futile. No safety concerns were raised
    during the trial."	['Negative']	['Negative']
not enough available families to get significant genetic results	['Insufficient_Enrollment']	['Neutral']
Decision by funding sponsor due to poor accrual	['Insufficient_Enrollment']	['Neutral']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
The pivotal study, BPS-314d-MR-PAH-302 (NCT01908699), failed to demonstrate efficacy.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Protocol revisions	['Study_Design']	['Neutral']
Vendor equipment agreement expired	['Business_Administrative']	['Possibly_Negative']
Study couldnt start due to investigator	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
"Based on the data and observed benefit-risk profile, the trial's independent oversight
    committee recommended that enrollment not resume."	['Negative']	['Negative']
PI does not have time to continue study	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
Project never received funding.	['Business_Administrative']	['Possibly_Negative']
no patients were enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Poor recrual.	['Insufficient_Enrollment']	['Neutral']
due to low follow up	['Negative', 'Business_Administrative']	['Negative', 'Possibly_Negative']
The study was not feasible.	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
business decision	['Business_Administrative']	['Possibly_Negative']
Study halted with no registration, the drug company sponsor withdrew support.	['Business_Administrative']	['Possibly_Negative']
Overhaul of Study Design	['Study_Design']	['Neutral']
With recent advances in immunotherapy scientific question not significant	['No_Context', 'Logistics_Resources', 'Insufficient_Data']	['Invalid_Reason', 'Neutral', 'Neutral']
Unable to enroll subjects	['Insufficient_Enrollment']	['Neutral']
According to the available data from the trialthe sponsor determined to terminate this study.	['Logistics_Resources', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
"DePuy discontinued this product in 4Q 2009.At the time of this decision DePuy reviewed all
    clinical studies for this product and decided to close this Study."	['Regulatory', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
COVID-19 Control Measures	['Covid19']	['Neutral']
Low Accrual	['Insufficient_Enrollment']	['Neutral']
Unable to keep patients attending yoga sessions	['Study_Design']	['Neutral']
PI decision	['Invalid_Reason']	['Invalid_Reason']
The site decided to stop the study	['Invalid_Reason']	['Invalid_Reason']
low enrollment	['Insufficient_Enrollment']	['Neutral']
Recruitment problems	['Insufficient_Enrollment']	['Neutral']
Please see Detailed Description for termination reason.	['No_Context']	['Invalid_Reason']
"Enrollment and/or interactions/interventions temporarily paused due to COVID-19 and expected to
    resume in the future. This is not a suspension of IRB approval."	['Covid19']	['Neutral']
PK time points were not being met as expected. Determination that risks outweighed benefit.	['Negative']	['Negative']
The trial has been terminated early due to the SARS-CoV-2 pandemic.	['Covid19']	['Neutral']
Change of practice pattern. Green light laser	['Study_Design']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Participants constantly reported knee pain.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Material issues. Re-start in assessment	['Logistics_Resources']	['Neutral']
This study was terminated early because the primary endpoint of PARAGON-HF was not met.	['Negative']	['Negative']
resource reallocation	['Logistics_Resources']	['Neutral']
slow recruitment	['Insufficient_Enrollment']	['Neutral']
Ethics Committee approval denied	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Study has been terminated due to slow enrollment.	['Insufficient_Enrollment']	['Neutral']
Study never opened	['Invalid_Reason']	['Invalid_Reason']
"Discontinued due to poor enrollment. Insufficient number of patients enrolled to permit a
    statistically rigorous assessment of safety and efficacy."	['Insufficient_Enrollment']	['Neutral']
Not enough patients	['Insufficient_Enrollment']	['Neutral']
Study has been suspended due to clinical hold.	['Invalid_Reason']	['Invalid_Reason']
Suspended due to COVID-19 pandemic	['Covid19']	['Neutral']
Per recommendation from DRT	['Interim_Analysis', 'Regulatory', 'Negative']	['Neutral', 'Neutral', 'Negative']
Drug supply issues	['Logistics_Resources']	['Neutral']
lack of response activity in the setting of an unacceptable toxicity profile	['Safety_Sideeffects', 'Endpoint_Met', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
"Per FDA CBER letter dated July 15, 2015, Kedrion SpA was released from the PMC to perform the
    study with Kedbumin 25% in pediatric patients."	['Regulatory', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
the study failed in recruiting the required number of subjects (sample size) during its period	['Insufficient_Enrollment']	['Neutral']
Very poor enrollment	['Insufficient_Enrollment']	['Neutral']
After a reliability pilot, main study stopped due to unrelated clinic closure.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
determined not to be human subjects research	['Invalid_Reason']	['Invalid_Reason']
There was less patients recruited.	['Insufficient_Enrollment']	['Neutral']
poor enrollment	['Insufficient_Enrollment']	['Neutral']
The number of the anticipated participants was not achieved	['Insufficient_Enrollment']	['Neutral']
Unable to enroll elegible subjects. No subjects enrolled, study closed.	['Insufficient_Enrollment']	['Neutral']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
No patients were enrolled in the study.	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Study withdrawn by supporter	['Business_Administrative']	['Possibly_Negative']
"Surgical practice evolution changed acceptable standard of care and lead to potential
    enrollment bias."	['Study_Design']	['Neutral']
"This study should be terminated as the study closed prior to 2007 and the investigator has
    since retired. No records are available."	['No_Context', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
Depletion of Funds and Illness of principal investigator	['Business_Administrative']	['Possibly_Negative']
Please see Detailed Description below for termination reason.	['No_Context']	['Invalid_Reason']
Device is no longer available	['Logistics_Resources']	['Neutral']
Study was withdrawn due to lack of resources.	['Logistics_Resources']	['Neutral']
Inability to further include additional patients	['Insufficient_Enrollment']	['Neutral']
Interim analyses demonstrated futility. Thus, recruitment curtailed 10/08.	['Negative']	['Negative']
Colloborating sponsor decision.	['Business_Administrative']	['Possibly_Negative']
"Attempts to recruit eligible subjects revealed that it would not be possible to enroll adequate
    numbers. Thus- no subjects were enrolled."	['Insufficient_Enrollment']	['Neutral']
Technical difficulties	['Logistics_Resources']	['Neutral']
COVID restrictions	['Covid19']	['Neutral']
Finding not secured	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
PI no longer interested in pursuing study.	['Study_Staff_Moved', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
"In the light of the on-going COVID-19 pandemic and the resulted difficulty in patient
    recruitment."	['Covid19']	['Neutral']
lack of funding	['Business_Administrative']	['Possibly_Negative']
Reallocation of resources to new HCC study.	['Business_Administrative']	['Possibly_Negative']
No recruitment	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Enrollment and study activities are temporarily suspended due to COVID-19.	['Covid19']	['Neutral']
Lack of Accrual	['Insufficient_Enrollment']	['Neutral']
The principal investigator decided to stop the study.	['Invalid_Reason']	['Invalid_Reason']
"Inability to reliably measure plasma oxytocin levels during third stage labour, regardless of
    administration method (intramuscular or inhaled)."	['Interim_Analysis', 'Logistics_Resources', 'Negative']	['Neutral', 'Neutral', 'Negative']
The study was cancelled prior to the enrollment of any participants.	['Invalid_Reason']	['Invalid_Reason']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Insufficient microRNA for the analysis	['Logistics_Resources', 'Insufficient_Data', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
This study was cancelled before enrolling any patients for business related reasons.	['Business_Administrative']	['Possibly_Negative']
Others	['Covid19', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Cancelled by PI	['No_Context', 'Study_Staff_Moved', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
Study terminated due to contamination droxidopa	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
"Several factors contributed to significant challenges in enrollment and led the Sponsor to
    discontinue the AMAG-FER-CKD-252 study as designed."	['Covid19', 'Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Manufacture didn't provide enough information for submitting IRB approval	['Logistics_Resources', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
"All patients were recruted but it has been difficulte to recrute all volunteers (15/30) .
    However data should be sufficient for analyse of data."	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
The results were not able to be consistantly reproduced. Thus the trial was terminated	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Study discontinued due to Approvable decision	['Covid19', 'Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
other upcoming studies; patients refusal of invasive follow up (DMSA)	['Negative', 'Another_Study']	['Negative', 'Neutral']
Existing vessel analysis software could not be applied to breast MRI data.	['Logistics_Resources']	['Neutral']
Business decision due to low subject recruitment and enrollment	['Business_Administrative']	['Possibly_Negative']
Study was terminated due to lack of funding.	['Business_Administrative']	['Possibly_Negative']
lack of effectiveness	['Negative']	['Negative']
No Funding	['Business_Administrative']	['Possibly_Negative']
"Study was terminated on 22Dec2017 due to slow enrollment; there were no safety or efficacy
    concerns."	['Insufficient_Enrollment']	['Neutral']
Lack of funding.	['Business_Administrative']	['Possibly_Negative']
insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsor is focusing on studies which can enable registration of duvelisib	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Insufficient financial resources to conduct research and complete trial.	['Business_Administrative']	['Possibly_Negative']
no patient corresponding to criteria	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
study size reached	['Invalid_Reason']	['Invalid_Reason']
Lack of resources.	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
"It was very difficult to fulfill the inclusion criteria, therefore the expected time of
    inclusion was delayed so much time."	['Insufficient_Enrollment']	['Neutral']
"The 16 subjects enrolled in the study should enable Amgen to adequately assess safety and
    tolerabili"	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Replaced by a new study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Recruitment challenges and not due to safety concerns.	['Insufficient_Enrollment']	['Neutral']
"The final assessments were conducted late and in a reduced format due to resource limitations
    at the site."	['Logistics_Resources']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
IRB process never completed.	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Clinical Hold from FDA	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Difficulties with protocol compliance in both arms. Will simplify protocol.	['Study_Design']	['Neutral']
important delays and malaria season missed, due to political changes	['Logistics_Resources', 'Insufficient_Enrollment', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Inadequate funding to support this fellow-in-training initiated study.	['Business_Administrative']	['Possibly_Negative']
Terminated because funding was not found	['Business_Administrative']	['Possibly_Negative']
Temporarily suspended due to COVID-19 pandemic.	['Covid19']	['Neutral']
Amgen decision (business)	['Business_Administrative']	['Possibly_Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Suspension of licence for rimonabant by European Medicines Agency	['Regulatory']	['Neutral']
"This study has been cancelled before initiation due to company's prioritisation decisions
    linked to resources restrictions."	['Business_Administrative']	['Possibly_Negative']
due to corona pandemic crisis	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Not enough patient recruited	['Insufficient_Enrollment']	['Neutral']
PI left institution	['Study_Staff_Moved']	['Neutral']
"Zn released from vehicle led to fortification levels higher than planned. New filter will be
    developed."	['Covid19', 'Interim_Analysis', 'Safety_Sideeffects']	['Neutral', 'Neutral', 'Safety_Sideeffects']
insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
Terminated for safety reasons	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
The sponsor did not fund the study.	['Business_Administrative']	['Possibly_Negative']
Difficult to recruit subjects in the area.	['Insufficient_Enrollment']	['Neutral']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Study suspended due to low accrual	['Insufficient_Enrollment']	['Neutral']
Study was terminated for business reasons.	['Business_Administrative']	['Possibly_Negative']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Corporate business decision, may consider different subject population	['Business_Administrative']	['Possibly_Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Problems implementing the trial	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
treatment substance not labled for sepsis anymore	['Logistics_Resources', 'Negative']	['Neutral', 'Negative']
Lifecell became part of Allergan; company deciscion	['Business_Administrative']	['Possibly_Negative']
Principal Investigator has transferred to another Institution	['Study_Staff_Moved']	['Neutral']
Suspended due to change in development plans and investigator	['Business_Administrative']	['Possibly_Negative']
The study was stopped when the original principal investigator moved to a new institution.	['Study_Staff_Moved']	['Neutral']
The principal investigator left the hospital	['Study_Staff_Moved']	['Neutral']
Drug was not available.	['Logistics_Resources']	['Neutral']
"Recruitment not started due to potential conflicting study at same institution. May renew study
    in the future."	['Insufficient_Enrollment']	['Neutral']
The study was stopped due to insufficient recruitment.	['Insufficient_Enrollment']	['Neutral']
Halt in funding	['Business_Administrative']	['Possibly_Negative']
PI leaving the institute for a fellowship.	['Study_Staff_Moved']	['Neutral']
Primary outcome not achieved.	['Negative']	['Negative']
Safety concerns	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Halted due to COVID-19.	['Covid19']	['Neutral']
Logistical issues	['Logistics_Resources']	['Neutral']
Not enough data to analyze the results.	['Success', 'Logistics_Resources', 'Study_Staff_Moved']	['Success', 'Neutral', 'Neutral']
Slow accrual and funding limitations.	['Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Due to potential concerns about liver safety (See Detailed Description)	['Covid19', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Due to a business decision to stop the project, the study was terminated early.	['Business_Administrative']	['Possibly_Negative']
The drug is not available	['Logistics_Resources']	['Neutral']
Futility analysis did not support continuation of the trial	['Negative']	['Negative']
inefficiency	['Safety_Sideeffects', 'Logistics_Resources', 'Endpoint_Met']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Insufficient efficacy in an unselected patient population	['Negative']	['Negative']
The study is currently suspended due to the COVID19 crisis	['Covid19']	['Neutral']
"In the perioperative setting of radical cystectomy-bladder replacement no improvement of UTI
    was noticed in 10 patients who took Urell following the protocol"	['Negative']	['Negative']
Difficulties in recruitment	['Insufficient_Enrollment']	['Neutral']
Data collection and recruitment has been suspended due to the COVID-19 pandemic	['Covid19']	['Neutral']
Principle investigator left the institution	['Study_Staff_Moved']	['Neutral']
The sponsor decided to withdraw the study.	['Business_Administrative']	['Possibly_Negative']
Study never initiated due to contract manufacturing issues	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
corona virus	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Study was terminated before a MTD was determined for administrative reasons	['Business_Administrative']	['Possibly_Negative']
The study was terminated due to the impacts of COVID-19 on patient safety and enrollment.	['Covid19']	['Neutral']
Frequent adverse events occurred early in treatment with poor tolerability.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Recommendation by study DSMC to the sponsor following interim analysis of 8 subjects.	['Negative']	['Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
failed to recruit, no suitable patients	['Insufficient_Enrollment']	['Neutral']
Insufficient staff	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
logistics reasons	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
All of the mentioned aim and objectives were achieved before the February 2007	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
The study was unable the accrue the required number of patients within a reasonable time.	['Insufficient_Enrollment']	['Neutral']
Funding withdrawn	['Business_Administrative']	['Possibly_Negative']
Study terminated due to funding issues	['Business_Administrative']	['Possibly_Negative']
post transfer of company ownership from Smith & Nephew to Bioventus LLC	['Business_Administrative']	['Possibly_Negative']
Lack of efficacy based on interim analysis	['Negative']	['Negative']
We were not able to recruit families	['Insufficient_Enrollment']	['Neutral']
Major difficulties of patient inclusions	['Insufficient_Enrollment']	['Neutral']
Data was not collected, because funding was unavailable to continue study.	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Unable to get product at this time	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Residency completed.	['Invalid_Reason']	['Invalid_Reason']
"Treament with rituximab during maintenance phase was stoped, according to DSMC recommendations,
    since 3 cases of deaths occured."	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
Due to lack of funding the study was terminated early	['Business_Administrative']	['Possibly_Negative']
Sponsor request	['Business_Administrative']	['Possibly_Negative']
Problems with execution	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Low rate of accrual.	['Insufficient_Enrollment']	['Neutral']
Study was terminated due to cardiac toxicities in the subjects	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Did not receive sensors from device company and did not initiate enrollment.	['Business_Administrative']	['Possibly_Negative']
"Study treatment AFQ056 failed to demonstrate efficacy in the adult patient with Fragile X
    Syndrome in 2 other clinical studies (CAFQ056B2214 and CAFQ056A2212)"	['Negative', 'Another_Study']	['Negative', 'Neutral']
Difficult recruitment	['Insufficient_Enrollment']	['Neutral']
Unable to recruit	['Insufficient_Enrollment']	['Neutral']
Sponsor's decision	['Business_Administrative']	['Possibly_Negative']
Low patient recruitment	['Insufficient_Enrollment']	['Neutral']
Change of Trial Sponsor	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Difficulty enrolling	['Insufficient_Enrollment']	['Neutral']
Lack of funding prevented further recruitment	['Business_Administrative']	['Possibly_Negative']
Funding problem.	['Business_Administrative']	['Possibly_Negative']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Contract terminated with Site Management Organization	['Business_Administrative']	['Possibly_Negative']
The sponsor has notified us that they are not funding the study	['Business_Administrative']	['Possibly_Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
The interim analysis has shown a significative difference between the two groups of patients.	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
research facilities temporarily closed due to COVID-19	['Covid19']	['Neutral']
slow recruitment and change in regulatory landscape	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Poor compliance with the therapy and lot of patients were lost to follow up.	['Study_Design']	['Neutral']
"lack of public funding; planned control arm with Hydroxychloroquine treatment showed out as not
    being standard of care anymore as time evolved."	['Business_Administrative']	['Possibly_Negative']
Did not have study population to continue	['Insufficient_Enrollment']	['Neutral']
Site PI left position and lack of a suitable replacement PI.	['Study_Staff_Moved']	['Neutral']
Early termination due to PI's decision to discontinue research activities.	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
due to introduction of another integrase inhibitor, recruitement was not feasible anymore.	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
no time	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Terminated due to failure to meet the primary efficacy endpoint in the Short-term Period	['Negative']	['Negative']
Stopping rules met	['Invalid_Reason']	['Invalid_Reason']
Study stopped due to a lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
"Retrospective record review only (no subject enrollment). Contract never executed between
    Sponsor and Site."	['Business_Administrative']	['Possibly_Negative']
The outpatient area of the department of psychiatry at CSMC closed.	['Study_Staff_Moved']	['Neutral']
Business Decision	['Business_Administrative']	['Possibly_Negative']
One of the investigators has left the institution	['Study_Staff_Moved']	['Neutral']
The PI decided.	['Invalid_Reason']	['Invalid_Reason']
Global sales of the Absorb BVS halted effective September 14, 2017.	['Business_Administrative']	['Possibly_Negative']
The trial was prematurely terminated due to a lack of efficacy of the investigational drug.	['Negative']	['Negative']
PI left institution	['Study_Staff_Moved']	['Neutral']
Interim analysis showed statistically significant results	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
The requirement for Post Marketing Surveillance was lifted by the Philippine FDA	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Covid-19	['Covid19']	['Neutral']
lack of suitable patients	['Insufficient_Enrollment']	['Neutral']
Study terminated due to slow accrual.	['Insufficient_Enrollment']	['Neutral']
Phase 1 studies are not performed in Saudi Arabia yet	['Invalid_Reason', 'Study_Design', 'Negative']	['Invalid_Reason', 'Neutral', 'Negative']
impossible to enroll participants	['Insufficient_Enrollment']	['Neutral']
Changes in departmental staff have led to a cut in research alotments.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
No subjects enrolled due to delay in device production	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Recruitment could not be completed	['Insufficient_Enrollment']	['Neutral']
The program is canceled due to company strategic reasons.	['Business_Administrative']	['Possibly_Negative']
"The study is temporarily suspended due to preclinical findings that are currently under
    evaluation"	['Success', 'Endpoint_Met', 'Negative']	['Success', 'Neutral', 'Negative']
Hiring freeze of research personnel due to COVID pandemic	['Covid19']	['Neutral']
patient did not enroll	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Development plan under review.	['Regulatory', 'Invalid_Reason', 'Negative']	['Neutral', 'Invalid_Reason', 'Negative']
Stopped due to slow inclusion	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Pharmaceutical company has terminated orteronel (TAK-700) development for Prostate Cancer	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Difficulty recruiting participants	['Insufficient_Enrollment']	['Neutral']
Due to graft failure.	['Logistics_Resources', 'Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Loss of laboratory performing molecular analysis	['Logistics_Resources', 'Study_Staff_Moved']	['Neutral', 'Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
Progressive Disease	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Technical and administrative problems	['Business_Administrative']	['Possibly_Negative']
"Study stopped not for safety reasons. Due to review of clinical development plans and
    priorities, Sponsor decided to stop development of the product."	['Business_Administrative']	['Possibly_Negative']
Funding Unavailable	['Business_Administrative']	['Possibly_Negative']
Withdrawn due to slow enrollment	['Insufficient_Enrollment']	['Neutral']
"Date of termination was Feb. 7, 2008. Reasons of termination were due to elevation of liver
    function tests and long elimination half-life of the compound."	['Interim_Analysis', 'No_Context', 'Safety_Sideeffects']	['Neutral', 'Invalid_Reason', 'Safety_Sideeffects']
Study discontinued	['Invalid_Reason']	['Invalid_Reason']
Company Decision	['Business_Administrative']	['Possibly_Negative']
"Due to the company's intent to conduct a new study under a different protocol with the smART+
    System which is a more advanced version of the smART System"	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Centers would not continue follow-up; two centers transitioned patients to a new study.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Unable to find patients	['Insufficient_Enrollment']	['Neutral']
Lack of patients compatible with the protocols criteria	['Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral']
"The study was terminated after the European Medicines Agency recommended to suspend the
    marketing authorisation of Raptiva in the European Union"	['Study_Design']	['Neutral']
Interim assessment: Lack of efficacy	['Negative']	['Negative']
Slow enrollment due to multiple screen failures	['Insufficient_Enrollment']	['Neutral']
Terminated to focus on a larger study within the clinical development program.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Investigator left institution	['Study_Staff_Moved']	['Neutral']
Compound terminated	['Invalid_Reason']	['Invalid_Reason']
no enrollment	['Insufficient_Enrollment']	['Neutral']
Slow Accrual - Only 1 patient enrolled in Phase 1 - Study never went to Phase II	['Insufficient_Enrollment']	['Neutral']
lack of efficacy	['Negative']	['Negative']
PI leaving institution	['Study_Staff_Moved']	['Neutral']
based on outcome of previous study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Insufficient Accrual	['Insufficient_Enrollment']	['Neutral']
Extremely slow enrollment	['Insufficient_Enrollment']	['Neutral']
"Study was prematurely terminated at the time of the first Interim Analysis (IA) as the study
    did not meet its primary efficacy objective."	['Negative']	['Negative']
Lack of patient enrollment.	['Insufficient_Enrollment']	['Neutral']
lack of recruitment	['Insufficient_Enrollment']	['Neutral']
Change in operating plans	['Business_Administrative']	['Possibly_Negative']
No Resources - No Personnel	['Logistics_Resources']	['Neutral']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
"decision of independent monitoring committee:Risk of death at 3 months higher in Albumin group
    than in control group, without reaching significance level."	['Negative']	['Negative']
"Termination due to relevant update of the operation system. Adaption of the application was not
    foreseen in the intervention study."	['Study_Design']	['Neutral']
Study was terminated because funding could not be secured	['Business_Administrative']	['Possibly_Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
insufficient recruitement speed	['Insufficient_Enrollment']	['Neutral']
"The study was terminated for business reasons and not due to any safety or efficacy concerns
    related to dalotuzumab."	['Business_Administrative']	['Possibly_Negative']
The number of responders in the test sessions was too low.	['Insufficient_Enrollment']	['Neutral']
"Due to former trials, drug has not demonstrated a clinical profile sufficient to move forward
    in mCRPC"	['Negative', 'Another_Study']	['Negative', 'Neutral']
no more inclusions	['Insufficient_Enrollment']	['Neutral']
Stopped early for futility, unable to meet accrual goals	['Insufficient_Enrollment']	['Neutral']
Study was closed due to administrative reasons; study did not enroll any participants.	['Business_Administrative']	['Possibly_Negative']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
Loss of funding	['Business_Administrative']	['Possibly_Negative']
the protocol is too complex and we are not able to recruit appropriate patients	['Insufficient_Enrollment']	['Neutral']
Futility	['Negative']	['Negative']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Manufacture of drug discontinued before any participants could be enrolled.	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
There were insufficient numbers recruited before the end of the student project	['Insufficient_Enrollment']	['Neutral']
Withdrawn by Principal Investigator	['Study_Staff_Moved', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Study was prematurely terminated.	['Invalid_Reason']	['Invalid_Reason']
Accrual was suboptimal and increasing the number of patients was not feasible.	['Insufficient_Enrollment']	['Neutral']
See Detailed Description	['No_Context']	['Invalid_Reason']
Organizational barriers	['Business_Administrative']	['Possibly_Negative']
Investigator retired. Other investigators did not want to continue study.	['Study_Staff_Moved']	['Neutral']
Study terminated due to slow patient recruitment.	['Insufficient_Enrollment']	['Neutral']
device not found to be adequate	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
"The decision to terminate this study after 202 mg/m2 cohort was taken as MTD achieved in other
    study at 185 mg/m2"	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Not enough inclusions.	['Insufficient_Enrollment']	['Neutral']
Recruitment issue: Enrollment expectation not met	['Insufficient_Enrollment']	['Neutral']
Astora business is closing	['Business_Administrative']	['Possibly_Negative']
Terminated by Sponsor of this study.	['Business_Administrative']	['Possibly_Negative']
The compound is being re-evaluated	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Investigator decided to withdraw participation in the study	['Business_Administrative']	['Possibly_Negative']
I have changed my center and gone to another center	['Study_Staff_Moved', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Strategic considerations	['Business_Administrative']	['Possibly_Negative']
Insufficient recruitment of study patients	['Insufficient_Enrollment']	['Neutral']
business reasons	['Business_Administrative']	['Possibly_Negative']
new medications with improved response released, nonaccrual	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Recruiting problems	['Insufficient_Enrollment']	['Neutral']
A new study is being designed. No patients were enrolled.	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Company decision not to pursue prior to submission	['Business_Administrative']	['Possibly_Negative']
Withdrawn due to low accrual	['Insufficient_Enrollment']	['Neutral']
manufacturing-related issues	['Logistics_Resources']	['Neutral']
The neutron facility closed down for financial reasons.	['Business_Administrative']	['Possibly_Negative']
0	['No_Context', 'Insufficient_Enrollment', 'Invalid_Reason']	['Invalid_Reason', 'Neutral', 'Invalid_Reason']
Recruiting patients too low	['Insufficient_Enrollment']	['Neutral']
Study was closed and reopened as NCT01717391	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
"This study did not complete enrollment due to COVID-19. Institutional constraints prevented
    this study from continuing and the study team no longer wishes to pursue this project."	['Covid19']	['Neutral']
lack of enrollment	['Insufficient_Enrollment']	['Neutral']
1)new FDS device design 2)improved Valsalva procedure 3)improved headbands and earpads.	['Study_Design']	['Neutral']
Reached sufficient pharmacokinetic exposures	['Interim_Analysis', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
"The app was not completed in time to conduct a clinical trial on it within the funding grant's
    award period"	['Business_Administrative']	['Possibly_Negative']
Administrative closed due to funding	['Business_Administrative']	['Possibly_Negative']
Terminated due to expiration of funding	['Business_Administrative']	['Possibly_Negative']
Extremely slow enrollment	['Insufficient_Enrollment']	['Neutral']
Enrollment and study activities are temporarily suspended due to COVID-19.	['Covid19']	['Neutral']
Low recruitment rate	['Insufficient_Enrollment']	['Neutral']
Difficult to recruit, very poor compliance with interventions	['Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral']
A business decision was made to not initiate this study.	['Business_Administrative']	['Possibly_Negative']
dyspnea	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
slow recruitment rate	['Insufficient_Enrollment']	['Neutral']
no patients who met enrollment criteria	['Insufficient_Enrollment']	['Neutral']
No participants were enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
"Closed for recruitment March 2020 due to the ongoing covid-19 situation and the termination of
    the study inclusion was done in August 2020."	['Covid19']	['Neutral']
Poor recruitment rate	['Insufficient_Enrollment']	['Neutral']
Number of patients recruited to small, no cooperation of study members	['Insufficient_Enrollment']	['Neutral']
Investigator left instititution	['Study_Staff_Moved']	['Neutral']
Change in staffing	['Logistics_Resources', 'Study_Staff_Moved', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
Enrollment and study activities are temporarily suspended due to COVID-19.	['Covid19']	['Neutral']
Replaced by another study	['Negative', 'Another_Study']	['Negative', 'Neutral']
Other - Pending evaluation of patients on study currently	['Success', 'No_Context', 'Logistics_Resources']	['Success', 'Invalid_Reason', 'Neutral']
Withdrawn due to lack of enrollment.	['Insufficient_Enrollment']	['Neutral']
administrative reasons (no impact/concern of subject rights, welfare, safety)	['Business_Administrative']	['Possibly_Negative']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
"New safety information reported in the post-marketing setting with efalizumab for treatment of
    chronic plaque psoriasis and trial conduct feasibility issues."	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Trial was suspended due unanticipated funding issues.	['Business_Administrative']	['Possibly_Negative']
Halted prematurely due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Slow Enrolling	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment as expected	['Insufficient_Enrollment']	['Neutral']
Funding ran out	['Business_Administrative']	['Possibly_Negative']
NEOD001 program terminated due to lack of clinical benefit	['Negative']	['Negative']
Safety and PK/PD data from Dose Escalation support further development; Dose Expansion canceled	['Covid19', 'Interim_Analysis', 'Success']	['Neutral', 'Neutral', 'Success']
Low patient recruitement rate and modification of the therapeutic standard	['Insufficient_Enrollment', 'Study_Design']	['Neutral', 'Neutral']
Results were obtained in another project.	['Negative', 'Another_Study']	['Negative', 'Neutral']
"The study was terminated on 10DEC2014 due to the inability to enroll the planned number of
    patients. There were no safety concerns."	['Insufficient_Enrollment']	['Neutral']
Study is being redesigned	['Study_Design']	['Neutral']
Study was terminated based on results from pivotal adult AHF study CRLX030A2301	['Negative', 'Another_Study']	['Negative', 'Neutral']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
No participants enrolled; study inactivated	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Ran out of funds	['Business_Administrative']	['Possibly_Negative']
Recruitment difficulty	['Insufficient_Enrollment']	['Neutral']
"The enrollment was terminated early because the premature analysis found similar response in
    the two arms."	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
PI left institution.	['Study_Staff_Moved']	['Neutral']
No funding was available for the cost of the IV N-acetylcysteine (NAC).	['Business_Administrative']	['Possibly_Negative']
low patient accrual	['Insufficient_Enrollment']	['Neutral']
Accrual goal met	['Invalid_Reason']	['Invalid_Reason']
"PI is no longer at University of Rochester, has moved to University of Florida, Gainesville. PI
    email now homonq@ufl.edu. Phone is 352-273-7675"	['Study_Staff_Moved']	['Neutral']
Lack of Enrollment	['Insufficient_Enrollment']	['Neutral']
Unable to accrue subjects	['Insufficient_Enrollment']	['Neutral']
COVID-19	['Covid19']	['Neutral']
Temporary suspension since March 20th 2020 due to COVID-19 pandemic	['Covid19']	['Neutral']
Tenofovir has become available in Korea.	['Covid19', 'Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral', 'Neutral']
safety issue observed on another hepatocellular study using OSI906	['Negative', 'Another_Study']	['Negative', 'Neutral']
Slow enrollment	['Insufficient_Enrollment']	['Neutral']
The study is being terminated for lack of efficacy	['Negative']	['Negative']
Trial had no patients accrued while open	['Insufficient_Enrollment']	['Neutral']
PI left our institution	['Study_Staff_Moved']	['Neutral']
Unable to complete the data collection for this study.	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Interim analysis determined the study did not meet criteria to proceed	['Negative']	['Negative']
Wrong entry	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
PI left JHU	['Study_Staff_Moved']	['Neutral']
This study was terminated prematurely due to 2 cases of agranulocytosis.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Slow inclusion rate, failure to recruit a priori determined no of patients.	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
sufficient data collected.	['Invalid_Reason']	['Invalid_Reason']
Business decision - not related to product quality or safety concerns	['Business_Administrative']	['Possibly_Negative']
Interim analysis performed on the first 10 patients showed no efficacy of cabazitaxel	['Negative']	['Negative']
"Temporarily paused due to COVID-19 and expected to resume. This is not a suspension of IRB
    approval."	['Covid19']	['Neutral']
due to the big difficulty to enrol suitable patients	['Insufficient_Enrollment']	['Neutral']
low accrual	['Insufficient_Enrollment']	['Neutral']
Business decision by funding source	['Business_Administrative']	['Possibly_Negative']
Mild infusion reactions were observed in two healthy volunteers.	['Safety_Sideeffects', 'Insufficient_Enrollment', 'Negative']	['Safety_Sideeffects', 'Neutral', 'Negative']
"NCT02921594 was not a RCT but a secondary pilot study designed to establish a fluoroscopic
    test-set up on 10 selected patients from another RCT."	['Negative', 'Another_Study']	['Negative', 'Neutral']
No patient	['Insufficient_Enrollment']	['Neutral']
PI is no longer with the institution	['Study_Staff_Moved']	['Neutral']
The molecule (GDC-276) is no longer in development.	['Logistics_Resources', 'Study_Design', 'Negative']	['Neutral', 'Neutral', 'Negative']
Interim analysis results did not meet criteria for second stage of trial	['Negative']	['Negative']
Drug delivery was below target dose due to partial obstruction by aggregated particles.	['Logistics_Resources']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
study closed prematurely upon PI's departure from VICC	['Study_Staff_Moved']	['Neutral']
Administrative reasons	['Business_Administrative']	['Possibly_Negative']
Study closed due to recruitment challenges.	['Insufficient_Enrollment']	['Neutral']
Terminated for lack of funding.	['Business_Administrative']	['Possibly_Negative']
"Treatment practice unexpectedly changed during the course of the study. Majority of follow-up
    MRI performed in external institutions. Consequently, the planned number of participants could
    not be reached."	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
No more eligible patients could be identified.	['Insufficient_Enrollment']	['Neutral']
Due to a very slow inclusion rate.	['Insufficient_Enrollment']	['Neutral']
Recruitment difficulties	['Insufficient_Enrollment']	['Neutral']
Terminated due to poor enrollment.	['Insufficient_Enrollment']	['Neutral']
Withdrawal of financial support from funder	['Business_Administrative']	['Possibly_Negative']
PI could not get support for project. PI left UAMS	['Logistics_Resources', 'Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Advised by DSMB based on interim-analysis, highly significant difference.	['Interim_Analysis', 'Safety_Sideeffects', 'Logistics_Resources']	['Neutral', 'Safety_Sideeffects', 'Neutral']
Business decision. Study never started	['Business_Administrative']	['Possibly_Negative']
Less patients than expected for inclusion, therefore recruitment is too low	['Insufficient_Enrollment']	['Neutral']
Lack of approval and funding from company	['Business_Administrative']	['Possibly_Negative']
"Subject registration did not proceed as expected; difficult to complete within scheduled time
    frame; prematurely terminated w/ 21 subjects randomized."	['Insufficient_Enrollment']	['Neutral']
Difficulties in recruiting patients	['Insufficient_Enrollment']	['Neutral']
Endpoint no longer deemed meaningful	['Study_Design']	['Neutral']
Interim analysis showed benefice of one therapy over the other one.	['Negative']	['Negative']
Slow inclusion	['Insufficient_Enrollment']	['Neutral']
Not funded	['Business_Administrative']	['Possibly_Negative']
Could not obtain dedicated ultrasound device.	['Logistics_Resources']	['Neutral']
Preserve clinical supplies	['Logistics_Resources']	['Neutral']
difficulties recruiting participants	['Insufficient_Enrollment']	['Neutral']
Problem to find eligible patients to include	['Insufficient_Enrollment']	['Neutral']
Unable to complete study	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Terminated due to slow accrual	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Research team no longer available.	['Logistics_Resources', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Neutral', 'Neutral', 'Neutral']
Unable to identify sufficient number of patients to enroll	['Insufficient_Enrollment']	['Neutral']
We planed to study later	['Invalid_Reason']	['Invalid_Reason']
"Recruitment will be too difficult due to available PBS funded treatment and recent Australian
    clinical guidelines will conflict with the premise of the study."	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Early termination of the study due to slow recruitment.	['Insufficient_Enrollment']	['Neutral']
low participation	['Insufficient_Enrollment']	['Neutral']
Hospital has a new protocol holding off feeding 2 hours for LT4 administration.	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Eligible candidate for recruitment was not found	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
lack of resources	['Logistics_Resources']	['Neutral']
inabililty to recruit at required rate	['Insufficient_Enrollment']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
difficulties in Recruiting patients	['Insufficient_Enrollment']	['Neutral']
Feasibility reasons; recruitment was too slow.	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Supply of Lepirudin ended on 01. April 2012, thus trial terminated on 31. March 2012	['Logistics_Resources']	['Neutral']
Funding ended prior to study completion	['Business_Administrative']	['Possibly_Negative']
Administrative	['Business_Administrative']	['Possibly_Negative']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Could not enroll patients	['Insufficient_Enrollment']	['Neutral']
"The NEVO stent will not be commercialized. Cordis decided to close the study after 3 years.
    This decision took the absence of safety signals into account."	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
inadequately recruitment rate, funding is not secured	['Business_Administrative']	['Possibly_Negative']
Data collection issues from the electronic health record.	['Logistics_Resources']	['Neutral']
Not funded	['Business_Administrative']	['Possibly_Negative']
2 patients enrolled lost of follow-up after completing 1st year visits.PI decided to close	['No_Context', 'Study_Staff_Moved', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
Clinical trial terminated due to results from recent nonclinical studies	['Negative', 'Another_Study']	['Negative', 'Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Poor Accrual	['Insufficient_Enrollment']	['Neutral']
"FDA's draft guidance (revised March 2015) provided two options for determining bioequivalence:
    1) in-vitro or 2) in-vivo studies"	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Poor subject compliance and inadequate recruitment	['Insufficient_Enrollment', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Study never published; terminated early due to low accrual.	['Insufficient_Enrollment']	['Neutral']
Recruitment on hold	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
Unable to accrue patients to the study.	['Insufficient_Enrollment']	['Neutral']
This trial was never initiated due to inability to obtain the device	['Logistics_Resources']	['Neutral']
Due to financial constraints, sponsor could not complete the study.	['Business_Administrative']	['Possibly_Negative']
PI withdrew protocol	['Study_Staff_Moved', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Insufficient faculty and staff.	['Logistics_Resources', 'Insufficient_Enrollment', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
"Study suspended due to blood supply challenges. Subsequently approved by FDA to reopen but will
    not do so because of changing clinical need."	['Logistics_Resources', 'Study_Design']	['Neutral', 'Neutral']
Study stopped prior to subject administered first dose, due to COVID-19	['Covid19']	['Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
never initiated	['Invalid_Reason']	['Invalid_Reason']
Lack of funding for the study at the Emory site	['Business_Administrative']	['Possibly_Negative']
New data available in public domain requires re-evaluation of protocol.	['Covid19', 'Success', 'No_Context']	['Neutral', 'Success', 'Invalid_Reason']
The final decision of the review of HES-containing solution shall be awaited.	['Interim_Analysis', 'No_Context', 'Logistics_Resources']	['Neutral', 'Invalid_Reason', 'Neutral']
Paitents were unwilling to be randomly assigned to a placebo group.	['Insufficient_Enrollment']	['Neutral']
This study was withdrawn to be replaced with a multi-site Phase I trial.	['Negative', 'Another_Study']	['Negative', 'Neutral']
study team failed to complete timely reviews, study suspended	['Interim_Analysis', 'Logistics_Resources', 'Regulatory']	['Neutral', 'Neutral', 'Neutral']
Study medication expired	['Logistics_Resources']	['Neutral']
Recruitment issue	['Insufficient_Enrollment']	['Neutral']
Sponsor decision	['Business_Administrative']	['Possibly_Negative']
Strategic considerations	['Business_Administrative']	['Possibly_Negative']
Lack of efficacy	['Negative']	['Negative']
Sponsor Decision	['Business_Administrative']	['Possibly_Negative']
terminated due to inability to recruit subjects	['Insufficient_Enrollment']	['Neutral']
The study was stopped due to poor enrollment.	['Insufficient_Enrollment']	['Neutral']
recruitment issues; changed protocol to prospective cohort study	['Insufficient_Enrollment', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
The study was registered but never started.	['Invalid_Reason']	['Invalid_Reason']
Could not obtain drug supply from manufacturer	['Logistics_Resources']	['Neutral']
Terminated due to software issues.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
temporarily suspended due to COVID-19	['Covid19']	['Neutral']
See termination reason in detailed description.	['No_Context']	['Invalid_Reason']
Study is currently Lapsed	['Invalid_Reason']	['Invalid_Reason']
Principal Investigator retired	['Study_Staff_Moved']	['Neutral']
Inadequate accrual	['Insufficient_Enrollment']	['Neutral']
Study was not started and participants were not enrolled	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
PI no longer at institution	['Study_Staff_Moved']	['Neutral']
We were unable to receive IVIG free from phamaceutical company.	['Business_Administrative']	['Possibly_Negative']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
"-  Insufficient rates of participant accrual

      -  Effects in opposite direction of hypothesis

      -  Study was not feasible"	['Insufficient_Enrollment']	['Neutral']
Institution not able to carry out research as of 2015	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Not able provide staff for recruting at present	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Withdrawn from IRB at PI's request	['Study_Staff_Moved']	['Neutral']
no eligible participant , technical difficulty, feasiblity	['Insufficient_Enrollment']	['Neutral']
COVID-19	['Covid19']	['Neutral']
Product development halted for business reasons.	['Business_Administrative']	['Possibly_Negative']
slow a accrul due to many competitive trials.	['Insufficient_Enrollment']	['Neutral']
Study stopped due to lack of enrollment	['Insufficient_Enrollment']	['Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
Inability to recruit subjects	['Insufficient_Enrollment']	['Neutral']
Slow enrollment.	['Insufficient_Enrollment']	['Neutral']
not enough inclusion	['Insufficient_Enrollment']	['Neutral']
No patient was recruited, study withdrawn for feasibility reasons.	['Logistics_Resources']	['Neutral']
"Haiti gained access to dolutegravir as first-line ART, so we cancelled the study before any
    patient was enrolled (we didn't want SOC group to receive EFV)"	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Study funding ended	['Business_Administrative']	['Possibly_Negative']
Because of inadequate accrual.	['Insufficient_Enrollment']	['Neutral']
Due to no enrollment, Celgene (sponsor) withdrew funding	['Business_Administrative']	['Possibly_Negative']
Due to budget limitations, the company decided to withdraw this study.	['Business_Administrative']	['Possibly_Negative']
Due to COVID-19	['Covid19']	['Neutral']
Feasibility of target enrollment within the context of available funding resources.	['Business_Administrative']	['Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
Ulipristal was withdrawal from the market	['Safety_Sideeffects', 'Logistics_Resources', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Changed study design prior to any patients enrolled.	['Study_Design']	['Neutral']
Change in procedure nd medication used instead of gum	['Study_Design']	['Neutral']
"Study terminated by Sponsor as a result of a business decision to discontinue the development
    program for MK-8342B for reasons unrelated to safety or efficacy."	['Business_Administrative']	['Possibly_Negative']
Facet no longer has ownership of ularitide.	['Business_Administrative']	['Possibly_Negative']
Recruitment challenges	['Insufficient_Enrollment']	['Neutral']
NIMH terminated study	['Interim_Analysis', 'Regulatory', 'Ethical_Reason']	['Neutral', 'Neutral', 'Neutral']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Accrual slow due to alternate trials and treatment options.	['Insufficient_Enrollment', 'Study_Design', 'Another_Study']	['Neutral', 'Neutral', 'Neutral']
Study stopped at 3 years. Funding for trial withdrawn by sponsor.	['Business_Administrative']	['Possibly_Negative']
lack of investigators	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
slow accrual	['Insufficient_Enrollment']	['Neutral']
Personnel changes at study site.	['Logistics_Resources', 'Study_Staff_Moved', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
"Strategic decision not to proceed with the opening of this study. There are no concerns over
    the safety or quality of the investigational products involved."	['Business_Administrative']	['Possibly_Negative']
Lack of funding	['Business_Administrative']	['Possibly_Negative']
Funding unavailable	['Business_Administrative']	['Possibly_Negative']
lack of enrollment. terminated in 2014. no data analysis.	['Insufficient_Enrollment']	['Neutral']
Other - not a safety issue	['Safety_Sideeffects', 'Endpoint_Met', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral', 'Neutral']
Unable to meet subject enrollment goal.	['Insufficient_Enrollment']	['Neutral']
Results did not show reason to continue with study	['Negative']	['Negative']
Unable to meet enrollment number to complete study, study stopped June 30, 2007	['Insufficient_Enrollment']	['Neutral']
"Patients meeting the inclusion/ exclusion criteria did not agree to participate. It became
    obvious that recruitment goals could not be met."	['Insufficient_Enrollment']	['Neutral']
No enrollment	['Insufficient_Enrollment']	['Neutral']
No subjects were enrolled.	['Insufficient_Enrollment']	['Neutral']
"The Neurologic AIDS Research Consortium Data Safety and Monitoring Board committee recommended
    to terminate the study early due to futility on 11/6/2009."	['Negative']	['Negative']
Recruitment logistics	['Logistics_Resources']	['Neutral']
Poor accrual	['Insufficient_Enrollment']	['Neutral']
"The investigational drug is unlikely to demonstrate efficacy over placebo for this indication.
    However, no safety issues were discovered."	['Negative']	['Negative']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Local Drug Authority didn't give permission to start.	['Logistics_Resources', 'Study_Design', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
no measurable response was detected at the 50% increase threshold.	['Negative']	['Negative']
Business decision	['Business_Administrative']	['Possibly_Negative']
Review of recruitment methods	['Covid19', 'Interim_Analysis', 'No_Context']	['Neutral', 'Neutral', 'Invalid_Reason']
Loss of recruitment	['Insufficient_Enrollment']	['Neutral']
The sponsor decided to stop the study.	['Business_Administrative']	['Possibly_Negative']
Study stopped early due to slow accrual and safety concerns.	['Insufficient_Enrollment']	['Neutral']
Not enough patients met study criteria for enrollment.	['Insufficient_Enrollment']	['Neutral']
PI Decision	['Invalid_Reason']	['Invalid_Reason']
Withdrawn due to low feasibility.	['Logistics_Resources']	['Neutral']
Insufficient Recruitment	['Insufficient_Enrollment']	['Neutral']
Inclusion of patients was stopped because 2 patients had clinical benefit.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Pilot study not necessary as new data has become available.	['Success', 'Insufficient_Data', 'Study_Design']	['Success', 'Neutral', 'Neutral']
Terminated by sponsor.	['Business_Administrative']	['Possibly_Negative']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
No study population. No subjects enrolled.	['Insufficient_Enrollment']	['Neutral']
Slow accrual and no cost extension not approved by NHLBI	['Insufficient_Enrollment']	['Neutral']
"The patient recruiting was stopped after 17 inclusions because of a reorganization of Intensive
    Care Units at the recruiting center."	['No_Context', 'Logistics_Resources', 'Study_Staff_Moved']	['Invalid_Reason', 'Neutral', 'Neutral']
Study was discontinued because of high drop out rate.	['Insufficient_Enrollment']	['Neutral']
Slow Accrual	['Insufficient_Enrollment']	['Neutral']
"This study was closed due to extremely low accrual, as well as a change in care when using the
    study drug."	['Insufficient_Enrollment']	['Neutral']
A future study will be taking place using the same patient population.	['Negative', 'Another_Study']	['Negative', 'Neutral']
"Early termination when the drug was no longer made available by the pharmaceutical company due
    to unanticipated management and administrative decisions."	['Business_Administrative']	['Possibly_Negative']
Insufficient enrollment	['Insufficient_Enrollment']	['Neutral']
the doctor performing the study suddenly changed work and moved	['Study_Staff_Moved']	['Neutral']
Difficulties in recruiting	['Insufficient_Enrollment']	['Neutral']
Slow recruitment.	['Insufficient_Enrollment']	['Neutral']
Pupil measurement methodology determined not appropriate in this population.	['Study_Design', 'Negative', 'Business_Administrative']	['Neutral', 'Negative', 'Possibly_Negative']
Accrual timelines	['Insufficient_Enrollment']	['Neutral']
no inclusion	['Insufficient_Enrollment']	['Neutral']
Unable to recruit necessary number of patients	['Insufficient_Enrollment']	['Neutral']
Resource Constraints	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Low enrollment	['Insufficient_Enrollment']	['Neutral']
Sponsors withdrew funding; preliminary efficacy data was not encouraging.	['Negative', 'Business_Administrative']	['Negative', 'Possibly_Negative']
Insufficient Accrual	['Insufficient_Enrollment']	['Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
"The Sponsor terminated the study due to recruitment infeasibility without having enrolled any
    patient."	['Insufficient_Enrollment']	['Neutral']
This is withdrawn because we started working on studies that are funded.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Major changes to study that were better suited to creating a whole new study	['Study_Design', 'Another_Study']	['Neutral', 'Neutral']
Funding issues.	['Business_Administrative']	['Possibly_Negative']
difficulty with enrollment	['Insufficient_Enrollment']	['Neutral']
No funding.	['Business_Administrative']	['Possibly_Negative']
"Analysis of the first 10 patients did not show anyt trend toward differences in PK profiles
    between imatinib vs no imatinib groups."	['Negative']	['Negative']
Treatment differences not detected with 7 point fingerstick monitoring	['Negative']	['Negative']
low enrollment rate	['Insufficient_Enrollment']	['Neutral']
"Changes affecting Post Authorization Study Regulatory effective from Dec09, impacted the
    requirements for Spanish studies at National and Regional level."	['No_Context', 'Regulatory', 'Insufficient_Enrollment']	['Invalid_Reason', 'Neutral', 'Neutral']
Funding issues	['Business_Administrative']	['Possibly_Negative']
The low accrual rate of the study (25% of the expected accrual rate)	['Insufficient_Enrollment']	['Neutral']
Terminated by institutional review board	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
terminated due to poor enrollment	['Insufficient_Enrollment']	['Neutral']
Administrative/Sponsor Business Decision - terminated - study was not completed	['Business_Administrative']	['Possibly_Negative']
The study never began.	['Invalid_Reason']	['Invalid_Reason']
This study has been terminated due to poor accrual	['Insufficient_Enrollment']	['Neutral']
Recruiting too slow, down to 1-0 patients per month	['Insufficient_Enrollment']	['Neutral']
COVID 19 pandemic	['Covid19']	['Neutral']
"The use of steroids to treat COVID prevents the use of VSTs for these patients. The Principal
    Investigator does not feel the study had an expectation of enrolling patients as the treatment
    options for COVID have evolved."	['Covid19']	['Neutral']
not enough patients meeting inclusion criteria	['Insufficient_Enrollment']	['Neutral']
Bayer terminated the program and sold the IP to Medronic	['Business_Administrative']	['Possibly_Negative']
The study has been stopped due to safety and futility concerns.	['Negative']	['Negative']
low study accrual	['Insufficient_Enrollment']	['Neutral']
Patient population did not benefit from single agent treatment.	['Study_Design', 'Negative', 'Another_Study']	['Neutral', 'Negative', 'Neutral']
Low patient recruitment	['Insufficient_Enrollment']	['Neutral']
Clinical Trial Material	['Logistics_Resources']	['Neutral']
No finding at halfway point of the study	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
No funding source available which was required for IRB approval	['Business_Administrative']	['Possibly_Negative']
Failure to recruit	['Insufficient_Enrollment']	['Neutral']
Recruitment not progressing as planned.	['Insufficient_Enrollment']	['Neutral']
Appropriate devices for fetal heart rate monitoring were not available.	['Logistics_Resources']	['Neutral']
Enrollment issues	['Insufficient_Enrollment']	['Neutral']
Study did not accrue the required number of study subjects.	['Insufficient_Enrollment']	['Neutral']
Due to COVID pandemic	['Covid19']	['Neutral']
toxicity of combination of medications	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Insufficient subject availability/findings for data analysis	['Insufficient_Enrollment']	['Neutral']
"The recruitment of participants was very difficult despite a change in the organisation. The
    inclusion criteria did not result in the expected number of participants, and the credits ran
    out."	['Insufficient_Enrollment']	['Neutral']
New device for dural plaque irradiation was approved by FDA.	['Study_Design']	['Neutral']
The feasability of inclusions has proven very low.	['Insufficient_Enrollment']	['Neutral']
The data did not support study endpoints	['Negative']	['Negative']
Low accrual	['Insufficient_Enrollment']	['Neutral']
Participants were not recruited promptly	['Insufficient_Enrollment']	['Neutral']
Subject enrollment is unsatisfactory	['Insufficient_Enrollment']	['Neutral']
No funding received	['Business_Administrative']	['Possibly_Negative']
Hepatic safety signal identified.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
Supply of adequate label was not provided to the MHRA	['Logistics_Resources']	['Neutral']
lack of patients	['Insufficient_Enrollment']	['Neutral']
Interim analysis indicated low probability of clinically significant result	['Negative']	['Negative']
Inability to enroll	['Insufficient_Enrollment']	['Neutral']
In light of new evidence, the decision was made by the sponsor to not proceed.	['Negative', 'Another_Study', 'Business_Administrative']	['Negative', 'Neutral', 'Possibly_Negative']
Primary investigator left institution	['Study_Staff_Moved']	['Neutral']
No participants enrolled	['Insufficient_Enrollment']	['Neutral']
very slow recruitment rate and a lot of pat. didn't fulfil BCR-ABL requirements	['Insufficient_Enrollment']	['Neutral']
Slow recruitment	['Insufficient_Enrollment']	['Neutral']
reprioritization of indications	['Regulatory', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Administratively complete.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
COVID-19	['Covid19']	['Neutral']
Due to difficulty in recruitment and resource restraints	['Logistics_Resources', 'Insufficient_Enrollment']	['Neutral', 'Neutral']
This study was terminated to prevent duplicative research efforts.	['Study_Design', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Suitable subjects could not be recruited within the estimated time frame.	['Insufficient_Enrollment']	['Neutral']
Per investigator's request.	['Invalid_Reason', 'Business_Administrative']	['Invalid_Reason', 'Possibly_Negative']
Lack of appropriate funds	['Business_Administrative']	['Possibly_Negative']
low accrual	['Insufficient_Enrollment']	['Neutral']
Administrative	['Business_Administrative']	['Possibly_Negative']
Insufficient funds	['Business_Administrative']	['Possibly_Negative']
lack of accrual	['Insufficient_Enrollment']	['Neutral']
Investigator no longer at LU.	['Study_Staff_Moved']	['Neutral']
The main reason that motivated the study termination was the slow recruitment of the trial.	['Insufficient_Enrollment']	['Neutral']
FDA did not approve	['Regulatory', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Investigator decided not to pursue the study due to other competing studies.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Insufficient Accrual	['Insufficient_Enrollment']	['Neutral']
Funding ended	['Business_Administrative']	['Possibly_Negative']
Corporate Decision	['Business_Administrative']	['Possibly_Negative']
We have decided to design a comparative study which is ongoing	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
unable to enroll any participants	['Insufficient_Enrollment']	['Neutral']
slow enrollment	['Insufficient_Enrollment']	['Neutral']
Business decision to stop the program	['Business_Administrative']	['Possibly_Negative']
Bankruptcy of Drug manufacturer: Drug not available	['Business_Administrative']	['Possibly_Negative']
Transfer of IND to different marketing authorization representative.	['Business_Administrative']	['Possibly_Negative']
"Study terminated due to enrolment challenges and availability of other options for DLBCL
    patients. The termination is not a consequence of any safety concern."	['Logistics_Resources', 'Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Difficulty recruiting	['Insufficient_Enrollment']	['Neutral']
Lack of enrollment	['Insufficient_Enrollment']	['Neutral']
slow accrual of participants	['Insufficient_Enrollment']	['Neutral']
Enrollment	['Insufficient_Enrollment']	['Neutral']
Research never begun and no subjects enrolled. Protocol term with IRB in Dec 2014	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Changes to the study design and the cell line	['Study_Design']	['Neutral']
"The P.I. decided to cancel this study. On 10/08/19, a study closure request was submitted to
    the IRB."	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Drug supply issues	['Logistics_Resources']	['Neutral']
Change of workplace for leading investigator, not replaced	['Study_Staff_Moved']	['Neutral']
Technical difficulties with the wet bench side of proposed studies.	['Logistics_Resources']	['Neutral']
PI unexpectedly passed away, study closed.	['Study_Staff_Moved']	['Neutral']
"Because the investigator's workplace and department have been changed, this study cannot be
    carried out."	['Study_Staff_Moved', 'Invalid_Reason', 'Study_Design']	['Neutral', 'Invalid_Reason', 'Neutral']
Due to extremely difficult enrollment.	['Insufficient_Enrollment']	['Neutral']
A sister study using Frova at a 10 mg dose had adverse effects.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Not a clinical trial; human specimens from treatment site for basic research.	['Logistics_Resources']	['Neutral']
Sponsor decision to terminate study	['Business_Administrative']	['Possibly_Negative']
No accrual last 2 years	['Insufficient_Enrollment']	['Neutral']
not commenced	['Invalid_Reason']	['Invalid_Reason']
The study was stopped due to efficacy reasons.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Interim analysis	['Interim_Analysis', 'No_Context', 'Endpoint_Met']	['Neutral', 'Invalid_Reason', 'Neutral']
Stopped due to futility.	['Negative']	['Negative']
The investigator no longer desires to persue the trial. No enrollments were made.	['Insufficient_Enrollment', 'Invalid_Reason', 'Business_Administrative']	['Neutral', 'Invalid_Reason', 'Possibly_Negative']
never funded and never started	['Business_Administrative']	['Possibly_Negative']
Terminated due to low enrollment	['Insufficient_Enrollment']	['Neutral']
To be submitted for grant application	['Business_Administrative']	['Possibly_Negative']
GSK2248761 development program is on clinical hold.	['Business_Administrative']	['Possibly_Negative']
Due to the product being discontinued	['Invalid_Reason', 'Study_Design', 'Business_Administrative']	['Invalid_Reason', 'Neutral', 'Possibly_Negative']
Recall of rescue medication, alternative rescue medication availability issues.	['Logistics_Resources']	['Neutral']
Lack of patient interest in the study.	['Insufficient_Enrollment']	['Neutral']
Lack of efficacy	['Negative']	['Negative']
Slow enrolment	['Insufficient_Enrollment']	['Neutral']
"The study was terminated prior to completion to focus on the development of a controlled
    release formulation."	['Study_Design']	['Neutral']
End of funding of study	['Business_Administrative']	['Possibly_Negative']
NO RECRUITMENT	['Insufficient_Enrollment']	['Neutral']
Permanently Closed Due to Lack of Accrual	['Insufficient_Enrollment']	['Neutral']
The sponsor decided not to conduct the expansion part of trial (part 2)	['Study_Design', 'Another_Study', 'Business_Administrative']	['Neutral', 'Neutral', 'Possibly_Negative']
Due to safety reasons. The region was considered too dangerous.	['Safety_Sideeffects', 'Insufficient_Enrollment']	['Safety_Sideeffects', 'Neutral']
"The notified body does not require data anymore and recruitment did not start. The study was
    thus terminated after approval from the investigator and the local ethical committee."	['Regulatory', 'Ethical_Reason', 'Invalid_Reason']	['Neutral', 'Neutral', 'Invalid_Reason']
Slow accrual	['Insufficient_Enrollment']	['Neutral']
Slow accrual.	['Insufficient_Enrollment']	['Neutral']
Decided to conduct study in adults first	['Invalid_Reason', 'Study_Design', 'Another_Study']	['Invalid_Reason', 'Neutral', 'Neutral']
The study was terminated early by the Sponsor for business reasons.	['Business_Administrative']	['Possibly_Negative']
"The study was terminated on December 19th, 2013 due to a business decision by the Sponsor. No
    safety concerns have been observed in this study."	['Business_Administrative']	['Possibly_Negative']
"PI Left institution on 8/6/2018 and study has been final reported with IRB. Never opened to
    accrual"	['Study_Staff_Moved']	['Neutral']
Business Decision	['Business_Administrative']	['Possibly_Negative']
"Due to COVID-19 and the fact that the study participants are part of the ""high-risk""
    population, the start of the recruiting process has been delayed at will."	['Covid19']	['Neutral']
The overall profile does not support development for obesity	['Negative']	['Negative']
This study has been terminated because of insufficient patient recruitment.	['Insufficient_Enrollment']	['Neutral']
A similar article was already published by another investigator.	['Negative', 'Another_Study']	['Negative', 'Neutral']
Non applicable clinical trial	['Insufficient_Enrollment', 'Invalid_Reason']	['Neutral', 'Invalid_Reason']
The patient registration was not successful.	['Insufficient_Enrollment']	['Neutral']
Difficulty in recruiting research subjects	['Insufficient_Enrollment']	['Neutral']
"Enrollment in the study was prematurely terminated due to recruitment challenges and not due to
    concerns of safety for the participants."	['Insufficient_Enrollment']	['Neutral']
Enrollment was stopped based on the Data Monitoring Committee's recommendation.	['Negative']	['Negative']
Funding cut due to government sequestration	['Business_Administrative']	['Possibly_Negative']
Due to unexpected operational issues outside of Lilly's control the study has been closed	['Logistics_Resources', 'Business_Administrative']	['Neutral', 'Possibly_Negative']
Due to low accrual	['Insufficient_Enrollment']	['Neutral']
inadequate number of enrolled study subjects	['Insufficient_Enrollment']	['Neutral']
Could not recruit patients	['Insufficient_Enrollment']	['Neutral']
Lost funding	['Business_Administrative']	['Possibly_Negative']
Budget/Funding	['Business_Administrative']	['Possibly_Negative']
poor accrual	['Insufficient_Enrollment']	['Neutral']
